PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Rao-Ruiz, P; Rotaru, DC; van der Loo, RJ; Mansvelder, HD; Stiedl, O; Smit, AB; Spijker, S				Rao-Ruiz, Priyanka; Rotaru, Diana C.; van der Loo, Rolinka J.; Mansvelder, Huibert D.; Stiedl, Oliver; Smit, August B.; Spijker, Sabine			Retrieval-specific endocytosis of GluA2-AMPARs underlies adaptive reconsolidation of contextual fear	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; LONG-TERM DEPRESSION; MEMORY RECONSOLIDATION; SYNAPTIC PLASTICITY; EXTINCTION; CONSOLIDATION; MECHANISMS; ERASURE; POTENTIATION; REACTIVATION	Upon retrieval, fear memories are rendered labile and prone to modification, necessitating a restabilization process of reconsolidation to persist further. This process is also crucial for modulating both strength and content of an existing memory and forms a promising therapeutic target for fear-related disorders. However, the molecular and cellular mechanism of adaptive reconsolidation still remains obscure. Here we show that retrieval of fear memory induces a biphasic temporal change in GluA2-containing AMPA-type glutamate receptor (AMPAR) membrane expression and synaptic strength in the mouse dorsal hippocampus. Blockade of retrieval-induced, regulated, GluA2-dependent endocytosis enhanced subsequent expression of fear. In addition, this blockade prevented the loss of fear response after reconsolidation-update of fear memory content in the long-term. Thus, endocytosis of GluA2-containing AMPARs allows plastic changes at the synaptic level that exerts an inhibitory constraint on memory strengthening and underlies the loss of fear response by reinterpretation of memory content during adaptive reconsolidation.	[Rao-Ruiz, Priyanka; Rotaru, Diana C.; van der Loo, Rolinka J.; Stiedl, Oliver; Smit, August B.; Spijker, Sabine] VU Univ Vrije Univ, Dept Mol & Cellular Neurobiol, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; [Rotaru, Diana C.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; [Stiedl, Oliver] Vrije Univ Amsterdam, Dept Funct Genom, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Spijker, S (corresponding author), VU Univ Vrije Univ, Dept Mol & Cellular Neurobiol, Ctr Neurogenom & Cognit Res, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	sabine.spijker@cncr.vu.nl	Spijker, Sabine/F-2300-2011; Stiedl, Oliver/AAB-5004-2021; Mansvelder, Huibert/N-6138-2018; Rotaru, Diana/AAZ-9058-2020	Stiedl, Oliver/0000-0002-4427-9221; Mansvelder, Huibert/0000-0003-1365-5340; Rotaru, Diana/0000-0002-0724-3596; Rao-Ruiz, Priyanka/0000-0001-9504-1427; Spijker, Sabine/0000-0002-6814-2019	Neuromics Marie Curie Early Stage Training grant [MEST-CT-2005-020919]	Neuromics Marie Curie Early Stage Training grant	The authors thank J. Peters, M. van den Oever, R. van Kesteren and S. A. Kushner for critical reading of previous versions of this manuscript, and K. W. Li for technical advice in relation to biotinylation experiments. P.R.-R. was supported by a Neuromics Marie Curie Early Stage Training grant (MEST-CT-2005-020919).	Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chan Wan Yee Macy, 2010, Learn Mem, V17, P512, DOI 10.1101/lm.1912510; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Counotte DS, 2011, NAT NEUROSCI, V14, P417, DOI 10.1038/nn.2770; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; Frankland PW, 2006, LEARN MEMORY, V13, P451, DOI 10.1101/lm.183406; Franklin K. B., 1997, MOUSE BRAIN STEREOTA; GORDON WC, 1973, PHYSIOL BEHAV, V10, P1071, DOI 10.1016/0031-9384(73)90190-X; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Lee JLC, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00168; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Mamiya N, 2009, J NEUROSCI, V29, P402, DOI 10.1523/JNEUROSCI.4639-08.2009; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Qiu SF, 2006, J NEUROSCI, V26, P12943, DOI 10.1523/JNEUROSCI.2561-06.2006; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; Robertson SD, 2010, J NEUROSCI, V30, P11305, DOI 10.1523/JNEUROSCI.0126-10.2010; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Tronson NC, 2006, NAT NEUROSCI, V9, P167, DOI 10.1038/nn1628; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; Wang SH, 2009, NAT NEUROSCI, V12, P905, DOI 10.1038/nn.2350	50	152	154	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1302	U117		10.1038/nn.2907	http://dx.doi.org/10.1038/nn.2907			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21909089				2022-12-17	WOS:000295254200019
J	Liu, LP; Belkadi, A; Darnall, L; Hu, TF; Drescher, C; Cotleur, AC; Padovani-Claudio, D; He, T; Choi, K; Lane, TE; Miller, RH; Ransohoff, RM				Liu, LiPing; Belkadi, Abdelmadjid; Darnall, Lindsey; Hu, Taofang; Drescher, Caitlin; Cotleur, Anne C.; Padovani-Claudio, Dolly; He, Tao; Choi, Karen; Lane, Thomas E.; Miller, Robert H.; Ransohoff, Richard M.			CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; BLOOD-BRAIN-BARRIER; INTERFERON-GAMMA; CHEMOKINE RECEPTORS; CNS DEMYELINATION; SPINAL-CORD; DISEASE; LESIONS; MICE	Multiple sclerosis is an inflammatory demyelinating disorder of the CNS. Recent studies have suggested diverse mechanisms as underlying demyelination, including a subset of lesions induced by an interaction between metabolic insult to oligodendrocytes and inflammatory mediators. For mice of susceptible strains, cuprizone feeding results in oligodendrocyte cell loss and demyelination of the corpus callosum. Remyelination ensues and has been extensively studied. Cuprizone-induced demyelination remains incompletely characterized. We found that mice lacking the type 2 CXC chemokine receptor (CXCR2) were relatively resistant to cuprizone-induced demyelination and that circulating CXCR2-positive neutrophils were important for cuprizone-induced demyelination. Our findings support a two-hit process of cuprizone-induced demyelination, supporting the idea that multiple sclerosis pathogenesis features extensive oligodendrocyte cell loss. These data suggest that cuprizone-induced demyelination is useful for modeling certain aspects of multiple sclerosis pathogenesis.	[Liu, LiPing; Darnall, Lindsey; Hu, Taofang; Drescher, Caitlin; Cotleur, Anne C.; He, Tao; Choi, Karen; Ransohoff, Richard M.] Cleveland Clin, Lerner Res Inst, Neuroinflammat Res Ctr, Dept Neurosci, Cleveland, OH 44106 USA; [Belkadi, Abdelmadjid; Padovani-Claudio, Dolly; Miller, Robert H.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Ctr Stem Cells, Cleveland, OH 44106 USA; [Belkadi, Abdelmadjid; Padovani-Claudio, Dolly; Miller, Robert H.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Ctr Regenerat Med, Cleveland, OH 44106 USA; [Lane, Thomas E.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; University of California System; University of California Irvine	Ransohoff, RM (corresponding author), Cleveland Clin, Lerner Res Inst, Neuroinflammat Res Ctr, Dept Neurosci, Cleveland, OH 44106 USA.	ransohr@ccf.org	liu, li/HGC-0900-2022		National Multiple Sclerosis Society [RG 3580]; US National Institutes of Health [NS32151, NS36674]; Myelin Repair Foundation; Nancy Davis Center Without Walls; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032151, R01NS036674, R37NS036674] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myelin Repair Foundation; Nancy Davis Center Without Walls; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. Stallcup for generously providing antibodies to PDGF receptor alpha and G. Kidd (Cleveland Clinic) for assistance with imaging. We thank G. Matsushima (University of North Carolina Chapel Hill) for helpful discussions regarding the cuprizone model. We thank X. Qu (Cleveland Clinic) for help with TUNEL staining. This research was supported by grants from the National Multiple Sclerosis Society (RG 3580 to R. M. R.), the US National Institutes of Health (NS32151 to R. M. R. and NS36674 to R. H. M.), the Myelin Repair Foundation (R. H. M.) and the Nancy Davis Center Without Walls (R. M. R.).	Aboul-Enein F, 2005, ACTA NEUROPATHOL, V109, P49, DOI 10.1007/s00401-004-0954-8; Armstrong RC, 2002, J NEUROSCI, V22, P8574; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Cammer W, 1999, J NEUROL SCI, V168, P116, DOI 10.1016/S0022-510X(99)00181-1; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Fuller ML, 2007, ANN NEUROL, V62, P288, DOI 10.1002/ana.21179; Gao X, 2000, MOL CELL NEUROSCI, V16, P338, DOI 10.1006/mcne.2000.0883; Glabinski AR, 1999, J NEUROVIROL, V5, P95, DOI 10.3109/13550289909029750; Iocca HA, 2008, J NEUROIMMUNOL, V194, P97, DOI 10.1016/j.jneuroim.2007.12.003; Jurevics H, 2002, J NEUROCHEM, V82, P126, DOI 10.1046/j.1471-4159.2002.00954.x; Kelchtermans H, 2008, TRENDS IMMUNOL, V29, P479, DOI 10.1016/j.it.2008.07.002; Kerstetter AE, 2009, EXP NEUROL, V220, P44, DOI 10.1016/j.expneurol.2009.07.010; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Lassmann H, 2007, REV NEUROL-FRANCE, V163, P651, DOI 10.1016/S0035-3787(07)90474-9; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Lin WS, 2006, BRAIN, V129, P1306, DOI 10.1093/brain/awl044; Linares D, 2006, J NEUROSCI, V26, P12672, DOI 10.1523/JNEUROSCI.0294-06.2006; Lindner M, 2009, GLIA, V57, P465, DOI 10.1002/glia.20833; Liu LP, 2006, J IMMUNOL, V176, P4399, DOI 10.4049/jimmunol.176.7.4399; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; LUDWIN SK, 1981, ANN NEUROL, V9, P301; Mahad DJ, 2004, J NEUROPATH EXP NEUR, V63, P262, DOI 10.1093/jnen/63.3.262; Mahad D, 2008, BRAIN, V131, P1722, DOI 10.1093/brain/awn105; Mason JL, 2000, J NEUROSCI, V20, P5703, DOI 10.1523/JNEUROSCI.20-15-05703.2000; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; McMahon EJ, 2002, J NEUROIMMUNOL, V130, P32, DOI 10.1016/S0165-5728(02)00205-9; McMahon EJ, 2001, J IMMUNOL, V167, P2964, DOI 10.4049/jimmunol.167.5.2964; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Pasquini LA, 2007, NEUROCHEM RES, V32, P279, DOI 10.1007/s11064-006-9165-0; Pernet V, 2008, J NEUROSCI, V28, P7435, DOI 10.1523/JNEUROSCI.0727-08.2008; Ransohoff RM, 2007, NAT NEUROSCI, V10, P1507, DOI 10.1038/nn1207-1507; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Remington LT, 2007, AM J PATHOL, V170, P1713, DOI 10.2353/ajpath.2007.060783; Savarin C, 2008, J VIROL, V82, P12432, DOI 10.1128/JVI.01267-08; Schreiber RC, 2001, NEUROREPORT, V12, P601, DOI 10.1097/00001756-200103050-00034; Shea-Donohue T, 2008, INNATE IMMUN-LONDON, V14, P117, DOI 10.1177/1753425908088724; Smith KJ, 2007, BRAIN PATHOL, V17, P230, DOI 10.1111/j.1750-3639.2007.00066.x; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Tran EH, 2000, J IMMUNOL, V164, P2759, DOI 10.4049/jimmunol.164.5.2759; Trapp BD, 2004, ANN NEUROL, V55, P455, DOI 10.1002/ana.20087; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; WAGNER T, 1977, EXP CELL RES, V107, P1, DOI 10.1016/0014-4827(77)90379-2; WAXMAN SG, 1979, J NEUROL SCI, V44, P45, DOI 10.1016/0022-510X(79)90221-1	48	152	156	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					319	U10		10.1038/nn.2491	http://dx.doi.org/10.1038/nn.2491			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20154684	Green Accepted			2022-12-17	WOS:000274860100013
J	Cueni, L; Canepari, M; Lujan, R; Emmenegger, Y; Watanabe, M; Bond, CT; Franken, P; Adelman, JP; Luthi, A				Cueni, Lucius; Canepari, Marco; Lujan, Rafael; Emmenegger, Yann; Watanabe, Masahiko; Bond, Chris T.; Franken, Paul; Adelman, John P.; Luthi, Anita			T-type Ca2+ channels, SK2 channels and SERCAs gate sleep-related oscillations in thalamic dendrites	NATURE NEUROSCIENCE			English	Article							CA2+-ACTIVATED K+ CHANNELS; SMALL-CONDUCTANCE; POTASSIUM CHANNELS; DIFFERENTIAL DISTRIBUTION; RETICULAR NUCLEUS; IN-VITRO; NEURONS; MODULATION; CURRENTS; DETERMINANTS	T-type Ca2+ channels (T channels) underlie rhythmic burst discharges during neuronal oscillations that are typical during sleep. However, the Ca2+-dependent effectors that are selectively regulated by T currents remain unknown. We found that, in dendrites of nucleus reticularis thalami (nRt), intracellular Ca2+ concentration increases were dominated by Ca2+ influx through T channels and shaped rhythmic bursting via competition between Ca2+-dependent small-conductance (SK)-type K1 channels and Ca2+ uptake pumps. Oscillatory bursting was initiated via selective activation of dendritically located SK2 channels, whereas Ca2+ sequestration by sarco/endoplasmic reticulum Ca2+-ATPases (SERCAs) and cumulative T channel inactivation dampened oscillations. Sk2(-/-) (also known as Kcnn2) mice lacked cellular oscillations, showed a greater than threefold reduction in low-frequency rhythms in the electroencephalogram of non-rapid-eye-movement sleep and had disrupted sleep. Thus, the interplay of T channels, SK2 channels and SERCAs in nRt dendrites comprises a specialized Ca2+ signaling triad to regulate oscillatory dynamics related to sleep.	[Cueni, Lucius; Canepari, Marco; Luthi, Anita] Univ Basel, Div Pharmacol & Neurobiol Biozentrum, CH-4056 Basel, Switzerland; [Lujan, Rafael] Univ Castilla La Mancha, Crib Fac Med, Dept Ciencias Med, Albacete 02006, Spain; [Emmenegger, Yann; Franken, Paul] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Bond, Chris T.; Adelman, John P.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Luthi, Anita] Univ Lausanne, Fac Biol & Med, Dept Cell Biol & Morphol, CH-1005 Lausanne, Switzerland	University of Basel; Universidad de Castilla-La Mancha; University of Lausanne; Hokkaido University; Oregon Health & Science University; University of Lausanne	Luthi, A (corresponding author), Univ Basel, Div Pharmacol & Neurobiol Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	anita.luthi@unil.ch	Luthi, Anita/ABE-1411-2021; Lujan, Rafael/G-2555-2015; Canepari, Marco/H-6772-2012; Watanabe, Masahiko/S-3614-2019; Franken, Paul/A-9633-2018; Canepari, Marco/AAJ-6709-2021; WATANABE, Masahiko/A-4055-2012	Canepari, Marco/0000-0001-9759-2388; Watanabe, Masahiko/0000-0001-5037-7138; Franken, Paul/0000-0002-2500-2921; Canepari, Marco/0000-0001-9759-2388; WATANABE, Masahiko/0000-0001-5037-7138; Lujan Miras, Rafael/0000-0003-2001-9545; Luthi, Anita/0000-0002-4954-4143				AMZICA F, 1992, NEUROSCIENCE, V51, P285, DOI 10.1016/0306-4522(92)90315-S; AVANZINI G, 1989, J PHYSIOL-LONDON, V416, P111, DOI 10.1113/jphysiol.1989.sp017752; BAL T, 1993, J PHYSIOL-LONDON, V468, P669, DOI 10.1113/jphysiol.1993.sp019794; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Blethyn KL, 2006, J NEUROSCI, V26, P2474, DOI 10.1523/JNEUROSCI.3607-05.2006; Bond CT, 2005, CURR OPIN NEUROBIOL, V15, P305, DOI 10.1016/j.conb.2005.05.001; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Canepari M, 2004, J NEUROSCI, V24, P3563, DOI 10.1523/JNEUROSCI.5374-03.2004; Contreras D, 2006, CNS NEUROL DISORD-DR, V5, P571, DOI 10.2174/187152706779025526; Crunelli V, 2006, CELL CALCIUM, V40, P175, DOI 10.1016/j.ceca.2006.04.022; Cui GH, 2004, J NEUROSCI, V24, P11079, DOI 10.1523/JNEUROSCI.2713-04.2004; Debarbieux F, 1998, J NEUROPHYSIOL, V79, P2911, DOI 10.1152/jn.1998.79.6.2911; Destexhe A, 1996, J NEUROSCI, V16, P169; Diana MA, 2007, J NEUROSCI, V27, P3823, DOI 10.1523/JNEUROSCI.4719-06.2007; DOMICH L, 1986, J PHYSIOL-LONDON, V379, P429, DOI 10.1113/jphysiol.1986.sp016262; Egger V, 2003, J NEUROSCI, V23, P7551; Fierro L, 1998, J PHYSIOL-LONDON, V510, P499, DOI 10.1111/j.1469-7793.1998.499bk.x; Franken P, 1999, SLEEP, V22, P155; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Frazier CJ, 2001, J GEN PHYSIOL, V118, P457, DOI 10.1085/jgp.118.5.457; Fuentealba P, 2005, PROG NEUROBIOL, V75, P125, DOI 10.1016/j.pneurobio.2005.01.002; Gottesmann C, 1996, NEUROSCI BIOBEHAV R, V20, P367, DOI 10.1016/0149-7634(95)00055-0; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; Ivanov AI, 2000, J NEUROSCI, V20, P4930; Joho RH, 2006, EUR J NEUROSCI, V23, P1567, DOI 10.1111/j.1460-9568.2006.04672.x; Joksovic PM, 2005, J PHYSIOL-LONDON, V566, P125, DOI 10.1113/jphysiol.2005.086579; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kramar EA, 2004, J NEUROSCI, V24, P5151, DOI 10.1523/JNEUROSCI.0800-04.2004; Kuisle M, 2006, J PHYSIOL-LONDON, V575, P83, DOI 10.1113/jphysiol.2006.110486; Liguori R, 2001, BRAIN, V124, P2417, DOI 10.1093/brain/124.12.2417; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Misquitta CM, 1999, CELL CALCIUM, V25, P277, DOI 10.1054/ceca.1999.0032; Munsch T, 1997, NEUROREPORT, V8, P2411, DOI 10.1097/00001756-199707280-00001; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; OGDEN D, 1995, PFLUG ARCH EUR J PHY, V429, P587, DOI 10.1007/BF00704165; Pape HC, 2004, PFLUG ARCH EUR J PHY, V448, P131, DOI 10.1007/s00424-003-1234-5; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Richter TA, 2005, J NEUROSCI, V25, P8267, DOI 10.1523/JNEUROSCI.1942-05.2005; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Talley EM, 1999, J NEUROSCI, V19, P1895; Uebachs M, 2006, J PHYSIOL-LONDON, V571, P519, DOI 10.1113/jphysiol.2005.103614; Vyazovskiy VV, 2002, BRAIN RES, V947, P204, DOI 10.1016/S0006-8993(02)02925-6	50	152	155	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					683	692		10.1038/nn.2124	http://dx.doi.org/10.1038/nn.2124			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18488023				2022-12-17	WOS:000256133700015
J	Engineer, CT; Perez, CA; Chen, YTH; Carraway, RS; Reed, AC; Shetake, JA; Jakkamsetti, V; Chang, KQ; Kilgard, MP				Engineer, Crystal T.; Perez, Claudia A.; Chen, YeTing H.; Carraway, Ryan S.; Reed, Amanda C.; Shetake, Jai A.; Jakkamsetti, Vikram; Chang, Kevin Q.; Kilgard, Michael P.			Cortical activity patterns predict speech discrimination ability	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; VOICED-VOICELESS DISTINCTION; FREQUENCY-MODULATED TONES; TIME PHONETIC PARAMETER; PRIMARY VISUAL-CORTEX; LANGUAGE DISCRIMINATION; TEMPORAL INFORMATION; SINGLE NEURONS; NEURAL-NETWORK; PERCEPTION	Neural activity in the cerebral cortex can explain many aspects of sensory perception. Extensive psychophysical and neurophysiological studies of visual motion and vibrotactile processing show that the firing rate of cortical neurons averaged across 50-500 ms is well correlated with discrimination ability. In this study, we tested the hypothesis that primary auditory cortex (A1) neurons use temporal precision on the order of 1-10 ms to represent speech sounds shifted into the rat hearing range. Neural discrimination was highly correlated with behavioral performance on 11 consonant-discrimination tasks when spike timing was preserved and was not correlated when spike timing was eliminated. This result suggests that spike timing contributes to the auditory cortex representation of consonant sounds.	[Engineer, Crystal T.; Perez, Claudia A.; Chen, YeTing H.; Carraway, Ryan S.; Reed, Amanda C.; Shetake, Jai A.; Jakkamsetti, Vikram; Chang, Kevin Q.; Kilgard, Michael P.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75080 USA	University of Texas System; University of Texas Dallas	Kilgard, MP (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, 800 W Campbell Rd, Richardson, TX 75080 USA.	novitski@utdallas.edu; kilgard@utdallas.edu	Jakkamsetti, Vikram/AAJ-8744-2020	Jakkamsetti, Vikram/0000-0001-6524-2893; Engineer, Crystal/0000-0002-2188-2335; Kilgard, Michael/0000-0002-6699-1818	NIDCD NIH HHS [R15 DC006624-01, R15 DC006624, R15 DC006624-01S1] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R15DC006624] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahissar E, 2001, P NATL ACAD SCI USA, V98, P13367, DOI 10.1073/pnas.201400998; BERTONCINI J, 1987, J ACOUST SOC AM, V82, P31, DOI 10.1121/1.395570; BLUMSTEIN SE, 1979, J ACOUST SOC AM, V66, P1001, DOI 10.1121/1.383319; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 1999, NEURAL COMPUT, V11, P103, DOI 10.1162/089976699300016836; Cooke JE, 2007, HEARING RES, V231, P90, DOI 10.1016/j.heares.2007.06.002; DeWeese MR, 2005, NEURON, V48, P479, DOI 10.1016/j.neuron.2005.10.016; DEWSON JH, 1969, EXP NEUROL, V24, P579, DOI 10.1016/0014-4886(69)90159-9; DOOLING RJ, 1989, PERCEPT PSYCHOPHYS, V46, P65, DOI 10.3758/BF03208075; Engineer ND, 2004, J NEUROPHYSIOL, V92, P73, DOI 10.1152/jn.00059.2004; Foffani G, 2004, J NEUROSCI METH, V135, P107, DOI 10.1016/j.jneumeth.2003.12.011; Fowler CA, 2003, J MEM LANG, V49, P396, DOI 10.1016/S0749-596X(03)00072-X; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; HEFFNER HE, 1989, BEHAV NEUROSCI, V103, P158, DOI 10.1037/0735-7044.103.1.158; JONGMAN A, 1989, J ACOUST SOC AM, V85, P1718, DOI 10.1121/1.397961; KAWAHARA H, 1997, P IEEE INT C AC SPEE, V2, P1303; KLUENDER KR, 1987, SCIENCE, V237, P1195, DOI 10.1126/science.3629235; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; Liu J, 2005, J NEUROSCI, V25, P711, DOI 10.1523/JNEUROSCI.4034-04.2005; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Narayan R, 2006, J NEUROPHYSIOL, V96, P252, DOI 10.1152/jn.01257.2005; Ohl FW, 1997, P NATL ACAD SCI USA, V94, P9440, DOI 10.1073/pnas.94.17.9440; Orduna I, 2005, BEHAV NEUROSCI, V119, P256, DOI 10.1037/0735-7044.119.1.256; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pruett JR, 2001, J NEUROPHYSIOL, V86, P2069, DOI 10.1152/jn.2001.86.4.2069; Qin L, 2004, BRAIN RES, V1024, P167, DOI 10.1016/j.brainres.2004.07.061; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; Reed P, 2003, J EXP ANAL BEHAV, V80, P205, DOI 10.1901/jeab.2003.80-205; Rennaker RL, 2005, J NEUROSCI METH, V142, P169, DOI 10.1016/j.jneumeth.2004.08.009; Rennaker RL, 2005, J NEUROSCI METH, V142, P97, DOI 10.1016/j.jneumeth.2004.07.018; RICHMOND BJ, 1990, J NEUROPHYSIOL, V64, P351, DOI 10.1152/jn.1990.64.2.351; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Rybalko N, 2006, EUR J NEUROSCI, V23, P1614, DOI 10.1111/j.1460-9568.2006.04688.x; Schnupp JWH, 2006, J NEUROSCI, V26, P4785, DOI 10.1523/JNEUROSCI.4330-05.2006; Sinnott JM, 1997, J ACOUST SOC AM, V102, P588, DOI 10.1121/1.419732; Steinschneider M, 1999, J NEUROPHYSIOL, V82, P2346, DOI 10.1152/jn.1999.82.5.2346; STEINSCHNEIDER M, 1995, BRAIN RES, V674, P147, DOI 10.1016/0006-8993(95)00008-E; Steinschneider M, 2005, CEREB CORTEX, V15, P170, DOI 10.1093/cercor/bhh120; Steinschneider M, 2003, J ACOUST SOC AM, V114, P307, DOI 10.1121/1.1582449; Tavabi K, 2007, EUR J NEUROSCI, V25, P3155, DOI 10.1111/j.1460-9568.2007.05572.x; Toro JM, 2005, J EXP PSYCHOL-ANIM B, V31, P95, DOI 10.1037/0097-7403.31.1.95; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Versnel H, 1998, J ACOUST SOC AM, V103, P2502, DOI 10.1121/1.422771; Walker KMM, 2008, J COGNITIVE NEUROSCI, V20, P135, DOI 10.1162/jocn.2008.20012; Wang L, 2007, J NEUROSCI, V27, P582, DOI 10.1523/JNEUROSCI.3699-06.2007; Weliky M, 2003, NEURON, V37, P703, DOI 10.1016/S0896-6273(03)00022-9; Wetzel W, 1998, NEUROSCI LETT, V252, P115, DOI 10.1016/S0304-3940(98)00561-8; Wong SW, 2003, SPEECH COMMUN, V41, P93, DOI 10.1016/S0167-6393(02)00096-1; Young ED, 2008, PHILOS T R SOC B, V363, P923, DOI 10.1098/rstb.2007.2151	50	152	153	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					603	608		10.1038/nn.2109	http://dx.doi.org/10.1038/nn.2109			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18425123	Green Accepted			2022-12-17	WOS:000255327300020
J	Gunhaga, L; Marklund, M; Sjodal, M; Hsieh, JC; Jessell, TM; Edlund, T				Gunhaga, L; Marklund, M; Sjodal, M; Hsieh, JC; Jessell, TM; Edlund, T			Specification of dorsal telencephalic character by sequential Wnt and FGF signaling	NATURE NEUROSCIENCE			English	Article							BONE MORPHOGENETIC PROTEINS; CENTRAL-NERVOUS-SYSTEM; SONIC HEDGEHOG; CHICK-EMBRYO; MAMMALIAN TELENCEPHALON; GENE-EXPRESSION; FLOOR PLATE; FATE MAP; FOREBRAIN; DIFFERENTIATION	Dorsoventral patterning of the telencephalon is established early in forebrain development and underlies many of the regional subdivisions that are critical to the later organization of neural circuits in the cerebral cortex and basal ganglia. Sonic hedgehog (Shh) is involved in the generation of the ventral-most telencephalic cells, but the identity of the extrinsic signal(s) that induce dorsal character in telencephalic cells is not known. Here we show in chick embryos that sequential Wnt and fibroblast growth factor (FGF) signaling specifies cells of dorsal telencephalic character.	Umea Ctr Mol Med, S-90187 Umea, Sweden; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Columbia University; Howard Hughes Medical Institute	Edlund, T (corresponding author), Umea Ctr Mol Med, Bldg 6M,4th Floor, S-90187 Umea, Sweden.	thomas.edlund@molbiol.umu.se						Bell E, 2001, DEV BIOL, V236, P76, DOI 10.1006/dbio.2001.0301; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.3.CO;2-X; Cobos I, 2001, DEV BIOL, V239, P46, DOI 10.1006/dbio.2001.0423; COULY G, 1988, DEVELOPMENT, V103, P101; Crossley PH, 2001, NEUROSCIENCE, V108, P183, DOI 10.1016/S0306-4522(01)00411-0; DICKINSON ME, 1994, DEVELOPMENT, V120, P1453; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Faure S, 2002, DEV BIOL, V244, P44, DOI 10.1006/dbio.2002.0579; Fernandez AS, 1998, DEVELOPMENT, V125, P2099; Ford-Perriss M, 2001, CLIN EXP PHARMACOL P, V28, P493, DOI 10.1046/j.1440-1681.2001.03477.x; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Golden JA, 1999, P NATL ACAD SCI USA, V96, P2439, DOI 10.1073/pnas.96.5.2439; Gunhaga L, 2000, DEVELOPMENT, V127, P3283; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hebert JM, 2002, NEURON, V35, P1029, DOI 10.1016/S0896-6273(02)00900-5; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Kohtz JD, 1998, DEVELOPMENT, V125, P5079; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee SMK, 2000, DEVELOPMENT, V127, P457; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Muroyama Y, 2002, GENE DEV, V16, P548, DOI 10.1101/gad.937102; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Puelles L, 1999, EUR J MORPHOL, V37, P139, DOI 10.1076/ejom.37.2.139.4756; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Shimamura K, 1997, DEVELOPMENT, V124, P2709; SMART IHM, 1979, NEOSTRIATUM, P127; Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100; TANABE Y, 1995, CURR BIOL, V5, P651, DOI 10.1016/S0960-9822(95)00130-8; Theil T, 2002, DEVELOPMENT, V129, P3045; Toresson H, 2000, MECH DEVELOP, V94, P183, DOI 10.1016/S0925-4773(00)00324-5; Watanabe Y, 1996, MECH DEVELOP, V57, P69, DOI 10.1016/0925-4773(96)00534-5; Wilson SI, 2001, NATURE, V411, P325, DOI 10.1038/35077115; Yun K, 2001, DEVELOPMENT, V128, P193	46	152	152	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					701	707		10.1038/nn1068	http://dx.doi.org/10.1038/nn1068			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12766771				2022-12-17	WOS:000183780400017
J	Dalton, P; Doolittle, N; Breslin, PAS				Dalton, P; Doolittle, N; Breslin, PAS			Gender-specific induction of enhanced sensitivity to odors	NATURE NEUROSCIENCE			English	Article							OLFACTORY SENSITIVITY; CYCLE		Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Dalton, P (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	pdalton@pobox.upenn.edu		Breslin, Paul/0000-0001-5988-8401				CAIN WS, 1982, CHEM SENSES, V7, P129, DOI 10.1093/chemse/7.2.129; Dalton P, 2000, NAT NEUROSCI, V3, P431, DOI 10.1038/74797; Dhong HJ, 1999, BRAIN RES, V824, P312, DOI 10.1016/S0006-8993(99)01241-X; Dorries K. M., 1992, SCI OLFACTION, P245; DOTY RL, 1981, J COMP PHYSIOL PSYCH, V95, P45, DOI 10.1037/h0077755; Fiedler Nancy, 1997, Environmental Health Perspectives, V105, P409, DOI 10.2307/3433347; GOWER DB, 1994, J STEROID BIOCHEM, V48, P409, DOI 10.1016/0960-0760(94)90082-5; PIETRAS RJ, 1974, PHYSIOL BEHAV, V12, P475, DOI 10.1016/0031-9384(74)90125-5; PORTER RH, 1983, PHYSIOL BEHAV, V30, P151, DOI 10.1016/0031-9384(83)90051-3; STEVENS JC, 1988, CHEM SENSES, V13, P643, DOI 10.1093/chemse/13.4.643; Voznessenskaya VV, 1995, ADV BIOSCI, V93, P399; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976	13	152	157	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					199	200		10.1038/nn803	http://dx.doi.org/10.1038/nn803			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11865309				2022-12-17	WOS:000174146000008
J	Venniro, M; Zhang, M; Caprioli, D; Hoots, JK; Golden, SA; Heins, C; Morales, M; Epstein, DH; Shaham, Y				Venniro, Marco; Zhang, Michelle; Caprioli, Daniele; Hoots, Jennifer K.; Golden, Sam A.; Heins, Conor; Morales, Marisela; Epstein, David H.; Shaham, Yavin			Volitional social interaction prevents drug addiction in rat models	NATURE NEUROSCIENCE			English	Article							CONTEXT-INDUCED RELAPSE; ENVIRONMENTAL ENRICHMENT; REINSTATEMENT MODEL; COCAINE SEEKING; INCUBATION; METHAMPHETAMINE; MECHANISMS; REINFORCEMENT; NEUROBIOLOGY; ABSTINENCE	Addiction treatment has not been appreciably improved by neuroscientific research. One problem is that mechanistic studies using rodent models do not incorporate volitional social factors, which play a critical role in human addiction. Here, using rats, we introduce an operant model of choice between drugs and social interaction. Independent of sex, drug class, drug dose, training conditions, abstinence duration, social housing, or addiction score in Diagnostic & Statistical Manual IV-based and intermittent access models, operant social reward prevented drug self-administration. This protection was lessened by delay or punishment of the social reward but neither measure was correlated with the addiction score. Social-choice-induced abstinence also prevented incubation of methamphetamine craving. This protective effect was associated with activation of central amygdala PKC delta-expressing inhibitory neurons and inhibition of anterior insular cortex activity. These findings highlight the need for incorporating social factors into neuroscience-based addiction research and support the wider implantation of socially based addiction treatments.	[Venniro, Marco; Zhang, Michelle; Hoots, Jennifer K.; Golden, Sam A.; Heins, Conor; Morales, Marisela; Epstein, David H.; Shaham, Yavin] NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Caprioli, Daniele] Sapienza Univ Rome, Dept Physiol & Pharmacol Vittorio Erspamer, Rome, Italy; [Caprioli, Daniele] Santa Lucia Fdn, IRCCS Fdn Santa Lucia, Rome, Italy	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Sapienza University Rome; IRCCS Santa Lucia	Venniro, M; Shaham, Y (corresponding author), NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	venniro.marco@nih.gov; yshaham@intra.nida.nih.gov	shaham, yavin/G-1306-2014; Venniro, Marco/AAX-7686-2020; Venniro, Marco/AAU-5988-2021; Caprioli, Daniele/AAA-7536-2019	Caprioli, Daniele/0000-0001-6198-0776; shaham, yavin/0000-0002-8242-3319; Golden, Sam/0000-0002-2104-2272; Venniro, Marco/0000-0001-7653-957X	Intramural Research Program of NIDA; NIH Center on Compulsive Behaviors; NARSAD Distinguished Investigator Grant Award; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000434] Funding Source: NIH RePORTER	Intramural Research Program of NIDA; NIH Center on Compulsive Behaviors; NARSAD Distinguished Investigator Grant Award; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Jin, A. Minier Toribio, and O. Lofaro for their help during the experiments. The research was supported by the Intramural Research Program of NIDA, a fellowship from the NIH Center on Compulsive Behaviors (M.V.), and NARSAD Distinguished Investigator Grant Award (Y.S.).	Ahmed SH, 2018, PROG NEURO-PSYCHOPH, V87, P3, DOI 10.1016/j.pnpbp.2017.09.027; Ahmed SH, 2013, CURR OPIN NEUROBIOL, V23, P581, DOI 10.1016/j.conb.2013.01.028; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Augier E, 2018, SCIENCE, V360, P1321, DOI 10.1126/science.aao1157; Azrin NH, 1996, BEHAV RES THER, V34, P41, DOI 10.1016/0005-7967(95)00049-4; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Banks ML, 2017, TRENDS PHARMACOL SCI, V38, P181, DOI 10.1016/j.tips.2016.11.002; Bardo MT, 2013, PHARMACOL REV, V65, P255, DOI 10.1124/pr.111.005124; Bossert JM, 2013, PSYCHOPHARMACOLOGY, V229, P453, DOI 10.1007/s00213-013-3120-y; Calu DJ, 2014, NEUROPHARMACOLOGY, V76, P395, DOI 10.1016/j.neuropharm.2013.04.030; Caprioli D, 2017, J NEUROSCI, V37, P1014, DOI 10.1523/JNEUROSCI.3091-16.2016; Caprioli D, 2015, ADDICT BIOL, V20, P913, DOI 10.1111/adb.12220; Caprioli D, 2015, BIOL PSYCHIAT, V78, P463, DOI 10.1016/j.biopsych.2015.02.018; Chauvet C, 2012, NEUROPHARMACOLOGY, V63, P635, DOI 10.1016/j.neuropharm.2012.05.014; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Dong Y, 2017, J NEUROSCI, V37, P10867, DOI 10.1523/JNEUROSCI.1821-17.2017; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fritz M, 2011, ADDICT BIOL, V16, P273, DOI 10.1111/j.1369-1600.2010.00285.x; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Grundemann J, 2015, CURR OPIN NEUROBIOL, V35, P200, DOI 10.1016/j.conb.2015.10.005; Heilig M, 2016, NAT REV NEUROSCI, V17, P592, DOI 10.1038/nrn.2016.67; Heyman Gene M, 2013, Front Psychiatry, V4, P31, DOI 10.3389/fpsyt.2013.00031; Higgins ST, 2003, ARCH GEN PSYCHIAT, V60, P1043, DOI 10.1001/archpsyc.60.9.1043; Insel TR, 2017, JAMA-J AM MED ASSOC, V318, P1215, DOI 10.1001/jama.2017.11295; Kawa AB, 2016, PSYCHOPHARMACOLOGY, V233, P3587, DOI 10.1007/s00213-016-4393-8; Kim J, 2017, NEURON, V93, P1464, DOI 10.1016/j.neuron.2017.02.034; Krasnova IN, 2014, NEUROPSYCHOPHARMACOL, V39, P2008, DOI 10.1038/npp.2014.50; Lash SJ, 2004, ADDICT BEHAV, V29, P337, DOI 10.1016/j.addbeh.2003.08.008; Li X, 2015, J NEUROSCI, V35, P8232, DOI 10.1523/JNEUROSCI.1022-15.2015; Li X, 2015, NEUROPSYCHOPHARMACOL, V40, P1297, DOI 10.1038/npp.2014.320; Marchant NJ, 2013, BIOL PSYCHIAT, V73, P256, DOI 10.1016/j.biopsych.2012.07.007; MARLATT GA, 1988, ANNU REV PSYCHOL, V39, P223, DOI 10.1146/annurev.ps.39.020188.001255; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Monterosso J, 2007, DRUG ALCOHOL DEPEN, V90, pS100, DOI 10.1016/j.drugalcdep.2006.09.004; Nader MA, 2014, NEUROPHARMACOLOGY, V76, P510, DOI 10.1016/j.neuropharm.2013.05.044; Nestler EJ, 2014, NEUROPHARMACOLOGY, V76, P259, DOI 10.1016/j.neuropharm.2013.04.004; PAXINOS G, 2008, RAT BRAIN STREOTAXIC; Pelloux Y, 2018, ADDICT BIOL, V23, P699, DOI 10.1111/adb.12527; Piazza PV, 2013, PSYCHOPHARMACOLOGY, V229, P387, DOI 10.1007/s00213-013-3224-4; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Schoenbaum G, 2016, NEUROPSYCHOPHARMACOL, V41, P2966, DOI 10.1038/npp.2016.147; Smith MA, 2012, PSYCHOPHARMACOLOGY, V224, P81, DOI 10.1007/s00213-012-2737-6; Solinas M, 2008, P NATL ACAD SCI USA, V105, P17145, DOI 10.1073/pnas.0806889105; Solinas M, 2010, PROG NEUROBIOL, V92, P572, DOI 10.1016/j.pneurobio.2010.08.002; Stitzer ML, 2011, HDB MOTIVATIONAL COU, V2nd, P549; Strickland JC, 2014, EXP CLIN PSYCHOPHARM, V22, P23, DOI 10.1037/a0034669; Theberge FR, 2013, BIOL PSYCHIAT, V73, P729, DOI 10.1016/j.biopsych.2012.12.019; Thiel KJ, 2012, ADDICT BIOL, V17, P365, DOI 10.1111/j.1369-1600.2011.00358.x; Tourigny SC, 1998, QUAL HEALTH RES, V8, P149, DOI 10.1177/104973239800800202; Vanderschuren LJMJ, 2016, NEUROSCI BIOBEHAV R, V70, P86, DOI 10.1016/j.neubiorev.2016.07.025; Venniro M, 2017, NEURON, V96, P414, DOI 10.1016/j.neuron.2017.09.024; Venniro M, 2017, NEUROPSYCHOPHARMACOL, V42, P1126, DOI 10.1038/npp.2016.287; Venniro M, 2016, PROG BRAIN RES, V224, P25, DOI 10.1016/bs.pbr.2015.08.004; Waldorf D, 1991, COCAINE CHANGES EXPE; Wise RA, 2014, NEUROPSYCHOPHARMACOL, V39, P254, DOI 10.1038/npp.2013.261; Wolf ME, 2016, NAT REV NEUROSCI, V17, P351, DOI 10.1038/nrn.2016.39; Zernig Gerald, 2013, Front Psychiatry, V4, P100, DOI 10.3389/fpsyt.2013.00100; Zimmer BA, 2012, NEUROPSYCHOPHARMACOL, V37, P1901, DOI 10.1038/npp.2012.37; Zlebnik NE, 2015, PSYCHOPHARMACOLOGY, V232, P3507, DOI 10.1007/s00213-015-3999-6	60	151	152	8	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2018	21	11					1520	+		10.1038/s41593-018-0246-6	http://dx.doi.org/10.1038/s41593-018-0246-6			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GY1UT	30323276	Green Accepted			2022-12-17	WOS:000448319500006
J	Poulin, JF; Caronia, G; Hofer, C; Cui, QL; Helm, B; Ramakrishnan, C; Chan, CS; Dombeck, DA; Deisseroth, K; Awatramani, R				Poulin, Jean-Francois; Caronia, Giuliana; Hofer, Caitlyn; Cui, Qiaoling; Helm, Brandon; Ramakrishnan, Charu; Chan, C. Savio; Dombeck, Daniel A.; Deisseroth, Karl; Awatramani, Rajeshwar			Mapping projections of molecularly defined dopamine neuron subtypes using intersectional genetic approaches	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; SINGLE-CELL TRANSCRIPTOMICS; MIDBRAIN DOPAMINE; NUCLEUS-ACCUMBENS; TRANSGENIC MICE; MOUSE; RECOMBINASE; DIVERSITY; CRE; SYSTEMS	Midbrain dopamine (DA) neurons have diverse functions that can in part be explained by their heterogeneity. Although molecularly distinct subtypes of DA neurons have been identified by single-cell gene expression profiling, fundamental features such as their projection patterns have not been elucidated. Progress in this regard has been hindered by the lack of genetic tools for studying DA neuron subtypes. Here we develop intersectional genetic labeling strategies, based on combinatorial gene expression, to map the projections of molecularly defined DA neuron subtypes. We reveal distinct genetically defined dopaminergic pathways arising from the substantia nigra pars compacta and from the ventral tegmental area that innervate specific regions of the caudate putamen, nucleus accumbens and amygdala. Together, the genetic toolbox and DA neuron subtype projections presented here constitute a resource that will accelerate the investigation of this clinically significant neurotransmitter system.	[Poulin, Jean-Francois; Caronia, Giuliana; Hofer, Caitlyn; Helm, Brandon; Awatramani, Rajeshwar] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Cui, Qiaoling; Chan, C. Savio] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Dombeck, Daniel A.] Northwestern Univ, Dept Neurobiol, Evanston, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Stanford University; Stanford University; Northwestern University	Awatramani, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.	r-awatramani@northwestern.edu		Chan, C. Savio/0000-0002-3474-1718; Poulin, Jean-Francois/0000-0002-1039-4985; Cui, Qiaoling/0000-0002-1632-4208; Awatramani, Rajeshwar/0000-0002-0713-2140	NIH [R01NS06977, R01NS047085, R01MH110556-01A1, 1R21NS072703-01A1, R01NS096240-01]; NARSAD; Paul Ruby Foundation; MJFF; CIHR; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS047085, R01NS096240, R01NS069777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA042012] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); Paul Ruby Foundation; MJFF; CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors wish to thank S. Ganguli, M. Jurado and I. Oksuz for technical assistance, S. Pieraut and A. Maximov for help with trimethropin injection protocol, and X. Zhuang (University of Chicago) and B. Lowell (Harvard) for sharing mouse strains. This work was supported by NIH grants R01NS06977 and R01NS047085 to C.S.C.; NIH grant R01MH110556-01A1 to D.A.D.; NIH grants R01MH110556-01A1, 1R21NS072703-01A1 and R01NS096240-01 and NARSAD and Paul Ruby Foundation grants to R.A.; and grants from MJFF and CIHR to J.-F.P.	Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Anderegg A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003973; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Baimel C, 2017, CELL REP, V18, P1346, DOI 10.1016/j.celrep.2017.01.030; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Berke JD, 2018, NAT NEUROSCI, V21, P787, DOI 10.1038/s41593-018-0152-y; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bourane S, 2015, SCIENCE, V350, P550, DOI 10.1126/science.aac8653; Brignani S, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00055; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Chen LN, 2008, J NEUROSCI, V28, P425, DOI 10.1523/JNEUROSCI.3602-07.2008; Chen LA, 2015, J NEUROSCI, V35, P890, DOI 10.1523/JNEUROSCI.0089-14.2015; Cho JR, 2017, NEURON, V94, P1205, DOI 10.1016/j.neuron.2017.05.020; Di Salvio M, 2010, NAT NEUROSCI, V13, P1481, DOI 10.1038/nn.2661; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Duan B, 2014, CELL, V159, P1417, DOI 10.1016/j.cell.2014.11.003; Dymecki SM, 2010, METHOD ENZYMOL, V477, P183, DOI 10.1016/S0076-6879(10)77011-7; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00124; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00022; GERFEN CR, 1987, J NEUROSCI, V7, P3915; Hintiryan H, 2016, NAT NEUROSCI, V19, P1100, DOI 10.1038/nn.4332; Hnasko TS, 2012, J NEUROSCI, V32, P15076, DOI 10.1523/JNEUROSCI.3128-12.2012; Hook PW, 2018, AM J HUM GENET, V102, P427, DOI 10.1016/j.ajhg.2018.02.001; Howe MW, 2016, NATURE, V535, P505, DOI 10.1038/nature18942; Hsu LC, 1999, BIOCHEM J, V339, P387, DOI 10.1042/0264-6021:3390387; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Joksimovic M, 2009, P NATL ACAD SCI USA, V106, P19185, DOI 10.1073/pnas.0904285106; Kabanova A, 2015, NAT NEUROSCI, V18, P872, DOI 10.1038/nn.4020; Khan S, 2017, J NEUROSCI, V37, P2305, DOI 10.1523/JNEUROSCI.2414-16.2016; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2015, NEURON, V85, P429, DOI 10.1016/j.neuron.2014.12.036; Lammel S, 2014, NEUROPHARMACOLOGY, V76, P351, DOI 10.1016/j.neuropharm.2013.03.019; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Matthews GA, 2016, CELL, V164, P617, DOI 10.1016/j.cell.2015.12.040; Menegas W, 2017, ELIFE, V6, DOI 10.7554/eLife.21886; Menegas W, 2015, ELIFE, V4, DOI 10.7554/eLife.10032; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mingote S, 2015, J NEUROSCI, V35, P16259, DOI 10.1523/JNEUROSCI.1674-15.2015; Morales M, 2017, NAT REV NEUROSCI, V18, P73, DOI 10.1038/nrn.2016.165; Nouri N, 2017, DEVELOPMENT, V144, P916, DOI 10.1242/dev.144949; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Osterwalder M, 2010, NAT METHODS, V7, P893, DOI 10.1038/nmeth.1521; Panman L, 2014, CELL REP, V8, P1018, DOI 10.1016/j.celrep.2014.07.016; Poulin JF, 2016, NAT NEUROSCI, V19, P1131, DOI 10.1038/nn.4366; Poulin JF, 2014, CELL REP, V9, P930, DOI 10.1016/j.celrep.2014.10.008; Ray RS, 2011, SCIENCE, V333, P637, DOI 10.1126/science.1205295; Roeper J, 2013, TRENDS NEUROSCI, V36, P336, DOI 10.1016/j.tins.2013.03.003; Sando R, 2013, NAT METHODS, V10, P1085, DOI [10.1038/NMETH.2640, 10.1038/nmeth.2640]; Sciolino NR, 2016, CELL REP, V15, P2563, DOI 10.1016/j.celrep.2016.05.034; Sgobio C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05598-1; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Steinkellner T, 2018, J CLIN INVEST, V128, P774, DOI 10.1172/JCI95795; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Trudeau LE, 2014, PROG BRAIN RES, V211, P141, DOI 10.1016/B978-0-444-63425-2.00006-4; Wallen A, 1999, EXP CELL RES, V253, P737, DOI 10.1006/excr.1999.4691; Yetnikoff L, 2014, NEUROSCIENCE, V282, P23, DOI 10.1016/j.neuroscience.2014.04.010; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	64	151	154	3	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2018	21	9					1260	+		10.1038/s41593-018-0203-4	http://dx.doi.org/10.1038/s41593-018-0203-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GS0DU	30104732	Green Accepted			2022-12-17	WOS:000443157700015
J	Lisman, J; Cooper, K; Sehgal, M; Silva, AJ				Lisman, John; Cooper, Katherine; Sehgal, Megha; Silva, Alcino J.			Memory formation depends on both synapse-specific modifications of synaptic strength and cell-specific increases in excitability	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; ELEMENT-BINDING PROTEIN; MEDIATED GENE-EXPRESSION; SPATIAL MEMORY; DENDRITIC SPINES; PLACE CELLS; NEURONS; CREB; LTP; POTENTIATION	The modification of synaptic strength produced by long-term potentiation (LTP) is widely thought to underlie memory storage. Indeed, given that hippocampal pyramidal neurons have >10,000 independently modifiable synapses, the potential for information storage by synaptic modification is enormous. However, recent work suggests that CREB-mediated global changes in neuronal excitability also play a critical role in memory formation. Because these global changes have a modest capacity for information storage compared with that of synaptic plasticity, their importance for memory function has been unclear. Here we review the newly emerging evidence for CREB-dependent control of excitability and discuss two possible mechanisms. First, the CREB-dependent transient change in neuronal excitability performs a memory-allocation function ensuring that memory is stored in ways that facilitate effective linking of events with temporal proximity (hours). Second, these changes may promote cell-assembly formation during the memory-consolidation phase. It has been unclear whether such global excitability changes and local synaptic mechanisms are complementary. Here we argue that the two mechanisms can work together to promote useful memory function.	[Lisman, John; Cooper, Katherine] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Sehgal, Megha; Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Dept Neurobiol, Dept Psychol,Integrat Ctr Learning & Memory, Los Angeles, CA 90024 USA; [Sehgal, Megha; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	Brandeis University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Silva, AJ (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Dept Neurobiol, Dept Psychol,Integrat Ctr Learning & Memory, Los Angeles, CA 90024 USA.; Silva, AJ (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA.	alcinojsilva@att.net	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Cooper, Katherine/0000-0002-6030-4773	NIH [U01NS090583, R56NS096710, R01DA043195, R01NS103168, U19NS104590, NSF IOS-1526941, 2RF1AG013622-21, R01MH113071]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH113071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090583, R01NS103168, R56NS096710, U19NS104590, R01NS106969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG013622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA043195] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NIH (grants U01NS090583, R56NS096710, R01DA043195, R01NS103168, U19NS104590, and NSF IOS-1526941 to J.L.; grants 2RF1AG013622-21 and R01MH113071 to A.J.S.) and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (to A.J.S.).	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; ALKON DL, 1984, J EXP BIOL, V112, P95; Araki Y, 2015, NEURON, V85, P173, DOI 10.1016/j.neuron.2014.12.023; Atherton LA, 2015, TRENDS NEUROSCI, V38, P560, DOI 10.1016/j.tins.2015.07.004; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bliss TVP, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-5; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brandalise F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13480; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; CASTELLUCCI V, 1976, SCIENCE, V194, P1176, DOI 10.1126/science.11560; Chen SP, 2014, ELIFE, V3, DOI 10.7554/eLife.03896; da Rosa MM, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00066; Debanne D, 1999, J NEUROSCI, V19, P10664, DOI 10.1523/JNEUROSCI.19-24-10664.1999; DISTERHOFT JF, 1986, P NATL ACAD SCI USA, V83, P2733, DOI 10.1073/pnas.83.8.2733; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Dudek SM, 2002, P NATL ACAD SCI USA, V99, P3962, DOI 10.1073/pnas.062510599; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; El Gaamouch F, 2012, J NEUROSCI, V32, P10767, DOI 10.1523/JNEUROSCI.5622-11.2012; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Gross C, 2011, J NEUROSCI, V31, P5693, DOI 10.1523/JNEUROSCI.6661-10.2011; Guzowski J. F., 2001, CURR PROTOC NEUROSCI, V15; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Kandel E R, 1989, J Neuropsychiatry Clin Neurosci, V1, P103; Kim JI, 2016, EXP NEUROBIOL, V25, P55, DOI 10.5607/en.2016.25.2.55; Kim J, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00044; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lopez de Armentia M, 2007, J NEUROSCI, V27, P13909, DOI 10.1523/JNEUROSCI.3850-07.2007; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meadows JP, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf5642; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Oh MM, 2015, NEUROSCIENTIST, V21, P372, DOI 10.1177/1073858414537382; Park S, 2016, NEUROPSYCHOPHARMACOL, V41, P2987, DOI 10.1038/npp.2016.73; Peters M, 2009, GENES BRAIN BEHAV, V8, P320, DOI 10.1111/j.1601-183X.2009.00474.x; Rashid AJ, 2016, SCIENCE, V353, P383, DOI 10.1126/science.aaf0594; Rogerson T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161655; Rogerson T, 2014, NAT REV NEUROSCI, V15, P157, DOI 10.1038/nrn3667; Rossetti T, 2017, NEURON, V96, P207, DOI 10.1016/j.neuron.2017.09.010; Ryan TJ, 2015, SCIENCE, V348, P1007, DOI 10.1126/science.aaa5542; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; STORM JF, 1990, PROG BRAIN RES, V83, P161; Tang S, 2017, NEURON, V93, P1315, DOI 10.1016/j.neuron.2017.02.032; Titley HK, 2017, NEURON, V95, P19, DOI 10.1016/j.neuron.2017.05.021; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Yokose J, 2017, SCIENCE, V355, P398, DOI 10.1126/science.aal2690; Yu XW, 2017, BEHAV BRAIN RES, V322, P206, DOI 10.1016/j.bbr.2016.07.042; Zhai SY, 2013, SCIENCE, V342, P1107, DOI 10.1126/science.1245622; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405; Zovkic IB, 2013, LEARN MEMORY, V20, P61, DOI 10.1101/lm.026575.112	71	151	157	9	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2018	21	3					309	314		10.1038/S41593-018-0076-6	http://dx.doi.org/10.1038/S41593-018-0076-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FZ7JH	29434376	Green Accepted			2022-12-17	WOS:000427776400005
J	Logan, T; Bendor, J; Toupin, C; Thorn, K; Edwards, RH				Logan, Todd; Bendor, Jacob; Toupin, Chantal; Thorn, Kurt; Edwards, Robert H.			alpha-Synuclein promotes dilation of the exocytotic fusion pore	NATURE NEUROSCIENCE			English	Article							ADRENAL CHROMAFFIN CELLS; DENSE-CORE VESICLES; PARKINSONS-DISEASE; GAMMA-SYNUCLEIN; SYNAPTIC DYSFUNCTION; VESICULAR MONOAMINE; MEMBRANE; MUTATION; RELEASE; ENDOCYTOSIS	The protein alpha-synuclein has a central role in the pathogenesis of Parkinson's disease. Like that of other proteins that accumulate in neurodegenerative disease, however, the function of alpha-synuclein remains unknown. Localization to the nerve terminal suggests a role in neurotransmitter release, and overexpression inhibits regulated exocytosis, but previous work has failed to identify a clear physiological defect in mice lacking all three synuclein isoforms. Using adrenal chromaffin cells and neurons, we now find that both overexpressed and endogenous synuclein accelerate the kinetics of individual exocytotic events, promoting cargo discharge and reducing pore closure ('kiss-and-run'). Thus, synuclein exerts dose-dependent effects on dilation of the exocytotic fusion pore. Remarkably, mutations that cause Parkinson's disease abrogate this property of alpha-synuclein without impairing its ability to inhibit exocytosis when overexpressed, indicating a selective defect in normal function.	[Logan, Todd; Bendor, Jacob; Toupin, Chantal; Edwards, Robert H.] Univ Calif San Francisco, UCSF Sch Med, Dept Neurol, San Francisco, CA 94143 USA; [Logan, Todd; Bendor, Jacob; Toupin, Chantal; Edwards, Robert H.] Univ Calif San Francisco, UCSF Sch Med, Dept Physiol, San Francisco, CA 94143 USA; [Logan, Todd; Edwards, Robert H.] Univ Calif San Francisco, UCSF Sch Med, Grad Program Biomed Sci, San Francisco, CA 94143 USA; [Thorn, Kurt] Univ Calif San Francisco, UCSF Sch Med, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Edwards, RH (corresponding author), Univ Calif San Francisco, UCSF Sch Med, Dept Neurol, San Francisco, CA 94143 USA.; Edwards, RH (corresponding author), Univ Calif San Francisco, UCSF Sch Med, Dept Physiol, San Francisco, CA 94143 USA.; Edwards, RH (corresponding author), Univ Calif San Francisco, UCSF Sch Med, Grad Program Biomed Sci, San Francisco, CA 94143 USA.	robert.edwards@ucsf.edu			NINDS [NS062715]; NIDA [DA10154]; Weill Institute for Neurosciences; John and Helen Cahill Family Endowment for Research on Parkinson's Disease; NINDS; A.P. Giannini Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Weill Institute for Neurosciences; John and Helen Cahill Family Endowment for Research on Parkinson's Disease; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); A.P. Giannini Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Edwards laboratory for discussion, D. Jullie for help with the pH oscillation experiment, A. Bertholet (UCSF) for the TOM20 antibody and B. Calagui and S. Batarni for technical assistance. We also thank K. Bohannon, M. Bittner and R. Holz for sharing data and providing suggestions. This work was supported by grants from NINDS (NS062715), NIDA (DA10154) and the Weill Institute for Neurosciences (to R.H.E.), the John and Helen Cahill Family Endowment for Research on Parkinson's Disease (to R.H.E.), a fellowship from NINDS (to T.L.) and a fellowship from the A.P. Giannini Foundation (to J.B.).	Alabi AA, 2013, ANNU REV PHYSIOL, V75, P393, DOI 10.1146/annurev-physiol-020911-153305; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Asensio CS, 2013, DEV CELL, V27, P425, DOI 10.1016/j.devcel.2013.10.007; Baksi S, 2016, FREE RADICAL BIO MED, V97, P292, DOI 10.1016/j.freeradbiomed.2016.06.025; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Braun AR, 2015, BIOPHYS J, V108, P1848, DOI 10.1016/j.bpj.2015.03.029; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chiang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4356; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; DeWitt DC, 2013, BIOCHEMISTRY-US, V52, P2385, DOI 10.1021/bi4002369; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Fumimura Y, 2007, J NEUROPATH EXP NEUR, V66, P354, DOI 10.1097/nen.0b013e3180517454; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Hao ZH, 2015, J CELL SCI, V128, P1365, DOI 10.1242/jcs.161414; HOLZ RW, 1978, P NATL ACAD SCI USA, V75, P5190, DOI 10.1073/pnas.75.10.5190; Hu G, 2013, ACS CHEM BIOL, V8, P1947, DOI 10.1021/cb400259n; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Jensen MB, 2011, J BIOL CHEM, V286, P42603, DOI 10.1074/jbc.M111.271130; Jullie D, 2014, J NEUROSCI, V34, P11106, DOI 10.1523/JNEUROSCI.0799-14.2014; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Langone F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114018; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Onoa B, 2010, J NEUROSCI, V30, P7917, DOI 10.1523/JNEUROSCI.5298-09.2010; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Senior SL, 2008, EUR J NEUROSCI, V27, P947, DOI 10.1111/j.1460-9568.2008.06055.x; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sirkis DW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003812; Soper JH, 2008, MOL BIOL CELL, V19, P1093, DOI 10.1091/mbc.E07-08-0827; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; TURKKA JT, 1986, EUR NEUROL, V25, P355, DOI 10.1159/000116034; Turner TN, 2015, NATURE, V520, P51, DOI 10.1038/nature14186; Unni VK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010589; van de Bospoort R., 2012, J CELL BIOL, V199, P883, DOI DOI 10.1083/JCB.201208024; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Wang LN, 2014, CURR BIOL, V24, P2319, DOI 10.1016/j.cub.2014.08.027; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang SM, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0206-x	60	151	153	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2017	20	5					681	+		10.1038/nn.4529	http://dx.doi.org/10.1038/nn.4529			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET1CU	28288128	Green Accepted, Green Submitted			2022-12-17	WOS:000400004300009
J	Korb, E; Herre, M; Zucker-Scharff, I; Darnell, RB; Allis, CD				Korb, Erica; Herre, Margo; Zucker-Scharff, Ilana; Darnell, Robert B.; Allis, C. David			BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR ANTAGONIST; LONG-TERM POTENTIATION; RNA-POLYMERASE-II; LATE-PHASE; IN-VIVO; SEIZURE SUSCEPTIBILITY; GENE; RAT; ELONGATION; EPILEPSY	Precise regulation of transcription is crucial for the cellular mechanisms underlying memory formation. However, the link between neuronal stimulation and the proteins that directly interact with histone modifications to activate transcription in neurons remains unclear. Brd4 is a member of the bromodomain and extra-terminal domain ( BET) protein family, which binds acetylated histones and is a critical regulator of transcription in many cell types, including transcription in response to external cues. Small molecule BET inhibitors are in clinical trials, yet almost nothing is known about Brd4 function in the brain. Here we show that Brd4 mediates the transcriptional regulation underlying learning and memory. The loss of Brd4 function affects critical synaptic proteins, which results in memory deficits in mice but also decreases seizure susceptibility. Thus Brd4 provides a critical link between neuronal activation and the transcriptional responses that occur during memory formation.	[Korb, Erica; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10021 USA; [Herre, Margo; Zucker-Scharff, Ilana; Darnell, Robert B.] Rockefeller Univ, Lab Mol Neurooncol, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Korb, E (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10021 USA.	ekorb@rockefeller.edu; alliscd@rockefeller.edu	Darnell, Robert B/B-9022-2008	Darnell, Robert B/0000-0002-5134-8088; Korb, Erica/0000-0002-7064-8123	Rubertson Foundation; Ruth Kirschstein US National Research Service Award fellowship [F32MH103921]; US National Institutes of Health [R01 NS34389, NS081706]; Simons Foundation Research Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, F32MH103921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034389, R01NS081706] Funding Source: NIH RePORTER	Rubertson Foundation; Ruth Kirschstein US National Research Service Award fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Research Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Ozato for the Brd4 construct, J. Gresack rind the Rockefeller behavioral core for guidance and suggestions, K. Thomas for microscopy expertise, the Memorial Sloan-Kettering Cancer Center histology core for immunohistochemistry support, A. Soshnev for the schematic model graphic, J. Gerace tor editing and members of the Allis laboratory tor feedback. Support for this work was provided by a grant from the Rubertson Foundation, a Ruth Kirschstein US National Research Service Award fellowship (F32MH103921), the US National Institutes of Health (R01 NS34389, NS081706) and a Simons Foundation Research Award. R.B.D. is an Investigator of the Howard Hughes Medical Institute.	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Bialer M, 2010, NAT REV DRUG DISCOV, V9, P68, DOI 10.1038/nrd2997; Borges K, 2001, J BIOL CHEM, V276, P25929, DOI 10.1074/jbc.M009105200; Brehme H, 2014, EPILEPSIA, V55, P175, DOI 10.1111/epi.12474; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Descalzi G, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-90; Dhir A., 2012, CURR PROT NEUROSCI, VChapter 9, DOI [DOI 10.1002/0471142301.NS0937S58, 10.1002/0471142301.ns0937s58]; Dietrich JB, 2013, CELL TISSUE RES, V352, P179, DOI 10.1007/s00441-013-1565-2; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; FREY U, 1989, NEUROSCI LETT, V97, P135, DOI 10.1016/0304-3940(89)90152-3; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; Gapp K, 2014, NEUROSCIENCE, V264, P99, DOI 10.1016/j.neuroscience.2012.11.040; Hara H, 2006, EUR J PHARMACOL, V531, P59, DOI 10.1016/j.ejphar.2005.11.044; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kanno T, 2014, NAT STRUCT MOL BIOL, V21, P1047, DOI 10.1038/nsmb.2912; Kato AS, 2010, TRENDS NEUROSCI, V33, P241, DOI 10.1016/j.tins.2010.02.004; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kodama M, 1999, EUR J PHARMACOL, V374, P11, DOI 10.1016/S0014-2999(99)00295-2; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Lussier MP, 2014, EUR J NEUROSCI, V39, P1148, DOI 10.1111/ejn.12494; Mattes H, 2010, J MED CHEM, V53, P5367, DOI 10.1021/jm901688m; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Mirguet O, 2013, J MED CHEM, V56, P7501, DOI 10.1021/jm401088k; Myers SJ, 1998, J NEUROSCI, V18, P6723; Nagarajan S, 2014, CELL REP, V8, P459, DOI 10.1016/j.celrep.2014.06.016; NAMBA T, 1994, BRAIN RES, V638, P36, DOI 10.1016/0006-8993(94)90630-0; Naydenov AV, 2014, NEURON, V83, P361, DOI 10.1016/j.neuron.2014.06.030; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Rakhade SN, 2012, J NEUROSCI, V32, P17800, DOI 10.1523/JNEUROSCI.6121-11.2012; Rogawski MA, 2013, ACTA NEUROL SCAND, V127, P9, DOI 10.1111/ane.12099; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Schael S, 2013, J BIOL CHEM, V288, P9303, DOI 10.1074/jbc.M113.461293; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; YAMAGUCHI S, 1993, EPILEPSY RES, V15, P179, DOI 10.1016/0920-1211(93)90054-B; Zhang JL, 2013, REV NEUROSCIENCE, V24, P499, DOI 10.1515/revneuro-2013-0021; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	51	151	156	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1464	+		10.1038/nn.4095	http://dx.doi.org/10.1038/nn.4095			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CS2OK	26301327	Green Accepted			2022-12-17	WOS:000361910600018
J	Guzman, YF; Tronson, NC; Jovasevic, V; Sato, K; Guedea, AL; Mizukami, H; Nishimori, K; Radulovic, J				Guzman, Yomayra F.; Tronson, Natalie C.; Jovasevic, Vladimir; Sato, Keisuke; Guedea, Anita L.; Mizukami, Hiroaki; Nishimori, Katsuhiko; Radulovic, Jelena			Fear-enhancing effects of septal oxytocin receptors	NATURE NEUROSCIENCE			English	Article							SOCIAL DEFEAT; MICE; STRESS; VASOPRESSIN; RELEASE; NEURONS; ANXIETY	The nonapeptide oxytocin is considered beneficial to mental health due to its anxiolytic, prosocial and antistress effects, but evidence for anxiogenic actions of oxytocin in humans has recently emerged. Using region-specific manipulations of the mouse oxytocin receptor (Oxtr) gene (Oxtr), we identified the lateral septum as the brain region mediating fear-enhancing effects of Oxtr. These effects emerge after social defeat and require Oxtr specifically coupled to the extracellular signal-regulated protein kinase pathway.	[Guzman, Yomayra F.; Tronson, Natalie C.; Jovasevic, Vladimir; Guedea, Anita L.; Radulovic, Jelena] Northwestern Univ, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Tronson, Natalie C.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Sato, Keisuke; Nishimori, Katsuhiko] Tohoku Univ, Grad Sch Agr Sci, Dept Mol & Cell Biol, Sendai, Miyagi 980, Japan; [Mizukami, Hiroaki] Jichi Med Univ, Ctr Mol Med, Div Genet Therapeut, Shimotsuke, Tochigi, Japan	Northwestern University; University of Michigan System; University of Michigan; Tohoku University; Jichi Medical University	Radulovic, J (corresponding author), Northwestern Univ, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA.	j-radulovic@northwestern.edu	Mizukami, Hiroaki/D-7674-2013	Mizukami, Hiroaki/0000-0001-8954-874X; Radulovic, Jelena/0000-0002-0268-2426; Tronson, Natalie/0000-0001-5676-1579; Guzman, Yomayra F./0000-0003-4802-8304	US National Institutes of Health [R01 MH078064, MH092065]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH092065, R01MH078064, R01MH073669] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by US National Institutes of Health grants R01 MH078064 (J.R.) and MH092065 (Y.F.G.). Part of this study carried out by K.N. and K.S. was the result of "Molecular study of the functional mechanism of oxytocin in brain" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. We thank P. Osten (Cold Spring Harbor) for providing the rAAV-Cre vector, and L. Li and W. G. Tourtellotte (Department of Pathology, Northwestern University) for providing B6.129S4-Gt(ROSA) mice and their help with the beta-galactosidase staining.	Ayers LW, 2011, NEUROPSYCHOPHARMACOL, V36, P2488, DOI 10.1038/npp.2011.138; Bartz JA, 2010, P NATL ACAD SCI USA, V107, P21371, DOI 10.1073/pnas.1012669107; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Carter CS, 1998, PSYCHONEUROENDOCRINO, V23, P779; Devost D, 2008, PROG BRAIN RES, V170, P167, DOI 10.1016/S0079-6123(08)00415-9; Ebner K, 2000, BRAIN RES, V872, P87, DOI 10.1016/S0006-8993(00)02464-1; Eldredge LC, 2008, DEVELOPMENT, V135, P2949, DOI 10.1242/dev.023960; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Grillon C., 2012, MOL PSYCHIATR, DOI [10.1038/mp.2012.156, DOI 10.1038/MP.2012.156.(13]; IsHak WW, 2011, J AFFECT DISORDERS, V130, P1, DOI 10.1016/j.jad.2010.06.001; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Mutso AA, 2012, J NEUROSCI, V32, P5747, DOI 10.1523/JNEUROSCI.0587-12.2012; Pagani JH, 2011, GENES BRAIN BEHAV, V10, P710, DOI 10.1111/j.1601-183X.2011.00709.x; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Radulovic J, 1999, J NEUROSCI, V19, P5016; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; ROCHE KE, 1979, SCIENCE, V204, P1343, DOI 10.1126/science.221973; Sato K, 2009, BIOSCI BIOTECH BIOCH, V73, P2145, DOI 10.1271/bbb.90287; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Stanciu M, 2001, MOL BRAIN RES, V94, P15, DOI 10.1016/S0169-328X(01)00174-7; Striepens N, 2012, P NATL ACAD SCI USA, V109, P18144, DOI 10.1073/pnas.1208852109; Tabak BA, 2011, PSYCHONEUROENDOCRINO, V36, P115, DOI 10.1016/j.psyneuen.2010.07.004; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; THOR DH, 1982, J COMP PHYSIOL PSYCH, V96, P1000, DOI 10.1037/0735-7036.96.6.1000; Tronson NC, 2008, NEUROPSYCHOPHARMACOL, V33, P1570, DOI 10.1038/sj.npp.1301550; Tronson NC, 2010, BIOL PSYCHIAT, V68, P1007, DOI 10.1016/j.biopsych.2010.09.004; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009	27	151	155	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1185	U36		10.1038/nn.3465	http://dx.doi.org/10.1038/nn.3465			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872596	Green Accepted			2022-12-17	WOS:000323597500008
J	Levitz, J; Pantoja, C; Gaub, B; Janovjak, H; Reiner, A; Hoagland, A; Schoppik, D; Kane, B; Stawski, P; Schier, AF; Trauner, D; Isacoff, EY				Levitz, Joshua; Pantoja, Carlos; Gaub, Benjamin; Janovjak, Harald; Reiner, Andreas; Hoagland, Adam; Schoppik, David; Kane, Brian; Stawski, Philipp; Schier, Alexander F.; Trauner, Dirk; Isacoff, Ehud Y.			Optical control of metabotropic glutamate receptors	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; HETEROLOGOUS EXPRESSION; REMOTE-CONTROL; ACTIVATION; INHIBITION; RHODOPSIN; CHANNELS; ROLES; TRANSGENESIS; MECHANISMS	G protein-coupled receptors (GPCRs), the largest family of membrane signaling proteins, respond to neurotransmitters, hormones and small environmental molecules. The neuronal function of many GPCRs has been difficult to resolve because of an inability to gate them with subtype specificity, spatial precision, speed and reversibility. To address this, we developed an approach for opto-chemical engineering of native GPCRs. We applied this to the metabotropic glutamate receptors (mGluRs) to generate light-agonized and light-antagonized mGluRs (LimGluRs). The light-agonized LimGluR2, on which we focused, was fast, bistable and supported multiple rounds of on/off switching. Light gated two of the primary neuronal functions of mGluR2: suppression of excitability and inhibition of neurotransmitter release. We found that the light-antagonized tool LimGluR2-block was able to manipulate negative feedback of synaptically released glutamate on transmitter release. We generalized the optical control to two additional family members: mGluR3 and mGluR6. This system worked in rodent brain slices and in zebrafish in vivo, where we found that mGluR2 modulated the threshold for escape behavior. These light-gated mGluRs pave the way for determining the roles of mGluRs in synaptic plasticity, memory and disease.	[Levitz, Joshua; Isacoff, Ehud Y.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Pantoja, Carlos; Janovjak, Harald; Reiner, Andreas; Hoagland, Adam; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Gaub, Benjamin; Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Grad Program, Berkeley, CA 94720 USA; [Schoppik, David; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Kane, Brian; Trauner, Dirk] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Stawski, Philipp; Trauner, Dirk] Univ Munich, Dept Chem, Munich, Germany; [Stawski, Philipp; Trauner, Dirk] Univ Munich, Ctr Integrated Prot Sci, Munich, Germany; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; University of California System; University of California Berkeley; University of Munich; University of Munich; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Trauner, D (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	dirk.trauner@lmu.de; ehud@berkeley.edu	Janovjak, Harald/O-9070-2016; isacoff, ehud/AAP-1459-2020; Reiner, Andreas/AGK-2170-2022	Janovjak, Harald/0000-0002-8023-9315; Reiner, Andreas/0000-0003-0802-7278; Erdmann, Philipp/0000-0001-8289-9133; Isacoff, Ehud Y./0000-0003-4775-9359; Schier, Alexander Franz/0000-0001-7645-5325; Schoppik, David/0000-0001-7969-9632	Nanomedicine Development Center for the Optical Control of Biological Function; US National Institutes of Health [PN2EY018241, R01HL109525]; Human Frontier Science Program [RGP0013/2010]; Deutsche Forschungsgemeinschaft [FOR 1279]; Fond der Chemischen Industrie; National Science Foundation [CHE-0233882, CHE-0840505]; European Molecular Biology Organization; Helen Hay Whitney postdoctoral fellowship; McKnight Endowment Fund for Neuroscience; Fulbright Foundation; Direct For Biological Sciences [1041078] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028971] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085357] Funding Source: NIH RePORTER	Nanomedicine Development Center for the Optical Control of Biological Function; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fond der Chemischen Industrie(Fonds der Chemischen Industrie); National Science Foundation(National Science Foundation (NSF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Helen Hay Whitney postdoctoral fellowship; McKnight Endowment Fund for Neuroscience; Fulbright Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A.P. Mariani (National Eye Institute) for 11-cis retinal, J.P. Pin (University of Montpellier) for the mGluR plasmids and E. Reuveny (Weizmann Institute) for the GIRK1 plasmid, K. Durkin, K. Dubay, T. Berger, G. Sandoz and S. Berlin for helpful discussions, A. Guyon, Z. Fu and S. Szobota for help with slice cultures, Z. Fu for molecular biology assistance, K. McDaniel, J. Maxfield, J. Saint-Hillaire and D. Weinman for fish care, E. Carroll for discussion and help with zebrafish set up, P. Gut (University of California, San Francisco) for zebrafish plasmids, H. Baier (University of California, San Francisco) for fish lines, and the College of Chemistry (University of California, Berkeley) for computing resources for the Monte Carlo simulations. Support for the work was provided by the Nanomedicine Development Center for the Optical Control of Biological Function, US National Institutes of Health grant PN2EY018241 (D.T. and E.Y.I.), the Human Frontier Science Program (RGP0013/2010 to E.Y.I.), the Deutsche Forschungsgemeinschaft (FOR 1279, D.T.), the Fond der Chemischen Industrie (Kekule fellowship to P.S.), National Science Foundation grants CHE-0233882 and CHE-0840505 (to the College of Chemistry at the University of California, Berkeley), a postdoctoral fellowship of the European Molecular Biology Organization (H.J.), a Helen Hay Whitney postdoctoral fellowship (D.S.), the McKnight Endowment Fund for Neuroscience and US National Institutes of Health grant R01HL109525 (A.F.S.), and a predoctoral fellowship from the Fulbright Foundation (B.G.).	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Altinbilek B, 2009, NEUROSCIENCE, V158, P149, DOI 10.1016/j.neuroscience.2008.07.045; Anwyl R, 2009, NEUROPHARMACOLOGY, V56, P735, DOI 10.1016/j.neuropharm.2009.01.002; Bailes HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030774; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bradley SJ, 2012, BIOCHEM PHARMACOL, V84, P249, DOI 10.1016/j.bcp.2012.04.009; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Caporale N, 2011, MOL THER, V19, P1212, DOI 10.1038/mt.2011.103; CHANG G, 1989, J AM CHEM SOC, V111, P4379, DOI 10.1021/ja00194a035; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Ehrengruber MU, 1997, P NATL ACAD SCI USA, V94, P7070, DOI 10.1073/pnas.94.13.7070; Fehrentz T, 2011, ANGEW CHEM INT EDIT, V50, P12156, DOI 10.1002/anie.201103236; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gorostiza P, 2007, P NATL ACAD SCI USA, V104, P10865, DOI 10.1073/pnas.0701274104; Grabher C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S10; Grauer SM, 1999, PSYCHOPHARMACOLOGY, V141, P405, DOI 10.1007/s002130050850; Gutierrez DV, 2011, J BIOL CHEM, V286, P25848, DOI 10.1074/jbc.M111.253674; Hanna L, 2013, NEUROPHARMACOLOGY, V66, P114, DOI 10.1016/j.neuropharm.2012.02.023; Haug MF, 2013, J COMP NEUROL, V521, P1533, DOI 10.1002/cne.23240; Iacovelli L, 2009, MOL PHARMACOL, V75, P991, DOI 10.1124/mol.108.052316; IKEDA SR, 1995, NEURON, V14, P1029, DOI 10.1016/0896-6273(95)90341-0; Janovjak H, 2010, NAT NEUROSCI, V13, P1027, DOI 10.1038/nn.2589; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Leaney JL, 2003, EUR J NEUROSCI, V18, P2110, DOI 10.1046/j.1460-9568.2003.02933.x; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Marek GJ, 2004, CURR OPIN PHARMACOL, V4, P18, DOI 10.1016/j.coph.2003.10.003; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Pei Y, 2008, PHYSIOLOGY, V23, P313, DOI 10.1152/physiol.00025.2008; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Raveh A, 2010, CELL, V143, P750, DOI 10.1016/j.cell.2010.10.018; Saugstad JA, 1996, J NEUROSCI, V16, P5979; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Szobota S, 2010, ANNU REV BIOPHYS, V39, P329, DOI 10.1146/annurev.biophys.093008.131400; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; Tsuji T, 2001, J PHYS CHEM A, V105, P9347, DOI 10.1021/jp004418v; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Yamashita T, 2000, J BIOL CHEM, V275, P34272, DOI 10.1074/jbc.M002954200; Yamashita T, 2001, J BIOCHEM-TOKYO, V130, P149, DOI 10.1093/oxfordjournals.jbchem.a002954; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	58	151	170	0	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					507	U190		10.1038/nn.3346	http://dx.doi.org/10.1038/nn.3346			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23455609	Green Submitted, Green Accepted			2022-12-17	WOS:000316723700023
J	Raimondo, JV; Kay, L; Ellender, TJ; Akerman, CJ				Raimondo, Joseph V.; Kay, Louise; Ellender, Tommas J.; Akerman, Colin J.			Optogenetic silencing strategies differ in their effects on inhibitory synaptic transmission	NATURE NEUROSCIENCE			English	Article							MODULATION; ACTIVATION; CULTURES; NEURONS; PH	Optogenetic silencing using light-driven ion fluxes permits rapid and effective inhibition of neural activity. Using rodent hippocampal neurons, we found that silencing activity with a chloride pump can increase the probability of synaptically evoked spiking after photoactivation; this did not occur with a proton pump. This effect can be accounted for by changes to the GABA(A) receptor reversal potential and demonstrates an important difference between silencing strategies.	[Akerman, Colin J.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Akerman, CJ (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	colin.akerman@pharm.ox.ac.uk	Ellender, Tommas/N-9927-2014; Raimondo, Joseph/AAS-7890-2020	Ellender, Tommas/0000-0001-9787-3307; Raimondo, Joseph/0000-0002-8266-3128	Medical Research Council [G0601503]; European Community; MRC [G0601503] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Bolam (Oxford University) for resources, and K. Deisseroth (Stanford University) and E. Boyden (Massachusetts Institute of Technology) for DNA constructs. We also thank G. Miesenbock, D. Katzel and B. Richards for comments. Supported by a grant from the Medical Research Council (G0601503); research leading to these results received funding under the European Community's Seventh Framework Programme (FP7/2007-2013).	Ascoli GA, 2010, J NEUROSCI, V30, P6434, DOI 10.1523/JNEUROSCI.4066-09.2010; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2012, J PHYSIOL-PARIS, V106, P104, DOI 10.1016/j.jphysparis.2011.09.005; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hartmann Anna-Maria, 2011, BMC Res Notes, V4, P526, DOI 10.1186/1756-0500-4-526; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/NMETH.1808, 10.1038/nmeth.1808]; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; STREIT P, 1989, EUR J NEUROSCI, V1, P603, DOI 10.1111/j.1460-9568.1989.tb00366.x; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Tyzio R, 2007, EPILEPSIA, V48, P96, DOI 10.1111/j.1528-1167.2007.01295.x; Wright R, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/728395; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	25	151	155	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1102	+		10.1038/nn.3143	http://dx.doi.org/10.1038/nn.3143			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22729174	Green Accepted			2022-12-17	WOS:000306844500012
J	Goffin, D; Allen, M; Zhang, L; Amorim, M; Wang, ITJ; Reyes, ARS; Mercado-Berton, A; Ong, C; Cohen, S; Hu, LD; Blendy, JA; Carlson, GC; Siegel, SJ; Greenberg, ME; Zhou, ZL				Goffin, Darren; Allen, Megan; Zhang, Le; Amorim, Maria; Wang, I-Ting Judy; Reyes, Arith-Ruth S.; Mercado-Berton, Amy; Ong, Caroline; Cohen, Sonia; Hu, Linda; Blendy, Julie A.; Carlson, Gregory C.; Siegel, Steve J.; Greenberg, Michael E.; Zhou, Zhaolan			Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses	NATURE NEUROSCIENCE			English	Article							MOUSE MODEL; HISTONE DEACETYLASE; PYRAMIDAL NEURONS; OSCILLATIONS; DEFICIENCY; AUTISM; MICE	Mutations in the MECP2 gene cause the autism spectrum disorder Rett syndrome (RTT). One of the most common MeCP2 mutations associated with RTT occurs at threonine 158, converting it to methionine (T158M) or alanine (T158A). To understand the role of T158 mutations in the pathogenesis of RTT, we generated knockin mice that recapitulate the MeCP2 T158A mutation. We found a causal role for T158A mutation in the development of RTT-like phenotypes, including developmental regression, motor dysfunction, and learning and memory deficits. These phenotypes resemble those present in Mecp2 null mice and manifest through a reduction in MeCP2 binding to methylated DNA and a decrease in MeCP2 protein stability. The age-dependent development of event-related neuronal responses was disrupted by MeCP2 mutation, suggesting that impaired neuronal circuitry underlies the pathogenesis of RTT and that assessment of event-related potentials (ERPs) may serve as a biomarker for RTT and treatment evaluation.	[Goffin, Darren; Allen, Megan; Zhang, Le; Amorim, Maria; Wang, I-Ting Judy; Reyes, Arith-Ruth S.; Zhou, Zhaolan] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Mercado-Berton, Amy; Blendy, Julie A.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Ong, Caroline; Cohen, Sonia; Hu, Linda; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Carlson, Gregory C.; Siegel, Steve J.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School; University of Pennsylvania	Zhou, ZL (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	zhaolan@mail.med.upenn.edu	de Amorim, Maria Galli/K-8259-2016	de Amorim, Maria Galli/0000-0002-1910-8770; Zhang, Le/0000-0002-4860-831X; Siegel, Steven/0000-0001-8058-9713; Goffin, Darren/0000-0001-6284-1452	US National Institutes of Health [R00 NS058391, P30 HD026979]; Philadelphia Foundation; International Rett Syndrome Foundation; Alavi-Dabiri Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655, P30HD026979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS058391] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philadelphia Foundation; International Rett Syndrome Foundation; Alavi-Dabiri Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is dedicated to the memory of Dr. Tom Kadesch, an inspirational colleague and mentor. We thank A. West, D. Epstein and members of the Zhou laboratory for critical readings of the manuscript, and the Intellectual and Developmental Disability Research Center Gene Manipulation Core (P30 HD18655) at the Children's Hospital Boston for generation of knockin mice (M. Thompson, Y. Zhou and H. Ye). This work was supported by grants from the US National Institutes of Health (R00 NS058391 and P30 HD026979), the Philadelphia Foundation and International Rett Syndrome Foundation to Z.Z. D.G. acknowledges the generous support of the Alavi-Dabiri Postdoctoral Fellowship. Z.Z. is a Pew Scholar in Biomedical Science.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Armstrong DD, 2005, J CHILD NEUROL, V20, P747, DOI 10.1177/08830738050200082401; BADER GG, 1989, BRAIN DEV-JPN, V11, P110, DOI 10.1016/S0387-7604(89)80078-6; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; D'Cruz JA, 2010, NEUROBIOL DIS, V38, P8, DOI 10.1016/j.nbd.2009.12.018; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Gandal MJ, 2010, BIOL PSYCHIAT, V68, P1100, DOI 10.1016/j.biopsych.2010.09.031; Gandal MJ, 2011, NEUROPHARMACOLOGY; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Jentarra GM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-19; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kerr B, 2008, HUM MOL GENET, V17, P1707, DOI 10.1093/hmg/ddn061; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Roberts TPL, 2010, AUTISM RES, V3, P8, DOI 10.1002/aur.111; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Schanen C, 2004, AM J MED GENET A, V126A, P129, DOI 10.1002/ajmg.a.20571; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Stauder JEA, 2006, BRAIN DEV-JPN, V28, P487, DOI 10.1016/j.braindev.2006.02.011; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2011, PROG BIOPHYS MOL BIO, V105, P14, DOI 10.1016/j.pbiomolbio.2010.10.004; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Vacca M, 2001, BRAIN DEV-JPN, V23, pS246, DOI 10.1016/S0387-7604(01)00343-6; Winterer G, 2000, CLIN NEUROPHYSIOL, V111, P837, DOI 10.1016/S1388-2457(99)00322-3; Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009	44	151	153	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					274	283		10.1038/nn.2997	http://dx.doi.org/10.1038/nn.2997			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22119903	Green Accepted			2022-12-17	WOS:000299603500019
J	Kaun, KR; Azanchi, R; Maung, Z; Hirsh, J; Heberlein, U				Kaun, Karla R.; Azanchi, Reza; Maung, Zaw; Hirsh, Jay; Heberlein, Ulrike			A Drosophila model for alcohol reward	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; CONDITIONED PLACE PREFERENCE; MUSHROOM BODY; ETHANOL SENSITIVITY; NEURAL MECHANISMS; DOPAMINE; NOTCH; EXPRESSION; NEURONS; PROTEIN	The rewarding properties of drugs contribute to the development of abuse and addiction. We developed a new assay for investigating the motivational properties of ethanol in the genetically tractable model Drosophila melanogaster. Flies learned to associate cues with ethanol intoxication and, although transiently aversive, the experience led to a long-lasting attraction for the ethanol-paired cue, implying that intoxication is rewarding. Temporally blocking transmission in dopaminergic neurons revealed that flies require activation of these neurons to express, but not develop, conditioned preference for ethanol-associated cues. Moreover, flies acquired, consolidated and retrieved these rewarding memories using distinct sets of neurons in the mushroom body. Finally, mutations in scabrous, encoding a fibrinogen-related peptide that regulates Notch signaling, disrupted the formation of memories for ethanol reward. Our results thus establish that Drosophila can be useful for understanding the molecular, genetic and neural mechanisms underling the rewarding properties of ethanol.	[Kaun, Karla R.; Azanchi, Reza; Maung, Zaw; Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Hirsh, Jay] Univ Virginia, Dept Biol, Charlottesville, VA USA	University of California System; University of California San Francisco; University of Virginia	Kaun, KR (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	karla.kaun@ucsf.edu; ulrike.heberlein@ucsf.edu		Kaun, Karla/0000-0002-8756-9528	Heart and Stroke Foundation of Canada; US National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Waddell, J. Levine, M. Sokolowski, A. Barron and members of the Heberlein laboratory for reagents, input and advice, and S. Birman (Developmental Biology Institute of Marseilles-Luminy), F. Wolf (Gallo Institute), S. Sweeney (University of York), K. Kaiser (Glasgow University), N. Baker (Albert Einstein College of Medicine) and the Bloomington Stock Center for flies. Funding was provided by a Heart and Stroke Foundation of Canada Research Fellowship to K. R. K. and the US National Institutes of Health to U.H.	Akalal DBG, 2010, J NEUROSCI, V30, P16699, DOI 10.1523/JNEUROSCI.1882-10.2010; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; BAKER NE, 1990, SCIENCE, V250, P1370, DOI 10.1126/science.2175046; Berger KH, 2008, ALCOHOL CLIN EXP RES, V32, P895, DOI 10.1111/j.1530-0277.2008.00659.x; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Cunningham CL, 2000, PHARMACOL BIOCHEM BE, V67, P693, DOI 10.1016/S0091-3057(00)00414-7; Deadwyler SA, 2010, ANN NY ACAD SCI, V1187, P140, DOI 10.1111/j.1749-6632.2009.05155.x; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; Dhonnchadha BAN, 2008, BEHAV BRAIN RES, V195, P39, DOI 10.1016/j.bbr.2008.06.026; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Gremel CM, 2009, NEUROPSYCHOPHARMACOL, V34, P1443, DOI 10.1038/npp.2008.179; Hardie SL, 2006, J NEUROSCI METH, V153, P243, DOI 10.1016/j.jneumeth.2005.11.001; HU XX, 1995, GENETICS, V141, P607; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; Kitamoto T, 2002, J NEUROGENET, V16, P205, DOI 10.1080/01677060216295; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; LaFerriere H, 2008, GENETICS, V178, P1895, DOI 10.1534/genetics.107.084582; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Nehring LC, 2005, J BIOL CHEM, V280, P20349, DOI 10.1074/jbc.M500273200; Pautassi RM, 2008, PHARMACOL BIOCHEM BE, V88, P393, DOI 10.1016/j.pbb.2007.09.012; Phillips TJ, 1996, INT REV NEUROBIOL, V39, P243, DOI 10.1016/S0074-7742(08)60669-8; Powell PA, 2001, NATURE, V409, P626, DOI 10.1038/35054566; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Risinger FO, 2001, J NEUROSCI, V21, P340, DOI 10.1523/JNEUROSCI.21-01-00340.2001; Rodan AR, 2010, INT REV NEUROBIOL, V91, P25, DOI 10.1016/S0074-7742(10)91002-7; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Walker BM, 2007, BEHAV NEUROSCI, V121, P401, DOI 10.1037/0735-7044.121.2.401; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	45	151	154	0	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					612	U103		10.1038/nn.2805	http://dx.doi.org/10.1038/nn.2805			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21499254	Green Accepted			2022-12-17	WOS:000289886600017
J	Chakrabarti, L; Best, TK; Cramer, NP; Carney, RSE; Isaac, JTR; Galdzicki, Z; Haydar, TF				Chakrabarti, Lina; Best, Tyler K.; Cramer, Nathan P.; Carney, Rosalind S. E.; Isaac, John T. R.; Galdzicki, Zygmunt; Haydar, Tarik F.			Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome	NATURE NEUROSCIENCE			English	Article							TS65DN MOUSE MODEL; LONG-TERM POTENTIATION; CORTICAL INTERNEURONS; FRONTAL-CORTEX; SPECIFICATION; EXPRESSION; HIPPOCAMPUS; FOREBRAIN; PHENOTYPE; DEFICITS	Over-inhibition is thought to be one of the underlying causes of the cognitive deficits in Ts65Dn mice, the most widely used model of Down syndrome. We found a direct link between gene triplication and defects in neuron production during embryonic development. These neurogenesis defects led to an imbalance between excitatory and inhibitory neurons and to increased inhibitory drive in the Ts65Dn forebrain. We discovered that Olig1 and Olig2, two genes that are triplicated in Down syndrome and in Ts65Dn mice, were overexpressed in the Ts65Dn forebrain. To test the hypothesis that Olig triplication causes the neurological phenotype, we used a genetic approach to normalize the dosage of these two genes and thereby rescued the inhibitory neuron phenotype in the Ts65Dn brain. These data identify seminal alterations during brain development and suggest a mechanistic relationship between triplicated genes and these brain abnormalities in the Ts65Dn mouse.	[Chakrabarti, Lina; Carney, Rosalind S. E.; Haydar, Tarik F.] Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA; [Best, Tyler K.; Cramer, Nathan P.; Galdzicki, Zygmunt] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Isaac, John T. R.] NINDS, Dev Synapt Plast Sect, Bethesda, MD 20892 USA	Children's National Health System; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Haydar, TF (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	thaydar@bu.edu		Cramer, Nathan/0000-0001-6146-3664; Haydar, Tarik/0000-0001-6772-3076	Dana Foundation; National Down Syndrome Society; Jerome Lejeune Foundation; Uniformed Services University of the Health Sciences; Intellectual and Developmental Disabilities Research Center [P30 HD40677];  [RO1 HD05780]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076503, ZIANS003011] Funding Source: NIH RePORTER	Dana Foundation; National Down Syndrome Society; Jerome Lejeune Foundation; Uniformed Services University of the Health Sciences; Intellectual and Developmental Disabilities Research Center; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank V. Gallo, J. Corbin, and members of Corbin and Haydar laboratories for discussions and critical reading of the manuscript. This work was supported by a Dana Foundation Neuro-Immuno Imaging grant (T. F. H.), RO1 HD05780 (T. F. H. and Z.G.), the National Down Syndrome Society (L. C.), the Jerome Lejeune Foundation (Z.G.), Uniformed Services University of the Health Sciences (Z.G.) and a gift from Robin and Rob Wilder. Imaging was supported by the Intellectual and Developmental Disabilities Research Center (P30 HD40677).	Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Chakrabarti L, 2007, J NEUROSCI, V27, P11483, DOI 10.1523/JNEUROSCI.3406-07.2007; Clark S, 2006, EXP NEUROL, V200, P256, DOI 10.1016/j.expneurol.2006.02.005; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Cortez MA, 2009, PEDIATR RES, V65, P499, DOI 10.1203/PDR.0b013e31819d9076; Costa ACS, 1999, PHYSIOL BEHAV, V68, P211, DOI 10.1016/S0031-9384(99)00178-X; Costa ACS, 2005, NEUROSCI LETT, V382, P317, DOI 10.1016/j.neulet.2005.03.031; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; Dierssen M, 2003, CEREB CORTEX, V13, P758, DOI 10.1093/cercor/13.7.758; Eisenstat DD, 1999, J COMP NEUROL, V414, P217, DOI 10.1002/(SICI)1096-9861(19991115)414:2<217::AID-CNE6>3.0.CO;2-I; EPSTEIN CJ, 1986, EXPERIENTIA, V42, P1117, DOI 10.1007/BF01941286; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; GOLDEN JA, 1994, J NEUROPATH EXP NEUR, V53, P513, DOI 10.1097/00005072-199409000-00011; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Harashima C, 2006, J COMP NEUROL, V494, P815, DOI 10.1002/cne.20844; Haydar TF, 2005, MENT RETARD DEV D R, V11, P303, DOI 10.1002/mrdd.20088; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hyde LA, 2001, BEHAV BRAIN RES, V118, P53, DOI 10.1016/S0166-4328(00)00313-2; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; KORENBERG JR, 1990, AM J MED GENET, P91; Kurt MA, 2000, BRAIN RES, V858, P191, DOI 10.1016/S0006-8993(00)01984-3; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Ma QF, 2006, J PHYSIOL-LONDON, V575, P379, DOI 10.1113/jphysiol.2006.113449; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Perez-Cremades D, 2010, J NEURAL TRANSM, V117, P445, DOI 10.1007/s00702-010-0376-9; Polleux F, 2004, MENT RETARD DEV D R, V10, P303, DOI 10.1002/mrdd.20044; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; SCHMIDTSIDOR B, 1990, CLIN NEUROPATHOL, V9, P181; SEGAL DJ, 1974, J CELL PHYSL, V90, P83; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Siarey RJ, 1997, NEUROPHARMACOLOGY, V36, P1549, DOI 10.1016/S0028-3908(97)00157-3; Sussel L, 1999, DEVELOPMENT, V126, P3359; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Valcanis H, 2003, J NEUROSCI, V23, P5113; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	50	151	151	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					927	U39		10.1038/nn.2600	http://dx.doi.org/10.1038/nn.2600			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20639873	Green Accepted			2022-12-17	WOS:000280400600010
J	Rossi, EA; Roorda, A				Rossi, Ethan A.; Roorda, Austin			The relationship between visual resolution and cone spacing in the human fovea	NATURE NEUROSCIENCE			English	Article							HUMAN RETINA; ADAPTIVE OPTICS; GANGLION-CELLS; TOPOGRAPHY; VISION; ACUITY; LIMITS	Visual resolution decreases rapidly outside of the foveal center. The anatomical and physiological basis for this reduction is unclear. We used simultaneous adaptive optics imaging and psychophysical testing to measure cone spacing and resolution across the fovea, and found that resolution was limited by cone spacing only at the foveal center. Immediately outside of the center, resolution was worse than cone spacing predicted and better matched the sampling limit of midget retinal ganglion cells.	[Rossi, Ethan A.; Roorda, Austin] Univ Calif Berkeley, Vis Sci Grad Grp, Berkeley, CA 94720 USA; [Roorda, Austin] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rossi, EA (corresponding author), Univ Calif Berkeley, Vis Sci Grad Grp, Berkeley, CA 94720 USA.	earossi@berkeley.edu	Rossi, Ethan/A-7933-2013; Rossi, Ethan/AAC-6204-2019	Rossi, Ethan/0000-0003-3210-0551; Rossi, Ethan/0000-0003-3210-0551	National Science Foundation Science and Technology Center [AST-9876783]; University of California, Santa Cruz; National Institutes of Health [EY014375]; NATIONAL EYE INSTITUTE [R01EY014375] Funding Source: NIH RePORTER	National Science Foundation Science and Technology Center(National Science Foundation (NSF)); University of California, Santa Cruz(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank K. Grieve for her assistance with data collection and P. Tiruveedhula for his help on software development. This work was supported by the National Science Foundation Science and Technology Center for Adaptive Optics under cooperative agreement AST-9876783 managed by the University of California, Santa Cruz and by National Institutes of Health grant EY014375.	Anderson RS, 1999, J OPT SOC AM A, V16, P2334, DOI 10.1364/JOSAA.16.002334; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; Drasdo N, 2007, VISION RES, V47, P2901, DOI 10.1016/j.visres.2007.01.007; ENOCH JM, 1973, DOC OPHTHALMOL, V34, P143, DOI 10.1007/BF00151803; GREEN DG, 1970, J PHYSIOL-LONDON, V207, P351, DOI 10.1113/jphysiol.1970.sp009065; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Marcos S, 1997, J OPT SOC AM A, V14, P731, DOI 10.1364/JOSAA.14.000731; Polyak S. L., 1941, RETINA-J RET VIT DIS; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Rossi EA, 2007, J VISION, V7, DOI 10.1167/7.8.14; THIBOS LN, 1987, J OPT SOC AM A, V4, P1524, DOI 10.1364/JOSAA.4.001524; WILLIAMS DR, 1987, J OPT SOC AM A, V4, P1514, DOI 10.1364/JOSAA.4.001514	15	151	152	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					156	157		10.1038/nn.2465	http://dx.doi.org/10.1038/nn.2465			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20023654	Green Accepted			2022-12-17	WOS:000273985800009
J	McGuire, LMM; Sabes, PN				McGuire, Leah M. M.; Sabes, Philip N.			Sensory transformations and the use of multiple reference frames for reach planning	NATURE NEUROSCIENCE			English	Article							DIRECT VISUOMOTOR TRANSFORMATIONS; POSTERIOR PARIETAL CORTEX; 3-DIMENSIONAL SPACE; PREMOTOR CORTEX; LIMB MOVEMENT; EYE-POSITION; VISUAL SPACE; REPRESENTATIONS; INFORMATION; TARGETS	The sensory signals that drive movement planning arrive in a variety of 'reference frames', and integrating or comparing them requires sensory transformations. We propose a model in which the statistical properties of sensory signals and their transformations determine how these signals are used. This model incorporates the patterns of gaze-dependent errors that we found in our human psychophysics experiment when the sensory signals available for reach planning were varied. These results challenge the widely held ideas that error patterns directly reflect the reference frame of the underlying neural representation and that it is preferable to use a single common reference frame for movement planning. We found that gaze-dependent error patterns, often cited as evidence for retinotopic reach planning, can be explained by a transformation bias and are not exclusively linked to retinotopic representations. Furthermore, the presence of multiple reference frames allows for optimal use of available sensory information and explains task-dependent reweighting of sensory signals.	[Sabes, Philip N.] Univ Calif San Francisco, Dept Physiol, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sabes, PN (corresponding author), Univ Calif San Francisco, Dept Physiol, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	sabes@phy.ucsf.edu			National Eye Institute [R01 EY-015679]; National Institute of Mental Health [P50 MH77970]; McKnight Endowment Fund for Neuroscience; National Science Foundation; NATIONAL EYE INSTITUTE [R01EY015679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); McKnight Endowment Fund for Neuroscience; National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank S. M. Beurze, S. van Pelt, W. P. Medendorp and S. J. Sober for generously providing their data for model comparison. This work was supported by the National Eye Institute (R01 EY-015679), the National Institute of Mental Health (P50 MH77970) and the McKnight Endowment Fund for Neuroscience. L. M. M. M. was supported by a graduate fellowship from the National Science Foundation.	Ahmed AA, 2008, CURR BIOL, V18, P763, DOI 10.1016/j.cub.2008.04.061; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Balslev D, 2008, J NEUROSCI, V28, P8968, DOI 10.1523/JNEUROSCI.1513-08.2008; Batista AP, 2007, J NEUROPHYSIOL, V98, P966, DOI 10.1152/jn.00421.2006; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Battaglia-Mayer A, 2003, CEREB CORTEX, V13, P1009, DOI 10.1093/cercor/13.10.1009; Battaglia-Mayer A, 2001, CEREB CORTEX, V11, P528, DOI 10.1093/cercor/11.6.528; Beurze SM, 2006, J NEUROPHYSIOL, V96, P352, DOI 10.1152/jn.01362.2005; Blohm G, 2007, J VISION, V7, DOI 10.1167/7.5.4; BOCK O, 1986, EXP BRAIN RES, V64, P476, DOI 10.1007/BF00340484; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Burnod Y, 1999, EXP BRAIN RES, V129, P325, DOI 10.1007/s002210050902; Caminiti R, 1998, CURR OPIN NEUROBIOL, V8, P753, DOI 10.1016/S0959-4388(98)80118-9; CARROZZO M, 1994, NEUROREPORT, V5, P453, DOI 10.1097/00001756-199401120-00021; Carrozzo M, 1999, EXP BRAIN RES, V129, P201, DOI 10.1007/s002210050890; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; Engel KC, 2002, ARCH ITAL BIOL, V140, P211; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Good P, 2000, PERMUTATION TESTS PR, V2; Helbig HB, 2007, EXP BRAIN RES, V179, P595, DOI 10.1007/s00221-006-0814-y; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Henriques DYP, 2002, J NEUROPHYSIOL, V87, P1677, DOI 10.1152/jn.00509.2001; Henriques DYP, 2000, EXP BRAIN RES, V132, P179, DOI 10.1007/s002210000340; Kluzik J, 2008, J NEUROPHYSIOL, V100, P1455, DOI 10.1152/jn.90334.2008; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kording Konrad P, 2006, Novartis Found Symp, V270, P191; KORDING KP, 2006, NIPS, P737; Lacquaniti F, 1998, EUR J NEUROSCI, V10, P195; LACQUANITI F, 1995, CEREB CORTEX, V5, P391, DOI 10.1093/cercor/5.5.391; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Lewald J, 2000, VISION RES, V40, P539, DOI 10.1016/S0042-6989(99)00197-2; McIntyre J, 1998, J NEUROSCI, V18, P8423, DOI 10.1523/JNEUROSCI.18-20-08423.1998; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Pouget A, 2002, COGNITION, V83, pB1, DOI 10.1016/S0010-0277(01)00163-9; Schlicht EJ, 2007, J NEUROPHYSIOL, V97, P4203, DOI 10.1152/jn.00160.2007; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582, DOI 10.1152/jn.1989.62.2.582; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; Van Pelt S, 2008, J NEUROPHYSIOL, V99, P2281, DOI 10.1152/jn.01281.2007; Vindras P, 1998, J NEUROPHYSIOL, V79, P3290, DOI 10.1152/jn.1998.79.6.3290; Wu W, 2007, EXP BRAIN RES, V176, P652, DOI 10.1007/s00221-006-0818-7; Wu W, 2006, EXP BRAIN RES, V175, P197, DOI 10.1007/s00221-006-0556-x; Yuille A. L., 1996, PERCEPTION BAYESIAN, P123, DOI DOI 10.1017/CBO9780511984037.006	50	151	153	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					1056	U134		10.1038/nn.2357	http://dx.doi.org/10.1038/nn.2357			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19597495	Green Submitted, Green Accepted			2022-12-17	WOS:000268396300021
J	Barnes, DC; Hofacer, RD; Zaman, AR; Rennaker, RL; Wilson, DA				Barnes, Dylan C.; Hofacer, Rylon D.; Zaman, Ashiq R.; Rennaker, Robert L.; Wilson, Donald A.			Olfactory perceptual stability and discrimination	NATURE NEUROSCIENCE			English	Article							PATTERN SEPARATION; DENTATE GYRUS; CORTEX; MEMORY; CA3	No two roses smell exactly alike, but our brain accurately bundles these variations into a single percept 'rose'. We found that ensembles of rat olfactory bulb neurons decorrelate complex mixtures that vary by as little as a single missing component, whereas olfactory (piriform) cortical neural ensembles perform pattern completion in response to an absent component, essentially filling in the missing information and allowing perceptual stability. This piriform cortical ensemble activity predicts olfactory perception.	[Barnes, Dylan C.; Hofacer, Rylon D.; Zaman, Ashiq R.; Wilson, Donald A.] Univ Oklahoma, Dept Zool, Neurobehav Inst, Norman, OK 73019 USA; [Rennaker, Robert L.] Univ Oklahoma, Sch Aerosp & Mech Engn, Neural Engn Lab, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Wilson, DA (corresponding author), Nathan S Kline Inst Psychiat Res, Emot Brain Inst, 140 Old Orangeburg Rd, Orangeburg, NY 10962 USA.	dwilson@nki.rfmh.org	Rennaker, Robert/K-9049-2013	Rennaker, Robert/0000-0003-1260-1973; Wilson, Donald/0000-0001-8918-2151	US National Institute on Deafness and other Communication Disorders [R01-DC03906, R01-DC008982]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003906, R01DC008982] Funding Source: NIH RePORTER	US National Institute on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by grant R01-DC03906 to D. A. W. and grant R01-DC008982 to R. L. R and D. A. W. from the US National Institute on Deafness and other Communication Disorders.	Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Ferreira ACS, 2003, J AGR FOOD CHEM, V51, P1377, DOI 10.1021/jf025847o; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HOPFIELD JJ, 1991, P NATL ACAD SCI USA, V88, P6462, DOI 10.1073/pnas.88.15.6462; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; POLAK EH, 1973, J THEOR BIOL, V40, P469, DOI 10.1016/0022-5193(73)90005-2; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Wilson D. A., 2006, LEARNING SMELL; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003	15	151	152	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2008	11	12					1378	1380		10.1038/nn.2217	http://dx.doi.org/10.1038/nn.2217			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	375JF	18978781	Green Accepted			2022-12-17	WOS:000261109300009
J	Van den Oever, MC; Goriounova, NA; Li, KW; Van der Schors, RC; Binnekade, R; Schoffelmeer, ANM; Mansvelder, HD; Smit, AB; Spijker, S; De Vries, TJ				Van den Oever, Michel C.; Goriounova, Natalia A.; Li, Ka Wan; Van der Schors, Roel C.; Binnekade, Rob; Schoffelmeer, Anton N. M.; Mansvelder, Huibert D.; Smit, August B.; Spijker, Sabine; De Vries, Taco J.			Prefrontal cortex AMPA receptor plasticity is crucial for cue-induced relapse to heroin-seeking	NATURE NEUROSCIENCE			English	Article							MEDIATED SYNAPTIC-TRANSMISSION; VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS; INDUCED REINSTATEMENT; COCAINE-SEEKING; TYROSINE PHOSPHORYLATION; BEHAVIORAL SENSITIZATION; CONDITIONED HEROIN; GLUTAMATE RELEASE	Associative learning processes have an important role in the initiation and persistence of heroin-seeking. Here we show in a rat self-administration model that reexposure to cues previously associated with heroin results in downregulation of AMPA receptor subunit GluR2 and concomitant upregulation of clathrin-coat assembly protein AP2m1 in synaptic membranes of the medial prefrontal cortex (mPFC). Reduced AMPA receptor expression in synaptic membranes was associated with a decreased AMPA/NMDA current ratio and increased rectification index in mPFC pyramidal neurons. Systemic or ventral (but not dorsal) mPFC injections of a peptide inhibiting GluR2 endocytosis attenuated both the rectification index and cue-induced relapse to heroin-seeking, without affecting sucrose-seeking. We conclude that GluR2 receptor endocytosis and the resulting synaptic depression in ventral mPFC are crucial for cue-induced relapse to heroin-seeking. As reexposure to conditioned stimuli is a major cause for heroin relapse, inhibition of GluR2 endocytosis may provide a new target for the treatment of heroin addiction.	[Van den Oever, Michel C.; Li, Ka Wan; Van der Schors, Roel C.; Smit, August B.; Spijker, Sabine; De Vries, Taco J.] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; [Goriounova, Natalia A.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Integrat Neurophysiol, NL-1081 HV Amsterdam, Netherlands; [Binnekade, Rob; Schoffelmeer, Anton N. M.; De Vries, Taco J.] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Anat & Neurosci, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Spijker, S (corresponding author), Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Mol & Cellular Neurobiol, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	sabine.spijker@cncr.vu.nl	van den Oever, Michel C/A-2180-2015; Goriounova, Natalia/ABE-6759-2020; De Vries, Taco J/B-2831-2014; Mansvelder, Huibert/N-6138-2018; Spijker, Sabine/F-2300-2011; van den Oever, Michel/GNW-3560-2022; Smit, August B/E-8410-2011	van den Oever, Michel C/0000-0001-5523-8612; Mansvelder, Huibert/0000-0003-1365-5340; van den Oever, Michel/0000-0001-5523-8612; li, ka wan/0000-0001-6983-5055; Goriounova, Natalia/0000-0002-5917-983X; De Vries, Taco/0000-0002-0340-4946; Spijker, Sabine/0000-0002-6814-2019	Medical Systems Biology; Netherlands Organization for Scientific Research	Medical Systems Biology; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The authors thank W. de Vries, H. Raaso, M. Stegeman and Y. Gouwenberg for technical assistance and Y. Shaham for valuable comments on the manuscript. This work was supported by grants from the Center for Medical Systems Biology (to M. C. V. d. O., S. S., R. C. V. d. S., K. W. L. and A. B. S.) and the Netherlands Organization for Scientific Research (to N. A. G. and H. D. M.).	Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Bossert JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2197, DOI 10.1038/sj.npp.1300977; Bossert JM, 2004, J NEUROSCI, V24, P10726, DOI 10.1523/JNEUROSCI.3207-04.2004; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Dingledine R, 1999, PHARMACOL REV, V51, P7; Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Fuchs RA, 2002, PSYCHOPHARMACOLOGY, V160, P425, DOI 10.1007/s00213-001-0997-7; Hayashi T, 2004, J NEUROSCI, V24, P6152, DOI 10.1523/JNEUROSCI.0799-04.2004; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Hu J, 2006, PROTEOMICS, V6, P4321, DOI 10.1002/pmic.200600026; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kastning K, 2007, P NATL ACAD SCI USA, V104, P2991, DOI 10.1073/pnas.0611170104; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Koya E, 2006, J NEUROCHEM, V98, P905, DOI 10.1111/j.1471-4159.2006.03917.x; KOYA E, 2008, NEUROPHARMACOLO 0508; LaLumiere RT, 2008, J NEUROSCI, V28, P3170, DOI 10.1523/JNEUROSCI.5129-07.2008; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Li KW, 2007, J PROTEOME RES, V6, P3127, DOI 10.1021/pr070086w; Liu T, 2006, J NEUROSCI METH, V158, P22, DOI 10.1016/j.jneumeth.2006.05.010; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; MCDONALD AJ, 1987, J COMP NEUROL, V262, P46, DOI 10.1002/cne.902620105; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; McFarland K, 2003, J NEUROSCI, V23, P3531; McLaughlin J, 2003, PSYCHOPHARMACOLOGY, V168, P57, DOI 10.1007/s00213-002-1196-x; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; Myme CIO, 2003, J NEUROPHYSIOL, V90, P771, DOI 10.1152/jn.00070.2003; Nestler EJ, 2002, NAT NEUROSCI, V5, P1076, DOI 10.1038/nn945; OBRIEN CP, 1986, CLASSICAL CONDITION, P329; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Rogers JL, 2008, NEUROSCIENCE, V151, P579, DOI 10.1016/j.neuroscience.2007.10.012; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Schmidt ED, 2005, EUR J NEUROSCI, V22, P2347, DOI 10.1111/j.1460-9568.2005.04435.x; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; THIERRY AM, 1973, BRAIN RES, V50, P230, DOI 10.1016/0006-8993(73)90614-8; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; WIKLER A, 1973, ARCH GEN PSYCHIAT, V28, P611; Zhou W, 2007, NEUROSCIENCE, V144, P1209, DOI 10.1016/j.neuroscience.2006.11.013	50	151	155	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2008	11	9					1053	1058		10.1038/nn.2165	http://dx.doi.org/10.1038/nn.2165			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	341NA	19160503				2022-12-17	WOS:000258720000015
J	Lockhart, DB; Ting, LH				Lockhart, Daniel B.; Ting, Lena H.			Optimal sensorimotor transformations for balance	NATURE NEUROSCIENCE			English	Article							AUTOMATIC POSTURAL RESPONSES; MUSCLE SYNERGIES; MOTOR CONTROL; STANCE; FORCE; PERTURBATIONS; INFORMATION; MOVEMENT; MODEL; CAT	Here we have identified a sensorimotor transformation that is used by a mammalian nervous system to produce a multijoint motor behavior. Using a simple biomechanical model, a delayed-feedback rule based on an optimal tradeoff between postural error and neural effort explained patterns of muscle activation in response to a sudden loss of balance in cats. Following the loss of large sensory afferents, changes in these muscle-activation patterns reflected an optimal reweighting of sensory feedback gains to minimize postural instability. Specifically, a loss of center-of-mass-acceleration information, which allowed for a rapid initial rise in the muscle activity in intact animals, was absent after large-fiber sensory neuropathy. Our results demonstrate that a simple and flexible neural feedback control strategy coordinates multiple muscles over time via a small set of extrinsic, task-level variables during complex multijoint natural movements.	Emory Univ, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA	Emory University; University System of Georgia; Georgia Institute of Technology	Ting, LH (corresponding author), Emory Univ, Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.	lting@emory.edu	Ting, Lena H/I-9311-2014		NICHD NIH HHS [R01 HD046922] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046922] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alexandrov AV, 2001, BIOL CYBERN, V84, P425, DOI 10.1007/PL00007986; Bosco G, 2000, J NEUROPHYSIOL, V83, P2931, DOI 10.1152/jn.2000.83.5.2931; BOYD IA, 1954, J PHYSIOL-LONDON, V124, P476, DOI 10.1113/jphysiol.1954.sp005122; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Chhabra M, 2006, NEURAL COMPUT, V18, P2320, DOI 10.1162/neco.2006.18.10.2320; d'Avella A, 2005, P NATL ACAD SCI USA, V102, P3076, DOI 10.1073/pnas.0500199102; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Deliagina TG, 2007, PHYSIOL BEHAV, V92, P148, DOI 10.1016/j.physbeh.2007.05.023; DIENER HC, 1988, J NEUROPHYSIOL, V59, P1888, DOI 10.1152/jn.1988.59.6.1888; Flash T, 2005, CURR OPIN NEUROBIOL, V15, P660, DOI 10.1016/j.conb.2005.10.011; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GOLLHOFER A, 1989, NEUROSCI LETT, V105, P73, DOI 10.1016/0304-3940(89)90014-1; Graziano M, 2006, ANNU REV NEUROSCI, V29, P105, DOI 10.1146/annurev.neuro.29.051605.112924; HE JP, 1991, P 28 IEEE C DEC CONT, V1, P518; Horak F. B., 1996, HDB PHYSIOL 12, P255; Hyngstrom AS, 2007, NAT NEUROSCI, V10, P363, DOI 10.1038/nn1852; INGLIS JT, 1994, EXP BRAIN RES, V101, P159; INGLIS JT, 1995, J NEUROPHYSIOL, V73, P1181, DOI 10.1152/jn.1995.73.3.1181; Jeka J, 2004, J NEUROPHYSIOL, V92, P2368, DOI 10.1152/jn.00983.2003; Jo S, 2004, BIOL CYBERN, V91, P188, DOI 10.1007/s00422-004-0497-z; JOHANSSON RS, 1992, EXP BRAIN RES, V89, P181, DOI 10.1007/BF00229015; Kuo AD, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S07; Lin DC, 2000, J NEUROPHYSIOL, V83, P652, DOI 10.1152/jn.2000.83.2.652; Loeb GE, 1999, EXP BRAIN RES, V126, P1, DOI 10.1007/s002210050712; Macpherson JM, 2007, J NEUROPHYSIOL, V97, P4357, DOI 10.1152/jn.01338.2006; MACPHERSON JM, 1988, J NEUROPHYSIOL, V60, P218, DOI 10.1152/jn.1988.60.1.218; MACPHERSON JM, 1994, EXP BRAIN RES, V101, P397; Macpherson JM, 1999, J NEUROPHYSIOL, V82, P3066, DOI 10.1152/jn.1999.82.6.3066; NASHNER LM, 1977, EXP BRAIN RES, V30, P13; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Poggio T, 2004, NATURE, V431, P768, DOI 10.1038/nature03014; Poppele R, 2003, TRENDS NEUROSCI, V26, P269, DOI 10.1016/S0166-2236(03)00073-0; Risher DW, 1997, J BIOMECH ENG-T ASME, V119, P417, DOI 10.1115/1.2798288; Runge CF, 1998, EXP BRAIN RES, V122, P403, DOI 10.1007/s002210050528; SCHAFER SS, 1967, EXPERIENTIA, V23, P1026, DOI 10.1007/BF02136428; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; SOECHTING JF, 1988, J NEUROPHYSIOL, V59, P1296, DOI 10.1152/jn.1988.59.4.1296; Stapley PJ, 2002, J NEUROSCI, V22, P5803; Ting LH, 2007, PROG BRAIN RES, V165, P299, DOI 10.1016/S0079-6123(06)65019-X; Ting LH, 2005, J NEUROPHYSIOL, V93, P609, DOI 10.1152/jn.00681.2004; Ting LH, 2004, J NEUROPHYSIOL, V92, P808, DOI 10.1152/jn.00773.2003; Todorov E, 2005, J ROBOTIC SYST, V22, P691, DOI 10.1002/rob.20093; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Torres-Oviedo G, 2006, J NEUROPHYSIOL, V96, P1530, DOI 10.1152/jn.00810.2005; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; van Antwerp KW, 2007, J BIOMECH, V40, P3570, DOI 10.1016/j.jbiomech.2007.06.001; van der Kooij H, 1999, BIOL CYBERN, V80, P299, DOI 10.1007/s004220050527	50	151	157	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1329	1336		10.1038/nn1986	http://dx.doi.org/10.1038/nn1986			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17873869				2022-12-17	WOS:000249720800021
J	Perez-Otano, I; Lujan, R; Tavalin, SJ; Plomann, M; Modregger, J; Liu, XB; Jones, EG; Heinemann, SF; Lo, DC; Ehlers, MD				Perez-Otano, I; Lujan, R; Tavalin, SJ; Plomann, M; Modregger, J; Liu, XB; Jones, EG; Heinemann, SF; Lo, DC; Ehlers, MD			Endocytosis and synaptic removal of NR3A-containing NMDA receptors by PACSIN1/syndapin1	NATURE NEUROSCIENCE			English	Article							CRITICAL PERIOD; SUBUNIT; TRAFFICKING; PROTEIN; LOCALIZATION; DENSITY; INTERNALIZATION; EXPRESSION; MEMBRANE; SYNAPSES	A key step in glutamatergic synapse maturation is the replacement of developmentally expressed N-methyl-D-aspartate receptors (NMDARs) with mature forms that differ in subunit composition, electrophysiological properties and propensity to elicit synaptic plasticity. However, the mechanisms underlying the removal and replacement of synaptic NMDARs are poorly understood. Here we demonstrate that NMDARs containing the developmentally regulated NR3A subunit undergo rapid endocytosis from the dendritic plasma membrane in cultured rat hippocampal neurons. This endocytic removal is regulated by PACSIN1/syndapin1, which directly and selectively binds the carboxy-terminal domain of NR3A through its NPF motifs and assembles a complex of proteins including dynamin and clathrin. Endocytosis of NR3A by PACSIN1 is activity dependent, and disruption of PACSIN1 function causes NR3A accumulation at synaptic sites. Our results reveal a new activity-dependent mechanism involved in the regulation of NMDAR expression at synapses during development, and identify a brain-specific endocytic adaptor that confers spatiotemporal and subunit specificity to NMDAR endocytosis.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Navarra, CIMA, Dept Neurosci, Cellular Neurobiol Lab, Pamplona 31008, Spain; Univ Castilla La Mancha, Fac Med, CRIB, Dept Ciencias Med, Albacete 02006, Spain; Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; Univ Cologne, Ctr Biochem, D-50931 Cologne, Germany; Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; University of Navarra; Universidad de Castilla-La Mancha; University of Tennessee System; University of Tennessee Health Science Center; University of Cologne; University of Cologne; University of California System; University of California Davis; Salk Institute; Duke University; Howard Hughes Medical Institute	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Perez-Otano, Isabel/S-9613-2017; Lujan, Rafael/G-2555-2015	Perez-Otano, Isabel/0000-0002-7222-8202; Lujan Miras, Rafael/0000-0003-2001-9545; Modregger, Jan/0000-0001-6209-5891	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402, R01NS046661, R01NS028709, R01NS032742, R01NS047574, R29NS032742] Funding Source: NIH RePORTER; NIMH NIH HHS [MH64748, R01 MH064748] Funding Source: Medline; NINDS NIH HHS [R01 NS047574, R01 NS039402, NS46661, NS39402, R01 NS28709, R01 NS028709, NS32742, R01 NS046661] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; BURGARD EC, 1994, DEV BRAIN RES, V80, P275, DOI 10.1016/0165-3806(94)90113-9; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; da Costa SR, 2003, MOL BIOL CELL, V14, P4397, DOI 10.1091/mbc.E03-05-0315; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; KATO N, 1993, P NATL ACAD SCI USA, V90, P7114, DOI 10.1073/pnas.90.15.7114; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; LEVITTGILMOUR TA, 1986, J NEUROSCI, V6, P1606; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Perez-Otano I, 2004, NEUROSIGNALS, V13, P175, DOI 10.1159/000077524; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Petralia RS, 2003, EUR J NEUROSCI, V18, P3207, DOI 10.1111/j.1460-9568.2003.03074.x; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Racca C, 2000, J NEUROSCI, V20, P2512; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Rao A, 1998, J NEUROSCI, V18, P1217; ROBERTS A, 1987, J FAM VIOLENCE, V2, P81, DOI DOI 10.1007/BF00976372; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Tovar KR, 2002, NEURON, V34, P253; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314	50	151	159	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					611	621		10.1038/nn1680	http://dx.doi.org/10.1038/nn1680			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16617342	Green Accepted			2022-12-17	WOS:000237417200011
J	Kurtzer, I; Herter, TM; Scott, SH				Kurtzer, I; Herter, TM; Scott, SH			Random change in cortical load representation suggests distinct control of posture and movement	NATURE NEUROSCIENCE			English	Article							EQUILIBRIUM-POINT CONTROL; PRIMARY MOTOR CORTEX; DIRECTIONAL ISOMETRIC FORCE; HUMAN ARM MOVEMENT; VOLUNTARY MOVEMENT; MECHANICAL LOADS; MUSCLE; TASK; NETWORKS; SHOULDER	Accurately maintaining a fixed limb posture and quickly moving between postures underlies both everyday skills, including holding and lifting a cup of coffee, and expert skills, such as an Olympic wrestler's holding and throwing an opponent. A fundamental question in limb motor control is whether the brain manages these contrasting goals of posture and movement through a single, robust control process or whether each engages a specialized control process. We addressed this question by examining how individual neurons in the primary motor cortex of macaque monkeys represent mechanical loads during posture and movement tasks. Notably, approximately half of the neurons that expressed load-related activity did so exclusively during either posture only or movement only. Further, those neurons with load-related activity during both tasks randomly switched their magnitude of response between tasks. These random changes in load representation suggest specialized control processes, one for posture and one for movement.	Queens Univ, Ctr Neurosci Studies, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Scott, SH (corresponding author), Queens Univ, Ctr Neurosci Studies, Dept Anat & Cell Biol, Botterell Hall, Kingston, ON K7L 3N6, Canada.	steve@biomed.queensu.ca						Andersen RA, 2004, TRENDS COGN SCI, V8, P486, DOI 10.1016/j.tics.2004.09.009; Ashe J, 1997, BEHAV BRAIN RES, V87, P255; Batschelet E., 1981, CIRCULAR STAT BIOL; Brooke JD, 1997, PROG NEUROBIOL, V51, P393, DOI 10.1016/S0301-0082(96)00061-5; Brown LE, 2003, J NEUROPHYSIOL, V90, P3105, DOI 10.1152/jn.00013.2003; Bullock D, 1998, CEREB CORTEX, V8, P48, DOI 10.1093/cercor/8.1.48; Cabel DW, 2001, J NEUROPHYSIOL, V86, P2102, DOI 10.1152/jn.2001.86.4.2102; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; FELDMAN AG, 1986, J MOTOR BEHAV, V18, P17; FETZ EE, 1987, CIBA F SYMP, V132, P98; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; GOMI H, 1993, NEURAL NETWORKS, V6, P485, DOI 10.1016/S0893-6080(05)80053-X; Gottlieb GL, 1997, J NEUROPHYSIOL, V78, P2985, DOI 10.1152/jn.1997.78.6.2985; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Gribble PL, 1998, J NEUROPHYSIOL, V79, P1409, DOI 10.1152/jn.1998.79.3.1409; Gribble PL, 2000, EXP BRAIN RES, V135, P474, DOI 10.1007/s002210000547; Hepp-Reymond MC, 1999, EXP BRAIN RES, V128, P123, DOI 10.1007/s002210050827; Hinder MR, 2003, J PHYSIOL-LONDON, V549, P953, DOI 10.1113/jphysiol.2002.033845; Holdefer RN, 2002, EXP BRAIN RES, V146, P233, DOI 10.1007/s00221-002-1166-x; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; JOYCE GC, 1969, J PHYSIOL-LONDON, V204, P461, DOI 10.1113/jphysiol.1969.sp008924; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kilner JM, 2000, J NEUROSCI, V20, P8838; KURTZER I, IN PRESS EXP BRAIN R; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; McAuley JH, 2003, PROG NEUROBIOL, V69, P27, DOI 10.1016/S0301-0082(03)00003-0; MUIR RB, 1983, BRAIN RES, V261, P312, DOI 10.1016/0006-8993(83)90635-2; Mussa-Ivaldi FA, 2000, PHILOS T R SOC B, V355, P1755, DOI 10.1098/rstb.2000.0733; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; Schaal S, 2004, NAT NEUROSCI, V7, P1137, DOI 10.1038/nn1322; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Scott SH, 1996, J MUSCLE RES CELL M, V17, P207, DOI 10.1007/BF00124243; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Scott SH, 2003, CURR OPIN NEUROBIOL, V13, P671, DOI 10.1016/j.conb.2003.10.012; Seki K, 2003, NAT NEUROSCI, V6, P1309, DOI 10.1038/nn1154; Sergio LE, 1998, J NEUROPHYSIOL, V80, P1577, DOI 10.1152/jn.1998.80.3.1577; Sergio LE, 2003, J NEUROPHYSIOL, V89, P212, DOI 10.1152/jn.00016.2002; Shapiro MB, 2002, J NEUROPHYSIOL, V88, P1059, DOI 10.1152/jn.2002.88.2.1059; STEIN RB, 1988, TRENDS NEUROSCI, V11, P328, DOI 10.1016/0166-2236(88)90097-5; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	45	151	152	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					498	504		10.1038/nn1420	http://dx.doi.org/10.1038/nn1420			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15768037				2022-12-17	WOS:000228040400021
J	Kennerley, SW; Diedrichsen, J; Hazeltine, E; Semjen, A; Ivry, RB				Kennerley, SW; Diedrichsen, J; Hazeltine, E; Semjen, A; Ivry, RB			Callosotomy patients exhibit temporal uncoupling during continuous bimanual movements	NATURE NEUROSCIENCE			English	Article							COORDINATION; DIRECTION; DYNAMICS	Rhythmic bimanual movements are highly constrained in the temporal domain, with the gestures of the two hands tightly synchronized. Previous studies have implicated a subcortical locus for temporal coupling based on the observation that these constraints persist in callosotomy patients. We now report that such coupling is restricted to movements entailing a discrete event (such as a movement onset). Three callosotomy patients exhibited a striking lack of temporal coupling during continuous movements, with the two hands oscillating at non-identical frequencies. We propose a subcortical locus of temporal coupling for movements involving discrete events. In contrast, synchronization between the hands during continuous movements depends on interhemispheric transmission across the corpus callosum.	Univ Calif Berkeley, Berkeley, CA 94720 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; CNRS, Ctr Rech Neurosci Cognit, F-13402 Marseille, France	University of California System; University of California Berkeley; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Centre National de la Recherche Scientifique (CNRS)	Ivry, RB (corresponding author), Univ Calif Berkeley, 3210 Tolman Hall 1650, Berkeley, CA 94720 USA.		Diedrichsen, Jörn/AAQ-2242-2020; Kennerley, Steven W/E-3330-2018; Diedrichsen, Jörn/A-7789-2010	Diedrichsen, Jörn/0000-0003-0264-8532; Kennerley, Steven W/0000-0002-5696-7507; Diedrichsen, Jörn/0000-0003-0264-8532; Hazeltine, Richard/0000-0002-0893-5789	NINDS NIH HHS [R01 NS30256, P50 NS17778] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS017778, R01NS030256] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BULLOCK D, 1988, PSYCHOL REV, V95, P49, DOI 10.1037/0033-295X.95.1.49; Carson RG, 1997, Q J EXP PSYCHOL-A, V50, P664, DOI 10.1080/027249897392062; Cattaert D, 1999, BIOL CYBERN, V81, P343, DOI 10.1007/s004220050567; Corballis PM, 2001, NEUROLOGY, V57, P1345, DOI 10.1212/WNL.57.7.1345; Eliassen JC, 1999, EXP BRAIN RES, V128, P573, DOI 10.1007/s002210050884; Eliassen JC, 2000, BRAIN, V123, P2501, DOI 10.1093/brain/123.12.2501; Fisher NI., 1995, STAT ANAL CIRCULAR D; Franz EA, 1996, PSYCHOL SCI, V7, P306, DOI 10.1111/j.1467-9280.1996.tb00379.x; Franz EA, 1997, Q J EXP PSYCHOL-A, V50, P684, DOI 10.1080/027249897392071; FRANZ EA, 1991, ACTA PSYCHOL, V77, P137, DOI 10.1016/0001-6918(91)90028-X; GAZZANIGA MS, 1985, NEUROLOGY, V35, P1763, DOI 10.1212/WNL.35.12.1763; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; HOLLERBACH JM, 1981, BIOL CYBERN, V39, P139, DOI 10.1007/BF00336740; Ivry RB, 1999, HUM MOVEMENT SCI, V18, P345, DOI 10.1016/S0167-9457(99)00014-7; Ivry RB, 1998, J EXP PSYCHOL HUMAN, V24, P463, DOI 10.1037/0096-1523.24.2.463; IVRY RB, IN PRESS BRAIN COGN; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Kelso J.A.S., 1995, DYNAMIC PATTERNS SEL; KELSO JAS, 1979, J EXP PSYCHOL HUMAN, V5, P229, DOI 10.1037/0096-1523.5.2.229; KELSO JAS, 1983, Q J EXP PSYCHOL-A, V35, P347; MARTENIUK RG, 1984, Q J EXP PSYCHOL-A, V36, P335, DOI 10.1080/14640748408402163; Porter R., 1995, CORTICOSPINAL FUNCTI, DOI 10.1093/acprof:oso/9780198523758.001.0001/acprof-9780198523758; PREILOWSKI BF, 1972, NEUROPSYCHOLOGIA, V10, P267, DOI 10.1016/0028-3932(72)90018-8; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; SEMJEN A, 1995, J EXP PSYCHOL HUMAN, V21, P1139, DOI 10.1037/0096-1523.21.5.1139; Serrien DJ, 2001, NEUROREPORT, V12, P2721, DOI 10.1097/00001756-200108280-00026; SIDTIS JJ, 1981, J NEUROSCI, V1, P323; TULLER B, 1989, EXP BRAIN RES, V75, P306; Verschueren SMP, 1999, EXP BRAIN RES, V127, P182, DOI 10.1007/s002210050788; ZAIDEL D, 1977, NEUROPSYCHOLOGIA, V15, P193, DOI 10.1016/0028-3932(77)90028-8; Zelaznik HN, 2000, J MOTOR BEHAV, V32, P193, DOI 10.1080/00222890009601370	32	151	153	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					376	381		10.1038/nn822	http://dx.doi.org/10.1038/nn822			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	534UQ	11914724				2022-12-17	WOS:000174606900019
J	Ernst, MO; Banks, MS; Bulthoff, HH				Ernst, MO; Banks, MS; Bulthoff, HH			Touch can change visual slant perception	NATURE NEUROSCIENCE			English	Article							IDEAL OBSERVERS; TEXTURE; PSYCHOPHYSICS; SHAPE; CUES	The visual system uses several signals to deduce the three-dimensional structure of the environment, including binocular disparity, texture gradients, shading and motion parallax. Although each of these sources of information is independently insufficient to yield reliable three-dimensional structure from everyday scenes, the visual system combines them by weighting the available information; altering the weights would therefore change the perceived structure. We report that haptic feedback (active touch) increases the weight of a consistent surface-slant signal relative to inconsistent signals. Thus, appearance of a subsequently viewed surface is changed: the surface appears slanted in the direction specified by the haptically reinforced signal.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA	Max Planck Society; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ernst, MO (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.		Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; Ernst, Marc/0000-0003-4197-8569				Backus BT, 1999, PERCEPTION, V28, P217, DOI 10.1068/p2753; Backus BT, 1999, VISION RES, V39, P1143, DOI 10.1016/S0042-6989(98)00139-4; BLAKE A, 1993, VISION RES, V33, P1723, DOI 10.1016/0042-6989(93)90037-W; Bradshaw MF, 1996, VISION RES, V36, P1255, DOI 10.1016/0042-6989(95)00190-5; BUCKLEY D, 1993, VISION RES, V33, P919, DOI 10.1016/0042-6989(93)90075-8; BULTHOFF HH, 1996, ATTENTION PERFORM, V16, P49; Clark J.J., 1990, DATA FUSION SENSORY; FESTINGER L, 1967, J EXPT PSYCHOL MONOG, V74; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; GILLAM B, 1993, PERCEPTION, V22, P1025, DOI 10.1068/p221025; HARRIS CS, 1965, PSYCHOL REV, V72, P419, DOI 10.1037/h0022616; JOHNSTON EB, 1993, VISION RES, V33, P813, DOI 10.1016/0042-6989(93)90200-G; Knill DC, 1998, VISION RES, V38, P1683, DOI 10.1016/S0042-6989(97)00325-8; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; LEDERMAN SJ, 1981, J EXP PSYCHOL HUMAN, V7, P902, DOI 10.1037/0096-1523.7.4.902; Massie T. H., 1994, PHANTOM HAPTIC INTER, V1, P295; Rock I., 1966, NATURE PERCEPTUAL AD; ROCK I, 1964, SCIENCE, V143, P595; ROGERS BJ, 1995, PERCEPTION, V24, P155, DOI 10.1068/p240155; Stratton G. M., 1897, PSYCHOL REV, V4, P463, DOI [10.1037/h0075482, DOI 10.1037/H0071173]; Stratton G.M., 1897, PSYCHOL REV, V4, P341, DOI [DOI 10.1037/H0075482, 10.1037/h0075482]; van Ee R, 1999, PERCEPTION, V28, P1121; VONHELMHOLTZ H, 1867, HDB PHYSIL OPTIK, V3; Walk R. D., 1981, INTERSENSORY PERCEPT; Welch R. B., 1978, PERCEPTUAL MODIFICAT; WELCH RB, 1986, HDB PERCEPTION HUMAN	26	151	153	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					69	73		10.1038/71140	http://dx.doi.org/10.1038/71140			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	292TB	10607397				2022-12-17	WOS:000085810200014
J	Rhea, EM; Logsdon, AF; Hansen, KM; Williams, LM; Reed, MJ; Baumann, KK; Holden, SJ; Raber, J; Banks, WA; Erickson, MA				Rhea, Elizabeth M.; Logsdon, Aric F.; Hansen, Kim M.; Williams, Lindsey M.; Reed, May J.; Baumann, Kristen K.; Holden, Sarah J.; Raber, Jacob; Banks, William A.; Erickson, Michelle A.			The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice	NATURE NEUROSCIENCE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; ENDOTHELIAL-CELLS; TARGETED REPLACEMENT; SPIKE GLYCOPROTEIN; VIRUS; GP120; INFECTION; TRANSPORT; COVID-19; SERUM	Rhea at al. show that intravenously injected, radiolabeled SARS-CoV-2 spike 1 protein crosses the mouse blood-brain barrier, likely through the mechanism of adsorptive transcytosis and is also taken up by peripheral tissues. It is unclear whether severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019, can enter the brain. Severe acute respiratory syndrome coronavirus 2 binds to cells via the S1 subunit of its spike protein. We show that intravenously injected radioiodinated S1 (I-S1) readily crossed the blood-brain barrier in male mice, was taken up by brain regions and entered the parenchymal brain space. I-S1 was also taken up by the lung, spleen, kidney and liver. Intranasally administered I-S1 also entered the brain, although at levels roughly ten times lower than after intravenous administration. APOE genotype and sex did not affect whole-brain I-S1 uptake but had variable effects on uptake by the olfactory bulb, liver, spleen and kidney. I-S1 uptake in the hippocampus and olfactory bulb was reduced by lipopolysaccharide-induced inflammation. Mechanistic studies indicated that I-S1 crosses the blood-brain barrier by adsorptive transcytosis and that murine angiotensin-converting enzyme 2 is involved in brain and lung uptake, but not in kidney, liver or spleen uptake.	[Rhea, Elizabeth M.; Logsdon, Aric F.; Hansen, Kim M.; Williams, Lindsey M.; Baumann, Kristen K.; Banks, William A.; Erickson, Michelle A.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA; [Rhea, Elizabeth M.; Logsdon, Aric F.; Hansen, Kim M.; Reed, May J.; Banks, William A.; Erickson, Michelle A.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Holden, Sarah J.; Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Neurol Psychiat & Radiat Med, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Div Neurosci, Dept Neurol, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Div Neurosci, Dept Radiat Med, Portland, OR 97201 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center	Banks, WA (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA.; Banks, WA (corresponding author), Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA.	wabanks1@uw.edu	Meredith, Elizabeth/AAM-4574-2021; Erickson, Michelle/AAR-8717-2021; Banks, William A/K-1330-2017; Erickson, Michelle/G-4815-2014	Banks, William A/0000-0002-0496-3619; Erickson, Michelle/0000-0002-2575-1594; Williams, Lindsey/0000-0002-6992-0652	VAPSHCS; National Institutes of Health [R21 AG065928-01, RF-1 AG059088]	VAPSHCS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the VAPSHCS (W.A.B. and M.A.E.) and research grant awards from the National Institutes of Health (R21 AG065928-01 to M.A.E. and RF-1 AG059088 to W.A.B. and J.R.). We thank R. Weaver, S. Pemberton and D. Quaranta for technical assistance.	Al-Ahmad AJ, 2017, AM J PHYSIOL-CELL PH, V313, pC421, DOI 10.1152/ajpcell.00116.2017; Banks WA, 2005, EXP NEUROL, V193, P218, DOI 10.1016/j.expneurol.2004.11.019; Banks WA, 2004, NEUROSCIENCE, V128, P143, DOI 10.1016/j.neuroscience.2004.06.021; Banks WA, 2001, J VIROL, V75, P4681, DOI 10.1128/JVI.75.10.4681-4691.2001; Banks WA, 1998, J NEUROSCI RES, V54, P522, DOI 10.1002/(SICI)1097-4547(19981115)54:4<522::AID-JNR9>3.0.CO;2-O; Banks WA, 1999, EXP NEUROL, V156, P165, DOI 10.1006/exnr.1998.7011; Banks WA, 1997, LIFE SCI, V61, pPL119, DOI 10.1016/S0024-3205(97)00597-3; Bansal AK, 2000, BRAIN RES, V879, P42, DOI 10.1016/S0006-8993(00)02725-6; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P215, DOI 10.1038/jcbfm.1983.29; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Bleau C, 2015, J VIROL, V89, P9896, DOI 10.1128/JVI.01501-15; Bullen CK, 2020, ALTEX-ALTERN ANIM EX, V37, P665, DOI 10.14573/altex.2006111; DEHOUCK MP, 1992, J NEUROCHEM, V58, P1790, DOI 10.1111/j.1471-4159.1992.tb10055.x; Dohgu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039565; Erickson MA, 2018, PHARMACOL REV, V70, P278, DOI 10.1124/pr.117.014647; Erickson MA, 2011, BRAIN BEHAV IMMUN, V25, P1637, DOI 10.1016/j.bbi.2011.06.006; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Guruprasad L, 2021, PROG BIOPHYS MOL BIO, V161, P39, DOI 10.1016/j.pbiomolbio.2020.10.006; GUTIERREZ EG, 1993, J NEUROIMMUNOL, V47, P169, DOI 10.1016/0165-5728(93)90027-V; Hassanzadeh K, 2020, ACS CHEM NEUROSCI, V11, P2361, DOI 10.1021/acschemneuro.0c00373; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Ibrahim IM, 2020, J INFECTION, V80, P554, DOI 10.1016/j.jinf.2020.02.026; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Kuo CL, 2020, J GERONTOL A-BIOL, V75, P1801, DOI 10.1093/gerona/glaa169; Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Machado C, 2020, NEUROL INDIA, V68, P989, DOI 10.4103/0028-3886.299165; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; MONTELARO RC, 1975, J GEN VIROL, V29, P127, DOI 10.1099/0022-1317-29-1-127; Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062; Neal EH, 2019, STEM CELL REP, V12, P1380, DOI 10.1016/j.stemcr.2019.05.008; Nottet HSLM, 1996, J IMMUNOL, V156, P1284; OH SK, 1992, J ACQ IMMUN DEF SYND, V5, P251; Prabakaran P, 2004, BIOCHEM BIOPH RES CO, V314, P235, DOI 10.1016/j.bbrc.2003.12.081; Raber J, 1996, VIROLOGY, V226, P362, DOI 10.1006/viro.1996.0664; Radzikowska U, 2020, ALLERGY, V75, P2829, DOI 10.1111/all.14429; RamosKuri M, 1996, ARCH MED RES, V27, P43; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; Rychert J, 2010, AIDS RES HUM RETROV, V26, P1139, DOI 10.1089/aid.2009.0290; Saleki K, 2020, REV NEUROSCIENCE, V31, P453, DOI 10.1515/revneuro-2020-0026; Schweighardt B, 2001, J NEUROVIROL, V7, P187; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Siegel JA, 2012, NEUROBIOL AGING, V33, P345, DOI 10.1016/j.neurobiolaging.2010.03.002; Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; TRIGUERO D, 1990, J NEUROCHEM, V54, P1882, DOI 10.1111/j.1471-4159.1990.tb04886.x; van Riel D, 2015, J PATHOL, V235, P277, DOI 10.1002/path.4461; Vankadari N, 2020, EMERG MICROBES INFEC, V9, P601, DOI 10.1080/22221751.2020.1739565; VILLEGAS JC, 1993, J NEUROCYTOL, V22, P67, DOI 10.1007/BF01181571; Walls AC, 2017, P NATL ACAD SCI USA, V114, P11157, DOI 10.1073/pnas.1708727114; Wang J, 2020, J LEUKOCYTE BIOL, V108, P17, DOI 10.1002/JLB.3COVR0520-272R; Wang YF, 2007, TOHOKU J EXP MED, V211, P379, DOI 10.1620/tjem.211.379; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xu J, 2005, CLIN INFECT DIS, V41, P1089, DOI 10.1086/444461; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762	59	150	151	12	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2021	24	3					368	378		10.1038/s41593-020-00771-8	http://dx.doi.org/10.1038/s41593-020-00771-8		DEC 2020	11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QQ7GU	33328624	Bronze, Green Accepted			2022-12-17	WOS:000599485400001
J	Stoodley, CJ; D'Mello, AM; Ellegood, J; Jakkamsetti, V; Liu, P; Nebel, MB; Gibson, JM; Kelly, E; Meng, FT; Cano, CA; Pascual, JM; Mostofsky, SH; Lerch, JP; Tsai, PT				Stoodley, Catherine J.; D'Mello, Anila M.; Ellegood, Jacob; Jakkamsetti, Vikram; Liu, Pei; Nebel, Mary Beth; Gibson, Jennifer M.; Kelly, Elyza; Meng, Fantao; Cano, Christopher A.; Pascual, Juan M.; Mostofsky, Stewart H.; Lerch, Jason P.; Tsai, Peter T.			Altered cerebellar connectivity in autism and cerebellar-mediated rescue of autism-related behaviors in mice	NATURE NEUROSCIENCE			English	Article							DIRECT-CURRENT STIMULATION; PURKINJE-CELLS; FUNCTIONAL CONNECTIVITY; CORTICAL THICKNESS; PARIETAL CORTEX; GRAY-MATTER; MOUSE MODEL; BRAIN; MRI; NETWORKS	Cerebellar abnormalities, particularly in Right Crus I (RCrusI), are consistently reported in autism spectrum disorders (ASD). Although RCrusI is functionally connected with ASD-implicated circuits, the contribution of RCrusI dysfunction to ASD remains unclear. Here neuromodulation of RCrusI in neurotypical humans resulted in altered functional connectivity with the inferior parietal lobule, and children with ASD showed atypical functional connectivity in this circuit. Atypical RCrusI-inferior parietal lobule structural connectivity was also evident in the Purkinje neuron (PN) TscI ASD mouse model. Additionally, chemogenetically mediated inhibition of RCrusI PN activity in mice was sufficient to generate ASD-related social, repetitive, and restricted behaviors, while stimulation of RCrusI PNs rescued social impairment in the PN TscI ASD mouse model. Together, these studies reveal important roles for RCrusI in ASD-related behaviors. Further, the rescue of social behaviors in an ASD mouse model suggests that investigation of the therapeutic potential of cerebellar neuromodulation in ASD may be warranted.	[Stoodley, Catherine J.; D'Mello, Anila M.] American Univ, Dept Psychol, Washington, DC 20016 USA; [Stoodley, Catherine J.; D'Mello, Anila M.] American Univ, Ctr Behav Neurosci, Washington, DC 20016 USA; [Ellegood, Jacob; Lerch, Jason P.] Hosp Sick Kids, Toronto Mouse Imaging Ctr, Toronto, ON, Canada; [Jakkamsetti, Vikram; Liu, Pei; Gibson, Jennifer M.; Kelly, Elyza; Meng, Fantao; Cano, Christopher A.; Pascual, Juan M.; Tsai, Peter T.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Nebel, Mary Beth; Mostofsky, Stewart H.] Kennedy Krieger Inst, Ctr Neurodev & Imaging Res, Baltimore, MD USA	American University; American University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Texas System; University of Texas Southwestern Medical Center Dallas; Kennedy Krieger Institute	Stoodley, CJ (corresponding author), American Univ, Dept Psychol, Washington, DC 20016 USA.; Stoodley, CJ (corresponding author), American Univ, Ctr Behav Neurosci, Washington, DC 20016 USA.; Tsai, PT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.	stoodley@american.edu; peter.tsai@utsouthwestern.edu	Jakkamsetti, Vikram/AAJ-8744-2020; Core, Vector/CAF-4832-2022; Nebel, Mary Beth/D-3305-2015; Stoodley, Catherine/P-2081-2016	Jakkamsetti, Vikram/0000-0001-6524-2893; Nebel, Mary Beth/0000-0003-0185-3382; Ellegood, Jacob/0000-0003-1504-3321; D'Mello, Anila/0000-0001-6653-7802; Pascual, Juan/0000-0002-0843-8221; tsai, peter/0000-0002-0729-9688; Stoodley, Catherine/0000-0003-2629-0213	National Institute of Neurologic Disorders and Stroke of the NIH [K08 NS083733]; Child Neurology Foundation; Tuberous Sclerosis Alliance; University of Texas Southwestern Medical Center; National Institute of Mental Health of the NIH [R15 MH106957]; Department of Psychology; American University; Canadian Institute for Health Research (CIHR); Ontario Brain Institute (OBI); Autism Speaks; National Institute of Mental Health [R01 MH085328-09, R01 MH078160-07, K01 MH109766]; National Institute of Neurological Disorders and Stroke [R01 NS048527-08]; National Institute of Drug Abuse [T32 DA007290-24]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078160, K01MH109766, R15MH106957, R01MH085328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS083733, R01NS048527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290] Funding Source: NIH RePORTER	National Institute of Neurologic Disorders and Stroke of the NIH; Child Neurology Foundation; Tuberous Sclerosis Alliance; University of Texas Southwestern Medical Center; National Institute of Mental Health of the NIH; Department of Psychology; American University; Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Brain Institute (OBI); Autism Speaks; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	A.M.D. and C.J.S. acknowledge the support of P. Turkeltaub, C. Barrett, B. Drury, and S. Martin in neuroimaging data collection and analysis. All neurobehavioral experiments were performed at the Department of Psychiatry Rodent Behavioral Core, and the authors thank the Director for Core services, S. Birnbaum, for her assistance. The authors also appreciate assistance from the UT Southwestern Whole Brain Microscopy Facility, and from B. Nieman and L. Spencer Noakes for their work on the MRI sequence used. P.T.T. acknowledges support from the National Institute of Neurologic Disorders and Stroke of the NIH (K08 NS083733) the Child Neurology Foundation, the Tuberous Sclerosis Alliance, and the University of Texas Southwestern Medical Center Disease Oriented Clinical Scholar Award. C.J.S. acknowledges funding from the National Institute of Mental Health of the NIH (R15 MH106957), pilot research funds from the Department of Psychology, and institutional startup funds from American University. J.P.L. and J.E. acknowledge support from the Canadian Institute for Health Research (CIHR) and the Ontario Brain Institute (OBI). S.H.M. acknowledges support from Autism Speaks, the National Institute of Mental Health (R01 MH085328-09, R01 MH078160-07, and K01 MH109766), and the National Institute of Neurological Disorders and Stroke (R01 NS048527-08). E.K. acknowledges funding from National Institute of Drug Abuse T32 training grant (T32 DA007290-24).	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Amadi U, 2014, NEUROIMAGE, V88, P155, DOI 10.1016/j.neuroimage.2013.11.037; Arancillo M, 2015, J NEUROPHYSIOL, V113, P578, DOI 10.1152/jn.00586.2014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Asano E, 2001, NEUROLOGY, V57, P1269, DOI 10.1212/WNL.57.7.1269; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Bednar I, 2002, MOL CELL NEUROSCI, V20, P354, DOI 10.1006/mcne.2002.1112; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bock NA, 2005, MAGNET RESON MED, V54, P1311, DOI 10.1002/mrm.20683; Boggio PS, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00294; Bohbot VD, 2007, J NEUROSCI, V27, P10078, DOI 10.1523/JNEUROSCI.1763-07.2007; Bolduc ME, 2009, DEV MED CHILD NEUROL, V51, P256, DOI 10.1111/j.1469-8749.2008.03224.x; Bozzali M, 2011, NEUROIMAGE, V54, P2045, DOI 10.1016/j.neuroimage.2010.08.069; Bryant JL, 2010, EUR J NEUROSCI, V32, P41, DOI 10.1111/j.1460-9568.2010.07244.x; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Catsman-Berrevoets CE, 2010, CORTEX, V46, P933, DOI 10.1016/j.cortex.2009.10.007; Clayden JD, 2013, FUNCT NEUROL, V28, P197, DOI 10.11138/FNeur/2013.28.3.197; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Cupolillo D, 2016, NEUROPSYCHOPHARMACOL, V41, P1457, DOI 10.1038/npp.2015.339; D'Mello AM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00408; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Deeley Q, 2007, BIOL PSYCHIAT, V62, P207, DOI 10.1016/j.biopsych.2006.09.037; Demirtas-Tatlidede A, 2010, SCHIZOPHR RES, V124, P91, DOI 10.1016/j.schres.2010.08.015; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; DMello AM, 2015, NEUROIMAGE-CLIN, V7, P631, DOI 10.1016/j.nicl.2015.02.007; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Evans AC, 2013, NEUROIMAGE, V80, P489, DOI 10.1016/j.neuroimage.2013.05.054; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Grimaldi G, 2016, NEUROSCIENTIST, V22, P83, DOI 10.1177/1073858414559409; Haswell CC, 2009, NAT NEUROSCI, V12, P970, DOI 10.1038/nn.2356; Hayar A, 2006, J NEUROSCI METH, V153, P203, DOI 10.1016/j.jneumeth.2005.10.023; Ho Daniel E., 2011, J STAT SOFTW, V42, P1, DOI [10.18637/jss.v042.i08, DOI 10.18637/JSS.V042.I08]; Hollingshead A., 2011, 4 FACTOR INDEX SOCIA, V8; Holmes A, 2001, BEHAV NEUROSCI, V115, P1129, DOI 10.1037//0735-7044.115.5.1129; Jack A, 2015, CEREB CORTEX, V25, P4240, DOI 10.1093/cercor/bhu146; Jack A, 2011, NEUROPSYCHOLOGIA, V49, P3689, DOI 10.1016/j.neuropsychologia.2011.09.024; Kelly C, 2012, NEUROIMAGE, V61, P1129, DOI 10.1016/j.neuroimage.2012.03.021; Khan AJ, 2015, BIOL PSYCHIAT, V78, P625, DOI 10.1016/j.biopsych.2015.03.024; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; LeBlanc JJ, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/921680; Lerch JP, 2008, NEUROBIOL AGING, V29, P23, DOI 10.1016/j.neurobiolaging.2006.09.013; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Limperopoulos C, 2007, PEDIATRICS, V120, P584, DOI 10.1542/peds.2007-1041; Marko MK, 2015, BRAIN, V138, P784, DOI 10.1093/brain/awu394; Marquez-Ruiz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036184; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mosconi MW, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00296; Mostofsky SH, 2006, J INT NEUROPSYCH SOC, V12, P314, DOI 10.1017/S1355617706060437; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Muschelli J, 2014, NEUROIMAGE, V96, P22, DOI 10.1016/j.neuroimage.2014.03.028; Nebel MB, 2016, BIOL PSYCHIAT, V79, P633, DOI 10.1016/j.biopsych.2015.08.029; Nieman BJ, 2006, PHYSIOL GENOMICS, V24, P154, DOI 10.1152/physiolgenomics.00217.2005; Peter S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12627; Quiroga RQ, 2012, CURR BIOL, V22, pR45, DOI 10.1016/j.cub.2011.11.005; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Reep RL, 2009, NEUROBIOL LEARN MEM, V91, P104, DOI 10.1016/j.nlm.2008.08.010; Reith RM, 2013, NEUROBIOL DIS, V51, P93, DOI 10.1016/j.nbd.2012.10.014; Ryu YH, 1999, EUR J NUCL MED, V26, P253, DOI 10.1007/s002590050385; Silverman JL, 2011, BRAIN RES, V1380, P120, DOI 10.1016/j.brainres.2010.09.026; Skefos J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081255; Spreng RN, 2013, J NEUROSCI, V33, P15226, DOI 10.1523/JNEUROSCI.2261-13.2013; Steadman PE, 2014, AUTISM RES, V7, P124, DOI 10.1002/aur.1344; Stoodley CJ, 2016, SEMIN FETAL NEONAT M, V21, P356, DOI 10.1016/j.siny.2016.04.010; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Stuart EA, 2010, MULTIVAR BEHAV RES, V45, P746, DOI 10.1080/00273171.2010.503544; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ullmann JFP, 2013, NEUROIMAGE, V78, P196, DOI 10.1016/j.neuroimage.2013.04.008; Van Overwalle F, 2014, NEUROIMAGE, V86, P554, DOI 10.1016/j.neuroimage.2013.09.033; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 2014, WECHSLER INTELLIGENC; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Whitney ER, 2008, CEREBELLUM, V7, P406, DOI 10.1007/s12311-008-0043-y; Williams JHG, 2006, NEUROPSYCHOLOGIA, V44, P610, DOI 10.1016/j.neuropsychologia.2005.06.010; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Yang M., CURR PROTOC NEUROSCI, V56; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Yuan E, 2012, HUM MOL GENET, V21, P4286, DOI 10.1093/hmg/dds262; Zhou HB, 2014, ELIFE, V3, DOI 10.7554/eLife.02536; Zielinski BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049172; 2012, MOUSE NERVOUS SYSTEM, P1	89	150	150	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2017	20	12					1744	+		10.1038/s41593-017-0004-1	http://dx.doi.org/10.1038/s41593-017-0004-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FO1HT	29184200	Green Accepted			2022-12-17	WOS:000416509800013
J	Hong, H; Yamins, DLK; Majaj, NJ; DiCarlo, JJ				Hong, Ha; Yamins, Daniel L. K.; Majaj, Najib J.; DiCarlo, James J.			Explicit information for category-orthogonal object properties increases along the ventral stream	NATURE NEUROSCIENCE			English	Article							INFEROTEMPORAL CORTEX; POPULATION RESPONSES; POSITION; NEURONS; RECOGNITION; PERCEPTION; CELLS; SHAPE; DISCRIMINATION; REPRESENTATION	Extensive research has revealed that the ventral visual stream hierarchically builds a robust representation for supporting visual object categorization tasks. We systematically explored the ability of multiple ventral visual areas to support a variety of 'category-orthogonal' object properties such as position, size and pose. For complex naturalistic stimuli, we found that the inferior temporal (IT) population encodes all measured category-orthogonal object properties, including those properties often considered to be low-level features (for example, position), more explicitly than earlier ventral stream areas. We also found that the IT population better predicts human performance patterns across properties. A hierarchical neural network model based on simple computational principles generates these same cross-area patterns of information. Taken together, our empirical results support the hypothesis that all behaviorally relevant object properties are extracted in concert up the ventral visual hierarchy, and our computational model explains how that hierarchy might be built.	[Hong, Ha; Yamins, Daniel L. K.; Majaj, Najib J.; DiCarlo, James J.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Hong, Ha; Yamins, Daniel L. K.; Majaj, Najib J.; DiCarlo, James J.] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hong, Ha] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Majaj, Najib J.] NYU, Ctr Neural Sci, New York, NY 10003 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); New York University	DiCarlo, JJ (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; DiCarlo, JJ (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dicarlo@mit.edu		Majaj, Najib/0000-0001-9910-5627	DARPA (Neovision2); NSF [IIS-0964269]; US National Institutes of Health [NEI-R01 EY014970]; Simons Center for the Global Brain; Office of Naval Research (MURI); Samsung Scholarship; NVIDIA; Amazon; NATIONAL EYE INSTITUTE [R01EY014970] Funding Source: NIH RePORTER	DARPA (Neovision2); NSF(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Center for the Global Brain; Office of Naval Research (MURI)(MURIOffice of Naval Research); Samsung Scholarship(Samsung); NVIDIA; Amazon; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to K. Schmidt and C. Stawarz for key technical support, and to D. Ardila, R. Rajalingham, J. Tenenbaum, S. Gershman, C. Jennings and J. Fan for useful suggestions. The infrastructure needed for this work was supported by DARPA (Neovision2) and the NSF (IIS-0964269). The bulk of the work presented in this manuscript was supported by the US National Institutes of Health (NEI-R01 EY014970), with partial support from the Simons Center for the Global Brain and the Office of Naval Research (MURI). H.H. was supported by a fellowship from the Samsung Scholarship. We thank NVIDIA for a grant of GPU hardware and Amazon for an education grant supporting computational and psychophysical work. Additional computational infrastructure support was provided by the McGovern Institute for Brain Research (OpenMind).	Bergstra James, 2013, INT C MACH LEARN, P115, DOI [10.5555/3042817.3042832, DOI 10.5555/3042817.3042832]; Bosking WH, 2002, NAT NEUROSCI, V5, P874, DOI 10.1038/nn908; Brown LE, 2005, EXP BRAIN RES, V165, P97, DOI 10.1007/s00221-005-2285-y; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; Chikkerur S, 2010, VISION RES, V50, P2233, DOI 10.1016/j.visres.2010.05.013; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; DiCarlo J.J., 2000, SOC NEUR ABSTR, V498; DiCarlo JJ, 2007, TRENDS COGN SCI, V11, P333, DOI 10.1016/j.tics.2007.06.010; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; Edelman S, 2003, COGNITIVE SCI, V27, P73, DOI 10.1207/s15516709cog2701_3; Efron B., 1994, INTRO BOOTSTRAP; Eurich CW, 1997, BIOL CYBERN, V76, P357, DOI 10.1007/s004220050349; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gochin PM, 1996, BEHAV BRAIN RES, V76, P99, DOI 10.1016/0166-4328(95)00185-9; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Hinton GE, 1986, PARALLEL DISTRIBUTED, P77; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Jones E., 2001, SCIPY OPEN SOURCE SC; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Khaligh-Razavi SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003915; Klikauer T, 2016, TRIPLEC-COMMUN CAPIT, V14, P260; Krizhevsky A., 2012, COMMUN ACM, P1097, DOI DOI 10.1145/3065386; LeCun Y, 1995, HDB BRAIN THEORY NEU, V3361, P1995, DOI DOI 10.1109/IJCNN.2004.1381049; Li N, 2009, J NEUROPHYSIOL, V102, P360, DOI 10.1152/jn.90745.2008; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MacEvoy SP, 2012, NEUROIMAGE, V63, P1901, DOI 10.1016/j.neuroimage.2012.08.043; Majaj NJ, 2015, J NEUROSCI, V35, P13402, DOI 10.1523/JNEUROSCI.5181-14.2015; MILNER PM, 1974, PSYCHOL REV, V81, P521, DOI 10.1037/h0037149; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Nienborg H, 2014, J NEUROSCI, V34, P3579, DOI 10.1523/JNEUROSCI.2340-13.2014; Nishio A, 2014, J NEUROSCI, V34, P11143, DOI 10.1523/JNEUROSCI.1451-14.2014; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rajalingham R, 2015, J NEUROSCI, V35, P12127, DOI 10.1523/JNEUROSCI.0573-15.2015; Rishel CA, 2013, NEURON, V77, P969, DOI 10.1016/j.neuron.2013.01.007; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Rust NC, 2010, J NEUROSCI, V30, P12978, DOI 10.1523/JNEUROSCI.0179-10.2010; Sayres R, 2008, J NEUROPHYSIOL, V100, P249, DOI 10.1152/jn.01383.2007; Sereno AB, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00028; Sereno AB, 2011, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00159; Serre T, 2007, PROG BRAIN RES, V165, P33, DOI 10.1016/S0079-6123(06)65004-8; SNIPPE HP, 1992, BIOL CYBERN, V66, P543, DOI 10.1007/BF00204120; Swaminathan SK, 2012, NAT NEUROSCI, V15, P315, DOI 10.1038/nn.3016; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Tsao DY, 2008, ANNU REV NEUROSCI, V31, P411, DOI 10.1146/annurev.neuro.30.051606.094238; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; VOGELS R, 1994, J NEUROPHYSIOL, V71, P1428, DOI 10.1152/jn.1994.71.4.1428; Yamins DLK, 2014, P NATL ACAD SCI USA, V111, P8619, DOI 10.1073/pnas.1403112111; Yildirim I., 2015, P ANN C COGN SCI SOC, V471; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; Zoccolan D, 2007, J NEUROSCI, V27, P12292, DOI 10.1523/JNEUROSCI.1897-07.2007	61	150	151	0	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2016	19	4					613	+		10.1038/nn.4247	http://dx.doi.org/10.1038/nn.4247			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH6OI	26900926				2022-12-17	WOS:000372909800019
J	Murakami, M; Vicente, MI; Costa, GM; Mainen, ZF				Murakami, Masayoshi; Vicente, M. Ines; Costa, Gil M.; Mainen, Zachary F.			Neural antecedents of self-initiated actions in secondary motor cortex	NATURE NEUROSCIENCE			English	Article							MEDIAL AGRANULAR CORTEX; PERCEPTUAL DECISION-MAKING; FRONTAL-CORTEX; REACTION-TIME; SUPERIOR COLLICULUS; PREFRONTAL CORTEX; CORTICAL CIRCUITS; NEURONAL-ACTIVITY; CAUDATE-NUCLEUS; BASAL GANGLIA	The neural origins of spontaneous or self-initiated actions are not well understood and their interpretation is controversial. To address these issues, we used a task in which rats decide when to abort waiting for a delayed tone. We recorded neurons in the secondary motor cortex (M2) and interpreted our findings in light of an integration-to-bound decision model. A first population of M2 neurons ramped to a constant threshold at rates proportional to waiting time, strongly resembling integrator output. A second population, which we propose provide input to the integrator, fired in sequences and showed trial-to-trial rate fluctuations correlated with waiting times. An integration model fit to these data also quantitatively predicted the observed inter-neuronal correlations. Together, these results reinforce the generality of the integration-to-bound model of decision-making. These models identify the initial intention to act as the moment of threshold crossing while explaining how antecedent subthreshold neural activity can influence an action without implying a decision.	[Murakami, Masayoshi; Vicente, M. Ines; Costa, Gil M.; Mainen, Zachary F.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal	Fundacao Champalimaud	Mainen, ZF (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal.	zmainen@neuro.fchampalimaud.org	Murakami, Masayoshi/AAM-8778-2020	Vicente, Maria Ines/0000-0002-9362-4394; Mainen, Zachary/0000-0001-7913-9109; MURAKAMI, MASAYOSHI/0000-0001-5511-1144	Uehara Memorial Foundation; Fundacao Bial [127/08]; Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/46314/2008, SFRH/BD/33274/2007, SFRH/BD/32947/2006]; European Research Council Advanced Investigator Grant [250334]; Champalimaud Foundation; Fundacao para a Ciencia e a Tecnologia, BEB/CNC PhD programme	Uehara Memorial Foundation(Uehara Memorial Foundation); Fundacao Bial(Bial Foundation); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Research Council Advanced Investigator Grant(European Research Council (ERC)); Champalimaud Foundation; Fundacao para a Ciencia e a Tecnologia, BEB/CNC PhD programme	We thank the members of the Mainen laboratory for discussion, M. Terrelonge for assistance with recording experiments, B. Burbach and M. Vinhas for technical assistance, E. Lottem for daily discussions, and C. Feierstein, H. Shteingart, Y. Loewenstein, J. Erlich, J. Paton and B. Atallah for helpful comments on the manuscript. This work was supported by the Uehara Memorial Foundation (M.M.), Fundacao Bial (127/08, M.M.), Fundacao para a Ciencia e a Tecnologia SFRH/BPD/46314/2008, M.M.; SFRH/BD/33274/2007, M.I.V.; SFRH/BD/32947/2006, G.M.C.), European Research Council Advanced Investigator Grant (250334, Z.F.M.) and Champalimaud Foundation (Z.F.M.). G.M.C. was supported by Fundacao para a Ciencia e a Tecnologia, as part of the BEB/CNC PhD programme.	Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Cardinal RN, 2004, ANN NY ACAD SCI, V1021, P33, DOI 10.1196/annals.1308.004; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; Fried I, 2011, NEURON, V69, P548, DOI 10.1016/j.neuron.2010.11.045; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gremel CM, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00110; Gremel CM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3264; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Jaramillo S, 2011, NAT NEUROSCI, V14, P246, DOI 10.1038/nn.2688; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Lak A., NEURON IN PRESS; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Lebedev MA, 2008, J NEUROPHYSIOL, V99, P166, DOI 10.1152/jn.00734.2007; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McGuire JT, 2013, PSYCHOL REV, V120, P395, DOI 10.1037/a0031910; Milosavljevic M, 2010, JUDGM DECIS MAK, V5, P437; MISCHEL W, 1972, J PERS SOC PSYCHOL, V21, P204, DOI 10.1037/h0032198; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; OKANO K, 1987, EXP BRAIN RES, V66, P155; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; REEP RL, 1990, J COMP NEUROL, V294, P262, DOI 10.1002/cne.902940210; REEP RL, 1987, BRAIN RES BULL, V19, P203, DOI 10.1016/0361-9230(87)90086-4; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Roesch MR, 2007, ANN NY ACAD SCI, V1104, P21, DOI 10.1196/annals.1390.001; Roitman JD, 2002, J NEUROSCI, V22, P9475; ROMO R, 1992, EXP BRAIN RES, V91, P396, DOI 10.1007/BF00227836; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Soltani A, 2010, NAT NEUROSCI, V13, P112, DOI 10.1038/nn.2450; STUESSE SL, 1990, EXP BRAIN RES, V80, P532; Stuphorn V, 2010, J NEUROPHYSIOL, V103, P801, DOI 10.1152/jn.00221.2009; Sul JH, 2011, NAT NEUROSCI, V14, P1202, DOI 10.1038/nn.2881; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Zingg B, 2014, CELL, V156, P1096, DOI 10.1016/j.cell.2014.02.023; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	150	150	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2014	17	11					1574	1582		10.1038/nn.3826	http://dx.doi.org/10.1038/nn.3826			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS0LT	25262496	Green Published			2022-12-17	WOS:000343969300023
J	Alonso, M; Lepousez, G; Wagner, S; Bardy, C; Gabellec, MM; Torquet, N; Lledo, PM				Alonso, Mariana; Lepousez, Gabriel; Wagner, Sebastien; Bardy, Cedric; Gabellec, Marie-Madeleine; Torquet, Nicolas; Lledo, Pierre-Marie			Activation of adult-born neurons facilitates learning and memory	NATURE NEUROSCIENCE			English	Article							MAMMALIAN OLFACTORY-BULB; ODOR DISCRIMINATION; CONTINUOUS NEUROGENESIS; SYNAPTIC INHIBITION; MICE; PLASTICITY; INCREASES; ACCURACY; SPEED; RAT	Thousand of local interneurons reach the olfactory bulb of adult rodents every day, but the functional effect of this process remains elusive. By selectively expressing channelrhodopsin in postnatal-born mouse neurons, we found that their activation accelerated difficult odor discrimination learning and improved memory. This amelioration was seen when photoactivation occurred simultaneously with odor presentation, but not when odor delivery lagged by 500 ms. In addition, learning was facilitated when light flashes were delivered at 40 Hz, but not at 10 Hz. Both in vitro and in vivo electrophysiological recordings of mitral cells revealed that 40-Hz stimuli produced enhanced GABAergic inhibition compared with 10-Hz stimulation. Facilitation of learning occurred specifically when photoactivated neurons were generated during adulthood. Taken together, our results demonstrate an immediate causal relationship between the activity of adult-born neurons and the function of the olfactory bulb circuit.	[Alonso, Mariana; Lepousez, Gabriel; Wagner, Sebastien; Bardy, Cedric; Gabellec, Marie-Madeleine; Torquet, Nicolas; Lledo, Pierre-Marie] Inst Pasteur, Lab Percept & Memory, Paris, France; [Alonso, Mariana; Lepousez, Gabriel; Wagner, Sebastien; Bardy, Cedric; Gabellec, Marie-Madeleine; Torquet, Nicolas; Lledo, Pierre-Marie] Ctr Natl Rech Sci, Unit Rech Assoc 2182, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Lledo, PM (corresponding author), Inst Pasteur, Lab Percept & Memory, Paris, France.	pmlledo@pasteur.fr	Torquet, Nicolas/ABF-9755-2020; Bardy, Cedric/F-1182-2019	Torquet, Nicolas/0000-0001-9032-193X; Bardy, Cedric/0000-0001-8321-0852	NovalisTaitbout; Letten Foundation; Foundation pour la Recherche Medical; Agence Nationale de la Recherche [ANR-BLAN-SVSE4-LS-110624, ANR-09-NEUR-004]	NovalisTaitbout; Letten Foundation; Foundation pour la Recherche Medical; Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank G. Gheusi for his advice regarding the use of olfactometers, L. Petreanu for the manipulation of the LEDs during behavioral experiments, K. Murray and N. Maffey for technical assistance, and M. Valley and G. Gheusi for their critical reading of the manuscript. We thank the ENP Network for Viral Transfer for viral vector production. This work was supported by NovalisTaitbout, the Letten Foundation, the Foundation pour la Recherche Medical, the Agence Nationale de la Recherche (ANR-BLAN-SVSE4-LS-110624 and ANR-09-NEUR-004 in the frame of "ERA-NET NEURON" of FP7 program by the European Commission).	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/S0896-6273(04)00753-6; Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Bardy C, 2010, J NEUROSCI, V30, P17023, DOI 10.1523/JNEUROSCI.4543-10.2010; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Cang JH, 2003, J NEUROSCI, V23, P4108; Chapuis J, 2012, NAT NEUROSCI, V15, P155, DOI 10.1038/nn.2966; Cleland TA, 2010, TRENDS NEUROSCI, V33, P130, DOI 10.1016/j.tins.2009.12.004; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; Dietz SB, 2005, J PHYSIOL-LONDON, V569, P475, DOI 10.1113/jphysiol.2005.095844; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Kay LM, 2006, SEMIN CELL DEV BIOL, V17, P433, DOI 10.1016/j.semcdb.2006.04.012; Koulakov AA, 2011, NEURON, V72, P124, DOI 10.1016/j.neuron.2011.07.031; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; Lepousez G, 2011, JOVE-J VIS EXP, DOI 10.3791/3380; Linster C, 2001, J NEUROSCI, V21, P9837, DOI 10.1523/JNEUROSCI.21-24-09837.2001; Lledo PM, 2006, SEMIN CELL DEV BIOL, V17, P443, DOI 10.1016/j.semcdb.2006.04.011; Mandairon N, 2006, P NATL ACAD SCI USA, V103, P13543, DOI 10.1073/pnas.0602750103; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Mandairon N, 2009, J NEUROPHYSIOL, V101, P2204, DOI 10.1152/jn.00076.2009; Matsutani S, 2008, ANAT SCI INT, V83, P218, DOI 10.1111/j.1447-073X.2007.00223.x; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Mouret A, 2009, J NEUROSCI, V29, P12302, DOI 10.1523/JNEUROSCI.3383-09.2009; Mouret A, 2009, ANN NY ACAD SCI, V1170, P239, DOI 10.1111/j.1749-6632.2009.03913.x; Murthy VN, 2011, ANNU REV NEUROSCI, V34, P233, DOI 10.1146/annurev-neuro-061010-113738; Mwilaria EK, 2008, CHEM SENSES, V33, P267, DOI 10.1093/chemse/bjm085; Neville KR, 2003, J NEUROPHYSIOL, V90, P3921, DOI 10.1152/jn.00475.2003; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Sakamoto M, 2011, P NATL ACAD SCI USA, V108, P8479, DOI 10.1073/pnas.1018782108; Shepherd GM, 2007, BRAIN RES REV, V55, P373, DOI 10.1016/j.brainresrev.2007.03.005; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Sultan S, 2010, FASEB J, V24, P2355, DOI 10.1096/fj.09-151456; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Valley MT, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.003.2009; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	51	150	152	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					897	U127		10.1038/nn.3108	http://dx.doi.org/10.1038/nn.3108			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22581183				2022-12-17	WOS:000304546700018
J	Sejourne, J; Placais, PY; Aso, Y; Siwanowicz, I; Trannoy, S; Thoma, V; Tedjakumala, SR; Rubin, GM; Tchenio, P; Ito, K; Isabel, G; Tanimoto, H; Preat, T				Sejourne, Julien; Placais, Pierre-Yves; Aso, Yoshinori; Siwanowicz, Igor; Trannoy, Severine; Thoma, Vladimiros; Tedjakumala, Stevanus R.; Rubin, Gerald M.; Tchenio, Paul; Ito, Kei; Isabel, Guillaume; Tanimoto, Hiromu; Preat, Thomas			Mushroom body efferent neurons responsible for aversive olfactory memory retrieval in Drosophila	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; TIMING-DEPENDENT PLASTICITY; EXTRINSIC NEURONS; CONSOLIDATED MEMORY; PROTEIN; BODIES; INTEGRATION; DOPAMINE; DYNAMICS; BEHAVIOR	Aversive olfactory memory is formed in the mushroom bodies in Drosophila melanogaster. Memory retrieval requires mushroom body output, but the manner in which a memory trace in the mushroom body drives conditioned avoidance of a learned odor remains unknown. To identify neurons that are involved in olfactory memory retrieval, we performed an anatomical and functional screen of defined sets of mushroom body output neurons. We found that MB-V2 neurons were essential for retrieval of both short- and long-lasting memory, but not for memory formation or memory consolidation. MB-V2 neurons are cholinergic efferent neurons that project from the mushroom body vertical lobes to the middle superiormedial protocerebrum and the lateral horn. Notably, the odor response of MB-V2 neurons was modified after conditioning. As the lateral horn has been implicated in innate responses to repellent odorants, we propose that MB-V2 neurons recruit the olfactory pathway involved in innate odor avoidance during memory retrieval.	[Sejourne, Julien; Placais, Pierre-Yves; Trannoy, Severine; Tchenio, Paul; Isabel, Guillaume; Preat, Thomas] Ecole Super Phys & Chim Ind Ville Paris, CNRS, Neurobiol Unit, Paris, France; [Aso, Yoshinori; Siwanowicz, Igor; Thoma, Vladimiros; Tedjakumala, Stevanus R.; Tanimoto, Hiromu] Max Planck Inst Neurobiol, Martinsried, Germany; [Aso, Yoshinori; Rubin, Gerald M.] Howard Hughes Med Inst, Ashburn, VA USA; [Tchenio, Paul] Univ Paris 11, CNRS, UPR 3321, F-91405 Orsay, France; [Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universite Paris Cite; Max Planck Society; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Tokyo	Preat, T (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS, Neurobiol Unit, Paris, France.	hiromut@neuro.mpg.de; thomas.preat@espci.fr	Aso, Yoshinori/ACJ-9439-2022; Trannoy, Severine/D-1530-2015; Tanimoto, Hiromu/J-6810-2016	Trannoy, Severine/0000-0002-5059-9846; Preat, Thomas/0000-0001-9976-1763; Thoma, Vladimiros/0000-0002-2688-4639; Rubin, Gerald/0000-0001-8762-8703	Japan Society for the Promotion of Science; Agence Nationale pour la Recherche; Fondation Bettencourt-Schueler; Fondation pour la Recherche Medicale; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung; Max-Planck-Gesellschaft; Region Ile-de-France; Deutscher Akademischer Austausch Dienst	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation Bettencourt-Schueler; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Max-Planck-Gesellschaft(Max Planck Society); Region Ile-de-France(Region Ile-de-France); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD))	We thank J. Urban and G. M. Technau for the MZ160 line, the members of the NP consortium for the NP2492 line, J.-M. Dura for the y<SUP>1</SUP>w<SUP>1118</SUP>; GAL80[y<SUP>+</SUP>], Sb line and for discussions, L. L. Looger for the UAS-GCaMP3 line, T. Kitamoto for the GAD1-GAL80 and Cha<SUP>3.3kb</SUP>-GAL80 lines, and V. Hakim, I. Rivals and members of our laboratories for discussions. This work was supported by grants from the Japan Society for the Promotion of Science (K. I.), the Agence Nationale pour la Recherche (T. P.), the Fondation Bettencourt-Schueler (T. P.), the Fondation pour la Recherche Medicale (T. P.), the Emmy-Noether Program from Deutsche Forschungsgemeinschaft (H. T.), the Bernstein Focus Learning from Bundesministerium fur Bildung und Forschung (H. T.) and the Max-Planck-Gesellschaft (H. T.). J. S. and G. I. were supported by the Fondation pour la Recherche Medicale, P.-Y.P. was supported by a grant from Region Ile-de-France and Y.A. was supported by Deutscher Akademischer Austausch Dienst.	Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Bashir ZI, 2003, NEUROSCI RES, V45, P363, DOI 10.1016/S0168-0102(03)00002-6; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Colomb J, 2009, GENES BRAIN BEHAV, V8, P407, DOI 10.1111/j.1601-183X.2009.00482.x; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; FIALA A, 2003, SCI STKE, pPL6; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Ito K, 1998, LEARN MEMORY, V5, P52; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; MAUELSHAGEN J, 1993, J NEUROPHYSIOL, V69, P609, DOI 10.1152/jn.1993.69.2.609; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Menzel R, 2005, J EXP BIOL, V208, P4317, DOI 10.1242/jeb.01908; Neckameyer WS, 2000, NEUROBIOL AGING, V21, P145, DOI 10.1016/S0197-4580(99)00109-8; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Sakai T, 2009, GENES BRAIN BEHAV, V8, P546, DOI 10.1111/j.1601-183X.2009.00503.x; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sepp KJ, 1999, GENETICS, V151, P1093; Takagawa K, 1996, NEUROSCI RES, V24, P237, DOI 10.1016/0168-0102(95)00999-X; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	50	150	151	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					903	U129		10.1038/nn.2846	http://dx.doi.org/10.1038/nn.2846			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21685917	Green Submitted			2022-12-17	WOS:000292081700019
J	Mayer, C; Boehm, U				Mayer, Christian; Boehm, Ulrich			Female reproductive maturation in the absence of kisspeptin/GPR54 signaling	NATURE NEUROSCIENCE			English	Article							ESTROGEN-RECEPTOR-ALPHA; HORMONE-SECRETION; DIPHTHERIA-TOXIN; ARCUATE NUCLEUS; NEUROBIOLOGICAL MECHANISMS; KISS-1 PEPTIDE; PREOPTIC AREA; NEURONS; PUBERTY; GPR54	Puberty onset is initiated in the brain by activation of gonadotropin-releasing hormone (GnRH) neurosecretion. Different permissive signals must be integrated for the initiation of reproductive maturation; however, the neural circuits controlling timely awakening of the reproductive axis are not understood. The identification of the neuropeptide kisspeptin as a potent activator of GnRH neuronal activity suggests that kisspeptin-releasing neurons might coordinate puberty onset. To test this hypothesis, we generated mice that specifically lack kisspeptin cells. Puberty onset in females was unaffected by kisspeptin neuron ablation. Furthermore, the animals were fertile, albeit with smaller ovaries. Consistent with this, female mice lacking neurons that express the kisspeptin receptor GPR54 were also fertile. Acute ablation of kisspeptin neurons in adult mice inhibited fertility, suggesting that there is compensation for the loss of kisspeptin neurons early in development. Our data indicate that the initiation and completion of reproductive maturation can occur in the absence of kisspeptin/GPR54 signaling.	[Mayer, Christian; Boehm, Ulrich] Univ Hamburg, Ctr Mol Neurobiol, Inst Neural Signal Transduct, D-2000 Hamburg, Germany	University of Hamburg	Boehm, U (corresponding author), Univ Hamburg, Ctr Mol Neurobiol, Inst Neural Signal Transduct, D-2000 Hamburg, Germany.	ulrich.boehm@zmnh.uni-hamburg.de		Mayer, Christian/0000-0003-3152-5574	Deutsche Forschungsgemeinschaft [BO1743/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are indebted to O. Pongs for continuous support. A. Marquardt and D. Drexler provided expert technical assistance. We thank R. Kuhn for providing the IGD3.2 embryonic stem cells and A. Waisman for providing the R26-iDTR mice, I. Hermans-Borgmeyer for help with embryonic stem cell work and blastocyst injections, A. Derin and U. Wolters for animal caretaking, B. Mann for performing the hormone assays and M. Roberson and K. Duncan for helpful discussions. This project was supported by Deutsche Forschungsgemeinschaft grant BO1743/2 to U.B.	Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Castellano JM, 2006, ENDOCRINOLOGY, V147, P4852, DOI 10.1210/en.2006-0117; Chan YM, 2009, J NEUROENDOCRINOL, V21, P1015, DOI 10.1111/j.1365-2826.2009.01926.x; Clarkson J, 2009, J NEUROENDOCRINOL, V21, P673, DOI 10.1111/j.1365-2826.2009.01892.x; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; Clarkson J, 2010, MOL CELL ENDOCRINOL, V324, P45, DOI 10.1016/j.mce.2010.01.026; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Cravo RM, 2011, NEUROSCIENCE, V173, P37, DOI 10.1016/j.neuroscience.2010.11.022; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Franceschini I, 2006, NEUROSCI LETT, V401, P225, DOI 10.1016/j.neulet.2006.03.039; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; GIBSON MJ, 1984, SCIENCE, V225, P949, DOI 10.1126/science.6382608; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Gutierrez-Pascual E, 2007, J NEUROENDOCRINOL, V19, P521, DOI 10.1111/j.1365-2826.2007.01558.x; Harris GC, 2003, ENDOCRINOLOGY, V144, P163, DOI 10.1210/en.2002-220767; Herbison AE, 2008, ENDOCRINOLOGY, V149, P597, DOI 10.1210/en.2007-1139; Herbison AE, 2010, ENDOCRINOLOGY, V151, P312, DOI 10.1210/en.2009-0552; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Kauffman AS, 2007, TRENDS NEUROSCI, V30, P504, DOI 10.1016/j.tins.2007.08.001; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Matsui H, 2004, BIOCHEM BIOPH RES CO, V320, P383, DOI 10.1016/j.bbrc.2004.05.185; Mayer C, 2010, P NATL ACAD SCI USA, V107, P22693, DOI 10.1073/pnas.1012406108; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Navarro VM, 2005, ENDOCRINOLOGY, V146, P1689, DOI 10.1210/en.2004-1353; Navarro VM, 2004, J PHYSIOL-LONDON, V561, P379, DOI 10.1113/jphysiol.2004.072298; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Ojeda SR, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2061; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Pineda R, 2010, ENDOCRINOLOGY, V151, P722, DOI 10.1210/en.2009-0803; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Seminara SB, 2008, J NEUROENDOCRINOL, V20, P727, DOI 10.1111/j.1365-2826.2008.01731.x; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tena-Sempere M, 2010, ENDOCRIN DEV, V17, P52, DOI 10.1159/000262528; Terasawa E, 2001, ENDOCR REV, V22, P111, DOI 10.1210/er.22.1.111; Wen SP, 2011, ENDOCRINOLOGY, V152, P1515, DOI 10.1210/en.2010-1208	46	150	155	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					704	U297		10.1038/nn.2818	http://dx.doi.org/10.1038/nn.2818			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516099				2022-12-17	WOS:000290958000012
J	Isomura, Y; Harukuni, R; Takekawa, T; Aizawa, H; Fukai, T				Isomura, Yoshikazu; Harukuni, Rie; Takekawa, Takashi; Aizawa, Hidenori; Fukai, Tomoki			Microcircuitry coordination of cortical motor information in self-initiation of voluntary movements	NATURE NEUROSCIENCE			English	Article							PYRAMIDAL TRACT NEURONS; PRIMATE MOTOR; IN-VIVO; SOMATOSENSORY CORTEX; PREFRONTAL CORTEX; NEURAL ACTIVITY; SPINAL-CORD; CELLS; RAT; INTERNEURONS	Motor cortex neurons are activated at different times during self-initiated voluntary movement. However, the manner in which excitatory and inhibitory neurons in distinct cortical layers help to organize voluntary movement is poorly understood. We carried out juxtacellular and multiunit recordings from actively behaving rats and found temporally and functionally distinct activations of excitatory pyramidal cells and inhibitory fast-spiking interneurons. Across cortical layers, pyramidal cells were activated diversely for sequential motor phases (for example, preparation, initiation and execution). In contrast, fast-spiking interneurons, including parvalbumin-positive basket cells, were recruited predominantly for motor execution, with pyramidal cells producing a command-like activity. Thus, fast-spiking interneurons may underlie command shaping by balanced inhibition or recurrent inhibition, rather than command gating by temporally alternating excitation and inhibition. Furthermore, initiation-associated pyramidal cells excited similar and different functional classes of neurons through putative monosynaptic connections. This suggests that these cells may temporally integrate information to initiate and coordinate voluntary movement.	[Isomura, Yoshikazu; Harukuni, Rie; Takekawa, Takashi; Aizawa, Hidenori; Fukai, Tomoki] RIKEN Brain Sci Inst, Saitama, Japan; [Fukai, Tomoki] Univ Tokyo, Chiba, Japan; [Fukai, Tomoki] Tamagawa Univ, Brain Res Ctr, Tokyo, Japan	RIKEN; University of Tokyo	Isomura, Y (corresponding author), RIKEN Brain Sci Inst, Saitama, Japan.	isomura@brain.riken.jp	Fukai, Tomoki/A-3936-2015	Fukai, Tomoki/0000-0001-6977-5638; Aizawa, Hidenori/0000-0002-2896-1298; Takekawa, Takashi/0000-0002-0821-9109	RIKEN; Ministry of Education, Culture, Sports, Science and Technology [18019041, 18700386, 40218871]; Grants-in-Aid for Scientific Research [21680036] Funding Source: KAKEN	RIKEN; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank G. Buzsaki and J. Tanji for helpful comments and discussion, M. Fujii, K. Ishii, M. Kobayashi, R. Nakatomi and S. Tanaka for technical assistance, and K. O'hara for developing the multi-rat task-training system. This work was supported by the institutional research grants from RIKEN (T. F.) and by Grants-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology (18019041 and 18700386 to Y. I. and 40218871 to T. F.).	Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; BAUSWEIN E, 1989, BRAIN RES, V493, P198, DOI 10.1016/0006-8993(89)91018-4; Beloozerova IN, 2003, J NEUROSCI, V23, P1087; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Cauli B, 1997, J NEUROSCI, V17, P3894; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Cho RH, 2004, NEUROSCI RES, V50, P381, DOI 10.1016/j.neures.2004.08.006; Cho RH, 2004, NEUROSCI RES, V50, P395, DOI 10.1016/j.neures.2004.08.007; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Fromm C, 1983, Adv Neurol, V39, P329; FROMM C, 1981, J NEUROSCI, V1, P453; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Georgopoulos AP, 2007, BRAIN RES REV, V55, P383, DOI 10.1016/j.brainresrev.2007.05.001; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; HASHIMOTO S, 1980, BRAIN RES, V197, P415, DOI 10.1016/0006-8993(80)91126-9; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Hyland B, 1998, BEHAV BRAIN RES, V94, P255, DOI 10.1016/S0166-4328(97)00157-5; Isomura Y, 2003, J NEUROSCI, V23, P8002; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Lee MG, 2004, J NEUROPHYSIOL, V92, P1182, DOI 10.1152/jn.01003.2003; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MATSUMURA M, 1992, J NEUROPHYSIOL, V68, P692, DOI 10.1152/jn.1992.68.3.692; Matsumura M, 1996, J NEUROSCI, V16, P7757; Merchant H, 2008, J NEUROSCI, V28, P9164, DOI 10.1523/JNEUROSCI.1898-08.2008; Okamoto H, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000404; OKANO K, 1987, EXP BRAIN RES, V66, P155; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Rao SG, 1999, J NEUROPHYSIOL, V81, P1903, DOI 10.1152/jn.1999.81.4.1903; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; STEFANIS C, 1964, J NEUROPHYSIOL, V27, P855, DOI 10.1152/jn.1964.27.5.855; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Turner RS, 2000, J NEUROSCI, V20, P7096, DOI 10.1523/JNEUROSCI.20-18-07096.2000; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; WILSON FAW, 1994, P NATL ACAD SCI USA, V91, P4009, DOI 10.1073/pnas.91.9.4009	50	150	150	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1586	U140		10.1038/nn.2431	http://dx.doi.org/10.1038/nn.2431			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19898469				2022-12-17	WOS:000272065600019
J	Tsuchiya, N; Moradi, F; Felsen, C; Yamazaki, M; Adolphs, R				Tsuchiya, Naotsugu; Moradi, Farshad; Felsen, Csilla; Yamazaki, Madoka; Adolphs, Ralph			Intact rapid detection of fearful faces in the absence of the amygdala	NATURE NEUROSCIENCE			English	Article							CONTINUOUS FLASH SUPPRESSION; AWARENESS; RECOGNITION; RESPONSES; DAMAGE	The amygdala is thought to process fear-related stimuli rapidly and nonconsciously. We found that an individual with complete bilateral amygdala lesions, who cannot recognize fear from faces, nonetheless showed normal rapid detection and nonconscious processing of those same fearful faces. We conclude that the amygdala is not essential for early stages of fear processing but, instead, modulates recognition and social judgment.	[Tsuchiya, Naotsugu; Moradi, Farshad; Felsen, Csilla; Adolphs, Ralph] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Tsuchiya, Naotsugu] Tamagawa Univ, Brain Sci Inst, Tokyo, Japan; [Adolphs, Ralph] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Tsuchiya, N (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	naotsu@gmail.com	Tsuchiya, Naotsugu/N-8153-2014	Tsuchiya, Naotsugu/0000-0003-4216-8701	National Institute of Mental Health; Simons Foundation; Japanese Ministry of Education, Culture, Sports and Technology; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; Japanese Ministry of Education, Culture, Sports and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Holcomb for help with recruiting and testing subjects. This work was funded by grants from the National Institute of Mental Health and the Simons Foundation to R. A. and was supported, in part, by Tamagawa University global Center of Excellence program of the Japanese Ministry of Education, Culture, Sports and Technology. N. T. is supported by the Japan Society for the Promotion of Science.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Lin JY, 2009, CURR BIOL, V19, P1118, DOI 10.1016/j.cub.2009.05.021; Mormann F, 2008, J NEUROSCI, V28, P8865, DOI 10.1523/JNEUROSCI.1640-08.2008; Ohman A, 2007, PHYSIOL BEHAV, V92, P180, DOI 10.1016/j.physbeh.2007.05.057; Pegna AJ, 2005, NAT NEUROSCI, V8, P24, DOI 10.1038/nn1364; Pessoa L, 2006, CEREB CORTEX, V16, P366, DOI 10.1093/cercorbhi115; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Whalen PJ, 1998, J NEUROSCI, V18, P411; Yang E, 2007, EMOTION, V7, P882, DOI 10.1037/1528-3542.7.4.882	14	150	156	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1224	1225		10.1038/nn.2380	http://dx.doi.org/10.1038/nn.2380			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19718036	Green Accepted			2022-12-17	WOS:000270170200009
J	Di Cristo, G; Chattopadhyaya, B; Kuhlman, SJ; Fu, Y; Belanger, MC; Wu, CZ; Rutishauser, U; Maffei, L; Huang, ZJ				Di Cristo, Graziella; Chattopadhyaya, Bidisha; Kuhlman, Sandra J.; Fu, Yu; Belanger, Marie-Claude; Wu, Cai Zhi; Rutishauser, Urs; Maffei, Lamberto; Huang, Z. Josh			Activity-dependent PSA expression regulates inhibitory maturation and onset of critical period plasticity	NATURE NEUROSCIENCE			English	Article							CELL-ADHESION MOLECULE; PRIMARY VISUAL-CORTEX; GAMMA-AMINOBUTYRIC-ACID; POLYSIALIC ACID; GABAERGIC INNERVATION; SYNAPTIC PLASTICITY; CEREBRAL-CORTEX; ADULT; AXONS; NCAM	Functional maturation of GABAergic innervation in the developing visual cortex is regulated by neural activity and sensory inputs and in turn influences the critical period of ocular dominance plasticity. Here we show that polysialic acid (PSA), presented by the neural cell adhesion molecule, has a role in the maturation of GABAergic innervation and ocular dominance plasticity. Concentrations of PSA significantly decline shortly after eye opening in the adolescent mouse visual cortex; this decline is hindered by visual deprivation. The developmental and activity-dependent regulation of PSA expression is inversely correlated with the maturation of GABAergic innervation. Premature removal of PSA in visual cortex results in precocious maturation of perisomatic innervation by basket interneurons, enhanced inhibitory synaptic transmission, and earlier onset of ocular dominance plasticity. The developmental and activity-dependent decline of PSA expression therefore regulates the timing of the maturation of GABAergic inhibition and the onset of ocular dominance plasticity.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11734 USA; SUNY Stony Brook, Neurosci Program, Stony Brook, NY 11790 USA; Univ Montreal, CHU St Justine, Montreal, PQ H3T 1C5, Canada; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Inst Neuro Fisiol Ctr Nazl Ricerca, I-56124 Pisa, Italy	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Memorial Sloan Kettering Cancer Center	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11734 USA.	huangj@cshl.edu	Kuhlman, Sandra/Q-1211-2015	Kuhlman, Sandra/0000-0003-0450-7282; Huang, Z. Josh/0000-0003-0592-028X	NEI NIH HHS [R01 EY 13564-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013564] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Bouzioukh F, 2001, J NEUROSCI, V21, P4721, DOI 10.1523/JNEUROSCI.21-13-04721.2001; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Bruses JL, 1998, J CELL BIOL, V140, P1177, DOI 10.1083/jcb.140.5.1177; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Dupuy ST, 1996, J NEUROSCI, V16, P6919; Echevarria D, 2000, DEV BRAIN RES, V123, P151, DOI 10.1016/S0165-3806(00)00089-4; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; El Maarouf A, 2003, J COMP NEUROL, V460, P203, DOI 10.1002/cne.10635; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Klostermann O, 1999, NEUROSCIENCE, V92, P1243, DOI 10.1016/S0306-4522(99)00009-3; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kurosawa N, 1997, J NEUROCHEM, V69, P494; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Minelli A, 2003, NEUROSCIENCE, V117, P337, DOI 10.1016/S0306-4522(02)00864-3; Morales B, 2002, J NEUROSCI, V22, P8084; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; Seki T, 1998, J NEUROSCI, V18, P3757; Soares S, 2000, J NEUROSCI, V20, P2551; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; Theodosis DT, 1999, J NEUROSCI, V19, P10228; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; Toki S, 2007, EUR J NEUROSCI, V25, P815, DOI 10.1111/j.1460-9568.2007.05288.x; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yamamoto N, 2000, J NEUROSCI, V20, P9145; YIN XH, 1995, DEVELOPMENT, V121, P3439	50	150	150	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1569	1577		10.1038/nn2008	http://dx.doi.org/10.1038/nn2008			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	18026099				2022-12-17	WOS:000251172900014
J	Goel, A; Jiang, B; Xu, LW; Song, LH; Kirkwood, A; Lee, HK				Goel, Anubhuthi; Jiang, Bin; Xu, Linda W.; Song, Lihua; Kirkwood, Alfredo; Lee, Hey-Kyoung			Cross-modal regulation of synaptic AMPA receptors in primary sensory cortices by visual experience	NATURE NEUROSCIENCE			English	Article							TRAFFICKING; PLASTICITY; EXPRESSION; NEURONS	Lack of a sensory input not only alters the cortical circuitry subserving the deprived sense, but also produces compensatory changes in the functionality of other sensory modalities. Here we report that visual deprivation produces opposite changes in synaptic function in primary visual and somatosensory cortices in rats, which are rapidly reversed by visual experience. This type of bidirectional cross-modal plasticity is associated with changes in synaptic AMPA receptor subunit composition.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Maryland, NACS Program, College Pk, MD 20742 USA; Johns Hopkins Univ, Mind Brain Inst, Dept Neurosci, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University	Lee, HK (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	hlee21@umd.edu		Lee, Hey-Kyoung/0000-0002-5554-983X	NATIONAL EYE INSTITUTE [R01EY014882, R01EY012124] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014882-02, R01 EY014882, R01-EY012124, R01 EY014882-03, R01 EY012124, R01-EY014882, R01 EY014882-01A1] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Goldreich D, 2003, J NEUROSCI, V23, P3439; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Washburn MS, 1997, J NEUROSCI, V17, P9393	13	150	153	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1001	1003		10.1038/nn1725	http://dx.doi.org/10.1038/nn1725			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819524	Green Accepted			2022-12-17	WOS:000240080300010
J	Voss, M; Ingram, JN; Haggard, P; Wolpert, DM				Voss, M; Ingram, JN; Haggard, P; Wolpert, DM			Sensorimotor attenuation by central motor command signals in the absence of movement	NATURE NEUROSCIENCE			English	Article							SOMATOSENSORY-EVOKED-POTENTIALS; VOLUNTARY MOVEMENT; HUMAN BRAIN; STIMULATION; PERCEPTION; SUPPRESSION; DELAY; TIME	Voluntary actions typically produce suppression of afferent sensation from the moving body part. We used transcranial magnetic stimulation to delay the output of motor commands from the motor cortex during voluntary movement. We show attenuation of sensation during this delay, in the absence of movement. We conclude that sensory suppression mainly relies on central signals related to the preparation for movement and that these signals are upstream of primary motor cortex.	Inst Neurol, Sobell Dept Motor Neurosci, London WC1N 3BG, England; Inst Cognit Neurosci, London WC1N 3AR, England; Dept Psychol, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Voss, M (corresponding author), Inst Neurol, Sobell Dept Motor Neurosci, Queen Sq, London WC1N 3BG, England.	martin.voss@charite.de	Haggard, Patrick/A-5081-2010	Wolpert, Daniel/0000-0003-2011-2790; Voss, Martin/0000-0002-5221-4647; Haggard, Patrick/0000-0001-7798-793X	Wellcome Trust [077730] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; CHAPMAN CE, 1987, EXP BRAIN RES, V68, P516; COHEN LG, 1987, BRAIN, V110, P451, DOI 10.1093/brain/110.2.451; DAY BL, 1989, BRAIN, V112, P649, DOI 10.1093/brain/112.3.649; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; PALMER E, 1994, J PHYSIOL-LONDON, V481, P509, DOI 10.1113/jphysiol.1994.sp020459; PASCUALLEONE A, 1994, ELECTROEN CLIN NEURO, V93, P230, DOI 10.1016/0168-5597(94)90045-0; Seki K, 2003, NAT NEUROSCI, V6, P1309, DOI 10.1038/nn1154; SEYAL M, 1992, ELECTROEN CLIN NEURO, V85, P397, DOI 10.1016/0168-5597(92)90053-E; Shergill SS, 2003, SCIENCE, V301, P187, DOI 10.1126/science.1085327; Shimazu H, 1999, NEUROREPORT, V10, P2457, DOI 10.1097/00001756-199908200-00004; VANHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464; Wasaka T, 2003, NEUROIMAGE, V20, P1830, DOI 10.1016/S1053-8119(03)00442-7; Williams SR, 2002, J NEUROPHYSIOL, V88, P1968, DOI 10.1152/jn.2002.88.4.1968; Ziemann U, 1997, BRAIN RES, V744, P32, DOI 10.1016/S0006-8993(96)01062-1	15	150	150	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					26	27		10.1038/nn1592	http://dx.doi.org/10.1038/nn1592			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16311591	Green Accepted			2022-12-17	WOS:000234288000013
J	Martinez, LM; Wang, QB; Reid, RC; Pillai, C; Alonso, JM; Sommer, FT; Hirsch, JA				Martinez, LM; Wang, QB; Reid, RC; Pillai, C; Alonso, JM; Sommer, FT; Hirsch, JA			Receptive field structure varies with layer in the primary visual cortex	NATURE NEUROSCIENCE			English	Article							COMPLEX CELLS; ORIENTATION SELECTIVITY; ORDINAL POSITION; CORTICAL SIMPLE; STRIATE CORTEX; LOCAL CIRCUITS; CAT; NEURONS; ORGANIZATION; PROJECTIONS	Here we ask whether visual response pattern varies with position in the cortical microcircuit by comparing the structure of receptive fields recorded from the different layers of the cat's primary visual cortex. We used whole-cell recording in vivo to show the spatial distribution of visually evoked excitatory and inhibitory inputs and to stain individual neurons. We quantified the distribution of 'On' and 'Off' responses and the presence of spatially opponent excitation and inhibition within the receptive field. The thalamorecipient layers (4 and upper 6) were dominated by simple cells, as defined by two criteria: they had separated On and Off subregions, and they had push-pull responses (in a given subregion, stimuli of the opposite contrast evoked responses of the opposite sign). Other types of response profile correlated with laminar location as well. Thus, connections unique to each visual cortical layer are likely to serve distinct functions.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ A Coruna, Dept Med, La Coruna 15006, Spain; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA; Redwood Neurosci Inst, Menlo Pk, CA 94025 USA	University of Southern California; Universidade da Coruna; Harvard University; Harvard Medical School; State University of New York (SUNY) System; SUNY Optometry	Hirsch, JA (corresponding author), Univ So Calif, Dept Biol Sci, 3641 Watt Way, Los Angeles, CA 90089 USA.	jhirsch@usc.edu	Hirsch, Judith/E-9006-2013	Pillai, Cinthi/0000-0002-7662-443X	NATIONAL EYE INSTITUTE [R01EY009593, R29EY009593] Funding Source: NIH RePORTER; NEI NIH HHS [EY09593, R01 EY009593] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brumberg JC, 1999, J NEUROPHYSIOL, V82, P1808, DOI 10.1152/jn.1999.82.4.1808; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1251, DOI 10.1152/jn.1979.42.5.1251; BULLIER J, 1980, J COMP NEUROL, V193, P913, DOI 10.1002/cne.901930407; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chisum HJ, 2003, J NEUROSCI, V23, P2947; Contreras D, 2003, J NEUROSCI, V23, P6936; DEAN AF, 1983, J PHYSIOL-LONDON, V344, P305, DOI 10.1113/jphysiol.1983.sp014941; DEANGELIS GC, 1995, TRENDS NEUROSCI, V18, P451, DOI 10.1016/0166-2236(95)94496-R; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1988, J NEUROSCI, V8, P1172; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GRIEVE KL, 1991, EXP BRAIN RES, V87, P521; HENRY GH, 1977, BRAIN RES, V133, P1, DOI 10.1016/0006-8993(77)90045-2; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; Hirsch JA, 1998, J NEUROSCI, V18, P8086; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kagan I, 2002, J NEUROPHYSIOL, V88, P2557, DOI 10.1152/jn.00858.2001; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Linden JF, 2003, CEREB CORTEX, V13, P83, DOI 10.1093/cercor/13.1.83; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; MATA ML, IN PRESS J NEUROPHYS; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; PALMER LA, 1981, J NEUROPHYSIOL, V46, P260, DOI 10.1152/jn.1981.46.2.260; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rivadulla C, 2001, J NEUROSCI, V21, P1710, DOI 10.1523/JNEUROSCI.21-05-01710.2001; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Swadlow HA, 1996, J NEUROPHYSIOL, V75, P1753, DOI 10.1152/jn.1996.75.4.1753; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P202, DOI 10.1152/jn.1981.46.2.202; Troyer TW, 1998, J NEUROSCI, V18, P5908; Usrey WM, 2003, J NEUROPHYSIOL, V89, P1003, DOI 10.1152/jn.00749.2002	50	150	151	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					372	379		10.1038/nn1404	http://dx.doi.org/10.1038/nn1404			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15711543	Green Accepted			2022-12-17	WOS:000227354600023
J	Marton, RM; Miura, Y; Sloan, SA; Li, QY; Revah, O; Levy, RJ; Huguenard, JR; Pasca, SP				Marton, Rebecca M.; Miura, Yuki; Sloan, Steven A.; Li, Qingyun; Revah, Omer; Levy, Rebecca J.; Huguenard, John R.; Pasca, Sergiu P.			Differentiation and maturation of oligodendrocytes in human three-dimensional neural cultures	NATURE NEUROSCIENCE			English	Article							PRECURSOR CELLS; STEM-CELLS; PROGENITOR CELLS; WHITE-MATTER; RNA-SEQ; ASTROCYTES; NEURONS; DISEASE; MYELIN; GENES	Investigating human oligodendrogenesis and the interaction of oligodendrocytes with neurons and astrocytes would accelerate our understanding of the mechanisms underlying white matter disorders. However, this is challenging because of the limited accessibility of functional human brain tissue. Here, we developed a new differentiation method of human induced pluripotent stem cells to generate three-dimensional brain organoids that contain oligodendrocytes as well as neurons and astrocytes, called human oligodendrocyte spheroids. We found that oligodendrocyte lineage cells derived in human oligodendrocyte spheroids transitioned through developmental stages similar to primary human oligodendrocytes and that the migration of oligodendrocyte lineage cells and their susceptibility to lysolecithin exposure could be captured by live imaging. Moreover, their morphology changed as they matured over time in vitro and started myelinating neurons. We anticipate that this method can be used to study oligodendrocyte development, myelination, and interactions with other major cell types in the CNS.	[Marton, Rebecca M.; Miura, Yuki; Sloan, Steven A.; Revah, Omer; Pasca, Sergiu P.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Marton, Rebecca M.] Stanford Univ, Sch Med, Program Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Li, Qingyun] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Levy, Rebecca J.; Huguenard, John R.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Pasca, Sergiu P.] Stanford Univ, Human Brain Organogenesis Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Pasca, SP (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Pasca, SP (corresponding author), Stanford Univ, Human Brain Organogenesis Program, Stanford, CA 94305 USA.	spasca@stanford.edu	Revah, Omer/AAW-4048-2021; Huguenard, John/I-5016-2012; Miura, Yuki/AAD-7566-2021; Pasca, Sergiu/AAY-3949-2021; Li, Qingyun/AAG-5200-2019	Huguenard, John/0000-0002-6950-1191; Miura, Yuki/0000-0002-1410-3612; Pasca, Sergiu/0000-0002-3216-3248; Li, Qingyun/0000-0002-3457-5967; Levy, Rebecca/0000-0003-0393-6835; Marton, Rebecca/0000-0001-7460-7102; Revah, Omer/0000-0002-4002-5689	US National Institutes of Health BRAINS Award [MH107800]; MQ Fellow Award; NYSCF Robertson Stem Cell Investigator Award; Stanford Wu Tsai Neurosciences Institute's Brain Rejuvenation Project; Human Brain Organogenesis Project; Kwan Research Fund; California Institute of Regenerative Medicine; Child Health Research Institute Pilot Award; NARSAD Independent Investigator Award from Brain and Behavior Research Foundation; National Science Foundation Graduate Research Fellowship; Bio-X Stanford Interdisciplinary Graduate Fellowship; Stanford Medicine's Dean's Fellowship; NIMH [T32GM007365, F30MH106261]; Bio-X Predoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH106261, U01MH115745, R01MH107800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034774] Funding Source: NIH RePORTER	US National Institutes of Health BRAINS Award; MQ Fellow Award; NYSCF Robertson Stem Cell Investigator Award; Stanford Wu Tsai Neurosciences Institute's Brain Rejuvenation Project; Human Brain Organogenesis Project; Kwan Research Fund; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Child Health Research Institute Pilot Award; NARSAD Independent Investigator Award from Brain and Behavior Research Foundation; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Bio-X Stanford Interdisciplinary Graduate Fellowship; Stanford Medicine's Dean's Fellowship; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Bio-X Predoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This paper is dedicated to the memory of our wonderful colleague and mentor Ben A. Barres. We thank B.A. Barres, B. Zuchero, and members of the Pasca laboratory for scientific input, J. Perrino (Stanford Cell Sciences Imaging Facility) for support with electron microscopy, as well as F. Sim (University of Buffalo) for providing the Sox10-MCS5:: eGFP plasmid. This work was supported by the US National Institutes of Health BRAINS Award (MH107800), the MQ Fellow Award, the NYSCF Robertson Stem Cell Investigator Award, the Stanford Wu Tsai Neurosciences Institute's Brain Rejuvenation Project and the Human Brain Organogenesis Project, the Kwan Research Fund and the California Institute of Regenerative Medicine, the Child Health Research Institute Pilot Award, and the NARSAD Independent Investigator Award from the Brain and Behavior Research Foundation (to S.P.P.); the National Science Foundation Graduate Research Fellowship and the Bio-X Stanford Interdisciplinary Graduate Fellowship (to R.M.M.); Stanford Medicine's Dean's Fellowship (to Y.M.); and NIMH T32GM007365, F30MH106261, and Bio-X Predoctoral Fellowship (to or supporting S.A.S.).	Amin H, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00121; Amin ND, 2018, NEURON, V100, P389, DOI 10.1016/j.neuron.2018.10.007; AUSTIN J, 1970, ARCH NEUROL-CHICAGO, V23, P502, DOI 10.1001/archneur.1970.00480300024003; BARRES BA, 1993, DEVELOPMENT, V118, P283; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020453; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; BLAKEMORE WF, 1977, J NEUROL SCI, V33, P31, DOI 10.1016/0022-510X(77)90179-4; Clarke KE, 2017, NEUROCHEM INT, V106, P74, DOI 10.1016/j.neuint.2016.12.009; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Dai XD, 2003, J NEUROSCI, V23, P5846; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Deborde S, 2016, J CLIN INVEST, V126, P1538, DOI 10.1172/JCI82658; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Di Lullo E, 2017, NAT REV NEUROSCI, V18, P573, DOI 10.1038/nrn.2017.107; Douvaras P, 2015, NAT PROTOC, V10, P1143, DOI 10.1038/nprot.2015.075; Fan J, 2016, NAT METHODS, V13, P241, DOI [10.1038/NMETH.3734, 10.1038/nmeth.3734]; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gomez-Ospina N, 2006, GENEREVIEWS; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; HALL SM, 1972, J CELL SCI, V10, P535; HARDY R, 1993, J NEUROSCI RES, V36, P121, DOI 10.1002/jnr.490360202; Hogberg HT, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt365; Kang SM, 2007, STEM CELLS, V25, P419, DOI 10.1634/stemcells.2005-0482; Karadottir R, 2007, NEUROSCIENCE, V145, P1426, DOI 10.1016/j.neuroscience.2006.08.070; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Lim RG, 2017, NAT NEUROSCI, V20, P648, DOI 10.1038/nn.4532; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Livesey MR, 2016, STEM CELLS, V34, P1040, DOI 10.1002/stem.2273; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Menichella DM, 2006, J NEUROSCI, V26, P10984, DOI 10.1523/JNEUROSCI.0304-06.2006; Moore CS, 2011, J NEUROSCI RES, V89, P13, DOI 10.1002/jnr.22482; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Numasawa-Kuroiwa Y, 2014, STEM CELL REP, V2, P648, DOI 10.1016/j.stemcr.2014.03.007; Orthmann-Murphy JL, 2007, J NEUROSCI, V27, P13949, DOI 10.1523/JNEUROSCI.3395-07.2007; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]; Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Penna I, 2011, INT J MOL SCI, V12, P5461, DOI 10.3390/ijms12095461; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pol SU, 2013, EXP NEUROL, V247, P694, DOI 10.1016/j.expneurol.2013.03.010; Renner M, 2017, EMBO J, V36, P1316, DOI 10.15252/embj.201694700; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Romero IG, 2015, ELIFE, V4, DOI 10.7554/eLife.07103; Simons M, 2006, J CELL SCI, V119, P4381, DOI 10.1242/jcs.03242; Sloan SA, 2018, NAT PROTOC, V13, P2062, DOI 10.1038/s41596-018-0032-7; Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035; SONTHEIMER H, 1989, NEURON, V2, P1135, DOI 10.1016/0896-6273(89)90180-3; Stacpoole SRL, 2013, STEM CELL REP, V1, P437, DOI 10.1016/j.stemcr.2013.09.006; Thomas CA, 2017, CELL STEM CELL, V21, P319, DOI 10.1016/j.stem.2017.07.009; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Knapp MS, 2006, LANCET NEUROL, V5, P413, DOI 10.1016/S1474-4422(06)70440-9; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Wolswijk G, 2000, BRAIN, V123, P105, DOI 10.1093/brain/123.1.105; Xiao DC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05209-1; Xue YC, 2016, NAT NEUROSCI, V19, P807, DOI 10.1038/nn.4297; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yoon SJ, 2019, NAT METHODS, V16, P75, DOI 10.1038/s41592-018-0255-0; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013	63	149	151	13	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2019	22	3					484	+		10.1038/s41593-018-0316-9	http://dx.doi.org/10.1038/s41593-018-0316-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HM4DL	30692691	Green Accepted			2022-12-17	WOS:000459423800019
J	Parker, NF; Cameron, CM; Taliaferro, JP; Lee, J; Choi, JY; Davidson, TJ; Daw, ND; Witten, IB				Parker, Nathan F.; Cameron, Courtney M.; Taliaferro, Joshua P.; Lee, Junuk; Choi, Jung Yoon; Davidson, Thomas J.; Daw, Nathaniel D.; Witten, Ilana B.			Reward and choice encoding in terminals of midbrain dopamine neurons depends on striatal target	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS; PREDICTION; ACTIVATION; PRIMATE; RELEASE; SIGNALS; ERROR; MODULATION; MOVEMENT; PATTERNS	Dopaminergic (DA) neurons in the midbrain provide rich topographic innervation of the striatum and are central to learning and to generating actions. Despite the importance of this DA innervation, it remains unclear whether and how DA neurons are specialized on the basis of the location of their striatal target. Thus, we sought to compare the function of subpopulations of DA neurons that target distinct striatal subregions in the context of an instrumental reversal learning task. We identified key differences in the encoding of reward and choice in dopamine terminals in dorsal versus ventral striatum: DA terminals in ventral striatum responded more strongly to reward consumption and reward-predicting cues, whereas DA terminals in dorsomedial striatum responded more strongly to contralateral choices. In both cases the terminals encoded a reward prediction error. Our results suggest that the DA modulation of the striatum is spatially organized to support the specialized function of the targeted subregion.	[Parker, Nathan F.; Cameron, Courtney M.; Taliaferro, Joshua P.; Lee, Junuk; Choi, Jung Yoon; Daw, Nathaniel D.; Witten, Ilana B.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Parker, Nathan F.; Cameron, Courtney M.; Taliaferro, Joshua P.; Lee, Junuk; Choi, Jung Yoon; Daw, Nathaniel D.; Witten, Ilana B.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Davidson, Thomas J.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA	Princeton University; Princeton University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Witten, IB (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.; Witten, IB (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	iwitten@princeton.edu		Choi, Jung Yoon/0000-0001-6345-4876; Daw, Nathaniel/0000-0001-5029-1430; Lee, Junuk/0000-0002-3596-2651; Davidson, Thomas/0000-0003-0836-6333	Pew Foundation; McKnight Foundation; NARSAD Foundation; Sloan Foundation; NIH DP2 New Innovator Award [R01 MH106689-02]; NSF Graduate Research Fellowship; Essig and Enright '82 Fund; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP2DA035149] Funding Source: NIH RePORTER	Pew Foundation; McKnight Foundation; NARSAD Foundation(NARSAD); Sloan Foundation(Alfred P. Sloan Foundation); NIH DP2 New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Essig and Enright '82 Fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Gregory, M. Applegate and J. Finkelstein for assistance in data collection; J. Pillow and A. Conway for advice with data analysis; M. Murugan and B. Engelhard for comments on the manuscript; and D. Tindall and P. Wallace for administrative support. I.B.W. was supported by the Pew, McKnight, NARSAD and Sloan Foundations, NIH DP2 New Innovator Award and an R01 MH106689-02; N.F.P was supported by an NSF Graduate Research Fellowship; and J.P.T. and I.B.W. were supported by the Essig and Enright '82 Fund.	ARBUTHNOTT GW, 1971, EXP NEUROL, V30, P484, DOI 10.1016/0014-4886(71)90149-X; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Brown HD, 2011, EUR J NEUROSCI, V34, P1997, DOI 10.1111/j.1460-9568.2011.07914.x; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Diuk C, 2013, J NEUROSCI, V33, P5797, DOI 10.1523/JNEUROSCI.5445-12.2013; DOMESICK VB, 1988, ANN NY ACAD SCI, V537, P10, DOI 10.1111/j.1749-6632.1988.tb42094.x; Friston KJ, 2005, NEUROIMAGE, V24, P244, DOI 10.1016/j.neuroimage.2004.08.055; Gershman SJ, 2009, J NEUROSCI, V29, P13524, DOI 10.1523/JNEUROSCI.2469-09.2009; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hamid AA, 2016, NAT NEUROSCI, V19, P117, DOI 10.1038/nn.4173; Hart AS, 2014, J NEUROSCI, V34, P698, DOI 10.1523/JNEUROSCI.2489-13.2014; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Howe MW, 2013, NATURE, V500, P575, DOI 10.1038/nature12475; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ilango A, 2014, J NEUROSCI, V34, P817, DOI 10.1523/JNEUROSCI.1703-13.2014; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2015, NEURON, V85, P429, DOI 10.1016/j.neuron.2014.12.036; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; LYNDBALTA E, 1994, NEUROSCIENCE, V59, P625, DOI 10.1016/0306-4522(94)90182-1; MARSHALL JF, 1979, SCIENCE, V206, P477, DOI 10.1126/science.504992; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; STARR BS, 1986, NEUROPHARMACOLOGY, V25, P455, DOI 10.1016/0028-3908(86)90168-1; Stefani MR, 2006, J NEUROSCI, V26, P8810, DOI 10.1523/JNEUROSCI.1656-06.2006; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Willuhn I, 2012, P NATL ACAD SCI USA, V109, P20703, DOI 10.1073/pnas.1213460109; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028	52	149	150	0	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2016	19	6					845	+		10.1038/nn.4287	http://dx.doi.org/10.1038/nn.4287			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DN0HI	27110917	Green Accepted			2022-12-17	WOS:000376744600015
J	Robertson, SD; Plummer, NW; de Marchena, J; Jensen, P				Robertson, Sabrina D.; Plummer, Nicholas W.; de Marchena, Jacqueline; Jensen, Patricia			Developmental origins of central norepinephrine neuron diversity	NATURE NEUROSCIENCE			English	Article							DOPAMINE-BETA-HYDROXYLASE; LOCUS-COERULEUS NEURONS; NORADRENERGIC NEURONS; RAT-BRAIN; DEVELOPING HINDBRAIN; NERVOUS-SYSTEM; MESSENGER-RNA; EXPOSURE; MICE; DISEASE	Central norepinephrine-producing neurons comprise a diverse population of cells differing in anatomical location, connectivity, function and response to disease and environmental insult. The mechanisms that generate this diversity are unknown. Here we elucidate the lineal relationship between molecularly distinct progenitor populations in the developing mouse hindbrain and mature norepinephrine neuron subtype identity. We have identified four genetically separable subpopulations of mature norepinephrine neurons differing in their anatomical location, axon morphology and efferent projection pattern. One of the subpopulations showed an unexpected projection to the prefrontal cortex, challenging the long-held belief that the locus coeruleus is the sole source of norepinephrine projections to the cortex. These findings reveal the embryonic origins of central norepinephrine neurons and provide multiple molecular points of entry for future study of individual norepinephrine circuits in complex behavioral and physiological processes including arousal, attention, mood, memory, appetite and homeostasis.	[Robertson, Sabrina D.; Plummer, Nicholas W.; de Marchena, Jacqueline; Jensen, Patricia] NIEHS, Neurobiol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jensen, P (corresponding author), NIEHS, Neurobiol Lab, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	patricia.jensen@nih.gov	Jensen, Patricia/Z-1523-2018	Jensen, Patricia/0000-0001-6459-7289; Robertson, Sabrina/0000-0003-4598-6929; /0000-0003-2971-814X	Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences [ZIA-ES-102805]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102805, ZICES102425] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Dymecki (Harvard Medical School) for Hoxa2-cre and RC:: FrePe mice and P. Charnay (INSERM) for Krox20cre mice. We thank T. Wolfgang, G. Keeley and the National Institute of Environmental Health Sciences Fluorescence Microscopy, Vivarium, Knockout Mice and Statistics services for assistance. This research was supported by the Intramural Research Program of the US National Institutes of Health, National Institute of Environmental Health Sciences (ZIA-ES-102805).	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Aroca P, 2006, J COMP NEUROL, V496, P802, DOI 10.1002/cne.20957; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Bang SJ, 2012, EUR J NEUROSCI, V35, P85, DOI 10.1111/j.1460-9568.2011.07936.x; Benarroch EE, 2008, ACTA NEUROPATHOL, V115, P629, DOI 10.1007/s00401-008-0351-9; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bertrand E, 1997, FOLIA NEUROPATHOL, V35, P80; Brunnstrom H, 2011, CLIN NEUROPATHOL, V30, P104, DOI 10.5414/NPP30104; Busch C, 1997, NEUROBIOL AGING, V18, P401, DOI 10.1016/S0197-4580(97)00035-3; Chambers D, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-6; Champagnat J, 2009, PHILOS T R SOC B, V364, P2469, DOI 10.1098/rstb.2009.0090; Chandler D, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00020; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Davenport PW, 2009, RESP PHYSIOL NEUROBI, V167, P72, DOI 10.1016/j.resp.2008.10.001; Del Pino J, 2011, TOXICOLOGY, V287, P145, DOI 10.1016/j.tox.2011.06.009; Engleka KA, 2012, CIRC RES, V110, P922, DOI 10.1161/CIRCRESAHA.112.266510; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Forray MI, 2000, BRAIN RES BULL, V52, P163, DOI 10.1016/S0361-9230(00)00229-X; FRITSCHY JM, 1990, J COMP NEUROL, V293, P616, DOI 10.1002/cne.902930407; Garel S, 2000, DEVELOPMENT, V127, P5297; Gaufo GO, 2004, DEVELOPMENT, V131, P1259, DOI 10.1242/dev.01029; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Gray PA, 2010, J NEUROSCI, V30, P14883, DOI 10.1523/JNEUROSCI.4031-10.2010; Grossmann KS, 2010, PROG BRAIN RES, V187, P19, DOI [10.1016/S0079-6123(10)87002-5, 10.1016/B978-0-444-53613-6.00002-2]; GRZANNA R, 1991, PROG BRAIN RES, V88, P89; HOKFELT T, 1973, ACTA PHYSIOL SCAND, V89, P286, DOI 10.1111/j.1748-1716.1973.tb05522.x; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jin SH, 2004, J COMP NEUROL, V477, P300, DOI 10.1002/cne.20263; Kimmel RA, 2000, GENE DEV, V14, P1377; KRUMLAUF R, 1993, J NEUROBIOL, V24, P1328, DOI 10.1002/neu.480241006; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LORANG D, 1994, J NEUROSCI, V14, P4903; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Mejias-Aponte CA, 2009, J NEUROSCI, V29, P3613, DOI 10.1523/JNEUROSCI.4632-08.2009; Miller MA, 1999, J NEUROCHEM, V73, P2028; Mohideen SS, 2011, TOXICOLOGY, V285, P67, DOI 10.1016/j.tox.2011.04.005; Myers EA, 2005, J COMP NEUROL, V492, P426, DOI 10.1002/cne.20727; O'Gorman S, 2005, DEV DYNAM, V234, P124, DOI 10.1002/dvdy.20402; Paxinos G., 2019, PAXINOS FRANKLINS MO, DOI [10.3390/ijms20225729, DOI 10.3390/IJMS20225729]; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rinaman L, 2011, AM J PHYSIOL-REG I, V300, pR222, DOI 10.1152/ajpregu.00556.2010; Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011; SAWCHENKO PE, 1981, SCIENCE, V214, P685, DOI 10.1126/science.7292008; Schofield Brett R, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0117s43; Simon HH, 2005, MOL CELL NEUROSCI, V28, P96, DOI 10.1016/j.mcn.2004.08.016; Slotkin TA, 2011, BRAIN RES BULL, V86, P435, DOI 10.1016/j.brainresbull.2011.08.009; Soulage C, 2004, NEUROCHEM INT, V45, P979, DOI 10.1016/j.neuint.2004.06.015; SWANSON LW, 1976, BRAIN RES, V110, P39, DOI 10.1016/0006-8993(76)90207-9; Thomas SA, 1998, J NEUROCHEM, V70, P2468; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	57	149	151	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1016	U65		10.1038/nn.3458	http://dx.doi.org/10.1038/nn.3458			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852112	Green Accepted			2022-12-17	WOS:000322323000011
J	Kubota, JT; Banaji, MR; Phelps, EA				Kubota, Jennifer T.; Banaji, Mahzarin R.; Phelps, Elizabeth A.			The neuroscience of race	NATURE NEUROSCIENCE			English	Review							ANTERIOR CINGULATE CORTEX; IN-GROUP; IMPLEMENTATION INTENTIONS; INTERRACIAL CONTACT; AMYGDALA ACTIVITY; SOCIAL COGNITION; RACIAL-ATTITUDES; ERROR-DETECTION; OWN-RACE; IMPLICIT	As the racial composition of the population changes, intergroup interactions are increasingly common. To understand how we perceive and categorize race and the attitudes that flow from it, scientists have used brain imaging techniques to examine how social categories of race and ethnicity are processed, evaluated and incorporated in decision-making. We review these findings, focusing on black and white race categories. A network of interacting brain regions is important in the unintentional, implicit expression of racial attitudes and its control. On the basis of the overlap in the neural circuitry of race, emotion and decision-making, we speculate as to how this emerging research might inform how we recognize and respond to variations in race and its influence on unintended race-based attitudes and decisions.	[Kubota, Jennifer T.; Phelps, Elizabeth A.] NYU, Dept Psychol, New York, NY 10003 USA; [Banaji, Mahzarin R.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Phelps, Elizabeth A.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; Harvard University; New York University	Phelps, EA (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	liz.phelps@nyu.edu			Macarthur Foundation Law and Neuroscience Network; National Institute of Mental Health [MIT080756]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080756] Funding Source: NIH RePORTER	Macarthur Foundation Law and Neuroscience Network; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank L. Atlas for help with Figure 1, A. Meilich for help with Table 1 and J. Reitzes for feedback on various stages of this manuscript. We would like to acknowledge support by grants from the Macarthur Foundation Law and Neuroscience Network and the National Institute of Mental Health (MIT080756).	Amodio DM, 2006, SOC COGN AFFECT NEUR, V1, P26, DOI 10.1093/scan/nsl002; Amodio DM, 2004, PSYCHOL SCI, V15, P88, DOI 10.1111/j.0963-7214.2004.01502003.x; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; Bargh JA, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P361; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Beer JS, 2008, NEUROIMAGE, V43, P775, DOI 10.1016/j.neuroimage.2008.08.033; Blair IV, 2002, PERS SOC PSYCHOL REV, V6, P242, DOI 10.1207/S15327957PSPR0603_8; Blair IV, 1996, J PERS SOC PSYCHOL, V70, P1142, DOI 10.1037/0022-3514.70.6.1142; Bodenhausen GV, 1998, INTENTIONAL FORGETTING: INTERDISCIPLINARY APPROACHES, P349; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; BRIGHAM JC, 1985, J SOC ISSUES, V41, P139, DOI 10.1111/j.1540-4560.1985.tb01133.x; Brosch T., PSYCHOL SCI IN PRESS; Caldara R, 2003, CLIN NEUROPHYSIOL, V114, P515, DOI 10.1016/S1388-2457(02)00407-8; Caprariello PA, 2009, GROUP PROCESS INTERG, V12, P147, DOI 10.1177/1368430208101053; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Correll J, 2006, J EXP SOC PSYCHOL, V42, P120, DOI 10.1016/j.jesp.2005.02.006; Cuddy AJC, 2009, BRIT J SOC PSYCHOL, V48, P1, DOI 10.1348/014466608X314935; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Dasgupta N., 2009, HDB PREJUDICE STEREO, P267; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Delgado MR, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.033.2009; Devine PG, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P339; Dovidio JF, 2004, ADV EXP SOC PSYCHOL, V36, P1, DOI 10.1016/S0065-2601(04)36001-6; Dunton BC, 1997, PERS SOC PSYCHOL B, V23, P316, DOI 10.1177/0146167297233009; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; FISKE S T, 1989, P253; Fiske Susan T, 2009, Du Bois Rev, V6, DOI 10.1017/S1742058X0909002X; Forbes CE, 2012, SOC COGN AFFECT NEUR, V7, P771, DOI 10.1093/scan/nsr052; Galinsky AD, 2000, J PERS SOC PSYCHOL, V78, P708, DOI 10.1037//0022-3514.78.4.708; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P1; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Gollwitzer PM, 1997, J PERS SOC PSYCHOL, V73, P186, DOI 10.1037/0022-3514.73.1.186; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Gross J.J., 1998, REV GEN PSYCHOL, V2, P271, DOI [10.1037/1089-2680.2.3.271, DOI 10.1037/1089-2680.2.3.271, https://doi.org/10.1037/1089-2680.2.3.271]; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Ito TA, 2005, COGN AFFECT BEHAV NE, V5, P21, DOI 10.3758/CABN.5.1.21; Ito TA, 2004, PERS SOC PSYCHOL B, V30, P1267, DOI 10.1177/0146167204264335; Ito TA, 2009, TRENDS COGN SCI, V13, P524, DOI 10.1016/j.tics.2009.10.002; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Knutson KM, 2007, HUM BRAIN MAPP, V28, P915, DOI 10.1002/hbm.20320; Korn HA, 2012, SOC NEUROSCI-UK, V7, P398, DOI 10.1080/17470919.2011.631739; Krill Austen, 2009, Front Evol Neurosci, V1, P1, DOI 10.3389/neuro.18.001.2009; LABAR KS, 1995, J NEUROSCI, V15, P6846; Lane KA, 2007, ANNU REV LAW SOC SCI, V3, P427, DOI 10.1146/annurev.lawsocsci.3.081806.112748; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Ledoux JE, 2001, AM J PSYCHIAT, V158, P1953, DOI 10.1176/appi.ajp.158.12.1953; Lieberman MD, 2005, NAT NEUROSCI, V8, P720, DOI 10.1038/nn1465; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Mathur VA, 2012, HUM BRAIN MAPP, V33, P1883, DOI 10.1002/hbm.21330; Mathur VA, 2010, NEUROIMAGE, V51, P1468, DOI 10.1016/j.neuroimage.2010.03.025; MCCONAHAY JB, 1981, J CONFLICT RESOLUT, V25, P563, DOI 10.1177/002200278102500401; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Olsson A, 2005, SCIENCE, V309, P785, DOI 10.1126/science.1113551; Olsson A, 2007, SOC COGN AFFECT NEUR, V2, P3, DOI 10.1093/scan/nsm005; OSTROM TM, 1993, J PERS SOC PSYCHOL, V64, P21, DOI 10.1037/0022-3514.64.1.21; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P488, DOI 10.1037/0022-3514.89.4.488; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phelps EA, 2003, NEUROPSYCHOLOGIA, V41, P203, DOI 10.1016/S0028-3932(02)00150-1; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phelps EA, 2001, NAT NEUROSCI, V4, P775, DOI 10.1038/90467; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Plant EA, 1998, J PERS SOC PSYCHOL, V75, P811, DOI 10.1037/0022-3514.75.3.811; Richeson JA, 2005, SOC COGNITION, V23, P336, DOI 10.1521/soco.2005.23.4.336; Richeson JA, 2003, NAT NEUROSCI, V6, P1323, DOI 10.1038/nn1156; Richeson JA, 2003, PSYCHOL SCI, V14, P287, DOI 10.1111/1467-9280.03437; Richeson JA, 2008, GROUP PROCESS INTERG, V11, P233, DOI 10.1177/1368430207088040; Ronquillo J, 2007, SOC COGN AFFECT NEUR, V2, P39, DOI 10.1093/scan/nsl043; Rooth DO, 2010, LABOUR ECON, V17, P523, DOI 10.1016/j.labeco.2009.04.005; Rossion B, 2003, NEUROIMAGE, V19, P877, DOI 10.1016/S1053-8119(03)00105-8; Rudman LA, 2001, J PERS SOC PSYCHOL, V81, P856, DOI 10.1037/0022-3514.81.5.856; Sabin JA, 2009, J HEALTH CARE POOR U, V20, P896, DOI 10.1353/hpu.0.0185; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; Santos A, 2010, CURR BIOL, V20, pR307, DOI 10.1016/j.cub.2010.02.009; Schiller D, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00024; Snipes SA, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-183; Sokol-Hessner P, 2013, SOC COGN AFFECT NEUR, V8, P341, DOI 10.1093/scan/nss002; Sokol-Hessner P, 2009, P NATL ACAD SCI USA, V106, P5035, DOI 10.1073/pnas.0806761106; Stanley D, 2008, CURR DIR PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-8721.2008.00568.x; Stanley DA, 2012, PHILOS T R SOC B, V367, P744, DOI 10.1098/rstb.2011.0300; Stanley DA, 2011, P NATL ACAD SCI USA, V108, P7710, DOI 10.1073/pnas.1014345108; Stewart BD, 2008, PERS SOC PSYCHOL B, V34, P1332, DOI 10.1177/0146167208321269; Todorov A, 2008, COGN NEUROPSYCHOL, V25, P395, DOI 10.1080/02643290802044996; TRANEL D, 1985, SCIENCE, V228, P1453, DOI 10.1126/science.4012303; U.S. Census Bureau, 2010, OV RAC HISP OR 2010; Van Bavel JJ, 2009, PERS SOC PSYCHOL B, V35, P321, DOI 10.1177/0146167208327743; Van Bavel JJ, 2008, PSYCHOL SCI, V19, P1131, DOI 10.1111/j.1467-9280.2008.02214.x; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wheeler ME, 2005, PSYCHOL SCI, V16, P56, DOI 10.1111/j.0956-7976.2005.00780.x; Young SG, 2012, SOC PSYCHOL PERS SCI, V3, P80, DOI 10.1177/1948550611409759	100	149	149	0	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2012	15	7					940	948		10.1038/nn.3136	http://dx.doi.org/10.1038/nn.3136			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	966EE	22735516	Green Accepted, Bronze			2022-12-17	WOS:000305819600008
J	Chen, FY; Zha, DJ; Fridberger, A; Zheng, JF; Choudhury, N; Jacques, SL; Wang, RK; Shi, XR; Nuttall, AL				Chen, Fangyi; Zha, Dingjun; Fridberger, Anders; Zheng, Jiefu; Choudhury, Niloy; Jacques, Steven L.; Wang, Ruikang K.; Shi, Xiaorui; Nuttall, Alfred L.			A differentially amplified motion in the ear for near-threshold sound detection	NATURE NEUROSCIENCE			English	Article							BASILAR-MEMBRANE MOTION; HAIR-CELLS; MECHANOELECTRICAL TRANSDUCTION; REVERSE TRANSDUCTION; TECTORIAL MEMBRANE; ORGAN; COCHLEA; AMPLIFICATION; SENSITIVITY; POTENTIALS	The ear is a remarkably sensitive pressure fluctuation detector. In guinea pigs, behavioral measurements indicate a minimum detectable sound pressure of similar to 20 mu Pa at 16 kHz. Such faint sounds produce 0.1-nm basilar membrane displacements, a distance smaller than conformational transitions in ion channels. It seems that noise within the auditory system would swamp such tiny motions, making weak sounds imperceptible. Here we propose a new mechanism contributing to a resolution of this problem and validate it through direct measurement. We hypothesized that vibration at the apical side of hair cells is enhanced compared with that at the commonly measured basilar membrane side. Using in vivo optical coherence tomography, we demonstrated that apical-side vibrations peaked at a higher frequency, had different timing and were enhanced compared with those at the basilar membrane. These effects depend nonlinearly on the stimulus sound pressure level. The timing difference and enhancement of vibrations are important for explaining how the noise problem is circumvented.	[Chen, Fangyi; Zha, Dingjun; Fridberger, Anders; Zheng, Jiefu; Shi, Xiaorui; Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Zha, Dingjun] Fourth Mil Med Univ, Dept Otolaryngol Head & Neck Surg, Xijing Hosp, Xian, Peoples R China; [Fridberger, Anders] Karolinska Inst, Dept Clin Sci Intervent & Technol, Ctr Hearing & Commun Res, Stockholm, Sweden; [Choudhury, Niloy; Jacques, Steven L.; Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Jacques, Steven L.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Shi, Xiaorui] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shi, Xiaorui] Chinese Acad Med Sci, Inst Microcirculat, Beijing 100037, Peoples R China; [Nuttall, Alfred L.] Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA	Oregon Health & Science University; Air Force Military Medical University; Karolinska Institutet; Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Microcirculation - CAMS; University of Michigan System; University of Michigan	Nuttall, AL (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	nuttall@ohsu.edu	Wang, Ruikang/L-3889-2019; Fridberger, Anders/E-8977-2010; Chen, Fangyi/I-3497-2018	Wang, Ruikang/0000-0001-5169-8822; Fridberger, Anders/0000-0002-7960-1559; Chen, Fangyi/0000-0002-5024-6215	US National Institutes of Health, National Institute on Deafness and Other Communication Disorders [DC00141, DC010399, DC010201]; Swedish Research Council [K2008-63X-14061-08-3]; Tysta Skolan Foundation; Horselskadades Riksforbund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010399, R01DC010201, R01DC010844] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Tysta Skolan Foundation; Horselskadades Riksforbund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank E. de Boer, T. Ren, A. Magnusson and P. Gillespie for critical discussions and reading of the manuscript. This work was supported by US National Institutes of Health, National Institute on Deafness and Other Communication Disorders grants DC00141 (A.L.N.), DC010399 (A.L.N.) and DC010201 (R.K.W.); and Swedish Research Council grant K2008-63X-14061-08-3, the Tysta Skolan Foundation and Horselskadades Riksforbund (A.F.).	ALLEN JB, 1980, J ACOUST SOC AM, V68, P1660, DOI 10.1121/1.385198; BADENKRISTENSEN K, 1983, J PHYSIOL-LONDON, V335, P699, DOI 10.1113/jphysiol.1983.sp014559; Barral J, 2010, P NATL ACAD SCI USA, V107, P8079, DOI 10.1073/pnas.0913657107; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Chen FY, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717134; Choudhury N, 2006, HEARING RES, V220, P1, DOI 10.1016/j.heares.2006.06.006; Cooper NP, 2006, J PHYSIOL-LONDON, V576, P49, DOI 10.1113/jphysiol.2006.114991; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; Dallos P, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P97, DOI 10.1142/9789812704931_0013; de Boer E, 2000, J ACOUST SOC AM, V107, P1497, DOI 10.1121/1.428436; DENK W, 1989, PHYS REV LETT, V63, P207, DOI 10.1103/PhysRevLett.63.207; DENK W, 1992, HEARING RES, V60, P89, DOI 10.1016/0378-5955(92)90062-R; FLOCK A, 1965, COLD SPRING HARB SYM, V30, P133, DOI 10.1101/SQB.1965.030.01.016; Frank G, 1999, P NATL ACAD SCI USA, V96, P4420, DOI 10.1073/pnas.96.8.4420; Fridberger A, 2006, P NATL ACAD SCI USA, V103, P1918, DOI 10.1073/pnas.0507231103; Fridberger A, 2004, J NEUROSCI, V24, P10057, DOI 10.1523/JNEUROSCI.2711-04.2004; Fridberger A, 2003, NAT NEUROSCI, V6, P446, DOI 10.1038/nn1047; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; HEFFNER R, 1971, J ACOUST SOC AM, V49, P1888, DOI 10.1121/1.1912596; HOOD LJ, 1991, HEARING RES, V55, P109, DOI 10.1016/0378-5955(91)90097-S; Hu XT, 1999, J NEUROPHYSIOL, V82, P2798, DOI 10.1152/jn.1999.82.5.2798; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; Jaramillo F, 1998, NAT NEUROSCI, V1, P384, DOI 10.1038/1597; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Khanna SM, 2000, HEARING RES, V149, P55, DOI 10.1016/S0378-5955(00)00162-3; KHANNA SM, 1982, SCIENCE, V215, P305, DOI 10.1126/science.7053580; Kolston PJ, 1999, P NATL ACAD SCI USA, V96, P3676, DOI 10.1073/pnas.96.7.3676; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; Narayan SS, 1998, SCIENCE, V282, P1882, DOI 10.1126/science.282.5395.1882; NUTTALL AL, 1991, HEARING RES, V51, P203, DOI 10.1016/0378-5955(91)90037-A; Nuttall AL, 1995, HEARING RES, V92, P170, DOI 10.1016/0378-5955(95)00216-2; OLSON ES, 1991, J ACOUST SOC AM, V89, P1262, DOI 10.1121/1.400535; Pickles J. O, 1988, INTRO PHYSL HEARING; PROSEN CA, 1978, J ACOUST SOC AM, V63, P559, DOI 10.1121/1.381754; RHODE WS, 1971, J ACOUST SOC AM, V49, P1218, DOI 10.1121/1.1912485; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Ruggero MA, 2005, P NATL ACAD SCI USA, V102, P18614, DOI 10.1073/pnas.0509323102; RUGGERO MA, 1991, J NEUROSCI, V11, P1057; SELLICK PM, 1982, J ACOUST SOC AM, V72, P131, DOI 10.1121/1.387996; Tomo I, 2007, BIOPHYS J, V93, P3279, DOI 10.1529/biophysj.107.105072; van Netten SM, 2003, P NATL ACAD SCI USA, V100, P15510, DOI 10.1073/pnas.2632626100; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; ZWISLOCKI JJ, 1979, SCIENCE, V204, P639, DOI 10.1126/science.432671	45	149	152	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					770	U366		10.1038/nn.2827	http://dx.doi.org/10.1038/nn.2827			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21602821	Green Accepted			2022-12-17	WOS:000290958000021
J	Dhawale, AK; Hagiwara, A; Bhalla, US; Murthy, VN; Albeanu, DF				Dhawale, Ashesh K.; Hagiwara, Akari; Bhalla, Upinder S.; Murthy, Venkatesh N.; Albeanu, Dinu F.			Non-redundant odor coding by sister mitral cells revealed by light addressable glomeruli in the mouse	NATURE NEUROSCIENCE			English	Article							RAT OLFACTORY-BULB; MITRAL/TUFTED CELLS; IN-VIVO; FUNCTIONAL-ORGANIZATION; OPTICAL INTERROGATION; NEURAL CIRCUITRY; TRANSGENIC MICE; CORTEX; INHIBITION; REPRESENTATIONS	Sensory inputs frequently converge on the brain in a spatially organized manner, often with overlapping inputs to multiple target neurons. Whether the responses of target neurons with common inputs become decorrelated depends on the contribution of local circuit interactions. We addressed this issue in the olfactory system using newly generated transgenic mice that express channelrhodopsin-2 in all of the olfactory sensory neurons. By selectively stimulating individual glomeruli with light, we identified mitral/tufted cells that receive common input (sister cells). Sister cells had highly correlated responses to odors, as measured by average spike rates, but their spike timing in relation to respiration was differentially altered. In contrast, non-sister cells correlated poorly on both of these measures. We suggest that sister mitral/tufted cells carry two different channels of information: average activity representing shared glomerular input and phase-specific information that refines odor representations and is substantially independent for sister cells.	[Hagiwara, Akari; Murthy, Venkatesh N.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hagiwara, Akari; Murthy, Venkatesh N.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Dhawale, Ashesh K.; Albeanu, Dinu F.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Dhawale, Ashesh K.; Bhalla, Upinder S.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Harvard University; Harvard University; Cold Spring Harbor Laboratory; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Murthy, VN (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	vnmurthy@fas.harvard.edu; albeanu@cshl.edu		Murthy, Venkatesh/0000-0003-2443-4252; Dhawale, Ashesh/0000-0001-7438-1115; Albeanu, Dinu/0000-0001-7825-7744	Cold Spring Harbor Laboratory; International Society for Neurochemistry (Tata Institute of Fundamental Research); Merck; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011291] Funding Source: NIH RePORTER	Cold Spring Harbor Laboratory; International Society for Neurochemistry (Tata Institute of Fundamental Research); Merck(Merck & Company); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the Genome Manipulation Facility at Harvard University for help with generating the ORC mice. We are grateful to M. Meister, A. Kepecs, G. Turner, A. Khan, S. Kumari and P. Gupta for comments on the manuscript. B. Burbach, H. Cho, R. Eifert and M. Davis provided excellent technical support. We thank G. Otazu and S. Ranade for advice on building tetrodes and H. Oviedo and A. Zador for access to the laser-scanning photostimulation rig. Our special thanks go to Megabus for swift transportation and to the House of Marks. A. K. D. and D. F. A. were supported by the Cold Spring Harbor Laboratory Fellows Program. Additional support for A. K. D. was provided by the International Society for Neurochemistry, Sarojini Damodaran fellowship (Tata Institute of Fundamental Research) and Merck.	Adams D., 1979, HITCHHIKERS GUIDE GA; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BUONVISO N, 1990, J NEUROPHYSIOL, V63, P447, DOI 10.1152/jn.1990.63.3.447; Chen TW, 2009, P NATL ACAD SCI USA, V106, P2401, DOI 10.1073/pnas.0810151106; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; Egana JI, 2005, NEUROSCIENCE, V134, P1069, DOI 10.1016/j.neuroscience.2005.04.027; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; Gordon S.., 1998, SYNAPTIC ORG BRAIN, V5; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hartwich K, 2009, J NEUROSCI, V29, P9563, DOI 10.1523/JNEUROSCI.1397-09.2009; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; Kapoor V, 2006, J NEUROSCI, V26, P11709, DOI 10.1523/JNEUROSCI.3371-06.2006; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Khan AG, 2008, NEURON, V57, P571, DOI 10.1016/j.neuron.2008.01.008; Kosaka T, 2004, NEUROSCI RES, V49, P373, DOI 10.1016/j.neures.2004.04.003; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; MONOD B, 1989, BEHAV BRAIN RES, V33, P51, DOI 10.1016/S0166-4328(89)80018-X; MOULY AM, 1986, BEHAV BRAIN RES, V21, P1, DOI 10.1016/0166-4328(86)90054-9; NICOLL RA, 1982, NATURE, V296, P441, DOI 10.1038/296441a0; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Quirk MC, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.013.2009; ROYET JP, 1988, J COMP NEUROL, V270, P559, DOI 10.1002/cne.902700409; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	50	149	150	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1404	U183		10.1038/nn.2673	http://dx.doi.org/10.1038/nn.2673			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20953197	Green Accepted			2022-12-17	WOS:000283658200022
J	Truccolo, W; Hochberg, LR; Donoghue, JP				Truccolo, Wilson; Hochberg, Leigh R.; Donoghue, John P.			Collective dynamics in human and monkey sensorimotor cortex: predicting single neuron spikes	NATURE NEUROSCIENCE			English	Article							CORTICAL-NEURONS; MOTOR; ENSEMBLE; AREA; CELL	Coordinated spiking activity in neuronal ensembles, in local networks and across multiple cortical areas, is thought to provide the neural basis for cognition and adaptive behavior. Examining such collective dynamics at the level of single neuron spikes has remained, however, a considerable challenge. We found that the spiking history of small and randomly sampled ensembles (similar to 20-200 neurons) could predict subsequent single neuron spiking with substantial accuracy in the sensorimotor cortex of humans and nonhuman behaving primates. Furthermore, spiking was better predicted by the ensemble's history than by the ensemble's instantaneous state (Ising models), emphasizing the role of temporal dynamics leading to spiking. Notably, spiking could be predicted not only by local ensemble spiking histories, but also by spiking histories in different cortical areas. These strong collective dynamics may provide a basis for understanding cognition and adaptive behavior at the level of coordinated spiking in cortical networks.	[Truccolo, Wilson; Donoghue, John P.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Truccolo, Wilson; Hochberg, Leigh R.; Donoghue, John P.] Brown Univ, Brown Inst Brain Sci, Providence, RI 02912 USA; [Hochberg, Leigh R.] Brown Univ, Div Engn, Providence, RI 02912 USA; [Hochberg, Leigh R.; Donoghue, John P.] Dept Vet Affairs, Rehabil Res & Dev Serv, Providence, RI USA; [Truccolo, Wilson; Hochberg, Leigh R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA USA; [Hochberg, Leigh R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Hochberg, Leigh R.] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Boston, MA USA	Brown University; Brown University; Brown University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital	Truccolo, W (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	wilson_truccolo@brown.edu	Hochberg, Leigh/R-6872-2019	Hochberg, Leigh/0000-0003-0261-2273	National Institute of Neurological Disorders and Stroke [5K01NS057389-02, NS-25074]; National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research [N01-HD53403]; Massachusetts General Hospital Deane Institute; Doris Duke Charitable Foundation; National Institute on Deafness and Other Communication Disorders [R01-DC-009899]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD053403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS025074, R01NS025074, K01NS057389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009899] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Massachusetts General Hospital Deane Institute; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. R. Fellows, C. Vargas-Irwin and B. Philip for collecting the nonhuman primate data. We thank our clinical trial participants for their dedication to this research, G. Friehs for his role as surgical investigator for the pilot clinical trial, J. Mukand for his role as clinical investigator for the pilot clinical trial, and A. Caplan, M. Serruya, M. Saleh and other employees of Cyberkinetics Neurotechnology Systems for data collection, manufacturing and clinical trial management. This study was based on work supported in part by the Office of Research and Development, Rehabilitation R&D Service, Department of Veterans Affairs ( L. R. H. and J. P. D.). This work was supported by the National Institute of Neurological Disorders and Stroke (5K01NS057389-02 to W. T. and NS-25074 (Javits Award) to J. P. D.), the National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research (N01-HD53403, subcontract to L. R. H.), the Massachusetts General Hospital Deane Institute ( L. R. H.), the Doris Duke Charitable Foundation ( L. R. H) and the National Institute on Deafness and Other Communication Disorders (R01-DC-009899 to L. R. H.).	Amit DJ, 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BAMBER D, 1975, J MATH PSYCHOL, V12, P387, DOI 10.1016/0022-2496(75)90001-2; BESAG J, 1975, J ROY STAT SOC D-STA, V24, P179, DOI 10.2307/2987782; Braitenberg VB, 1998, CORTEX STAT GEOMETRY; Cover TM., 1991, ELEMENTS INFORM THEO; Daley D., 2003, INTRO THEORY POINT P, V1; Dayan P., 2001, THEORETICAL NEUROSCI; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Elston GN, 2002, CEREB CORTEX, V12, P1071, DOI 10.1093/cercor/12.10.1071; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Geman S, 1987, P INT C MATH, V1, P1496; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; GIDAS B, 1988, STOCHASTIC DIFFERENT; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hatsopoulos NG, 2007, J NEUROSCI, V27, P5105, DOI 10.1523/JNEUROSCI.3570-06.2007; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hyvarinen A, 2006, NEURAL COMPUT, V18, P2283, DOI 10.1162/neco.2006.18.10.2283; JAYNES ET, 1982, P IEEE, V70, P939, DOI 10.1109/PROC.1982.12425; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Landau L. D., 2013, STAT PHYS; Marre O, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.138101; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; TRUCCOLO W, ANAL PARALL IN PRESS; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	39	149	150	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					105	U275		10.1038/nn.2455	http://dx.doi.org/10.1038/nn.2455			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19966837	Green Accepted			2022-12-17	WOS:000273056300020
J	Moore, DR; Shannon, RV				Moore, David R.; Shannon, Robert V.			Beyond cochlear implants: awakening the deafened brain	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; ELECTRICAL-STIMULATION; STEM IMPLANT; SPEECH RECOGNITION; DISTORTED SPEECH; CRITICAL PERIOD; CHILDREN; HEARING; PERFORMANCE; PERCEPTION	Cochlear implants have provided hearing to more than 120,000 deaf people. Recent surgical developments include direct electrical stimulation of the brain, bilateral implants and implantation in children less than 1 year old. However, research is beginning to refocus on the role of the brain in providing benefits to implant users. The auditory system is able to use the highly impoverished input provided by implants to interpret speech, but this only works well in those who have developed language before their deafness or in those who receive their implant at a very young age. We discuss recent evidence suggesting that developing the ability of the brain to learn how to use an implant may be as important as further improvements of the implant technology.	[Moore, David R.] MRC, Inst Hearing Res, Nottingham, England; [Moore, David R.] Natl Biomed Res Unit Hearing, Nottingham, England; [Shannon, Robert V.] House Ear Res Inst, Los Angeles, CA USA	University of Nottingham; House Research Institute	Moore, DR (corresponding author), MRC, Inst Hearing Res, Nottingham, England.	david.moore@ihr.mrc.ac.uk			Medical Research Council [MC_U135097130] Funding Source: Medline; MRC [MC_U135097130] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Colletti V, 2005, LARYNGOSCOPE, V115, P1974, DOI 10.1097/01.mlg.0000178327.42926.ec; Colletti V, 2007, OTOL NEUROTOL, V28, P39, DOI 10.1097/01.mao.0000247808.47712.02; Dahmen JC, 2007, CURR OPIN NEUROBIOL, V17, P456, DOI 10.1016/j.conb.2007.07.004; Davis MH, 2005, J EXP PSYCHOL GEN, V134, P222, DOI 10.1037/0096-3445.134.2.222; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; Eggermont JJ, 2008, AM J AUDIOL, V17, pS162, DOI 10.1044/1059-0889(2008/07-0025); Eisen MD, 2003, OTOL NEUROTOL, V24, P500, DOI 10.1097/00129492-200305000-00025; Eisenberg LS, 2000, J ACOUST SOC AM, V107, P2704, DOI 10.1121/1.428656; Fallon JB, 2009, J COMP NEUROL, V512, P101, DOI 10.1002/cne.21886; Faulkner A, 2006, EAR HEARING, V27, P139, DOI 10.1097/01.aud.0000202357.40662.85; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2008, HEARING RES, V242, P198, DOI 10.1016/j.heares.2007.11.010; GALVIN JJ, ANN N Y ACA IN PRESS; Harris JA, 2008, J NEUROSCI, V28, P10990, DOI 10.1523/JNEUROSCI.2697-08.2008; HYSON RL, 1989, J NEUROSCI, V9, P2835; Kamke MR, 2005, NEURON, V48, P675, DOI 10.1016/j.neuron.2005.09.014; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Kral A, 2006, PROG BRAIN RES, V157, P283, DOI 10.1016/S0079-6123(06)57018-9; Krueger B, 2008, OTOL NEUROTOL, V29, P509, DOI 10.1097/MAO.0b013e318171972f; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Leake PA, 2008, HEARING RES, V242, P86, DOI 10.1016/j.heares.2008.06.002; Lenarz T, 2006, OTOL NEUROTOL, V27, P838, DOI 10.1097/01.mao.0000232010.01116.e9; Levi DM, 2009, PHILOS T R SOC B, V364, P399, DOI 10.1098/rstb.2008.0203; Loebach JL, 2008, J ACOUST SOC AM, V124, P552, DOI 10.1121/1.2931948; Maurer MH, 2008, PROTEOM CLIN APPL, V2, P437, DOI 10.1002/prca.200780044; Moore CM, 2002, HEARING RES, V164, P82, DOI 10.1016/S0378-5955(01)00415-4; Moore DR, 2008, HEARING RES, V238, P147, DOI 10.1016/j.heares.2007.11.013; Moore DR, 2009, PHILOS T R SOC B, V364, P409, DOI 10.1098/rstb.2008.0187; Moore DR, 2005, BRAIN LANG, V94, P72, DOI 10.1016/j.bandl.2004.11.009; MOORE DR, 1992, NEUROREPORT, V3, P269, DOI 10.1097/00001756-199203000-00014; Mossop JE, 2000, HEARING RES, V147, P183, DOI 10.1016/S0378-5955(00)00054-X; Norena AJ, 2006, NAT NEUROSCI, V9, P932, DOI 10.1038/nn1720; Otto SR, 2002, J NEUROSURG, V96, P1063, DOI 10.3171/jns.2002.96.6.1063; Otto SR, 2008, OTOL NEUROTOL, V29, P1147, DOI 10.1097/MAO.0b013e31818becb4; Parks T. N., 2004, PLASTICITY AUDITORY; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Sabes JH, 2007, INT J AUDIOL, V46, P374, DOI 10.1080/14992020701297565; SHANNON RV, 1990, HEARING RES, V47, P159, DOI 10.1016/0378-5955(90)90173-M; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; SHANNON RV, 1993, OTOLARYNG HEAD NECK, V108, P634, DOI 10.1177/019459989310800603; Sharma A, 2007, INT J AUDIOL, V46, P494, DOI 10.1080/14992020701524836; Spahr AJ, 2004, ARCH OTOLARYNGOL, V130, P624, DOI 10.1001/archotol.130.5.624; Stacey PC, 2008, J SPEECH LANG HEAR R, V51, P526, DOI 10.1044/1092-4388(2008/038); Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Tierney TS, 1997, J COMP NEUROL, V378, P295, DOI 10.1002/(SICI)1096-9861(19970210)378:2<295::AID-CNE11>3.0.CO;2-R; TUCCI DL, 1987, ANN OTO RHINOL LARYN, V96, P343, DOI 10.1177/000348948709600321; Vongpaisal T, 2006, J SPEECH LANG HEAR R, V49, P1091, DOI 10.1044/1092-4388(2006/078); Wright BA, 2009, PHILOS T R SOC B, V364, P301, DOI 10.1098/rstb.2008.0262	50	149	154	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2009	12	6					686	691		10.1038/nn.2326	http://dx.doi.org/10.1038/nn.2326			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	450DJ	19471266				2022-12-17	WOS:000266380900008
J	Soto, D; Coombs, ID; Kelly, L; Farrant, M; Cull-Candy, SG				Soto, David; Coombs, Ian D.; Kelly, Leah; Farrant, Mark; Cull-Candy, Stuart G.			Stargazin attenuates intracellular polyamine block of calcium-permeable AMPA receptors	NATURE NEUROSCIENCE			English	Article							FIBER-INTERNEURON SYNAPSES; LONG-TERM POTENTIATION; 2 DISTINCT MECHANISMS; GLUTAMATE RECEPTORS; KAINATE RECEPTORS; CA2+ PERMEABILITY; SUBUNIT; NEURONS; CHANNELS; TRAFFICKING	Endogenous polyamines profoundly affect the activity of various ion channels, including that of calcium-permeable AMPA-type glutamate receptors (CP-AMPARs). Here we show that stargazin, a transmembrane AMPAR regulatory protein ( TARP) known to influence transport, gating and desensitization of AMPARs, greatly reduces block of CP-AMPARs by intracellular polyamines. By decreasing CP-AMPAR affinity for cytoplasmic polyamines, stargazin enhances the charge transfer following single glutamate applications and eliminates the frequency-dependent facilitation seen with repeated applications. In cerebellar stellate cells, which express both synaptic CP-AMPARs and stargazin, we found that the rectification and unitary conductance of channels underlying excitatory postsynaptic currents were matched by those of recombinant AMPARs only when the latter were associated with stargazin. Taken together, our observations establish modulatory actions of stargazin that are specific to CP-AMPARs, and suggest that during synaptic transmission the activity of such receptors, and thus calcium influx, is fundamentally changed by TARPs.	UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Farrant, M (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	m.farrant@ucl.ac.uk	Soto, David/L-4403-2014	Soto, David/0000-0001-7995-3805; Farrant, Mark/0000-0002-9918-0376; Cull-Candy, Stuart G/0000-0002-0831-8326; Coombs, Ian/0000-0003-1006-7471	Wellcome Trust [074340] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; Beierlein M, 2006, J NEUROSCI, V26, P9935, DOI 10.1523/JNEUROSCI.0958-06.2006; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bischofberger J, 2002, TRENDS NEUROSCI, V25, P600, DOI 10.1016/S0166-2236(02)02259-2; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bowie D, 1998, J NEUROSCI, V18, P8175; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Cu CH, 1998, NEUROPHARMACOLOGY, V37, P1381, DOI 10.1016/S0028-3908(98)00112-9; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Kott S, 2007, J NEUROSCI, V27, P3780, DOI 10.1523/JNEUROSCI.4185-06.2007; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Moss FJ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-23; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Sharp AH, 2001, NEUROSCIENCE, V105, P599, DOI 10.1016/S0306-4522(01)00220-2; Shin J, 2005, J NEUROPHYSIOL, V93, P2634, DOI 10.1152/jn.01054.2004; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Yamazaki M, 2004, NEUROSCI RES, V50, P369, DOI 10.1016/j.neures.2004.10.002; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	50	149	149	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1260	1267		10.1038/nn1966	http://dx.doi.org/10.1038/nn1966			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17873873	Green Accepted			2022-12-17	WOS:000249720800012
J	Dai, Y; Taru, H; Deken, SL; Grill, B; Ackley, B; Nonet, ML; Jin, YS				Dai, Ya; Taru, Hidenori; Deken, Scott L.; Grill, Brock; Ackley, Brian; Nonet, Michael L.; Jin, Yishi			SYD-2 Liprin-alpha organizes presynaptic active zone formation through ELKS	NATURE NEUROSCIENCE			English	Article							ANAPHASE-PROMOTING COMPLEX; RIM-BINDING PROTEINS; CAENORHABDITIS-ELEGANS; C-ELEGANS; SYNAPSE FORMATION; RECEPTOR; FAMILY; FORMS; LOCALIZATION; CYTOMATRIX	A central event in synapse development is formation of the presynaptic active zone in response to positional cues. Three active zone proteins, RIM, ELKS (also known as ERC or CAST) and Liprin-alpha, bind each other and are implicated in linking active zone formation to synaptic vesicle release. Loss of function in Caenorhabditis elegans syd-2 Liprin-alpha alters the size of presynaptic specializations and disrupts synaptic vesicle accumulation. Here we report that a missense mutation in the coiled-coil domain of SYD-2 causes a gain of function. In HSN synapses, the syd-2(gf) mutation promotes synapse formation in the absence of syd-1, which is essential for HSN synapse formation. syd-2(gf) also partially suppresses the synaptogenesis defects in syg-1 and syg-2 mutants. The activity of syd-2(gf) requires elks-1, an ELKS homolog; but not unc-10, a RIM homolog. The mutant SYD-2 shows increased association with ELKS. These results establish a functional dependency for assembly of the presynaptic active zone in which SYD-2 plays a key role.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Sinsheimer Labs, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Washington University (WUSTL)	Jin, YS (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Sinsheimer Labs, 1156 High St, Santa Cruz, CA 95064 USA.	jin@biology.ucsc.edu	Taru, Hidenori/B-7059-2009	Jin, Yishi/0000-0002-9371-9860; Ackley, Brian/0000-0002-1257-2407; Grill, Brock/0000-0002-0379-3267				Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BLOOM FE, 1972, STRUCTURE FUNCTION S, P101; BRENNER S, 1974, GENETICS, V77, P71; Deken SL, 2005, J NEUROSCI, V25, P5975, DOI 10.1523/JNEUROSCI.0804-05.2005; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; JIN Y, 2005, WORMBOOK; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kim S, 2003, J BIOL CHEM, V278, P6291, DOI 10.1074/jbc.M212287200; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Olsen O, 2006, CURR OPIN CELL BIOL, V18, P223, DOI 10.1016/j.ceb.2006.02.010; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shin H, 2003, J BIOL CHEM, V278, P11393, DOI 10.1074/jbc.M211874200; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Turner CE, 2001, CURR OPIN CELL BIOL, V13, P593, DOI 10.1016/S0955-0674(00)00256-8; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yeh E, 2005, J NEUROSCI, V25, P3833, DOI 10.1523/JNEUROSCI.4978-04.2005; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	42	149	151	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1479	1487		10.1038/nn1808	http://dx.doi.org/10.1038/nn1808			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115037				2022-12-17	WOS:000242404000011
J	Chen, YZ; Geisler, WS; Seidemann, E				Chen, Yuzhi; Geisler, Wilson S.; Seidemann, Eyal			Optimal decoding of correlated neural population responses in the primate visual cortex	NATURE NEUROSCIENCE			English	Article							VOLTAGE-SENSITIVE DYES; STRIATE CORTEX; CORTICAL DYNAMICS; FUNCTIONAL ARCHITECTURE; BEHAVING MONKEYS; SINGLE NEURONS; AREA MT; MACAQUE; DISCRIMINATION; ORGANIZATION	Even the simplest environmental stimuli elicit responses in large populations of neurons in early sensory cortical areas. How these distributed responses are read out by subsequent processing stages to mediate behavior remains unknown. Here we used voltage-sensitive dye imaging to measure directly population responses in the primary visual cortex ( V1) of monkeys performing a demanding visual detection task. We then evaluated the ability of different decoding rules to detect the target from the measured neural responses. We found that small visual targets elicit widespread responses in V1, and that response variability at distant sites is highly correlated. These correlations render most previously proposed decoding rules inefficient relative to one that uses spatially antagonistic center-surround summation. This optimal decoder consistently outperformed the monkey in the detection task, demonstrating the sensitivity of our techniques. Overall, our results suggest an unexpected role for inhibitory mechanisms in efficient decoding of neural population responses.	Univ Texas, Dept Psychol, Austin, TX 78712 USA; Univ Texas, Ctr Preceptual Syst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Seidemann, E (corresponding author), Univ Texas, Dept Psychol, 1 Univ Stn,A8000, Austin, TX 78712 USA.	eyal@mail.cps.utexas.edu		Geisler, Wilson/0000-0003-4630-6614; Seidemann, Eyal/0000-0003-2841-5948	NATIONAL EYE INSTITUTE [R01EY016454, R01EY016752] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016454, R01 EY016752-01, R01 EY016752] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BARLOW HB, 1995, COGNITIVE NEUROSCIEN, P401; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; DeValois RL, 1988, SPATIAL VISION; Duda R.O., 2001, PATTERN CLASSIFICATI, V20; Efron B., 1993, INTRO BOOTSTRAP; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GREEN DM, 1966, SIGNAL DETECTION THE; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1963, J PHYSIOL-LONDON, V165, P559, DOI 10.1113/jphysiol.1963.sp007079; JOHNSON KO, 1980, J NEUROPHYSIOL, V43, P1793, DOI 10.1152/jn.1980.43.6.1793; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; Lee D, 1998, J NEUROSCI, V18, P1161; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.neuro.11.1.253; MCLLWAIN JT, 1986, TRENDS NEUROSCI, V9, P354, DOI DOI 10.1016/0166-2236(86)90113-X); MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Slovin H, 2002, J NEUROPHYSIOL, V88, P3421, DOI 10.1152/jn.00194.2002; SNIPPE HP, 1992, BIOL CYBERN, V67, P183, DOI 10.1007/BF00201025; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; SPARKS DL, 1990, COLD SPRING HARB SYM, V55, P805; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; WOOLSEY CN, 1952, BIOL MENTAL HLTH DIS; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	45	149	150	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1412	1420		10.1038/nn1792	http://dx.doi.org/10.1038/nn1792			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17057706	Green Accepted			2022-12-17	WOS:000242403800019
J	Grill-Spector, K; Sayres, R; Ress, D				Grill-Spector, Kalanit; Sayres, Rory; Ress, David			High-resolution imaging reveals highly selective nonface clusters in the fusiform face area	NATURE NEUROSCIENCE			English	Article							MONKEY INFEROTEMPORAL CORTEX; LATERAL OCCIPITAL COMPLEX; HUMAN OBJECT AREAS; MACAQUE; FMRI; ORGANIZATION; PERCEPTION; REPRESENTATIONS; EXPERTISE; GYRUS	A region in ventral human cortex (fusiform face area, FFA) thought to be important for face perception responds strongly to faces and less strongly to nonface objects. This pattern of response may reflect a uniform face-selective neural population or activity averaged across populations with heterogeneous selectivity. Using high-resolution functional magnetic resonance imaging (MRI), we found that the FFA has a reliable heterogeneous structure: localized subregions within the FFA highly selective to faces are spatially interdigitated with localized subregions highly selective to different object categories. We found a preponderance of face-selective responses in the FFA, but no difference in selectivity to faces compared to nonfaces. Thus, standard fMRI of the FFA reflects averaging of heterogeneous highly selective neural populations of differing sizes, rather than higher selectivity to faces. These results suggest that visual processing in this region is not exclusive to faces. Overall, our approach provides a framework for understanding the fine-scale structure of neural representations in the human brain.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Stanford University; Stanford University; Brown University	Grill-Spector, K (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	kalanit@psych.stanford.edu		Grill-Spector, Kalanit/0000-0002-5404-9606	NATIONAL EYE INSTITUTE [F31EY015937, R21EY016199] Funding Source: NIH RePORTER; NEI NIH HHS [1 R21EY016199-0, 5 F31 EY015937] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Avidan G, 2002, CURR BIOL, V12, P964, DOI 10.1016/S0960-9822(02)00872-2; Chapman B, 1998, P NATL ACAD SCI USA, V95, P2609, DOI 10.1073/pnas.95.5.2609; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Duda R.O., 2001, PATTERN CLASSIFICATI, V20; Edelman S, 1998, PSYCHOBIOLOGY, V26, P309; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Gauthier I, 2001, CURR OPIN NEUROBIOL, V11, P219, DOI 10.1016/S0959-4388(00)00200-2; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hasson U, 2001, J COGNITIVE NEUROSCI, V13, P744, DOI 10.1162/08989290152541412; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Saleem KS, 2002, NEURON, V34, P685, DOI 10.1016/S0896-6273(02)00718-3; Sayres R, 2006, J NEUROPHYSIOL, V95, P995, DOI 10.1152/jn.00500.2005; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004	39	149	150	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1177	1185		10.1038/nn1745	http://dx.doi.org/10.1038/nn1745			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16892057				2022-12-17	WOS:000240080800020
J	Rust, NC; Movshon, JA				Rust, NC; Movshon, JA			In praise of artifice	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELD STRUCTURE; PRIMARY VISUAL-CORTEX; SIMPLE CELLS; SPATIAL STRUCTURE; NATURAL SCENES; CORTICAL-NEURONS; RESPONSES; ADAPTATION; CONTRAST; SIGNALS	The visual system evolved to process natural images, and the goal of visual neuroscience is to understand the computations it uses to do this. Indeed the goal of any theory of visual function is a model that will predict responses to any stimulus, including natural scenes. It has, however, recently become common to take this fundamental principle one step further: trying to use photographic or cinematographic representations of natural scenes ( natural stimuli) as primary probes to explore visual computations. This approach is both challenging and controversial, and we argue that this use of natural images is so fraught with difficulty that it is not useful. Traditional methods for exploring visual computations that use artificial stimuli with carefully selected properties have been and continue to be the most effective tools for visual neuroscience. The proper use of natural stimuli is to test models based on responses to these synthetic stimuli, not to replace them.	NYU, Howard Hughes Med Inst, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	Howard Hughes Medical Institute; New York University; New York University	Rust, NC (corresponding author), NYU, Howard Hughes Med Inst, New York, NY 10003 USA.	rust@cns.nyu.edu						ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Angelucci A, 2002, PROG BRAIN RES, V136, P373; Arcas BAY, 2003, NEURAL COMPUT, V15, P1715, DOI 10.1162/08997660360675017; Bair W, 2004, J NEUROSCI, V24, P7305, DOI 10.1523/JNEUROSCI.0554-04.2004; Barlow H., 1961, SENSORY COMMUNICATIO, P217; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CHANDRAN PKG, 1985, ADV CAPD, V1, P18; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; CREUTZFELDT OD, 1978, NATURWISSENSCHAFTEN, V65, P307, DOI 10.1007/BF00368371; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DEVALOIS KK, 1979, J PHYSIOL-LONDON, V291, P483, DOI 10.1113/jphysiol.1979.sp012827; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; Lennie P, 2005, J OPT SOC AM A, V22, P2013, DOI 10.1364/JOSAA.22.002013; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Paninski L, 2004, NEURAL COMPUT, V16, P2533, DOI 10.1162/0899766042321797; Prenger R, 2004, NEURAL NETWORKS, V17, P663, DOI 10.1016/j.neunet.2004.03.008; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Shapley R., 1984, PROG RETIN RES, V3, P263, DOI [10.1016/0278-4327(84)90011-7, DOI 10.1016/0278-4327(84)90011-7]; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Smith MA, 2002, J NEUROSCI, V22, P8334, DOI 10.1523/jneurosci.22-18-08334.2002; Smyth D, 2003, J NEUROSCI, V23, P4746; SPITZER H, 1985, J NEUROPHYSIOL, V53, P1266, DOI 10.1152/jn.1985.53.5.1266; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Touryan J, 2005, NEURON, V45, P781, DOI 10.1016/j.neuron.2005.01.029; Touryan J, 2002, J NEUROSCI, V22, P10811; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303	49	149	150	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1647	1650		10.1038/nn1606	http://dx.doi.org/10.1038/nn1606			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16306892				2022-12-17	WOS:000233576200009
J	Segev, R; Goodhouse, J; Puchalla, J; Berry, MJ				Segev, R; Goodhouse, J; Puchalla, J; Berry, MJ			Recording spikes from a large fraction of the ganglion cells in a retinal patch	NATURE NEUROSCIENCE			English	Article							TIGER SALAMANDER RETINA; AMACRINE CELLS; NEURONAL SIGNALS; MAMMALIAN RETINA; WAVELET PACKETS; NEURAL SIGNALS; CATS RETINA; CLASSIFICATION; SYSTEM; CORTEX	To understand a neural circuit completely requires simultaneous recording from most of the neurons in that circuit. Here we report recording and spike sorting techniques that enable us to record from all or nearly all of the ganglion cells in a patch of the retina. With a dense multi-electrode array, each ganglion cell produces a unique pattern of activity on many electrodes when it fires an action potential. Signals from all of the electrodes are combined with an iterative spike sorting algorithm to resolve ambiguities arising from overlapping spike waveforms. We verify that we are recording from a large fraction of ganglion cells over the array by labeling the ganglion cells with a retrogradely transported dye and by comparing the number of labeled and recorded cells. Using these methods, we show that about 60 receptive fields of ganglion cells cover each point in visual space in the salamander, consistent with anatomical findings.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Berry, MJ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	berry@princeton.edu						ATIYA AF, 1992, IEEE T BIO-MED ENG, V39, P723, DOI 10.1109/10.142647; Balasubramanian V, 2002, NETWORK-COMP NEURAL, V13, P531, DOI 10.1088/0954-898X/13/4/306; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P421, DOI 10.1113/jphysiol.1974.sp010617; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P457, DOI 10.1113/jphysiol.1974.sp010618; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hulata E, 2000, PHYS REV LETT, V85, P4637, DOI 10.1103/PhysRevLett.85.4637; Hulata E, 2002, J NEUROSCI METH, V117, P1, DOI 10.1016/S0165-0270(02)00032-8; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; LEWICKI MS, 1994, NEURAL COMPUT, V6, P1005, DOI 10.1162/neco.1994.6.5.1005; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Rodieck RW., 1998, 1 STEPS SEEING, V1; Roth G., 1987, VISUAL BEHAV SALAMAN, DOI 10.1007/978-3-642-72713-9; Sakai HM, 1997, J NEUROPHYSIOL, V78, P2018, DOI 10.1152/jn.1997.78.4.2018; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; TORIS CB, 1995, J COMP NEUROL, V352, P535, DOI 10.1002/cne.903520405; Vetter RJ, 2004, IEEE T BIO-MED ENG, V51, P896, DOI 10.1109/TBME.2004.826680; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WATT CB, 1988, J COMP NEUROL, V272, P114, DOI 10.1002/cne.902720108; Wheeler B., 1994, ENABLING TECHNOLOGIE, P167; WHEELER BC, 1988, J BIOMED ENG, V10, P47, DOI 10.1016/0141-5425(88)90025-8; YANG XW, 1988, IEEE T BIO-MED ENG, V35, P806, DOI 10.1109/10.7287; Zhang I, 2001, NEUROREPORT, V12, P1371, DOI 10.1097/00001756-200105250-00017; Zhang J, 2004, VISUAL NEUROSCI, V21, P157, DOI 10.1017/S0952523804042075	30	149	151	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1155	1162		10.1038/nn1323	http://dx.doi.org/10.1038/nn1323			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ					2022-12-17	WOS:000224156900026
J	Gaiano, N; Kohtz, JD; Turnbull, DH; Fishell, G				Gaiano, N; Kohtz, JD; Turnbull, DH; Fishell, G			A method for rapid gain-of-function studies in the mouse embryonic nervous system	NATURE NEUROSCIENCE			English	Article							RETROVIRAL VECTORS; SONIC-HEDGEHOG; GENE-TRANSFER; LINEAGE ANALYSIS; NEURONAL CLONES; CEREBRAL-CORTEX; HIGH-TITER; STEM-CELL; EXPRESSION; DIFFERENTIATION	We used ultrasound image-guided injections of high-titer retroviral vectors to obtain widespread introduction of genes into the mouse nervous system in utero as early as embryonic day 8.5 (E8.5). The vectors used included internal promoters that substantially improved proviral gene expression in the ventricular zone of the brain. To demonstrate the utility of this system, we extended our previous work in vitro by infecting the telencephalon in vivo as early as E8.5 with a virus expressing Sonic Hedgehog. Infected embryos showed gross morphological brain defects, as well as ectopic expression of ventral telencephalic markers characteristic of either the medial or lateral ganglionic eminences.	NYU, Sch Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Radiol, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; New York University; New York University; New York University	Fishell, G (corresponding author), NYU, Sch Med, Dev Genet Program, 540 1st Ave, New York, NY 10016 USA.	turnbull@saturn.med.nyu.edu		Turnbull, Daniel/0000-0003-0889-5155; Fishell, Gordon/0000-0002-9640-9278	NHLBI NIH HHS [HL62334] Funding Source: Medline; NINDS NIH HHS [NS38461, NS32993] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL062334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038461, R01NS032993] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Altaba ARI, 1997, CELL, V90, P193, DOI 10.1016/S0092-8674(00)80325-6; Bao ZZ, 1997, J NEUROSCI, V17, P1425; Bell EJD, 1997, MOL BIOTECHNOL, V7, P289, DOI 10.1007/BF02740819; BIGNAMI A, 1974, J COMP NEUROL, V153, P27, DOI 10.1002/cne.901530104; BULFONE A, 1993, MECH DEVELOP, V40, P129, DOI 10.1016/0925-4773(93)90071-5; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Cepko CL, 1998, CURR TOP DEV BIOL, V36, P51; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; EIDELMAN O, 1984, J BIOL CHEM, V259, P4622; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gaiano N, 1996, BBA-REV CANCER, V1288, pO11, DOI 10.1016/0304-419X(96)00017-0; GORMAN CM, 1985, CELL, V42, P519, DOI 10.1016/0092-8674(85)90109-6; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; JOHNSON AD, 1994, GENE, V147, P223, DOI 10.1016/0378-1119(94)90070-1; KEMPLER G, 1993, VIROLOGY, V193, P690, DOI 10.1006/viro.1993.1177; Kohtz JD, 1998, DEVELOPMENT, V125, P5079; Lange C, 1997, GENE THER, V4, P303, DOI 10.1038/sj.gt.3300395; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P376, DOI 10.1006/bbrc.1996.5882; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Olsson M, 1997, NEURON, V19, P761, DOI 10.1016/S0896-6273(00)80959-9; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; RAKIC P, 1995, P NATL ACAD SCI USA, V92, P11323, DOI 10.1073/pnas.92.25.11323; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Sawicki JA, 1998, EXP CELL RES, V244, P367, DOI 10.1006/excr.1998.4175; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shimamura K, 1997, DEVELOPMENT, V124, P2709; SLACK JMW, 1994, CURR BIOL, V4, P116, DOI 10.1016/S0960-9822(94)00027-8; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; Takahashi T, 1996, J NEUROSCI, V16, P6183; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Toresson H, 1999, DEVELOPMENT, V126, P1317; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Yan YL, 1998, DEV DYNAM, V213, P370, DOI 10.1002/(SICI)1097-0177(199812)213:4<370::AID-AJA3>3.0.CO;2-O; YEE JK, 1994, METHOD CELL BIOL, V43, P99	50	149	155	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1999	2	9					812	819		10.1038/12186	http://dx.doi.org/10.1038/12186			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FB	10461220				2022-12-17	WOS:000083882900012
J	Sengpiel, F; Stawinski, P; Bonhoeffer, T				Sengpiel, F; Stawinski, P; Bonhoeffer, T			Influence of experience on orientation maps in cat visual cortex	NATURE NEUROSCIENCE			English	Article							MONKEY STRIATE CORTEX; POSTSYNAPTIC ACTIVITY; CORTICAL-CELLS; KITTENS; ORGANIZATION; SELECTIVITY; CONTOURS; AREA-18; COLUMNS	Experience is known to affect the development of ocular dominance maps in visual cortex, but it has remained controversial whether orientation preference maps are similarly affected by limiting visual experience to a single orientation early in life. Here we used optical imaging based on intrinsic signals to show that the visual cortex of kittens reared in a striped environment responded to all orientations, but devoted up to twice as much surface area to the experienced orientation as the orthogonal one. This effect is due to an instructive role of visual experience whereby some neurons shift their orientation preferences toward the experienced orientation. Thus, although cortical orientation maps are remarkably rigid in the sense that orientations that have never been seen by the animal occupy a large portion of the cortical territory, visual experience can nevertheless alter neuronal responses to oriented contours.	Max Planck Inst Neurobiol, D-82152 Munich, Germany	Max Planck Society	Sengpiel, F (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18A, D-82152 Munich, Germany.		Sengpiel, Frank/A-4682-2010; Bonhoeffer, Tobias/B-9481-2009	Sengpiel, Frank/0000-0002-7060-1851; Bonhoeffer, Tobias/0000-0001-7897-6634				BLAKEMORE C, 1977, PHILOS T ROY SOC B, V278, P425, DOI 10.1098/rstb.1977.0052; BLAKEMORE C, 1973, NATURE, V241, P467, DOI 10.1038/241467a0; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; BLAKEMORE C, 1974, J PHYSIOL-LONDON, V237, P195, DOI 10.1113/jphysiol.1974.sp010478; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BLASDEL GG, 1977, J PHYSIOL-LONDON, V265, P615, DOI 10.1113/jphysiol.1977.sp011734; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Bonhoeffer Tobias, 1996, P55; COLEMAN PD, 1981, BRAIN RES, V214, P1, DOI 10.1016/0006-8993(81)90435-2; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CYNADER M, 1977, NATURE, V270, P177, DOI 10.1038/270177a0; Freeman, 1979, DEV NEUROBIOLOGY VIS, P31; FREEMAN RD, 1973, NATURE, V246, P359, DOI 10.1038/246359a0; FREGNAC Y, 1978, J PHYSIOL-LONDON, V278, P27, DOI 10.1113/jphysiol.1978.sp012290; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; Godecke I, 1996, NATURE, V379, P251, DOI 10.1038/379251a0; GORDON B, 1982, EXP BRAIN RES, V46, P144; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; HIRSCH HVB, 1970, SCIENCE, V168, P869, DOI 10.1126/science.168.3933.869; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubener M, 1997, J NEUROSCI, V17, P9270; RAUSCHECKER JP, 1979, NATURE, V280, P58, DOI 10.1038/280058a0; RAUSCHECKER JP, 1981, J PHYSIOL-LONDON, V310, P215, DOI 10.1113/jphysiol.1981.sp013545; SENGPIEL F, 1994, J NEUROSCI, V14, P6855; SINGER W, 1981, EXP BRAIN RES, V41, P199; STRYKER MP, 1975, SCIENCE, V190, P904, DOI 10.1126/science.1188372; STRYKER MP, 1978, J NEUROPHYSIOL, V41, P896, DOI 10.1152/jn.1978.41.4.896; SWINDALE NV, 1982, TRENDS NEUROSCI, V5, P235, DOI 10.1016/0166-2236(82)90135-7; TIEMAN SB, 1982, J COMP NEUROL, V211, P353, DOI 10.1002/cne.902110403; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980	35	149	153	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					727	732		10.1038/11192	http://dx.doi.org/10.1038/11192			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FA	10412062				2022-12-17	WOS:000083882800012
J	Spiller, KJ; Restrepo, CR; Khan, T; Dominique, MA; Fang, TC; Canter, RG; Roberts, CJ; Miller, KR; Ransohoff, RM; Trojanowski, JQ; Lee, VMY				Spiller, Krista J.; Restrepo, Clark R.; Khan, Tahiyana; Dominique, Myrna A.; Fang, Terry C.; Canter, Rebecca G.; Roberts, Christopher J.; Miller, Kelly R.; Ransohoff, Richard M.; Trojanowski, John Q.; Lee, Virginia M. -Y.			Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; GLIAL ACTIVATION; EXTEND SURVIVAL; CELLS; PROGRESSION; PATHWAY; MUTANT; MICE; MICROGLIA/MACROPHAGES	Though motor neurons selectively degenerate in amyotrophic lateral sclerosis, other cell types are likely involved in this disease. We recently generated rNLS8 mice in which human TDP-43 (hTDP-43) pathology could be reversibly induced in neurons and expected that microglia would contribute to neurodegeneration. However, only subtle microglial changes were detected during disease in the spinal cord, despite progressive motor neuron loss; microglia still reacted to inflammatory triggers in these mice. Notably, after hTDP-43 expression was suppressed, microglia dramatically proliferated and changed their morphology and gene expression profiles. These abundant, reactive microglia selectively cleared neuronal hTDP-43. Finally, when microgliosis was blocked during the early recovery phase using PLX3397, a CSF1R and c-kit inhibitor, rNLS8 mice failed to regain full motor function, revealing an important neuroprotective role for microglia. Therefore, reactive microglia exert neuroprotective functions in this amyotrophic lateral sclerosis model, and definition of the underlying mechanism could point toward novel therapeutic strategies.	[Spiller, Krista J.; Restrepo, Clark R.; Khan, Tahiyana; Dominique, Myrna A.; Miller, Kelly R.; Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, CNDR,Inst Aging, Philadelphia, PA 19104 USA; [Fang, Terry C.; Canter, Rebecca G.; Roberts, Christopher J.] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA; [Ransohoff, Richard M.] Third Rock Ventures, Boston, MA USA	University of Pennsylvania; Pennsylvania Medicine; Biogen	Spiller, KJ (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, CNDR,Inst Aging, Philadelphia, PA 19104 USA.	spillerk@upenn.edu		Spiller, Krista/0000-0002-1980-694X; Restrepo, Clark/0000-0003-2411-2966	Judith and Jean Pape Adams Charitable Foundation; ALS Association [AG PO1-017586]; NATIONAL INSTITUTE ON AGING [T32AG000255, P01AG017586, P30AG010124] Funding Source: NIH RePORTER	Judith and Jean Pape Adams Charitable Foundation; ALS Association; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank S. Leight for administrative support, K.L. Spiller and K. Brunden for valuable feedback, V. Van Deerlin and E. Suh for the genetic analysis of the ALS patients studied here, E. Lee for help with microscopy, and D. Cotton-Samuel for assistance with tissue sectioning and immunostaining. This work was supported by the Judith and Jean Pape Adams Charitable Foundation and the ALS Association (K.J.S.), AG PO1-017586 (V.M.-Y.L.) as well as gifts from the Koller and Pottruck families. Finally, we thank our ALS patients and their families for making human ALS tissue samples available to us for our studies.	Alshikho MJ, 2016, NEUROLOGY, V87, P2554, DOI 10.1212/WNL.0000000000003427; Barbeito AG, 2010, J NEURAL TRANSM, V117, P981, DOI 10.1007/s00702-010-0429-0; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brettschneider J, 2014, ACTA NEUROPATHOL, V128, P423, DOI 10.1007/s00401-014-1299-6; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Damani MR, 2011, AGING CELL, V10, P263, DOI 10.1111/j.1474-9726.2010.00660.x; De Blase L. M., 2017, NEURON, V95; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Graeber MB, 1998, BRAIN RES, V813, P241, DOI 10.1016/S0006-8993(98)00859-2; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Herman AM, 2012, EXP NEUROL, V235, P297, DOI 10.1016/j.expneurol.2012.02.011; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hu J, 2012, BIOINFORMATICS, V28, P1933, DOI 10.1093/bioinformatics/bts294; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Korin B, 2017, NAT NEUROSCI, V20, P1300, DOI 10.1038/nn.4610; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinez HR, 2017, CYTOKINE, V90, P1, DOI 10.1016/j.cyto.2016.09.022; Martinez-Muriana A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25663; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Offen D, 2009, J MOL NEUROSCI, V38, P85, DOI 10.1007/s12031-007-9004-z; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Polazzi E, 2013, NEUROSIGNALS, V21, P112, DOI 10.1159/000337115; Rabin SJ, 2010, HUM MOL GENET, V19, P313, DOI 10.1093/hmg/ddp498; Schafer DP, 2013, CURR OPIN NEUROBIOL, V23, P1034, DOI 10.1016/j.conb.2013.09.012; Spiller KJ, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0377-5; Spiller KJ, 2016, J NEUROSCI, V36, P7707, DOI 10.1523/JNEUROSCI.1457-16.2016; Swarup V, 2011, J EXP MED, V208, P2429, DOI 10.1084/jem.20111313; Tateishi T, 2010, J NEUROIMMUNOL, V222, P76, DOI 10.1016/j.jneuroim.2010.03.004; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Tong JB, 2013, EMBO J, V32, P1917, DOI 10.1038/emboj.2013.122; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; Waisman A, 2015, TRENDS IMMUNOL, V36, P625, DOI 10.1016/j.it.2015.08.005; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Walker AK, 2015, HUM MOL GENET, V24, P7241, DOI 10.1093/hmg/ddv424; Walker AK, 2015, ACTA NEUROPATHOL, V130, P643, DOI 10.1007/s00401-015-1460-x; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Zurcher NR, 2015, NEUROIMAGE-CLIN, V7, P409, DOI 10.1016/j.nicl.2015.01.009	50	148	149	4	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2018	21	3					329	+		10.1038/s41593-018-0083-7	http://dx.doi.org/10.1038/s41593-018-0083-7			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FZ7JH	29463850	Green Accepted			2022-12-17	WOS:000427776400008
J	Heller, EA; Cates, HM; Pena, CJ; Sun, HS; Shao, NY; Feng, J; Golden, SA; Herman, JP; Walsh, JJ; Mazei-Robison, M; Ferguson, D; Knight, S; Gerber, MA; Nievera, C; Han, MH; Russo, SJ; Tamminga, CS; Neve, RL; Shen, L; Zhang, HS; Zhang, F; Nestler, EJ				Heller, Elizabeth A.; Cates, Hannah M.; Pena, Catherine J.; Sun, Haosheng; Shao, Ningyi; Feng, Jian; Golden, Sam A.; Herman, James P.; Walsh, Jessica J.; Mazei-Robison, Michelle; Ferguson, Deveroux; Knight, Scott; Gerber, Mark A.; Nievera, Christian; Han, Ming-Hu; Russo, Scott J.; Tamminga, Carol S.; Neve, Rachael L.; Shen, Li; Zhang, H. Steve; Zhang, Feng; Nestler, Eric J.			Locus-specific epigenetic remodeling controls addiction- and depression-related behaviors	NATURE NEUROSCIENCE			English	Article							COCAINE-INDUCED PLASTICITY; NUCLEUS-ACCUMBENS; DELTA-FOSB; HISTONE ACETYLATION; MEMORY FORMATION; BINDING PROTEIN; TRANSCRIPTION; METHYLATION; EXPRESSION; BRAIN	Chronic exposure to drugs of abuse or stress regulates transcription factors, chromatin-modifying enzymes and histone post-translational modifications in discrete brain regions. Given the promiscuity of the enzymes involved, it has not yet been possible to obtain direct causal evidence to implicate the regulation of transcription and consequent behavioral plasticity by chromatin remodeling that occurs at a single gene. We investigated the mechanism linking chromatin dynamics to neurobiological phenomena by applying engineered transcription factors to selectively modify chromatin at a specific mouse gene in vivo. We found that histone methylation or acetylation at the Fosb locus in nucleus accumbens, a brain reward region, was sufficient to control drug- and stress-evoked transcriptional and behavioral responses via interactions with the endogenous transcriptional machinery. This approach allowed us to relate the epigenetic landscape at a given gene directly to regulation of its expression and to its subsequent effects on reward behavior.	[Heller, Elizabeth A.; Cates, Hannah M.; Pena, Catherine J.; Sun, Haosheng; Shao, Ningyi; Feng, Jian; Golden, Sam A.; Walsh, Jessica J.; Mazei-Robison, Michelle; Ferguson, Deveroux; Russo, Scott J.; Shen, Li; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Heller, Elizabeth A.; Cates, Hannah M.; Pena, Catherine J.; Sun, Haosheng; Shao, Ningyi; Feng, Jian; Golden, Sam A.; Walsh, Jessica J.; Mazei-Robison, Michelle; Ferguson, Deveroux; Russo, Scott J.; Shen, Li; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Herman, James P.] NEI, NIH, Bethesda, MD 20892 USA; [Walsh, Jessica J.; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Knight, Scott; Gerber, Mark A.; Nievera, Christian] Sigma Aldrich, St Louis, MO USA; [Tamminga, Carol S.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Zhang, H. Steve] Sangamo Biosci Inc, Richmond, CA USA; [Ferguson, Deveroux; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Icahn School of Medicine at Mount Sinai; Merck KGaA; MilliporeSigma; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Sangamo Therapeutics, Inc.; Massachusetts Institute of Technology (MIT)	Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	SHAO, Ning-Yi/N-4947-2015; Pena, Catherine Jensen/AAU-3014-2021; Mazei-Robison, Michelle/I-4304-2017; Russo, Scott/R-7107-2019; Heller, Elizabeth A/W-4653-2019; Han, Ming-Hu/G-8836-2012	SHAO, Ning-Yi/0000-0003-4231-828X; Pena, Catherine Jensen/0000-0002-2884-5035; Mazei-Robison, Michelle/0000-0002-2372-1420; Russo, Scott/0000-0002-6470-1805; Heller, Elizabeth A/0000-0002-2984-8705; Golden, Sam/0000-0002-2104-2272; Walsh, Jessica/0000-0001-8466-8451; Sun, Haosheng/0000-0003-3919-559X; Herman, James/0000-0001-6916-2807; Cates, Hannah/0000-0002-9413-0847; Ferguson, Deveroux/0000-0001-9302-5992	National Institute on Drug Abuse; National Institute of Mental Health; Hope for Depression Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH094405, P50MH096890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007135, P01DA008227, R37DA007359, F32DA035518] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hope for Depression Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors wish to thank G. Stuber and R. Ung for their help in generating social interaction heat maps. This work was supported by grants from the National Institute on Drug Abuse (E.A.H. and E.J.N.), the National Institute of Mental Health and the Hope for Depression Research Foundation (E.J.N.).	Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Ernst J, 2013, GENOME RES, V23, P1142, DOI 10.1101/gr.144840.112; Feng J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r65; Filion GJ, 2010, NAT GENET, V42, P4, DOI 10.1038/ng0110-4; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Garriga-Canut M, 2012, P NATL ACAD SCI USA, V109, pE3136, DOI 10.1073/pnas.1206506109; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Grimmer MR, 2014, NUCLEIC ACIDS RES, V42, P10856, DOI 10.1093/nar/gku708; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kennedy PJ, 2013, NAT NEUROSCI, V16, P434, DOI 10.1038/nn.3354; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Laganiere J, 2010, J NEUROSCI, V30, P16469, DOI 10.1523/JNEUROSCI.2440-10.2010; Malvaez M, 2011, J NEUROSCI, V31, P16941, DOI 10.1523/JNEUROSCI.2747-11.2011; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Maze I, 2011, P NATL ACAD SCI USA, V108, P3035, DOI 10.1073/pnas.1015483108; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Paxinos G, 2012, MOUSE BRAIN STEREOTA; Peixoto L, 2013, NEUROPSYCHOPHARMACOL, V38, P62, DOI 10.1038/npp.2012.86; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Robison AJ, 2013, J NEUROSCI, V33, P4295, DOI 10.1523/JNEUROSCI.5192-12.2013; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Rogge GA, 2013, J NEUROSCI, V33, P6623, DOI 10.1523/JNEUROSCI.4472-12.2013; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Smith AE, 2008, J BIOL CHEM, V283, P9878, DOI 10.1074/jbc.M710393200; Smith DJ, 2009, RNA, V15, P1, DOI 10.1261/rna.1322709; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Sun HS, 2012, J NEUROSCI, V32, P17454, DOI 10.1523/JNEUROSCI.1357-12.2012; Vialou V, 2012, J NEUROSCI, V32, P7577, DOI 10.1523/JNEUROSCI.1381-12.2012; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	40	148	151	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2014	17	12					1720	1727		10.1038/nn.3871	http://dx.doi.org/10.1038/nn.3871			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU2ZY	25347353	Green Accepted, Green Submitted			2022-12-17	WOS:000345484000019
J	Qin, SZ; Cho, S; Chen, TW; Rosenberg-Lee, M; Geary, DC; Menon, V				Qin, Shaozheng; Cho, Soohyun; Chen, Tianwen; Rosenberg-Lee, Miriam; Geary, David C.; Menon, Vinod			Hippocampal-neocortical functional reorganization underlies children's cognitive development	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY; LOBE CONTRIBUTIONS; DEVELOPING BRAIN; MATURATION; FMRI; PREDICTORS; KNOWLEDGE	The importance of the hippocampal system for rapid learning and memory is well recognized, but its contributions to a cardinal feature of children's cognitive development-the transition from procedure-based to memory-based problem-solving strategies-are unknown. Here we show that the hippocampal system is pivotal to this strategic transition. Longitudinal functional magnetic resonance imaging (fMRI) in 7-9-year-old children revealed that the transition from use of counting to memory-based retrieval parallels increased hippocampal and decreased prefrontal-parietal engagement during arithmetic problem solving. Longitudinal improvements in retrieval-strategy use were predicted by increased hippocampal-neocortical functional connectivity. Beyond childhood, retrieval-strategy use continued to improve through adolescence into adulthood and was associated with decreased activation but more stable interproblem representations in the hippocampus. Our findings provide insights into the dynamic role of the hippocampus in the maturation of memory-based problem solving and establish a critical link between hippocampal-neocortical reorganization and children's cognitive development.	[Qin, Shaozheng; Cho, Soohyun; Chen, Tianwen; Rosenberg-Lee, Miriam; Menon, Vinod] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA; [Cho, Soohyun] Chung Ang Univ, Dept Psychol, Seoul 156756, South Korea; [Geary, David C.] Univ Missouri, Dept Psychol Sci, Columbia, MO USA; [Menon, Vinod] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Menon, Vinod] Stanford Univ, Program Neurosci, Stanford, CA 94305 USA	Stanford University; Chung Ang University; University of Missouri System; University of Missouri Columbia; Stanford University; Stanford University	Qin, SZ (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA.	szqin@stanford.edu; menon@stanford.edu	Qin, Shaozheng/AAD-2107-2019; Chen, Tianwen/I-9154-2012; Menon, Vinod/J-6402-2013	Qin, Shaozheng/0000-0002-1859-2150; Menon, Vinod/0000-0003-1622-9857	US National Institutes of Health [HD047520, HD059205, MH101394]; Child Health Research Institute at Stanford University; Lucile Packard Foundation for Children's Health and Stanford CTAS [UL1RR025744]; Netherlands Organization for Scientific Research [NWO446.10.010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059205, R01HD047520] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057610] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH101394] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Child Health Research Institute at Stanford University; Lucile Packard Foundation for Children's Health and Stanford CTAS; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from US National Institutes of Health (HD047520, HD059205 and MH101394), Child Health Research Institute at Stanford University, Lucile Packard Foundation for Children's Health and Stanford CTAS (UL1RR025744) and Netherlands Organization for Scientific Research (NWO446.10.010).	Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Butterworth B., 1999, MATH BRAIN; Can DD, 2013, BRAIN LANG, V124, P34, DOI 10.1016/j.bandl.2012.10.007; Cantlon JF, 2009, J COGNITIVE NEUROSCI, V21, P2217, DOI 10.1162/jocn.2008.21159; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Cho S, 2012, J COGNITIVE NEUROSCI, V24, P1849, DOI 10.1162/jocn_a_00246; Cho S, 2011, DEVELOPMENTAL SCI, V14, P989, DOI 10.1111/j.1467-7687.2011.01055.x; Cohen JR, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00047; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Geary D. C., 1996, MATH COGNITION, P63, DOI [10.1080/135467996387543, DOI 10.1080/135467996387543]; Geary DC, 2012, J EXP CHILD PSYCHOL, V113, P49, DOI 10.1016/j.jecp.2012.03.003; Geary DC, 2011, DEV PSYCHOL, V47, P1539, DOI 10.1037/a0025510; GEARY DC, 1991, DEV PSYCHOL, V27, P787, DOI 10.1037/0012-1649.27.5.787; Geary DC, 2004, J EXP CHILD PSYCHOL, V88, P121, DOI 10.1016/j.jecp.2004.03.002; Geary DC, 1994, CHILDRENS MATH DEV R, DOI [DOI 10.1037/10163-000, 10.1037/10163-000]; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2013, TRENDS COGN SCI, V17, P401, DOI 10.1016/j.tics.2013.06.007; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Kuhl P. K., 2009, COGNITIVE NEUROSCIEN, P837; Kumaran D, 2009, NEURON, V63, P889, DOI 10.1016/j.neuron.2009.07.030; McClelland, 1988, PARALLEL DISTRIBUTED; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McClelland JL, 2001, MECH COGNITIVE DEV B; Menon V., 2014, HDB MATH COGNITION, DOI [10.1093/oxfordhb/9780199642342.013.041, DOI 10.1093/OXFORDHB/9780199642342.013.041]; Qin SZ, 2012, P NATL ACAD SCI USA, V109, P7941, DOI 10.1073/pnas.1120408109; Qin SZ, 2009, NEUROIMAGE, V46, P874, DOI 10.1016/j.neuroimage.2009.02.039; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; Rosenberg-Lee M, 2011, NEUROIMAGE, V57, P796, DOI 10.1016/j.neuroimage.2011.05.013; Siegler R., 2006, CHILDREN DEV; Siegler R.S., 1996, EMERGING MINDS PROCE, DOI [10.5860/choice.34-5984, DOI 10.5860/CHOICE.34-5984]; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Supekar K, 2013, P NATL ACAD SCI USA, V110, P8230, DOI 10.1073/pnas.1222154110; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; van Kesteren MTR, 2012, TRENDS NEUROSCI, V35, P211, DOI 10.1016/j.tins.2012.02.001; Wu SS, 2008, DEV NEUROPSYCHOL, V33, P365, DOI 10.1080/87565640801982445; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125	44	148	149	4	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2014	17	9					1263	1269		10.1038/nn.3788	http://dx.doi.org/10.1038/nn.3788			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO2DJ	25129076	Green Accepted			2022-12-17	WOS:000341125400021
J	Barron, HC; Dolan, RJ; Behrens, TEJ				Barron, Helen C.; Dolan, Raymond J.; Behrens, Timothy E. J.			Online evaluation of novel choices by simultaneous representation of multiple memories	NATURE NEUROSCIENCE			English	Article							ORBITOFRONTAL CORTEX; EPISODIC MEMORY; DECISION-MAKING; MECHANISMS; HIPPOCAMPAL; PREDICTION; REPETITION; SUPPORTS; REMEMBER; FUTURE	Prior experience is critical for decision-making. It enables explicit representation of potential outcomes and provides training to valuation mechanisms. However, we can also make choices in the absence of prior experience by merely imagining the consequences of a new experience. Using functional magnetic resonance imaging repetition suppression in humans, we examined how neuronal representations of novel rewards can be constructed and evaluated. A likely novel experience was constructed by invoking multiple independent memories in hippocampus and medial prefrontal cortex. This construction persisted for only a short time period, during which new associations were observed between the memories for component items. Together, these findings suggest that, in the absence of direct experience, coactivation of multiple relevant memories can provide a training signal to the valuation system that allows the consequences of new experiences to be imagined and acted on.	[Barron, Helen C.; Dolan, Raymond J.; Behrens, Timothy E. J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Behrens, Timothy E. J.] Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford, England	University of London; University College London; University of Oxford	Barron, HC (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.	helen.barron.10@ucl.ac.uk; behrens@fmrib.ox.ac.uk		Dolan, Ray/0000-0001-9356-761X; Behrens, Timothy/0000-0003-0048-1177	Wellcome Trust [WT088312AIA, 098362/Z/12/Z, 091593/Z/10/Z]; Medical Research Council [G1000411]	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Dayan, E.A. Maguire, N. Burgess, S.W. Kennerley, L.T. Hunt, M.C. Klein-Flugge and E.D. Boorman for helpful comments on an earlier draft of the manuscript, and H. Blumenthal's Fat Duck Cookbook for recipe inspiration. This study was supported by the Wellcome Trust (grant WT088312AIA to T.E.J.B. and a Senior Investigator Award to R.J.D., 098362/Z/12/Z), the Medical Research Council (grant G1000411 to H.C.B.). The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust Strategic Award Grant 091593/Z/10/Z.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5909, DOI 10.1073/pnas.0711433105; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Gershman SJ, 2014, J EXP PSYCHOL GEN, V143, P182, DOI 10.1037/a0030844; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Harris A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021074; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Janowski V, 2013, SOC COGN AFFECT NEUR, V8, P201, DOI 10.1093/scan/nsr086; Jocham G, 2012, NAT NEUROSCI, V15, P960, DOI 10.1038/nn.3140; Johnson A, 2005, NEURAL NETWORKS, V18, P1163, DOI 10.1016/j.neunet.2005.08.009; Johnson A, 2007, CURR OPIN NEUROBIOL, V17, P692, DOI 10.1016/j.conb.2008.01.003; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Jones JL, 2012, SCIENCE, V338, P953, DOI 10.1126/science.1227489; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Klein SB, 2002, SOC COGNITION, V20, P353, DOI 10.1521/soco.20.5.353.21125; Klein-Flugge MC, 2013, J NEUROSCI, V33, P3202, DOI 10.1523/JNEUROSCI.2532-12.2013; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kumaran D, 2009, NEURON, V63, P889, DOI 10.1016/j.neuron.2009.07.030; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; McDannald MA, 2012, EUR J NEUROSCI, V35, P991, DOI 10.1111/j.1460-9568.2011.07982.x; Nicolle A, 2012, NEURON, V75, P1114, DOI 10.1016/j.neuron.2012.07.023; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; RUDY JW, 1989, BEHAV BRAIN RES, V34, P97, DOI 10.1016/S0166-4328(89)80093-2; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schacter DL, 2007, NATURE, V445, P27, DOI 10.1038/445027a; Steiner AP, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00131; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Sutton R.S., 1990, P 7 INT C MACH LEARN, V216, P224; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Wimmer GE, 2012, SCIENCE, V338, P270, DOI 10.1126/science.1223252; Zeithamova D, 2012, NEURON, V75, P168, DOI 10.1016/j.neuron.2012.05.010	50	148	148	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1492	+		10.1038/nn.3515	http://dx.doi.org/10.1038/nn.3515			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	24013592	Green Accepted, Green Published			2022-12-17	WOS:000324795300023
J	Chen, JL; Lin, WC; Cha, JW; So, PT; Kubota, Y; Nedivi, E				Chen, Jerry L.; Lin, Walter C.; Cha, Jae Won; So, Peter T.; Kubota, Yoshiyuki; Nedivi, Elly			Structural basis for the role of inhibition in facilitating adult brain plasticity	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; EXPERIENCE-DEPENDENT PLASTICITY; PRIMARY VISUAL-CORTEX; CRITICAL PERIOD; MONOCULAR DEPRIVATION; MOUSE MODEL; INTERNEURONS; RESPONSES; NEURONS; CONNECTIONS	Although inhibition has been implicated in mediating plasticity in the adult brain, the underlying mechanism remains unclear. Here we present a structural mechanism for the role of inhibition in experience-dependent plasticity. Using chronic in vivo two-photon microscopy in the mouse neocortex, we show that experience drives structural remodeling of superficial layer 2/3 interneurons in an input- and circuit-specific manner, with up to 16% of branch tips undergoing remodeling. Visual deprivation initially induces dendritic branch retractions, and this is accompanied by a loss of inhibitory inputs onto neighboring pyramidal cells. The resulting decrease in inhibitory tone, also achievable pharmacologically using the antidepressant fluoxetine, provides a permissive environment for further structural adaptation, including addition of new synapse-bearing branch tips. Our findings suggest that therapeutic approaches that reduce inhibition, when combined with an instructive stimulus, could facilitate restructuring of mature circuits impaired by damage or disease, improving function and perhaps enhancing cognitive abilities.	[Chen, Jerry L.; Lin, Walter C.; Nedivi, Elly] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Chen, Jerry L.; Nedivi, Elly] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lin, Walter C.] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02138 USA; [Cha, Jae Won; So, Peter T.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [So, Peter T.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Kubota, Yoshiyuki] Japan Sci & Technol Agcy, Tokyo, Japan; [Kubota, Yoshiyuki] Natl Inst Physiol Sci, Div Cerebral Circuitry, Okazaki, Aichi 444, Japan; [Kubota, Yoshiyuki] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Okazaki, Aichi, Japan; [Nedivi, Elly] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Massachusetts Institute of Technology (MIT)	Nedivi, E (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	nedivi@mit.edu	Nedivi, Elly/ABC-9923-2021	/0000-0002-1710-0767; Kubota, Yoshiyuki/0000-0002-0950-7460; Chen, Jerry/0000-0002-7409-7859	US National Eye Institute [R01 EY017656]; Stanley Center for Psychiatric Research; MIT-Portugal; Singapore-MIT Alliance-2; Singapore-MIT Alliance for Research and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan [20500300, 22120518]; Grants-in-Aid for Scientific Research [22120518] Funding Source: KAKEN; NATIONAL EYE INSTITUTE [R01EY017656] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Stanley Center for Psychiatric Research; MIT-Portugal; Singapore-MIT Alliance-2; Singapore-MIT Alliance for Research and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Leslie, R. Schecter and J. Hoch for comments on the manuscript; M. F. Bear for helpful discussions; M. Kozberg for assistance in data analysis; J. Coleman, H. B. Yu, S. Horng and C. McCurry for assistance with optical intrinsic imaging; Y. Yamamoto (Yokohama Demonstration Laboratory, SII NanoTecnnology Inc.) for data collection assistance by Zeiss NVision40; S. Hatada and H. Kita (National Institute of Physiological Sciences) for serial electron microscopy reconstruction; and Y. Kawaguchi for valuable discussions regarding EM reconstructions. This work was sponsored by grants to E.N. from the US National Eye Institute (R01 EY017656) and from the Stanley Center for Psychiatric Research. J. L. C. was supported in part by the MIT-Portugal program. J. W. C. was supported in part by the Singapore-MIT Alliance-2 and Singapore-MIT Alliance for Research and Technology. Y. K. was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (20500300, 22120518).	Antonini A, 1999, J NEUROSCI, V19, P4388; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; Bullier J, 2001, PROG BRAIN RES, V134, P193; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Dong HW, 2004, J COMP NEUROL, V475, P361, DOI 10.1002/cne.20164; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; HENDRY SHC, 1994, J NEUROSCI, V14, P2383; HENDRY SHC, 1990, J NEUROSCI, V10, P2438; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; HENDRY SHC, 1988, NEURON, V1, P701, DOI 10.1016/0896-6273(88)90169-9; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HIRSCH JA, 1993, J PHYSIOL-LONDON, V461, P247, DOI 10.1113/jphysiol.1993.sp019512; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kaiser KMM, 2004, J NEUROSCI, V24, P1319, DOI 10.1523/JNEUROSCI.2852-03.2004; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kameyama K, 2010, J NEUROSCI, V30, P1551, DOI 10.1523/JNEUROSCI.5025-09.2010; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kubota Y, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.004.2009; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lee WCA, 2008, P NATL ACAD SCI USA, V105, P19968, DOI 10.1073/pnas.0810149105; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; Yamashita A, 2003, J COMP NEUROL, V464, P426, DOI 10.1002/cne.10810	49	148	149	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					587	U73		10.1038/nn.2799	http://dx.doi.org/10.1038/nn.2799			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21478885	Green Accepted, Green Published			2022-12-17	WOS:000289886600014
J	Bouvier, J; Thoby-Brisson, M; Renier, N; Dubreuil, V; Ericson, J; Champagnat, J; Pierani, A; Chedotal, A; Fortin, G				Bouvier, Julien; Thoby-Brisson, Muriel; Renier, Nicolas; Dubreuil, Veronique; Ericson, Johan; Champagnat, Jean; Pierani, Alessandra; Chedotal, Alain; Fortin, Gilles			Hindbrain interneurons and axon guidance signaling critical for breathing	NATURE NEUROSCIENCE			English	Article							PRE-BOTZINGER COMPLEX; RESPIRATORY RHYTHM GENERATION; PREBOTZINGER COMPLEX; SPINAL-CORD; IN-VITRO; GENETIC IDENTIFICATION; EXPRESSING NEURONS; PACEMAKER NEURONS; MOTOR-NEURON; IDENTITY	Breathing is a bilaterally synchronous behavior that relies on a respiratory rhythm generator located in the brainstem. An essential component of this generator is the preBotzinger complex (preBotC), which paces inspirations. Little is known about the developmental origin of the interneuronal populations forming the preBotC oscillator network. We found that the homeobox gene Dbx1 controls the fate of glutamatergic interneurons required for preBotC rhythm generation in the mouse embryo. We also found that a conditional inactivation in Dbx1-derived cells of the roundabout homolog 3 (Robo3) gene, which is necessary for axonal midline crossing, resulted in left-right de-synchronization of the preBotC oscillator. Together, these findings identify Dbx1-derived interneurons as the core rhythmogenic elements of the preBotC oscillator and indicate that Robo3-dependent guidance signaling in these cells is required for bilaterally synchronous activity.	[Pierani, Alessandra] Univ Paris Diderot, CNRS, UMR 7592, Inst Jacques Monod, Paris, France; [Bouvier, Julien; Thoby-Brisson, Muriel; Champagnat, Jean; Fortin, Gilles] CNRS UPR 3294, Inst Neurobiol Alfred Fessard, Gif Sur Yvette, France; [Renier, Nicolas; Chedotal, Alain] INSERM, U968, Paris, France; [Renier, Nicolas; Chedotal, Alain] UPMC Univ Paris 06, UMR S968, Inst Vis, Paris, France; [Renier, Nicolas; Chedotal, Alain] CNRS, UMR 7210, Paris, France; [Dubreuil, Veronique] Univ Paris Diderot, CNRS, UMR 7216, Paris, France; [Ericson, Johan] Karolinska Inst, Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet	Pierani, A (corresponding author), Univ Paris Diderot, CNRS, UMR 7592, Inst Jacques Monod, Paris, France.	pierani.alessandra@ijm.univ-paris-diderot.fr; alain.chedotal@inserm.fr; gilles.fortin@inaf.cnrs-gif.fr	Bouvier, Julien/C-1018-2017; Chedotal, Alain/F-2750-2017; Renier, Nicolas/E-1855-2018; Thoby-Brisson, Muriel/E-1167-2014; Pierani, Alessandra/O-6136-2017	Bouvier, Julien/0000-0002-1307-4426; Chedotal, Alain/0000-0001-7577-3794; Renier, Nicolas/0000-0003-2642-4402; Thoby-Brisson, Muriel/0000-0003-3214-1724; Pierani, Alessandra/0000-0002-4872-4791; Ericson, Johan/0000-0002-8019-7127; Dubreuil, Veronique/0000-0001-8060-3597; Fortin, Gilles/0000-0002-2123-8603	Region Ile-de-France; Fondation pour la Recherche Medicale; Fondation pour la Recherche Medicale Equipe; Association Francaise contre les Myopathies [ASS-SUB06-00123]; Ville de Paris [2006 ASES 102]; Agence Nationale de la Recherche [ANR-05-NEUR-007-01, ANR-08-MNPS-030-01, ANR-07-NEUR-007-01]; Centre National de la Recherche Scientifique; Institut de la Sante et de la Recherche Medicale	Region Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation pour la Recherche Medicale Equipe(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Ville de Paris; Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	We thank J.-F. Brunet, C. Goridis and A. Lumsden for comments on the manuscript; M. Tessier-Lavigne for providing the Robo3 knockout; S. Karaz for providing specimens; and S. Autran and V. Mezieres for technical assistance with genotyping. J.B. is supported by Region Ile-de-France and the Fondation pour la Recherche Medicale. This work was supported by grants from Fondation pour la Recherche Medicale Equipe (A.C.), the Association Francaise contre les Myopathies (ASS-SUB06-00123, A.C.), the Ville de Paris (2006 ASES 102, A. P.) and the Agence Nationale de la Recherche (ANR-05-NEUR-007-01 BIS to A. P., ANR-08-MNPS-030-01 to A. C. and ANR-07-NEUR-007-01 to G. F.). This work benefited from the facilities and expertise of the Imagif Cell Biology Unit and the Anicampus mouse facility of the Gif-sur-Yvette campus. This work was supported by Centre National de la Recherche Scientifique and the Institut de la Sante et de la Recherche Medicale.	BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Bouvier J, 2008, EUR J NEUROSCI, V28, P510, DOI 10.1111/j.1460-9568.2008.06345.x; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cohen-Tannoudji M, 1998, MOL CELL BIOL, V18, P1444, DOI 10.1128/MCB.18.3.1444; Del Negro CA, 2001, J NEUROPHYSIOL, V86, P59, DOI 10.1152/jn.2001.86.1.59; Dubreuil V, 2009, J NEUROSCI, V29, P14836, DOI 10.1523/JNEUROSCI.2623-09.2009; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; FUNK GD, 1993, J NEUROPHYSIOL, V70, P1497, DOI 10.1152/jn.1993.70.4.1497; Garcia-Campmany L, 2010, CURR OPIN NEUROBIOL, V20, P116, DOI 10.1016/j.conb.2010.01.002; Geisen MJ, 2008, PLOS BIOL, V6, P1178, DOI 10.1371/journal.pbio.0060142; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johnson SM, 2001, J NEUROPHYSIOL, V85, P1772, DOI 10.1152/jn.2001.85.4.1772; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Koizumi H, 2008, J NEUROSCI, V28, P2353, DOI 10.1523/JNEUROSCI.3553-07.2008; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Liu YY, 2003, EUR J NEUROSCI, V17, P41, DOI 10.1046/j.1460-9568.2003.02418.x; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Marillat V, 2004, NEURON, V43, P69, DOI 10.1016/j.neuron.2004.06.018; McKay LC, 2005, NAT NEUROSCI, V8, P1142, DOI 10.1038/nn1517; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Morgado-Valle C, 2010, J NEUROSCI, V30, P3634, DOI 10.1523/JNEUROSCI.3040-09.2010; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Renier N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000325; Rose MF, 2009, P NATL ACAD SCI USA, V106, P22462, DOI 10.1073/pnas.0911579106; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Srour M, 2010, SCIENCE, V328, P592, DOI 10.1126/science.1186463; Stornetta RL, 2003, J COMP NEUROL, V455, P499, DOI 10.1002/cne.10504; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Tan WB, 2010, J COMP NEUROL, V518, P1862, DOI 10.1002/cne.22308; Thoby-Brisson M, 2005, J NEUROSCI, V25, P4307, DOI 10.1523/JNEUROSCI.0551-05.2005; Thoby-Brisson M, 2009, NAT NEUROSCI, V12, P1028, DOI 10.1038/nn.2354; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Wilson SI, 2008, NEURON, V59, P413, DOI 10.1016/j.neuron.2008.07.020; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027	50	148	149	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1066	U55		10.1038/nn.2622	http://dx.doi.org/10.1038/nn.2622			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20680010	Green Submitted			2022-12-17	WOS:000281332600011
J	Grandl, J; Kim, SE; Uzzell, V; Bursulaya, B; Petrus, M; Bandell, M; Patapoutian, A				Grandl, Joerg; Kim, Sung Eun; Uzzell, Valerie; Bursulaya, Badry; Petrus, Matt; Bandell, Michael; Patapoutian, Ardem			Temperature-induced opening of TRPV1 ion channel is stabilized by the pore domain	NATURE NEUROSCIENCE			English	Article							CAPSAICIN RECEPTOR; HEAT ACTIVATION; COLD RECEPTOR; THERMOSENSATION; VOLTAGE; SENSITIVITY; SENSATION; STIMULI; THERMODYNAMICS; REVEALS	TRPV1 is the founding and best-studied member of the family of temperature-activated transient receptor potential ion channels (thermoTRPs). Voltage, chemicals and heat allosterically gate TRPV1. Molecular determinants of TRPV1 activation by capsaicin, allicin, acid, ammonia and voltage have been identified. However, the structures and mechanisms mediating TRPV1's pronounced temperature sensitivity remain unclear. Recent studies of the related channel TRPV3 identified residues in the pore region that are required for heat activation. We used both random and targeted mutagenesis screens of rat TRPV1 and identified point mutations in the outer pore region that specifically impair temperature activation. Single-channel analysis indicated that TRPV1 mutations disrupted heat sensitivity by ablating long channel openings, which are part of the temperature-gating pathway. We propose that sequential occupancy of short and long open states on activation provides a mechanism for enhancing temperature sensitivity. Our results suggest that the outer pore is important for the heat sensitivity of thermoTRPs.	[Grandl, Joerg; Kim, Sung Eun; Uzzell, Valerie; Patapoutian, Ardem] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Bursulaya, Badry; Petrus, Matt; Bandell, Michael; Patapoutian, Ardem] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	apatapou@gnf.org	KIM, SUNG EUN/E-4918-2011	Grandl, Jorg/0000-0001-7179-7609	US National Institutes of Health; Novartis Research Foundation; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046303] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Marelli and T. Orth for preparing mini-prep DNA, M. Caterina for providing rat TRPV1 plasmid DNA, and B. Coste for critical reading of the manuscript. This research was supported by the US National Institutes of Health, the Novartis Research Foundation and a fellowship to J.G. from the American Heart Association.	Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Guler AD, 2002, J NEUROSCI, V22, P6408; Hille B., 2001, ION CHANNELS EXCITAB; Hui KK, 2003, BIOPHYS J, V84, P2957, DOI 10.1016/S0006-3495(03)70022-8; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Premkumar LS, 2002, J PHYSIOL-LONDON, V545, P107, DOI 10.1113/jphysiol.2002.016352; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Talavera K, 2008, TRENDS NEUROSCI, V31, P287, DOI 10.1016/j.tins.2008.03.002; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107	40	148	149	3	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					708	714		10.1038/nn.2552	http://dx.doi.org/10.1038/nn.2552			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20414199	Green Accepted			2022-12-17	WOS:000278003300015
J	Van Buskirk, C; Sternberg, PW				Van Buskirk, Cheryl; Sternberg, Paul W.			Epidermal growth factor signaling induces behavioral quiescence in Caenorhabditis elegans	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; VULVAR INDUCTION; TYROSINE KINASE; FACTOR RECEPTOR; NERVOUS-SYSTEM; LET-23; GENE; EXPRESSION; NEUREGULIN; SYNAPSES	The epidermal growth factor receptor (EGFR)/ErbB receptor tyrosine kinases regulate several aspects of development, including the development of the mammalian nervous system. ErbB signaling also has physiological effects on neuronal function, with influences on synaptic plasticity and daily cycles of activity. However, little is known about the effectors of EGFR activation in neurons. Here we show that EGF signaling has a nondevelopmental effect on behavior in Caenorhabditis elegans. Ectopic expression of the EGF-like ligand LIN-3 at any stage induces a reversible cessation of feeding and locomotion. These effects are mediated by neuronal EGFR ( also called LET-23) and phospholipase C-gamma (PLC-gamma), diacylglycerol-binding proteins, and regulators of synaptic vesicle release. Activation of EGFR within a single neuron, ALA, is sufficient to induce a quiescent state. This pathway modulates the cessation of pharyngeal pumping and locomotion that normally occurs during the lethargus period that precedes larval molting. Our results reveal an evolutionarily conserved role for EGF signaling in the regulation of behavioral quiescence.	CALTECH, Div Biol 156 29, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Sternberg, PW (corresponding author), CALTECH, Div Biol 156 29, Howard Hughes Med Inst, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	pws@caltech.edu		Sternberg, Paul/0000-0002-7699-0173; Van Buskirk, Cheryl/0000-0003-1929-5948	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018341] Funding Source: NIH RePORTER; NIDA NIH HHS [DA018341] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; AROIAN RV, 1994, EMBO J, V13, P360, DOI 10.1002/j.1460-2075.1994.tb06269.x; AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; Avery Leon, 1993, Genetics, V134, P455; BRENNER S, 1974, GENETICS, V77, P71; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chang C, 1999, CURR BIOL, V9, P237, DOI 10.1016/S0960-9822(99)80112-2; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; Dutt A, 2004, PLOS BIOL, V2, P1799, DOI 10.1371/journal.pbio.0020334; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; HILL RJ, 1992, NATURE, V358, P470, DOI 10.1038/358470a0; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Hwang BJ, 2004, DEVELOPMENT, V131, P143, DOI 10.1242/dev.00924; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; Keane J, 2003, GENETICS, V164, P153; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; Lesa GM, 1997, MOL BIOL CELL, V8, P779, DOI 10.1091/mbc.8.5.779; Majewski H, 1998, PROG NEUROBIOL, V55, P463, DOI 10.1016/S0301-0082(98)00017-3; Moghal N, 2003, EXP CELL RES, V284, P150, DOI 10.1016/S0014-4827(02)00097-6; Nonet ML, 1998, J NEUROSCI, V18, P70; OKKEMA PG, 1993, GENETICS, V135, P385; Popovici C, 2002, NEUROSCI LETT, V329, P116, DOI 10.1016/S0304-3940(02)00595-5; Pujol N, 2000, DEVELOPMENT, V127, P3361; Raizen DM, 2006, GENETICS, V173, P177, DOI 10.1534/genetics.106.057380; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Snodgrass-Belt P, 2005, BRAIN RES, V1038, P171, DOI 10.1016/j.brainres.2005.01.030; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Tabuse Y, 2002, J BIOCHEM, V132, P519, DOI 10.1093/oxfordjournals.jbchem.a003251; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; TREININ M, 1995, NEURON, V14, P871, DOI 10.1016/0896-6273(95)90231-7; van der Linden AM, 2003, CURR BIOL, V13, P516, DOI 10.1016/S0960-9822(03)00164-7; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yin XY, 2004, MOL BIOL CELL, V15, P3938, DOI 10.1091/mbc.E04-03-0198	49	148	185	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1300	1307		10.1038/nn1981	http://dx.doi.org/10.1038/nn1981			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17891142				2022-12-17	WOS:000249720800017
J	Paz, R; Boraud, T; Natan, C; Bergman, H; Vaadia, E				Paz, R; Boraud, T; Natan, C; Bergman, H; Vaadia, E			Preparatory activity in motor cortex reflects learning of local visuomotor skills	NATURE NEUROSCIENCE			English	Article							ADULT SQUIRREL-MONKEYS; REACHING MOVEMENTS; PREMOTOR CORTEX; INTERNAL-MODELS; NEURONAL-ACTIVITY; REPRESENTATIONS; DYNAMICS; ADAPTATION; DIRECTION; CONSOLIDATION	In humans, learning to produce correct visually guided movements to adapt to new sensorimotor conditions requires the formation of an internal model that represents the new transformation between visual input and the required motor command. When the new environment requires adaptation to directional errors, learning generalizes poorly to untrained locations and directions, indicating that such learning is local. Here we replicated these behavioral findings in rhesus monkeys using a visuomotor rotation task and simultaneously recorded neuronal activity. Specific changes in activity were observed only in a subpopulation of cells in the motor cortex with directional properties corresponding to the locally learned rotation. These changes adhered to the dynamics of behavior during learning and persisted between learning and relearning of the same rotation. These findings suggest a neural mechanism for the locality of newly acquired sensorimotor tasks and provide electrophysiological evidence for their retention in working memory.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Univ Victor Segalen, Neurophysiol Lab, CNRS, UMR 5543, Bordeaux, France	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Paz, R (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, Box 12272, IL-91120 Jerusalem, Israel.		Boraud, Thomas/A-6260-2008; Vaadia, Eilon/E-9347-2011					ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; Baraduc P, 2002, J NEUROPHYSIOL, V88, P973, DOI 10.1152/jn.2002.88.2.973; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; CRAMMOND DJ, 1994, J NEUROPHYSIOL, V71, P1281, DOI 10.1152/jn.1994.71.3.1281; Flanagan JR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0005.1999; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Ghahramani Z, 1996, J NEUROSCI, V16, P7085; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Hess G, 1996, EUR J NEUROSCI, V8, P658, DOI 10.1111/j.1460-9568.1996.tb01251.x; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; KARNI A, 1995, NATURE, V377, P155; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; MITZ AR, 1991, J NEUROSCI, V11, P1855; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Muellbacher W, 2001, EXP BRAIN RES, V136, P431, DOI 10.1007/s002210000614; Nezafat R, 2001, EXP BRAIN RES, V140, P66, DOI 10.1007/s002210100787; Nudo RJ, 1996, J NEUROSCI, V16, P785; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn.2002.88.2.991; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; Pine ZM, 1996, NEUROREPORT, V7, P2357, DOI 10.1097/00001756-199610020-00016; Plautz EJ, 2000, NEUROBIOL LEARN MEM, V74, P27, DOI 10.1006/nlme.1999.3934; POGGIO T, 1990, SCIENCE, V247, P978, DOI 10.1126/science.247.4945.978; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schaal S, 1998, NEURAL COMPUT, V10, P2047, DOI 10.1162/089976698300016963; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Shadmehr R, 2000, J NEUROSCI, V20, P7807; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582, DOI 10.1152/jn.1989.62.2.582; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Yin PB, 2001, EXP BRAIN RES, V141, P250, DOI 10.1007/s002210100892	46	148	148	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					882	890		10.1038/nn1097	http://dx.doi.org/10.1038/nn1097			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872127				2022-12-17	WOS:000184413700019
J	Cayouette, M; Raff, M				Cayouette, M; Raff, M			Asymmetric segregation of Numb: a mechanism for neural specification from Drosophila to mammals	NATURE NEUROSCIENCE			English	Review							CELL-DIVISION; NEUROEPITHELIAL CELLS; CORTICAL NEUROGENESIS; ENDOCYTIC PROTEIN; NERVOUS-SYSTEM; MOUSE NUMB; STEM-CELLS; NOTCH; FATE; LOCALIZATION	It is a major challenge to understand how the neuroepithelial cells of the developing CNS choose between alternative cell fates to generate cell diversity. In invertebrates such as Drosophila melanogaster and Caenorhabditis elegans, asymmetric segregation of cell-fate determining proteins or mRNAs to the two daughter cells during precursor cell division plays a crucial part in cell diversification. There is increasing evidence that this mechanism also operates in vertebrate neural development and that Numb proteins, which function as cell-fate determinants during Drosophila development, may also function in this way in vertebrates. Recent studies on mouse cortical progenitor cells have provided the strongest evidence yet that this is the case. Here, we review these and other findings that suggest an important role for the asymmetric segregation of Numb proteins in vertebrate neural development.	UCL, Cell Biol Unit, London WC1E 6BT, England; UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Cayouette, M (corresponding author), Stanford Univ, Dept Neurobiol, Fairchild Bldg,299 Campus Dr,D231, Stanford, CA 94305 USA.	m.cayouette@stanford.edu		Cayouette, Michel/0000-0003-4655-9048				Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; Cayouette M, 2001, J NEUROSCI, V21, P5643, DOI 10.1523/JNEUROSCI.21-15-05643.2001; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rice DS, 2001, MOL CELL NEUROSCI, V18, P525, DOI 10.1006/mcne.2001.1024; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schaefer M, 2001, EXP CELL RES, V271, P66, DOI 10.1006/excr.2001.5371; Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4; SHEN Q, IN PRESS DEVELOPMENT; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wan S, 2000, DEV BIOL, V217, P153, DOI 10.1006/dbio.1999.9499; Xie Y, 2001, BIOCHEM GENET, V39, P117, DOI 10.1023/A:1010269908398; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X	41	148	154	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1265	1269		10.1038/nn1202-1265	http://dx.doi.org/10.1038/nn1202-1265			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12447381				2022-12-17	WOS:000179447500008
J	Shewan, D; Dwivedy, A; Anderson, R; Holt, CE				Shewan, D; Dwivedy, A; Anderson, R; Holt, CE			Age-related changes underlie switch in netrin-1 responsiveness as growth cones advance along visual pathway	NATURE NEUROSCIENCE			English	Article							ADENOSINE A2B RECEPTOR; AXON GUIDANCE; INTERMEDIATE TARGET; PROTEIN-SYNTHESIS; CYCLIC-AMP; DCC; EXPRESSION; ATTRACTION; NEURONS; XENOPUS	Retinal axons are led out of the eye by netrin-1, an attractive guidance cue which is secreted at the optic nerve head. In the optic pathway, however, netrin-1 is expressed in areas that exclude retinal axon growth. This suggests that axons may change in their responsiveness to netrin-1 as they advance along the pathway. Indeed, in our 'whole-pathway' preparation in Xenopus, a gradual change from attraction to repulsion occurred as retinal axons emerged from progressively distal points along the pathway. We also found that axons that were aged in culture without pathway experience underwent a similar change, which correlated with a decline in cyclic AMP (cAMP) and netrin-1 receptor expression. Cyclic AMP elevators and adenosine A2b receptor agonists rejuvenated the behavior of old growth cones, causing them to regain attraction to netrin-1, whereas antagonists caused young growth cones to be repelled. These findings show that netrin-1 responsiveness is developmentally regulated and suggest that intrinsic changes that lower cAMP levels underlie this regulation.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Holt, CE (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	ceh@mole.bio.cam.ac.uk		Holt, Christine Elizabeth/0000-0003-2829-121X				ANDERSON RB, IN PRESS MECH DEV; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Diefenbach TJ, 2000, J NEUROSCI, V20, P1484; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Erskine L, 2000, J NEUROSCI, V20, P4975; Feoktistov I, 1997, PHARMACOL REV, V49, P381; Gad JM, 2000, EXP EYE RES, V70, P711, DOI 10.1006/exer.2000.0823; Galko MJ, 2000, SCIENCE, V289, P1365, DOI 10.1126/science.289.5483.1365; GRANT P, 1986, DEV BIOL, V114, P475, DOI 10.1016/0012-1606(86)90212-5; HENDERSON LP, 1986, DEV BIOL, V113, P381, DOI 10.1016/0012-1606(86)90173-9; HOLT CE, 1989, J NEUROSCI, V9, P3123; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Johansson K, 2001, DEV BRAIN RES, V130, P133, DOI 10.1016/S0165-3806(01)00221-8; Kvanta A, 1997, EXP EYE RES, V65, P595, DOI 10.1006/exer.1996.0352; Lee SMK, 1997, DEVELOPMENT, V124, P959; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Ringstedt T, 2000, J NEUROSCI, V20, P4983; SHEWAN D, 1995, J NEUROSCI, V15, P2057, DOI 10.1523/JNEUROSCI.15-03-02057.1995; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Trousse F, 2001, DEVELOPMENT, V128, P3927; Wiemelt AP, 1997, J BIOL CHEM, V272, P31489, DOI 10.1074/jbc.272.50.31489; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	41	148	153	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					955	962		10.1038/nn919	http://dx.doi.org/10.1038/nn919			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12352982				2022-12-17	WOS:000178242200014
J	Lee, A; Westenbroek, RE; Haeseleer, F; Palczewski, K; Scheuer, T; Catterall, WA				Lee, A; Westenbroek, RE; Haeseleer, F; Palczewski, K; Scheuer, T; Catterall, WA			Differential modulation of Ca(v)2.1 channels by calmodulin and Ca2+-binding protein 1	NATURE NEUROSCIENCE			English	Article							PRESYNAPTIC CALCIUM CURRENT; BETA-GAMMA-SUBUNITS; RAT BRAIN-STEM; CA2+ CHANNELS; N-TYPE; SUBCELLULAR-DISTRIBUTION; ALPHA(1A) SUBUNITS; FACILITATION; INACTIVATION; SYNTAXIN	Ca(v)2.1 channels, which mediate P/Q-type Ca2+ currents, undergo Ca2+/calmodulin (CaM) dependent inactivation and facilitation that can significantly alter synaptic efficacy. Here we report that the neuronal Ca2+-binding protein 1 (CaBP1) modulates Ca(v)2.1 channels in a manner that is markedly different from modulation by CaM. CaBP1 enhances inactivation, causes a depolarizing shift in the voltage dependence of activation, and does not support Ca2+-dependent facilitation of Ca(v)2.1 channels. These inhibitory effects of CaBP1 do not require Ca2+, but depend on the CaM-binding domain in the alpha(1) subunit of Ca(v)2.1 channels (alpha(1)2.1). CaBP1 binds to the CaM-binding domain, co-immunoprecipitates with alpha(1)2.1 from transfected cells and brain extracts, and colocalizes with alpha(1)2.1 in discrete microdomains of neurons in the hippocampus and cerebellum. Our results identify an interaction between Ca2+ channels and CaBP1 that may regulate Ca2+-dependent forms of synaptic plasticity by inhibiting Ca2+ influx into neurons.	Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.			Lee, Amy/0000-0001-8021-0443	NATIONAL EYE INSTITUTE [R01EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625, F32NS010645] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY08061, R01 EY008061] Funding Source: Medline; NINDS NIH HHS [R01 NS022625, F32 NS010645, F32 NS10645, R01 NS22625] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Chen XL, 2001, J PHYSIOL-LONDON, V532, P649, DOI 10.1111/j.1469-7793.2001.0649e.x; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; GREENLEE DV, 1982, BIOCHEMISTRY-US, V21, P2759, DOI 10.1021/bi00540a028; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rodney GG, 2000, BIOCHEMISTRY-US, V39, P7807, DOI 10.1021/bi0005660; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Sakurai T, 1996, J CELL BIOL, V134, P511, DOI 10.1083/jcb.134.2.511; Sallese M, 2000, FASEB J, V14, P2569, DOI 10.1096/fj.00-0072com; Schaad NC, 1996, P NATL ACAD SCI USA, V93, P9253, DOI 10.1073/pnas.93.17.9253; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Weiss JL, 2000, J BIOL CHEM, V275, P40082, DOI 10.1074/jbc.M008603200; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; YAMAKI T, 1980, BIOCHEM BIOPH RES CO, V94, P727, DOI 10.1016/0006-291X(80)91293-0; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	39	148	154	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					210	217		10.1038/nn805	http://dx.doi.org/10.1038/nn805			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11865310	Green Accepted			2022-12-17	WOS:000174146000010
J	Preissl, S; Fang, RX; Huang, H; Zhao, Y; Raviram, R; Gorkin, DU; Zhang, YX; Sos, BC; Afzal, V; Dickel, DE; Kuan, S; Visel, A; Pennacchio, LA; Zhang, K; Ren, B				Preissl, Sebastian; Fang, Rongxin; Huang, Hui; Zhao, Yuan; Raviram, Ramya; Gorkin, David U.; Zhang, Yanxiao; Sos, Brandon C.; Afzal, Veena; Dickel, Diane E.; Kuan, Samantha; Visel, Axel; Pennacchio, Len A.; Zhang, Kun; Ren, Bing			Single-nucleus analysis of accessible chromatin in developing mouse forebrain reveals cell-type-specific transcriptional regulation	NATURE NEUROSCIENCE			English	Article							NEURONAL SUBTYPES; HUMAN GENOME; RNA-SEQ; DNA; BINDING; EXPRESSION; LANDSCAPE; DIVERSITY; ELEMENTS; DATABASE	Analysis of chromatin accessibility can reveal transcriptional regulatory sequences, but heterogeneity of primary tissues poses a significant challenge in mapping the precise chromatin landscape in specific cell types. Here we report single-nucleus ATAC-seq, a combinatorial barcoding-assisted single-cell assay for transposase-accessible chromatin that is optimized for use on flash-frozen primary tissue samples. We apply this technique to the mouse forebrain through eight developmental stages. Through analysis of more than 15,000 nuclei, we identify 20 distinct cell populations corresponding to major neuronal and non-neuronal cell types. We further define cell-type-specific transcriptional regulatory sequences, infer potential master transcriptional regulators and delineate developmental changes in forebrain cellular composition. Our results provide insight into the molecular and cellular dynamics that underlie forebrain development in the mouse and establish technical and analytical frameworks that are broadly applicable to other heterogeneous tissues.	[Preissl, Sebastian; Fang, Rongxin; Huang, Hui; Zhao, Yuan; Raviram, Ramya; Gorkin, David U.; Zhang, Yanxiao; Kuan, Samantha; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Preissl, Sebastian; Gorkin, David U.; Ren, Bing] Univ Calif San Diego, Sch Med, Ctr Epigen, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Fang, Rongxin; Zhao, Yuan] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Huang, Hui; Sos, Brandon C.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Sos, Brandon C.; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Afzal, Veena; Dickel, Diane E.; Visel, Axel; Pennacchio, Len A.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA USA; [Visel, Axel; Pennacchio, Len A.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Visel, Axel] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Pennacchio, Len A.] Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Inst Genom Med, Moores Canc Ctr, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Merced; University of California System; University of California Berkeley; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, La Jolla, CA 92093 USA.; Ren, B (corresponding author), Univ Calif San Diego, Sch Med, Ctr Epigen, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Ren, B (corresponding author), Univ Calif San Diego, Sch Med, Inst Genom Med, Moores Canc Ctr, La Jolla, CA 92093 USA.	biren@ucsd.edu	Zhang, Yanxiao/Q-8263-2019; Zhang, Kun/ABE-6349-2020; Visel, Axel/A-9398-2009	Zhang, Kun/0000-0002-7596-5224; Visel, Axel/0000-0002-4130-7784; Fang, Rongxin/0000-0003-0107-7504; Preissl, Sebastian/0000-0001-8971-5616; Pennacchio, Len/0000-0002-8748-3732; Huang, Hui/0000-0002-4319-543X; Dickel, Diane/0000-0001-5497-6824; Zhang, Yanxiao/0000-0001-9618-637X	National Human Genome Research Institute [U54HG006997]; National Institute Mental Health [1U19MH114831, U01MH098977]; NIH [2P50 GM085764]; Ludwig Institute for Cancer Research; Deutsche Forschungsgemeinschaft (DFG) [PR 1668/1-1]; Ruth L. Kirschstein National Research Service Award NIH/NCI [T32 CA009523]; US Department of Energy [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, K12GM068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH114831, U01MH098977] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute Mental Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ruth L. Kirschstein National Research Service Award NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Li for bioinformatic support. We thank M. He and T. Osothprarop for providing the Tn5 enzyme. We thank D. Gao for sequencing on the MiSeq. This study was funded in part by the National Human Genome Research Institute (U54HG006997 to B.R.), National Institute Mental Health (1U19MH114831 to B.R., U01MH098977 to K.Z.), NIH (2P50 GM085764 to B.R.), and the Ludwig Institute for Cancer Research (to B.R.). S.P. was supported by a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft (DFG, PR 1668/1-1). R.R. was supported by a Ruth L. Kirschstein National Research Service Award NIH/NCI T32 CA009523. Research conducted at the E.O. Lawrence Berkeley National Laboratory was performed under US Department of Energy Contract DE-AC02-05CH11231, University of California.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Amini S, 2014, NAT GENET, V46, P1343, DOI 10.1038/ng.3119; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Glasgow SM, 2014, NAT NEUROSCI, V17, P1322, DOI 10.1038/nn.3790; Gray LT, 2017, ELIFE, V6, DOI 10.7554/eLife.21883; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heng YHE, 2014, CEREB CORTEX, V24, P261, DOI 10.1093/cercor/bhs307; Hori K, 2008, GENE DEV, V22, P166, DOI 10.1101/gad.1628008; Hsu LCL, 2015, P NATL ACAD SCI USA, V112, P12199, DOI 10.1073/pnas.1507145112; Huttner HB, 2014, NAT NEUROSCI, V17, P801, DOI 10.1038/nn.3706; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Loug JE, 2009, CEREB CORTEX, V19, pI96, DOI 10.1093/cercor/bhp045; Luo CY, 2017, SCIENCE, V357, P600, DOI 10.1126/science.aan3351; Martynoga B, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008359; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Nord AS, 2015, NEURON, V85, P27, DOI 10.1016/j.neuron.2014.11.011; Onorati M, 2014, NAT NEUROSCI, V17, P1804, DOI 10.1038/nn.3860; Pernet V, 2008, J NEUROSCI, V28, P7435, DOI 10.1523/JNEUROSCI.0727-08.2008; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Rousseau A, 2006, J NEUROPATH EXP NEUR, V65, P1149, DOI 10.1097/01.jnen.0000248543.90304.2b; Silberberg SN, 2016, NEURON, V92, P59, DOI 10.1016/j.neuron.2016.09.027; Su YJ, 2017, NAT NEUROSCI, V20, P476, DOI 10.1038/nn.4494; Subramanian L, 2011, P NATL ACAD SCI USA, V108, pE265, DOI 10.1073/pnas.1101109108; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Yuan F, 2015, SCI REP-UK, V5, DOI 10.1038/srep18550; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	63	147	157	9	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2018	21	3					432	+		10.1038/s41593-018-0079-3	http://dx.doi.org/10.1038/s41593-018-0079-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FZ7JH	29434377	Green Accepted, Green Published, Green Submitted			2022-12-17	WOS:000427776400018
J	Alexander, AS; Nitz, DA				Alexander, Andrew S.; Nitz, Douglas A.			Retrosplenial cortex maps the conjunction of internal and external spaces	NATURE NEUROSCIENCE			English	Article							HEAD-DIRECTION CELLS; POSTERIOR PARIETAL CORTEX; REFERENCE FRAMES; ENTORHINAL CORTEX; SPATIAL MEMORY; PATH-INTEGRATION; VISUAL-STIMULI; RAT; NAVIGATION; NEURONS	Intelligent behavior demands not only multiple forms of spatial representation, but also coordination among the brain regions mediating those representations. Retrosplenial cortex is densely interconnected with the majority of cortical and subcortical brain structures that register an animal's position in multiple internal and external spatial frames of reference. This unique anatomy suggests that it functions to integrate distinct forms of spatial information and provides an interface for transformations between them. Evidence for this was found in rats traversing two different routes placed at different environmental locations. Retrosplenial ensembles robustly encoded conjunctions of progress through the current route, position in the larger environment and the left versus right turning behavior of the animal. Thus, the retrosplenial cortex has the requisite dynamics to serve as an intermediary between brain regions generating different forms of spatial mapping, a result that is consistent with navigational and episodic memory impairments following damage to this region in humans.	[Alexander, Andrew S.; Nitz, Douglas A.] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA	University of California System; University of California San Diego	Nitz, DA (corresponding author), Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA.	dnitz@ucsd.edu		Alexander, Andrew/0000-0002-1735-3449	National Science Foundation [IOS-1149718]; National Science Foundation Graduate Research Fellowship [DGE-1144086]; Direct For Biological Sciences [1149718] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank S. Cowen, L. Quinn, L. Rangel, J. Olson and L. Shelley for reviewing the manuscript. Special thanks to A. Chiba, B. La and S. Kolbu for helping with the design and implementation of experiments and analyses. This work funded by National Science Foundation IOS-1149718 and National Science Foundation Graduate Research Fellowship DGE-1144086.	ANDERSEN RA, 1987, EXP BRAIN RES, V67, P316; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Auger SD, 2013, CORTEX, V49, P2904, DOI 10.1016/j.cortex.2013.08.002; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; CHEN LL, 1994, EXP BRAIN RES, V101, P24, DOI 10.1007/BF00243213; Cho JW, 2001, BEHAV NEUROSCI, V115, P3, DOI 10.1037//0735-7044.115.1.3; Cooper BG, 2001, J NEUROSCI, V21, P3986, DOI 10.1523/JNEUROSCI.21-11-03986.2001; Cooper BG, 2001, BEHAV NEUROSCI, V115, P1012, DOI 10.1037//0735-7044.115.5.1012; Cooper BG, 1999, NEUROREPORT, V10, P625, DOI 10.1097/00001756-199902250-00033; Cowen SL, 2014, J NEUROSCI, V34, P232, DOI 10.1523/JNEUROSCI.1199-13.2014; Czajkowski R, 2014, P NATL ACAD SCI USA, V111, P8661, DOI 10.1073/pnas.1313222111; Czajkowski R, 2013, J NEUROSCI, V33, P15779, DOI 10.1523/JNEUROSCI.2646-13.2013; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Elduayen C, 2014, BEHAV BRAIN RES, V272, P303, DOI 10.1016/j.bbr.2014.07.009; Gupta K, 2014, CEREB CORTEX, V24, P1630, DOI 10.1093/cercor/bht020; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hindley EL, 2014, BEHAV BRAIN RES, V263, P98, DOI 10.1016/j.bbr.2014.01.028; Ino T, 2007, CORTEX, V43, P248, DOI 10.1016/S0010-9452(08)70479-9; Keene CS, 2008, BEHAV NEUROSCI, V122, P651, DOI 10.1037/0735-7044.122.3.651; Keene CS, 2009, NEUROBIOL LEARN MEM, V91, P408, DOI 10.1016/j.nlm.2008.10.009; Maeshima S, 2001, J CLIN NEUROSCI, V8, P450, DOI 10.1054/jocn.2000.0801; MCNAUGHTON BL, 1994, CEREB CORTEX, V4, P27, DOI 10.1093/cercor/4.1.27; McNaughton Bruce L., 1995, P585; MULLER RU, 1987, J NEUROSCI, V7, P1951; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; Nitz D, 2009, NEUROBIOL LEARN MEM, V91, P179, DOI 10.1016/j.nlm.2008.08.007; Nitz DA, 2012, NAT NEUROSCI, V15, P1365, DOI 10.1038/nn.3213; Nitz DA, 2011, J NEUROPHYSIOL, V105, P1815, DOI 10.1152/jn.00573.2010; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Paxinos G, 2005, RAT BRAIN STEREOTAXI, DOI 10.1016/c2009-0-63235-9; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Raposo D, 2014, NAT NEUROSCI, V17, P1784, DOI 10.1038/nn.3865; Ravassard P, 2013, SCIENCE, V340, P1342, DOI 10.1126/science.1232655; REEP RL, 1994, EXP BRAIN RES, V100, P67; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sherrill KR, 2013, J NEUROSCI, V33, P19304, DOI 10.1523/JNEUROSCI.1825-13.2013; Smith DM, 2012, HIPPOCAMPUS, V22, P1121, DOI 10.1002/hipo.20958; Spiers HJ, 2006, NEUROIMAGE, V31, P1826, DOI 10.1016/j.neuroimage.2006.01.037; Sulpizio V, 2013, BEHAV BRAIN RES, V242, P62, DOI 10.1016/j.bbr.2012.12.031; TAUBE JS, 1990, J NEUROSCI, V10, P436; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; van Groen T, 2003, J COMP NEUROL, V463, P249, DOI 10.1002/cne.10757; VANGROEN T, 1992, J COMP NEUROL, V315, P200, DOI 10.1002/cne.903150207; VANGROEN T, 1990, J COMP NEUROL, V300, P593, DOI 10.1002/cne.903000412; Vann SD, 2005, BEHAV NEUROSCI, V119, P1682, DOI 10.1037/0735-7044.119.6.1682; VOGT BA, 1983, J COMP NEUROL, V216, P192, DOI 10.1002/cne.902160207; Whitlock JR, 2012, NEURON, V73, P789, DOI 10.1016/j.neuron.2011.12.028; Wilber AA, 2014, J NEUROSCI, V34, P5431, DOI 10.1523/JNEUROSCI.0511-14.2014; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; Wyss JM, 1992, HIPPOCAMPUS, V1, P1; Zilles K., 1985, CORTEX RAT STEREOTAX	55	147	150	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2015	18	8					1143	+		10.1038/nn.4058	http://dx.doi.org/10.1038/nn.4058			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN7HO	26147532				2022-12-17	WOS:000358605400016
J	Grone, BP; Baraban, SC				Grone, Brian P.; Baraban, Scott C.			Animal models in epilepsy research: legacies and new directions	NATURE NEUROSCIENCE			English	Article							TUBEROUS SCLEROSIS COMPLEX; POTASSIUM CHANNEL GENE; ABSENCE EPILEPSY; MUTANT MICE; CAENORHABDITIS-ELEGANS; SPONTANEOUS SEIZURES; ZEBRAFISH MODEL; DRAVET SYNDROME; MOUSE MUTANTS; RAT MODEL	Human epilepsies encompass a wide variety of clinical, behavioral and electrical manifestations. Correspondingly, studies of this disease in nonhuman animals have brought forward an equally wide array of animal models; that is, species and acute or chronic seizure induction protocols. Epilepsy research has a long history of comparative anatomical and physiological studies on a range of mostly mammalian species. Nonetheless, a relatively limited number of rodent models have emerged as the primary choices for most investigations. In many cases, these animal models are selected on the basis of convenience or tradition, although technical or experimental rationale does, and should, factor into these decisions. More complex mammalian brains and, genetic model organisms including zebrafish have been studied less, but offer substantial advantages that are becoming widely recognized.	[Grone, Brian P.; Baraban, Scott C.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Grone, BP (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	brian.grone@ucsf.edu		Baraban, Scott/0000-0003-1975-9781	US National Institutes of Health; Citizens United for Research in Epilepsy; Dravet Syndrome Foundation; California Institute for Regenerative Medicine; Lennox-Gastaut Syndrome foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079214] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Citizens United for Research in Epilepsy; Dravet Syndrome Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Lennox-Gastaut Syndrome foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank R. Hunt and M. Howard for discussions and advice. S.C.B. is supported by funds from the US National Institutes of Health, Citizens United for Research in Epilepsy, Dravet Syndrome Foundation and California Institute for Regenerative Medicine. B.P.G. is supported, in part, by funds from the Lennox-Gastaut Syndrome foundation.	Abou-Khalil B, 2001, NEUROLOGY, V57, P2265, DOI 10.1212/WNL.57.12.2265; [Anonymous], 1869, BR MED J, V2, P371; Arrenberg AB, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00074; AVANZINI G, 1995, ITAL J NEUROL SCI, V16, P5, DOI 10.1007/BF02229068; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2007, EPILEPSIA, V48, P1151, DOI 10.1111/j.1528-1167.2007.01075.x; Baraban SC, 2013, JOVE-J VIS EXP, DOI 10.3791/50104; Baraban SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3410; Baraban SC, 2009, NEUROMETHODS, V40, P59, DOI 10.1007/978-1-60327-263-6_4; Baulac S, 2012, HUM MOL GENET, V21, P3546, DOI 10.1093/hmg/dds184; Bell MR, 2011, NAT NEUROSCI, V14, P505, DOI 10.1038/nn.2777; Bertram E, 2007, EPILEPSIA, V48, P65, DOI 10.1111/j.1528-1167.2007.01068.x; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Bradford HF, 1995, PROG NEUROBIOL, V47, P477, DOI 10.1016/0301-0082(95)00030-5; Buckmaster PS, 2014, J COMP NEUROL, V522, P1691, DOI 10.1002/cne.23509; Buckmaster PS, 2004, COMPARATIVE MED, V54, P473; Calcagnotto M. E., 2011, YOUMANS TXB NEUROLOG, P659; Cantallops I, 2000, HIPPOCAMPUS, V10, P269, DOI 10.1002/1098-1063(2000)10:3<269::AID-HIPO7>3.0.CO;2-R; Chege SW, 2012, DEV NEUROBIOL, V72, P186, DOI 10.1002/dneu.20937; Chieppa MN, 2014, NEURODEGENER DIS, V13, P246, DOI 10.1159/000353472; Clasadonte J., 2012, JASPERS BASIC MECH E; DICHTER M, 1969, J NEUROPHYSIOL, V32, P649, DOI 10.1152/jn.1969.32.5.649; Do Carmo S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-37; Duranthon V, 2012, TRANSGENIC RES, V21, P699, DOI 10.1007/s11248-012-9599-x; Ferrier D, 1873, J Anat Physiol, V8, P152; Fletcher CF, 1999, HUM MOL GENET, V8, P1907, DOI 10.1093/hmg/8.10.1907; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Frankel WN, 2001, GENOMICS, V74, P306, DOI 10.1006/geno.2001.6564; Frankel WN, 1999, EPILEPSY RES, V36, P97, DOI 10.1016/S0920-1211(99)00044-3; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Granato M, 1996, DEVELOPMENT, V123, P399; GREEN MC, 1962, J HERED, V53, P233, DOI 10.1093/oxfordjournals.jhered.a107180; GUTNICK MJ, 1975, EXP NEUROL, V46, P418, DOI 10.1016/0014-4886(75)90146-6; HALL CS, 1947, J HERED, V38, P2; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Harvard S. C., 2014, ADV EXP MED BIOL, V813, P243; Hortopan GA, 2011, DEV DYNAM, V240, P1964, DOI 10.1002/dvdy.22680; Hortopan GA, 2010, J NEUROSCI, V30, P13718, DOI 10.1523/JNEUROSCI.1887-10.2010; Howbert JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081920; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hunt RF, 2012, EXP NEUROL, V237, P199, DOI 10.1016/j.expneurol.2012.06.013; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jirsa VK, 2014, BRAIN, V137, P2210, DOI 10.1093/brain/awu133; JOBE PC, 1991, CRIT REV NEUROBIOL, V6, P183; Jones DL, 2007, J NEUROPHYSIOL, V98, P2737, DOI 10.1152/jn.00938.2007; Kandratavicius L, 2014, NEUROPSYCH DIS TREAT, V10, P1693, DOI 10.2147/NDT.S50371; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kopeloff LM, 1942, AM J PSYCHIAT, V98, P881, DOI 10.1176/ajp.98.6.881; Krogh A, 1929, SCIENCE, V70, P200, DOI 10.1126/science.70.1809.200; Lakaye B, 2002, EPILEPSIA, V43, P123, DOI 10.1046/j.1528-1157.43.s.5.17.x; Loscher W, 2011, SEIZURE-EUR J EPILEP, V20, P359, DOI 10.1016/j.seizure.2011.01.003; LOSCHER W, 1984, METHOD FIND EXP CLIN, V6, P531; Loscher W, 2004, EPILEPSIA, V45, P1228, DOI 10.1111/j.0013-9580.2004.21204.x; Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011; Lynch Vincent J., 2009, Yale Journal of Biology and Medicine, V82, P53; Margoliash D, 2010, J CLIN NEUROPHYSIOL, V27, P433, DOI 10.1097/WNP.0b013e3181fe06f6; McKhann GM, 2003, NEUROSCIENCE, V122, P551, DOI 10.1016/S0306-4522(03)00562-1; Moens Cecilia B., 2008, Briefings in Functional Genomics & Proteomics, V7, P454, DOI 10.1093/bfgp/eln046; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Noebels J L, 1999, Adv Neurol, V79, P227; NOEBELS JL, 1979, SCIENCE, V204, P1334, DOI 10.1126/science.572084; Pamenter ME, 2012, J CEREBR BLOOD F MET, V32, P2033, DOI 10.1038/jcbfm.2012.103; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Parent JM, 1997, J NEUROSCI, V17, P3727; PINEL JPJ, 1975, PHYSIOL PSYCHOL, V3, P127, DOI 10.3758/BF03337488; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P1; Potschka H, 2013, EPILEPSIA, V54, P571, DOI 10.1111/epi.12138; Pun RYK, 2012, NEURON, V75, P1022, DOI 10.1016/j.neuron.2012.08.002; Puranam RS, 1999, CURR OPIN NEUROBIOL, V9, P281, DOI 10.1016/S0959-4388(99)80041-5; PURPURA DP, 1972, EXPT MODELS EPILEPSY; Putnam TJ, 1937, SCIENCE, V85, P525, DOI 10.1126/science.85.2213.525; Ramirez IBR, 2012, HUM MOL GENET, V21, P1744, DOI 10.1093/hmg/ddr608; Raol YH, 2012, PROG MOL BIOL TRANSL, V105, P57, DOI 10.1016/B978-0-12-394596-9.00003-2; Renninger SL, 2013, METHODS, V62, P255, DOI 10.1016/j.ymeth.2013.05.016; Roosen-Runge EC, 1938, BIOL BULL-US, V75, P119, DOI 10.2307/1537678; Ryan K, 2012, J NEUROSCI, V32, P11250, DOI 10.1523/JNEUROSCI.0907-12.2012; Sakurai A, 2014, ELIFE, V3, DOI 10.7554/eLife.02598; SALKOFF L, 1978, NATURE, V273, P156, DOI 10.1038/273156a0; Schauwecker PE, 2011, EPILEPSY RES, V97, P1, DOI 10.1016/j.eplepsyres.2011.09.005; Schwartzkroin PA, 2004, ADV EXP MED BIOL, V548, P145; Schwartzkroin PA, 1993, EPILEPSY MODELS MECH; SEYFRIED TN, 1985, EPILEPSIA, V26, P143, DOI 10.1111/j.1528-1157.1985.tb05398.x; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Suls A, 2013, AM J HUM GENET, V93, P967, DOI 10.1016/j.ajhg.2013.09.017; Sun L, 2012, J NEUROSCI, V32, P14145, DOI 10.1523/JNEUROSCI.2932-12.2012; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Szabo CA, 2012, COMPARATIVE MED, V62, P535; TAUCK DL, 1985, J NEUROSCI, V5, P1016; TEILLET MA, 1991, P NATL ACAD SCI USA, V88, P6966, DOI 10.1073/pnas.88.16.6966; Teng Y, 2010, HUM MOL GENET, V19, P4409, DOI 10.1093/hmg/ddq364; Thomas RH, 2014, NAT REV NEUROL, V10, P283, DOI 10.1038/nrneurol.2014.62; TRIMBLE M, 1977, PSYCHOPHARMACOLOGY, V51, P159, DOI 10.1007/BF00431733; TSUJI S, 1971, GENET RES, V17, P83, DOI 10.1017/S0016672300012040; Velluti JC, 1997, EPILEPSY RES, V28, P29, DOI 10.1016/S0920-1211(97)00028-4; Wang YL, 2007, ANN NEUROL, V61, P139, DOI 10.1002/ana.21058; Williams SN, 2004, HUM MOL GENET, V13, P2043, DOI 10.1093/hmg/ddh209; WILLNER P, 1991, TRENDS PHARMACOL SCI, V12, P131, DOI 10.1016/0165-6147(91)90529-2; Young NA, 2013, P NATL ACAD SCI USA, V110, P19107, DOI 10.1073/pnas.1318894110; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	103	147	151	2	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2015	18	3					339	343		10.1038/nn.3934	http://dx.doi.org/10.1038/nn.3934			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC2SO	25710835	Green Submitted			2022-12-17	WOS:000350195100010
J	Gomez-Marin, A; Paton, JJ; Kampff, AR; Costa, RM; Mainen, ZF				Gomez-Marin, Alex; Paton, Joseph J.; Kampff, Adam R.; Costa, Rui M.; Mainen, Zachary F.			Big behavioral data: psychology, ethology and the foundations of neuroscience	NATURE NEUROSCIENCE			English	Article							SYSTEM; MAPS; RATS; PERSONALITY; CONTINGENCY; DECISIONS; HUMANS; BRAIN	Behavior is a unifying organismal process where genes, neural function, anatomy and environment converge and interrelate. Here we review the current state and discuss the future effect of accelerating advances in technology for behavioral studies, focusing on rodents as an example. We frame our perspective in three dimensions: the degree of experimental constraint, dimensionality of data and level of description. We argue that 'big behavioral data' presents challenges proportionate to its promise and describe how these challenges might be met through opportunities afforded by the two rival conceptual legacies of twentieth century behavioral science, ethology and psychology. We conclude that, although 'more is not necessarily better', copious, quantitative and open behavioral data has the potential to transform and unify these two disciplines and to solidify the foundations of others, including neuroscience, but only if the development of new theoretical frameworks and improved experimental designs matches the technological progress.	[Gomez-Marin, Alex; Paton, Joseph J.; Kampff, Adam R.; Costa, Rui M.; Mainen, Zachary F.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal	Fundacao Champalimaud	Mainen, ZF (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal.	zmainen@neuro.fchampalimaud.org	; Gomez Marin, Alejandro/M-6408-2015	Paton, Joseph/0000-0002-1663-6455; Mainen, Zachary/0000-0001-7913-9109; Kampff, Adam/0000-0003-3079-019X; Gomez Marin, Alejandro/0000-0003-2764-2583				[Anonymous], 1927, CONDITIONAL REFLEXES; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Benjamini Y, 2010, NEUROSCI BIOBEHAV R, V34, P1351, DOI 10.1016/j.neubiorev.2010.04.004; Berman GJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0672; Bialek W, 2014, P NATL ACAD SCI USA, V111, P7212, DOI 10.1073/pnas.1324045111; Biro PA, 2012, ANIM BEHAV, V83, P1295, DOI 10.1016/j.anbehav.2012.01.036; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/NMETH.1328, 10.1038/nmeth.1328]; Brembs B, 2009, J NEUROGENET, V23, P120, DOI 10.1080/01677060802471643; Briegel HJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00522; Brown AEX, 2013, P NATL ACAD SCI USA, V110, P791, DOI 10.1073/pnas.1211447110; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Busse L, J NEUROSCI; Carandini M, 2013, NAT NEUROSCI, V16, P824, DOI 10.1038/nn.3410; Catania KC, 2005, NATURE, V433, P519, DOI 10.1038/nature03250; Censi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002891; COLWILL RM, 1985, J EXP PSYCHOL ANIM B, V11, P120, DOI 10.1037/0097-7403.11.1.120; Conway Morris S., 2003, LIFES SOLUTION INEVI; Costa RM, 2011, CURR OPIN NEUROBIOL, V21, P579, DOI 10.1016/j.conb.2011.05.004; Darwin C., 1998, EXPRESS EMOT MAN; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; DICKINSON A, 1983, Q J EXP PSYCHOL-B, V35, P35, DOI 10.1080/14640748308400912; Dominici N, 2011, SCIENCE, V334, P997, DOI 10.1126/science.1210617; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Fechner G. T., 1860, BREITKOPF HARTEL; Friston KJ, 2010, BIOL CYBERN, V102, P227, DOI 10.1007/s00422-010-0364-z; GOLANI I, 1992, BEHAV BRAIN SCI, V15, P249, DOI 10.1017/S0140525X00068539; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; Gouvea TS, 2014, FRONT NEUROROBOTICS, V8, DOI 10.3389/fnbot.2014.00010; Harrington M E, 1995, Proc Inst Mech Eng H, V209, P129, DOI 10.1243/PIME_PROC_1995_209_330_02; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Hull C.L., 1943, PRINCIPLES BEHAV INT, DOI DOI 10.2307/1416955; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jin DZ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001108; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Jordan D, 2013, P NATL ACAD SCI USA, V110, P14018, DOI 10.1073/pnas.1308282110; Kain JS, 2012, P NATL ACAD SCI USA, V109, P19834, DOI 10.1073/pnas.1211988109; Kane SA, 2014, J EXP BIOL, V217, P225, DOI 10.1242/jeb.092403; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kepecs A, 2007, J NEUROPHYSIOL, V98, P205, DOI 10.1152/jn.00071.2007; Kepecs A, 2012, PHILOS T R SOC B, V367, P1322, DOI 10.1098/rstb.2012.0037; Konorski J., 1948, CONDITIONED REFLEXES; Koralek AC, 2012, NATURE, V483, P331, DOI 10.1038/nature10845; Kwon YJ, 2014, HEALTHC INFORM RES, V20, P69, DOI 10.4258/hir.2014.20.1.69; Lorenz K, 1937, NATURWISSENSCHAFTEN, V25, P289, DOI 10.1007/BF01492648; LORENZ KZ, 1958, SCI AM, V199, P67, DOI 10.1038/scientificamerican1258-67; Luce RD, 1986, RESPONSE TIMES; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Muybridge E., 1969, ANIMAL LOCOMOTION; Portugues R, 2014, NEURON, V81, P1328, DOI 10.1016/j.neuron.2014.01.019; Proekt A, 2012, P NATL ACAD SCI USA, V109, P10564, DOI 10.1073/pnas.1206894109; Schaefer AT, 2012, CURR OPIN NEUROBIOL, V22, P170, DOI 10.1016/j.conb.2011.11.004; Schall JD, 2004, ANNU REV PSYCHOL, V55, P23, DOI 10.1146/annurev.psych.55.090902.141907; Scott BB, 2013, NEURON, V80, P371, DOI 10.1016/j.neuron.2013.08.002; Selen LPJ, 2012, J NEUROSCI, V32, P2276, DOI 10.1523/JNEUROSCI.5273-11.2012; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton Richard S., 1988, IEEE T NEURAL NETWOR, V16, P285, DOI [10.1109/TNN.1998.712192, DOI 10.1109/TNN.1998.712192]; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Thorndike EL, 1911, ANIMAL INTELLIGENCE; TINBERGEN N., 1951, STUDY INSTINCT; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Vannoni E, 2014, J NEUROSCI METH, V234, P26, DOI 10.1016/j.jneumeth.2014.04.026; Venkatraman S, 2010, J NEUROPHYSIOL, V104, P569, DOI 10.1152/jn.00121.2010; Vogelstein JT, 2014, SCIENCE, V344, P386, DOI 10.1126/science.1250298; Von Frisch K., 1955, DANCING BEES ACCOUNT; von Uexkull Joseph D., 2010, FORAY WORLDS ANIMALS; Winter Y, 2011, J NEUROSCI METH, V196, P276, DOI 10.1016/j.jneumeth.2011.01.017; Wu HY, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185561	75	147	151	0	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2014	17	11					1455	1462		10.1038/nn.3812	http://dx.doi.org/10.1038/nn.3812			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS0LT	25349912	Green Submitted			2022-12-17	WOS:000343969300010
J	Lee, Y; Karuppagounder, SS; Shin, JH; Lee, YI; Ko, HS; Swing, D; Jiang, HS; Kang, SU; Lee, BD; Kang, HC; Kim, D; Tessarollo, L; Dawson, VL; Dawson, TM				Lee, Yunjong; Karuppagounder, Senthilkumar S.; Shin, Joo-Ho; Lee, Yun-Il; Ko, Han Seok; Swing, Debbie; Jiang, Haisong; Kang, Sung-Ung; Lee, Byoung Dae; Kang, Ho Chul; Kim, Donghoon; Tessarollo, Lino; Dawson, Valina L.; Dawson, Ted M.			Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss	NATURE NEUROSCIENCE			English	Article							RNA SYNTHETASE COMPLEX; POLYMERASE-1-DEPENDENT CELL-DEATH; APOPTOSIS-INDUCING FACTOR; PARKINSONS-DISEASE; S-NITROSYLATION; ALPHA-SYNUCLEIN; PHOSPHORYLATION; UBIQUITINATION; EXPRESSION; BINDING	The defining pathogenic feature of Parkinson's disease is the age-dependent loss of dopaminergic neurons. Mutations and inactivation of parkin, an ubiquitin E3 ligase, induce Parkinson's disease through accumulation of pathogenic substrates. We found that transgenic overexpression of a parkin substrate, aminoacyl-tRNA synthetase complex interacting multifunctional protein-2 (AIMP2), led to a selective, age-dependent, progressive loss of dopaminergic neurons via activation of poly(ADP-ribose) polymerase-1 (PARP1). AIMP2 accumulation in vitro and in vivo resulted in PARP1 overactivation and dopaminergic cell toxicity via direct association of these proteins in the nucleus, providing a path to PARP1 activation other than DNA damage. Inhibition of PARP1 through gene deletion or drug inhibition reversed behavioral deficits and protected against dopamine neuron death in AIMP2 transgenic mice. These data indicate that brain-permeable PARP inhibitors could effectively delay or prevent disease progression in Parkinson's disease.	[Lee, Yunjong; Karuppagounder, Senthilkumar S.; Shin, Joo-Ho; Lee, Yun-Il; Ko, Han Seok; Jiang, Haisong; Kang, Sung-Ung; Lee, Byoung Dae; Kang, Ho Chul; Kim, Donghoon; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Baltimore, MD 21218 USA; [Lee, Yunjong] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Lee, Yunjong; Karuppagounder, Senthilkumar S.; Shin, Joo-Ho; Lee, Yun-Il; Ko, Han Seok; Jiang, Haisong; Kang, Sung-Ung; Lee, Byoung Dae; Kang, Ho Chul; Kim, Donghoon; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Lee, Yunjong; Karuppagounder, Senthilkumar S.; Shin, Joo-Ho; Jiang, Haisong; Kang, Sung-Ung; Dawson, Valina L.; Dawson, Ted M.] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA USA; [Shin, Joo-Ho] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Div Pharmacol,Dept Mol Cell Biol, Suwon, South Korea; [Ko, Han Seok; Kim, Donghoon] Diana Helis Henry Med Res Fdn, New Orleans, LA USA; [Swing, Debbie; Tessarollo, Lino] NCI, Neural Dev Sect, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA; [Lee, Byoung Dae] Kyung Hee Univ, Dept Neurosci, Age Related & Brain Dis Res Ctr, Seoul, South Korea; [Kang, Ho Chul] Ajou Univ, Sch Med, Dept Biomed Sci, Suwon 441749, South Korea; [Kang, Ho Chul] Ajou Univ, Sch Med, Dept Physiol, Suwon 441749, South Korea; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Sungkyunkwan University (SKKU); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kyung Hee University; Ajou University; Ajou University; Johns Hopkins University	Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Baltimore, MD 21218 USA.	vdawson@jhmi.edu; tdawson@jhmi.edu	Dawson, Valina/Y-9757-2019; Shin, Joo-Ho/P-1417-2018; Karuppagounder, Senthilkumar/I-6752-2013	Karuppagounder, Senthilkumar/0000-0002-3281-9913; Lee, Yunjong/0000-0003-0182-2279; Dawson, Valina/0000-0002-2915-3970	US National Institutes of Health [NS38377]; JPB Foundation; Samsung Scholarship Foundation; Adrienne Helis Malvin Medical Research Foundation; Diana Helis Henry Medical Research Foundation; Intramural Research Program of the National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZICBC010903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067525, P50NS038377] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; Samsung Scholarship Foundation(Samsung); Adrienne Helis Malvin Medical Research Foundation; Diana Helis Henry Medical Research Foundation; Intramural Research Program of the National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the US National Institutes of Health (NS38377) and the JPB Foundation. Y.-I.L. was supported by the Samsung Scholarship Foundation. T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. The authors acknowledge the joint participation and support by the Adrienne Helis Malvin Medical Research Foundation and the Diana Helis Henry Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with the Johns Hopkins Hospital and the Johns Hopkins University School of Medicine and the Foundation's Parkinson's Disease Programs. D.S. and L.T. were supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, US National Institutes of Health.	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chesselet MF, 2011, LANCET NEUROL, V10, P1108, DOI 10.1016/S1474-4422(11)70227-7; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Cookson MR, 2003, NEUROMOL MED, V3, P1, DOI 10.1385/NMM:3:1:1; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Corti O, 2013, CURR OPIN NEUROBIOL, V23, P100, DOI 10.1016/j.conb.2012.11.002; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Dawson TM, 2006, J NEURAL TRANSM-SUPP, P209; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; DEMURCIA G, 1994, MOL CELL BIOCHEM, V138, P15, DOI 10.1007/BF00928438; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; GERMAN DC, 1989, ANN NEUROL, V26, P507, DOI 10.1002/ana.410260403; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Han JM, 2008, P NATL ACAD SCI USA, V105, P11206, DOI 10.1073/pnas.0800297105; Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2006, J BIOL CHEM, V281, P16193, DOI 10.1074/jbc.C600041200; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Lee Y, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009324; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; MacCallum PR, 2006, J GEN VIROL, V87, P3251, DOI 10.1099/vir.0.82051-0; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Meng FJ, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-34; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172; Park SG, 2010, IUBMB LIFE, V62, P296, DOI 10.1002/iub.324; Plummer R, 2008, CLIN CANCER RES, V14, P7917, DOI 10.1158/1078-0432.CCR-08-1223; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Royo NC, 2008, BRAIN RES, V1190, P15, DOI 10.1016/j.brainres.2007.11.015; Rudow G, 2008, ACTA NEUROPATHOL, V115, P461, DOI 10.1007/s00401-008-0352-8; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Sprengel R, 2007, Handb Exp Pharmacol, P49; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wang C, 2005, HUM MOL GENET, V14, P3885, DOI 10.1093/hmg/ddi413; Wang HM, 2003, ANN NY ACAD SCI, V991, P132; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	52	147	153	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1392	+		10.1038/nn.3500	http://dx.doi.org/10.1038/nn.3500			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974709	Green Accepted			2022-12-17	WOS:000324795300011
J	Yoon, KJ; Buice, MA; Barry, C; Hayman, R; Burgess, N; Fiete, IR				Yoon, KiJung; Buice, Michael A.; Barry, Caswell; Hayman, Robin; Burgess, Neil; Fiete, Ila R.			Specific evidence of low-dimensional continuous attractor dynamics in grid cells	NATURE NEUROSCIENCE			English	Article							PARAMETRIC WORKING-MEMORY; MEDIAL ENTORHINAL CORTEX; PERSISTENT ACTIVITY; PATH-INTEGRATION; HEAD-DIRECTION; OSCILLATORY INTERFERENCE; NEURAL INTEGRATOR; PREFRONTAL CORTEX; VISUAL-CORTEX; NETWORK MODEL	We examined simultaneously recorded spikes from multiple rat grid cells, to explain mechanisms underlying their activity. Among grid cells with similar spatial periods, the population activity was confined to lie close to a two-dimensional (2D) manifold: grid cells differed only along two dimensions of their responses and otherwise were nearly identical. Relationships between cell pairs were conserved despite extensive deformations of single-neuron responses. Results from novel environments suggest such structure is not inherited from hippocampal or external sensory inputs. Across conditions, cell-cell relationships are better conserved than responses of single cells. Finally, the system is continually subject to perturbations that, were the 2D manifold not attractive, would drive the system to inhabit a different region of state space than observed. These findings have strong implications for theories of grid-cell activity and substantiate the general hypothesis that the brain computes using low-dimensional continuous attractors.	[Yoon, KiJung; Buice, Michael A.; Fiete, Ila R.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA; [Barry, Caswell; Burgess, Neil] UCL, Inst Cognit Neurosci, London, England; [Burgess, Neil] UCL, Inst Neurol, London, England; [Barry, Caswell; Hayman, Robin] UCL, Div Psychol & Language Sci, Inst Behav Neurosci, London, England	University of Texas System; University of Texas Austin; University of London; University College London; University of London; University College London; University of London; University College London	Fiete, IR (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA.	ilafiete@mail.clm.utexas.edu	Burgess, Neil/B-2420-2009	Burgess, Neil/0000-0003-0646-6584; Fiete, Ila/0000-0003-4738-2539	Sloan Foundation; Searle Scholar; McKnight Scholar; Wellcome Trust, UK; Office of Naval Research through ONR MURI [N00014-10-1-0936]; ONR-Young Investigator Program; MRC [G1000854] Funding Source: UKRI; Medical Research Council [G1000854] Funding Source: researchfish	Sloan Foundation(Alfred P. Sloan Foundation); Searle Scholar; McKnight Scholar; Wellcome Trust, UK(Wellcome Trust); Office of Naval Research through ONR MURI; ONR-Young Investigator Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to D. Tank for insightful comments. We thank members of the Moser laboratory for public release of some of their data sets, which we used in this study. I. R. F. is funded as a Sloan Foundation Fellow, a Searle Scholar and a McKnight Scholar. We acknowledge funding from the Wellcome Trust, UK and the Office of Naval Research through ONR MURI N00014-10-1-0936 and the ONR-Young Investigator Program to I.R.F.	Aksay E, 2003, CEREB CORTEX, V13, P1173, DOI 10.1093/cercor/bhg099; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; Artin M, 2011, ALGEBRA; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Barry C, 2012, P NATL ACAD SCI USA, V109, P17687, DOI 10.1073/pnas.1209918109; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BLAIR HT, 1995, J NEUROSCI, V15, P6260; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Burak Y, 2006, J NEUROSCI, V26, P9352, DOI 10.1523/JNEUROSCI.2857-06.2006; Burak Y, 2012, P NATL ACAD SCI USA, V109, P17645, DOI 10.1073/pnas.1117386109; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Domnisoru C, 2013, NATURE, V495, P199, DOI 10.1038/nature11973; Fiete IR, 2008, J NEUROSCI, V28, P6858, DOI 10.1523/JNEUROSCI.5684-07.2008; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Guanella A, 2007, INT J NEURAL SYST, V17, P231, DOI 10.1142/S0129065707001093; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Latham PE, 2003, J PHYSIOL-PARIS, V97, P683, DOI 10.1016/j.jphysparis.2004.01.022; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; Pastoll H, 2013, NEURON, V77, P141, DOI 10.1016/j.neuron.2012.11.032; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmidt-Hieber C, 2013, NAT NEUROSCI, V16, P325, DOI 10.1038/nn.3340; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, SCIENCE, V290, P2268, DOI 10.1126/science.290.5500.2268; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; TAUBE JS, 1990, J NEUROSCI, V10, P436; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011; Welinder PE, 2008, HIPPOCAMPUS, V18, P1283, DOI 10.1002/hipo.20519; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang K, 1996, J NEUROSCI, V16, P2112	50	147	147	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1077	U141		10.1038/nn.3450	http://dx.doi.org/10.1038/nn.3450			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23852111	Green Accepted			2022-12-17	WOS:000322323000018
J	Zheng, S; Gray, EE; Chawla, G; Porse, BT; O'Dell, TJ; Black, DL				Zheng, Sika; Gray, Erin E.; Chawla, Geetanjali; Porse, Bo Torben; O'Dell, Thomas J.; Black, Douglas L.			PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2	NATURE NEUROSCIENCE			English	Article							TRACT BINDING-PROTEIN; NONSENSE-MEDIATED DECAY; LONG-TERM POTENTIATION; AMPA RECEPTOR FUNCTION; MESSENGER-RNA DECAY; EXCITATORY SYNAPSES; EXPRESSION; SWITCH; CELLS; MOUSE	Postsynaptic density protein 95 (PSD-95) is essential for synaptic maturation and plasticity. Although its synaptic regulation has been widely studied, the control of PSD-95 cellular expression is not understood. We found that Psd-95 was controlled post-transcriptionally during neural development. Psd-95 was transcribed early in mouse embryonic brain, but most of its product transcripts were degraded. The polypyrimidine tract binding proteins PTBP1 and PTBP2 repressed Psd-95 (also known as Dlg4) exon 18 splicing, leading to premature translation termination and nonsense-mediated mRNA decay. The loss of first PTBP1 and then of PTBP2 during embryonic development allowed splicing of exon 18 and expression of PSD-95 late in neuronal maturation. Re-expression of PTBP1 or PTBP2 in differentiated neurons inhibited PSD-95 expression and impaired the development of glutamatergic synapses. Thus, expression of PSD-95 during early neural development is controlled at the RNA level by two PTB proteins whose sequential downregulation is necessary for synapse maturation.	[Zheng, Sika; Chawla, Geetanjali; Black, Douglas L.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; [Gray, Erin E.] Univ Calif Los Angeles, Interdept PhD Program Neurosci, Los Angeles, CA 90024 USA; [Porse, Bo Torben] Univ Copenhagen, Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Porse, Bo Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Porse, Bo Torben] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [O'Dell, Thomas J.] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA; [Black, Douglas L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Black, DL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA.	dougb@microbio.ucla.edu	Chawla, Geetanjali/AAH-9493-2021; Zheng, Sika/ABB-9203-2020	Chawla, Geetanjali/0000-0003-0354-3716; Zheng, Sika/0000-0002-0573-4981; Porse, Bo/0000-0001-6043-0844	US National Institutes of Health [RO1 GM 49662, R01 MH60919, NIH F32 MH84562]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060919, F31MH085462] Funding Source: NIH RePORTER; Lundbeck Foundation [R5-2006-99] Funding Source: researchfish	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lundbeck Foundation(Lundbeckfonden)	We thank J. Baraban and E. Anderson for thoughtful suggestions on the manuscript, and K. Martin, L. Zipursky, W. Yang and members of the Black laboratory for helpful discussion. We thank S. Sharma for the His-tagged PTBP1 recombinant proteins, and A. Han and S. Sharma for help with the EMSA experiments. We thank Q. Lin for help with Imaris software. This work was supported in part by grants from the US National Institutes of Health (RO1 GM 49662 to D.L.B., R01 MH60919 to T.J.O. and NIH F32 MH84562 to E.E.G.). D.L.B. is an Investigator of the Howard Hughes Medical Institute.	Amir-Ahmady B, 2005, RNA, V11, P699, DOI 10.1261/rna.2250405; Ashiya M, 1997, RNA, V3, P996; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Black DL, 2008, NEURON, V58, P297, DOI 10.1016/j.neuron.2008.04.019; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Carlisle HJ, 2008, J PHYSIOL-LONDON, V586, P5885, DOI 10.1113/jphysiol.2008.163469; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 2010, NUCLEIC ACIDS RES, V38, P1086, DOI 10.1093/nar/gkp1136; Chen L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002806; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Guo L, 2007, NEUROSCIENCE, V145, P100, DOI 10.1016/j.neuroscience.2006.11.042; Hyvonen MT, 2006, RNA, V12, P1569, DOI 10.1261/rna.39806; Iwasato T, 2004, GENESIS, V38, P130, DOI 10.1002/gene.20009; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Liu HY, 2002, RNA, V8, P137, DOI 10.1017/S1355838202015029; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Spellman R, 2005, BIOCHEM SOC T, V33, P457, DOI 10.1042/BST0330457; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wyneken U, 2001, NEUROSCIENCE, V102, P65, DOI 10.1016/S0306-4522(00)00469-3; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zheng S, 2010, J CLIN INVEST, V120, P2446, DOI 10.1172/JCI33144	50	147	152	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					381	U202		10.1038/nn.3026	http://dx.doi.org/10.1038/nn.3026			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22246437	Green Accepted, Green Submitted			2022-12-17	WOS:000300793100011
J	Mak, GK; Weiss, S				Mak, Gloria K.; Weiss, Samuel			Paternal recognition of adult offspring mediated by newly generated CNS neurons	NATURE NEUROSCIENCE			English	Article							INBREEDING AVOIDANCE; OLFACTORY-BULB; STIMULATED NEUROGENESIS; KIN RECOGNITION; NEWBORN NEURONS; BEHAVIOR; MICE; DISCRIMINATION; PROLACTIN; EXPOSURE	In mammals, olfaction is often used to distinguish individuals on the basis of their unique odor types (genetically programmed body odors). Parental-offspring recognition behavior is mediated, in part, by learning and processing of different odor types and is crucial for reproductive success. Maternal recognition behavior and associated brain plasticity has been well characterized, but paternal recognition behavior and brain plasticity is poorly understood. We found that paternal-adult offspring recognition behavior in mice was dependent on postnatal offspring interaction and was associated with increased neurogenesis in the paternal olfactory bulb and hippocampus. Newly generated paternal olfactory interneurons were preferentially activated by adult offspring odors. Disrupting prolactin signaling abolished increased paternal neurogenesis and adult offspring recognition. Rescuing this neurogenesis restored recognition behavior. Thus, neurogenesis in the paternal brain may be involved in offspring recognition.	[Mak, Gloria K.; Weiss, Samuel] Univ Calgary, Fac Med, Dept Cell Biol & Anat, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary	Weiss, S (corresponding author), Univ Calgary, Fac Med, Dept Cell Biol & Anat, Hotchkiss Brain Inst, Calgary, AB, Canada.	weiss@ucalgary.ca			Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	We are grateful to K. Markham for her helpful instruction and mentorship. We thank C. Gregg, B. Kolb, K. Lukowiak and D. van der Kooy for comments on earlier versions of this manuscript. This work was supported by the Canadian Institutes of Health Research and studentship (G.K.M.) and scientist (S.W.) awards from the Alberta Heritage Foundation for Medical Research.	Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; DEWSBURY DA, 1988, BEHAV GENET, V18, P525, DOI 10.1007/BF01065519; Dubas JS, 2009, HUM NATURE-INT BIOS, V20, P80, DOI 10.1007/s12110-009-9058-4; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; Hurst JL, 2005, P ROY SOC B-BIOL SCI, V272, P715, DOI 10.1098/rspb.2004.3004; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Kelly PA, 2001, FRONT NEUROENDOCRIN, V22, P140, DOI 10.1006/frne.2001.0212; Ling C, 2000, ENDOCRINOLOGY, V141, P3564, DOI 10.1210/en.141.10.3564; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Lonstein JS, 2000, NEUROSCI BIOBEHAV R, V24, P669, DOI 10.1016/S0149-7634(00)00036-1; Lonstein JS, 2002, CURR PROTOC NEUROSCI, V8; Magavi SSP, 2005, J NEUROSCI, V25, P10729, DOI 10.1523/JNEUROSCI.2250-05.2005; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; MAKIN JW, 1984, BEHAV NEURAL BIOL, V41, P135, DOI 10.1016/S0163-1047(84)90513-2; MANNING CJ, 1992, NATURE, V360, P581, DOI 10.1038/360581a0; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ormandy CJ, 1997, J MAMMARY GLAND BIOL, V2, P355, DOI 10.1023/A:1026395229025; OSTERMEYER MC, 1983, DEV PSYCHOBIOL, V16, P75, DOI 10.1002/dev.420160202; Pillay N, 2002, MAMM BIOL, V67, P212, DOI 10.1078/1616-5047-00032; Porter RH, 1998, GENETICA, V104, P259, DOI 10.1023/A:1026404319384; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; Restrepo D, 2006, TRENDS NEUROSCI, V29, P604, DOI 10.1016/j.tins.2006.08.001; Rochefort C, 2005, EUR J NEUROSCI, V22, P2863, DOI 10.1111/j.1460-9568.2005.04486.x; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Ruscio MG, 2008, BEHAV BRAIN RES, V187, P9, DOI 10.1016/j.bbr.2007.08.028; Sanchez-Andrade G, 2005, J REPROD DEVELOP, V51, P547, DOI 10.1262/jrd.17031; Sherborne AL, 2007, CURR BIOL, V17, P2061, DOI 10.1016/j.cub.2007.10.041; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Singh PB, 2001, REPRODUCTION, V121, P529, DOI 10.1530/reprod/121.4.529; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; WOODROFFE R, 1994, TRENDS ECOL EVOL, V9, P294, DOI 10.1016/0169-5347(94)90033-7; Yamazaki K, 2000, P NATL ACAD SCI USA, V97, P10500, DOI 10.1073/pnas.180320997	37	147	151	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					753	U134		10.1038/nn.2550	http://dx.doi.org/10.1038/nn.2550			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20453850				2022-12-17	WOS:000278003300021
J	Mann, EO; Mody, I				Mann, Edward O.; Mody, Istvan			Control of hippocampal gamma oscillation frequency by tonic inhibition and excitation of interneurons	NATURE NEUROSCIENCE			English	Article							PARVALBUMIN-POSITIVE INTERNEURONS; FAST NETWORK OSCILLATIONS; LONG-TERM POTENTIATION; IN-VITRO; GABA(A) RECEPTORS; NMDA RECEPTORS; RAT HIPPOCAMPUS; BEHAVING RAT; SUBUNITS; ACTIVATION	Gamma-frequency oscillations depend on phasic synaptic GABA(A) receptor (GABA(A)R)-mediated inhibition to synchronize spike timing. The spillover of synaptically released GABA can also activate extrasynaptic GABA(A)Rs, and such tonic inhibition may also contribute to modulating network dynamics. In many neuronal cell types, tonic inhibition is mediated by delta subunit-containing GABA(A)Rs. We found that the frequency of in vitro cholinergically induced gamma oscillations in the mouse hippocampal CA3 region was increased by the activation of NMDA receptors (NMDARs) on interneurons. The NMDAR-dependent increase of gamma oscillation frequency was counteracted by the tonic inhibition of the interneurons mediated by delta subunit-containing GABA(A)Rs. Recordings of synaptic currents during gamma activity revealed that NMDAR-mediated increases in oscillation frequency correlated with a progressive synchronization of phasic excitation and inhibition in the network. Thus, the balance between tonic excitation and tonic inhibition of interneurons may modulate gamma frequency by shaping interneuronal synchronization.	[Mann, Edward O.; Mody, Istvan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mody, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	mody@ucla.edu		Mann, Edward/0000-0002-2468-7148	Epilepsy Foundation Postdoctoral Fellowship; US National Institutes of Health [NS30549, NS02808]; Coelho Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030549, R37NS030549, P01NS002808] Funding Source: NIH RePORTER	Epilepsy Foundation Postdoctoral Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coelho Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by a Epilepsy Foundation Postdoctoral Fellowship to E.O.M. and US National Institutes of Health grants NS30549 and NS02808 and the Coelho Endowment to I.M.	Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Banke TG, 2006, J NEUROSCI, V26, P11720, DOI 10.1523/JNEUROSCI.2887-06.2006; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Glykys J, 2007, J PHYSIOL-LONDON, V582, P1163, DOI 10.1113/jphysiol.2007.134460; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Harney SC, 2008, J NEUROSCI, V28, P11685, DOI 10.1523/JNEUROSCI.3035-08.2008; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Hrabetova S, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-12-j0002.2000; Lamsa K, 2007, J PHYSIOL-LONDON, V584, P885, DOI 10.1113/jphysiol.2007.137380; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lozovaya NA, 2004, J PHYSIOL-LONDON, V558, P451, DOI 10.1113/jphysiol.2004.063792; MACDONALD JF, 1991, J PHYSIOL-LONDON, V432, P483, DOI 10.1113/jphysiol.1991.sp018396; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Middleton S, 2008, P NATL ACAD SCI USA, V105, P18572, DOI 10.1073/pnas.0809302105; Misra C, 2000, J PHYSIOL-LONDON, V524, P147, DOI 10.1111/j.1469-7793.2000.00147.x; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Nagy J, 2008, CURR NEUROPHARMACOL, V6, P39, DOI 10.2174/157015908783769662; Oren I, 2006, J NEUROSCI, V26, P9923, DOI 10.1523/JNEUROSCI.1580-06.2006; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Standaert DG, 1996, MOL BRAIN RES, V42, P89, DOI 10.1016/S0169-328X(96)00117-9; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; Towers SK, 2004, J PHYSIOL-LONDON, V559, P721, DOI 10.1113/jphysiol.2004.071191; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Trigo FF, 2008, EUR J NEUROSCI, V28, P841, DOI 10.1111/j.1460-9568.2008.06404.x; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Wang XJ, 1996, J NEUROSCI, V16, P6402; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Zar JH., 1999, BIOSTATISTICAL ANAL	50	147	148	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					205	U90		10.1038/nn.2464	http://dx.doi.org/10.1038/nn.2464			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20023655	Green Accepted			2022-12-17	WOS:000273985800016
J	Berman, DE; Dall'Armi, C; Voronov, SV; McIntire, LBJ; Zhang, H; Moore, AZ; Staniszewski, A; Arancio, O; Kim, TW; Di Paolo, G				Berman, Diego E.; Dall'Armi, Claudia; Voronov, Sergey V.; McIntire, Laura Beth J.; Zhang, Hong; Moore, Ann Z.; Staniszewski, Agniezka; Arancio, Ottavio; Kim, Tae-Wan; Di Paolo, Gilbert			Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; NERVE-TERMINALS; IN-VIVO; SECRETED OLIGOMERS; PRECURSOR PROTEIN; ION CHANNELS; MEMORY; SYNAPTOJANIN-1; NEURODEGENERATION	Synaptic dysfunction caused by oligomeric assemblies of amyloid-beta peptide (A beta) has been linked to cognitive deficits in Alzheimer's disease. Here we found that incubation of primary cortical neurons with oligomeric A beta decreases the level of phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P-2), a phospholipid that regulates key aspects of neuronal function. The destabilizing effect of A beta on PtdIns(4,5)P-2 metabolism was Ca2+-dependent and was not observed in neurons that were derived from mice that are haploinsufficient for Synj1. This gene encodes synaptojanin 1, the main PtdIns(4,5)P-2 phosphatase in the brain and at the synapses. We also found that the inhibitory effect of A beta on hippocampal long-term potentiation was strongly suppressed in slices from Synj1(+/-) mice, suggesting that A beta-induced synaptic dysfunction can be ameliorated by treatments that maintain the normal PtdIns(4,5)P-2 balance in the brain.	[Berman, Diego E.; Dall'Armi, Claudia; Voronov, Sergey V.; McIntire, Laura Beth J.; Zhang, Hong; Moore, Ann Z.; Staniszewski, Agniezka; Arancio, Ottavio; Kim, Tae-Wan; Di Paolo, Gilbert] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, Coll Phys & Surg,Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University	Kim, TW (corresponding author), Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, Coll Phys & Surg,Dept Pathol & Cell Biol, 630 West 168th St, New York, NY 10032 USA.	twk16@columbia.edu; gil.dipaolo@columbia.edu	arancio, ottavio/AAB-7959-2019	arancio, ottavio/0000-0001-6335-164X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD047733] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442, R01NS056049, R01NS043467] Funding Source: NIH RePORTER; NCCIH NIH HHS [R01 AT002643, AT002643] Funding Source: Medline; NICHD NIH HHS [R21 HD047733, HD047733, R21 HD047733-02, R21 HD047733-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS049442, R01 NS056049-02, R01 NS056049, NS056049, R01 NS056049-01, R01 NS043467, NS049442, NS043467] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; Banker G., 1991, CULTURING NERVE CELL; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kim JH, 2001, J NEUROSCI, V21, P1327; Kim WT, 2002, P NATL ACAD SCI USA, V99, P17143, DOI 10.1073/pnas.222657399; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Lott IT, 2001, MENT RETARD DEV D R, V7, P172, DOI 10.1002/mrdd.1025; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; Marjaux E, 2004, NEURON, V42, P189, DOI 10.1016/S0896-6273(04)00218-1; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; STOKES CE, 1987, J NEUROCHEM, V48, P1018, DOI 10.1111/j.1471-4159.1987.tb05619.x; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Townsend M, 2006, ANN NEUROL, V60, P668, DOI 10.1002/ana.21051; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	48	147	154	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					547	554		10.1038/nn.2100	http://dx.doi.org/10.1038/nn.2100			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18391946	Green Accepted			2022-12-17	WOS:000255327300013
J	Huxter, JR; Senior, TJ; Allen, K; Csicsvari, J				Huxter, John R.; Senior, Timothy J.; Allen, Kevin; Csicsvari, Jozsef			Theta phase-specific codes for two-dimensional position, trajectory and heading in the hippocampus	NATURE NEUROSCIENCE			English	Article							FREELY MOVING RATS; PLACE CELLS; PATH-INTEGRATION; MEMORY SEQUENCES; PYRAMIDAL CELLS; SYNAPTIC PLASTICITY; POPULATION ACTIVITY; DIRECTION CELLS; SLICE CULTURES; TEMPORAL CODE	Temporal coding is a means of representing information by the time, as opposed to the rate, at which neurons fire. Evidence of temporal coding in the hippocampus comes from place cells, whose spike times relative to theta oscillations reflect a rat's position while running along stereotyped trajectories. This arises from the backwards shift in cell firing relative to local theta oscillations (phase precession). Here we demonstrate phase precession during place-field crossings in an open-field foraging task. This produced spike sequences in each theta cycle that disambiguate the rat's trajectory through two-dimensional space and can be used to predict movement direction. Furthermore, position and movement direction were maximally predicted from firing in the early and late portions of the theta cycle, respectively. This represents the first direct evidence of a combined representation of position, trajectory and heading in the hippocampus, organized on a fine temporal scale by theta oscillations.	[Huxter, John R.; Senior, Timothy J.; Allen, Kevin; Csicsvari, Jozsef] Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England	University of Oxford	Csicsvari, J (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.	Jozsef.csicsvari@pharm.ox.ac.uk		Allen, Kevin/0000-0001-5319-3721	MRC [MC_U138169944] Funding Source: UKRI; Medical Research Council [MC_U138169944] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BURGESS N, 1994, NEURAL NETWORKS, V7, P1065, DOI 10.1016/S0893-6080(05)80159-5; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Fisher NI., 1995, STAT ANAL CIRCULAR D; Foster DJ, 2007, HIPPOCAMPUS, V17, P1093, DOI 10.1002/hipo.20345; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Golob EJ, 1999, J NEUROSCI, V19, P7198, DOI 10.1523/JNEUROSCI.19-16-07198.1999; GREENSTEIN YJ, 1988, BRAIN RES, V438, P331, DOI 10.1016/0006-8993(88)91358-3; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Jones MW, 2005, HIPPOCAMPUS, V15, P867, DOI 10.1002/hipo.20119; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; Lisman JE, 2005, NEURAL NETWORKS, V18, P1191, DOI 10.1016/j.neunet.2005.08.008; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Maaswinkel H, 1999, HIPPOCAMPUS, V9, P553, DOI 10.1002/(SICI)1098-1063(1999)9:5<553::AID-HIPO9>3.3.CO;2-7; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; Maurer AP, 2006, HIPPOCAMPUS, V16, P785, DOI 10.1002/hipo.20202; McNaughton BL, 1996, J EXP BIOL, V199, P173; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Muller R U, 1991, Hippocampus, V1, P243, DOI 10.1002/hipo.450010306; MULLER RU, 1989, J NEUROSCI, V9, P4101; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; SHARP PE, 1994, J NEUROSCI, V14, P2339; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; TAUBE JS, 1990, J NEUROSCI, V10, P420; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; WHISHAW IQ, 1971, PHYSIOL BEHAV, V6, P391, DOI 10.1016/0031-9384(71)90172-7; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yamaguchi Y, 2002, J NEUROPHYSIOL, V87, P2629, DOI 10.1152/jn.2002.87.6.2629; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	50	147	147	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					587	594		10.1038/nn.2106	http://dx.doi.org/10.1038/nn.2106			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18425124				2022-12-17	WOS:000255327300018
J	Murphy, GJ; Darcy, DP; Isaacson, JS				Murphy, GJ; Darcy, DP; Isaacson, JS			Intraglomerular inhibition: signaling mechanisms of an olfactory microcircuit	NATURE NEUROSCIENCE			English	Article							CALCIUM CURRENT; GABA RELEASE; DENDRODENDRITIC INHIBITION; SYNAPTIC ORGANIZATION; ACTION-POTENTIALS; GLOMERULAR LAYER; NMDA RECEPTORS; CA2+ CHANNELS; T-TYPE; BULB	Microcircuits composed of principal neuron and interneuron dendrites have an important role in shaping the representation of sensory information in the olfactory bulb. Here we establish the physiological features governing synaptic signaling in dendrodendritic microcircuits of olfactory bulb glomeruli. We show that dendritic gamma-aminobutyric acid (GABA) release from periglomerular neurons mediates inhibition of principal tufted cells, retrograde inhibition of sensory input and lateral signaling onto neighboring periglomerular cells. We find that L-type dendritic Ca2+ spikes in periglomerular cells underlie dendrodendritic transmission by depolarizing periglomerular dendrites and activating P/Q type channels that trigger GABA release. Ca2+ spikes in periglomerular cells are evoked by powerful excitatory inputs from a single principal cell, and glutamate release from the dendrites of single principal neurons activates a large ensemble of periglomerular cells.	Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Isaacson, JS (corresponding author), Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA.	jisaacson@ucsd.edu		Murphy, Gabe/0000-0002-9321-8556	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC005679, R01DC004682] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC04682, DC005679] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Avery RB, 1996, J NEUROSCI, V16, P5567; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Cadetti L, 2001, NEUROREPORT, V12, P3117, DOI 10.1097/00001756-200110080-00027; Cang JH, 2003, J NEUROSCI, V23, P4108; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Christie JM, 2001, J NEUROPHYSIOL, V85, P169, DOI 10.1152/jn.2001.85.1.169; Egger V, 2003, J NEUROSCI, V23, P7551; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Halabisky B, 2000, J NEUROSCI, V20, P5124; Hausser M, 1997, J NEUROSCI, V17, P7606; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; Holderith NB, 2003, EUR J NEUROSCI, V18, P344, DOI 10.1046/j.1460-9568.2003.02756.x; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Isaacson JS, 2001, P NATL ACAD SCI USA, V98, P337, DOI 10.1073/pnas.021445798; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Kosaka K, 1998, NEUROSCI RES, V30, P101, DOI 10.1016/S0168-0102(98)00002-9; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Magee JC, 1996, J NEUROPHYSIOL, V76, P3460, DOI 10.1152/jn.1996.76.5.3460; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; McQuiston AR, 2001, J NEUROPHYSIOL, V86, P1899, DOI 10.1152/jn.2001.86.4.1899; Murphy GJ, 2004, J NEUROSCI, V24, P3023, DOI 10.1523/JNEUROSCI.5745-03.2004; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; PINCHING AJ, 1971, J CELL SCI, V9, P347; Power JM, 2005, J PHYSIOL-LONDON, V562, P439, DOI 10.1113/jphysiol.2004.076711; PRICE JL, 1970, J CELL SCI, V7, P125; Puopolo M, 1998, EUR J NEUROSCI, V10, P1073, DOI 10.1046/j.1460-9568.1998.00115.x; REGEHR W, 1993, NEURON, V11, P145, DOI 10.1016/0896-6273(93)90278-Y; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; Salin PA, 2001, J NEUROPHYSIOL, V85, P1275, DOI 10.1152/jn.2001.85.3.1275; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Schwindt P, 1996, J NEUROPHYSIOL, V76, P3731, DOI 10.1152/jn.1996.76.6.3731; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Smith TC, 2002, NAT NEUROSCI, V5, P760, DOI 10.1038/nn882; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stengel W, 1998, EUR J PHARMACOL, V342, P339, DOI 10.1016/S0014-2999(97)01495-7; Toida K, 1998, J COMP NEUROL, V392, P179, DOI 10.1002/(SICI)1096-9861(19980309)392:2<179::AID-CNE3>3.0.CO;2-#; WHITE EL, 1972, BRAIN RES, V37, P69, DOI 10.1016/0006-8993(72)90346-0; WHITE EL, 1973, BRAIN RES, V60, P299, DOI 10.1016/0006-8993(73)90792-0; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	50	147	148	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					354	364		10.1038/nn1403	http://dx.doi.org/10.1038/nn1403			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15696160				2022-12-17	WOS:000227354600021
J	Melcher, D; Morrone, MC				Melcher, D; Morrone, MC			Spatiotopic temporal integration of visual motion across saccadic eye movements	NATURE NEUROSCIENCE			English	Article							PARIETAL CORTEX; SUCCESSIVE FIXATIONS; RECEPTIVE-FIELDS; OPTIC FLOW; NEURONS; SPACE; INFORMATION; REPRESENTATION; PERCEPTION; FAILURE	Saccadic eye movements pose many challenges for stable and continuous vision, such as how information from successive fixations is amalgamated into a single precept. Here we show in humans that motion signals are temporally integrated across separate fixations, but only when the motion stimulus falls either on the same retinal region (retinotopic integration) or on different retinal positions that correspond to the same external spatial coordinates (spatiotopic integration). We used individual motion signals that were below detection threshold, implicating spatiotopic trans-saccadic integration in relatively early stages of visual processing such as the middle temporal area (MT) or V5 of visual cortex. The trans-saccadic buildup of important congruent visual information while irrelevant non-congruent information fades could provide a simple and robust strategy to stabilize perception during eye movements.	Univ Vita Salute San Raffaele, Fac Psychol, Milan, Italy; CNR, Inst Neurosci, Pisa, Italy	Vita-Salute San Raffaele University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Morrone, MC (corresponding author), Univ Vita Salute San Raffaele, Fac Psychol, Via Olgettina 58, Milan, Italy.		Melcher, David/D-1775-2010; Morrone, Maria Concetta/C-6756-2014	Melcher, David/0000-0003-0926-585X; Morrone, Maria Concetta/0000-0002-1025-0316				BARLOW HB, 1958, J PHYSIOL-LONDON, V141, P337, DOI 10.1113/jphysiol.1958.sp005978; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; BRIDGEMAN B, 1983, B PSYCHONOMIC SOC, V21, P285; Brockmole JR, 2002, J EXP PSYCHOL HUMAN, V28, P315, DOI 10.1037//0096-1523.28.2.315; Burr DC, 1998, VISION RES, V38, P1731, DOI 10.1016/S0042-6989(97)00346-5; Burr DC, 2001, VISION RES, V41, P1891, DOI 10.1016/S0042-6989(01)00072-4; BURR DC, 1982, J PHYSIOL-LONDON, V333, P1; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; HAYHOE M, 1991, PERCEPTION, V20, P393, DOI 10.1068/p200393; IRWIN DE, 1991, COGNITIVE PSYCHOL, V23, P420, DOI 10.1016/0010-0285(91)90015-G; JONIDES J, 1983, SCIENCE, V222, P188, DOI 10.1126/science.6623072; Land MF., 2001, ANIMAL EYES; Melcher D, 2001, NATURE, V412, P401, DOI 10.1038/35086646; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; SALZMAN CD, 1990, NATURE, V346, P106; SHIOIRI S, 1989, VISION RES, V29, P915, DOI 10.1016/0042-6989(89)90106-5; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wexler M, 2001, NATURE, V409, P85, DOI 10.1038/35051081; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	29	147	151	1	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					877	881		10.1038/nn1098	http://dx.doi.org/10.1038/nn1098			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872128				2022-12-17	WOS:000184413700018
J	Nickols, JC; Valentine, W; Kanwal, S; Carter, BD				Nickols, JC; Valentine, W; Kanwal, S; Carter, BD			Activation of the transcription factor NF-kappa B in Schwann cells is required for peripheral myelin formation	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; NERVOUS-SYSTEM; KROX-20; DIFFERENTIATION; INHIBITION; MEDIATORS; APOPTOSIS; SURVIVAL; GROWTH; OCT-6	Peripheral myelin formation is initiated by axonal cues that trigger a differentiation program in associated Schwann cells. Here, we define one essential differentiation signal: activation of the transcription factor NF-kappaB. In rat sciatic nerves, NF-kappaB was highly upregulated in pre-myelinating Schwann cells, and then its expression progressively declined until it was nearly absent in adults. Similarly, in co-cultures of Schwann cells and sensory neurons, NF-kappaB activation paralleled myelination, and blocking its activity or using cells from mice lacking the NF-kappaB subunit p65 markedly attenuated myelination. Inhibiting NF-kappaB also prevented activation of Oct-6, a transcription factor induced by axonal contact and required for proper myelin formation. These results show that the activation of NF-kappaB is an essential signal for the progression of axon-associated Schwann cells into a myelinating phenotype.	Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Carter, BD (corresponding author), Vanderbilt Univ, Sch Med, 221 Kirkland Hall, Nashville, TN 37232 USA.	bruce.carter@vanderbilt.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038220] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES06387] Funding Source: Medline; NIMH NIH HHS [MH19732] Funding Source: Medline; NINDS NIH HHS [NS38220] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arroyo EJ, 1998, J NEUROSCI, V18, P7891; Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Blanchard AD, 1996, J NEUROSCI RES, V46, P630, DOI 10.1002/(SICI)1097-4547(19961201)46:5<630::AID-JNR11>3.0.CO;2-0; Bushdid PB, 1998, NATURE, V392, P615, DOI 10.1038/33435; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Forghani R, 1999, J NEUROSCI METH, V89, P129, DOI 10.1016/S0165-0270(99)00043-6; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Haggiag S, 2001, J NEUROSCI RES, V64, P564, DOI 10.1002/jnr.1108; Huang CJ, 2002, INT J DEV NEUROSCI, V20, P289, DOI 10.1016/S0736-5748(02)00022-9; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Scherer SS, 1997, CURR OPIN NEUROL, V10, P386, DOI 10.1097/00019052-199710000-00006; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Xu JH, 1998, J CELL BIOL, V140, P709, DOI 10.1083/jcb.140.3.709; Zorick TS, 1999, DEVELOPMENT, V126, P1397	28	147	150	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					161	167		10.1038/nn995	http://dx.doi.org/10.1038/nn995			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12514737				2022-12-17	WOS:000180669100016
J	Thomas, OM; Cumming, BG; Parker, AJ				Thomas, OM; Cumming, BG; Parker, AJ			A specialization for relative disparity in V2	NATURE NEUROSCIENCE			English	Article							RANDOM-DOT STEREOGRAMS; INFERIOR TEMPORAL CORTEX; VISUAL-CORTEX; DEPTH DISCRIMINATION; BINOCULAR DISPARITY; V1; RESPONSES; NEURONS; MOTION; REPRESENTATION	Stereoscopic depth perception relies on binocular disparities, or small geometric differences between the retinal images of each eye. The most reliable binocular depth judgments are those that are based on relative disparities between two simultaneously visible features in a scene. Many cortical areas contain neurons that are sensitive to disparity, but it is unclear whether any areas show a specific sensitivity to relative disparity. We recorded from neurons in the early cortical visual area V2 of the awake macaque during presentation of random-dot patterns. The depth of a central region ('center'), and that of an annular surrounding region ('surround'), were manipulated independently in these stimuli. Some cells were fully selective for the resulting relative disparities. Most showed partial selectivity, which nonetheless indicated a sensitivity for the depth relationship between center and surround. Both types of neural response could support psychophysical judgments of relative depth.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Thomas, OM (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.		Parker, Andrew J/I-7867-2013	Parker, Andrew J/0000-0001-5800-0407; Thomas, Owen/0000-0003-2877-3075	NATIONAL EYE INSTITUTE [Z01EY000404, ZIAEY000404] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bakin JS, 2000, J NEUROSCI, V20, P8188; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Bradley DC, 1998, J NEUROSCI, V18, P7552; Cumming BG, 1999, J NEUROSCI, V19, P5602; Eifuku S, 1999, J NEUROPHYSIOL, V82, P2462, DOI 10.1152/jn.1999.82.5.2462; ERKELENS CJ, 1985, VISION RES, V25, P583, DOI 10.1016/0042-6989(85)90164-6; ERKELENS CJ, 1985, VISION RES, V25, P1689, DOI 10.1016/0042-6989(85)90141-5; Fleet DJ, 1996, VISION RES, V36, P1839, DOI 10.1016/0042-6989(95)00313-4; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Julesz B., 1971, FDN CYCLOPEAN PERCEP; KUMAR T, 1992, VISION RES, V32, P1667, DOI 10.1016/0042-6989(92)90159-G; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; POGGIO GF, 1985, VISION RES, V25, P397, DOI 10.1016/0042-6989(85)90065-3; Prince SJD, 2000, J NEUROSCI, V20, P3387, DOI 10.1523/JNEUROSCI.20-09-03387.2000; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; REGAN D, 1986, INVEST OPHTH VIS SCI, V27, P584; ROE AW, 1995, J NEUROSCI, V15, P3689; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; WESTHEIMER G, 1979, EXP BRAIN RES, V36, P585; [No title captured]	23	147	151	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					472	478		10.1038/nn837	http://dx.doi.org/10.1038/nn837			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11967544				2022-12-17	WOS:000175272000019
J	Barth, AL; Malenka, RC				Barth, AL; Malenka, RC			NMDAR EPSC kinetics do not regulate the critical period for LTP at thalamocortical synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; VISUAL-CORTEX; IN-VIVO; RECEPTORS; EXPERIENCE; EXPRESSION; SUBTYPES		Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Palo Alto, CA 94304 USA	Stanford University	Barth, AL (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, 1201 Welch Rd,Room P105, Palo Alto, CA 94304 USA.							CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Fox K, 1999, NAT NEUROSCI, V2, P297, DOI 10.1038/7203; GOLD JI, 1994, P NATL ACAD SCI USA, V91, P3941, DOI 10.1073/pnas.91.9.3941; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Shi J, 1997, J NEUROSCI, V17, P6264; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tovar KR, 1999, J NEUROSCI, V19, P4180; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851	15	147	150	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					235	236		10.1038/85070	http://dx.doi.org/10.1038/85070			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224537				2022-12-17	WOS:000167178300008
J	Tost, H; Champagne, FA; Meyer-Lindenberg, A				Tost, Heike; Champagne, Frances A.; Meyer-Lindenberg, Andreas			Environmental influence in the brain, human welfare and mental health	NATURE NEUROSCIENCE			English	Review							PARTNER PREFERENCE FORMATION; PITUITARY-ADRENAL RESPONSES; MESSENGER-RNA EXPRESSION; MATERNAL-CARE; CHILDHOOD MALTREATMENT; SOCIAL-ENVIRONMENT; NUCLEUS-ACCUMBENS; CHRONIC STRESS; AIR-POLLUTION; GLUCOCORTICOID-RECEPTORS	The developing human brain is shaped by environmental exposures-for better or worse. Many exposures relevant to mental health are genuinely social in nature or believed to have social subcomponents, even those related to more complex societal or area-level influences. The nature of how these social experiences are embedded into the environment may be crucial. Here we review select neuroscience evidence on the neural correlates of adverse and protective social exposures in their environmental context, focusing on human neuroimaging data and supporting cellular and molecular studies in laboratory animals. We also propose the inclusion of innovative methods in social neuroscience research that may provide new and ecologically more valid insight into the social-environmental risk architecture of the human brain.	[Tost, Heike; Meyer-Lindenberg, Andreas] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Mannheim, Germany; [Champagne, Frances A.] Columbia Univ, Dept Psychol, New York, NY 10027 USA	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Columbia University	Tost, H (corresponding author), Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Mannheim, Germany.	heike.tost@zi-mannheim.de	Tost, med. Dr. phil. Heike/AAX-8305-2020; Meyer-Lindenberg, Andreas/H-1076-2011; Champagne, Frances Anne/Q-1220-2018	Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Champagne, Frances Anne/0000-0002-3922-084X	German Federal Ministry of Education and Research, BMBF [01GQ1102]; European Union [HEALTH-F2-2010-241909, 115300, 602805]	German Federal Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	The authors thank E. Bilek, T. Tornros and M. Reichert for help with the figures and U. Reininghaus for epidemiological input. TIT gratefully acknowledges grant support by the German Federal Ministry of Education and Research, BMBF (01GQ1102). A.M.-L. acknowledges funding from the European Union Seventh Framework Programme under the grant agreements HEALTH-F2-2010-241909 (EU-GEI), 115300 (EU-AIMS) and 602805 (EU-Aggressotype).	Akdeniz C, 2014, JAMA PSYCHIAT, V71, P672, DOI 10.1001/jamapsychiatry.2014.35; Akdeniz C, 2014, SOC PSYCH PSYCH EPID, V49, P507, DOI 10.1007/s00127-014-0858-4; Alcaro A, 2007, BRAIN RES REV, V56, P283, DOI 10.1016/j.brainresrev.2007.07.014; Andersen SL, 2004, NEUROPSYCHOPHARMACOL, V29, P1988, DOI 10.1038/sj.npp.1300528; Bale T.L., 2015, NAT NEUROSCI, V8; Barik J, 2013, SCIENCE, V339, P332, DOI 10.1126/science.1226767; Beck KD, 2002, PHYSIOL BEHAV, V75, P661, DOI 10.1016/S0031-9384(02)00670-4; Bentall RP, 2008, SCHIZOPHRENIA BULL, V34, P1012, DOI 10.1093/schbul/sbn103; Biggio F, 2014, EUR NEUROPSYCHOPHARM, V24, P1152, DOI 10.1016/j.euroneuro.2014.03.009; Bilek E, 2015, P NATL ACAD SCI USA, V112, P5207, DOI 10.1073/pnas.1421831112; Bowler Diana E, 2010, BMC Public Health, V10, P456, DOI 10.1186/1471-2458-10-456; Brun E, 2012, BIOMATERIALS, V33, P886, DOI 10.1016/j.biomaterials.2011.10.025; Calderon-Garciduenas L, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00613; Calhoun CD, 2014, DEV PSYCHOPATHOL, V26, P605, DOI 10.1017/S0954579414000261; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Cantor-Graae E, 2007, CAN J PSYCHIAT, V52, P277, DOI 10.1177/070674370705200502; Cao Y, 2014, HORM BEHAV, V65, P57, DOI 10.1016/j.yhbeh.2013.11.005; Cardoso C, 2014, PSYCHONEUROENDOCRINO, V49, P161, DOI 10.1016/j.psyneuen.2014.07.014; Carpenter LL, 2011, PSYCHOPHARMACOLOGY, V214, P367, DOI 10.1007/s00213-010-2007-4; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598; Champagne FA, 2007, BEHAV NEUROSCI, V121, P1353, DOI 10.1037/0735-7044.121.6.1353; Champagne FA, 2013, BEHAV NEUROSCI, V127, P628, DOI 10.1037/a0034186; Chen FS, 2011, P NATL ACAD SCI USA, V108, P19937, DOI 10.1073/pnas.1113079108; Christmas J J, 1973, J Natl Med Assoc, V65, P483; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Creswell KG, 2015, SOC COGN AFFECT NEUR, V10, P869, DOI 10.1093/scan/nsu132; de Leeuw M, 2015, SCHIZOPHRENIA BULL, V41, P94, DOI 10.1093/schbul/sbu153; Deoni SCL, 2013, NEUROIMAGE, V82, P77, DOI 10.1016/j.neuroimage.2013.05.090; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; DIORIO D, 1993, J NEUROSCI, V13, P3839; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dye C, 2008, SCIENCE, V319, P766, DOI 10.1126/science.1150198; Ebner-Priemer U.W., 2012, FRONT PSYCHOL, V3, P596, DOI [10.3389/fpsyg.2012.00596, DOI 10.3389/FPSYG.2012.00596]; Ebner-Priemer UW, 2009, J ABNORM PSYCHOL, V118, P195, DOI 10.1037/a0014868; Eisenberger NI, 2007, NEUROIMAGE, V35, P1601, DOI 10.1016/j.neuroimage.2007.01.038; Eisenberger NI, 2012, NAT REV NEUROSCI, V13, P421, DOI 10.1038/nrn3231; Eisenberger NI, 2011, P NATL ACAD SCI USA, V108, P11721, DOI 10.1073/pnas.1108239108; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; Fearon P, 2006, PSYCHOL MED, V36, P1541, DOI 10.1017/S0033291706008774; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; Flinn MV, 2011, NEUROSCI BIOBEHAV R, V35, P1611, DOI 10.1016/j.neubiorev.2011.01.005; Fonken LK, 2011, MOL PSYCHIATR, V16, P987, DOI 10.1038/mp.2011.76; Francis DD, 2002, J NEUROSCI, V22, P7840; Freeman SM, 2014, PSYCHONEUROENDOCRINO, V45, P128, DOI 10.1016/j.psyneuen.2014.03.023; Frumkin P, 2001, AM J PREV MED, V20, P234, DOI 10.1016/S0749-3797(00)00317-2; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Gatzke-Kopp LM, 2011, NEUROSCI BIOBEHAV R, V35, P794, DOI 10.1016/j.neubiorev.2010.09.013; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P2621, DOI 10.1016/j.neuropsychologia.2005.09.011; GREENOUGH WT, 1973, EXP NEUROL, V41, P371, DOI 10.1016/0014-4886(73)90278-1; Grimm O, 2014, JAMA PSYCHIAT, V71, P531, DOI 10.1001/jamapsychiatry.2014.9; Haddad L, 2015, SCHIZOPHRENIA BULL, V41, P115, DOI 10.1093/schbul/sbu072; Haluza D, 2014, INT J ENV RES PUB HE, V11, P5445, DOI 10.3390/ijerph110505445; Hart H, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00052; Heller AS, 2015, J NEUROSCI, V35, P10503, DOI 10.1523/JNEUROSCI.0569-15.2015; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Herringa RJ, 2013, P NATL ACAD SCI USA, V110, P19119, DOI 10.1073/pnas.1310766110; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Holz NE, 2015, NEUROPSYCHOPHARMACOL, V40, P996, DOI 10.1038/npp.2014.277; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Keebaugh AC, 2011, HORM BEHAV, V60, P498, DOI 10.1016/j.yhbeh.2011.07.018; Kelly BD, 2010, SCHIZOPHR RES, V116, P75, DOI 10.1016/j.schres.2009.10.015; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; Kim P, 2013, P NATL ACAD SCI USA, V110, P18442, DOI 10.1073/pnas.1308240110; Kirkbride JB, 2008, BRIT J PSYCHIAT, V193, P18, DOI 10.1192/bjp.bp.107.041566; KIRSCHBAUM C, 1995, PSYCHOSOM MED, V57, P468, DOI 10.1097/00006842-199509000-00009; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Krol KM, 2015, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00459; Kubota JT, 2012, NAT NEUROSCI, V15, P940, DOI 10.1038/nn.3136; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Levesque S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-105; Lim L, 2014, AM J PSYCHIAT, V171, P854, DOI 10.1176/appi.ajp.2014.13101427; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Luby J, 2013, JAMA PEDIATR, V167, P1135, DOI 10.1001/jamapediatrics.2013.3139; Maas J, 2006, J EPIDEMIOL COMMUN H, V60, P587, DOI 10.1136/jech.2005.043125; McEwen BS, 2013, PERSPECT PSYCHOL SCI, V8, P673, DOI 10.1177/1745691613506907; McEwen BS, 2010, ANN NY ACAD SCI, V1204, pE38, DOI 10.1111/j.1749-6632.2010.05568.x; Meyer-Lindenberg A, 2012, NAT NEUROSCI, V15, P663, DOI 10.1038/nn.3083; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Meyer-Lindenberg A, 2010, NATURE, V468, P194, DOI 10.1038/nature09569; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; Morgan C, 2010, SCHIZOPHRENIA BULL, V36, P655, DOI 10.1093/schbul/sbq051; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nagasawa M, 2015, SCIENCE, V348, P333, DOI 10.1126/science.1261022; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Niwa M, 2013, SCIENCE, V339, P335, DOI 10.1126/science.1226931; Olff M, 2013, PSYCHONEUROENDOCRINO, V38, P1883, DOI 10.1016/j.psyneuen.2013.06.019; Panksepp J, 2007, BEHAV NEUROSCI, V121, P1364, DOI 10.1037/0735-7044.121.6.1364; Park Bum Jin, 2010, Environmental Health and Preventive Medicine, V15, P18, DOI 10.1007/s12199-009-0086-9; Park Bum-Jin, 2007, Journal of Physiological Anthropology, V26, P123, DOI 10.2114/jpa2.26.123; Pechtel P, 2014, NEUROIMAGE, V97, P236, DOI 10.1016/j.neuroimage.2014.04.025; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Pena CJ, 2014, EUR J NEUROSCI, V39, P946, DOI 10.1111/ejn.12479; Pena CJ, 2013, ENDOCRINOLOGY, V154, P4340, DOI 10.1210/en.2013-1595; Peterson BS, 2015, JAMA PSYCHIAT, V72, P531, DOI 10.1001/jamapsychiatry.2015.57; Pournajafi-Nazarloo H, 2011, PSYCHONEUROENDOCRINO, V36, P780, DOI 10.1016/j.psyneuen.2010.10.015; Radua J, 2012, NEUROSCI BIOBEHAV R, V36, P2325, DOI 10.1016/j.neubiorev.2012.07.012; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; Riem MME, 2015, DEV PSYCHOPATHOL, V27, P507, DOI 10.1017/S0954579415000127; Ross HE, 2009, FRONT NEUROENDOCRIN, V30, P534, DOI 10.1016/j.yfrne.2009.05.004; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; Scholz J, 2015, NEUROIMAGE, V109, P190, DOI 10.1016/j.neuroimage.2015.01.027; Seeman TE, 1996, PSYCHOSOM MED, V58, P459, DOI 10.1097/00006842-199609000-00008; Seidel K, 2011, J NEUROENDOCRINOL, V23, P1166, DOI 10.1111/j.1365-2826.2011.02208.x; Shonkoff JP, 2012, P NATL ACAD SCI USA, V109, P17302, DOI 10.1073/pnas.1121259109; Shtasel-Gottlieb Z, 2015, J ADOLESCENT HEALTH, V56, P215, DOI 10.1016/j.jadohealth.2014.10.001; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Smith AS, 2012, HORM BEHAV, V61, P320, DOI 10.1016/j.yhbeh.2011.11.010; Sripada RK, 2014, NEUROPSYCHOPHARMACOL, V39, P2244, DOI 10.1038/npp.2014.75; Steinheuser V, 2014, PSYCHOSOM MED, V76, P678, DOI 10.1097/PSY.0000000000000113; Stoop R, 2015, ANNU REV NEUROSCI, V38, P369, DOI 10.1146/annurev-neuro-071714-033904; Swain JE, 2012, BEHAV BRAIN SCI, V35, P378, DOI 10.1017/S0140525X12001112; Tost H., 2011, BIOL PSYCHIAT, V70, pe41; Tost H., 2011, BIOL PSYCHIAT, V70, pe37; Tost H, 2012, NAT MED, V18, P211, DOI 10.1038/nm.2671; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; U.S.Census Bureau, 2004, CURR POP SURV DEF EX; van Buuren M, 2011, BIOL PSYCHIAT, V70, P81, DOI 10.1016/j.biopsych.2011.03.011; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Wan MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088436; Wang H, 2013, NAT NEUROSCI, V16, P919, DOI 10.1038/nn.3420; Wang XD, 2011, J NEUROSCI, V31, P13625, DOI 10.1523/JNEUROSCI.2259-11.2011; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weissbrod A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3018; Whitaker LR, 2013, NEURON, V77, P335, DOI 10.1016/j.neuron.2012.11.022; Wilker EH, 2015, STROKE, V46, P1161, DOI 10.1161/STROKEAHA.114.008348; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5; Younger J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013309; Zammit S, 2010, ARCH GEN PSYCHIAT, V67, P914, DOI 10.1001/archgenpsychiatry.2010.101; ZOLI M, 1990, J CHEM NEUROANAT, V3, P355	141	146	148	6	120	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1421	1431		10.1038/nn.4108	http://dx.doi.org/10.1038/nn.4108			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CS2OK	26404717				2022-12-17	WOS:000361910600011
J	Zhang, SL; Qi, J; Li, XP; Wang, HL; Britt, JP; Hoffman, AF; Bonci, A; Lupica, CR; Morales, M				Zhang, Shiliang; Qi, Jia; Li, Xueping; Wang, Hui-Ling; Britt, Jonathan P.; Hoffman, Alexander F.; Bonci, Antonello; Lupica, Carl R.; Morales, Marisela			Dopaminergic and glutamatergic microdomains in a subset of rodent mesoaccumbens axons	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; RELEASE GLUTAMATE; NUCLEUS-ACCUMBENS; RAT-BRAIN; NEURONS; INNERVATION; PROJECTIONS; SYNAPSES; MIDBRAIN	Mesoaccumbens fibers are thought to co-release dopamine and glutamate. However, the mechanism is unclear, and co-release by mesoaccumbens fibers has not been documented. Using electron microcopy, we found that some mesoaccumbens fibers have vesicular transporters for dopamine (VMAT2) in axon segments that are continuous with axon terminals that lack VMAT2, but contain vesicular glutamate transporters type 2 (VGIuT2). In vivo overexpression of VMAT2 did not change the segregation of the two vesicular types, suggesting the existence of highly regulated mechanisms for maintaining this segregation. The mesoaccumbens axon terminals containing VGIuT2 vesicles make asymmetric synapses, commonly associated with excitatory signaling. Using optogenetics, we found that dopamine and glutamate were released from the same mesoaccumbens fibers. These findings reveal a complex type of signaling by mesoaccumbens fibers in which dopamine and glutamate can be released from the same axons, but are not normally released at the same site or from the same synaptic vesicles.	[Zhang, Shiliang; Qi, Jia; Li, Xueping; Wang, Hui-Ling; Morales, Marisela] NIDA, Neuronal Networks Sect, US Natl Inst Hlth, Baltimore, MD 21224 USA; [Britt, Jonathan P.; Bonci, Antonello] NIDA, Synapt Plast Sect, US Natl Inst Hlth, Baltimore, MD USA; [Hoffman, Alexander F.; Lupica, Carl R.] NIDA, Electrophysiol Res Sect, US Natl Inst Hlth, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Morales, M (corresponding author), NIDA, Neuronal Networks Sect, US Natl Inst Hlth, Baltimore, MD 21224 USA.	mmorales@intra.nida.nih.gov	Hoffman, Alexander F/H-3035-2012; Core, Vector/CAF-4832-2022; Britt, jonathan/D-8877-2011; Hoffman, Alex/AIF-4544-2022; Lupica, Carl/AAY-3193-2021	Hoffman, Alexander F/0000-0002-2676-0628; Britt, jonathan/0000-0003-3044-9565; Hoffman, Alex/0000-0002-2676-0628; Lupica, Carl/0000-0002-5375-3263	National Institute on Drug Abuse;  [NS050274]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000543, ZICDA000555, ZIADA000457, ZIADA000437] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The viral packaging and in vitro testing of the AAV-DIO-VMAT2(Myc) vector were done by the National Institute on Drug Abuse Intramural Research Program Optogenetics and Transgenic Technology Core (OTTC). We thank O. Kiehn and L. Borgius (Karolinska Institutet) for providing the Vglut2-Cre transgenic mice and K. Deisseroth (Stanford University) for the Th-Cre transgenic rats. Resources for three-dimensional analysis were supported by NS050274. The Intramural Research Program of the National Institute on Drug Abuse supported this work.	Adrover MF, 2014, J NEUROSCI, V34, P3183, DOI 10.1523/JNEUROSCI.4958-13.2014; Berube-Carriere N, 2012, EUR J NEUROSCI, V35, P527, DOI 10.1111/j.1460-9568.2012.07992.x; Berube-Carriere N, 2009, J COMP NEUROL, V517, P873, DOI 10.1002/cne.22194; Dal Bo G, 2004, J NEUROCHEM, V88, P1398, DOI 10.1046/j.1471-4159.2003.02277.x; Descarries L, 1996, J COMP NEUROL, V375, P167; Foss SM, 2013, J NEUROSCI, V33, P10647, DOI 10.1523/JNEUROSCI.5662-12.2013; FREUND TF, 1984, NEUROSCIENCE, V13, P1189, DOI 10.1016/0306-4522(84)90294-X; Hnasko TS, 2012, J NEUROSCI, V32, P15076, DOI 10.1523/JNEUROSCI.3128-12.2012; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Kawano M, 2006, J COMP NEUROL, V498, P581, DOI 10.1002/cne.21054; Li XP, 2013, BRAIN STRUCT FUNCT, V218, P1159, DOI 10.1007/s00429-012-0452-z; Morales M, 2014, NEUROSCIENCE, V282, P60, DOI 10.1016/j.neuroscience.2014.05.032; Morales M, 2012, ANN NY ACAD SCI, V1248, P71, DOI 10.1111/j.1749-6632.2011.06299.x; Moss J, 2011, EUR J NEUROSCI, V33, P1205, DOI 10.1111/j.1460-9568.2011.07594.x; Root DH, 2014, NAT NEUROSCI, V17, P1543, DOI 10.1038/nn.3823; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Yamaguchi T, 2015, EUR J NEUROSCI, V41, P760, DOI 10.1111/ejn.12818; Yamaguchi T, 2011, J NEUROSCI, V31, P8476, DOI 10.1523/JNEUROSCI.1598-11.2011	21	146	148	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2015	18	3					386	392		10.1038/nn.3945	http://dx.doi.org/10.1038/nn.3945			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC2SO	25664911	Green Accepted			2022-12-17	WOS:000350195100018
J	Sejnowski, TJ; Churchland, PS; Movshon, JA				Sejnowski, Terrence J.; Churchland, Patricia S.; Movshon, J. Anthony			Putting big data to good use in neuroscience	NATURE NEUROSCIENCE			English	Article								Big data has transformed fields such as physics and genomics. Neuroscience is set to collect its own big data sets, but to exploit its full potential, there need to be ways to standardize, integrate and synthesize diverse types of data from different levels of analysis and across species. This will require a cultural shift in sharing data across labs, as well as to a central role for theorists in neuroscience research.	[Sejnowski, Terrence J.; Churchland, Patricia S.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA; [Churchland, Patricia S.] Univ Calif San Diego, Dept Philosophy, San Diego, CA 92103 USA; [Movshon, J. Anthony] NYU, Ctr Neural Sci, New York, NY 10003 USA	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; New York University	Sejnowski, TJ (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	terry@salk.edu	Sejnowski, Terrence/AAV-5558-2021		Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; CHURCHLAND PS, 1988, SCIENCE, V242, P741, DOI 10.1126/science.3055294; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/nmeth.1310, 10.1038/NMETH.1310]; Falkner AL, 2014, J NEUROSCI, V34, P5971, DOI 10.1523/JNEUROSCI.5109-13.2014; Mountain M, 2014, PHYS TODAY, V67, P8, DOI 10.1063/PT.3.2255; National Institutes of Health, 2014, BRAIN 2025 SCI VIS; Shepherd G. M., 1988, NEUROBIOLOGY, V8; Vogelstein JT, 2014, SCIENCE, V344, P386, DOI 10.1126/science.1250298; Wu TF, 2012, IEEE T SYST MAN CY B, V42, P1027, DOI 10.1109/TSMCB.2012.2195170	9	146	149	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2014	17	11					1440	1441		10.1038/nn.3839	http://dx.doi.org/10.1038/nn.3839			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS0LT	25349909	Green Accepted			2022-12-17	WOS:000343969300007
J	McKinnon, PJ				McKinnon, Peter J.			Maintaining genome stability in the nervous system	NATURE NEUROSCIENCE			English	Review							STRAND BREAK REPAIR; DNA-DAMAGE RESPONSE; TELANGIECTASIA-LIKE DISORDER; ATAXIA-TELANGIECTASIA; CHROMATIN STATE; SECKEL-SYNDROME; MITOTIC ENTRY; DEVELOPMENTAL DELAY; ADULT NEUROGENESIS; NEURAL DEVELOPMENT	Active maintenance of genome stability is a prerequisite for the development and function of the nervous system. The high replication index during neurogenesis and the long life of mature neurons highlight the need for efficient cellular programs to safeguard genetic fidelity. Multiple DNA damage response pathways ensure that replication stress and other types of DNA lesions, such as oxidative damage, do not affect neural homeostasis. Numerous human neurologic syndromes result from defective DNA damage signaling and compromised genome integrity. These syndromes can involve different neuropathology, which highlights the diverse maintenance roles that are required for genome stability in the nervous system. Understanding how DNA damage signaling pathways promote neural development and preserve homeostasis is essential for understanding fundamental brain function.	St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA	St Jude Children's Research Hospital	McKinnon, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Genet, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.mckinnon@stjude.org			US National Institutes of Health [NS-37956, CA-96832]; Cancer Center Support grant [P30 CA21765]; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765, P01CA096832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956, R56NS037956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support grant; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	P.J.M. is supported by the US National Institutes of Health (NS-37956, CA-96832), a Cancer Center Support grant (P30 CA21765) and the American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Anttinen A, 2008, BRAIN, V131, P1979, DOI 10.1093/brain/awn126; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Baker SA, 2013, CELL, V152, P984, DOI 10.1016/j.cell.2013.01.038; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Barzilai A, 2007, ANTIOXID REDOX SIGN, V9, P211, DOI 10.1089/ars.2007.9.211; Borgesius NZ, 2011, J NEUROSCI, V31, P12543, DOI 10.1523/JNEUROSCI.1589-11.2011; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Caviness VS, 2009, TRENDS NEUROSCI, V32, P443, DOI 10.1016/j.tins.2009.05.003; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Compe E, 2012, NAT REV MOL CELL BIO, V13, P343, DOI 10.1038/nrm3350; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Deans B, 2000, EMBO J, V19, P6675, DOI 10.1093/emboj/19.24.6675; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Du F, 2008, P NATL ACAD SCI USA, V105, P6409, DOI 10.1073/pnas.0710766105; Fortini P, 2013, MUTAT RES-FUND MOL M, V743, P160, DOI 10.1016/j.mrfmmm.2013.03.004; Frappart PO, 2005, NAT MED, V11, P538, DOI 10.1038/nm1228; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Huang E, 2010, NAT CELL BIOL, V12, P563, DOI 10.1038/ncb2058; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kamileri I, 2012, TRENDS GENET, V28, P566, DOI 10.1016/j.tig.2012.06.004; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kishi Y, 2012, NAT NEUROSCI, V15, P1127, DOI 10.1038/nn.3165; Klingseisen A, 2011, GENE DEV, V25, P2011, DOI 10.1101/gad.169037; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Latella L, 2004, MOL CELL BIOL, V24, P6350, DOI 10.1128/MCB.24.14.6350-6361.2004; Lee YS, 2012, NAT NEUROSCI, V15, P819, DOI 10.1038/nn.3097; Lee Y, 2012, EMBO J, V31, P1177, DOI 10.1038/emboj.2011.493; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; McKinnon PJ, 2012, ANNU REV PATHOL-MECH, V7, P303, DOI 10.1146/annurev-pathol-011811-132509; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Nouspikel T, 2003, BIOESSAYS, V25, P168, DOI 10.1002/bies.10227; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; O'Driscoll M, 2007, AM J HUM GENET, V81, P77, DOI 10.1086/518696; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Reynolds JJ, 2012, NUCLEIC ACIDS RES, V40, P6608, DOI 10.1093/nar/gks318; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Saxowsky TT, 2006, CHEM REV, V106, P474, DOI 10.1021/cr040466q; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shimada M, 2009, J RADIAT RES, V50, P295, DOI 10.1269/jrr.09039; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397; Sulli G, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3344; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sykora P, 2011, P NATL ACAD SCI USA, V108, P7437, DOI 10.1073/pnas.1100084108; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Taylor AMR, 2004, DNA REPAIR, V3, P1219, DOI 10.1016/j.dnarep.2004.04.009; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Woodbine L, 2013, J CLIN INVEST, V123, P2969, DOI 10.1172/JCI67349; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; ZHAO K, 1993, EMBO J, V12, P3237, DOI 10.1002/j.1460-2075.1993.tb05993.x	99	146	152	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1523	1529		10.1038/nn.3537	http://dx.doi.org/10.1038/nn.3537			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24165679	Green Accepted			2022-12-17	WOS:000326205700007
J	O'Connor, DH; Hires, SA; Guo, ZCV; Li, N; Yu, JN; Sun, QQ; Huber, D; Svoboda, K				O'Connor, Daniel H.; Hires, S. Andrew; Guo, Zengcai V.; Li, Nuo; Yu, Jianing; Sun, Qian-Quan; Huber, Daniel; Svoboda, Karel			Neural coding during active somatosensation revealed using illusory touch	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; SCANNING SENSORIMOTOR SYSTEM; OBJECT LOCALIZATION; CORTICAL MICROSTIMULATION; VIBRISSA CORTEX; TRANSGENIC MICE; MOTOR CORTEX; LAYER 5; WHISKER; BEHAVIOR	Active sensation requires the convergence of external stimuli with representations of body movements. We used mouse behavior, electrophysiology and optogenetics to dissect the temporal interactions among whisker movement, neural activity and sensation of touch. We photostimulated layer 4 activity in single barrels in a closed loop with whisking. Mimicking touch-related neural activity caused illusory perception of an object at a particular location, but scrambling the timing of the spikes over one whisking cycle (tens of milliseconds) did not abolish the illusion, indicating that knowledge of instantaneous whisker position is unnecessary for discriminating object locations. The illusions were induced only during bouts of directed whisking, when mice expected touch, and in the relevant barrel. Reducing activity biased behavior, consistent with a spike count code for object detection at a particular location. Our results show that mice integrate coding of touch with movement over timescales of a whisking bout to produce perception of active touch.	[O'Connor, Daniel H.; Hires, S. Andrew; Guo, Zengcai V.; Li, Nuo; Yu, Jianing; Sun, Qian-Quan; Huber, Daniel; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	svobodak@janelia.hhmi.org	Hires, Samuel/E-4717-2015; Huber, Daniel/C-2932-2013	Huber, Daniel/0000-0002-0744-7679; Sun, Qian-Quan/0000-0002-5807-9327	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bagdasarian K, 2013, NAT NEUROSCI, V16, P622, DOI 10.1038/nn.3378; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Clack NG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002591; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Histed MH, 2013, PROG NEUROBIOL, V103, P115, DOI 10.1016/j.pneurobio.2012.01.006; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Kleinfeld D, 2011, NEURON, V72, P455, DOI 10.1016/j.neuron.2011.10.009; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Liao GY, 2008, GENESIS, V46, P289, DOI 10.1002/dvg.20393; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Mitchinson B, 2011, PHILOS T R SOC B, V366, P3037, DOI 10.1098/rstb.2011.0156; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Pammer L, 2013, J NEUROSCI, V33, P6726, DOI 10.1523/JNEUROSCI.4316-12.2013; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; Slotnick B, 2009, J EXP ANAL BEHAV, V91, P253, DOI 10.1901/jeab.2009.91-253; Veinante P, 2000, J COMP NEUROL, V424, P197, DOI 10.1002/1096-9861(20000821)424:2<197::AID-CNE1>3.0.CO;2-6; Voigts J, 2008, J NEUROPHYSIOL, V100, P504, DOI 10.1152/jn.00012.2008; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yarbus A. L., 1967, EYE MOVEMENTS VISION, P171; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	57	146	147	2	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					958	U238		10.1038/nn.3419	http://dx.doi.org/10.1038/nn.3419			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23727820	Green Published, Green Accepted			2022-12-17	WOS:000321180900031
J	Beltramo, R; D'Urso, G; Dal Maschio, M; Farisello, P; Bovetti, S; Clovis, Y; Lassi, G; Tucci, V; Tonelli, DD; Fellin, T				Beltramo, Riccardo; D'Urso, Giulia; Dal Maschio, Marco; Farisello, Pasqualina; Bovetti, Serena; Clovis, Yoanne; Lassi, Glenda; Tucci, Valter; Tonelli, Davide De Pietri; Fellin, Tommaso			Layer-specific excitatory circuits differentially control recurrent network dynamics in the neocortex	NATURE NEUROSCIENCE			English	Article							LESS-THAN-1 HZ OSCILLATION; BARREL CORTEX; IN-VIVO; SENSORY RESPONSES; CORTICAL CIRCUITS; VISUAL-CORTEX; SLEEP; NEURONS; STIMULATION; RHYTHMS	In the absence of external stimuli, the mammalian neocortex shows intrinsic network oscillations. These dynamics are characterized by translaminar assemblies of neurons whose activity synchronizes rhythmically in space and time. How different cortical layers influence the formation of these spontaneous cellular assemblies is poorly understood. We found that excitatory neurons in supragranular and infragranular layers have distinct roles in the regulation of intrinsic low-frequency oscillations in mice in vivo. Optogenetic activation of infragranular neurons generated network activity that resembled spontaneous events, whereas photoinhibition of these same neurons substantially attenuated slow ongoing dynamics. In contrast, light activation and inhibition of supragranular cells had modest effects on spontaneous slow activity. This study represents, to the best of our knowledge, the first causal demonstration that excitatory circuits located in distinct cortical layers differentially control spontaneous low-frequency dynamics.	[Beltramo, Riccardo; D'Urso, Giulia; Dal Maschio, Marco; Farisello, Pasqualina; Bovetti, Serena; Clovis, Yoanne; Lassi, Glenda; Tucci, Valter; Tonelli, Davide De Pietri; Fellin, Tommaso] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy	Istituto Italiano di Tecnologia - IIT	Fellin, T (corresponding author), Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy.	tommaso.fellin@iit.it	De Pietri Tonelli, Davide/AAD-8055-2021; De Pietri Tonelli, Davide/E-2102-2011; Dal Maschio, Marco/G-3871-2017	De Pietri Tonelli, Davide/0000-0001-9537-8900; De Pietri Tonelli, Davide/0000-0001-9537-8900; Lassi, Glenda/0000-0001-5102-3294; Bovetti, Serena/0000-0002-0471-4081; dal maschio, marco/0000-0003-0150-6647; Tucci, Valter/0000-0002-3796-3826	Italian Institute of Technology; San Paolo "Programma in Neuroscienze", MIUR FIRB [RBAP11X42L]; Telethon-Italy [GGP10138]	Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); San Paolo "Programma in Neuroscienze", MIUR FIRB; Telethon-Italy(Fondazione Telethon)	We thank J. Assad, A. Bacci, E Benfenati, A. Blau and G. Carmignoto for critical reading and helpful comments on the manuscript. We thank C. Gerfen (US National Institute of Mental Health) for Rbp4-cre mice, K. Deisseroth (Stanford University) for pAAV-EF1a.DIO.hChR2(H134R)-EYFP.WPRE.hGH (Addgene 20298), pAAV-EF1.dflox.hChR2(H134R)-mCherry.WPRE.hGH (Addgene 20297) and pAAV-EFla.DIO.eNpHR-eYFP.WP.hGH (Addgene 20949), K. Svoboda (Howard Hughes Medical Institute, Janelia Farm) for pCAGGS-ChR2-Venus (Addgene 15753), E. Boyden (Massachusetts Institute of Technology) for pAAV-CAG-ArchT-GFP (Addgene 29777), FCK-Arch-GFP (Addgene 22217) and AAV2/1.flex.CBA.Arch-GFP.WPRE.SV40 (Addgene 22222) and S. Guazzi for subcloning and amplification of some of the plasmids used in this study. This work was supported by the Italian Institute of Technology and grants from San Paolo "Programma in Neuroscienze", MIUR FIRB (RBAP11X42L) and Telethon-Italy (GGP10138) to T.F.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Amzica F, 1998, NEUROSCIENCE, V82, P671; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brecht M, 2007, CURR OPIN NEUROBIOL, V17, P408, DOI 10.1016/j.conb.2007.07.008; Brown SP, 2009, CURR OPIN NEUROBIOL, V19, P415, DOI 10.1016/j.conb.2009.07.011; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chauvette S, 2010, CEREB CORTEX, V20, P2660, DOI 10.1093/cercor/bhq009; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Contreras D, 2004, NEURAL NETWORKS, V17, P633, DOI 10.1016/j.neunet.2004.04.003; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Dal Maschio M, 2010, OPT EXPRESS, V18, P18720, DOI 10.1364/OE.18.018720; Destexhe A, 2011, CURR OPIN NEUROBIOL, V21, P717, DOI 10.1016/j.conb.2011.06.002; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Jha SK, 2005, J NEUROSCI, V25, P9266, DOI 10.1523/JNEUROSCI.2722-05.2005; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kirov R, 2009, P NATL ACAD SCI USA, V106, P15460, DOI 10.1073/pnas.0904438106; Le Bon-Jegoa M, 2007, FRONT NEUROSCI-SWITZ, V1, P123, DOI 10.3389/neuro.01.1.1.009.2007; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Massimini M, 2007, P NATL ACAD SCI USA, V104, P8496, DOI 10.1073/pnas.0702495104; METHERATE R, 1992, J NEUROSCI, V12, P4701; Meyer HS, 2010, CEREB CORTEX, V20, P2277, DOI 10.1093/cercor/bhq067; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/nmeth.1505, 10.1038/NMETH.1505]; Peters A., 1990, CEREBRAL CORTEX COMP; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wester JC, 2012, J NEUROSCI, V32, P5454, DOI 10.1523/JNEUROSCI.5006-11.2012	50	146	146	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					227	234		10.1038/nn.3306	http://dx.doi.org/10.1038/nn.3306			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23313909				2022-12-17	WOS:000314260200020
J	Tritsch, NX; Rodriguez-Contreras, A; Crins, TTH; Wang, HC; Borst, JGG; Bergles, DE				Tritsch, Nicolas X.; Rodriguez-Contreras, Adrian; Crins, Tom T. H.; Wang, Han Chin; Borst, J. Gerard G.; Bergles, Dwight E.			Calcium action potentials in hair cells pattern auditory neuron activity before hearing onset	NATURE NEUROSCIENCE			English	Article							TRAPEZOID BODY; MEDIAL NUCLEUS; STIMULATION; MATURATION	We found rat central auditory neurons to fire action potentials in a precise sequence of mini-bursts before the age of hearing onset. This stereotyped pattern was initiated by hair cells in the cochlea, which trigger brief bursts of action potentials in auditory neurons each time they fire a Ca(2+) spike. By generating theta-like activity, hair cells may limit the influence of synaptic depression in developing auditory circuits and promote consolidation of synapses.	[Tritsch, Nicolas X.; Wang, Han Chin; Bergles, Dwight E.] Johns Hopkins Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Rodriguez-Contreras, Adrian; Crins, Tom T. H.; Borst, J. Gerard G.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Crins, Tom T. H.] Univ Med Ctr Rotterdam, Dept Otorhinolaryngol Head & Neck Surg, Rotterdam, Netherlands; [Bergles, Dwight E.] Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Johns Hopkins Medicine	Bergles, DE (corresponding author), Johns Hopkins Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA.	g.borst@erasmusmc.nl; dbergles@jhmi.edu	Bergles, Dwight/U-8343-2019; Tritsch, Nicolas/U-5266-2019; Rodriguez-Contreras, Adrian/ABC-8325-2020	Bergles, Dwight/0000-0002-7133-7378; Tritsch, Nicolas/0000-0003-3181-7681; Wang, Han Chin/0000-0001-8270-6645	US National Center for Research Resources [G12-RR03060]; European Union [LSHM-CT-2005-019055]; Heinsius Houbolt fund and SenterNovem (The Netherlands) [BSIK 03053]; US National Institutes of Health [DC008860, DC009464]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [SC1HD068129] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC009464, R01DC008860] Funding Source: NIH RePORTER	US National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); European Union(European Commission); Heinsius Houbolt fund and SenterNovem (The Netherlands)(Netherlands Government); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the US National Center for Research Resources (G12-RR03060) to A. R.-C., the European Union (EUSynapse, LSHM-CT-2005-019055), Heinsius Houbolt fund and SenterNovem (The Netherlands, Neuro-Bsik, BSIK 03053) to J.G.G.B., and the US National Institutes of Health (DC008860 and DC009464) to D.E.B.	Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Brenowitz S, 2001, J NEUROSCI, V21, P9487, DOI 10.1523/JNEUROSCI.21-23-09487.2001; CARLIER E, 1975, J PHYSIOL-PARIS, V70, P129; GUINAN JJ, 1990, HEARING RES, V49, P321, DOI 10.1016/0378-5955(90)90111-2; Johnson SL, 2005, J PHYSIOL-LONDON, V563, P177, DOI 10.1113/jphysiol.2004.074740; Jones TA, 2007, J NEUROPHYSIOL, V98, P1898, DOI 10.1152/jn.00472.2007; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Sonntag M, 2009, J NEUROSCI, V29, P9510, DOI 10.1523/JNEUROSCI.1377-09.2009; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Tritsch NX, 2010, J NEUROSCI, V30, P1539, DOI 10.1523/JNEUROSCI.3875-09.2010; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Walsh Edward J., 1992, P161; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	15	146	146	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1050	1052		10.1038/nn.2604	http://dx.doi.org/10.1038/nn.2604			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20676105	Green Accepted			2022-12-17	WOS:000281332600007
J	Xu, JY; Xiao, N; Xia, J				Xu, Junyu; Xiao, Nan; Xia, Jun			Thrombospondin 1 accelerates synaptogenesis in hippocampal neurons through neuroligin 1	NATURE NEUROSCIENCE			English	Article							SYNAPSE FORMATION; RECEPTOR; CNS	In cultured rat hippocampal neurons, we found that thrombospondin 1 (TSP1) increased the speed of synapse formation in young neurons, but not the final density of synapses in mature neurons. TSP1 interacted with neuroligin 1 (NL1) and application of the NL1 extracellular domain blocked TSP1-induced synaptogenesis. Furthermore, knocking down endogenous NL1 inhibited TSP1's effect. Our results indicate that TSP1 accelerates the speed of synaptogenesis through NL1 in hippocampal neurons.	[Xu, Junyu; Xiao, Nan; Xia, Jun] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Xia, J (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	jxia@ust.hk	Xiao, Nan/A-4775-2012; Xia, Jun/C-7234-2009	Xia, Jun/0000-0001-9308-2188; Xiao, Nan/0000-0001-7264-3046	Research Grants Council of Hong Kong [HKUST6429/06M, N_HKUST605/07, HKUST6/CRF/08, 663107, AoE/B-15/01]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	We thank W. Tung, C. He, P. Ieong and C. Sheng for technical assistance, A. M. Craig for YFP-NL1/2 and neurexin, P. Scheiffele for HA-NL1 and D. Comoletti for Flag-NL1-ECD cDNA constructs. This work was supported in part by grants from the Research Grants Council of Hong Kong (HKUST6429/06M, N_HKUST605/07, HKUST6/CRF/08, 663107 and AoE/B-15/01).	Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	13	146	149	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					22	24		10.1038/nn.2459	http://dx.doi.org/10.1038/nn.2459			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19915562				2022-12-17	WOS:000273056300008
J	Siegert, S; Scherf, BG; Del Punta, K; Didkovsky, N; Heintz, N; Roska, B				Siegert, Sandra; Scherf, Brigitte Gross; Del Punta, Karina; Didkovsky, Nick; Heintz, Nathaniel; Roska, Botond			Genetic address book for retinal cell types	NATURE NEUROSCIENCE			English	Article							STARBURST AMACRINE CELLS; GANGLION-CELLS; MOUSE RETINA; BIPOLAR CELLS; DIRECTIONAL SELECTIVITY; MAMMALIAN RETINA; CAT RETINA; IN-VIVO; EXPRESSION; LIGHT	The mammalian brain is assembled from thousands of neuronal cell types that are organized in distinct circuits to perform behaviorally relevant computations. Transgenic mouse lines with selectively marked cell types would facilitate our ability to dissect functional components of complex circuits. We carried out a screen for cell type-specific green fluorescent protein expression in the retina using BAC transgenic mice from the GENSAT project. Among others, we identified mouse lines in which the inhibitory cell types of the night vision and directional selective circuit were selectively labeled. We quantified the stratification patterns to predict potential synaptic connectivity between marked cells of different lines and found that some of the lines enabled targeted recordings and imaging of cell types from developing or mature retinal circuits. Our results suggest the potential use of a stratification-based screening approach for characterizing neuronal circuitry in other layered brain structures, such as the neocortex.	[Siegert, Sandra; Scherf, Brigitte Gross; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland; [Del Punta, Karina; Didkovsky, Nick; Heintz, Nathaniel] Rockefeller Univ, GENSAT Project, New York, NY 10021 USA; [Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA	Friedrich Miescher Institute for Biomedical Research; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland.	botond.roska@fmi.ch	Roska, Botond/AAD-7268-2021; Siegert, Sandra/GWC-4507-2022	Siegert, Sandra/0000-0001-8635-0877	Friedrich Miescher Institute funds; US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology; Marie Curie Excellence; National Center for Competence in Research in Genetics; European Union [HEALTH-F2-223156]; National Institute of Neurological Disorders and Stroke [N01NS02331, HHSN271200723701C]; Howard Hughes Medical Institute	Friedrich Miescher Institute funds; US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology; Marie Curie Excellence(European Commission); National Center for Competence in Research in Genetics; European Union(European Commission); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank M. Ciminelli, P. Dyer, S. Djaffer, J. Hall and Y. Shimada for technical assistance, and F. Rijli, P. S. Lagali and K. Farrow for comments on the manuscript. This study was supported by Friedrich Miescher Institute funds, a US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology Program grant, a Marie Curie Excellence grant, a National Center for Competence in Research in Genetics grant and a European Union HEALTH-F2-223156 grant to B. R., and by National Institute of Neurological Disorders and Stroke contracts N01NS02331 and HHSN271200723701C to N. H. N. H. is an Howard Hughes Medical Institute investigator.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Balse E, 2006, J PHYSIOL-LONDON, V571, P391, DOI 10.1113/jphysiol.2005.100891; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Dowling J.E., 1987, RETINA APPROACHABLE; FAMIGLIETTI EV, 1983, BRAIN RES, V261, P138, DOI 10.1016/0006-8993(83)91293-3; FREED MA, 1988, J NEUROSCI, V8, P2303; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MCGUIRE BA, 1986, J NEUROSCI, V6, P907; Morgan JL, 2006, NAT NEUROSCI, V9, P85, DOI 10.1038/nn1615; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Rice DS, 2000, J COMP NEUROL, V424, P327, DOI 10.1002/1096-9861(20000821)424:2<327::AID-CNE10>3.0.CO;2-6; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Rotolo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004099; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3; Tomomura M, 2001, EUR J NEUROSCI, V14, P57, DOI 10.1046/j.0953-816x.2001.01624.x; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Walsh MK, 2008, J NEUROSCI METH, V169, P214, DOI 10.1016/j.jneumeth.2007.11.029; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	33	146	150	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1197	U30		10.1038/nn.2370	http://dx.doi.org/10.1038/nn.2370			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19648912				2022-12-17	WOS:000269317300024
J	Le Bras, B; Barallobre, MJ; Homman-Lidiye, J; Ny, A; Wyns, S; Tammela, T; Haiko, P; Karkkainen, MJ; Yuan, L; Muriel, MP; Chatzopoulou, E; Breant, A; Zalc, B; Carmeliet, P; Alitalo, K; Eichmann, A; Thomas, JL				Le Bras, B; Barallobre, MJ; Homman-Lidiye, J; Ny, A; Wyns, S; Tammela, T; Haiko, P; Karkkainen, MJ; Yuan, L; Muriel, MP; Chatzopoulou, E; Breant, A; Zalc, B; Carmeliet, P; Alitalo, K; Eichmann, A; Thomas, JL			VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain	NATURE NEUROSCIENCE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RAT OPTIC-NERVE; STIMULATES AXONAL OUTGROWTH; IN-VITRO; LYMPHATIC VESSELS; PRECURSOR CELLS; SPINAL-CORD; STEM-CELLS; NEUROGENESIS; DIFFERENTIATION	Vascular endothelial growth factor C (VEGF-C) was first identified as a regulator of the vascular system, where it is required for the development of lymphatic vessels. Here we report actions of VEGF-C in the central nervous system. We detected the expression of the VEGF-C receptor VEGFR-3 in neural progenitor cells in Xenopus laevis and mouse embryos. In Xenopus tadpole VEGF-C knockdowns and in mice lacking Vegfc, the proliferation of neural progenitors expressing VEGFR-3 was severely reduced, in the absence of intracerebral blood vessel defects. In addition, Vegfc-deficient mouse embryos showed a selective loss of oligodendrocyte precursor cells (OPCs) in the embryonic optic nerve. In vitro, VEGF-C stimulated the proliferation of OPCs expressing VEGFR-3 and nestin-positive ventricular neural cells. VEGF-C thus has a new, evolutionary conserved function as a growth factor selectively required by neural progenitor cells expressing its receptor VEGFR-3.	INSERM, U711, F-75013 Paris, France; Univ Paris 06, Fac Med Pitie Salpetriere, IFR 70, F-75005 Paris, France; Catholic Univ Louvain VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; Univ Helsinki, Haartman Inst & Biomed, FIN-00014 Helsinki, Finland; Univ Helsinki, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland; Univ Helsinki, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland; INSERM, U679, F-75651 Paris, France; Coll France, F-75005 Paris, France; INSERM, U36x, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Flanders Institute for Biotechnology (VIB); University of Helsinki; Ludwig Institute for Cancer Research; University of Helsinki; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm)	Thomas, JL (corresponding author), INSERM, U711, F-75013 Paris, France.	jlthomas@ccr.jussieu.fr	Thomas, Jean-Leon/F-1151-2016; Carmeliet, Peter/AAQ-5140-2020; Alitalo, Kari K/J-5013-2014; Messier, Claude/A-2322-2008; Ny, Annelii/R-7712-2018; Barallobre, Maria Jose/L-9928-2014	Carmeliet, Peter/0000-0001-7961-1821; Alitalo, Kari K/0000-0002-7331-0902; Messier, Claude/0000-0002-4791-1763; Ny, Annelii/0000-0002-3678-5941; Barallobre, Maria Jose/0000-0002-0101-7803; Homman-Ludiye, Jihane/0000-0001-6689-1457; /0000-0003-3675-6961	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075183] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL075183-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avantaggiato V, 1998, MECH DEVELOP, V73, P221, DOI 10.1016/S0925-4773(98)00049-5; BARRES BA, 1992, J NEUROBIOL, V23, P1221, DOI 10.1002/neu.480230912; BREIER G, 1992, DEVELOPMENT, V114, P521; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Joukov V, 1996, EMBO J, V15, P1751; Joukov V, 1998, J BIOL CHEM, V273, P6599, DOI 10.1074/jbc.273.12.6599; Jussila L, 2002, PHYSIOL REV, V82, P673, DOI 10.1152/physrev.00005.2002; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kirkin V, 2001, EUR J BIOCHEM, V268, P5530, DOI 10.1046/j.1432-1033.2001.02476.x; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Mi HY, 1999, J NEUROSCI, V19, P1049; Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001; MUDHAR HS, 1993, DEVELOPMENT, V118, P539; Nieuwkoop P.D., 1975, NORMAL TABLE XENOPUS; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Rowitch DH, 2002, TRENDS NEUROSCI, V25, P417, DOI 10.1016/S0166-2236(02)02201-4; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shi JY, 1998, J NEUROSCI, V18, P4627; Shibata T, 1997, J NEUROSCI, V17, P9212; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Spassky N, 2002, J NEUROSCI, V22, P5992; Spassky N, 1998, J NEUROSCI, V18, P8331; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Sun T, 2003, J NEUROSCI, V23, P9547; YANG K, 1996, J NEUROSCI, V16, P6089; Yourey PA, 2000, J NEUROSCI, V20, P6781, DOI 10.1523/JNEUROSCI.20-18-06781.2000	49	146	148	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					340	348		10.1038/nn1646	http://dx.doi.org/10.1038/nn1646			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16462734				2022-12-17	WOS:000235645600013
J	Taylor-Clarke, M; Jacobsen, P; Haggard, P				Taylor-Clarke, M; Jacobsen, P; Haggard, P			Keeping the world a constant size: object constancy in human touch	NATURE NEUROSCIENCE			English	Article							REPRESENTATION; PLASTICITY; VISION; CORTEX	The perceived size of objects touching different regions of skin varies across the body surface by much less than is predicted from variations in tactile receptor density. Here we show that altering the visual experience of the body alters perceived tactile distances. We propose that the brain attempts to preserve tactile size constancy by rescaling the primary, distorted body-surface representation into object-centered space according to visual experience of the body.	UCL, Inst Neurosci Cognit, London WC1N 3AR, England; UCL, Dept Psychol, London WC1N 3AR, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; University of London; University College London; University of Oxford	Taylor-Clarke, M (corresponding author), UCL, Inst Neurosci Cognit, 17 Queen Sq, London WC1N 3AR, England.	p.haggard@ucl.ac.uk	Haggard, Patrick/A-5081-2010	Jacobsen, Pamela/0000-0001-8847-7775; Haggard, Patrick/0000-0001-7798-793X				BORING EG, 1964, AM J PSYCHOL, V77, P494, DOI 10.2307/1421027; Calford MB, 2002, NEUROSCIENCE, V111, P709, DOI 10.1016/S0306-4522(02)00022-2; Gandevia SC, 1999, J PHYSIOL-LONDON, V514, P609, DOI 10.1111/j.1469-7793.1999.609ae.x; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; GREEN BG, 1982, PERCEPT PSYCHOPHYS, V31, P315, DOI 10.3758/BF03202654; Iriki A, 1996, NEUROREPORT, V7, P2325; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Kurth R, 2000, NEUROREPORT, V11, P1487, DOI 10.1097/00001756-200005150-00025; Marr D., 1982, VISION; PAILLARD J, 1983, ARCH NEUROL-CHICAGO, V40, P548, DOI 10.1001/archneur.1983.04050080048008; Penfield W, 1950, CEREBRAL CORTEX MAN, DOI DOI 10.1001/JAMA.1950.02920160086033; Ramachandran VS, 2000, ARCH NEUROL-CHICAGO, V57, P317, DOI 10.1001/archneur.57.3.317; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; WEBER EH, 1978, SENSE TOUCH; WEINSTEIN SIDNEY, 1968, P195	15	146	146	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					219	220		10.1038/nn1199	http://dx.doi.org/10.1038/nn1199			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966526				2022-12-17	WOS:000189197900010
J	Fukuchi-Shimogori, T; Grove, EA				Fukuchi-Shimogori, T; Grove, EA			Emx2 patterns the neocortex by regulating FGF positional signaling	NATURE NEUROSCIENCE			English	Article							CEREBRAL-CORTEX; MOLECULAR REGIONALIZATION; AREA IDENTITY; MOUSE-BRAIN; EXPRESSION; SPECIFICATION; GENES; TELENCEPHALON; MECHANISMS; FAMILY	Molecular genetic studies implicate fibroblast growth factor 8 (FGF8), and the transcription factor Emx2, in development of the neocortical area map. Both are proposed to specify area position along the anterior-to-posterior axis of the cortical primordium. Whether FGF8 and Emx2 act independently or coordinately, or whether one controls the other, has not been determined. Here we report that Emx2, by regulating FGF8, has an indirect but vital role in area-map development. Using electroporation- mediated gene transfer in living mouse embryos, we found that overexpressing Emx2 altered the area map, but only when ectopic Emx2 overlapped the FGF8 source. Furthermore, we found that FGF8 levels were decreased by excess Emx2, and increased in mice lacking Emx2. Finally, cortical domain shifts that characterize Emx2 mutants were rescued by sequestering excess FGF8 with a truncated FGF receptor construct. These findings begin to clarify the signaling network that patterns the neocortical area map.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Grove, EA (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, 947 E 58th St,MC0926, Chicago, IL 60637 USA.	egrove@drugs.bsd.uchicago.edu	Shimogori, Tomomi/L-2893-2013	Shimogori, Tomomi/0000-0002-6931-5401				Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; Aoto K, 2002, DEV BIOL, V251, P320, DOI 10.1006/dbio.2002.0811; Arimatsu Y, 1999, DEVELOPMENT, V126, P629; Bachler M, 2001, MECH DEVELOP, V100, P313, DOI 10.1016/S0925-4773(00)00518-9; BARBE MF, 1991, J NEUROSCI, V11, P519; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Cecchi C, 2000, TRENDS NEUROSCI, V23, P347, DOI 10.1016/S0166-2236(00)01608-8; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Eagleson KL, 1999, CEREB CORTEX, V9, P562, DOI 10.1093/cercor/9.6.562; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; GROVE EA, 1992, NEURON, V8, P217, DOI 10.1016/0896-6273(92)90289-P; Grove EA, 1998, DEVELOPMENT, V125, P2315; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Maruoka Y, 1998, MECH DEVELOP, V74, P175, DOI 10.1016/S0925-4773(98)00061-6; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Monuki ES, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn752; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; Nauta W., 1986, FUNDAMENTAL NEUROANA; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Ornitz DM, 2001, GENOME BIOL, V2; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Ragsdale CW, 2001, CURR OPIN NEUROBIOL, V11, P50, DOI 10.1016/S0959-4388(00)00173-2; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Shamim H, 1999, DEVELOPMENT, V126, P945; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Theil T, 1999, DEVELOPMENT, V126, P3561; Tole S, 2001, J NEUROSCI, V21, P1580, DOI 10.1523/JNEUROSCI.21-05-01580.2001; Tole S, 2000, DEV BIOL, V217, P254, DOI 10.1006/dbio.1999.9509; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Xu JS, 2000, DEVELOPMENT, V127, P1833; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Yoshida M, 1997, DEVELOPMENT, V124, P101; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601	49	146	151	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					825	831		10.1038/nn1093	http://dx.doi.org/10.1038/nn1093			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872126				2022-12-17	WOS:000184413700011
J	Zatorre, RJ				Zatorre, RJ			Absolute pitch: a model for understanding the influence of genes and development on neural and cognitive function	NATURE NEUROSCIENCE			English	Review							MUSICAL PITCH; AUDITORY-CORTEX; IDENTIFICATION; RECOGNITION; POSSESSORS; TONES	Absolute pitch (AP), the ability to identify or produce the pitch of a sound without any reference point, is discussed here as a possible model system for understanding the neurobiology of complex cognitive functions. AP is of interest because it may reflect an atypical organization of sensory representations. Indications are that it depends on both genetic factors and exposure to musical training during childhood, supporting the idea of a sensitive period. Functional and structural neuroimaging studies suggest special roles for working memory and associative memory mechanisms in AP, and results from these studies indicate that there may be structural markers of AP in asymmetries of cortical areas. AP seems to depend on the nervous system's response to experiential, maturational and genetic factors, making it a good candidate model for understanding how these interactions play out in cognitive development generally.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	Zatorre, RJ (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	robert.zatorre@mcgill.ca						Bachem A, 1937, J ACOUST SOC AM, V9, P146, DOI 10.1121/1.1915919; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Baharloo S, 2000, AM J HUM GENET, V67, P755, DOI 10.1086/303057; Bornstein MH., 1987, CATEGORICAL PERCEPTI, P287; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Gregersen PK, 2001, AM J MED GENET, V98, P280, DOI 10.1002/1096-8628(20010122)98:3<280::AID-AJMG1083>3.0.CO;2-6; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Keenan JP, 2001, NEUROIMAGE, V14, P1402, DOI 10.1006/nimg.2001.0925; KLEIN M, 1984, SCIENCE, V223, P1306, DOI 10.1126/science.223.4642.1306; KRUMHANSI CL, 1990, COGNITIVE FDN MUSICA; Langner G, 2002, HEARING RES, V168, P110, DOI 10.1016/S0378-5955(02)00367-2; LEVITIN DJ, 1994, PERCEPT PSYCHOPHYS, V56, P414, DOI 10.3758/BF03206733; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/0033-295X.101.2.343; MIYAZAKI K, 1988, PERCEPT PSYCHOPHYS, V44, P501, DOI 10.3758/BF03207484; Miyazaki K, 2002, PERCEPT PSYCHOPHYS, V64, P1337, DOI 10.3758/BF03194776; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Petrides M, 1995, ANN NY ACAD SCI, V769, P85, DOI 10.1111/j.1749-6632.1995.tb38133.x; POLLACK I, 1952, J ACOUST SOC AM, V24, P745, DOI 10.1121/1.1906969; Saffran JR, 2001, DEV PSYCHOL, V37, P74, DOI 10.1037//0012-1649.37.1.74; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; SERGEANT D, 1969, J RES MUSIC EDUC, V17, P135, DOI 10.2307/3344200; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; Ward W.D., 1999, PSYCHOL MUSIC PP, P265, DOI DOI 10.1016/B978-012213564-4/50009-3; WAYMAN JW, 1992, J ACOUST SOC AM, V91, P3527, DOI 10.1121/1.402841; WITELSON SF, 1973, BRAIN, V96, P641, DOI 10.1093/brain/96.3.641; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172; ZATORRE RJ, 1989, MEM COGNITION, V17, P582, DOI 10.3758/BF03197081; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	29	146	152	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					692	695		10.1038/nn1085	http://dx.doi.org/10.1038/nn1085			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	694NJ	12830161				2022-12-17	WOS:000183780400014
J	Knecht, S; Floel, A; Drager, B; Breitenstein, C; Sommer, J; Henningsen, H; Ringelstein, EB; Pascual-Leone, A				Knecht, S; Floel, A; Drager, B; Breitenstein, C; Sommer, J; Henningsen, H; Ringelstein, EB; Pascual-Leone, A			Degree of language lateralization determines susceptibility to unilateral brain lesions	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; RIGHT-HEMISPHERE; DOPPLER SONOGRAPHY; FUNCTIONAL MRI; WADA TEST; SPEECH; EXCITABILITY; ACTIVATION; HANDEDNESS; DOMINANCE	Language is considered a function of either the left or, in exceptional cases, the right side of the brain. Functional imaging studies show, however, that in the general population a graded continuum from left hemispheric to right hemispheric language lateralization exists. To determine the functional relevance of lateralization differences, we suppressed language regions using transcranial magnetic stimulation (TMS) in healthy human subjects who differed in lateralization of language-related brain activation. Language disruption correlated with both the degree and side of lateralization. Subjects with weak lateralization (more bilaterality) were less affected by either left- or right-side TMS than were subjects with strong lateralization to one hemisphere. Thus in some people, language processing seems to be distributed evenly between the hemispheres, allowing for ready compensation after a unilateral lesion.	Univ Munster, Dept Neurol, D-48129 Munster, Germany; Harvard Univ, Sch Med, Lab Magnet Brain Stimulat, Boston, MA 02215 USA	University of Munster; Harvard University; Harvard Medical School	Knecht, S (corresponding author), Univ Munster, Dept Neurol, Albert Schweitzer Str 33, D-48129 Munster, Germany.		Pascual-Leone, Alvaro/G-6566-2011; Floel, Agnes/A-9426-2017; Pascual-Leone, Alvaro/AAC-5101-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382; Knecht, Stefan/0000-0003-1056-9228				Bakar M, 1996, ARCH NEUROL-CHICAGO, V53, P1026, DOI 10.1001/archneur.1996.00550100112020; Baynes K, 1998, SCIENCE, V280, P902, DOI 10.1126/science.280.5365.902; Binder JR, 1996, NEUROLOGY, V46, P978, DOI 10.1212/WNL.46.4.978; BOTTINI G, 1994, BRAIN, V117, P1241, DOI 10.1093/brain/117.6.1241; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Deppe M, 2000, J CEREBR BLOOD F MET, V20, P263, DOI 10.1097/00004647-200002000-00006; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Epstein CM, 1998, J CLIN NEUROPHYSIOL, V15, P325, DOI 10.1097/00004691-199807000-00004; Flitman SS, 1998, NEUROLOGY, V50, P175, DOI 10.1212/WNL.50.1.175; Gazzaniga MS, 1996, BRAIN, V119, P1255, DOI 10.1093/brain/119.4.1255; George MS, 1996, ARCH NEUROL-CHICAGO, V53, P665, DOI 10.1001/archneur.1996.00550070103017; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; JENNUM P, 1994, NEUROLOGY, V44, P269, DOI 10.1212/WNL.44.2.269; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Knecht S, 1998, STROKE, V29, P82, DOI 10.1161/01.STR.29.1.82; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Knecht S, 1998, STROKE, V29, P1155, DOI 10.1161/01.STR.29.6.1155; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; KURTHEN M, 1992, BRAIN LANG, V43, P694, DOI 10.1016/0093-934X(92)90091-R; LICHTHEIM L, 1884, BRAIN, V7, P443; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASCUALLEONE A, 1991, NEUROLOGY, V41, P697, DOI 10.1212/WNL.41.5.697; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Rafal R, 2001, NAT NEUROSCI, V4, P862, DOI 10.1038/nn0901-862; Risse GL, 1997, BRAIN COGNITION, V33, P118, DOI 10.1006/brcg.1997.0887; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wassermann EM, 1999, NEUROPSYCHOLOGIA, V37, P537, DOI 10.1016/S0028-3932(98)00102-X; WILLMES K, 1993, BRAIN, V116, P1527, DOI 10.1093/brain/116.6.1527	30	146	151	0	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					695	699		10.1038/nn868	http://dx.doi.org/10.1038/nn868			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12055632				2022-12-17	WOS:000176414300021
J	Sanders, LD; Newport, EL; Neville, HJ				Sanders, LD; Newport, EL; Neville, HJ			Segmenting nonsense: an event-related potential index of perceived onsets in continuous speech	NATURE NEUROSCIENCE			English	Article							BRAIN POTENTIALS; CUES; SEGMENTATION; INFANTS; WORDS	Speech segmentation, determining where one word ends and the next begins in continuous speech, is necessary for auditory language processing. However, because there are few direct indices of this fast, automatic process, it has been difficult to study. We recorded event-related brain potentials (ERPs) while adult humans listened to six pronounceable nonwords presented as continuous speech and compared the responses to nonword onsets before and after participants learned the nonsense words. In subjects showing the greatest behavioral evidence of word learning, word onsets elicited a larger N100 after than before training. Thus N100 amplitude indexes speech segmentation even for recently learned words without any acoustic segmentation cues. The timing and distribution of these results suggest specific processes that may be central to speech segmentation.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Rochester; University of Oregon	Sanders, LD (corresponding author), Univ Maryland, Dept Linguist, 3416 Marie Mt Hall, College Pk, MD 20742 USA.			Sanders, Lisa/0000-0001-6763-1462	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000128, R01DC000167, F32DC000128, R01DC000481] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC00481, DC00167, R01 DC000128-24, R01 DC000481, F32 DC000128, DC00128, R01 DC000167-26, R01 DC000167, R01 DC000128, R01 DC000167-21, R01 DC000481-12] Funding Source: Medline; NIGMS NIH HHS [T32 GM007257, 5-T32-GM07257] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHWILLA DJ, 1995, PSYCHOPHYSIOLOGY, V32, P274, DOI 10.1111/j.1469-8986.1995.tb02956.x; CUTLER A, 1992, J MEM LANG, V31, P218, DOI 10.1016/0749-596X(92)90012-M; CUTLER A, 1989, NATURE, V340, P229, DOI 10.1038/340229a0; HANSON JS, 1990, ECOL MODEL, V49, P277, DOI 10.1016/0304-3800(90)90031-B; HINK RF, 1978, BIOL PSYCHOL, V6, P1, DOI 10.1016/0301-0511(78)90002-9; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; JUSCZYK PW, 1995, COGNITIVE PSYCHOL, V29, P1, DOI 10.1006/cogp.1995.1010; McCandliss BD, 1997, COGNITIVE PSYCHOL, V33, P88, DOI 10.1006/cogp.1997.0661; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Sanders LD, 2000, J SPEECH LANG HEAR R, V43, P1301, DOI 10.1044/jslhr.4306.1301; SANDERS LD, IN PRESS COGN BRAIN; SANDERS LD, IN PRESS J SPEECH LA	13	146	148	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					700	703		10.1038/nn873	http://dx.doi.org/10.1038/nn873			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	566EP	12068301	Green Accepted			2022-12-17	WOS:000176414300022
J	Schmidt, MF; Konishi, M				Schmidt, MF; Konishi, M			Gating of auditory responses in the vocal control system of awake songbirds	NATURE NEUROSCIENCE			English	Article							WHITE-CROWNED SPARROW; ADULT ZEBRA FINCHES; SONG SYSTEM; CONTROL NUCLEUS; MAINTENANCE; PATHWAYS; FEEDBACK; NEURONS; BIRDS; ORGANIZATION	Nucleus HVc of the avian song system is a forebrain structure critical in song production, perception and learning. Here we show that most HVc neurons that respond to auditory stimuli under anesthesia show no responses to the same stimulus in the awake, unrestrained bird. This suppression of auditory responses in awake birds does not occur in the forebrain field L complex, which is one of the auditory input stages for HVc. Gating of auditory input at the junction between the auditory and vocal control system may be essential for regulating auditory feedback signals necessary for song learning and maintenance.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Schmidt, MF (corresponding author), CALTECH, Div Biol, M-C 216-76, Pasadena, CA 91125 USA.	schmidt@etho.caltech.edu	Schmidt, Marc/B-1597-2008		NIDCD NIH HHS [DC00125, R03 DC03041] Funding Source: Medline; NIH HHS [NH55984] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC003041] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; BRENOWITZ EA, 1991, SCIENCE, V251, P303, DOI 10.1126/science.1987645; Capsius B, 1996, HEARING RES, V96, P59, DOI 10.1016/0378-5955(96)00038-X; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Doupe A J, 1993, Curr Opin Neurobiol, V3, P104, DOI 10.1016/0959-4388(93)90043-X; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Lewicki MS, 1996, J NEUROSCI, V16, P5854; Lewicki MS, 1996, J NEUROSCI, V16, P6987; Li R, 1997, BRAIN RES, V763, P239, DOI 10.1016/S0006-8993(97)00417-4; Margoliash D, 1997, J NEUROBIOL, V33, P671, DOI 10.1002/(SICI)1097-4695(19971105)33:5<671::AID-NEU12>3.0.CO;2-C; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; MCCASLAND JS, 1981, P NATL ACAD SCI-BIOL, V78, P7815, DOI 10.1073/pnas.78.12.7815; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; METZNER W, 1993, J NEUROSCI, V13, P1899; MUELLER-PREUSS P, 1981, Brain Research, V215, P61; Newsome WT, 1996, CURR BIOL, V6, P357, DOI 10.1016/S0960-9822(02)00494-3; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Okanoya K, 1997, J NEUROBIOL, V33, P343; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; Reinke H, 1998, J COMP NEUROL, V391, P147; Schmidt MF, 1998, J NEUROSCI, V18, P895; Striedter GF, 1998, J NEUROBIOL, V34, P27, DOI 10.1002/(SICI)1097-4695(199801)34:1<27::AID-NEU3>3.0.CO;2-E; TENCATE C, 1984, BEHAVIOUR, V91, P263, DOI 10.1163/156853984X00100; TODT D, 1986, VERHALTENSBIOLOGIE, P22; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Vates GE, 1997, J COMP NEUROL, V380, P275; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; VICARIO DS, 1993, J NEUROBIOL, V24, P488, DOI 10.1002/neu.480240407; Volman SF, 1996, J COMP PHYSIOL A, V178, P849; VU ET, 1994, J NEUROSCI, V14, P6924; WASER MS, 1976, J COMP PHYSIOL PSYCH, V91, P28; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	40	146	147	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					513	518		10.1038/2232	http://dx.doi.org/10.1038/2232			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196550				2022-12-17	WOS:000076406900017
J	Gouwens, NW; Sorensen, SA; Berg, J; Lee, C; Jarsky, T; Ting, J; Sunkin, SM; Feng, D; Anastassiou, CA; Barkan, E; Bickley, K; Blesie, N; Braun, T; Brouner, K; Budzillo, A; Caldejon, S; Casper, T; Castelli, D; Chong, P; Crichton, K; Cuhaciyan, C; Daigle, TL; Dailey, R; Dee, N; Desta, T; Ding, SL; Dingman, S; Doperalski, A; Dotson, N; Egdorf, T; Fisher, M; de Frates, RA; Garren, E; Garwood, M; Gary, A; Gaudreault, N; Godfrey, K; Gorham, M; Gu, H; Habel, C; Hadley, K; Harrington, J; Harris, JA; Henry, A; Hill, D; Josephsen, S; Kebede, S; Kim, L; Kroll, M; Lee, B; Lemon, T; Link, KE; Liu, XX; Long, B; Mann, R; McGraw, M; Mihalas, S; Mukora, A; Murphy, GJ; Ng, L; Ngo, K; Nguyen, TN; Nicovich, PR; Oldre, A; Park, D; Parry, S; Perkins, J; Potekhina, L; Reid, D; Robertson, M; Sandman, D; Schroedter, M; Slaughterbeck, C; Soler-Llavina, G; Sulc, J; Szafer, A; Tasic, B; Taskin, N; Teeter, C; Thatra, N; Tung, H; Wakeman, W; Williams, G; Young, R; Zhou, Z; Farrell, C; Peng, HC; Hawrylycz, MJ; Lein, E; Ng, L; Arkhipov, A; Bernard, A; Phillips, JW; Zeng, HK; Koch, C				Gouwens, Nathan W.; Sorensen, Staci A.; Berg, Jim; Lee, Changkyu; Jarsky, Tim; Ting, Jonathan; Sunkin, Susan M.; Feng, David; Anastassiou, Costas A.; Barkan, Eliza; Bickley, Kris; Blesie, Nicole; Braun, Thomas; Brouner, Krissy; Budzillo, Agata; Caldejon, Shiella; Casper, Tamara; Castelli, Dan; Chong, Peter; Crichton, Kirsten; Cuhaciyan, Christine; Daigle, Tanya L.; Dailey, Rachel; Dee, Nick; Desta, Tsega; Ding, Song-Lin; Dingman, Samuel; Doperalski, Alyse; Dotson, Nadezhda; Egdorf, Tom; Fisher, Michael; de Frates, Rebecca A.; Garren, Emma; Garwood, Marissa; Gary, Amanda; Gaudreault, Nathalie; Godfrey, Keith; Gorham, Melissa; Gu, Hong; Habel, Caroline; Hadley, Kristen; Harrington, James; Harris, Julie A.; Henry, Alex; Hill, DiJon; Josephsen, Sam; Kebede, Sara; Kim, Lisa; Kroll, Matthew; Lee, Brian; Lemon, Tracy; Link, Katherine E.; Liu, Xiaoxiao; Long, Brian; Mann, Rusty; McGraw, Medea; Mihalas, Stefan; Mukora, Alice; Murphy, Gabe J.; Ng, Lindsay; Ngo, Kiet; Thuc Nghi Nguyen; Nicovich, Philip R.; Oldre, Aaron; Park, Daniel; Parry, Sheana; Perkins, Jed; Potekhina, Lydia; Reid, David; Robertson, Miranda; Sandman, David; Schroedter, Martin; Slaughterbeck, Cliff; Soler-Llavina, Gilberto; Sulc, Josef; Szafer, Aaron; Tasic, Bosiljka; Taskin, Naz; Teeter, Corinne; Thatra, Nivretta; Tung, Herman; Wakeman, Wayne; Williams, Grace; Young, Rob; Zhou, Zhi; Farrell, Colin; Peng, Hanchuan; Hawrylycz, Michael J.; Lein, Ed; Ng, Lydia; Arkhipov, Anton; Bernard, Amy; Phillips, John W.; Zeng, Hongkui; Koch, Christof			Classification of electrophysiological and morphological neuron types in the mouse visual cortex	NATURE NEUROSCIENCE			English	Article							CELL-TYPES; GABAERGIC INTERNEURONS; PYRAMIDAL NEURONS; VISUALIZATION; DIVERSITY; CIRCUITS; MODELS	Understanding the diversity of cell types in the brain has been an enduring challenge and requires detailed characterization of individual neurons in multiple dimensions. To systematically profile morpho-electric properties of mammalian neurons, we established a single-cell characterization pipeline using standardized patch-clamp recordings in brain slices and biocytin-based neuronal reconstructions. We built a publicly accessible online database, the Allen Cell Types Database, to display these datasets. Intrinsic physiological properties were measured from 1,938 neurons from the adult laboratory mouse visual cortex, morphological properties were measured from 461 reconstructed neurons, and 452 neurons had both measurements available. Quantitative features were used to classify neurons into distinct types using unsupervised methods. We established a taxonomy of morphologically and electrophysiologically defined cell types for this region of the cortex, with 17 electrophysiological types, 38 morphological types and 46 morpho-electric types. There was good correspondence with previously defined transcriptomic cell types and subclasses using the same transgenic mouse lines.	[Gouwens, Nathan W.; Sorensen, Staci A.; Berg, Jim; Lee, Changkyu; Jarsky, Tim; Ting, Jonathan; Sunkin, Susan M.; Feng, David; Anastassiou, Costas A.; Barkan, Eliza; Bickley, Kris; Blesie, Nicole; Braun, Thomas; Brouner, Krissy; Budzillo, Agata; Caldejon, Shiella; Casper, Tamara; Castelli, Dan; Chong, Peter; Crichton, Kirsten; Cuhaciyan, Christine; Daigle, Tanya L.; Dailey, Rachel; Dee, Nick; Desta, Tsega; Ding, Song-Lin; Dingman, Samuel; Doperalski, Alyse; Dotson, Nadezhda; Egdorf, Tom; Fisher, Michael; de Frates, Rebecca A.; Garren, Emma; Garwood, Marissa; Gary, Amanda; Gaudreault, Nathalie; Godfrey, Keith; Gorham, Melissa; Gu, Hong; Habel, Caroline; Hadley, Kristen; Harrington, James; Harris, Julie A.; Henry, Alex; Hill, DiJon; Josephsen, Sam; Kebede, Sara; Kim, Lisa; Kroll, Matthew; Lee, Brian; Lemon, Tracy; Link, Katherine E.; Liu, Xiaoxiao; Long, Brian; Mann, Rusty; McGraw, Medea; Mihalas, Stefan; Mukora, Alice; Murphy, Gabe J.; Ng, Lindsay; Ngo, Kiet; Thuc Nghi Nguyen; Nicovich, Philip R.; Oldre, Aaron; Park, Daniel; Parry, Sheana; Perkins, Jed; Potekhina, Lydia; Reid, David; Robertson, Miranda; Sandman, David; Schroedter, Martin; Slaughterbeck, Cliff; Soler-Llavina, Gilberto; Sulc, Josef; Szafer, Aaron; Tasic, Bosiljka; Taskin, Naz; Teeter, Corinne; Thatra, Nivretta; Tung, Herman; Wakeman, Wayne; Williams, Grace; Young, Rob; Zhou, Zhi; Farrell, Colin; Peng, Hanchuan; Hawrylycz, Michael J.; Lein, Ed; Ng, Lydia; Arkhipov, Anton; Bernard, Amy; Phillips, John W.; Zeng, Hongkui; Koch, Christof] Allen Inst Brain Sci, Seattle, WA 98109 USA	Allen Institute for Brain Science	Zeng, HK (corresponding author), Allen Inst Brain Sci, Seattle, WA 98109 USA.	hongkuiz@alleninstitute.org	Arkhipov, Anton/AAE-7801-2020	Arkhipov, Anton/0000-0003-1106-8310; Ding, Song-Lin/0000-0002-7072-5272; Ng, Lindsay/0000-0002-4134-1608; Tung, Herman/0000-0002-0812-3318; Bernard, Amy/0000-0003-2540-1153; de Frates, Rebecca/0000-0002-7820-093X; Barkan, Eliza/0000-0001-7871-4327; Budzillo, Agata/0000-0002-1762-435X; Long, Brian/0000-0002-7793-5969; Berg, Jim/0000-0002-3300-5399; Feng, David/0000-0002-4920-8123; Ting, Jonathan/0000-0001-8266-0392; McGraw, Medea/0000-0001-5267-489X; Budzillo, Agata/0000-0002-2723-3272; Gorham, Melissa/0000-0002-6770-9474; Dee, Nick/0000-0002-2831-9254	Allen Institute for Brain Science; National Institute of Mental Health and Eunice Kennedy Shriver National Institute of Child Health & Human Development, parts of the National Institutes of Health [U01MH105982]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105982] Funding Source: NIH RePORTER	Allen Institute for Brain Science; National Institute of Mental Health and Eunice Kennedy Shriver National Institute of Child Health & Human Development, parts of the National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Z. Popovich for creating the Mozak custom user interface for the 3D reconstruction software Vaa3D and the Mozak citizen-scientists who contributed to the reconstruction work. They also thank B. Berg, S. Coulter, C. Dang, and A. Jones for leadership and guidance. This work was funded by the Allen Institute for Brain Science. The study was also supported by award number U01MH105982 to H.Z. from the National Institute of Mental Health and Eunice Kennedy Shriver National Institute of Child Health & Human Development, parts of the National Institutes of Health. The content in this story and the associated study do not necessarily represent the official views of the NIH. We dedicate this paper to the vision, encouragement, and long-term support of our founder, Paul G. Allen.	Arkhipov A, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006535; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Ascoli GA, 2007, J NEUROSCI, V27, P9247, DOI 10.1523/JNEUROSCI.2055-07.2007; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Baudry JP, 2010, J COMPUT GRAPH STAT, V19, P332, DOI 10.1198/jcgs.2010.08111; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bernard A, 2009, CURR OPIN NEUROBIOL, V19, P530, DOI 10.1016/j.conb.2009.09.010; Boldog E, 2018, NAT NEUROSCI, V21, P1185, DOI 10.1038/s41593-018-0205-2; Bortone DS, 2014, NEURON, V82, P474, DOI 10.1016/j.neuron.2014.02.021; Braitenberg VB, 1998, CORTEX STAT GEOMETRY; Breiman L., 1984, CLASSIFICATION REGRE, DOI DOI 10.1201/9781315139470; Bria A, 2016, NAT METHODS, V13, P192, DOI 10.1038/nmeth.3767; Daigle TL, 2018, CELL, V174, P465, DOI 10.1016/j.cell.2018.06.035; Dehorter N, 2015, SCIENCE, V349, P1216, DOI 10.1126/science.aab3415; Deitcher Y, 2017, CEREB CORTEX, V27, P5398, DOI 10.1093/cercor/bhx226; Druckmann S, 2013, CEREB CORTEX, V23, P2994, DOI 10.1093/cercor/bhs290; Egger V, 2008, CEREB CORTEX, V18, P876, DOI 10.1093/cercor/bhm126; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Gouwens NW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02718-3; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; He M, 2016, NEURON, V92, P555, DOI 10.1016/j.neuron.2016.10.009; Hennig C, 2007, COMPUT STAT DATA AN, V52, P258, DOI 10.1016/j.csda.2006.11.025; James G, 2014, INTRO STAT LEARNING; Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462; Kaczorowski CC, 2007, J PHYSIOL-LONDON, V578, P799, DOI 10.1113/jphysiol.2006.124586; Kanari L, 2019, CEREB CORTEX, V29, P1719, DOI 10.1093/cercor/bhy339; Killick R, 2012, J AM STAT ASSOC, V107, P1590, DOI 10.1080/01621459.2012.737745; Kim EJ, 2015, NEURON, V88, P1253, DOI 10.1016/j.neuron.2015.11.002; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Lodato S, 2015, ANNU REV CELL DEV BI, V31, P699, DOI 10.1146/annurev-cellbio-100814-125353; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Paul A, 2017, CELL, V171, P522, DOI 10.1016/j.cell.2017.08.032; Peng HC, 2014, NAT PROTOC, V9, P193, DOI 10.1038/nprot.2014.011; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Schubert D, 2003, J NEUROSCI, V23, P2961; Scorcioni R, 2008, NAT PROTOC, V3, P866, DOI 10.1038/nprot.2008.51; Stockton DB, 2017, NEUROINFORMATICS, V15, P333, DOI 10.1007/s12021-017-9337-x; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Tebaykin D, 2018, J NEUROPHYSIOL, V119, P1329, DOI 10.1152/jn.00604.2017; Teeter C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02717-4; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Tremblay R, 2016, NEURON, V91, P260, DOI 10.1016/j.neuron.2016.06.033; Tripathy SJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005814; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; von Engelhardt J, 2007, J NEUROSCI, V27, P5633, DOI 10.1523/JNEUROSCI.4647-06.2007; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zeng HK, 2017, NAT REV NEUROSCI, V18, P530, DOI 10.1038/nrn.2017.85; ZHANG L, 1994, PFLUG ARCH EUR J PHY, V426, P247, DOI 10.1007/BF00374778; Zhou Z, 2016, NEUROINFORMATICS, V14, P41, DOI 10.1007/s12021-015-9278-1; Zhou Z, 2015, NEUROINFORMATICS, V13, P153, DOI 10.1007/s12021-014-9249-y; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	58	145	144	7	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2019	22	7					1182	+		10.1038/s41593-019-0417-0	http://dx.doi.org/10.1038/s41593-019-0417-0			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IE8GO	31209381	Green Submitted, Green Accepted			2022-12-17	WOS:000472612100019
J	Lim, ET; Uddin, M; De Rubeis, S; Chan, Y; Kamumbu, AS; Zhang, XC; D'Gama, AM; Kim, SN; Hill, RS; Goldberg, AP; Poultney, C; Minshew, NJ; Kushima, I; Aleksic, B; Ozaki, N; Parellada, M; Arango, C; Penzol, MJ; Carracedo, A; Kolevzon, A; Hultman, CM; Weiss, LA; Fromer, M; Chiocchetti, AG; Freitag, CM; Church, GM; Scherer, SW; Buxbaum, JD; Walsh, CA				Lim, Elaine T.; Uddin, Mohammed; De Rubeis, Silvia; Chan, Yingleong; Kamumbu, Anne S.; Zhang, Xiaochang; D'Gama, Alissa M.; Kim, Sonia N.; Hill, Robert Sean; Goldberg, Arthur P.; Poultney, Christopher; Minshew, Nancy J.; Kushima, Itaru; Aleksic, Branko; Ozaki, Norio; Parellada, Mara; Arango, Celso; Penzol, Maria J.; Carracedo, Angel; Kolevzon, Alexander; Hultman, Christina M.; Weiss, Lauren A.; Fromer, Menachem; Chiocchetti, Andreas G.; Freitag, Christine M.; Church, George M.; Scherer, Stephen W.; Buxbaum, Joseph D.; Walsh, Christopher A.		Autism Sequencing Consortium	Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder	NATURE NEUROSCIENCE			English	Article							DE-NOVO MUTATIONS; SMALL-CELL CARCINOMA; SOMATIC MUTATIONS; RISK; SMARCA4; GENES; FRAMEWORK; SELECTION; AMYGDALA; GENOME	We systematically analyzed postzygotic mutations (PZMs) in whole-exome sequences from the largest collection of trios (5,947) with autism spectrum disorder (ASD) available, including 282 unpublished trios, and performed resequencing using multiple independent technologies. We identified 7.5% of de novo mutations as PZMs, 83.3% of which were not described in previous studies. Damaging, nonsynonymous PZMs within critical exons of prenatally expressed genes were more common in ASD probands than controls (P < 1 x 10(-6)), and genes carrying these PZMs were enriched for expression in the amygdala (P = 5.4 x 10(-3)). Two genes (KLF16 and MSANTD2) were significantly enriched for PZMs genome-wide, and other PZMs involved genes (SCN2A, HNRNPU and SMARCA4) whose mutation is known to cause ASD or other neurodevelopmental disorders. PZMs constitute a significant proportion of de novo mutations and contribute importantly to ASD risk.	[Lim, Elaine T.; Kamumbu, Anne S.; Zhang, Xiaochang; D'Gama, Alissa M.; Kim, Sonia N.; Hill, Robert Sean; Walsh, Christopher A.] Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Gen, Boston, MA USA; [Lim, Elaine T.; Kamumbu, Anne S.; Zhang, Xiaochang; D'Gama, Alissa M.; Kim, Sonia N.; Hill, Robert Sean; Walsh, Christopher A.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Lim, Elaine T.; Kamumbu, Anne S.; Zhang, Xiaochang; D'Gama, Alissa M.; Kim, Sonia N.; Hill, Robert Sean; Walsh, Christopher A.] Harvard Med Sch, Dept Pediat & Neurol, Boston, MA 02215 USA; [Lim, Elaine T.; Chan, Yingleong; Kamumbu, Anne S.; Zhang, Xiaochang; D'Gama, Alissa M.; Kim, Sonia N.; Hill, Robert Sean; Church, George M.; Walsh, Christopher A.] Broad Inst & Harvard, Program Med & Populat Genet, Cambridge, MA 02138 USA; [Lim, Elaine T.; Chan, Yingleong; Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Uddin, Mohammed] Mohammed Bin Rashid Univ Med & Hlth Sci, Coll Med, Dubai, U Arab Emirates; [De Rubeis, Silvia; Goldberg, Arthur P.; Poultney, Christopher; Kolevzon, Alexander; Fromer, Menachem; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [De Rubeis, Silvia; Goldberg, Arthur P.; Poultney, Christopher; Fromer, Menachem; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Minshew, Nancy J.] Univ Pittsburgh, Ctr Excellence Autism Res, Dept Psychiat, Pittsburgh, PA USA; [Kushima, Itaru; Aleksic, Branko; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi, Japan; [Parellada, Mara; Arango, Celso] Univ Complutense, Hosp Gen Univ Gregorio Maranon, CIBERSAM, IiSGM,Sch Med,Child & Adolescent Psychiat Dept, Madrid, Spain; [Penzol, Maria J.] Hosp Gen Univ Gregorio Maranon, CIBERSAM, IiSGM, Child & Adolescent Psychiat Dept, Madrid, Spain; [Carracedo, Angel] Univ Santiago Compostela, Ctr Nacl Genotipado Plataforma Recursos Biomol &, Inst Salud Carlos III, CeGen PRB2 ISCIII,Grp Med Xenom, Santiago De Compostela, Spain; [Carracedo, Angel] SERGAS, CIBERER, Fdn Publ Galega Med Xenom, Grp Med Xenom, Santiago De Compostela, Spain; [Carracedo, Angel] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah, Saudi Arabia; [Kolevzon, Alexander; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Kolevzon, Alexander] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Kolevzon, Alexander] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiss, Lauren A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Weiss, Lauren A.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA USA; [Fromer, Menachem] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Chiocchetti, Andreas G.; Freitag, Christine M.] Goethe Univ, Univ Hosp Frankfurt, Autism Res & Intervent Ctr Excellence, Dept Child & Adolescent Psychiat Psychosomat & Ps, Frankfurt, Germany; [Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Gen, Toronto, ON, Canada; [Scherer, Stephen W.] Hosp Sick Children, Program Genet & Genome Biol GGB, Toronto, ON, Canada; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON, Canada; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nagoya University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Complutense University of Madrid; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; General University Gregorio Maranon Hospital; Instituto de Salud Carlos III; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; King Abdulaziz University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Karolinska Institutet; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Icahn School of Medicine at Mount Sinai	Walsh, CA (corresponding author), Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Gen, Boston, MA USA.; Walsh, CA (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.; Walsh, CA (corresponding author), Harvard Med Sch, Dept Pediat & Neurol, Boston, MA 02215 USA.; Walsh, CA (corresponding author), Broad Inst & Harvard, Program Med & Populat Genet, Cambridge, MA 02138 USA.	elimtt@gmail.com; Christopher.Walsh@childrens.harvard.edu	Parellada, Mara/AAQ-1272-2021; Lim, Elaine/H-9032-2016; Maciel, Patricia/AAH-2102-2020; Maciel, Patrícia/B-5989-2009; Aleksic, Branko/G-1540-2011; Ozaki, Norio/M-8908-2014; Passos-Bueno, Maria Rita/I-6796-2016; Arango, Celso/AAZ-8314-2021; Parellada, Mara/GQH-7619-2022; Betancur, Catalina/K-3791-2017; Yu, Timothy W./AAF-5738-2019; Aleksic, Branko/L-7851-2019; Scherer, Stephen W./B-3785-2013; Reichenberg, Abraham/GQB-1227-2022; De Rubeis, Silvia/E-9852-2013; Carracedo, Angel/D-4257-2012; Sandin, Sven/L-5357-2015; Buxbaum, Joseph D/G-6001-2010	Parellada, Mara/0000-0001-7977-3601; Maciel, Patricia/0000-0002-0920-6350; Maciel, Patrícia/0000-0002-0920-6350; Aleksic, Branko/0000-0001-8982-4580; Ozaki, Norio/0000-0002-7360-4898; Passos-Bueno, Maria Rita/0000-0002-9248-3008; Arango, Celso/0000-0003-3382-4754; Betancur, Catalina/0000-0002-3327-4804; Yu, Timothy W./0000-0003-2988-7701; Aleksic, Branko/0000-0001-8982-4580; Scherer, Stephen W./0000-0002-8326-1999; De Rubeis, Silvia/0000-0001-9383-6883; Carracedo, Angel/0000-0003-1085-8986; Sandin, Sven/0000-0001-6994-4884; church, george/0000-0001-6232-9969; Buxbaum, Joseph/0000-0001-8898-8313; Fernandez-Prieto, Montse/0000-0003-3800-9476; PENZOL, MARIA JOSE/0000-0002-5282-9502; Freitag, Christine Margarete/0000-0001-9676-4782; Walsh, Christopher/0000-0002-0156-2238; Lee, So Lun/0000-0003-3056-9778; Kim, Sonia Nan/0000-0002-2998-2621; Lim, Teng Ting/0000-0003-3651-0654; Kushima, Itaru/0000-0002-0018-5178; Chiocchetti, Andreas G/0000-0002-7329-9985; Uddin, Mohammed/0000-0001-6867-5803; Hansen-Kiss, Emily/0000-0002-5263-9581	Simons Foundation [178093, 368485]; National Institutes of Health (NIH) [R01MH083565, RC2MH089952, U01MH106883, R01MH097849, U01MH100233, U01MH100209, U01MH100229, U01MH100239, U01MH111661, U01MH111660, U01MH111658, U01MH111662]; Centre for Applied Genomics; University of Toronto McLaughlin Centre; Genome Canada; Autism Speaks; AMED; Spanish Ministry of Economy and Competitiveness; Instituto de Salud Carlos III; CIBERSAM; ERA-NET NEURON; Network of European Funding for Neuroscience Research; Fundacion Maria Jose Jove; Institute of Health Carlos III-Fondo de Investigaciones Sanitarias [PI13/01136]; Seaver Foundation; Office of Research Infrastructure of the National Institutes of Health [S10OD018522]; NIH [NCRR 1S10RR028832-01]; NHLBI [HL-102923, HL-102924, HL-102925, HL-102926, HL-103010]; GlaxoSmithKline-Canadian Institutes of Heath Research Chair in Genome Sciences at the Hospital for Sick Children; University of Toronto; NIGMS [T32GM007753]; NRSA [5T32 GM007226-39];  [PI10/02989]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028832] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL102926, UC2HL103010, UC2HL102923, RC2HL102924, RC2HL102923, RC2HL102926, UC2HL102925, UC2HL102924, RC2HL102925, RC2HL103010] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG008525, P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007226, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH106883, RC2MH089952, R21MH106888, U01MH111661, U01MH100239, R01MH097849, R01MH113362, R01MH083565, R01MH095797, U01MH100233, U01MH100209, U01MH100229, U01MH111662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032457] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	Simons Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre for Applied Genomics; University of Toronto McLaughlin Centre; Genome Canada(Genome Canada); Autism Speaks; AMED; Spanish Ministry of Economy and Competitiveness(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); CIBERSAM; ERA-NET NEURON; Network of European Funding for Neuroscience Research; Fundacion Maria Jose Jove; Institute of Health Carlos III-Fondo de Investigaciones Sanitarias; Seaver Foundation; Office of Research Infrastructure of the National Institutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); GlaxoSmithKline-Canadian Institutes of Heath Research Chair in Genome Sciences at the Hospital for Sick Children; University of Toronto(University of Toronto); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to all the families who participated in the research, including the Simons Foundation Autism Research Initiative (SFARI) Simplex Collection (SSC), the Autism Sequencing Consortium (ASC) and Autism Speaks. We acknowledge the clinicians and organizations that contributed to samples used in this study, including the ASC and SSC principal investigators; the coordinators and staff at the ASC and SSC sites for the recruitment and comprehensive assessment of simplex families; and the ASC, SFARI and NDAR staff for facilitating access to the data sets. This work was supported by a grant from the Simons Foundation (178093, C.A.W.); the National Institutes of Health (NIH) grants R01MH083565, RC2MH089952 and U01MH106883 to C.A.W.; grants R01MH097849, U01MH100233, U01MH100209, U01MH100229, U01MH100239, U01MH111661, U01MH111660, U01MH111658, U01MH111662 and R01MH097849 to the Autism Sequencing Consortium; grants from the Centre for Applied Genomics, the University of Toronto McLaughlin Centre, Genome Canada and Autism Speaks (S.W.S.); Simons Foundation grant (368485, G.M.C.); SRPBS and Brain/MINDS grants from AMED (I.K., B.A., N.O.); grants from the Spanish Ministry of Economy and Competitiveness (M.P.), Instituto de Salud Carlos III (M.P.), PI10/02989 (M.P.), CIBERSAM (M.P.) and ERA-NET NEURON (M.P., C.M.F.), Network of European Funding for Neuroscience Research (M.P.), and Fundacion Maria Jose Jove and The Institute of Health Carlos III-Fondo de Investigaciones Sanitarias grant project PI13/01136 (A.C.) and the Seaver Foundation. We thank A. Hossain and N. Hatem for their help with sample preparation; F. Zhao and C. Stevens for their help with reprocessing the BAM files; and M. Daly, S. McCarroll, G. Genovese and J. Hirschhorn for comments and suggestions. Research reported in this paper was supported by the Office of Research Infrastructure of the National Institutes of Health under award number S10OD018522. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was supported in part through the computational resources and staff expertise provided by the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai. Additional computing support was provided by the Harvard Medical School's Orchestra High-Performance Computing Group, which is partially supported by NIH grant NCRR 1S10RR028832-01. The NHLBI GO Exome Sequencing Project and its ongoing studies produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010). C.A.W. is an Investigator of the Howard Hughes Medical Institute; S.W.S. is funded by the GlaxoSmithKline-Canadian Institutes of Heath Research Chair in Genome Sciences at the Hospital for Sick Children and University of Toronto; A.M.D. is supported by the NIGMS (T32GM007753) and NRSA (5T32 GM007226-39); S.D.R. is supported by the Seaver Foundation.	Acuna-Hidalgo R, 2015, AM J HUM GENET, V97, P67, DOI 10.1016/j.ajhg.2015.05.008; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Campbell IM, 2014, AM J HUM GENET, V95, P173, DOI 10.1016/j.ajhg.2014.07.003; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Freed D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006245; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jamuar SS, 2014, NEW ENGL J MED, V371, P733, DOI 10.1056/NEJMoa1314432; Jelinic P, 2014, NAT GENET, V46, P424, DOI 10.1038/ng.2922; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Kosho T, 2014, AM J MED GENET C, V166, P262, DOI 10.1002/ajmg.c.31407; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Le Loarer F, 2015, NAT GENET, V47, P1200, DOI 10.1038/ng.3399; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; O'Roak BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6595; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Prendergast JGD, 2011, GENOME RES, V21, P1777, DOI 10.1101/gr.122275.111; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Ramos P, 2014, NAT GENET, V46, P427, DOI 10.1038/ng.2928; Rutishauser U, 2013, NEURON, V80, P887, DOI 10.1016/j.neuron.2013.08.029; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Uddin M, 2014, NAT GENET, V46, P742, DOI 10.1038/ng.2980; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002	50	145	149	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2017	20	9					1217	+		10.1038/nn.4598	http://dx.doi.org/10.1038/nn.4598			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FF0JJ	28714951	Green Submitted, Green Accepted			2022-12-17	WOS:000408587700008
J	Zimmer, ER; Parent, MJ; Souza, DG; Leuzy, A; Lecrux, C; Kim, HI; Gauthier, S; Pellerin, L; Hamel, E; Rosa-Neto, P				Zimmer, Eduardo R.; Parent, Maxime J.; Souza, Debora G.; Leuzy, Antoine; Lecrux, Clotilde; Kim, Hyoung-Ihl; Gauthier, Serge; Pellerin, Luc; Hamel, Edith; Rosa-Neto, Pedro			[F-18]FDG PET signal is driven by astroglial glutamate transport	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; ENERGY-METABOLISM; ASTROCYTES; BRAIN; EXPRESSION; NEURONS; MODEL	Contributions of glial cells to neuroenergetics have been the focus of extensive debate. Here we provide positron emission tomography evidence that activation of astrocytic glutamate transport via the excitatory amino acid transporter GLT-1 triggers widespread but graded glucose uptake in the rodent brain. Our results highlight the need for a reevaluation of the interpretation of [F-18]FDG positron emission tomography data, whereby astrocytes would be recognized as contributing to the [F-18]FDG signal.	[Zimmer, Eduardo R.; Parent, Maxime J.; Leuzy, Antoine; Gauthier, Serge; Rosa-Neto, Pedro] McGill Univ, TNL, MCSA, Douglas Mental Hlth Univ Inst,Dept Neurol & Neuro, Montreal, PQ, Canada; [Zimmer, Eduardo R.; Parent, Maxime J.; Leuzy, Antoine; Gauthier, Serge; Rosa-Neto, Pedro] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Zimmer, Eduardo R.; Parent, Maxime J.; Leuzy, Antoine; Gauthier, Serge; Rosa-Neto, Pedro] McGill Univ, Dept Pharmacol, Montreal, PQ, Canada; [Zimmer, Eduardo R.; Souza, Debora G.] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil; [Lecrux, Clotilde] McGill Univ, Montreal Neurol Inst, Lab Cerebrovasc Res, Montreal, PQ, Canada; [Kim, Hyoung-Ihl] Gwangju Inst Sci & Technol, Dept Med Syst Engn, Gwangju, South Korea; [Kim, Hyoung-Ihl] Gwangju Inst Sci & Technol, Sch Mechatron, Gwangju, South Korea; [Kim, Hyoung-Ihl] Presbyterian Med Ctr, Dept Neurosurg, Jeonju, South Korea; [Rosa-Neto, Pedro] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Souza, Debora G.; Pellerin, Luc] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Zimmer, Eduardo R.] Pontificia Univ Catolica Rio Grande do Sul, Brain Inst Rio Grande do Sul BraIns, Porto Alegre, RS, Brazil; [Leuzy, Antoine] Karolinska Inst, Div Translat Alzheimers Neurobiol, Dept Neurobiol Care Sci & Soc, Ctr Alzheimers Res, Stockholm, Sweden	McGill University; McGill University; McGill University; Universidade Federal do Rio Grande do Sul; McGill University; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); McGill University; University of Lausanne; Pontificia Universidade Catolica Do Rio Grande Do Sul; Karolinska Institutet	Rosa-Neto, P (corresponding author), McGill Univ, TNL, MCSA, Douglas Mental Hlth Univ Inst,Dept Neurol & Neuro, Montreal, PQ, Canada.; Rosa-Neto, P (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.; Rosa-Neto, P (corresponding author), McGill Univ, Dept Pharmacol, Montreal, PQ, Canada.; Rosa-Neto, P (corresponding author), McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada.	pedro@bic.mni.mcgill.ca	Zimmer, Eduardo R Rigon/I-2932-2015; Rosa-Neto, Pedro/F-5077-2015; Lecrux, Clotilde/AAG-1415-2019; Pellerin, Luc/A-8912-2017	Zimmer, Eduardo R Rigon/0000-0002-5349-0053; Rosa-Neto, Pedro/0000-0001-9116-1376; Lecrux, Clotilde/0000-0003-3521-5266; Pellerin, Luc/0000-0002-1016-1970	iMSE from GIST; National Research Foundation of Korea [NRF:2013R1A2A2A01067890]; Canadian Institutes of Health Research (CIHR) [MOP-11-51-31, MOP-142417]; Alan Tiffin Foundation; Alzheimer's Association [NIRG-08-92090]; Fonds de la recherche en sante du Quebec; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); INCT for Excitotoxicity and Neuroprotection; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); department of Physiology, University of Lausanne	iMSE from GIST; National Research Foundation of Korea(National Research Foundation of Korea); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alan Tiffin Foundation; Alzheimer's Association(Alzheimer's Association); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); INCT for Excitotoxicity and Neuroprotection; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); department of Physiology, University of Lausanne	We thank D. Onofre Souza, L. Valmor Cruz Portela, F. Urruth Fontella and A. Silva da Rocha from the Department of Biochemistry at UFRGS for fruitful discussions and for helping to conduct biochemical assays. This work was supported by a grant from iMSE from GIST and by the National Research Foundation of Korea (NRF:2013R1A2A2A01067890 to H.-I.K.), the Canadian Institutes of Health Research (CIHR; MOP-11-51-31 to P.R.-N. and MOP-142417 to EH.), the Alan Tiffin Foundation, the Alzheimer's Association (NIRG-08-92090 to P.R.-N.), the Fonds de la recherche en sante du Quebec (Chercheur boursier), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), the INCT for Excitotoxicity and Neuroprotection and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). Work in the laboratory of L.P. is financially supported by the department of Physiology, University of Lausanne.	Choi H, 2014, NEUROIMAGE, V99, P226, DOI 10.1016/j.neuroimage.2014.05.039; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Figley CR, 2011, EUR J NEUROSCI, V33, P577, DOI 10.1111/j.1460-9568.2010.07584.x; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Lauritzen M, 2001, J CEREBR BLOOD F MET, V21, P1367, DOI 10.1097/00004647-200112000-00001; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Magistretti PJ, 1996, MOL PSYCHIATR, V1, P445; MAZZIOTTA JC, 1981, NEUROLOGY, V31, P503, DOI 10.1212/WNL.31.5.503; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; Nehlig A, 2007, GLIA, V55, P1238, DOI 10.1002/glia.20376; Pellerin L, 2003, J CEREBR BLOOD F MET, V23, P1282, DOI 10.1097/01.WCB.0000096064.12129.3D; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; PHELPS ME, 1985, SCIENCE, V228, P799, DOI 10.1126/science.2860723; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; SOKOLOFF L, 1993, DEV NEUROSCI-BASEL, V15, P194, DOI 10.1159/000111335; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Voutsinos-Porche B, 2003, CEREB CORTEX, V13, P1110, DOI 10.1093/cercor/13.10.1110; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4; Zimmer ER, 2015, J CEREBR BLOOD F MET, V35, P1169, DOI 10.1038/jcbfm.2015.35	20	145	146	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2017	20	3					393	395		10.1038/nn.4492	http://dx.doi.org/10.1038/nn.4492			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9DU	28135241	Green Accepted			2022-12-17	WOS:000394920400016
J	Weilinger, NL; Lohman, AW; Rakai, BD; Ma, EMM; Bialecki, J; Maslieieva, V; Rilea, T; Bandet, MV; Ikuta, NT; Scott, L; Colicos, MA; Teskey, GC; Winship, IR; Thompson, RJ				Weilinger, Nicholas L.; Lohman, Alexander W.; Rakai, Brooke D.; Ma, Evelyn M. M.; Bialecki, Jennifer; Maslieieva, Valentyna; Rilea, Travis; Bandet, Mischa V.; Ikuta, Nathan T.; Scott, Lucas; Colicos, Michael A.; Teskey, G. Campbell; Winship, Ian R.; Thompson, Roger J.			Metabotropic NMDA receptor signaling couples Src family kinases to pannexin-1 during excitotoxicity	NATURE NEUROSCIENCE			English	Article							ISCHEMIC BRAIN-DAMAGE; LONG-TERM DEPRESSION; DENDRITIC SPINES; ACUTE STROKE; BLOOD-FLOW; MK-801; RELEASE; RAT; ACTIVATION; CHANNELS	Overactivation of neuronal N-methyl-d-aspartate receptors (NMDARs) causes excitotoxicity and is necessary for neuronal death. In the classical view, these ligand-gated Ca2+-permeable ionotropic receptors require co-agonists and membrane depolarization for activation. We report that NMDARs signal during ligand binding without activation of their ion conduction pore. Pharmacological pore block with MK-801, physiological pore block with Mg2+ or a Ca2+-impermeable NMDAR variant prevented NMDAR currents, but did not block excitotoxic dendritic blebbing and secondary currents induced by exogenous NMDA. NMDARs, Src kinase and Panx1 form a signaling complex, and activation of Panx1 required phosphorylation at Y308. Disruption of this NMDAR-Src-Panx1 signaling complex in vitro or in vivo by administration of an interfering peptide either before or 2 h after ischemia or stroke was neuroprotective. Our observations provide insights into a new signaling modality of NMDARs that has broad-reaching implications for brain physiology and pathology.	[Weilinger, Nicholas L.; Lohman, Alexander W.; Rakai, Brooke D.; Ma, Evelyn M. M.; Bialecki, Jennifer; Maslieieva, Valentyna; Rilea, Travis; Scott, Lucas; Colicos, Michael A.; Teskey, G. Campbell; Thompson, Roger J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Weilinger, Nicholas L.; Lohman, Alexander W.; Ma, Evelyn M. M.; Teskey, G. Campbell; Thompson, Roger J.] Univ Calgary, Cumming Sch Med, Dept Cell Biol & Anat, Calgary, AB, Canada; [Bandet, Mischa V.; Ikuta, Nathan T.] Univ Alberta, Dept Psychiat, Neurochem Res Unit, Edmonton, AB, Canada; [Scott, Lucas; Colicos, Michael A.] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Alberta; University of Calgary	Thompson, RJ (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.; Thompson, RJ (corresponding author), Univ Calgary, Cumming Sch Med, Dept Cell Biol & Anat, Calgary, AB, Canada.	rj.thompson@ucalgary.ca	Thompson, Roger/L-3930-2016	Thompson, Roger/0000-0002-7019-7246	Canadian Institutes for Health Research (CIHR) [136812, 110967, 201022, 130495]; Alberta Innovates-Health Solutions (AI-HS); Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; AI-HS; Cumming School of Medicine via the Ronald and Irene Ward Foundation; Gwendolyn McLean Fund; Hotchkiss Brain Institute; CIHR; Alberta Innovates [201400500] Funding Source: researchfish	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions (AI-HS); Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); AI-HS; Cumming School of Medicine via the Ronald and Irene Ward Foundation; Gwendolyn McLean Fund; Hotchkiss Brain Institute; CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	We thank J. Bains (University of Calgary) for critical reading of the manuscript and C. Sank for technical assistance. Plasmids encoding Panx1<SUP>Y308F</SUP>, GluN1<SUP>WT</SUP> and GluN1<SUP>N616R</SUP> were generated by F. Visser in the Hotchkiss Brain Institute Molecular Core Facility. Dominant active/inactive constructs for Src kinase and Src<INF>48</INF> peptides were from D. Fujita (University of Calgary) and M. Salter (Sick Kids Research Institute), respectively. Myc-tagged Panx1 constructs were from C. Naus (University of British Columbia). This work was supported by Canadian Institutes for Health Research (CIHR) grants 136812 (R. J. T.), 110967 (I. R. W.), 201022 (M. A. C.) and 130495 (G. C. T.). R. J. T., G. C. T., M. A. C. and I. R. W. received grants from Alberta Innovates-Health Solutions (AI-HS), the Canadian Foundation for Innovation and the Natural Sciences and Engineering Research Council of Canada. R. J. T. and I. R. W. received funds from AI-HS. Additional support was provided to R. J. T. by the Cumming School of Medicine via the Ronald and Irene Ward Foundation and the Gwendolyn McLean Fund. N. L. W. is supported by an AI-HS scholarship and Dr. T. Chen Fong scholarship from the Hotchkiss Brain Institute. A. W. L. is supported by AI-HS and CIHR.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Alaverdashvili M, 2013, NEUROSCI BIOBEHAV R, V37, P950, DOI 10.1016/j.neubiorev.2013.03.026; Armitage GA, 2010, J CEREBR BLOOD F MET, V30, P1432, DOI 10.1038/jcbfm.2010.73; Babiec WE, 2014, J NEUROSCI, V34, P5285, DOI 10.1523/JNEUROSCI.5419-13.2014; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; BOAST CA, 1988, BRAIN RES, V442, P345, DOI 10.1016/0006-8993(88)91522-3; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; BUCHAN A, 1990, J NEUROSCI, V10, P311; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen QX, 1997, J NEUROSCI, V17, P4032; Cheng Yu Dennis, 2004, NeuroRx, V1, P36, DOI 10.1007/BF03206566; Chou Mary T-H, 2010, Genes Cancer, V1, P225; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; CORBETT D, 1990, BRAIN RES, V514, P300, DOI 10.1016/0006-8993(90)91424-F; Diener HC, 2008, STROKE, V39, P1751, DOI 10.1161/STROKEAHA.107.503334; Dravid SM, 2007, J PHYSIOL-LONDON, V581, P107, DOI 10.1113/jphysiol.2006.124958; Dzubay JA, 1996, J NEUROSCI, V16, P4129; Fischer MJM, 2010, MICROVASC RES, V80, P258, DOI 10.1016/j.mvr.2010.04.004; FOSTER AC, 1988, J NEUROSCI, V8, P4745; FRAZZINI VI, 1994, NEUROSURGERY, V34, P1040, DOI 10.1227/00006123-199406000-00013; GILL R, 1988, NEUROSCIENCE, V25, P847, DOI 10.1016/0306-4522(88)90040-1; Hill MD, 2012, LANCET NEUROL, V11, P942, DOI 10.1016/S1474-4422(12)70225-9; Johnstone SR, 2012, J MEMBRANE BIOL, V245, P319, DOI 10.1007/s00232-012-9453-3; Kubo T, 2001, BRAIN RES BULL, V54, P413, DOI 10.1016/S0361-9230(01)00429-4; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; LOBNER D, 1993, J NEUROSCI, V13, P4861; Lohman AW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397976; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nabavi S, 2013, P NATL ACAD SCI USA, V110, P4027, DOI 10.1073/pnas.1219454110; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Nguyen PV, 1997, J NEUROPHYSIOL, V78, P281, DOI 10.1152/jn.1997.78.1.281; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Ogden KK, 2011, TRENDS PHARMACOL SCI, V32, P726, DOI 10.1016/j.tips.2011.08.003; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Rakai BD, 2013, J STROKE CEREBROVASC, V22, P397, DOI 10.1016/j.jstrokecerebrovasdis.2011.10.001; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Saver JL, 2015, NEW ENGL J MED, V372, P528, DOI 10.1056/NEJMoa1408827; Saver JL, 2004, STROKE, V35, pE106, DOI 10.1161/01.STR.0000124458.98123.52; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Shih AY, 2009, J CEREBR BLOOD F MET, V29, P738, DOI 10.1038/jcbfm.2008.166; Stein IS, 2015, J NEUROSCI, V35, P12303, DOI 10.1523/JNEUROSCI.4289-14.2015; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wang JJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005431; Weilinger NL, 2013, ACTA PHARMACOL SIN, V34, P39, DOI 10.1038/aps.2012.95; Weilinger NL, 2012, J NEUROSCI, V32, P12579, DOI 10.1523/JNEUROSCI.1267-12.2012; WHISHAW IQ, 1990, BEHAV BRAIN RES, V41, P49, DOI 10.1016/0166-4328(90)90053-H; Wicki-Stordeur LE, 2013, CELL COMMUN ADHES, V20, P73, DOI 10.3109/15419061.2013.791681; YAO H, 1993, STROKE, V24, P864, DOI 10.1161/01.STR.24.6.864	63	145	146	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2016	19	3					432	+		10.1038/nn.4236	http://dx.doi.org/10.1038/nn.4236			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE7MU	26854804				2022-12-17	WOS:000370822200015
J	Song, J; Sun, JQ; Moss, J; Wen, ZX; Sun, GJ; Hsu, D; Zhong, C; Davoudi, H; Christian, KM; Toni, N; Ming, GL; Song, HJ				Song, Juan; Sun, Jiaqi; Moss, Jonathan; Wen, Zhexing; Sun, Gerald J.; Hsu, Derek; Zhong, Chun; Davoudi, Heydar; Christian, Kimberly M.; Toni, Nicolas; Ming, Guo-li; Song, Hongjun			Parvalbumin interneurons mediate neuronal circuitry-neurogenesis coupling in the adult hippocampus	NATURE NEUROSCIENCE			English	Article							GENERATED NEURONS; PROLIFERATION; INTEGRATION; BEHAVIOR	Using immunohistology, electron microscopy, electrophysiology and optogenetics, we found that proliferating adult mouse hippocampal neural precursors received immature GABAergic synaptic inputs from parvalbumin-expressing interneurons. Recently shown to suppress adult quiescent neural stem cell activation, parvalbumin interneuron activation promoted newborn neuronal progeny survival and development. Our results suggest a niche mechanism involving parvalbumin interneurons that couples local circuit activity to the diametric regulation of two critical early phases of adult hippocampal neurogenesis.	[Song, Juan; Sun, Jiaqi; Wen, Zhexing; Sun, Gerald J.; Hsu, Derek; Zhong, Chun; Davoudi, Heydar; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Song, Juan; Wen, Zhexing; Zhong, Chun; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Song, Juan] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Song, Juan] Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC USA; [Sun, Jiaqi] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Moss, Jonathan; Toni, Nicolas] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Sun, Gerald J.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Davoudi, Heydar] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Tsinghua University; University of Lausanne; Johns Hopkins University; Johns Hopkins University	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.	nicolas.toni@unil.ch; gming1@jhmi.edu; shongju1@jhmi.edu	Toni, Nicolas/M-2057-2014; Wen, Zhexing/B-9313-2014; Wen, Zhexing/L-1228-2018	Toni, Nicolas/0000-0001-5585-268X; Wen, Zhexing/0000-0002-1518-3845; Davoudi, Heydar/0000-0003-0094-8494; Ming, Guo-li/0000-0002-2517-6075	US National Institutes of Health [NS047344, ES021957, NS048271, HD069184]; Brain & Behavior Research Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Maryland Stem Cell Research Fund; Swiss National Science Foundation [PP00A-119026/1]; The Brain & Behavior Research Foundationand Maryland Stem Cell Research Fund; Fondation Leenaards; Children's Tumor Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087874, P20MH084018, R21MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047344, R37NS047344, R01NS048271, R56NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain & Behavior Research Foundation(NARSAD); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Maryland Stem Cell Research Fund; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); The Brain & Behavior Research Foundationand Maryland Stem Cell Research Fund; Fondation Leenaards; Children's Tumor Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Song and Ming laboratories for discussion, L. Tsai and K. Deisseroth for initial help with optogenetics, and Q. Hussaini, Y. Cai and L. Liu for technical support. The electron microscopy images were acquired at the electron microscopy facility of the University of Lausanne. This work was supported by grants from the US National Institutes of Health (NS047344, ES021957) and The Brain & Behavior Research Foundation to H.S., from the US National Institutes of Health (NS048271, HD069184), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, The Brain & Behavior Research Foundation and Maryland Stem Cell Research Fund to G.M., from the Swiss National Science Foundation (PP00A-119026/1) to N.T., from The Brain & Behavior Research Foundationand Maryland Stem Cell Research Fund to K.M.C., by postdoctoral fellowships from Maryland Stem Cell Research Fund to J. Song, Z.W. and C.Z., from the Fondation Leenaards to J.M., and by a pre-doctoral fellowship from The Children's Tumor Foundation to G.J.S.	Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; Kim WR, 2009, EUR J NEUROSCI, V29, P1408, DOI 10.1111/j.1460-9568.2009.06693.x; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Liu S, 2013, NAT NEUROSCI, V16, P89, DOI 10.1038/nn.3267; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Markwardt SJ, 2011, NAT NEUROSCI, V14, P1407, DOI 10.1038/nn.2935; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023	20	145	149	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1728	1730		10.1038/nn.3572	http://dx.doi.org/10.1038/nn.3572			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24212671	Green Accepted, Green Submitted			2022-12-17	WOS:000327416800008
J	Deng, JV; Rodriguiz, RM; Hutchinson, AN; Kim, IH; Wetsel, WC; West, AE				Deng, Jie V.; Rodriguiz, Ramona M.; Hutchinson, Ashley N.; Kim, Il-Hwan; Wetsel, William C.; West, Anne E.			MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants	NATURE NEUROSCIENCE			English	Article							MOUSE MODEL; RETT-SYNDROME; DOPAMINERGIC MODULATION; SYNAPTIC PLASTICITY; BDNF TRANSCRIPTION; SPINY NEURONS; MUTANT MICE; DELTA-FOSB; COCAINE; EXPRESSION	MeCP2 is a methyl DNA-binding transcriptional regulator that contributes to the development and function of CNS synapses; however, the requirement for MeCP2 in stimulus-regulated behavioral plasticity is not fully understood. Here we show that acute viral manipulation of MeCP2 expression in the nucleus accumbens (NAc) bidirectionally modulates amphetamine (AMPH)-induced conditioned place preference. Mecp2 hypomorphic mutant mice have more NAc GABAergic synapses and show deficient AMPH-induced structural plasticity of NAc dendritic spines. Furthermore, these mice show deficient plasticity of striatal immediate early gene inducibility after repeated AMPH administration. Notably, psychostimulants induce phosphorylation of MeCP2 at Ser421, a site that regulates MeCP2's function as a repressor. Phosphorylation is selectively induced in GABAergic interneurons of the NAc, and its extent strongly predicts the degree of behavioral sensitization. These data reveal new roles for MeCP2 both in mesolimbocortical circuit development and in the regulation of psychostimulant-induced behaviors.	[Deng, Jie V.; Hutchinson, Ashley N.; Wetsel, William C.; West, Anne E.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Rodriguiz, Ramona M.; Kim, Il-Hwan; Wetsel, William C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Rodriguiz, Ramona M.; Wetsel, William C.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	West, AE (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	west@neuro.duke.edu			National Institute of Drug Abuse [R01-DA022202, F32-DA025447]; March of Dimes Foundation [1-FY07-482]; Duke University; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA025447, R01DA022202] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); March of Dimes Foundation(March of Dimes); Duke University; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are deeply grateful to M. E. Greenberg (Harvard Medical School), Z. Zhou and S. Cohen for sharing unpublished data and reagents. We thank N. Calakos (Duke University Medical Center) and F. Polleux (University of North Carolina, Chapel Hill) for providing transgenic mice; K. Vaishnav, J. Zhou, L. Du, M. Fukui, M. Cools, N. Negbenebor, P. Pattabiraman, W.-H. Qian, R. Chereau and M. Presby for technical assistance; and D. Fitzpatrick, G. Feng, J.O. McNamara, A. Brunet and M. Caron for critical reading of the manuscript. Support for this work was provided by National Institute of Drug Abuse grants R01-DA022202 (A.E.W.) and F32-DA025447 (J.V.D.); grant 1-FY07-482 from the March of Dimes Foundation (A.E.W.); along with the Duke University postdoctoral training program in Fundamental and Translational Neuroscience and the predoctoral Pharmacological Sciences Training Program.	Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bracci E, 2002, J NEUROPHYSIOL, V87, P2190, DOI 10.1152/jn.00754.2001; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Cassel S, 2006, MOL PHARMACOL, V70, P487, DOI 10.1124/mol.106.022301; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gruber AJ, 2009, J NEUROPHYSIOL, V101, P1876, DOI 10.1152/jn.91002.2008; Guzman JN, 2003, J NEUROSCI, V23, P8931; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; Robinson TE, 1997, J NEUROSCI, V17, P8491; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Tzschentke TM, 2003, MOL PSYCHIATR, V8, P373, DOI 10.1038/sj.mp.4001269; Wiltschko AB, 2010, NEUROPSYCHOPHARMACOL, V35, P1261, DOI 10.1038/npp.2009.226; Zhang DS, 2002, J NEUROCHEM, V82, P1453, DOI 10.1046/j.1471-4159.2002.01089.x; Zhang JH, 2006, J NEUROSCI, V26, P13287, DOI 10.1523/JNEUROSCI.3795-06.2006; Zhang ZW, 2010, J NEUROPHYSIOL, V103, P2470, DOI 10.1152/jn.00601.2009; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	48	145	154	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1128	U132		10.1038/nn.2614	http://dx.doi.org/10.1038/nn.2614			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20711186	Green Accepted			2022-12-17	WOS:000281332600019
J	Magalhaes, AC; Holmes, KD; Dale, LB; Comps-Agrar, L; Lee, D; Yadav, PN; Drysdale, L; Poulter, MO; Roth, BL; Pin, JP; Anisman, H; Ferguson, SSG				Magalhaes, Ana C.; Holmes, Kevin D.; Dale, Lianne B.; Comps-Agrar, Laetitia; Lee, Dennis; Yadav, Prem N.; Drysdale, Linsay; Poulter, Michael O.; Roth, Bryan L.; Pin, Jean-Philippe; Anisman, Hymie; Ferguson, Stephen S. G.			CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling	NATURE NEUROSCIENCE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CENTRAL-NERVOUS-SYSTEM; SEROTONIN RECEPTORS; RAT; DESENSITIZATION; TRAFFICKING; PSD-95; INTERNALIZATION; ENDOCYTOSIS; LOCALIZATION	Stress and anxiety disorders are risk factors for depression and these behaviors are modulated by corticotrophin-releasing factor receptor 1 (CRFR1) and serotonin receptor (5-HT2R). However, the potential behavioral and cellular interaction between these two receptors is unclear. We found that pre-administration of corticotrophin-releasing factor (CRF) into the prefrontal cortex of mice enhanced 5-HT2R-mediated anxiety behaviors in response to 2,5-dimethoxy-4-iodoamphetamine. In both heterologous cell cultures and mouse cortical neurons, activation of CRFR1 also enhanced 5-HT2 receptor-mediated inositol phosphate formation. CRFR1-mediated increases in 5-HT2R signaling were dependent on receptor internalization and receptor recycling via rapid recycling endosomes, resulting in increased expression of 5-HT2R on the cell surface. Sensitization of 5-HT2R signaling by CRFR1 required intact PDZ domain-binding motifs at the end of the C-terminal tails of both receptor types. These data suggest a mechanism by which CRF, a peptide known to be released by stress, enhances anxiety-related behavior via sensitization of 5-HT2R signaling.	[Magalhaes, Ana C.; Holmes, Kevin D.; Dale, Lianne B.; Lee, Dennis; Drysdale, Linsay; Poulter, Michael O.; Ferguson, Stephen S. G.] Univ Western Ontario, J Allyn Taylor Ctr Cell Biol, Mol Brain Res Grp, Robarts Res & Dept Physiol & Pharmacol, London, ON, Canada; [Comps-Agrar, Laetitia; Pin, Jean-Philippe] Univ Montpellier I & II, INSERM, U661, Inst Genom Fonct,Dept Pharmacol Mol,CNRS,UMR 5203, Montpellier, France; [Yadav, Prem N.; Roth, Bryan L.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Anisman, Hymie] Carleton Univ, Inst Neurosci, Ctr Res Stress Coping & Wellbeing, Life Sci Res Ctr, Ottawa, ON K1S 5B6, Canada	Western University (University of Western Ontario); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of North Carolina; University of North Carolina Chapel Hill; Carleton University	Ferguson, SSG (corresponding author), Univ Western Ontario, J Allyn Taylor Ctr Cell Biol, Mol Brain Res Grp, Robarts Res & Dept Physiol & Pharmacol, London, ON, Canada.	ferguson@robarts.ca	Roth, Bryan/ABE-7032-2020; Pin, Jean-Philippe/Y-6668-2019; Yadav, Prem N./R-1197-2019; Roth, Bryan L/F-3928-2010; Poulter, Michael/K-3909-2013	Roth, Bryan/0000-0002-0561-6520; Pin, Jean-Philippe/0000-0002-1423-345X; Poulter, Michael/0000-0001-7469-8462; Comps-Agrar, Laetitia/0000-0002-5260-6536	Canadian Institutes for Health Research (CIHR) [MOP 62738, MOP 81118]; Ontario Mental Health Foundation; CisBio; French government; CNRS; INSERM; Agence Nationale de la Recherche [Blan06-3_135092]; US National Institutes of Health [R01MH61887, U19MH82441]; Michael Hooker Distinguished Chair of Pharmacology; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441, R01MH061887] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Mental Health Foundation; CisBio; French government; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Hooker Distinguished Chair of Pharmacology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	A. C. M. and D. L. received Canadian Institutes for Health Research (CIHR) fellowships. K. D. H. received a fellowship from the Ontario Mental Health Foundation. L. C.-A. was supported by a Conventions Industrielles de Formation par la Recherche fellowship from CisBio and the French government. J.-P.P. was supported by CNRS, INSERM, the Agence Nationale de la Recherche grant Blan06-3_135092 and CisBio. S. S. G. F. and H. A. hold Tier I Canada Research Chairs, and S. S. G. F. is a Heart and Stroke Foundation of Ontario Career Investigator. This research was funded by CIHR grant MOP 62738 to S. S. G. F., CIHR grant MOP 81118 to H. A., US National Institutes of Health grants R01MH61887 and U19MH82441 and the Michael Hooker Distinguished Chair of Pharmacology to B. L. R.	Abbas AI, 2009, J NEUROSCI, V29, P7124, DOI 10.1523/JNEUROSCI.1090-09.2009; Anisman H, 2008, PROG NEUROBIOL, V85, P1, DOI 10.1016/j.pneurobio.2008.01.004; Anisman H, 2008, NEUROSCI BIOBEHAV R, V32, P1185, DOI 10.1016/j.neubiorev.2008.03.001; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Bhatnagar A, 2001, J BIOL CHEM, V276, P8269, DOI 10.1074/jbc.M006968200; Bockaert J, 2006, CELL TISSUE RES, V326, P553, DOI 10.1007/s00441-006-0286-1; Celada P, 2004, J PSYCHIATR NEUROSCI, V29, P252; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; CONN PJ, 1985, J PHARMACOL EXP THER, V234, P195; CUMMINGS S, 1983, J NEUROSCI, V3, P1355; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033; DESOUZA EB, 1985, J NEUROSCI, V5, P3189; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Doherty MD, 2000, BRAIN RES, V864, P176, DOI 10.1016/S0006-8993(00)02062-X; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson Stephen S. G., 2003, V237, P121; Gavarini S, 2006, MOL BIOL CELL, V17, P4619, DOI 10.1091/mbc.E06-03-0218; Gray JA, 2001, MOL PHARMACOL, V60, P1020, DOI 10.1124/mol.60.5.1020; Heisler LK, 2007, GENES BRAIN BEHAV, V6, P491, DOI 10.1111/j.1601-183X.2007.00316.x; Holmes A, 2003, TRENDS PHARMACOL SCI, V24, P580, DOI 10.1016/j.tips.2003.09.011; Holmes KD, 2006, J NEUROCHEM, V96, P934, DOI 10.1111/j.1471-4159.2005.03603.x; Holsboer Florian, 2003, Curr Opin Investig Drugs, V4, P46; HOYER D, 1994, PHARMACOL REV, V46, P157; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Leonard BE, 2005, EUR PSYCHIAT, V20, pS302, DOI 10.1016/S0924-9338(05)80180-4; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; Marion S, 2004, J BIOL CHEM, V279, P2945, DOI 10.1074/jbc.M308742200; Merali Z, 2004, EUR J NEUROSCI, V20, P229, DOI 10.1111/j.1460-9568.2004.03468.x; Merali Z, 2006, J NEUROSCI, V26, P10387, DOI 10.1523/JNEUROSCI.1219-06.2006; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Millan MJ, 2005, THERAPIE, V60, P441, DOI 10.2515/therapie:2005065; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Paxinos G., 1997, MOUSE BRAIN STEREOTA; Pillay NS, 2007, EXPERT OPIN EMERG DR, V12, P541, DOI 10.1517/14728214.12.4.541; Schlag BD, 2004, J PHARMACOL EXP THER, V310, P865, DOI 10.1124/jpet.104.067306; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Tan HB, 2004, J NEUROSCI, V24, P5000, DOI 10.1523/JNEUROSCI.0143-04.2004; Trimble N, 2007, NEUROGASTROENT MOTIL, V19, P754, DOI 10.1111/j.1365-2982.2007.00951.x; Valdez GR, 2006, CNS DRUGS, V20, P887, DOI 10.2165/00023210-200620110-00002; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Xia Z, 2003, NEUROSCIENCE, V122, P907, DOI 10.1016/S0306-4522(03)00589-X; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200	48	145	151	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					622	U140		10.1038/nn.2529	http://dx.doi.org/10.1038/nn.2529			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20383137	Green Accepted, Green Submitted			2022-12-17	WOS:000277065700021
J	Petzold, GC; Hagiwara, A; Murthy, VN				Petzold, Gabor C.; Hagiwara, Akari; Murthy, Venkatesh N.			Serotonergic modulation of odor input to the mammalian olfactory bulb	NATURE NEUROSCIENCE			English	Article							EXTERNAL TUFTED CELLS; PRESYNAPTIC INHIBITION; ELECTRICAL-STIMULATION; SYNAPTIC-TRANSMISSION; NEURONAL-ACTIVITY; MESSENGER-RNA; SENSORY INPUT; RAPHE NUCLEI; RAT-BRAIN; IN-VITRO	Centrifugal serotonergic fibers innervate the olfactory bulb, but the importance of these projections for olfactory processing is unclear. We examined serotonergic modulation of sensory input to olfactory glomeruli using mice that express synaptopHluorin in olfactory receptor neurons (ORN). Odor-evoked synaptic input to glomeruli was attenuated by increased serotonin signaling through serotonin 2C (5-HT2C) receptors and amplified by decreased serotonergic activity. Intravital multiphoton calcium imaging revealed that 5-HT2C receptor activation amplified odor-evoked activity in a subset of juxtaglomerular cells and attenuated glutamate release from ORN terminals via GABA(B) receptors. Endogenous serotonin released by electrical stimulation of the dorsal raphe nucleus attenuated odor-evoked responses without detectable bias in glomerular position or odor identity. Weaker glomerular responses, however, were less sensitive to raphe stimulation than strong responses. Our data indicate that the serotonergic system regulates odor inputs in the olfactory bulb and suggest that behavioral states may alter odor processing at the earliest stages.	[Petzold, Gabor C.; Hagiwara, Akari; Murthy, Venkatesh N.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Petzold, Gabor C.; Hagiwara, Akari; Murthy, Venkatesh N.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Petzold, GC (corresponding author), Charite, Dept Expt Neurol, Charitepl 1, D-13353 Berlin, Germany.	gabor.petzold@charite.de; vnmurthy@fas.harvard.edu		Murthy, Venkatesh/0000-0003-2443-4252	Marie Curie Fellowship Program of the European Union	Marie Curie Fellowship Program of the European Union(European Commission)	We thank T. Sato for writing data acquisition and analysis software for all the microscopy, G. Szabo for the GAD65-GFP mice and the members of the Murthy laboratory for numerous discussions. This work was supported in part by the Marie Curie Fellowship Program of the European Union (G. C. P.).	Aghajanian GK, 2000, BRAIN RES REV, V31, P302, DOI 10.1016/S0165-0173(99)00046-6; Albeanu DF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002146; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; AUNGST JL, 2005, SOC NEUR ABSTR; Baumann MH, 2001, NEUROPSYCHOPHARMACOL, V24, P492, DOI 10.1016/S0893-133X(00)00221-9; Best AR, 2008, J NEUROSCI, V28, P6508, DOI 10.1523/JNEUROSCI.0678-08.2008; BLOOM FE, 1964, J PHARMACOL EXP THER, V146, P16; Boothman L, 2006, BRIT J PHARMACOL, V149, P861, DOI 10.1038/sj.bjp.0706935; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BRODIN E, 1990, BRAIN RES, V535, P227, DOI 10.1016/0006-8993(90)91605-G; Chen CF, 2003, J NEUROSCI, V23, P3130; Dacks AM, 2008, J NEUROPHYSIOL, V99, P2077, DOI 10.1152/jn.01372.2007; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dremencov E, 2005, NEUROPHARMACOLOGY, V48, P34, DOI 10.1016/j.neuropharm.2004.09.013; Glass JD, 2000, BRAIN RES, V859, P224, DOI 10.1016/S0006-8993(00)01963-6; Gunther S, 2006, J NEUROBIOL, V66, P949, DOI 10.1002/neu.20253; Gurden H, 2006, NEURON, V52, P335, DOI 10.1016/j.neuron.2006.07.022; Hajos-Korcsok E, 2002, PHARMACOL BIOCHEM BE, V71, P807, DOI 10.1016/S0091-3057(01)00718-3; Hardy A, 2005, NEUROSCIENCE, V131, P717, DOI 10.1016/j.neuroscience.2004.10.034; Hayar A, 2005, J NEUROSCI, V25, P8197, DOI 10.1523/JNEUROSCI.2374-05.2005; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; JACOBS BL, 1991, PHARMACOL REV, V43, P563; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; JACOBS BL, 1993, TRENDS NEUROSCI, V16, P346, DOI 10.1016/0166-2236(93)90090-9; Kepecs A, 2007, J NEUROPHYSIOL, V98, P205, DOI 10.1152/jn.00071.2007; LALLEY PM, 1994, BRAIN RES, V648, P87, DOI 10.1016/0006-8993(94)91909-7; Langdon PE, 1997, DEV BRAIN RES, V102, P291, DOI 10.1016/S0165-3806(97)00090-4; MAINEN ZF, 2007, SOC NEUR ABSTR; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; MCLEAN JH, 1987, J NEUROSCI, V7, P3016; McLean JH, 1996, BEHAV NEUROSCI, V110, P1426, DOI 10.1037/0735-7044.110.6.1426; MCLEAN JH, 1995, J COMP NEUROL, V353, P371, DOI 10.1002/cne.903530305; MCLEAN JH, 1987, J NEUROSCI, V7, P3029; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Parrish-Aungst S, 2007, J COMP NEUROL, V501, P825, DOI 10.1002/cne.21205; Petzold GC, 2008, NEURON, V58, P897, DOI 10.1016/j.neuron.2008.04.029; Pirez N, 2008, J NEUROSCI, V28, P6360, DOI 10.1523/JNEUROSCI.0793-08.2008; POMPEIANO M, 1992, J NEUROSCI, V12, P440; RHOADES RW, 1994, J NEUROPHYSIOL, V72, P2438, DOI 10.1152/jn.1994.72.5.2438; Shea SD, 2008, J NEUROSCI, V28, P10711, DOI 10.1523/JNEUROSCI.3853-08.2008; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; VONBAUMGARTEN R, 1963, PFLUGERS ARCH GES PH, V277, P125; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Waterhouse BD, 2004, BRAIN RES, V1000, P183, DOI 10.1016/j.brainres.2003.11.030; Westerink BHC, 2001, J NEUROSCI METH, V109, P53, DOI 10.1016/S0165-0270(01)00401-0; Zhang XD, 2005, NEURON, V45, P11, DOI 10.1016/j.neuron.2004.12.014	50	145	148	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2009	12	6					784	U142		10.1038/nn.2335	http://dx.doi.org/10.1038/nn.2335			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	450DJ	19430472				2022-12-17	WOS:000266380900023
J	Emes, RD; Pocklington, AJ; Anderson, CNG; Bayes, A; Collins, MO; Vickers, CA; Croning, MDR; Malik, BR; Choudhary, JS; Armstrong, JD; Grant, SGN				Emes, Richard D.; Pocklington, Andrew J.; Anderson, Christopher N. G.; Bayes, Alex; Collins, Mark O.; Vickers, Catherine A.; Croning, Mike D. R.; Malik, Bilal R.; Choudhary, Jyoti S.; Armstrong, J. Douglas; Grant, Seth G. N.			Evolutionary expansion and anatomical specialization of synapse proteome complexity	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; IN-SITU HYBRIDIZATION; NMDA-RECEPTOR; POSTSYNAPTIC DENSITY-95; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; MULTIPROTEIN COMPLEXES; MOLECULAR CONSTITUENTS; SIGNALING COMPLEXES; FILAMENTOUS GROWTH	Understanding the origins and evolution of synapses may provide insight into species diversity and the organization of the brain. Using comparative proteomics and genomics, we examined the evolution of the postsynaptic density (PSD) and membrane-associated guanylate kinase (MAGUK)-associated signaling complexes (MASCs) that underlie learning and memory. PSD and MASC orthologs found in yeast carry out basic cellular functions to regulate protein synthesis and structural plasticity. We observed marked changes in signaling complexity at the yeast-metazoan and invertebrate-vertebrate boundaries, with an expansion of key synaptic components, notably receptors, adhesion/cytoskeletal proteins and scaffold proteins. A proteomic comparison of Drosophila and mouse MASCs revealed species-specific adaptation with greater signaling complexity in mouse. Although synaptic components were conserved amongst diverse vertebrate species, mapping mRNA and protein expression in the mouse brain showed that vertebrate-specific components preferentially contributed to differences between brain regions. We propose that the evolution of synapse complexity around a core proto-synapse has contributed to invertebrate-vertebrate differences and to brain specialization.	[Anderson, Christopher N. G.; Bayes, Alex; Collins, Mark O.; Croning, Mike D. R.; Choudhary, Jyoti S.; Grant, Seth G. N.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Emes, Richard D.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England; [Pocklington, Andrew J.; Malik, Bilal R.; Armstrong, J. Douglas] Univ Edinburgh, Inst Adapt & Neural Computat, Sch Informat, Edinburgh EH1 2QL, Midlothian, Scotland; [Vickers, Catherine A.] Univ Edinburgh, Div Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; [Vickers, Catherine A.] Okinawa Inst Sci & Technol, Neurobiol Res Unit, Okinawa, Japan	Wellcome Trust Sanger Institute; Keele University; University of Edinburgh; University of Edinburgh; Okinawa Institute of Science & Technology Graduate University	Grant, SGN (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	sg3@sanger.ac.uk	Collins, Mark/A-3752-2012; Collins, Mark/AAB-7484-2021; Choudhary, Jyoti/S-1232-2017; Emes, Richard D/C-5341-2008; Bayés, Àlex/H-2854-2015	Collins, Mark/0000-0002-7656-4975; Choudhary, Jyoti/0000-0003-0881-5477; Emes, Richard D/0000-0001-6855-5481; Bayés, Àlex/0000-0002-5265-6306; Malik, Bilal/0000-0001-5522-4990; Armstrong, Douglas/0000-0002-5397-3864; Pocklington, Andrew/0000-0002-2137-0452; Grant, Seth/0000-0001-8732-8735	MRC [G90/112, G90/93] Funding Source: UKRI; Medical Research Council [G90/93, G90/112] Funding Source: Medline; Wellcome Trust [077155] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Dosemeci A, 2007, MOL CELL PROTEOMICS, V6, P1749, DOI 10.1074/mcp.M700040-MCP200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elion EA, 2005, SCIENCE, V307, P687, DOI 10.1126/science.1109500; Erdman S, 2001, GENETICS, V159, P919; Grant SGN, 2005, HUM MOL GENET, V14, pR225, DOI 10.1093/hmg/ddi330; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harashima T, 2006, MOL CELL, V22, P819, DOI 10.1016/j.molcel.2006.05.011; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Husi H, 2001, J NEUROCHEM, V77, P281, DOI 10.1046/j.1471-4159.2001.t01-1-00248.x; Imai JH, 2007, J COMP NEUROL, V501, P316, DOI 10.1002/cne.21246; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Laumonnier F, 2007, AM J HUM GENET, V80, P205, DOI 10.1086/511441; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Moore BR, 2004, BIOL REV, V79, P301, DOI 10.1017/S1464793103006225; Nakazawa T, 2006, EMBO J, V25, P2867, DOI 10.1038/sj.emboj.7601156; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Palecek SP, 2002, MICROBIOL-SGM, V148, P893, DOI 10.1099/00221287-148-4-893; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Pocklington AJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100041; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Ruiz-Canada C, 2002, J NEUROCHEM, V82, P1490, DOI 10.1046/j.1471-4159.2002.01092.x; Ryan TJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-6; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Truman James W., 1993, P1245; Velthuis AJWT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-129; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yamauchi T, 2002, MASS SPECTROM REV, V21, P266, DOI 10.1002/mas.10033; Yoshimura Y, 2004, J NEUROCHEM, V88, P759, DOI 10.1046/j.1471-4159.2003.02136.x; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102	50	145	148	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					799	806		10.1038/nn.2135	http://dx.doi.org/10.1038/nn.2135			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18536710	Green Accepted			2022-12-17	WOS:000257089400017
J	de Quervain, DJF; Kolassa, IT; Ertl, V; Onyut, PL; Neuner, F; Elbert, T; Papassotiropoulos, A				de Quervain, Dominique J-F; Kolassa, Iris-Tatjana; Ertl, Verena; Onyut, P. Lamaro; Neuner, Frank; Elbert, Thomas; Papassotiropoulos, Andreas			A deletion variant of the alpha 2b-adrenoceptor is related to emotional memory in Europeans and Africans	NATURE NEUROSCIENCE			English	Review							POSTTRAUMATIC-STRESS-DISORDER; DECLARATIVE MEMORY	Emotionally arousing events are recalled better than neutral events. This phenomenon, which helps us to remember important and potentially vital information, depends on the activation of noradrenergic transmission in the brain. Here we show that a deletion variant of ADRA2B, the gene encoding the alpha 2b-adrenergic receptor, is related to enhanced emotional memory in healthy Swiss subjects and in survivors of the Rwandan civil war who experienced highly aversive emotional situations.	Univ Zurich, Div Psychiat Res, CH-8032 Zurich, Switzerland; Univ Konstanz, Dept Psychol, D-78457 Constance, Germany; Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; Mbarara Univ Sci & Technol, Fac Sci & Educ, Mbarara, Uganda; Univ Basel, Div Mol Psychol, CH-4055 Basel, Switzerland; Univ Basel, Biozentrum, Life Sci Training Facil, CH-4056 Basel, Switzerland	University of Zurich; University of Konstanz; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Mbarara University of Science & Technology; University of Basel; University of Basel	de Quervain, DJF (corresponding author), Univ Zurich, Div Psychiat Res, Lenggstr 31, CH-8032 Zurich, Switzerland.	quervain@bli.unizh.ch; andreas.papas@unibas.ch	Kolassa, Iris Tatjana/Y-3032-2018; Elbert, Thomas/C-8556-2009	Elbert, Thomas/0000-0003-1332-4939; Papassotiropoulos, Andreas/0000-0002-2210-9651; Neuner, Frank/0000-0001-5427-3432; de Quervain, Dominique/0000-0001-7131-2464				CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; LANG PJ, 1999, A4 CTR RES PSYCH U F; Maheu FS, 2004, BEHAV NEUROSCI, V118, P420, DOI 10.1037/0735-7044.118.2.420; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; McGaugh JL, 2003, MEMORY EMOTION MAKIN; O'Carroll RE, 1999, PSYCHOL MED, V29, P1083, DOI 10.1017/S0033291799008703; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Small KM, 2001, J BIOL CHEM, V276, P4917, DOI 10.1074/jbc.M008118200; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Strange BA, 2004, P NATL ACAD SCI USA, V101, P11454, DOI 10.1073/pnas.0404282101; Wechsler D., 1997, WAIS 3 WECHSLER ADUL; Zilmer, 1998, D2 TEST ATTENTION	14	145	145	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1137	1139		10.1038/nn1945	http://dx.doi.org/10.1038/nn1945			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17660814	Green Submitted			2022-12-17	WOS:000249144000015
J	Williams, MA; Dang, S; Kanwisher, NG				Williams, Mark A.; Dang, Sabin; Kanwisher, Nancy G.			Only some spatial patterns of fMRI response are read out in task performance	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; MICROSTIMULATION; REPRESENTATIONS; RECOGNITION	Classification methods show that the spatial pattern of a functional magnetic resonance imaging response across the cortex contains category information, but whether such patterns are used, or 'read out', in behavioral performance remains untested. We show that although the spatial pattern in both the retinotopic and lateral occipital cortex (LOC) in humans contains category information, only in the LOC is the pattern stronger for correct than for incorrect trials. Thus, some, but not all, spatial patterns are read out during task performance.	MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia; Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA	Massachusetts Institute of Technology (MIT); Macquarie University; Harvard University; Massachusetts General Hospital	Williams, MA (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	markaw@mit.edu		Williams, Mark/0000-0002-3897-5167	NEI NIH HHS [R01 EY013455-05A1, R01 EY013455] Funding Source: Medline; PHS HHS [13455] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Chambers CD, 2005, TRENDS COGN SCI, V9, P542, DOI 10.1016/j.tics.2005.09.010; Cohen MR, 2004, CURR OPIN NEUROBIOL, V14, P169, DOI 10.1016/j.conb.2004.03.016; COX AN, 1970, ASTROPHYS J SUPPL S, V19, P261, DOI 10.1086/190208; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Kamitani Y, 2006, CURR BIOL, V16, P1096, DOI 10.1016/j.cub.2006.04.003; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Langleben DD, 2005, HUM BRAIN MAPP, V26, P262, DOI 10.1002/hbm.20191; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006	14	145	145	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					685	686		10.1038/nn1900	http://dx.doi.org/10.1038/nn1900			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17486103	Green Accepted			2022-12-17	WOS:000246799800009
J	Morfini, G; Pigino, G; Szebenyi, G; You, YM; Pollema, S; Brady, ST				Morfini, Gerardo; Pigino, Gustavo; Szebenyi, Gyorgyi; You, Yimei; Pollema, Sarah; Brady, Scott T.			JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport	NATURE NEUROSCIENCE			English	Article							BULBAR MUSCULAR-ATROPHY; N-TERMINAL KINASE; MOTOR-NEURON DEGENERATION; TRANSGENIC MOUSE MODEL; KINESIN HEAVY-CHAIN; REPEAT EXPANSION; PROTEIN-KINASES; LIGHT-CHAINS; DISEASE; STRESS	Expansion of the polyglutamine ( polyQ) stretch in the androgen receptor ( AR) protein leads to spinal and bulbar muscular atrophy ( SBMA), a neurodegenerative disease characterized by lower motor neuron degeneration. The pathogenic mechanisms underlying SBMA remain unknown, but recent experiments show that inhibition of fast axonal transport ( FAT) by polyQ-expanded proteins, including polyQ-AR, represents a new cytoplasmic pathogenic lesion. Using pharmacological, biochemical and cell biological experiments, we found a new pathogenic pathway that is affected in SBMA and results in compromised FAT. PolyQ-AR inhibits FAT in a human cell line and in squid axoplasm through a pathway that involves activation of cJun N-terminal kinase ( JNK) activity. Active JNK phosphorylated kinesin-1 heavy chains and inhibited kinesin-1 microtubule-binding activity. JNK inhibitors prevented polyQ-AR-mediated inhibition of FAT and reversed suppression of neurite formation by polyQ-AR. We propose that JNK represents a promising target for therapeutic interventions in SBMA.	Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; Marine Biol Lab, Woods Hole, MA 02543 USA; Univ Texas, SW Med Ctr, Basic Neurosci Ctr, Dallas, TX 75390 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Marine Biological Laboratory - Woods Hole; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Brady, ST (corresponding author), Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA.	stbrady@uic.edu	Morfini, Gerardo/AAP-8070-2021; Pigino, Gustavo/L-7002-2019	Morfini, Gerardo/0000-0001-6059-5518; 	NINDS NIH HHS [NS41170, NS23320, R01 NS023868, NS23868, NS43408] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041170, R01NS043408, R01NS023868, R01NS023320] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Avila DM, 2003, EXP BIOL MED, V228, P982, DOI 10.1177/153537020322800815; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; BROOKS BP, 1995, TRENDS NEUROSCI, V18, P459, DOI 10.1016/0166-2236(95)94497-S; Burnstein KL, 2005, J CELL BIOCHEM, V95, P657, DOI 10.1002/jcb.20460; Cao J, 2004, J BIOL CHEM, V279, P35903, DOI 10.1074/jbc.M402353200; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coffey ET, 2000, J NEUROSCI, V20, P7602; Cowan KJ, 2003, HUM MOL GENET, V12, P1377, DOI 10.1093/hmg/ddg151; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; FEIGUIN F, 1994, J CELL BIOL, V127, P1021, DOI 10.1083/jcb.127.4.1021; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; GOEMAEREVANNESTE J, 1988, J NEUROCHEM, V51, P1746, DOI 10.1111/j.1471-4159.1988.tb01154.x; Grant P, 2000, J NEUROCYTOL, V29, P843, DOI 10.1023/A:1010999509251; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hirokawa N, 2003, TRENDS BIOCHEM SCI, V28, P558, DOI 10.1016/j.tibs.2003.08.006; HOLLENBECK PJ, 1993, J NEUROCHEM, V60, P2265, DOI 10.1111/j.1471-4159.1993.tb03513.x; Ishihara H, 2001, J NEUROL, V248, P856, DOI 10.1007/s004150170069; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jorgensen JS, 2001, MOL ENDOCRINOL, V15, P1496, DOI 10.1210/me.15.9.1496; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KUIPER GGJM, 1993, BIOCHEM J, V296, P161, DOI 10.1042/bj2960161; Lafevre-Bernt MA, 2003, J BIOL CHEM, V278, P34918, DOI 10.1074/jbc.M302841200; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Mandelkow E, 2002, TRENDS CELL BIOL, V12, P585, DOI 10.1016/S0962-8924(02)02400-5; McManamny P, 2002, HUM MOL GENET, V11, P2103, DOI 10.1093/hmg/11.18.2103; MCQUARRIE IG, 1989, NEUROBIOL AGING, V10, P359, DOI 10.1016/0197-4580(89)90049-3; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2005, TRENDS MOL MED, V11, P64, DOI 10.1016/j.molmed.2004.12.002; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; Morfini G, 2002, NEUROMOL MED, V2, P89, DOI 10.1385/NMM:2:2:089; Morfini G, 2001, DEV NEUROSCI-BASEL, V23, P364, DOI 10.1159/000048720; Morfini G., 2000, KINESIN PROTOCOLS, P147; Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje; Pigino G, 2003, J NEUROSCI, V23, P4499; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schmidt BJ, 2002, NEUROLOGY, V59, P770, DOI 10.1212/WNL.59.5.770; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; TRAISH AM, 1986, ENDOCRINOLOGY, V118, P1327, DOI 10.1210/endo-118-4-1327; Wilson CM, 1996, MOL CELL ENDOCRINOL, V120, P51, DOI 10.1016/0303-7207(96)03819-1; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	50	145	149	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					907	916		10.1038/nn1717	http://dx.doi.org/10.1038/nn1717			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16751763				2022-12-17	WOS:000238590800017
J	Nitschke, JB; Dixon, GE; Sarinopoulos, I; Short, SJ; Cohen, JD; Smith, EE; Kosslyn, SM; Rose, RM; Davidson, RJ				Nitschke, JB; Dixon, GE; Sarinopoulos, I; Short, SJ; Cohen, JD; Smith, EE; Kosslyn, SM; Rose, RM; Davidson, RJ			Altering expectancy dampens neural response to aversive taste in primary taste cortex	NATURE NEUROSCIENCE			English	Article; Proceedings Paper	34th Annual Meeting of the Society-for-Neuroscience	OCT 23-27, 2004	San Diego, CA	Soc Neurosci			FUNCTIONAL NEUROANATOMY; GUSTATORY CORTEX; INSULAR CORTEX; MACAQUE MONKEY; CONFIDENCE-INTERVALS; PLACEBO; PAIN; ACTIVATION; HUMANS; REPRESENTATION	The primary taste cortex consists of the insula and operculum. Previous work has indicated that neurons in the primary taste cortex respond solely to sensory input from taste receptors and lingual somatosensory receptors. Using functional magnetic resonance imaging, we show here that expectancy modulates these neural responses in humans. When subjects were led to believe that a highly aversive bitter taste would be less distasteful than it actually was, they reported it to be less aversive than when they had accurate information about the taste and, moreover, the primary taste cortex was less strongly activated. In addition, the activation of the right insula and operculum tracked online ratings of the aversiveness for each taste. Such expectancy-driven modulation of primary sensory cortex may affect perceptions of external events.	Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Waisman Ctr, Dept Psychiat, Madison, WI 53705 USA; Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Waisman Ctr, Dept Psychol, Madison, WI 53705 USA; Princeton Univ, Dept Psychol, Ctr Study Brain, Princeton, NJ 08544 USA; Columbia Univ, Dept Psychol, New York, NY 10027 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Univ Texas, Med Branch, Mind Brain Body & Hlth Initiat, Galveston, TX 77555 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Princeton University; Columbia University; Harvard University; University of Texas System; University of Texas Medical Branch Galveston	Nitschke, JB (corresponding author), Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Waisman Ctr, Dept Psychiat, 1500 Highland Ave, Madison, WI 53705 USA.	jnitschke@wisc.edu; rjdavids@wisc.edu	sarinopoulos, isidoros/B-5453-2010	Short, Sarah/0000-0003-0985-999X; Davidson, Richard/0000-0002-8506-4964; Sarinopoulos, Issidoros/0000-0001-9879-5515	NICHD NIH HHS [P30 HD03352] Funding Source: Medline; NIMH NIH HHS [K08-MH63984, T32-MH18931, K05-MH00875, P50-MH52354, MH40747, MH43454] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH052354, R37MH043454, K05MH000875, R01MH040747, K08MH063984, R01MH043454, T32MH018931] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adolphs R, 2000, J NEUROSCI, V20, P2683; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Benedetti F, 1999, J NEUROSCI, V19, P3639; Bornstein W S, 1940, Yale J Biol Med, V12, P719; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P371, DOI 10.1093/chemse/26.4.371; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Damasio Antonio, 2003, LOOKING SPINOZA JOY; Kobayakawa T, 1999, CHEM SENSES, V24, P201, DOI 10.1093/chemse/24.2.201; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Mai JK, 2004, ATLAS HUMAN BRAIN; Mayberg HS, 2002, AM J PSYCHIAT, V159, P728, DOI 10.1176/appi.ajp.159.5.728; Montgomery G, 1996, PSYCHOL SCI, V7, P174, DOI 10.1111/j.1467-9280.1996.tb00352.x; MOTTA G, 1959, Bull Sci Med (Bologna), V131, P480; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; OGAWA H, 1994, NEUROSCI RES, V20, P1, DOI 10.1016/0168-0102(94)90017-5; Ostrowsky K, 2000, EPILEPSIA, V41, P681, DOI 10.1111/j.1528-1157.2000.tb00228.x; PENFIELD W, 1955, BRAIN, V78, P445, DOI 10.1093/brain/78.4.445; Penfield W, 1954, EPILEPSY FUNCTIONAL; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; PFAFFMANN C, 1971, HDB SENSORY PHYSL, P75; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Pritchard TC, 1999, BEHAV NEUROSCI, V113, P663, DOI 10.1037/0735-7044.113.4.663; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; ROLLS ET, 1988, J PHYSIOL-LONDON, V397, P1, DOI 10.1113/jphysiol.1988.sp016984; ROLLS ET, 1999, BRAIN EMOTION; SCOTT TR, 1986, J NEUROPHYSIOL, V56, P876, DOI 10.1152/jn.1986.56.3.876; Scott TR, 1999, J NEUROPHYSIOL, V81, P60, DOI 10.1152/jn.1999.81.1.60; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Stewart-Williams S, 2004, PSYCHOL BULL, V130, P324, DOI 10.1037/0033-2909.130.2.324; SUDAKOV K, 1971, BRAIN RES, V28, P19, DOI 10.1016/0006-8993(71)90521-X; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanriover N, 2004, J NEUROSURG, V100, P891, DOI 10.3171/jns.2004.100.5.0891; Taylor SF, 2000, NEUROPSYCHOLOGIA, V38, P1415, DOI 10.1016/S0028-3932(00)00032-4; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; YAXLEY S, 1988, PHYSIOL BEHAV, V42, P223, DOI 10.1016/0031-9384(88)90074-1; YAXLEY S, 1990, J NEUROPHYSIOL, V63, P689, DOI 10.1152/jn.1990.63.4.689; Zald DH, 2002, J NEUROPHYSIOL, V87, P1068, DOI 10.1152/jn.00358.2001; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143	50	145	149	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					435	442		10.1038/nn1645	http://dx.doi.org/10.1038/nn1645			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	016UI	16462735				2022-12-17	WOS:000235645600024
J	Laviolette, SR; Gallegos, RA; Henriksen, SJ; van der Kooy, D				Laviolette, SR; Gallegos, RA; Henriksen, SJ; van der Kooy, D			Opiate state controls bi-directional reward signaling via GABA(A) receptors in the ventral tegmental area	NATURE NEUROSCIENCE			English	Article							A10 DOPAMINE NEURONS; NUCLEUS-ACCUMBENS; SINGLE EXPOSURE; RAT; MORPHINE; RELEASE; RETROGRADE; SENSITIZATION; LOCALIZATION; INVOLVEMENT	The neural mechanisms that mediate the transition from a drug-naive state to a state of drug dependence and addiction are not yet known. Here we show that a discrete population of GABA(A) receptors in the mammalian ventral tegmental area (VTA) serves as a potential addiction switching mechanism by gating reward transmission through one of two neural motivational systems: either a dopamine-independent (opiate-naive) or a dopaminergic (opiate-dependent or opiate-withdrawn) system. Bi-directional transmission of reward signals through this GABA(A) receptor substrate is dynamically controlled by the opiate state of the organism and involves a molecular alteration of the GABA(A) receptor. After opiate exposure and subsequent withdrawal, the functional conductance properties of the rat VTA GABA(A) receptor switch from an inhibitory to an excitatory signaling mode.	Univ Toronto, Dept Anat & Cell Biol, Neurobiol Res Grp, Toronto, ON M5S 1A8, Canada; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto; Scripps Research Institute; University of Toronto	Laviolette, SR (corresponding author), Univ Toronto, Dept Anat & Cell Biol, Neurobiol Res Grp, Toronto, ON M5S 1A8, Canada.	laviolette@bns.pitt.edu						Auger AP, 2001, P NATL ACAD SCI USA, V98, P8059, DOI 10.1073/pnas.131016298; Bechara A, 1998, PHARMACOL BIOCHEM BE, V59, P1, DOI 10.1016/S0091-3057(97)00047-6; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bonci A, 1997, J NEUROSCI, V17, P796; Borsook D, 1999, J MOL NEUROSCI, V12, P35, DOI 10.1385/JMN:12:1:35; Brebner K, 2000, PHARMACOL BIOCHEM BE, V66, P857, DOI 10.1016/S0091-3057(00)00286-0; CHURCHILL L, 1992, NEUROCHEM RES, V17, P101, DOI 10.1007/BF00966870; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; Dockstader CL, 2001, EUR J NEUROSCI, V13, P995, DOI 10.1046/j.1460-9568.2001.01455.x; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; Garzon M, 2001, SYNAPSE, V41, P311, DOI 10.1002/syn.1088; GERRITS MAFM, 1994, PSYCHOPHARMACOLOGY, V114, P486, DOI 10.1007/BF02249340; GRACE AA, 1979, EUR J PHARMACOL, V59, P211, DOI 10.1016/0014-2999(79)90283-8; GYSLING K, 1983, BRAIN RES, V277, P119, DOI 10.1016/0006-8993(83)90913-7; JOHNSON SW, 1992, J NEUROSCI, V12, P483; KALIVAS PW, 1990, J PHARMACOL EXP THER, V253, P858; KALIVAS PW, 1993, BRAIN RES REV, V18, P75, DOI 10.1016/0165-0173(93)90008-N; KLITENICK MA, 1992, J NEUROSCI, V12, P2623; Laviolette SR, 2003, MOL PSYCHIATR, V8, P50, DOI 10.1038/sj.mp.4001197; Laviolette SR, 2002, BEHAV BRAIN RES, V129, P17, DOI 10.1016/S0166-4328(01)00327-8; Laviolette SR, 2001, EUR J NEUROSCI, V13, P1009, DOI 10.1046/j.1460-9568.2001.01458.x; MACKEY WB, 1985, PHARMACOL BIOCHEM BE, V22, P101, DOI 10.1016/0091-3057(85)90492-7; Margeta-Mitrovic M, 1999, J COMP NEUROL, V405, P299, DOI 10.1002/(SICI)1096-9861(19990315)405:3<299::AID-CNE2>3.0.CO;2-6; Mark TL, 2001, DRUG ALCOHOL DEPEN, V61, P195, DOI 10.1016/S0376-8716(00)00162-9; Nader K, 1997, J NEUROSCI, V17, P383, DOI 10.1523/JNEUROSCI.17-01-00383.1997; Nestler EJ, 2001, AM J ADDICTION, V10, P201, DOI 10.1080/105504901750532094; Olmstead MC, 1998, J NEUROSCI, V18, P5035; OLPE HR, 1977, BRAIN RES, V134, P577, DOI 10.1016/0006-8993(77)90834-4; Robinson TE, 2000, ADDICTION, V95, pS91; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schulteis G, 1997, PSYCHOPHARMACOLOGY, V129, P56, DOI 10.1007/s002130050162; SEMBA K, 1992, J COMP NEUROL, V323, P387, DOI 10.1002/cne.903230307; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Steffensen SC, 2001, BRAIN RES, V906, P190, DOI 10.1016/S0006-8993(01)02581-1; STEININGER TL, 1992, J COMP NEUROL, V321, P515, DOI 10.1002/cne.903210403; STINUS L, 1982, PSYCHOPHARMACOLOGY, V77, P186, DOI 10.1007/BF00431946; Svingos AL, 2001, SYNAPSE, V41, P221, DOI 10.1002/syn.1079; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; VANBOCKSTAELE EJ, 1995, BRAIN RES, V682, P215, DOI 10.1016/0006-8993(95)00334-M; Vanderschuren LJMJ, 2001, EUR J NEUROSCI, V14, P1533, DOI 10.1046/j.0953-816x.2001.01775.x; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; Westerink BHC, 1996, J NEUROSCI, V16, P2605; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Xi ZX, 1998, BRAIN RES, V798, P156, DOI 10.1016/S0006-8993(98)00406-5	47	145	149	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					160	169		10.1038/nn1182	http://dx.doi.org/10.1038/nn1182			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14730310				2022-12-17	WOS:000188468500014
J	Carroll, P; Lewin, GR; Koltzenburg, M; Toyka, KV; Thoenen, H				Carroll, P; Lewin, GR; Koltzenburg, M; Toyka, KV; Thoenen, H			A role for BDNF in mechanosensation	NATURE NEUROSCIENCE			English	Article							SENSORY NEURONS; NERVOUS-SYSTEM; CUTANEOUS MECHANORECEPTORS; NEUROTROPHIC FACTOR; MESSENGER-RNA; TRK RECEPTORS; TOUCH DOMES; EXPRESSION; RAT; HIPPOCAMPAL	Brain-derived neurotrophic factor (BDNF) is a survival factor for certain sensory neurons during development. Using electrophysiology in BDNF-deficient mice, we show here that slowly adapting mechanoreceptors (SAM), but not other types of cutaneous afferents, require BDNF in postnatal life for normal mechanotransduction. Neurons lacking BDNF did not die, but instead showed a profound and specific reduction in their mechanical sensitivity, which was quantitatively the same in BDNF -/- and BDNF +/- animals. Postnatal treatment of BDNF +/- mice with recombinant BDNF completely rescued the mechanosensitivity deficit. Therefore BDNF is important for regulating SAM mechanosensitivity, independent of any survival-promoting function.	Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; Max Planck Inst Neurobiol, Dept Neurobiochem, D-82152 Planegg Martinsried, Germany; Max Delbruck Ctr Mol Med, Growth Factor & Regenerat Grp, D-13122 Berlin, Germany	University of Wurzburg; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Koltzenburg, M (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.		Carroll, Patrick/AAL-7773-2021; Lewin, Gary R/B-8028-2011; Koltzenburg, Martin/C-1349-2008	Koltzenburg, Martin/0000-0001-9181-5966; Lewin, Gary/0000-0002-2890-6352				Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Apfel SC, 1996, MOL CELL NEUROSCI, V7, P134, DOI 10.1006/mcne.1996.0010; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; EMFORS P, 1994, CELL, V77, P503; EMFORS P, 1994, NATURE, V368, P147; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lawson SN., 1992, SENSORY NEURONS DIVE, P27; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lindholm D, 1996, EUR J NEUROSCI, V8, P1452, DOI 10.1111/j.1460-9568.1996.tb01607.x; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; MICHAEL GJ, 1997, J NEUROSCI, V17, P8479; MILLS LR, 1989, DEV BIOL, V136, P61, DOI 10.1016/0012-1606(89)90130-9; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; NURSE CA, 1984, NEUROSCIENCE, V11, P521, DOI 10.1016/0306-4522(84)90042-3; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Stucky CL, 1997, J NEUROSCI, V17, P4398; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; WETMORE C, 1995, J COMP NEUROL, V353, P143, DOI 10.1002/cne.903530113; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302	27	145	150	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					42	46		10.1038/242	http://dx.doi.org/10.1038/242			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195107				2022-12-17	WOS:000076361000016
J	Saunders, BT; Richard, JM; Margolis, EB; Janak, PH				Saunders, Benjamin T.; Richard, Jocelyn M.; Margolis, Elyssa B.; Janak, Patricia H.			Dopamine neurons create Pavlovian conditioned stimuli with circuit-defined motivational properties	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS CORE; VENTRAL TEGMENTAL AREA; PARKINSONS-DISEASE; PREDICTION ERRORS; INCENTIVE SALIENCE; ACTION INITIATION; DORSAL STRIATUM; REWARD; BEHAVIOR; SIGNALS	Environmental cues, through Pavlovian learning, become conditioned stimuli that guide animals toward the acquisition of rewards (for example, food) that are necessary for survival. We tested the fundamental role of midbrain dopamine neurons in conferring predictive and motivational properties to cues, independent of external rewards. We found that brief phasic optogenetic excitation of dopamine neurons, when presented in temporal association with discrete sensory cues, was sufficient to instantiate those cues as conditioned stimuli that subsequently both evoked dopamine neuron activity on their own and elicited cue-locked conditioned behavior. Notably, we identified highly parcellated functions for dopamine neuron subpopulations projecting to different regions of striatum, revealing dissociable dopamine systems for the generation of incentive value and conditioned movement invigoration. Our results indicate that dopamine neurons orchestrate Pavlovian conditioning via functionally heterogeneous, circuit-specific motivational signals to create, gate, and shape cue-controlled behaviors.	[Saunders, Benjamin T.; Richard, Jocelyn M.; Janak, Patricia H.] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; [Saunders, Benjamin T.; Richard, Jocelyn M.; Janak, Patricia H.] Johns Hopkins Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21205 USA; [Margolis, Elyssa B.] Univ Calif San Francisco, Alcoholism & Addict Res Grp, Wheeler Ctr Neurobiol Addict, Dept Neurol, San Francisco, CA 94143 USA; [Janak, Patricia H.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Saunders, Benjamin T.; Richard, Jocelyn M.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Medicine; University of Minnesota System; University of Minnesota Twin Cities	Saunders, BT; Janak, PH (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.; Saunders, BT; Janak, PH (corresponding author), Johns Hopkins Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21205 USA.; Janak, PH (corresponding author), Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.; Saunders, BT (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	bts@umn.edu; patricia.janak@jhu.edu	Richard, Jocelyn/I-4327-2019	Richard, Jocelyn/0000-0001-5750-0418; Saunders, Benjamin/0000-0002-4733-1101; Janak, Patricia/0000-0002-3333-9049	National Institutes of Health [DA036996, DA042895, AA022290, AA025384, DA030529, DA035943]; Brain and Behavior Research Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA025384, K99AA025384, F32AA022290, P50AA017072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035943, R00DA042895, R01DA030529, F32DA036996, K99DA042895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Keiflin and all members of the Janak laboratory for discussion and comments on the manuscript; A. Haimbaugh, D. Acs, H. Pribut, K. Lineback, N. Pettas, B. Persaud, and L. Kinny for assistance with histology and behavioral video scoring; P. Fong for conducting surgical procedures for ex vivo physiology studies; K. Deisseroth (Stanford) for the ChR2 construct; E. Boyden (MIT) for the ChrimsonR construct; and the Janelia Research Campus GENIE Project and Stanford Gene Vector and Virus Core for the GCaMP6f construct. This work was supported by National Institutes of Health grants DA036996 (B.T.S.), DA042895 (B.T.S.), AA022290 (J.M.R.), AA025384 (J.M.R.), DA030529 (E.B.M.), and DA035943 (P.H.J.), as well as grants from the Brain and Behavior Research Foundation (B.T.S. and J.M.R.).	Azulay JP, 1999, BRAIN, V122, P111, DOI 10.1093/brain/122.1.111; Bassareo V, 1999, NEUROSCIENCE, V89, P637, DOI 10.1016/S0306-4522(98)00583-1; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Burgess CP, 2017, CELL REP, V20, P2513, DOI 10.1016/j.celrep.2017.08.047; Chang CY, 2016, NAT NEUROSCI, V19, P111, DOI 10.1038/nn.4191; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Corbit LH, 2007, J NEUROSCI, V27, P13977, DOI 10.1523/JNEUROSCI.4097-07.2007; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; da Silva JA, 2018, NATURE, V554, P244, DOI 10.1038/nature25457; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Dayan P, 2014, COGN AFFECT BEHAV NE, V14, P473, DOI 10.3758/s13415-014-0277-8; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Dodson PD, 2016, P NATL ACAD SCI USA, V113, pE2180, DOI 10.1073/pnas.1515941113; Eshel N, 2016, NAT NEUROSCI, V19, P479, DOI 10.1038/nn.4239; Eshel N, 2015, NATURE, V525, P243, DOI 10.1038/nature14855; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Fraser KM, 2017, EUR J NEUROSCI, V46, P2047, DOI 10.1111/ejn.13642; Haber SN, 2000, J NEUROSCI, V20, P2369; Hamid AA, 2016, NAT NEUROSCI, V19, P117, DOI 10.1038/nn.4173; Howe MW, 2016, NATURE, V535, P505, DOI 10.1038/nature18942; Ilango A, 2014, J NEUROSCI, V34, P817, DOI 10.1523/JNEUROSCI.1703-13.2014; Keiflin R, 2015, NEURON, V88, P247, DOI 10.1016/j.neuron.2015.08.037; KELLEY AE, 1991, PSYCHOPHARMACOLOGY, V103, P187, DOI 10.1007/BF02244202; Kim CK, 2016, NAT METHODS, V13, P325, DOI [10.1038/NMETH.3770, 10.1038/nmeth.3770]; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; KLOCKGETHER T, 1995, MOVEMENT DISORD, V10, P460, DOI 10.1002/mds.870100410; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Margolis EB, 2014, J NEUROSCI, V34, P14707, DOI 10.1523/JNEUROSCI.2144-14.2014; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Millan EZ, 2017, NEUROSCIENCE, V360, P106, DOI 10.1016/j.neuroscience.2017.07.044; Morales M, 2017, NAT REV NEUROSCI, V18, P73, DOI 10.1038/nrn.2016.165; Parker NF, 2016, NAT NEUROSCI, V19, P845, DOI 10.1038/nn.4287; Pascoli V, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.017; Richard JM, 2011, J NEUROSCI, V31, P12866, DOI 10.1523/JNEUROSCI.1339-11.2011; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rothermel M, 2013, J NEUROSCI, V33, P15195, DOI 10.1523/JNEUROSCI.1618-13.2013; Saddoris MP, 2015, J NEUROSCI, V35, P11572, DOI 10.1523/JNEUROSCI.2344-15.2015; Saunders BT, 2012, EUR J NEUROSCI, V36, P2521, DOI 10.1111/j.1460-9568.2012.08217.x; Sharnoff M, 2017, NASSER'S PEACE: EGYPT'S RESPONSE TO THE 1967 WAR WITH ISRAEL, P1, DOI 10.1038/nn.4538; Steinberg EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094771; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; TAYLOR JR, 1984, PSYCHOPHARMACOLOGY, V84, P405, DOI 10.1007/BF00555222; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wassum KM, 2013, BIOL PSYCHIAT, V73, P747, DOI 10.1016/j.biopsych.2012.12.005; Willuhn I, 2012, P NATL ACAD SCI USA, V109, P20703, DOI 10.1073/pnas.1213460109; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Yang HB, 2018, NEURON, V97, P434, DOI 10.1016/j.neuron.2017.12.022	55	144	145	6	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2018	21	8					1072	+		10.1038/s41593-018-0191-4	http://dx.doi.org/10.1038/s41593-018-0191-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO3BK	30038277	Green Submitted, Green Accepted			2022-12-17	WOS:000439859000010
J	Lu, RW; Sun, WZ; Liang, YJ; Kerlin, A; Bierfeld, J; Seelig, JD; Wilson, DE; Scholl, B; Mohar, B; Tanimoto, M; Koyama, M; Fitzpatrick, D; Orger, MB; Ji, N				Lu, Rongwen; Sun, Wenzhi; Liang, Yajie; Kerlin, Aaron; Bierfeld, Jens; Seelig, Johannes D.; Wilson, Daniel E.; Scholl, Benjamin; Mohar, Boaz; Tanimoto, Masashi; Koyama, Minoru; Fitzpatrick, David; Orger, Michael B.; Ji, Na			Video-rate volumetric functional imaging of the brain at synaptic resolution	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; CELLULAR RESOLUTION; GABAERGIC NEURONS; NEURAL ACTIVITY; EXTENDED DEPTH; HIGH-SPEED; MICROSCOPY; ORIENTATION; NETWORK; ORGANIZATION	Neurons and neural networks often extend hundreds of micrometers in three dimensions. Capturing the calcium transients associated with their activity requires volume imaging methods with subsecond temporal resolution. Such speed is a challenge for conventional two-photon laser-scanning microscopy, because it depends on serial focal scanning in 3D and indicators with limited brightness. Here we present an optical module that is easily integrated into standard two-photon laser-scanning microscopes to generate an axially elongated Bessel focus, which when scanned in 2D turns frame rate into volume rate. We demonstrated the power of this approach in enabling discoveries for neurobiology by imaging the calcium dynamics of volumes of neurons and synapses in fruit flies, zebrafish larvae, mice and ferrets in vivo. Calcium signals in objects as small as dendritic spines could be resolved at video rates, provided that the samples were sparsely labeled to limit overlap in their axially projected images.	[Lu, Rongwen; Sun, Wenzhi; Liang, Yajie; Kerlin, Aaron; Seelig, Johannes D.; Mohar, Boaz; Tanimoto, Masashi; Koyama, Minoru; Ji, Na] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Bierfeld, Jens; Orger, Michael B.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal; [Seelig, Johannes D.] Ctr Adv European Studies & Res, Bonn, Germany; [Wilson, Daniel E.; Scholl, Benjamin; Fitzpatrick, David] Max Planck Florida Inst Neurosci, Dept Funct Architecture & Dev Cerebral Cortex, Jupiter, FL USA; [Tanimoto, Masashi] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi, Japan	Howard Hughes Medical Institute; Fundacao Champalimaud; Center of Advanced European Studies & Research (CAESAR); Max Planck Society; Nagoya University	Ji, N (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	jin@janelia.hhmi.org		Lu, Rongwen/0000-0002-0224-7969; Koyama, Minoru/0000-0002-9774-9223; Orger, Michael/0000-0002-9763-8902; Tanimoto, Masashi/0000-0002-7653-1081; Liang, Yajie/0000-0002-4798-4882	Howard Hughes Medical Institute; Japanese Society for the Promotion of Science [S2602, 15K06708]; National Eye Institute of the NIH [2 R01 EY011488-17]; Champalimaud Foundation and the Bial Foundation [185/12]; NATIONAL EYE INSTITUTE [R01EY011488] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Eye Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Champalimaud Foundation and the Bial Foundation(Bial Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank V.Jayaraman for discussions, Y. Aso and Y. Sun for help with fly anatomy, and J. Kuhl for help with illustration. R.L., W.S., Y.L., A.K., J.D.S., B.M., M.T., M.K. and N.J. were supported by the Howard Hughes Medical Institute.M.T. was also supported by the Japanese Society for the Promotion of Science (S2602 and 15K06708). D.E.W., B.S. and D.F. were supported by the National Eye Institute of the NIH under Grant 2 R01 EY011488-17. J.B. was supported by a PhD fellowship from the Portuguese Fundacao para a Ciencia e a Tecnologia. M.B.O was supported by the Champalimaud Foundation and the Bial Foundation (185/12).	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Botcherby EJ, 2006, OPT COMMUN, V268, P253, DOI 10.1016/j.optcom.2006.07.026; Bouchard MB, 2015, NAT PHOTONICS, V9, P113, DOI [10.1038/NPHOTON.2014.323, 10.1038/nphoton.2014.323]; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Drapeau P, 1999, J NEUROSCI METH, V88, P1, DOI 10.1016/S0165-0270(99)00008-4; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Gahtan E, 2001, J NEUROSCI METH, V108, P97, DOI 10.1016/S0165-0270(01)00382-X; Gobel W, 2007, PHYSIOLOGY, V22, P358, DOI 10.1152/physiol.00032.2007; Goodman JW., 2005, INTRO FOURIER OPTICS; Hestrin S, 2005, TRENDS NEUROSCI, V28, P304, DOI 10.1016/j.tins.2005.04.001; Hu H, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00195; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Ji N, 2008, NAT METHODS, V5, P197, DOI 10.1038/NMETH.1175; Ji N, 2016, NAT NEUROSCI, V19, P1154, DOI 10.1038/nn.4358; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kameyama K, 2010, J NEUROSCI, V30, P1551, DOI 10.1523/JNEUROSCI.5025-09.2010; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; Kubota Y, 2014, CURR OPIN NEUROBIOL, V26, P7, DOI 10.1016/j.conb.2013.10.003; Lister JA, 1999, DEVELOPMENT, V126, P3757; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; McGinley MJ, 2015, NEURON, V87, P1143, DOI 10.1016/j.neuron.2015.09.012; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048; Paken JMP, 2016, ELIFE, V5, DOI 10.7554/eLife.14985; Panier T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00065; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Podgorski K, 2016, J NEUROPHYSIOL, V116, P1012, DOI 10.1152/jn.00275.2016; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Reimer J, 2014, NEURON, V84, P355, DOI 10.1016/j.neuron.2014.09.033; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Severi KE, 2014, NEURON, V83, P692, DOI 10.1016/j.neuron.2014.06.032; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Song Antoine, PREPRINT; STAMNES JJ, 1982, APPL OPTICS, V21, P1628, DOI 10.1364/AO.21.001628; Sun WZ, 2016, NAT NEUROSCI, V19, P308, DOI 10.1038/nn.4196; Tan ZC, 2015, SCI REP-UK, V5, DOI 10.1038/srep12597; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Theriault G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00139; Theriault G, 2013, OPT EXPRESS, V21, P10095, DOI 10.1364/OE.21.010095; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Vogt K, 2016, ELIFE, V5, DOI 10.7554/eLife.14009; Weir PT, 2015, P NATL ACAD SCI USA, V112, pE5523, DOI 10.1073/pnas.1514415112; WELFORD WT, 1960, J OPT SOC AM, V50, P749, DOI 10.1364/JOSA.50.000749; Wilson DE, 2016, NAT NEUROSCI, V19, P1003, DOI 10.1038/nn.4323; Yang WJ, 2016, NEURON, V89, P269, DOI 10.1016/j.neuron.2015.12.012	56	144	147	9	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2017	20	4					620	+		10.1038/nn.4516	http://dx.doi.org/10.1038/nn.4516			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EP7LH	28250408	Green Submitted, Green Accepted			2022-12-17	WOS:000397558800017
J	Sandoe, J; Eggan, K				Sandoe, Jackson; Eggan, Kevin			Opportunities and challenges of pluripotent stem cell neurodegenerative disease models	NATURE NEUROSCIENCE			English	Review							TARGETED GENE CORRECTION; MOTOR-NEURONS; ALZHEIMERS-DISEASE; HUMAN FIBROBLASTS; GLIAL-CELLS; DIFFERENTIATION; LINES; ALS; GENERATION; DERIVATION	Human neurodegenerative disorders are among the most difficult to study. In particular, the inability to readily obtain the faulty cell types most relevant to these diseases has impeded progress for decades. Recent advances in pluripotent stem cell technology now grant access to substantial quantities of disease-pertinent neurons both with and without predisposing mutations. While this suite of technologies has revolutionized the field of 'in vitro disease modeling', great care must be taken in their deployment if robust, durable discoveries are to be made. Here we review what we perceive to be several of the stumbling blocks in the use of stem cells for the study of neurological disease and offer strategies to overcome them.	[Sandoe, Jackson] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Sandoe, Jackson; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Eggan, K (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	keggan@scrb.harvard.edu	Eggan, Kevin/P-7119-2018		Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aizawa E, 2012, MOL THER, V20, P424, DOI 10.1038/mt.2011.266; Alegre-Abarrategui J, 2008, NEUROPATH APPL NEURO, V34, P272, DOI 10.1111/j.1365-2990.2007.00888.x; Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; An MC, 2012, CELL STEM CELL, V11, P253, DOI 10.1016/j.stem.2012.04.026; Andersen MS, 2002, J MOL MED-JMM, V80, P770, DOI 10.1007/s00109-002-0393-8; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Brockington A, 2013, ACTA NEUROPATHOL, V125, P95, DOI 10.1007/s00401-012-1058-5; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chang T, 2011, STEM CELLS, V29, P2090, DOI 10.1002/stem.749; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cooper O., 2012, SCI TRANSL MED, V4; Corti S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004108; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Dawson TM, 2002, NAT NEUROSCI, V5, P1058, DOI 10.1038/nn941; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Double KL, 2010, PROG NEUROBIOL, V92, P316, DOI 10.1016/j.pneurobio.2010.06.001; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hester ME, 2011, MOL THER, V19, P1905, DOI 10.1038/mt.2011.135; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Jeon I, 2012, STEM CELLS, V30, P2054, DOI 10.1002/stem.1135; Juurlink B. H. J., 1998, NEUROMETH, V33, P53; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Keller JN, 2000, NEUROSCIENCE, V98, P149, DOI 10.1016/S0306-4522(00)00067-1; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Kriks S., 2011, NATURE, V418, P50; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Seeley WW, 2006, ANN NEUROL, V60, P660, DOI 10.1002/ana.21055; Sergent-Tanguy S, 2003, J NEUROSCI METH, V129, P73, DOI 10.1016/S0165-0270(03)00210-3; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takazawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040154; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomoda K, 2012, CELL STEM CELL, V11, P91, DOI 10.1016/j.stem.2012.05.019; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Verlinsky Y, 2005, REPROD BIOMED ONLINE, V10, P105, DOI 10.1016/S1472-6483(10)60810-3; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; von Steyern FV, 1999, EUR J NEUROSCI, V11, P2093, DOI 10.1046/j.1460-9568.1999.00631.x; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	99	144	148	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					780	789		10.1038/nn.3425	http://dx.doi.org/10.1038/nn.3425			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799470				2022-12-17	WOS:000321180900007
J	Schiemann, J; Schlaudraff, F; Klose, V; Bingmer, M; Seino, S; Magill, PJ; Zaghloul, KA; Schneider, G; Liss, B; Roeper, J				Schiemann, Julia; Schlaudraff, Falk; Klose, Verena; Bingmer, Markus; Seino, Susumu; Magill, Peter J.; Zaghloul, Kareem A.; Schneider, Gaby; Liss, Birgit; Roeper, Jochen			K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; IN-VIVO; PARKINSONS-DISEASE; SPIKE TRAINS; DORSOMEDIAL STRIATUM; MIDBRAIN NEURONS; FIRING PATTERN; CELLS; EXPRESSION; RECEPTORS	Phasic activation of the dopamine (DA) midbrain system in response to unexpected reward or novelty is critical for adaptive behavioral strategies. This activation of DA midbrain neurons occurs via a synaptically triggered switch from low-frequency background spiking to transient high-frequency burst firing. We found that, in medial DA neurons of the substantia nigra (SN), activity of ATP-sensitive potassium (K-ATP) channels enabled NMDA-mediated bursting in vitro as well as spontaneous in vivo burst firing in anesthetized mice. Cell-selective silencing of K-ATP channel activity in medial SN DA neurons revealed that their K-ATP channel-gated burst firing was crucial for novelty-dependent exploratory behavior. We also detected a transcriptional upregulation of K-ATP channel and NMDA receptor subunits, as well as high in vivo burst firing, in surviving SN DA neurons from Parkinson's disease patients, suggesting that burst-gating K-ATP channel function in DA neurons affects phenotypes in both disease and health.	[Schiemann, Julia; Klose, Verena; Roeper, Jochen] Goethe Univ Frankfurt, Inst Neurophysiol, Neurosci Ctr, Frankfurt, Germany; [Schlaudraff, Falk; Liss, Birgit] Univ Ulm, Inst Appl Physiol, Ulm, Germany; [Bingmer, Markus; Schneider, Gaby] Goethe Univ Frankfurt, Dept Comp Sci & Math, Frankfurt, Germany; [Seino, Susumu] Kobe Univ, Div Cellular & Mol Med, Kobe, Hyogo 657, Japan; [Magill, Peter J.] Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3QT, England; [Magill, Peter J.] Univ Oxford, Oxford Parkinsons Dis Ctr, Oxford, England; [Zaghloul, Kareem A.] NINDS, Surg Neurol Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA	Goethe University Frankfurt; Ulm University; Goethe University Frankfurt; Kobe University; University of Oxford; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Roeper, J (corresponding author), Goethe Univ Frankfurt, Inst Neurophysiol, Neurosci Ctr, Frankfurt, Germany.	birgit.liss@uni-ulm.de; roeper@em.uni-frankfurt.de	Zaghloul, Kareem/AAV-4208-2020	Magill, Peter/0000-0001-7141-7071; Roeper, Jochen/0000-0003-2145-8742; liss, Birgit/0000-0002-6733-9207	Gemeinnutzige Hertiestiftung; BMBF Nationales Genomforschungsnetzwerk NGFN-II/plus [01GS08134]; Alfried Krupp prize; LOEWE-Schwerpunkt Neuronale Koordination Forschungsschwerpunkt Frankfurt NeFF; Bernstein Fokus Neurotechnology Frankfurt; doctoral fellowship Studienstiftung des deutschen Volkes; Medical Research Council UK [U138197109];  [SFB815];  [SFB497]; Medical Research Council [MC_U138197109] Funding Source: researchfish; MRC [MC_U138197109] Funding Source: UKRI	Gemeinnutzige Hertiestiftung; BMBF Nationales Genomforschungsnetzwerk NGFN-II/plus; Alfried Krupp prize; LOEWE-Schwerpunkt Neuronale Koordination Forschungsschwerpunkt Frankfurt NeFF; Bernstein Fokus Neurotechnology Frankfurt; doctoral fellowship Studienstiftung des deutschen Volkes; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Petzoldt, H. Schalk and A. Parg for assistance in immunohistochemistry, and M. Fauler for mRNA expression data analysis. The study was supported by Gemeinnutzige Hertiestiftung (J.R. and B. L.), SFB815 (J.R.), SFB497 (B. L.), BMBF Nationales Genomforschungsnetzwerk NGFN-II/plus (01GS08134, J.R. and B. L.), Alfried Krupp prize (B. L.), LOEWE-Schwerpunkt Neuronale Koordination Forschungsschwerpunkt Frankfurt NeFF (J.R. and G. S.), Bernstein Fokus Neurotechnology Frankfurt (G. S. and M. B.), doctoral fellowship Studienstiftung des deutschen Volkes (J.S.) and Medical Research Council UK (U138197109, P.J.M.).	Andrews ZB, 2009, J NEUROSCI, V29, P14057, DOI 10.1523/JNEUROSCI.3890-09.2009; Bayer HM, 2007, J NEUROPHYSIOL, V98, P1428, DOI 10.1152/jn.01140.2006; Bingmer M, 2011, J NEUROSCI METH, V201, P426, DOI 10.1016/j.jneumeth.2011.08.013; Bodi N, 2009, BRAIN, V132, P2385, DOI 10.1093/brain/awp094; Brazhnik E, 2008, J NEUROSCI, V28, P10386, DOI 10.1523/JNEUROSCI.2387-08.2008; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Brown MTC, 2009, J NEUROSCI, V29, P2915, DOI 10.1523/JNEUROSCI.4423-08.2009; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Dabrowski M, 2003, DIABETOLOGIA, V46, P1375, DOI 10.1007/s00125-003-1198-1; Deacon RMJ, 2006, PHYSIOL BEHAV, V87, P723, DOI 10.1016/j.physbeh.2006.01.013; Deister CA, 2009, J NEUROSCI, V29, P15888, DOI 10.1523/JNEUROSCI.4053-09.2009; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Fridlyand LE, 2010, AM J PHYSIOL-ENDOC M, V299, pE517, DOI 10.1152/ajpendo.00177.2010; Geng XH, 2011, AM J PHYSIOL-ENDOC M, V300, pE276, DOI 10.1152/ajpendo.00262.2010; Gomis A, 1998, BRIT J PHARMACOL, V123, P443, DOI 10.1038/sj.bjp.0701628; GRACE AA, 1984, J NEUROSCI, V4, P2877; Grundemann J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn084; Grundemann J, 2011, METHODS MOL BIOL, V755, P363, DOI 10.1007/978-1-61779-163-5_30; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harnett MT, 2009, NEURON, V62, P826, DOI 10.1016/j.neuron.2009.05.011; Henny P, 2012, NAT NEUROSCI, V15, P613, DOI 10.1038/nn.3048; Herrik KF, 2010, J NEUROPHYSIOL, V104, P1726, DOI 10.1152/jn.01126.2009; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; JOHNSON SW, 1992, J NEUROSCI, V12, P2000; JOHNSON SW, 1992, SCIENCE, V258, P665, DOI 10.1126/science.1329209; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Krebs RM, 2011, NEUROIMAGE, V58, P647, DOI 10.1016/j.neuroimage.2011.06.038; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lex B, 2010, NEUROPSYCHOPHARMACOL, V35, P1788, DOI 10.1038/npp.2010.46; Lex B, 2010, CEREB CORTEX, V20, P873, DOI 10.1093/cercor/bhp151; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; Mameli-Engvall M, 2006, NEURON, V50, P911, DOI 10.1016/j.neuron.2006.05.007; Martin-Ibanez R, 2006, EUR J NEUROSCI, V23, P1063, DOI 10.1111/j.1460-9568.2006.04601.x; Miki T, 1997, P NATL ACAD SCI USA, V94, P11969, DOI 10.1073/pnas.94.22.11969; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Opland DM, 2010, BRAIN RES, V1350, P65, DOI 10.1016/j.brainres.2010.04.028; Parker JG, 2011, J NEUROSCI, V31, P11362, DOI 10.1523/JNEUROSCI.2411-11.2011; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Rutledge RB, 2009, J NEUROSCI, V29, P15104, DOI 10.1523/JNEUROSCI.3524-09.2009; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shen KZ, 2010, J NEUROSCI, V30, P1882, DOI 10.1523/JNEUROSCI.3200-09.2010; Ulusoy A, 2009, MOL THER, V17, P1574, DOI 10.1038/mt.2009.142; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; WILSON CJ, 1977, BRAIN RES, V136, P243, DOI 10.1016/0006-8993(77)90801-0; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; YAMADA T, 1990, BRAIN RES, V526, P303, DOI 10.1016/0006-8993(90)91236-A; Zaghloul KA, 2009, SCIENCE, V323, P1496, DOI 10.1126/science.1167342; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang D, 2008, SYNAPSE, V62, P169, DOI 10.1002/syn.20479; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	57	144	149	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1272	U141		10.1038/nn.3185	http://dx.doi.org/10.1038/nn.3185			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22902720	Green Accepted			2022-12-17	WOS:000308072600018
J	Purushothaman, G; Marion, R; Li, K; Casagrande, VA				Purushothaman, Gopathy; Marion, Roan; Li, Keji; Casagrande, Vivien A.			Gating and control of primary visual cortex by pulvinar	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; SUPERIOR COLLICULUS; CORTICOCORTICAL CONNECTIONS; ORIENTATION SELECTIVITY; INFERIOR PULVINAR; SPATIAL ATTENTION; MACAQUE MONKEY; CAT; THALAMUS; LESIONS	The primary visual cortex (V1) receives its driving input from the eyes via the lateral geniculate nucleus (LGN) of the thalamus. The lateral pulvinar nucleus of the thalamus also projects to V1, but this input is not well understood. We manipulated lateral pulvinar neural activity in prosimian primates and assessed the effect on supra-granular layers of V1 that project to higher visual cortex. Reversibly inactivating lateral pulvinar prevented supra-granular V1 neurons from responding to visual stimulation. Reversible, focal excitation of lateral pulvinar receptive fields increased the visual responses in coincident V1 receptive fields fourfold and shifted partially overlapping V1 receptive fields toward the center of excitation. V1 responses to regions surrounding the excited lateral pulvinar receptive fields were suppressed. LGN responses were unaffected by these lateral pulvinar manipulations. Excitation of lateral pulvinar after LGN lesion activated supra-granular layer V1 neurons. Thus, lateral pulvinar is able to powerfully control and gate information outflow from V1.	[Purushothaman, Gopathy; Casagrande, Vivien A.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37203 USA; [Marion, Roan] Vanderbilt Univ, Grad Program Neurosci, Nashville, TN USA; [Li, Keji; Casagrande, Vivien A.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Casagrande, VA (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37203 USA.	gopathy.purushothaman@vanderbilt.edu; vivien.casagrande@vanderbilt.edu			US National Institutes of Health [R01-EY01778, P30-EY008126, T32-EY07135, P30-HD15052]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY001778, T32EY007135, P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH064913] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Mavity-Hudson for histology, S. Walston, Y. Jiang, D. Yampolsky, J. Mavity-Hudson, J. Patel and D. Rinker for help with experiments, D. Yampolsky for technical and computational assistance, and M. Feurtado for veterinary assistance. We thank F. Ebner, J. Kaas, R. Khumbani, J. Schall, P. Wallisch and K.-W. Yao for their suggestions and comments on the work. This work was supported by US National Institutes of Health grants R01-EY01778, P30-EY008126, T32-EY07135 and P30-HD15052.	Arend I, 2008, PROG BRAIN RES, V171, P475, DOI 10.1016/S0079-6123(08)00669-9; BENDER DB, 1987, EXP BRAIN RES, V69, P140; Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; BENEVENTO LA, 1976, BRAIN RES, V108, P1, DOI 10.1016/0006-8993(76)90160-8; Berman RA, 2011, J NEUROSCI, V31, P373, DOI 10.1523/JNEUROSCI.4738-10.2011; BISHOP PO, 1971, J PHYSIOL-LONDON, V216, P39, DOI 10.1113/jphysiol.1971.sp009508; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Casanova C., 2004, VISUAL NEUROSCIENCES, P592; CHALUPA LM, 1977, BEHAV BIOL, V20, P149, DOI 10.1016/S0091-6773(77)90721-0; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; De Pasquale R, 2011, J NEUROSCI, V31, P16494, DOI 10.1523/JNEUROSCI.3664-11.2011; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DESIMONE R, 1990, COLD SH Q B, V55, P963; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FERSTER D, 1986, J NEUROSCI, V6, P1284; Fischer J, 2009, HUM BRAIN MAPP, V30, P101, DOI 10.1002/hbm.20485; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P292, DOI 10.1152/jn.1985.53.1.292; Ivanov I, 2010, AM J PSYCHIAT, V167, P397, DOI 10.1176/appi.ajp.2009.09030398; Kaas JH, 2007, BRAIN RES REV, V55, P285, DOI 10.1016/j.brainresrev.2007.02.008; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Karnath HO, 2002, BRAIN, V125, P350, DOI 10.1093/brain/awf032; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Logothetis NK, 2010, NAT NEUROSCI, V13, P1283, DOI 10.1038/nn.2631; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; McCormick D. A., 2003, EXCITATORY INHIBITOR, P113; MIZE RR, 1989, NEUROSCI LETT, V104, P31, DOI 10.1016/0304-3940(89)90324-8; Molotchnikoff S, 1996, VISION RES, V36, P2037, DOI 10.1016/0042-6989(95)00311-8; OGREN MP, 1977, BRAIN RES, V137, P343, DOI 10.1016/0006-8993(77)90344-4; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; Purves D., 2004, NEUROSCIENCEZ; RAFAL RD, 1987, P NATL ACAD SCI USA, V84, P7349, DOI 10.1073/pnas.84.20.7349; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; REZAK M, 1979, BRAIN RES, V167, P19, DOI 10.1016/0006-8993(79)90260-9; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Rockland KS, 1998, J COMP NEUROL, V390, P515, DOI 10.1002/(SICI)1096-9861(19980126)390:4<515::AID-CNE5>3.0.CO;2-3; Sherman SM, 2011, J NEUROPHYSIOL, V106, P1068, DOI 10.1152/jn.00429.2011; Smith AT, 2009, J NEUROPHYSIOL, V101, P917, DOI 10.1152/jn.90963.2008; Snow JC, 2009, P NATL ACAD SCI USA, V106, P4054, DOI 10.1073/pnas.0810086106; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SOMERS DC, 1995, J NEUROSCI, V15, P5448; UNGERLEIDER LG, 1979, NEUROPSYCHOLOGIA, V17, P493, DOI 10.1016/0028-3932(79)90056-3; Van Essen DC, 2005, PROG BRAIN RES, V149, P173, DOI 10.1016/S0079-6123(05)49013-5; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; Ward R, 2002, NAT NEUROSCI, V5, P99, DOI 10.1038/nn794; Wilke M, 2010, J NEUROSCI, V30, P8650, DOI 10.1523/JNEUROSCI.0953-10.2010; Wilke M, 2009, P NATL ACAD SCI USA, V106, P9465, DOI 10.1073/pnas.0900714106	51	144	145	4	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					905	U136		10.1038/nn.3106	http://dx.doi.org/10.1038/nn.3106			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22561455	Green Accepted			2022-12-17	WOS:000304546700019
J	Liu, X; Davis, RL				Liu, Xu; Davis, Ronald L.			The GABAergic anterior paired lateral neuron suppresses and is suppressed by olfactory learning	NATURE NEUROSCIENCE			English	Article							DROSOPHILA MUSHROOM BODY; MEMORY TRACE; SYNAPTIC-TRANSMISSION; FEEDBACK NEURONS; GABA(A) RECEPTOR; APIS-MELLIFERA; REPRESENTATION; MELANOGASTER; INTERNEURONS; HIPPOCAMPUS	GABAergic neurotransmitter systems are important for many cognitive processes, including learning and memory. We identified a single neuron in each hemisphere of the Drosophila brain, the anterior paired lateral (APL) neuron, as a GABAergic neuron that broadly innervated the mushroom bodies. Reducing GABA synthesis in the APL neuron enhanced olfactory learning, suggesting that the APL neuron suppressed learning by releasing the inhibitory neurotransmitter GABA. Functional optical-imaging experiments revealed that the APL neuron responded to both odor and electric-shock stimuli that was presented to the fly with increases of intracellular calcium and released neurotransmitter. Notably, a memory trace formed in the APL neuron by pairing odor with electric shock. This trace was detected as a reduced calcium response in the APL neuron after conditioning specifically to the trained odor. These results demonstrate a mutual suppression between the GABAergic APL neuron and olfactory learning, and emphasize the functional neuroplasticity of the GABAergic system as a result of learning.	[Liu, Xu; Davis, Ronald L.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Davis, Ronald L.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	US National Institutes of Health [NS19904]; Baylor College of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019904, R37NS019904, R01NS052351] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Axel, D. Reiff, G. Miesenbock, A. Ferrus and H. Nash for various fly stocks, L. Griffith for constructive suggestions, and W. Krause for assistance in functional optical imaging. This work was supported by US National Institutes of Health grant NS19904 to R. L. D. and the R. P. Doherty-Welch Chair in Science at the Baylor College of Medicine.	Acebes A, 2004, CURR BIOL, V14, P704, DOI 10.1016/j.cub.2004.04.003; Berry J, 2008, PROG BRAIN RES, V169, P293, DOI 10.1016/S0079-6123(07)00018-0; Burrows M, 1996, NEUROBIOLOGY INSECT; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Collinson N, 2002, J NEUROSCI, V22, P5572; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Grunewald B, 1999, J COMP NEUROL, V404, P114; Grunewald B, 1999, J COMP PHYSIOL A, V185, P565, DOI 10.1007/s003590050417; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Harrison JB, 1996, CELL TISSUE RES, V284, P269, DOI 10.1007/s004410050587; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kuppers B, 2003, J NEUROCHEM, V84, P939, DOI 10.1046/j.1471-4159.2003.01554.x; Liu X, 2007, NEURON, V56, P1090, DOI 10.1016/j.neuron.2007.10.036; Liu X, 2006, CURR OPIN NEUROBIOL, V16, P679, DOI 10.1016/j.conb.2006.09.003; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yasuyama K, 2003, J COMP NEUROL, V466, P299, DOI 10.1002/cne.10867; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155	34	144	146	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2009	12	1					53	59		10.1038/nn.2235	http://dx.doi.org/10.1038/nn.2235			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	388HL	19043409	Green Accepted			2022-12-17	WOS:000262010800015
J	Flajolet, M; Wang, ZF; Futter, M; Shen, WX; Nuangchamnong, N; Bendor, J; Wallach, I; Nairn, AC; Surmeier, DJ; Greengard, P				Flajolet, Marc; Wang, Zhongfeng; Futter, Marie; Shen, Weixing; Nuangchamnong, Nina; Bendor, Jacob; Wallach, Iwona; Nairn, Angus C.; Surmeier, D. James; Greengard, Paul			FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity	NATURE NEUROSCIENCE			English	Article							FIBROBLAST-GROWTH-FACTOR; LONG-TERM POTENTIATION; SIGNAL-TRANSDUCTION; PC12 CELLS; DOPAMINE; EXPRESSION; INVOLVEMENT; MODULATION; ACTIVATION; ERK	Abnormalities of striatal function have been implicated in several major neurological and psychiatric disorders, including Parkinson's disease, schizophrenia and depression. Adenosine, via activation of A(2A) receptors, antagonizes dopamine signaling at D2 receptors and A(2A) receptor antagonists have been tested as therapeutic agents for Parkinson's disease. We found a direct physical interaction between the G protein-coupled A(2A) receptor (A(2A)R) and the receptor tyrosine kinase fibroblast growth factor receptor (FGFR). Concomitant activation of these two classes of receptors, but not individual activation of either one alone, caused a robust activation of the MAPK/ERK pathway, differentiation and neurite extension of PC12 cells, spine morphogenesis in primary neuronal cultures, and cortico-striatal plasticity that was induced by a previously unknown A(2A)R/FGFR-dependent mechanism. The discovery of a direct physical interaction between the A(2A) and FGF receptors and the robust physiological consequences of this association shed light on the mechanism underlying FGF functions as a co-transmitter and open new avenues for therapeutic interventions.	[Flajolet, Marc; Futter, Marie; Nuangchamnong, Nina; Bendor, Jacob; Wallach, Iwona; Nairn, Angus C.; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Wang, Zhongfeng; Shen, Weixing; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	Rockefeller University; Northwestern University; Feinberg School of Medicine; Yale University	Greengard, P (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10065 USA.	greengard@rockefeller.edu		Bendor, Jacob/0000-0003-1455-4891; Moreira, Nina/0000-0001-6476-4518; Greengard, Paul/0000-0002-4437-0893; Wallach, Iwona/0000-0002-4968-6475; Nairn, Angus/0000-0002-7075-0195	US National Institutes of Health [MH074866, NS34696]; Simons Foundation; Picower Foundation; US Medical Research and Materiel Command [W81XWH-04-2-0009]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034696, R01NS034696] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Picower Foundation; US Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to J. Rogers and H. Rebholz for critical reading of the manuscript, and to A. Nishi and G. Fisone for helpful discussions. This work was supported in part by grants from the US National Institutes of Health (MH074866 to P. G., A. C. N. and D. J. S., and NS34696 to D. J. S), the Simons Foundation, the Picower Foundation, and by award W81XWH-04-2-0009 from the US Medical Research and Materiel Command Neurotoxin Exposure Treatment Program to Intra-Cellular Therapies. M. F. was supported in part by a 2006 National Alliance for Research on Schizophrenia And Depression Young Investigator Award.	Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; Claus P, 2004, NEUROSCI LETT, V360, P117, DOI 10.1016/j.neulet.2004.01.046; D'Alcantara P, 2001, NEUROSCIENCE, V107, P455, DOI 10.1016/S0306-4522(01)00372-4; Ding J, 2008, J NEUROSCI, V28, P6483, DOI 10.1523/JNEUROSCI.0435-08.2008; Dono R, 2003, AM J PHYSIOL-REG I, V284, pR867, DOI 10.1152/ajpregu.00533.2002; DURCAN MJ, 1989, EUR J PHARMACOL, V168, P285, DOI 10.1016/0014-2999(89)90789-9; Ferguson SSG, 2003, TRENDS NEUROSCI, V26, P119, DOI 10.1016/S0166-2236(03)00022-5; Ferre S, 1997, PSYCHOPHARMACOLOGY, V133, P107, DOI 10.1007/s002130050380; Ferre S, 1997, TRENDS NEUROSCI, V20, P482, DOI 10.1016/S0166-2236(97)01096-5; Flajolet M, 2003, P NATL ACAD SCI USA, V100, P16006, DOI 10.1073/pnas.2136600100; Flajolet M, 2000, GENE, V242, P369, DOI 10.1016/S0378-1119(99)00511-9; Forget C, 2006, EUR J NEUROSCI, V23, P608, DOI 10.1111/j.1460-9568.2006.04570.x; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P228, DOI 10.1111/j.1600-0773.1995.tb00135.x; Fumagalli F, 2008, PSYCHOPHARMACOLOGY, V196, P357, DOI 10.1007/s00213-007-0966-x; Futter M, 2005, P NATL ACAD SCI USA, V102, P3489, DOI 10.1073/pnas.0409802102; Fuxe K, 2007, J NEURAL TRANSM, V114, P49, DOI 10.1007/s00702-006-0589-0; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Goldin M, 2003, EUR J NEUROSCI, V17, P2529, DOI 10.1046/j.1460-9568.2003.02694.x; Grothe C, 2007, BRAIN RES REV, V54, P80, DOI 10.1016/j.brainresrev.2006.12.001; Hayashi H, 2001, J CELL SCI, V114, P1387; JAHANGEER S, 1993, P NATL ACAD SCI USA, V90, P8782, DOI 10.1073/pnas.90.19.8782; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; Kobayashi S, 1999, J BIOL CHEM, V274, P20358, DOI 10.1074/jbc.274.29.20358; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Lee SP, 2003, LIFE SCI, V74, P173, DOI 10.1016/j.lfs.2003.09.028; Lindskog M, 2002, NATURE, V418, P774, DOI 10.1038/nature00817; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; Ornitz DM, 2001, GENOME BIOL, V2; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; Shah BH, 2004, TRENDS NEUROSCI, V27, P48, DOI 10.1016/j.tins.2003.11.003; Song BW, 2002, J PHARMACOL EXP THER, V301, P605, DOI 10.1124/jpet.301.2.605; Song WJ, 2000, J NEUROPHYSIOL, V83, P322, DOI 10.1152/jn.2000.83.1.322; SOROKIN A, 1994, J BIOL CHEM, V269, P17056; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Tepper JM, 2008, BRAIN RES REV, V58, P272, DOI 10.1016/j.brainresrev.2007.10.008; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thomason PA, 2002, CURR BIOL, V12, pR399, DOI 10.1016/S0960-9822(02)00885-0; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Zimmermann H, 1996, PROG NEUROBIOL, V49, P589, DOI 10.1016/0301-0082(96)00026-3	46	144	145	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2008	11	12					1402	1409		10.1038/nn.2216	http://dx.doi.org/10.1038/nn.2216			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	375JF	18953346	Green Accepted			2022-12-17	WOS:000261109300013
J	Spiegel, I; Adamsky, K; Eshed, Y; Milo, R; Sabanay, H; Sarig-Nadir, O; Horresh, I; Scherer, SS; Rasband, MN; Peles, E				Spiegel, Ivo; Adamsky, Konstantin; Eshed, Yael; Milo, Ron; Sabanay, Helena; Sarig-Nadir, Offra; Horresh, Ido; Scherer, Steven S.; Rasband, Matthew N.; Peles, Elior			A central role for Necl4 ( SynCAM4) in Schwann cell- axon interaction and myelination	NATURE NEUROSCIENCE			English	Article							ADHESION MOLECULE; IMMUNOGLOBULIN SUPERFAMILY; N-CADHERIN; PROTEIN; NECTIN; GLYCOPROTEIN; EXPRESSION; CHANNELS; DOMAIN; NODES	Myelination in the peripheral nervous system requires close contact between Schwann cells and the axon, but the underlying molecular basis remains largely unknown. Here we show that cell adhesion molecules (CAMs) of the nectin-like (Necl, also known as SynCAM or Cadm) family mediate Schwann cell-axon interaction during myelination. Necl4 is the main Necl expressed by myelinating Schwann cells and is located along the internodes in direct apposition to Necl1, which is localized on axons. Necl4 serves as the glial binding partner for axonal Necl1, and the interaction between these two CAMs mediates Schwann cell adhesion. The disruption of the interaction between Necl1 and Necl4 by their soluble extracellular domains, or the expression of a dominant-negative Necl4 in Schwann cells, inhibits myelination. These results suggest that Necl proteins are important for mediating axon-glia contact during myelination in peripheral nerves.	Weizmann Inst Sci, Dept Mol & Cell Biol, IL-76100 Rehovot, Israel; Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; Univ Connecticut, Hlth Sci Ctr, Dept Neurosci, Farmington, CT 06032 USA	Weizmann Institute of Science; University of Pennsylvania; University of Connecticut	Peles, E (corresponding author), Weizmann Inst Sci, Dept Mol & Cell Biol, POB 26, IL-76100 Rehovot, Israel.	peles@weizmann.ac.il	Scherer, Steven S/F-7979-2011; Spiegel, Ivo/O-4025-2014	Peles, Elior/0000-0002-3325-0597; Milo, Ron/0000-0003-1641-2299; Spiegel, Ivo/0000-0003-0979-1358; Rasband, Matthew/0000-0001-8184-2477	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044916, R01NS050220, R37NS044916] Funding Source: NIH RePORTER; NINDS NIH HHS [R37 NS044916, R01 NS044916, NS044916, NS50220, R01 NS050220, R01 NS050220-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bartsch U, 2003, FRONT BIOSCI-LANDMRK, V8, pD477, DOI 10.2741/1028; Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; Dong XH, 2006, J BIOL CHEM, V281, P10610, DOI 10.1074/jbc.M513459200; DUGANDZIJANOVAKOVIC S, 1995, J NEUROSCI, V15, P492; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Fujita E, 2005, DEV BRAIN RES, V154, P199, DOI 10.1016/j.devbrainres.2004.10.015; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Gunn-Moore FJ, 2006, MOL CELL NEUROSCI, V33, P441, DOI 10.1016/j.mcn.2006.09.003; HALL SM, 1971, J CELL SCI, V9, P769; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; Irie K, 2004, SEMIN CELL DEV BIOL, V15, P643, DOI 10.1016/j.semcdb.2004.09.002; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Koticha D, 2006, DEV BIOL, V293, P1, DOI 10.1016/j.ydbio.2005.05.028; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; Ohno N, 2006, J NEUROSCI RES, V84, P568, DOI 10.1002/jnr.20949; Ohta Y, 2005, DEV BRAIN RES, V156, P23, DOI 10.1016/j.devbrainres.2005.01.001; OWENS GC, 1990, J CELL BIOL, V111, P1171, DOI 10.1083/jcb.111.3.1171; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Schafer DP, 2004, J NEUROSCI, V24, P3176, DOI 10.1523/JNEUROSCI.5427-03.2004; SEILHEIMER B, 1989, J CELL BIOL, V109, P3095, DOI 10.1083/jcb.109.6.3095; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Sokal R. R., 1994, BIOMETRY PRINCIPLES; Spiegel I, 2002, MOL CELL NEUROSCI, V20, P283, DOI 10.1006/mcne.2002.1110; Spiegel I, 2002, MOL MEMBR BIOL, V19, P95, DOI 10.1080/09687680210130009; Spiegel I, 2006, NEURON GLIA BIOL, V2, P27, DOI 10.1017/S1740925X0600007X; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; THOMAS PK, 1984, PERIPHERAL NEUROPATH, V1, P97; Traka M, 2002, J NEUROSCI, V22, P3016, DOI 10.1523/JNEUROSCI.22-08-03016.2002; TRAPP BD, 1989, J NEUROCYTOL, V18, P47, DOI 10.1007/BF01188423; Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002; Wanner IB, 2006, GLIA, V54, P439, DOI 10.1002/glia.20390; Williams YN, 2006, ONCOGENE, V25, P1446, DOI 10.1038/sj.onc.1209192; Yageta M, 2002, CANCER RES, V62, P5129; Zhou Y, 2005, BBA-BIOMEMBRANES, V1669, P142, DOI 10.1016/j.bbamem.2005.01.013	48	144	153	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					861	869		10.1038/nn1915	http://dx.doi.org/10.1038/nn1915			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558405	Green Accepted			2022-12-17	WOS:000247560200016
J	Doricchi, F; Guariglia, P; Gasparini, M; Tomaiuolo, F				Doricchi, F; Guariglia, P; Gasparini, M; Tomaiuolo, F			Dissociation between physical and mental number line bisection in right hemisphere brain damage	NATURE NEUROSCIENCE			English	Article							UNILATERAL NEGLECT; SPACE; REPRESENTATION; HEMIANOPIA; MAGNITUDE; ANATOMY; CORTEX	To compare numeric quantities, humans make use of a 'mental number line' with smaller quantities located to the left of larger ones; it is unclear, however, whether orienting along the number line is like orienting along a physical line. We found that in brain-damaged subjects with defective leftward orienting, rightward deviation in the bisection of numeric and physical intervals is doubly dissociated. Deviation in numeric interval bisection was associated with prefrontal damage and spatial working memory deficit.	IRCCS, LENA, Fdn Santa Lucia, Rome, Italy; Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; Univ Roma La Sapienza, Dipartimento Sci Neurol Cattedra 5, Rome, Italy; Auxilium Vitae Volterra, Pisa, Italy	IRCCS Santa Lucia; Sapienza University Rome; Sapienza University Rome	Doricchi, F (corresponding author), IRCCS, LENA, Fdn Santa Lucia, Rome, Italy.	Fabrizio.Doricchi@uniroma1.it	Tomaiuolo, Francesco/AAC-1534-2019	Tomaiuolo, Fancesco/0000-0003-1230-2770				Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 2004, CURR OPIN NEUROBIOL, V14, P218, DOI 10.1016/j.conb.2004.03.008; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0096-3445.122.3.371; Della Sala S, 2004, NEUROPSYCHOLOGIA, V42, P1358, DOI 10.1016/j.neuropsychologia.2004.02.011; Doricchi F, 1999, NEUROLOGY, V52, P1845, DOI 10.1212/WNL.52.9.1845; Doricchi F, 2005, BRAIN, V128, P1386, DOI 10.1093/brain/awh461; Doricchi F, 2003, NEUROREPORT, V14, P2239, DOI 10.1097/00001756-200312020-00021; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Leibovitch FS, 1998, NEUROLOGY, V50, P901, DOI 10.1212/WNL.50.4.901; Malhotra P, 2005, BRAIN, V128, P424, DOI 10.1093/brain/awh372; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Rizzuto DS, 2005, NAT NEUROSCI, V8, P415, DOI 10.1038/nn1424; Rossetti Y, 2004, PSYCHOL SCI, V15, P426, DOI 10.1111/j.0956-7976.2004.00696.x; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	15	144	146	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1663	1665		10.1038/nn1563	http://dx.doi.org/10.1038/nn1563			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16261135				2022-12-17	WOS:000233576200013
J	Hirsch, JA; Martinez, LM; Pillai, C; Alonso, JM; Wang, QB; Sommer, FT				Hirsch, JA; Martinez, LM; Pillai, C; Alonso, JM; Wang, QB; Sommer, FT			Functionally distinct inhibitory neurons at the first stage of visual cortical processing	NATURE NEUROSCIENCE			English	Article							CAT STRIATE CORTEX; RAT SOMATOSENSORY CORTEX; ORIENTATION SELECTIVITY; RECEPTIVE-FIELDS; SIMPLE CELLS; IN-VIVO; SYNAPTIC INTEGRATION; MACAQUE MONKEY; BASKET CELLS; CONTRAST	Here we explore inhibitory circuits at the thalamocortical stage of processing in layer 4 of the cat's visual cortex, focusing on the anatomy and physiology of the interneurons themselves. Our immediate aim was to explore the inhibitory mechanisms that contribute to orientation selectivity, perhaps the most dramatic response property to emerge across the thalamocortical synapse. The broader goal was to understand how inhibitory circuits operate. Using whole-cell recording in cats in vivo, we found that layer 4 contains two populations of inhibitory cells defined by receptive field class-simple and complex. The simple cells were selective for stimulus orientation, whereas the complex cells were not. Our observations help to explain how neurons become sensitive to stimulus orientation and maintain that selectivity as stimulus contrast changes. Overall, the work suggests that different sources of inhibition, either selective for specific features or broadly tuned, interact to provide appropriate representations of elements within the environment.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ A Coruna, Dept Med, La Coruna 15006, Spain; SUNY Optometry, Dept Biol Sci, New York, NY 10036 USA; Redwood Neurosci Inst, Menlo Pk, CA 94025 USA	University of Southern California; Universidade da Coruna; State University of New York (SUNY) System	Hirsch, JA (corresponding author), Univ So Calif, Dept Biol Sci, 3641 Watt Way, Los Angeles, CA 90089 USA.	jhirsch@usc.edu	Hirsch, Judith/E-9006-2013	Pillai, Cinthi/0000-0002-7662-443X	NEI NIH HHS [EY09593] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009593, R29EY009593] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Bruno RM, 2002, J NEUROSCI, V22, P10966; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1251, DOI 10.1152/jn.1979.42.5.1251; BURR D, 1981, EXP BRAIN RES, V43, P455; Buzas P, 2001, J COMP NEUROL, V437, P259, DOI 10.1002/cne.1282; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Carandini M, 2002, J NEUROSCI, V22, P10053; Chisum HJ, 2003, J NEUROSCI, V23, P2947; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1986, J NEUROSCI, V6, P1284; GABBOTT PLA, 1986, EXP BRAIN RES, V61, P323; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; HENRY GH, 1977, BRAIN RES, V133, P1, DOI 10.1016/0006-8993(77)90045-2; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2003, CEREB CORTEX, V13, P63, DOI 10.1093/cercor/13.1.63; HIRSCH JA, 1995, J PHYSIOL-LONDON, V483, P183, DOI 10.1113/jphysiol.1995.sp020577; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kayser AS, 2002, NEURON, V33, P131, DOI 10.1016/S0896-6273(01)00570-0; LAURITZEN TZ, IN PRESS J NEUROSCI; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; MARTIN KAC, 1983, EXP BRAIN RES, V50, P193; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2003, J NEUROPHYSIOL, V90, P342, DOI 10.1152/jn.01018.2002; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SILLITO AM, 1992, PROG BRAIN RES, V90, P349; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; TANAKA K, 1985, VISION RES, V25, P357, DOI 10.1016/0042-6989(85)90060-4; Thomson AM, 2003, CEREB CORTEX, V13, P136, DOI 10.1093/cercor/13.2.136; Troyer TW, 2002, J NEUROPHYSIOL, V87, P2741, DOI 10.1152/jn.2002.87.6.2741; Troyer TW, 1998, J NEUROSCI, V18, P5908; Usrey WM, 2003, J NEUROPHYSIOL, V89, P1003, DOI 10.1152/jn.00749.2002; VOLGUSHEV M, 1993, VISUAL NEUROSCI, V10, P1151, DOI 10.1017/S0952523800010257; Wielaard DJ, 2001, J NEUROSCI, V21, P5203, DOI 10.1523/JNEUROSCI.21-14-05203.2001	50	144	144	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1300	1308		10.1038/nn1152	http://dx.doi.org/10.1038/nn1152			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14625553				2022-12-17	WOS:000186725600015
J	Fu, AKY; Fu, WY; Cheung, J; Tsim, KWK; Ip, FCF; Wang, JH; Ip, NY				Fu, AKY; Fu, WY; Cheung, J; Tsim, KWK; Ip, FCF; Wang, JH; Ip, NY			Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction	NATURE NEUROSCIENCE			English	Article							CYCLIN-DEPENDENT KINASE-5; RECEPTOR EPSILON-SUBUNIT; DIRECTED PROTEIN-KINASE; MUSCLE-SPECIFIC KINASE; NEURITE OUTGROWTH; GENE-EXPRESSION; REGULATORY SUBUNIT; SKELETAL-MUSCLE; C-JUN; ARIA	Here we describe an important involvement of Cdk5/p35 in regulating the gene expression of acetylcholine receptor (AChR) at the neuromuscular synapse. Cdk5 and p35 were prominently expressed in embryonic muscle, and concentrated at the neuromuscular junction in adulthood. Neuregulin increased the p35-associated Cdk5 kinase activity in the membrane fraction of cultured C2C12 myotubes. Co-immunoprecipitation studies revealed the association between Cdk5, p35 and ErbB receptors in muscle and cultured myotubes. Inhibition of Cdk5 activity not only blocked the NRG-induced AChR transcription, but also attenuated ErbB activation in cultured myotubes. In light of our finding that overexpression of p35 alone led to an increase in AChR promoter activity in muscle, Cdk5 activation is sufficient to mediate the up-regulation of AChR gene expression. Taken together, these results reveal the unexpected involvement of Cdk5/p35 in neuregulin signaling at the neuromuscular synapse.	Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Biotechnol Res Inst, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Biotechnol Res Inst, Dept Biochem, Clear Water Bay, Hong Kong, Hong Kong, Peoples R China.			Fu, Kit Yu/0000-0003-4085-6201; Tsim, Karl/0000-0003-4808-1674; Ip, Nancy Yuk-Yu/0000-0002-2763-8907				CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Ching YP, 2000, GENE, V242, P285, DOI 10.1016/S0378-1119(99)00499-0; CHU GC, 1995, NEURON, V14, P329, DOI 10.1016/0896-6273(95)90289-9; CORFAS G, 1993, J NEUROSCI, V13, P2118; Feinmesser RL, 1999, J BIOL CHEM, V274, P16168, DOI 10.1074/jbc.274.23.16168; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Fu AKY, 1999, EUR J NEUROSCI, V11, P373, DOI 10.1046/j.1460-9568.1999.00443.x; Fu AKY, 1999, MOL CELL NEUROSCI, V14, P241, DOI 10.1006/mcne.1999.0784; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Gramolini AO, 1999, P NATL ACAD SCI USA, V96, P3223, DOI 10.1073/pnas.96.6.3223; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Ip FCF, 2000, MOL CELL NEUROSCI, V16, P661, DOI 10.1006/mcne.2000.0892; IP FCF, 1995, J NEUROCHEM, V65, P2393; Kiyokawa N, 1997, ONCOGENE, V15, P2633, DOI 10.1038/sj.onc.1201442; Kwon YT, 2000, RES PRO CEL, V30, P241; Lazaro JB, 1997, J CELL SCI, V110, P1251; LEW J, 1992, J BIOL CHEM, V267, P25922; LEW J, 1995, TRENDS BIOCHEM SCI, V20, P33, DOI 10.1016/S0968-0004(00)88948-3; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; LOEB JA, 1995, J CELL BIOL, V130, P127, DOI 10.1083/jcb.130.1.127; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ojala J, 1997, ANTISENSE NUCLEIC A, V7, P31, DOI 10.1089/oli.1.1997.7.31; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Philpott A, 1997, GENE DEV, V11, P1409, DOI 10.1101/gad.11.11.1409; Pigino G, 1997, J CELL SCI, V110, P257; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Sheng M, 1997, BIOESSAYS, V19, P847, DOI 10.1002/bies.950191004; Si JT, 1996, J BIOL CHEM, V271, P19752, DOI 10.1074/jbc.271.33.19752; Si JT, 1997, J BIOL CHEM, V272, P10367; Si JT, 1999, MOL BRAIN RES, V67, P18, DOI 10.1016/S0169-328X(99)00028-5; Si JT, 1999, J NEUROSCI, V19, P8498; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Tansey MG, 1996, J CELL BIOL, V134, P465, DOI 10.1083/jcb.134.2.465; Tomizawa K, 1996, NEUROSCIENCE, V74, P519, DOI 10.1016/0306-4522(96)00136-4; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Yang JF, 1997, FEBS LETT, V403, P163, DOI 10.1016/S0014-5793(97)00044-6; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	44	144	161	1	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					374	381		10.1038/86019	http://dx.doi.org/10.1038/86019			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276227				2022-12-17	WOS:000168762200017
J	Burgos-Robles, A; Kimchi, EY; Izadmehr, EM; Porzenheim, MJ; Ramos-Guasp, WA; Nieh, EH; Felix-Ortiz, AC; Namburi, P; Leppla, CA; Presbrey, KN; Anandalingam, KK; Pagan-Rivera, PA; Anahtar, M; Beyeler, A; Tye, KM				Burgos-Robles, Anthony; Kimchi, Eyal Y.; Izadmehr, Ehsan M.; Porzenheim, Mary Jane; Ramos-Guasp, William A.; Nieh, Edward H.; Felix-Ortiz, Ada C.; Namburi, Praneeth; Leppla, Christopher A.; Presbrey, Kara N.; Anandalingam, Kavitha K.; Pagan-Rivera, Pablo A.; Anahtar, Melodi; Beyeler, Anna; Tye, Kay M.			Amygdala inputs to prefrontal cortex guide behavior amid conflicting cues of reward and punishment	NATURE NEUROSCIENCE			English	Article							BASOLATERAL AMYGDALA; PRELIMBIC CORTEX; CINGULATE CORTEX; FIRING PATTERNS; SINGLE UNITS; FEAR; NEURONS; EXTINCTION; EXPRESSION; HIPPOCAMPAL	Orchestrating appropriate behavioral responses in the face of competing signals that predict either rewards or threats in the environment is crucial for survival. The basolateral nucleus of the amygdala (BLA) and prelimbic (PL) medial prefrontal cortex have been implicated in reward-seeking and fear-related responses, but how information flows between these reciprocally connected structures to coordinate behavior is unknown. We recorded neuronal activity from the BLA and PL while rats performed a task wherein competing shock-and sucrose-predictive cues were simultaneously presented. The correlated firing primarily displayed a BLA -> PL directionality during the shock-associated cue. Furthermore, BLA neurons optogenetically identified as projecting to PL more accurately predicted behavioral responses during competition than unidentified BLA neurons. Finally photostimulation of the BLA -> PL projection increased freezing, whereas both chemogenetic and optogenetic inhibition reduced freezing. Therefore, the BLA -> PL circuit is critical in governing the selection of behavioral responses in the face of competing signals.	[Burgos-Robles, Anthony; Kimchi, Eyal Y.; Izadmehr, Ehsan M.; Porzenheim, Mary Jane; Ramos-Guasp, William A.; Nieh, Edward H.; Felix-Ortiz, Ada C.; Namburi, Praneeth; Leppla, Christopher A.; Presbrey, Kara N.; Anandalingam, Kavitha K.; Pagan-Rivera, Pablo A.; Anahtar, Melodi; Beyeler, Anna; Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA; [Kimchi, Eyal Y.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts General Hospital	Tye, KM (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	kaytye@mit.edu	Beyeler, Anna/V-9934-2019; Core, Vector/CAF-4832-2022	/0000-0003-2154-6224; /0000-0003-2371-5706	Brain and Behavior Research Foundation (NARSAD Young Investigator Award); NIMH; Collaborative Clinical Neuroscience Fellowship; American Brain Foundation Clinical Research Training Fellowship; MIT Summer Research Program; Center for Brains, Minds and Machines (CBMM); NSF [CCF-1231216]; NIH [1R25-MH092912-01, R01-MH102441-01, R01-AA023305-01, DP2-DK-102256-01]; National Science Foundation Graduate Research Fellowship (NSF GRFP); Integrative Neuronal Systems Training Fellowship [T32 GM007484]; Training Program in the Neurobiology of Learning and Memory; NRSA [5T32GM007484-38]; Singleton fellowship; Leventhal fellowship; Whitaker fellowship; NSF Graduate Research Fellowship; Integrative Neuronal Systems Fellowship; James R. Killian Fellowship; MIT Undergraduate Research Opportunities Program; MIT Research Assistantship Program; JPB Foundation; PIIF; PNDRF; JFDP; Whitehall Foundation; Klingenstein Foundation; NARSAD Young Investigator Award; Alfred P Sloan Foundation; New York Stem Cell Foundation; McKnight Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA023305] Funding Source: NIH RePORTER	Brain and Behavior Research Foundation (NARSAD Young Investigator Award); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Collaborative Clinical Neuroscience Fellowship; American Brain Foundation Clinical Research Training Fellowship; MIT Summer Research Program; Center for Brains, Minds and Machines (CBMM); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship (NSF GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Integrative Neuronal Systems Training Fellowship; Training Program in the Neurobiology of Learning and Memory; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singleton fellowship; Leventhal fellowship; Whitaker fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Integrative Neuronal Systems Fellowship; James R. Killian Fellowship; MIT Undergraduate Research Opportunities Program; MIT Research Assistantship Program; JPB Foundation; PIIF; PNDRF; JFDP; Whitehall Foundation; Klingenstein Foundation(Klingenstein Philanthropies); NARSAD Young Investigator Award(NARSAD); Alfred P Sloan Foundation(Alfred P. Sloan Foundation); New York Stem Cell Foundation; McKnight Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors thank S. Sorooshyari for discussion and assistance on Matlab programming, as well as C. Wildes, and the entire Tye laboratory for discussion and support on this project. A. B.-R. was supported by the Brain and Behavior Research Foundation (NARSAD Young Investigator Award) and NIMH (Research Supplement to Promote Diversity in Health-Related Sciences). E.Y.K. was supported by the Collaborative Clinical Neuroscience Fellowship and the American Brain Foundation Clinical Research Training Fellowship. W.A.R.-G. and P.A.P.-R. were supported by the MIT Summer Research Program, which received support from the Center for Brains, Minds and Machines (CBMM), NSF (STC Award CCF-1231216) and NIH (Endure Award 1R25-MH092912-01). E.H.N. was supported by the National Science Foundation Graduate Research Fellowship (NSF GRFP), the Integrative Neuronal Systems Training Fellowship (T32 GM007484) and the Training Program in the Neurobiology of Learning and Memory. A.C.F.-O. was supported by an institutional NRSA training grant (5T32GM007484-38). P.N. was supported by the Singleton, Leventhal and Whitaker fellowships. C.A.L. was supported by an NSF Graduate Research Fellowship, an Integrative Neuronal Systems Fellowship and the James R. Killian Fellowship. M.J.P., K.N.P. and M.A. were supported by the MIT Undergraduate Research Opportunities Program. K.K.A. was supported by the MIT Research Assistantship Program. K.M.T. is a New York Stem Cell Foundation-Robertson Investigator and McKnight Scholar, and this work was supported by funding from the JPB Foundation, PIIF, PNDRF, JFDP, Whitehall Foundation, Klingenstein Foundation, NARSAD Young Investigator Award, Alfred P Sloan Foundation, New York Stem Cell Foundation, McKnight Foundation, NIH R01-MH102441-01 (NIMH), R01-AA023305-01 (NIAAA) and NIH Director's New Innovator Award DP2-DK-102256-01 (NIDDK).	ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Amir A, 2015, J NEUROSCI, V35, P12994, DOI 10.1523/JNEUROSCI.0407-15.2015; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Beyeler A, 2016, NEURON, V90, P348, DOI 10.1016/j.neuron.2016.03.004; BLANCHARD RJ, 1986, J COMP PSYCHOL, V100, P101, DOI 10.1037/0735-7036.100.2.101; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Burgos-Robles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057575; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Choi JS, 2010, P NATL ACAD SCI USA, V107, P21773, DOI 10.1073/pnas.1010079108; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Comte M, 2016, CEREB CORTEX, V26, P144, DOI 10.1093/cercor/bhu185; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Cristianini N., 2000, INTRO SUPPORT VECTOR; Dilgen J, 2013, J NEUROPHYSIOL, V110, P221, DOI 10.1152/jn.00531.2012; Do-Monte FH, 2015, NATURE, V519, P460, DOI 10.1038/nature14030; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Felix-Ortiz AC, 2016, NEUROSCIENCE, V321, P197, DOI 10.1016/j.neuroscience.2015.07.041; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Ferguson JE, 2009, SENSOR ACTUAT A-PHYS, V156, P388, DOI 10.1016/j.sna.2009.10.001; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Good PI, 2005, PERMUTATION PARAMETR; Hastie TJ, 2011, ELEMENTS STAT LEARNI; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Ishikawa A, 2008, NEUROSCIENCE, V155, P573, DOI 10.1016/j.neuroscience.2008.06.037; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Jin JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08388; Johansen JP, 2010, NAT NEUROSCI, V13, P979, DOI 10.1038/nn.2594; Kanske P, 2011, CEREB CORTEX, V21, P911, DOI 10.1093/cercor/bhq157; Karalis N, 2016, NAT NEUROSCI, V19, P605, DOI 10.1038/nn.4251; Keistler C, 2015, LEARN MEMORY, V22, P509, DOI 10.1101/lm.038810.115; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Kim J, 2016, NAT NEUROSCI, V19, P1636, DOI 10.1038/nn.4414; Klavir O, 2013, NEURON, V80, P1290, DOI 10.1016/j.neuron.2013.09.035; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Laviolette SR, 2005, J NEUROSCI, V25, P6066, DOI 10.1523/JNEUROSCI.1168-05.2005; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Likhtik E, 2006, J NEUROPHYSIOL, V96, P3257, DOI 10.1152/jn.00577.2006; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Livneh U, 2012, NEURON, V75, P133, DOI 10.1016/j.neuron.2012.05.016; Mahn M, 2016, NAT NEUROSCI, V19, P554, DOI 10.1038/nn.4266; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/NMETH.1808, 10.1038/nmeth.1808]; McGarry LM, 2016, J NEUROSCI, V36, P9391, DOI 10.1523/JNEUROSCI.0874-16.2016; Meyer RM, 2014, MOL PSYCHIATR, V19, P1284, DOI 10.1038/mp.2013.135; Moorman DE, 2015, P NATL ACAD SCI USA, V112, P9472, DOI 10.1073/pnas.1507611112; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Narayanan Nandakumar S., 2009, V489, P135, DOI 10.1007/978-1-59745-543-5_7; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paz R, 2009, J NEUROPHYSIOL, V101, P2507, DOI 10.1152/jn.91259.2008; Pendyam S, 2013, J NEUROPHYSIOL, V110, P844, DOI 10.1152/jn.00961.2012; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P147, DOI 10.1152/jn.1987.57.1.147; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rohr CS, 2016, HUM BRAIN MAPP, V37, P2234, DOI 10.1002/hbm.23169; Sangha S, 2014, NEUROPSYCHOPHARMACOL, V39, P2405, DOI 10.1038/npp.2014.89; Schlkopf B., 2001, LEARNING KERNELS SUP; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Shabel SJ, 2009, P NATL ACAD SCI USA, V106, P15031, DOI 10.1073/pnas.0905580106; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Smith KS, 2012, P NATL ACAD SCI USA, V109, P18932, DOI 10.1073/pnas.1216264109; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Stujenske JM, 2014, NEURON, V83, P919, DOI 10.1016/j.neuron.2014.07.026; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Valdes JL, 2006, EUR J NEUROSCI, V23, P1352, DOI 10.1111/j.1460-9568.2006.04659.x; Zhang WJ, 2013, J NEUROSCI, V33, P722, DOI 10.1523/JNEUROSCI.2970-12.2013	74	143	144	5	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2017	20	6					824	+		10.1038/nn.4553	http://dx.doi.org/10.1038/nn.4553			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EV8FU	28436980	Green Accepted, Green Published			2022-12-17	WOS:000402016900012
J	Lucantonio, F; Stalnaker, TA; Shaham, Y; Niv, Y; Schoenbaum, G				Lucantonio, Federica; Stalnaker, Thomas A.; Shaham, Yavin; Niv, Yael; Schoenbaum, Geoffrey			The impact of orbitofrontal dysfunction on cocaine addiction	NATURE NEUROSCIENCE			English	Review							ORBITAL PREFRONTAL CORTEX; DECISION-MAKING; DRUG-ADDICTION; BASOLATERAL AMYGDALA; NEURONAL-ACTIVITY; METHAMPHETAMINE ABUSERS; AMPHETAMINE EXPOSURE; BEHAVIORAL-CONTROL; REWARD PREFERENCE; EXPERIENCED RATS	Cocaine addiction is characterized by poor judgment and maladaptive decision-making. Here we review evidence implicating the orbitofrontal cortex in such behavior. This evidence suggests that cocaine-induced changes in orbitofrontal cortex disrupt the representation of states and transition functions that form the basis of flexible and adaptive 'model-based' behavioral control. By impairing this function, cocaine exposure leads to an overemphasis on less flexible, maladaptive 'model-free' control systems. We propose that such an effect accounts for the complex pattern of maladaptive behaviors associated with cocaine addiction.	[Lucantonio, Federica; Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Stalnaker, Thomas A.; Shaham, Yavin; Schoenbaum, Geoffrey] Natl Inst Drug Abuse, Intramural Res Program, Baltimore, MD USA; [Niv, Yael] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Niv, Yael] Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Princeton University; Princeton University	Schoenbaum, G (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	schoenbg@schoenbaumlab.org	shaham, yavin/G-1306-2014		US National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000434, ZIADA000587] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This review is dedicated to the family of Jacob Peter Waletzky. The work of writing it was supported by funding from the intramural and extramural programs of the US National Institute on Drug Abuse, including time while G. S. and T. A. S. were employed at the University of Maryland, Baltimore. The opinions expressed in this article are the author's own and do not reflect the view of the US National Institutes of Health, the Department of Health and Human Services, or the United States government.	Adinoff R, 2001, AM J PSYCHIAT, V158, P390, DOI 10.1176/appi.ajp.158.3.390; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Burke KA, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/002.2007, 10.3389/neuro.07.002.2007]; Burke KA, 2009, EUR J NEUROSCI, V30, P1941, DOI 10.1111/j.1460-9568.2009.06992.x; Calu DJ, 2007, LEARN MEMORY, V14, P325, DOI 10.1101/lm.534807; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Coffey SF, 2003, EXP CLIN PSYCHOPHARM, V11, P18, DOI 10.1037/1064-1297.11.1.18; Cousens GA, 2003, INTEGR PHYS BEH SCI, V38, P272, DOI 10.1007/BF02688858; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; Crombag HS, 2005, CEREB CORTEX, V15, P341, DOI 10.1093/cercor/bhh136; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Ersche KD, 2008, PSYCHOPHARMACOLOGY, V197, P421, DOI 10.1007/s00213-007-1051-1; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Fillmore MT, 2006, J PSYCHOPHARMACOL, V20, P24, DOI 10.1177/0269881105057000; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Fuchs RA, 2004, J NEUROSCI, V24, P6600, DOI 10.1523/JNEUROSCI.1924-04.2004; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; Heil SH, 2006, ADDICT BEHAV, V31, P1290, DOI 10.1016/j.addbeh.2005.09.005; Hikosaka K, 2004, EUR J NEUROSCI, V19, P1046, DOI 10.1111/j.0953-816X.2004.03120.x; Homayoun H, 2006, J NEUROSCI, V26, P8025, DOI 10.1523/JNEUROSCI.0842-06.2006; Im HI, 2010, NAT NEUROSCI, V13, P1120, DOI 10.1038/nn.2615; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Izquierdo A, 2010, NEUROPSYCHOPHARMACOL, V35, P505, DOI 10.1038/npp.2009.155; Jentsch JD, 2002, NEUROPSYCHOPHARMACOL, V26, P183, DOI 10.1016/S0893-133X(01)00355-4; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kantak KM, 2005, PSYCHOPHARMACOLOGY, V181, P227, DOI 10.1007/s00213-005-2243-1; Kim SJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1383, DOI 10.1038/sj.npp.1300699; Kirby KN, 2004, ADDICTION, V99, P461, DOI 10.1111/j.1360-0443.2003.00669.x; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; KREMER EF, 1978, J EXP PSYCHOL ANIM B, V4, P22, DOI 10.1037/0097-7403.4.1.22; Krueger DD, 2009, BEHAV PHARMACOL, V20, P695, DOI 10.1097/FBP.0b013e328333a2bb; Lasseter HC, 2009, EUR J NEUROSCI, V30, P1370, DOI 10.1111/j.1460-9568.2009.06906.x; Liu X, 2007, J NEUROSCI, V27, P4587, DOI 10.1523/JNEUROSCI.5227-06.2007; LONDON ED, 1990, ARCH GEN PSYCHIAT, V47, P567; Lu L, 2005, NAT NEUROSCI, V8, P212, DOI 10.1038/nn1383; Lyoo IK, 2004, PSYCHIAT RES-NEUROIM, V131, P135, DOI 10.1016/j.pscychresns.2004.04.001; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; Mendelson JH, 1996, NEW ENGL J MED, V334, P965, DOI 10.1056/NEJM199604113341507; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Nestler EJ, 2002, NEUROBIOL LEARN MEM, V78, P637, DOI 10.1006/nlme.2002.4084; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2000, NEUROREPORT, V11, P399, DOI 10.1097/00001756-200002070-00035; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; O'Neill J, 2001, ALCOHOL CLIN EXP RES, V25, P1673; O'Neill J, 2001, ADDICT BIOL, V6, P347, DOI 10.1080/13556210020077073; Ostlund SB, 2007, J NEUROSCI, V27, P4819, DOI 10.1523/JNEUROSCI.5443-06.2007; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Pears A, 2003, J NEUROSCI, V23, P11189; Pickens CL, 2003, J NEUROSCI, V23, P11078; Porter JN, 2011, J NEUROSCI, V31, P4926, DOI 10.1523/JNEUROSCI.5426-10.2011; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; Roesch MR, 2007, J NEUROSCI, V27, P245, DOI 10.1523/JNEUROSCI.4080-06.2007; Roesch MR, 2005, J NEUROPHYSIOL, V94, P2457, DOI 10.1152/jn.00373.2005; ROLLS ET, 1994, J NEUROSCI, V14, P5437; Schoenbaum G, 2005, CEREB CORTEX, V15, P1162, DOI 10.1093/cercor/bhh216; Schoenbaum G, 2004, EUR J NEUROSCI, V19, P1997, DOI 10.1111/j.1460-9568.2004.03274.x; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 2008, BIOL PSYCHIAT, V63, P256, DOI 10.1016/j.biopsych.2007.06.003; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Shaham Y, 2005, NAT NEUROSCI, V8, P1437, DOI 10.1038/nn1105-1437; Simon NW, 2007, BEHAV NEUROSCI, V121, P543, DOI 10.1037/0735-7044.121.3.543; Stalnaker TA, 2006, EUR J NEUROSCI, V24, P2643, DOI 10.1111/j.1460-9568.2006.05128.x; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Taylor JR, 2001, BIOL PSYCHIAT, V50, P137, DOI 10.1016/S0006-3223(01)01106-4; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tsuchida A, 2010, J NEUROSCI, V30, P16868, DOI 10.1523/JNEUROSCI.1958-10.2010; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Volkow N D, 1990, NIDA Res Monogr, V105, P47; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; VOLKOW ND, 1988, J NEURORADIOLOGY, V15, P288; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; VOLKOW ND, 1991, AM J PSYCHIAT, V148, P621; Volkow ND, 2001, AM J PSYCHIAT, V158, P383, DOI 10.1176/appi.ajp.158.3.383; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; Winstanley CA, 2007, J NEUROSCI, V27, P10497, DOI 10.1523/JNEUROSCI.2566-07.2007; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Wyvell CL, 2001, J NEUROSCI, V21, P7831, DOI 10.1523/JNEUROSCI.21-19-07831.2001	100	143	147	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					358	366		10.1038/nn.3014	http://dx.doi.org/10.1038/nn.3014			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22267164	Green Accepted			2022-12-17	WOS:000300793100007
J	Pangrsic, T; Lasarow, L; Reuter, K; Takago, H; Schwander, M; Riedel, D; Frank, T; Tarantino, LM; Bailey, JS; Strenzke, N; Brose, N; Muller, U; Reisinger, E; Moser, T				Pangrsic, Tina; Lasarow, Livia; Reuter, Kirsten; Takago, Hideki; Schwander, Martin; Riedel, Dietmar; Frank, Thomas; Tarantino, Lisa M.; Bailey, Janice S.; Strenzke, Nicola; Brose, Nils; Mueller, Ulrich; Reisinger, Ellen; Moser, Tobias			Hearing requires otoferlin-dependent efficient replenishment of synaptic vesicles in hair cells	NATURE NEUROSCIENCE			English	Article							TRANSMITTER RELEASE; CALCIUM-DEPENDENCE; DETERMINES FAST; MYOSIN VI; RIBBON; EXOCYTOSIS; DEAFNESS; TRANSMISSION; ENDOCYTOSIS; POOL	Inner hair cell ribbon synapses indefatigably transmit acoustic information. The proteins mediating their fast vesicle replenishment (hundreds of vesicles per s) are unknown. We found that an aspartate to glycine substitution in the C2F domain of the synaptic vesicle protein otoferlin impaired hearing by reducing vesicle replenishment in the pachanga mouse model of human deafness DFNB9. In vitro estimates of vesicle docking, the readily releasable vesicle pool (RRP), Ca2+ signaling and vesicle fusion were normal. Moreover, we observed postsynaptic excitatory currents of variable size and spike generation. However, mutant active zones replenished vesicles at lower rates than wild-type ones and sound-evoked spiking in auditory neurons was sparse and only partially improved during longer interstimulus intervals. We conclude that replenishment does not match the release of vesicles at mutant active zones in vivo and a sufficient standing RRP therefore cannot be maintained. We propose that otoferlin is involved in replenishing synaptic vesicles.	[Pangrsic, Tina; Takago, Hideki; Frank, Thomas; Moser, Tobias] Univ Med Ctr Gottingen, Dept Otolaryngol, InnerEarLab, Gottingen, Germany; [Pangrsic, Tina; Takago, Hideki; Frank, Thomas; Moser, Tobias] Univ Med Ctr Gottingen, Ctr Mol Physiol Brain, Gottingen, Germany; [Lasarow, Livia; Strenzke, Nicola] Univ Med Ctr Gottingen, Dept Otolaryngol, Auditory Syst Physiol Grp, Gottingen, Germany; [Reuter, Kirsten; Reisinger, Ellen] Univ Med Ctr Gottingen, Dept Otolaryngol, Mol Biol Cochlear Neurotransmiss Grp, Gottingen, Germany; [Schwander, Martin; Mueller, Ulrich] Scripps Res Inst, Dept Cell Biol, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Electron Microscopy Lab, D-37077 Gottingen, Germany; [Tarantino, Lisa M.; Bailey, Janice S.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, Gottingen, Germany; [Brose, Nils] Ctr Mol Physiol Brain, Gottingen, Germany; [Moser, Tobias] Univ Gottingen, Bernstein Ctr Computat Neurosci, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Gottingen; Scripps Research Institute; Max Planck Society; University of North Carolina; University of North Carolina Chapel Hill; Max Planck Society; University of Gottingen	Moser, T (corresponding author), Univ Med Ctr Gottingen, Dept Otolaryngol, InnerEarLab, Gottingen, Germany.	ereisin@gwdg.de; tmoser@gwdg.de	Frank, Thomas/F-5273-2012; Strenzke, Nicola/AAP-5349-2021; Moser, Tobias/L-5068-2014	Frank, Thomas/0000-0002-5113-176X; Strenzke, Nicola/0000-0003-1673-1046; Moser, Tobias/0000-0001-7145-0533; Reisinger, Ellen/0000-0003-3739-7569; Takago, Hideki/0000-0003-2875-4667	German Research Foundation (Center for Molecular Physiology of the Brain); European Commission; Max-Planck-Society; German Ministry for Education and Science via the Bernstein Focus Neurotechnology Goettingen [01GQ0810]; State of Lower Saxony; US National Institutes of Health [DC007704]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007704] Funding Source: NIH RePORTER	German Research Foundation (Center for Molecular Physiology of the Brain)(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Max-Planck-Society(Max Planck SocietyFoundation CELLEX); German Ministry for Education and Science via the Bernstein Focus Neurotechnology Goettingen; State of Lower Saxony(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank E. Glowatzki and D. Khimich for teaching us the postsynaptic patch clamp, K. Tittman, D. Fasshauer and R. Jahn for advice and support for protein biochemistry, C.P. Richter and M.A. Cheatham for advice on the electrocochleography, A. Leonov and C. Griesinger for the DM-nitrophen, P. Jonas for the parvalbumin taqman probe, members of the InnerEarLab for discussion, M. Rutherford, J. Singer, E. Neher, J. Siegel, P. Heil, T. Sakaba, R. Nouvian, A. Lysakowski and A. Lee for comments on the manuscript and C. Rudiger, S. Blume, N. Dankenbrink-Werder and M. Koppler for expert technical assistance. This work was supported by a fellowship of the Alexander von Humboldt Foundation to T.P., a fellowship of the Boehringer Ingelheim Fonds to K.R., a fellowship of MED-EL company to H.T., grants from the German Research Foundation (Center for Molecular Physiology of the Brain, T.M. and N.B.; Fellowship to N.S.), the European Commission (Eurohear, T.M.), the Max-Planck-Society (Tandemproject, T.M. and N.B.), the German Ministry for Education and Science via the Bernstein Focus Neurotechnology Goettingen (grant no. 01GQ0810 to T.M.), the State of Lower Saxony ('VW-Vorab' to T.M. and Christoph Matthias), and the US National Institutes of Health (DC007704, U.M.).	Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Dulon D, 2009, J NEUROSCI, V29, P10474, DOI 10.1523/JNEUROSCI.1009-09.2009; Eisen MD, 2004, J NEUROPHYSIOL, V91, P2422, DOI 10.1152/jn.01130.2003; Frank T, 2009, P NATL ACAD SCI USA, V106, P4483, DOI 10.1073/pnas.0813213106; Geisler CD., 1998, SOUND SYNAPSE; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Gomis A, 1999, J NEUROSCI, V19, P6309; Goodman MB, 2000, J NEUROSCI METH, V100, P13, DOI 10.1016/S0165-0270(00)00224-7; Goutman JD, 2007, P NATL ACAD SCI USA, V104, P16341, DOI 10.1073/pnas.0705756104; Grant L, 2010, J NEUROSCI, V30, P4210, DOI 10.1523/JNEUROSCI.4439-09.2010; Griesinger CB, 2005, NATURE, V435, P212, DOI 10.1038/nature03567; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; Hosoi N, 2007, J NEUROSCI, V27, P14286, DOI 10.1523/JNEUROSCI.4122-07.2007; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Jackman SL, 2009, NAT NEUROSCI, V12, P303, DOI 10.1038/nn.2267; Johnson SL, 2005, J PHYSIOL-LONDON, V563, P177, DOI 10.1113/jphysiol.2004.074740; Keen EC, 2006, P NATL ACAD SCI USA, V103, P5537, DOI 10.1073/pnas.0601103103; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; KIANG NYS, 1965, DISCHARGE PATTERN SI; Li GL, 2009, J NEUROSCI, V29, P7558, DOI 10.1523/JNEUROSCI.0514-09.2009; MCCUE MP, 1994, J NEUROSCI, V14, P6058; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Moser T, 2006, J PHYSIOL-LONDON, V576, P55, DOI 10.1113/jphysiol.2006.114835; Neef A, 2007, J NEUROSCI, V27, P12933, DOI 10.1523/JNEUROSCI.1996-07.2007; Neef J, 2009, J NEUROSCI, V29, P10730, DOI 10.1523/JNEUROSCI.1577-09.2009; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; Rabl K, 2005, J NEUROSCI, V25, P4633, DOI 10.1523/JNEUROSCI.4298-04.2005; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Roux I, 2009, HUM MOL GENET, V18, P4615, DOI 10.1093/hmg/ddp429; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; Schnee ME, 2005, NEURON, V47, P243, DOI 10.1016/j.neuron.2005.06.004; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Spassova MA, 2004, JARO-J ASSOC RES OTO, V5, P376, DOI 10.1007/s10162-004-5003-8; Starr A., 2008, SENSES COMPREHENSIVE, P397; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Strenzke N, 2009, J NEUROSCI, V29, P7991, DOI 10.1523/JNEUROSCI.0632-09.2009; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Wittig JH, 2008, J NEUROPHYSIOL, V100, P1724, DOI 10.1152/jn.90322.2008; Wolfel M, 2007, J NEUROSCI, V27, P3198, DOI 10.1523/JNEUROSCI.4471-06.2007; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	50	143	151	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					869	U116		10.1038/nn.2578	http://dx.doi.org/10.1038/nn.2578			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20562868	Green Published			2022-12-17	WOS:000279173900020
J	Varga, C; Lee, SY; Soltesz, I				Varga, Csaba; Lee, Soo Yeun; Soltesz, Ivan			Target-selective GABAergic control of entorhinal cortex output	NATURE NEUROSCIENCE			English	Article							RAT; HIPPOCAMPUS; CELLS	The medial entorhinal cortex (MEC) is a major center for spatial navigation and memory. We found that cannabinoid type 1 receptor-expressing GABAergic basket cells selectively innervated principal cells in layer II of the rat MEC that projected outside the hippocampus but avoided neighboring cells that give rise to the perforant pathway to the dentate gyrus. These results indicate that the organization of GABAergic microcircuits reflects the long-distance axonal targets of principal neurons.	[Varga, Csaba; Lee, Soo Yeun; Soltesz, Ivan] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Varga, C (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.	cvarga@uci.edu		Varga, Csaba/0000-0002-9188-1282	US National Institutes of Health [NS35915]; American Epilepsy Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035915, R29NS035915, R01NS035915] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Epilepsy Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Zhu and M. Cid for technical assistance and I. Sears-Kraxberger and H.S. Keirstead for their generous support with electron microscopy. This work was supported by the US National Institutes of Health grant NS35915 (I.S.) and the American Epilepsy Society (S.Y.L.).	Adelmann G, 1996, ANAT EMBRYOL, V193, P481; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; Deng PY, 2009, NEURON, V63, P230, DOI 10.1016/j.neuron.2009.06.022; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Fujimaru Y, 1996, NEUROSCI RES, V24, P329, DOI 10.1016/0168-0102(95)01008-4; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614	15	143	144	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					822	824		10.1038/nn.2570	http://dx.doi.org/10.1038/nn.2570			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512133	Green Accepted, Green Submitted			2022-12-17	WOS:000279173900013
J	Schiller, D; Freeman, JB; Mitchell, JP; Uleman, JS; Phelps, EA				Schiller, Daniela; Freeman, Jonathan B.; Mitchell, Jason P.; Uleman, James S.; Phelps, Elizabeth A.			A neural mechanism of first impressions	NATURE NEUROSCIENCE			English	Article							POSTERIOR CINGULATE CORTEX; SOCIAL COGNITION; BRAIN ACTIVITY; HUMAN AMYGDALA; MEMORY; TRUSTWORTHINESS; ACTIVATION; EMOTION; FACES; PREDICTION	Evaluating social others requires processing complex information. Nevertheless, we can rapidly form an opinion of an individual during an initial encounter. Moreover, people can vary in these opinions, even though the same information is provided. We investigated the brain mechanisms that give rise to the impressions that are formed on meeting a new person. Neuroimaging revealed that responses in the amygdala and the posterior cingulate cortex (PCC) were stronger while encoding social information that was consistent, relative to inconsistent, with subsequent evaluations. In addition, these responses scaled parametrically with the strength of evaluations. These findings provide evidence for encoding differences on the basis of subsequent evaluations, suggesting that the amygdala and PCC are important for forming first impressions.	[Schiller, Daniela; Phelps, Elizabeth A.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Schiller, Daniela; Freeman, Jonathan B.; Uleman, James S.; Phelps, Elizabeth A.] NYU, Dept Psychol, New York, NY 10003 USA; [Freeman, Jonathan B.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Mitchell, Jason P.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	New York University; New York University; Tufts University; Harvard University	Schiller, D (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	schiller@cns.nyu.edu; liz.phelps@nyu.edu	Schiller, Daniela/Q-2431-2018; Uleman, Jim/AAO-1710-2020	Schiller, Daniela/0000-0002-0357-7724; Uleman, Jim/0000-0001-8805-705X	Seaver Foundation; James S. McDonnell Foundation; Fulbright	Seaver Foundation; James S. McDonnell Foundation; Fulbright	We thank I. Levy and D. Amodio for fruitful discussions and comments, C. Raio for assistance with data collection, and K. Sanzenbach and the Center for Brain Imaging at New York University for technical assistance. This study was funded by a Seaver Foundation grant to the Center for Brain Imaging, a James S. McDonnell Foundation grant to E.A.P. and a Fulbright award to D.S.	ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; AMBADY N, 1993, J PERS SOC PSYCHOL, V64, P431, DOI 10.1037/0022-3514.64.3.431; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; ANDERSON NH, 1961, J ABNORM SOC PSYCH, V63, P346, DOI 10.1037/h0046719; ASCH SE, 1946, J ABNORM SOC PSYCH, V41, P258, DOI 10.1037/h0055756; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Cunningham WA, 2008, PSYCHOL SCI, V19, P152, DOI 10.1111/j.1467-9280.2008.02061.x; Delgado MR, 2008, PHILOS T R SOC B, V363, P3787, DOI 10.1098/rstb.2008.0161; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; EVERITT B J, 1992, P401; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/S0960-9822(03)00891-1; HASTIE R, 1986, PSYCHOL REV, V93, P258, DOI 10.1037/0033-295X.93.3.258; Heberlein AS, 2004, P NATL ACAD SCI USA, V101, P7487, DOI 10.1073/pnas.0308220101; Johnson MK, 2006, SOC COGN AFFECT NEUR, V1, P56, DOI 10.1093/scan/nsl004; JOHNSON MK, 1985, J EXP PSYCHOL LEARN, V11, P22, DOI 10.1037/0278-7393.11.1.22; Jones E.E., 1987, ATTRIBUTION PERCEIV, P27; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lieberman MD, 2001, PSYCHOL SCI, V12, P135, DOI 10.1111/1467-9280.00323; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mitchell JP, 2004, J NEUROSCI, V24, P4912, DOI 10.1523/JNEUROSCI.0481-04.2004; Mitchell JP, 2002, P NATL ACAD SCI USA, V99, P15238, DOI 10.1073/pnas.232395699; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Pessoa L, 2005, P NATL ACAD SCI USA, V102, P5612, DOI 10.1073/pnas.0500566102; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Schiller D, 2008, J NEUROSCI, V28, P11517, DOI 10.1523/JNEUROSCI.2265-08.2008; Seymour B, 2008, CURR OPIN NEUROBIOL, V18, P173, DOI 10.1016/j.conb.2008.07.010; SORNERVILLE LH, 2006, J COGNITIVE NEUROSCI, V18, P1253; Taber KH, 2004, J NEUROPSYCH CLIN N, V16, P127, DOI 10.1176/appi.neuropsych.16.2.127; Talairach J., 1988, COPLANAR STEREOTAXIC; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P119, DOI 10.1093/scan/nsn009; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; ULEMAN JS, 2005, NEW UNCONSCIOUS, P362; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816	47	143	146	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2009	12	4					508	514		10.1038/nn.2278	http://dx.doi.org/10.1038/nn.2278			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	424JN	19270690				2022-12-17	WOS:000264563100026
J	Vasudevan, A; Long, JE; Crandall, JE; Rubenstein, JLR; Bhide, PG				Vasudevan, Anju; Long, Jason E.; Crandall, James E.; Rubenstein, John L. R.; Bhide, Pradeep G.			Compartment-specific transcription factors orchestrate angiogenesis gradients in the embryonic brain	NATURE NEUROSCIENCE			English	Article							MOUSE CORPUS STRIATUM; NEURAL-TUBE; VENTRAL FOREBRAIN; BASAL FOREBRAIN; GENE-EXPRESSION; CELL-CYCLE; DLX GENES; TELENCEPHALON; DIFFERENTIATION; MECHANISMS	Prevailing notions of cerebral vascularization imply that blood vessels sprout passively into the brain parenchyma from pial vascular plexuses to meet metabolic needs of growing neuronal populations. Endothelial cells, building blocks of blood vessels, are thought to be homogeneous in the brain with respect to their origins, gene expression patterns and developmental mechanisms. These current notions that cerebral angiogenesis is regulated by local environmental signals contrast with current models of cell-autonomous regulation of neuronal development. Here we demonstrate that telencephalic angiogenesis in mice progresses in an orderly, ventral-to-dorsal gradient regulated by compartment-specific homeobox transcription factors. Our data offer new perspectives on intrinsic regulation of angiogenesis in the embryonic telencephalon, call for a revision of the current models of telencephalic angiogenesis and support novel roles for endothelial cells in brain development.	[Vasudevan, Anju; Bhide, Pradeep G.] Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Vasudevan, Anju; Bhide, Pradeep G.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Long, Jason E.; Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA; [Crandall, James E.] Univ Massachusetts, Sch Med, Eunice Kennedy Shriver Ctr Mental Retardat Inc, Waltham, MA 02452 USA	Harvard University; Massachusetts General Hospital; Harvard University; University of California System; University of California San Francisco; University of Massachusetts System	Bhide, PG (corresponding author), Massachusetts Gen Hosp, Charlestown, MA 02129 USA.	anju.vasudevan@mgh.harvard.edu; bhide@helix.mgh.harvard.edu		Bhide, Pradeep/0000-0003-4236-9415; VASUDEVAN, ANJU/0000-0001-9814-2389	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043426, P30NS045776, R01NS043246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020796] Funding Source: NIH RePORTER; NIDA NIH HHS [R01DA020796, R01 DA020796, R01 DA020796-03] Funding Source: Medline; NINDS NIH HHS [R01NS43246,, R01 NS043246, R01 NS043426-05, P30 NS045776-05, P30NS045776, P30 NS045776, R01 NS043426] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Bayer S. A., 1991, J NEOCORTICAL DEV; BAYER SA, 1987, PROG NEUROBIOL, V29, P57, DOI 10.1016/0301-0082(87)90015-3; Ben-Ari Y, 2004, TRENDS NEUROSCI, V27, P422, DOI 10.1016/j.tins.2004.05.002; Bhide PG, 1996, J COMP NEUROL, V374, P506; BREIER G, 1992, DEVELOPMENT, V114, P521; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; Cohen MM, 2003, ANN ACAD MED SINGAP, V32, P244; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Eisenstat DD, 1999, J COMP NEUROL, V414, P217, DOI 10.1002/(SICI)1096-9861(19991115)414:2<217::AID-CNE6>3.0.CO;2-I; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; GERFEN CR, 1989, SCIENCE, V246, P385, DOI 10.1126/science.2799392; Ghanem N, 2007, J NEUROSCI, V27, P5012, DOI 10.1523/JNEUROSCI.4725-06.2007; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; KEYNES R, 1990, NEURON, V4, P1, DOI 10.1016/0896-6273(90)90438-L; KEYNES RJ, 1988, DEVELOPMENT, V103, P413; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kurz H, 2000, J NEURO-ONCOL, V50, P17, DOI 10.1023/A:1006485716743; Kusakabe T, 2006, MOL ENDOCRINOL, V20, P1796, DOI 10.1210/me.2005-0327; Marin O, 2000, J NEUROSCI, V20, P6063; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nery S, 2003, CEREB CORTEX, V13, P895, DOI 10.1093/cercor/13.9.895; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P313, DOI 10.1097/00005072-199904000-00001; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Sheth AN, 1997, J COMP NEUROL, V383, P220; Shimamura K, 1997, DEV NEUROSCI-BASEL, V19, P88, DOI 10.1159/000111190; Stoykova A, 2000, J NEUROSCI, V20, P8042; Stoykova A, 1996, DEVELOPMENT, V122, P3453; STRONG LH, 1964, J COMP NEUROL, V123, P151, DOI 10.1002/cne.901230111; Super H, 1997, DEV BRAIN RES, V98, P15, DOI 10.1016/S0165-3806(96)00155-1; Sussel L, 1999, DEVELOPMENT, V126, P3359; Takahashi T, 1999, J NEUROSCI, V19, P10357; Takahashi T, 1996, J NEUROSCI, V16, P6183; Yuan BB, 2000, DEV DYNAM, V217, P180, DOI 10.1002/(SICI)1097-0177(200002)217:2<180::AID-DVDY5>3.0.CO;2-3; Yun K, 2002, DEVELOPMENT, V129, P5029	49	143	145	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					429	439		10.1038/nn2074	http://dx.doi.org/10.1038/nn2074			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344991	Green Accepted			2022-12-17	WOS:000254359300015
J	Pfeiffenberger, C; Cutforth, T; Woods, G; Yamada, J; Renteria, RC; Copenhagen, DR; Flanagan, JG; Feldheim, DA				Pfeiffenberger, C; Cutforth, T; Woods, G; Yamada, J; Renteria, RC; Copenhagen, DR; Flanagan, JG; Feldheim, DA			Ephrin-As and neural activity are required for eye-specific patterning during retinogeniculate mapping	NATURE NEUROSCIENCE			English	Article							BETA-2 SUBUNIT; AXON GUIDANCE; SEGREGATION; PROJECTIONS; RECEPTORS; COMPETITION; REFINEMENT; EXPRESSION; INFUSION; COLUMNS	In mammals, retinal ganglion cell (RGC) projections initially intermingle and then segregate into a stereotyped pattern of eye-specific layers in the dorsal lateral geniculate nucleus (dLGN). Here we found that in mice deficient for ephrin-A2, ephrin-A3 and ephrin-A5, eye-specific inputs segregated but the shape and location of eye-specific layers were profoundly disrupted. In contrast, mice that lacked correlated retinal activity did not segregate eye-specific inputs. Inhibition of correlated neural activity in ephrin mutants led to overlapping retinal projections that were located in inappropriate regions of the dLGN. Thus, ephrin-As and neural activity act together to control patterning of eye-specific retinogeniculate layers.	Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA; Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Calif San Francisco, Sch Med, Dept Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	University of California System; University of California Santa Cruz; Columbia University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Feldheim, DA (corresponding author), Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA.	feldheim@biology.ucsc.edu	Flanagan, John/AAM-2995-2020	Renteria, Rene/0000-0002-4490-0735	NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA023767, P01 CA23767] Funding Source: Medline; NEI NIH HHS [EY014689, R01 EY014689] Funding Source: Medline; NIDCD NIH HHS [R01 DC004209, R01 DC04209] Funding Source: Medline; NIGMS NIH HHS [T32 GM008646, GM08646] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Crowley JC, 2002, CURR OPIN NEUROBIOL, V12, P104, DOI 10.1016/S0959-4388(02)00297-0; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Demas J, 2003, J NEUROSCI, V23, P2851; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 2000, CURR BIOL, V10, pR52, DOI 10.1016/S0960-9822(00)00293-1; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; GODEMENT P, 1987, J COMP NEUROL, V255, P97, DOI 10.1002/cne.902550108; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2002, J NEUROSCI, V22, P9419; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; METIN C, 1983, CR ACAD SCI III-VIE, V296, P157; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pham TA, 2001, NEURON, V31, P409, DOI 10.1016/S0896-6273(01)00381-6; RAKIC P, 1981, SCIENCE, V214, P928, DOI 10.1126/science.7302569; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Vanderhaeghen P, 2004, TRENDS NEUROSCI, V27, P384, DOI 10.1016/j.tins.2004.05.009; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8	35	143	146	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1022	1027		10.1038/nn1508	http://dx.doi.org/10.1038/nn1508			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025107	Green Accepted			2022-12-17	WOS:000230760200013
J	Smith, MA; Majaj, NJ; Movshon, JA				Smith, MA; Majaj, NJ; Movshon, JA			Dynamics of motion signaling by neurons in macaque area MT	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; SUPERIOR TEMPORAL SULCUS; ORIENTATION SELECTIVITY; 2-DIMENSIONAL PATTERNS; FUNCTIONAL-PROPERTIES; CORTICAL-NEURONS; SINGLE NEURONS; V1 NEURONS; PERCEPTION; DIRECTION	Most neurons in macaque area MT are selective for the direction of stimulus motion. By comparing direction selectivity for gratings and plaids, we classified MT neurons as pattern direction selective (PDS) or component direction selective (CDS). We compared the time course of responses in CDS and PDS neurons in opiate-anesthetized macaques, using a rapid pseudorandom sequence of gratings and plaids that moved in different directions. On average, responses began 6 ms earlier in CDS neurons than in PDS neurons. More importantly, the pattern-selective responses of PDS neurons did not reach their fully selective state until 50-75 ms after the responses of CDS neurons had stabilized. The population motion response of MT is therefore initially dominated by component motion signals, and does not completely represent pattern motion until substantially later. The circuits that compute pattern motion take more time to finish their work than those signaling component motion.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Movshon, JA (corresponding author), Carnegie Mellon Univ, Ctr Neural Basis Cognit, 4400 5th Ave,115 Mellon Inst, Pittsburgh, PA 15232 USA.	movshon@nyu.edu		Smith, Matthew A/0000-0003-1192-9942	NATIONAL EYE INSTITUTE [R01EY002017] Funding Source: NIH RePORTER; NEI NIH HHS [EY02017] Funding Source: Medline; PHS HHS [T32-7136] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALBRECHT DG, 1995, VISUAL NEUROSCI, V12, P1191, DOI 10.1017/S0952523800006817; Albrecht DG, 2002, J NEUROPHYSIOL, V88, P888, DOI 10.1152/jn.2002.88.2.888; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Bair W, 2003, J NEUROSCI, V23, P7690; BAIR W, 1994, J NEUROSCI, V14, P2870; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Bullier J, 2001, PROG BRAIN RES, V134, P193; Carandini M, 1997, J NEUROSCI, V17, P8621; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CELEBRINI S, 1993, VISUAL NEUROSCI, V10, P811, DOI 10.1017/S0952523800006052; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Gallyas F, 1979, Neurol Res, V1, P203; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; GIZZI MS, 1990, J NEUROPHYSIOL, V63, P1529, DOI 10.1152/jn.1990.63.6.1529; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KOOI FL, 1992, PERCEPTION, V21, P583, DOI 10.1068/p210583; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Li B, 2001, EUR J NEUROSCI, V14, P690, DOI 10.1046/j.0953-816x.2001.01689.x; LORENCEAU J, 1993, VISION RES, V33, P1207, DOI 10.1016/0042-6989(93)90209-F; Masson GS, 2002, J NEUROSCI, V22, P5149, DOI 10.1523/JNEUROSCI.22-12-05149.2002; Maunsell J. H., 1987, MATTERS INTELLIGENCE, P59, DOI DOI 10.1007/978-94-009-3833-5_3; MCCLURKIN JW, 1991, SCIENCE, V253, P675, DOI 10.1126/science.1908118; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Movshon A, 1985, PATTERN RECOGN, V54, P117; Movshon JA, 1996, J NEUROSCI, V16, P7733; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Priebe NJ, 2003, J NEUROSCI, V23, P5650; RAIGUEL SE, 1989, BRAIN RES, V493, P155, DOI 10.1016/0006-8993(89)91010-X; Raiguel SE, 1999, J NEUROPHYSIOL, V82, P1944, DOI 10.1152/jn.1999.82.4.1944; RICHMOND BJ, 1990, J NEUROPHYSIOL, V64, P351, DOI 10.1152/jn.1990.64.2.351; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Ringach DL, 2003, J NEUROPHYSIOL, V90, P342, DOI 10.1152/jn.01018.2002; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; YO C, 1992, VISION RES, V32, P135, DOI 10.1016/0042-6989(92)90121-X; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452; Zipser K, 1996, J NEUROSCI, V16, P7376	49	143	143	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					220	228		10.1038/nn1382	http://dx.doi.org/10.1038/nn1382			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15657600				2022-12-17	WOS:000226638200022
J	Rico, B; Beggs, HE; Schahin-Reed, D; Kimes, N; Schmidt, A; Reichardt, LF				Rico, B; Beggs, HE; Schahin-Reed, D; Kimes, N; Schmidt, A; Reichardt, LF			Control of axonal branching and synapse formation by focal adhesion kinase	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; CENTRAL-NERVOUS-SYSTEM; P190 RHOGAP; IN-VIVO; PROTEIN; GROWTH; CELLS; PHOSPHORYLATION; PLASTICITY; STABILITY	The formation of neuronal networks in the central nervous system (CNS) requires precise control of axonal branch development and stabilization. Here we show that cell-specific ablation of the murine gene Ptk2 (more commonly known as fak), encoding focal adhesion kinase (FAK), increases the number of axonal terminals and synapses formed by neurons in vivo. Consistent with this, fak mutant neurons also form greater numbers of axonal branches in culture because they have increased branch formation and reduced branch retraction. Expression of wild-type FAK, but not that of several FAK variants that prevent interactions with regulators of Rho family GTPases including the p190 Rho guanine nuclear exchange factor (p190RhoGEF), rescues the axonal arborization phenotype observed in fak mutant neurons. In addition, expression of a mutant p190RhoGEF that cannot associate with FAK results in a phenotype very similar to that of neurons lacking FAK. Thus, FAK functions as a negative regulator of axonal branching and synapse formation, and it seems to exert its actions, in part, through Rho family GTPases.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Reichardt, LF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	brico@umh.es; lfr@cgl.ucsf.edu		Rico, Beatriz/0000-0002-0581-851X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019090] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS019090-26, R01 NS019090] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARREGUI CO, 1994, J NEUROSCI, V14, P6967; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; Barry ST, 1996, CELL ADHES COMMUN, V4, P387, DOI 10.3109/15419069709004456; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Chan-Palay V, 1977, CEREBELLAR DENTATE N; Contestabile A, 2003, INT J DEV NEUROSCI, V21, P83, DOI 10.1016/S0736-5748(02)00126-0; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gao PP, 1999, P NATL ACAD SCI USA, V96, P4073, DOI 10.1073/pnas.96.7.4073; Garin N, 2002, J COMP NEUROL, V447, P210, DOI 10.1002/cne.10226; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; ILLC D, 1995, NATURE, V377, P539; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Klingbeil CK, 2001, J CELL BIOL, V152, P97, DOI 10.1083/jcb.152.1.97; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Mandell JW, 1996, J NEUROSCI, V16, P5727; Mantych KB, 2001, J NEUROSCI, V21, P6802, DOI 10.1523/JNEUROSCI.21-17-06802.2001; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Menegon A, 1999, EUR J NEUROSCI, V11, P3777, DOI 10.1046/j.1460-9568.1999.00798.x; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Ren XD, 2000, J CELL SCI, V113, P3673; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Seki T, 1998, J NEUROSCI, V18, P3757; Sorra KE, 1998, J COMP NEUROL, V398, P225; Taylor JM, 1999, J CELL SCI, V112, P231; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yang YC, 2003, J NEUROSCI, V23, P4072; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200	50	143	145	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1059	1069		10.1038/nn1317	http://dx.doi.org/10.1038/nn1317			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15378065	Green Accepted			2022-12-17	WOS:000224156900015
J	Miceli, G; Fouch, E; Capasso, R; Shelton, JR; Tomaiuolo, F; Caramazza, A				Miceli, G; Fouch, E; Capasso, R; Shelton, JR; Tomaiuolo, F; Caramazza, A			The dissociation of color from form and function knowledge	NATURE NEUROSCIENCE			English	Article							MENTAL-IMAGERY; PERCEPTION; BRAIN; PATIENT; DEFICIT; ATTRIBUTES; IMPAIRMENT; BLINDNESS; LESIONS	We report on two brain-damaged subjects who exhibit the uncommon pattern of loss of object color knowledge, but spared color perception and naming. The subject P.C.O., as in previously reported patients, is also impaired in processing other perceptual and functional properties of objects. I.O.C., in contrast, is the first subject on record to have impaired object color knowledge, but spared knowledge of object form, size and function. This pattern of performance is consistent with the view that semantic information about color and other perceptual properties of objects is grounded in modality-specific systems. Lesion analysis suggests that such grounding requires the integrity of the mesial temporal regions of the left hemisphere.	Harvard Univ, Cognit Neuropsychol Lab, Cambridge, MA 02138 USA; Univ Cattolica Sacro Cuore, Dept Neurol, I-00168 Rome, Italy; IRCCS S Lucia, I-00179 Rome, Italy	Harvard University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Santa Lucia	Caramazza, A (corresponding author), Harvard Univ, Cognit Neuropsychol Lab, William James Hall,33 Kirkland St, Cambridge, MA 02138 USA.	caram@wjh.harvard.edu	Tomaiuolo, Francesco/AAC-1534-2019; Miceli, Gabriele/J-8908-2014	Capasso, Rita/0000-0003-1523-7302; Tomaiuolo, Fancesco/0000-0003-1230-2770; Miceli, Gabriele/0000-0002-8835-094X	NIDCD NIH HHS [DC04245] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Allport D. A., 1985, CURRENT PERSPECTIVES, P207; Bartolomeo P, 1997, CORTEX, V33, P369, DOI 10.1016/S0010-9452(08)70012-1; Bartolomeo P, 1998, NEUROPSYCHOLOGIA, V36, P239, DOI 10.1016/S0028-3932(97)00103-6; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Caramazza A, 1998, NEUROCASE, V4, P265, DOI 10.1093/neucas/4.4.265; Cavanagh P, 1998, NAT NEUROSCI, V1, P242, DOI 10.1038/688; Chao LL, 1999, J COGNITIVE NEUROSCI, V11, P25, DOI 10.1162/089892999563229; Coltheart M, 1998, NEUROCASE, V4, P353, DOI 10.1080/13554799808410632; Cowey A, 1995, BEHAV BRAIN RES, V71, P89, DOI 10.1016/0166-4328(95)00046-1; DAVIDOFF J, 1989, COGNITIVE NEUROPSYCH, V6, P165, DOI 10.1080/02643298908253417; Economo C., 1925, CYTOARCHITEKTONIK HI; FARAH MJ, 1988, BRAIN COGNITION, V8, P147, DOI 10.1016/0278-2626(88)90046-2; Farnsworth D, 1947, FARNSWORTH DICHOTOMO; Forde EME, 1999, APHASIOLOGY, V13, P169, DOI 10.1080/026870399402172; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; HEYWOOD CA, 1987, J NEUROL NEUROSUR PS, V50, P22, DOI 10.1136/jnnp.50.1.22; HUMPHREYS GW, IN PRESS BRAIN BEHAV; Ishihara S, 1974, TESTS COLOUR BLINDNE; JACKENDOFF R, 1987, COGNITION, V26, P89, DOI 10.1016/0010-0277(87)90026-6; LAIACONA M, 1993, CORTEX, V29, P727, DOI 10.1016/S0010-9452(13)80293-6; LAMBONRALPH MA, 1998, NEUROCASE, V4, P311; LUZZATTI C, 1994, NEUROPSYCHOLOGIA, V32, P933, DOI 10.1016/0028-3932(94)90044-2; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; MARTIN A, 2000, NEW COGNITIVE NEUROS, P1023; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; MEADOWS JC, 1974, BRAIN, V97, P615, DOI 10.1093/brain/97.1.615; MICHELI G, 1994, BATTERIA ANAL DEFICI; MILLER G, 1976, LANGUAGE PROPERTIES; Moss HE, 1998, NEUROCASE, V4, P291, DOI 10.1080/13554799808410629; Riddoch M. J., 1993, BORB BIRMINGHAM OBJE; Samson D, 1998, NEUROCASE, V4, P273; Shelton JR, 1998, NEUROCASE, V4, P339, DOI 10.1093/neucas/4.4.339; Shuren JE, 1996, NEUROPSYCHOLOGIA, V34, P485, DOI 10.1016/0028-3932(95)00153-0; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669; ZEKI S, 1990, BRAIN, V113, P1721, DOI 10.1093/brain/113.6.1721; Zeki S, 1999, P NATL ACAD SCI USA, V96, P14124, DOI 10.1073/pnas.96.24.14124	38	143	149	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					662	667		10.1038/88497	http://dx.doi.org/10.1038/88497			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	438PG	11369950				2022-12-17	WOS:000169061800022
J	Formento, E; Minassian, K; Wagner, F; Mignardot, JB; Le Goff-Mignardot, CG; Rowald, A; Bloch, J; Micera, S; Capogrosso, M; Courtine, G				Formento, Emanuele; Minassian, Karen; Wagner, Fabien; Mignardot, Jean Baptiste; Le Goff-Mignardot, Camille G.; Rowald, Andreas; Bloch, Jocelyne; Micera, Silvestro; Capogrosso, Marco; Courtine, Gregoire			Electrical spinal cord stimulation must preserve proprioception to enable locomotion in humans with spinal cord injury	NATURE NEUROSCIENCE			English	Article							HIGH-FREQUENCY STIMULATION; CIRCUIT REORGANIZATION; EPIDURAL STIMULATION; FUNCTIONAL WALKING; MOTOR CONTROL; LUMBAR CORD; MODULATION; INPUT; CAT; MOTONEURONS	Epidural electrical stimulation (EES) of the spinal cord restores locomotion in animal models of spinal cord injury but is less effective in humans. Here we hypothesized that this interspecies discrepancy is due to interference between EES and proprioceptive information in humans. Computational simulations and preclinical and clinical experiments reveal that EES blocks a significant amount of proprioceptive input in humans, but not in rats. This transient deafferentation prevents modulation of reciprocal inhibitory networks involved in locomotion and reduces or abolishes the conscious perception of leg position. Consequently, continuous EES can only facilitate locomotion within a narrow range of stimulation parameters and is unable to provide meaningful locomotor improvements in humans without rehabilitation. Simulations showed that burst stimulation and spatiotemporal stimulation profiles mitigate the cancellation of proprioceptive information, enabling robust control over motor neuron activity. This demonstrates the importance of stimulation protocols that preserve proprioceptive information to facilitate walking with EES.	[Formento, Emanuele; Micera, Silvestro] Swiss Fed Inst Technol EPFL, Inst Bioengn, Bertarelli Fdn Chair Translat NeuroEngn, Lausanne, Switzerland; [Formento, Emanuele; Minassian, Karen; Wagner, Fabien; Mignardot, Jean Baptiste; Le Goff-Mignardot, Camille G.; Rowald, Andreas; Courtine, Gregoire] Swiss Fed Inst Technol EPFL, Sch Life Sci, Ctr Neuroprosthet, Lausanne, Switzerland; [Formento, Emanuele; Minassian, Karen; Wagner, Fabien; Mignardot, Jean Baptiste; Le Goff-Mignardot, Camille G.; Rowald, Andreas; Courtine, Gregoire] Swiss Fed Inst Technol EPFL, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland; [Rowald, Andreas; Capogrosso, Marco] Univ Fribourg, Dept Med, Fac Sci, Fribourg, Switzerland; [Bloch, Jocelyne; Courtine, Gregoire] Univ Hosp Lausanne CHUV, Dept Neurosurg, Lausanne, Switzerland; [Micera, Silvestro] Scuola Super Sant Anna, Inst Biorobot, Neural Engn Area, Pisa, Italy	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Fribourg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Scuola Superiore Sant'Anna	Courtine, G (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, Ctr Neuroprosthet, Lausanne, Switzerland.; Courtine, G (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland.; Courtine, G (corresponding author), Univ Hosp Lausanne CHUV, Dept Neurosurg, Lausanne, Switzerland.	gregoire.courtine@epfl.ch	Wagner, Fabien/ABC-4084-2020; Formento, Emanuele/AAX-9095-2020; Micera, Silvestro/AAD-6630-2021; Bloch, Jocelyne/A-9668-2017	Wagner, Fabien/0000-0002-9582-6109; Formento, Emanuele/0000-0002-7870-2710; courtine, gregoire/0000-0002-5744-4142; Rowald, Andreas/0000-0001-5493-195X; Bloch, Jocelyne/0000-0002-6405-1590; Mignardot, Jean-Baptiste/0000-0003-0614-0453; Capogrosso, Marco/0000-0002-0975-316X; Minassian, Karen/0000-0003-4197-6141	HBP Neurorobotics Platform from the European Union's Horizon 2020 Framework Programme for Research and Innovation [720270]; European Union [720270, 785907]; RESTORE: Eurostars [E10889]; Wings for Life; GTXmedical; European Research Council [HOW2WALKAGAIN 682999]; National Center of Competence in Research (NCCR) Robotics of the Swiss National Science Foundation; Commission of Technology and Innovation (CTI) Innosuisse (CTI) OptiStim [25761.1]; International Foundation for Research in Paraplegia (IRP); Michel-Adrien Voirol Foundation; Firmenich Foundation; Pictet Group Charitable Foundation; Panacee Foundation; Marie-Curie EPFL fellowship program; Wyss Center for Neuroengineering	HBP Neurorobotics Platform from the European Union's Horizon 2020 Framework Programme for Research and Innovation; European Union(European Commission); RESTORE: Eurostars; Wings for Life; GTXmedical; European Research Council(European Research Council (ERC)European Commission); National Center of Competence in Research (NCCR) Robotics of the Swiss National Science Foundation; Commission of Technology and Innovation (CTI) Innosuisse (CTI) OptiStim; International Foundation for Research in Paraplegia (IRP); Michel-Adrien Voirol Foundation; Firmenich Foundation; Pictet Group Charitable Foundation; Panacee Foundation; Marie-Curie EPFL fellowship program; Wyss Center for Neuroengineering	We thank K. Bartholdi, A. Bichat, and L. Baud for their help with the rat experiments, and we thank all the individuals involved in the STIMO clinical study. This research was supported by the HBP Neurorobotics Platform, funded from the European Union's Horizon 2020 Framework Programme for Research and Innovation under the Specific Grant Agreement No. 720270 (Human Brain Project SGA1). Financial support was provided by the European Union's Horizon 2020 Framework Programme for Research and Innovation under Specific Grant Agreements No. 720270 (Human Brain Project SGA1) and No. 785907 (Human Brain Project SGA2); RESTORE: Eurostars E10889, Wings for Life, GTXmedical, Consolidator Grant from the European Research Council (ERC-2015-CoG HOW2WALKAGAIN 682999), Wyss Center for Neuroengineering, National Center of Competence in Research (NCCR) Robotics of the Swiss National Science Foundation, the Commission of Technology and Innovation (CTI) Innosuisse (CTI) OptiStim 25761.1, International Foundation for Research in Paraplegia (IRP), the Michel-Adrien Voirol Foundation, the Firmenich Foundation, the Pictet Group Charitable Foundation, the Panacee Foundation, and the Marie-Curie EPFL fellowship program.	Albert F, 2006, EXP BRAIN RES, V172, P163, DOI 10.1007/s00221-005-0325-2; Angeli CA, 2018, NEW ENGL J MED, V379, P1244, DOI 10.1056/NEJMoa1803588; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Asboth L, 2018, NAT NEUROSCI, V21, P576, DOI 10.1038/s41593-018-0093-5; Bawa P, 2008, MUSCLE NERVE, V38, P1604, DOI 10.1002/mus.21184; Buonocore M, 2008, SPINE, V33, pE90, DOI 10.1097/BRS.0b013e3181642a97; BURKE RE, 1968, J PHYSIOL-LONDON, V196, P605, DOI 10.1113/jphysiol.1968.sp008526; CALANCIE B, 1993, ELECTROEN CLIN NEURO, V89, P177, DOI 10.1016/0168-5597(93)90131-8; CAPADAY C, 1986, J NEUROSCI, V6, P1308; Capogrosso M, 2016, NATURE, V539, P284, DOI 10.1038/nature20118; Capogrosso M, 2013, J NEUROSCI, V33, P19326, DOI 10.1523/JNEUROSCI.1688-13.2013; Carhart MR, 2004, IEEE T NEUR SYS REH, V12, P32, DOI 10.1109/TNSRE.2003.822763; Cole J., 1995, PRIDE DAILY MARATHON; COLLINS WF, 1984, J NEUROPHYSIOL, V52, P980, DOI 10.1152/jn.1984.52.5.980; CONWAY BA, 1987, EXP BRAIN RES, V68, P643; Courtine GG, 2007, J PHYSIOL-LONDON, V582, P1125, DOI 10.1113/jphysiol.2007.128447; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Dietz V, 2000, GAIT POSTURE, V11, P102, DOI 10.1016/S0966-6362(99)00052-1; Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; Dy CJ, 2010, J NEUROPHYSIOL, V103, P2808, DOI 10.1152/jn.00316.2009; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; Gerasimenko YP, 2006, J NEUROSCI METH, V157, P253, DOI 10.1016/j.jneumeth.2006.05.004; Gill ML, 2018, NAT MED, V24, P1677, DOI 10.1038/s41591-018-0175-7; Han J, 2016, J SPORT HEALTH SCI, V5, P80, DOI 10.1016/j.jshs.2014.10.004; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; HARRISON PJ, 1981, J PHYSIOL-LONDON, V312, P455, DOI 10.1113/jphysiol.1981.sp013638; Herman R, 2002, SPINAL CORD, V40, P65, DOI 10.1038/sj.sc.3101263; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HNIK P, 1973, PFLUG ARCH EUR J PHY, V341, P155, DOI 10.1007/BF00587322; Hultborn H, 2007, ACTA PHYSIOL, V189, P111, DOI 10.1111/j.1748-1716.2006.01651.x; HUNTER JP, 1994, J PHYSIOL-LONDON, V474, P407, DOI 10.1113/jphysiol.1994.sp020032; ISHIKAWA K, 1966, EXP NEUROL, V15, P140, DOI 10.1016/0014-4886(66)90039-2; Johnson WL, 2008, J BIOMECH, V41, P610, DOI 10.1016/j.jbiomech.2007.10.004; Johnson WL, 2011, IEEE T BIO-MED ENG, V58, P3328, DOI 10.1109/TBME.2011.2106784; Kiehn O, 2016, NAT REV NEUROSCI, V17, P224, DOI 10.1038/nrn.2016.9; KOERBER HR, 1991, J NEUROPHYSIOL, V65, P1313, DOI 10.1152/jn.1991.65.6.1313; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; MENDELL LM, 1971, J NEUROPHYSIOL, V34, P171, DOI 10.1152/jn.1971.34.1.171; Mignardot JB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3621; Minassian K, 2007, HUM MOVEMENT SCI, V26, P275, DOI 10.1016/j.humov.2007.01.005; Minassian K, 2004, SPINAL CORD, V42, P401, DOI 10.1038/sj.sc.3101615; Moraud EM, 2016, NEURON, V89, P814, DOI 10.1016/j.neuron.2016.01.009; MUNSON JB, 1980, J NEUROPHYSIOL, V44, P713, DOI 10.1152/jn.1980.44.4.713; Musienko P, 2012, J NEUROPHYSIOL, V107, P2072, DOI 10.1152/jn.00730.2011; Park SW, 2008, NEUROREHAB NEURAL RE, V22, P486, DOI 10.1177/1545968308316906; Prochazka A, 1999, PROG BRAIN RES, V123, P133, DOI 10.1016/S0079-6123(08)62850-2; Prochazka A., 1996, COMPR PHYSL, V76, P125; Prochazka A, 2007, INTEGR COMP BIOL, V47, P474, DOI 10.1093/icb/icm065; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Rattay F, 2000, SPINAL CORD, V38, P473, DOI 10.1038/sj.sc.3101039; Restuccia D, 2000, J NEUROL NEUROSUR PS, V69, P91, DOI 10.1136/jnnp.69.1.91; Roll JP, 2004, EXP BRAIN RES, V157, P359, DOI 10.1007/s00221-004-1853-x; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Saal HP, 2015, NEUROPSYCHOLOGIA, V79, P344, DOI 10.1016/j.neuropsychologia.2015.06.010; SANES JN, 1985, HUM NEUROBIOL, V4, P101; Schindler-Ivens S, 2000, EXP BRAIN RES, V133, P233, DOI 10.1007/s002210000377; SEGEV I, 1990, J NEUROPHYSIOL, V64, P648, DOI 10.1152/jn.1990.64.2.648; SU CF, 1992, SPINE, V17, P504, DOI 10.1097/00007632-199205000-00006; Takeoka A, 2014, CELL, V159, P1626, DOI 10.1016/j.cell.2014.11.019; Tuthill JC, 2018, CURR BIOL, V28, pR194, DOI 10.1016/j.cub.2018.01.064; VALLBO AB, 1990, J PHYSIOL-LONDON, V421, P553, DOI 10.1113/jphysiol.1990.sp017961; Vallery H., 2013, IEEE INT C REH ROB, V2013; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Wagner F., 2018, NATURE, DOI [10.1038/s41593-018-0262-6, DOI 10.1038/S41593-018-0262-6]; Wenger N, 2016, NAT MED, V22, P138, DOI 10.1038/nm.4025; Wenger N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008325; Wojtusch J, 2015, IEEE-RAS INT C HUMAN, P74, DOI 10.1109/HUMANOIDS.2015.7363534	70	142	148	6	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2018	21	12					1728	+		10.1038/s41593-018-0262-6	http://dx.doi.org/10.1038/s41593-018-0262-6			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB8GE	30382196	Green Accepted, Green Submitted			2022-12-17	WOS:000451324700011
J	Padilla, SL; Qiu, J; Soden, ME; Sanz, E; Nestor, CC; Barker, FD; Quintana, A; Zweifel, LS; Ronnekleiv, OK; Kelly, MJ; Palmiter, RD				Padilla, Stephanie L.; Qiu, Jian; Soden, Marta E.; Sanz, Elisenda; Nestor, Casey C.; Barker, Forrest D.; Quintana, Albert; Zweifel, Larry S.; Ronnekleiv, Oline K.; Kelly, Martin J.; Palmiter, Richard D.			Agouti-related peptide neural circuits mediate adaptive behaviors in the starved state	NATURE NEUROSCIENCE			English	Article							POMC-EXPRESSING PROGENITORS; RAT THALAMIC NEURONS; PREDATION RISK; MESSENGER-RNA; HYPOTHALAMIC NEURONS; ESTROGEN-RECEPTOR; FORAGING BEHAVIOR; FEEDING CIRCUITS; ARCUATE NUCLEUS; Y-RECEPTORS	In the face of starvation, animals will engage in high-risk behaviors that would normally be considered maladaptive. Starving rodents, for example, will forage in areas that are more susceptible to predators and will also modulate aggressive behavior within a territory of limited or depleted nutrients. The neural basis of these adaptive behaviors likely involves circuits that link innate feeding, aggression and fear. Hypothalamic agouti-related peptide (AgRP)-expressing neurons are critically important for driving feeding and project axons to brain regions implicated in aggression and fear. Using circuit-mapping techniques in mice, we define a disynaptic network originating from a subset of AgRP neurons that project to the medial nucleus of the amygdala and then to the principal bed nucleus of the stria terminalis, which suppresses territorial aggression and reduces contextual fear. We propose that AgRP neurons serve as a master switch capable of coordinating behavioral decisions relative to internal state and environmental cues.	[Padilla, Stephanie L.; Barker, Forrest D.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Qiu, Jian; Nestor, Casey C.; Ronnekleiv, Oline K.; Kelly, Martin J.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Soden, Marta E.; Zweifel, Larry S.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Soden, Marta E.; Zweifel, Larry S.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Sanz, Elisenda; Quintana, Albert] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Sanz, Elisenda; Quintana, Albert] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, E-08193 Barcelona, Spain; [Ronnekleiv, Oline K.; Kelly, Martin J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Autonomous University of Barcelona; Autonomous University of Barcelona; Oregon Health & Science University; Oregon National Primate Research Center	Padilla, SL (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	slp23@uw.edu	Zweifel, Larry/O-3284-2017; Sanz, Elisenda/I-2765-2015; Quintana, Albert/N-5544-2015	Zweifel, Larry/0000-0003-3465-5331; Sanz, Elisenda/0000-0002-7932-8556; Nestor, Casey/0000-0001-5939-2131; Soden, Marta/0000-0002-0695-8653; Quintana, Albert/0000-0003-1674-7160	Hilda Preston Davis Foundation; US National Institutes of Health [R01DK068098, R01NS038809, R01MH094536, R01DA024908]; Marie Sklodowska-Curie award [H2020-MSCA-IF-2014-658352]; Ramon y Cajal fellowship [RyC-2012-11873]; European Research Council Starting Grant NEUROMITO [ERC-2014-StG-638106]; MINECO Proyectos I+D de Excelencia [SAF2014-57981P]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024908] Funding Source: NIH RePORTER	Hilda Preston Davis Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Sklodowska-Curie award; Ramon y Cajal fellowship(Spanish Government); European Research Council Starting Grant NEUROMITO; MINECO Proyectos I+D de Excelencia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Kafer and M. Chiang for technical assistance generating the new line of mice and maintaining the mouse colonies. We thank M. A. Patterson and B. C. Jarvie for careful reading of this paper and the entire Palmiter laboratory for discussions and critiques. We thank D.J. Anderson and L. Lo (Caltech) for generously providing H129 Delta-fs-TK-TT. We thank E. Strakbein at U.W. Scientific Instruments for the development of tools and apparatus used in this manuscript. This work was supported by funds from the Hilda Preston Davis Foundation (S.L.P.), the US National Institutes of Health (R01DK068098, R01NS038809, M.J.K. and O.K.R.; R01MH094536, L.S.Z.; R01DA024908, R.D.P.), a Marie Sklodowska-Curie award (H2020-MSCA-IF-2014-658352, E.S.), a Ramon y Cajal fellowship (RyC-2012-11873, A.Q.), European Research Council Starting Grant NEUROMITO (ERC-2014-StG-638106, A.Q.) and MINECO Proyectos I+D de Excelencia (SAF2014-57981P, A.Q.).	ANDERSON PK, 1986, CAN J ZOOL, V64, P2645, DOI 10.1139/z86-384; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Bian XL, 2013, BRAIN RES, V1509, P8, DOI 10.1016/j.brainres.2013.03.012; Bosch MA, 2013, MOL CELL ENDOCRINOL, V367, P85, DOI 10.1016/j.mce.2012.12.021; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Brown J. L., 1964, Wilson Bulletin, V76, P160; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Dietrich MO, 2015, CELL, V160, P1222, DOI 10.1016/j.cell.2015.02.024; Gore B.B., 2013, CURR PROTOC NEUROSCI, V65, P4; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Han S, 2015, CELL, V162, P363, DOI 10.1016/j.cell.2015.05.057; Heimer-McGinn V, 2013, NEUROSCI LETT, V555, P36, DOI 10.1016/j.neulet.2013.09.007; Hong WZ, 2014, CELL, V158, P1348, DOI 10.1016/j.cell.2014.07.049; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Kennedy A, 2014, COLD SH Q B, V79, P199, DOI 10.1101/sqb.2014.79.024984; Keshavarzi S, 2014, J NEUROSCI, V34, P8699, DOI 10.1523/JNEUROSCI.1176-14.2014; King BM, 2003, AM J PHYSIOL-REG I, V284, pR965, DOI 10.1152/ajpregu.00249.2002; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; KOHLER SL, 1989, ECOLOGY, V70, P1811, DOI 10.2307/1938114; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; KREBS JR, 1980, ARDEA, V68, P83; Laundre JW, 2014, SCIENCE, V346, P33, DOI 10.1126/science.1260170; Pereno GL, 2011, J PHYSIOL BIOCHEM, V67, P71, DOI 10.1007/s13105-010-0051-5; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Liu J, 2013, INT J NEUROPSYCHOPH, V16, P105, DOI 10.1017/S146114571100174X; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; MAGNHAGEN C, 1988, CAN J FISH AQUAT SCI, V45, P592, DOI 10.1139/f88-072; Niimi K, 2012, BRAIN RES, V1480, P41, DOI 10.1016/j.brainres.2012.08.050; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Qiu J, 2003, J NEUROSCI, V23, P9529; Sanz E, 2015, J NEUROSCI, V35, P5549, DOI 10.1523/JNEUROSCI.3614-14.2015; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stowers L, 2013, CURR OPIN NEUROBIOL, V23, P339, DOI 10.1016/j.conb.2013.01.007; Sun QQ, 2001, J PHYSIOL-LONDON, V531, P81, DOI 10.1111/j.1469-7793.2001.0081j.x; Sun QQ, 2001, J PHYSIOL-LONDON, V531, P67, DOI 10.1111/j.1469-7793.2001.0067j.x; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Whitham J, 2000, J CHEM ECOL, V26, P1659, DOI 10.1023/A:1005590913680; Xu PW, 2015, J CLIN INVEST, V125, P2861, DOI 10.1172/JCI80941	54	142	144	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2016	19	5					734	+		10.1038/nn.4274	http://dx.doi.org/10.1038/nn.4274			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK2RM	27019015	Green Accepted			2022-12-17	WOS:000374762100013
J	Wheeler, MA; Smith, CJ; Ottolini, M; Barker, BS; Purohit, AM; Grippo, RM; Gaykema, RP; Spano, AJ; Beenhakker, MP; Kucenas, S; Patel, MK; Deppmann, CD; Guler, AD				Wheeler, Michael A.; Smith, Cody J.; Ottolini, Matteo; Barker, Bryan S.; Purohit, Aarti M.; Grippo, Ryan M.; Gaykema, Ronald P.; Spano, Anthony J.; Beenhakker, Mark P.; Kucenas, Sarah; Patel, Manoj K.; Deppmann, Christopher D.; Guler, Ali D.			Genetically targeted magnetic control of the nervous system	NATURE NEUROSCIENCE			English	Article							ION CHANNELS; NEURAL CIRCUITS; REMOTE-CONTROL; NEURONS; TRPV4; MICE; NANOPARTICLES; ACTIVATION; ZEBRAFISH; RECEPTOR	Optogenetic and chemogenetic actuators are critical for deconstructing the neural correlates of behavior. However, these tools have several limitations, including invasive modes of stimulation or slow on/off kinetics. We have overcome these disadvantages by synthesizing a single-component, magnetically sensitive actuator, "Magneto," comprising the cation channel TRPV4 fused to the paramagnetic protein ferritin. We validated noninvasive magnetic control over neuronal activity by demonstrating remote stimulation of cells using in vitro calcium imaging assays, electrophysiological recordings in brain slices, in vivo electrophysiological recordings in the brains of freely moving mice, and behavioral outputs in zebrafish and mice. As proof of concept, we used Magneto to delineate a causal role of striatal dopamine receptor 1 neurons in mediating reward behavior in mice. Together our results present Magneto as an actuator capable of remotely controlling circuits associated with complex animal behaviors.	[Wheeler, Michael A.; Smith, Cody J.; Purohit, Aarti M.; Grippo, Ryan M.; Spano, Anthony J.; Kucenas, Sarah; Deppmann, Christopher D.; Guler, Ali D.] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Wheeler, Michael A.; Barker, Bryan S.] Univ Virginia, Neurosci Grad Program, Charlottesville, VA USA; [Ottolini, Matteo; Barker, Bryan S.; Gaykema, Ronald P.; Patel, Manoj K.] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA; [Beenhakker, Mark P.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Kucenas, Sarah; Deppmann, Christopher D.] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA; [Deppmann, Christopher D.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Guler, AD (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA USA.	aguler@virginia.edu		Guler, Ali Deniz/0000-0001-8218-850X	US National Institutes of Health (NIH) National Center for Research Resources [RR025616]; NIH National Institute of General Medical Sciences (NIGMS) [5T32GM008328]; NIH NIGMS [5T32GM008136]; Neuroscience Center of Excellence fellowship; Wagner Fellowship; NIH National Institute of Neurological Disorders and Stroke (NINDS) [F32NS087791]; NIH NINDS [R01NS072212, R01NS075157, R01NS072388]; UVa startup funds; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008328, T32GM008136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072212, R01NS072388, R01NS075157, F32NS087791] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Neuroscience Center of Excellence fellowship; Wagner Fellowship; NIH National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); UVa startup funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Condron, Beenhakker, Kucenas, Patel, Deppmann and Guler labs for comments and suggestions. In particular, we are thankful for technical assistance provided by A. Morris, P. Neff, A. Rainwater and S. Young. We are thankful for comments on the manuscript from M. Caterina, I. Cheng, B. Condron, K. Gamage and I. Provencio. We acknowledge the UVa Keck Center for Cellular Imaging staff for use of the Leica confocal microscopy system, supported by US National Institutes of Health (NIH) National Center for Research Resources RR025616. This work was supported by NIH National Institute of General Medical Sciences (NIGMS) 5T32GM008328, NIH NIGMS 5T32GM008136, a Neuroscience Center of Excellence fellowship and a Wagner Fellowship (M.A.W.); NIH National Institute of Neurological Disorders and Stroke (NINDS) F32NS087791 (C.J.S.); NIH NINDS R01NS072212 (S.K.); NIH NINDS R01NS075157 (M.K.P.); NIH NINDS R01NS072388 (C.D.D.); and UVa startup funds (A.D.G.).	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Bernstein JG, 2012, CURR OPIN NEUROBIOL, V22, P61, DOI 10.1016/j.conb.2011.10.023; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chen R, 2015, SCIENCE, V347, P1477, DOI 10.1126/science.1261821; Chen SJ, 2016, NAT METHODS, V13, P147, DOI [10.1038/NMETH.3691, 10.1038/nmeth.3691]; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Gore BB, 2013, J NEUROSCI, V33, P8640, DOI 10.1523/JNEUROSCI.5532-12.2013; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Guler AD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1749; Guler AD, 2002, J NEUROSCI, V22, P6408; Hargus NJ, 2013, J NEUROPHYSIOL, V110, P1144, DOI 10.1152/jn.00383.2013; HERSCH SM, 1995, J NEUROSCI, V15, P5222; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Huang H, 2010, NAT NANOTECHNOL, V5, P602, DOI [10.1038/NNANO.2010.125, 10.1038/nnano.2010.125]; Hughes S, 2008, J R SOC INTERFACE, V5, P855, DOI 10.1098/rsif.2007.1274; Iordanova B, 2010, J BIOL INORG CHEM, V15, P957, DOI 10.1007/s00775-010-0657-7; Jeong JW, 2015, CELL, V162, P662, DOI 10.1016/j.cell.2015.06.058; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lei L, 2013, J BIOL CHEM, V288, P10427, DOI 10.1074/jbc.M113.457291; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Long XY, 2015, SCI BULL, V60, P2107, DOI 10.1007/s11434-015-0902-0; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Matthews BD, 2010, INTEGR BIOL-UK, V2, P435, DOI 10.1039/c0ib00034e; McFarland TJ, 2006, PLASMID, V56, P62, DOI 10.1016/j.plasmid.2005.11.005; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Quintana A, 2012, NAT NEUROSCI, V15, P1547, DOI 10.1038/nn.3239; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Smith CJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001961; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stanley S, 2014, CURR OPIN BIOTECH, V28, P69, DOI 10.1016/j.copbio.2013.11.014; Stanley SA, 2015, NAT MED, V21, P92, DOI 10.1038/nm.3730; Stanley SA, 2012, SCIENCE, V336, P604, DOI 10.1126/science.1216753; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Stuber GD, 2012, BIOL PSYCHIAT, V71, P1061, DOI 10.1016/j.biopsych.2011.11.010; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Wheeler MA, 2014, NEURON, V82, P587, DOI 10.1016/j.neuron.2014.04.009; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zengin-Toktas Y, 2013, NEUROPHARMACOLOGY, V70, P74, DOI 10.1016/j.neuropharm.2012.12.011	48	142	148	17	190	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2016	19	5					756	+		10.1038/nn.4265	http://dx.doi.org/10.1038/nn.4265			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK2RM	26950006	Green Accepted			2022-12-17	WOS:000374762100016
J	Roy, M; Shohamy, D; Daw, N; Jepma, M; Wimmer, GE; Wager, TD				Roy, Mathieu; Shohamy, Daphna; Daw, Nathaniel; Jepma, Marieke; Wimmer, G. Elliott; Wager, Tor D.			Representation of aversive prediction errors in the human periaqueductal gray	NATURE NEUROSCIENCE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; HUMAN BRAIN; DECISION-MAKING; HUMAN STRIATUM; FEAR; REWARD; AMYGDALA; PAIN; SYSTEM; MODEL	Pain is a primary driver of learning and motivated action. It is also a target of learning, as nociceptive brain responses are shaped by learning processes. We combined an instrumental pain avoidance task with an axiomatic approach to assessing fMRI signals related to prediction errors (PEs), which drive reinforcement-based learning. We found that pain PEs were encoded in the periaqueductal gray (PAG), a structure important for pain control and learning in animal models. Axiomatic tests combined with dynamic causal modeling suggested that ventromedial prefrontal cortex, supported by putamen, provides an expected value-related input to the PAG, which then conveys PE signals to prefrontal regions important for behavioral regulation, including orbitofrontal, anterior mid-cingulate and dorsomedial prefrontal cortices. Thus, pain-related learning involves distinct neural circuitry, with implications for behavior and pain dynamics.	[Roy, Mathieu; Jepma, Marieke; Wager, Tor D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Roy, Mathieu] Concordia Univ, PERFORM Ctr, Montreal, PQ, Canada; [Shohamy, Daphna; Wimmer, G. Elliott] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Daw, Nathaniel] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Wimmer, G. Elliott] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	University of Colorado System; University of Colorado Boulder; Concordia University - Canada; Columbia University; New York University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wager, TD (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	tor.wager@colorado.edu	Wimmer, G. Elliott/AAJ-8537-2020; Roy, Mathieu/H-1963-2017	Wimmer, G. Elliott/0000-0002-2227-119X; JEPMA, MARIEKE/0000-0002-7903-0135	US National Institutes of Health [R01DA035484, R01MH076136]; Canadian Institute of Health Research; Fonds de Recherche en Sante du Quebec; James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035484, R01DA027794] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank D. Abraham and A. Pingree for help with data collection and A. Krishnan, L. Schmidt and L. Atlas for help with data analyses. This work was supported by a grant from the US National Institutes of Health to T.D.W. (R01DA035484 and R01MH076136) and by Canadian Institute of Health Research and Fonds de Recherche en Sante du Quebec fellowships to M.R. N.D. was supported by a Scholar Award from the James S. McDonnell Foundation.	Attar CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042397; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Beissner F, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00116; Boll S, 2013, EUR J NEUROSCI, V37, P758, DOI 10.1111/ejn.12094; Brooks AM, 2013, TRENDS COGN SCI, V17, P281, DOI 10.1016/j.tics.2013.04.001; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; Buhle JT, 2013, SOC COGN AFFECT NEUR, V8, P609, DOI 10.1093/scan/nss038; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Daw N. D., 2011, DECISION MAKING AFFE, VXXIII, DOI [10.1093/acprof:oso/9780199600434.003.0001, DOI 10.1093/ACPROF:OSO/9780199600434.003.0001]; Delgado MR, 2008, PHILOS T R SOC B, V363, P3787, DOI 10.1098/rstb.2008.0161; Gallistel CR, 2009, PSYCHOL REV, V116, P439, DOI 10.1037/a0015251; Garrison J, 2013, NEUROSCI BIOBEHAV R, V37, P1297, DOI 10.1016/j.neubiorev.2013.03.023; HERRERO MT, 1991, BRAIN RES, V543, P201, DOI 10.1016/0006-8993(91)90029-U; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Johansen JP, 2010, NAT NEUROSCI, V13, P979, DOI 10.1038/nn.2594; Keay KA, 2001, NEUROSCI BIOBEHAV R, V25, P669, DOI 10.1016/S0149-7634(01)00049-5; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Krasne FB, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00041; Li J, 2011, NAT NEUROSCI, V14, P1250, DOI 10.1038/nn.2904; Li JA, 2011, J NEUROSCI, V31, P5504, DOI 10.1523/JNEUROSCI.6316-10.2011; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; McNally GP, 2011, TRENDS NEUROSCI, V34, P283, DOI 10.1016/j.tins.2011.03.005; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Niv Y, 2012, J NEUROSCI, V32, P551, DOI 10.1523/JNEUROSCI.5498-10.2012; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Price JL, 2007, ANN NY ACAD SCI, V1121, P54, DOI 10.1196/annals.1401.008; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Reynolds SM, 2008, NAT NEUROSCI, V11, P423, DOI 10.1038/nn2061; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Rutledge RB, 2010, J NEUROSCI, V30, P13525, DOI 10.1523/JNEUROSCI.1747-10.2010; Satpute AB, 2013, P NATL ACAD SCI USA, V110, P17101, DOI 10.1073/pnas.1306095110; Schiller D, 2008, J NEUROSCI, V28, P11517, DOI 10.1523/JNEUROSCI.2265-08.2008; Schmidt L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001266; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; Seymour B, 2012, J NEUROSCI, V32, P5833, DOI 10.1523/JNEUROSCI.0053-12.2012; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Stephan KE, 2007, J BIOSCIENCES, V32, P129, DOI 10.1007/s12038-007-0012-5; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Wager TD, 2009, NEUROIMAGE, V47, P836, DOI 10.1016/j.neuroimage.2009.05.044; Wimmer GE, 2012, EUR J NEUROSCI, V35, P1092, DOI 10.1111/j.1460-9568.2012.08017.x; Wunderlich K, 2012, NAT NEUROSCI, V15, P786, DOI 10.1038/nn.3068; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006	48	142	143	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2014	17	11					1607	1612		10.1038/nn.3832	http://dx.doi.org/10.1038/nn.3832			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS0LT	25282614	Green Accepted			2022-12-17	WOS:000343969300027
J	Proville, RD; Spolidoro, M; Guyon, N; Dugue, GP; Selimi, F; Isope, P; Popa, D; Lena, C				Proville, Remi D.; Spolidoro, Maria; Guyon, Nicolas; Dugue, Guillaume P.; Selimi, Fekrije; Isope, Philippe; Popa, Daniela; Lena, Clement			Cerebellum involvement in cortical sensorimotor circuits for the control of voluntary movements	NATURE NEUROSCIENCE			English	Article							MOTOR CORTEX; DISCRIMINATION RATHER; SENSORY ACQUISITION; INTERNAL-MODELS; MOSSY FIBER; ORGANIZATION; PROJECTIONS; TOPOGRAPHY; NEURONS; NUCLEI	Sensorimotor integration is crucial to perception and motor control. How and where this process takes place in the brain is still largely unknown. Here we analyze the cerebellar contribution to sensorimotor integration in the whisker system of mice. We identify an area in the cerebellum where cortical sensory and motor inputs converge at the cellular level. Optogenetic stimulation of this area affects thalamic and motor cortex activity, alters parameters of ongoing movements and thereby modifies qualitatively and quantitatively touch events against surrounding objects. These results shed light on the cerebellum as an active component of sensorimotor circuits and show the importance of sensorimotor cortico-cerebellar loops in the fine control of voluntary movements.	[Proville, Remi D.; Spolidoro, Maria; Guyon, Nicolas; Dugue, Guillaume P.; Popa, Daniela; Lena, Clement] Ecole Normale Super, Inst Biol, F-75231 Paris, France; [Proville, Remi D.; Spolidoro, Maria; Guyon, Nicolas; Dugue, Guillaume P.; Popa, Daniela; Lena, Clement] CNRS, UMR8197, Paris, France; [Proville, Remi D.; Spolidoro, Maria; Guyon, Nicolas; Dugue, Guillaume P.; Popa, Daniela; Lena, Clement] INSERM, U1024, Paris, France; [Selimi, Fekrije] Coll France, Ctr Interdisciplinary Res Biol, F-75231 Paris, France; [Selimi, Fekrije] CNRS, UMR7241, Paris, France; [Selimi, Fekrije] INSERM, U1050, Paris, France; [Isope, Philippe] Univ Strasbourg, Inst Neurosci Cellulaires & Integrat, CNRS, UPR 3212, Strasbourg, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lena, C (corresponding author), Ecole Normale Super, Inst Biol, 24 Rue Lhomond, F-75231 Paris, France.	daniela.popa@ens.fr; clement.lena@ens.fr	Léna, Clément/P-6929-2019; Léna, Clément/T-8458-2018; Guyon, Nicolas/AAP-9247-2021; , clement/ADN-8076-2022; Léna, Clément/ABE-4862-2021	Léna, Clément/0000-0002-1431-7717; Léna, Clément/0000-0002-1431-7717; Léna, Clément/0000-0002-1431-7717; Popa, Daniela/0000-0002-8389-1122; Isope, Philippe/0000-0002-0630-5935; Guyon, Nicolas/0000-0003-1287-8606; Proville, Remi/0000-0002-5829-1344	France's Agence Nationale de la Recherche [ANR-09-MNPS-38, ANR-11-BSV4-028 01, ANR-12-BSV4-0027]; France's Centre National de la Recherche Scientifique (CNRS); France's Institut National de la Sante et de la Recherche Medicale (INSERM); Ecole Normale Superieure (ENS); Fondation pour la recherche medicale [FRM - FDT20120925324]; Labex Memolife; European Union; French Government; PSL* Research University [ANR: ANR-10-LABX-54 MEMO LIFE, ANR-10-LABX-0087 IEC, ANR-11-IDEX-0001-02]	France's Agence Nationale de la Recherche(French National Research Agency (ANR)); France's Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); France's Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ecole Normale Superieure (ENS); Fondation pour la recherche medicale(Fondation pour la Recherche Medicale); Labex Memolife; European Union(European Commission); French Government; PSL* Research University	This work was supported by France's Agence Nationale de la Recherche (ANR-09-MNPS-38, ANR-11-BSV4-028 01, ANR-12-BSV4-0027), France's Centre National de la Recherche Scientifique (CNRS), France's Institut National de la Sante et de la Recherche Medicale (INSERM; C.L., D.P.), the Ecole Normale Superieure (ENS), the Fondation pour la recherche medicale (FRM - FDT20120925324, R.D.P.), Labex Memolife (R.D.P.) and the European Union (CBTOUCH-FP7-People-2011-IEF, M.S.). We are grateful to B. Barbour, V. Ego-Stengel, D. Shulz, L. Bourdieu and J.-F. Leger for careful reading of the manuscript. We thank G. Paresys, Y. Cabirou and B. Mathieu for excellent technical assistance and A. Boudet for help with the autofluorescence video acquisition. This work received support under the program "Investissements d'Avenir" launched by the French Government and implemented by the ANR: ANR-10-LABX-54 MEMO LIFE, ANR-10-LABX-0087 IEC, ANR-11-IDEX-0001-02 PSL* Research University.	ALLEN GI, 1974, PHYSIOL REV, V54, P957, DOI 10.1152/physrev.1974.54.4.957; Alloway KD, 2008, CEREB CORTEX, V18, P979, DOI 10.1093/cercor/bhm138; Anderson SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044560; ANDERSSON G, 1984, NEUROSCI LETT, V46, P47, DOI 10.1016/0304-3940(84)90197-6; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Aumann TD, 1998, J COMP NEUROL, V396, P121, DOI 10.1002/(SICI)1096-9861(19980622)396:1<121::AID-CNE9>3.0.CO;2-2; Bosman LWJ, 2010, J PHYSIOL-LONDON, V588, P3757, DOI 10.1113/jphysiol.2010.195180; Boubenec Y, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00074; Cerminara NL, 2009, J PHYSIOL-LONDON, V587, P429, DOI 10.1113/jphysiol.2008.163337; Chaumont J, 2013, P NATL ACAD SCI USA, V110, P16223, DOI 10.1073/pnas.1302310110; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; FUTAMI T, 1986, Neuroscience Research, V3, P321, DOI 10.1016/0168-0102(86)90024-6; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; Grant RA, 2009, J NEUROPHYSIOL, V101, P862, DOI 10.1152/jn.90783.2008; Haiss F, 2005, J NEUROSCI, V25, P1579, DOI 10.1523/JNEUROSCI.3760-04.2005; Herculano-Houzel S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00012; Holdefer RN, 2000, J NEUROPHYSIOL, V84, P585, DOI 10.1152/jn.2000.84.1.585; Holtzman T, 2009, EUR J NEUROSCI, V29, P328, DOI 10.1111/j.1460-9568.2008.06572.x; Huang CC, 2013, ELIFE, V2, DOI 10.7554/eLife.00400; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Jenkinson EW, 2000, J NEUROPHYSIOL, V84, P1781, DOI 10.1152/jn.2000.84.4.1781; Jorntell H, 1999, J PHYSIOL-LONDON, V514, P551, DOI 10.1111/j.1469-7793.1999.551ae.x; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kleinfeld D, 2011, NEURON, V72, P455, DOI 10.1016/j.neuron.2011.10.009; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Lang EJ, 2006, J PHYSIOL-LONDON, V571, P101, DOI 10.1113/jphysiol.2005.102764; Leergaard TB, 2004, J COMP NEUROL, V478, P306, DOI 10.1002/cne.20289; Leergaard TB, 2007, FRONT NEUROSCI-SWITZ, V1, P211, DOI 10.3389/neuro.01.1.1.016.2007; Liu XG, 2003, J NEUROPHYSIOL, V89, P1223, DOI 10.1152/jn.00817.2002; Lu XF, 2007, EUR J NEUROSCI, V25, P2374, DOI 10.1111/j.1460-9568.2007.05482.x; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Morissette J, 1996, EXP BRAIN RES, V109, P240; Na J, 1997, NEUROSCI RES, V28, P77, DOI 10.1016/S0168-0102(97)00031-X; O'Connor SM, 2002, J NEUROPHYSIOL, V87, P2137, DOI 10.1152/jn.00229.2001; Odeh F, 2005, J NEUROSCI, V25, P5680, DOI 10.1523/JNEUROSCI.0558-05.2005; Parsons LM, 1997, LEARN MEMORY, V4, P49, DOI 10.1101/lm.4.1.49; Popa D, 2013, J NEUROSCI, V33, P6552, DOI 10.1523/JNEUROSCI.5521-12.2013; Reinert KC, 2004, J NEUROPHYSIOL, V92, P199, DOI 10.1152/jn.01275.2003; Rowland NC, 2010, NEUROSCIENCE, V166, P698, DOI 10.1016/j.neuroscience.2009.12.048; SASAKI K, 1976, EXP BRAIN RES, V24, P495; SCHWARZ C, 1995, J NEUROSCI, V15, P3475; Sugihara I, 2007, J NEUROSCI, V27, P9696, DOI 10.1523/JNEUROSCI.1579-07.2007; Sultan F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1912; Suzuki L, 2012, J NEUROSCI, V32, P10854, DOI 10.1523/JNEUROSCI.0857-12.2012; Teune TM, 2000, PROG BRAIN RES, V124, P141; Van Dijck G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057669; Voogd J, 2004, J NEUROCYTOL, V33, P5, DOI 10.1023/B:NEUR.0000029645.72074.2b; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; WOOLSTON DC, 1981, BRAIN RES, V209, P255, DOI 10.1016/0006-8993(81)90152-9	50	142	144	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2014	17	9					1233	1239		10.1038/nn.3773	http://dx.doi.org/10.1038/nn.3773			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO2DJ	25064850				2022-12-17	WOS:000341125400017
J	Shenhav, A; Straccia, MA; Cohen, JD; Botvinick, MM				Shenhav, Amitai; Straccia, Mark A.; Cohen, Jonathan D.; Botvinick, Matthew M.			Anterior cingulate engagement in a foraging context reflects choice difficulty, not foraging value	NATURE NEUROSCIENCE			English	Article							DECISION-MAKING; FRONTAL-CORTEX; NEURAL BASIS; CONFLICT; ERROR; SIGNALS; COMPETITION; SURPRISE; TASK; TIME	Previous theories predict that human dorsal anterior cingulate (dACC) should respond to decision difficulty. An alternative theory has been recently advanced that proposes that dACC evolved to represent the value of 'non-default', foraging behavior, calling into question its role in choice difficulty. However, this new theory does not take into account that choosing whether or not to pursue foraging-like behavior can also be more difficult than simply resorting to a default. The results of two neuroimaging experiments show that dACC is only associated with foraging value when foraging value is confounded with choice difficulty; when the two are dissociated, dACC engagement is only explained by choice difficulty, and not the value of foraging. In addition to refuting this new theory, our studies help to formalize a fundamental connection between choice difficulty and foraging-like decisions, while also prescribing a solution for a common pitfall in studies of reward-based decision making.	[Shenhav, Amitai; Straccia, Mark A.; Cohen, Jonathan D.; Botvinick, Matthew M.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Shenhav, Amitai; Straccia, Mark A.; Cohen, Jonathan D.; Botvinick, Matthew M.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Shenhav, A (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	ashenhav@princeton.edu			C.V. Starr Foundation; National Institute of Mental Health [R01MH098815-01]; John Templeton Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098815] Funding Source: NIH RePORTER	C.V. Starr Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); John Templeton Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors are grateful to S. Feng for assistance in data analysis. This work is supported by the C.V. Starr Foundation (A.S.), the National Institute of Mental Health R01MH098815-01 (M.M.B.) and the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation.	Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Boorman ED, 2013, J NEUROSCI, V33, P2242, DOI 10.1523/JNEUROSCI.3022-12.2013; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bryden DW, 2011, J NEUROSCI, V31, P18266, DOI 10.1523/JNEUROSCI.4715-11.2011; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Garrison J, 2013, NEUROSCI BIOBEHAV R, V37, P1297, DOI 10.1016/j.neubiorev.2013.03.023; Grinband J, 2011, NEUROIMAGE, V57, P303, DOI 10.1016/j.neuroimage.2010.12.027; Hare TA, 2011, P NATL ACAD SCI USA, V108, P18120, DOI 10.1073/pnas.1109322108; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; Kolling N, 2014, NEURON, V81, P1190, DOI 10.1016/j.neuron.2014.01.033; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Milosavljevic M, 2010, JUDGM DECIS MAK, V5, P437; Mobbs D, 2013, J NEUROSCI, V33, P9866, DOI 10.1523/JNEUROSCI.2238-12.2013; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; Pearson JM, 2014, NEURON, V82, P950, DOI 10.1016/j.neuron.2014.04.037; Pochon JB, 2008, J NEUROSCI, V28, P3468, DOI 10.1523/JNEUROSCI.4195-07.2008; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Rushworth MFS, 2012, CURR OPIN NEUROBIOL, V22, P946, DOI 10.1016/j.conb.2012.04.011; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shenhav A, 2014, P NATL ACAD SCI USA, V111, P10978, DOI 10.1073/pnas.1405725111; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Stephens D.W., 1986, pi; Venkatraman V, 2012, EUR J NEUROSCI, V35, P1075, DOI 10.1111/j.1460-9568.2012.08009.x; Weissman DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062405; Wessel JR, 2012, J NEUROSCI, V32, P7528, DOI 10.1523/JNEUROSCI.6352-11.2012; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931	37	142	143	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2014	17	9					1249	1254		10.1038/nn.3771	http://dx.doi.org/10.1038/nn.3771			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO2DJ	25064851	Green Accepted, hybrid			2022-12-17	WOS:000341125400019
J	Yano, H; Baranov, SV; Baranova, OV; Kim, J; Pan, YC; Yablonska, S; Carlisle, DL; Ferrante, RJ; Kim, AH; Friedlander, RM				Yano, Hiroko; Baranov, Sergei V.; Baranova, Oxana V.; Kim, Jinho; Pan, Yanchun; Yablonska, Svitlana; Carlisle, Diane L.; Ferrante, Robert J.; Kim, Albert H.; Friedlander, Robert M.			Inhibition of mitochondrial protein import by mutant huntingtin	NATURE NEUROSCIENCE			English	Article							DEFECTIVE AXONAL-TRANSPORT; SYNAPTIC DEGENERATION; NEUROLOGICAL PHENOTYPE; ENERGY DEFICIT; DISEASE; AGGREGATION; DYSFUNCTION; DYNAMICS; MICE; ACCUMULATION	Mitochondrial dysfunction is associated with neuronal loss in Huntington's disease (HD), a neurodegenerative disease caused by an abnormal polyglutamine expansion in huntingtin (Htt). However, the mechanisms linking mutant Htt and mitochondrial dysfunction in HD remain unknown. We identify an interaction between mutant Htt and the TIM23 mitochondrial protein import complex. Remarkably, recombinant mutant Htt directly inhibited mitochondrial protein import in vitro. Furthermore, mitochondria from brain synaptosomes of presymptomatic HD model mice and from mutant Htt-expressing primary neurons exhibited a protein import defect, suggesting that deficient protein import is an early event in HD. The mutant Htt-induced mitochondrial import defect and subsequent neuronal death were attenuated by overexpression of TIM23 complex subunits, demonstrating that deficient mitochondrial protein import causes mutant Htt-induced neuronal death. Collectively, these findings provide evidence for a direct link between mutant Htt, mitochondrial dysfunction and neuronal pathology, with implications for mitochondrial protein import-based therapies in HD.	[Yano, Hiroko; Baranov, Sergei V.; Baranova, Oxana V.; Kim, Jinho; Yablonska, Svitlana; Carlisle, Diane L.; Ferrante, Robert J.; Friedlander, Robert M.] Univ Pittsburgh, Dept Neurol Surg, Neuroapoptosis Lab, Pittsburgh, PA 15260 USA; [Yano, Hiroko; Pan, Yanchun; Kim, Albert H.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA; [Yano, Hiroko; Kim, Albert H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Yano, Hiroko] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Kim, Albert H.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Friedlander, Robert M.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Friedlander, RM (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Neuroapoptosis Lab, Pittsburgh, PA 15260 USA.	friedlanderr@upmc.edu	Kim, Albert H./HGF-0057-2022; Friedlander, Robert M/A-2845-2016	Friedlander, Robert M/0000-0003-4423-9219	US National Institutes of Health [R01 NS039324, NS077748, K01 AG033724]; Huntington's Disease Society of America (Coalition for the Cure); Brain & Behavior Research Foundation (NARSAD Young Investigator Award); DSF Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG033724] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntington's Disease Society of America (Coalition for the Cure); Brain & Behavior Research Foundation (NARSAD Young Investigator Award); DSF Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to J.T. Greenamyre, B. Kristal, I.G. Stavrovskaya and members of the Friedlander laboratory for discussion and technical support. We thank M. Lesort for assistance generating recombinant GST-Httex1. This work was supported by US National Institutes of Health grants R01 NS039324 and NS077748 (to R.M.F.) and K01 AG033724 (to H.Y.), Huntington's Disease Society of America (Coalition for the Cure) (R.M.F.), the Brain & Behavior Research Foundation (NARSAD Young Investigator Award) (H.Y.) and the DSF Charitable Foundation (R.M.F.).	Acevedo-Torres K, 2009, DNA REPAIR, V8, P126, DOI 10.1016/j.dnarep.2008.09.004; Ahting U, 2009, BBA-BIOENERGETICS, V1787, P371, DOI 10.1016/j.bbabio.2008.12.001; Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Costa V, 2012, EMBO J, V31, P1853, DOI 10.1038/emboj.2012.65; Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Hersch S.M., 2012, MOVEMENT DISORD, P683; Johri A, 2012, BBA-MOL BASIS DIS, V1822, P664, DOI 10.1016/j.bbadis.2011.11.014; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li QA, 2010, P NATL ACAD SCI USA, V107, P21146, DOI 10.1073/pnas.1014862107; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MacKenzie JA, 2007, BBA-MOL BASIS DIS, V1772, P509, DOI 10.1016/j.bbadis.2006.12.002; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Milnerwood AJ, 2010, TRENDS NEUROSCI, V33, P513, DOI 10.1016/j.tins.2010.08.002; Mochel F, 2012, J BIOL CHEM, V287, P1361, DOI 10.1074/jbc.M111.309849; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P101, DOI 10.1016/j.bbadis.2011.10.016; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Vogtle FN, 2012, DEV CELL, V23, P234, DOI 10.1016/j.devcel.2012.07.018; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Yu ZX, 2003, J NEUROSCI, V23, P2193; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	46	142	147	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2014	17	6					822	831		10.1038/nn.3721	http://dx.doi.org/10.1038/nn.3721			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI1TO	24836077	Green Accepted			2022-12-17	WOS:000336638000018
J	Chen, Y; Wang, HB; Yoon, SO; Xu, XM; Hottiger, MO; Svaren, J; Nave, KA; Kim, HA; Olson, EN; Lu, QR				Chen, Ying; Wang, Haibo; Yoon, Sung Ok; Xu, Xiaomei; Hottiger, Michael O.; Svaren, John; Nave, Klaus A.; Kim, Haesun A.; Olson, Eric N.; Lu, Q. Richard			HDAC-mediated deacetylation of NF-kappa B is critical for Schwann cell myelination	NATURE NEUROSCIENCE			English	Article							PERIPHERAL-NERVE; DIFFERENTIATION; REMYELINATION; TRANSCRIPTION; RECEPTOR; GENES; MICE	Schwann cell myelination is tightly regulated by timely expression of key transcriptional regulators that respond to specific environmental cues, but the molecular mechanisms underlying such a process are poorly understood. We found that the acetylation state of NF-kappa B, which is regulated by histone deacetylases (HDACs) 1 and 2, is critical for orchestrating the myelination program. Mice lacking both HDACs 1 and 2 (HDAC1/2) exhibited severe myelin deficiency with Schwann cell development arrested at the immature stage. NF-kappa B p65 became heavily acetylated in HDAC1/2 mutants, inhibiting the expression of positive regulators of myelination and inducing the expression of differentiation inhibitors. We observed that the NF-.B protein complex switched from associating with p300 to associating with HDAC1/2 as Schwann cells differentiated. NF-kappa B and HDAC1/2 acted in a coordinated fashion to regulate the transcriptionally linked chromatin state for Schwann cell myelination. Thus, our results reveal an HDAC-mediated developmental switch for controlling myelination in the peripheral nervous system.	[Chen, Ying; Wang, Haibo; Xu, Xiaomei; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Chen, Ying; Wang, Haibo; Xu, Xiaomei; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA; [Yoon, Sung Ok] Ohio State Univ, Dept Mol & Cellular Biochem, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Hottiger, Michael O.] Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8001 Zurich, Switzerland; [Svaren, John] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Svaren, John] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Nave, Klaus A.] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Kim, Haesun A.] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; Ohio State University; University of Zurich; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society; Rutgers State University Newark; Rutgers State University New Brunswick	Lu, QR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	qrichard.lu@utsouthwestern.edu	Nave, Klaus-Armin/C-8883-2011; Yoon, Sung Ok/C-5992-2012; Svaren, John/A-1605-2010; Hottiger, Michael O./J-7747-2013	Svaren, John/0000-0003-2963-7921; Hottiger, Michael O./0000-0002-7323-2270	US National Institutes of Health [NS072427]; National Multiple Sclerosis Society [RG3978]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072427] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank D. Meijer for Dhh-cre mice, B. Carter and J. Chan for critical comments, and P. Casaccia for initial discussions. We thank Q. Weng and Z. Ma for technical support, O. Nakagawa and J. Chen for the p300/CBP and p65/RelA expression vectors, and R. Kageyama for the Hes5 luciferase reporter. This study was funded in part by grants from the US National Institutes of Health (NS072427) and the National Multiple Sclerosis Society (RG3978) to Q.R.L.	Antonellis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000174; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; He Y, 2010, NAT NEUROSCI, V13, P1472, DOI 10.1038/nn.2686; Jacob C, 2011, NAT NEUROSCI, V14, P429, DOI 10.1038/nn.2762; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jang SW, 2006, J NEUROCHEM, V98, P1678, DOI 10.1111/j.1471-4159.2006.04069.x; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nickols JC, 2003, NAT NEUROSCI, V6, P161, DOI 10.1038/nn995; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004	23	142	146	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					437	U59		10.1038/nn.2780	http://dx.doi.org/10.1038/nn.2780			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21423191	Green Accepted			2022-12-17	WOS:000288849400014
J	Azim, E; Jabaudon, D; Fame, RM; Macklis, JD				Azim, Eiman; Jabaudon, Denis; Fame, Ryann M.; Macklis, Jeffrey D.			SOX6 controls dorsal progenitor identity and interneuron diversity during neocortical development	NATURE NEUROSCIENCE			English	Article							RAT OCCIPITAL CORTEX; CEREBRAL-CORTEX; CORTICAL INTERNEURONS; IMMUNOREACTIVE NEURONS; MOUSE TELENCEPHALON; GENE SOX6; SPECIFICATION; EXPRESSION; MIGRATION; SUBTYPE	The neuronal diversity of the CNS emerges largely from controlled spatial and temporal segregation of cell type-specific molecular regulators. We found that the transcription factor SOX6 controls the molecular segregation of dorsal (pallial) from ventral (subpallial) telencephalic progenitors and the differentiation of cortical interneurons, regulating forebrain progenitor and interneuron heterogeneity. During corticogenesis in mice, SOX6 and SOX5 were largely mutually exclusively expressed in pallial and subpallial progenitors, respectively, and remained mutually exclusive in a reverse pattern in postmitotic neuronal progeny. Loss of SOX6 from pallial progenitors caused their inappropriate expression of normally subpallium-restricted developmental controls, conferring mixed dorsal-ventral identity. In postmitotic cortical interneurons, loss of SOX6 disrupted the differentiation and diversity of cortical interneuron subtypes, analogous to SOX5 control over cortical projection neuron development. These data indicate that SOX6 is a central regulator of both progenitor and cortical interneuron diversity during neocortical development.	[Azim, Eiman; Jabaudon, Denis; Fame, Ryann M.; Macklis, Jeffrey D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Neurosci, Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02115 USA; [Azim, Eiman; Jabaudon, Denis; Fame, Ryann M.; Macklis, Jeffrey D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Neurosci, Ctr Nervous Syst Repair,Dept Neurol, Boston, MA USA; [Azim, Eiman; Jabaudon, Denis; Fame, Ryann M.; Macklis, Jeffrey D.] Massachusetts Gen Hosp, Nayef Al Rodhan Labs, Boston, MA 02114 USA; [Azim, Eiman; Jabaudon, Denis; Fame, Ryann M.; Macklis, Jeffrey D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Azim, Eiman; Jabaudon, Denis; Fame, Ryann M.; Macklis, Jeffrey D.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Fame, Ryann M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Macklis, JD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Neurosci, Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02115 USA.	jeffrey_macklis@hms.harvard.edu	Jabaudon, Denis/B-8802-2014	Jabaudon, Denis/0000-0003-2438-4769; Fame, Ryann/0000-0002-8244-2624; Azim, Eiman/0000-0002-1015-1772	US National Institutes of Health [NS49553, NS45523, NS41590, F31 NS060421]; Travis Roy Foundation; Spastic Paraplegia Foundation; Massachusetts Spinal Cord Injury research program; Harvard Stem Cell Institute; Swiss National Science Foundation; Holcim Foundation; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS041590, F31NS060421, R01NS049553, R01NS045523, R01NS041590] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Travis Roy Foundation; Spastic Paraplegia Foundation; Massachusetts Spinal Cord Injury research program; Harvard Stem Cell Institute; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Holcim Foundation; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Billmers, A. Palmer, L. Pasquina, K. Quinn, D. Schuback, E. Sievert, A. Wheeler and T. Yamamoto for superb technical assistance, G. Fishell, R. BatistaBrito, G. Miyoshi, P. Arlotta, B. Molyneaux, H. Padmanabhan, F. Guillemot, Q. Ma, C. Cepko and L. Goodrich for helpful discussions and input, U. Berger for technical assistance with in situ hybridization, C. Lois, R. Hevner, V. Lefebvre, F. Guillemot, V. Pachnis and Y. Yanagawa for generously sharing mice, antibodies and reagents, and current and past members of our laboratory for helpful suggestions. This work was partially supported by grants from the US National Institutes of Health ( NS49553 and NS45523; additional infrastructure supported by NS41590), the Travis Roy Foundation, the Spastic Paraplegia Foundation, the Massachusetts Spinal Cord Injury research program, and the Harvard Stem Cell Institute to J. D. M., and by the Jane and Lee Seidman Fund for CNS Research, and the Emily and Robert Pearlstein Fund for Nervous System Repair. E. A. was partially supported by a US National Institutes of Health individual predoctoral National Research Service Award fellowship ( F31 NS060421). D. J. was partially supported by fellowships from the Swiss National Science Foundation and the Holcim Foundation. R. M. F. was partially supported by a National Science Foundation Graduate Research Fellowship.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Armijo JA, 2002, REV NEUROLOGIA, V34, P409, DOI 10.33588/rn.3405.2001404; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Batista-Brito R, 2008, CEREB CORTEX, V18, P2306, DOI 10.1093/cercor/bhm258; Britan A, 2006, SHOCK WAVES, V16, P1, DOI 10.1007/s00193-006-0019-0; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Carney RSE, 2006, J NEUROSCI, V26, P11562, DOI 10.1523/JNEUROSCI.3092-06.2006; CAVANAGH ME, 1988, J COMP NEUROL, V268, P1, DOI 10.1002/cne.902680102; CAVANAGH ME, 1990, J COMP NEUROL, V297, P553, DOI 10.1002/cne.902970408; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; CONNOR F, 1995, NUCLEIC ACIDS RES, V23, P3365, DOI 10.1093/nar/23.17.3365; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Du TG, 2008, DEVELOPMENT, V135, P1559, DOI 10.1242/dev.015123; Flames N, 2005, NEURON, V46, P377, DOI 10.1016/j.neuron.2005.04.020; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fode C, 2000, GENE DEV, V14, P67; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Joshi PS, 2008, NEURON, V60, P258, DOI 10.1016/j.neuron.2008.08.006; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Ma QF, 1997, J NEUROSCI, V17, P3644; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Molnar Z, 2002, BIOESSAYS, V24, P530, DOI 10.1002/bies.10100; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Narahara M, 2002, BIOL PHARM BULL, V25, P705, DOI 10.1248/bpb.25.705; Nobrega-Pereira S, 2008, NEURON, V59, P733, DOI 10.1016/j.neuron.2008.07.024; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wonders CP, 2008, DEV BIOL, V314, P127, DOI 10.1016/j.ydbio.2007.11.018; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Zhao Y, 2008, J COMP NEUROL, V510, P79, DOI 10.1002/cne.21772	49	142	144	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1238	U51		10.1038/nn.2387	http://dx.doi.org/10.1038/nn.2387			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19657336	Green Accepted, Green Submitted			2022-12-17	WOS:000270170200012
J	Dean, C; Liu, HS; Dunning, FM; Chang, PY; Jackson, MB; Chapman, ER				Dean, Camin; Liu, Huisheng; Dunning, F. Mark; Chang, Payne Y.; Jackson, Meyer B.; Chapman, Edwin R.			Synaptotagmin-IV modulates synaptic function and long-term potentiation by regulating BDNF release	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL EXCITATORY SYNAPSES; FUSION PORE KINETICS; NEUROTROPHIC FACTOR; NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; PC12 CELLS; NEURONS; VESICLES; BRAIN; EXOCYTOSIS	Synaptotagmin-IV (syt-IV) is a membrane trafficking protein that influences learning and memory, but its localization and role in synaptic function remain unclear. We found that syt-IV localized to brain-derived neurotrophic factor (BDNF)-containing vesicles in hippocampal neurons. Syt-IV/BDNF-harboring vesicles underwent exocytosis in both axons and dendrites, and syt-IV inhibited BDNF release at both sites. Knockout of syt-IV increased, and overexpression decreased, the rate of synaptic vesicle exocytosis from presynaptic terminals indirectly via changes in postsynaptic release of BDNF. Thus, postsynaptic syt-IV regulates the trans-synaptic action of BDNF to control presynaptic vesicle dynamics. Furthermore, selective loss of presynaptic syt-IV increased spontaneous quantal release, whereas a loss of postsynaptic syt-IV increased quantal amplitude. Finally, syt-IV knockout mice showed enhanced long-term potentiation (LTP), which depended entirely on disinhibition of BDNF release. Thus, regulation of BDNF secretion by syt-IV emerges as a mechanism for maintaining synaptic strength in a useful range during LTP.	[Dean, Camin; Liu, Huisheng; Dunning, F. Mark; Chang, Payne Y.; Jackson, Meyer B.; Chapman, Edwin R.] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; [Dean, Camin; Liu, Huisheng; Dunning, F. Mark; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Dept Physiol, 1300 Univ Ave, Madison, WI 53706 USA.	camin@physiology.wisc.edu; chapman@physiology.wisc.edu	Liu, Huisheng/D-2917-2011	Chapman, Edwin/0000-0001-9787-8140	US National Institutes of Health National Research Service Award [NS049748]; US National Institutes of Health [NS30016, NS44057]; National Institute of General Medical Sciences [GM 56827]; National Institute of Mental Health [MH61876]; American Heart Association [0440168N]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS049748, R01NS030016, R01NS044057, R37NS030016] Funding Source: NIH RePORTER	US National Institutes of Health National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M.-M. Poo and N. Matsuda for sharing their BDNF-pHluorin data with us and for comments on the manuscript, H. Herschman for providing the syt-IV knockout mice and members of the Chapman and Jackson laboratories for helpful discussions and comments on the manuscript. This work was supported by a US National Institutes of Health National Research Service Award to C. D. (NS049748), US National Institutes of Health grants to M. B. J. (NS30016 and NS44057) and to E. R. C. (National Institute of General Medical Sciences GM 56827 and National Institute of Mental Health MH61876), and American Heart Association (0440168N) grants to E. R. C. E. R. C. is an investigator of the Howard Hughes Medical Institute.	Ahras M, 2006, J CELL BIOL, V173, P241, DOI 10.1083/jcb.200506163; Aicardi G, 2004, P NATL ACAD SCI USA, V101, P15788, DOI 10.1073/pnas.0406960101; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Balkowiec A, 2002, J NEUROSCI, V22, P10399; Berton F, 2000, EUR J NEUROSCI, V12, P1294, DOI 10.1046/j.1460-9568.2000.00013.x; Bhalla A, 2005, MOL BIOL CELL, V16, P4755, DOI 10.1091/mbc.E05-04-0277; Bhalla A, 2008, J BIOL CHEM, V283, P21799, DOI 10.1074/jbc.M709628200; Bohnert S, 2005, J BIOL CHEM, V280, P42336, DOI 10.1074/jbc.M506750200; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chang PY, 2006, J PHYSIOL-LONDON, V576, P427, DOI 10.1113/jphysiol.2006.112128; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Chen GQ, 1999, J NEUROSCI, V19, P7983; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Denovan-Wright EM, 1998, MOL BRAIN RES, V55, P350, DOI 10.1016/S0169-328X(98)00042-4; Ferguson GD, 2000, P NATL ACAD SCI USA, V97, P5598, DOI 10.1073/pnas.100104597; Ferguson GD, 2004, HIPPOCAMPUS, V14, P964, DOI 10.1002/hipo.20013; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Ibata K, 2000, J NEUROCHEM, V74, P518, DOI 10.1046/j.1471-4159.2000.740518.x; Ibata K, 2002, NEUROSCI RES, V43, P401, DOI 10.1016/S0168-0102(02)00066-4; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Osborne SL, 1999, J BIOL CHEM, V274, P59, DOI 10.1074/jbc.274.1.59; Pawlu C, 2004, NEURON, V42, P607, DOI 10.1016/S0896-6273(04)00269-7; Peng WP, 2002, MOL BRAIN RES, V108, P94, DOI 10.1016/S0169-328X(02)00518-1; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Richards DA, 2005, J CELL BIOL, V168, P929, DOI 10.1083/jcb.200407148; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Shakiryanova D, 2006, NAT NEUROSCI, V9, P896, DOI 10.1038/nn1719; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Ting JT, 2006, J NEUROSCI, V26, P372, DOI 10.1523/JNEUROSCI.3997-05.2006; Tyler WJ, 2006, J PHYSIOL-LONDON, V574, P787, DOI 10.1113/jphysiol.2006.111310; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zhang Q, 2004, P NATL ACAD SCI USA, V101, P9441, DOI 10.1073/pnas.0401960101; Zhang ZJ, 2009, NAT NEUROSCI, V12, P163, DOI 10.1038/nn.2252	50	142	143	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2009	12	6					767	2315		10.1038/nn.2315	http://dx.doi.org/10.1038/nn.2315			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	450DJ	19448629	Green Accepted			2022-12-17	WOS:000266380900021
J	Carvalho, RF; Beutler, M; Marler, KJM; Knoll, B; Becker-Barroso, E; Heintzmann, R; Ng, T; Drescher, U				Carvalho, RF; Beutler, M; Marler, KJM; Knoll, B; Becker-Barroso, E; Heintzmann, R; Ng, T; Drescher, U			Silencing of EphA3 through a cis interaction with ephrinA5	NATURE NEUROSCIENCE			English	Article							RECEPTOR TYROSINE KINASES; GANGLION-CELL AXONS; LIPID RAFTS; MOLECULAR GRADIENTS; VISUAL-SYSTEM; A LIGANDS; GUIDANCE; ADHESION; GROWTH; MAP	EphAs and ephrinAs are expressed in multiple areas of the developing brain in overlapping countergradients, notably in the retina and tectum. Here they are involved in targeting retinal axons to their correct topographic position in the tectum. We have used truncated versions of EphA3, single-amino acid point mutants of ephrinA5 and fluorescence resonance energy transfer technology to uncover a cis interaction between EphA3 and ephrinA5 that is independent of the established ligand-binding domain of EphA3. This cis interaction abolishes the induction of tyrosine phosphorylation of EphA3 and results in a loss of sensitivity of retinal axons to ephrinAs in trans. Our data suggest that formation of this complex transforms the uniform expression of EphAs in the nasal part of the retina into a gradient of functional EphAs and has a key role in controlling retinotectal mapping.	Univ London Kings Coll, Ctr Dev Neurobiol, Med Res Council, London SE1 1UL, England; Univ London Kings Coll, Randall Div Cell & Mol Biophys, London SE1 1UL, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; University of London; King's College London	Drescher, U (corresponding author), Univ London Kings Coll, Ctr Dev Neurobiol, Med Res Council, New Hunts House,Guys Hosp Campus, London SE1 1UL, England.	uwe.drescher@kcl.ac.uk	Heintzmann, Rainer/I-5667-2012; Heintzmann, Rainer/AAY-4849-2020; Drescher, Uwe/C-5438-2009	Heintzmann, Rainer/0000-0002-4950-1936; Drescher, Uwe/0000-0001-9725-7643; Ng, Tony/0000-0003-3894-5619	MRC [G0100152] Funding Source: UKRI; Medical Research Council [G0100152] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G9900989B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bastiaens PIH, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P136; Bohme B, 1996, J BIOL CHEM, V271, P24747, DOI 10.1074/jbc.271.40.24747; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; CIOSSEK T, 1995, ONCOGENE, V11, P2085; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Erskine L, 2000, J NEUROSCI, V20, P4975; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Goodhill GJ, 2004, NEURAL COMPUT, V16, P2221, DOI 10.1162/0899766041941934; Gu CK, 2005, ONCOGENE, V24, P4243, DOI 10.1038/sj.onc.1208584; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Himanen JP, 2002, ACTA CRYSTALLOGR D, V58, P533, DOI 10.1107/S0907444902000264; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Labrador JP, 1997, EMBO J, V16, P3889, DOI 10.1093/emboj/16.13.3889; Loschinger J, 2000, PHILOS T ROY SOC B, V355, P971, DOI 10.1098/rstb.2000.0633; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Niclou SP, 2000, J NEUROSCI, V20, P4962; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Ringstedt T, 2000, J NEUROSCI, V20, P4983; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Sobieszczuk DF, 1999, CURR BIOL, V9, pR469, DOI 10.1016/S0960-9822(99)80296-6; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wu CB, 1997, J BIOL CHEM, V272, P3554, DOI 10.1074/jbc.272.6.3554; Yates PA, 2004, J NEUROBIOL, V59, P95, DOI 10.1002/neu.10341; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Yin Y, 2004, NEUROSCI RES, V48, P285, DOI 10.1016/j.neures.2003.11.009; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	50	142	146	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					322	330		10.1038/nn1655	http://dx.doi.org/10.1038/nn1655			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491080				2022-12-17	WOS:000235645600011
J	Roelfsema, PR; Lamme, VAF; Spekreijse, H				Roelfsema, PR; Lamme, VAF; Spekreijse, H			Synchrony and covariation of firing rates in the primary visual cortex during contour grouping	NATURE NEUROSCIENCE			English	Article							STRIATE CORTICAL ACTIVITY; SELECTIVE ATTENTION; FEATURE-INTEGRATION; NEURONAL SYNCHRONY; FAST OSCILLATIONS; ALERT MACAQUE; RESPONSES; REPRESENTATION; CONNECTIONS; COHERENCE	The visual system imposes structure onto incoming information, by grouping image elements of a single object together, and by segregating them from elements that belong to other objects and the background. One influential theory holds that the code for grouping and segmentation is carried by the synchrony of neuronal discharges on a millisecond time scale. We tested this theory by recording neuronal activity in the primary visual cortex ( area V1) of monkeys engaged in a contour-grouping task. We found that synchrony was unrelated to contour grouping. The firing rates of V1 neurons are also correlated across trials. We demonstrate that this rate covariation is mainly determined by fluctuations in visual attention. Moreover, we show that rate covariation depends on perceptual grouping, as it is strongest between neurons that respond to features of the same object.	Netherlands Ophthalm Res Inst, Dept Vis & Cognit, NL-1105 BA Amsterdam, Netherlands; Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, NL-1018 WB Amsterdam, Netherlands; UvA, Acad Med Ctr, Dept Visual Syst Anal, Grad Sch Neurosci Amsterdam, NL-1100 AA Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Roelfsema, PR (corresponding author), Netherlands Ophthalm Res Inst, Dept Vis & Cognit, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	p.roelfsema@ioi.knaw.nl	Roelfsema, Pieter/J-6903-2013	Roelfsema, Pieter/0000-0002-1625-0034				Angelucci A, 2002, J NEUROSCI, V22, P8633; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bosking WH, 1997, J NEUROSCI, V17, P2112; Brosch M, 1997, CEREB CORTEX, V7, P70, DOI 10.1093/cercor/7.1.70; Buchel C, 2000, NEURAL NETWORKS, V13, P871, DOI 10.1016/S0893-6080(00)00066-6; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Friedman-Hill S, 2000, CEREB CORTEX, V10, P1105, DOI 10.1093/cercor/10.11.1105; Frien A, 2000, EUR J NEUROSCI, V12, P1466, DOI 10.1046/j.1460-9568.2000.00026.x; FRIEN A, 1994, NEUROREPORT, V5, P2273, DOI 10.1097/00001756-199411000-00017; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gail A, 2000, CEREB CORTEX, V10, P840, DOI 10.1093/cercor/10.9.840; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; GUR M, 1987, VISION RES, V27, P2081, DOI 10.1016/0042-6989(87)90122-2; Houtkamp R, 2003, PERCEPT PSYCHOPHYS, V65, P1136, DOI 10.3758/BF03194840; KELLMAN PJ, 1991, COGNITIVE PSYCHOL, V23, P141, DOI 10.1016/0010-0285(91)90009-D; KONIG P, 1994, J NEUROSCI METH, V54, P31, DOI 10.1016/0165-0270(94)90157-0; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 1998, NATURE, V396, P362, DOI 10.1038/24608; Lee D, 1998, J NEUROSCI, V18, P1161; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Maldonado PE, 2000, CEREB CORTEX, V10, P1117, DOI 10.1093/cercor/10.11.1117; McIntosh AR, 1999, SCIENCE, V284, P1531, DOI 10.1126/science.284.5419.1531; NELSON JI, 1992, VISUAL NEUROSCI, V9, P21, DOI 10.1017/S0952523800006349; Nowak LG, 1995, J NEUROPHYSIOL, V74, P2379, DOI 10.1152/jn.1995.74.6.2379; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Roelfsema PR, 2000, VISION RES, V40, P1385, DOI 10.1016/S0042-6989(00)00004-3; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Roelfsema PR, 2001, NEURON, V31, P853, DOI 10.1016/S0896-6273(01)00408-1; Roelfsema PR, 1998, CEREB CORTEX, V8, P385, DOI 10.1093/cercor/8.5.385; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; Scholte HS, 2001, VISION RES, V41, P2569, DOI 10.1016/S0042-6989(01)00148-1; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SPORNS O, 1989, P NATL ACAD SCI USA, V86, P7265, DOI 10.1073/pnas.86.18.7265; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Super H, 2003, J NEUROSCI, V23, P3407; Thiele A, 2003, NATURE, V421, P366, DOI 10.1038/nature01285; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; VANKAN PLE, 1985, EXP BRAIN RES, V60, P559, DOI 10.1007/BF00236942; Verghese P, 1996, NATURE, V381, P161, DOI 10.1038/381161a0; von der Malsburg C, 1999, NEURON, V24, P95, DOI 10.1016/S0896-6273(00)80825-9; Worden MS, 2000, J NEUROSCI, V20	50	142	142	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					982	991		10.1038/nn1304	http://dx.doi.org/10.1038/nn1304			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15322549				2022-12-17	WOS:000223546700018
J	Osu, R; Hirai, S; Yoshioka, T; Kawato, M				Osu, R; Hirai, S; Yoshioka, T; Kawato, M			Random presentation enables subjects to adapt to two opposing forces on the hand	NATURE NEUROSCIENCE			English	Article							MOTOR WORKING-MEMORY; INTERNAL-MODELS; DISPLACEMENT; INTERFERENCE; ENVIRONMENT; IMPEDANCE; DYNAMICS	Studies have shown that humans cannot simultaneously learn opposing force fields or opposing visuomotor rotations, even when provided with arbitrary contextual information, probably because of interference in their working memory(1-6). In contrast, we found that subjects can adapt to two opposing force fields when provided with contextual cues and can consolidate motor memories if random and frequent switching occurs. Because significant aftereffects were seen, this study suggests that multiple internal models can be acquired simultaneously during learning and predictively switched, depending only on contextual information.	ATR Computat Neurosci Labs, Seika, Kyoto 6190288, Japan; Nara Inst Sci & Technol, Nara 6300101, Japan	Nara Institute of Science & Technology	Osu, R (corresponding author), ATR Computat Neurosci Labs, 2-2-2 Hikaridai, Seika, Kyoto 6190288, Japan.	osu@atr.jp						Bock O, 2001, EXP BRAIN RES, V138, P359, DOI 10.1007/s002210100704; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; CUNNINGHAM HA, 1994, J EXP PSYCHOL HUMAN, V20, P987, DOI 10.1037/0096-1523.20.5.987; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Karniel A, 2002, EXP BRAIN RES, V143, P520, DOI 10.1007/s00221-002-1054-4; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; KRAVITZ JH, 1972, PERCEPT PSYCHOPHYS, V12, P305, DOI 10.3758/BF03207210; SHADMEHR R, IN PRESS MOTOR CORTE; Takahashi CD, 2001, J NEUROPHYSIOL, V86, P1047, DOI 10.1152/jn.2001.86.2.1047; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; Wada Y, 2003, NEUROSCI RES, V46, P319, DOI 10.1016/S0168-0102(03)00094-4; WELCH RB, 1993, PERCEPT PSYCHOPHYS, V54, P195, DOI 10.3758/BF03211756; Wigmore V, 2002, J EXP PSYCHOL HUMAN, V28, P447, DOI 10.1037//0096-1523.28.2.447; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	15	142	143	0	17	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					111	112		10.1038/nn1184	http://dx.doi.org/10.1038/nn1184			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14745452				2022-12-17	WOS:000188468500007
J	Usdin, TB; Hoare, SRJ; Wang, T; Mezey, E; Kowalak, JA				Usdin, TB; Hoare, SRJ; Wang, T; Mezey, E; Kowalak, JA			TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus	NATURE NEUROSCIENCE			English	Article							MESSENGER-RIBONUCLEIC-ACID; RENIN-RELEASING FACTOR; RAT SENSORY NEURONS; PARATHYROID-HORMONE; PTH2 RECEPTOR		NIMH, Cell Biol Unit, Genet Lab, Bethesda, MD 20892 USA; NINDS, Basic Neurosci Program, Bethesda, MD 20892 USA; NIMH, Lab Neurotoxicol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Usdin, TB (corresponding author), NIMH, Cell Biol Unit, Genet Lab, Bldg 36,Room 3D06,36 Convent Dr MSC4094, Bethesda, MD 20892 USA.		Hoare, Sam/J-9018-2019; Mezey, Eva/A-8105-2008	Mezey, Eva/0000-0002-5907-4691	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002685, Z01MH002685] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Behar V, 1996, ENDOCRINOLOGY, V137, P2748, DOI 10.1210/en.137.7.2748; BENNETT HPJ, 1978, BIOCHEM J, V175, P1139, DOI 10.1042/bj1751139; CUI M, 1995, NEUROSCIENCE, V66, P459, DOI 10.1016/0306-4522(94)00567-O; FRASER RA, 1990, ENDOCRINOLOGY, V127, P2517, DOI 10.1210/endo-127-5-2517; Gardella TJ, 1996, J BIOL CHEM, V271, P19888, DOI 10.1074/jbc.271.33.19888; HINGTGEN CM, 1995, J NEUROSCI, V15, P5411; HOARE SRJ, IN PRESS ENDOCRINOLO; PANG PKT, 1988, AM J PHYSIOL, V255, pR643, DOI 10.1152/ajpregu.1988.255.4.R643; PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499; URBAN JH, 1992, NEUROENDOCRINOLOGY, V55, P574, DOI 10.1159/000126170; Usdin TB, 1999, ENDOCRINOLOGY, V140, P3363, DOI 10.1210/en.140.7.3363; Usdin TB, 1997, ENDOCRINOLOGY, V138, P831, DOI 10.1210/en.138.2.831; USDIN TB, 1995, J BIOL CHEM, V270, P15455, DOI 10.1074/jbc.270.26.15455; Usdin TB, 1996, ENDOCRINOLOGY, V137, P4285, DOI 10.1210/en.137.10.4285; VANDEKAR LD, 1987, HYPERTENSION, V9, P598, DOI 10.1161/01.HYP.9.6.598	15	142	153	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					941	943		10.1038/14724	http://dx.doi.org/10.1038/14724			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526330				2022-12-17	WOS:000083883300008
J	Nikolakopoulou, AM; Montagne, A; Kisler, K; Dai, ZH; Wang, YM; Huuskonen, MT; Sagare, AP; Lazic, D; Sweeney, MD; Kong, P; Wang, M; Owens, NC; Lawson, EJ; Xie, XC; Zhao, Z; Zlokovic, BV				Nikolakopoulou, Angeliki M.; Montagne, Axel; Kisler, Kassandra; Dai, Zhonghua; Wang, Yaoming; Huuskonen, Mikko T.; Sagare, Abhay P.; Lazic, Divna; Sweeney, Melanie D.; Kong, Pan; Wang, Min; Owens, Nelly Chuqui; Lawson, Erica J.; Xie, Xiaochun; Zhao, Zhen; Zlokovic, Berislav, V			Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss	NATURE NEUROSCIENCE			English	Article							BLOOD-BRAIN-BARRIER; VASCULAR CELLS; CAPILLARY PERICYTES; RECEPTOR-BETA; TAM RECEPTOR; PROTEIN; DISEASE; DYSFUNCTION; BREAKDOWN; PDGF	Pericytes are positioned between brain capillary endothelial cells, astrocytes and neurons. They degenerate in multiple neurological disorders. However, their role in the pathogenesis of these disorders remains debatable. Here we generate an inducible pericyte-specific Cre line and cross pericyte-specific Cre mice with iDTR mice carrying Cre-dependent human diphtheria toxin receptor. After pericyte ablation with diphtheria toxin, mice showed acute blood-brain barrier breakdown, severe loss of blood flow, and a rapid neuron loss that was associated with loss of pericyte-derived pleiotrophin (PTN), a neurotrophic growth factor. Intracerebroventricular PTN infusions prevented neuron loss in pericyte-ablated mice despite persistent circulatory changes. Silencing of pericyte-derived Ptn rendered neurons vulnerable to ischemic and excitotoxic injury. Our data demonstrate a rapid neurodegeneration cascade that links pericyte loss to acute circulatory collapse and loss of PTN neurotrophic support. These findings may have implications for the pathogenesis and treatment of neurological disorders that are associated with pericyte loss and/or neurovascular dysfunction.	[Nikolakopoulou, Angeliki M.; Montagne, Axel; Kisler, Kassandra; Dai, Zhonghua; Wang, Yaoming; Huuskonen, Mikko T.; Sagare, Abhay P.; Lazic, Divna; Sweeney, Melanie D.; Kong, Pan; Wang, Min; Owens, Nelly Chuqui; Lawson, Erica J.; Xie, Xiaochun; Zhao, Zhen; Zlokovic, Berislav, V] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90007 USA; [Nikolakopoulou, Angeliki M.; Montagne, Axel; Kisler, Kassandra; Dai, Zhonghua; Wang, Yaoming; Huuskonen, Mikko T.; Sagare, Abhay P.; Lazic, Divna; Sweeney, Melanie D.; Kong, Pan; Wang, Min; Owens, Nelly Chuqui; Lawson, Erica J.; Xie, Xiaochun; Zhao, Zhen; Zlokovic, Berislav, V] Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Los Angeles, CA 90007 USA; [Lazic, Divna] Univ Belgrade, Inst Biol Res, Dept Neurobiol, Belgrade, Serbia	University of Southern California; University of Southern California; University of Belgrade	Zlokovic, BV (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90007 USA.; Zlokovic, BV (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Los Angeles, CA 90007 USA.	zlokovic@usc.edu	Montagne, Axel/AAV-4343-2020; Huuskonen, Mikko/AAG-8814-2020; zhao, zhen/A-2080-2012	Montagne, Axel/0000-0001-5564-985X; Huuskonen, Mikko/0000-0002-7170-3016; zhao, zhen/0000-0001-8967-5570; Dai, Zhonghua/0000-0001-5610-5037; Kisler, Kassandra/0000-0002-4161-2498	National Institutes of Health [R01AG039452, R01NS100459, R01AG023084, R01NS090904, R01NS034467]; Foundation Leducq Transatlantic Network of Excellence [16 CVD 05]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034467, R01NS090904, R01NS100459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG052350, RF1AG039452, R01AG023084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Leducq Transatlantic Network of Excellence; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work of B.V.Z. is supported by the National Institutes of Health grants R01AG039452, R01NS100459, as well as R01AG023084, R01NS090904, R01NS034467, and the Foundation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease reference no. 16 CVD 05.	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Asai H, 2011, CELL BIOCHEM FUNCT, V29, P660, DOI 10.1002/cbf.1802; Barnes SR, 2016, MAGN RESON MED, V75, P1967, DOI 10.1002/mrm.25793; Barnes SR, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0062-3; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Berthiaume AA, 2018, CELL REP, V22, P8, DOI 10.1016/j.celrep.2017.12.016; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Chen KP, 2016, ONCOTARGET, V7, P14199, DOI 10.18632/oncotarget.7348; Cuttler AS, 2011, GENESIS, V49, P673, DOI 10.1002/dvg.20769; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gauthier SA, 2012, METHODS MOL BIOL, V849, P261, DOI 10.1007/978-1-61779-551-0_18; Ghosh M, 2015, ANN NEUROL, V78, P887, DOI 10.1002/ana.24512; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Guo H, 2004, NEURON, V41, P563, DOI 10.1016/S0896-6273(04)00019-4; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Halliday MR, 2016, J CEREBR BLOOD F MET, V36, P216, DOI 10.1038/jcbfm.2015.44; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Ishii Y, 2006, J NEUROCHEM, V98, P588, DOI 10.1111/j.1471-4159.2006.03922.x; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Kisler K, 2018, NAT PROTOC, V13, P1377, DOI 10.1038/nprot.2018.034; Kisler K, 2017, NAT NEUROSCI, V20, P406, DOI 10.1038/nn.4489; Krellman JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100597; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Ma QY, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0286-0; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mazziotti R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15488; Mishra A, 2016, NAT NEUROSCI, V19, P1619, DOI 10.1038/nn.4428; Montagne A, 2018, NAT MED, V24, P326, DOI 10.1038/nm.4482; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Nikolakopoulou AM, 2016, ASN NEURO, V8, DOI 10.1177/1759091416630220; Nikolakopoulou AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176225; Niu F, 2014, J NEUROSCI, V34, P11812, DOI 10.1523/JNEUROSCI.1139-14.2014; Ogura S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90905; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Park DY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15296; Park L, 2007, J CEREBR BLOOD F MET, V27, P1908, DOI 10.1038/sj.jcbfm.9600491; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Ruck T, 2014, JOVE-J VIS EXP, DOI 10.3791/52204; Sabbagh MF, 2018, ELIFE, V7, DOI 10.7554/eLife.36187; Sagare AP, 2015, NEUROSCI LETT, V607, P97, DOI 10.1016/j.neulet.2015.09.025; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Stefanska A, 2015, AGING-US, V7, P370, DOI 10.18632/aging.100756; Sweatt JD, 2010, MECHANISMS OF MEMORY, 2ND EDITION, P1, DOI 10.1016/B978-0-12-374951-2.00001-9; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Trost A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00020; Trost A, 2013, INVEST OPHTH VIS SCI, V54, P7910, DOI 10.1167/iovs.13-12946; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Victor MB, 2014, NEURON, V84, P311, DOI 10.1016/j.neuron.2014.10.016; Wang YM, 2012, STROKE, V43, P2444, DOI 10.1161/STROKEAHA.112.658997; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Winkler EA, 2013, ACTA NEUROPATHOL, V125, P111, DOI 10.1007/s00401-012-1039-8; Wu ZH, 2003, J NEUROSCI METH, V130, P53, DOI 10.1016/S0165-0270(03)00206-1; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zehendner CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13497; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhao Z, 2015, NAT NEUROSCI, V18, P978, DOI 10.1038/nn.4025; Zheng LS, 2010, J NEUROSCI RES, V88, P1273, DOI 10.1002/jnr.22302; Zhong ZH, 2010, J NEUROSCI, V30, P15521, DOI 10.1523/JNEUROSCI.4437-10.2010; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	81	141	143	10	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2019	22	7					1089	+		10.1038/s41593-019-0434-z	http://dx.doi.org/10.1038/s41593-019-0434-z			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IE8GO	31235908	Green Accepted			2022-12-17	WOS:000472612100010
J	Lebreton, M; Abitbol, R; Daunizeau, J; Pessiglione, M				Lebreton, Mael; Abitbol, Raphaelle; Daunizeau, Jean; Pessiglione, Mathias			Automatic integration of confidence in the brain valuation signal	NATURE NEUROSCIENCE			English	Article							ORBITOFRONTAL CORTEX; DECISION-MAKING; PREFRONTAL CORTEX; COMMON CURRENCY; CHOICE; REWARD; REPRESENTATIONS; RESPONSES; REGIONS; HUMANS	A key process in decision-making is estimating the value of possible outcomes. Growing evidence suggests that different types of values are automatically encoded in the ventromedial prefrontal cortex (VMPFC). Here we extend this idea by suggesting that any overt judgment is accompanied by a second-order valuation (a confidence estimate), which is also automatically incorporated in VMPFC activity. In accordance with the predictions of our normative model of rating tasks, two behavioral experiments showed that confidence levels were quadratically related to first-order judgments (age, value or probability ratings). The analysis of three functional magnetic resonance imaging data sets using similar rating tasks confirmed that the quadratic extension of first-order ratings (our proxy for confidence) was encoded in VMPFC activity, even if no confidence judgment was required of the participants. Such an automatic aggregation of value and confidence in a same brain region might provide insight into many distortions of judgment and choice.	[Lebreton, Mael; Abitbol, Raphaelle; Daunizeau, Jean; Pessiglione, Mathias] Ctr NeuroImagerie Rech CENIR, Inst Cerveau & Moelle Epiniere ICM, Motivat Brain & Behav Team, Paris, France; [Lebreton, Mael; Abitbol, Raphaelle; Daunizeau, Jean; Pessiglione, Mathias] Univ Paris 06, UMR 1127, CNRS UMR 7225, INSERM UMRS 975, Paris, France; [Abitbol, Raphaelle] Univ Paris 01, Ctr Econ Sorbonne, F-75231 Paris 05, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; heSam Universite; Universite Pantheon-Sorbonne	Pessiglione, M (corresponding author), Ctr NeuroImagerie Rech CENIR, Inst Cerveau & Moelle Epiniere ICM, Motivat Brain & Behav Team, Paris, France.	mathias.pessiglione@gmail.com	Daunizeau, Jean/F-9225-2010; Lebreton, Maël/J-3179-2019; Pessiglione, Mathias/E-2141-2017; Daunizeau, Jean/AAB-3996-2019	Daunizeau, Jean/0000-0001-9142-1270; Lebreton, Maël/0000-0002-2071-4890; Pessiglione, Mathias/0000-0002-6992-3677; 	Schlumberger Foundation; French Ministere de la Recherche; Direction Generale de l'Armement; Fondation pour la Recherche Medicale; Amsterdam Brain and Cognition Talent Grant from the University of Amsterdam	Schlumberger Foundation(Schlumberger); French Ministere de la Recherche(Ministry of Research, France); Direction Generale de l'Armement; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Amsterdam Brain and Cognition Talent Grant from the University of Amsterdam	The study was funded by a Starting Grant for the European Research Council (ERC-BioMotiv) and a Research Grant from the Schlumberger Foundation. M.L. received a PhD fellowship from the French Ministere de la Recherche and an Amsterdam Brain and Cognition Talent Grant from the University of Amsterdam. R.A. received a PhD fellowship from the Direction Generale de l'Armement and a grant from the Fondation pour la Recherche Medicale. This work also benefited from the program "Investissements d'avenir" (ANR-10-IAIHU-06). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abitbol R, 2015, J NEUROSCI, V35, P2308, DOI 10.1523/JNEUROSCI.1878-14.2015; ADAMS JK, 1957, AM J PSYCHOL, V70, P432, DOI 10.2307/1419580; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Clithero JA, 2014, SOC COGN AFFECT NEUR, V9, P1289, DOI 10.1093/scan/nst106; Cooper JC, 2008, NEUROIMAGE, V39, P538, DOI 10.1016/j.neuroimage.2007.08.009; Costa VD, 2010, HUM BRAIN MAPP, V31, P1446, DOI 10.1002/hbm.20948; Daunizeau J., 2014, EXPONENTIAL SIGMOID; de Gardelle V, 2014, PSYCHOL SCI, V25, P1286, DOI 10.1177/0956797614528956; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Elliott R, 2003, J NEUROSCI, V23, P303; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; GRIFFIN D, 1992, COGNITIVE PSYCHOL, V24, P411, DOI 10.1016/0010-0285(92)90013-R; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Harvey AH, 2010, J NEUROSCI, V30, P9597, DOI 10.1523/JNEUROSCI.1086-10.2010; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Lebreton M, 2012, J NEUROSCI, V32, P7146, DOI 10.1523/JNEUROSCI.4821-11.2012; Lebreton M, 2009, NEURON, V64, P431, DOI 10.1016/j.neuron.2009.09.040; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; Lichtenstein S., 1982, HEURISTICS BIASES, P306; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; Morgenstern O., 1944, GAME THEORY EC BEHAV; Moritz S, 2006, NEUROIMAGE, V33, P1188, DOI 10.1016/j.neuroimage.2006.08.003; Peters J, 2010, BEHAV BRAIN RES, V213, P135, DOI 10.1016/j.bbr.2010.04.031; Pierce C.S., 1884, MEMOIRS NATL ACAD SC, V3, P73; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Pleskac TJ, 2010, PSYCHOL REV, V117, P864, DOI 10.1037/a0019737; Roesch MR, 2007, ANN NY ACAD SCI, V1121, P431, DOI 10.1196/annals.1401.004; Rolls ET, 2010, NEUROIMAGE, V53, P694, DOI 10.1016/j.neuroimage.2010.06.073; Samuelson PA, 1938, ECONOMICA-NEW SER, V5, P61, DOI 10.2307/2548836; Schwarze U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054324; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Vickers D., 1979, DECISION PROCESSES V; White TP, 2014, BRAIN COGNITION, V85, P191, DOI 10.1016/j.bandc.2013.12.002; Yeung N, 2012, PHILOS T R SOC B, V367, P1310, DOI 10.1098/rstb.2011.0416; Yu SL, 2015, J EXP PSYCHOL GEN, V144, P489, DOI 10.1037/xge0000062	42	141	141	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2015	18	8					1159	+		10.1038/nn.4064	http://dx.doi.org/10.1038/nn.4064			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN7HO	26192748				2022-12-17	WOS:000358605400018
J	Hait, NC; Wise, LE; Allegood, JC; O'Brien, M; Avni, D; Reeves, TM; Knapp, PE; Lu, JY; Luo, C; Miles, MF; Milstien, S; Lichtman, AH; Spiegel, S				Hait, Nitai C.; Wise, Laura E.; Allegood, Jeremy C.; O'Brien, Megan; Avni, Dorit; Reeves, Thomas M.; Knapp, Pamela E.; Lu, Junyan; Luo, Cheng; Miles, Michael F.; Milstien, Sheldon; Lichtman, Aron H.; Spiegel, Sarah			Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; LONG-TERM-MEMORY; EPIGENETIC MECHANISMS; SPHINGOSINE-1-PHOSPHATE; ACETYLATION; BDNF; FTY720; MODEL; RECONSOLIDATION; IMMUNITY	FTY720 (fingolimod), an FDA-approved drug for treatment of multiple sclerosis, has beneficial effects in the CNS that are not yet well understood, independent of its effects on immune cell trafficking. We show that FTY720 enters the nucleus, where it is phosphorylated by sphingosine kinase 2 (SphK2), and that nuclear FTY720-P binds and inhibits class I histone deacetylases (HDACs), enhancing specific histone acetylations. FTY720 is also phosphorylated in mice and accumulates in the brain, including the hippocampus, inhibits HDACs and enhances histone acetylation and gene expression programs associated with memory and learning, and rescues memory deficits independently of its immunosuppressive actions. Sphk2(-/-) mice have lower levels of hippocampal sphingosine-l-phosphate, an endogenous HDAC inhibitor, and reduced histone acetylation, and display deficits in spatial memory and impaired contextual fear extinction. Thus, sphingosine-l-phosphate and SphK2 play specific roles in memory functions and FTY720 may be a useful adjuvant therapy to facilitate extinction of aversive memories.	[Hait, Nitai C.; Allegood, Jeremy C.; Avni, Dorit; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23284 USA; [Hait, Nitai C.; Allegood, Jeremy C.; Avni, Dorit; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA USA; [Wise, Laura E.; O'Brien, Megan; Miles, Michael F.; Lichtman, Aron H.] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA USA; [Reeves, Thomas M.; Knapp, Pamela E.] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA USA; [Lu, Junyan; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23284 USA.	sspiegel@vcu.edu		Lu, Junyan/0000-0002-9211-0746; Avni, Dorit/0000-0002-0444-881X	US National Institutes of Health (NIH) [R37GM043880]; NIH [P30CA16059]; National Natural Science Foundation of China [91029704];  [5P01DA009789];  [R21AG042745];  [R01NS057758]; NATIONAL CANCER INSTITUTE [P30CA016059, R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880, R37GM043880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG042745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by US National Institutes of Health (NIH) grant R37GM043880 to S.S. Behavioral studies were supported by 5P01DA009789 to A.H.L. and R21AG042745 to L.E.W. LTP studies were supported by R01NS057758 to T.M.R. The Lipidomics core was supported in part by NIH grant P30CA16059 to the Massey Cancer Center. Modeling studies were supported by National Natural Science Foundation of China grant 91029704 to C.L. We thank R. Proia (US National Institutes of Health) for providing the Sphk2<SUP>-/-</SUP> mice, B.L. Mason for technical assistance and S. Lima for discussions.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Blondeau N, 2007, J NEUROCHEM, V103, P509, DOI 10.1111/j.1471-4159.2007.04755.x; Bredy TW, 2008, LEARN MEMORY, V15, P39, DOI 10.1101/lm.801108; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Bressi JC, 2010, BIOORG MED CHEM LETT, V20, P3142, DOI 10.1016/j.bmcl.2010.03.091; Briard E, 2011, CHEMMEDCHEM, V6, P667, DOI 10.1002/cmdc.201000477; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Brzozka MM, 2010, BIOL PSYCHIAT, V68, P33, DOI 10.1016/j.biopsych.2010.03.015; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Fujita Y, 2012, J PSYCHIATR RES, V46, P635, DOI 10.1016/j.jpsychires.2012.01.026; Graff J, 2014, CELL, V156, P261, DOI 10.1016/j.cell.2013.12.020; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hawk JD, 2012, J CLIN INVEST, V122, P3593, DOI 10.1172/JCI64145; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1125, DOI 10.1037/0735-7044.121.5.1125; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; Mauceri D, 2011, NEURON, V71, P117, DOI 10.1016/j.neuron.2011.04.022; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Orlandini M, 1996, P NATL ACAD SCI USA, V93, P11675, DOI 10.1073/pnas.93.21.11675; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Tronson NC, 2012, TRENDS NEUROSCI, V35, P145, DOI 10.1016/j.tins.2011.10.003; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zovkic IB, 2013, NEUROPSYCHOPHARMACOL, V38, P77, DOI 10.1038/npp.2012.79	49	141	145	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2014	17	7					971	980		10.1038/nn.3728	http://dx.doi.org/10.1038/nn.3728			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AK0IX	24859201	Green Accepted			2022-12-17	WOS:000338097200014
J	Walsh, JJ; Friedman, AK; Sun, HS; Heller, EA; Ku, SM; Juarez, B; Burnham, VL; Mazei-Robison, MS; Ferguson, D; Golden, SA; Koo, JW; Chaudhury, D; Christoffe, DJ; Pomeranz, L; Friedman, JM; Russo, SJ; Nestler, EJ; Han, MH				Walsh, Jessica J.; Friedman, Allyson K.; Sun, Haosheng; Heller, Elizabeth A.; Ku, Stacy M.; Juarez, Barbara; Burnham, Veronica L.; Mazei-Robison, Michelle S.; Ferguson, Deveroux; Golden, Sam A.; Koo, Ja Wook; Chaudhury, Dipesh; Christoffe, Daniel J.; Pomeranz, Lisa; Friedman, Jeffrey M.; Russo, Scott J.; Nestler, Eric J.; Han, Ming-Hu			Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway	NATURE NEUROSCIENCE			English	Article							SOCIAL DEFEAT; DOPAMINERGIC-NEURONS; SUSCEPTIBILITY; CIRCUIT	Mechanisms controlling release of brain-derived neurotrophic factor (BDNF) in the mesolimbic dopamine reward pathway remain unknown. We report that phasic optogenetic activation of this pathway increases BDNF amounts in the nucleus accumbens (NAc) of socially stressed mice but not of stress-naive mice. This stress gating of BDNF signaling is mediated by corticotrophin-releasing factor (CRF) acting in the NAc. These results unravel a stress context-detecting function of the brain's mesolimbic circuit.	[Walsh, Jessica J.; Friedman, Allyson K.; Ku, Stacy M.; Juarez, Barbara; Burnham, Veronica L.; Chaudhury, Dipesh; Nestler, Eric J.; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Walsh, Jessica J.; Sun, Haosheng; Heller, Elizabeth A.; Ku, Stacy M.; Juarez, Barbara; Burnham, Veronica L.; Mazei-Robison, Michelle S.; Ferguson, Deveroux; Golden, Sam A.; Koo, Ja Wook; Christoffe, Daniel J.; Russo, Scott J.; Nestler, Eric J.; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY USA; [Pomeranz, Lisa; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; Rockefeller University	Han, MH (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ming-hu.han@mssm.edu	Heller, Elizabeth A/W-4653-2019; Russo, Scott/R-7107-2019; Han, Ming-Hu/G-8836-2012; Mazei-Robison, Michelle/I-4304-2017; Core, Vector/CAF-4832-2022	Heller, Elizabeth A/0000-0002-2984-8705; Russo, Scott/0000-0002-6470-1805; Mazei-Robison, Michelle/0000-0002-2372-1420; Juarez, Barbara/0000-0001-7897-8031; Pomeranz, Lisa/0000-0002-8117-7355; Walsh, Jessica/0000-0001-8466-8451; Friedman, Allyson/0000-0002-8190-3011; Sun, Haosheng/0000-0003-3919-559X; Christoffel, Dan/0000-0002-6303-5134; Ferguson, Deveroux/0000-0001-9302-5992; Golden, Sam/0000-0002-2104-2272	National Institute of Mental Health [R01 MH092306]; Johnson & Johnson/International Mental Health Research Organization Rising Star Translational Research Award; National Research Service Awards [F31 MH095425, F32 MH096464]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH096678, F31MH108326, P50MH096890, F31MH095425, F32MH096464, K99MH094405, R01MH092306, T32MH087004, R01MH051399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014133, T32DA007135] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johnson & Johnson/International Mental Health Research Organization Rising Star Translational Research Award; National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Mental Health (R01 MH092306: D.C. and M.-H.H.), Johnson & Johnson/International Mental Health Research Organization Rising Star Translational Research Award (M.-H.H.) and National Research Service Awards (F31 MH095425: J.J.W.; F32 MH096464: A.K.F.).	Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Koo JW, 2012, SCIENCE, V338, P124, DOI 10.1126/science.1222265; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lemos JC, 2012, NATURE, V490, P402, DOI 10.1038/nature11436; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pecina S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-8; Schnitzer MJ, 2002, NATURE, V416, P683, DOI 10.1038/416683a; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Wanat MJ, 2013, NAT NEUROSCI, V16, P383, DOI 10.1038/nn.3335	20	141	142	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					27	29		10.1038/nn.3591	http://dx.doi.org/10.1038/nn.3591			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24270188	Green Accepted			2022-12-17	WOS:000329080000009
J	Mellios, N; Sugihara, H; Castro, J; Banerjee, A; Le, C; Kumar, A; Crawford, B; Strathmann, J; Tropea, D; Levine, SS; Edbauer, D; Sur, M				Mellios, Nikolaos; Sugihara, Hiroki; Castro, Jorge; Banerjee, Abhishek; Le, Chuong; Kumar, Arooshi; Crawford, Benjamin; Strathmann, Julia; Tropea, Daniela; Levine, Stuart S.; Edbauer, Dieter; Sur, Mriganka			miR-132, an experience-dependent microRNA, is essential for visual cortex plasticity	NATURE NEUROSCIENCE			English	Article							MONOCULAR DEPRIVATION; MORPHOGENESIS	Using quantitative analyses, we identified microRNAs (miRNAs) that were abundantly expressed in visual cortex and that responded to dark rearing and/or monocular deprivation. The most substantially altered miRNA, miR-132, was rapidly upregulated after eye opening and was delayed by dark rearing. In vivo inhibition of miR-132 in mice prevented ocular dominance plasticity in identified neurons following monocular deprivation and affected the maturation of dendritic spines, demonstrating its critical role in the plasticity of visual cortex circuits.	[Mellios, Nikolaos; Sugihara, Hiroki; Castro, Jorge; Banerjee, Abhishek; Le, Chuong; Kumar, Arooshi; Crawford, Benjamin; Tropea, Daniela; Sur, Mriganka] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Strathmann, Julia; Edbauer, Dieter] DZNE German Ctr Neurodegenerat Dis, Munich, Germany; [Levine, Stuart S.] MIT, Biomicro Ctr, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Massachusetts Institute of Technology (MIT)	Sur, M (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	msur@mit.edu	Edbauer, Dieter/M-9906-2019; Tropea, Daniela/AAX-8147-2020	Edbauer, Dieter/0000-0002-7186-4653; Levine, Stuart/0000-0001-7363-562X; Sugihara, Hiroki/0000-0002-0637-3700; Tropea, Daniela/0000-0001-9730-6636	US National Eye Institute [1F32EY020066-01]; Helmholtz Young Investigator program [HZ-NG-607]; Simons Foundation; US National Institutes of Health [EY017098, EY007023]; NATIONAL EYE INSTITUTE [R01EY007023, R01EY017098, F32EY020066] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Helmholtz Young Investigator program; Simons Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Sharma and C. Runyan for feedback, G. Kreiman for assistance with data analysis, M. Constantine-Paton and her laboratory for sharing equipment and B. Karki for technical assistance. Supported by US National Eye Institute Ruth L. Kirschstein Postdoctoral Fellowship 1F32EY020066-01 (N.M.), Helmholtz Young Investigator program HZ-NG-607 (D. E.), a Simons Foundation postdoctoral fellowship (A. B.) and US National Institutes of Health EY017098 and EY007023 to M.S.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105	15	141	148	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1240	1242		10.1038/nn.2909	http://dx.doi.org/10.1038/nn.2909			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21892155	Green Accepted, Green Submitted			2022-12-17	WOS:000295254200008
J	Sun, YF; Dykes, IM; Liang, XQ; Eng, SR; Evans, SM; Turner, EE				Sun, Yunfu; Dykes, Iain M.; Liang, Xingqun; Eng, S. Raisa; Evans, Sylvia M.; Turner, Eric E.			A central role for Islet1 in sensory neuron development linking sensory and spinal gene regulatory programs	NATURE NEUROSCIENCE			English	Article							DORSAL-ROOT GANGLION; TRANSCRIPTION FACTOR; PROGENITOR CELLS; FACTOR LBX1; DIFFERENTIATION; EXPRESSION; SPECIFICATION; SURVIVAL; BRN3A; REQUIREMENT	We used conditional knockout strategies in mice to determine the developmental events and gene expression program regulated by the LIM-homeodomain factor Islet1 in developing sensory neurons. Early development of the trigeminal and dorsal root ganglia was grossly normal in the absence of Islet1. From E12.5 onward, however, Isl1 mutant embryos showed a loss of the nociceptive markers TrkA and Runx1 and a near absence of cutaneous innervation. Proprioceptive neurons characterized by the expression of TrkC, Runx3 and Etv1 were relatively spared. Microarray analysis of Isl1 mutant ganglia revealed prolonged expression of developmental regulators that are normally restricted to early sensory neurogenesis and ectopic expression of transcription factors that are normally found in the CNS, but not in sensory ganglia. Later excision of Isl1 did not reactivate early genes, but resulted in decreased expression of transcripts related to specific sensory functions. Together these results establish a central role for Islet1 in the transition from sensory neurogenesis to subtype specification.	[Dykes, Iain M.; Eng, S. Raisa; Turner, Eric E.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 93093 USA; [Sun, Yunfu; Liang, Xingqun; Evans, Sylvia M.] Univ Calif San Diego, Dept Med, La Jolla, CA 93093 USA; [Sun, Yunfu; Evans, Sylvia M.] Univ Calif San Diego, Sch Pharm & Pharmaceut Sci, La Jolla, CA 93093 USA; [Turner, Eric E.] VA San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Turner, EE (corresponding author), Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr, La Jolla, CA 93093 USA.	syevans@ucsd.edu; eturner@ucsd.edu	Turner, Eric e/K-3556-2015; Evans, Sylvia/G-1980-2015; Dykes, Iain/H-4641-2019	Turner, Eric e/0000-0001-5499-6788; Dykes, Iain/0000-0002-1030-3721	Department of Veterans Affairs MERIT; US National Institutes of Health [HD33442, MH065496, HL074066]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033442, N01HD023144] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065496] Funding Source: NIH RePORTER	Department of Veterans Affairs MERIT(US Department of Veterans Affairs); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank T. Jessell, S. Arber, L. Reichardt, M. Wegner, D. Lima and S. Pfaff for antibodies, and Q. Ma and J. Johnson for in situ hybridization probes (Methods). We would also like to thank N. Webster and L. Shireen of the University of California San Diego/Veterans Affairs Microarray Core for assistance with microarray technology, and G. C. Parico and A. Jackson for technical assistance. Mouse monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank, maintained under contract NO1-HD23144 from the US National Institute of Child Health and Human Development. This work was supported in part by Department of Veterans Affairs MERIT funding and US National Institutes of Health awards HD33442 and MH065496 to E. E. T. and HL074066 to S. M. E. E. E. T. is a National Alliance for Research on Schizophrenia and Depression Investigator.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Anderson DJ, 1999, CURR OPIN NEUROBIOL, V9, P517, DOI 10.1016/S0959-4388(99)00015-X; Breslin MB, 2003, J BIOL CHEM, V278, P38991, DOI 10.1074/jbc.M306795200; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; ChotteauLelievre A, 1997, ONCOGENE, V15, P937, DOI 10.1038/sj.onc.1201261; Eng SR, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-3; Eng SR, 2004, DEVELOPMENT, V131, P3859, DOI 10.1242/dev.01260; Eng SR, 2001, J NEUROSCI, V21, P541, DOI 10.1523/JNEUROSCI.21-02-00541.2001; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Huang EJ, 1999, DEVELOPMENT, V126, P2869; Ichikawa H, 2004, DEV BRAIN RES, V150, P41, DOI 10.1016/j.devbrainres.2004.02.004; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Lanier J, 2007, DEV BIOL, V302, P703, DOI 10.1016/j.ydbio.2006.10.050; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; LAWSON SN, 1979, J NEUROCYTOL, V8, P265, DOI 10.1007/BF01236122; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Lei L, 2006, DEV BIOL, V300, P758, DOI 10.1016/j.ydbio.2006.08.062; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Liu WD, 2006, BIOCHEM J, V397, P169, DOI 10.1042/BJ20051669; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; Mizuhara E, 2005, J BIOL CHEM, V280, P3645, DOI 10.1074/jbc.M411652200; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Paratore C, 2002, DEV BIOL, V250, P168, DOI 10.1006/dbio.2002.0795; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Rebelo S, 2006, MOL CELL NEUROSCI, V33, P236, DOI 10.1016/j.mcn.2006.07.013; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Vellani V, 2006, J NEUROSCI, V26, P5109, DOI 10.1523/JNEUROSCI.3870-05.2006; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Yoshikawa M, 2007, DEV BIOL, V303, P663, DOI 10.1016/j.ydbio.2006.12.007; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	50	141	146	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2008	11	11					1283	1293		10.1038/nn.2209	http://dx.doi.org/10.1038/nn.2209			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	366HZ	18849985	Green Accepted			2022-12-17	WOS:000260472700017
J	Doyere, V; Debiec, J; Monfils, MH; Schafe, GE; LeDoux, JE				Doyere, Valerie; Debiec, Jacek; Monfils, Marie-H; Schafe, Glenn E.; LeDoux, Joseph E.			Synapse-specific reconsolidation of distinct fear memories in the lateral amygdala	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RETRIEVAL	When reactivated, memories enter a labile, protein synthesis dependent state, a process referred to as reconsolidation. Here, we show in rats that fear memory retrieval produces a synaptic potentiation in the lateral amygdala that is selective to the reactivated memory, and that disruption of reconsolidation is correlated with a reduction of synaptic potentiation in the lateral amygdala. Thus, both retrieval and reconsolidation alter memories via synaptic plasticity at selectively targeted synapses.	NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA; Univ Paris 11, CNRS, UMR8620, NAMC, F-91405 Orsay, France; Yale Univ, Dept Psychol, New Haven, CT 06520 USA	New York University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Yale University	LeDoux, JE (corresponding author), NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, 4 Washington Pl, New York, NY 10003 USA.	ledoux@cns.nyu.edu	Debiec, Jacek/B-6820-2008; Monfils, Marie/F-1282-2013	Debiec, Jacek/0000-0002-8473-1534; Monfils, Marie-H./0000-0001-8971-6651; Doyere, Valerie/0000-0002-3851-669X	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038774, K05MH067048, R01MH046516, P50MH058911] Funding Source: NIH RePORTER; NIMH NIH HHS [K05 MH067048, R01 MH46516, P50 MH58911, R37 MH38774] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Debiec J, 2006, P NATL ACAD SCI USA, V103, P3428, DOI 10.1073/pnas.0507168103; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lindquist DH, 2004, J NEUROSCI, V24, P3610, DOI 10.1523/JNEUROSCI.4839-03.2004; Miller CA, 2006, LEARN MEMORY, V13, P498, DOI 10.1101/lm.304606; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rybalko N, 2006, EUR J NEUROSCI, V23, P1614, DOI 10.1111/j.1460-9568.2006.04688.x; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schafe GE, 2005, J NEUROSCI, V25, P10010, DOI 10.1523/JNEUROSCI.3307-05.2005; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022	13	141	144	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					414	416		10.1038/nn1871	http://dx.doi.org/10.1038/nn1871			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17351634				2022-12-17	WOS:000245228600009
J	Mevorach, C; Humphreys, GW; Shalev, L				Mevorach, C; Humphreys, GW; Shalev, L			Opposite biases in salience-based selection for the left and right posterior parietal cortex	NATURE NEUROSCIENCE			English	Article							VISUAL-ATTENTION; BRAIN; LATERALIZATION; SEARCH; FOREST; TREES	Visual selection is determined in part by the saliency of stimuli. We assessed the brain mechanisms determining attentional responses to saliency. Repetitive transcranial magnetic stimulation (rTMS) was applied to the left and right posterior parietal cortices (PPC) immediately before participants were asked to identify a compound letter. rTMS to the right PPC disrupted the guidance of attention toward salient stimuli, whereas rTMS to the left PPC affected the ability to bias selection away from salient stimuli. We conclude that right and left PPC have opposite roles in biasing selection to and from salient stimuli in the environment.	Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England; Open Univ Israel, Dept Educ & Psychol, Raanana, Israel	University of Birmingham; Open University Israel	Mevorach, C (corresponding author), Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England.	c.mevorach@bham.ac.uk	Mevorach, Carmel/AAT-9229-2021; Shalev, Lilach/ABA-8783-2021	Mevorach, Carmel/0000-0003-1596-1026; 	BBSRC [BB/E000134/1] Funding Source: UKRI; MRC [G9806428] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E000134/1] Funding Source: Medline; Medical Research Council [G9806428] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Fockert J, 2004, J COGNITIVE NEUROSCI, V16, P751, DOI 10.1162/089892904970762; Evans MA, 2000, NEUROPSYCHOLOGIA, V38, P225, DOI 10.1016/S0028-3932(99)00080-9; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HUMPHREYS GW, 1994, NATURE, V372, P357, DOI 10.1038/372357a0; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; LAMB MR, 1988, PERCEPT PSYCHOPHYS, V44, P172, DOI 10.3758/BF03208710; Mevorach C, 2006, NEUROPSYCHOLOGIA, V44, P307, DOI 10.1016/j.neuropsychologia.2005.04.015; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; POSNER MI, 1984, J NEUROSCI, V4, P25; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492	15	141	144	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					740	742		10.1038/nn1709	http://dx.doi.org/10.1038/nn1709			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699505				2022-12-17	WOS:000237895200013
J	Morishita, W; Marie, H; Malenka, RC				Morishita, W; Marie, H; Malenka, RC			Distinct triggering and expression mechanisms underlie LTD of AMPA and NMDA synaptic responses	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CALCIUM-DEPENDENT INACTIVATION; ALPHA-ACTININ; RECEPTORS; CALMODULIN; TRANSMISSION; BINDING; ENDOCYTOSIS; CHANNEL; DYNAMIN	Although long-term depression (LTD) of AMPA receptor - mediated postsynaptic currents (AMPAR EPSCs) has been extensively examined, little is known about the mechanisms responsible for LTD of NMDA receptor ( NMDAR)- mediated EPSCs. Here we show differences in the intracellular signaling cascades that mediate LTD of AMPAR EPSCs versus NMDAR EPSCs in rat hippocampus. Both forms of LTD were blocked by inhibitors of protein phosphatase 1, but only LTD of AMPAR EPSCs was affected by inhibition of calcineurin. Notably, in contrast to LTD of AMPAR EPSCs, LTD of NMDAR EPSCs was unaffected by endocytosis inhibitors. A role for calcium-dependent actin depolymerization in LTD of NMDAR EPSCs was supported by the findings that the actin stabilizer phalloidin and a cofilin inhibitory peptide each blocked LTD of NMDAR EPSCs but not AMPAR EPSCs. These results suggest that the same pattern of afferent activity elicits depression of AMPAR- and NMDAR-mediated synaptic responses by means of distinct triggering and expression mechanisms.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, 1201 Welch Rd, Palo Alto, CA 94304 USA.	malenka@stanford.edu	Marie, Hélène/F-1404-2011	Marie, Hélène/0000-0003-2310-6097	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063394, R37MH063394] Funding Source: NIH RePORTER; NIMH NIH HHS [MH063394] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison DW, 1998, J NEUROSCI, V18, P2423; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; GEAN PW, 1993, NEUROSCI LETT, V158, P170, DOI 10.1016/0304-3940(93)90256-K; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Kim CH, 1999, J NEUROSCI, V19, P4314; Kotecha SA, 2003, INT REV NEUROBIOL, V54, P53; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Lei SB, 2001, J NEUROSCI, V21, P8464, DOI 10.1523/JNEUROSCI.21-21-08464.2001; Li B, 2003, J NEUROSCI, V23, P11244; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Tovar KR, 2002, NEURON, V34, P253; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; XIAO MY, 1994, EUR J NEUROSCI, V6, P1055, DOI 10.1111/j.1460-9568.1994.tb00600.x; XIE XP, 1992, J NEUROPHYSIOL, V67, P1009, DOI 10.1152/jn.1992.67.4.1009; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	48	141	148	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1043	1050		10.1038/nn1506	http://dx.doi.org/10.1038/nn1506			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025109				2022-12-17	WOS:000230760200016
J	Pattyn, A; Simplicio, N; van Doorninck, JH; Goridis, C; Guillemot, FO; Brunet, JF				Pattyn, A; Simplicio, N; van Doorninck, JH; Goridis, C; Guillemot, FO; Brunet, JF			Ascl1/Mash1 is required for the development of central serotonergic neurons	NATURE NEUROSCIENCE			English	Article							HOMEOBOX GENE PHOX2B; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; PRONEURAL GENES; MOTOR-NEURON; EXPRESSION; SPECIFICATION; IDENTITY; MASH1; PROGENITORS	The transcriptional control of the differentiation of central serotonergic (5-HT) neurons in vertebrates has recently come under scrutiny and has been shown to involve the homeobox genes Nkx2-2 and Lmx1b, the Ets-domain gene Pet1 (also known as Fev) and the zinc-finger gene Gata3. The basic helix-loop-helix (bHLH) gene Ascl1 (also known as Mash1) is coexpressed with Nkx2-2 in the neuroepithelial domain of the hindbrain, which gives rise to 5-HT neurons. Here we show in the mouse that Ascl1 is essential for the birth of 5-HT neurons, both as a proneural gene for the production of postmitotic neuronal precursors and as a determinant of the serotonergic phenotype for the parallel activation of Gata3, Lmx1b and Pet1. Thus Ascl1, which is essential for noradrenergic differentiation, is also a determinant of the serotonergic phenotype.	Ecole Normale Super, CNRS, UMR 8542, F-75005 Paris, France; Natl Inst Med Res, London NW7 1AA, England; Erasmus MC, Dept Cell Biol, NL-3000 DR Rotterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; MRC National Institute for Medical Research; Erasmus University Rotterdam; Erasmus MC	Brunet, JF (corresponding author), Ecole Normale Super, CNRS, UMR 8542, F-75005 Paris, France.	jfbrunet@biologie.ens.fr	Alexandre, Pattyn/ABF-1346-2020	Brunet, Jean-Francois/0000-0002-1985-6103; Pattyn, Alexandre/0000-0003-1215-1482				Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Blaugrund E, 1996, DEVELOPMENT, V122, P309; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Cau E, 1997, DEVELOPMENT, V124, P1611; Cheng LP, 2003, J NEUROSCI, V23, P9961; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hirsch MR, 1998, DEVELOPMENT, V125, P599; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; KONIG N, 1988, J NEUROSCI RES, V20, P212, DOI 10.1002/jnr.490200210; Lanigan TM, 1998, J NEUROBIOL, V34, P126, DOI 10.1002/(SICI)1097-4695(19980205)34:2<126::AID-NEU3>3.0.CO;2-4; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Lo LC, 1998, DEVELOPMENT, V125, P609; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Pabst O, 1998, MECH DEVELOP, V73, P85, DOI 10.1016/S0925-4773(98)00035-5; Pabst O, 2003, DEVELOPMENT, V130, P1193, DOI 10.1242/dev.00346; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Pata I, 1999, DEVELOPMENT, V126, P5523; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Pattyn A, 2000, MOL CELL NEUROSCI, V15, P235, DOI 10.1006/mcne.1999.0826; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Shimamura K, 1995, DEVELOPMENT, V121, P3923; TAKEBAYASHI K, 1995, J BIOL CHEM, V270, P1342, DOI 10.1074/jbc.270.3.1342; Tiveron MC, 2003, DEV BIOL, V260, P46, DOI 10.1016/S0012-1606(03)00213-6; Tiveron MC, 1996, J NEUROSCI, V16, P7649; TORK I, 1990, ANN NY ACAD SCI, V600, P9; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; van Doorninck J H, 1999, J Neurosci, V19, pRC12	43	141	149	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					589	595		10.1038/nn1247	http://dx.doi.org/10.1038/nn1247			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15133515				2022-12-17	WOS:000221640300012
J	Huk, AC; Heeger, DJ				Huk, AC; Heeger, DJ			Pattern-motion responses in human visual cortex	NATURE NEUROSCIENCE			English	Article							AREA MT; COHERENCE; FMRI; PERCEPTION; NEURONS; MACAQUE; SIGNAL; BRAIN; MRI; V5	Physiological models of visual motion processing posit that 'pattern-motion cells' represent the direction of moving objects independent of their particular spatial pattern. We performed fMRI experiments to identify neuronal activity in the human brain selective for pattern motion. A protocol using adaptation to moving 'plaid' stimuli allowed us to separate pattern-motion responses from other types of motion-related activity within the same brain structures, and revealed strong pattern-motion selectivity in human visual area MT+. Reducing the perceptual coherence of the plaids yielded a corresponding decrease in pattern-motion responsivity, providing evidence that percepts of coherent motion are closely linked to the activity of pattern-motion cells in human MT+.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Huk, AC (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290,Hlth Sci Bldg,Room G-424, Seattle, WA 98195 USA.		Huk, Alexander/A-8031-2016	Huk, Alexander/0000-0003-1430-6935	NATIONAL EYE INSTITUTE [R01EY012741] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY12741] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Chawla D, 1998, NEUROIMAGE, V7, P86, DOI 10.1006/nimg.1997.0319; Chawla D, 1999, NEUROIMAGE, V9, P508, DOI 10.1006/nimg.1999.0432; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Engel SA, 2001, J NEUROSCI, V21, P3949, DOI 10.1523/JNEUROSCI.21-11-03949.2001; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Huk AC, 2000, J NEUROPHYSIOL, V83, P3525, DOI 10.1152/jn.2000.83.6.3525; KOOI FL, 1992, PERCEPT PSYCHOPHYS, V52, P415, DOI 10.3758/BF03206701; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Li B, 2001, EUR J NEUROSCI, V14, P690, DOI 10.1046/j.0953-816x.2001.01689.x; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; SMITH AT, 1992, VISION RES, V32, P393, DOI 10.1016/0042-6989(92)90148-C; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WELCH L, 1989, NATURE, V337, P734, DOI 10.1038/337734a0; WELCH L, 1990, PERCEPTION, V19, P425, DOI 10.1068/p190425; ZEKI S, 1991, J NEUROSCI, V11, P641	30	141	141	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					72	75		10.1038/nn774	http://dx.doi.org/10.1038/nn774			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11731801				2022-12-17	WOS:000173031800018
J	Murakami, TC; Mano, T; Saikawa, S; Horiguchi, SA; Shigeta, D; Baba, K; Sekiya, H; Shimizu, Y; Tanaka, KF; Kiyonari, H; Iino, M; Mochizuki, H; Tainaka, K; Ueda, HR				Murakami, Tatsuya C.; Mano, Tomoyuki; Saikawa, Shu; Horiguchi, Shuhei A.; Shigeta, Daichi; Baba, Kousuke; Sekiya, Hiroshi; Shimizu, Yoshihiro; Tanaka, Kenji F.; Kiyonari, Hiroshi; Iino, Masamitsu; Mochizuki, Hideki; Tainaka, Kazuki; Ueda, Hiroki R.			A three-dimensional single-cell-resolution whole-brain atlas using CUBIC-X expansion microscopy and tissue clearing	NATURE NEUROSCIENCE			English	Article							WAXHOLM SPACE; SCALING RULES; BODY; RECONSTRUCTION; VISUALIZATION; ACTIVATION; VERSATILE; ORGANS	A three-dimensional single-cell-resolution mammalian brain atlas will accelerate systems-level identification and analysis of cellular circuits underlying various brain functions. However, its construction requires efficient subcellular-resolution imaging throughout the entire brain. To address this challenge, we developed a fluorescent-protein-compatible, whole-organ clearing and homogeneous expansion protocol based on an aqueous chemical solution (CUBIC-X). The expanded, well-cleared brain enabled us to construct a point-based mouse brain atlas with single-cell annotation (CUBIC-Atlas). CUBIC-Atlas reflects inhomogeneous whole-brain development, revealing a significant decrease in the cerebral visual and somatosensory cortical areas during postnatal development. Probabilistic activity mapping of pharmacologically stimulated Arc-dVenus reporter mouse brains onto CUBIC-Atlas revealed the existence of distinct functional structures in the hippocampal dentate gyrus. CUBIC-Atlas is shareable by an open-source web-based viewer, providing a new platform for whole-brain cell profiling.	[Murakami, Tatsuya C.; Mano, Tomoyuki; Shigeta, Daichi; Tainaka, Kazuki; Ueda, Hiroki R.] Univ Tokyo, Grad Sch Med, Dept Syst Pharmacol, Tokyo, Japan; [Mano, Tomoyuki; Ueda, Hiroki R.] Univ Tokyo, WPI IRCN, UTIAS, Tokyo, Japan; [Saikawa, Shu] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Chiba, Japan; [Horiguchi, Shuhei A.; Ueda, Hiroki R.] RIKEN, Quantitat Biol Ctr, Lab Synthet Biol, Osaka, Japan; [Horiguchi, Shuhei A.] Osaka Univ, Sch Engn Sci, Dept Syst Sci, Osaka, Japan; [Baba, Kousuke; Mochizuki, Hideki] Osaka Univ, Dept Neurol, Grad Sch Med, Osaka, Japan; [Baba, Kousuke] Osaka Univ, Grad Sch Med, Dept Kampo Med, Osaka, Japan; [Sekiya, Hiroshi; Iino, Masamitsu] Univ Tokyo, Grad Sch Med, Dept Pharmacol, Tokyo, Japan; [Shimizu, Yoshihiro] RIKEN, Quantitat Biol Ctr, Lab Cell Free Prot Synth, Osaka, Japan; [Tanaka, Kenji F.] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Anim Resource Dev Unit, Kobe, Hyogo, Japan; [Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Genet Engn Team, Kobe, Hyogo, Japan; [Iino, Masamitsu] Nihon Univ, Sch Med, Div Cellular & Mol Pharmacol, Tokyo, Japan; [Tainaka, Kazuki] Niigata Univ, Brain Res Inst, Niigata, Japan	University of Tokyo; University of Tokyo; University of Tokyo; RIKEN; Osaka University; Osaka University; Osaka University; University of Tokyo; RIKEN; Keio University; RIKEN; RIKEN; Nihon University; Niigata University	Ueda, HR (corresponding author), Univ Tokyo, Grad Sch Med, Dept Syst Pharmacol, Tokyo, Japan.; Ueda, HR (corresponding author), Univ Tokyo, WPI IRCN, UTIAS, Tokyo, Japan.; Ueda, HR (corresponding author), RIKEN, Quantitat Biol Ctr, Lab Synthet Biol, Osaka, Japan.	uedah-tky@umin.ac.jp	Shimizu, Yoshihiro/A-6472-2016; Ueda, Hiroki R/C-5037-2014	Shimizu, Yoshihiro/0000-0003-3499-1394; Ueda, Hiroki R/0000-0001-8342-9176; Murakami, Tatsuya/0000-0002-3734-9359; Mano, Tomoyuki/0000-0001-7495-0306; Horiguchi, Shuhei/0000-0002-8459-1914; Tainaka, Kazuki/0000-0002-5943-8723; Tanaka, Kenji/0000-0003-2511-0057	AMED-CREST (AMED/MEXT) [JP17gm0610006]; CREST (JST/MEXT); Brain/MINDS (AMED/MEXT) [JP17dm0207049]; Basic Science and Platform Technology Program for Innovative Biological Medicine (AMED/MEXT) [JP17am0301025]; Translational Research Network Program from Japan Agency for Medical Research and development (AMED); World Premier International Research Center Initiative (MEXT); JSPS KAKENHI [16J05041, 25221004, 16K15124, 23115006, 15H01558, 17H05688]; Naito Foundation; Grants-in-Aid for Scientific Research [17H05688] Funding Source: KAKEN	AMED-CREST (AMED/MEXT); CREST (JST/MEXT); Brain/MINDS (AMED/MEXT); Basic Science and Platform Technology Program for Innovative Biological Medicine (AMED/MEXT); Translational Research Network Program from Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); World Premier International Research Center Initiative (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all lab members at The University of Tokyo and RIKEN QBiC, in particular: A. Millius and W Kylius for editing, E. A. Susaki and A. Kuno for discovering the tissue-swelling phenomenon, S. Shoi for helping with statistical analysis, K. Yoshida for helping with the decomposing transformation matrix, and C. Shimizu for supporting swelling experiments. We also thank H. Hayakawa and S. Jiang for supporting the preparation of a C57BL/6 J mouse brain, D. Perrin and H. Yukinaga for informatics instruction, J. Kaneshiro, T. Watanabe and Olympus Engineering for helping design the microscope, T. Mitani and K. Matsumoto for reproducibility confirmation, S. Takano, S. Yamazoe and T. Tsukuda for the measurements of zeta potentials and Bitplane for instruction of Imaris 8.1.2. This work was supported by a grant from AMED-CREST (AMED/MEXT, grant number JP17gm0610006, to H.R.U.), CREST (JST/MEXT, to H.R.U.), Brain/MINDS (AMED/MEXT, grant number JP17dm0207049, to H.R.U. and H.M.), Basic Science and Platform Technology Program for Innovative Biological Medicine (AMED/MEXT, grant number JP17am0301025, to H.R.U.), Translational Research Network Program from Japan Agency for Medical Research and development (AMED, to H.M.), World Premier International Research Center Initiative (MEXT, to H.R.U), a Grant-in-Aid for Scientific Research (JSPS KAKENHI, grant number 16J05041, to T.C.M.), a Grant-in-Aid for Scientific Research (S) (JSPS KAKENHI, grant number 25221004, to H.R.U.), Grant-in-Aid for Challenging Exploratory Research (JSPS KAKENHI, grant number 16K15124, to K.T.), a Grant-in-Aid for Scientific Research on Innovative Areas (JSPS KAKENHI, grant number 23115006, to H.R.U., 15H01558, to H.M., 17H05688, to K.T.), and a Grant-in-Aid from the Naito Foundation (to K.T.).	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Amunts K, 2013, SCIENCE, V340, P1472, DOI 10.1126/science.1235381; Aoyagi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116280; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bastian M, 2009, INT AAAI C WEBLOGS S, DOI DOI 10.13140/2.1.1341.1520; Bria A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-316; Calabrese E, 2015, NEUROIMAGE, V117, P408, DOI 10.1016/j.neuroimage.2015.05.072; Chang JB, 2017, NAT METHODS, V14, P593, DOI [10.1038/NMETH.4261, 10.1038/nmeth.4261]; Chechik G, 1998, NEURAL COMPUT, V10, P1759, DOI 10.1162/089976698300017124; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Cope M, 1989, Adv Exp Med Biol, V248, P33; Costantini I, 2015, SCI REP-UK, V5, DOI 10.1038/srep09808; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Dong H. W., 2008, ALLEN REFERENCE ATLA; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Hagberg AA, 2008, 7 PYTH SCI C SCIPY20, P11; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Herculano-Houzel S, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00064; Herculano-Houzel S, 2011, BRAIN BEHAV EVOLUT, V78, P302, DOI 10.1159/000330825; Inamura N, 2012, GENESIS, V50, P424, DOI 10.1002/dvg.20808; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Kanemaru K, 2014, CELL REP, V8, P311, DOI 10.1016/j.celrep.2014.05.056; Kasukawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023228; Ke MT, 2016, CELL REP, V14, P2718, DOI 10.1016/j.celrep.2016.02.057; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kim Y, 2015, CELL REP, V10, P292, DOI 10.1016/j.celrep.2014.12.014; Ku T, 2016, NAT BIOTECHNOL, V34, P973, DOI 10.1038/nbt.3641; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Menegas W, 2015, ELIFE, V4, DOI 10.7554/eLife.10032; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Murphy K, 2011, IEEE T MED IMAGING, V30, P1901, DOI 10.1109/TMI.2011.2158349; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Okamura-Oho Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045373; Pan CC, 2016, NAT METHODS, V13, P859, DOI 10.1038/nmeth.3964; Papp EA, 2014, NEUROIMAGE, V97, P374, DOI 10.1016/j.neuroimage.2014.04.001; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rohlfing T, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00027; Saalfeld S, 2009, BIOINFORMATICS, V25, P1984, DOI 10.1093/bioinformatics/btp266; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Schwarz MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124650; Seiriki K, 2017, NEURON, V94, P1085, DOI 10.1016/j.neuron.2017.05.017; Shimada T, 2005, PHYSICA A, V350, P144, DOI 10.1016/j.physa.2004.11.033; Steder B, 2011, IEEE INT CONF ROBOT, P2601, DOI 10.1109/ICRA.2011.5980187; Susaki EA, 2016, CELL CHEM BIOL, V23, P137, DOI 10.1016/j.chembiol.2015.11.009; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2016, ANNU REV CELL DEV BI, V32, P713, DOI 10.1146/annurev-cellbio-111315-125001; Tanaka KF, 2010, BIOL PSYCHIAT, V67, P770, DOI 10.1016/j.biopsych.2009.12.020; Tatsuki F, 2016, NEURON, V90, P70, DOI 10.1016/j.neuron.2016.02.032; Tillberg PW, 2016, NAT BIOTECHNOL, V34, P987, DOI 10.1038/nbt.3625; Treweek JB, 2015, NAT PROTOC, V10, P1860, DOI 10.1038/nprot.2015.122; Vanderhaeghen P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001859; Velez-Fort M, 2014, NEURON, V83, P1431, DOI 10.1016/j.neuron.2014.08.001; von Bartheld CS, 2016, J COMP NEUROL, V524, P3865, DOI 10.1002/cne.24040; Vousden DA, 2015, BRAIN STRUCT FUNCT, V220, P2043, DOI 10.1007/s00429-014-0774-0; Warnes G. R., 2020, SCI OPEN; Wills R, 2000, BUS WEEK, P21; WRAY S, 1988, BIOCHIM BIOPHYS ACTA, V933, P184, DOI 10.1016/0005-2728(88)90069-2; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	68	140	141	15	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2018	21	4					625	+		10.1038/s41593-018-0109-1	http://dx.doi.org/10.1038/s41593-018-0109-1			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB1FG	29507408				2022-12-17	WOS:000428796000021
J	Corey, DR				Corey, David R.			Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy	NATURE NEUROSCIENCE			English	Editorial Material								Nusinersen (Spinraza) is a recently approved drug for treating spinal muscular atrophy. Approval of nusinersen may signal new opportunities for using antisense oligonucleotides as treatments for devastating neurological diseases.	[Corey, David R.] UT Southwestern, Dept Pharmacol, Dallas, TX 75235 USA; [Corey, David R.] UT Southwestern, Dept Biochem, Dallas, TX 75235 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Corey, DR (corresponding author), UT Southwestern, Dept Pharmacol, Dallas, TX 75235 USA.; Corey, DR (corresponding author), UT Southwestern, Dept Biochem, Dallas, TX 75235 USA.	david.corey@utsouthwestern.edu						Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Corey D. R., NAT REV DRU IN PRESS; DeVos SL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0481; Faravelli I, 2015, NAT REV NEUROL, V11, P351, DOI 10.1038/nrneurol.2015.77; Finkel RS, 2016, LANCET, V388, P3017, DOI 10.1016/S0140-6736(16)31408-8; Havens MA, 2016, NUCLEIC ACIDS RES, V44, P6549, DOI 10.1093/nar/gkw533; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Lim SR, 2001, J BIOL CHEM, V276, P45476, DOI 10.1074/jbc.M107632200; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; US Food and Drug Administration, 2016, FDA APPR 1 DRUG SPIN; US Food & Drug Administration, 2016, SPINR NUS INJ	12	140	144	6	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2017	20	4					497	499		10.1038/nn.4508	http://dx.doi.org/10.1038/nn.4508			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EP7LH	28192393				2022-12-17	WOS:000397558800001
J	Lerch, JP; van der Kouwe, AJW; Raznahan, A; Pans, T; Johansen-Berg, H; Miller, KL; Smith, SM; Fischl, B; Sotiropoulos, SN				Lerch, Jason P.; van der Kouwe, Andre J. W.; Raznahan, Armin; Pans, Tomas; Johansen-Berg, Heidi; Miller, Karla L.; Smith, Stephen M.; Fischl, Bruce; Sotiropoulos, Stamatios N.			Studying neuroanatomy using MRI	NATURE NEUROSCIENCE			English	Review							VOXEL-BASED MORPHOMETRY; NEURITE ORIENTATION DISPERSION; AXON DIAMETER DISTRIBUTION; HUMAN CORTICAL DEVELOPMENT; HUMAN CONNECTOME PROJECT; PULSED-FIELD GRADIENT; BRAIN WHITE-MATTER; VIVO DIFFUSION MRI; HEAD MOTION; MAGNETIZATION-TRANSFER	The study of neuroanatomy using imaging enables key insights into how our brains function, are shaped by genes and environment, and change with development, aging and disease. Developments in MRI acquisition, image processing and data modeling have been key to these advances. However, MRI provides an indirect measurement of the biological signals we aim to investigate. Thus, artifacts and key questions of correct interpretation can confound the readouts provided by anatomical MRI. In this review we provide an overview of the methods for measuring macro- and mesoscopic structure and for inferring microstructural properties; we also describe key artifacts and confounds that can lead to incorrect conclusions. Ultimately, we believe that, although methods need to improve and caution is required in interpretation, structural MRI continues to have great promise in furthering our understanding of how the brain works.	[Lerch, Jason P.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Lerch, Jason P.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [van der Kouwe, Andre J. W.; Fischl, Bruce] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Res, Charlestown, MA USA; [van der Kouwe, Andre J. W.; Fischl, Bruce] Harvard Med Sch, Charlestown, MA USA; [van der Kouwe, Andre J. W.; Fischl, Bruce] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [van der Kouwe, Andre J. W.; Fischl, Bruce] Harvard Med Sch, Boston, MA USA; [Raznahan, Armin] NIMH, Dev Neurogen Unit, Child Psychiat Branch, Bethesda, MD 20892 USA; [Pans, Tomas] Rotman Res Inst, Toronto, ON, Canada; [Pans, Tomas] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Pans, Tomas] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Pans, Tomas] Child Mind Inst, Ctr Developing Brain, New York, NY USA; [Johansen-Berg, Heidi; Miller, Karla L.; Smith, Stephen M.; Sotiropoulos, Stamatios N.] Univ Oxford, Oxford Ctr Funct MRI Brain FMRIB, Oxford, MS USA; [Fischl, Bruce] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Sotiropoulos, Stamatios N.] Univ Nottingham, Sch Med, Sir Peter Mansfield Imaging Ctr, Nottingham NG7 2RD, England	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto; Massachusetts Institute of Technology (MIT); University of Nottingham	Lerch, JP (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada.; Lerch, JP (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	jason.lerch@utoronto.ca	Sotiropoulos, Stamatios/I-1163-2019; Raznahan, Armin/F-4534-2012	Sotiropoulos, Stamatios/0000-0003-4735-5776; Raznahan, Armin/0000-0002-5622-1190; Miller, Karla/0000-0002-2511-3189; Smith, Stephen/0000-0001-8166-069X; Johansen-Berg, Heidi/0000-0002-4134-9730	Ontario Brain Institutes' POND grant; EPSRC [EP/L023067/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L023067/1] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002949] Funding Source: NIH RePORTER	Ontario Brain Institutes' POND grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Hammill for his assistance in the preparation of Figures 2 and 3, which contain data from The Ontario Brain Institutes' POND grant (to J.P.L.), and we thank L. Wald (Massachusetts General Hospital) for providing the images in Figure 6. Figure 1 contains data from R0IMH085772-01A1 (to T.P.).	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alexander-Bloch A, 2016, HUM BRAIN MAPP, V37, P2385, DOI 10.1002/hbm.23180; Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Alexander-Bloch A, 2013, J NEUROSCI, V33, P2889, DOI 10.1523/JNEUROSCI.3554-12.2013; Alexander-Bloch AF, 2014, BIOL PSYCHIAT, V76, P438, DOI 10.1016/j.biopsych.2014.02.010; Amlien IK, 2016, CEREB CORTEX, V26, P257, DOI 10.1093/cercor/bhu214; Anderson PJ, 2015, SEMIN PERINATOL, V39, P147, DOI 10.1053/j.semperi.2015.01.008; Andersson JLR, 2016, NEUROIMAGE, V141, P556, DOI 10.1016/j.neuroimage.2016.06.058; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Assaf Y, 1998, J MAGN RESON, V131, P69, DOI 10.1006/jmre.1997.1313; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Biedermann S, 2012, NEUROIMAGE, V61, P1206, DOI 10.1016/j.neuroimage.2012.04.010; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; BOTTOMLEY PA, 1987, MED PHYS, V14, P1, DOI 10.1118/1.596111; Boulby PA, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, P143, DOI 10.1002/0470869526.ch6; CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0; Cao J, 1999, ANN STAT, V27, P925; Chakravarty MM, 2013, HUM BRAIN MAPP, V34, P2635, DOI 10.1002/hbm.22092; Chang LC, 2012, MAGN RESON MED, V68, P1654, DOI 10.1002/mrm.24173; Chen CH, 2013, P NATL ACAD SCI USA, V110, P17089, DOI 10.1073/pnas.1308091110; Chung MK, 2001, NEUROIMAGE, V14, P595, DOI 10.1006/nimg.2001.0862; Clark CA, 2000, MAGN RESON MED, V44, P852, DOI 10.1002/1522-2594(200012)44:6<852::AID-MRM5>3.0.CO;2-A; Colgan N, 2016, NEUROIMAGE, V125, P739, DOI 10.1016/j.neuroimage.2015.10.043; Collin G, 2014, CEREB CORTEX, V24, P2258, DOI 10.1093/cercor/bht064; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dell'Acqua F, 2013, HUM BRAIN MAPP, V34, P2464, DOI 10.1002/hbm.22080; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; Deoni SCL, 2011, MAGN RESON MED, V65, P1021, DOI 10.1002/mrm.22685; Devlin JT, 2007, NEUROIMAGE, V37, P1033, DOI 10.1016/j.neuroimage.2006.09.055; Douaud G, 2009, NEUROIMAGE, V46, P958, DOI 10.1016/j.neuroimage.2009.03.044; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Drobnjak I, 2016, MAGN RESON MED, V75, P688, DOI 10.1002/mrm.25631; Dubois J, 2008, BRAIN, V131, P2028, DOI 10.1093/brain/awn137; Ducharme S, 2016, NEUROIMAGE, V125, P267, DOI 10.1016/j.neuroimage.2015.10.010; Eichner C, 2014, MAGN RESON MED, V71, P1518, DOI 10.1002/mrm.24809; Evans AC, 2013, NEUROIMAGE, V80, P489, DOI 10.1016/j.neuroimage.2013.05.054; Falk EB, 2013, P NATL ACAD SCI USA, V110, P17615, DOI 10.1073/pnas.1310134110; Fan QY, 2016, NEUROIMAGE, V124, P1108, DOI 10.1016/j.neuroimage.2015.08.075; Ferizi U, 2015, NEUROIMAGE, V118, P468, DOI 10.1016/j.neuroimage.2015.06.027; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fischl B, 1999, II INFLATION FLATTEN, V207, P195, DOI DOI 10.1006/NIMG.1998.0396; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; FRAM EK, 1987, MAGN RESON IMAGING, V5, P201, DOI 10.1016/0730-725X(87)90021-X; French L, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00323; French L, 2015, JAMA PSYCHIAT, V72, P1002, DOI 10.1001/jamapsychiatry.2015.1131; Fuss J, 2014, HIPPOCAMPUS, V24, P131, DOI 10.1002/hipo.22227; Gallichan D, 2016, MAGN RESON MED, V75, P1030, DOI 10.1002/mrm.25670; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Glasser MF, 2016, NAT NEUROSCI, V19, P1175, DOI 10.1038/nn.4361; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Golub Y, 2011, J PSYCHIATR RES, V45, P650, DOI 10.1016/j.jpsychires.2010.10.014; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gowland PA, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, P111, DOI 10.1002/0470869526.ch5; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hughes E. J., 2016, MAGN RESON MED; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Jbabdi S, 2015, NAT NEUROSCI, V18, P1546, DOI 10.1038/nn.4134; Jelescu IO, 2016, NEUROIMAGE, V132, P104, DOI 10.1016/j.neuroimage.2016.02.004; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kaden E, 2007, NEUROIMAGE, V37, P474, DOI 10.1016/j.neuroimage.2007.05.012; Kaden E, 2016, MAGN RESON MED, V75, P1752, DOI 10.1002/mrm.25734; Keifer OP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8582; Kim H, 2016, NEUROIMAGE, V138, P28, DOI 10.1016/j.neuroimage.2016.05.034; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kodiweera C, 2016, NEUROIMAGE, V128, P180, DOI 10.1016/j.neuroimage.2015.12.033; KUCHARCZYK W, 1994, RADIOLOGY, V192, P521, DOI 10.1148/radiology.192.2.8029426; Lampinen B., 2016, MAGN RESON MED; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; Lee NR, 2014, HUM BRAIN MAPP, V35, P1885, DOI 10.1002/hbm.22299; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Lerch JP, 2011, NEUROIMAGE, V54, P2086, DOI 10.1016/j.neuroimage.2010.09.086; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Lusebrink F, 2013, NEUROIMAGE, V70, P122, DOI 10.1016/j.neuroimage.2012.12.016; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; Margulies DS, 2016, P NATL ACAD SCI USA, V113, P12574, DOI 10.1073/pnas.1608282113; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McGowan JC, 1999, NEUROLOGY, V53, pS3; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393; Mills KL, 2016, NEUROIMAGE, V141, P273, DOI 10.1016/j.neuroimage.2016.07.044; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Nilsson M, 2013, MAGN RESON MATER PHY, V26, P345, DOI 10.1007/s10334-013-0371-x; Odgers CL, 2012, J CHILD PSYCHOL PSYC, V53, P1009, DOI 10.1111/j.1469-7610.2012.02565.x; Olesen OV, 2012, IEEE T MED IMAGING, V31, P79, DOI 10.1109/TMI.2011.2165157; Ooi MB, 2013, MAGN RESON MED, V69, P803, DOI 10.1002/mrm.24285; Ozarslan E, 2009, J MAGN RESON, V199, P56, DOI 10.1016/j.jmr.2009.04.002; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Pardoe HR, 2016, NEUROIMAGE, V135, P177, DOI 10.1016/j.neuroimage.2016.05.005; Paus T, 2016, HAND CLINIC, V138, P17, DOI 10.1016/B978-0-12-802973-2.00002-1; Paus T., 2013, POPULATION NEUROSCIE, DOI [10.1007/978-3-642-36450-1, DOI 10.1007/978-3-642-36450-1]; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pike GB, 1996, MAGNET RESON MED, V36, P95, DOI 10.1002/mrm.1910360117; Preibisch C, 2009, MAGN RESON MED, V62, P240, DOI 10.1002/mrm.21969; Pruessner JC, 2002, CEREB CORTEX, V12, P1342, DOI 10.1093/cercor/12.12.1342; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Raznahan A, 2016, CEREB CORTEX, V26, P70, DOI 10.1093/cercor/bhu174; Raznahan A, 2014, P NATL ACAD SCI USA, V111, P1592, DOI 10.1073/pnas.1316911111; Raznahan A, 2012, P NATL ACAD SCI USA, V109, P11366, DOI 10.1073/pnas.1203350109; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Reardon PK, 2016, J NEUROSCI, V36, P2438, DOI 10.1523/JNEUROSCI.3195-15.2016; Reid A. T., 2016, BRAIN STRUCT FUNCT; Reisert M., 2016, NEUROIMAGE S; Reuter M, 2015, NEUROIMAGE, V107, P107, DOI 10.1016/j.neuroimage.2014.12.006; Rudrapatna SU, 2016, MAGN RESON MED, V76, P83, DOI 10.1002/mrm.25856; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schafer A, 2012, HUM BRAIN MAPP, V33, P2831, DOI 10.1002/hbm.21404; Schmaal L., 2016, MOL PSYCHIAT; Schmitt JE, 2014, P NATL ACAD SCI USA, V111, P6774, DOI 10.1073/pnas.1311630111; Scholtens LH, 2015, HUM BRAIN MAPP, V36, P3038, DOI 10.1002/hbm.22826; Scholz J, 2015, NEUROIMAGE, V109, P190, DOI 10.1016/j.neuroimage.2015.01.027; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sepehrband F, 2015, HUM BRAIN MAPP, V36, P3687, DOI 10.1002/hbm.22872; Setsompop K, 2013, NEUROIMAGE, V80, P220, DOI 10.1016/j.neuroimage.2013.05.078; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shemesh N, 2010, NMR BIOMED, V23, P757, DOI 10.1002/nbm.1550; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; Simon TJ, 2005, NEUROIMAGE, V25, P169, DOI 10.1016/j.neuroimage.2004.11.018; Smith E, 2016, HUM BRAIN MAPP, V37, P2616, DOI 10.1002/hbm.23195; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Sotiropoulos SN, 2012, NEUROIMAGE, V60, P1412, DOI 10.1016/j.neuroimage.2012.01.056; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; Stikov N, 2015, NEUROIMAGE, V118, P397, DOI 10.1016/j.neuroimage.2015.05.023; Stikov N, 2015, MAGN RESON MED, V73, P514, DOI 10.1002/mrm.25135; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044195; Studholme C, 2011, ANNU REV BIOMED ENG, V13, P345, DOI [10.1146/annurev-bioeng-071910-124654, 10.1146/annurev-biocng-071910-124654]; Tardif CL, 2010, HUM BRAIN MAPP, V31, P943, DOI 10.1002/hbm.20908; Tardif CL, 2009, NEUROIMAGE, V44, P827, DOI 10.1016/j.neuroimage.2008.09.053; Tardif CL, 2016, NEUROIMAGE, V131, P55, DOI 10.1016/j.neuroimage.2015.08.047; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Tee YK, 2014, NMR BIOMED, V27, P1019, DOI 10.1002/nbm.3147; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Thomas AG, 2009, NEUROIMAGE, V48, P117, DOI 10.1016/j.neuroimage.2009.05.097; Thomas C, 2013, NEUROIMAGE, V73, P225, DOI 10.1016/j.neuroimage.2012.03.069; Thompson PM, 2014, BRAIN IMAGING BEHAV, V8, P153, DOI 10.1007/s11682-013-9269-5; Tisdall MD, 2016, NEUROIMAGE, V127, P11, DOI 10.1016/j.neuroimage.2015.11.054; Toro R, 2009, BRAIN STRUCT FUNCT, V213, P501, DOI 10.1007/s00429-009-0203-y; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Trefler A, 2016, NEUROIMAGE, V133, P41, DOI 10.1016/j.neuroimage.2016.02.034; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; van der Kouwe A., 2009, P 17 SCI M ISMRM, V17, P4623; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; van der Kouwe AJW, 2006, MAGN RESON MED, V56, P1019, DOI 10.1002/mrm.21038; van Niekerk A. M. J., 2016, PHYS MEDICA, V32, P158; Vandekar SN, 2015, J NEUROSCI, V35, P599, DOI 10.1523/JNEUROSCI.3628-14.2015; Voineskos AN, 2009, NEUROIMAGE, V45, P370, DOI 10.1016/j.neuroimage.2008.12.028; Vu AT, 2015, NEUROIMAGE, V122, P318, DOI 10.1016/j.neuroimage.2015.08.004; Walker-Samuel S, 2013, NAT MED, V19, P1067, DOI 10.1038/nm.3252; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Watanabe H, 2011, J MAGN RESON, V212, P426, DOI 10.1016/j.jmr.2011.08.001; Westin CF, 2016, NEUROIMAGE, V135, P345, DOI 10.1016/j.neuroimage.2016.02.039; Xu JQ, 2013, NEUROIMAGE, V83, P991, DOI 10.1016/j.neuroimage.2013.07.055; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yushkevich PA, 2008, NEUROIMAGE, V41, P448, DOI 10.1016/j.neuroimage.2008.01.013; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	175	140	142	3	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2017	20	3					314	326		10.1038/nn.4501	http://dx.doi.org/10.1038/nn.4501			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9DU	28230838	Green Accepted, Green Submitted			2022-12-17	WOS:000394920400005
J	Sarkar, S; Doring, A; Zemp, FJ; Silva, C; Lun, XQ; Wang, XL; Kelly, J; Hader, W; Hamilton, M; Mercier, P; Dunn, JF; Kinniburgh, D; van Rooijen, N; Robbins, S; Forsyth, P; Cairncross, G; Weiss, S; Yong, VW				Sarkar, Susobhan; Doering, Axinia; Zemp, Franz J.; Silva, Claudia; Lun, Xueqing; Wang, Xiuling; Kelly, John; Hader, Walter; Hamilton, Mark; Mercier, Philippe; Dunn, Jeff F.; Kinniburgh, Dave; van Rooijen, Nico; Robbins, Stephen; Forsyth, Peter; Cairncross, Gregory; Weiss, Samuel; Yong, V. Wee			Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells	NATURE NEUROSCIENCE			English	Article							CANCER STEM-CELLS; AMPHOTERICIN-B; IN-VIVO; GLIOMA GROWTH; GLIOBLASTOMA; DIFFERENTIATION; MICROGLIA/MACROPHAGES; PROLIFERATION; CHEMOTHERAPY; PROGRESSION	Brain tumor initiating cells (BTICs) contribute to the genesis and recurrence of gliomas. We examined whether the microglia and macrophages that are abundant in gliomas alter BTIC growth. We found that microglia derived from non-glioma human subjects markedly mitigated the sphere-forming capacity of glioma patient-derived BTICs in culture by inducing the expression of genes that control cell cycle arrest and differentiation. This sphere-reducing effect was mimicked by macrophages, but not by neurons or astrocytes. Using a drug screen, we validated amphotericin B (AmpB) as an activator of monocytoid cells and found that AmpB enhanced the microglial reduction of BTIC spheres. In mice harboring intracranial mouse or patient-derived BTICs, daily systemic treatment with non-toxic doses of AmpB substantially prolonged life. Notably, microglia and monocytes cultured from glioma patients were inefficient at reducing the sphere-forming capacity of autologous BTICs, but this was rectified by AmpB. These results provide new insights into the treatment of gliomas.	[Sarkar, Susobhan; Doering, Axinia; Silva, Claudia; Kelly, John; Hader, Walter; Hamilton, Mark; Mercier, Philippe; Cairncross, Gregory; Yong, V. Wee] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Sarkar, Susobhan; Doering, Axinia; Silva, Claudia; Kelly, John; Hader, Walter; Hamilton, Mark; Mercier, Philippe; Dunn, Jeff F.; Weiss, Samuel; Yong, V. Wee] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Zemp, Franz J.; Lun, Xueqing; Wang, Xiuling; Robbins, Stephen; Forsyth, Peter; Cairncross, Gregory] Univ Calgary, Southern Alberta Canc Res Inst, Calgary, AB, Canada; [Kinniburgh, Dave] Univ Calgary, Ctr Toxicol, Calgary, AB, Canada; [van Rooijen, Nico] Vrije Univ Amsterdam, Dept Mol Cell Biol, Amsterdam, Netherlands	University of Calgary; University of Calgary; University of Calgary; University of Calgary; Vrije Universiteit Amsterdam	Yong, VW (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.	vyong@ucalgary.ca	Van Rooijen, Nico/Z-1578-2019	Yong, V. Wee/0000-0002-2600-3563; Robbins, Stephen/0000-0001-7475-1665	Alberta Innovates Health Solutions/Alberta Cancer Foundation; Canadian Institutes of Health Research; Canada Research Chair (Tier 1) in Neuroimmunology; Alberta Innovates [201201230] Funding Source: researchfish	Alberta Innovates Health Solutions/Alberta Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair (Tier 1) in Neuroimmunology; Alberta Innovates	We acknowledge the technical assistance of Y. Fan, X. Zhang, F. Yong, J. Wang, H. Mowbray, B. Verhaeghe, M. Keough, R. Hassam, B. Mckenzie and A. Luchman. Clodronate was a gift from Roche Diagnostics GmbH. We thank Alberta Innovates Health Solutions/Alberta Cancer Foundation and the Canadian Institutes of Health Research for operating grant support. V.W.Y. is a Canada Research Chair (Tier 1) in Neuroimmunology, for which salary support is gratefully acknowledged.	Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bertrand J, 2009, INT J ONCOL, V34, P717, DOI 10.3892/ijo_00000198; Bettinger I, 2002, ACTA NEUROPATHOL, V103, P351, DOI 10.1007/s00401-001-0472-x; Brantley EC, 2010, TRANSL ONCOL, V3, P380, DOI 10.1593/tlo.10208; Brescia P, 2013, STEM CELLS, V31, P857, DOI 10.1002/stem.1317; Charles NA, 2012, GLIA, V60, P502, DOI 10.1002/glia.21264; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheng L, 2010, BIOCHEM PHARMACOL, V80, P654, DOI 10.1016/j.bcp.2010.04.035; Chicoine MR, 2007, NEUROSURGERY, V60, P372, DOI 10.1227/01.NEU.0000249280.61761.2E; Dietrich J, 2010, EXPERT REV ANTICANC, V10, P709, DOI 10.1586/ERA.09.190; Edman LC, 2008, STEM CELLS, V26, P1891, DOI 10.1634/stemcells.2007-0753; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Galarneau H, 2007, CANCER RES, V67, P8874, DOI 10.1158/0008-5472.CAN-07-0177; Galvao Rui Pedro, 2013, Curr Pathobiol Rep, V1, P19; Giuliani F, 2005, J LEUKOCYTE BIOL, V78, P135, DOI 10.1189/jlb.0804477; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Hwang SY, 2009, BBA-MOL CELL RES, V1793, P1656, DOI 10.1016/j.bbamcr.2009.08.011; Kees T, 2012, NEURO-ONCOLOGY, V14, P64, DOI 10.1093/neuonc/nor182; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; Kerber M, 2008, CANCER RES, V68, P7342, DOI 10.1158/0008-5472.CAN-07-6241; Lawrence DMP, 2006, GLIA, V53, P81, DOI 10.1002/glia.20261; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Mora R, 2009, GLIA, V57, P561, DOI 10.1002/glia.20785; Neumann H, 2013, NAT NEUROSCI, V16, P253, DOI 10.1038/nn.3338; Polfliet MMJ, 2001, J NEUROIMMUNOL, V116, P188, DOI 10.1016/S0165-5728(01)00282-X; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; RUBISSOW MJ, 1970, LANCET, V1, P565; Samanani S, 2013, CNS NEUROL DISORD-DR, V12, P741, DOI 10.2174/18715273113126660177; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tang XQ, 2013, IMMUNOLOGY, V138, P93, DOI 10.1111/imm.12023; TOKUDA Y, 1993, ANTIMICROB AGENTS CH, V37, P2228, DOI 10.1128/AAC.37.10.2228; WILLIAMS K, 1992, J NEUROPATH EXP NEUR, V51, P538, DOI 10.1097/00005072-199209000-00009; WILSON E, 1991, ANTIMICROB AGENTS CH, V35, P796, DOI 10.1128/AAC.35.5.796; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Wu A, 2008, STEM CELLS DEV, V17, P173, DOI 10.1089/scd.2007.0133; Yang I, 2010, J CLIN NEUROSCI, V17, P6, DOI 10.1016/j.jocn.2009.05.006; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	43	140	142	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					46	55		10.1038/nn.3597	http://dx.doi.org/10.1038/nn.3597			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24316889				2022-12-17	WOS:000329080000013
J	Chalasani, SH; Kato, S; Albrecht, DR; Nakagawa, T; Abbott, LF; Bargmann, CI				Chalasani, Sreekanth H.; Kato, Saul; Albrecht, Dirk R.; Nakagawa, Takao; Abbott, L. F.; Bargmann, Cornelia I.			Neuropeptide feedback modifies odor-evoked dynamics in Caenorhabditis elegans olfactory neurons	NATURE NEUROSCIENCE			English	Article							CIS-REGULATORY ARCHITECTURE; C-ELEGANS; IN-VIVO; RECEPTOR NEURONS; SENSORY NEURONS; NERVOUS-SYSTEM; NEURAL CIRCUIT; GENE FAMILIES; ADAPTATION; PROTEIN	Many neurons release classical transmitters together with neuropeptide co-transmitters whose functions are incompletely understood. Here we define the relationship between two transmitters in the olfactory system of C. elegans, showing that a neuropeptide-to-neuropeptide feedback loop alters sensory dynamics in primary olfactory neurons. The AWC olfactory neuron is glutamatergic and also expresses the peptide NLP-1. Worms with nlp-1 mutations show increased AWC-dependent behaviors, suggesting that NLP-1 limits the normal response. The receptor for NLP-1 is the G protein-coupled receptor NPR-11, which acts in postsynaptic AIA interneurons. Feedback from AIA interneurons modulates odor-evoked calcium dynamics in AWC olfactory neurons and requires INS-1, a neuropeptide released from AIA. The neuropeptide feedback loop dampens behavioral responses to odors on short and long timescales. Our results point to neuronal dynamics as a site of behavioral regulation and reveal the ability of neuropeptide feedback to remodel sensory networks on multiple timescales.	[Chalasani, Sreekanth H.; Kato, Saul; Albrecht, Dirk R.; Nakagawa, Takao; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Kato, Saul; Abbott, L. F.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, Dept Physiol & Cellular Biophys, New York, NY USA	Howard Hughes Medical Institute; Rockefeller University; Columbia University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	cori@rockefeller.edu	Oka, Yoshitaka/C-9670-2010; Albrecht, Dirk/B-9941-2011	Oka, Yoshitaka/0000-0002-3482-3051; Bargmann, Cornelia/0000-0002-8484-0618	Mathers Foundation; Howard Hughes Medical Institute; Burroughs Wellcome Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER	Mathers Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the C. elegans knockout consortium and the Caenorhabditis Genetic Center (CGC) for strains, Y.H. Wang for the alpha 16Z chimera, L. Looger for GCaMP2.2b, Y.Iino for discussions about ins-1, and L. Vosshall, G. Lee, E. Feinberg, M. Tsunozaki, J. Gray, J. Garrison, P. McGrath and members of the Bargmann laboratory for critical help, advice and insights. Peptide synthesis was performed by the Proteomics Resource Center of the Rockefeller University. This work was funded by the Mathers Foundation and by the Howard Hughes Medical Institute (C. I. B.). D. R. A. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund.	Bargmann C. I., 2006, WORMBOOK; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BRENNER S, 1974, GENETICS, V77, P71; Burnstock G, 2004, CURR OPIN PHARMACOL, V4, P47, DOI 10.1016/j.coph.2003.08.001; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Colbert HA, 1997, J NEUROSCI, V17, P8259; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Gomez C, 2005, J CHEM NEUROANAT, V29, P238, DOI 10.1016/j.jchemneu.2005.01.005; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Horoszok L, 2001, BRIT J PHARMACOL, V132, P1247, DOI 10.1038/sj.bjp.0703937; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Ivell R, 2002, TRENDS ENDOCRIN MET, V13, P343, DOI 10.1016/S1043-2760(02)00664-1; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 2008, WORMBOOK; Lockery SR, 2009, NAT NEUROSCI, V12, P377, DOI 10.1038/nn0409-377; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Matsuki M, 2006, P NATL ACAD SCI USA, V103, P1112, DOI 10.1073/pnas.0506954103; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Mody SM, 2000, MOL PHARMACOL, V57, P13; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Palmitessa A, 2005, J BIOL CHEM, V280, P24649, DOI 10.1074/jbc.M502637200; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Stein C, 2009, BRAIN RES REV, V60, P90, DOI 10.1016/j.brainresrev.2008.12.017; Stein W, 2007, EUR J NEUROSCI, V26, P1148, DOI 10.1111/j.1460-9568.2007.05744.x; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Tsunozaki M, 2008, NEURON, V59, P959, DOI 10.1016/j.neuron.2008.07.038; Wachowiak M, 2009, ANN NY ACAD SCI, V1170, P286, DOI 10.1111/j.1749-6632.2009.04015.x; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yamada K, 2009, GENETICS, V181, P1347, DOI 10.1534/genetics.108.099002	49	140	145	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					615	U130		10.1038/nn.2526	http://dx.doi.org/10.1038/nn.2526			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20364145	Green Accepted, Green Published			2022-12-17	WOS:000277065700020
J	Naumann, EA; Kampff, AR; Prober, DA; Schier, AF; Engert, F				Naumann, Eva A.; Kampff, Adam R.; Prober, David A.; Schier, Alexander F.; Engert, Florian			Monitoring neural activity with bioluminescence during natural behavior	NATURE NEUROSCIENCE			English	Article							IN-VIVO; ZEBRAFISH; CA2+; AEQUORIN; SLEEP; HYPOCRETIN; NEURONS; SINGLE; BRAIN; VISUALIZATION	Existing techniques for monitoring neural activity in awake, freely behaving vertebrates are invasive and difficult to target to genetically identified neurons. We used bioluminescence to non-invasively monitor the activity of genetically specified neurons in freely behaving zebrafish. Transgenic fish with the Ca2+-sensitive photoprotein green fluorescent protein (GFP)-Aequorin in most neurons generated large and fast bioluminescent signals that were related to neural activity, neuroluminescence, which could be recorded continuously for many days. To test the limits of this technique, we specifically targeted GFP-Aequorin to the hypocretin-positive neurons of the hypothalamus. We found that neuroluminescence generated by this group of similar to 20 neurons was associated with periods of increased locomotor activity and identified two classes of neural activity corresponding to distinct swim latencies. Our neuroluminescence assay can report, with high temporal resolution and sensitivity, the activity of small subsets of neurons during unrestrained behavior.	[Naumann, Eva A.; Kampff, Adam R.; Schier, Alexander F.; Engert, Florian] Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Prober, David A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	Harvard University; California Institute of Technology	Engert, F (corresponding author), Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	florian@mcb.harvard.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Schier, Alexander Franz/0000-0001-7645-5325; Naumann, Eva Aimable/0000-0002-7215-4717; Kampff, Adam/0000-0003-3079-019X	McKnight Foundation; Harvard Mind, Brain and Behavior post-doctoral fellows; US National Institutes of Health; NATIONAL EYE INSTITUTE [R01EY014429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS060996] Funding Source: NIH RePORTER	McKnight Foundation; Harvard Mind, Brain and Behavior post-doctoral fellows; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. Hastings and T. Wilson for bountiful advice and discussion and generously providing an intensified CCD camera. We also thank L. Tricoire for the kind gift of the GFP-apoAequorin construct, M. Orger, A. Douglass, P. Ramdya, and members of the Engert and Schier laboratories for comments and advice, A. Douglass for N beta t-gal4 vectors, P. Ramdya for providing the nacre strains and B. Obama for his stimulation package. We thank S. Zimmerman, K. Hurley, and J. Miller for excellent zebrafish care. This work was funded by the McKnight Foundation (F. E.), the Harvard Mind, Brain and Behavior post-doctoral fellows program (A. R. K.), and the US National Institutes of Health (A. F. S. and D. A. P.).	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; ASHLEY CC, 1968, NATURE, V219, P1168, DOI 10.1038/2191168a0; Baraban SC, 2007, CURR OPIN NEUROL, V20, P164, DOI 10.1097/WCO.0b013e328042bae0; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Brustein E, 2003, PFLUG ARCH EUR J PHY, V446, P766, DOI 10.1007/s00424-003-1138-4; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cheung CY, 2006, INT J DEV BIOL, V50, P561, DOI 10.1387/ijdb.062151cc; Clark DA, 2007, J NEUROSCI, V27, P6083, DOI 10.1523/JNEUROSCI.1032-07.2007; Curie T, 2007, MOL IMAGING, V6, P30, DOI 10.2310/7290.2006.00033; Daunert S, 2006, PHOTOPROTEINS BIOANA; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Drobac E, 2010, J NEUROSCI RES, V88, P695, DOI 10.1002/jnr.22249; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Hastings JW, 2003, METHOD ENZYMOL, V360, P75; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; Kralik JD, 2001, METHODS, V25, P121, DOI 10.1006/meth.2001.1231; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Lillesaar C, 2007, DEV DYNAM, V236, P1072, DOI 10.1002/dvdy.21095; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Martin JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000275; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Miller EK, 2008, NEURON, V60, P483, DOI 10.1016/j.neuron.2008.10.033; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Ramdya P, 2008, NAT NEUROSCI, V11, P1083, DOI 10.1038/nn.2166; Rogers KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000974; Rogers KL, 2005, EUR J NEUROSCI, V21, P597, DOI 10.1111/j.1460-9568.2005.03871.x; Roncali E, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2976426; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; SHIMOMURA O, 1993, CELL CALCIUM, V14, P373, DOI 10.1016/0143-4160(93)90041-4; SMITH SJ, 1980, J PHYSIOL-LONDON, V300, P167, DOI 10.1113/jphysiol.1980.sp013157; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Teranishi K, 1997, BIOSCI BIOTECH BIOCH, V61, P1219, DOI 10.1271/bbb.61.1219; Tricoire L, 2006, P NATL ACAD SCI USA, V103, P9500, DOI 10.1073/pnas.0603176103; Wen L, 2008, DEV BIOL, V314, P84, DOI 10.1016/j.ydbio.2007.11.012; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	50	140	147	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2010	13	4					513	U146		10.1038/nn.2518	http://dx.doi.org/10.1038/nn.2518			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	575NI	20305645	Green Accepted, Green Submitted			2022-12-17	WOS:000276073500023
J	Liu, Q; Vrontou, S; Rice, FL; Zylka, MJ; Dong, XZ; Anderson, DJ				Liu, Qin; Vrontou, Sophia; Rice, Frank L.; Zylka, Mark J.; Dong, Xinzhong; Anderson, David J.			Molecular genetic visualization of a rare subset of unmyelinated sensory neurons that may detect gentle touch	NATURE NEUROSCIENCE			English	Article							TACTILE AFFERENTS; HUMAN SKIN; FAMILY; RECEPTORS; FIBERS; HAIRY; GPCRS	C-fiber tactile afferents are a subpopulation of unmyelinated cutaneous sensory neurons activated by gentle stroking. Using a genetically encoded tracer, we found that Mas-related G protein-coupled receptor B4 marks a rare subpopulation of unmyelinated, nonpeptidergic sensory fibers that exclusively innervate hairy skin. These fibers terminate in large arborizations similar in size and distribution to C-fiber tactile afferent receptive fields, suggesting that MrgprB4 may provide genetic access to these elusive neurons in mice.	Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Howard Hughes Med Inst, Pasadena, CA 91125 USA; Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; Univ N Carolina, Ctr Neurosci, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	Johns Hopkins University; California Institute of Technology; Howard Hughes Medical Institute; Albany Medical College; University of North Carolina; University of North Carolina Chapel Hill	Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	xdong2@jhmi.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048499] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS048499] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Habler HJ, 1999, NEUROSCIENCE, V89, P1259, DOI 10.1016/S0306-4522(98)00322-4; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; KUMAZAWA T, 1977, J PHYSIOLOGY PARIS, V73, P287; Lawson SN, 2002, J PHYSIOL-LONDON, V540, P989, DOI 10.1113/jphysiol.2001.013086; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Schmidt R, 2002, J NEUROPHYSIOL, V88, P1859, DOI 10.1152/jn.2002.88.4.1859; SENO N, 1993, NEUROSCIENCE, V55, P563, DOI 10.1016/0306-4522(93)90524-J; SUGIURA Y, 1986, SCIENCE, V234, P358, DOI 10.1126/science.3764416; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; Wessberg J, 2003, J NEUROPHYSIOL, V89, P1567, DOI 10.1152/jn.00256.2002; Zotterman Y, 1939, J PHYSIOL-LONDON, V95, P1; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	15	140	141	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					946	948		10.1038/nn1937	http://dx.doi.org/10.1038/nn1937			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618277				2022-12-17	WOS:000248357500007
J	Kholmanskikh, SS; Koeller, HB; Wynshaw-Boris, A; Gomez, T; Letourneau, PC; Ross, ME				Kholmanskikh, SS; Koeller, HB; Wynshaw-Boris, A; Gomez, T; Letourneau, PC; Ross, ME			Calcium-dependent interaction of Lis1 with IQGAP1 and Cdc42 promotes neuronal motility	NATURE NEUROSCIENCE			English	Article							INTRACELLULAR CA2+ FLUCTUATIONS; RHO-GTPASES; NMDA RECEPTORS; ACTIN CYTOSKELETON; SPINE MORPHOLOGY; CELL-MIGRATION; RAT-BRAIN; MICROTUBULE; BINDING; CALMODULIN	Lis1 gene defects impair neuronal migration, causing the severe human brain malformation lissencephaly. Although much is known about its interactions with microtubules, microtubule-binding proteins such as CLIP-170, and with the dynein motor complex, the response of Lis1 to neuronal motility signals has not been elucidated. Lis1 deficiency is associated with deregulation of the Rho-family GTPases Cdc42, Rac1 and RhoA, and ensuing actin cytoskeletal defects, but the link between Lis1 and Rho GTPases remains unclear. We report here that calcium influx enhances neuronal motility through Lis1-dependent regulation of Rho GTPases. Lis1 promotes Cdc42 activation through interaction with the calcium sensitive GTPase scaffolding protein IQGAP1, maintaining the perimembrane localization of IQGAP1 and CLIP170 and thereby tethering microtubule ends to the cortical actin cytoskeleton. Lis1 thus is a key component of neuronal motility signal transduction that regulates the cytoskeleton by complexing with IQGAP1, active Cdc42 and CLIP-170 upon calcium influx.	Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; Univ Calif San Diego, San Diego Sch Med, Dept Pediat, La Jolla, CA 92093 USA; Univ Wisconsin, Sch Med, Dept Neurosci, Madison, WI 53706 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	Cornell University; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities	Ross, ME (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, 1300 York Ave, New York, NY 10021 USA.	mer2005@med.cornell.edu	Letourneau, Paul C/A-6764-2009	Gomez, Timothy/0000-0002-1515-8228	NICHD NIH HHS [R01HD19950] Funding Source: Medline; NINDS NIH HHS [R01NS35515, P01NS39404] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD019950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035515, P01NS039404] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Assadi AH, 2003, NAT GENET, V35, P270, DOI 10.1038/ng1257; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; FISHMAN RB, 1993, J NEUROSCI, V13, P3485; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; GASSER UE, 1990, J NEUROSCI, V10, P1276; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Komuro H, 1998, J NEUROBIOL, V37, P110, DOI 10.1002/(SICI)1097-4695(199810)37:1<110::AID-NEU9>3.3.CO;2-Q; Lansbergen G, 2004, J CELL BIOL, V166, P1003, DOI 10.1083/jcb.200402082; Li QW, 2004, BIOCHEM BIOPH RES CO, V317, P787, DOI 10.1016/j.bbrc.2004.03.119; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; LOTURCO JJ, 1991, J NEUROSCI, V11, P792; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Meng YH, 2003, REV NEUROSCIENCE, V14, P233; Messersmith EK, 1997, MOL CELL NEUROSCI, V9, P347, DOI 10.1006/mcne.1997.0646; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rickard JE, 1996, TRENDS CELL BIOL, V6, P178, DOI 10.1016/0962-8924(96)10017-9; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; ROSSI DJ, 1993, NEUROPHARMACOLOGY, V32, P1239, DOI 10.1016/0028-3908(93)90018-X; Schell MJ, 1997, J NEUROSCI, V17, P1604; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Waterman-Storer CM, 1999, CURR OPIN CELL BIOL, V11, P61, DOI 10.1016/S0955-0674(99)80008-8; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; Wittmann T, 2001, J CELL SCI, V114, P3795; WOLENSKI JS, 1995, TRENDS CELL BIOL, V5, P310, DOI 10.1016/S0962-8924(00)89053-4; Xu HT, 2004, P NATL ACAD SCI USA, V101, P4296, DOI 10.1073/pnas.0303893101	48	140	144	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					50	57		10.1038/nn1619	http://dx.doi.org/10.1038/nn1619			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16369480				2022-12-17	WOS:000234288000017
J	Lin, JC; Ho, WH; Gurney, A; Rosenthal, A				Lin, JC; Ho, WH; Gurney, A; Rosenthal, A			The netrin-G1 ligand NGL-1 promotes the outgrowth of thalamocortical axons	NATURE NEUROSCIENCE			English	Article							C-ELEGANS; EXPRESSION; RECEPTOR; IDENTIFICATION; PROTEINS; LAMININ; FAMILY; UNC-5; CHEMOREPELLENT; MIGRATIONS	Netrin-G1 is a lipid-anchored protein that is structurally related to the netrin family of axon guidance molecules. Netrin-G1 does not bind any of the known netrin receptors and its function is not known. Here we identify human netrin-G1 ligand (NGL-1), a transmembrane protein containing leucine-rich repeat (LRR) and immunoglobulin (Ig) domains that specifically interacts with netrin-G1 through its LRR region. Whereas netrin-G1 is expressed highly in mouse thalamic axons, NGL-1 is most abundant in the striatum and the cerebral cortex the intermediate and final targets, respectively, of thalamocortical axons (TCAs). Surface-bound NGL-1 stimulates, but soluble NGL-1 disrupts, the growth of embryonic thalamic axons, and in vitro data indicate that NGL-1 activity may be mediated at least partially by netrin-G1. Our findings provide evidence that netrin-G1 functions as an important component of the NGL-1 receptor to promote TCA outgrowth and that membrane-bound netrins can participate in receiving axonal signaling pathways.	Rinat Neurosci Corp, Palo Alto, CA 94304 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Lin, JC (corresponding author), Rinat Neurosci Corp, 3155 Porter Dr, Palo Alto, CA 94304 USA.							Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Klein RD, 1996, P NATL ACAD SCI USA, V93, P7108, DOI 10.1073/pnas.93.14.7108; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Metin C, 1996, J NEUROSCI, V16, P3219; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Nakashiba T, 2000, J NEUROSCI, V20, P6540, DOI 10.1523/JNEUROSCI.20-17-06540.2000; Redies C, 1997, J COMP NEUROL, V381, P230, DOI 10.1002/(SICI)1096-9861(19970505)381:2<230::AID-CNE9>3.0.CO;2-4; Rosenthal A, 1999, NEURON, V22, P201, DOI 10.1016/S0896-6273(00)81077-6; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Yin Y, 2000, MECH DEVELOP, V96, P115, DOI 10.1016/S0925-4773(00)00369-5; Yin Y, 2002, MOL CELL NEUROSCI, V19, P344, DOI 10.1006/mcne.2001.1089; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	24	140	148	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1270	1276		10.1038/nn1148	http://dx.doi.org/10.1038/nn1148			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14595443				2022-12-17	WOS:000186725600011
J	Sippy, T; Cruz-Martin, A; Jeromin, A; Schweizer, FE				Sippy, T; Cruz-Martin, A; Jeromin, A; Schweizer, FE			Acute changes in short-term plasticity at synapses with elevated levels of neuronal calcium sensor-1	NATURE NEUROSCIENCE			English	Article							ADRENAL CHROMAFFIN CELLS; CULTURED HIPPOCAMPAL-NEURONS; PAIRED-PULSE FACILITATION; TRANSMITTER RELEASE; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; BINDING-PROTEINS; NERVE-TERMINALS; PYRAMIDAL CELLS; CA2+ CHANNELS	Short-term synaptic plasticity is a defining feature of neuronal activity, but the underlying molecular mechanisms are poorly understood. Depression of synaptic activity might be due to limited vesicle availability, whereas facilitation is thought to result from elevated calcium levels. However, it is unclear whether the strength and direction (facilitation versus depression) of plasticity at a given synapse result from preexisting synaptic strength or whether they are regulated by separate mechanisms. Here we show, in rat hippocampal cell cultures, that increases in the calcium binding protein neuronal calcium sensor-1 (NCS-1) can switch paired-pulse depression to facilitation without altering basal synaptic transmission or initial neurotransmitter release probability. Facilitation persisted during high-frequency trains of stimulation, indicating that NCS-1 can recruit 'dormant' vesicles. Our results suggest that NCS-1 acts as a calcium sensor for short-term plasticity by facilitating neurotransmitter output independent of initial release. We conclude that separate mechanisms are responsible for determining basal synaptic strength and short-term plasticity.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Interdept Ph D Program Neurosci, Los Angeles, CA 90095 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Baylor College of Medicine	Schweizer, FE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, 650 Charles E Young Dr S, Los Angeles, CA 90095 USA.		Cruz-Martín, Alberto/AAO-5320-2020	Cruz-Martin, Alberto/0000-0002-3271-7220	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041317] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS041317, NS41317, R01 NS041317-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atluri PP, 1996, J NEUROSCI, V16, P5661; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Burgoyne RD, 2001, BIOCHEM J, V353, P1; COX JA, 1994, J BIOL CHEM, V269, P32807; Cummings DD, 1996, J NEUROSCI, V16, P5312; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Genin A, 2001, NEUROSCIENCE, V106, P571, DOI 10.1016/S0306-4522(01)00301-3; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Jinno S, 2002, NEUROSCIENCE, V113, P449, DOI 10.1016/S0306-4522(02)00172-0; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Koizumi S, 2002, J BIOL CHEM, V277, P30315, DOI 10.1074/jbc.M201132200; Marder E, 1998, ANNU REV NEUROSCI, V21, P25, DOI 10.1146/annurev.neuro.21.1.25; McFerran BW, 1999, J BIOL CHEM, V274, P30258, DOI 10.1074/jbc.274.42.30258; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; OLAFSSON P, 1995, P NATL ACAD SCI USA, V92, P8001, DOI 10.1073/pnas.92.17.8001; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Rajebhosale M, 2003, J BIOL CHEM, V278, P6075, DOI 10.1074/jbc.M204702200; RIVOSECCHI R, 1994, J PHYSIOL-LONDON, V474, P223, DOI 10.1113/jphysiol.1994.sp020015; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Vyshedskiy A, 2000, J NEUROSCI, V20, P6326, DOI 10.1523/JNEUROSCI.20-17-06326.2000; Waldeck RF, 2000, J NEUROSCI, V20, P5312, DOI 10.1523/JNEUROSCI.20-14-05312.2000; Weiss JL, 2001, J BIOL CHEM, V276, P44804, DOI 10.1074/jbc.M103262200; Weiss JL, 2000, J BIOL CHEM, V275, P40082, DOI 10.1074/jbc.M008603200; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILCOX KS, 1994, J NEUROSCI, V14, P1775, DOI 10.1523/JNEUROSCI.14-03-01775.1994; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zucker RS, 2001, J PHYSIOL-LONDON, V531, P583, DOI 10.1111/j.1469-7793.2001.0583h.x; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	42	140	146	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1031	1038		10.1038/nn1117	http://dx.doi.org/10.1038/nn1117			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12947410	Green Accepted			2022-12-17	WOS:000185633600014
J	Angleson, JK; Cochilla, AJ; Kilic, G; Nussinovitch, I; Betz, WJ				Angleson, JK; Cochilla, AJ; Kilic, G; Nussinovitch, I; Betz, WJ			Regulation of dense cove release from neuroendocrine cells revealed by imaging single exocytic events	NATURE NEUROSCIENCE			English	Article							RAT ANTERIOR-PITUITARY; MOTOR-NERVE TERMINALS; PROLACTIN SECRETION; CHROMAFFIN CELLS; TRANSMITTER RELEASE; DOPAMINE; LACTOTROPHS; PROTEINS; RECEPTOR; HORMONE	Using FM1-43 fluorescence, we have optically detected single exocytic and endocytic events in rat pituitary lactotrophs. About fifty discrete fluorescent spots abruptly appear around the entire surface of a cell bathed in FM1-43 and high-potassium saline. The spots, which also immunostain for prolactin, reflect the labeling of dense cores as well as membranes of exocytosed secretory granules. Stained cores are not released, but remain attached to the cell and are eventually endocytosed. However, in cells exposed to dopamine (or an analog, bromocriptine), the cores dissolve and are secreted after several seconds. Solubilization of dense cores is mediated through a reduction in cytoplasmic cyclic AMP. Thus, the composition of secretions from individual secretory granules is regulated.	Univ Colorado, Sch Med, Dept Physiol & Biophys, Denver, CO 80262 USA; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Anat & Cell Biol, IL-91010 Jerusalem, Israel	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Hebrew University of Jerusalem	Betz, WJ (corresponding author), Univ Colorado, Sch Med, Dept Physiol & Biophys, 4200 E 9th, Denver, CO 80262 USA.							Abraham EJ, 1998, ENDOCRINOLOGY, V139, P2988, DOI 10.1210/en.139.6.2988; Aspinwall CA, 1997, J BIOL CHEM, V272, P31308, DOI 10.1074/jbc.272.50.31308; BAUER CK, 1994, PFLUG ARCH EUR J PHY, V428, P17, DOI 10.1007/BF00374747; BENTABOU S, 1994, J PHYSIOL-LONDON, V476, P29; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BLASCHKO H, 1967, NATURE, V215, P58, DOI 10.1038/215058a0; BRUE T, 1992, J CLIN ENDOCR METAB, V75, P1338, DOI 10.1210/jc.75.5.1338; Carbajal ME, 1997, ENDOCRINOLOGY, V138, P5374, DOI 10.1210/en.138.12.5374; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Colomer V, 1996, J BIOL CHEM, V271, P48, DOI 10.1074/jbc.271.1.48; DECAMILLI P, 1979, NATURE, V278, P252, DOI 10.1038/278252a0; DELAESCALERA GM, 1992, ENDOCR REV, V13, P241, DOI 10.1210/er.13.2.241; DELAESCALERA GMM, 1988, NEUROENDOCRINOLOGYS, V47, P545; EINHORN LC, 1993, J PHYSIOL-LONDON, V462, P563, DOI 10.1113/jphysiol.1993.sp019569; FOMINA AF, 1995, J NEUROSCI, V15, P4982; Fox GQ, 1996, CELL TISSUE RES, V284, P303, DOI 10.1007/s004410050590; FUJITA H, 1983, CELL TISSUE RES, V229, P129; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Han WP, 1999, J NEUROSCI, V19, P900; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; HORVATH E, 1974, ARCH PATHOL, V97, P221; INGRAM CD, 1988, CELL TISSUE RES, V252, P655, DOI 10.1007/BF00216653; JOURNOT L, 1987, J BIOL CHEM, V262, P1506; LAMBERTS SWJ, 1990, PHYSIOL REV, V70, P279, DOI 10.1152/physrev.1990.70.2.279; LEW AM, 1994, J BIOL CHEM, V269, P12007; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; MAEDA T, 1991, LAB INVEST, V65, P679; MALGAROLI A, 1987, J BIOL CHEM, V262, P13920; MARTIN TFJ, 1983, J BIOL CHEM, V258, P4816; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Rahamimoff R, 1997, NEURON, V18, P17, DOI 10.1016/S0896-6273(01)80043-X; RENDT J, 1994, ENDOCRINOLOGY, V135, P501, DOI 10.1210/en.135.2.501; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; SCEPEK S, 1993, EMBO J, V12, P1811, DOI 10.1002/j.1460-2075.1993.tb05829.x; SINHA YN, 1995, ENDOCR REV, V16, P354, DOI 10.1210/er.16.3.354; SINHA YN, 1980, ENDOCRINOLOGY, V107, P1959, DOI 10.1210/endo-107-6-1959; SINHA YN, 1981, ENDOCRINOLOGY, V108, P1091, DOI 10.1210/endo-108-3-1091; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; STJOHN PA, 1986, ENDOCRINOLOGY, V119, P2783; VANHAASTERT PJM, 1984, J BIOL CHEM, V259, P20; WHALLEY T, 1995, J CELL BIOL, V131, P1183, DOI 10.1083/jcb.131.5.1183; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; ZOREC R, 1991, J GEN PHYSIOL, V97, P473, DOI 10.1085/jgp.97.3.473	45	140	141	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					440	446		10.1038/8107	http://dx.doi.org/10.1038/8107			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321248				2022-12-17	WOS:000084609400014
J	Siegert, S; Seo, J; Kwon, EJ; Rudenko, A; Cho, S; Wang, WY; Flood, Z; Martorell, AJ; Ericsson, M; Mungenast, AE; Tsai, LH				Siegert, Sandra; Seo, Jinsoo; Kwon, Ester J.; Rudenko, Andrii; Cho, Sukhee; Wang, Wenyuan; Flood, Zachary; Martorell, Anthony J.; Ericsson, Maria; Mungenast, Alison E.; Tsai, Li-Huei			The schizophrenia risk gene product miR-137 alters presynaptic plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; NEUROTRANSMITTER RELEASE; FUNCTIONAL-NEURONS; CA2+ SENSOR; MICRORNA; EXPRESSION; HIPPOCAMPUS; SYNAPSIN; SYNAPTOTAGMIN-1; RECOGNITION	Noncoding variants in the human MIR137 gene locus increase schizophrenia risk with genome-wide significance. However, the functional consequence of these risk alleles is unknown. Here we examined induced human neurons harboring the minor alleles of four disease-associated single nucleotide polymorphisms in MIR137. We observed increased MIR137 levels compared to those in major allele-carrying cells. microRNA-137 gain of function caused downregulation of the presynaptic target genes complexin-1 (Cplx1), Nsf and synaptotagmin-1 (Syt1), leading to impaired vesicle release. In vivo, miR-137 gain of function resulted in changes in synaptic vesicle pool distribution, impaired induction of mossy fiber long-term potentiation and deficits in hippocampus-dependent learning and memory. By sequestering endogenous miR-137, we were able to ameliorate the synaptic phenotypes. Moreover, reinstatement of Syt1 expression partially restored synaptic plasticity, demonstrating the importance of Syt1 as a miR-137 target. Our data provide new insight into the mechanism by which miR-137 dysregulation can impair synaptic plasticity in the hippocampus.	[Siegert, Sandra; Seo, Jinsoo; Kwon, Ester J.; Rudenko, Andrii; Cho, Sukhee; Wang, Wenyuan; Flood, Zachary; Martorell, Anthony J.; Mungenast, Alison E.; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Siegert, Sandra; Seo, Jinsoo; Kwon, Ester J.; Rudenko, Andrii; Cho, Sukhee; Wang, Wenyuan; Flood, Zachary; Martorell, Anthony J.; Mungenast, Alison E.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Ericsson, Maria] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Tsai, Li-Huei] Broad Inst MIT & Harvard, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Siegert, Sandra/GWC-4507-2022; Rudenko, Andrey/AAG-4696-2020; Seo, Jinsoo/AAD-4950-2019	Siegert, Sandra/0000-0001-8635-0877; Rudenko, Andrey/0000-0001-6858-3650; Seo, Jinsoo/0000-0001-6432-6964; Kwon, Ester/0000-0002-6335-9681; Mungenast, Alison/0000-0003-1020-0471	Human Frontier Science Program (HFSP); Swiss National Science Foundation; Simons Foundation; NARSAD; Simons Center for the Social Brain [RO1 MH 091115]; US National Institutes of Health [RO1 MH 091115]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091115] Funding Source: NIH RePORTER	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Simons Foundation; NARSAD(NARSAD); Simons Center for the Social Brain; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Cohen (McLean Hospital) and J. Madison (Broad Institute/Stanley Center) for providing the human fibroblasts; N. Nadif Kasri (Radbound University Medical Center Nijmegen) and A. Aschrafi (Radbound University Medical Center Nijmegen) for sharing the Sponge<INF>Control</INF> and Sponge<INF>miR-137</INF> plasmids; T. Sudhof (Stanford School of Medicine) for providing us the Syt1-KD and Syt1-KD<INF>Control</INF> plasmid<SUP>37</SUP>; K. Jones for the synaptosomal preparation protocol; W. Xu, J. Penney and M. Benevento for comments on the manuscript; and the members of the Tsai laboratory for their overall comments on the project. S. S. was supported by a Human Frontier Science Program (HFSP) long-term postdoctoral fellowship and a Swiss National Science Foundation fellowship for prospective researchers. E.J.K. was supported by a Simons Foundation Postdoctoral Fellowship. A.R. was supported by a NARSAD Young Investigator Award. This work was supported by a Seed Grant from the Simons Center for the Social Brain and US National Institutes of Health grant RO1 MH 091115 to L.-H.T.	Bacaj T, 2013, NEURON, V80, P947, DOI 10.1016/j.neuron.2013.10.026; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Busskamp V, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145508; Cao P, 2013, J NEUROSCI, V33, P1714, DOI 10.1523/JNEUROSCI.4087-12.2013; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chen Q, 2009, NEUROSCI LETT, V465, P248, DOI 10.1016/j.neulet.2009.09.032; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; COUSIN MA, 2008, CURRENT PROTOCOLS NE, pCH2; Devanna P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03994; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Eastwood SL, 2001, NEUROSCIENCE, V105, P219, DOI 10.1016/S0306-4522(01)00141-5; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feng J, 2002, J NEUROSCI, V22, P4372, DOI 10.1523/JNEUROSCI.22-11-04372.2002; Focking M, 2015, MOL PSYCHIATR, V20, P424, DOI 10.1038/mp.2014.63; Frankle W. Gordon, 2003, Neuron, V39, P205, DOI 10.1016/S0896-6273(03)00423-9; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Heckers S, 1998, NAT NEUROSCI, V1, P318, DOI 10.1038/1137; Herzer S, 2012, J NEUROENDOCRINOL, V24, P1492, DOI 10.1111/j.1365-2826.2012.02358.x; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Jorquera RA, 2012, J NEUROSCI, V32, P18234, DOI 10.1523/JNEUROSCI.3212-12.2012; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kao HT, 2009, HANDBOOK OF NEUROCHEMISTRY AND MOLECULAR NEUROBIOLOGY: SCHIZOPHRENIA, THIRD EDITION, P267, DOI 10.1007/978-0-387-30410-6_2.4; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kwon E, 2013, MOL PSYCHIATR, V18, P11, DOI 10.1038/mp.2011.170; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Littleton JT, 2001, P NATL ACAD SCI USA, V98, P12233, DOI 10.1073/pnas.221450198; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonart G, 1998, NEURON, V21, P1141, DOI 10.1016/S0896-6273(00)80631-5; Martin JA, 2011, CURR BIOL, V21, P97, DOI 10.1016/j.cub.2010.12.014; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Pfisterer U, 2011, CELL CYCLE, V10, P3311, DOI 10.4161/cc.10.19.17584; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pieribone VA, 2002, J COMP NEUROL, V454, P105, DOI 10.1002/cne.10417; Reid CA, 1999, J PHYSIOL-LONDON, V518, P121, DOI 10.1111/j.1469-7793.1999.0121r.x; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Sawada K, 2005, ARCH GEN PSYCHIAT, V62, P263, DOI 10.1001/archpsyc.62.3.263; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; van Hooijdonk LWA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-2; Vawter MP, 2002, MOL PSYCHIATR, V7, P571, DOI 10.1038/sj.mp.4001158; Vicario-Abejon C, 2004, CURR PROTOC NEUROSCI; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Weinberger DR, 1999, BIOL PSYCHIAT, V45, P395, DOI 10.1016/S0006-3223(98)00331-X; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Won H, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00019; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Xu W, 2012, NEURON, V73, P990, DOI 10.1016/j.neuron.2011.12.036; Yoshimizu T, 2015, MOL PSYCHIATR, V20, P162, DOI 10.1038/mp.2014.143	70	139	141	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2015	18	7					1008	+		10.1038/nn.4023	http://dx.doi.org/10.1038/nn.4023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CL3QU	26005852	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000356866200016
J	Rodenas-Ruano, A; Chavez, AE; Cossio, MJ; Castillo, PE; Zukin, RS				Rodenas-Ruano, Alma; Chavez, Andres E.; Cossio, Maria J.; Castillo, Pablo E.; Zukin, R. Suzanne			REST-dependent epigenetic remodeling promotes the developmental switch in synaptic NMDA receptors	NATURE NEUROSCIENCE			English	Article							2B SUBUNIT GENE; TERM DEPRESSION; IN-VIVO; EXPRESSION; TRANSCRIPTION; EXPERIENCE; HIPPOCAMPAL; REPRESSION; SEQUENCES; BINDING	NMDA receptors (NMDARs) are critical to synaptogenesis, neural circuitry and higher cognitive functions. A hallmark feature of NMDARs is an early postnatal developmental switch from those containing primarily GluN2B to primarily GluN2A subunits. Although the switch in phenotype has been an area of intense interest for two decades, the mechanisms that trigger it and the link between experience and the switch are unclear. Here we show a new role for the transcriptional repressor REST in the developmental switch of synaptic NMDARs. REST is activated at a critical window of time and acts via epigenetic remodeling to repress Grin2b expression and alter NMDAR properties at rat hippocampal synapses. Knockdown of REST in vivo prevented the decline in GluN2B and developmental switch in NMDARs. Maternal deprivation impaired REST activation and acquisition of the mature NMDAR phenotype. Thus, REST is essential for experience-dependent fine-tuning of genes involved in synaptic plasticity.	[Rodenas-Ruano, Alma; Chavez, Andres E.; Cossio, Maria J.; Castillo, Pablo E.; Zukin, R. Suzanne] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Zukin, RS (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	pablo.castillo@einstein.yu.edu; suzanne.zukin@einstein.yu.edu		Castillo, Pablo/0000-0002-9834-1801	US National Institutes of Health [R01 NS46742, NS20752]; F.M. Kirby Foundation [R01 MH081935]; Ruth L. Kirschstein Award from the US National Institute of Neurological Disorders and Stroke [F32NS071821]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020752, R01NS046742, F32NS071821] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F.M. Kirby Foundation; Ruth L. Kirschstein Award from the US National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants to R.S.Z. (R01 NS46742 and NS20752) and P.E.C. (R01 MH081935) and support from the F.M. Kirby Foundation. A.E.C. was supported by a Ruth L. Kirschstein Award from the US National Institute of Neurological Disorders and Stroke (F32NS071821). We thank K.-M. Noh (Albert Einstein College of Medicine) for providing the shRNA REST lentiviral construct, and A. Etgen and all the members of the Zukin and Castillo laboratories for their constructive comments on the data and the manuscript.	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Desai A, 2002, J BIOL CHEM, V277, P46374, DOI 10.1074/jbc.M203032200; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; Gray JA, 2011, NEURON, V71, P1085, DOI 10.1016/j.neuron.2011.08.007; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Huang Z, 2011, NAT CELL BIOL, V13, P142, DOI 10.1038/ncb2153; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; Ku HY, 2008, NEUROPSYCHOPHARMACOL, V33, P2847, DOI 10.1038/npp.2008.36; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Matta JA, 2011, NEURON, V70, P339, DOI 10.1016/j.neuron.2011.02.045; Meaney MJ, 2010, NAT NEUROSCI, V13, P1313, DOI 10.1038/nn1110-1313; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x; Noh KM, 2012, P NATL ACAD SCI USA, V109, pE962, DOI 10.1073/pnas.1121568109; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Prybylowski K, 2002, J NEUROSCI, V22, P8902; Qiang M, 2005, MOL PHARMACOL, V67, P2115, DOI 10.1124/mol.104.010751; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Sasner M, 1996, J BIOL CHEM, V271, P21316, DOI 10.1074/jbc.271.35.21316; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; Xu Z, 2009, J NEUROSCI, V29, P8764, DOI 10.1523/JNEUROSCI.1014-09.2009; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yeo M, 2009, J NEUROSCI, V29, P14652, DOI 10.1523/JNEUROSCI.2934-09.2009; Yu HB, 2011, GENOME RES, V21, P1284, DOI 10.1101/gr.114488.110	50	139	143	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1382	1390		10.1038/nn.3214	http://dx.doi.org/10.1038/nn.3214			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013VZ	22960932	Green Accepted			2022-12-17	WOS:000309335300018
J	Wang, LM; Han, XQ; Mehren, J; Hiroi, M; Billeter, JC; Miyamoto, T; Amrein, H; Levine, JD; Anderson, DJ				Wang, Liming; Han, Xiaoqing; Mehren, Jennifer; Hiroi, Makoto; Billeter, Jean-Christophe; Miyamoto, Tetsuya; Amrein, Hubert; Levine, Joel D.; Anderson, David J.			Hierarchical chemosensory regulation of male-male social interactions in Drosophila	NATURE NEUROSCIENCE			English	Article							CUTICULAR HYDROCARBONS; GUSTATORY RECEPTORS; PHEROMONE RECEPTOR; MALE-AGGRESSION; MALE COURTSHIP; SEX-PHEROMONE; MUTANT MICE; BEHAVIOR; TASTE; MELANOGASTER	Pheromones regulate male social behaviors in Drosophila, but the identities and behavioral role(s) of these chemosensory signals, and how they interact, are incompletely understood. We found that (z)-7-tricosene, a male-enriched cuticular hydrocarbon that was previously shown to inhibit male-male courtship, was essential for normal levels of aggression. The mechanisms by which (z)-7-tricosene induced aggression and suppressed courtship were independent, but both required the gustatory receptor Gr32a. Sensitivity to (z)-7-tricosene was required for the aggression-promoting effect of 11-cis-vaccenyl acetate (cVA), an olfactory pheromone, but (z)-7-tricosene sensitivity was independent of cVA. (z)-7-tricosene and cVA therefore regulate aggression in a hierarchical manner. Furthermore, the increased courtship caused by depletion of male cuticular hydrocarbons was suppressed by a mutation in the olfactory receptor Or47b. Thus, male social behaviors are controlled by gustatory pheromones that promote aggression and suppress courtship, and whose influences are dominant to olfactory pheromones that enhance these behaviors.	[Wang, Liming; Han, Xiaoqing; Anderson, David J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Han, Xiaoqing; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Mehren, Jennifer] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA; [Hiroi, Makoto] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Billeter, Jean-Christophe; Levine, Joel D.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Miyamoto, Tetsuya; Amrein, Hubert] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Rockefeller University; University of California System; University of California Berkeley; University of Toronto; University Toronto Mississauga; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wang, LM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	lmwang@caltech.edu; wuwei@caltech.edu	Wang, Liming/C-8402-2011; han, xiao/HDN-9782-2022; Billeter, Jean-Christophe/G-5399-2012; Amrein, Hubert/AAG-9480-2021; Hiroi, Makoto/B-6834-2008	Amrein, Hubert/0000-0001-8799-7250; Hiroi, Makoto/0000-0002-0136-5891; Billeter, Jean-Christophe/0000-0001-7796-4068	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009014, R01DC005606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031389] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDA NIH HHS [R01 DA031389] Funding Source: Medline; NIDCD NIH HHS [R01 DC005606, R01 DC009014] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/nmeth.1310, 10.1038/NMETH.1310]; DAVIS TL, 1989, SYNTHESIS-STUTTGART, P936, DOI 10.1055/s-1989-27435; Fernandez MD, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000541; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Issa FA, 2006, CURR BIOL, V16, P2217, DOI 10.1016/j.cub.2006.08.065; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Krupp JJ, 2008, CURR BIOL, V18, P1373, DOI 10.1016/j.cub.2008.07.089; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wang LM, 2008, P NATL ACAD SCI USA, V105, P5657, DOI 10.1073/pnas.0801327105; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; WENKERT E, 1985, J ORG CHEM, V50, P719, DOI 10.1021/jo00205a042; Wolff Nancy, 2009, J Correct Health Care, V15, P58, DOI 10.1177/1078345808326622; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	50	139	141	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					757	U392		10.1038/nn.2800	http://dx.doi.org/10.1038/nn.2800			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516101	Green Accepted			2022-12-17	WOS:000290958000019
J	Cremona, ML; Matthies, HJG; Pau, K; Bowton, E; Speed, N; Lute, BJ; Anderson, M; Sen, N; Robertson, SD; Vaughan, RA; Rothman, JE; Galli, A; Javitch, JA; Yamamoto, A				Cremona, M. Laura; Matthies, Heinrich J. G.; Pau, Kelvin; Bowton, Erica; Speed, Nicole; Lute, Brandon J.; Anderson, Monique; Sen, Namita; Robertson, Sabrina D.; Vaughan, Roxanne A.; Rothman, James E.; Galli, Aurelio; Javitch, Jonathan A.; Yamamoto, Ai			Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; CLATHRIN-DEPENDENT MECHANISM; CELL-SURFACE EXPRESSION; DOPAMINE TRANSPORTER; GLUTAMATE TRANSPORTER; LIPID MICRODOMAINS; RAFT MICRODOMAINS; COCAINE BINDING; RECEPTOR; CHOLESTEROL	Plasmalemmal neurotransmitter transporters (NTTs) regulate the level of neurotransmitters, such as dopamine (DA) and glutamate, after their release at brain synapses. Stimuli including protein kinase C (PKC) activation can lead to the internalization of some NTTs and a reduction in neurotransmitter clearance capacity. We found that the protein Flotillin-1 (Flot1), also known as Reggie-2, was required for PKC-regulated internalization of members of two different NTT families, the DA transporter (DAT) and the glial glutamate transporter EAAT2, and we identified a conserved serine residue in Flot1 that is essential for transporter internalization. Further analysis revealed that Flot1 was also required to localize DAT within plasma membrane microdomains in stable cell lines, and was essential for amphetamine-induced reverse transport of DA in neurons but not for DA uptake. In sum, our findings provide evidence for a critical role of Flot1-enriched membrane microdomains in PKC-triggered DAT endocytosis and the actions of amphetamine.	[Cremona, M. Laura; Pau, Kelvin; Anderson, Monique; Yamamoto, Ai] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10027 USA; [Cremona, M. Laura; Pau, Kelvin; Anderson, Monique; Yamamoto, Ai] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY USA; [Matthies, Heinrich J. G.; Bowton, Erica; Speed, Nicole; Lute, Brandon J.; Robertson, Sabrina D.; Galli, Aurelio] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Mol Neurosci, Kennedy Ctr, Nashville, TN 37232 USA; [Sen, Namita; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, New York, NY USA; [Sen, Namita; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Sen, Namita; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY USA; [Vaughan, Roxanne A.] Univ N Dakota, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Rothman, James E.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Columbia University; Columbia University; Vanderbilt University; Columbia University; Columbia University; Columbia University; University of North Dakota Grand Forks; Yale University	Yamamoto, A (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10027 USA.	ay46@columbia.edu	Matthies, Heinrich/AAD-2375-2019; Yamamoto, Ai/D-1100-2011; Matthies, Heinrich/B-7284-2017	Matthies, Heinrich/0000-0003-3615-7571; Matthies, Heinrich/0000-0003-3615-7571; Javitch, Jonathan/0000-0001-7395-2967; Robertson, Sabrina/0000-0003-4598-6929	US National Institute of Neurological Disorders and Stroke [RO1 NS050199]; Parkinson's Disease Foundation; US National Institute on Drug Abuse [PO1 DA12408, DA13975, K05 DA022413, DA13147]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013975, P01DA012408, R56DA013975, R01DA013147, K05DA022413] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Parkinson's Disease Foundation; US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Karam, T. Melia, A. Pizzo, H. Stenmark and H. Yano for critical reading of this manuscript, and J. Rothstein (Johns Hopkins) for the Eaat2 cDNA. This work was supported by US National Institute of Neurological Disorders and Stroke research grant RO1 NS050199 and the Parkinson's Disease Foundation (A.Y.) and US National Institute on Drug Abuse research grants PO1 DA12408 (A. G. and J. A. J.), DA13975 (A. G.), K05 DA022413 (J. A. J.) and DA13147 (R. A. V.).	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Bauer M, 2006, FEBS LETT, V580, P5559, DOI 10.1016/j.febslet.2006.08.077; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Becart S, 2003, J CELL SCI, V116, P2565, DOI 10.1242/jcs.00449; Benlimame N, 1998, MOL BIOL CELL, V9, P1773, DOI 10.1091/mbc.9.7.1773; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Buckley KM, 2000, J PHYSIOL-LONDON, V525, P11, DOI 10.1111/j.1469-7793.2000.t01-2-00011.x; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Chang MY, 2001, J NEUROCHEM, V77, P754, DOI 10.1046/j.1471-4159.2001.00284.x; Chen R, 2009, J PHARMACOL EXP THER, V328, P912, DOI 10.1124/jpet.108.147959; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Escartin C, 2006, J NEUROSCI, V26, P5978, DOI 10.1523/JNEUROSCI.0302-06.2006; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Galbiati F, 1998, GENE, V210, P229, DOI 10.1016/S0378-1119(98)00064-X; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gonzalez MI, 2005, J NEUROCHEM, V94, P1180, DOI 10.1111/j.1471-4159.2005.03330.x; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Guillet BA, 2005, NEUROCHEM INT, V46, P337, DOI 10.1016/j.neuint.2004.10.006; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Jacobowitz DM, 2004, NEUROTOX RES, V6, P245, DOI 10.1007/BF03033435; Kahlig KM, 2004, J BIOL CHEM, V279, P8966, DOI 10.1074/jbc.M303976200; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; Kato N, 2006, J IMMUNOL, V177, P147, DOI 10.4049/jimmunol.177.1.147; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Robbins AK, 1998, BIOTECHNIQUES, V25, P240, DOI 10.2144/98252st04; Sen N, 2005, NEUROPHARMACOLOGY, V49, P780, DOI 10.1016/j.neuropharm.2005.08.014; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Stuermer CAO, 2011, J NEUROCHEM, V116, P708, DOI 10.1111/j.1471-4159.2010.07007.x; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Vaughan RA, 1996, J BIOL CHEM, V271, P21672, DOI 10.1074/jbc.271.35.21672; Wang LB, 2003, J LIPID RES, V44, P807, DOI 10.1194/jlr.M200449-JLR200; Wharton J, 2005, J BIOL CHEM, V280, P13483, DOI 10.1074/jbc.M413891200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhou JZ, 2004, J NEUROSCI, V24, P6301, DOI 10.1523/JNEUROSCI.1404-04.2004	50	139	142	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					469	U103		10.1038/nn.2781	http://dx.doi.org/10.1038/nn.2781			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21399631	Green Accepted			2022-12-17	WOS:000288849400018
J	Shim, S; Goh, EL; Ge, SY; Sailor, K; Yuan, JP; Roderick, HL; Bootman, MD; Worley, PF; Song, HJ; Ming, GL				Shim, S; Goh, EL; Ge, SY; Sailor, K; Yuan, JP; Roderick, HL; Bootman, MD; Worley, PF; Song, HJ; Ming, GL			XTRPC1-dependent chemotropic guidance of neuronal growth cones	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH; INTRACELLULAR CALCIUM; COMMISSURAL AXONS; TRP CHANNELS; MYELIN; REGENERATION; NETRINS; NOGO; CNS; ACTIVATION	Calcium arising through release from intracellular stores and from influx across the plasma membrane is essential for signalling by specific guidance cues and by factors that inhibit axon regeneration. The mediators of calcium influx in these cases are largely unknown. Transient receptor potential channels (TRPCs) belong to a superfamily of Ca2+-permeable, receptor-operated channels that have important roles in sensing and responding to changes in the local environment. Here we report that XTRPC1, a Xenopus homolog of mammalian TRPC1, is required for proper growth cone turning responses of Xenopus spinal neurons to microscopic gradients of netrin-1, brain-derived neurotrophic factor and myelin-associated glycoprotein, but not to semaphorin 3A. Furthermore, XTRPC1 is required for midline guidance of axons of commissural interneurons in the developing Xenopus spinal cord. Thus, members of the TRPC family may serve as a key mediator for the Ca2+ influx that regulates axon guidance during development and inhibits axon regeneration in adulthood.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Babraham Inst, Mol Signalling Lab, Cambridge CB2 4AT, England	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, 733 N Broadway, Baltimore, MD 21205 USA.	gming1@bs.jhmi.edu	Sailor, Kurt/GSO-2237-2022; Bootman, Martin/AAB-3330-2019; Goh, Eyleen/A-8006-2013; Ming, Guo-li/J-7880-2013; Sailor, Kurt Andrew/AFN-4046-2022	Sailor, Kurt/0000-0002-9574-6838; Bootman, Martin/0000-0002-6447-3451; Sailor, Kurt Andrew/0000-0002-9574-6838; Roderick, Hywel/0000-0001-7065-3523; Ming, Guo-li/0000-0002-2517-6075; Goh, Eyleen/0000-0002-8244-6959	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271, R56NS047344, R37NS047344, R01NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C116, BBS/E/B/00001116] Funding Source: Medline; NEI NIH HHS [T32 EY017203] Funding Source: Medline; NIA NIH HHS [R01 AG024984] Funding Source: Medline; NICHD NIH HHS [R01 HD069184] Funding Source: Medline; NINDS NIH HHS [R01 NS047344, R01 NS048271, R56 NS047344, R37 NS047344] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Bobanovic LK, 1999, BIOCHEM J, V340, P593, DOI 10.1042/0264-6021:3400593; Brereton HM, 2000, MOL CELL BIOCHEM, V214, P63, DOI 10.1023/A:1007193720930; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; GORDON XW, 2005, NATURE, V434, P898; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Moran MM, 2004, CURR OPIN NEUROBIOL, V14, P362, DOI 10.1016/j.conb.2004.05.003; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Phelps PE, 1999, J COMP NEUROL, V409, P285; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Roberts A, 2000, BRAIN RES BULL, V53, P585, DOI 10.1016/S0361-9230(00)00392-0; ROBERTS A, 1988, DEVELOPMENT, V103, P447; Sayers LG, 1997, BIOCHEM J, V323, P273, DOI 10.1042/bj3230273; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	50	139	144	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					730	735		10.1038/nn1459	http://dx.doi.org/10.1038/nn1459			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880110	Green Accepted, Green Published			2022-12-17	WOS:000229345300012
J	Petersen, PH; Zou, KY; Krauss, S; Zhong, WM				Petersen, PH; Zou, KY; Krauss, S; Zhong, WM			Continuing role for mouse Numb and Numbl in maintaining progenitor cells during cortical neurogenesis	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ASYMMETRIC DIVISION; NEURONAL DIFFERENTIATION; MAMMALIAN NUMB; NOTCH; FATES; FOREBRAIN; GENE; SPECIFICATION	Neural progenitor cells in the developing neocortex change over time to produce different neurons, a phenomenon that is also observed in other regions of the nervous system. Mouse Numb (also known as m-numb) and Numbl (also known as numblike or Nbl) are redundant but essential in maintaining virtually all progenitor cells during early neurogenesis. They do this by allowing cells to choose progenitor over neuronal fates. To determine whether their roles change as neurogenesis progresses, we conditionally ablated both genes in the embryonic dorsal forebrain after initial waves of neurogenesis. Here we report that these proteins continue to be required for progenitor-cell maintenance, contrary to recently reported findings. As occurs during early neurogenesis, the loss of Numb and Numbl causes premature progenitor-cell depletion and, consequently, a highly specific malformation of the neocortex and hippocampus. Because progenitor cells can proliferate without Numb and Numbl before neurogenesis, we propose that Numb-mediated asymmetric cell divisions, which diversify many cell fates in Drosophila melanogaster, represent a general mechanism in mammals for stem cells to balance self-renewal and differentiation.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ Oslo, Natl Hosp, Sect Cellular & Genet Therapy, Inst Microbiol, Oslo, Norway	Yale University; University of Oslo; National Hospital Norway	Zhong, WM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	weimin.zhong@yale.edu	, PeturHenry/H-1506-2011	Krauss, Stefan/0000-0001-6992-8091	NINDS NIH HHS [R01 NS042048] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Fode C, 2000, GENE DEV, V14, P67; FRANTZ GD, 1994, J NEUROSCI, V14, P472; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; GU M, 1994, SCIENCE, V265, P103; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Lear BC, 1999, MECH DEVELOP, V88, P207, DOI 10.1016/S0925-4773(99)00190-2; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Machon O, 2002, NEUROSCIENCE, V112, P951, DOI 10.1016/S0306-4522(02)00053-2; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Qian XM, 1998, DEVELOPMENT, V125, P3143; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shen Q, 2002, DEVELOPMENT, V129, P4843; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; van den Bout CJ, 2002, MECH DEVELOP, V110, P179, DOI 10.1016/S0925-4773(01)00597-4; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; VERDI JM, 1996, CURR BIOL, V6, P113; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844; Zhong WM, 2003, NEURON, V37, P11, DOI 10.1016/S0896-6273(02)01178-9; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X	48	139	150	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					803	811		10.1038/nn1289	http://dx.doi.org/10.1038/nn1289			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15273690				2022-12-17	WOS:000222930800009
J	Chesler, EJ; Lu, L; Wang, JT; Williams, RW; Manly, KF				Chesler, EJ; Lu, L; Wang, JT; Williams, RW; Manly, KF			WebQTL: Rapid exploratory analysis of gene expression and genetic networks for brain and behavior	NATURE NEUROSCIENCE			English	Database Review							STRAINS		Univ Tennessee, Ctr Genom & Bioinformat, Dept Anat & Neurobiol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Genom & Bioinformat, Dept Pathol & Lab Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Chesler, EJ (corresponding author), Univ Tennessee, Ctr Genom & Bioinformat, Dept Anat & Neurobiol, 855 Monroe Ave, Memphis, TN 38163 USA.	echesler@utmem.edu	Chesler, Elissa/K-4641-2019; Williams, Robert W./H-8789-2016	Chesler, Elissa/0000-0002-5642-5062; Williams, Robert W./0000-0001-8924-4447				Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chesler EJ, 2003, NEUROINFORMATICS, V1, P343, DOI 10.1385/NI:1:4:343; Fehr C, 2002, J NEUROSCI, V22, P3730; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Williams M, 2001, NUCL ENG INT, V46, P18	6	139	141	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					485	486		10.1038/nn0504-485	http://dx.doi.org/10.1038/nn0504-485			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114364				2022-12-17	WOS:000221101300019
J	Tecott, LH; Nestler, EJ				Tecott, LH; Nestler, EJ			Neurobehavioral assessment in the information age	NATURE NEUROSCIENCE			English	Article							ANIMAL-MODELS; MUTANT MICE; HIPPOCAMPAL FUNCTION; COCAINE-SEEKING; ANXIETY; RATS; DISEASE; MAZE	The elucidation of the human and mouse genomes provides new opportunities for exploring the genetic underpinnings of complex mammalian behaviors. This information also provides new windows into the pathophysiology and treatment of neuropsychiatric diseases. Optimal use of the rapidly escalating numbers of mouse lines engineered for these purposes is hindered, however, by practical and theoretical limitations of common behavioral analyses. New strategies combining automated behavioral monitoring and information technologies are currently under development in both academic and industrial settings. These hold promise, both for improving the throughput of mouse behavioral assessment and for providing new insights into the neurobiology of mammalian behavioral regulation.	Univ Calif San Francisco, Sch Med, Ctr Neurobiol & Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Tecott, LH (corresponding author), Univ Calif San Francisco, Sch Med, Ctr Neurobiol & Psychiat, 401 Parnassus Ave, San Francisco, CA 94143 USA.	tecott@itsa.ucsf.edu						Ahmad-Annuar A, 2003, CURR OPIN NEUROL, V16, P451, DOI 10.1097/01.wco.0000084221.82329.29; Bates GP, 2003, CURR OPIN NEUROL, V16, P465, DOI 10.1097/01.wco.0000084223.82329.bb; Blanchard DC, 2003, EUR J PHARMACOL, V463, P97, DOI 10.1016/S0014-2999(03)01276-7; Blanchard RJ, 2003, PHYSIOL BEHAV, V79, P515, DOI 10.1016/S0031-9384(03)00157-4; Brunner D, 2002, DRUG DISCOV TODAY, V7, pS107, DOI 10.1016/S1359-6446(02)02423-6; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Dell'Omo G, 2000, BEHAV BRAIN RES, V115, P1, DOI 10.1016/S0166-4328(00)00234-5; Dell'Omo G, 2002, EUR J NEUROSCI, V16, P735, DOI 10.1046/j.1460-9568.2002.02128.x; Ferrel K, 1999, NETW COMPUT, V10, P22; Gerlai R, 1999, TRENDS NEUROSCI, V22, P47, DOI 10.1016/S0166-2236(98)01346-0; Gerlai R, 2002, TRENDS NEUROSCI, V25, P506, DOI 10.1016/S0166-2236(02)02250-6; Gerlai R, 2001, BEHAV BRAIN RES, V125, P269, DOI 10.1016/S0166-4328(01)00296-0; GOULDING EH, 2002, APPETITE, V39, P78; Green A.R., 1985, NEUROPHARMACOLOGY SE, P326; Hunter AJ, 2000, HUM MOL GENET, V9, P893, DOI 10.1093/hmg/9.6.893; KAAKKOLA S, 1990, PHARMACOL TOXICOL, V67, P95, DOI 10.1111/j.1600-0773.1990.tb00792.x; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; LISTER RG, 1990, PHARMACOL THERAPEUT, V46, P321, DOI 10.1016/0163-7258(90)90021-S; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; MCCLEARN GE, 1979, ALCOHOL CLIN EXP RES, V3, P255, DOI 10.1111/j.1530-0277.1979.tb05310.x; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Owens T, 2001, NAT MED, V7, P161, DOI 10.1038/84603; Paigen K, 2000, MAMM GENOME, V11, P715, DOI 10.1007/s003350010152; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Scott MR, 2000, ARCH VIROL, P113; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Shekhar A, 2001, PSYCHOPHARMACOLOGY, V157, P327; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Tecott LH, 2003, AM J PSYCHIAT, V160, P646, DOI 10.1176/appi.ajp.160.4.646; van der Staay FJ, 2002, GENES BRAIN BEHAV, V1, P9, DOI 10.1046/j.1601-1848.2001.00007.x; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Vyssotski AL, 2002, HIPPOCAMPUS, V12, P27, DOI 10.1002/hipo.10002; Wahlsten D, 2003, TRENDS NEUROSCI, V26, P132, DOI 10.1016/S0166-2236(03)00033-X; Wehner JM, 1996, BEHAV GENET, V26, P301, DOI 10.1007/BF02359386; Whishaw IQ, 1996, PHYSIOL BEHAV, V60, P1191, DOI 10.1016/S0031-9384(96)00176-X; Willner P., 1991, BEHAV MODELS PSYCHOP, P3; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5	43	139	142	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					462	466		10.1038/nn1225	http://dx.doi.org/10.1038/nn1225			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114359				2022-12-17	WOS:000221101300014
J	Aksay, E; Gamkrelidze, G; Seung, HS; Baker, R; Tank, DW				Aksay, E; Gamkrelidze, G; Seung, HS; Baker, R; Tank, DW			In vivo intracellular recording and perturbation of persistent activity in a neural integrator	NATURE NEUROSCIENCE			English	Article							EYE-POSITION; BRAIN-STEM; PLATEAU POTENTIALS; OCULOMOTOR SYSTEM; PYRAMIDAL NEURONS; MOTOR-NEURONS; ALERT CAT; MEMORY; MOVEMENTS; GOLDFISH	To investigate the mechanisms of persistent neural activity, we obtained in vivo intracellular recordings from neurons in an oculomotor neural integrator of the goldfish during spontaneous saccades and fixations. Persistent changes in firing rate following saccades were associated with step changes in interspike membrane potential that were correlated with changes in eye position. Perturbation of persistent activity with brief intracellular current pulses designed to mimic saccadic input only induced transient changes of firing rate and membrane potential. When neurons were hyperpolarized below action potential threshold, position-correlated step changes in membrane potential remained. Membrane potential fluctuations were greater during more depolarized steps. These results suggest that sustained changes in firing rate are supported not by either membrane multistability or changes in pacemaker currents, but rather by persistent changes in the rate or amplitude of synaptic inputs.	Bell Labs, Lucent Technol, Biol Computat Res Dept, Murray Hill, NJ 07974 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; MIT, Howard Hughes Med Inst, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Alcatel-Lucent; Lucent Technologies; AT&T; New York University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Baker, R (corresponding author), Bell Labs, Lucent Technol, Biol Computat Res Dept, 700 Mt Ave, Murray Hill, NJ 07974 USA.		Gamkrelidze, Georgi/ABC-6891-2021	Aksay, Emre/0000-0002-4561-4175; Baker, Robert/0000-0001-7920-1769				Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; AMITAI Y, 1994, NEUROSCIENCE, V63, P151, DOI 10.1016/0306-4522(94)90013-2; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; Catterall W A, 1999, Adv Neurol, V79, P441; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; EASTER SS, 1971, VISION RES, V11, P333, DOI 10.1016/0042-6989(71)90244-6; Ermentrout B, 1998, NEURAL COMPUT, V10, P1721, DOI 10.1162/089976698300017106; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Fuster JM, 1995, MEMORY CEREBRAL CORT; GODAUX E, 1989, EXP BRAIN RES, V77, P94; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V405, P345, DOI 10.1113/jphysiol.1988.sp017336; KAMATH BY, 1976, MATH BIOSCI, V30, P341, DOI 10.1016/0025-5564(76)90073-0; KATZ B, 1973, J PHYSIOL-LONDON, V230, P707, DOI 10.1113/jphysiol.1973.sp010213; KELLER EL, 1971, J NEUROPHYSIOL, V34, P908, DOI 10.1152/jn.1971.34.5.908; KIEHN O, 1991, TRENDS NEUROSCI, V14, P68, DOI 10.1016/0166-2236(91)90023-N; Kiehn O, 1998, CURR OPIN NEUROBIOL, V8, P746, DOI 10.1016/S0959-4388(98)80117-7; LLINAS R, 1986, J PHYSIOL-LONDON, V376, P163, DOI 10.1113/jphysiol.1986.sp016147; LOPEZBARNEO J, 1982, J NEUROPHYSIOL, V47, P329, DOI 10.1152/jn.1982.47.2.329; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; MCFARLAND JL, 1992, J NEUROPHYSIOL, V68, P319, DOI 10.1152/jn.1992.68.1.319; PASTOR AM, 1991, J NEUROPHYSIOL, V66, P2125, DOI 10.1152/jn.1991.66.6.2125; PASTOR AM, 1994, P NATL ACAD SCI USA, V91, P807, DOI 10.1073/pnas.91.2.807; Perrier JF, 1999, J NEUROPHYSIOL, V82, P730, DOI 10.1152/jn.1999.82.2.730; Prut Y, 1999, NATURE, V401, P590, DOI 10.1038/44145; REUVENI I, 1993, J NEUROSCI, V13, P4609; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.ne.12.030189.000341; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Robinson DA., 1981, HDB PHYSL AM PHYSL 1, V2, P1275; ROSEN MJ, 1972, IEEE T BIO-MED ENG, VBM19, P362, DOI 10.1109/TBME.1972.324139; SCHULTZ W, 1992, EXP BRAIN RES, V91, P363; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; SHEN L, 1989, BIOL CYBERN, V61, P319, DOI 10.1007/BF00203180; SKAVENSKI AA, 1973, J NEUROPHYSIOL, V36, P724, DOI 10.1152/jn.1973.36.4.724; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	38	139	141	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					184	193		10.1038/84023	http://dx.doi.org/10.1038/84023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175880				2022-12-17	WOS:000167178100018
J	Rajan, R				Rajan, R			Receptor organ damage causes loss of cortical surround inhibition without topographic map plasticity	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; PRIMARY AUDITORY-CORTEX; ADULT FLYING-FOX; STRIATE CORTEX; INFERIOR COLLICULUS; RESPONSE PROPERTIES; GABAERGIC NEURONS; DIGIT AMPUTATION; FIELD PROPERTIES; FUNCTIONAL-ROLE	Following restricted peripheral damage, reorganization of adult sensory or motor cortex is believed to depend on loss of surround inhibition, which unmasks latent inputs to the deprived cortex. Here I demonstrate that limited damage to auditory receptors causes loss of functional surround inhibition in the cortex, unmasking of latent inputs and significantly altered neural coding. However, these changes do not lead to plasticity of the cortical map, defined by the most sensitive input from the receptor surface to each cortical location. Thus, in sensory cortex, loss of surround inhibition as a consequence of receptor organ damage does not necessarily result in cortical map plasticity.	Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	Monash University	Rajan, R (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia.		rajan, ramesh/L-4842-2019; Rajan, Ramesh/A-5945-2008	Rajan, Ramesh/0000-0001-9862-0520				ALLOWAY KD, 1989, EXP BRAIN RES, V78, P514; BATUEV AS, 1989, EXP BRAIN RES, V76, P198; CALFORD MB, 1988, NATURE, V332, P446, DOI 10.1038/332446a0; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; CALFORD MB, 1991, J NEUROPHYSIOL, V65, P178, DOI 10.1152/jn.1991.65.2.178; CALFORD MB, 1991, P ROY SOC B-BIOL SCI, V243, P269, DOI 10.1098/rspb.1991.0041; DAmelio F, 1996, J NEUROSCI RES, V44, P532; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; DYKES RW, 1984, J NEUROPHYSIOL, V52, P1066, DOI 10.1152/jn.1984.52.6.1066; EVANS EF, 1980, EXP BRAIN RES, V40, P115; GARRAGHTY PE, 1991, SOMATOSENS MOT RES, V8, P347, DOI 10.3109/08990229109144757; HENDRY SHC, 1986, P NATL ACAD SCI USA, V83, P1536, DOI 10.1073/pnas.83.5.1536; HENDRY SHC, 1990, J NEUROSCI, V10, P2438; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; JONES EG, 1993, CEREB CORTEX, V3, P361, DOI 10.1093/cercor/3.5.361-a; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kiang NYS, 1965, DISCHARGE PATTERNS S; LIBERMAN MC, 1988, HEARING RES, V34, P179, DOI 10.1016/0378-5955(88)90105-0; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; MANLEY GA, 1976, J PHYSIOL-LONDON, V258, P323, DOI 10.1113/jphysiol.1976.sp011422; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; POLLAK GD, 1993, HEARING RES, V65, P99, DOI 10.1016/0378-5955(93)90205-F; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; RAJAN R, 1991, HEARING RES, V53, P153, DOI 10.1016/0378-5955(91)90222-U; RAMOA AS, 1988, EXP BRAIN RES, V73, P285; RASMUSSON DD, 1992, SOMATOSENS MOT RES, V9, P279, DOI 10.3109/08990229209144777; RASMUSSON DD, 1993, SOMATOSENS MOT RES, V10, P69, DOI 10.3109/08990229309028825; RAUSELL E, 1992, P NATL ACAD SCI USA, V89, P2571, DOI 10.1073/pnas.89.7.2571; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; SANES JN, 1990, EXP BRAIN RES, V79, P479; SCHMIEDT RA, 1989, HEARING RES, V42, P23, DOI 10.1016/0378-5955(89)90115-9; SCHREINER CE, 1990, J NEUROPHYSIOL, V64, P1442, DOI 10.1152/jn.1990.64.5.1442; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; VATER M, 1992, J COMP PHYSIOL A, V171, P541; VOLKOV IO, 1991, NEUROSCIENCE, V43, P307, DOI 10.1016/0306-4522(91)90295-Y; WALL JT, 1988, TRENDS NEUROSCI, V11, P549, DOI 10.1016/0166-2236(88)90184-1; WARREN R, 1989, J COMP NEUROL, V288, P583, DOI 10.1002/cne.902880405; WELKER E, 1989, EXP BRAIN RES, V74, P441, DOI 10.1007/BF00247346; YANG LC, 1992, J NEUROPHYSIOL, V68, P1760, DOI 10.1152/jn.1992.68.5.1760	41	139	139	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					138	143		10.1038/388	http://dx.doi.org/10.1038/388			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195129				2022-12-17	WOS:000076361100015
J	McHenry, JA; Otis, JM; Rossi, MA; Robinson, JE; Kosyk, O; Miller, NW; McElligott, ZA; Budygin, EA; Rubinow, DR; Stuber, GD				McHenry, Jenna A.; Otis, James M.; Rossi, Mark A.; Robinson, J. Elliott; Kosyk, Oksana; Miller, Noah W.; McElligott, Zoe A.; Budygin, Evgeny A.; Rubinow, David R.; Stuber, Garret D.			Hormonal gain control of a medial preoptic area social reward circuit	NATURE NEUROSCIENCE			English	Article							NEURAL-CONTROL; SEXUAL-BEHAVIOR; GABA NEURONS; FEMALE RATS; ESTROGEN; DOPAMINE; NUCLEUS; HYPOTHALAMUS; ESTRADIOL; MICE	Neural networks that control reproduction must integrate social and hormonal signals, tune motivation, and coordinate social interactions. However, the neural circuit mechanisms for these processes remain unresolved. The medial preoptic area (mPOA), an essential node for social behaviors, comprises molecularly diverse neurons with widespread projections. Here we identify a steroid responsive subset of neurotensin (Nts)-expressing mPOA neurons that interface with the ventral tegmental area (VTA) to form a socially engaged reward circuit. Using in vivo two-photon imaging in female mice, we show that mPOA(Nts) neurons preferentially encode, attractive male cues compared to nonsocial appetitive stimuli. Ovarian hormone signals regulate both the physiological and cue encoding properties of these cells. Furthermore, optogenetic stimulation of mPOA(Nts)-VTA circuitry promotes rewarding phenotypes, social approach and striatal dopamine release. Collectively, these data demonstrate that steroid-sensitive mPOA neurons encode ethologically relevant stimuli and co-opt midbrain reward circuits to promote prosocial behaviors critical for species survival.	[McHenry, Jenna A.; Otis, James M.; Rossi, Mark A.; Kosyk, Oksana; Miller, Noah W.; McElligott, Zoe A.; Budygin, Evgeny A.; Rubinow, David R.; Stuber, Garret D.] Univ North Carolina Chapel Hill, Dept Psychiat, Chapel Hill, NC 27514 USA; [Robinson, J. Elliott; Stuber, Garret D.] Univ North Carolina Chapel Hill, Neurosci Curriculum, Chapel Hill, NC 27514 USA; [McElligott, Zoe A.; Stuber, Garret D.] Univ North Carolina Chapel Hill, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27514 USA; [Budygin, Evgeny A.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA; [Budygin, Evgeny A.] St Petersburg State Univ, Inst Translat Biomed, St Petersburg, Russia; [Stuber, Garret D.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC 27514 USA; [Stuber, Garret D.] Univ North Carolina Chapel Hill, Neurosci Ctr, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Wake Forest University; Saint Petersburg State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Stuber, GD (corresponding author), Univ North Carolina Chapel Hill, Dept Psychiat, Chapel Hill, NC 27514 USA.; Stuber, GD (corresponding author), Univ North Carolina Chapel Hill, Neurosci Curriculum, Chapel Hill, NC 27514 USA.; Stuber, GD (corresponding author), Univ North Carolina Chapel Hill, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27514 USA.; Stuber, GD (corresponding author), Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC 27514 USA.; Stuber, GD (corresponding author), Univ North Carolina Chapel Hill, Neurosci Ctr, Chapel Hill, NC 27514 USA.	gstuber@med.unc.edu	Budygin, Evgeny/ABD-1899-2021; Otis, James/AFD-4354-2022; Core, Vector/CAF-4832-2022; McElligott, Zoe/AAX-5415-2021; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Robinson, J. Elliott/0000-0001-9417-3938; Stuber, Garret/0000-0003-1730-4855	National Institute of Mental Health [T32-MH093315]; National Institute on Drug Abuse [F32-DA041184, R01 DA032750, R01 DA038168]; ABMRF; NIAAA [K01 AA020911, F30AA021312]; NIDDK [F32-DK112564]; Foundation of Hope; Brain and Behavior Research Foundation; Simons Foundation; Department of Psychiatry at UNC-CH; National Institute on Alcohol Abuse and Alcoholism [AA022449]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK112564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH093315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007431, P30NS045892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F30AA021312, U01AA020911, R01AA022449, K01AA023555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA038168, R01DA032750, R37DA032750, F32DA041184] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ABMRF; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Foundation of Hope; Brain and Behavior Research Foundation; Simons Foundation; Department of Psychiatry at UNC-CH; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the Stuber laboratory for discussion and support. We thank S. Smith for advice on two-photon imaging, the UNC vector core for viral packaging, and the UNC Neuroscience Center Microscopy Core, especially V. Ghukasyan, for his training and assistance (P30 NS045892). We thank K. Deisseroth for viral constructs (Stanford University). We thank L. Tarantino and S. Schoenrock for their input and assistance with hormone manipulation procedures. We thank K. Schilling-Scrivo, L. Eckman, J. Rodriguez and G. Tipton for technical assistance and R. Ung for assistance with coding. J.A.M. was supported by the National Institute of Mental Health (T32-MH093315), J.M.O. was supported by the National Institute on Drug Abuse (F32-DA041184), Z.A.M. was supported by ABMRF and NIAAA (K01 AA020911), J.E.R. was supported by NIAAA (F30AA021312) and M.A.R. was supported by NIDDK (F32-DK112564). This study was supported by funds from the Foundation of Hope, the Brain and Behavior Research Foundation, the Simons Foundation, the National Institute on Drug Abuse (R01 DA032750 and R01 DA038168) (G.D.S.), the Department of Psychiatry at UNC-CH, and the National Institute on Alcohol Abuse and Alcoholism (AA022449) (E.A.B.).	ALEXANDER MJ, 1989, ENDOCRINOLOGY, V125, P2111, DOI 10.1210/endo-125-4-2111; Anderson DJ, 2014, CELL, V157, P187, DOI 10.1016/j.cell.2014.03.003; Asaba A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00231; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; BUENO J, 1976, BRAIN RES, V101, P67, DOI 10.1016/0006-8993(76)90988-4; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; CAROOM D, 1971, PHYSIOL BEHAV, V7, P659, DOI 10.1016/0031-9384(71)90126-0; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dey S, 2015, CELL, V161, P1334, DOI 10.1016/j.cell.2015.04.052; Dhungel S, 2011, HORM BEHAV, V59, P193, DOI 10.1016/j.yhbeh.2010.11.011; Dulac C, 2014, SCIENCE, V345, P765, DOI 10.1126/science.1253291; EDWARDS D. A., 1970, Horm. Behav., V1, P299, DOI 10.1016/0018-506X(70)90022-X; HERBISON AE, 1991, J NEUROENDOCRINOL, V3, P587, DOI 10.1111/j.1365-2826.1991.tb00322.x; HORI T, 1968, ENDOCRINOL JAPON, V15, P215; Hull EM, 2007, HORM BEHAV, V52, P45, DOI 10.1016/j.yhbeh.2007.03.030; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; Kow LM, 2016, STEROIDS, V111, P46, DOI 10.1016/j.steroids.2016.02.018; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Luscher C, 2016, ANNU REV NEUROSCI, V39, P257, DOI 10.1146/annurev-neuro-070815-013920; McHenry JA, 2015, FRONT NEUROENDOCRIN, V38, P65, DOI 10.1016/j.yfrne.2015.04.001; Micevych P, 2013, J NEUROENDOCRINOL, V25, P1012, DOI 10.1111/jne.12103; Nieh EH, 2016, NEURON, V90, P1286, DOI 10.1016/j.neuron.2016.04.035; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; O'Connell LA, 2012, SCIENCE, V336, P1154, DOI 10.1126/science.1218889; Petrulis A, 2013, FRONT NEUROENDOCRIN, V34, P255, DOI 10.1016/j.yfrne.2013.07.007; Pfaff D, 2011, ENDOCRINOLOGY, V152, P1209, DOI 10.1210/en.2010-1007; Phelan MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108415; Rilling JK, 2014, SCIENCE, V345, P771, DOI 10.1126/science.1252723; Roepke TA, 2007, ENDOCRINOLOGY, V148, P4937, DOI 10.1210/en.2007-0605; Ronnekleiv OK, 2005, FRONT NEUROENDOCRIN, V26, P65, DOI 10.1016/j.yfrne.2005.05.001; Root CM, 2014, NATURE, V515, P269, DOI 10.1038/nature13897; Schiller CE, 2016, COMPR PHYSIOL, V6, P1135, DOI 10.1002/cphy.c150014; Schmidt PJ, 2009, ANN NY ACAD SCI, V1179, P70, DOI 10.1111/j.1749-6632.2009.04982.x; Smith MJ, 2001, ENDOCRINOLOGY, V142, P3006, DOI 10.1210/en.142.7.3006; Sorwell KG, 2008, BEHAV NEUROSCI, V122, P788, DOI 10.1037/0735-7044.122.4.788; Stowers L, 2016, CURR OPIN NEUROBIOL, V38, P74, DOI 10.1016/j.conb.2016.04.001; Stuber GD, 2016, NAT NEUROSCI, V19, P198, DOI 10.1038/nn.4220; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tobiansky DJ, 2016, NEUROPSYCHOPHARMACOL, V41, P1897, DOI 10.1038/npp.2015.360; Tobiansky DJ, 2013, BEHAV NEUROSCI, V127, P293, DOI 10.1037/a0031949; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Watters JJ, 1998, J NEUROSCI, V18, P6672; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307; YAGI K, 1973, BRAIN RES, V53, P343, DOI 10.1016/0006-8993(73)90219-9; Yang TH, 2016, CURR OPIN NEUROBIOL, V38, P89, DOI 10.1016/j.conb.2016.04.015; Yoest Katie E., 2014, Central Nervous System Agents in Medicinal Chemistry, V14, P83	49	138	139	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2017	20	3					449	458		10.1038/nn.4487	http://dx.doi.org/10.1038/nn.4487			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9DU	28135243	Green Accepted, Green Submitted			2022-12-17	WOS:000394920400022
J	Franke, B; Stein, JL; Ripke, S; Anttila, V; Hibar, DP; van Hulzen, KJE; Arias-Vasquez, A; Smoller, JW; Nichols, TE; Neale, MC; McIntosh, AM; Lee, P; McMahon, FJ; Meyer-Lindenberg, A; Mattheisen, M; Andreassen, OA; Gruber, O; Sachdev, PS; Roiz-Santianez, R; Saykin, AJ; Ehrlich, S; Mather, KA; Turner, JA; Wright, MJ; O'Donovan, MC; Thompson, PM; Neale, BM; Medland, SE; Sullivan, PF				Franke, Barbara; Stein, Jason L.; Ripke, Stephan; Anttila, Verneri; Hibar, Derrek P.; van Hulzen, Kimm J. E.; Arias-Vasquez, Alejandro; Smoller, Jordan W.; Nichols, Thomas E.; Neale, Michael C.; McIntosh, Andrew M.; Lee, Phil; McMahon, Francis J.; Meyer-Lindenberg, Andreas; Mattheisen, Manuel; Andreassen, Ole A.; Gruber, Oliver; Sachdev, Perminder S.; Roiz-Santianez, Roberto; Saykin, Andrew J.; Ehrlich, Stefan; Mather, Karen A.; Turner, Jessica A.; Wright, Margaret J.; O'Donovan, Michael C.; Thompson, Paul M.; Neale, Benjamin M.; Medland, Sarah E.; Sullivan, Patrick F.		Psychiat Genomics Consortium; ENIGMA Consortium	Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept	NATURE NEUROSCIENCE			English	Article							GENOME-WIDE ASSOCIATION; METAANALYSIS; ENDOPHENOTYPE; INDIVIDUALS; PERSPECTIVE; PHENOTYPES; DISORDERS; DISCOVERY; RELATIVES; VARIANTS	Schizophrenia is a devastating psychiatric illness with high heritability. Brain structure and function differ, on average, between people with schizophrenia and healthy individuals. As common genetic associations are emerging for both schizophrenia and brain imaging phenotypes, we can now use genome-wide data to investigate genetic overlap. Here we integrated results from common variant studies of schizophrenia (33,636 cases, 43,008 controls) and volumes of several (mainly subcortical) brain structures (11,840 subjects). We did not find evidence of genetic overlap between schizophrenia risk and subcortical volume measures either at the level of common variant genetic architecture or for single genetic markers. These results provide a proof of concept (albeit based on a limited set of structural brain measures) and define a roadmap for future studies investigating the genetic covariance between structural or functional brain phenotypes and risk for psychiatric disorders.	[Franke, Barbara; van Hulzen, Kimm J. E.; Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Franke, Barbara; Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Franke, Barbara; van Hulzen, Kimm J. E.; Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Stein, Jason L.; Hibar, Derrek P.; Thompson, Paul M.] Univ So Calif, Keck Sch Med, Imaging Genet Ctr, Mark & Mary Stevens Neuroimaging & Informat Inst, Marina Del Rey, CA USA; [Stein, Jason L.] Univ Calif Los Angeles, Sch Med, Dept Neurol, Neurogenet Program, Los Angeles, CA 90024 USA; [Ripke, Stephan; Anttila, Verneri; Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan; Anttila, Verneri; Smoller, Jordan W.; Lee, Phil; Neale, Benjamin M.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Ripke, Stephan] Charite, Dept Psychiat & Psychotherapy, Campus Charite Mitte, D-13353 Berlin, Germany; [Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Smoller, Jordan W.; Lee, Phil; Neale, Benjamin M.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Smoller, Jordan W.; Lee, Phil] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Nichols, Thomas E.] Univ Oxford, FMRIB Ctr, Oxford, England; [Nichols, Thomas E.] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England; [Nichols, Thomas E.] Univ Warwick, Warwick Mfg Grp, Coventry CV4 7AL, W Midlands, England; [Neale, Michael C.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Neale, Michael C.] Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA USA; [McIntosh, Andrew M.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [McMahon, Francis J.] NIH, US Dept HHS, Intramural Res Program, Bethesda, MD USA; [Meyer-Lindenberg, Andreas] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Mannheim, Germany; [Mattheisen, Manuel] Aarhus Univ, Dept Biomed, iPSYCH, Aarhus, Denmark; [Mattheisen, Manuel] IPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark; [Mattheisen, Manuel] IPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Copenhagen, Denmark; [Mattheisen, Manuel] Aarhus Univ, ISEQ, Ctr Integrated Sequencing, iPSYCH, Aarhus, Denmark; [Andreassen, Ole A.] Univ Oslo, Inst Clin Med, NORMENT KG Jebsen Ctr, Oslo, Norway; [Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Gruber, Oliver] Univ Med Ctr, Dept Psychiat & Psychotherapy, Ctr Translat Res Syst Neurosci & Psychia, Gottingen, Germany; [Sachdev, Perminder S.; Mather, Karen A.] Univ New S Wales, Sch Psychiat, Ctr Healthy Brain Ageing, Sydney, NSW, Australia; [Sachdev, Perminder S.] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW, Australia; [Roiz-Santianez, Roberto] Univ Cantabria IDIVAL, Sch Med, Univ Hosp Marques Valdecilla, Dept Psychiat, Santander, Spain; [Roiz-Santianez, Roberto] Cibersam Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Saykin, Andrew J.] Indiana Univ Sch Med, Ctr Neuroimaging Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Saykin, Andrew J.] Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Indianapolis, IN 46202 USA; [Saykin, Andrew J.] Indiana Univ Sch Med, Med & Mol Genet, Indianapolis, IN 46202 USA; [Ehrlich, Stefan] Tech Univ Dresden, Fac Med, Dept Child & Adolescent Psychiat, D-01062 Dresden, Germany; [Ehrlich, Stefan] Tech Univ Dresden, Univ Hosp, D-01062 Dresden, Germany; [Turner, Jessica A.] Georgia State Univ, Atlanta, GA 30303 USA; [Turner, Jessica A.] Mind Res Network, Albuquerque, NM USA; [Wright, Margaret J.; Medland, Sarah E.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Wright, Margaret J.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [O'Donovan, Michael C.] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Gen, Cardiff CF10 3AX, S Glam, Wales; [O'Donovan, Michael C.] Cardiff Univ, Natl Ctr Mental Hlth, Cardiff CF10 3AX, S Glam, Wales; [Neale, Benjamin M.] Broad Inst MIT & Harvard Cambridge, Med & Populat Genet Program, Cambridge, MA USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Radboud University Nijmegen; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Oxford; University of Warwick; University of Warwick; Virginia Commonwealth University; Virginia Commonwealth University; Royal Infirmary of Edinburgh; University of Edinburgh; National Institutes of Health (NIH) - USA; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Oslo; University of Oslo; University of Gottingen; University of New South Wales Sydney; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University System of Georgia; Georgia State University; Lovelace Respiratory Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland; Cardiff University; Cardiff University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Karolinska Institutet; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Franke, B (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.; Franke, B (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands.; Franke, B (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.; Sullivan, PF (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.; Sullivan, PF (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC USA.; Sullivan, PF (corresponding author), Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA.	barbara.franke@radboudumc.nl; pfsulliv@med.unc.edu	Medland, Sarah/AAT-7595-2020; Milani, Lili/N-1097-2019; Francks, Clyde/E-1384-2012; Wu, Jingqin/V-9319-2019; Franke, Barbara/D-4836-2009; Sachdev, Perminder/ABC-1137-2020; Karen, Mather A/O-9795-2016; Turner, Jessica A/H-7282-2015; de Geus, Eco J.C./M-9318-2015; Agerbo, Esben/A-2645-2012; Medland, Sarah E/C-7630-2013; Myin-Germeys, Inez/L-5106-2014; Wright, Margaret Jane/A-4560-2016; Andreassen, Ole A./AAY-7531-2020; Hansen, Thomas Folkmann/O-5965-2014; Slominsky, Petr A/B-4640-2016; Singleton, Andrew B/C-3010-2009; Liu, Jianjun/AAK-4989-2020; Reichenberg, Abraham/GQB-1227-2022; Winkler, Anderson M/P-7773-2016; Matarin, Mar/F-1771-2016; Hardy, John/C-2451-2009; Hulshoff Pol, Hilleke Evertje/B-4795-2014; Gruber, Oliver/AAY-5563-2020; Mecocci, Patrizia/W-2116-2019; Slominsky, Petr/AAO-1852-2020; Simmons, Andrew/B-8848-2008; Melle, Ingrid S/B-4858-2011; Crespo-Facorro, BENEDICTO/GXZ-9830-2022; Webb, Bradley T/B-1459-2009; Wardlaw, Joanna M/Y-3456-2019; Partida, Gabriel Cuellar/C-6686-2017; Ho, Beng-Choon/D-6959-2011; Strike, Lachlan T/R-3902-2018; McQuillin, Andrew/C-1623-2008; Desrivières, Sylvane/ABC-4336-2021; Pantelis, Christos/H-7722-2014; Heinz, Andreas/ABB-7736-2020; Bokhoven, J.H.L.M. van van/H-8015-2014; Mattheisen, Manuel/B-4949-2012; McIntosh, Andrew M/B-9379-2008; Mattheisen, Manuel/S-3725-2019; Weale, Michael E/F-2587-2010; Bergen, Sarah/I-8313-2012; Westman, Eric/H-5771-2011; O'Donovan, Michael C/P-7005-2018; Zimprich, Fritz/W-1738-2017; Lopez, Lorna/AAR-4912-2020; Konte, Bettina/AAT-1142-2021; Crespo-Facorro, BENEDICTO/AAY-2238-2021; Mortensen, Preben B/D-2358-2015; Ehrlich, Stefan/ABB-4650-2020; van Os, Jim/C-2113-2014; Deary, Ian J/C-6297-2009; Domenici, Enrico/K-8194-2016; Walton, Esther/P-9832-2019; Hartmann, Annette/AAS-6331-2021; Lee, Jimmy/ABB-2919-2020; Hansell, Narelle K/A-4553-2016; Francks, Clyde/AGU-8875-2022; Ruderfer, Douglas M/M-5795-2016; Hoogman, Martine/G-8958-2015; Mattingsdal, Morten/Q-9367-2016; Hakobjan, Marina/A-5594-2016; O'Neill, Francis A/C-5582-2008; Zimprich, Fritz/O-1406-2019; Ripke, Stephan/AAK-5486-2021; Klein, Marieke/G-9870-2015; Ashbrook, David George/H-5702-2019; Pike, Bruce/K-5562-2014; Brown, Matthew A/E-5749-2010; Bramon, Elvira/HHC-3809-2022; Teumer, Alexander/S-7438-2019; /ABD-6198-2020; Lawrie, Stephen MacGregor/AAD-1607-2021; Rentería, Miguel E./M-6671-2017; Fukunaga, Masaki/F-6441-2013; McMahon, Francis J/A-7290-2009; McDonald, Colm/C-1430-2009; Nichols, Thomas E./N-9902-2017; Luciano, Michelle/F-7277-2010; Degenhardt, Franziska/H-4169-2017; Fernandez, Guillen/B-3771-2009; Zwiers, Marcel P/D-2968-2009; KUČINSKAS, Vaidutis/A-4798-2013; McMahon, Katie L/C-6440-2009; Thompson, Paul M/C-4194-2018; Meier, Sandra/AAB-1242-2021; Ryten, Mina/Q-8419-2016; Scott, Rodney/B-2827-2013; Saykin, Andrew/A-1318-2007; Ptackova, Hana/M-9763-2017; Meyer-Lindenberg, Andreas/H-1076-2011; Franke, Lude/P-7036-2016; murray, robin/F-8658-2012; Fisher, Simon/E-9130-2012; Collier, David/D-1649-2011; Sprooten, Emma/N-3836-2017; Gudnason, Vilmundur/K-6885-2015; Lee, Sang Hong/A-2569-2011; Kelly, Brian/G-7755-2013; Magnusson, Patrik/C-4458-2017; Mowry, Bryan/G-5046-2010; Cannon, Dara/C-1323-2009; Schofield, Peter/C-9669-2011; Williams, Robert W./H-8789-2016; de Zubicaray, Greig/B-1763-2008	Medland, Sarah/0000-0003-1382-380X; Milani, Lili/0000-0002-5323-3102; Francks, Clyde/0000-0002-9098-890X; Wu, Jingqin/0000-0002-2052-3875; Franke, Barbara/0000-0003-4375-6572; Sachdev, Perminder/0000-0002-9595-3220; Karen, Mather A/0000-0003-4143-8941; Turner, Jessica A/0000-0003-0076-8434; de Geus, Eco J.C./0000-0001-6022-2666; Agerbo, Esben/0000-0002-2849-524X; Medland, Sarah E/0000-0003-1382-380X; Wright, Margaret Jane/0000-0001-7133-4970; Hansen, Thomas Folkmann/0000-0001-6703-7762; Slominsky, Petr A/0000-0003-3530-0655; Liu, Jianjun/0000-0002-3255-3019; Winkler, Anderson M/0000-0002-4169-9781; Matarin, Mar/0000-0002-4717-5735; Hardy, John/0000-0002-3122-0423; Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; Mecocci, Patrizia/0000-0003-0729-5246; Slominsky, Petr/0000-0003-3530-0655; Simmons, Andrew/0000-0003-2306-5811; Melle, Ingrid S/0000-0002-9783-548X; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Webb, Bradley T/0000-0002-0576-5366; Wardlaw, Joanna M/0000-0002-9812-6642; Partida, Gabriel Cuellar/0000-0001-7648-4097; Ho, Beng-Choon/0000-0003-3976-1555; Strike, Lachlan T/0000-0003-2885-5898; McQuillin, Andrew/0000-0003-1567-2240; Desrivières, Sylvane/0000-0002-9120-7060; Pantelis, Christos/0000-0002-9565-0238; Heinz, Andreas/0000-0001-5405-9065; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Mattheisen, Manuel/0000-0002-8442-493X; McIntosh, Andrew M/0000-0002-0198-4588; Mattheisen, Manuel/0000-0002-8442-493X; Weale, Michael E/0000-0003-4593-1186; Bergen, Sarah/0000-0002-5888-0034; Westman, Eric/0000-0002-3115-2977; O'Donovan, Michael C/0000-0001-7073-2379; Zimprich, Fritz/0000-0002-6998-5480; Lopez, Lorna/0000-0002-0241-9783; Konte, Bettina/0000-0001-5287-308X; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Mortensen, Preben B/0000-0002-5230-9865; Ehrlich, Stefan/0000-0003-2132-4445; Deary, Ian J/0000-0002-1733-263X; Domenici, Enrico/0000-0001-7436-6919; Walton, Esther/0000-0002-0935-2200; Lee, Jimmy/0000-0002-7724-7445; Hansell, Narelle K/0000-0002-8229-9741; Ruderfer, Douglas M/0000-0002-2365-386X; Hoogman, Martine/0000-0002-1261-7628; Mattingsdal, Morten/0000-0003-4440-0324; O'Neill, Francis A/0000-0002-7531-7657; Zimprich, Fritz/0000-0002-6998-5480; Klein, Marieke/0000-0001-8784-5679; Ashbrook, David George/0000-0002-7397-8910; Pike, Bruce/0000-0001-8924-683X; Brown, Matthew A/0000-0003-0538-8211; Bramon, Elvira/0000-0003-1369-5983; Teumer, Alexander/0000-0002-8309-094X; Lawrie, Stephen MacGregor/0000-0002-2444-5675; Rentería, Miguel E./0000-0003-4626-7248; Fukunaga, Masaki/0000-0003-1010-2644; McMahon, Francis J/0000-0002-9469-305X; McDonald, Colm/0000-0003-1661-5192; Nichols, Thomas E./0000-0002-4516-5103; Luciano, Michelle/0000-0003-0935-7682; Fernandez, Guillen/0000-0002-5522-0604; Zwiers, Marcel P/0000-0001-5483-2935; McMahon, Katie L/0000-0002-6357-615X; Thompson, Paul M/0000-0002-4720-8867; Blangero, John/0000-0001-6250-5723; Whelan, Christopher/0000-0003-0308-5583; Klovins, Janis/0000-0001-8362-5505; Scott, Rodney/0000-0001-7724-3404; van der Lee, Sven/0000-0003-1606-8643; Stein, Jason/0000-0003-4829-0513; Saykin, Andrew/0000-0002-1376-8532; Cairns, Murray/0000-0003-2490-2538; Stogmann, Elisabeth/0000-0003-4688-8482; Escott-Price, Valentina/0000-0003-1784-5483; Black, Donald/0000-0001-8038-1971; Papiol, Sergi/0000-0001-9366-8728; Joa, Inge/0000-0002-5516-2336; Gopal, Srihari/0000-0001-5254-2192; Giusti-Rodriguez, Paola/0000-0002-1921-1305; Satizabal, Claudia L/0000-0002-1115-4430; Fedko, Iryna/0000-0003-1962-916X; Haukvik, Unn Kristin/0000-0002-0363-4127; Romanczuk-Seiferth, Nina/0000-0002-6931-269X; Risacher, Shannon/0000-0002-3304-7943; So, Hon-Cheong/0000-0002-7102-833X; Lovestone, Simon/0000-0003-0473-4565; Ptackova, Hana/0000-0002-5694-3695; Cavalleri, Gianpiero/0000-0002-9802-0506; Seshadri, Sudha/0000-0001-6135-2622; Myin-Germeys, Inez/0000-0002-3731-4930; Borglum, Anders/0000-0001-8627-7219; Carless, Melanie/0000-0001-8350-2302; Thalamuthu, Anbupalam/0000-0002-7114-1260; Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Van Duijn, Cornelia/0000-0002-2374-9204; Ohi, Kazutaka/0000-0001-9577-9640; White, Tonya/0000-0003-0271-1896; Franke, Lude/0000-0002-5159-8802; murray, robin/0000-0003-0829-0519; Fisher, Simon/0000-0002-3132-1996; Nothen, Markus/0000-0002-8770-2464; van 't Ent, Dennis/0000-0003-2001-1375; Collier, David/0000-0003-4087-1559; Ikeda, Masashi/0000-0001-6237-2449; IWATA, Nakao/0000-0003-3189-6076; Bastin, Mark/0000-0002-0490-0845; YAO, YIN/0000-0003-3053-8429; Moran, Jennifer/0000-0002-5664-4716; Bruggeman, Richard/0000-0002-3238-8471; Sprooten, Emma/0000-0002-1691-9105; Sim, Kang/0000-0003-3209-9626; Buxbaum, Joseph/0000-0001-8898-8313; Bacanu, Silviu-Alin/0000-0002-4364-1583; Gollub, Randy L./0000-0002-9434-4044; Toncheva, Draga/0000-0002-7451-6363; Julia Cano, Antonio/0000-0001-6064-3620; Curran, Joanne/0000-0002-6898-155X; Gudnason, Vilmundur/0000-0001-5696-0084; Lubinski, Jan/0000-0003-2931-3003; Perkins, Diana/0000-0001-9396-2206; ripke, stephan/0000-0003-3622-835X; Schall, Ulrich/0000-0001-9041-4562; Tooney, Paul/0000-0003-3745-4367; Walter, Henrik/0000-0002-9403-6121; Le Hellard, Stephanie/0000-0002-8085-051X; Lee, Sang Hong/0000-0001-9701-2718; Adolfsson, Rolf/0000-0001-9785-8473; Kelly, Brian/0000-0003-4460-1134; Grimm, Oliver/0000-0002-0767-0301; Magnusson, Patrik/0000-0002-7315-7899; Buccola, Nancy/0000-0003-1378-4636; Mowry, Bryan/0000-0002-4115-5645; Cannon, Dara/0000-0001-7378-3411; Schofield, Peter/0000-0003-2967-9662; Williams, Robert W./0000-0001-8924-4447; /0000-0002-8114-7615; Chauhan, Ganesh/0000-0002-8564-5021; Pers, Tune/0000-0003-0207-4831; Quested, Digby/0000-0001-6155-3336; Legge, Sophie/0000-0001-6617-0289; Djurovic, Srdjan/0000-0002-8140-8061; Schmaal, Lianne/0000-0001-9822-048X; Petryshen, Tracey/0000-0002-7972-4612; Knight, Joanne/0000-0002-7148-1660; Curtis, David/0000-0002-4089-9183; Jonsson, Erik/0000-0001-8368-6332; Ehrenreich, Hannelore/0000-0001-8371-5711; Walters, James/0000-0002-6980-4053; Freedman, Robert/0000-0002-2181-2898; Wassink, Thomas/0000-0002-0952-8333; Zai, Clement C/0000-0003-0496-7262; Palotie, Aarno/0000-0002-2527-5874; de Zubicaray, Greig/0000-0003-4506-0579; Wen, Wei/0000-0003-2753-3870; Demontis, Ditte/0000-0001-9124-2766; marsal, sara/0000-0001-5515-3854; den Braber, A./0000-0002-3377-2627; Pocklington, Andrew/0000-0002-2137-0452	US National Institute of Mental Health (NIMH) [U01 MH094421]; Netherlands Scientific Organization [NWO 480-05-003]; Max Planck Society; Max-Planck-Forderstiftung; DFG Center for Nanoscale Microscopy AMP; Molecular Physiology of the Brain (CNMPB), Gottingen, Germany; NIMH [P50 MH080272, U01 MH081928, R01 MH092380, K99 MH101367, MH085548, MH085542, MH071681, MH061884, MH58693, MH52618, R01 MH083094, R01 MH041953, R01 MH068881]; Massachusetts General Hospital Executive Committee on Research; NCRR [RR026075]; Department of Veterans Affairs Merit Review Program; Lundbeck Foundation; Danish Strategic Research Council; Aarhus University; Stanley Research Foundation; UK Medical Research Council (MRC) Centre [G0800509]; MRC Programme [G0801418]; European Community's Seventh Framework Programme [HEALTH-F2-2010-241909]; European Union Seventh Framework Programme (FP7) [279227]; MRC/Welsh Assembly Government; Margaret Temple Award from the British Medical Association; Wellcome Trust [076113/C/04/Z, 076113/CI04/Z, 072894/Z/03/Z, 090532/Z/09/Z, 075491/Z/04/B, 068545/Z/02]; National Institute for Health Research programme grant [RP-PG-0310-1002]; WTCCC2 grant [WTCCC-084710]; Janssen Research Foundation, Beerse, Belgium; Netherlands Organization for Health Research and Development (ZonMw) in the Mental Health program; Danish Council for Strategic Research [09-067048]; Danish National Advanced Technology Foundation [001-2009-2]; Lundbeck Foundation [R24-A3243]; EU; Wellcome Trust as part of the WTCCC2 project; MRC; Research Council of Norway [213837, 217776, 223273]; South-East Norway Health Authority [2013-123]; K. G. Jebsen Foundation; Donald and Barbara Zucker Foundation; North Shore - Long Island Jewish Health System Foundation; Stanley Foundation; NARSAD; SynSys [EU FP7-242167]; Sigrid Juselius Foundation; Academy of Finland [251704]; Sohlberg Foundation; Swedish Research Council [2006-4472, 2009-5269, 2009-3413, 345-2003-3883, 315-2004-6977, 80576801, 70374401]; County Council of Vasterbotten, Sweden; County Council of Norrbotten, Sweden; Bank of Sweden Tercentenary Foundation; Swedish Council for Planning and Coordination of Research; Swedish Council for Research in the Humanities and Social Sciences; Swedish Council for Social Research; Estonian Ministry of Science and Education [SF0180142s08]; US National Institutes of Health (NIH) [R01 DK075787]; University of Tartu [SP1GVARENG]; European Regional Development Fund [3.2.0304.11-0312]; FP7 grant [313010]; Singapore National Medical Research Council [NMRC/TCR/003/2008]; Singapore Biomedical Research Council; Singapore Agency for Science, Technology and Research (A*STAR); Uppsala University, Uppsala University Hospital, Science for Life Laboratory; Stockholm County Council; Karolinska Insititutet; Australian Schizophrenia Research Bank; National Health and Medical Research Council [386500]; Pratt Foundation; Ramsay Health Care; Viertel Charitable Foundation; Schizophrenia Research Institute; NSW Department of Health; National Health and Medical Research Council (Australia); Australian National Health and Medical Research Council; German Federal Ministry of Education and Research (BMBF) through the Integrated Genome Research Network MooDS under the National Genome Research Network plus (NGFNplus) [01GS08144, 01GS08147]; Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders), under e:Med Programme (GlaxoSmithKline); Bavarian Ministry of Commerce; BMBF [01GS0481]; German Research Foundation (DFG); Alfried Krupp von Bohlen und Halbach-Stiftung; European Union [279227, HEALTH-F4-2009-242257, HEALTH-2011-1.1-2]; Stanley Medical Research Institute; Stanley Center for Psychiatric Research; Sylvan Herman Foundation; Friedman Brain Institute at the Mount Sinai School of Medicine; Karolinska Institutet, Karolinska University Hospital; Swedish County Council; Soderstrom Konigska Foundation; Juvenile Diabetes Research Foundation [WT0618S8]; National Institute of Health Research of England; Walter E. Nichols, M. D., Professorship in the School of Medicine; Eleanor Nichols Endowment; Walter F. AMP; Rachael L. Nichols Endowment; William and Mary McIvor Endowment, Stanford University; NIH [MH67257, MH59588, MH59571, MH59565, MH59587, MH60870, MH59566, MH59586, MH61675, MH60879, MH81800, MH46276, MH46289, MH46318, MH79469, MH79470, R01D0042157-01A, MH081802]; Genetic Association Information Network (GAIN); Paul Michael Donovan Charitable Foundation; National Center for Research Resources [U54 RR020278]; WTCCC2 project [085475/B/08/Z, 085475/Z/08/Z]; MRC [G0000934]; Hong Kong Research Grants Council project [GRF 774707M, 777511M, 776412M, 776513M]; NIH institutes contributing to the Big Data to Knowledge (BD2K) initiative [U54 EB020403]; NIBIB; NCI.ADNI; Alzheimer's Disease Neuroimaging Initiative (ADNI) (NIH) [U01 AG024904]; US Department of Defense [W81XWH-12-2-0012]; US National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Northern California Institute for Research and Education; Knut and Alice Wallenberg Foundation; Torsten and Ragnar Soderbergs Foundation; HelseVest RHF [911554]; Scottish Mental Health Research Network; National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Award; Health Foundation Clinician Scientist Fellowship; Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL); Hersenstichting Nederland; Netherlands Organization for Scientific Research (NWO); European Community [602450, 602805]; Vici grant from the NWO [016.130.669]; Center for Brain Science Neuroinformatics Research Group; Athinoula A. Martinos Center for Biomedical Imaging; Center for Human Genetic Research; European Union-funded FP6 Integrated Project IMAGEN [LSHM-CT-2007-037286]; FP7 projects [602450, 603016]; Innovative Medicine Initiative Project EU-AIMS [115300-2]; Medical Research Council programme grant [93558]; NIHR Biomedical Research Center; Swedish Research Council (FORMAS); BMBF (eMED SysAlc) [01ZX1311A, 1EV0711]; BMBF through the Integrated Genome Research Network MooDS under the National Genome Research Network plus (NGFNplus) [01GS08144, 01GS08147, 01GS08148]; Integrated Network IntegraMent, under the auspices of the e:Med Programme [01ZX1314A, 01ZX1314C, 01ZX1314G]; Exzellenz-Stiftung of the Max Planck Society; BMBF in the framework of the National Genome Research Network (NGFN) [FKZ 01GS0481]; Bergen Research Foundation; University of Bergen; Dr Einar Martens Fund; K. G. Jebsen Foundation and the Research Council of Norway; Netherlands Organization for Scientific Research (Geestkracht program grant) [10-000-1002]; Center for Medical Systems Biology (CSMB, NWO Genomics); Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL); VU University's Institutes for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam; University Medical Center Groningen, Leiden University Medical Center; Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health; NWO; NWO large investment grant [1750102007010]; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; VU University Amsterdam; European Community's Seventh Framework Programme (FP7) [602450, 602805, 278948]; NWO [MW904-61-193, MaGW-nr 400-07-080, MagW 480-04-004, 51.02.060, 668.772, NWO/SPI 56-464-14192]; European Research Council [ERC-230374]; Utrecht University; NWO Brain and Cognition [433-09-220]; Australian National Health and Medical Research Council (NHMRC)/Australian Research Council Strategic Award [401162]; NHMRC [1045325, 310667, 401184, 525453, 568940, 389875, 486682, 1009064]; Commonwealth Scientific and Industrial Research Organisation Flagship Collaboration Fund grant; Australian Government; Alzheimer's Australia Dementia Research Foundation; National Science Foundation [BCS-1229450]; Autism Speaks; Australian Research Council [FT110100548, FT0991634]; NHMRC fellowship [619667]; BMBF (grants) [01ZZ9603, 01ZZ0103, 01ZZ0403]; DFG [GR 1912/5-1]; German Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; University Medicine Greifswald; NHMRC program [401184, 350833, 568969]; NHMRC project grant [525453]; NHMRC capacity building grant [568940]; The NIMH [R01 MH078075, MH065580, MH001760, RC2 MH089964, R01 MH084098, K01 MH085812, R01 MH100141, R01 MH077139, R01 MH095034, R01 MH062276, R01 MH068922, R01 MH068921, MH 41953, MH083094, K99MH102357];  [CZ. 2.16/3.1.00/24022OPPK];  [NT/13770-4];  [00064203 FN Motol];  [1RC2 MH089951];  [1RC2 MH089995];  [R01MH62873];  [R01 NS080655];  [R01AG040060];  [R01 EB008432];  [R01 MH097268];  [R01 MH085667];  [R01 MH089722];  [ERC-2010-AdG 268800-NEUROSCHEMA]; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [G0801418, G1100616, MR/L016400/1, MR/K026992/1, MC_UU_12013/1, MR/L010305/1, G0901858, MC_UU_12013/2, G0800509, MR/P005748/1, G0000934, MR/L023784/2] Funding Source: researchfish; Wellcome Trust [100309/A/12/Z] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050735] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015922, R01EB008432, U54EB020403, R01EB005846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059586, R01MH083094, ZIAMH002810, R01MH061884, R01MH071681, R01MH062873, R01MH059566, R01MH081802, R01MH059588, R01MH061675, RC2MH089995, U01MH046276, R01MH060870, K24MH094614, R01MH068881, R01MH060879, K01MH099232, R01MH068922, K23MH001760, R01MH094343, K01MH085812, R01MH041953, U01MH046318, R01MH059587, K99MH101367, R01MH085542, R01MH085548, R01MH058693, R01MH084098, U01MH094421, R01MH059565, R01MH089722, R01MH095034, R01MH081800, U01MH079469, RC2MH089964, R01MH067257, R01MH085667, U01MH079470, U01MH081928, R01MH062276, R01MH068921, U01MH109528, R01MH092380, P50MH080272, R01MH100141, R01MH059571, R00MH102357, R01MH052618, U01MH046289, RC2MH089951, K01MH065580, R01MH097268, U01MH085520, R01MH077139, R01MH078075, K99MH102357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040060, R01AG033193, R01AG008122, R01AG054076, U01AG024904, U24AG021886] Funding Source: NIH RePORTER; MRC [MC_UU_12013/2, G0800509, G0801418, G0901858, G1100616, MR/L016400/1, MR/L023784/2, MC_UU_12013/1, MR/P005748/1] Funding Source: UKRI	US National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Netherlands Scientific Organization; Max Planck Society(Max Planck SocietyFoundation CELLEX); Max-Planck-Forderstiftung; DFG Center for Nanoscale Microscopy AMP; Molecular Physiology of the Brain (CNMPB), Gottingen, Germany; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Massachusetts General Hospital Executive Committee on Research; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Veterans Affairs Merit Review Program(US Department of Veterans Affairs); Lundbeck Foundation(Lundbeckfonden); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Aarhus University; Stanley Research Foundation; UK Medical Research Council (MRC) Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community's Seventh Framework Programme(European Commission); European Union Seventh Framework Programme (FP7); MRC/Welsh Assembly Government(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Margaret Temple Award from the British Medical Association; Wellcome Trust(Wellcome Trust); National Institute for Health Research programme grant; WTCCC2 grant; Janssen Research Foundation, Beerse, Belgium; Netherlands Organization for Health Research and Development (ZonMw) in the Mental Health program; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish National Advanced Technology Foundation; Lundbeck Foundation(Lundbeckfonden); EU(European Commission); Wellcome Trust as part of the WTCCC2 project(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Council of Norway(Research Council of Norway); South-East Norway Health Authority; K. G. Jebsen Foundation; Donald and Barbara Zucker Foundation; North Shore - Long Island Jewish Health System Foundation; Stanley Foundation; NARSAD(NARSAD); SynSys; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Sohlberg Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); County Council of Vasterbotten, Sweden; County Council of Norrbotten, Sweden; Bank of Sweden Tercentenary Foundation; Swedish Council for Planning and Coordination of Research; Swedish Council for Research in the Humanities and Social Sciences; Swedish Council for Social Research; Estonian Ministry of Science and Education(Ministry of Education and Research, Estonia); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tartu; European Regional Development Fund(European Commission); FP7 grant; Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Uppsala University, Uppsala University Hospital, Science for Life Laboratory; Stockholm County Council(Stockholm County Council); Karolinska Insititutet(Karolinska Institutet); Australian Schizophrenia Research Bank; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Pratt Foundation; Ramsay Health Care; Viertel Charitable Foundation; Schizophrenia Research Institute; NSW Department of Health; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); German Federal Ministry of Education and Research (BMBF) through the Integrated Genome Research Network MooDS under the National Genome Research Network plus (NGFNplus)(Federal Ministry of Education & Research (BMBF)); Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders), under e:Med Programme (GlaxoSmithKline); Bavarian Ministry of Commerce; BMBF(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Alfried Krupp von Bohlen und Halbach-Stiftung; European Union(European Commission); Stanley Medical Research Institute; Stanley Center for Psychiatric Research; Sylvan Herman Foundation; Friedman Brain Institute at the Mount Sinai School of Medicine; Karolinska Institutet, Karolinska University Hospital(Karolinska Institutet); Swedish County Council; Soderstrom Konigska Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Health Research of England(National Institute for Health Research (NIHR)); Walter E. Nichols, M. D., Professorship in the School of Medicine; Eleanor Nichols Endowment; Walter F. AMP; Rachael L. Nichols Endowment; William and Mary McIvor Endowment, Stanford University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetic Association Information Network (GAIN); Paul Michael Donovan Charitable Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); WTCCC2 project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hong Kong Research Grants Council project(Hong Kong Research Grants Council); NIH institutes contributing to the Big Data to Knowledge (BD2K) initiative; NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCI.ADNI; Alzheimer's Disease Neuroimaging Initiative (ADNI) (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Northern California Institute for Research and Education; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Torsten and Ragnar Soderbergs Foundation; HelseVest RHF; Scottish Mental Health Research Network; National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Award(NARSAD); Health Foundation Clinician Scientist Fellowship; Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL); Hersenstichting Nederland; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); Vici grant from the NWO; Center for Brain Science Neuroinformatics Research Group; Athinoula A. Martinos Center for Biomedical Imaging; Center for Human Genetic Research; European Union-funded FP6 Integrated Project IMAGEN; FP7 projects; Innovative Medicine Initiative Project EU-AIMS; Medical Research Council programme grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Biomedical Research Center; Swedish Research Council (FORMAS)(Swedish Research CouncilSwedish Research Council Formas); BMBF (eMED SysAlc)(Federal Ministry of Education & Research (BMBF)); BMBF through the Integrated Genome Research Network MooDS under the National Genome Research Network plus (NGFNplus)(Federal Ministry of Education & Research (BMBF)); Integrated Network IntegraMent, under the auspices of the e:Med Programme; Exzellenz-Stiftung of the Max Planck Society; BMBF in the framework of the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); Bergen Research Foundation; University of Bergen; Dr Einar Martens Fund; K. G. Jebsen Foundation and the Research Council of Norway; Netherlands Organization for Scientific Research (Geestkracht program grant); Center for Medical Systems Biology (CSMB, NWO Genomics); Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL); VU University's Institutes for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam; University Medical Center Groningen, Leiden University Medical Center; Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWO(Netherlands Organization for Scientific Research (NWO)); NWO large investment grant; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; VU University Amsterdam; European Community's Seventh Framework Programme (FP7)(European Commission); NWO(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); Utrecht University; NWO Brain and Cognition; Australian National Health and Medical Research Council (NHMRC)/Australian Research Council Strategic Award(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Commonwealth Scientific and Industrial Research Organisation Flagship Collaboration Fund grant; Australian Government(Australian GovernmentCGIAR); Alzheimer's Australia Dementia Research Foundation; National Science Foundation(National Science Foundation (NSF)); Autism Speaks; Australian Research Council(Australian Research Council); NHMRC fellowship(National Health and Medical Research Council (NHMRC) of Australia); BMBF (grants)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); German Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany(Siemens AG); Federal State of Mecklenburg-West Pomerania; University Medicine Greifswald; NHMRC program(National Health and Medical Research Council (NHMRC) of Australia); NHMRC project grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC capacity building grant(National Health and Medical Research Council (NHMRC) of Australia); The NIMH; ; ; ; ; ; ; ; ; ; ; ; ; ; Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	PGC. The authors are grateful to the many family members who participated in the studies that recruited these samples, to the many clinicians who assisted in their recruitment, and to our team members, without whom this study would have been impossible. Core funding for the PGC is from the US National Institute of Mental Health (NIMH; U01 MH094421). Statistical analyses were carried out on the Genetic Cluster Computer (http://www.geneticcluster.org/) hosted by SURFsara and financially supported by the Netherlands Scientific Organization (NWO 480-05-003), along with a supplement from the Dutch Brain Foundation and the VU University Amsterdam. The GRAS data collection was supported by the Max Planck Society, the Max-Planck-Forderstiftung and the DFG Center for Nanoscale Microscopy & Molecular Physiology of the Brain (CNMPB), Gottingen, Germany. The Boston CIDAR project was supported by the NIMH (P50 MH080272, R. W. M.; U01 MH081928, L. J. S.; R01 MH092380, T. L. P.) and the Massachusetts General Hospital Executive Committee on Research (T. L. P.). P. H. L. is supported by NIMH K99 MH101367. ISC Portugal: C. N. P. and M. T. P. have been supported by NIMH grants MH085548, MH085542, MH071681, MH061884, MH58693 and MH52618 and NCRR grant RR026075. C. N. P., M. T. P. and A. H. F. have been supported by grants from the Department of Veterans Affairs Merit Review Program. The Danish Aarhus study was supported by grants from Lundbeck Foundation, Danish Strategic Research Council, Aarhus University, and Stanley Research Foundation. Work in Cardiff was supported by UK Medical Research Council (MRC) Centre (G0800509) and MRC Programme (G0801418) grants, the European Community's Seventh Framework Programme (HEALTH-F2-2010-241909, Project EU-GEI) the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement 279227, a fellowship to J. W. from the MRC/Welsh Assembly Government and the Margaret Temple Award from the British Medical Association. We thank Novartis for their input in obtaining CLOZUK samples, staff at The Doctor's Laboratory (L. Levett and A. Levett) for help with sample acquisition and data linkage, and staff in Cardiff (K. Mantripragada and L. Hopkins) for sample management. CLOZUK and some other samples were genotyped at the Broad Institute or by the Wellcome Trust Case Control Consortium (WTCCC) and Wellcome Trust Case Control Consortium 2 (WTCCC2) (WT 083948/Z/07/Z). We acknowledge use of the British 1958 Birth Cohort DNA (MRC: G0000934) and the Wellcome Trust (068545/Z/0 and 076113/C/04/Z), the UK Blood Services Common Controls (UKBS-CC collection), funded by the Wellcome Trust (076113/C/04/Z) and by a National Institute for Health Research programme grant to National Health Service Blood and Transplant (RP-PG-0310-1002). Virginia Commonwealth University investigators were supported by NIMH grants R01 MH083094, R01 MH041953, and R01 MH068881 and WTCCC2 grant WTCCC-084710. Recruitment of families in Bulgaria was funded by the Janssen Research Foundation, Beerse, Belgium. We thank the staff in the Neuroscience Biomarkers Genomic Lab led by R. Favis at Janssen for sample processing and the staff at Illumina for genotyping Janssen DNA samples. We also thank A. Santos, N. Bottrel, M.-A. Franc and W. Cafferty of Janssen Research & Development) for operational support. Dutch samples were funded by the Netherlands Organization for Health Research and Development (ZonMw) in the Mental Health program and by NIMH R01 MH078075. Danish samples were funded by the Danish Council for Strategic Research (Journ. nr.; r 09-067048), the Danish National Advanced Technology Foundation (Journ. nr. 001-2009-2), the Lundbeck Foundation (Journ. nr. R24-A3243), and the EU 7th Framework Programme. The Wellcome Trust supported this study as part of the WTCCC2 project. E. Bramon holds a MRC New Investigator Award and a MRC Centenary Award. The TOP Study was supported by the Research Council of Norway (213837, 217776, 223273), South-East Norway Health Authority (2013-123) and K. G. Jebsen Foundation. This work was supported by the Donald and Barbara Zucker Foundation, the North Shore - Long Island Jewish Health System Foundation and grants from the Stanley Foundation (A. K. M.), NARSAD (A. K. M.), NIMH (MH065580 to T. Lencz; MH001760 to A. K. M.), and NIMH RC2 MH089964 and R01 MH084098. Finnish samples were funded by SynSys (EU FP7-242167), Sigrid Juselius Foundation, the Academy of Finland (grant 251704), and the Sohlberg Foundation. The Swedish Research Council (grants 2006-4472, 2009-5269, 2009-3413) and the County Councils of Vasterbotten and Norrbotten, Sweden, supported the collection of the Umea samples. The Betula Study, from which the Umea controls were recruited, is supported by grants from the Swedish Research Council (grants 345-2003-3883, 315-2004-6977) and the Bank of Sweden Tercentenary Foundation, the Swedish Council for Planning and Coordination of Research, the Swedish Council for Research in the Humanities and Social Sciences and the Swedish Council for Social Research. We acknowledge support from NIMH K01 MH085812 (M. C. K.) and NIMH R01 MH100141 (M. C. K.). Estonian Genome Center at the University of Tartu (EGCUT) work was supported by Targeted Financing from the Estonian Ministry of Science and Education (SF0180142s08), US National Institutes of Health (NIH) grant R01 DK075787, the Development Fund of the University of Tartu (grant SP1GVARENG), the European Regional Development Fund to the Centre of Excellence in Genomics (EXCEGEN; grant 3.2.0304.11-0312) and FP7 grant 313010. M. Macek was supported by CZ. 2.16/3.1.00/24022OPPK, NT/13770-4 and 00064203 FN Motol. Funding from the Singapore National Medical Research Council (NMRC/TCR/003/2008) and the Singapore Biomedical Research Council. We acknowledge the support of the Singapore Agency for Science, Technology and Research (A*STAR). Genotyping of the Swedish Hubin sample was performed by the SNP&SEQ Technology Platform in Uppsala, which is supported by Uppsala University, Uppsala University Hospital, Science for Life Laboratory and the Swedish Research Council (contracts 80576801 and 70374401). The Swedish Hubin sample was supported by Swedish Research Council (I. A., E. G. J.) and Stockholm County Council and the Karolinska Insititutet (E. G. J.). B. J. M., V. J. C., R. J. S., S. V. C., F. A. H., A. V. J., C. M. L., P. T. M., C. P. and U. S. were supported by the Australian Schizophrenia Research Bank, which is supported by an enabling grant from the National Health and Medical Research Council (386500), the Pratt Foundation, Ramsay Health Care, the Viertel Charitable Foundation, the Schizophrenia Research Institute and the NSW Department of Health. C. P. is supported by a Senior Principal Research Fellowship from the National Health and Medical Research Council (Australia). The Perth sample collection was funded by Australian National Health and Medical Research Council project grants and the Australian Schizophrenia Research Bank.; r The Bonn/Mannheim sample was genotyped in a study that was supported by the German Federal Ministry of Education and Research (BMBF) through the Integrated Genome Research Network MooDS (Systematic Investigation of the Molecular Causes of Major Mood Disorders and Schizophrenia; grant 01GS08144 to M. M. N. and S. C., grant 01GS08147 to M. R.), under the National Genome Research Network plus (NGFNplus), and the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders), under e:Med Programme (GlaxoSmithKline control sample; B. M.-M.) This work has been funded by the Bavarian Ministry of Commerce and by the BMBF in the framework of the National Genome Research Network, Forderkennzeichen 01GS0481 and the Bavarian Ministry of Commerce. M. M. N. is a member of the German Research Foundation (DFG)-funded Excellence Cluster ImmunoSensation. M. M. N. also received support from the Alfried Krupp von Bohlen und Halbach-Stiftung. M. R. was supported by the 7th Framework Programme of the European Union (ADAMS project, HEALTH-F4-2009-242257; CRESTAR project, HEALTH-2011-1.1-2) grant 279227. J. Knight holds the Joanne Murphy Professor in Behavioural Science. The Stanley Center for Psychiatric Research at the Broad Institute acknowledges funding from the Stanley Medical Research Institute. Support for the Sweden Schizophrenia Study (principal investigators P. F. S., C. M. H. and P. Sklar) was provided by the NIMH (R01 MH077139 and R01 MH095034), the Stanley Center for Psychiatric Research, the Sylvan Herman Foundation, the Friedman Brain Institute at the Mount Sinai School of Medicine, the Karolinska Institutet, Karolinska University Hospital, the Swedish Research Council, the Swedish County Council and the Soderstrom Konigska Foundation. We acknowledge use of DNA from the UK Blood Services Collection of Common Controls (UKBS collection), funded by the Wellcome Trust grant 076113/CI04/Z, by Juvenile Diabetes Research Foundation grant WT0618S8, and by the National Institute of Health Research of England. The Multicenter Genetics Studies of Schizophrenia and Molecular Genetics of Schizophrenia studies study were supported by NIMH grant R01 MH062276 (to D. F. L., C. L., M. J. O. and D. B. W.), grant R01 MH068922 (to P. V. G.), grant R01 MH068921 (to A. E. P.) and grant R01 MH068881 (to B. P. R.). D. F. L. was supported by the Walter E. Nichols, M. D., Professorship in the School of Medicine, the Eleanor Nichols Endowment, the Walter F. & Rachael L. Nichols Endowment and the William and Mary McIvor Endowment, Stanford University. This study was supported by NIH R01 grants (MH67257 to N. G. B., MH59588 to B. J. M., MH59571 to P. V. G., MH59565 to R. F., MH59587 to F. A., MH60870 to W. F. B., MH59566 to D. W. B., MH59586 to J. M. S., MH61675 to D. F. L., MH60879 to C. R. C. and MH81800 to P. V. G.), NIH U01 grants (MH46276 to C. R. C., MH46289 to C. Kaufmann, MH46318 to M. T. Tsuang, MH79469 to P. V. G. and MH79470 to D. F. L.), the Genetic Association Information Network (GAIN) and The Paul Michael Donovan Charitable Foundation. Genotyping was carried out by the Center for Genotyping and Analysis at the Broad Institute of Harvard and MIT (S. Gabriel and D. B. Mirel), supported by grant U54 RR020278 from the National Center for Research Resources. D. R. W. and R. E. S. thank the staff of the Lieber Institute and the Clinical Brain Disorders Branch of the Intramural Research Program of the NIMH for their assistance in data collection and management.; r We acknowledge the Irish contribution to the International Schizophrenia Consortium (ISC) study, the WTCCC2 schizophrenia study and WTCCC2 controls from the 1958BC and UKNBS, the Science Foundation Ireland (08/IN.1/B1916). We acknowledge use of the Trinity Biobank sample from the Irish Blood Transfusion Service and the Trinity Centre for High Performance Computing. Funding for this study was provided by the WTCCC2 project (085475/B/08/Z and 085475/Z/08/Z), the Wellcome Trust (072894/Z/03/Z, 090532/Z/09/Z and 075491/Z/04/B), NIMH grants (MH 41953 and MH083094) and British 1958 Birth Cohort DNA collection funded by the MRC (grant G0000934) and the Wellcome Trust (grant 068545/Z/02). Collection of the UK National Blood Service controls was funded by the Wellcome Trust. We acknowledge Hong Kong Research Grants Council project grants GRF 774707M, 777511M, 776412M and 776513M. E NIGMA. ENIGMA was supported in part by a consortium grant (U54 EB020403 to P. M. T.) from the NIH institutes contributing to the Big Data to Knowledge (BD2K) initiative, including the NIBIB and NCI.ADNI and ADNI2GO: Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (NIH grant U01 AG024904) and US Department of Defense (award W81XWH-12-2-0012). ADNI is funded by the US National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N. V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health. The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory of Neuro Imaging at the University of Southern California. Betula: this sample collection was supported by a Wallenberg Scholar grant from the Knut and Alice Wallenberg Foundation and a grant from Torsten and Ragnar Soderbergs Foundation to L. N., and a grant from HelseVest RHF (grant 911554) to S. L. H. Bipolar Family Study: The Bipolar Family Study wishes to thank the Scottish Mental Health Research Network for research assistant support; the Brain Research Imaging Centre Edinburgh, a center in the Scottish Funding Council Scottish Imaging Network-A Platform for Scientific Excellence (SINAPSE) Collaboration, for image acquisition; and the Wellcome Trust Clinical Research Facility for genotyping. Genotyping was supported by a National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Award (to A. M. M.), and data collection was supported by the Health Foundation Clinician Scientist Fellowship.; r BIG: This work makes use of the BIG (Brain Imaging Genetics) database, first established in Nijmegen, the Netherlands, in 2007. This resource is now part of the Cognomics Initiative (http://www.cognomics.nl/), a joint initiative by researchers of the Donders Centre for Cognitive Neuroimaging, the Human Genetics and Cognitive Neuroscience departments of the Radboud University Medical Centre and the Max Planck Institute for Psycholinguistics in Nijmegen. The Cognomics Initiative is supported by the participating departments and centers and by external grants from the Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL), the Hersenstichting Nederland and the Netherlands Organization for Scientific Research (NWO). We wish to thank all persons who kindly participated in the BIG research. The research leading to these results also receives funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements 602450 (IMAGEMEND) and 602805 (Aggressotype) and from ERC-2010-AdG 268800-NEUROSCHEMA. B. F. is supported by a Vici grant from the NWO (grant 016.130.669). Brain Genomics Superstruct Project (GSP): Data were provided [ in part] by the Brain GSP of Harvard University and the Massachusetts General Hospital, with support from the Center for Brain Science Neuroinformatics Research Group, the Athinoula A. Martinos Center for Biomedical Imaging and the Center for Human Genetic Research. Twenty individual investigators at Harvard and Massachusetts General Hospital generously contributed data to GSP. GIG: The GIG (Genomic Imaging Gottingen) sample was established at the Center for Translational Research in Systems Neuroscience and Psychiatry at Gottingen University. We thank M. Keil, E. Diekhof, T. Melcher and I. Henseler for assistance in MRI data acquisition, and E. Binder and H. Mohr for help with genotyping. We are grateful to all persons who kindly participated in the GIG study. IMAGEN: IMAGEN was supported by the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-Related Behaviour in Normal Brain Function and Psychopathology) (LSHM-CT-2007-037286), the FP7 projects IMAGEMEND (602450) and MATRICS (603016), and the Innovative Medicine Initiative Project EU-AIMS (115300-2), the Medical Research Council programme grant "Developmental pathways into adolescent substance abuse" (93558), as well as the NIHR Biomedical Research Center "Mental Health". Further support was provided by the Swedish Research Council (FORMAS) and the BMBF (eMED SysAlc 01ZX1311A; Forschungsnetz AERIAL; 1EV0711). MooDS: The establishment of the MooDS sample was funded by the BMBF through the Integrated Genome Research Network MooDS (grant 01GS08144 to M. M. N. and S. C., grant 01GS08147 to M. R. and A. M.-L. and grant 01GS08148 to A. Heinz), under the auspices of the National Genome Research Network plus (NGFNplus), and through the Integrated Network IntegraMent, under the auspices of the e:Med Programme (grant 01ZX1314A to M. M. N., grant 01ZX1314C to H. Walter, grant 01ZX1314G to M. R.). MPIP: The MPIP Munich Morphometry Sample comprises images acquired as part of the Munich Antidepressant Response Signature Study and the Recurrent Unipolar Depression (RUD) Case-Control study performed at the MPIP, and control subject data acquired at the Ludwig Maximilians University, Munich, Department of Psychiatry. We wish to acknowledge A. Olynyik and radiographers R. Schirmer, E. Schreiter, R. Borschke and I. Eidner for image acquisition and data preparation. We thank D. P.; r Auer for local study management in the initial phase of the RUD study. We are grateful to GlaxoSmithKline for providing the genotypes of the RUD case-control sample. We thank the staff of the Center of Applied Genotyping for generating the genotypes of the MARS cohort. The study is supported by a grant of the Exzellenz-Stiftung of the Max Planck Society. This work has also been funded by the BMBF in the framework of the National Genome Research Network (NGFN), FKZ 01GS0481. NCNG: Sample collection was supported by grants from the Bergen Research Foundation and the University of Bergen, the Dr Einar Martens Fund, the K. G. Jebsen Foundation and the Research Council of Norway, to S. L. H., V. M. S. and T. E. NESDA: Funding was obtained from the Netherlands Organization for Scientific Research (Geestkracht program grant 10-000-1002), the Center for Medical Systems Biology (CSMB, NWO Genomics), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL), VU University's Institutes for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam, University Medical Center Groningen, Leiden University Medical Center and NIH (R01D0042157-01A, MH081802, Grand Opportunity grants 1RC2 MH089951 and 1RC2 MH089995). Part of the genotyping and analyses were funded by the Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health. Computing was supported by BiG Grid, the Dutch e-Science Grid, which is financially supported by NWO. NeuroIMAGE: NeuroIMAGE was supported by NIH grant R01MH62873 (to S. V. Faraone), NWO large investment grant 1750102007010 (to J. Buitelaar) and grants from Radboud University Nijmegen Medical Center, University Medical Center Groningen and Accare, and VU University Amsterdam. The research leading to these results also receives funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements 602450 (IMAGEMEND), 278948 (TACTICS) and 602805 (Aggressotype). NTR-Adults and Brainscale: We would like to thank all twin participants from the Netherlands Twin Register. The NTR-Adult and Brainscale studies were supported by the NWO (MW904-61-193 (E. J. C. d. G. and D. I. B.), MaGW-nr 400-07-080 (D. v. t. E.), MagW 480-04-004 (D. B), (51.02.060 (H. H.), 668.772 (D. B. and H. H.); NWO/SPI 56-464-14192 (D. B.), the European Research Council (ERC-230374) (D. B.), High Potential Grant Utrecht University (H. H.), NWO Brain and Cognition 433-09-220 (H. H.) and the Neuroscience Campus Amsterdam. Older Australian Twins Study (OATS): We would like to acknowledge and thank the OATS participants, their supporters and respective research teams. OATS is supported by Australian National Health and Medical Research Council (NHMRC)/Australian Research Council Strategic Award 401162 and NHMRC project grant 1045325 to P. S. S. and colleagues. OATS was facilitated through access to the Australian Twin Registry, a national research resource supported by NHMRC enabling grant 310667, administered by the University of Melbourne. DNA was extracted by Genetic Repositories Australia, an Enabling Facility supported by NHMRC grant 401184. OATS genotyping was partly funded by a Commonwealth Scientific and Industrial Research Organisation Flagship Collaboration Fund grant. H. B. is supported by the Australian Government funded Dementia Collaborative Research Centre, UNSW. N. J. A. was supported by NHMRC project grant 525453 and K. A. M.; r is supported by an Alzheimer's Australia Dementia Research Foundation postdoctoral fellowship and NHMRC capacity building grant 568940. QTIM: D. P. H., N. J., C. R. K. C. and P. M. T. are supported, in part, by NIH grants R01 NS080655, R01AG040060, R01 EB008432, R01 MH097268, U01 AG024904, R01 MH085667, R01 MH089722, P41 EB015922 and R01 MH094343. R. K. W. is supported by National Science Foundation (BCS-1229450). J. L. S. was supported by the NIMH (K99MH102357) and Autism Speaks. S. E. M. and G. I. d. Z. are supported by Future Fellowships (FT110100548, FT0991634) from the Australian Research Council, and G. W. M. is supported by an NHMRC fellowship (619667). The QTIM study is supported by grants from the NIH (R01 HD050735) and the NHMRC (389875, 486682, 1009064). We thank the twins and siblings for their participation, M. Grace and A. Eldridge for twin recruitment, A. Al Najjar and other radiographers for scanning, K. McAloney and D. Park for research support, and A. Henders and staff for DNA sample processing and preparation. SHIP: The Study of Health in Pomerania (SHIP) is supported by the BMBF (grants 01ZZ9603, 01ZZ0103 and 01ZZ0403) and the DFG (GR 1912/5-1). Genome-wide data and MRI scans were supported by a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. SHIP-TREND-0: This cohort is part of the Community Medicine Research (CMR) net of the University of Greifswald, which is funded by the BMBF and the German Ministry of Cultural Affairs, as well as by the Social Ministry of the Federal State of Mecklenburg-West Pomerania. CMR encompasses several research projects that share data from SHIP. MRI scans were supported by a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. The SHIP authors are grateful to M. Stanke for the opportunity to use his server cluster for SNP imputation as well as to H. Prokisch and T. Meitinger (HelmholtzZentrum Munchen) for genotyping the SHIP-TREND cohort, which was supported by the BMBF (grant 03ZIK012). We thank all staff members and participants of the SHIP studies, as well as all of the genotyping staff for generating the SHIP SNP data set. D. J. is supported by a scholarship from the Gerhard-Domagk Programme of the University Medicine Greifswald. Sydney Memory and Ageing Study (Sydney MAS): We would like to thank the Sydney MAS participants, their supporters and respective research teams. Sydney MAS was supported by NHMRC program grants 350833 and 568969 to P. S. S., H. B. and G. Andrews. DNA was extracted by Genetic Repositories Australia, an Enabling Facility supported by NHMRC grant 401184. H. B. is supported by the Australian Government funded Dementia Collaborative Research Centre, UNSW. N. J. A. was supported by NHMRC project grant 525453 and K. A. M. is supported by an Alzheimer's Australia Dementia Research Foundation postdoctoral fellowship. Both S. Reppermund and K. A. M. are supported by NHMRC capacity building grant 568940. Data used in preparing this article were obtained from the ADNI database (http://adni.loni.usc.edu/). Many investigators in ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.	Blokland GAM, 2012, TWIN RES HUM GENET, V15, P351, DOI 10.1017/thg.2012.11; Boos HBM, 2007, ARCH GEN PSYCHIAT, V64, P297, DOI 10.1001/archpsyc.64.3.297; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cannon TD, 2006, ANNU REV CLIN PSYCHO, V2, P267, DOI 10.1146/annurev.clinpsy.2.022305.095232; Deng XT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S14; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Ge T, 2015, P NATL ACAD SCI USA, V112, P2479, DOI 10.1073/pnas.1415603112; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Haijma SV, 2013, SCHIZOPHRENIA BULL, V39, P1129, DOI 10.1093/schbul/sbs118; Hariri AR, 2003, BRIT MED BULL, V65, P259, DOI 10.1093/bmb/65.1.259; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; Ho Y.Y.W., J INVEST DE IN PRESS; Kendler KS, 2010, MOL PSYCHIATR, V15, P789, DOI 10.1038/mp.2010.8; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Narr KL, 2005, CEREB CORTEX, V15, P708, DOI 10.1093/cercor/bhh172; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Plaisier SB, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq636; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rose EJ, 2013, SCHIZOPHRENIA BULL, V39, P518, DOI 10.1093/schbul/sbs056; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Thermenos HW, 2013, AM J MED GENET B, V162, P604, DOI 10.1002/ajmg.b.32170; Toulopoulou T, 2015, MOL PSYCHIATR, V20, P1386, DOI 10.1038/mp.2014.152; van Erp TGM, 2016, MOL PSYCHIATR, V21, P547, DOI 10.1038/mp.2015.63; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Weinberger DR, 1996, NEUROPSYCHOPHARMACOL, V14, pS1, DOI 10.1016/0893-133X(95)00199-N; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Witte JS, 2014, NAT REV GENET, V15, P765, DOI 10.1038/nrg3786; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097	38	138	141	0	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2016	19	3					420	+		10.1038/nn.4228	http://dx.doi.org/10.1038/nn.4228			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE7MU	26854805	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000370822200014
J	Zhang, Z; Ferretti, V; Guntan, I; Moro, A; Steinberg, EA; Ye, ZW; Zecharia, AY; Yu, X; Vyssotski, AL; Brickley, SG; Yustos, R; Pillidge, ZE; Harding, EC; Wisden, W; Franks, NP				Zhang, Zhe; Ferretti, Valentina; Guentan, Ilke; Moro, Alessandro; Steinberg, Eleonora A.; Ye, Zhiwen; Zecharia, Anna Y.; Yu, Xiao; Vyssotski, Alexei L.; Brickley, Stephen G.; Yustos, Raquel; Pillidge, Zoe E.; Harding, Edward C.; Wisden, William; Franks, Nicholas P.			Neuronal ensembles sufficient for recovery sleep and the sedative actions of alpha(2) adrenergic agonists	NATURE NEUROSCIENCE			English	Article							VENTROLATERAL PREOPTIC NUCLEUS; LOCUS-COERULEUS NEURONS; BASAL FOREBRAIN; ALPHA(2A)-ADRENERGIC RECEPTOR; GENERAL-ANESTHESIA; GABAERGIC NEURONS; TRANSGENIC MICE; C-FOS; DEXMEDETOMIDINE; RAT	Do sedatives engage natural sleep pathways? It is usually assumed that anesthetic-induced sedation and loss of righting reflex (LORR) arise by influencing the same circuitry to lesser or greater extents. For the alpha 2 adrenergic receptor agonist dexmedetomidine, we found that sedation and LORR were in fact distinct states, requiring different brain areas: the preoptic hypothalamic area and locus coeruleus (LC), respectively. Selective knockdown of alpha 2A adrenergic receptors from the LC abolished dexmedetomidine-induced LORR, but not sedation. Instead, we found that dexmedetomidine-induced sedation resembled the deep recovery sleep that follows sleep deprivation. We used TetTag pharmacogenetics in mice to functionally mark neurons activated in the preoptic hypothalamus during dexmedetomidine-induced sedation or recovery sleep. The neuronal ensembles could then be selectively reactivated. In both cases, non-rapid eye movement sleep, with the accompanying drop in body temperature, was recapitulated. Thus, alpha 2 adrenergic receptor-induced sedation and recovery sleep share hypothalamic circuitry sufficient for producing these behavioral states.	[Zhang, Zhe; Ferretti, Valentina; Guentan, Ilke; Moro, Alessandro; Steinberg, Eleonora A.; Ye, Zhiwen; Zecharia, Anna Y.; Yu, Xiao; Brickley, Stephen G.; Yustos, Raquel; Pillidge, Zoe E.; Harding, Edward C.; Wisden, William; Franks, Nicholas P.] Imperial Coll London, Dept Life Sci, South Kensington, England; [Vyssotski, Alexei L.] Univ Zurich, ETH Zurich, Inst Neuroinformat, Zurich, Switzerland	Imperial College London; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Franks, NP (corresponding author), Imperial Coll London, Dept Life Sci, South Kensington, England.	w.wisden@imperial.ac.uk; n.franks@imperial.ac.uk	Harding, Edward/AAD-4566-2020; Ferretti, Valentina/V-2394-2019; Wisden, William/A-4071-2011	Harding, Edward/0000-0002-5803-2780; Ferretti, Valentina/0000-0002-5747-8852; Wisden, William/0000-0003-4743-0334; Franks, Nicholas/0000-0003-4874-4212; Moro, Alessandro/0000-0001-9793-6216; Ye, Zhiwen/0000-0003-4311-1037; Guntan, Ilke/0000-0002-6936-537X; Yu, Xiao/0000-0001-9441-1705; Zhang, Zhe/0000-0002-0899-8077; Brickley, Stephen/0000-0002-0930-7346; Vyssotski, Alexei/0000-0002-9021-1471	Medical Research Council [G0901892, G0800399]; Biotechnology and Biological Sciences Research Council (BBSRC) [G021691, BB/K018159/1]; Wellcome Trust [WT094211MA]; BBSRC CASE studentship; Wellcome Trust Vacation Scholarship; BBSRC doctoral training grant [BB/F017324/1]; UK-China Scholarships; ERASMUS program; Biotechnology and Biological Sciences Research Council [BB/K018159/1, 1100129] Funding Source: researchfish; Medical Research Council [G0601498] Funding Source: researchfish; BBSRC [BB/K018159/1] Funding Source: UKRI; MRC [G0901892, G0601498, G0800399] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust Vacation Scholarship(Wellcome Trust); BBSRC doctoral training grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK-China Scholarships; ERASMUS program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (G0901892, N.P.F., S.G.B. and W.W.;G0800399, W.W.), the Biotechnology and Biological Sciences Research Council (BBSRC) (G021691 and BB/K018159/1, N.P.F., S.G.B. and W.W.), the Wellcome Trust (WT094211MA, S.G.B., N.P.F. and W.W.), a BBSRC CASE studentship (E.A.S.), a Wellcome Trust Vacation Scholarship ( Z.E.P.), a BBSRC doctoral training grant (BB/F017324/1, E.C.H.), UK-China Scholarships for Excellence/China Scholarship scheme (X.Y. and Z.Y.) and the ERASMUS program (I.G. and A.M.).	Adams R, 2013, BRIT J ANAESTH, V111, P703, DOI 10.1093/bja/aet194; AGHAJANIAN GK, 1982, SCIENCE, V215, P1394, DOI 10.1126/science.6278591; Alam MA, 2014, J NEUROPHYSIOL, V111, P287, DOI 10.1152/jn.00504.2013; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Berridge CW, 2012, SLEEP MED REV, V16, P187, DOI 10.1016/j.smrv.2011.12.003; Bol CJJG, 1997, J PHARMACOL EXP THER, V283, P1051; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Carter ME, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00043; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; CORREASALES C, 1992, ANESTHESIOLOGY, V76, P948, DOI 10.1097/00000542-199206000-00013; DREW GM, 1979, BRIT J PHARMACOL, V67, P133; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Gelegen C, 2014, EUR J NEUROSCI, V40, P2311, DOI 10.1111/ejn.12570; Gerashchenko D, 2008, P NATL ACAD SCI USA, V105, P10227, DOI 10.1073/pnas.0803125105; Gilsbach R, 2009, MOL PHARMACOL, V75, P1160, DOI 10.1124/mol.109.054544; Gong H, 2004, J PHYSIOL-LONDON, V556, P935, DOI 10.1113/jphysiol.2003.056622; Hu FY, 2012, ANESTHESIOLOGY, V117, P1006, DOI 10.1097/ALN.0b013e3182700ab9; Hunter JC, 1997, BRIT J PHARMACOL, V122, P1339, DOI 10.1038/sj.bjp.0701520; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lakhlani PP, 1997, P NATL ACAD SCI USA, V94, P9950, DOI 10.1073/pnas.94.18.9950; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; MACDONALD E, 1991, J PHARMACOL EXP THER, V259, P848; Mastakov MY, 2001, MOL THER, V3, P225, DOI 10.1006/mthe.2001.0246; MCGINTY DJ, 1968, SCIENCE, V160, P1253, DOI 10.1126/science.160.3833.1253; McGregor R, 2010, NAT NEUROSCI, V13, P1448, DOI 10.1038/nn1210-1448; Modirrousta M, 2004, NEUROSCIENCE, V129, P803, DOI 10.1016/j.neuroscience.2004.07.028; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Nelson LE, 2003, ANESTHESIOLOGY, V98, P428, DOI 10.1097/00000542-200302000-00024; Reijmers L, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.027.2009; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Rihel J, 2013, CURR OPIN NEUROBIOL, V23, P831, DOI 10.1016/j.conb.2013.04.010; Saito YC, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00192; Sanders RD, 2012, ANESTHESIOLOGY, V117, P945, DOI 10.1097/ALN.0b013e3182700c93; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; SEIDEL WF, 1995, J PHARMACOL EXP THER, V275, P263; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; STERMAN MB, 1962, EXP NEUROL, V6, P103, DOI 10.1016/0014-4886(62)90081-X; Szymusiak R, 2007, SLEEP MED, V8, P291, DOI 10.1016/j.sleep.2007.03.013; Takahashi K, 2010, NEUROSCIENCE, V169, P1115, DOI 10.1016/j.neuroscience.2010.06.009; Takahashi K, 2009, NEUROSCIENCE, V161, P269, DOI 10.1016/j.neuroscience.2009.02.075; Tan CM, 2002, P NATL ACAD SCI USA, V99, P12471, DOI 10.1073/pnas.122368499; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Vyssotski AL, 2009, CURR BIOL, V19, P1159, DOI 10.1016/j.cub.2009.05.070; Zecharia AY, 2009, J NEUROSCI, V29, P2177, DOI 10.1523/JNEUROSCI.4997-08.2009	50	138	152	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2015	18	4					553	+		10.1038/nn.3957	http://dx.doi.org/10.1038/nn.3957			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE4DL	25706476	Green Accepted			2022-12-17	WOS:000351780900017
J	Lewis, TL; Mao, TY; Svoboda, K; Arnold, DB				Lewis, Tommy L., Jr.; Mao, Tianyi; Svoboda, Karel; Arnold, Don B.			Myosin-dependent targeting of transmembrane proteins to neuronal dendrites	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; MEMBRANE-PROTEINS; AXONAL-TRANSPORT; AMPA RECEPTORS; TAIL DOMAIN; MICROTUBULES; VA; ACTIN; KINESIN; KIF17	The distinct electrical properties of axonal and dendritic membranes are largely a result of specific transport of vesicle-bound membrane proteins to each compartment. How this specificity arises is unclear because kinesin motors that transport vesicles cannot autonomously distinguish dendritically projecting microtubules from those projecting axonally. We hypothesized that interaction with a second motor might enable vesicles containing dendritic proteins to preferentially associate with dendritically projecting microtubules and avoid those that project to the axon. Here we show that in rat cortical neurons, localization of several distinct transmembrane proteins to dendrites is dependent on specific myosin motors and an intact actin network. Moreover, fusion with a myosin-binding domain from Melanophilin targeted Channelrhodopsin-2 specifically to the somatodendritic compartment of neurons in mice in vivo. Together, our results suggest that dendritic transmembrane proteins direct the vesicles in which they are transported to avoid the axonal compartment through interaction with myosin motors.	[Lewis, Tommy L., Jr.; Arnold, Don B.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Lewis, Tommy L., Jr.; Arnold, Don B.] Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA USA; [Mao, Tianyi; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA USA	University of Southern California; University of Southern California; Howard Hughes Medical Institute	Arnold, DB (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	darnold@usc.edu		Lewis, Tommy/0000-0001-7033-7010; Mao, Tianyi/0000-0002-3532-8319	US National Institutes of Health [NS-041963, MH-071439]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH071439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041963, F32NS080464] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The TfR-GFP and JPA5-CD8 (G. Banker, Oregon Health Sciences University), NLG-HA (M. Silverman, Simon Fraser University), GluR1-GFP (R. Malinow, University of California at San Diego) and siRNA vector (J. Esteban, University of Michigan) plasmids and the antibodies to GluR1 (R. Wenthold, US National Institutes of Health-National Institute on Deafness and Other Communication Disorders) and EAAT3 (S. Amara, University of Pittsburgh) were gifts. The authors would like to thank E. Liman, N. Segil, D. McKemy and members of the Arnold lab for comments on the manuscript and S. H. Kwon for creating the illustrations. This work was supported by US National Institutes of Health grants NS-041963 and MH-071439 to D. B. A. and support from the Howard Hughes Medical Institute to K. S.	Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Cheng CL, 2002, J NEUROSCI, V22, P10643; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Das SS, 2006, J NEUROSCI, V26, P8115, DOI 10.1523/JNEUROSCI.1015-06.2006; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Dillman JF, 1996, P NATL ACAD SCI USA, V93, P141, DOI 10.1073/pnas.93.1.141; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Geething NC, 2007, J BIOL CHEM, V282, P21518, DOI 10.1074/jbc.M701932200; Guillaud L, 2003, J NEUROSCI, V23, P131; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Kaech S, 1997, J NEUROSCI, V17, P9565; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Kural C, 2007, P NATL ACAD SCI USA, V104, P5378, DOI 10.1073/pnas.0700145104; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; POLLARD TD, 1984, J CELL BIOL, V99, P33; Pranchevicius MCS, 2008, CELL MOTIL CYTOSKEL, V65, P441, DOI 10.1002/cm.20269; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Rosales CR, 2005, EUR J NEUROSCI, V22, P2381, DOI 10.1111/j.1460-9568.2005.04400.x; RUBERTI F, 2000, J NEUROSCI, V20, P1; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; West AE, 1997, J NEUROSCI, V17, P6038; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789	47	138	141	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2009	12	5					568	576		10.1038/nn.2318	http://dx.doi.org/10.1038/nn.2318			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438SJ	19377470	Green Accepted			2022-12-17	WOS:000265575400013
J	Russell, IJ; Legan, PK; Lukashkina, VA; Lukashkin, AN; Goodyear, RJ; Richardson, GP				Russell, Ian J.; Legan, P. Kevin; Lukashkina, Victoria A.; Lukashkin, Andrei N.; Goodyear, Richard J.; Richardson, Guy P.			Sharpened cochlear tuning in a mouse with a genetically modified tectorial membrane	NATURE NEUROSCIENCE			English	Article							INNER-EAR; DISTORTION-PRODUCT; FREQUENCY MAP; HAIR-CELLS; RESPONSES; ORGAN; CORTI; STIMULATION; BEHAVIOR; DEAFNESS	Frequency tuning in the cochlea is determined by the passive mechanical properties of the basilar membrane and active feedback from the outer hair cells, sensory- effector cells that detect and amplify sound- induced basilar membrane motions. The sensory hair bundles of the outer hair cells are imbedded in the tectorial membrane, a sheet of extracellular matrix that overlies the cochlea's sensory epithelium. The tectorial membrane contains radially organized collagen fibrils that are imbedded in an unusual striated- sheet matrix formed by two glycoproteins, alpha-tectorin ( Tecta) and beta-tectorin ( Tectb). In Tectb(-/-) mice the structure of the striated- sheet matrix is disrupted. Although these mice have a low- frequency hearing loss, basilar- membrane and neural tuning are both significantly enhanced in the high-frequency regions of the cochlea, with little loss in sensitivity. These findings can be attributed to a reduction in the acting mass of the tectorial membrane and reveal a new function for this structure in controlling interactions along the cochlea.	Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Russell, IJ (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	I.J.Russell@sussex.ac.uk; G.P.Richardson@sussex.ac.uk	Lukashkin, Andrei N/N-1447-2017	Lukashkin, Andrei N/0000-0003-4577-8716; Lukashkina, Victoria/0000-0002-9154-8746; Legan, P. Kevin/0000-0002-7403-6415; Russell, Ian/0000-0002-4915-2772	Medical Research Council [G0301057, G0801693] Funding Source: Medline; Wellcome Trust [071394] Funding Source: Medline; MRC [G0301057] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALLEN JB, 1993, J ACOUST SOC AM, V94, P809, DOI 10.1121/1.408182; ALLEN JB, 1980, J ACOUST SOC AM, V68, P1660, DOI 10.1121/1.385198; BONFILS P, 1986, HEARING RES, V24, P277, DOI 10.1016/0378-5955(86)90026-2; BROWN AM, 1992, P ROY SOC B-BIOL SCI, V250, P29, DOI 10.1098/rspb.1992.0126; Chan DK, 2005, BIOPHYS J, V89, P4382, DOI 10.1529/biophysj.105.070474; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; CRANE HD, 1982, J ACOUST SOC AM, V72, P93, DOI 10.1121/1.388029; Dallos P, 2003, JARO-J ASSOC RES OTO, V4, P416, DOI 10.1007/s10162-002-3049-z; DALLOS P, 1972, SCIENCE, V177, P356, DOI 10.1126/science.177.4046.356; DALLOS P, 1976, J ACOUST SOC AM, V59, P591, DOI 10.1121/1.380903; Dallos P., 1996, COCHLEA, P1; EHRET G, 1984, HEARING RES, V14, P45, DOI 10.1016/0378-5955(84)90068-6; Freeman DM, 2003, HEARING RES, V180, P11, DOI 10.1016/S0378-5955(03)00072-8; Freeman DM, 2003, HEARING RES, V180, P1, DOI 10.1016/S0378-5955(03)00073-X; Fridberger A, 2006, P NATL ACAD SCI USA, V103, P1918, DOI 10.1073/pnas.0507231103; GASKILL SA, 1990, J ACOUST SOC AM, V88, P821, DOI 10.1121/1.399732; Geisler CD., 1998, SOUND SYNAPSE; GOODYEAR R, 1992, J COMP NEUROL, V325, P243, DOI 10.1002/cne.903250208; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; HASKO JA, 1988, HEARING RES, V35, P21, DOI 10.1016/0378-5955(88)90037-8; Hemmert W, 2000, BIOPHYS J, V78, P2285, DOI 10.1016/S0006-3495(00)76775-0; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Knipper M, 2001, J BIOL CHEM, V276, P39046, DOI 10.1074/jbc.M103385200; KOSSL M, 1995, P NATL ACAD SCI USA, V92, P276, DOI 10.1073/pnas.92.1.276; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Lukashkin AN, 2005, J NEUROSCI METH, V148, P122, DOI 10.1016/j.jneumeth.2005.04.014; LUKASHKIN AN, IN PRESS J ACOUST SO; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Naidu RC, 1998, HEARING RES, V124, P124, DOI 10.1016/S0378-5955(98)00133-6; Nowotny M, 2006, P NATL ACAD SCI USA, V103, P2120, DOI 10.1073/pnas.0511125103; Rau A, 1999, J COMP NEUROL, V405, P271; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Rueda J, 1996, ANAT EMBRYOL, V194, P501; Russell IJ, 1999, J NEUROPHYSIOL, V82, P676, DOI 10.1152/jn.1999.82.2.676; SELLICK PM, 1980, HEARING RES, V2, P439, DOI 10.1016/0378-5955(80)90080-5; Shera CA, 2004, EAR HEARING, V25, P86, DOI 10.1097/01.AUD.0000121200.90211.83; Shera CA, 2003, J ACOUST SOC AM, V114, P244, DOI 10.1121/1.1575750; Shoelson B, 2004, BIOPHYS J, V87, P2768, DOI 10.1529/biophysj.104.040774; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Steele CR, 2005, INT J SOLIDS STRUCT, V42, P5887, DOI 10.1016/j.ijsolstr.2005.03.056; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; von Bekesy G., 1960, EXPT HEARING; ZWISLOCKI J, 2002, AUDITORY SOUND TRANS; ZWISLOCKI JJ, 1980, HEARING RES, V2, P171, DOI 10.1016/0378-5955(80)90055-6; ZWISLOCKI JJ, 1986, HEARING RES, V22, P155, DOI 10.1016/0378-5955(86)90091-2; ZWISLOCKI JJ, 1989, HEARING RES, V42, P211, DOI 10.1016/0378-5955(89)90146-9	49	138	142	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					215	223		10.1038/nn1828	http://dx.doi.org/10.1038/nn1828			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220887	Green Accepted			2022-12-17	WOS:000244175200016
J	Rasse, TM; Fouquet, W; Schmid, A; Kittel, RJ; Mertel, S; Sigrist, CB; Schmidt, M; Guzman, A; Merino, C; Qin, G; Quentin, C; Madeo, FF; Heckmann, M; Sigrist, SJ				Rasse, TM; Fouquet, W; Schmid, A; Kittel, RJ; Mertel, S; Sigrist, CB; Schmidt, M; Guzman, A; Merino, C; Qin, G; Quentin, C; Madeo, FF; Heckmann, M; Sigrist, SJ			Glutamate receptor dynamics organizing synapse formation in vivo	NATURE NEUROSCIENCE			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; ACTIVE ZONE; NEUROTRANSMITTER RELEASE; FUNCTIONAL COMPONENTS; GENETIC DISSECTION; LATERAL MOVEMENTS; QUANTAL CONTENT; PLASTICITY; PROTEINS; LOCALIZATION	Insight into how glutamatergic synapses form in vivo is important for understanding developmental and experience-triggered changes of excitatory circuits. Here, we imaged postsynaptic densities (PSDs) expressing a functional, GFP-tagged glutamate receptor subunit (GluR-IIA(GFP)) at neuromuscular junctions of Drosophila melanogaster larvae for several days in vivo. New PSDs, associated with functional and structural presynaptic markers, formed independently of existing synapses and grew continuously until reaching a stable size within hours. Both in vivo photoactivation and photobleaching experiments showed that extrasynaptic receptors derived from diffuse, cell-wide pools preferentially entered growing PSDs. After entering PSDs, receptors were largely immobilized. In comparison, other postsynaptic proteins tested (PSD-95, NCAM and PAK homologs) exchanged faster and with no apparent preference for growing synapses. We show here that new glutamatergic synapses form de novo and not by partitioning processes from existing synapses, suggesting that the site-specific entry of particular glutamate receptor complexes directly controls the assembly of individual PSDs.	European Neurosci Inst Gottingen, Max Planck Soc, D-37073 Gottingen, Germany; IMB, Graz, Austria; Inst Physiol, D-79104 Freiburg, Germany	Max Planck Society	Sigrist, SJ (corresponding author), European Neurosci Inst Gottingen, Max Planck Soc, Waldweg 33, D-37073 Gottingen, Germany.	heckmann@physiologie.uni-freiburg.de; ssigris@gwdg.de	Kittel, Robert J/G-6404-2015	Kittel, Robert J/0000-0002-9199-4826; Heckmann, Manfred/0000-0002-4874-1735; Schmidt, Manuela/0000-0003-1972-3519; Madeo, Frank/0000-0002-5070-1329				Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Albin SD, 2004, J NEUROSCI, V24, P6871, DOI 10.1523/JNEUROSCI.1538-04.2004; Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Bachmann A, 2004, J CELL SCI, V117, P1899, DOI 10.1242/jcs.01029; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bresler T, 2004, J NEUROSCI, V24, P1507, DOI 10.1523/JNEUROSCI.3819-03.2004; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Featherstone DE, 2000, BRAIN RES BULL, V53, P501, DOI 10.1016/S0361-9230(00)00383-X; Fiala JC, 2002, NAT NEUROSCI, V5, P297, DOI 10.1038/nn830; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Heimbeck G, 1999, J NEUROSCI, V19, P6599; Karunanithi S, 2002, J NEUROSCI, V22, P10267; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Niell CM, 2004, ANNU REV PHYSIOL, V66, P771, DOI 10.1146/annurev.physiol.66.082602.095217; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Renger JJ, 2000, J NEUROSCI, V20, P3980; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Sigrist SJ, 2002, J NEUROSCI, V22, P7362; Sone M, 2000, DEVELOPMENT, V127, P4157; Stewart BA, 1996, J NEUROSCI, V16, P3877; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	50	138	141	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					898	905		10.1038/nn1484	http://dx.doi.org/10.1038/nn1484			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	16136672				2022-12-17	WOS:000230137100017
J	Citron, M				Citron, M			Alzheimer's disease: treatments in discovery and development	NATURE NEUROSCIENCE			English	Review							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE; GAMMA-SECRETASE; MOUSE MODEL; A-BETA; A-BETA-42; PATHOLOGY; CLEAVAGE; NOTCH	Alzheimer's disease is the single biggest unmet medical need in neurology. Current drugs are safe, but of limited benefit to most patients. This review discusses the scientific basis and current status of promising disease-modifying therapies in the discovery and development stages. I describe the major targets of anti-amyloid therapy and the main focus of disease modification approaches. In addition, two new potential treatment approaches supported by retrospective epidemiology are outlined.	Amgen Inc, Dept Neurosci, Thousand Oaks, CA 91320 USA	Amgen	Citron, M (corresponding author), Amgen Inc, Dept Neurosci, M-S 29-2-B,1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	mcitron@amgen.com						Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bush AI, 2002, P NATL ACAD SCI USA, V99, P7317, DOI 10.1073/pnas.122249699; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; CITRON M, IN PRESS J NEUROSCI; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Doody RS, 1999, ALZ DIS ASSOC DIS, V13, pS20, DOI 10.1097/00002093-199911001-00004; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Golde TE, 2001, DRUG DISCOV TODAY, V6, P1049, DOI 10.1016/S1359-6446(01)01965-1; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hock B J Jr, 2001, Trends Genet, V17, pS7, DOI 10.1016/S0168-9525(01)02449-0; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; JOACHIM CL, 1992, ALZ DIS ASSOC DIS, V6, P7, DOI 10.1097/00002093-199205000-00003; Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; McGeer PL, 2001, NEUROBIOL AGING, V22, P799, DOI 10.1016/S0197-4580(01)00289-5; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Samuels SC, 1998, PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, P267; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Soto C, 1999, MOL MED TODAY, V5, P343, DOI 10.1016/S1357-4310(99)01508-7; Steinberg D, 2002, SCIENTIST, V16, P22; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1	29	138	175	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1055	1057		10.1038/nn940	http://dx.doi.org/10.1038/nn940			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403985				2022-12-17	WOS:000179041300013
J	Dawson, TM; Dawson, VL				Dawson, TM; Dawson, VL			Neuroprotective and neurorestorative strategies for Parkinson's disease	NATURE NEUROSCIENCE			English	Review							ALPHA-SYNUCLEIN; 2 PARTS; GDNF; AGGREGATION; GENETICS; THERAPY; MODELS; STRESS	Advances in understanding the molecular mechanisms of cell death and the pathogenesis of sporadic and familial Parkinson's disease are creating new opportunities for the development of neuroprotective and/or neurorestorative therapies. Here we review many of these advances, highlighting areas and strategies that might be particularly suited to the development of innovative approaches that prevent degeneration and/or restore function in Parkinson's disease.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21287 USA.	tdawson@jhmi.edu	Dawson, Valina/Y-9757-2019	Dawson, Valina/0000-0002-2915-3970				Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bjorklund A, 2000, NAT MED, V6, P1207, DOI 10.1038/81291; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Chung KKK, 2001, TRENDS NEUROSCI, V24, pS7, DOI 10.1016/S0166-2236(00)01998-6; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Date I, 2001, CELL TRANSPLANT, V10, P397; Dawson TM, 2002, NEURON, V35, P219, DOI 10.1016/S0896-6273(02)00780-8; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Dunnett SB, 2001, NAT REV NEUROSCI, V2, P365, DOI 10.1038/35072572; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Gash DM, 1998, ANN NEUROL, V44, pS121, DOI 10.1002/ana.410440718; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lansbury PT, 2002, CURR OPIN GENET DEV, V12, P299, DOI 10.1016/S0959-437X(02)00302-7; Lavedan C, 2002, NEUROSCI LETT, V322, P57, DOI 10.1016/S0304-3940(01)02513-7; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Mayor S, 2002, BRIT MED J, V324, P997; McKay R, 2002, ANN NY ACAD SCI, V961, P44, DOI 10.1111/j.1749-6632.2002.tb03045.x; Mizuno Y, 2001, CURR OPIN NEUROL, V14, P477, DOI 10.1097/00019052-200108000-00008; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Polymeropoulos MH, 2000, ANN NY ACAD SCI, V920, P28; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Wolfe Michael S., 2002, Current Topics in Medicinal Chemistry, V2, P371, DOI 10.2174/1568026024607535; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zhang Y, 2000, NEUROBIOL DIS, V7, P240, DOI 10.1006/nbdi.2000.0319	35	138	160	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1058	1061		10.1038/nn941	http://dx.doi.org/10.1038/nn941			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403986				2022-12-17	WOS:000179041300014
J	Newman, AJ; Bavelier, D; Corina, D; Jezzard, P; Neville, HJ				Newman, AJ; Bavelier, D; Corina, D; Jezzard, P; Neville, HJ			A critical period for right hemisphere recruitment in American Sign Language processing	NATURE NEUROSCIENCE			English	Article							2ND LANGUAGE; MATURATIONAL CONSTRAINTS; CEREBRAL ORGANIZATION; BILINGUAL BRAIN; ACQUISITION; ENGLISH; AGE; COMPREHENSION; VARIABILITY; EXPERIENCE	Signed languages such as American Sign Language (ASL) are natural languages that are formally similar to spoken languages, and thus present an opportunity to examine the effects of language structure and modality on the neural organization for language. Native learners of spoken languages show predominantly left-lateralized patterns of neural activation for language processing, whereas native learners of ASL show extensive right hemisphere (RH) and LH activation. We demonstrate that the RH angular gyrus is active during ASL processing only in native signers (hearing, ASL-English bilinguals) but not in those who acquired ASL after puberty (hearing, native English speakers). This is the first demonstration of a 'sensitive' or 'critical' period for language in an RH structure. This has implications for language acquisition and for understanding age-related changes in neuroplasticity more generally.	Univ Oregon 1227, Dept Psychol, Eugene, OR 97403 USA; Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Univ Washington, Dept Psychol, Seattle, WA 98195 USA; John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England	University of Oregon; University of Rochester; University of Washington; University of Washington Seattle; University of Oxford	Newman, AJ (corresponding author), Univ Oregon 1227, Dept Psychol, Eugene, OR 97403 USA.		; Newman, Aaron/A-6835-2011	Bavelier, Daphne/0000-0002-5904-1240; Newman, Aaron/0000-0001-5290-8342; Jezzard, Peter/0000-0001-7912-2251	NIDCD NIH HHS [R29 DCO3099, DC00128] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC003099] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Bavelier D, 1998, NEUROREPORT, V9, P1537, DOI 10.1097/00001756-199805110-00054; Chee MWL, 1999, J NEUROSCI, V19, P3050; Corina D, 1998, APHASIA IN ATYPICAL POPULATIONS, P261; CURTIS S, 1977, GENIE PSYCHOL STUDY; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Dehaene S, 1997, NEUROREPORT, V8, P3809, DOI 10.1097/00001756-199712010-00030; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Flege JE, 1999, J MEM LANG, V41, P78, DOI 10.1006/jmla.1999.2638; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; Grezes J, 1999, BRAIN, V122, P1875, DOI 10.1093/brain/122.10.1875; Hickok G, 1999, BRAIN LANG, V66, P233, DOI 10.1006/brln.1998.1995; Hickok G, 1998, TRENDS COGN SCI, V2, P465, DOI 10.1016/S1364-6613(98)01263-7; Hickok G, 1996, NATURE, V381, P699, DOI 10.1038/381699a0; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; Klein D, 1999, NEUROREPORT, V10, P2841, DOI 10.1097/00001756-199909090-00026; Klima E., 1979, SIGNS LANGUAGE; Lenneberg Eric H, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; Neville HJ, 1997, BRAIN LANG, V57, P285, DOI 10.1006/brln.1997.1739; Neville HJ, 1998, P NATL ACAD SCI USA, V95, P922, DOI 10.1073/pnas.95.3.922; NEWPORT EL, 1990, COGNITIVE SCI, V14, P11, DOI 10.1207/s15516709cog1401_2; OJEMANN GA, 1978, ARCH NEUROL-CHICAGO, V35, P409, DOI 10.1001/archneur.1978.00500310011002; OYAMA S, 1976, J PSYCHOLINGUIST RES, V5, P261, DOI 10.1007/BF01067377; Paradis M, 1998, APHASIA IN ATYPICAL POPULATIONS, P35; PENFIELD W, 1959, SPEECH MECHANISMS BR; Perani D, 1996, NEUROREPORT, V7, P2439, DOI 10.1097/00001756-199611040-00007; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; RADEMACHER J, 1992, J COGNITIVE NEUROSCI, V4, P352, DOI 10.1162/jocn.1992.4.4.352; SODERFELDT B, 1994, BRAIN LANG, V46, P59, DOI 10.1006/brln.1994.1004; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; WeberFox CM, 1996, J COGNITIVE NEUROSCI, V8, P231, DOI 10.1162/jocn.1996.8.3.231; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; ZOLAMORGAN S, 1988, SPATIAL COGNITION BR	35	138	146	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					76	80		10.1038/nn775	http://dx.doi.org/10.1038/nn775			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	507MG	11753419				2022-12-17	WOS:000173031800019
J	Mori, Y; Imaizumi, K; Katayama, T; Yoneda, T; Tohyama, M				Mori, Y; Imaizumi, K; Katayama, T; Yoneda, T; Tohyama, M			Two cis-acting elements in the 3 ' untranslated region of alpha-CaMKII regulate its dendritic targeting	NATURE NEUROSCIENCE			English	Article							LOCAL PROTEIN-SYNTHESIS; LONG-TERM POTENTIATION; MESSENGER-RNA TRANSPORT; HIPPOCAMPAL-NEURONS; BINDING PROTEIN; MEMORY STORAGE; LIVING NEURONS; RAT-BRAIN; KINASE-II; LOCALIZATION	Dendritic localization of the or subunit of Ca2+/calmodulin-dependent protein kinase II (alpha CaMKII) mRNA in CNS neurons requires its 3' untranslated region (3'UTR). We investigated this targeting mechanism by identifying two cis-acting elements in the 3'UTR. One is a 30-nucleotide element that mediated dendritic translocation. A homologous sequence in the 3'UTR of neurogranin, transcripts of which also reside in dendrites, also funtioned in cis to promote its dendritic transport. Other putative elements in the alpha CaMKII mRNA inhibit its transport in a resting state. This inhibition was removed in depolarized neurons, and such activity-dependent derepression was a primary requirement for their dendritic targeting.	Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka 5650871, Japan; Tanabe Seiyaku Corp, Discovery Res Lab, Yodogawa Ku, Osaka 5320031, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan	Osaka University; Mitsubishi Tanabe Pharma Corporation; Japan Science & Technology Agency (JST)	Mori, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BANGI C, 2000, J NEUROSCI, V20, pRC76; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; BENSON DL, 1992, NEUROSCIENCE, V46, P851, DOI 10.1016/0306-4522(92)90189-9; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; BROCKE L, 1995, J NEUROSCI, V15, P6797; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chakravarthy B, 1999, TRENDS NEUROSCI, V22, P12, DOI 10.1016/S0166-2236(98)01288-0; Deshler JO, 1998, CURR BIOL, V8, P489, DOI 10.1016/S0960-9822(98)70200-3; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Gomi F, 2000, J NEUROSCI, V20, P3206, DOI 10.1523/JNEUROSCI.20-09-03206.2000; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; IMAIZUMI K, 1991, BRAIN RES, V551, P36, DOI 10.1016/0006-8993(91)90910-N; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kiebler MA, 2000, NEURON, V25, P19, DOI 10.1016/S0896-6273(00)80868-5; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kuhl D, 1998, CURR OPIN NEUROBIOL, V8, P600, DOI 10.1016/S0959-4388(98)80087-1; LANDRENEAU RJ, 1994, CANC PRINCIPLES PRAC, V8, P1; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; Muslimov IA, 1997, J NEUROSCI, V17, P4722; Oleynikov Y, 1998, TRENDS CELL BIOL, V8, P381, DOI 10.1016/S0962-8924(98)01348-8; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Racca C, 1997, J NEUROSCI, V17, P1691; RAO A, 1991, J NEUROSCI, V11, P2881; Righi M, 2000, J NEUROSCI, V20, P3165, DOI 10.1523/JNEUROSCI.20-09-03165.2000; Roegiers F, 2000, TRENDS CELL BIOL, V10, P220, DOI 10.1016/S0962-8924(00)01767-0; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Schuman EM, 1999, NEURON, V23, P645, DOI 10.1016/S0896-6273(01)80023-4; Severt WL, 1999, J CELL SCI, V112, P3691; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; STEWARD O, 1988, J NEUROSCI, V8, P176; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; Tiedge H, 1999, SCIENCE, V283, P186, DOI 10.1126/science.283.5399.186; Tiedge H, 1996, J NEUROSCI, V16, P7171; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3	47	138	139	1	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1079	1084		10.1038/80591	http://dx.doi.org/10.1038/80591			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036263				2022-12-17	WOS:000167177600011
J	Ueyama, T; Krout, KE; Van Nguyen, X; Karpitskiy, V; Kollert, A; Mettenleiter, TC; Loewy, AD				Ueyama, T; Krout, KE; Van Nguyen, X; Karpitskiy, V; Kollert, A; Mettenleiter, TC; Loewy, AD			Suprachiasmatic nucleus: a central autonomic clock	NATURE NEUROSCIENCE			English	Article							NERVOUS-SYSTEM; PSEUDORABIES VIRUS; NEURAL CIRCUITS; RAT; ORGANIZATION; PROJECTIONS; TRANSPORT; NEURONS		Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Wakayama Med Coll, Dept Anat & Neurobiol, Wakayama 6410012, Japan; Friedrich Loeffler Inst, Inst Mol Biol, Fed Res Ctr Virus Dis Anim, D-17498 Insel Riems, Germany	Washington University (WUSTL); Wakayama Medical University; Friedrich Loeffler Institute	Loewy, AD (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.		Mettenleiter, h. c. Thomas C./U-1016-2019		NHLBI NIH HHS [HL-25449] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025449, R37HL025449] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		GILLETTE MU, 1993, J BIOL RHYTHM, V8, pS53; JANSEN ASP, 1995, SCIENCE, V270, P644, DOI 10.1126/science.270.5236.644; Jons A, 1997, J VIROL METHODS, V66, P283, DOI 10.1016/S0166-0934(97)00065-7; Kalsbeek A, 1996, J NEUROENDOCRINOL, V8, P299, DOI 10.1046/j.1365-2826.1996.04597.x; Loewy AD, 1998, NEUROSCI BIOBEHAV R, V22, P679, DOI 10.1016/S0149-7634(98)00006-2; LUITEN PGM, 1985, BRAIN RES, V329, P374, DOI 10.1016/0006-8993(85)90554-2; MARSON L, 1993, NEUROSCIENCE, V55, P263, DOI 10.1016/0306-4522(93)90471-Q; Marson L, 1997, J COMP NEUROL, V389, P584; Moore RY, 1997, ANNU REV MED, V48, P253, DOI 10.1146/annurev.med.48.1.253; Muller JE, 1999, AM J HYPERTENS, V12, p35S, DOI 10.1016/S0895-7061(98)00278-7; Nagai K, 1996, PROG BRAIN RES, V111, P253, DOI 10.1016/S0079-6123(08)60413-6; RUDNEY JD, 1995, CRIT REV ORAL BIOL M, V6, P343, DOI 10.1177/10454411950060040501; Smith JE, 1998, BRAIN RES, V786, P153, DOI 10.1016/S0006-8993(97)01437-6; Thompson RH, 1996, J COMP NEUROL, V376, P143, DOI 10.1002/(SICI)1096-9861(19961202)376:1<143::AID-CNE9>3.0.CO;2-3; WATTS AG, 1987, J COMP NEUROL, V258, P204, DOI 10.1002/cne.902580204	15	138	142	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1051	1053		10.1038/15973	http://dx.doi.org/10.1038/15973			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570479				2022-12-17	WOS:000085810100006
J	Sims, R; Hill, M; Williams, J				Sims, Rebecca; Hill, Matthew; Williams, Julie			The multiplex model of the genetics of Alzheimer's disease	NATURE NEUROSCIENCE			English	Review							GENOME-WIDE ASSOCIATION; POLYGENIC RISK SCORE; MISSENSE MUTATIONS; APOLIPOPROTEIN-E; CHROMATIN ACCESSIBILITY; IDENTIFIES VARIANTS; COGNITIVE DECLINE; COMMON VARIANTS; A-BETA; ONSET	Genes play a strong role in Alzheimer's disease (AD), with late-onset AD showing heritability of 58-79% and early-onset AD showing over 90%. Genetic association provides a robust platform to build our understanding of the etiology of this complex disease. Over 50 loci are now implicated for AD, suggesting that AD is a disease of multiple components, as supported by pathway analyses (immunity, endocytosis, cholesterol transport, ubiquitination, amyloid-beta and tau processing). Over 50% of late-onset AD heritability has been captured, allowing researchers to calculate the accumulation of AD genetic risk through polygenic risk scores. A polygenic risk score predicts disease with up to 90% accuracy and is an exciting tool in our research armory that could allow selection of those with high polygenic risk scores for clinical trials and precision medicine. It could also allow cellular modelling of the combined risk. Here we propose the multiplex model as a new perspective from which to understand AD. The multiplex model reflects the combination of some, or all, of these model components (genetic and environmental), in a tissue-specific manner, to trigger or sustain a disease cascade, which ultimately results in the cell and synaptic loss observed in AD.	[Sims, Rebecca; Hill, Matthew; Williams, Julie] Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff, Wales; [Hill, Matthew; Williams, Julie] Cardiff Univ, Sch Med, UK Dementia Res Inst, Cardiff, Wales	Cardiff University; Cardiff University	Williams, J (corresponding author), Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff, Wales.; Williams, J (corresponding author), Cardiff Univ, Sch Med, UK Dementia Res Inst, Cardiff, Wales.	williamsj@cardiff.ac.uk	, beccie/AAM-3770-2021; Hill, Matthew/E-7730-2010	, beccie/0000-0002-3885-1199; Hill, Matthew/0000-0001-6776-8709; Williams, Julie/0000-0002-4069-0259	UK Dementia Research Institute at Cardiff [MC_PC_17112]; Medical Research Council [MR/K013041/1]; Alzheimer's Society; Alzheimer's Research UK [ARUK-NC2018-WAL]; Dementia Platform UK [HQR00720]; European Joint Programme for Neurodegenerative Disease [MR/N029402/1]; Welsh Assembly Government, Centre for Ageing & Dementia Research [SGR544:CADR]; MRC [G0300429, MR/M009076/1, G0902227, MR/K013041/1, MC_PC_17112, MR/L023784/1, MR/L023784/2, G0600237] Funding Source: UKRI	UK Dementia Research Institute at Cardiff; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Society; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Dementia Platform UK; European Joint Programme for Neurodegenerative Disease; Welsh Assembly Government, Centre for Ageing & Dementia Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Cardiff University was supported by the UK Dementia Research Institute at Cardiff (MC_PC_17112), Medical Research Council MR/K013041/1), the Alzheimer's Society, Alzheimer's Research UK (ARUK-NC2018-WAL), Dementia Platform UK (HQR00720), the European Joint Programme for Neurodegenerative Disease (MR/N029402/1), the Welsh Assembly Government, Centre for Ageing & Dementia Research (SGR544:CADR) and a donation from the Moondance Charitable Foundation. We thank T. D. Cushion, G. Leonenko, J. Harwood and B. Lan-Leung for their support preparing this manuscript. Finally, we thank all patients and affected families for their continued generosity and willingness to participate in medical research; without their involvement, there would be no advancement in our knowledge of disease genetics.	Ahmad S, 2018, ALZHEIMERS DEMENT, V14, P848, DOI 10.1016/j.jalz.2018.01.005; Akbarian S, 2015, NAT NEUROSCI, V18, P1707, DOI 10.1038/nn.4156; Alasoo K, 2018, NAT GENET, V50, P424, DOI 10.1038/s41588-018-0046-7; Amlie-Wolf A, 2019, J ALZHEIMERS DIS, V72, P301, DOI 10.3233/JAD-190568; Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757; Arber C, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0268-4; Arendt T, 2010, AM J PATHOL, V177, P15, DOI 10.2353/ajpath.2010.090955; Axelrud LK, 2018, AM J PSYCHIAT, V175, P555, DOI 10.1176/appi.ajp.2017.17050529; Baker E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218111; Bellenguez C, 2017, NEUROBIOL AGING, V59, DOI 10.1016/j.neurobiolaging.2017.07.001; Biffi A, 2010, ARCH NEUROL-CHICAGO, V67, P677, DOI 10.1001/archneurol.2010.108; Bis JC, 2020, MOL PSYCHIATR, V25, P1859, DOI 10.1038/s41380-018-0112-7; Bouleau S, 2015, J ALZHEIMERS DIS, V45, P1015, DOI 10.3233/JAD-142802; Bralten J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.017; Braskie Meredith N, 2011, Int J Alzheimers Dis, V2011, P490140, DOI 10.4061/2011/490140; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Bushman DM, 2015, ELIFE, V4, DOI 10.7554/eLife.05116; Chandler HL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36820-3; Chauhan G, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.12.028; Claes C, 2019, ALZHEIMERS DEMENT, V15, P453, DOI 10.1016/j.jalz.2018.09.006; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Del-Aguila JL, 2018, J ALZHEIMERS DIS, V62, P745, DOI 10.3233/JAD-170834; Desikan RS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002258; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Eaton WW, 2007, J AUTOIMMUN, V29, P1, DOI 10.1016/j.jaut.2007.05.002; Escott-Price V, 2017, LANCET NEUROL, V16, P582, DOI 10.1016/S1474-4422(17)30202-8; Escott-Price V, 2017, NEUROBIOL AGING, V49, DOI 10.1016/j.neurobiolaging.2016.07.018; Escott-Price V, 2015, BRAIN, V138, P3673, DOI 10.1093/brain/awv268; Escott-Price V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094661; Esquerda-Canals G, 2017, J ALZHEIMERS DIS, V57, P1171, DOI 10.3233/JAD-170045; Farlik M, 2015, CELL REP, V10, P1386, DOI 10.1016/j.celrep.2015.02.001; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Foley SF, 2017, BIOL PSYCHIAT, V81, P154, DOI 10.1016/j.biopsych.2016.02.033; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Galimberti Daniela, 2011, Ther Adv Neurol Disord, V4, P203, DOI 10.1177/1756285611404470; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Garcia-Reitboeck P, 2018, CELL REP, V24, P2300, DOI 10.1016/j.celrep.2018.07.094; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Geiger JT, 2016, NEUROBIOL DIS, V94, P55, DOI 10.1016/j.nbd.2016.06.004; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Guerreiro R, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.028; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Gusareva ES, 2018, NEUROBIOL AGING, V72, DOI 10.1016/j.neurobiolaging.2018.08.001; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hibar DP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13624; Hollingworth P, 2012, MOL PSYCHIATR, V17, P1316, DOI 10.1038/mp.2011.125; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Honig LS, 2018, NEW ENGL J MED, V378, P321, DOI 10.1056/NEJMoa1705971; Huang KL, 2017, NAT NEUROSCI, V20, P1052, DOI 10.1038/nn.4587; Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jagust W, 2018, NAT REV NEUROSCI, V19, P687, DOI 10.1038/s41583-018-0067-3; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Johnson ECB, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0282-4; Jones L, 2015, ALZHEIMERS DEMENT, V11, P658, DOI 10.1016/j.jalz.2014.05.1757; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Jun GR, 2017, ALZHEIMERS DEMENT, V13, P727, DOI 10.1016/j.jalz.2016.12.012; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; Kunkle BW, 2017, JAMA NEUROL, V74, P1113, DOI 10.1001/jamaneurol.2017.1518; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lancaster TM, 2019, BRAIN BEHAV IMMUN, V79, P267, DOI 10.1016/j.bbi.2019.02.011; Lancaster TM, 2015, ALZHEIMERS DEMENT, V11, P1144, DOI 10.1016/j.jalz.2014.10.012; Lee MH, 2018, NATURE, V563, P639, DOI 10.1038/s41586-018-0718-6; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lee SH, 2013, HUM MOL GENET, V22, P832, DOI 10.1093/hmg/dds491; Lewis CM, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0489-y; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Liao F, 2017, CURR OPIN LIPIDOL, V28, P60, DOI 10.1097/MOL.0000000000000383; Lin YT, 2018, NEURON, V98, P1141, DOI 10.1016/j.neuron.2018.05.008; Liu GY, 2014, NEUROBIOL AGING, V35, P786, DOI 10.1016/j.neurobiolaging.2013.10.084; Liu JZ, 2017, NAT GENET, V49, P325, DOI 10.1038/ng.3766; Liu XY, 2019, CELL, V177, P1022, DOI 10.1016/j.cell.2019.04.014; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; Logue MW, 2014, ALZHEIMERS DEMENT, V10, P609, DOI 10.1016/j.jalz.2014.06.010; Lopez OL, 2009, J NEUROL NEUROSUR PS, V80, P1056, DOI 10.1136/jnnp.2008.158964corr1; Louwersheimer E, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.12.007; Lu QS, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006933; Lupton MK, 2016, NEUROBIOL AGING, V40, P68, DOI 10.1016/j.neurobiolaging.2015.12.023; Magno L, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0469-0; Marioni RE, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0150-6; Matarin M, 2015, CELL REP, V10, P633, DOI 10.1016/j.celrep.2014.12.041; McConnell MJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal1641; Meng WH, 2018, EBIOMEDICINE, V28, P180, DOI 10.1016/j.ebiom.2018.01.023; Mormino EC, 2016, NEUROLOGY, V87, P481, DOI 10.1212/WNL.0000000000002922; Moskvina V, 2013, JAMA NEUROL, V70, P1268, DOI 10.1001/jamaneurol.2013.448; Mostafavi S, 2018, NAT NEUROSCI, V21, P811, DOI 10.1038/s41593-018-0154-9; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Novikova G., 2019, INTEGRATION ALZHEIME, DOI [10.1101/694281, DOI 10.1101/694281]; Olah M, 2018, SINGLE CELL BASED AT, DOI [10.1101/343780, DOI 10.1101/343780, DOI 10.1101/343780V1]; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Raj T, 2018, NAT GENET, V50, P1584, DOI 10.1038/s41588-018-0238-1; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Rajan KB, 2015, NEUROLOGY, V85, P898, DOI 10.1212/WNL.0000000000001774; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Ricciarelli R, 2017, CURR NEUROPHARMACOL, V15, P926, DOI 10.2174/1570159X15666170116143743; Ridge PG, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0486-1; Ridge PG, 2016, NEUROBIOL AGING, V41, DOI 10.1016/j.neurobiolaging.2016.02.024; Ridge PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079771; Rius-Perez S, 2018, NEUROLOGIA, V33, P112, DOI 10.1016/j.nrl.2015.07.010; Robbins JP, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00504; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rojas I. D, 2020, COMMON VARIANTS ALZH, DOI [10.1101/19012021, DOI 10.1101/19012021]; Ropacki SA, 2005, AM J PSYCHIAT, V162, P2022, DOI 10.1176/appi.ajp.162.11.2022; Rosenblum WI, 2014, NEUROBIOL AGING, V35, P969, DOI 10.1016/j.neurobiolaging.2013.10.085; Ruiz A, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.2; Salih DA, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz022; Satizabal CL, 2019, NAT GENET, V51, P1624, DOI 10.1038/s41588-019-0511-y; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; Saykin AJ, 2010, ALZHEIMERS DEMENT, V6, P265, DOI 10.1016/j.jalz.2010.03.013; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shin IS, 2005, AM J GERIAT PSYCHIAT, V13, P469, DOI 10.1176/appi.ajgp.13.6.469; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Skene NG, 2018, NAT GENET, V50, P825, DOI 10.1038/s41588-018-0129-5; Skene NG, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00016; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Steinberg S, 2015, NAT GENET, V47, P445, DOI 10.1038/ng.3246; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tansey KE, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0523-8; Thompson PM, 2017, NEUROIMAGE, V145, P389, DOI 10.1016/j.neuroimage.2015.11.057; Valentina EP, 2017, ANN NEUROL, V82, P311, DOI 10.1002/ana.24999; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wetzel-Smith MK, 2014, NAT MED, V20, P1452, DOI 10.1038/nm.3736; Wilkosz PA, 2010, INT PSYCHOGERIATR, V22, P281, DOI 10.1017/S1041610209991001; Wingo TS, 2012, ARCH NEUROL-CHICAGO, V69, P59, DOI 10.1001/archneurol.2011.221; Yagi Takuya, 2012, Rinsho Shinkeigaku, V52, P1134; Yiannopoulou KG, 2013, THER ADV NEUROL DISO, V6, P19, DOI 10.1177/1756285612461679; Yu CH, 2016, OMICS, V20, P400, DOI 10.1089/omi.2016.0063; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhao J, 2017, HUM MOL GENET, V26, P2690, DOI 10.1093/hmg/ddx155; Zhao Z, 2015, NAT NEUROSCI, V18, P978, DOI 10.1038/nn.4025	149	137	138	14	89	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2020	23	3					311	322		10.1038/s41593-020-0599-5	http://dx.doi.org/10.1038/s41593-020-0599-5		FEB 2020	12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KV1SH	32112059	Green Accepted			2022-12-17	WOS:000517049500002
J	Martin-Fernandez, M; Jamison, S; Robin, LM; Zhao, Z; Martin, ED; Aguilar, J; Benneyworth, MA; Marsicano, G; Araque, A				Martin-Fernandez, Mario; Jamison, Stephanie; Robin, Laurie M.; Zhao, Zhe; Martin, Eduardo D.; Aguilar, Juan; Benneyworth, Michael A.; Marsicano, Giovanni; Araque, Alfonso			Synapse-specific astrocyte gating of amygdala-related behavior	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CONDITIONED FEAR; HIPPOCAMPAL SYNAPSES; INHIBITORY CIRCUITS; TRANSMITTER RELEASE; D-SERINE; MODULATION; TRANSMISSION; RESPONSES; NEURONS	The amygdala plays key roles in fear and anxiety. Studies of the amygdala have largely focused on neuronal function and connectivity. Astrocytes functionally interact with neurons, but their role in the amygdala remains largely unknown. We show that astrocytes in the medial subdivision of the central amygdala (CeM) determine the synaptic and behavioral outputs of amygdala circuits. To investigate the role of astrocytes in amygdala-related behavior and identify the underlying synaptic mechanisms, we used exogenous or endogenous signaling to selectively activate CeM astrocytes. Astrocytes depressed excitatory synapses from basolateral amygdala via A(1) adenosine receptor activation and enhanced inhibitory synapses from the lateral subdivision of the central amygdala via A(2A) receptor activation. Furthermore, astrocytic activation decreased the firing rate of CeM neurons and reduced fear expression in a fear-conditioning paradigm. Therefore, we conclude that astrocyte activity determines fear responses by selectively regulating specific synapses, which indicates that animal behavior results from the coordinated activity of neurons and astrocytes.	[Martin-Fernandez, Mario; Jamison, Stephanie; Araque, Alfonso] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Robin, Laurie M.; Zhao, Zhe; Marsicano, Giovanni] INSERM, NeuroCtr Magendie Endocannabinoids & Neuroadaptat, Bordeaux, France; [Robin, Laurie M.; Zhao, Zhe; Marsicano, Giovanni] Univ Bordeaux, Bordeaux, France; [Martin, Eduardo D.] CSIC, Inst Cajal, Madrid, Spain; [Aguilar, Juan] Hosp Nacl Paraplejicos, Serv Salud Castilla La Mancha, Toledo, Spain; [Benneyworth, Michael A.] Univ Minnesota, Mouse Behav Core, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Hospital Nacional de Paraplejicos; University of Minnesota System; University of Minnesota Twin Cities	Araque, A (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	araque@umn.edu	Aguilar, Juan/Q-2206-2015; Core, Vector/CAF-4832-2022; Aguilar, Juan/N-3850-2019; Martín, Eduardo D./V-3344-2017; zhao, zhe/AAD-8756-2022	Aguilar, Juan/0000-0002-8070-3923; Aguilar, Juan/0000-0002-8070-3923; Martín, Eduardo D./0000-0003-1768-3488; zhao, zhe/0000-0001-9453-0560; Marsicano, Giovanni/0000-0003-3804-1951; Martin-Fernandez, Mario/0000-0002-4228-5847; Araque, Alfonso/0000-0003-3840-1144	NIH-NINDS [R01NS097312-01]; Human Frontier Science Program [RGP0036/2014]; INSERM; Fondation pour la Recherche Medicale [DRM20101220445]; China Scholarship Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097312] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Human Frontier Science Program(Human Frontier Science Program); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Chen (UCSD, La Jolla, California, USA) for providing IP3R2-mice, and W. Buno, G. Perea, M. Navarrete and A. Covelo for helpful comments. This work was supported by NIH-NINDS (R01NS097312-01 to A.A.), the Human Frontier Science Program (Research Grant RGP0036/2014 to A.A. and G.M.), INSERM (to G.M.), Fondation pour la Recherche Medicale (DRM20101220445 to G.M.) and the China Scholarship Council (to Z.Z.). We thank the MnDRIVE Optogenetics Core at the University of Minnesota for technical support, and B. Roth and the UNC Vector Core (Chapel Hill, North Carolina, USA) for providing the Gq-DREADD adeno-associated virus.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Appaix F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035169; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2002, J NEUROSCI, V22, P2443, DOI 10.1523/JNEUROSCI.22-07-02443.2002; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Bhat RV, 1996, GLIA, V17, P169; Braga MFM, 2003, J NEUROSCI, V23, P442, DOI 10.1523/JNEUROSCI.23-02-00442.2003; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Covelo A, 2016, NEUROSCIENCE, V323, P62, DOI 10.1016/j.neuroscience.2015.02.036; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Dumont EC, 2002, EUR J NEUROSCI, V15, P545, DOI 10.1046/j.0953-816x.2001.01879.x; DUNWIDDIE TV, 1994, J PHARMACOL EXP THER, V268, P537; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fields RD, 2014, NEUROSCIENTIST, V20, P426, DOI 10.1177/1073858413504465; Gomez-Gonzalo M, 2015, CEREB CORTEX, V25, P3699, DOI 10.1093/cercor/bhu231; Hagos L, 2016, NEUROSCI LETT, V631, P13, DOI 10.1016/j.neulet.2016.08.010; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Kamprath K, 2011, NEUROPSYCHOPHARMACOL, V36, P652, DOI 10.1038/npp.2010.196; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1043; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Martin R, 2015, SCIENCE, V349, P730, DOI 10.1126/science.aaa7945; MCDONALD AJ, 1982, J COMP NEUROL, V208, P401, DOI 10.1002/cne.902080409; MCDONALD AJ, 1982, J COMP NEUROL, V212, P293, DOI 10.1002/cne.902120307; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Oliveira JF, 2015, TRENDS NEUROSCI, V38, P535, DOI 10.1016/j.tins.2015.07.006; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Penzo MA, 2015, NATURE, V519, P455, DOI 10.1038/nature13978; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2016, ELIFE, V5, DOI 10.7554/eLife.20362; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perez-Alvarez A, 2014, J NEUROSCI, V34, P12738, DOI 10.1523/JNEUROSCI.2401-14.2014; Perez-Alvarez A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00051; Poskanzer KE, 2016, P NATL ACAD SCI USA, V113, pE2675, DOI 10.1073/pnas.1520759113; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Ramikie TS, 2014, NEURON, V81, P1111, DOI 10.1016/j.neuron.2014.01.012; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Scofield MD, 2015, BIOL PSYCHIAT, V78, P441, DOI 10.1016/j.biopsych.2015.02.016; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Sherwood MW, 2017, GLIA, V65, P502, DOI 10.1002/glia.23107; Tovote P, 2016, NATURE, V534, P206, DOI 10.1038/nature17996; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	64	137	142	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2017	20	11					1540	+		10.1038/nn.4649	http://dx.doi.org/10.1038/nn.4649			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL0QV	28945222	Green Accepted			2022-12-17	WOS:000413916800015
J	Uematsu, A; Tan, BZ; Ycu, EA; Cuevas, JS; Koivumaa, J; Junyent, F; Kremer, EJ; Witten, IB; Deisseroth, K; Johansen, JP				Uematsu, Akira; Tan, Bao Zhen; Ycu, Edgar A.; Cuevas, Jessica Sulkes; Koivumaa, Jenny; Junyent, Felix; Kremer, Eric J.; Witten, Ilana B.; Deisseroth, Karl; Johansen, Joshua P.			Modular organization of the brainstem noradrenaline system coordinates opposing learning states	NATURE NEUROSCIENCE			English	Article							LOCUS-COERULEUS NEURONS; DOUBLE-LABELING TECHNIQUE; MEDIAL PREFRONTAL CORTEX; FEAR EXTINCTION; RABIES VIRUS; NORADRENERGIC SYSTEM; SIGNALING PATHWAYS; CERULEUS NEURONS; CONDITIONED FEAR; MEMORY FORMATION	Noradrenaline modulates global brain states and diverse behaviors through what is traditionally believed to be a homogeneous cell population in the brainstem locus coeruleus (LC). However, it is unclear how LC coordinates disparate behavioral functions. We report a modular LC organization in rats, endowed with distinct neural projection patterns and coding properties for flexible specification of opposing behavioral learning states. LC projection mapping revealed functionally distinct cell modules with specific anatomical connectivity. An amygdala-projecting ensemble promoted aversive learning, while an independent medial prefrontal cortex-projecting ensemble extinguished aversive responses to enable flexible behavior. LC neurons displayed context-dependent inter-relationships, with moderate, discrete activation of distinct cell populations by fear or safety cues and robust, global recruitment of most cells by strong aversive stimuli. These results demonstrate a modular organization in LC in which combinatorial activation modes are coordinated with projection-and behavior-specific cell populations, enabling adaptive tuning of emotional responding and behavioral flexibility.	[Uematsu, Akira; Tan, Bao Zhen; Ycu, Edgar A.; Cuevas, Jessica Sulkes; Koivumaa, Jenny; Johansen, Joshua P.] RIKEN, Lab Neural Circuitry Memory, Brain Sci Inst, Wako, Saitama, Japan; [Cuevas, Jessica Sulkes; Johansen, Joshua P.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Junyent, Felix; Kremer, Eric J.] Inst Genet Mol Montpellier, Montpellier, France; [Witten, Ilana B.] Princeton Neurosci Inst, Princeton, NJ USA; [Witten, Ilana B.] Dept Psychol, Princeton, NJ USA; [Deisseroth, Karl] Stanford Univ, Bioengn Dept, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Johansen, Joshua P.] RIKEN, BSI Kao Collaborat Ctr, Wako, Saitama, Japan	RIKEN; University of Tokyo; Universite de Montpellier; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; RIKEN	Uematsu, A; Johansen, JP (corresponding author), RIKEN, Lab Neural Circuitry Memory, Brain Sci Inst, Wako, Saitama, Japan.; Johansen, JP (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.; Johansen, JP (corresponding author), RIKEN, BSI Kao Collaborat Ctr, Wako, Saitama, Japan.	akirauematsu0104@gmail.com; jjohans@brain.riken.jp	Kremer, Eric J/D-3734-2013; Uematsu, Akira/N-7395-2018; Kremer, EJ/P-9838-2019; Johansen, Joshua/N-8010-2015	Uematsu, Akira/0000-0002-0679-2649; Kremer, EJ/0000-0001-6114-7530; Johansen, Joshua/0000-0003-4240-1550	RIKEN SPRP; KAKENHI [16H01291, 15H04264, 15H01301, 16K21620, 26750380, 16H05928]; Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology [11041047]	RIKEN SPRP; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology	We thank M. Iwasaki, A. Umetsu, K. Mori and A. Krejcirikova for excellent technical assistance and H. Hamanaka for setting up rabies virus production in the lab. We thank C. Yokoyama, A. Luthi, H. Schiff, T. Shimogori, S. Fujisawa, T. McHugh, A. Benucci and members of the Johansen lab for comments on earlier versions of the manuscript. We also thank J. Kleinschmidt (German Cancer Research Center) for his gift of the AAV helper vectors and the RIKEN Research Resources Center for help with viral titering. This work was supported by RIKEN SPRP (A.U. and B.Z.T.), KAKENHI 16H01291, 15H04264, 15H01301 (J.P.J.), 16K21620 (B.Z.T.), 26750380, 16H05928 (A.U.)) and the Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology (11041047, J.P.J.).	Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Belkin Molly R, 2015, Drugs Context, V4, P212286, DOI 10.7573/dic.212286; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bouret S, 2009, J NEUROPHYSIOL, V101, P898, DOI 10.1152/jn.91048.2008; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Bush DEA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00154; Chandler DJ, 2014, P NATL ACAD SCI USA, V111, P6816, DOI 10.1073/pnas.1320827111; Do-Monte FHM, 2010, BEHAV BRAIN RES, V211, P89, DOI 10.1016/j.bbr.2010.03.014; Faber ESL, 2008, J NEUROSCI, V28, P10803, DOI 10.1523/JNEUROSCI.1796-08.2008; Finke S, 1999, J VIROL, V73, P3818, DOI 10.1128/JVI.73.5.3818-3825.1999; Fitzgerald PJ, 2015, P NATL ACAD SCI USA, V112, pE3729, DOI 10.1073/pnas.1500682112; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Giustino TF, 2016, NEUROBIOL LEARN MEM, V130, P26, DOI 10.1016/j.nlm.2016.01.009; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Herry C, 2014, NAT NEUROSCI, V17, P1644, DOI 10.1038/nn.3869; Hugues S, 2007, SYNAPSE, V61, P933, DOI 10.1002/syn.20448; Johansen JP, 2014, P NATL ACAD SCI USA, V111, pE5584, DOI 10.1073/pnas.1421304111; Kalwani RM, 2014, J NEUROSCI, V34, P13656, DOI 10.1523/JNEUROSCI.2566-14.2014; Kebschull JM, 2016, NEURON, V91, P975, DOI 10.1016/j.neuron.2016.07.036; Latagliata EC, 2016, PSYCHOPHARMACOLOGY, V233, P973, DOI 10.1007/s00213-015-4177-6; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LeDoux JE, 2014, P NATL ACAD SCI USA, V111, P2871, DOI 10.1073/pnas.1400335111; Li Y, 2016, BRAIN RES, V1641, P274, DOI 10.1016/j.brainres.2016.02.023; Mahn M, 2016, NAT NEUROSCI, V19, P554, DOI 10.1038/nn.4266; Maren S, 2016, NEUROPSYCHOPHARMACOL, V41, P58, DOI 10.1038/npp.2015.180; Martins ARO, 2015, NAT NEUROSCI, V18, P1483, DOI 10.1038/nn.4090; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/NMETH.1808, 10.1038/nmeth.1808]; McCall JG, 2017, ELIFE, V6, DOI 10.7554/eLife.2017.e18247; McCall JG, 2015, NEURON, V87, P605, DOI 10.1016/j.neuron.2015.07.002; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Mueller D, 2008, J NEUROSCI, V28, P369, DOI 10.1523/JNEUROSCI.3248-07.2008; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; NAGAI T, 1981, NEUROSCI LETT, V23, P117, DOI 10.1016/0304-3940(81)90027-6; NAKAMURA S, 1975, BRAIN RES, V99, P372, DOI 10.1016/0006-8993(75)90039-6; Ozawa T, 2017, NAT NEUROSCI, V20, P90, DOI 10.1038/nn.4439; Quirarte GL, 1998, BRAIN RES, V808, P134, DOI 10.1016/S0006-8993(98)00795-1; RASMUSSEN K, 1986, BRAIN RES, V371, P335, DOI 10.1016/0006-8993(86)90371-9; ROOM P, 1981, BRAIN RES, V221, P219, DOI 10.1016/0006-8993(81)90773-3; SARA SJ, 1991, PROG BRAIN RES, V88, P571; Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011; Schiff HC, 2017, NEUROPSYCHOPHARMACOL, V42, P895, DOI 10.1038/npp.2016.238; Schwarz LA, 2015, NATURE, V524, P88, DOI 10.1038/nature14600; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; SWANSON LW, 1976, BRAIN RES, V110, P39, DOI 10.1016/0006-8993(76)90207-9; Tully K, 2007, P NATL ACAD SCI USA, V104, P14146, DOI 10.1073/pnas.0704621104; Uematsu A, 2015, LEARN MEMORY, V22, P444, DOI 10.1101/lm.037283.114; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	53	137	139	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2017	20	11					1602	+		10.1038/nn.4642	http://dx.doi.org/10.1038/nn.4642			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL0QV	28920933				2022-12-17	WOS:000413916800021
J	Wei, XX; Stocker, AA				Wei, Xue-Xin; Stocker, Alan A.			A Bayesian observer model constrained by efficient coding can explain 'anti-Bayesian' percepts	NATURE NEUROSCIENCE			English	Article							SPATIAL-FREQUENCY ANALYSIS; SENSORY INTEGRATION; STATISTICS; EXPECTATIONS; INFORMATION; VISIBILITY; INFERENCE	Bayesian observer models provide a principled account of the fact that our perception of the world rarely matches physical reality. The standard explanation is that our percepts are biased toward our prior beliefs. However, reported psychophysical data suggest that this view may be simplistic. We propose a new model formulation based on efficient coding that is fully specified for any given natural stimulus distribution. The model makes two new and seemingly anti-Bayesian predictions. First, it predicts that perception is often biased away from an observer's prior beliefs. Second, it predicts that stimulus uncertainty differentially affects perceptual bias depending on whether the uncertainty is induced by internal or external noise. We found that both model predictions match reported perceptual biases in perceived visual orientation and spatial frequency, and were able to explain data that have not been explained before. The model is general and should prove applicable to other perceptual variables and tasks.	[Wei, Xue-Xin; Stocker, Alan A.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Stocker, Alan A.] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Stocker, AA (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	astocker@sas.upenn.edu	Stocker, Alan A/A-6514-2008	Stocker, Alan A/0000-0002-2041-1515	Office of Naval Research [N000141110744]; University of Pennsylvania	Office of Naval Research(Office of Naval Research); University of Pennsylvania	We thank V. DeGardelle, S. Kouider and J. Sackur for providing their data. We also would like to express our gratitude to E. Salinas, J. Gold and D. Swingley for providing valuable feedback on previous versions of the manuscript. The work was supported by the Office of Naval Research (grant N000141110744) and the University of Pennsylvania (including a Benjamin Franklin fellowship to X.-X.W.).	ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H., 1961, SENSORY COMMUNICATIO, P217; Bayes M., 1763, PHILOS T, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; Bowers JS, 2012, PSYCHOL BULL, V138, P389, DOI 10.1037/a0026450; Brayanov JB, 2010, J NEUROPHYSIOL, V103, P1518, DOI 10.1152/jn.00814.2009; Brunel N, 1998, NEURAL COMPUT, V10, P1731, DOI 10.1162/089976698300017115; Burge J, 2011, P NATL ACAD SCI USA, V108, P16849, DOI 10.1073/pnas.1108491108; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Chalk M, 2010, J VISION, V10, DOI 10.1167/10.8.2; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; Crane BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051383; Curry R.E., 1972, NASA SP; Cuturi LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056862; Dan Y, 1996, J NEUROSCI, V16, P3351; de Gardelle V, 2010, J VISION, V10, DOI 10.1167/10.10.6; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Fechner G. T., 1860, BREITKOPF HARTEL; FISCHER BJ, 2010, INT JT C NEUR NETW, P1; Ganguli Deep, 2010, Adv Neural Inf Process Syst, V2010, P658; Ganguli D, 2014, NEURAL COMPUT, V26, P2103, DOI 10.1162/NECO_a_00638; Geisler WS, 2009, J VISION, V9, DOI 10.1167/9.13.17; GEORGESON MA, 1980, PHILOS T ROY SOC B, V290, P11, DOI 10.1098/rstb.1980.0079; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; HELMHOLTZ H, 2000, TREATISE PHYSL OPTIC; Jastrow J., 1892, AM J PSYCHOL, V5, P214, DOI [10.2307/1410867, DOI 10.2307/1410867]; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Jones M, 2011, BEHAV BRAIN SCI, V34, P215, DOI [10.1017/S0140525X11001439, 10.1017/S0140525X10003134]; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; LINSKER R, 1988, COMPUTER, V21, P105, DOI 10.1109/2.36; McDonnell MD, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.058103; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Putzeys T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002453; ROSE D, 1974, EXP BRAIN RES, V20, P1; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; Salinas E, 2006, PLOS BIOL, V4, P2383, DOI 10.1371/journal.pbio.0040387; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Stilp CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030845; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Stocker AA., 2006, ADV NEURAL INF PROCE, V18, P1289; SWITKES E, 1978, VISION RES, V18, P1393, DOI 10.1016/0042-6989(78)90232-8; Tomassini A, 2010, VISION RES, V50, P541, DOI 10.1016/j.visres.2009.12.005; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P3178, DOI 10.1073/pnas.1108790109; Wang Z., 2012, ADV NEURAL INF PROCE, V25, P2177; Webb BS, 2010, VISION RES, V50, P2274, DOI 10.1016/j.visres.2010.04.019; Wei X.-X., 2012, ADV NEURAL INFORM PR, V25, P1313; Xue-Xin Wei, 2012, Artificial Neural Networks and Machine Learning - ICANN 2012. Proceedings 22nd International Conference on Artificial Neural Networks, P523, DOI 10.1007/978-3-642-33269-2_66	52	137	137	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1509	+		10.1038/nn.4105	http://dx.doi.org/10.1038/nn.4105			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CS2OK	26343249				2022-12-17	WOS:000361910600023
J	Margolis, DJ; Lutcke, H; Schulz, K; Haiss, F; Weber, B; Kugler, S; Hasan, MT; Helmchen, F				Margolis, David J.; Luetcke, Henry; Schulz, Kristina; Haiss, Florent; Weber, Bruno; Kuegler, Sebastian; Hasan, Mazahir T.; Helmchen, Fritjof			Reorganization of cortical population activity imaged throughout long-term sensory deprivation	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; ENCODED CALCIUM INDICATOR; BARREL CORTEX; IN-VIVO; FUNCTIONAL-ORGANIZATION; SYNAPTIC MECHANISMS; INHIBITORY NEURONS; PYRAMIDAL CELLS; NEURAL ACTIVITY; VISUAL-CORTEX	Sensory maps are reshaped by experience. It is unknown how map plasticity occurs in vivo in functionally diverse neuronal populations because activity of the same cells has not been tracked over long time periods. Here we used repeated two-photon imaging of a genetic calcium indicator to measure whisker-evoked responsiveness of the same layer 2/3 neurons in adult mouse barrel cortex over weeks, first with whiskers intact, then during continued trimming of all but one whisker. Across the baseline period, neurons displayed heterogeneous yet stable responsiveness. During sensory deprivation, responses to trimmed whisker stimulation globally decreased, whereas responses to spared whisker stimulation increased for the least active neurons and decreased for the most active neurons. These findings suggest that recruitment of inactive, 'silent' neurons is part of a convergent redistribution of population activity underlying sensory map plasticity. Sensory-driven responsiveness is a key property controlling experience-dependent activity changes in individual neurons.	[Margolis, David J.; Luetcke, Henry; Schulz, Kristina; Helmchen, Fritjof] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Margolis, David J.; Schulz, Kristina; Weber, Bruno; Helmchen, Fritjof] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Margolis, David J.; Schulz, Kristina; Weber, Bruno; Helmchen, Fritjof] Swiss Fed Inst Technol, Zurich, Switzerland; [Haiss, Florent; Weber, Bruno] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Kuegler, Sebastian] Univ Med Gottingen, Dept Neurol, Ctr Mol Physiol Brain, Gottingen, Germany; [Hasan, Mazahir T.] Max Planck Inst Med Res, Heidelberg, Germany	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Gottingen; Max Planck Society	Helmchen, F (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.	helmchen@hifo.uzh.ch	Lütcke, Henry/J-7021-2012; Weber, Bruno/E-4400-2013; Haiss, Florent/L-1685-2015; Helmchen, Fritjof/A-6255-2008; Hasan, Mazahir/L-3679-2017	Haiss, Florent/0000-0001-8351-3685; Helmchen, Fritjof/0000-0002-8867-9569; Hasan, Mazahir/0000-0001-9985-7271; Lutcke, Henry/0000-0001-7225-4374	AMBIZIONE from the Swiss National Science Foundation (SNSF); German Academic Exchange Service (DAAD); SNSF [3100A0-114624]; EU [223524, 243914]; Swiss SystemsX.ch initiative; Max Planck Society; Fritz Thyssen Stiftung	AMBIZIONE from the Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); SNSF(Swiss National Science Foundation (SNSF)); EU(European Commission); Swiss SystemsX.ch initiative; Max Planck Society(Max Planck SocietyFoundation CELLEX); Fritz Thyssen Stiftung	We thank H. Kasper, S. Giger and D. Gockeritz for technical assistance and A. Holtmaat, B. Gahwiler, M. Schwab, M. Thallmair and V. Planchamp for comments on an earlier version of the manuscript. This work was supported by an AMBIZIONE grant from the Swiss National Science Foundation (SNSF) to D.J.M.; a postdoctoral fellowship from the German Academic Exchange Service (DAAD) to H.L.; an SNSF grant to F. Helmchen (3100A0-114624); the EU-FP7 program (PLASTICISE project 223524 to F. Helmchen, and BRAIN-I-NETS project 243914 to F. Helmchen and F. Haiss); a grant from the Swiss SystemsX.ch initiative (project 2008/2011-Neurochoice) to F. Helmchen and B.W.; and the Max Planck Society and the Fritz Thyssen Stiftung (M.T.H.).	Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Barth AL, 2012, TRENDS NEUROSCI, V35, P345, DOI 10.1016/j.tins.2012.03.008; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brecht Michael, 2005, P1; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Cheetham CEJ, 2008, J NEUROSCI, V28, P9249, DOI 10.1523/JNEUROSCI.2974-08.2008; Cheetham CEJ, 2007, J NEUROSCI, V27, P3456, DOI 10.1523/JNEUROSCI.5143-06.2007; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Jacob V, 2012, NEURON, V73, P391, DOI 10.1016/j.neuron.2011.11.034; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Minderer M, 2012, J PHYSIOL-LONDON, V590, P99, DOI 10.1113/jphysiol.2011.219014; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Oberlaender M, 2012, NEURON, V74, P648, DOI 10.1016/j.neuron.2012.03.022; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Shoham S, 2006, J COMP PHYSIOL A, V192, P777, DOI 10.1007/s00359-006-0117-6; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Wen JA, 2011, J NEUROSCI, V31, P4456, DOI 10.1523/JNEUROSCI.6042-10.2011; Yamada Y, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00018; Yassin L, 2010, NEURON, V68, P1043, DOI 10.1016/j.neuron.2010.11.029; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485	50	137	138	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1539	1546		10.1038/nn.3240	http://dx.doi.org/10.1038/nn.3240			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23086335				2022-12-17	WOS:000310424900014
J	Andreassi, C; Zimmermann, C; Mitter, R; Fusco, S; Devita, S; Saiardi, A; Riccio, A				Andreassi, Catia; Zimmermann, Carola; Mitter, Richard; Fusco, Salvatore; Devita, Serena; Saiardi, Adolfo; Riccio, Antonella			An NGF-responsive element targets myo-inositol monophosphatase-1 mRNA to sympathetic neuron axons	NATURE NEUROSCIENCE			English	Article							LOCAL PROTEIN-SYNTHESIS; TRANSCRIPTION FACTOR; GROWTH CONES; TRANSLATION; ACTIN; LOCALIZATION; LITHIUM; SIGNAL; CREB; MECHANISM	mRNA localization is an evolutionary conserved mechanism that underlies the establishment of cellular polarity and specialized cell functions. To identify mRNAs localized in subcellular compartments of developing neurons, we took an original approach that combines compartmentalized cultures of rat sympathetic neurons and sequential analysis of gene expression (SAGE). Unexpectedly, the most abundant transcript in axons was mRNA for myo-inositol monophosphatase-1 (Impa1), a key enzyme that regulates the inositol cycle and the main target of lithium in neurons. A novel localization element within the 3' untranslated region of Impa1 mRNA specifically targeted Impa1 transcript to sympathetic neuron axons and regulated local IMPA1 translation in response to nerve growth factor (NGF). Selective silencing of IMPA1 synthesis in axons decreased nuclear CREB activation and induced axonal degeneration. These results provide insights into mRNA transport in axons and reveal a new NGF-responsive localization element that directs the targeting and local translation of an axonal transcript.	[Andreassi, Catia; Zimmermann, Carola; Fusco, Salvatore; Devita, Serena; Saiardi, Adolfo; Riccio, Antonella] UCL, MRC, Lab Mol & Cell Biol, London, England; [Andreassi, Catia; Zimmermann, Carola; Fusco, Salvatore; Devita, Serena; Riccio, Antonella] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Mitter, Richard] Canc Res UK, London Res Inst, London, England; [Saiardi, Adolfo] UCL, MRC, Cell Biol Unit, London, England	University of London; University College London; University of London; University College London; Cancer Research UK; University of London; University College London	Riccio, A (corresponding author), UCL, MRC, Lab Mol & Cell Biol, London, England.	a.riccio@ucl.ac.uk	Fusco, Salvatore/K-7867-2018; Fusco, Salvatore/AAA-6651-2021	Fusco, Salvatore/0000-0003-3294-0016; Fusco, Salvatore/0000-0003-3294-0016; Mitter, Richard/0000-0002-1279-3760	UK Medical Research Council (MRC) [G0500/792, G117/533, G0802010]; European Research Council [MIRG-CT-2005-016501]; Medical Research Council [MC_U122680443, G120/934, G0802010] Funding Source: researchfish; MRC [G120/934, MC_U122680443, G0802010] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to R. Kuruvilla, A. Lloyd and M. Raff for insightful comments and to all members of the Riccio laboratory for helpful discussion. CamKII-alpha-5'<INF>myrd</INF>GFP3' expression vector was kindly provided by E. Schuman (California Institute of Technology). We thank A. Garedew for helping with the SAGE assay and statistical analysis. We also thank A. Vaughan for help with microscopy analysis. This work was supported by the UK Medical Research Council (MRC; Research Grant G0500/792) and the European Research Council (Marie Curie International Reintegration Grant MIRG-CT-2005-016501). A. R. is a recipient of a MRC Career Development Award (G117/533) and an MRC Senior Non-Clinical Fellowship (G0802010).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Bassell GJ, 1998, J NEUROSCI, V18, P251; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Chau JFL, 2005, FASEB J, V19, P1887, DOI 10.1096/fj.05-4192fje; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Condeelis J, 2005, BIOL CELL, V97, P97; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Cryns K, 2008, NEUROPSYCHOPHARMACOL, V33, P674, DOI 10.1038/sj.npp.1301431; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Eng H, 1999, J NEUROSCI, V19, P1; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Hengst U, 2007, SEMIN CELL DEV BIOL, V18, P209, DOI 10.1016/j.semcdb.2007.01.003; Huang F, 2005, J NEUROSCI, V25, P7199, DOI 10.1523/JNEUROSCI.1779-05.2005; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Machado-Vieira R, 2009, BIPOLAR DISORD, V11, P92, DOI 10.1111/j.1399-5618.2009.00714.x; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Resnick AC, 2008, FRONT BIOSCI-LANDMRK, V13, P856, DOI 10.2741/2726; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Tanizawa Y, 2006, GENE DEV, V20, P3296, DOI 10.1101/gad.1497806; VANCE JE, 1995, NEUROBIOL AGING, V16, P493, DOI 10.1016/0197-4580(94)00180-9; Velculescu VE, 2000, TRENDS GENET, V16, P423, DOI 10.1016/S0168-9525(00)02114-4; Wang SM, 2007, TRENDS GENET, V23, P42, DOI 10.1016/j.tig.2006.11.001; Watson FL, 1999, J NEUROSCI, V19, P7889; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59; Zhang XH, 2002, NEURON, V36, P675, DOI 10.1016/S0896-6273(02)01023-1; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	49	137	138	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					291	U6		10.1038/nn.2486	http://dx.doi.org/10.1038/nn.2486			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20118926				2022-12-17	WOS:000274860100010
J	Stanford, TR; Shankar, S; Massoglia, DP; Costello, MG; Salinas, E				Stanford, Terrence R.; Shankar, Swetha; Massoglia, Dino P.; Costello, M. Gabriela; Salinas, Emilio			Perceptual decision making in less than 30 milliseconds	NATURE NEUROSCIENCE			English	Article							GRADUAL SPECIFICATION; DIFFUSION-MODEL; REACTION-TIME; INTEGRATION; MASKING; NEURONS; SPEED; DISCRIMINATION; MECHANISM; STRENGTH	In perceptual discrimination tasks, a subject's response time is determined by both sensory and motor processes. Measuring the time consumed by the perceptual evaluation step alone is therefore complicated by factors such as motor preparation, task difficulty and speed-accuracy tradeoffs. Here we present a task design that minimizes these confounding factors and allows us to track a subject's perceptual performance with unprecedented temporal resolution. We find that monkeys can make accurate color discriminations in less than 30 ms. Furthermore, our simple task design provides a tool for elucidating how neuronal activity relates to sensory as opposed to motor processing, as demonstrated with neural data from cortical oculomotor neurons. In these cells, perceptual information acts by accelerating and decelerating the ongoing motor plans associated with correct and incorrect choices, as predicted by a race-to-threshold model, and the time course of these neural events parallels the time course of the subject's choice accuracy.	[Stanford, Terrence R.; Shankar, Swetha; Massoglia, Dino P.; Costello, M. Gabriela; Salinas, Emilio] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27106 USA	Wake Forest University; Wake Forest Baptist Medical Center	Salinas, E (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27106 USA.	esalinas@wfubmc.edu		Costello, M. Gabriela/0000-0003-2990-3011; Stanford, Terrence/0000-0003-0759-5599; Salinas, Emilio/0000-0001-7411-5693	National Institutes of Health/National Eye Institute [R01 EY12389]; NATIONAL EYE INSTITUTE [R01EY012389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030750] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research was supported by the National Institutes of Health/National Eye Institute grant R01 EY12389 to T. R. S.	Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; BERGEN JR, 1983, NATURE, V303, P696, DOI 10.1038/303696a0; Bodelon C, 2007, J NEUROSCI, V27, P725, DOI 10.1523/JNEUROSCI.3860-06.2007; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; Breitmeyer BG, 2004, CONSCIOUS COGN, V13, P829, DOI 10.1016/j.concog.2004.08.007; Breitmeyer BG, 2000, PERCEPT PSYCHOPHYS, V62, P1572, DOI 10.3758/BF03212157; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Davison A.C., 2006, BOOTSTRAP METHODS TH; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Efron B, 1982, JACKKNIFE BOOTSTRAP; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Feng S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000284; GHEZ C, 1989, BRAIN BEHAV EVOLUT, V33, P69, DOI 10.1159/000115902; Ghose GM, 2006, J VISION, V6, P429, DOI 10.1167/6.4.10; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HENING W, 1988, EXP BRAIN RES, V71, P116, DOI 10.1007/BF00247527; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Luce RD, 1986, RESPONSE TIMES; Ludwig CJH, 2005, J NEUROSCI, V25, P9907, DOI 10.1523/JNEUROSCI.2197-05.2005; Matsumora T, 2008, J NEUROPHYSIOL, V100, P3361, DOI 10.1152/jn.90551.2008; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; MEYER DE, 1988, BIOL PSYCHOL, V26, P3, DOI 10.1016/0301-0511(88)90013-0; Nieder A, 2007, J NEUROSCI, V27, P5986, DOI 10.1523/JNEUROSCI.1056-07.2007; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pare M, 1996, J NEUROPHYSIOL, V76, P3666, DOI 10.1152/jn.1996.76.6.3666; Posner MI., 1978, CHRONOMETRIC EXPLORA; Ratcliff R, 2000, J EXP PSYCHOL HUMAN, V26, P127, DOI 10.1037/0096-1523.26.1.127; Ratcliff R, 2007, J NEUROPHYSIOL, V97, P1756, DOI 10.1152/jn.00393.2006; Salinas E, 2008, NEURON, V60, P946, DOI 10.1016/j.neuron.2008.12.011; Sanders A.F., 1998, ELEMENTS HUMAN PERFO, DOI 10.4324/9780203774250; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Siegel S., 1988, NONPARAMETRIC STAT B, V2nd; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Soltani A, 2006, J NEUROSCI, V26, P3731, DOI 10.1523/JNEUROSCI.5159-05.2006; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; [No title captured]	49	137	137	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					379	U26		10.1038/nn.2485	http://dx.doi.org/10.1038/nn.2485			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	559WW	20098418	Green Accepted			2022-12-17	WOS:000274860100021
J	Rao, VR; Pintchovski, SA; Chin, J; Peebles, CL; Mitra, S; Finkbeiner, S				Rao, Vikram R.; Pintchovski, Sean A.; Chin, Jeannie; Peebles, Carol L.; Mitra, Siddhartha; Finkbeiner, Steven			AMPA receptors regulate transcription of the plasticity-related immediate-early gene Arc	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CYTOSKELETON-ASSOCIATED PROTEIN; MESSENGER-RNA; SYNAPTIC PLASTICITY; EXPRESSION; ACTIVATION; BRAIN; KINASE; MEMORY; HIPPOCAMPUS	Learning and memory depend critically on long-term synaptic plasticity, which requires neuronal gene expression. In the prevailing view, AMPA receptors mediate fast excitatory synaptic transmission and effect short-term plasticity, but they do not directly regulate neuronal gene expression. By studying regulation of Arc, a gene required for long-term plasticity, we uncovered a new role for AMPA receptors in neuronal gene expression. Spontaneous synaptic activity or activity induced by brain-derived neurotrophic factor ( BDNF) elicited Arc expression in cultures of rat cortical neurons and in organotypic brain slices. Notably, inhibiting AMPA receptors strongly potentiated activity-dependent Arc expression. We found that AMPA receptors negatively regulate Arc transcription, but not translation or stability, through a mechanism involving a pertussis toxin-sensitive G protein. These results provide insights into the activity-dependent mechanisms of Arc expression and suggest that, in addition to effecting short-term plasticity, AMPA receptors regulate genes involved in long-term plasticity.	Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94158 USA; Univ Calif San Francisco, Med Sci Training Program, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	sfinkbeiner@gladstone.ucsf.edu		Chin, Jeannie/0000-0001-9902-3744				Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kawai F, 1999, J NEUROSCI, V19, P2954; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McIntyre CK, 2005, P NATL ACAD SCI USA, V102, P10718, DOI 10.1073/pnas.0504436102; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; Mokin M, 2006, J NEUROPHYSIOL, V95, P215, DOI 10.1152/jn.00737.2005; Montag-Sallaz M, 2003, LEARN MEMORY, V10, P99, DOI 10.1101/lm.53403; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Ons S, 2004, J NEUROCHEM, V89, P1111, DOI 10.1111/j.1471-4159.2004.02396.x; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Perkinton MS, 1999, J NEUROSCI, V19, P5861, DOI 10.1523/JNEUROSCI.19-14-05861.1999; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Schuman EM, 1997, NEURON, V18, P339, DOI 10.1016/S0896-6273(00)81234-9; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; WANG YZ, 1995, J BIOL CHEM, V270, P22783, DOI 10.1074/jbc.270.39.22783; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wheeler DG, 2004, MOL CELL NEUROSCI, V26, P50, DOI 10.1016/j.mcn.2003.12.016; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; YU WF, 1995, BRAIN RES, V692, P190, DOI 10.1016/0006-8993(95)00665-D; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	50	137	139	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					887	895		10.1038/nn1708	http://dx.doi.org/10.1038/nn1708			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16732277				2022-12-17	WOS:000238590800014
J	Beck, DM; Kastner, S				Beck, DM; Kastner, S			Stimulus context modulates competition in human extrastriate cortex	NATURE NEUROSCIENCE			English	Article							SELECTIVE ATTENTION; NEURONAL RESPONSES; DIRECTED ATTENTION; NEURAL MECHANISMS; VISUAL-ATTENTION; AREA V4; MACAQUE; SEARCH; V1; SEGREGATION	When multiple stimuli appear simultaneously in the visual field, they are not processed independently, but rather interact in a mutually suppressive way, suggesting that they compete for neural representation in visual cortex. The biased competition model of selective attention predicts that the competition can be influenced by both top-down and bottom-up mechanisms. Directed attention has been shown to bias competition in favor of the attended stimulus in extrastriate cortex. Here, we show that suppressive interactions among multiple stimuli are eliminated in extrastriate cortex when they are presented in the context of pop-out displays, in which a single item differs from the others, but not in heterogeneous displays, in which all items differ from each other. The pop-out effects seemed to originate in early visual cortex and were independent of attentional top-down control, suggesting that stimulus context may provide a powerful influence on neural competition in human visual cortex.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA	Princeton University; Princeton University	Beck, DM (corresponding author), Princeton Univ, Dept Psychol, Green Hall, Princeton, NJ 08544 USA.	dbeck@princeton.edu	Beck, Diane M/F-7536-2010	Beck, Diane M/0000-0001-9802-5828; Kastner, Sabine/0000-0002-9742-965X	NIMH NIH HHS [P50 MH062196, R01 MH064043, P50 MH-62196, R01 MH-64043] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064043, P50MH062196] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; BANKS WP, 1976, PERCEPT PSYCHOPHYS, V19, P361, DOI 10.3758/BF03204244; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Broadbent Donald Eric, 2013, PERCEPTION COMMUNICA; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; BUNDESEN C, 1983, PERCEPT PSYCHOPHYS, V33, P487, DOI 10.3758/BF03202901; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; Constantinidis C, 2005, J NEUROSCI, V25, P233, DOI 10.1523/JNEUROSCI.3379-04.2005; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Fockert J, 2004, J COGNITIVE NEUROSCI, V16, P751, DOI 10.1162/089892904970762; De Weerd P, 1999, NAT NEUROSCI, V2, P753, DOI 10.1038/11234; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DRIVER J, 1992, NATURE, V360, P73, DOI 10.1038/360073a0; DRIVER J, 1989, J EXP PSYCHOL HUMAN, V15, P448, DOI 10.1037/0096-1523.15.3.448; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Duncan J, 1998, PHILOS T ROY SOC B, V353, P1307, DOI 10.1098/rstb.1998.0285; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gallant JL, 2000, NEURON, V27, P227, DOI 10.1016/S0896-6273(00)00032-5; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kahneman D., 1981, PERCEPTUAL ORG, P181; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kastner S, 1999, VISUAL NEUROSCI, V16, P587, DOI 10.1017/S095252389916317X; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Li ZP, 1999, P NATL ACAD SCI USA, V96, P10530, DOI 10.1073/pnas.96.18.10530; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MILLER EK, 1993, BRAIN RES, V616, P25, DOI 10.1016/0006-8993(93)90187-R; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Neisser U., 1967, COGNITIVE PSYCHOL; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; NOTHDURFT HC, 1993, VISION RES, V33, P1937, DOI 10.1016/0042-6989(93)90020-W; Ogawa T, 2004, J NEUROSCI, V24, P6371, DOI 10.1523/JNEUROSCI.0569-04.2004; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P777, DOI 10.1152/jn.2000.83.2.777; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 1999, J NEUROSCI, V19, P1736; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037/0096-1523.25.3.661; Yantis S, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P73	49	137	140	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1110	1116		10.1038/nn1501	http://dx.doi.org/10.1038/nn1501			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16007082	Green Accepted			2022-12-17	WOS:000230760200024
J	Popescu, G; Auerbach, A				Popescu, G; Auerbach, A			Modal gating of NMDA receptors and the shape of their synaptic response	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTORS; BURST-KINETICS; TIME COURSE; XENOPUS-OOCYTES; ION CHANNELS; K+ CHANNEL; GLUTAMATE; ACETYLCHOLINE; CURRENTS; NEURONS	N-methyl-D-aspartate receptor (NMDAR) channels mediate the slow component of excitatory potentials at glutamatergic synapses. They have complex kinetic behavior, and much remains to be understood about NMDAR gating mechanisms and the molecular events that shape the synaptic current. Here we show that an individual NMDAR produces at least three stable patterns of activity. For all modes, channels gate by the same mechanism and can occupy either of two open states. The relative stability of the open states differs across modes because of a common perturbation to the NMDAR structure that may be subject to cellular control. Simulations indicate that native NMDAR-mediated synaptic responses arise mainly from the most common mode, and that the slow rise and decay of the current can be attributed to multiple transitions between fully liganded open and closed states rather than to agonist dissociation.	SUNY Buffalo, Ctr Single Mol Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Popescu, G (corresponding author), SUNY Buffalo, Ctr Single Mol Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.		popescu, gabriela k/AAB-6155-2022	popescu, gabriela k/0000-0003-4658-2002	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA015164] Funding Source: NIH RePORTER; NIDA NIH HHS [F32 DA015164, DA015164] Funding Source: Medline; NINDS NIH HHS [NS036554] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; AUERBACH A, 1986, J PHYSIOL-LONDON, V378, P119, DOI 10.1113/jphysiol.1986.sp016211; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; Catacuzzeno L, 1999, J MEMBRANE BIOL, V170, P165, DOI 10.1007/s002329900546; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DELCOUR AH, 1993, J NEUROSCI, V13, P181; DELCOUR AH, 1993, SCIENCE, V259, P980, DOI 10.1126/science.8094902; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dreyer I, 2001, FEBS LETT, V505, P233, DOI 10.1016/S0014-5793(01)02832-0; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; GIBB AJ, 1991, P ROY SOC B-BIOL SCI, V243, P39, DOI 10.1098/rspb.1991.0007; Grosman C, 2001, P NATL ACAD SCI USA, V98, P14102, DOI 10.1073/pnas.251402498; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HOWE JR, 1991, J PHYSIOL-LONDON, V432, P143, DOI 10.1113/jphysiol.1991.sp018381; HOWE JR, 1992, J PHYSIOL-LONDON, V455, P529, DOI 10.1113/jphysiol.1992.sp019315; HOWE JR, 1988, PROC R SOC SER B-BIO, V233, P407, DOI 10.1098/rspb.1988.0030; Ivanova-Nikolova TT, 1998, J GEN PHYSIOL, V112, P199, DOI 10.1085/jgp.112.2.199; JAHR CE, 1990, J NEUROSCI, V10, P1830; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; KLECKNER NW, 1995, J PHYSIOL-LONDON, V486, P411, DOI 10.1113/jphysiol.1995.sp020822; Leffler J. E., 1963, RATES EQUILIBRIA ORG; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1992, J NEUROSCI, V12, P635; MAGLEBY KL, 1983, J PHYSIOL-LONDON, V344, P605, DOI 10.1113/jphysiol.1983.sp014958; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NARANJO D, 1993, SCIENCE, V260, P1811, DOI 10.1126/science.8511590; Premkumar LS, 1996, NEURON, V16, P869, DOI 10.1016/S0896-6273(00)80107-5; Premkumar LS, 1997, J GEN PHYSIOL, V110, P485, DOI 10.1085/jgp.110.5.485; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; STERN P, 1994, J PHYSIOL-LONDON, V476, P391, DOI 10.1113/jphysiol.1994.sp020140; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; Yakubovich D, 2000, J PHYSIOL-LONDON, V524, P737, DOI 10.1111/j.1469-7793.2000.00737.x; Zhu YL, 2001, J GEN PHYSIOL, V117, P275, DOI 10.1085/jgp.117.3.275	44	137	139	1	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					476	483		10.1038/nn1044	http://dx.doi.org/10.1038/nn1044			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12679783				2022-12-17	WOS:000182553200014
J	Villarreal, DM; Do, V; Haddad, E; Derrick, BE				Villarreal, DM; Do, V; Haddad, E; Derrick, BE			NMDA receptor antagonists sustain LTP and spatial memory: active processes mediate LTP decay	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; FREELY MOVING RATS; DENTATE GYRUS; ANESTHETIZED RATS; PERFORANT PATH; LATE-PHASE; DEPRESSION; HIPPOCAMPUS; DEPOTENTIATION; STIMULATION	Although long-term potentiation (LTP) is long-lasting, it is not permanent and decays within weeks after its induction. Little is known about the processes underlying this decay. Here we assessed the contribution of synaptic activity to LTP decay by determining the effect of the competitive NMDA receptor antagonist CPP on the decay of perforant path-dentate LTR CPP blocked decay over a one-week period when administered daily following the induction of LTP, and blocked decay of the late, protein-synthesis-dependent phase of LTP when administered two days after LTP induction. CPP administered for a five-day period following spatial memory training enhanced subsequent memory retention. These data suggest that LTP is normally a persistent process that is actively reversed by NMDA receptor activation, and that both the early and late phases of LTP are dynamic processes regulated by NMDA receptors. These data also support the view that LTP is involved in maintaining spatial memory.	Univ Texas, Dept Biol, San Antonio, TX 78249 USA; Univ Texas, Cajal Neurosci Res Ctr, Div Life Sci, San Antonio, TX 78249 USA	University of Texas System; University of Texas System	Derrick, BE (corresponding author), Univ Texas, Dept Biol, 6900 N Loop 1604 W, San Antonio, TX 78249 USA.		Derrick, Brian/P-3005-2014	Derrick, Brian/0000-0001-6940-6509	NIDA NIH HHS [DA01983] Funding Source: Medline	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ABRAHAM WC, 1988, BRAIN RES, V462, P40, DOI 10.1016/0006-8993(88)90582-3; ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BARNES CA, 1985, BEHAV NEUROSCI, V99, P1040, DOI 10.1037/0735-7044.99.6.1040; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Barnes CA, 1996, EUR J NEUROSCI, V8, P565, DOI 10.1111/j.1460-9568.1996.tb01241.x; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHRISTIE BR, 1992, SYNAPSE, V10, P1, DOI 10.1002/syn.890100102; CHRISTIE BR, 1992, NEURON, V9, P79, DOI 10.1016/0896-6273(92)90222-Y; DESMOND NL, 1991, BRAIN RES, V552, P93, DOI 10.1016/0006-8993(91)90664-H; DESMOND NL, 1983, BRAIN RES, V265, P21, DOI 10.1016/0006-8993(83)91329-X; Doyere V, 1997, J NEUROPHYSIOL, V77, P571, DOI 10.1152/jn.1997.77.2.571; EBBINGHAUS H, 1913, MEMORY CONTRIBUTIONS; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Kulla A, 1999, EUR J NEUROSCI, V11, P3864, DOI 10.1046/j.1460-9568.1999.00807.x; LAMBERT JD, 1990, J NEUROPHYSIOL, V4, P119; LAROCHE S, 1989, NEUROSCIENCE, V28, P375, DOI 10.1016/0306-4522(89)90184-X; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; MARTENS R, 1975, SPORTWISSENSCHAFT, V5, P9; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Morris RGM, 1991, LONG TERM POTENTIATI, P267; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Norris CM, 1999, NEUROBIOL LEARN MEM, V71, P194, DOI 10.1006/nlme.1998.3864; OLTON DS, 1977, LEARN MOTIV, V8, P289, DOI 10.1016/0023-9690(77)90054-6; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; PAXINOS G, 1982, STEREOTAXIC ATLAS RA; Shors TJ, 1997, BEHAV BRAIN SCI, V20, P597, DOI 10.1017/S0140525X97001593; STAUBLI U, 1987, BRAIN RES, V435, P227, DOI 10.1016/0006-8993(87)91605-2; Strack S, 1997, J NEUROCHEM, V68, P2119; Thorndike EL, 1927, AM J PSYCHOL, V39, P212, DOI 10.2307/1415413; Xiao MY, 1996, EUR J NEUROSCI, V8, P1916, DOI 10.1111/j.1460-9568.1996.tb01335.x; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783	37	137	143	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					48	52		10.1038/nn776	http://dx.doi.org/10.1038/nn776			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11740500				2022-12-17	WOS:000173031800014
J	Jacobs, HIL; Hedden, T; Schultz, AP; Sepulcre, J; Perea, RD; Amariglio, RE; Papp, KV; Rentz, DM; Sperling, RA; Johnson, KA				Jacobs, Heidi I. L.; Hedden, Trey; Schultz, Aaron P.; Sepulcre, Jorge; Perea, Rodrigo D.; Amariglio, Rebecca E.; Papp, Kathryn V.; Rentz, Dorene M.; Sperling, Reisa A.; Johnson, Keith A.			Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals	NATURE NEUROSCIENCE			English	Article							SURFACE-BASED ANALYSIS; PRECLINICAL ALZHEIMERS-DISEASE; CLINICALLY NORMAL INDIVIDUALS; WHITE-MATTER; IN-VIVO; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; RETROSPLENIAL CORTEX; NEURONAL DYSFUNCTION; PATHOLOGICAL PROCESS	Animal models of Alzheimer's disease have suggested that tau pathology propagation, facilitated by amyloid pathology, may occur along connected pathways. To investigate these ideas in humans, we combined amyloid scans with longitudinal data on white matter connectivity, hippocampal volume, tau positron emission tomography and memory performance in 256 cognitively healthy older individuals. Lower baseline hippocampal volume was associated with increased mean diffusivity of the connecting hippocampal cingulum bundle (HCB). HCB diffusivity predicted tau accumulation in the downstream-connected posterior cingulate cortex in amyloid-positive but not in amyloid-negative individuals. Furthermore, HCB diffusivity predicted memory decline in amyloid-positive individuals with high posterior cingulate cortex tau binding. Our results provide in vivo evidence that higher amyloid pathology strengthens the association between HCB diffusivity and tau accumulation in the downstream posterior cingulate cortex and facilitates memory decline. This confirms amyloid's crucial role in potentiating neural vulnerability and memory decline marking the onset of preclinical Alzheimer's disease.	[Jacobs, Heidi I. L.; Schultz, Aaron P.; Sepulcre, Jorge; Johnson, Keith A.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Div Nucl Med & Mol Imaging, Boston, MA 02115 USA; [Jacobs, Heidi I. L.; Hedden, Trey; Schultz, Aaron P.; Sepulcre, Jorge; Perea, Rodrigo D.; Sperling, Reisa A.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02115 USA; [Jacobs, Heidi I. L.] Maastricht Univ, Sch Mental Hlth & Neurosci, Fac Hlth Med & Life Sci, Alzheimer Ctr Limburg, Maastricht, Netherlands; [Amariglio, Rebecca E.; Papp, Kathryn V.; Rentz, Dorene M.; Sperling, Reisa A.; Johnson, Keith A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Ctr Alzheimer Res & Treatment, Boston, MA USA; [Amariglio, Rebecca E.; Papp, Kathryn V.; Rentz, Dorene M.; Sperling, Reisa A.; Johnson, Keith A.] Harvard Med Sch, Dept Neurol, Massachusetts Gen Hosp, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Maastricht University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Jacobs, HIL (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Div Nucl Med & Mol Imaging, Boston, MA 02115 USA.; Jacobs, HIL (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02115 USA.; Jacobs, HIL (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Fac Hlth Med & Life Sci, Alzheimer Ctr Limburg, Maastricht, Netherlands.	hjacobs@mgh.harvard.edu	Sepulcre, Jorge/ABE-6375-2020; Jacobs, Heidi/E-9550-2011; Hedden, Trey/AAA-7653-2021; Schultz, Aaron P/Q-1034-2019	Jacobs, Heidi/0000-0001-7620-3822; Schultz, Aaron P/0000-0002-0418-0999; Sepulcre, Jorge/0000-0002-4199-2304	Athinoula A. Martinos Center for Biomedical Imaging [P41 EEB015896, S10RR021110, S100D010364, S10RR023401, S10RR023043, 1S10RR019307]; Harvard Aging Brain Study [P01 AG036694]; Alzheimer Nederland [WE.15-2014-06]; NIH [P01 AG036694, K01 AG040197, P50 AG005134, R01 AG053509, R01 AG034556, K23EB019023, R01 EB014894, R21 AG038994, R01 AG026484, P50 AG00513421, U19 AG10483, R13 AG042201174210, R01 AG027435, R01 AG037497]; NIA [K23 AG053422-01]; Alzheimer's Association; Alzheimers Association [ZEN-10-174210]; Fidelity Biosciences; Harvard NeuroDiscovery Center;  [U01 AG032438];  [U01 AG024904];  [K24 AG0350007];  [U19 AG010483]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019307, S10RR023043, S10RR021110, S10RR023401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015896, R01EB014894, P41EB022544, K23EB019023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG035007, R01AG034556, R01AG046396, R01AG037497, U01AG032438, P50AG005134, R01AG026484, R21AG038994, P01AG036694, U01AG024904, R01AG027435, R01AG053509, K23AG053422, U19AG010483, K01AG040197] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010364] Funding Source: NIH RePORTER	Athinoula A. Martinos Center for Biomedical Imaging; Harvard Aging Brain Study; Alzheimer Nederland; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); Alzheimers Association(Alzheimer's Association); Fidelity Biosciences; Harvard NeuroDiscovery Center; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the Athinoula A. Martinos Center for Biomedical Imaging, P41 EEB015896 and shared instrumentation grants S10RR021110, S100D010364, S10RR023401, S10RR023043 and 1S10RR019307. The research was supported in major part by the Harvard Aging Brain Study (P01 AG036694). We thank all the participants of the Harvard Aging Brain Study. H.I.L.J. received funding from Alzheimer Nederland (WE.15-2014-06). T.H. received funding from NIH grant K01 AG040197, P01 AG036694, P50 AG005134, R01 AG053509 and R01 AG034556. J.S. received funding from NIH grant K23EB019023. K.P. is funded by NIA grant K23 AG053422-01 and the Alzheimer's Association. K.J. received funding from NIH grants R01 EB014894, R21 AG038994, R01 AG026484, R01 AG034556, P50 AG00513421, U19 AG10483, P01 AG036694, R13 AG042201174210, R01 AG027435 and R01 AG037497 and the Alzheimers Association grant ZEN-10-174210. R.S. receives research support from the following grants: P01 AG036694, U01 AG032438, U01 AG024904, R01 AG037497, R01 AG034556, K24 AG0350007, P50 AG005134, U19 AG010483, R01 AG027435, Fidelity Biosciences, Harvard NeuroDiscovery Center and the Alzheimer's Association.	Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Amariglio RE, 2012, NEUROPSYCHOLOGIA, V50, P2880, DOI 10.1016/j.neuropsychologia.2012.08.011; Benton A., 1983, CONTRIBUTIONS NEUROP; Braak H, 1996, ACTA NEUROPATHOL, V92, P197, DOI 10.1007/s004010050508; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2015, BRAIN, V138, P2814, DOI 10.1093/brain/awv236; Braak H, 2011, ACTA NEUROPATHOL, V121, P589, DOI 10.1007/s00401-011-0825-z; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Dagley A, 2017, NEUROIMAGE, V144, P255, DOI 10.1016/j.neuroimage.2015.03.069; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Delacourte A, 2002, EXP GERONTOL, V37, P1291, DOI 10.1016/S0531-5565(02)00141-9; Dillen KNH, 2016, NEUROBIOL AGING, V44, P114, DOI 10.1016/j.neurobiolaging.2016.04.010; Domen P, 2017, SCHIZOPHRENIA BULL, V43, P160, DOI 10.1093/schbul/sbw061; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frings L, 2015, BRAIN, V138, P3089, DOI 10.1093/brain/awv229; Gordon BA, 2016, BRAIN, V139, P2249, DOI 10.1093/brain/aww139; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Greve DN, 2014, NEUROIMAGE, V92, P225, DOI 10.1016/j.neuroimage.2013.12.021; Hanseeuw BJ, 2017, ANN NEUROL, V81, P583, DOI 10.1002/ana.24910; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Heilbronner SR, 2014, J NEUROSCI, V34, P10041, DOI 10.1523/JNEUROSCI.5459-13.2014; Hu W, 2016, ALZHEIMERS DEMENT, V12, P1066, DOI 10.1016/j.jalz.2016.01.014; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Hyman BT, 2011, ARCH NEUROL-CHICAGO, V68, P1062, DOI 10.1001/archneurol.2011.70; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Jicha GA, 2006, ARCH NEUROL-CHICAGO, V63, P674, DOI 10.1001/archneur.63.5.674; Johnson KA, 2016, ANN NEUROL, V79, P110, DOI 10.1002/ana.24546; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Khan UA, 2014, NAT NEUROSCI, V17, P304, DOI 10.1038/nn.3606; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kuchibhotla KV, 2014, P NATL ACAD SCI USA, V111, P510, DOI 10.1073/pnas.1318807111; Leemans, 2009, P INT SOC MAG RESON, V245, P3537, DOI DOI 10.1093/occmed/kqr069; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lewis J, 2016, ACTA NEUROPATHOL, V131, P27, DOI 10.1007/s00401-015-1507-z; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2; MASUR DM, 1989, J CLIN EXP NEUROPSYC, V11, P615, DOI 10.1080/01688638908400920; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mormino EC, 2014, JAMA NEUROL, V71, P1379, DOI 10.1001/jamaneurol.2014.2031; Mormino EC, 2014, NEUROLOGY, V82, P1760, DOI 10.1212/WNL.0000000000000431; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Pooler AM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0199-x; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Reitan RM., 1979, TRAIL MAKING TEST MA; Rieckmann A, 2016, NEUROBIOL AGING, V42, P177, DOI 10.1016/j.neurobiolaging.2016.03.016; Scholl M, 2016, NEURON, V89, P971, DOI 10.1016/j.neuron.2016.01.028; Sepulcre J, 2016, J NEUROSCI, V36, P7364, DOI 10.1523/JNEUROSCI.0639-16.2016; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Shoup TM, 2013, J LABELLED COMPD RAD, V56, P736, DOI 10.1002/jlcr.3098; Stancu IC, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-51; Stefanits H, 2012, ACTA NEUROPATHOL, V123, P449, DOI 10.1007/s00401-011-0936-6; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Villain N, 2010, BRAIN, V133, P3301, DOI 10.1093/brain/awq203; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Walsh DM, 2016, NAT REV NEUROSCI, V17, P251, DOI 10.1038/nrn.2016.13; Wang L, 2016, JAMA NEUROL, V73, P1070, DOI 10.1001/jamaneurol.2016.2078; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328	70	136	136	6	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2018	21	3					424	+		10.1038/s41593-018-0070-z	http://dx.doi.org/10.1038/s41593-018-0070-z			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FZ7JH	29403032	Green Accepted			2022-12-17	WOS:000427776400017
J	Smith, SL; Hausser, M				Smith, Spencer L.; Haeusser, Michael			Parallel processing of visual space by neighboring neurons in mouse visual cortex	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; SPATIAL-INTERVAL DISCRIMINATION; RECEPTIVE-FIELD PROPERTIES; IN-VIVO; STRIATE CORTEX; ORIENTATION COLUMNS; INHIBITORY NEURONS; OPTIC TRACT; CAT; ORGANIZATION	Visual cortex shows smooth retinotopic organization on the macroscopic scale, but it is unknown how receptive fields are organized at the level of neighboring neurons. This information is crucial for discriminating among models of visual cortex. We used in vivo two-photon calcium imaging to independently map ON and OFF receptive field subregions of local populations of layer 2/3 neurons in mouse visual cortex. Receptive field subregions were often precisely shared among neighboring neurons. Furthermore, large subregions seem to be assembled from multiple smaller, non-overlapping subregions of other neurons in the same local population. These experiments provide, to our knowledge, the first characterization of the diversity of receptive fields in a dense local network of visual cortex and reveal elementary units of receptive field organization. Our results suggest that a limited pool of afferent receptive fields is available to a local population of neurons and reveal new organizational principles for the neural circuitry of the mouse visual cortex.	[Smith, Spencer L.] UCL, Wolfson Inst Biomed Res, London, England; UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London; University of London; University College London	Smith, SL (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	spencer.smith@wibr.ucl.ac.uk	Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957	Wellcome Trust; Gatsby Charitable Foundation; Human Frontier Science Program; MRC [G0500244] Funding Source: UKRI; Medical Research Council [G0500244] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; Human Frontier Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to B. Clark, M. Carandini, J. Cottam, M. Havenith, J. Jack, B. Judkewitz, P. Latham, M. London, A. Mathy, I. Smith and C. Wilms for discussions and for comments on the manuscript. This work was supported by a Human Frontier Science Program Long-Term Fellowship to S.L.S., and grants by the Wellcome Trust and the Gatsby Charitable Foundation to M.H.	BALKEMA GW, 1982, J NEUROPHYSIOL, V48, P968, DOI 10.1152/jn.1982.48.4.968; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gao EQ, 2010, J NEUROSCI, V30, P5912, DOI 10.1523/JNEUROSCI.6456-09.2010; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Gauthier JL, 2009, PLOS BIOL, V7, P747, DOI 10.1371/journal.pbio.1000063; Gordon JA, 1997, LEARN MEMORY, V4, P245, DOI 10.1101/lm.4.3.245; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; HAMMOND P, 1974, J PHYSIOL-LONDON, V242, P99, DOI 10.1113/jphysiol.1974.sp010696; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; LEVI DM, 1987, J OPT SOC AM A, V4, P1304, DOI 10.1364/JOSAA.4.001304; LEVI DM, 1990, VISION RES, V30, P1735, DOI 10.1016/0042-6989(90)90156-F; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; MANGINI NJ, 1980, J COMP NEUROL, V193, P203, DOI 10.1002/cne.901930114; Mata ML, 2005, J NEUROPHYSIOL, V93, P919, DOI 10.1152/jn.00668.2004; METIN C, 1988, EXP BRAIN RES, V69, P594; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nauhaus I, 2008, NEURON, V57, P673, DOI 10.1016/j.neuron.2008.01.020; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; SOODAK RE, 1987, P NATL ACAD SCI USA, V84, P3936, DOI 10.1073/pnas.84.11.3936; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; TORREALBA F, 1982, J COMP NEUROL, V211, P377, DOI 10.1002/cne.902110405; TORREALBA F, 1981, BRAIN RES, V219, P428, DOI 10.1016/0006-8993(81)90305-X; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; WAGOR E, 1980, J COMP NEUROL, V193, P187, DOI 10.1002/cne.901930113; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; Yeh CI, 2009, J NEUROSCI, V29, P11753, DOI 10.1523/JNEUROSCI.1991-09.2009; Yen SC, 2007, J NEUROPHYSIOL, V97, P1326, DOI 10.1152/jn.00747.2006	50	136	136	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1144	U149		10.1038/nn.2620	http://dx.doi.org/10.1038/nn.2620			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20711183	Green Accepted			2022-12-17	WOS:000281332600021
J	Wang, XN; Shaw, R; Tsang, HTH; Reid, E; O'Kane, CJ				Wang, Xinnan; Shaw, Robert; Tsang, Hilda T. H.; Reid, Evan; O'Kane, Cahir J.			Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; II RECEPTOR; PROTEIN; GENE; STABILITY; SPASTIN; FORM; MUTATIONS; PROLIFERATION; LOCALIZATION	To understand the functions of NIPA1, mutated in the neurodegenerative disease hereditary spastic paraplegia, and of ichthyin, mutated in autosomal recessive congenital ichthyosis, we have studied their Drosophila melanogaster ortholog, spichthyin ( Spict). Spict is found on early endosomes. Loss of Spict leads to upregulation of bone morphogenetic protein ( BMP) signaling and expansion of the neuromuscular junction. BMP signaling is also necessary for a normal microtubule cytoskeleton and axonal transport; analysis of loss- and gain- of- function phenotypes indicate that Spict may antagonize this function of BMP signaling. Spict interacts with BMP receptors and promotes their internalization from the plasma membrane, implying that it inhibits BMP signaling by regulating BMP receptor traffic. This is the first demonstration of a role for a hereditary spastic paraplegia protein or ichthyin family member in a specific signaling pathway, and implies disease mechanisms for hereditary spastic paraplegia that involve dependence of the microtubule cytoskeleton on BMP signaling.	Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Univ Cambridge, Dept Med Genet, Cambridge CB2 2XY, England; Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England	University of Cambridge; University of Cambridge; University of Cambridge	O'Kane, CJ (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	c.okane@gen.cam.ac.uk	O'Kane, Cahir/Q-6681-2019; Reid, Evan/F-3250-2010; Wang, Xinnan/B-2393-2013; O'Kane, Cahir J/C-4413-2011	O'Kane, Cahir/0000-0002-3488-2078; Reid, Evan/0000-0003-1623-7304; 	Wellcome Trust [073483] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Bakowska JC, 2005, BIOCHEM BIOPH RES CO, V334, P1042, DOI 10.1016/j.bbrc.2005.06.201; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Casso D, 2000, MECH DEVELOP, V91, P449; Chai JH, 2003, AM J HUM GENET, V73, P898, DOI 10.1086/378816; Chen SH, 2005, AGENT BASED SOC SYST, V1, P135, DOI 10.1007/4-431-26925-8_13; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; DiGiovanna JJ, 2003, AM J CLIN DERMATOL, V4, P81, DOI 10.2165/00128071-200304020-00002; Dudu V, 2006, CURR BIOL, V16, P625, DOI 10.1016/j.cub.2006.02.061; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751; Goold RG, 1999, J CELL SCI, V112, P3373; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Kaneko S, 2006, MOVEMENT DISORD, V21, P1531, DOI 10.1002/mds.21005; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Lefevre C, 2004, HUM MOL GENET, V13, P2473, DOI 10.1093/hmg/ddh263; Li AG, 2004, EMBO J, V23, P1770, DOI 10.1038/sj.emboj.7600183; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Rainier S, 2003, AM J HUM GENET, V73, P967, DOI 10.1086/378817; Ralston A, 2005, DEV BIOL, V280, P187, DOI 10.1016/j.ydbio.2005.01.018; Reed JA, 2005, NEUROGENETICS, V6, P79, DOI 10.1007/s10048-004-0209-9; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Reid E, 2003, J MED GENET, V40, P81, DOI 10.1136/jmg.40.2.81; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Vadlamudi RK, 2005, MOL CELL BIOL, V25, P3726, DOI 10.1128/MCB.25.9.3726-3736.2005; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; WEBSTER DR, 1989, J CELL SCI, V92, P57; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zeitlmann L, 2001, J BIOL CHEM, V276, P9123, DOI 10.1074/jbc.M009270200; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	50	136	138	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					177	185		10.1038/nn1841	http://dx.doi.org/10.1038/nn1841			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220882	Green Accepted			2022-12-17	WOS:000244175200012
J	Pasalar, S; Roitman, AV; Durfee, WK; Ebner, TJ				Pasalar, S.; Roitman, A. V.; Durfee, W. K.; Ebner, T. J.			Force field effects on cerebellar Purkinje cell discharge with implications for internal models	NATURE NEUROSCIENCE			English	Article							CIRCULAR MANUAL TRACKING; SIMPLE SPIKE DISCHARGE; PRIMARY MOTOR CORTEX; NEURONAL-ACTIVITY; REACHING MOVEMENTS; VENTRAL PARAFLOCCULUS; VOLUNTARY MOVEMENT; ARM MOVEMENTS; MONKEY; DYNAMICS	The cerebellum has been hypothesized to provide internal models for limb movement control. If the cerebellum is the site of an inverse dynamics model, then cerebellar neural activity should signal limb dynamics and be coupled to arm muscle activity. To address this, we recorded from 166 task-related Purkinje cells in two monkeys performing circular manual tracking under varying viscous and elastic loads. Hand forces and arm muscle activity increased with the load, and their spatial tuning differed markedly between the viscous and elastic fields. In contrast, the simple spike firing of 91.0% of the Purkinje cells was not significantly modulated by the force nor was their spatial tuning affected. For the 15 cells with a significant force effect, changes were small and isolated. These results do not support the hypothesis that Purkinje cells represent the output of an inverse dynamics model of the arm. Instead these neurons provide a kinematic representation of arm movements.	Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Mech Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ebner, TJ (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	ebner001@umn.edu			NINDS NIH HHS [R01-NS-18338] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018338] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amirikian B, 2000, NEUROSCI RES, V36, P73, DOI 10.1016/S0168-0102(99)00112-1; Batschelet E., 1981, CIRCULAR STAT BIOL; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; Coltz JD, 1999, J NEUROSCI, V19, P1782; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Flanagan JR, 1997, J NEUROSCI, V17, P1519; FORTIER PA, 1989, J NEUROPHYSIOL, V62, P198, DOI 10.1152/jn.1989.62.1.198; FRYSINGER RC, 1984, J NEUROPHYSIOL, V51, P32, DOI 10.1152/jn.1984.51.1.32; Fu QG, 1997, J NEUROPHYSIOL, V78, P478, DOI 10.1152/jn.1997.78.1.478; Gomi H, 1998, J NEUROPHYSIOL, V80, P818, DOI 10.1152/jn.1998.80.2.818; Goodkin HP, 2003, J NEUROPHYSIOL, V89, P896, DOI 10.1152/jn.00115.2002; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Liu XG, 2003, J NEUROPHYSIOL, V89, P1223, DOI 10.1152/jn.00817.2002; MARPLEHORVAT DE, 1990, J PHYSIOL-LONDON, V428, P595, DOI 10.1113/jphysiol.1990.sp018230; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; Maschke M, 2004, J NEUROPHYSIOL, V91, P230, DOI 10.1152/jn.00557.2003; Mason CR, 2006, J NEUROPHYSIOL, V95, P144, DOI 10.1152/jn.00492.2005; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Monzee J, 2004, J NEUROPHYSIOL, V91, P1230, DOI 10.1152/jn.01120.2002; Norris SA, 2004, J NEUROPHYSIOL, V92, P1867, DOI 10.1152/jn.01251.2003; Ostry DJ, 2003, EXP BRAIN RES, V153, P275, DOI 10.1007/s00221-003-1624-0; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Richter S, 2004, J MOTOR BEHAV, V36, P28, DOI 10.3200/JMBR.36.1.28-38; Roitman AV, 2005, J NEUROSCI, V25, P9244, DOI 10.1523/JNEUROSCI.1886-05.2005; SCHIEBER MH, 1985, J NEUROPHYSIOL, V54, P1228, DOI 10.1152/jn.1985.54.5.1228; Schweighofer N, 1998, EUR J NEUROSCI, V10, P86, DOI 10.1046/j.1460-9568.1998.00006.x; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; SHIDARA M, 1993, NATURE, V365, P50, DOI 10.1038/365050a0; SMITH AM, 1981, J NEUROPHYSIOL, V45, P286, DOI 10.1152/jn.1981.45.2.286; Suh M, 2000, J NEUROPHYSIOL, V84, P1835, DOI 10.1152/jn.2000.84.4.1835; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Timmann D, 1996, BEHAV BRAIN RES, V81, P99, DOI 10.1016/S0166-4328(96)89075-9; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Xiao J, 2006, EXP BRAIN RES, V168, P106, DOI 10.1007/s00221-005-0074-2	47	136	136	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1404	1411		10.1038/nn1783	http://dx.doi.org/10.1038/nn1783			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17028585				2022-12-17	WOS:000242403800018
J	Veruki, ML; Morkve, SH; Hartveit, E				Veruki, Margaret Lin; Morkve, Svein Harald; Hartveit, Espen			Activation of a presynaptic glutamate transporter regulates synaptic transmission through electrical signaling	NATURE NEUROSCIENCE			English	Article							AMINO-ACID TRANSPORTER; ROD BIPOLAR CELLS; MAMMALIAN RIBBON SYNAPSE; RAT RETINA; AMACRINE CELLS; EXTRASYNAPTIC GLUTAMATE; TRANSMITTER CLEARANCE; TIGER SALAMANDER; CURRENTS; LOCALIZATION	Whereas glutamate transporters in glial cells and postsynaptic neurons contribute significantly to re-uptake of synaptically released transmitter, the functional role of presynaptic glutamate transporters is poorly understood. Here, we used electrophysiological recording to examine the functional properties of a presynaptic glutamate transporter in rat retinal rod bipolar cells and its role in regulating glutamatergic synaptic transmission between rod bipolar cells and amacrine cells. Release of glutamate activated the presynaptic transporter with a time course that suggested a perisynaptic localization. The transporter was also activated by spillover of glutamate from neighboring rod bipolar cells. By recording from pairs of rod bipolar cells and All amacrine cells, we demonstrate that activation of the transporter-associated anion current hyperpolarizes the presynaptic terminal and thereby inhibits synaptic transmission by suppressing transmitter release. Given the evidence for presynaptic glutamate transporters, similar mechanisms could be of general importance for transmission in the nervous system.	Univ Bergen, Dept Biomed, N-5009 Bergen, Norway	University of Bergen	Hartveit, E (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	espen.hartveit@biomed.uib.no		Hartveit, Espen/0000-0003-1798-1901; Veruki, Margaret/0000-0002-0532-144X				Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bergles DE, 2002, J NEUROSCI, V22, P10153; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Billups D, 2002, J PHYSIOL-LONDON, V545, P183, DOI 10.1113/jphysiol.2002.024877; Cavelier P, 2005, PROG BIOPHYS MOL BIO, V87, P3, DOI 10.1016/j.pbiomolbio.2004.06.001; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Chen WZ, 2004, J NEUROSCI, V24, P1136, DOI 10.1523/JNEUROSCI.1586-03.2004; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DEROUICHE A, 1995, J NEUROSCI RES, V42, P131, DOI 10.1002/jnr.490420115; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; ELIASOF S, 1993, J NEUROSCI, V13, P402; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; GUNDERSEN V, 1993, NEUROSCIENCE, V57, P97, DOI 10.1016/0306-4522(93)90114-U; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Hasegawa J, 2006, NEURON, V50, P63, DOI 10.1016/j.neuron.2006.02.022; He Y, 2000, J COMP NEUROL, V418, P255; Huang YHH, 2004, CURR OPIN NEUROBIOL, V14, P346, DOI 10.1016/j.conb.2004.05.007; Morkve SH, 2002, J PHYSIOL-LONDON, V542, P147, DOI 10.1113/jphysiol.2002.020305; Otis TS, 1998, J NEUROSCI, V18, P7099; Palmer MJ, 2003, J NEUROSCI, V23, P11332; Palmer MJ, 2003, J NEUROSCI, V23, P4831; PICAUD S, 1995, P NATL ACAD SCI USA, V92, P9417, DOI 10.1073/pnas.92.20.9417; Pow DV, 2000, NEUROSCI LETT, V280, P21, DOI 10.1016/S0304-3940(99)00988-X; Protti DA, 1998, J NEUROSCI, V18, P3715; Rauen T, 1998, CELL TISSUE RES, V291, P19; RAUEN T, 1994, NEUROSCI LETT, V169, P137, DOI 10.1016/0304-3940(94)90375-1; Rauen T, 1996, CELL TISSUE RES, V286, P325, DOI 10.1007/s004410050702; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; SARANTIS M, 1988, NATURE, V332, P451, DOI 10.1038/332451a0; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Singer JH, 2003, J NEUROSCI, V23, P10923; TACHIBANA M, 1988, P NATL ACAD SCI USA, V85, P5315, DOI 10.1073/pnas.85.14.5315; TACHIBANA M, 1987, P NATL ACAD SCI USA, V84, P3501, DOI 10.1073/pnas.84.10.3501; Veruki ML, 2003, J PHYSIOL-LONDON, V549, P759, DOI 10.1113/jphysiol.2003.039982; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Ward MM, 2004, CELL TISSUE RES, V315, P305, DOI 10.1007/s00441-003-0849-3; YAMASHITA M, 1991, VISUAL NEUROSCI, V6, P399, DOI 10.1017/S0952523800006635; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	49	136	143	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1388	1396		10.1038/nn1793	http://dx.doi.org/10.1038/nn1793			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17041592				2022-12-17	WOS:000242403800016
J	Mejat, A; Ramond, F; Bassel-Duby, R; Khochbin, S; Olson, EN; Schaeffer, L				Mejat, A; Ramond, F; Bassel-Duby, R; Khochbin, S; Olson, EN; Schaeffer, L			Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; MEF2 TRANSCRIPTION FACTOR; ALPHA-SUBUNIT GENE; ELECTRICAL-ACTIVITY; SKELETAL-MUSCLE; NUCLEAR-ORGANIZATION; MOUSE EMBRYOGENESIS; MYOGENIC FACTORS; DIFFERENTIATION; MYOD	Electrical activity arising from motor innervation influences skeletal muscle physiology by controlling the expression of many muscle genes, including those encoding acetylcholine receptor (AChR) subunits. How electrical activity is converted into a transcriptional response remains largely unknown. We show that motor innervation controls chromatin acetylation in skeletal muscle and that histone deacetylase 9 (HDAC9) is a signal-responsive transcriptional repressor which is downregulated upon denervation, with consequent upregulation of chromatin acetylation and AChR expression. Forced expression of Hdac9 in denervated muscle prevents upregulation of activity-dependent genes and chromatin acetylation by linking myocyte enhancer factor 2 (MEF2) and class I HDACs. By contrast, Hdac9-null mice are supersensitive to denervation-induced changes in gene expression and show chromatin hyperacetylation and delayed perinatal downregulation of myogenin, an activator of AChR genes. These findings show a molecular mechanism to account for the control of chromatin acetylation by presynaptic neurons and the activity-dependent regulation of skeletal muscle genes by motor innervation.	Ecole Normale Super, CNRS, UMR 5161,Inst Federat Rech 128, Equipe Differenciat Neuromusculaire, F-69364 Lyon 07, France; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; INSERM, U309, Inst Albert Bonniot, F-38706 La Tronche, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Schaeffer, L (corresponding author), Ecole Normale Super, CNRS, UMR 5161,Inst Federat Rech 128, Equipe Differenciat Neuromusculaire, 46 Allee Italie, F-69364 Lyon 07, France.	lschaeff@ens-lyon.fr	MEJAT, Alexandre/G-8635-2013; Ramond, Francis/GVS-2149-2022; Khochbin, Saadi/M-8090-2013	Khochbin, Saadi/0000-0002-0455-0857; schaeffer, laurent/0000-0001-6600-503X				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Baxter J, 2002, CURR OPIN CELL BIOL, V14, P372, DOI 10.1016/S0955-0674(02)00339-3; BESSEREAU JL, 1994, P NATL ACAD SCI USA, V91, P1304, DOI 10.1073/pnas.91.4.1304; Bessereau JL, 1998, J BIOL CHEM, V273, P12786, DOI 10.1074/jbc.273.21.12786; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; CHENG TC, 1993, SCIENCE, V261, P215, DOI 10.1126/science.8392225; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; DUCLERT A, 1991, NEUROREPORT, V2, P25, DOI 10.1097/00001756-199101000-00006; EFTIMIE R, 1991, P NATL ACAD SCI USA, V88, P1349, DOI 10.1073/pnas.88.4.1349; Fisher AG, 2002, CURR OPIN GENET DEV, V12, P193, DOI 10.1016/S0959-437X(02)00286-1; Fromm L, 1998, GENE DEV, V12, P3074, DOI 10.1101/gad.12.19.3074; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; GUNDERSEN K, 1995, MOL CELL BIOL, V15, P7127; Hediger F, 2002, NAT CELL BIOL, V4, pE53, DOI 10.1038/ncb0302-e53; Hyatt JPK, 2003, AM J PHYSIOL-CELL PH, V285, pC1161, DOI 10.1152/ajpcell.00128.2003; KLARSFELD A, 1989, NEURON, V2, P1229, DOI 10.1016/0896-6273(89)90307-3; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Lemercier C, 2002, J BIOL CHEM, V277, P22045, DOI 10.1074/jbc.M201736200; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; MERLIE JP, 1994, J BIOL CHEM, V269, P2461; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Ornatsky OI, 1997, J BIOL CHEM, V272, P33271, DOI 10.1074/jbc.272.52.33271; PIETTE J, 1990, NATURE, V345, P353, DOI 10.1038/345353a0; Polesskaya A, 2001, MOL CELL BIOL, V21, P5312, DOI 10.1128/MCB.21.16.5312-5320.2001; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; TANG JC, 1994, DEVELOPMENT, V120, P1799; Walke W, 1996, J NEUROSCI, V16, P3641; WITZEMANN V, 1991, FEBS LETT, V282, P259, DOI 10.1016/0014-5793(91)80490-T; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Xu Q, 2002, MOL BIOL CELL, V13, P1940, DOI 10.1091/mbc.02-02-0016; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang CL, 2001, P NATL ACAD SCI USA, V98, P7354, DOI 10.1073/pnas.131198498; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	50	136	143	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					313	321		10.1038/nn1408	http://dx.doi.org/10.1038/nn1408			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15711539				2022-12-17	WOS:000227354600016
J	Celikel, T; Szostak, VA; Feldman, DE				Celikel, T; Szostak, VA; Feldman, DE			Modulation of spike timing by sensory deprivation during induction of cortical map plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; SYNAPTIC MODIFICATION; VISUAL-CORTEX; RESPONSES; POTENTIATION; SPECIFICITY; NEURONS; MEMORY; LTP	Deprivation-induced plasticity of sensory cortical maps involves long-term potentiation (LTP) and depression (LTD) of cortical synapses, but how sensory deprivation triggers LTP and LTD in vivo is unknown. Here we tested whether spike timing-dependent forms of LTP and LTD are involved in this process. We measured spike trains from neurons in layer 4 (L4) and layers 2 and 3 (L2/3) of rat somatosensory cortex before and after acute whisker deprivation, a manipulation that induces whisker map plasticity involving LTD at L4-to-L2/3 (L4-L2/3) synapses. Whisker deprivation caused an immediate reversal of firing order for most L4 and L2/3 neurons and a substantial decorrelation of spike trains, changes known to drive timing-dependent LTD at L4-L2/3 synapses in vitro. In contrast, spike rate changed only modestly. Thus, whisker deprivation is likely to drive map plasticity by spike timing-dependent mechanisms.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Feldman, DE (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dfeldman@ucsd.edu	Celikel, Tansu/P-4235-2018		NCRR NIH HHS [P41-RR09754] Funding Source: Medline; NINDS NIH HHS [R01 NS046652-02, R01 NS046652, 1 R01 NS046652] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046652] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brumberg JC, 1999, J NEUROPHYSIOL, V82, P1808, DOI 10.1152/jn.1999.82.4.1808; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; DeWeese MR, 2003, J NEUROSCI, V23, P7940; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Fregnac Y, 1999, J NEUROBIOL, V41, P69; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Gerstein G., 1999, CRC METH NEUROSCI S, P157; Glazewski S, 1998, EUR J NEUROSCI, V10, P2107, DOI 10.1046/j.1460-9568.1998.00222.x; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Goldreich D, 1999, J NEUROPHYSIOL, V82, P1311, DOI 10.1152/jn.1999.82.3.1311; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Huber KM, 1998, NEUROPHARMACOLOGY, V37, P571, DOI 10.1016/S0028-3908(98)00050-1; Kelly MK, 1999, J NEUROSCI, V19, P9117, DOI 10.1523/JNEUROSCI.19-20-09117.1999; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2000, J NEUROSCI, V20, P7579; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Schubert D, 2003, J NEUROSCI, V23, P2961; SIMONS DJ, 1979, BRAIN RES, V165, P327, DOI 10.1016/0006-8993(79)90564-X; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wallace H, 2001, J NEUROSCI, V21, P3881, DOI 10.1523/JNEUROSCI.21-11-03881.2001; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	50	136	138	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					534	541		10.1038/nn1222	http://dx.doi.org/10.1038/nn1222			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15064767	Green Accepted			2022-12-17	WOS:000221101300031
J	Lee, RC; Clandinin, TR; Lee, CH; Chen, PL; Meinertzhagen, IA; Zipursky, SL				Lee, RC; Clandinin, TR; Lee, CH; Chen, PL; Meinertzhagen, IA; Zipursky, SL			The protocadherin Flamingo is required for axon target selection in the Drosophila visual system	NATURE NEUROSCIENCE			English	Article							LAMINA-SPECIFIC CONNECTIVITY; GLIAL-CELLS; N-CADHERIN; POLARITY; EXPRESSION; GUIDANCE; EYE; ULTRASTRUCTURE; MELANOGASTER; RECEPTORS	Photoreceptor neurons (R cells) in the Drosophila visual system elaborate a precise map of visual space in the brain. The eye contains some 750 identical modules called ommatidia, each containing eight photoreceptor cells (R1-R8). Cells R1-R6 synapse in the lamina; R7 and R8 extend through the lamina and terminate in the underlying medulla. In a screen for visual behavior mutants, we identified alleles of flamingo (fmi) that disrupt the precise maps elaborated by these neurons. These mutant R1-R6 neurons select spatially inappropriate targets in the lamina. During target selection, Flamingo protein is dynamically expressed in R1-R6 growth cones. Loss of fmi function in R cells also disrupts the local pattern of synaptic terminals in the medulla, and Flamingo is transiently expressed in R8 axons as they enter the target region. We propose that Flamingo-mediated interactions between R-cell growth cones within the target field regulate target selection.	Univ Calif Los Angeles, Howard Hughes Med Inst, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Dalhousie Univ, Life Sci Ctr, Inst Neurosci, Halifax, NS B3H 4J1, Canada	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University; Dalhousie University	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, David Geffen Sch Med, Dept Biol Chem, Box 951662, Los Angeles, CA 90095 USA.		Lee, Chi-Hon/G-9190-2012	Meinertzhagen, Ian/0000-0002-6578-4526; Chen, Pei-Ling/0000-0001-6025-4318; Zipursky, Stephen/0000-0001-5630-7181; Lee, Chi-Hon/0000-0002-6138-711X	NEI NIH HHS [EY03592] Funding Source: Medline; NIGMS NIH HHS [GM08042] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008754] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY003592] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chae J, 1999, DEVELOPMENT, V126, P5421; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Das G, 2002, DEV CELL, V2, P655, DOI 10.1016/S1534-5807(02)00147-8; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Formstone CJ, 2001, MECH DEVELOP, V109, P91, DOI 10.1016/S0925-4773(01)00515-9; FROHLICH A, 1993, J NEUROBIOL, V24, P1642; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Meinertzhagen IA, 1996, J NEUROSCI METH, V69, P59, DOI 10.1016/S0165-0270(96)00021-0; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; STARK WS, 1986, CELL TISSUE RES, V246, P481, DOI 10.1007/BF00215187; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tissir F, 2002, MECH DEVELOP, V112, P157, DOI 10.1016/S0925-4773(01)00623-2; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; White NM, 2000, DEVELOPMENT, V127, P1681; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X	39	136	136	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					557	563		10.1038/nn1063	http://dx.doi.org/10.1038/nn1063			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12754514				2022-12-17	WOS:000183140400011
J	Hiyama, TY; Watanabe, E; Ono, K; Inenaga, K; Tamkun, MM; Yoshida, S; Noda, M				Hiyama, TY; Watanabe, E; Ono, K; Inenaga, K; Tamkun, MM; Yoshida, S; Noda, M			Na-x channel involved in CNS sodium-level sensing	NATURE NEUROSCIENCE			English	Article							NEURONS		Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448585, Japan; Natl Inst Basic Biol, Ctr Transgen Anim & Plants, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Dept Mol Biomech, Okazaki, Aichi 4448585, Japan; Kyushu Dent Coll, Dept Physiol, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; Colorado State Univ, Dept Physiol, Ft Collins, CO 80523 USA; Natl Inst Physiol Sci, Lab Intracellular Metab, Okazaki, Aichi 4448585, Japan; Nagasaki Univ, Sch Med, Dept Physiol, Nagasaki 8528523, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Kyushu Dental University; Colorado State University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Nagasaki University	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448585, Japan.		Ono, Kentaro/AAV-5616-2021; Noda, Masaharu/D-7146-2016; Hiyama, Takeshi/X-4134-2018	Ono, Kentaro/0000-0003-0891-7705; Noda, Masaharu/0000-0002-3796-524X; Hiyama, Takeshi/0000-0001-8612-8707; Watanabe, Eiji/0000-0001-9089-8122				Denton DA, 1996, P NATL ACAD SCI USA, V93, P7397, DOI 10.1073/pnas.93.14.7397; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; JOHNSON AK, 1990, CURRENT TOPICS NEURO, V10, P149; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MINTA A, 1989, J BIOL CHEM, V264, P19449; NOSE H, 1992, J APPL PHYSIOL, V73, P1419, DOI 10.1152/jappl.1992.73.4.1419; OLIET SHR, 1993, NATURE, V364, P341, DOI 10.1038/364341a0; WAKERLEY JB, 1978, BRAIN RES, V148, P425, DOI 10.1016/0006-8993(78)90730-8; Watanabe E, 2000, J NEUROSCI, V20, P7743; Wells T, 1998, MOL CELL ENDOCRINOL, V136, P103, DOI 10.1016/S0303-7207(97)00219-0	11	136	137	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					511	512		10.1038/nn856	http://dx.doi.org/10.1038/nn856			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992118				2022-12-17	WOS:000175874600007
J	Kreple, CJ; Lu, Y; Taughert, RJ; Schwager-Gutman, AL; Du, JY; Stump, M; Wang, YM; Ghobbeh, A; Fan, R; Cosme, CV; Sowers, LP; Welsh, MJ; Radley, JJ; LaLumiere, RT; Wemmie, JA				Kreple, Collin J.; Lu, Yuan; Taughert, Rebecca J.; Schwager-Gutman, Andrea L.; Du, Jianyang; Stump, Madeliene; Wang, Yimo; Ghobbeh, Ali; Fan, Rong; Cosme, Caitlin V.; Sowers, Levi P.; Welsh, Michael J.; Radley, Jason J.; LaLumiere, Ryan T.; Wemmie, John A.			Acid-sensing ion channels contribute to synaptic transmission and inhibit cocaine-evoked plasticity	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR; EXOCYTOSED PROTONS; NEURONS; ASIC1; MICE; 1A; PREFERENCE; FEEDBACK; RECEPTOR; AMYGDALA	Acid-sensing ion channel 1A (ASIC1A) is abundant in the nucleus accumbens (NAc), a region known for its role in addiction. Because ASIC1A has been suggested to promote associative learning, we hypothesized that disrupting ASIC1A in the NAc would reduce drug-associated learning and memory. However, contrary to this hypothesis, we found that disrupting ASIC1A in the mouse NAc increased cocaine-conditioned place preference, suggesting an unexpected role for ASIC1A in addiction-related behavior. Moreover, overexpressing ASIC1A in rat NAc reduced cocaine self-administration. Investigating the underlying mechanisms, we identified a previously unknown postsynaptic current during neurotransmission that was mediated by ASIC1A and ASIC2 and thus well positioned to regulate synapse structure and function. Consistent with this possibility, disrupting ASIC1A altered dendritic spine density and glutamate receptor function, and increased cocaine-evoked plasticity, which resemble changes previously associated with cocaine-induced behavior. Together, these data suggest that ASIC1A inhibits the plasticity underlying addiction-related behavior and raise the possibility of developing therapies for drug addiction by targeting ASIC-dependent neurotransmission.	[Kreple, Collin J.] Univ Iowa, Med Scientist Training Program, Iowa City, IA USA; [Kreple, Collin J.; Welsh, Michael J.; Wemmie, John A.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Lu, Yuan; Wang, Yimo; Ghobbeh, Ali; Fan, Rong; Wemmie, John A.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Taughert, Rebecca J.; Stump, Madeliene; Welsh, Michael J.; Radley, Jason J.; LaLumiere, Ryan T.; Wemmie, John A.] Univ Iowa, Interdisciplinary Grad Program Neurosci, Iowa City, IA USA; [Schwager-Gutman, Andrea L.; Cosme, Caitlin V.; Welsh, Michael J.; Radley, Jason J.; LaLumiere, Ryan T.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Du, Jianyang] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Sowers, Levi P.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Welsh, Michael J.; Wemmie, John A.] Univ Iowa, Dept Neurosurg, Iowa City, IA USA; [Welsh, Michael J.] Howard Hughes Med Inst, Iowa City, IA USA; [Wemmie, John A.] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Wemmie, JA (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.	john-wemmie@uiowa.edu	LaLumiere, Ryan/K-2545-2014	LaLumiere, Ryan/0000-0002-1235-0521; Wemmie, John/0000-0001-7531-9065; Welsh, Michael/0000-0002-1646-6206; Cosme, Caitlin/0000-0002-8024-7841	Department of Veterans Affairs (Merit Award); National Institute of Mental Health [5R01MH085724]; US National Institutes of Health Heart, Lung, and Blood Institute [R01HL113863]; NARSAD Independent Investigator Award; US National Institutes of Health [MH095972, DA034684]; University of Iowa Interdisciplinary Training Program in Pain Research National Institute of Neurological Disorders and Stroke [T32NS045549]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095972, R56MH095972, R01MH085724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS045549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034684] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000741] Funding Source: NIH RePORTER	Department of Veterans Affairs (Merit Award)(US Department of Veterans Affairs); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institutes of Health Heart, Lung, and Blood Institute; NARSAD Independent Investigator Award(NARSAD); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa Interdisciplinary Training Program in Pain Research National Institute of Neurological Disorders and Stroke; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	We thank M. Lutter and M. Price for critically reading the manuscript. We also thank M. Price for providing Asic2<SUP>-/-</SUP> mice. We thank the University of Iowa Gene Transfer Vector Core and Central Microscopy Research Facility. J.A.W. was supported by the Department of Veterans Affairs (Merit Award), the National Institute of Mental Health (5R01MH085724), the US National Institutes of Health Heart, Lung, and Blood Institute (R01HL113863) and a NARSAD Independent Investigator Award. J.J.R. was supported by the US National Institutes of Health (MH095972). R.T.L. was supported by the US National Institutes of Health (DA034684). C.J.K. was supported by the University of Iowa Interdisciplinary Training Program in Pain Research National Institute of Neurological Disorders and Stroke T32NS045549. M.J.W. receives funding from the Howard Hughes Medical Institute.	Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Baron A, 2002, J BIOL CHEM, V277, P50463, DOI 10.1074/jbc.M208848200; Beg AA, 2008, CELL, V132, P149, DOI 10.1016/j.cell.2007.10.058; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Cho JH, 2008, J NEUROPHYSIOL, V99, P426, DOI 10.1152/jn.00940.2007; Christoffel DJ, 2011, J NEUROSCI, V31, P314, DOI 10.1523/JNEUROSCI.4763-10.2011; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Dietz DM, 2012, NAT NEUROSCI, V15, P891, DOI 10.1038/nn.3094; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Gillessen T, 1997, J NEUROPHYSIOL, V77, P1639, DOI 10.1152/jn.1997.77.3.1639; Golden SA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011957; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Huston JP, 2013, TRENDS PHARMACOL SCI, V34, P162, DOI 10.1016/j.tips.2013.01.004; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jiang Q, 2013, NEUROSCIENCE, V246, P170, DOI 10.1016/j.neuroscience.2013.04.059; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; MANEV H, 1990, NEUROPHARMACOLOGY, V29, P1103, DOI 10.1016/0028-3908(90)90033-N; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moussawi K, 2011, P NATL ACAD SCI USA, V108, P385, DOI 10.1073/pnas.1011265108; Napier TC, 2013, NEUROSCI BIOBEHAV R, V37, P2081, DOI 10.1016/j.neubiorev.2013.05.002; Palmer MJ, 2003, J NEUROSCI, V23, P11332; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Shah GN, 2005, P NATL ACAD SCI USA, V102, P16771, DOI 10.1073/pnas.0508449102; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Vessey JP, 2005, J NEUROSCI, V25, P4108, DOI 10.1523/JNEUROSCI.5253-04.2005; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; White NM, 2005, PHARMACOL BIOCHEM BE, V81, P786, DOI 10.1016/j.pbb.2005.06.002; Wu PY, 2013, J NEUROSCI, V33, P1828, DOI 10.1523/JNEUROSCI.4132-12.2013; Zeng WZ, 2012, NEUROSCI BULL, V28, P1, DOI 10.1007/s12264-012-1068-2; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Zha XM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-1; Zha XM, 2009, J NEUROSCI, V29, P8438, DOI 10.1523/JNEUROSCI.1284-09.2009; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	49	135	137	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2014	17	8					1083	1091		10.1038/nn.3750	http://dx.doi.org/10.1038/nn.3750			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AM1XA	24952644	Green Accepted			2022-12-17	WOS:000339641400014
J	Lafer-Sousa, R; Conway, BR				Lafer-Sousa, Rosa; Conway, Bevil R.			Parallel, multi-stage processing of colors, faces and shapes in macaque inferior temporal cortex	NATURE NEUROSCIENCE			English	Article							INFEROTEMPORAL CORTEX; CHROMATIC MECHANISMS; NEURAL BASIS; RESPONSES; BRAIN; ARCHITECTURE; NEURONS; REPRESENTATIONS; DISCRIMINATION; ORGANIZATION	Visual-object processing culminates in inferior temporal cortex (IT). To assess the organization of IT, we measured functional magnetic resonance imaging responses in alert monkeys to achromatic images (faces, fruit, bodies and places) and colored gratings. IT contained multiple color-biased regions, which were typically ventral to face patches and yoked to them, spaced regularly at four locations predicted by known anatomy. Color and face selectivity increased for more anterior regions, indicative of a broad hierarchical arrangement. Responses to non-face shapes were found across IT, but were stronger outside color-biased regions and face patches, consistent with multiple parallel streams. IT also contained multiple coarse eccentricity maps: face patches overlapped central representations, color-biased regions spanned mid-peripheral representations and place-biased regions overlapped peripheral representations. These results show that IT comprises parallel, multi-stage processing networks subject to one organizing principle.	[Lafer-Sousa, Rosa; Conway, Bevil R.] Wellesley Coll, Neurosci Program, Wellesley, MA 02181 USA; [Conway, Bevil R.] Harvard Univ, Sch Med, Dept Neurobiol, Cambridge, MA 02138 USA	Wellesley College; Harvard University	Conway, BR (corresponding author), Wellesley Coll, Neurosci Program, Wellesley, MA 02181 USA.	bconway@wellesley.edu	Conway, Bevil/AAG-2412-2020	Conway, Bevil/0000-0001-7715-9253	National Science Foundation [0918064]; US National Institutes of Health [EY023322]; Whitehall Foundation; Radcliffe Institute for Advanced Study (Harvard University); Wellesley College; National Institute of Biomedical Imaging and Bioengineering; US National Institutes of Health Shared Instrumentation Grant Program and/or High-End Instrumentation Grant Program [S1ORR021110]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021110] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484] Funding Source: NIH RePORTER; Direct For Biological Sciences [0918064] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; Radcliffe Institute for Advanced Study (Harvard University); Wellesley College; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); US National Institutes of Health Shared Instrumentation Grant Program and/or High-End Instrumentation Grant Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	fMRI data were analyzed using the jip toolbox generously provided by J. Mandeville (Massachusetts General Hospital, http://www.nitrc.org/projects/jip/), and analysisscripts compiled by S. Moeller (RWTH Aachen University). We thank J. Maunsell, D. Hubel and M. Livingstone for research space, helpful discussions and assistance with animal protocols. A. Rehding, N. Kanwisher, J. Di Carlo and P. Mayo provided valuable comments on the manuscript. B.R.C. gratefully acknowledges seminal conversations that took place with D. Tsao, with whom the idea to map multiple stimulus dimensions in IT was conceived and initially begun. We thank Y. Liu for implementing the simulation shown in Figure 5 and help with MRI analysis. We thank J. McCready and E. Erzinger, who designed and built the fMRI primate chair, and C. Stoughton and G. Gagin, who trained the animals. We thank L. Wald and A. Mareyam for providing the four-channel magnetic resonance coil. We thank W. Vanduffel, J. Mandeville, J. Polimeni, T. Witzel, M. O'Hara, G. Khandewal, M. Histed and P. Mayo for help running the experiments and conducting the analyses. This paper is dedicated to the memory of our mentor and beloved friend, David Hubel, who died September 22, 2013 (age 87). This work was supported by grants from the National Science Foundation (0918064), the US National Institutes of Health (EY023322), the Whitehall Foundation, the Radcliffe Institute for Advanced Study (Harvard University) and Wellesley College. This research was carried out at the Athinoula A. Martinos Center for Biomedical Imaging at the Massachusetts General Hospital, using resources provided by the Center for Functional Neuroimaging Technologies (P41EB015896) and a P41 Biotechnology Resource grant supported by the National Institute of Biomedical Imaging and Bioengineering. This work also involved the use of instrumentation supported by the US National Institutes of Health Shared Instrumentation Grant Program and/or High-End Instrumentation Grant Program (S1ORR021110).	ALLMAN JM, 1974, BRAIN RES, V81, P199, DOI 10.1016/0006-8993(74)90936-6; Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Bell AH, 2009, J NEUROPHYSIOL, V101, P688, DOI 10.1152/jn.90657.2008; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Bouvier SE, 2006, CEREB CORTEX, V16, P183, DOI 10.1093/cercor/bhi096; CAVANAGH P, 1989, J EXP PSYCHOL HUMAN, V15, P3, DOI 10.1037/0096-1523.15.1.3; Conover WJ, 1980, PRACTICAL NONPARAMET; Conway BR, 2007, NEURON, V56, P560, DOI 10.1016/j.neuron.2007.10.008; Conway BR, 2006, CEREB CORTEX, V16, P1604, DOI 10.1093/cercor/bhj099; Conway BR, 2010, J NEUROSCI, V30, P14955, DOI 10.1523/JNEUROSCI.4348-10.2010; Conway BR, 2009, P NATL ACAD SCI USA, V106, P18034, DOI 10.1073/pnas.0810943106; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Harada T, 2009, EUR J NEUROSCI, V30, P1960, DOI 10.1111/j.1460-9568.2009.06995.x; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Heywood CA, 2003, NEUROL CLIN, V21, P483, DOI 10.1016/S0733-8619(02)00102-0; IWAI E, 1988, BRAIN RES, V444, P397, DOI 10.1016/0006-8993(88)90955-9; IWAI E, 1987, J COMP NEUROL, V261, P362, DOI 10.1002/cne.902610304; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; Katsuyama N, 2010, NEUROSCI LETT, V484, P168, DOI 10.1016/j.neulet.2010.08.040; Kemp R, 1996, PERCEPTION, V25, P37, DOI 10.1068/p250037; Koida K, 2007, NAT NEUROSCI, V10, P108, DOI 10.1038/nn1823; Konkle T, 2012, NEURON, V74, P1114, DOI 10.1016/j.neuron.2012.04.036; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Ku SP, 2011, NEURON, V70, P352, DOI 10.1016/j.neuron.2011.02.048; Matsumora T, 2008, J NEUROPHYSIOL, V100, P3361, DOI 10.1152/jn.90551.2008; Moro V, 2008, NEURON, V60, P235, DOI 10.1016/j.neuron.2008.09.022; Op de Beeck HP, 2008, CEREB CORTEX, V18, P1676, DOI 10.1093/cercor/bhm196; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Roe AW, 2012, NEURON, V74, P12, DOI 10.1016/j.neuron.2012.03.011; Rolls ET, 2008, J NEUROPSYCHOL, V2, P325, DOI 10.1348/174866407X258903; Sereno Martin I., 1991, P160; Srihasam K, 2012, NEURON, V73, P608, DOI 10.1016/j.neuron.2011.12.022; Stoughton CM, 2008, CURR BIOL, V18, pR698, DOI 10.1016/j.cub.2008.06.018; Stoughton CM, 2012, J NEUROSCI, V32, P15216, DOI 10.1523/JNEUROSCI.2048-12.2012; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tootell RBH, 2004, CEREB CORTEX, V14, P353, DOI 10.1093/cercor/bhh001; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; VANESSEN DC, 1990, COLD SPRING HARB SYM, V55, P679; Yasuda M, 2010, CEREB CORTEX, V20, P1630, DOI 10.1093/cercor/bhp227; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0	49	135	136	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1870	1878		10.1038/nn.3555	http://dx.doi.org/10.1038/nn.3555			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24141314	Green Accepted, Green Submitted			2022-12-17	WOS:000327416800026
J	Chapuis, J; Wilson, DA				Chapuis, Julie; Wilson, Donald A.			Bidirectional plasticity of cortical pattern recognition and behavioral sensory acuity	NATURE NEUROSCIENCE			English	Article							PIRIFORM CORTEX; ALZHEIMERS-DISEASE; OLFACTORY CORTEX; ODOR; DISCRIMINATION; NETWORK; NEURONS; MEMORY; RATS; HIPPOCAMPUS	Learning to adapt to a complex and fluctuating environment requires the ability to adjust neural representations of sensory stimuli. Through pattern completion processes, cortical networks can reconstruct familiar patterns from degraded input patterns, whereas pattern separation processes allow discrimination of even highly overlapping inputs. Here we show that the balance between pattern separation and completion is experience dependent. Rats given extensive training with overlapping complex odorant mixtures showed improved behavioral discrimination ability and enhanced piriform cortical ensemble pattern separation. In contrast, behavioral training to disregard normally detectable differences between overlapping mixtures resulted in impaired piriform cortical ensemble pattern separation (enhanced pattern completion) and impaired discrimination. This bidirectional effect was not found in the olfactory bulb; it may be due to plasticity within olfactory cortex itself. Thus pattern recognition, and the balance between pattern separation and completion, is highly malleable on the basis of task demands and occurs in concert with changes in perceptual performance.	[Chapuis, Julie; Wilson, Donald A.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA; [Chapuis, Julie; Wilson, Donald A.] NYU, Langone Sch Med, Dept Child & Adolescent Psychiat, New York, NY USA	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center	Chapuis, J (corresponding author), Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA.	jchapuis@nki.rfmh.org; donald.wilson@nyumc.org		Wilson, Donald/0000-0001-8918-2151	US National Institutes of Health [DC003906, DC008982]; Fyssen Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003906, R01DC008982] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fyssen Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by US National Institutes of Health grants DC003906 and DC008982 to D.A.W. and a Fyssen Foundation post-doctoral grant to J.C.	BAKIN JS, 1992, BRAIN RES, V577, P226, DOI 10.1016/0006-8993(92)90278-H; Barnes CA, 1997, NATURE, V388, P272, DOI 10.1038/40859; Barnes DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018130; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; Beshel J, 2007, J NEUROSCI, V27, P8358, DOI 10.1523/JNEUROSCI.1199-07.2007; Brosh I, 2009, LEARN MEMORY, V16, P413, DOI 10.1101/lm.1430809; Chapuis J, 2009, J NEUROSCI, V29, P10287, DOI 10.1523/JNEUROSCI.0505-09.2009; Chen CFF, 2011, J NEUROPHYSIOL, V106, P3136, DOI 10.1152/jn.00721.2011; Cohen-Matsliah SI, 2009, EUR J NEUROSCI, V30, P1339, DOI 10.1111/j.1460-9568.2009.06894.x; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fletcher ML, 2010, LEARN MEMORY, V17, P561, DOI 10.1101/lm.941510; Fletcher ML, 2005, J NEUROSCI, V25, P792, DOI 10.1523/JNEUROSCI.4673-04.2005; Fletcher ML, 2003, J NEUROSCI, V23, P6946; FREEMAN WJ, 1982, PSYCHOPHYSIOLOGY, V19, P44, DOI 10.1111/j.1469-8986.1982.tb02598.x; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; HASSELMO ME, 1992, J NEUROPHYSIOL, V67, P1230, DOI 10.1152/jn.1992.67.5.1230; Jones SV, 2008, J NEUROSCI, V28, P13106, DOI 10.1523/JNEUROSCI.4465-08.2008; Kadohisa M, 2006, P NATL ACAD SCI USA, V103, P15206, DOI 10.1073/pnas.0604313103; Kay LM, 2010, J NEUROPHYSIOL, V104, P829, DOI 10.1152/jn.00166.2010; Kay LM, 2009, TRENDS NEUROSCI, V32, P207, DOI 10.1016/j.tins.2008.11.008; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Li F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015401; Li W, 2010, BRAIN, V133, P2714, DOI 10.1093/brain/awq209; Martin C, 2007, J NEUROPHYSIOL, V98, P2196, DOI 10.1152/jn.00524.2007; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; Murphy C, 1999, PHYSIOL BEHAV, V66, P177, DOI 10.1016/S0031-9384(98)00262-5; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nusser Z, 2001, J NEUROPHYSIOL, V86, P2823, DOI 10.1152/jn.2001.86.6.2823; Preacher K. J., 2002, CALCULATION TEST DIF; Resnik J, 2011, NAT NEUROSCI, V14, P791, DOI 10.1038/nn.2802; Restrepo D, 2009, TRENDS NEUROSCI, V32, P525, DOI 10.1016/j.tins.2009.06.001; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Saar D, 2003, EUR J NEUROSCI, V17, P2727, DOI 10.1046/j.1460-9568.2003.02699.x; Saar D, 1999, J NEUROSCI, V19, P8616; Seckinger RA, 2004, SCHIZOPHR RES, V69, P55, DOI 10.1016/S0920-9964(03)00124-5; SMITH DV, 1979, CHEM SENS FLAV, V4, P215, DOI 10.1093/chemse/4.3.215; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Suzuki N, 2011, J NEUROSCI, V31, P2156, DOI 10.1523/JNEUROSCI.5430-10.2011; Suzuki N, 2010, J COMP NEUROL, V518, P1670, DOI 10.1002/cne.22295; Tanila H, 1997, J NEUROSCI, V17, P5167; Tanila H, 1997, J NEUROSCI, V17, P5155; Tristan C, 2009, EUR J NEUROSCI, V29, P921, DOI 10.1111/j.1460-9568.2009.06651.x; Wesson DW, 2008, CHEM SENSES, V33, P581, DOI 10.1093/chemse/bjn029; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Wilson DA, 2010, J NEUROSCI, V30, P1760, DOI 10.1523/JNEUROSCI.5636-09.2010	50	135	135	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					155	U194		10.1038/nn.2966	http://dx.doi.org/10.1038/nn.2966			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101640	Green Accepted			2022-12-17	WOS:000298414400026
J	Mittmann, W; Wallace, DJ; Czubayko, U; Herb, JT; Schaefer, AT; Looger, LL; Denk, W; Kerr, JND				Mittmann, Wolfgang; Wallace, Damian J.; Czubayko, Uwe; Herb, Jan T.; Schaefer, Andreas T.; Looger, Loren L.; Denk, Winfried; Kerr, Jason N. D.			Two-photon calcium imaging of evoked activity from L5 somatosensory neurons in vivo	NATURE NEUROSCIENCE			English	Article							CELLULAR RESOLUTION; PYRAMIDAL NEURONS; VISUAL-CORTEX; NEURAL ACTIVITY; MICROSCOPY; DENDRITES; BRAIN; AWAKE; MICE; ORGANIZATION	Multiphoton imaging (MPI) is widely used for recording activity simultaneously from many neurons in superficial cortical layers in vivo. We combined regenerative amplification multiphoton microscopy (RAMM) with genetically encoded calcium indicators to extend MPI of neuronal population activity into layer 5 (L5) of adult mouse somatosensory cortex. We found that this approach could be used to record and quantify spontaneous and sensory-evoked activity in populations of L5 neuronal somata located as much as 800. m below the pia. In addition, we found that RAMM could be used to simultaneously image activity from large (similar to 80) populations of apical dendrites and follow these dendrites down to their somata of origin.	[Mittmann, Wolfgang; Wallace, Damian J.; Czubayko, Uwe; Kerr, Jason N. D.] Max Planck Inst Biol Cybernet, Network Imaging Grp, Tubingen, Germany; [Mittmann, Wolfgang; Denk, Winfried] Max Planck Inst Med Res, Dept Biomed Opt, Heidelberg, Germany; [Looger, Loren L.] Howard Hughes Med Inst, Ashburn, VA USA	Max Planck Society; Max Planck Society; Howard Hughes Medical Institute	Kerr, JND (corresponding author), Max Planck Inst Biol Cybernet, Network Imaging Grp, Tubingen, Germany.	jason@tuebingen.mpg.de	denk, winfried/I-6627-2012	Schaefer, Andreas/0000-0002-4677-8788; Kerr, Jason/0000-0001-9459-883X	Max Planck Society	Max Planck Society(Max Planck Society)	We would like to thank P. Theer for technical help with the RegA, J. Sawinski for help with detection system fabrication and D. S. Greenberg for dendrite morphology analysis. This work was supported by the Max Planck Society.	de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 2001, Patent No. 6249379; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Ji N, 2010, NAT METHODS, V7, P141, DOI 10.1038/NMETH.1411; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lavis LD, 2008, ACS CHEM BIOL, V3, P142, DOI 10.1021/cb700248m; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Meyer HS, 2010, CEREB CORTEX, V20, P2277, DOI 10.1093/cercor/bhq067; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Rueckel M, 2006, P NATL ACAD SCI USA, V103, P17137, DOI 10.1073/pnas.0604791103; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; THEER P, 2004, COMBINED FACULTIES N, V100; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tsai PS, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2804014; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	38	135	139	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1089	U195		10.1038/nn.2879	http://dx.doi.org/10.1038/nn.2879			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21743473				2022-12-17	WOS:000293123700025
J	Etxeberria, A; Mangin, JM; Aguirre, A; Gallo, V				Etxeberria, Ainhoa; Mangin, Jean-Marie; Aguirre, Adan; Gallo, Vittorio			Adult-born SVZ progenitors receive transient synapses during remyelination in corpus callosum	NATURE NEUROSCIENCE			English	Article							OLIGODENDROCYTE DEVELOPMENT; SUBVENTRICULAR ZONE; WHITE-MATTER; GLUTAMATE; AXONS; RELEASE	We found that demyelinated axons formed functional glutamatergic synapses onto adult-born NG2(+) oligodendrocyte progenitor cells (OPCs) migrating from the subventricular zone after focal demyelination of adult mice corpus callosum. This glutamatergic input was substantially reduced compared with endogenous callosal OPCs 1 week after lesion and was lost on differentiation into oligodendrocytes. Therefore, axon-oligodendrocyte progenitor synapse formation is a transient and regulated step that occurs during remyelination of callosal axons.	[Etxeberria, Ainhoa; Mangin, Jean-Marie; Aguirre, Adan; Gallo, Vittorio] Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA	Children's National Health System	Gallo, V (corresponding author), Childrens Natl Med Ctr, Ctr Neurosci Res, Washington, DC 20010 USA.	vgallo@cnmcresearch.org	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	US National Institutes of Health [R01NS045702, K99NS057944, P30HD40677]; Department of Education and Science of the Spanish Government; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045702, K99NS057944, R00NS057944] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education and Science of the Spanish Government; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. Gage (Salk Institute) and J. Goldman (Columbia University) for the pNIT-GFP retrovirus, A. Nishiyama (University of Connecticut) for the NG2-dsRed mouse and D. Rowitch (University of California San Francisco) for antibody to Olig2. We are particularly grateful to J. Corbin for discussion and to R. McCarter for help with statistical analysis. This work was supported by grants from the US National Institutes of Health (R01NS045702 and R01NS045702 to V. G., K99NS057944 to A. A. and Intellectual and Developmental Disabilities Research Center P30HD40677). A. E. was supported by a Postdoctoral Fellowship from the Department of Education and Science of the Spanish Government.	Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Chittajallu R, 2005, J NEUROSCI, V25, P8601, DOI 10.1523/JNEUROSCI.2122-05.2005; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Yuan XQ, 1998, DEVELOPMENT, V125, P2901; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	10	135	137	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					287	289		10.1038/nn.2500	http://dx.doi.org/10.1038/nn.2500			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20173746	Green Accepted			2022-12-17	WOS:000274860100009
J	George, MS; Abbott, LF; Siegelbaum, SA				George, Meena S.; Abbott, L. F.; Siegelbaum, Steven A.			HCN hyperpolarization-activated cation channels inhibit EPSPs by interactions with M-type K+ channels	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; RAT HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; I-H; INTRINSIC EXCITABILITY; INTEGRATIVE PROPERTIES; POTASSIUM CHANNELS; DISTAL DENDRITES; VOLTAGE; PLASTICITY	The processing of synaptic potentials by neuronal dendrites depends on both their passive cable properties and active voltage-gated channels, which can generate complex effects as a result of their nonlinear properties. We characterized the actions of HCN (hyperpolarization-activated cyclic nucleotide-gated cation) channels on dendritic processing of subthreshold excitatory postsynaptic potentials (EPSPs) in mouse CA1 hippocampal neurons. The HCN channels generated an excitatory inward current (I-h) that exerted a direct depolarizing effect on the peak voltage of weak EPSPs, but produced a paradoxical hyperpolarizing effect on the peak voltage of stronger, but still subthreshold, EPSPs. Using a combined modeling and experimental approach, we found that the inhibitory action of I-h was caused by its interaction with the delayed-rectifier M-type K+ current. In this manner, I-h can enhance spike firing in response to an EPSP when spike threshold is low and can inhibit firing when spike threshold is high.	[George, Meena S.; Abbott, L. F.; Siegelbaum, Steven A.] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Abbott, L. F.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Siegelbaum, Steven A.] Columbia Univ, Dept Pharmacol, New York, NY USA; [Siegelbaum, Steven A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	sas8@columbia.edu			US National Institutes of Health [MH80745]; US National Institutes of Health Director's Pioneer Award; US National Institutes of Health Roadmap for Medical Research [5-DP1-OD114-02]; Columbia University's Medical Scientist Training Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080745] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000114] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University's Medical Scientist Training Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Dudman for helpful advice and for providing custom data-acquisition routines written in Igor. This work was partially supported by grant MH80745 from the US National Institutes of Health to S. A. S. L. A. and M. S. G. were supported in part by a US National Institutes of Health Director's Pioneer Award, part of the US National Institutes of Health Roadmap for Medical Research, through grant number 5-DP1-OD114-02. M. S. G. was supported in part by Columbia University's Medical Scientist Training Program.	Angelo K, 2007, J NEUROSCI, V27, P8643, DOI 10.1523/JNEUROSCI.5284-06.2007; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Carnevale N. T., 2006, NEURON BOOK; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chen XX, 2004, J PHYSIOL-LONDON, V559, P187, DOI 10.1113/jphysiol.2004.068114; Chevaleyre V, 2002, P NATL ACAD SCI USA, V99, P9538, DOI 10.1073/pnas.142213199; Dayan P., 2005, THEORETICAL NEUROSCI; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hu H, 2007, J NEUROSCI, V27, P1853, DOI 10.1523/JNEUROSCI.4463-06.2007; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; KOCH C, 1995, J COMPUT NEUROSCI, V2, P63, DOI 10.1007/BF00962708; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rosenkranz JA, 2006, J NEUROSCI, V26, P3229, DOI 10.1523/JNEUROSCI.4333-05.2006; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Stuart G, 1998, J NEUROSCI, V18, P3501; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Vervaeke K, 2006, J PHYSIOL-LONDON, V576, P235, DOI 10.1113/jphysiol.2006.111336; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Yue CY, 2006, J NEUROPHYSIOL, V95, P3480, DOI 10.1152/jn.01333.2005	47	135	138	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2009	12	5					577	584		10.1038/nn.2307	http://dx.doi.org/10.1038/nn.2307			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438SJ	19363490	Green Accepted			2022-12-17	WOS:000265575400014
J	Miyamoto, T; Amrein, H				Miyamoto, Tetsuya; Amrein, Hubert			Suppression of male courtship by a Drosophila pheromone receptor	NATURE NEUROSCIENCE			English	Article							MELANOGASTER; PERCEPTION; BEHAVIOR; NEURONS; FRUIT; BRAIN	In male Drosophila, chemosensory cues control many aspects of social behavior. We found that males with a mutated Gustatory receptor 32a gene (Gr32a) show high courtship toward males and mated females, indicating that GR32a functions as a pheromone receptor for a male inhibitory pheromone. Notably, we discovered that tarsal Gr32a-expressing neurons were essential for courtship suppression and projected to the ventrolateral protocerebrum, implying direct communication of chemosensory neurons with a higher-order brain structure.	[Miyamoto, Tetsuya; Amrein, Hubert] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Miyamoto, T (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	hoa1@duke.edu	Amrein, Hubert/AAG-9480-2021	Amrein, Hubert/0000-0001-8799-7250	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009014, R01DC005606] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC005606, 01DC005606, R01 DC009014, 01DC009014] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Amrein H, 2004, CURR OPIN NEUROBIOL, V14, P435, DOI 10.1016/j.conb.2004.07.008; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Rong YS, 2001, GENETICS, V157, P1307; SCOTT D, 1986, P NATL ACAD SCI USA, V83, P8429, DOI 10.1073/pnas.83.21.8429; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7	14	135	138	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					874	876		10.1038/nn.2161	http://dx.doi.org/10.1038/nn.2161			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18641642	Green Accepted			2022-12-17	WOS:000257969100009
J	Liu, BH; Wu, GK; Arbuckle, R; Tao, HW; Zhang, LI				Liu, Bao-hua; Wu, Guangying K.; Arbuckle, Robert; Tao, Huizhong W.; Zhang, Li I.			Defining cortical frequency tuning with recurrent excitatory circuitry	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; PRIMARY AUDITORY-CORTEX; RECEPTIVE-FIELDS; SIMPLE CELLS; BARREL CORTEX; ORIENTATION SELECTIVITY; THALAMOCORTICAL SYSTEM/; DIRECTION SELECTIVITY; SYNAPTIC INTEGRATION; GABA(B) RECEPTORS	Neurons in the recipient layers of sensory cortices receive excitatory input from two major sources: the feedforward thalamocortical and recurrent intracortical inputs. To address their respective functional roles, we developed a new method for silencing cortex by competitively activating GABA(A) while blocking GABA(B) receptors. In the rat primary auditory cortex, in vivo whole-cell recording from the same neuron before and after local cortical silencing revealed that thalamic input occupied the same area of frequency-intensity tonal receptive field as the total excitatory input, but showed a flattened tuning curve. In contrast, excitatory intracortical input was sharply tuned with a tuning curve that closely matched that of suprathreshold responses. This can be attributed to a selective amplification of cortical cells' responses at preferred frequencies by intracortical inputs from similarly tuned neurons. Thus, weakly tuned thalamocortical inputs determine the subthreshold responding range, whereas intracortical inputs largely define the tuning. Such circuits may ensure a faithful conveyance of sensory information.	Univ So Calif, Zilka Neurogenet Inst, Los Angeles, CA 90033 USA; Univ So Calif, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Zhang, LI (corresponding author), Univ So Calif, Zilka Neurogenet Inst, Los Angeles, CA 90033 USA.	liizhang@usc.edu	Wu, Guangying/E-8117-2010; Tao, Huizhong W/HDM-9767-2022	Wu, Guangying/0000-0002-7243-5412	NEI NIH HHS [R21 EY018718, R21 EY018718-01] Funding Source: Medline; NIDCD NIH HHS [R03 DC006814, R03 DC006814-03, R01 DC008983-01, R01 DC008983] Funding Source: Medline; NATIONAL EYE INSTITUTE [R21EY018718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC006814, R01DC008983] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alonso JM, 2005, J NEUROPHYSIOL, V94, P26, DOI 10.1152/jn.01281.2004; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; CALFORD MB, 1981, J NEUROPHYSIOL, V45, P1013, DOI 10.1152/jn.1981.45.6.1013; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Fox K, 2003, J NEUROSCI, V23, P8380; GAMES KD, 1988, HEARING RES, V34, P1, DOI 10.1016/0378-5955(88)90047-0; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Miller LM, 2001, J NEUROSCI, V21, P8136, DOI 10.1523/JNEUROSCI.21-20-08136.2001; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; MILLER W, 1988, CABIOS, V4, P11; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Porter JT, 2004, J NEUROPHYSIOL, V92, P2762, DOI 10.1152/jn.00196.2004; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Roerig B, 2002, CEREB CORTEX, V12, P187, DOI 10.1093/cercor/12.2.187; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; VILLA AEP, 1991, EXP BRAIN RES, V86, P506, DOI 10.1007/BF00230524; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005; Winer JA, 2005, TRENDS NEUROSCI, V28, P255, DOI 10.1016/j.tins.2005.03.009; Wu GY, 2006, NEURON, V52, P705, DOI 10.1016/j.neuron.2006.10.009; Yamauchi T, 2000, EUR J NEUROSCI, V12, P3433, DOI 10.1046/j.1460-9568.2000.00248.x; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhang YF, 1997, J NEUROPHYSIOL, V78, P3489, DOI 10.1152/jn.1997.78.6.3489; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004	41	135	136	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1594	1600		10.1038/nn2012	http://dx.doi.org/10.1038/nn2012			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17994013	Green Accepted			2022-12-17	WOS:000251172900017
J	Cheng, LP; Samad, OA; Xu, Y; Mizuguchi, R; Luo, P; Shirasawa, S; Goulding, M; Ma, QF				Cheng, LP; Samad, OA; Xu, Y; Mizuguchi, R; Luo, P; Shirasawa, S; Goulding, M; Ma, QF			Lbx1 and Tlx3 are opposing switches in determining GABAergic versus glutamatergic transmitter phenotypes	NATURE NEUROSCIENCE			English	Article							DORSAL SPINAL-CORD; GENE-EXPRESSION; PAIN MECHANISMS; HOMEOBOX GENES; NEURONS; SPECIFICATION; INTERNEURONS; CIRCUITS; GABA; RECEPTORS	Most neurons in vertebrates make a developmental choice between two principal neurotransmitter phenotypes (glutamatergic versus GABAergic). Here we show that the homeobox gene Lbx1 determines a GABAergic cell fate in the dorsal spinal cord at early embryonic stages. In Lbx1(-/-) mice, the presumptive GABAergic neurons are transformed into glutamatergic cells. Furthermore, overexpression of Lbx1 in the chick spinal cord is sufficient to induce GABAergic differentiation. Paradoxically, Lbx1 is also expressed in glutamatergic neurons. We previously reported that the homeobox genes Tlx1 and Tlx3 determine glutamatergic cell fate. Here we show that impaired glutamatergic differentiation, observed in Tlx3(-/-) mice, is restored in Tlx3(-/-) Lbx1(-/-) mice. These genetic studies suggest that Lbx1 expression defines a basal GABAergic differentiation state, and Tlx3 acts to antagonize Lbx1 to promote glutamatergic differentiation.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Int Med Ctr Japan, Dept Pathol, Shinjuku Ku, Tokyo 1628655, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Salk Institute; National Center for Global Health & Medicine - Japan	Ma, QF (corresponding author), Dana Farber Canc Inst, 1 Jimmy Fund Way, Boston, MA 02115 USA.	Qiufu_ma@dfci.harvard.edu	samad, omar/K-1921-2012					Azkue JJ, 1998, BRAIN RES, V790, P74, DOI 10.1016/S0006-8993(98)00050-X; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Dickenson AH, 2002, BRIT J ANAESTH, V88, P755, DOI 10.1093/bja/88.6.755; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Gardner E.P., 2000, PRINCIPLES NEURAL SC, P430; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Gross MK, 2000, DEVELOPMENT, V127, P413; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Kerchner GA, 2001, NEURON, V32, P477, DOI 10.1016/S0896-6273(01)00479-2; Kruger M, 2002, J NEUROCHEM, V82, P774, DOI 10.1046/j.1471-4159.2002.01078.x; Logan C, 1998, J NEUROSCI, V18, P5389, DOI 10.1523/JNEUROSCI.18-14-05389.1998; Lu Y, 2005, J NEUROSCI, V25, P3900, DOI 10.1523/JNEUROSCI.0102-05.2005; Lu Y, 2003, J NEUROSCI, V23, P8752; Malcangio M, 1996, TRENDS PHARMACOL SCI, V17, P457; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Muller T, 2005, GENE DEV, V19, P733, DOI 10.1101/gad.326105; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Polgar E, 1999, BRAIN RES, V833, P71, DOI 10.1016/S0006-8993(99)01500-0; Qian Y, 2002, GENE DEV, V16, P1220, DOI 10.1101/gad.982802; SCHAFFNER AE, 1993, DEV BRAIN RES, V72, P265, DOI 10.1016/0165-3806(93)90192-D; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Shirasawa S, 2000, NAT GENET, V24, P287, DOI 10.1038/73516; SOMOGYI R, 1995, J NEUROSCI, V15, P2575; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8	37	135	140	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1510	1515		10.1038/nn1569	http://dx.doi.org/10.1038/nn1569			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16234809				2022-12-17	WOS:000232966600025
J	Wig, GS; Grafton, ST; Demos, KE; Kelley, WM				Wig, GS; Grafton, ST; Demos, KE; Kelley, WM			Reductions in neural activity underlie behavioral components of repetition priming	NATURE NEUROSCIENCE			English	Article							INFERIOR PREFRONTAL CORTEX; FUNCTIONAL MRI EVIDENCE; IMPLICIT MEMORY; CORTICAL ACTIVITY; TEMPORAL CORTEX; HUMAN BRAIN; FMRI; PET; SPECIFICITY; RETRIEVAL	Repetition priming is a nonconscious form of memory that is accompanied by reductions in neural activity when an experience is repeated. To date, however, there is no direct evidence that these neural reductions underlie the behavioral advantage afforded to repeated material. Here we demonstrate a causal linkage between neural and behavioral priming in humans. fMRI ( functional magnetic resonance imaging) was used in combination with transcranial magnetic stimulation (TMS) to target and disrupt activity in the left frontal cortex during repeated classification of objects. Left-frontal TMS disrupted both the neural and behavioral markers of priming. Neural priming in early sensory regions was unaffected by left-frontal TMS - a finding that provides evidence for separable conceptual and perceptual components of priming.	Dartmouth Coll, Ctr Cognit Neurosci, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College	Wig, GS (corresponding author), Dartmouth Coll, Ctr Cognit Neurosci, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	gagan.wig@dartmouth.edu		Demos, Kathryn/0000-0002-8578-4312	NIMH NIH HHS [MH64667] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH064667] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bergerbest D, 2004, J COGNITIVE NEUROSCI, V16, P966, DOI 10.1162/0898929041502760; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; DEMB JB, 1995, J NEUROSCI, V15, P5870; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Dobbins IG, 2004, NATURE, V428, P316, DOI 10.1038/nature02400; Donaldson DI, 2001, NEURON, V31, P1047, DOI 10.1016/S0896-6273(01)00429-9; FRISTON KJ, 1992, P ROY SOC B-BIOL SCI, V248, P223, DOI 10.1098/rspb.1992.0065; GABRIELI JDE, 1995, PSYCHOL SCI, V6, P76, DOI 10.1111/j.1467-9280.1995.tb00310.x; Grafton ST, 1998, J NEUROSCI, V18, P9420; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; GRAFTON ST, 1992, J NEUROSCI, V12, P2542; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; KARNI A, 1995, NATURE, V377, P155; KEANE MM, 1991, BEHAV NEUROSCI, V105, P326, DOI 10.1037/0735-7044.105.2.326; Koutstaal W, 2001, NEUROPSYCHOLOGIA, V39, P184, DOI 10.1016/S0028-3932(00)00087-7; Maccotta L, 2004, J COGNITIVE NEUROSCI, V16, P1625, DOI 10.1162/0898929042568451; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SCHACTER DL, 1993, ANNU REV NEUROSCI, V16, P159, DOI 10.1146/annurev.ne.16.030193.001111; Schacter DL, 2004, NAT REV NEUROSCI, V5, P853, DOI 10.1038/nrn1534; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; van Mier H, 1998, J NEUROPHYSIOL, V80, P2177, DOI 10.1152/jn.1998.80.4.2177; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Wagner AD, 1997, J COGNITIVE NEUROSCI, V9, P714, DOI 10.1162/jocn.1997.9.6.714; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	37	135	137	0	12	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1228	1233		10.1038/nn1515	http://dx.doi.org/10.1038/nn1515			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16056222				2022-12-17	WOS:000231483800023
J	Chen, SZ; Rio, C; Ji, RR; Dikkes, P; Coggeshall, RE; Woolf, CJ; Corfas, G				Chen, SZ; Rio, C; Ji, RR; Dikkes, P; Coggeshall, RE; Woolf, CJ; Corfas, G			Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR GDNF; SPINAL-CORD; SURVIVAL FACTOR; UP-REGULATION; EXPRESSION; NEURONS; NEUREGULIN; PROTEIN; PAIN; PHOSPHORYLATION	Here we studied the role of signaling through ErbB-family receptors in interactions between unmyelinated axons and non-myelinating Schwann cells in adult nerves. We generated transgenic mice that postnatally express a dominant-negative ErbB receptor in non-myelinating but not in myelinating Schwann cells. These mutant mice present a progressive peripheral neuropathy characterized by extensive Schwann cell proliferation and death, loss of unmyelinated axons and marked heat and cold pain insensitivity. At later stages, C-fiber sensory neurons die by apoptosis, a process that may result from reduced GDNF (glial cell line-derived neurotrophic factor) expression in the sciatic nerve. Neuregulin 1 (NRG1)-ErbB signaling mediates, therefore, reciprocal interactions between non-myelinating Schwann cells and unmyelinated sensory neuron axons that are critical for Schwann cell and C-fiber sensory neuron survival. This study provides new insights into ErbB signaling in adult Schwann cells, the contribution of non-myelinating Schwann cells in maintaining trophic support of sensory neurons, and the possible role of disrupted ErbB signaling in peripheral sensory neuropathies.	Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA; Univ Texas, Med Branch, Dept Anat & Neurosci, Galveston, TX 77555 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Texas System; University of Texas Medical Branch Galveston	Corfas, G (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	gabriel.corfas@tch.harvard.edu	Río, Carlos/GQA-4045-2022; Corfas, Gabriel/AAH-2378-2020; Ji, Ru-Rong/L-7070-2017; Woolf, Clifford/A-9784-2010	Río, Carlos/0000-0003-2666-7746; Corfas, Gabriel/0000-0001-5412-9473; Ji, Ru-Rong/0000-0002-9355-3688; 	NICHD NIH HHS [P30-HD 18655] Funding Source: Medline; NIDCD NIH HHS [R01 DC04820] Funding Source: Medline; NINDS NIH HHS [NS38253, R01 NS35884, NS39518, NS40698] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253, R01NS040698, R01NS039518, R37NS039518, R01NS035884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004820] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Barbieri S, 1995, Electromyogr Clin Neurophysiol, V35, P39; Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8; Bennett DLH, 1998, J NEUROSCI, V18, P3059; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; BROWN MJ, 1976, ARCH NEUROL-CHICAGO, V33, P164, DOI 10.1001/archneur.1976.00500030020004; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CHEN MS, 1994, J COMP NEUROL, V349, P389, DOI 10.1002/cne.903490306; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; COHEN JA, 1992, J NEUROSCI RES, V31, P622, DOI 10.1002/jnr.490310406; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; Crone SA, 2003, NEURON, V37, P29, DOI 10.1016/S0896-6273(02)01128-5; Dutsch M, 2002, J CLIN NEUROPHYSIOL, V19, P575; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Hammarberg H, 1996, NEUROREPORT, V7, P857, DOI 10.1097/00001756-199603220-00004; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; JESSEN KR, 1990, DEVELOPMENT, V109, P91; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Ji RR, 1997, J NEUROSCI, V17, P1776; JOHNSON EM, 1988, TRENDS NEUROSCI, V11, P299, DOI 10.1016/0166-2236(88)90090-2; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Lee DE, 1999, BRAIN RES, V845, P117, DOI 10.1016/S0006-8993(99)01956-3; Lewis SE, 1999, J NEUROSCI, V19, P8945, DOI 10.1523/JNEUROSCI.19-20-08945.1999; Mahanthappa NK, 1996, J NEUROSCI, V16, P4673; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; Matheson CR, 1997, J NEUROBIOL, V32, P22, DOI 10.1002/(SICI)1097-4695(199701)32:1<22::AID-NEU3>3.3.CO;2-B; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Naveilhan P, 1997, EUR J NEUROSCI, V9, P1450, DOI 10.1111/j.1460-9568.1997.tb01499.x; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; POVER CM, 1993, J NEUROSCI METH, V49, P123, DOI 10.1016/0165-0270(93)90116-9; Prevot V, 2003, J NEUROSCI, V23, P230; Rio C, 2002, J COMP NEUROL, V442, P156, DOI 10.1002/cne.10085; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Sanchez RM, 2001, J NEUROSCI, V21, P8154, DOI 10.1523/JNEUROSCI.21-20-08154.2001; Scherer S.S., 1996, GLIAL CELL DEV, P165; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Syroid DE, 1996, P NATL ACAD SCI USA, V93, P9229, DOI 10.1073/pnas.93.17.9229; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; Trupp M, 1997, J NEUROSCI, V17, P3554; Widenfalk J, 2001, J NEUROSCI, V21, P3457, DOI 10.1523/JNEUROSCI.21-10-03457.2001; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	49	135	136	2	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1186	1193		10.1038/nn1139	http://dx.doi.org/10.1038/nn1139			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14555954				2022-12-17	WOS:000186229200018
J	Liu, L; Yermolaieva, O; Johnson, WA; Abboud, FM; Welsh, MJ				Liu, L; Yermolaieva, O; Johnson, WA; Abboud, FM; Welsh, MJ			Identification and function of thermosensory neurons in Drosophila larvae	NATURE NEUROSCIENCE			English	Article							SENSORY NEURONS; EXPRESSION; MELANOGASTER; RECEPTOR; SPECIFICITY; INDICATORS; FIBERS; GENE; SKIN	Although the ability to sense temperature is critical for many organisms, the underlying mechanisms are poorly understood. Using the calcium reporter yellow cameleon 2.1 and electrophysiological recordings, we identified thermosensitive neurons and examined their physiologic response in Drosophila melanogaster larvae. In the head, terminal sensory organ neurons showed increased activity in response to cooling by less than or equal to1 degreesC, heating reduced their basal activity, and different units showed distinct response patterns. Neither cooling nor heating affected dorsal organ neurons. Body wall neurons showed a variety of distinct response patterns to both heating and cooling; the diverse thermal responses were strikingly similar to those described in mammals. These data establish a functional map of thermoresponsive neurons in Drosophila larvae and provide a foundation for understanding mechanisms of thermoreception in both insects and mammals.	Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, EMRB 500, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.			Welsh, Michael/0000-0002-1646-6206; Johnson, Wayne/0000-0002-6961-5498; Abboud, Francois/0000-0002-7284-9148	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL14388] Funding Source: Medline; NIDDK NIH HHS [DK25295] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRAND AH, 1993, DEVELOPMENT, V118, P401; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; BULLOCK TH, 1956, J PHYSIOL-LONDON, V134, P47, DOI 10.1113/jphysiol.1956.sp005624; Campbell AL, 2002, MICRON, V33, P211, DOI 10.1016/S0968-4328(01)00010-5; Campero M, 2001, J PHYSIOL-LONDON, V535, P855, DOI 10.1111/j.1469-7793.2001.t01-1-00855.x; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; DARIANSMITH I, 1973, J NEUROPHYSIOL, V36, P325, DOI 10.1152/jn.1973.36.2.325; DYKES RW, 1975, BRAIN RES, V98, P485, DOI 10.1016/0006-8993(75)90368-6; Grueber WB, 2002, DEVELOPMENT, V129, P2867; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hart S, 1998, BIOSCIENCE, V48, P3, DOI 10.2307/1313221; Heimbeck G, 1999, J NEUROSCI, V19, P6599; IGGO A, 1969, J PHYSIOL-LONDON, V200, P403, DOI 10.1113/jphysiol.1969.sp008701; KENSHALO DR, 1977, J NEUROPHYSIOL, V40, P319, DOI 10.1152/jn.1977.40.2.319; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; LONG RR, 1977, J NEUROPHYSIOL, V40, P489, DOI 10.1152/jn.1977.40.3.489; Martin J. H., 1991, PRINCIPLES NEURAL SC, V3, P341; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Oppliger FY, 2000, J INSECT PHYSIOL, V46, P135, DOI 10.1016/S0022-1910(99)00109-2; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; RUBIN GM, 1985, COLD SPRING HARB SYM, V50, P329, DOI 10.1101/SQB.1985.050.01.042; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schmitz H, 1998, J COMP PHYSIOL A, V182, P647, DOI 10.1007/s003590050210; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Susser E, 1999, BRAIN, V122, P239, DOI 10.1093/brain/122.2.239; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; WU CF, 1983, J NEUROSCI, V3, P1888	29	135	137	2	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					267	273		10.1038/nn1009	http://dx.doi.org/10.1038/nn1009			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12563263				2022-12-17	WOS:000181178300015
J	Hernandez, PJ; Sadeghian, K; Kelley, AE				Hernandez, PJ; Sadeghian, K; Kelley, AE			Early consolidation of instrumental learning requires protein synthesis in the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; MEMORY; DOPAMINE; ACQUISITION; EXTINCTION; RECEPTORS; NMDA; RAT; NEUROSCIENCE; ACTIVATION	It is widely held that long-term memories are established by consolidation of newly acquired information into stable neural representations, a process that requires protein synthesis and synaptic plasticity. Plasticity within the nucleus accumbens (NAc), a major component of the ventral striatum, is thought to mediate instrumental learning processes and many aspects of drug addiction. Here we show that the inhibition of protein synthesis within the NAc disrupts consolidation of an appetitive instrumental learning task (lever-pressing for food) in rats. Post-trial infusions of anisomycin immediately after the first several training sessions prevented consolidation, whereas infusions delayed by 2 or 4 hours had no effect. However, if the rats were allowed to learn the task, the behavior was not sensitive to disruption by intra-accumbens anisomycin. Control infusions into the medial NAc shell or the dorsolateral striatum did not impair learning; in fact, an enhancement was observed in the latter case. These results show that de novo protein synthesis within the NAc is necessary for the consolidation, but not reconsolidation, of appetitive instrumental memories.	Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hernandez, PJ (corresponding author), Univ Wisconsin, Neurosci Training Program, 7226 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	phernand@wisc.edu			NIDA NIH HHS [DA04788] Funding Source: Medline; NIGMS NIH HHS [GM07507] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA004788, R01DA004788, R29DA004788] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; AGRANOFF BW, 1967, SCI AM, V216, P115, DOI 10.1038/scientificamerican0667-115; Baldwin AE, 2000, BEHAV NEUROSCI, V114, P84, DOI 10.1037/0735-7044.114.1.84; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Bracha V, 1998, BRAIN RES, V788, P169, DOI 10.1016/S0006-8993(97)01535-7; CARLI M, 1985, NATURE, V313, P679, DOI 10.1038/313679a0; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Crofts HS, 2001, CEREB CORTEX, V11, P1015, DOI 10.1093/cercor/11.11.1015; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; FAIRLEY P, 1986, BEHAV NEUROSCI, V100, P652, DOI 10.1037/0735-7044.100.5.652; FLEXNER LB, 1965, EXP NEUROL, V13, P264, DOI 10.1016/0014-4886(65)90114-7; FLOOD JF, 1973, PHYSIOL BEHAV, V10, P555, DOI 10.1016/0031-9384(73)90221-7; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Haber SN, 2000, J NEUROSCI, V20, P2369; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelley AE, 1997, P NATL ACAD SCI USA, V94, P12174, DOI 10.1073/pnas.94.22.12174; KELLEY AE, 1982, NEUROSCIENCE, V7, P615, DOI 10.1016/0306-4522(82)90067-7; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; MARSHALL JF, 1980, J COMP PHYSIOL PSYCH, V94, P833, DOI 10.1037/h0077825; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Meiri N, 1998, BRAIN RES, V789, P48, DOI 10.1016/S0006-8993(97)01528-X; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Parkinson JA, 2000, PROG BRAIN RES, V126, P263; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petri HL, 1984, NEUROPSYCHOLOGY MEMO, P287; RESCORLA RA, 1991, Q J EXP PSYCHOL-B, V43, P1; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; Skinner B. F, 1953, SCI HUMAN BEHAV; Smith-Roe SL, 2000, J NEUROSCI, V20, P7737; SPRINGER AD, 1976, BEHAV BIOL, V17, P547, DOI 10.1016/S0091-6773(76)90973-1; Thorndike EL, 1911, ANIMAL INTELLIGENCE; Vianna MRM, 2001, P NATL ACAD SCI USA, V98, P12251, DOI 10.1073/pnas.211433298; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2	40	135	138	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1327	1331		10.1038/nn973	http://dx.doi.org/10.1038/nn973			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12426572				2022-12-17	WOS:000179447500016
J	Eskandar, EN; Assad, JA				Eskandar, EN; Assad, JA			Dissociation of visual, motor and predictive signals in parietal cortex during visual guidance	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; PURSUIT; SYSTEM	The role of the posterior parietal cortex (PPC) in the visual guidance of movements was studied in monkeys trained to use a joystick to guide a spot to a target. Visual and motor influences were dissociated by transiently occluding the spot and by varying the relationship between the direction of joystick and spot movements. We found a strong segregation of function in PPC during visual guidance. Neurons in area MST were selectively modulated by the direction of visible moving stimuli, whereas neurons in area MIP were selectively modulated by the direction of hand movement. In contrast, the selectivity of cells in the lateral intraparietal area (LIP) did not directly depend on either visual input or motor output, but rather seemed to encode a predictive representation of stimulus movement. These predictive signals may be an important link in visuomotor transformations.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Assad, JA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jassad@hms.harvard.edu						ABRAMSON N, 1963, INFORMATION THEORY C; Andersen RA, 1987, HDB PHYSL 1, VV, P483; ASSAD JA, 1995, NATURE, V373, P518, DOI 10.1038/373518a0; BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; BECKER W, 1985, EXP BRAIN RES, V57, P562; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; Critchley M., 1953, PARIETAL LOBES; DALLOS PJ, 1963, IEEE T AUTOMAT CONTR, P218; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KALASKA JF, 1995, CEREB CORTEX, V5, P410, DOI 10.1093/cercor/5.5.410; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; OPTICAN LM, 1987, J NEUROPHYSIOL, V57, P162, DOI 10.1152/jn.1987.57.1.162; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0	17	135	136	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					88	93		10.1038/4594	http://dx.doi.org/10.1038/4594			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195185				2022-12-17	WOS:000078409300018
J	Dube, U; Del-Aguila, JL; Li, ZR; Budde, JP; Jiang, S; Hsu, S; Ibanez, L; Fernandez, MV; Farias, F; Norton, J; Gentsch, J; Wang, FX; Salloway, S; Masters, CL; Lee, JH; Graff-Radford, NR; Chhatwal, JP; Bateman, RJ; Morris, JC; Karch, CM; Harari, O; Cruchaga, C; Allegri, R; Amtashar, F; Benzinger, T; Berman, S; Bodge, C; Brandon, S; Brooks, W; Buck, J; Buckles, V; Chea, S; Chrem, P; Chui, H; Cinco, J; Clifford, J; D'Mello, M; Donahue, T; Douglas, J; Edigo, N; Erekin-Taner, N; Fagan, A; Farlow, M; Farrar, A; Feldman, H; Flynn, G; Fox, N; Franklie, E; Fujii, H; Gant, C; Gardener, S; Ghetti, B; Goate, A; Goldman, J; Gordon, B; Gray, J; Gurney, J; Hassenstab, J; Hirohara, M; Holtzman, D; Hornbeck, R; DiBari, SH; Ikeuchi, T; Ikonomovic, S; Jerome, G; Jucker, M; Kasuga, K; Kawarabayashi, T; Klunk, W; Koeppe, R; Kuder-Buletta, E; Laske, C; Levin, J; Marcus, D; Martins, R; Mason, NS; Maue-Dreyfus, D; McDade, E; Montoya, L; Mori, H; Nagamatsu, A; Neimeyer, K; Noble, J; Perrin, R; Raichle, M; Ringman, J; Roh, JH; Schofield, P; Shimada, H; Shiroto, T; Shoji, M; Sigurdson, W; Sohrabi, H; Sparks, P; Suzuki, K; Swisher, L; Taddei, K; Wang, J; Wang, P; Weiner, M; Wolfsberger, M; Xiong, CJ; Xu, X				Dube, Umber; Del-Aguila, Jorge L.; Li, Zeran; Budde, John P.; Jiang, Shan; Hsu, Simon; Ibanez, Laura; Fernandez, Maria Victoria; Farias, Fabiana; Norton, Joanne; Gentsch, Jen; Wang, Fengxian; Salloway, Stephen; Masters, Colin L.; Lee, Jae-Hong; Graff-Radford, Neill R.; Chhatwal, Jasmeer P.; Bateman, Randall J.; Morris, John C.; Karch, Celeste M.; Harari, Oscar; Cruchaga, Carlos; Allegri, Ricardo; Amtashar, Fatima; Benzinger, Tammie; Berman, Sarah; Bodge, Courtney; Brandon, Susan; Brooks, William; Buck, Jill; Buckles, Virginia; Chea, Sochenda; Chrem, Patricio; Chui, Helena; Cinco, Jake; Clifford, Jack; D'Mello, Mirelle; Donahue, Tamara; Douglas, Jane; Edigo, Noelia; Erekin-Taner, Nilufer; Fagan, Anne; Farlow, Marty; Farrar, Angela; Feldman, Howard; Flynn, Gigi; Fox, Nick; Franklie, Erin; Fujii, Hisako; Gant, Cortaiga; Gardener, Samantha; Ghetti, Bernardino; Goate, Alison; Goldman, Jill; Gordon, Brian; Gray, Julia; Gurney, Jenny; Hassenstab, Jason; Hirohara, Mie; Holtzman, David; Hornbeck, Russ; DiBari, Siri Houeland; Ikeuchi, Takeshi; Ikonomovic, Snezana; Jerome, Gina; Jucker, Mathias; Kasuga, Kensaku; Kawarabayashi, Takeshi; Klunk, William; Koeppe, Robert; Kuder-Buletta, Elke; Laske, Christoph; Levin, Johannes; Marcus, Daniel; Martins, Ralph; Mason, Neal Scott; Maue-Dreyfus, Denise; McDade, Eric; Montoya, Lucy; Mori, Hiroshi; Nagamatsu, Akem; Neimeyer, Katie; Noble, James; Perrin, Richard; Raichle, Marc; Ringman, John; Roh, Jee Hoon; Schofield, Peter; Shimada, Hiroyuki; Shiroto, Tomoyo; Shoji, Mikio; Sigurdson, Wendy; Sohrabi, Hamid; Sparks, Paige; Suzuki, Kazushi; Swisher, Laura; Taddei, Kevin; Wang, Jen; Wang, Peter; Weiner, Mike; Wolfsberger, Mary; Xiong, Chengjie; Xu, Xiong		DIAN	An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations	NATURE NEUROSCIENCE			English	Article							POSTERIOR CINGULATE; HYPOMETABOLISM; GENES; QUANTIFICATION; ATROPHY; ENERGY	Parietal cortex RNA-sequencing (RNA-seq) data were generated from individuals with and without Alzheimer disease (AD; n(control) = 13; n(AD) = 83) from the Knight Alzheimer Disease Research Center (Knight ADRC). Using this and an independent (Mount Sinai Brain Bank (MSBB)) AD RNA-seq dataset, cortical circular RNA (circRNA) expression was quantified in the context of AD. Significant associations were identified between circRNA expression and AD diagnosis, clinical dementia severity and neuropathological severity. It was demonstrated that most circRNA-AD associations are independent of changes in cognate linear messenger RNA expression or estimated brain cell-type proportions. Evidence was provided for circRNA expression changes occurring early in presymptomatic AD and in autosomal dominant AD. It was also observed that AD-associated circRNAs coexpressed with known AD genes. Finally, potential microRNA-binding sites were identified in AD-associated circRNAs for miRNAs predicted to target AD genes. Together, these results highlight the importance of analyzing non-linear RNAs and support future studies exploring the potential roles of circRNAs in AD pathogenesis.	[Dube, Umber] Washington Univ, Sch Med, Med Scientist Training Program, St Louis, MO USA; [Dube, Umber; Del-Aguila, Jorge L.; Li, Zeran; Budde, John P.; Jiang, Shan; Hsu, Simon; Ibanez, Laura; Fernandez, Maria Victoria; Farias, Fabiana; Norton, Joanne; Gentsch, Jen; Wang, Fengxian; Karch, Celeste M.; Harari, Oscar; Cruchaga, Carlos] Washington Univ, Sch Med, Dept Psychiat, 660 S Euclid Ave,CB8134, St Louis, MO 63110 USA; [Dube, Umber; Bateman, Randall J.; Morris, John C.; Cruchaga, Carlos] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Salloway, Stephen] Brown Univ, Alpert Med Sch, 345 Blackstone Blvd, Providence, RI 02912 USA; [Masters, Colin L.] Univ Melbourne, Florey Inst, Howard Florey Labs, Level 1, Parkville, Vic, Australia; [Lee, Jae-Hong] Univ Ulsan, Dept Neurol, Coll Med, Seoul, South Korea; [Graff-Radford, Neill R.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Chhatwal, Jasmeer P.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Karch, Celeste M.; Cruchaga, Carlos] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63130 USA; [Cruchaga, Carlos] Washington Univ, Sch Med, NeuroGen & Informat, St Louis, MO 63130 USA; [Allegri, Ricardo; Chrem, Patricio; Edigo, Noelia] FLENI, Inst Neurol Res, Buenos Aires, DF, Argentina; [Amtashar, Fatima; Benzinger, Tammie; Brandon, Susan; Buckles, Virginia; Donahue, Tamara; Fagan, Anne; Farrar, Angela; Flynn, Gigi; Franklie, Erin; Gant, Cortaiga; Gordon, Brian; Gray, Julia; Gurney, Jenny; Hassenstab, Jason; Holtzman, David; Hornbeck, Russ; Jerome, Gina; Marcus, Daniel; Maue-Dreyfus, Denise; McDade, Eric; Perrin, Richard; Raichle, Marc; Sigurdson, Wendy; Swisher, Laura; Wang, Peter; Wolfsberger, Mary; Xiong, Chengjie; Xu, Xiong] Washington Univ, St Louis Sch Med, St Louis, MO 63110 USA; [Berman, Sarah; Ikonomovic, Snezana; Klunk, William] Univ Pittsburgh, Pittsburgh, PA USA; [Bodge, Courtney] Brown Univ, Butler Hosp, Providence, RI 02912 USA; [Brooks, William; D'Mello, Mirelle; Schofield, Peter] Neurosci Res Australia, Sydney, NSW, Australia; [Buck, Jill; Farlow, Marty; Ghetti, Bernardino] Indiana Univ, Bloomington, IN USA; [Chea, Sochenda; Clifford, Jack; Erekin-Taner, Nilufer] Mayo Clin Jacksonville, 4500 San Pablo Rd, Jacksonville, FL 32224 USA; [Chui, Helena; Montoya, Lucy; Ringman, John] Univ Southern Calif, Los Angeles, CA USA; [Cinco, Jake; Douglas, Jane; Fox, Nick] UCL, London, England; [Feldman, Howard] Univ Calif San Diego, San Diego, CA 92103 USA; [Fujii, Hisako; Mori, Hiroshi; Shimada, Hiroyuki] Osaka City Univ, Osaka, Japan; [Gardener, Samantha; Martins, Ralph; Sohrabi, Hamid; Taddei, Kevin] Edith Cowan Univ, Perth, WA, Australia; [Goate, Alison; Wang, Jen] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Goldman, Jill; Neimeyer, Katie; Noble, James] Columbia Univ, New York, NY USA; [Hirohara, Mie; Kawarabayashi, Takeshi; Shiroto, Tomoyo; Shoji, Mikio] Hirosaki Univ, Hirosaki, Aomori, Japan; [DiBari, Siri Houeland; Levin, Johannes] German Ctr Neurodegenerat Dis DZNE Munich, Munich, Germany; [Ikeuchi, Takeshi; Kasuga, Kensaku] Niigata Univ, Niigata, Japan; [Jucker, Mathias; Kuder-Buletta, Elke; Laske, Christoph] German Ctr Neurodegnerat Dis DZNE Tubingen, Tubingen, Germany; [Koeppe, Robert] Univ Michigan, Ann Arbor, MI 48109 USA; [Mason, Neal Scott] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Nagamatsu, Akem; Suzuki, Kazushi] Univ Tokyo, Bunkyo Ku, Tokyo, Japan; [Roh, Jee Hoon] Asan Med Ctr, Seoul, South Korea; [Sparks, Paige] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Weiner, Mike] Univ Calif San Francisco, San Francisco, CA 94143 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Brown University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Ulsan; Mayo Clinic; Harvard University; Harvard Medical School; Massachusetts General Hospital; Washington University (WUSTL); Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University; Butler Hospital Rhode Island; Neuroscience Research Australia; Indiana University System; Indiana University Bloomington; Mayo Clinic; University of Southern California; University of London; University College London; University of California System; University of California San Diego; Osaka Metropolitan University; Edith Cowan University; Icahn School of Medicine at Mount Sinai; Columbia University; Hirosaki University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Niigata University; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tokyo; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco	Cruchaga, C (corresponding author), Washington Univ, Sch Med, Dept Psychiat, 660 S Euclid Ave,CB8134, St Louis, MO 63110 USA.; Cruchaga, C (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.; Cruchaga, C (corresponding author), Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63130 USA.; Cruchaga, C (corresponding author), Washington Univ, Sch Med, NeuroGen & Informat, St Louis, MO 63130 USA.	ccruchaga@wustl.edu	JH, Roh/F-4078-2014; Noble, James McCallum/AAA-4218-2020; Fox, Nick C/B-1319-2009; Benzinger, Tammie/L-6104-2013; Gordon, Brian/U-7794-2019; Kasuga, Kensaku/AAQ-6627-2020; ALLEGRI, RICARDO FRANCISCO/AAY-4898-2021; wang, peter/AAD-5851-2020; Levin, Johannes/E-4052-2010; Hassenstab, Jason/AAF-2063-2020; Levin, Johannes/W-8686-2019; Cruchaga, Carlos/ABF-4065-2020; Li, Zeran/AAZ-5312-2020; Berman, Sarah/I-2792-2014; Sohrabi, Hamid Reza/L-2461-2016; Gardener, Samantha/D-1718-2016	JH, Roh/0000-0002-3243-0529; Noble, James McCallum/0000-0003-0648-6702; Fox, Nick C/0000-0002-6660-657X; Benzinger, Tammie/0000-0002-8114-0552; Gordon, Brian/0000-0003-2109-2955; Kasuga, Kensaku/0000-0002-2178-0769; Levin, Johannes/0000-0001-5092-4306; Levin, Johannes/0000-0001-5092-4306; Cruchaga, Carlos/0000-0002-0276-2899; Berman, Sarah/0000-0002-5096-4962; Sohrabi, Hamid Reza/0000-0001-8017-8682; Li, Zeran/0000-0002-7434-6499; Budde, John/0000-0001-7778-7276; Shoji, Mikio/0000-0003-1027-1712; Dube, Umber/0000-0001-9324-1927; Allegri, Ricardo Francisco/0000-0001-7166-1234; Morris, John/0000-0001-9820-5618; Bateman, Randall/0000-0002-7729-1702; Klunk, William/0000-0001-5512-0251; Del Aguila, Jorge L./0000-0002-6364-8707; Masters, Colin/0000-0003-3072-7940; Gardener, Samantha/0000-0002-1933-5260; Feldman, Howard/0000-0002-9258-4538; Brooks, William Seymour/0000-0001-8603-4233; Hsu, Simon/0000-0002-0799-3549	National Institutes of Health (NIH) [R01AG044546, P01AG003991, RF1AG053303, R01AG058501, U01AG058922, RF1AG058501, R01AG057777]; Alzheimer Association [NIRG-11-200110, BAND-14-338165, AARG-16-441560, BFG-15-362540]; Tau Consortium; NIH [P50 AG05681, P01 AG03991, P01 AG026276]; DIAN - National Institute on Aging [UF1AG032438]; German Center for Neurodegenerative Diseases; Raul Carrea Institute for Neurological Research; Research and Development Grants for Dementia from the Japan Agency for Medical Research and Development; Korea Health Technology R&D Project through the Korea Health Industry Development Institute;  [NIH AG046374];  [K23 AG049087]; NATIONAL INSTITUTE ON AGING [U01AG058922, P01AG026276, U01AG052411, R56AG064877, K23AG049087, P01AG003991, R01AG044546, RF1AG058501, RF1AG053303, RF1AG044546, P50AG005681, R01AG057777, K01AG046374] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Tau Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIAN - National Institute on Aging; German Center for Neurodegenerative Diseases; Raul Carrea Institute for Neurological Research; Research and Development Grants for Dementia from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Korea Health Technology R&D Project through the Korea Health Industry Development Institute; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank all the participants and their families, as well as the many institutions and their staff. This work was supported by grants from the National Institutes of Health (NIH: grant nos R01AG044546, P01AG003991, RF1AG053303, R01AG058501, U01AG058922, RF1AG058501 and R01AG057777), the Alzheimer Association (grant nos NIRG-11-200110, BAND-14-338165, AARG-16-441560 and BFG-15-362540), grant no. NIH AG046374 (C.M.K.), Tau Consortium (C.M.K.) and grant no. K23 AG049087 (J.P.C.). The recruitment and clinical characterization of research participants at Washington University were supported by NIH P50 AG05681, P01 AG03991, and P01 AG026276. This work was supported by access to equipment made possible by the Hope Center for Neurological Disorders, and the Departments of Neurology and Psychiatry at Washington University School of Medicine. The results published here are in part based on data obtained from the AMP-AD Knowledge Portal accessed via the cited accession numbers. The MSBB data were generated from postmortem brain tissue collected through the Mount Sinai VA Medical Center Brain Bank and were provided by E. Schadt from Mount Sinai School of Medicine. Data collection and sharing for this project were supported by DIAN (UF1AG032438) funded by the National Institute on Aging, the German Center for Neurodegenerative Diseases, Raul Carrea Institute for Neurological Research, with partial support by the Research and Development Grants for Dementia from the Japan Agency for Medical Research and Development, and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute. This manuscript has been reviewed by DIAN study investigators for scientific content and consistency of data interpretation with previous DIAN study publications. We acknowledge the altruism of the participants and their families and contributions of the DIAN research and support staff at each of the participating sites for their contributions to this study.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Bai Y, 2018, J NEUROSCI, V38, P32, DOI 10.1523/JNEUROSCI.1348-17.2017; Barrett SP, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007114; Barrett SP, 2016, DEVELOPMENT, V143, P1838, DOI 10.1242/dev.128074; Bateman RJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt59; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cheng J, 2016, BIOINFORMATICS, V32, P1094, DOI 10.1093/bioinformatics/btv656; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Glazar P, 2014, RNA, V20, P1666, DOI 10.1261/rna.043687.113; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Gruner H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38907; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; Kljajevic V, 2014, NEUROBIOL AGING, V35, P1973, DOI 10.1016/j.neurobiolaging.2014.04.006; Krishnan KC, 2018, CELL SYST, V6, P103, DOI 10.1016/j.cels.2017.12.006; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Li X, 2018, MOL CELL, V71, P428, DOI 10.1016/j.molcel.2018.06.034; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Li ZR, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0551-4; Liang DM, 2017, MOL CELL, V68, P940, DOI 10.1016/j.molcel.2017.10.034; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lukiw Walter J., 2013, Frontiers in Genetics, V4, P307, DOI [10.3389/fgene.2013.00307, 10.3389/fgene.2013.00077]; Maass PG, 2017, J MOL MED, V95, P1179, DOI 10.1007/s00109-017-1582-9; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosconi L, 2006, J NUCL MED, V47, P1778; Na H, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004542; Pamudurti NR, 2017, MOL CELL, V66, P9, DOI 10.1016/j.molcel.2017.02.021; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Perkins M, 2016, J ALZHEIMERS DIS, V53, P95, DOI 10.3233/JAD-151205; Pine PS, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0281-x; Piwecka M, 2017, SCIENCE, V357, DOI 10.1126/science.aam8526; R Core Team, 2018, R LANG ENV STAT COMP; Raj T, 2018, NAT GENET, V50, P1584, DOI 10.1038/s41588-018-0238-1; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schroeter ML, 2012, BRAIN, V135, P201, DOI 10.1093/brain/awr311; Smith R, 2016, J ALZHEIMERS DIS, V51, P339, DOI 10.3233/JAD-151004; Veno MT, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0801-3; Verheijen J, 2018, TRENDS GENET, V34, P434, DOI 10.1016/j.tig.2018.02.007; Wang LG, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0922-z; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang MH, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.185; Wang MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16923; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Westholm JO, 2014, CELL REP, V9, P1966, DOI 10.1016/j.celrep.2014.10.062; Yang Y, 2012, FEBS LETT, V586, P3608, DOI 10.1016/j.febslet.2012.08.003; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	61	134	141	20	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2019	22	11					1903	+		10.1038/s41593-019-0501-5	http://dx.doi.org/10.1038/s41593-019-0501-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JI3VI	31591557	Green Accepted, Green Submitted			2022-12-17	WOS:000493396600017
J	Tellez, LA; Han, WF; Zhang, XB; Ferreira, TL; Perez, IO; Shammah-Lagnado, SJ; van den Pol, AN; de Araujo, IE				Tellez, Luis A.; Han, Wenfei; Zhang, Xiaobing; Ferreira, Tatiana L.; Perez, Isaac O.; Shammah-Lagnado, Sara J.; van den Pol, Anthony N.; de Araujo, Ivan E.			Separate circuitries encode the hedonic and nutritional values of sugar	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; NUCLEUS-ACCUMBENS; INDIRECT PATHWAYS; STRIATAL NEURONS; DOPAMINE; TASTE; REWARD; REINFORCEMENT; SELECTION; DROSOPHILA	Sugar exerts its potent reinforcing effects via both gustatory and post-ingestive pathways. It is, however, unknown whether sweetness and nutritional signals engage segregated brain networks to motivate ingestion. We found in mice that separate basal ganglia circuitries mediated the hedonic and nutritional actions of sugar. During sugar intake, suppressing hedonic value inhibited dopamine release in ventral, but not dorsal, striatum, whereas suppressing nutritional value inhibited dopamine release in dorsal, but not ventral, striatum. Consistently, cell-specific ablation of dopamine-excitable cells in dorsal, but not ventral, striatum inhibited sugar's ability to drive the ingestion of unpalatable solutions. Conversely, optogenetic stimulation of dopamine-excitable cells in dorsal, but not ventral, striatum substituted for sugar in its ability to drive the ingestion of unpalatable solutions. Our data indicate that sugar recruits a distributed dopamine-excitable striatal circuitry that acts to prioritize energy-seeking over taste quality.	[Tellez, Luis A.; Han, Wenfei; Ferreira, Tatiana L.; Perez, Isaac O.; de Araujo, Ivan E.] John B Pierce Lab, New Haven, CT USA; [Tellez, Luis A.; Han, Wenfei; Ferreira, Tatiana L.; de Araujo, Ivan E.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Zhang, Xiaobing; van den Pol, Anthony N.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Ferreira, Tatiana L.] Fed Univ ABC, Math Comp & Cognit Ctr, Santo Andre, SP, Brazil; [Shammah-Lagnado, Sara J.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Carlos, SP, Brazil; [de Araujo, Ivan E.] Yale Univ, Sch Arts & Sci, Dept Physiol, New Haven, CT USA	Yale University; The John B Pierce Laboratory, Inc; Yale University; Yale University; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Yale University	de Araujo, IE (corresponding author), John B Pierce Lab, New Haven, CT USA.; de Araujo, IE (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA.; de Araujo, IE (corresponding author), Yale Univ, Sch Arts & Sci, Dept Physiol, New Haven, CT USA.	iaraujo@jbpierce.org	Ferreira, Tatiana L/E-3762-2013; FERREIRA, TATIANA/I-8386-2016; Core, Vector/CAF-4832-2022; ZHANG, XIAOBING/J-4076-2015	FERREIRA, TATIANA/0000-0002-2805-513X; ZHANG, XIAOBING/0000-0002-5707-193X; Tellez, Luis A/0000-0002-3101-5817; De Araujo, Ivan/0000-0003-3081-3339	US National Institutes of Health [R01DC014859, R01CA180030, R01 DK103176, DK084052, NS48476]; China Scholarship Council [201206260072]; FAPESP (Sao Paulo) [2013/09405-3]; NATIONAL CANCER INSTITUTE [R01CA180030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103176, R01DK084052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014859] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); FAPESP (Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by US National Institutes of Health grants R01DC014859 and R01CA180030 (to I. E. d. A.), and R01 DK103176, DK084052 and NS48476 (to A. N. v. d. P.), the China Scholarship Council 201206260072 (to W. H.) and FAPESP (Sao Paulo) 2013/09405-3 (to T.L.F.).	Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Costa RM, 2007, ANN NY ACAD SCI, V1104, P172, DOI 10.1196/annals.1390.015; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; DELONG MR, 1983, J NEUROSCI, V3, P1599; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; Ericsson J, 2013, J NEUROSCI, V33, P8045, DOI 10.1523/JNEUROSCI.5881-12.2013; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Grillner S, 2013, J PHYSIOL-LONDON, V591, P5425, DOI 10.1113/jphysiol.2012.246660; Hajnal A, 2005, PHYSIOL BEHAV, V84, P363, DOI 10.1016/j.physbeh.2004.12.014; HOLMAN GL, 1969, J COMP PHYSIOL PSYCH, V69, P432, DOI 10.1037/h0028233; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; O'Doherty JP, 2014, NEUROSCI BIOBEHAV R, V43, P259, DOI 10.1016/j.neubiorev.2014.03.027; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Planert H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057054; Ren XY, 2010, J NEUROSCI, V30, P8012, DOI 10.1523/JNEUROSCI.5749-09.2010; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Sclafani A, 2001, APPETITE, V36, P79, DOI 10.1006/appe.2000.0370; SHAMMAHLAGNADO SJ, 1992, NEUROSCIENCE, V50, P403, DOI 10.1016/0306-4522(92)90433-3; Stephenson-Jones M, 2013, P NATL ACAD SCI USA, V110, pE3670, DOI 10.1073/pnas.1314815110; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007; WURTZ RH, 1986, PROG BRAIN RES, V64, P175; Yamagata N, 2015, P NATL ACAD SCI USA, V112, P578, DOI 10.1073/pnas.1421930112; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Zuker CS, 2015, CELL, V161, P9, DOI 10.1016/j.cell.2015.03.016	31	134	137	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2016	19	3					465	+		10.1038/nn.4224	http://dx.doi.org/10.1038/nn.4224			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE7MU	26807950	Green Accepted			2022-12-17	WOS:000370822200018
J	Luthi, A; Luscher, C				Luethi, Andreas; Luescher, Christian			Pathological circuit function underlying addiction and anxiety disorders	NATURE NEUROSCIENCE			English	Review							VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; EVOKED SYNAPTIC PLASTICITY; AMYGDALA INHIBITORY CIRCUITS; MIDBRAIN DOPAMINE NEURONS; SUBSTANCE USE DISORDERS; FEAR MEMORY; NUCLEUS-ACCUMBENS; LATERAL AMYGDALA; CONDITIONED FEAR	Current models of addiction and anxiety stem from the idea that aberrant function and remodeling of neural circuits cause the pathological behaviors. According to this hypothesis, a disease-defining experience (for example, drug reward or stress) would trigger specific forms of synaptic plasticity, which in susceptible subjects would become persistent and lead to the disease. While the notion of synaptic diseases has received much attention, no candidate disorder has been sufficiently investigated to yield new, rational therapies that could be tested in the clinic. Here we review the arguments in favor of abnormal neuronal plasticity underlying addiction and anxiety disorders, with a focus on the functional diversity of neurons that make up the circuits involved. We argue that future research must strive to obtain a comprehensive description of the relevant functional anatomy. This will allow identification of molecular mechanisms that govern the induction and expression of disease-relevant plasticity in identified neurons. To establish causality, one will have to test whether normalization of function can reverse pathological behavior. With these elements in hand, it will be possible to propose blueprints for manipulations to be tested in translational studies. The challenge is daunting, but new techniques, above all optogenetics, may enable decisive advances.	[Luethi, Andreas] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland; [Luescher, Christian] Univ Hosp Geneva, Neurol Clin, Dept Clin Neurosci, Geneva, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Geneva; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland.	andreas.luthi@fmi.ch; christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596	Swiss National Science Foundation; Swiss national competence center for research on synaptic basis of disease (Synapsy); European Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss national competence center for research on synaptic basis of disease (Synapsy); European Research Council(European Research Council (ERC)European Commission)	We thank the many colleagues who have, with discussions and suggestions on the manuscript, helped us improve this review. A.L. and C.L. are supported by grants from the Swiss National Science Foundation and the Swiss national competence center for research on synaptic basis of disease (Synapsy). C.L. is an European Research Council advanced grant holder.	Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Anthony TE, 2014, CELL, V156, P522, DOI 10.1016/j.cell.2013.12.040; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Britt JP, 2013, CURR OPIN NEUROBIOL, V23, P539, DOI 10.1016/j.conb.2013.01.010; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Brown MTC, 2012, NATURE, V492, P452, DOI 10.1038/nature11657; Capogna M, 2014, CURR OPIN NEUROBIOL, V26, P110, DOI 10.1016/j.conb.2014.01.006; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; CASSELL MD, 1986, J COMP NEUROL, V246, P478, DOI 10.1002/cne.902460406; Childress A R, 1988, NIDA Res Monogr, V84, P25; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Di Luca M, 2011, EUR J NEUROSCI, V33, P768, DOI 10.1111/j.1460-9568.2010.07596.x; Dobi A, 2010, J NEUROSCI, V30, P218, DOI 10.1523/JNEUROSCI.3884-09.2010; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Goldberg JA, 2011, NEUROSCIENCE, V198, P27, DOI 10.1016/j.neuroscience.2011.08.067; Good CH, 2010, J NEUROSCI, V30, P7900, DOI 10.1523/JNEUROSCI.1507-10.2010; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Heikkinen AE, 2009, NEUROPSYCHOPHARMACOL, V34, P290, DOI 10.1038/npp.2008.89; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Houbaert X, 2013, J NEUROSCI, V33, P13805, DOI 10.1523/JNEUROSCI.1457-13.2013; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; Jayachandran R, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001820; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Khelfaoui M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0160; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; KRETTEK JE, 1978, J COMP NEUROL, V178, P255, DOI 10.1002/cne.901780205; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee BR, 2013, NAT NEUROSCI, V16, P1644, DOI 10.1038/nn.3533; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Luscher C, 2013, J NEUROSCI, V33, P17641, DOI 10.1523/JNEUROSCI.3406-13.2013; Mameli M, 2011, NAT NEUROSCI, V14, P414, DOI 10.1038/nn.2763; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Merikangas KR, 1998, ADDICT BEHAV, V23, P893, DOI 10.1016/S0306-4603(98)00076-8; Morales M, 2014, NEUROSCIENCE, V282, P60, DOI 10.1016/j.neuroscience.2014.05.032; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Omelchenko N, 2010, J NEUROSCI RES, V88, P981, DOI 10.1002/jnr.22265; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pare D, 2012, CURR OPIN NEUROBIOL, V22, P717, DOI 10.1016/j.conb.2012.02.014; Pascoli V, 2014, NATURE, V509, P459, DOI 10.1038/nature13257; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Roeper J, 2013, TRENDS NEUROSCI, V36, P336, DOI 10.1016/j.tins.2013.03.003; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; See RE, 2003, ANN NY ACAD SCI, V985, P294; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Sparta DR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00129; Spronk DB, 2013, NEUROSCI BIOBEHAV R, V37, P1838, DOI 10.1016/j.neubiorev.2013.07.003; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Suvrathan A, 2010, P NATL ACAD SCI USA, V107, P11591, DOI 10.1073/pnas.1002262107; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758; Taylor SR, 2014, J COMP NEUROL, V522, P3308, DOI 10.1002/cne.23603; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; TURNER BH, 1991, J COMP NEUROL, V313, P295, DOI 10.1002/cne.903130208; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Ungless MA, 2012, TRENDS NEUROSCI, V35, P422, DOI 10.1016/j.tins.2012.02.003; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; VANBOCKSTAELE EJ, 1995, BRAIN RES, V682, P215, DOI 10.1016/0006-8993(95)00334-M; Vialou V, 2014, J NEUROSCI, V34, P3878, DOI 10.1523/JNEUROSCI.1787-13.2014; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Yuan TF, 2013, NEURON, V80, P1025, DOI 10.1016/j.neuron.2013.07.050	99	134	140	0	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2014	17	12					1635	1643		10.1038/nn.3849	http://dx.doi.org/10.1038/nn.3849			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU2ZY	25402855				2022-12-17	WOS:000345484000008
J	Willuhn, I; Burgeno, LM; Groblewski, PA; Phillips, PEM				Willuhn, Ingo; Burgeno, Lauren M.; Groblewski, Peter A.; Phillips, Paul E. M.			Excessive cocaine use results from decreased phasic dopamine signaling in the striatum	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS; SEEKING BEHAVIOR; DRUG-ADDICTION; NEURAL BASIS; RELEASE; REINFORCEMENT; CORE; RATS; SENSITIZATION; ESCALATION	Drug addiction is a neuropsychiatric disorder marked by escalating drug use. Dopamine neurotransmission in the ventromedial striatum (VMS) mediates acute reinforcing effects of abused drugs, but with protracted use the dorsolateral striatum is thought to assume control over drug seeking. We measured striatal dopamine release during a cocaine self-administration regimen that produced escalation of drug taking in rats. Surprisingly, we found that phasic dopamine decreased in both regions as the rate of cocaine intake increased, with the decrement in dopamine in the VMS significantly correlated with the rate of escalation. Administration of the dopamine precursor (L)-DOPA at a dose that replenished dopamine signaling in the VMS reversed escalation, thereby demonstrating a causal relationship between diminished dopamine transmission and excessive drug use. Together these data provide mechanistic and therapeutic insight into the excessive drug intake that emerges following protracted use.	[Willuhn, Ingo; Burgeno, Lauren M.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Willuhn, Ingo; Burgeno, Lauren M.; Groblewski, Peter A.; Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Willuhn, I (corresponding author), Univ Amsterdam, Acad Med Ctr, Netherlands Inst Neurosci, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	ingo.willuhn@gmail.com	Willuhn, Ingo/AAP-4276-2021; Phillips, Paul/E-7813-2013; Phillips, Paul E. M./A-4463-2008	Willuhn, Ingo/0000-0001-6540-6894; Phillips, Paul/0000-0002-8749-7026; Phillips, Paul E. M./0000-0002-8749-7026; Burgeno, Lauren/0000-0001-9305-1621	German Research Foundation (Deutsche Forschungsgemeinschaft) [WI 3643/1-1]; awards from the Alcohol and Drug Institute (P.E.MP.); provost of the University of Washington (P.E.M.P.); US National Institutes of Health grants [T32-DA027858, F32-DA033004, P01-DA015916, R21-DA021793, R01-DA027858]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA015916, T32DA007278, R21DA021793, R01DA027858, F32DA033004] Funding Source: NIH RePORTER	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); awards from the Alcohol and Drug Institute (P.E.MP.); provost of the University of Washington (P.E.M.P.); US National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Ng-Evans, C. Akers Sanford, C. Zietz, N. Murray and D. Hadidi for technical support and M. Arnold and J. Clark for feedback. This work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) grant WI 3643/1-1 (I.W.), awards from the Alcohol and Drug Institute (P.E.MP.) and the provost of the University of Washington (P.E.M.P.), and US National Institutes of Health grants T32-DA027858 (L.M.B.), F32-DA033004 (P.A.G.), P01-DA015916 (P.E.M.P.), R21-DA021793 (P.E.M.P.) and R01-DA027858 (P.E.M.P.).	Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Ahmed SH, 2003, J NEUROCHEM, V86, P102, DOI 10.1046/j.1471-4159.2003.01833.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bradberry CW, 2000, J NEUROSCI, V20, P7109, DOI 10.1523/JNEUROSCI.20-18-07109.2000; Calipari ES, 2013, NEUROPSYCHOPHARMACOL, V38, P2385, DOI 10.1038/npp.2013.136; Calipari ES, 2014, ADDICT BIOL, V19, P145, DOI 10.1111/j.1369-1600.2012.00456.x; Clark JJ, 2013, J NEUROSCI, V33, P3526, DOI 10.1523/JNEUROSCI.5119-12.2013; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; DACKIS CA, 1985, NEUROSCI BIOBEHAV R, V9, P469, DOI 10.1016/0149-7634(85)90022-3; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; DEWIT H, 1977, CAN J PSYCHOL, V31, P195, DOI 10.1037/h0081662; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; ETTENBERG A, 1982, PSYCHOPHARMACOLOGY, V78, P204, DOI 10.1007/BF00428151; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Ferrario CR, 2005, BIOL PSYCHIAT, V58, P751, DOI 10.1016/j.biopsych.2005.04.046; Ferris MJ, 2012, NEUROPSYCHOPHARMACOL, V37, P1708, DOI 10.1038/npp.2012.17; Henry PK, 2009, PSYCHOPHARMACOLOGY, V205, P237, DOI 10.1007/s00213-009-1534-3; Ito R, 2002, J NEUROSCI, V22, P6247; Ito R, 2000, J NEUROSCI, V20, P7489; Jonkman S, 2012, NEUROPSYCHOPHARMACOL, V37, P1612, DOI 10.1038/npp.2012.6; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Keramati M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061489; Lynch WJ, 2006, PSYCHOPHARMACOLOGY, V185, P306, DOI 10.1007/s00213-006-0323-5; Mariani JJ, 2012, PSYCHIAT CLIN N AM, V35, P425, DOI 10.1016/j.psc.2012.03.012; Mateo Y, 2005, NEUROPSYCHOPHARMACOL, V30, P1455, DOI 10.1038/sj.npp.1300687; Owesson-White CA, 2009, EUR J NEUROSCI, V30, P1117, DOI 10.1111/j.1460-9568.2009.06916.x; PAN HT, 1991, J NEUROCHEM, V56, P1299, DOI 10.1111/j.1471-4159.1991.tb11425.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Phillips PEM, 2003, TRAC-TREND ANAL CHEM, V22, P509, DOI 10.1016/S0165-9936(03)00907-5; PICKENS R, 1968, J PHARMACOL EXP THER, V161, P122; Porrino LJ, 2007, PROG NEURO-PSYCHOPH, V31, P1593, DOI 10.1016/j.pnpbp.2007.08.040; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROBLEDO P, 1992, ANN NY ACAD SCI, V654, P509, DOI 10.1111/j.1749-6632.1992.tb26015.x; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Stuber GD, 2005, NEURON, V46, P661, DOI 10.1016/j.neuron.2005.04.036; Stuber GD, 2005, NEUROPSYCHOPHARMACOL, V30, P853, DOI 10.1038/sj.npp.1300619; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; White NM, 1996, ADDICTION, V91, P921, DOI 10.1111/j.1360-0443.1996.tb03586.x; WIGHTMAN RM, 1988, NEUROSCIENCE, V25, P513, DOI 10.1016/0306-4522(88)90255-2; Willuhn I, 2012, P NATL ACAD SCI USA, V109, P20703, DOI 10.1073/pnas.1213460109; WISE RA, 1995, PSYCHOPHARMACOLOGY, V120, P10, DOI 10.1007/BF02246140; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Zernig G, 2007, PHARMACOLOGY, V80, P65, DOI 10.1159/000103923	50	134	136	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2014	17	5					704	+		10.1038/nn.3694	http://dx.doi.org/10.1038/nn.3694			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF9DS	24705184	Green Accepted			2022-12-17	WOS:000335016200014
J	Rangel, A				Rangel, Antonio			Regulation of dietary choice by the decision-making circuitry	NATURE NEUROSCIENCE			English	Review							PAVLOVIAN APPROACH BEHAVIOR; HUMAN ORBITOFRONTAL CORTEX; RECEPTOR MESSENGER-RNA; NUCLEUS-ACCUMBENS; PREFRONTAL CORTEX; FOOD-INTAKE; INDIVIDUAL-DIFFERENCES; PREDICTION ERRORS; GHRELIN INCREASES; NEURONAL-ACTIVITY	To advance our understanding of how the brain makes food decisions, it is essential to combine knowledge from two fields that have not yet been well integrated: the neuro-computational basis of decision-making and the homeostatic regulators of feeding. This Review integrates these two literatures from a neuro-computational perspective, with an emphasis in describing the variables computed by different neural systems and how they affect dietary choice. We highlight what is unique about feeding decisions, the mechanisms through which metabolic and endocrine factors affect the decision-making circuitry, why making healthy food choices is difficult for many people, and key processes at work in the obesity epidemic.	CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Rangel, A (corresponding author), CALTECH, Pasadena, CA 91125 USA.	rangel@hss.caltech.edu			National Science Foundation [AR3.SELFCNTRL-1-NSF.ARR1]; Lipper Foundation; Betty and gordon Moore Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG038866] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Lipper Foundation; Betty and gordon Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The support of the National Science Foundation (AR3.SELFCNTRL-1-NSF.ARR1), the Lipper Foundation, and the Betty and gordon Moore Foundation is greatfully acknowledged.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; APFELBAUM M, 1981, PHARMACOL BIOCHEM BE, V15, P89, DOI 10.1016/0091-3057(81)90344-0; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Balleine BW, 2000, J NEUROSCI, V20, P8954; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Beeler JA, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00049; Benoit SC, 2004, RECENT PROG HORM RES, V59, P267, DOI 10.1210/rp.59.1.267; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 2003, BRAIN COGNITION, V52, P106, DOI 10.1016/S0278-2626(03)00014-9; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berthoud HR, 2011, CURR OPIN NEUROBIOL, V21, P888, DOI 10.1016/j.conb.2011.09.004; Camille N, 2011, J NEUROSCI, V31, P7527, DOI 10.1523/JNEUROSCI.6527-10.2011; Cannon CM, 2003, J NEUROSCI, V23, P10827; Carlini VP, 2004, BIOCHEM BIOPH RES CO, V313, P635, DOI 10.1016/j.bbrc.2003.11.150; Clegg DJ, 2005, AM J PHYSIOL-REG I, V288, pR981, DOI 10.1152/ajpregu.00675.2004; Clifton PG, 1998, BEHAV NEUROSCI, V112, P502, DOI 10.1037/0735-7044.112.3.502; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Crum AJ, 2011, HEALTH PSYCHOL, V30, P424, DOI 10.1037/a0023467; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Cutler DM, 2003, J ECON PERSPECT, V17, P93, DOI 10.1257/089533003769204371; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; de Wit S, 2012, J NEUROSCI, V32, P12066, DOI 10.1523/JNEUROSCI.1088-12.2012; de Wit S, 2009, J NEUROSCI, V29, P11330, DOI 10.1523/JNEUROSCI.1639-09.2009; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Domingos AI, 2011, NAT NEUROSCI, V14, P1562, DOI 10.1038/nn.2977; Druce MR, 2005, INT J OBESITY, V29, P1130, DOI 10.1038/sj.ijo.0803001; DRUCKER DB, 1994, PHYSIOL BEHAV, V56, P701, DOI 10.1016/0031-9384(94)90230-5; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Emond M, 1999, AM J PHYSIOL-REG I, V276, pR1545, DOI 10.1152/ajpregu.1999.276.5.R1545; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Farr SA, 2006, PEPTIDES, V27, P1420, DOI 10.1016/j.peptides.2005.10.006; Fehr E., 2013, NEUROECONOMICS DECIS; Garcia J., 1966, PSYCHON SCI, V4, P123, DOI [10.3758/BF03342209, DOI 10.3758/BF03342209]; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Hare TA, 2011, P NATL ACAD SCI USA, V108, P18120, DOI 10.1073/pnas.1109322108; Hare TA, 2011, J NEUROSCI, V31, P11077, DOI 10.1523/JNEUROSCI.6383-10.2011; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Harris A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021074; Higgs S, 2005, PHYSIOL BEHAV, V85, P67, DOI 10.1016/j.physbeh.2005.04.003; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Ikeda S, 2010, J HEALTH ECON, V29, P268, DOI 10.1016/j.jhealeco.2010.01.002; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kanoski SE, 2007, BEHAV BRAIN RES, V182, P57, DOI 10.1016/j.bbr.2007.05.004; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Lathe R, 2001, J ENDOCRINOL, V169, P205, DOI 10.1677/joe.0.1690205; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Lin A, 2012, SOC COGN AFFECT NEUR, V7, P274, DOI 10.1093/scan/nsr006; Malik S, 2008, CELL METAB, V7, P400, DOI 10.1016/j.cmet.2008.03.007; Mann T, 2007, CURR DIR PSYCHOL SCI, V16, P280, DOI 10.1111/j.1467-8721.2007.00520.x; MARGULES DL, 1962, SCIENCE, V135, P374, DOI 10.1126/science.135.3501.374; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Niv Y, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P331, DOI 10.1016/B978-0-12-374176-9.00022-1; Ostlund SB, 2007, J NEUROSCI, V27, P4819, DOI 10.1523/JNEUROSCI.5443-06.2007; Oswald KD, 2011, INT J EAT DISORDER, V44, P203, DOI 10.1002/eat.20808; Overduin J, 2012, AM J PHYSIOL-REG I, V303, pR259, DOI 10.1152/ajpregu.00488.2011; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Parkinson JA, 2002, BEHAV BRAIN RES, V137, P149, DOI 10.1016/S0166-4328(02)00291-7; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Pecina S., 2004, BEHAV PHARMACOL, V15, P9395; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; PRICE JL, 1981, J NEUROSCI, V1, P1242; Rangel A, 2013, NEUROECONOMICS DECIS; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Rolls ET, 2003, CEREB CORTEX, V13, P308, DOI 10.1093/cercor/13.3.308; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; Rozin P, 1998, PSYCHOL SCI, V9, P392, DOI 10.1111/1467-9280.00073; Shigemura N, 2003, ARCH HISTOL CYTOL, V66, P253, DOI 10.1679/aohc.66.253; Simon SA, 2006, NAT REV NEUROSCI, V7, P890, DOI 10.1038/nrn2006; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Smith KS, 2005, J NEUROSCI, V25, P8637, DOI 10.1523/JNEUROSCI.1902-05.2005; Smith KS, 2007, J NEUROSCI, V27, P1594, DOI 10.1523/JNEUROSCI.4205-06.2007; Stowers L, 2013, CURR OPIN NEUROBIOL, V23, P339, DOI 10.1016/j.conb.2013.01.007; Szczypka MS, 2000, NAT GENET, V25, P102, DOI 10.1038/75484; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wang LP, 2011, NEURON, V72, P1055, DOI 10.1016/j.neuron.2011.10.019; Wansink B., 2010, MINDLESS EATING WHY; Wassum KM, 2009, P NATL ACAD SCI USA, V106, P12512, DOI 10.1073/pnas.0905874106; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Wimmer E.G., 2011, ATTENTION PERFORMANC; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	100	134	136	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1717	1724		10.1038/nn.3561	http://dx.doi.org/10.1038/nn.3561			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	257VV	24270272	Green Accepted			2022-12-17	WOS:000327416800006
J	McNamee, D; Rangel, A; O'Doherty, JP				McNamee, Daniel; Rangel, Antonio; O'Doherty, John P.			Category-dependent and category-independent goal-value codes in human ventromedial prefrontal cortex	NATURE NEUROSCIENCE			English	Article							HUMAN ORBITOFRONTAL CORTEX; CONNECTIVITY-BASED PARCELLATION; DECISION-MAKING; SUBJECTIVE VALUE; REWARD; REPRESENTATION; CHOICE; NEUROBIOLOGY; COMPUTATIONS; CLASSIFIERS	To choose between manifestly distinct options, it is suggested that the brain assigns values to goals using a common currency. Although previous studies have reported activity in ventromedial prefrontal cortex (vmPFC) correlating with the value of different goal stimuli, it remains unclear whether such goal-value representations are independent of the associated stimulus categorization, as required by a common currency. Using multivoxel pattern analyses on functional magnetic resonance imaging (fMRI) data, we found a region of medial prefrontal cortex to contain a distributed goal-value code that is independent of stimulus category. More ventrally in the vmPFC, we found spatially distinct areas of the medial orbitofrontal cortex to contain unique category-dependent distributed value codes for food and consumer items. These results implicate the medial prefrontal cortex in the implementation of a common currency and suggest a ventral versus dorsal topographical organization of value signals in the vmPFC.	[McNamee, Daniel; O'Doherty, John P.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [McNamee, Daniel; Rangel, Antonio; O'Doherty, John P.] CALTECH, Pasadena, CA 91125 USA; [Rangel, Antonio; O'Doherty, John P.] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	Trinity College Dublin; California Institute of Technology; California Institute of Technology	McNamee, D (corresponding author), Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland.	dmcnamee@caltech.edu	O'Doherty, John P/F-1204-2013; McNamee, Daniel/AAK-4700-2020	McNamee, Daniel/0000-0001-9928-4960	Science Foundation Ireland [08/IN.1/B1844]; Gordon and Betty foundation; Direct For Biological Sciences [0922982] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094258] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Gordon and Betty foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank V. Chib and E. Boorman for helpful discussions, and J. Stanley for assistance. This work was funded by Science Foundation Ireland grant 08/IN.1/B1844 and a grant from the Gordon and Betty foundation (to J.P.O.).	Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Cai XY, 2012, J NEUROSCI, V32, P3791, DOI 10.1523/JNEUROSCI.3864-11.2012; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Clithero JA, 2011, NEUROIMAGE, V56, P699, DOI 10.1016/j.neuroimage.2010.03.057; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Duarte A, 2010, J COGNITIVE NEUROSCI, V22, P1819, DOI 10.1162/jocn.2009.21316; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Formisano E, 2012, NEUROIMAGE, V62, P1249, DOI 10.1016/j.neuroimage.2012.02.078; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2011, P NATL ACAD SCI USA, V108, P18120, DOI 10.1073/pnas.1109322108; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Harris A., 2011, PLOS ONE, V6; Hastie T., 2008, ELEMENTS STAT LEARNI; Jimura K, 2012, NEUROPSYCHOLOGIA, V50, P544, DOI 10.1016/j.neuropsychologia.2011.11.007; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kahnt T, 2012, J NEUROSCI, V32, P6240, DOI 10.1523/JNEUROSCI.0257-12.2012; Kahnt T, 2010, P NATL ACAD SCI USA, V107, P6010, DOI 10.1073/pnas.0912838107; Kim H, 2011, CEREB CORTEX, V21, P769, DOI 10.1093/cercor/bhq145; Krajbich I, 2009, SCIENCE, V326, P596, DOI 10.1126/science.1177302; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Levy DJ, 2011, J NEUROSCI, V31, P14693, DOI 10.1523/JNEUROSCI.2218-11.2011; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; Lin A, 2012, SOC COGN AFFECT NEUR, V7, P274, DOI 10.1093/scan/nsr006; Louie K, 2012, ANN NY ACAD SCI, V1251, P13, DOI [10.1111/j.1749-6632.2012.06496, 10.1111/j.1749-6632.2012.06496.x]; Mackey S, 2010, EUR J NEUROSCI, V32, P1940, DOI 10.1111/j.1460-9568.2010.07465.x; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; Mitchell TM., 1997, MACH LEARN; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Mukherjee S, 2003, J MACH LEARN RES, V1, P1; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty JP, 2007, ANN NY ACAD SCI, V1121, P254, DOI 10.1196/annals.1401.036; O'Doherty JP, 2011, ANN NY ACAD SCI, V1239, P118, DOI 10.1111/j.1749-6632.2011.06290.x; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Pereira F, 2011, NEUROIMAGE, V56, P476, DOI 10.1016/j.neuroimage.2010.05.026; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Sescousse G, 2010, J NEUROSCI, V30, P13095, DOI 10.1523/JNEUROSCI.3501-10.2010; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tusche A, 2010, J NEUROSCI, V30, P8024, DOI 10.1523/JNEUROSCI.0064-10.2010; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Wallis JD, 2012, NAT NEUROSCI, V15, P13, DOI 10.1038/nn.2956; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027	60	134	141	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					479	U152		10.1038/nn.3337	http://dx.doi.org/10.1038/nn.3337			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23416449	Green Accepted, Green Submitted			2022-12-17	WOS:000316723700019
J	Agosto, J; Choi, JC; Parisky, KM; Stilwell, G; Rosbash, M; Griffith, LC				Agosto, Jose; Choi, James C.; Parisky, Katherine M.; Stilwell, Geoffrey; Rosbash, Michael; Griffith, Leslie C.			Modulation of GABA(A) receptor desensitization uncouples sleep onset and maintenance in Drosophila	NATURE NEUROSCIENCE			English	Article							GABA(A) RECEPTORS; ANTIEPILEPTIC DRUGS; INSECTICIDE RESISTANCE; CYCLODIENE RESISTANCE; MUSHROOM BODIES; REDUCED SLEEP; A RECEPTOR; MELANOGASTER; CARBAMAZEPINE; MECHANISMS	Many lines of evidence indicate that GABA and GABA(A) receptors make important contributions to human sleep regulation. Pharmacological manipulation of these receptors has differential effects on sleep onset and sleep maintenance insomnia. Here we show that sleep is regulated by GABA in Drosophila and that a mutant GABAA receptor, Rdl(A302S), specifically decreases sleep latency. The drug carbamazepine (CBZ) has the opposite effect on sleep; it increases sleep latency as well as decreasing sleep. Behavioral and physiological experiments indicated that Rdl(A302S) mutant flies are resistant to the effects of CBZ on sleep latency and that mutant RDLA302S channels are resistant to the effects of CBZ on desensitization, respectively. These results suggest that this biophysical property of the channel, specifically channel desensitization, underlies the regulation of sleep latency in flies. These experiments uncouple the regulation of sleep latency from that of sleep duration and suggest that the kinetics of GABA(A) receptor signaling dictate sleep latency.	[Choi, James C.; Parisky, Katherine M.; Griffith, Leslie C.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Agosto, Jose; Rosbash, Michael] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02254 USA; [Agosto, Jose; Choi, James C.; Parisky, Katherine M.; Rosbash, Michael; Griffith, Leslie C.] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Stilwell, Geoffrey] Cambria Biosci, Woburn, MA 01801 USA	Brandeis University; Brandeis University; Howard Hughes Medical Institute; Brandeis University	Griffith, LC (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	griffith@brandeis.edu		Griffith, Leslie/0000-0003-3164-9876	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [T32 GM007122] Funding Source: Medline; NIMH NIH HHS [MH 067284, R01 MH067284, R01 MH067284-06A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ambrosio AF, 2002, NEUROCHEM RES, V27, P121, DOI 10.1023/A:1014814924965; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Aronstein K, 1996, INVERTEBR NEUROSCI, V2, P115, DOI 10.1007/BF02214114; ARONSTEIN K, 1994, PESTIC BIOCHEM PHYS, V48, P229, DOI 10.1006/pest.1994.1024; Bazil CW, 2003, CNS DRUGS, V17, P719, DOI 10.2165/00023210-200317100-00003; Boileau AJ, 2002, NEUROPHARMACOLOGY, V43, P695, DOI 10.1016/S0028-3908(02)00036-9; BRAND AH, 1995, CURR OPIN NEUROBIOL, V5, P572, DOI 10.1016/0959-4388(95)80061-1; BREWSTER ME, 1991, J PHARM SCI, V80, P380, DOI 10.1002/jps.2600800420; Buhr A, 2002, HUM GENET, V111, P154, DOI 10.1007/s00439-002-0766-7; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; FFRENCHCONSTANT RH, 1991, P NATL ACAD SCI USA, V88, P7209, DOI 10.1073/pnas.88.16.7209; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gottesmann C, 2002, NEUROSCIENCE, V111, P231, DOI 10.1016/S0306-4522(02)00034-9; GRANGER P, 1995, MOL PHARMACOL, V47, P1189; GREENLEAF AL, 1979, CELL, V18, P613, DOI 10.1016/0092-8674(79)90116-8; Greenspan RJ, 2004, HUM MOL GENET, V13, pR267, DOI 10.1093/hmg/ddh248; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Hodge JJL, 2005, J NEUROBIOL, V63, P235, DOI 10.1002/neu.20126; Holbrook AM, 2000, CAN MED ASSOC J, V162, P225; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Lancel M, 1999, SLEEP, V22, P33, DOI 10.1093/sleep/22.1.33; Lee D, 2003, J NEUROSCI, V23, P4625; Masson M, 2005, CHEM PHARM BULL, V53, P958, DOI 10.1248/cpb.53.958; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Priestley CM, 2003, BRIT J PHARMACOL, V140, P1363, DOI 10.1038/sj.bjp.0705542; Rosenberg Russell P, 2006, Ann Clin Psychiatry, V18, P49, DOI 10.1080/10401230500464711; Roth T, 2005, J CLIN PSYCHIAT, V66, P10; ROTH T, 2005, J CLIN PSYCHIAT S9, V9, P42; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SMITH GB, 1995, TRENDS PHARMACOL SCI, V16, P162, DOI 10.1016/S0165-6147(00)89009-4; Spina E, 2004, EPILEPTIC DISORD, V6, P57; STILWELL GE, 1995, J MOL BIOL, V253, P223, DOI 10.1006/jmbi.1995.0547; van Swinderen B, 2004, CURR BIOL, V14, P81, DOI 10.1016/j.cub.2003.12.057; ZHANG HG, 1994, J PHYSIOL-LONDON, V479, P65, DOI 10.1113/jphysiol.1994.sp020278	39	134	135	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					354	359		10.1038/nn2046	http://dx.doi.org/10.1038/nn2046			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18223647	Green Accepted			2022-12-17	WOS:000253548300019
J	Christensen, MS; Lundbye-Jensen, J; Geertsen, SS; Petersen, TH; Paulson, OB; Nielsen, JB				Christensen, Mark Schram; Lundbye-Jensen, Jesper; Geertsen, Svend Sparre; Petersen, Tue Hvass; Paulson, Olaf B.; Nielsen, Jens Bo			Premotor cortex modulates somatosensory cortex during voluntary movements without proprioceptive feedback	NATURE NEUROSCIENCE			English	Article							PATHWAYS; SENSE	Movement perception relies on sensory feedback, but the involvement of efference copies remains unclear. We investigated movements without proprioceptive feedback using ischemic nerve block during fMRI in healthy humans, and found preserved activation of the primary somatosensory cortex. This activation was associated with increased interaction with premotor cortex during voluntary movements, which demonstrates that perception of movements relies in part on predictions of sensory consequences of voluntary movements that are mediated by the premotor cortex.	Univ Copenhagen, Panum Inst, Dept Exercise & Sport Sci, DK-2200 Copenhagen, Denmark; Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, DK-2650 Hvidovre, Denmark; Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; Univ Copenhagen Hosp, Rigshosp, Ctr Neurosci, Neurobiol Res Unit,Dept Neurol, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Christensen, MS (corresponding author), Univ Copenhagen, Panum Inst, Dept Exercise & Sport Sci, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	markc@drcmr.dk	Geertsen, Svend/L-8526-2014; Paulson, Olaf B./N-6924-2016; Lundbye-Jensen, Jesper/ABH-4025-2020; Geertsen, Svend/ABG-6254-2020; Nielsen, Jens Bo/C-7632-2015	Geertsen, Svend/0000-0003-4497-3616; Paulson, Olaf B./0000-0001-7712-8596; Lundbye-Jensen, Jesper/0000-0003-3144-861X; Geertsen, Svend/0000-0003-4497-3616; Nielsen, Jens Bo/0000-0001-5568-2916				Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blankenburg F, 2006, PLOS BIOL, V4, P459, DOI 10.1371/journal.pbio.0040069; COLE JD, 1991, ELECTROEN CLIN NEURO, V80, P103, DOI 10.1016/0168-5597(91)90147-P; Ellaway PH, 2004, J PHYSIOL-LONDON, V556, P651, DOI 10.1113/jphysiol.2003.060483; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; FORGET R, 1987, HUM NEUROBIOL, V6, P27; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; LASZLO JI, 1966, Q J EXP PSYCHOL, V18, P1, DOI 10.1080/14640746608400001; SINCLAIR DC, 1948, J NEUROPHYSIOL, V11, P75, DOI 10.1152/jn.1948.11.2.75; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; TAUB E, 1966, SCIENCE, V151, P593, DOI 10.1126/science.151.3710.593; VANHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464	14	134	137	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					417	419		10.1038/nn1873	http://dx.doi.org/10.1038/nn1873			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17369825				2022-12-17	WOS:000245228600010
J	Mizuguchi, R; Kriks, S; Cordes, R; Gossler, A; Ma, QF; Goulding, M				Mizuguchi, Rumiko; Kriks, Sonja; Cordes, Ralf; Gossler, Achim; Ma, Qiufu; Goulding, Martyn			Ascl1 and Gsh1/2 control inhibitory and excitatory cell fate in spinal sensory interneurons	NATURE NEUROSCIENCE			English	Article							NEURONAL DIFFERENTIATION; CORD; SPECIFICATION; GENE; LBX1; NEUROGENESIS; EXPRESSION; PATHWAY; MASH1; PRESENILIN-1	Sensory information from the periphery is integrated and transduced by excitatory and inhibitory interneurons in the dorsal spinal cord. Recent studies have identified a number of postmitotic factors that control the generation of these sensory interneurons. We show that Gsh1/2 and Ascl1 (Mash1), which are expressed in sensory interneuron progenitors, control the choice between excitatory and inhibitory cell fates in the developing mouse spinal cord. During the early phase of neurogenesis, Gsh1/2 and Ascl1 coordinately regulate the expression of Tlx3, which is a critical postmitotic determinant for dorsal glutamatergic sensory interneurons. However, at later developmental times, Ascl1 controls the expression of Ptf1a in dIL(A) progenitors to promote inhibitory neuron differentiation while at the same time upregulating Notch signaling to ensure the proper generation of dIL(B) excitatory neurons. We propose that this switch in Ascl1 function enables the cogeneration of inhibitory and excitatory sensory interneurons from a common pool of dorsal progenitors.	Scripps Res Inst, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Hannover Med Sch, Inst Mol Biol, Hannover, Germany	Scripps Research Institute; Harvard University; Dana-Farber Cancer Institute; Hannover Medical School	Goulding, M (corresponding author), Scripps Res Inst, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	goulding@salk.edu						ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Casarosa S, 1999, DEVELOPMENT, V126, P525; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Dottori M, 2001, DEVELOPMENT, V128, P4127; Esni F, 2004, DEVELOPMENT, V131, P4213, DOI 10.1242/dev.01280; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Gross MK, 2000, DEVELOPMENT, V127, P413; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Handler M, 2000, DEVELOPMENT, V127, P2593; Helms AW, 2005, DEVELOPMENT, V132, P2709, DOI 10.1242/dev.01859; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; JASONI CL, 1994, DEVELOPMENT, V120, P769; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Koizumi K, 2001, DEVELOPMENT, V128, P1391; Kriks S, 2005, DEVELOPMENT, V132, P2991, DOI 10.1242/dev.01878; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Li H, 1996, EMBO J, V15, P714, DOI 10.1002/j.1460-2075.1996.tb00407.x; Li SG, 2005, P NATL ACAD SCI USA, V102, P10688, DOI 10.1073/pnas.0504799102; Matise M, 2002, NEURON, V34, P491, DOI 10.1016/S0896-6273(02)00710-9; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P376, DOI 10.1006/bbrc.1996.5882; Sapir T, 2004, J NEUROSCI, V24, P1255, DOI 10.1523/JNEUROSCI.3187-03.2004; SZENTAGOTHAI J, 1964, J COMP NEUROL, V122, P219, DOI 10.1002/cne.901220207; Szucsik JC, 1997, DEV BIOL, V191, P230, DOI 10.1006/dbio.1997.8733; Willis Jr W. D., 1991, SENSORY MECH SPINAL; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0	38	134	134	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					770	778		10.1038/nn1706	http://dx.doi.org/10.1038/nn1706			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16715081				2022-12-17	WOS:000237895200017
J	Farah, MJ				Farah, MJ			Emerging ethical issues in neuroscience	NATURE NEUROSCIENCE			English	Article							PERSONALITY; FLUOXETINE; MEMORY; METHYLPHENIDATE; ENHANCEMENT; PERFORMANCE; DISORDERS; BEHAVIOR; AMYGDALA	There is growing public awareness of the ethical issues raised by progress in many areas of neuroscience. This commentary reviews the issues, which are triaged in terms of their novelty and their imminence, with an exploration of the relevant ethical principles in each case.	Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Farah, MJ (corresponding author), Univ Penn, Ctr Cognit Neurosci, 3815 Walnut St, Philadelphia, PA 19104 USA.	mfarah@psych.upenn.edu						American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; ANDERSON J, 1990, ADAPTIVE CHARACTERIS; Armstrong K, 1999, NEW ENGL J MED, V341, P1389, DOI 10.1056/NEJM199910283411810; Babcock Q, 2000, J AM COLL HEALTH, V49, P143, DOI 10.1080/07448480009596296; BERMAN RM, 1999, NEUROBIOLOGY MENTAL, P419; Blank R. H., 1999, BRAIN POLICY NEW NEU; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Caldwell JA, 2000, PSYCHOPHARMACOLOGY, V150, P272, DOI 10.1007/s002130000450; Campbell ML, 2001, AM J HEALTH-SYST PH, V58, P1301, DOI 10.1093/ajhp/58.14.1301; CANLI T, IN PRESS BRAIN COGN; Capron AM, 1999, NEW ENGL J MED, V340, P1430, DOI 10.1056/NEJM199905063401812; Cherek DR, 2002, PSYCHOPHARMACOLOGY, V159, P266, DOI 10.1007/s002130100915; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Churchland Paul, 1995, ENGINE REASON SEAT S; Coccaro EF, 1997, BIOL PSYCHIAT, V42, P546, DOI 10.1016/S0006-3223(97)00309-0; Coccaro EF, 1997, ARCH GEN PSYCHIAT, V54, P1081; Craik F.I.M., 1992, HDB AGING COGNITION; Diller LD, 1996, HASTINGS CENT REP, V26, P12, DOI 10.2307/3528571; Dougherty DD, 1999, LANCET, V354, P2132, DOI 10.1016/S0140-6736(99)04030-1; Elliott R, 1997, PSYCHOPHARMACOLOGY, V131, P196, DOI 10.1007/s002130050284; Flett GL, 1997, PSYCHOL BULL, V121, P395, DOI 10.1037/0033-2909.121.3.395; FUKUYAMA F, 2002, OUR PSOTHUMAN FUTURE; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; George MS, 1996, J NEUROPSYCH CLIN N, V8, P373; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Grossman LS, 1999, PSYCHIATR SERV, V50, P349, DOI 10.1176/ps.50.3.349; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Ingvar M, 1997, EXP NEUROL, V146, P553, DOI 10.1006/exnr.1997.6581; Knutson B, 1998, AM J PSYCHIAT, V155, P373, DOI 10.1176/ajp.155.3.373; Kramer P. D., 1993, LISTENING PROZAC; Lagarde D., 1995, FUND CLIN PHARM, V9, P1; Langleben DD, 2002, NEUROIMAGE, V15, P727, DOI 10.1006/nimg.2001.1003; Luria A.R, 1968, MIND MNEMONIST LITTL; Malhi GS, 2002, J PSYCHOSOM RES, V53, P709, DOI 10.1016/S0022-3999(02)00423-3; Manuck SB, 1998, NEUROPSYCHOPHARMACOL, V19, P287, DOI 10.1016/S0893-133X(98)00015-3; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Morse SJ, 2000, LAW PHILOS, V19, P3; NEAUREGARD M, 2001, J NEUROSCI, V21, P1; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; OVSVIEW F, 1997, J NEUROL NEUROSUR PS, V63, P701; Parens E, 1998, ENHANCING HUMAN TRAI; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; Redmond G, 1997, INT J FERTIL WOMEN M, V42, P67; SALZMAN C, 1995, J CLIN PSYCHOPHARM, V15, P23, DOI 10.1097/00004714-199502000-00005; Shastry BS, 1997, BIOESSAYS, V19, P199, DOI 10.1002/bies.950190304; Solomon PR, 2002, JAMA-J AM MED ASSOC, V288, P835, DOI 10.1001/jama.288.7.835; Truog RD, 1997, HASTINGS CENT REP, V27, P29, DOI 10.2307/3528024; Tse WS, 2002, PSYCHOPHARMACOLOGY, V161, P324, DOI 10.1007/s00213-002-1049-7; Valenstein E. S., 1986, GREAT DESPERATE CURE; Walsh MT, 2001, ACTA PSYCHIAT SCAND, V104, P84, DOI 10.1034/j.1600-0447.2001.00357.x	52	134	136	3	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1123	1129		10.1038/nn1102-1123	http://dx.doi.org/10.1038/nn1102-1123			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	609CG	12404006	Green Submitted			2022-12-17	WOS:000178884600014
J	Turk, DJ; Heatherton, TF; Kelley, WM; Funnell, MG; Gazzaniga, MS; Macrae, CN				Turk, DJ; Heatherton, TF; Kelley, WM; Funnell, MG; Gazzaniga, MS; Macrae, CN			Mike or me? Self-recognition in a split-brain patient	NATURE NEUROSCIENCE			English	Article									Dartmouth Coll, Ctr Cognit Neurosci, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College	Turk, DJ (corresponding author), Dartmouth Coll, Ctr Cognit Neurosci, Dept Psychol & Brain Sci, Moore Hall, Hanover, NH 03755 USA.	david.j.turk@dartmouth.edu	Turk, David/C-5201-2008; Turk, David J/G-8878-2013; Heatherton, Todd F/H-5478-2011; Macrae, Neil/C-4761-2008		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031443] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS031443, R01 NS31443] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 1999, MEMORY, V7, P679, DOI 10.1080/096582199387805; DERENZI E, 1986, NEUROPSYCHOLOGIA, V24, P385; GAZZANIGA MS, 1983, ANN NEUROL, V13, P536, DOI 10.1002/ana.410130511; Gazzaniga MS, 1998, SCI AM, V279, P50, DOI 10.1038/scientificamerican0798-50; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Keenan JP, 2000, NEUROPSYCHOLOGIA, V38, P1047, DOI 10.1016/S0028-3932(99)00145-1; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kircher TTJ, 2002, NEUROPSYCHOLOGIA, V40, P683, DOI 10.1016/S0028-3932(01)00138-5; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; Maguire EA, 1999, HIPPOCAMPUS, V9, P54, DOI 10.1002/(SICI)1098-1063(1999)9:1<54::AID-HIPO6>3.0.CO;2-O	14	134	143	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					841	842		10.1038/nn907	http://dx.doi.org/10.1038/nn907			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195428				2022-12-17	WOS:000177656300012
J	Gotter, AL; Manganaro, T; Weaver, DR; Kolakowski, LF; Possidente, B; Sriram, S; MacLaughlin, DT; Reppert, SM				Gotter, AL; Manganaro, T; Weaver, DR; Kolakowski, LF; Possidente, B; Sriram, S; MacLaughlin, DT; Reppert, SM			A time-less function for mouse Timeless	NATURE NEUROSCIENCE			English	Article							CIRCADIAN CLOCK; TRANSCRIPTION; LOOP		Massachusetts Gen Hosp, Lab Dev Chronobiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Surg, Pediat Surg Res Lab, Boston, MA 02114 USA; Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78284 USA; Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Health San Antonio; Skidmore College	Reppert, SM (corresponding author), Massachusetts Gen Hosp, Lab Dev Chronobiol, Boston, MA 02114 USA.			Weaver, David/0000-0001-7941-6719	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039303] Funding Source: NIH RePORTER; NICHD NIH HHS [R37HD14427] Funding Source: Medline; NIMH NIH HHS [MH12117] Funding Source: Medline; NINDS NIH HHS [R01NS39303] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Koike N, 1998, FEBS LETT, V441, P427, DOI 10.1016/S0014-5793(98)01597-X; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 1999, MOL CELL BIOL, V19, P5316; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; TISCHKAU SA, 1999, J NEUROSCI, V19, P1; TOTHENFLUH A, IN PRESS GENETICS	11	134	138	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					755	756		10.1038/77653	http://dx.doi.org/10.1038/77653			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903565				2022-12-17	WOS:000167177300007
J	Boulanger, L; Poo, M				Boulanger, L; Poo, M			Presynaptic depolarization facilitates neurotrophin-induced synaptic potentiation	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; DENDRITIC GROWTH; MESSENGER-RNA; TRANSMISSION; BDNF; PLASTICITY; TRKB	Neurotrophins have been proposed to participate in activity-dependent modifications of neuronal connectivity and synaptic efficacy. Preferential strengthening of active inputs requires restriction of putative neurotrophin-mediated synaptic potentiation to active synapses. Here we report that potentiation of synaptic efficacy by brain-derived neurotrophic factor (BDNF) is greatly facilitated by presynaptic depolarization at developing neuromuscular synapses. Brief depolarization In the presence of low-level BDNF results in a marked potentiation of both evoked and spontaneous synaptic transmission, whereas exposure to either BDNF or depolarization alone is without effect. This potentiation depends on the relative timing of depolarization and reflects an enhancement of transmitter secretion from the presynaptic neuron. Thus synapses made by active inputs may be selectively strengthened by secreted neurotrophins as part of activity-dependent refinement of developing connections or of mature synapses.	Univ Calif San Diego, Dept Biol 0357, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Poo, M (corresponding author), Univ Calif San Diego, Dept Biol 0357, 9500 Gilman Dr, La Jolla, CA 92093 USA.			Boulanger, Lisa/0000-0002-6578-7890				BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Berninger B, 1996, CURR OPIN NEUROBIOL, V6, P324, DOI 10.1016/S0959-4388(96)80115-2; BIFFO S, 1995, DEVELOPMENT, V121, P2461; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; CARTER BD, 1995, J BIOL CHEM, V270, P21751, DOI 10.1074/jbc.270.37.21751; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; CONNOLLY JL, 1985, J NEUROSCI RES, V13, P183, DOI 10.1002/jnr.490130113; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Frank L, 1996, EUR J NEUROSCI, V8, P1220, DOI 10.1111/j.1460-9568.1996.tb01290.x; FUNAKOSHI H, 1995, SCIENCE, V268, P1495, DOI 10.1126/science.7770776; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Gottschalk W, 1998, J NEUROSCI, V18, P6830; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KATZ B, 1962, PROC R SOC SER B-BIO, V155, P455, DOI 10.1098/rspb.1962.0012; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; LU B, 1991, P NATL ACAD SCI USA, V88, P6289, DOI 10.1073/pnas.88.14.6289; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Ming GL, 1997, J NEUROSCI, V17, P7860; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; REDDY R, 1995, J CELL BIOL, V24, P14340; SCHWARTZ LM, 1985, NATURE, V314, P747, DOI 10.1038/314747a0; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stoop R, 1996, J NEUROSCI, V16, P3256; Tabti N, 1998, CULTURING NERVE CELL, P237; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; Wang XH, 1998, J NEUROSCI, V18, P4985; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2	50	134	137	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					346	351		10.1038/7258	http://dx.doi.org/10.1038/7258			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204541				2022-12-17	WOS:000080532000013
J	Asboth, L; Friedli, L; Beauparlant, J; Martinez-Gonzalez, C; Anil, S; Rey, E; Baud, L; Pidpruzhnykova, G; Anderson, MA; Shkorbatova, P; Batti, L; Pages, S; Kreider, J; Schneider, BL; Barraud, Q; Courtine, G				Asboth, Leonie; Friedli, Lucia; Beauparlant, Janine; Martinez-Gonzalez, Cristina; Anil, Selin; Rey, Elodie; Baud, Laetitia; Pidpruzhnykova, Galyna; Anderson, Mark A.; Shkorbatova, Polina; Batti, Laura; Pages, Stephane; Kreider, Julie; Schneider, Bernard L.; Barraud, Quentin; Courtine, Gregoire			Cortico-reticulo-spinal circuit reorganization enables functional recovery after severe spinal cord contusion	NATURE NEUROSCIENCE			English	Article							LOCOMOTOR RECOVERY; DESCENDING PATHWAYS; MOTOR CORTEX; INJURY; NEURONS; CONNECTIVITY; PLASTICITY; STIMULATION; TRANSMISSION; ACTIVATION	Severe spinal cord contusions interrupt nearly all brain projections to lumbar circuits producing leg movement. Failure of these projections to reorganize leads to permanent paralysis. Here we modeled these injuries in rodents. A severe contusion abolished all motor cortex projections below injury. However, the motor cortex immediately regained adaptive control over the paralyzed legs during electrochemical neuromodulation of lumbar circuits. Glutamatergic reticulospinal neurons with residual projections below the injury relayed the cortical command downstream. Gravity-assisted rehabilitation enabled by the neuromodulation therapy reinforced these reticulospinal projections, rerouting cortical information through this pathway. This circuit reorganization mediated a motor cortex-dependent recovery of natural walking and swimming without requiring neuromodulation. Cortico-reticulo-spinal circuit reorganization may also improve recovery in humans.	[Asboth, Leonie; Friedli, Lucia; Beauparlant, Janine; Martinez-Gonzalez, Cristina; Anil, Selin; Rey, Elodie; Baud, Laetitia; Pidpruzhnykova, Galyna; Anderson, Mark A.; Shkorbatova, Polina; Kreider, Julie; Barraud, Quentin; Courtine, Gregoire] Swiss Fed Inst Technol EPFL, Sch Life Sci, Ctr Neuroprosthet, Geneva, Switzerland; [Asboth, Leonie; Friedli, Lucia; Beauparlant, Janine; Martinez-Gonzalez, Cristina; Anil, Selin; Rey, Elodie; Baud, Laetitia; Pidpruzhnykova, Galyna; Anderson, Mark A.; Shkorbatova, Polina; Kreider, Julie; Barraud, Quentin; Courtine, Gregoire] Swiss Fed Inst Technol EPFL, Sch Life Sci, Brain Mind Inst, Geneva, Switzerland; [Shkorbatova, Polina] RAS, Pavlov Inst Physiol, St Petersburg, Russia; [Batti, Laura; Pages, Stephane] Wyss Ctr Bio & Neuroengn, Campus Biotech, Geneva, Switzerland; [Schneider, Bernard L.] Swiss Fed Inst Technol EPFL, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland; [Courtine, Gregoire] Univ Hosp Lausanne CHUV, Dept Neurosurg, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Courtine, G (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, Ctr Neuroprosthet, Geneva, Switzerland.; Courtine, G (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, Brain Mind Inst, Geneva, Switzerland.; Courtine, G (corresponding author), Univ Hosp Lausanne CHUV, Dept Neurosurg, Lausanne, Switzerland.	gregoire.courtine@epfl.ch	Shkorbatova, Polina/AAN-8956-2020; Schneider, Bernard/H-6168-2011	Shkorbatova, Polina/0000-0001-5777-7775; Schneider, Bernard/0000-0001-5485-8748; Asboth, Leonie/0000-0003-2414-9574; courtine, gregoire/0000-0002-5744-4142; Barraud, Quentin/0000-0003-0894-1959; Batti, Laura/0000-0003-3717-8470; Martinez-Gonzalez, Cristina/0000-0001-9969-1160	International Paraplegic Foundation (IRP); European Research Council [ERC-2015-CoG HOW2WALKAGAIN 682999]; Swiss National Science Foundation [310030A_146925, 310030B_166674, 316030_145035, CRSII3_160696]; National Center of Competence in Research (NCCR) Robotics	International Paraplegic Foundation (IRP); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) Robotics(Swiss National Science Foundation (SNSF))	We are grateful to Kissei Comtec (Japan) for providing the KinemaTracer software; J. Bloch for comments on the manuscript; S. Arber for various advices and providing plasmids; D. Trono and S. Offner for their support for the production of the viruses used in this study; E. Bezard for providing us with DREADD plasmids; T. Isa for providing us with plasmids; A. Karpova from the Janelia Virus Service Facility for providing the retro-AAV vectors; J. Courtine for the voiceover in movies; T. Laroche, R. Guiet and O. Burri at the EPFL Biolmaging and optics Core Facility for their assistance; E Pidoux, V Padrun and A. Aebi for AAV vector production; and G. Ulrich, A. Nguyen, J.H. Ghelman, E-Y. Helleboid, S. Ghazanfari, E. de Saint-Exupry M. Decroux and M.-C. Ung for their help with animal care and data analysis. Financial support was provided by the International Paraplegic Foundation (IRP), a Consolidator Grant from the European Research Council (ERC-2015-CoG HOW2WALKAGAIN 682999) and the Swiss National Science Foundation including an individual grant (subside 310030A_146925), a Bonus of Excellence (310030B_166674), R'Equip (subside 316030_145035), Sinergia (CRSII3_160696) and the National Center of Competence in Research (NCCR) Robotics.	Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Bachmann LC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005972; Baker SN, 2017, J NEUROSCI, V37, P9778, DOI 10.1523/JNEUROSCI.3368-16.2017; Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Barthelemy D, 2015, PROG BRAIN RES, V218, P79, DOI 10.1016/bs.pbr.2014.12.012; Basaldella E, 2015, CELL, V163, P301, DOI 10.1016/j.cell.2015.09.023; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Belhaj-Saif A, 2000, J NEUROPHYSIOL, V83, P3147, DOI 10.1152/jn.2000.83.5.3147; Capogrosso M, 2016, NATURE, V539, P284, DOI 10.1038/nature20118; Carhart MR, 2004, IEEE T NEUR SYS REH, V12, P32, DOI 10.1109/TNSRE.2003.822763; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Cowley KC, 2008, J PHYSIOL-LONDON, V586, P1623, DOI 10.1113/jphysiol.2007.148361; Dominici N, 2012, NAT MED, V18, P1142, DOI 10.1038/nm.2845; Esposito MS, 2014, NATURE, V508, P351, DOI 10.1038/nature13023; Friedli L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5811; Gerasimenko YP, 2015, J NEUROTRAUM, V32, P1968, DOI 10.1089/neu.2015.4008; Gomez JL, 2017, SCIENCE, V357, P503, DOI 10.1126/science.aan2475; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Hilton BJ, 2016, J NEUROSCI, V36, P4080, DOI 10.1523/JNEUROSCI.3386-15.2016; Hollis ER, 2016, NAT NEUROSCI, V19, P697, DOI 10.1038/nn.4282; James ND, 2011, J NEUROSCI, V31, P18543, DOI 10.1523/JNEUROSCI.4306-11.2011; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; Kadoya K, 2016, NAT MED, V22, P479, DOI 10.1038/nm.4066; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Kawai R, 2015, NEURON, V86, P800, DOI 10.1016/j.neuron.2015.03.024; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Koch P, 2016, ANN CLIN TRANSL NEUR, V3, P233, DOI 10.1002/acn3.278; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Matsuyama K, 2004, PROG BRAIN RES, V143, P239, DOI 10.1016/S0079-6123(03)43024-0; Mignardot JB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3621; Miri A, 2017, NEURON, V95, P683, DOI 10.1016/j.neuron.2017.06.042; Mushahwar VK, 2007, J NEURAL ENG, V4, pS181, DOI 10.1088/1741-2560/4/3/S05; NATHAN PW, 1994, BRAIN, V117, P337, DOI 10.1093/brain/117.2.337; Nathan PW, 1996, BRAIN, V119, P1809, DOI 10.1093/brain/119.6.1809; NUDO RJ, 1988, J COMP NEUROL, V277, P53, DOI 10.1002/cne.902770105; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; Pivetta C, 2014, CELL, V156, P537, DOI 10.1016/j.cell.2013.12.014; Radhakrishna M, 2017, CURR PHARM DESIGN, V23, P1789, DOI 10.2174/1381612822666161227152200; Rossignol S, 2001, J PHYSIOL-LONDON, V533, P65, DOI 10.1111/j.1469-7793.2001.0065b.x; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Siegel CS, 2015, J NEUROSCI, V35, P1443, DOI 10.1523/JNEUROSCI.3713-14.2015; Silver J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020602; Slawinska U, 2012, SCIENCE, V338, DOI 10.1126/science.1226082; Takeoka A, 2014, CELL, V159, P1626, DOI 10.1016/j.cell.2014.11.019; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; von Zitzewitz J, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026007; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wernig A, 2015, BRAIN, V138, DOI 10.1093/brain/awu371; Zaaimi B, 2012, BRAIN, V135, P2277, DOI 10.1093/brain/aws115; Zorner B, 2014, BRAIN, V137, P1716, DOI 10.1093/brain/awu078	56	133	136	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2018	21	4					576	+		10.1038/s41593-018-0093-5	http://dx.doi.org/10.1038/s41593-018-0093-5			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB1FG	29556028				2022-12-17	WOS:000428796000016
J	Sun, WZ; Tan, ZC; Mensh, BD; Ji, N				Sun, Wenzhi; Tan, Zhongchao; Mensh, Brett D.; Ji, Na			Thalamus provides layer 4 of primary visual cortex with orientation- and direction-tuned inputs	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; RECEPTIVE-FIELDS; RESPONSE PROPERTIES; SELECTIVITY; NEURONS; STRIATE; PROJECTIONS; CONNECTIONS; MECHANISMS; PLASTICITY	Understanding the functions of a brain region requires knowing the neural representations of its myriad inputs, local neurons and outputs. Primary visual cortex (V1) has long been thought to compute visual orientation from untuned thalamic inputs, but very few thalamic inputs have been measured in any mammal. We determined the response properties of similar to 28,000 thalamic boutons and similar to 4,000 cortical neurons in layers 1-5 of awake mouse V1. Using adaptive optics that allows accurate measurement of bouton activity deep in cortex, we found that around half of the boutons in the main thalamorecipient L4 carried orientation-tuned information and that their orientation and direction biases were also dominant in the L4 neuron population, suggesting that these neurons may inherit their selectivity from tuned thalamic inputs. Cortical neurons in all layers exhibited sharper tuning than thalamic boutons and a greater diversity of preferred orientations. Our results provide data-rich constraints for refining mechanistic models of cortical computation.	[Sun, Wenzhi; Tan, Zhongchao; Mensh, Brett D.; Ji, Na] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA	Howard Hughes Medical Institute	Ji, N (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA.	jin@janelia.hhmi.org			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank M. Cembrowski, Y. Dan, R. Egnor, A. Kerlin, J. Magee, G. Murphy, S. Sternson, M. Stryker and K. Svoboda for comments on the manuscript. A. Hu for help with histology. This work was supported by Howard Hughes Medical Institute.	Antonini A, 1999, J NEUROSCI, V19, P4388; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1271, DOI 10.1152/jn.1979.42.5.1271; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Constantinople CM, 2013, SCIENCE, V340, P1591, DOI 10.1126/science.1236425; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; Dana H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108697; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Glickfeld LL, 2013, NAT NEUROSCI, V16, P219, DOI 10.1038/nn.3300; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Harrington ME, 1997, NEUROSCI BIOBEHAV R, V21, P705, DOI 10.1016/S0149-7634(96)00019-X; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Hei XJ, 2014, J NEUROPHYSIOL, V112, P362, DOI 10.1152/jn.00121.2014; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Ji N., 2011, P NATL ACAD SCI USA, V109, P22; Ji N, 2014, NEURON, V83, P1242, DOI 10.1016/j.neuron.2014.08.009; Ji N, 2010, NAT METHODS, V7, P141, DOI 10.1038/NMETH.1411; Kuhlmann L, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00081; Li YT, 2015, CEREB CORTEX, V25, P2466, DOI 10.1093/cercor/bhu049; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2015, ANNU REV NEUROSCI, V38, P413, DOI 10.1146/annurev-neuro-071714-033807; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; Priebe NJ, 2012, NEURON, V75, P194, DOI 10.1016/j.neuron.2012.06.011; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rochefort NL, 2011, NEURON, V71, P425, DOI 10.1016/j.neuron.2011.06.013; SANDERSON KJ, 1991, EXP BRAIN RES, V85, P324; Scholl B, 2013, J NEUROSCI, V33, P10616, DOI 10.1523/JNEUROSCI.0404-13.2013; Sherman SM, 2012, CURR OPIN NEUROBIOL, V22, P575, DOI 10.1016/j.conb.2012.03.005; SMITH EL, 1990, VISUAL NEUROSCI, V5, P525, DOI 10.1017/S0952523800000699; Sun YJ, 2013, J NEUROSCI, V33, P5326, DOI 10.1523/JNEUROSCI.4810-12.2013; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; VIDYASAGAR TR, 1982, EXP BRAIN RES, V46, P157; Vidyasagar TR, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12374; Wang C, 2014, NAT METHODS, V11, P1037, DOI [10.1038/NMETH.3068, 10.1038/nmeth.3068]; Wang K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8276; Zhao XY, 2013, J NEUROSCI, V33, P12751, DOI 10.1523/JNEUROSCI.0095-13.2013	52	133	133	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2016	19	2					308	+		10.1038/nn.4196	http://dx.doi.org/10.1038/nn.4196			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DC4EG	26691829	Green Accepted			2022-12-17	WOS:000369172600019
J	De la Rossa, A; Bellone, C; Golding, B; Vitali, I; Moss, J; Toni, N; Luscher, C; Jabaudon, D				De la Rossa, Andres; Bellone, Camilla; Golding, Bruno; Vitali, Ilaria; Moss, Jonathan; Toni, Nicolas; Luescher, Christian; Jabaudon, Denis			In vivo reprogramming of circuit connectivity in postmitotic neocortical neurons	NATURE NEUROSCIENCE			English	Article							CEREBRAL-CORTEX; SOMATOSENSORY CORTEX; DENDRITIC MORPHOLOGY; AXONAL PROJECTIONS; PYRAMIDAL NEURONS; SPINY NEURONS; MOTOR CORTEX; ROR-BETA; LAYER 4; CELLS	The molecular mechanisms that control how progenitors generate distinct subtypes of neurons, and how undifferentiated neurons acquire their specific identity during corticogenesis, are increasingly understood. However, whether postmitotic neurons can change their identity at late stages of differentiation remains unknown. To study this question, we developed an electrochemical in vivo gene delivery method to rapidly manipulate gene expression specifically in postmitotic neurons. Using this approach, we found that the molecular identity, morphology, physiology and functional input-output connectivity of layer 4 mouse spiny neurons could be specifically reprogrammed during the first postnatal week by ectopic expression of the layer 5B output neuron-specific transcription factor Fezf2. These findings reveal a high degree of plasticity in the identity of postmitotic neocortical neurons and provide a proof of principle for postnatal re-engineering of specific neural microcircuits in vivo.	[De la Rossa, Andres; Bellone, Camilla; Golding, Bruno; Vitali, Ilaria; Luescher, Christian; Jabaudon, Denis] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland; [Moss, Jonathan; Toni, Nicolas] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Luescher, Christian; Jabaudon, Denis] Univ Hosp Geneva, Clin Neurol, Geneva, Switzerland	University of Geneva; University of Lausanne; University of Geneva	Jabaudon, D (corresponding author), Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland.	denis.jabaudon@unige.ch	Toni, Nicolas/M-2057-2014; Lüscher, Christian/A-2496-2011; Jabaudon, Denis/B-8802-2014	Toni, Nicolas/0000-0001-5585-268X; Lüscher, Christian/0000-0001-7917-4596; Jabaudon, Denis/0000-0003-2438-4769; bellone, camilla/0000-0002-6774-6275; Vitali, Ilaria/0000-0001-9536-0292	Swiss National Science Foundation [PP00P3-123447, PP00A-119026]; Velux Foundation; 3R Foundation; Brain and Behavior Research Foundation; joint Leenaards Foundation for Scientific Research Award	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Foundation(Velux Fonden); 3R Foundation; Brain and Behavior Research Foundation; joint Leenaards Foundation for Scientific Research Award	We thank G. Fishell (New York University) for the gift of the Dlx5/6 plasmid, C.L. Cepko (Harvard University) for the pCAGIG_IRES_GFP and pCAG_ERT2-CRE-ERT2 plasmids, and B. Sauer (US National Institutes of Health) for the pBS302_STOP plasmid, obtained through Addgene. We are thankful to E. Azim and A. Dayer for helpful comments on the manuscript, and to A. Zimmerman and F. Smets for help with the experiments. We thank B. Cerutti for help with the statistical analysis. C.B. is supported by an Ambizione grant from the Swiss National Science Foundation. C.L. is supported by the Swiss National Science Foundation. The Jabaudon laboratory is supported by the Swiss National Science Foundation (PP00P3-123447), the Velux Foundation, the 3R Foundation and the Brain and Behavior Research Foundation. N.T. and J.M. are supported by the Swiss National Science Foundation (PP00A-119026). D.J. and N.T. are supported by a joint Leenaards Foundation for Scientific Research Award.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Andjelic S, 2009, J NEUROPHYSIOL, V101, P641, DOI 10.1152/jn.91094.2008; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Barnabe-Heider F, 2008, NAT METHODS, V5, P189, DOI 10.1038/NMETH.1174; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Callaway EM, 2011, J NEUROSCI, V31, P7456, DOI 10.1523/JNEUROSCI.5222-10.2011; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; Czupryn A, 2011, SCIENCE, V334, P1133, DOI 10.1126/science.1209870; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Garcia NVD, 2011, NATURE, V472, P351, DOI 10.1038/nature09865; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Jabaudon D, 2012, CEREB CORTEX, V22, P996, DOI 10.1093/cercor/bhr182; Kim J, 2012, CURR OPIN NEUROBIOL, V22, P778, DOI 10.1016/j.conb.2012.05.001; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Lowery RL, 2009, DEV NEUROBIOL, V69, P674, DOI 10.1002/dneu.20735; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nakagawa Y, 2003, DEV NEUROSCI-BASEL, V25, P234, DOI 10.1159/000072271; Narboux-Neme N, 2012, J NEUROSCI, V32, P6183, DOI 10.1523/JNEUROSCI.0343-12.2012; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Sheets PL, 2011, J NEUROPHYSIOL, V106, P2216, DOI 10.1152/jn.00232.2011; Sperry RW, 1943, J EXP ZOOL, V92, P263, DOI 10.1002/jez.1400920303; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; TERASHIMA T, 1985, J COMP NEUROL, V232, P83, DOI 10.1002/cne.902320108; Vandenbroucke RE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm440; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Viaene AN, 2011, J NEUROSCI, V31, P12738, DOI 10.1523/JNEUROSCI.1565-11.2011; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	50	133	134	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					193	200		10.1038/nn.3299	http://dx.doi.org/10.1038/nn.3299			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	080RE	23292682				2022-12-17	WOS:000314260200016
J	Lin, Q; Wei, W; Coelho, CM; Li, X; Baker-Andresen, D; Dudley, K; Ratnu, VS; Boskovic, Z; Kobor, MS; Sun, YE; Bredy, TW				Lin, Quan; Wei, Wei; Coelho, Carlos M.; Li, Xiang; Baker-Andresen, Danay; Dudley, Kevin; Ratnu, Vikram S.; Boskovic, Zoran; Kobor, Michael S.; Sun, Yi E.; Bredy, Timothy W.			The brain-specific microRNA miR-128b regulates the formation of fear-extinction memory	NATURE NEUROSCIENCE			English	Article							CALCINEURIN; PLASTICITY; RECEPTORS; CREB; RNAS	MicroRNAs are small non-coding RNAs that mediate post-transcriptional gene silencing. Fear-extinction learning in C57/Bl6J mice led to increased expression of the brain-specific microRNA miR-128b, which disrupted stability of several plasticity-related target genes and regulated formation of fear-extinction memory. Increased miR-128b activity may therefore facilitate the transition from retrieval of the original fear memory toward the formation of a new fear-extinction memory.	[Wei, Wei; Coelho, Carlos M.; Li, Xiang; Baker-Andresen, Danay; Dudley, Kevin; Ratnu, Vikram S.; Boskovic, Zoran; Bredy, Timothy W.] Univ Queensland, Psychiat Epigenom Lab, Queensland Brain Inst, Brisbane, Qld, Australia; [Lin, Quan; Sun, Yi E.] Univ Calif Los Angeles, David Geffen Sch Med, Intellectual Dev & Disabil Res Ctr, Los Angeles, CA 90095 USA; [Kobor, Michael S.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada	University of Queensland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of British Columbia	Bredy, TW (corresponding author), Univ Queensland, Psychiat Epigenom Lab, Queensland Brain Inst, Brisbane, Qld, Australia.	t.bredy@uq.edu.au	Boskovic, Zoran/Y-2764-2018; Coelho, Carlos/A-5065-2010; Wei, Wei/C-3471-2016	Boskovic, Zoran/0000-0002-9867-1827; Coelho, Carlos/0000-0002-2320-7931; Wei, Wei/0000-0001-5768-7729; Kobor, Michael/0000-0003-4140-1743; Dudley, Kevin/0000-0001-5762-1068; Bredy, Timothy/0000-0003-3280-126X	Michael Smith Foundation for Health Research; US National Institutes of Health [R01 MH084095]; Canadian Institutes of Health Research; National Institute on Drug Abuse [K99DA026503-01]; Australian Research Council [DP1096148]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA026503] Funding Source: NIH RePORTER	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. Greengard and A. Nairn for their comments and the generous gift of RCS antibody, G. Quirk and C. Stevenson for suggestions, and R. Tweedale for editing the manuscript. This work was supported by a scholar award from the Michael Smith Foundation for Health Research (M. S. K.), a US National Institutes of Health EUREKA grant (R01 MH084095, Y.E.S.), and previous grants from the Canadian Institutes of Health Research, the Michael Smith Foundation for Health Research and the National Institute on Drug Abuse (K99DA026503-01), and a current grant from the Australian Research Council (DP1096148, T.W.B.).	Baumgartel K, 2008, NAT NEUROSCI, V11, P572, DOI 10.1038/nn.2113; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lauzon NM, 2009, J NEUROSCI, V29, P4836, DOI 10.1523/JNEUROSCI.0178-09.2009; Lin CH, 2003, J NEUROSCI, V23, P1574; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Mueller D, 2010, BIOL PSYCHIAT, V68, P1055, DOI 10.1016/j.biopsych.2010.08.014; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Schaefer A, 2010, J EXP MED, V207, P1843, DOI 10.1084/jem.20100451	15	133	136	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1115	1117		10.1038/nn.2891	http://dx.doi.org/10.1038/nn.2891			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21841775	Green Submitted			2022-12-17	WOS:000294284900009
J	Voss, JL; Paller, KA				Voss, Joel L.; Paller, Ken A.			An electrophysiological signature of unconscious recognition memory	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED POTENTIALS; EXPLICIT MEMORY; PERCEPTUAL FLUENCY; FAMILIARITY; REPETITION; IMPLICIT; BRAIN; RETRIEVAL; JUDGMENTS; AMNESIA	Contradicting the common assumption that accurate recognition reflects explicit-memory processing, we provide evidence for recognition lacking two hallmark explicit-memory features: awareness of memory retrieval and facilitation by attentive encoding. Kaleidoscope images were encoded in conjunction with an attentional diversion and were subsequently recognized more accurately than those encoded without diversion. Confidence in recognition was superior following attentive encoding, although recognition was markedly accurate when people claimed to be unaware of memory retrieval. This 'implicit recognition' was associated with frontal-occipital negative brain potentials at 200-400 ms post-stimulus-onset, which were spatially and temporally distinct from positive brain potentials corresponding to explicit recollection and familiarity. This dissociation between behavioral and electrophysiological characteristics of 'implicit recognition' versus explicit recognition indicates that a neurocognitive mechanism with properties similar to those that produce implicit memory can be operative in standard recognition tests. People can accurately discriminate repeat stimuli from new stimuli without necessarily knowing it.	[Voss, Joel L.; Paller, Ken A.] Northwestern Univ, Interdept Neurosci Program, Evanston, IL 60208 USA; [Voss, Joel L.; Paller, Ken A.] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Voss, JL (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	joelvoss@illinois.edu	Paller, Ken/M-2676-2019	Voss, Joel/0000-0003-4180-9335; Paller, Ken/0000-0003-4415-4143	US National Institutes of Health [P30-AG13854]; National Science Foundation [0518800, 0818912]; NATIONAL INSTITUTE ON AGING [P30AG013854] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Rearick for help with collecting pilot data and A. Gisbert and P. Reber for providing code used to generate stimuli. Financial support was provided by grants from the US National Institutes of Health (P30-AG13854) and National Science Foundation (0518800 and 0818912).	CLAPAREDE E, 1951, ORG PATHOLOGY THOUGH, P58; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Conroy MA, 2005, COGN AFFECT BEHAV NE, V5, P14, DOI 10.3758/CABN.5.1.14; Curran T, 2003, PSYCHOPHYSIOLOGY, V40, P979, DOI 10.1111/1469-8986.00116; Donaldson DI, 2001, NEURON, V31, P1047, DOI 10.1016/S0896-6273(01)00429-9; Evans KM, 2007, NEUROPSYCHOLOGIA, V45, P1777, DOI 10.1016/j.neuropsychologia.2006.12.014; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; GARDINER JM, 1991, MEM COGNITION, V19, P617, DOI 10.3758/BF03197157; Hamann SB, 1997, BEHAV NEUROSCI, V111, P850, DOI 10.1037/0735-7044.111.4.850; Hampton RR, 2004, CURR OPIN NEUROBIOL, V14, P192, DOI 10.1016/j.conb.2004.03.006; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Holdstock JS, 2005, HIPPOCAMPUS, V15, P203, DOI 10.1002/hipo.20046; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; JACOBY LL, 1989, J EXP PSYCHOL GEN, V118, P126, DOI 10.1037/0096-3445.118.2.126; JOHNSTON WA, 1991, J EXP PSYCHOL LEARN, V17, P210, DOI 10.1037/0278-7393.17.2.210; Keane MM, 2006, NEUROPSYCHOLOGIA, V44, P834, DOI 10.1016/j.neuropsychologia.2005.08.003; Levy DA, 2004, PSYCHOL SCI, V15, P680, DOI 10.1111/j.0956-7976.2004.00740.x; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Mecklinger A, 2000, PSYCHOPHYSIOLOGY, V37, P565, DOI 10.1111/1469-8986.3750565; Misra M, 2003, PSYCHOPHYSIOLOGY, V40, P115, DOI 10.1111/1469-8986.00012; Mulligan NW, 1998, J EXP PSYCHOL LEARN, V24, P27, DOI 10.1037/0278-7393.24.1.27; Paller KA, 1998, NEUROPSYCHOLOGIA, V36, P559, DOI 10.1016/S0028-3932(97)00132-2; Paller KA, 2003, NEURON, V38, P507, DOI 10.1016/S0896-6273(03)00198-3; Paller KA, 2007, TRENDS COGN SCI, V11, P243, DOI 10.1016/j.tics.2007.04.002; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Schacter DL, 2007, CURR OPIN NEUROBIOL, V17, P171, DOI 10.1016/j.conb.2007.02.001; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; Schott B, 2002, J COGNITIVE NEUROSCI, V14, P578, DOI 10.1162/08989290260045828; Schott BH, 2005, P NATL ACAD SCI USA, V102, P1257, DOI 10.1073/pnas.0409070102; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Stark CEL, 2000, BEHAV NEUROSCI, V114, P459, DOI 10.1037/0735-7044.114.3.459; Verfaellie M, 1999, NEUROPSYCHOLOGY, V13, P198, DOI 10.1037/0894-4105.13.2.198; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Voss J., 2008, LEARNING MEMORY COMP, P79; Voss JL, 2006, J NEUROSCI, V26, P926, DOI 10.1523/JNEUROSCI.3931-05.2006; Voss JL, 2008, CEREB CORTEX, V18, P1712, DOI 10.1093/cercor/bhm200; Voss JL, 2008, LEARN MEMORY, V15, P454, DOI 10.1101/lm.971208; Westerberg CE, 2006, NEUROPSYCHOLOGY, V20, P193, DOI 10.1037/0894-4105.20.2.193; Whittlesea BWA, 2000, J EXP PSYCHOL LEARN, V26, P547, DOI 10.1037/0278-7393.26.3.547; Wig GS, 2005, NAT NEUROSCI, V8, P1228, DOI 10.1038/nn1515; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Wixted JT, 2007, PSYCHOL REV, V114, P152, DOI 10.1037/0033-295X.114.1.152; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2001, J EXP PSYCHOL GEN, V130, P361, DOI 10.1037//0096-3445.130.3.361	49	133	139	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2009	12	3					349	355		10.1038/nn.2260	http://dx.doi.org/10.1038/nn.2260			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	410LF	19198606	Green Accepted			2022-12-17	WOS:000263577900021
J	Daw, MI; Ashby, MC; Isaac, JTR				Daw, Michael I.; Ashby, Michael C.; Isaac, John T. R.			Coordinated developmental recruitment of latent fast spiking interneurons in layer IV barrel cortex	NATURE NEUROSCIENCE			English	Article							RAT SOMATOSENSORY CORTEX; THALAMOCORTICAL FEEDFORWARD INHIBITION; CRITICAL PERIOD; SYNAPTIC PLASTICITY; EXCITATORY ACTIONS; TRANSGENIC MICE; SILENT SYNAPSES; NEURONS; NEOCORTEX; GABA	Feedforward inhibitory GABAergic transmission is critical for mature cortical circuit function; in the neonate, however, GABA is depolarizing and believed to have a different role. Here we show that the GABA(A) receptor-mediated conductance is depolarizing in excitatory (stellate) cells in neonatal (postnatal day [P]3-5) layer IV barrel cortex, but GABAergic transmission at this age is not engaged by thalamocortical input in the feedforward circuit and has no detectable circuit function. However, recruitment occurs at P6-7 as a result of coordinated increases in thalamic drive to fast-spiking interneurons, fast-spiking interneuron-stellate cell connectivity and hyperpolarization of the GABA(A) receptor-mediated response. Thus, GABAergic circuits are not engaged by thalamocortical input in the neonate, but are poised for a remarkably coordinated development of feedforward inhibition at the end of the first postnatal week, which has profound effects on circuit function at this critical time in development.	Univ Bristol, Dept Anat, MRC, Ctr Synap Plast, Bristol BS8 1TD, Avon, England; NINDS, NIH, Bethesda, MD 20892 USA	University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Isaac, JTR (corresponding author), Univ Bristol, Dept Anat, MRC, Ctr Synap Plast, Bristol BS8 1TD, Avon, England.	isaacj@ninds.nih.gov		Daw, Michael/0000-0002-8374-5977; Ashby, Michael/0000-0002-8593-8473	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003011, ZIANS003011] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)		AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; Agmon A, 1996, J NEUROSCI, V16, P4684; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; AKEMAN CJ, 2006, J NEUROSCI, V26, P5117; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Bannister NJ, 2005, J NEUROSCI, V25, P5259, DOI 10.1523/JNEUROSCI.0827-05.2005; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Beierlein M, 2002, J NEUROSCI, V22, P9885; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; BURGARD EC, 1993, J NEUROPHYSIOL, V69, P230, DOI 10.1152/jn.1993.69.1.230; CastroAlamancos MA, 1997, PROG NEUROBIOL, V51, P581, DOI 10.1016/S0301-0082(97)00002-6; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Daw MI, 2006, J NEUROSCI, V26, P4178, DOI 10.1523/JNEUROSCI.0150-06.2006; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KELLER A, 1987, J COMP NEUROL, V262, P1, DOI 10.1002/cne.902620102; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; KIM HG, 1995, CEREB CORTEX, V5, P148, DOI 10.1093/cercor/5.2.148; KRIEGSTEIN AR, 1987, DEV BRAIN RES, V34, P161, DOI 10.1016/0165-3806(87)90206-9; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MOUNTCASTLE VB, 1959, B JOHNS HOPKINS HOSP, V105, P201; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Petersen RS, 2002, CURR OPIN NEUROBIOL, V12, P441, DOI 10.1016/S0959-4388(02)00338-0; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Staiger JF, 1996, EUR J NEUROSCI, V8, P2273, DOI 10.1111/j.1460-9568.1996.tb01191.x; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wells JE, 2000, J NEUROSCI, V20, P8822; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	47	133	134	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					453	461		10.1038/nn1866	http://dx.doi.org/10.1038/nn1866			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17351636				2022-12-17	WOS:000245228600016
J	Patel, MR; Lehrman, EK; Poon, VY; Crump, JG; Zhen, M; Bargmann, CI; Shen, K				Patel, Maulik R.; Lehrman, Emily K.; Poon, Vivian Y.; Crump, Justin G.; Zhen, Mei; Bargmann, Cornelia I.; Shen, Kang			Hierarchical assembly of presynaptic components in defined C. elegans synapses	NATURE NEUROSCIENCE			English	Article							ACTIVE ZONE; LIPRIN-ALPHA; NEUROTRANSMITTER RELEASE; CAENORHABDITIS-ELEGANS; SYNAPTIC VESICLES; TYROSINE-PHOSPHATASE; NERVOUS-SYSTEM; PROTEIN; RECEPTOR; COMPLEX	The presynaptic regions of axons accumulate synaptic vesicles, active zone proteins and periactive zone proteins. However, the rules for orderly recruitment of presynaptic components are not well understood. We systematically examined molecular mechanisms of presynaptic development in egg-laying synapses of Caenorhabditis elegans, demonstrating that two scaffolding molecules, SYD-1 and SYD-2, have key roles in presynaptic assembly. SYD-2 (liprin-alpha) was previously shown to regulate the size and the shape of active zones. We now show that in syd-1 and syd-2 mutants, synaptic vesicles and numerous other presynaptic proteins fail to accumulate at presynaptic sites. SYD-1 and SYD-2 function cell-autonomously at presynaptic terminals, downstream of synaptic specificity molecule SYG-1. SYD-1 is likely to act upstream of SYD-2 to positively regulate its synaptic assembly activity. These data imply a hierarchical organization of presynaptic assembly, in which transmembrane specificity molecules initiate synaptogenesis by recruiting a few key scaffolding proteins, which in turn assemble other presynaptic components.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Univ So Calif, Zilkha Neurogent Inst, Los Angeles, CA 90089 USA; Univ Toronto, Samuel Lunenfeld Res Inst, Dept Med Genet & Microbiol, Toronto, ON M5G 1X5, Canada; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Stanford University; Stanford University; University of Southern California; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Howard Hughes Medical Institute; Rockefeller University	Shen, K (corresponding author), Stanford Univ, Dept Biol Sci, 385 Serra Mall, Stanford, CA 94305 USA.	kangshen@stanford.edu	Zhen, Mei/A-4967-2012	Zhen, Mei/0000-0003-0086-9622; Bargmann, Cornelia/0000-0002-8484-0618	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS048392, 1R01NS048392] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Ackley BD, 2004, TRENDS NEUROSCI, V27, P540, DOI 10.1016/j.tins.2004.07.003; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BRENNER S, 1974, GENETICS, V77, P71; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; FISCHER V, 1990, P NATL ACAD SCI USA, V87, P1988; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; Hata Y, 1996, J NEUROSCI, V16, P2488; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Ko J, 2003, J NEUROSCI, V23, P1667; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Olsen O, 2005, J CELL BIOL, V170, P1127, DOI 10.1083/jcb.200503011; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shin H, 2003, J BIOL CHEM, V278, P11393, DOI 10.1074/jbc.M211874200; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yeh E, 2005, J NEUROSCI, V25, P3833, DOI 10.1523/JNEUROSCI.4978-04.2005; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	50	133	164	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1488	1498		10.1038/nn1806	http://dx.doi.org/10.1038/nn1806			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115039	Green Accepted			2022-12-17	WOS:000242404000012
J	Blanchi, B; Kelly, LM; Viemari, JC; Lafon, I; Burnet, H; Bevengut, M; Tillmanns, S; Daniel, L; Graf, T; Hilaire, G; Sieweke, MH				Blanchi, B; Kelly, LM; Viemari, JC; Lafon, I; Burnet, H; Bevengut, M; Tillmanns, S; Daniel, L; Graf, T; Hilaire, G; Sieweke, MH			MafB deficiency causes defective respiratory rhythmogenesis and fatal central apnea at birth	NATURE NEUROSCIENCE			English	Article							PRE-BOTZINGER COMPLEX; INFANT-DEATH-SYNDROME; IN-VIVO; PREBOTZINGER COMPLEX; EXPRESSION PATTERN; SEGMENTATION GENE; PACEMAKER NEURONS; RHYTHM GENERATION; REVEALS; MATURATION	The genetic basis for the development of brainstem neurons that generate respiratory rhythm is unknown. Here we show that mice deficient for the transcription factor MafB die from central apnea at birth and are defective for respiratory rhythmogenesis in vitro. MafB is expressed in a subpopulation of neurons in the preBotzinger complex (preBotC), a putative principal site of rhythmogenesis. Brainstems from Mafb(-/-) mice are insensitive to preBotC electrolytic lesion or stimulation and modulation of rhythmogenesis by hypoxia or peptidergic input. Furthermore, in Mafb(-/-) mice the preBotC, but not major neuromodulatory groups, presents severe anatomical defects with loss of cellularity. Our results show an essential role of MafB in central respiratory control, possibly involving the specification of rhythmogenic preBotC neurons.	Univ Mediterrane, INSERM, CNRS, Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France; CNRS, Grp Etud Reseaux Moteurs, F-13009 Marseille, France; Fac Med Timone, IBDM, Lab Pathol Nerveuse & Musculaire, F-13005 Marseille, France; Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Yeshiva University; Albert Einstein College of Medicine	Sieweke, MH (corresponding author), Univ Mediterrane, INSERM, CNRS, Ctr Immunol Marseille Luminy, Campus Luminy,Case 906, F-13288 Marseille 09, France.	sieweke@ciml.univ-mrs.fr	Sieweke, Michael/AAR-7515-2020; Graf, Thomas/B-4252-2015; daniel, laurent/R-2826-2016	Sieweke, Michael/0000-0002-3228-9537; Graf, Thomas/0000-0003-2774-4117; daniel, laurent/0000-0002-7539-0109; blanchi, bruno/0000-0002-0814-5525; Viemari, Jean-Charles/0000-0001-6614-1461				Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; Champagnat J, 1997, TRENDS NEUROSCI, V20, P119, DOI 10.1016/S0166-2236(96)10078-3; Chatonnet F, 2002, EUR J NEUROSCI, V15, P684, DOI 10.1046/j.1460-9568.2002.01909.x; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; del Toro ED, 2001, J NEUROSCI, V21, P5637, DOI 10.1523/JNEUROSCI.21-15-05637.2001; DIPASQUALE E, 1992, EXP BRAIN RES, V89, P459; Eichmann A, 1997, MECH DEVELOP, V65, P111, DOI 10.1016/S0925-4773(97)00063-4; ERRCHIDI S, 1990, J PHYSIOL-LONDON, V429, P497, DOI 10.1113/jphysiol.1990.sp018269; FELDMAN JL, 2003, ANN REV NEUROSCI; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; Fortin G, 2000, RESP PHYSIOL, V122, P247, DOI 10.1016/S0034-5687(00)00163-8; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Guyenet PG, 2002, J NEUROSCI, V22, P3806; Guyenet PG, 2001, J NEUROPHYSIOL, V86, P438, DOI 10.1152/jn.2001.86.1.438; Hertwig P., 1942, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSL, V80, P220, DOI 10.1007/BF01741984; Hilaire G, 1997, NEUROSCI LETT, V224, P13, DOI 10.1016/S0304-3940(97)13458-9; Hilaire G, 1999, PHYSIOL REV, V79, P325, DOI 10.1152/physrev.1999.79.2.325; Jacquin TD, 1996, NEURON, V17, P747, DOI 10.1016/S0896-6273(00)80206-8; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; KINNEY HC, 1995, SCIENCE, V269, P1446, DOI 10.1126/science.7660131; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; Koshiya N, 1996, J PHYSIOL-LONDON, V491, P859, DOI 10.1113/jphysiol.1996.sp021263; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; McCrimmon DR, 2000, BIOESSAYS, V22, P6, DOI 10.1002/(SICI)1521-1878(200001)22:1<6::AID-BIES3>3.0.CO;2-Q; Mellen NM, 2003, NEURON, V37, P821, DOI 10.1016/S0896-6273(03)00092-8; MONTEAU R, 1991, PROG NEUROBIOL, V37, P83, DOI 10.1016/0301-0082(91)90024-U; ONIMARU H, 1995, EXP BRAIN RES, V106, P57; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Pabst O, 2003, DEVELOPMENT, V130, P1193, DOI 10.1242/dev.00346; Poon CS, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-09-j0003.2000; Ptak K, 2002, EUR J NEUROSCI, V16, P2245, DOI 10.1046/j.1460-9568.2002.02305.x; Qian Y, 2001, GENE DEV, V15, P2533, DOI 10.1101/gad.921501; Ramirez JM, 1998, J PHYSIOL-LONDON, V507, P895, DOI 10.1111/j.1469-7793.1998.895bs.x; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Ren J, 2003, J NEUROSCI, V23, P1569; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Sadl VS, 2002, DEV BIOL, V249, P16, DOI 10.1006/dbio.2002.0751; Shirasawa S, 2000, NAT GENET, V24, P287, DOI 10.1038/73516; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Solomon IC, 1999, J NEUROPHYSIOL, V81, P1150, DOI 10.1152/jn.1999.81.3.1150; St-John WM, 1998, PROG NEUROBIOL, V56, P97, DOI 10.1016/S0301-0082(98)00031-8; Thoby-Brisson M, 2000, J NEUROSCI, V20, P5858, DOI 10.1523/JNEUROSCI.20-15-05858.2000; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Viemari JC, 2003, EUR J NEUROSCI, V17, P1233, DOI 10.1046/j.1460-9568.2003.02561.x; Wang H, 2001, J COMP NEUROL, V434, P128, DOI 10.1002/cne.1169; WANG WG, 1993, J APPL PHYSIOL, V74, P2801, DOI 10.1152/jappl.1993.74.6.2801	50	133	140	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1091	1099		10.1038/nn1129	http://dx.doi.org/10.1038/nn1129			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14513037				2022-12-17	WOS:000185633600022
J	Drier, EA; Tello, MK; Cowan, M; Wu, P; Blace, N; Sacktor, TC; Yin, JCP				Drier, EA; Tello, MK; Cowan, M; Wu, P; Blace, N; Sacktor, TC; Yin, JCP			Memory enhancement and formation by atypical PKM activity in Drosophila melanogaster	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; LONG-TERM POTENTIATION; CAENORHABDITIS-ELEGANS; PERSISTENT ACTIVATION; CONSOLIDATED MEMORY; CELL-POLARITY; M-ZETA; MAINTENANCE; BAZOOKA; FACILITATION	Synaptic stimulation activates signal transduction pathways, producing persistently active protein kinases. PKMzeta is a truncated, persistently active isoform of atypical protein kinase C-zeta (aPKCzeta), which lacks the N-terminal pseudosubstrate regulatory domain. Using a Pavlovian olfactory learning task in Drosophila, we found that induction of the mouse aPKMzeta (MaPKMzeta) transgene enhanced memory. The enhancement required persistent kinase activity and was temporally specific, with optimal induction at 30 minutes after training. Induction also enhanced memory after massed training and corrected the memory defect of radish mutants, but did not improve memory produced by spaced training. The 'M' isoform of the Drosophila homolog of MaPKCzeta (DaPKM) was present and active in fly heads. Chelerythrine, an inhibitor of PKMzeta, and the induction of a dominant-negative MaPKMzeta transgene inhibited memory without affecting learning. Finally, induction of DaPKM after training also enhanced memory. These results show that atypical PKM is sufficient to enhance memory in Drosophila and suggest that it is necessary for normal memory maintenance.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; SUNY Downstate Med Ctr, Dept Physiol, Lab Mol Neurosci, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Dept Pharmacol, Lab Mol Neurosci, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Dept Neurol, Lab Mol Neurosci, Brooklyn, NY 11203 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Yin, JCP (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.			Blace, Nancy/0000-0002-6174-6004	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA015753] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Angenstein F, 1997, PROG NEURO-PSYCHOPH, V21, P427, DOI 10.1016/S0278-5846(97)00012-2; Bandyopadhyay G, 1999, BIOCHEM J, V337, P461, DOI 10.1042/0264-6021:3370461; Bortolotto ZA, 2000, EUR J NEUROSCI, V12, P4055, DOI 10.1046/j.1460-9568.2000.00291.x; BOYNTON S, 1992, GENETICS, V131, P655; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CONNOLLY JB, 1998, DROSOPHILA PRACTICAL, P265; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; FOLKERS E, 1993, P NATL ACAD SCI USA, V90, P8123, DOI 10.1073/pnas.90.17.8123; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Grunbaum L, 1998, J NEUROSCI, V18, P4384; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hrabetova S, 1996, J NEUROSCI, V16, P5324; INOUE M, 1977, J BIOL CHEM, V252, P7610; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Laudanna C, 1998, J BIOL CHEM, V273, P30306, DOI 10.1074/jbc.273.46.30306; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Osten P, 1996, J NEUROSCI, V16, P2444; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Romanelli A, 1999, MOL CELL BIOL, V19, P2921; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; SCHWARTZ JH, 1993, P NATL ACAD SCI USA, V90, P8310, DOI 10.1073/pnas.90.18.8310; Sossin W S, 1994, Learn Mem, V1, P189; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; TAKAI Y, 1977, BIOCHEM BIOPH RES CO, V77, P542, DOI 10.1016/S0006-291X(77)80013-2; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; VanderZee EA, 1997, PROG NEURO-PSYCHOPH, V21, P379, DOI 10.1016/S0278-5846(97)00010-9; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	49	133	139	0	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					316	324		10.1038/nn820	http://dx.doi.org/10.1038/nn820			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11914720				2022-12-17	WOS:000174606900011
J	Nativio, R; Donahue, G; Berson, A; Lan, YM; Amlie-Wolf, A; Tuzer, F; Toledo, JB; Gosai, SJ; Gregory, BD; Torres, C; Trojanowski, JQ; Wang, LS; Johnson, FB; Bonini, NM; Berger, SL				Nativio, Raffaella; Donahue, Greg; Berson, Amit; Lan, Yemin; Amlie-Wolf, Alexandre; Tuzer, Ferit; Toledo, Jon B.; Gosai, Sager J.; Gregory, Brian D.; Torres, Claudio; Trojanowski, John Q.; Wang, Li-San; Johnson, F. Brad; Bonini, Nancy M.; Berger, Shelley L.			Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							HISTONE H4 ACETYLATION; EMBRYONIC STEM-CELLS; DNA-DAMAGE RESPONSE; GENE-EXPRESSION; HUMAN BRAIN; LYSINE 16; DEVELOPMENTAL REGULATION; HUMAN GENOME; LIFE-SPAN; SENESCENCE	Aging is the strongest risk factor for Alzheimer's disease (AD), although the underlying mechanisms remain unclear. The chromatin state, in particular through the mark H4K16ac, has been implicated in aging and thus may play a pivotal role in age-associated neurodegeneration. Here we compare the genome-wide enrichment of H4K16ac in the lateral temporal lobe of AD individuals against both younger and elderly cognitively normal controls. We found that while normal aging leads to H4K16ac enrichment, AD entails dramatic losses of H4K16ac in the proximity of genes linked to aging and AD. Our analysis highlights the presence of three classes of AD-related changes with distinctive functional roles. Furthermore, we discovered an association between the genomic locations of significant H4K16ac changes with genetic variants identified in prior AD genome-wide association studies and with expression quantitative trait loci. Our results establish the basis for an epigenetic link between aging and AD.	[Nativio, Raffaella; Donahue, Greg; Lan, Yemin; Berger, Shelley L.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Epigenet Program, Philadelphia, PA 19104 USA; [Berson, Amit; Gosai, Sager J.; Gregory, Brian D.; Bonini, Nancy M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Amlie-Wolf, Alexandre; Toledo, Jon B.; Trojanowski, John Q.; Wang, Li-San; Johnson, F. Brad] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Tuzer, Ferit; Torres, Claudio] Drexel Univ, Coll Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Drexel University	Berger, SL (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Epigenet Program, Philadelphia, PA 19104 USA.; Bonini, NM (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.; Johnson, FB (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA.	johnsonb@pennmedicine.upenn.edu; nbonini@sas.upenn.edu; bergers@pennmedicine.upenn.edu	Gregory, Brian D/G-2890-2010	Amlie-Wolf, Alexandre/0000-0002-2073-1519; Berson, Amit/0000-0003-2526-745X; Toledo, Jon/0000-0003-4366-9268	NIH [R01-NS078283];  [AG10124];  [AG17586]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078283, R35NS097275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017586, P30AG010124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. Schuck and G. Gibbons for assistance with brain tissue selection and retrieval; the Penn Flow Cytometry core for technical assistance; P. Sen and M. Sammons for edits and comments to the manuscript and P. Ortega for insightful scientific discussions. This work was funded by NIH grant R01-NS078283 (to S.L.B., N.M.B. and F.B.J.). J.Q.T. is supported by AG10124 and AG17586.	Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Bennett DA, 2015, TRANSL RES, V165, P200, DOI 10.1016/j.trsl.2014.05.006; Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blalock EM, 2011, J CHEM NEUROANAT, V42, P118, DOI 10.1016/j.jchemneu.2011.06.007; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Contrepois K, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-15; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Garcia-Moreno F, 2015, P NATL ACAD SCI USA, V112, pE5058, DOI 10.1073/pnas.1506377112; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Gutchess A, 2014, SCIENCE, V346, P579, DOI 10.1126/science.1254604; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hill NL, 2011, TOP GERIATR REHABIL, V27, P257, DOI 10.1097/TGR.0b013e31821e588e; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HS, 2006, J NEUROSCI METH, V156, P284, DOI 10.1016/j.jneumeth.2006.02.018; Inestrosa NC, 2014, J MOL CELL BIOL, V6, P64, DOI 10.1093/jmcb/mjt051; Jiang ST, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-6; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerimoglu C, 2017, CELL REP, V20, P538, DOI 10.1016/j.celrep.2017.06.072; Kirouac L, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0149-16.2017; Kozak ML, 2010, EMBO J, V29, P158, DOI 10.1038/emboj.2009.314; Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Matevossian A, 2008, J VIS EXP, V13, P717; Meda L, 2001, NEUROBIOL AGING, V22, P885, DOI 10.1016/S0197-4580(01)00307-4; Mirra SS, 1997, NEUROBIOL AGING, V18, pS91, DOI 10.1016/S0197-4580(97)00058-4; Nagy C, 2015, J NEUROPATH EXP NEUR, V74, P459, DOI 10.1097/NEN.0000000000000190; Nica AC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0362; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rai TS, 2014, GENE DEV, V28, P2712, DOI 10.1101/gad.247528.114; Sammons MA, 2015, GENOME RES, V25, P179, DOI 10.1101/gr.181883.114; Schenker NM, 2005, J HUM EVOL, V49, P547, DOI 10.1016/j.jhevol.2005.06.004; Schmidt EM, 2015, BIOINFORMATICS, V31, P2601, DOI 10.1093/bioinformatics/btv201; Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Stadler F, 2005, J NEUROCHEM, V94, P324, DOI 10.1111/j.1471-4159.2005.03190.x; Taylor GCA, 2013, GENOME RES, V23, P2053, DOI 10.1101/gr.155028.113; Toledo JB, 2015, BRAIN, V138, P2701, DOI 10.1093/brain/awv199; Toledo JB, 2014, ALZHEIMERS DEMENT, V10, P477, DOI 10.1016/j.jalz.2013.06.003; Valenta T, 2006, EMBO J, V25, P2326, DOI 10.1038/sj.emboj.7601147; Vermunt MW, 2016, NAT NEUROSCI, V19, P494, DOI 10.1038/nn.4229; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Walton M, 1998, MOL BRAIN RES, V61, P11, DOI 10.1016/S0169-328X(98)00169-7; Wan WB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/301575; Wan YZ, 2014, AGING CELL, V13, P890, DOI 10.1111/acel.12247; Zhang KL, 2012, PROTEOMICS, V12, P1261, DOI 10.1002/pmic.201200010; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou ZF, 2011, P NATL ACAD SCI USA, V108, P6626, DOI 10.1073/pnas.1018514108; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	70	132	135	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2018	21	4					497	+		10.1038/s41593-018-0101-9	http://dx.doi.org/10.1038/s41593-018-0101-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GB1FG	29507413	hybrid, Green Accepted			2022-12-17	WOS:000428796000009
J	Kang, ZH; Wang, CH; Zepp, J; Wu, L; Sun, K; Zhao, JJ; Chandrasekharan, U; DiCorleto, PE; Trapp, BD; Ransohoff, RM; Li, XX				Kang, Zizhen; Wang, Chenhui; Zepp, Jarod; Wu, Ling; Sun, Kevin; Zhao, Junjie; Chandrasekharan, Unni; DiCorleto, Paul E.; Trapp, Bruce D.; Ransohoff, Richard M.; Li, Xiaoxia			Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2(+) glial cells	NATURE NEUROSCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; MULTIPLE-SCLEROSIS; ANIMAL-MODELS; ADULT BRAIN; T-CELLS; OLIGODENDROCYTE; MYELIN; CNS	Interleukin 17 (IL-17) is a signature cytokine of Th17 cells. We previously reported that deletion of NF-kappa B activator 1 (Act1), the key transducer of IL-17 receptor signaling, from the neuroectodermal lineage in mice (neurons, oligodendrocytes and astrocytes) results in attenuated severity of experimental autoimmune encephalomyelitis (EAE). Here we examined the cellular basis of this observation. EAE disease course was unaffected by deletion of Act1 in neurons or mature oligodendrocytes, and Act1 deletion in astrocytes only modestly affected disease course. Deletion of Act1 in NG2(+) glia resulted in markedly reduced EAE severity. Furthermore, IL-17 induced characteristic inflammatory mediator expression in NG2(+) glial cells. IL-17 also exhibited strong inhibitory effects on the maturation of oligodendrocyte lineage cells in vitro and reduced their survival. These data identify NG2(+) glia as the major CNS cellular target of IL-17 in EAE. The sensitivity of oligodendrocyte lineage cells to IL-17-mediated toxicity further suggests a direct link between inflammation and neurodegeneration in multiple sclerosis.	[Kang, Zizhen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Kang, Zizhen; Wang, Chenhui; Zepp, Jarod; Wu, Ling; Sun, Kevin; Zhao, Junjie; Li, Xiaoxia] Cleveland Clin, Dept Immunol, Cleveland, OH 44106 USA; [Chandrasekharan, Unni; DiCorleto, Paul E.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Trapp, Bruce D.; Ransohoff, Richard M.] Cleveland Clin, Dept Neurosci, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Cleveland Clin, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Cleveland Clin, Mellen Ctr Mississippi Treatment & Res, Cleveland, OH 44106 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Li, XX (corresponding author), Cleveland Clin, Dept Immunol, Cleveland, OH 44106 USA.	lix@ccf.org	Zhao, Junjie/AAH-1152-2021	, Zizhen/0000-0001-5621-8912; Wang, Chenhui/0000-0002-3186-3066	US National Institutes of Health [R01NS071996, P01HL103453]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088088, T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG046399] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge W.B. Stallcup (Burnham Institute for Medical Research) for providing antibodies to NG2 and K.-A. Nave for providing Cnp1-cre transgenic mice (Max Planck Institute of Experimental Medicine). We also thank the Dana-Farber Cancer Institute for providing the Olig2-cre transgenic mice. This investigation was supported by grants from the US National Institutes of Health (R01NS071996 and P01HL103453).	Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Butts BD, 2008, CELL DEATH DIFFER, V15, P1178, DOI 10.1038/cdd.2008.70; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Furuta S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001374; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Hara H, 2011, J NEUROIMMUNOL, V233, P135, DOI 10.1016/j.jneuroim.2010.12.011; Hisahara S, 2003, NEUROSCI RES, V46, P387, DOI 10.1016/S0168-0102(03)00127-5; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Kaga Y, 2006, J NEUROSCI, V26, P12339, DOI 10.1523/JNEUROSCI.3573-06.2006; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Lev N, 2004, NEUROSCI LETT, V359, P139, DOI 10.1016/j.neulet.2004.01.076; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mc Guire C, 2011, TRENDS NEUROSCI, V34, P619, DOI 10.1016/j.tins.2011.09.002; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Paintlia MK, 2011, J NEUROCHEM, V116, P508, DOI 10.1111/j.1471-4159.2010.07136.x; Patel J, 2012, INT J MOL SCI, V13, P10647, DOI 10.3390/ijms130810647; Pedraza CE, 2008, GLIA, V56, P1339, DOI 10.1002/glia.20702; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2002, P NATL ACAD SCI USA, V99, P9386, DOI 10.1073/pnas.142294499; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Raasch J, 2011, BRAIN, V134, P1184, DOI 10.1093/brain/awq359; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Yan YP, 2012, MOL THER, V20, P1338, DOI 10.1038/mt.2012.12; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	55	132	137	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1401	+		10.1038/nn.3505	http://dx.doi.org/10.1038/nn.3505			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995070	Green Accepted			2022-12-17	WOS:000324795300012
J	Gilman, SR; Chang, J; Xu, B; Bawa, TS; Gogos, JA; Karayiorgou, M; Vitkup, D				Gilman, Sarah R.; Chang, Jonathan; Xu, Bin; Bawa, Tejdeep S.; Gogos, Joseph A.; Karayiorgou, Maria; Vitkup, Dennis			Diverse types of genetic variation converge on functional gene networks involved in schizophrenia	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINE PATHOLOGY; GENOME-WIDE ASSOCIATION; COPY-NUMBER VARIATION; RARE DE-NOVO; COMMON VARIANTS; AUTISM; MICRODELETIONS; DISORDERS; MUTATIONS; PATHWAYS	Despite the successful identification of several relevant genomic loci, the underlying molecular mechanisms of schizophrenia remain largely unclear. We developed a computational approach (NETBAG+) that allows an integrated analysis of diverse disease-related genetic data using a unified statistical framework. The application of this approach to schizophrenia-associated genetic variations, obtained using unbiased whole-genome methods, allowed us to identify several cohesive gene networks related to axon guidance, neuronal cell mobility, synaptic function and chromosomal remodeling. The genes forming the networks are highly expressed in the brain, with higher brain expression during prenatal development. The identified networks are functionally related to genes previously implicated in schizophrenia, autism and intellectual disability. A comparative analysis of copy number variants associated with autism and schizophrenia suggests that although the molecular networks implicated in these distinct disorders may be related, the mutations associated with each disease are likely to lead, at least on average, to different functional consequences.	[Gilman, Sarah R.; Chang, Jonathan; Bawa, Tejdeep S.; Vitkup, Dennis] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA; [Gilman, Sarah R.; Chang, Jonathan; Bawa, Tejdeep S.; Vitkup, Dennis] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Xu, Bin; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY USA; [Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Gogos, Joseph A.] Columbia Univ, Dept Neurosci, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Vitkup, D (corresponding author), Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA.	dv2121@columbia.edu			Simons Foundation (SFARI award) [SF51]; US National Centers for Biomedical Computing (MAGNet) [U54CA121852]; US National Institute of Mental Health [MH061399, MH077235]; Lieber Center for Schizophrenia Research at Columbia University; US National Institute of General Medical Sciences [T32 GM082797]; US National Alliance for Research in Schizophrenia and Depression (NARSAD); NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM082797, R01GM079759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077235, R01MH061399] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007079] Funding Source: NIH RePORTER	Simons Foundation (SFARI award); US National Centers for Biomedical Computing (MAGNet); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lieber Center for Schizophrenia Research at Columbia University; US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Alliance for Research in Schizophrenia and Depression (NARSAD); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We are grateful to all participating families and to clinical collaborators J.L. Roos and H. Pretorius, as well as to nursing sisters R. van Wyk, C. Botha and H. van den Berg for subject recruitment and evaluation. We would also like to sincerely thank M. Wigler, D. Geschwind, G. Fischbach and all members of the Vitkup laboratory for discussions. This work was supported in part by a grant from the Simons Foundation (SFARI award number SF51), US National Centers for Biomedical Computing (MAGNet) grant U54CA121852 to Columbia University, US National Institute of Mental Health grants MH061399 (to M. K.) and MH077235 (to J.A.G.) and the Lieber Center for Schizophrenia Research at Columbia University. S. R. G. was supported in part by US National Institute of General Medical Sciences training grant T32 GM082797. B. X. was partially supported by a US National Alliance for Research in Schizophrenia and Depression (NARSAD) Young Investigator Award.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Arguello PA, 2012, TRENDS NEUROSCI, V35, P3, DOI 10.1016/j.tins.2011.11.007; Bassett AS, 2010, J PSYCHIATR RES, V44, P1005, DOI 10.1016/j.jpsychires.2010.06.013; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Girard SL, 2012, CURR NEUROL NEUROSCI, V12, P261, DOI 10.1007/s11910-012-0266-7; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jia P, 2010, MOL PSYCHIATR, V15, P453, DOI 10.1038/mp.2009.93; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kirov G, 2009, MOL PSYCHIATR, V14, P796, DOI 10.1038/mp.2008.33; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kvajo M, 2010, CURR TOP BEHAV NEURO, V4, P629, DOI 10.1007/7854_2010_41; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pickard B, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001955; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Sun J, 2008, AM J MED GENET B, V147B, P1173, DOI 10.1002/ajmg.b.30743; Tandon R, 2008, SCHIZOPHR RES, V100, P4, DOI 10.1016/j.schres.2008.01.022; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979	49	132	137	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1723	+		10.1038/nn.3261	http://dx.doi.org/10.1038/nn.3261			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23143521	Green Accepted			2022-12-17	WOS:000311706700019
J	Schwartz, GW; Okawa, H; Dunn, FA; Morgan, JL; Kerschensteiner, D; Wong, RO; Rieke, F				Schwartz, Gregory W.; Okawa, Haruhisa; Dunn, Felice A.; Morgan, Josh L.; Kerschensteiner, Daniel; Wong, Rachel O.; Rieke, Fred			The spatial structure of a nonlinear receptive field	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; MOUSE RETINA; BIPOLAR CELLS; QUANTITATIVE-ANALYSIS; PRIMATE RETINA; IN-VIVO; CAT; SENSITIVITY; CONTACTS; IDENTIFICATION	Understanding a sensory system implies the ability to predict responses to a variety of inputs from a common model. In the retina, this includes predicting how the integration of signals across visual space shapes the outputs of retinal ganglion cells. Existing models of this process generalize poorly to predict responses to new stimuli. This failure arises in part from properties of the ganglion cell response that are not well captured by standard receptive-field mapping techniques: nonlinear spatial integration and fine-scale heterogeneities in spatial sampling. Here we characterize a ganglion cell's spatial receptive field using a mechanistic model based on measurements of the physiological properties and connectivity of only the primary excitatory circuitry of the retina. The resulting simplified circuit model successfully predicts ganglion-cell responses to a variety of spatial patterns and thus provides a direct correspondence between circuit connectivity and retinal output.	[Schwartz, Gregory W.; Okawa, Haruhisa; Dunn, Felice A.; Wong, Rachel O.; Rieke, Fred] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Morgan, Josh L.] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Kerschensteiner, Daniel] Washington Univ, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA; [Kerschensteiner, Daniel] Washington Univ, Dept Anat & Neurobiol, St Louis, MO USA; [Rieke, Fred] Howard Hughes Med Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; Harvard University; Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute	Schwartz, GW (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	gregws@uw.edu		Schwartz, Greg/0000-0001-8909-4397	US National Institutes of Health [EY11850, EY10699, EY017101, EY 01730]; Howard Hughes Medical Institute; Helen Hay Whitney Foundation; NATIONAL EYE INSTITUTE [R01EY017101, R01EY010699, P30EY001730, R01EY011850] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Helen Hay Whitney Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Perkel, G. Field, M. Berry and W. Bair for helpful comments on the manuscript. This research was made possible by support from the US National Institutes of Health (EY11850 to ER., EY10699 and EY017101 to R.O.W. and the Vision Core Grant EY 01730), the Howard Hughes Medical Institute (F.R.) and the Helen Hay Whitney Foundation (G.W.S.).	Ala-Laurila P, 2011, NAT NEUROSCI, V14, P1309, DOI 10.1038/nn.2927; AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Berntson A, 2000, J PHYSIOL-LONDON, V524, P879, DOI 10.1111/j.1469-7793.2000.00879.x; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Brown SP, 2000, NEURON, V27, P371, DOI 10.1016/S0896-6273(00)00044-1; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P257, DOI 10.1113/jphysiol.1978.sp012232; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; COHEN E, 1991, J NEUROPHYSIOL, V65, P352, DOI 10.1152/jn.1991.65.2.352; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; CREUTZFELDT OD, 1970, J NEUROPHYSIOL, V33, P654, DOI 10.1152/jn.1970.33.5.654; Dacey D, 2000, VISION RES, V40, P1801, DOI 10.1016/S0042-6989(00)00039-0; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; Demb JB, 1999, J NEUROSCI, V19, P9756; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FREED MA, 1992, P NATL ACAD SCI USA, V89, P236, DOI 10.1073/pnas.89.1.236; Gauthier JL, 2009, PLOS BIOL, V7, P747, DOI 10.1371/journal.pbio.1000063; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; Jakobs TC, 2008, J COMP NEUROL, V510, P221, DOI 10.1002/cne.21795; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; KIER CK, 1995, J NEUROSCI, V15, P7673; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; Koizumi A, 2011, J COMP NEUROL, V519, P341, DOI 10.1002/cne.22522; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Lin B, 2005, EUR J NEUROSCI, V21, P1257, DOI 10.1111/j.1460-9568.2005.03967.x; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MILLS SL, 1995, NATURE, V377, P734, DOI 10.1038/377734a0; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; Morgan JL, 2011, NEURON, V71, P1014, DOI 10.1016/j.neuron.2011.08.025; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Passaglia CL, 2002, VISION RES, V42, P683, DOI 10.1016/S0042-6989(01)00312-1; Petrusca D, 2007, J NEUROSCI, V27, P11019, DOI 10.1523/JNEUROSCI.2836-07.2007; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Schwartz G, 2011, J GEN PHYSIOL, V138, P283, DOI 10.1085/jgp.201110629; Soo FS, 2011, J NEUROSCI, V31, P2145, DOI 10.1523/JNEUROSCI.5129-10.2011; STONE C, 1993, VISUAL NEUROSCI, V10, P31, DOI 10.1017/S0952523800003205; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; THIBOS LN, 1983, VISION RES, V23, P1561, DOI 10.1016/0042-6989(83)90170-0; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Zeck GM, 2005, EUR J NEUROSCI, V22, P2016, DOI 10.1111/j.1460-9568.2005.04390.x	50	132	132	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1572	1580		10.1038/nn.3225	http://dx.doi.org/10.1038/nn.3225			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23001060	Green Accepted, Green Submitted			2022-12-17	WOS:000310424900018
J	Sul, JH; Jo, S; Lee, D; Jung, MW				Sul, Jung Hoon; Jo, Suhyun; Lee, Daeyeol; Jung, Min Whan			Role of rodent secondary motor cortex in value-based action selection	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; DECISION-MAKING; AFFERENT CONNECTIONS; MATCHING BEHAVIOR; NEURONAL-ACTIVITY; AGRANULAR CORTEX; EYE FIELDS; REWARD; RAT	Despite widespread neural activity related to reward values, signals related to upcoming choice have not been clearly identified in the rodent brain. Here we examined neuronal activity in the lateral (AGl) and medial (AGm) agranular cortex, corresponding to the primary and secondary motor cortex, respectively, in rats performing a dynamic foraging task. Choice signals, before behavioral manifestation of the rat's choice, arose in the AGm earlier than in any other areas of the rat brain previously studied under free-choice conditions. The AGm also conveyed neural signals for decision value and chosen value. By contrast, upcoming choice signals arose later, and value signals were weaker, in the AGl. We also found that AGm lesions made the rats' choices less dependent on dynamically updated values. These results suggest that rodent secondary motor cortex might be uniquely involved in both representing and reading out value signals for flexible action selection.	[Sul, Jung Hoon; Jo, Suhyun; Jung, Min Whan] Ajou Univ, Neurosci Lab, Inst Med Sci, Sch Med, Suwon 441749, South Korea; [Jo, Suhyun; Jung, Min Whan] Ajou Univ, Grad Program Neurosci, Sch Med, Suwon 441749, South Korea; [Lee, Daeyeol] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Ajou University; Ajou University; Yale University	Jung, MW (corresponding author), Ajou Univ, Neurosci Lab, Inst Med Sci, Sch Med, Suwon 441749, South Korea.	min@ajou.ac.kr	Jung, Min Whan/GXF-5216-2022; Lee, Daeyeol/A-6794-2008	Lee, Daeyeol/0000-0003-3474-019X; Jo, Suhyun/0000-0002-6538-8240	Brain Research Center; Korea National Research Foundation [2011-0015618]; Cognitive Neuroscience Program; Ministry of Education, Science and Technology, Korea [2011-0019209]; US National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029330] Funding Source: NIH RePORTER	Brain Research Center; Korea National Research Foundation(National Research Foundation of Korea); Cognitive Neuroscience Program; Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Lee for discussion, P. Nachev for commenting on the manuscript, J.W. Ghim for helping with analysis and E. Seuter for proofreading the manuscript. This work was supported by a grant from the Brain Research Center of the 21st Century Frontier Research Program, a Korea National Research Foundation grant (2011-0015618), the Cognitive Neuroscience Program, and the Original Technology Research Program for Brain Science (2011-0019209) funded by the Ministry of Education, Science and Technology, Korea (to M.W.J.), and the US National Institutes of Health (to D.L.).	AKINTUNDE A, 1992, BRAIN RES, V575, P86, DOI 10.1016/0006-8993(92)90427-B; Baeg EH, 2001, CEREB CORTEX, V11, P441, DOI 10.1093/cercor/11.5.441; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; DONOGHUE JP, 1983, J COMP NEUROL, V217, P390, DOI 10.1002/cne.902170404; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; Hoshi E, 2007, CURR OPIN NEUROBIOL, V17, P234, DOI 10.1016/j.conb.2007.02.003; Huh N, 2009, LEARN MEMORY, V16, P315, DOI 10.1101/lm.1295509; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kargo WJ, 2007, J NEUROSCI, V27, P3548, DOI 10.1523/JNEUROSCI.3604-06.2007; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Kim YB, 2007, J NEUROPHYSIOL, V98, P3548, DOI 10.1152/jn.00310.2007; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; MILLER MW, 1987, EXP BRAIN RES, V67, P339; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; PASSINGHAM RE, 1988, BEHAV NEUROSCI, V102, P101, DOI 10.1037/0735-7044.102.1.101; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; REEP RL, 1990, J COMP NEUROL, V294, P262, DOI 10.1002/cne.902940210; REEP RL, 1984, NEUROSCI LETT, V44, P247, DOI 10.1016/0304-3940(84)90030-2; REEP RL, 1987, BRAIN RES BULL, V19, P203, DOI 10.1016/0361-9230(87)90086-4; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; SANDERSON KJ, 1984, BRAIN RES, V292, P251, DOI 10.1016/0006-8993(84)90761-3; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Seo H, 2009, J NEUROSCI, V29, P3627, DOI 10.1523/JNEUROSCI.4726-08.2009; Sohn JW, 2007, J NEUROSCI, V27, P13655, DOI 10.1523/JNEUROSCI.2982-07.2007; STADDON JER, 1981, J EXP ANAL BEHAV, V35, P397, DOI 10.1901/jeab.1981.35-397; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; TANJI J, 1994, NEUROSCI RES, V19, P251, DOI 10.1016/0168-0102(94)90038-8; Thevarajah D, 2009, J NEUROSCI, V29, P1998, DOI 10.1523/JNEUROSCI.4764-08.2009; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31, DOI [DOI 10.1016/j.bbr.2003.09.028, DOI 10.1016/j.pscychresns.2017.01.006]; Wang Y, 1998, BRAIN RES, V781, P137, DOI 10.1016/S0006-8993(97)01223-7	50	132	132	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1202	U139		10.1038/nn.2881	http://dx.doi.org/10.1038/nn.2881			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21841777	Green Accepted			2022-12-17	WOS:000294284900022
J	Szuts, TA; Fadeyev, V; Kachiguine, S; Sher, A; Grivich, MV; Agrochao, M; Hottowy, P; Dabrowski, W; Lubenov, EV; Siapas, AG; Uchida, N; Litke, AM; Meister, M				Szuts, Tobi A.; Fadeyev, Vitaliy; Kachiguine, Sergei; Sher, Alexander; Grivich, Matthew V.; Agrochao, Margarida; Hottowy, Pawel; Dabrowski, Wladyslaw; Lubenov, Evgueniy V.; Siapas, Athanassios G.; Uchida, Naoshige; Litke, Alan M.; Meister, Markus			A wireless multi-channel neural amplifier for freely moving animals	NATURE NEUROSCIENCE			English	Article							MOUSE VISUAL-CORTEX; INTEGRATED-CIRCUIT; RECORDING-SYSTEM; SCALE; RAT; TECHNOLOGY; RESPONSES; NEURONS; CELLS	Conventional neural recording systems restrict behavioral experiments to a flat indoor environment compatible with the cable that tethers the subject to recording instruments. To overcome these constraints, we developed a wireless multi-channel system for recording neural signals from rats. The device takes up to 64 voltage signals from implanted electrodes, samples each at 20 kHz, time-division multiplexes them into one signal and transmits that output by radio frequency to a receiver up to 60 m away. The system introduces <4 mu V of electrode-referred noise, comparable to wired recording systems, and outperforms existing rodent telemetry systems in channel count, weight and transmission range. This allows effective recording of brain signals in freely behaving animals. We report measurements of neural population activity taken outdoors and in tunnels. Neural firing in the visual cortex was relatively sparse, correlated even across large distances and was strongly influenced by locomotor activity.	[Szuts, Tobi A.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; [Fadeyev, Vitaliy; Kachiguine, Sergei; Sher, Alexander; Grivich, Matthew V.; Litke, Alan M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Agrochao, Margarida; Uchida, Naoshige; Meister, Markus] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Agrochao, Margarida] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, Oeiras, Portugal; [Hottowy, Pawel; Dabrowski, Wladyslaw] AGH Univ Sci & Technol, Fac Phys & Appl Comp Sci, Krakow, Poland; [Lubenov, Evgueniy V.; Siapas, Athanassios G.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Lubenov, Evgueniy V.; Siapas, Athanassios G.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Uchida, Naoshige; Meister, Markus] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; University of California System; University of California Santa Cruz; Harvard University; Fundacao Champalimaud; Instituto Gulbenkian de Ciencia; AGH University of Science & Technology; California Institute of Technology; California Institute of Technology; Harvard University	Szuts, TA (corresponding author), Harvard Univ, Program Biophys, Cambridge, MA 02138 USA.	szuts@fas.harvard.edu; meister@fas.harvard.edu	Hottowy, Pawel/R-4981-2019; Dabrowski, Wladyslaw/AAS-6369-2020	Dabrowski, Wladyslaw/0000-0001-9061-9568; Sher, Alexander/0000-0001-6655-6456; Meister, Markus/0000-0003-2136-6506; Uchida, Naoshige/0000-0002-5755-9409	McKnight Foundation; Gordon and Betty Moore Foundation; Polish Ministry of Science and Higher Education; National Science Foundation; Burroughs Wellcome Fund Career Award at the Scientific Interface	McKnight Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Foundation(National Science Foundation (NSF)); Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund)	We thank A. Leifer and E. Soucy for technical assistance and O. Mazor and A. Biewener for advice. Funding was provided by the McKnight Foundation (M. M., T. A. S.) the Gordon and Betty Moore Foundation (M. M.), the Polish Ministry of Science and Higher Education (W. D., P. H.), the National Science Foundation (PHY-0750525, A. M. L.) and the Burroughs Wellcome Fund Career Award at the Scientific Interface (A. S.).	Barlow H., 1961, SENSORY COMMUNICATIO, P217; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; BORTON DA, 2009, EMBC 2009 ANN INT C, P5531; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Calhoun J. B, 1963, ECOLOGY SOCIOLOGY NO; Chalupa LM, 2008, EYE RETINA VISUAL SY; Chestek CA, 2009, IEEE T NEUR SYS REH, V17, P330, DOI 10.1109/TNSRE.2009.2023293; Dabrowski W, 2005, NUCL INSTRUM METH A, V541, P405, DOI 10.1016/j.nima.2005.01.082; Dabrowski W, 2004, BIOSENS BIOELECTRON, V19, P749, DOI 10.1016/j.bios.2003.08.005; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Felsen G, 2005, NAT NEUROSCI, V8, P1643, DOI 10.1038/nn1608; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; GREGORY JA, 2009, EMBC 2009 ANN INT C, P3833; Grybos P, 2006, P 5 INT M SUBSTR INT, P208; Hampson RE, 2009, J NEUROSCI METH, V182, P195, DOI 10.1016/j.jneumeth.2009.06.007; Harrison RR, 2009, IEEE T NEUR SYS REH, V17, P322, DOI 10.1109/TNSRE.2009.2023298; Hottowy P, 2008, P 6 INT M SUBSTR INT, P261; Jermakowicz WJ, 2009, J NEUROPHYSIOL, V101, P2279, DOI 10.1152/jn.91207.2008; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Kohn A, 2009, CURR OPIN NEUROBIOL, V19, P434, DOI 10.1016/j.conb.2009.06.007; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lewen GD, 2001, NETWORK-COMP NEURAL, V12, P317, DOI 10.1088/0954-898X/12/3/305; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miranda H, 2010, IEEE T BIOMED CIRC S, V4, P181, DOI 10.1109/TBCAS.2010.2044573; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; SINNAMON HM, 1984, PHYSIOL BEHAV, V33, P185, DOI 10.1016/0031-9384(84)90098-2; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yamamoto J, 2008, J NEUROPHYSIOL, V100, P2430, DOI 10.1152/jn.90687.2008; YIN M, 2009, EMBC 2009 ANN INT C, P1608	38	132	138	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					263	U363		10.1038/nn.2730	http://dx.doi.org/10.1038/nn.2730			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21240274				2022-12-17	WOS:000286595400026
J	Hoeck, JD; Jandke, A; Blake, SM; Nye, E; Spencer-Dene, B; Brandner, S; Behrens, A				Hoeck, Joerg D.; Jandke, Anett; Blake, Sophia M.; Nye, Emma; Spencer-Dene, Bradley; Brandner, Sebastian; Behrens, Axel			Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun	NATURE NEUROSCIENCE			English	Article							RADIAL GLIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; CYCLIN-E; INTERMEDIATE PROGENITORS; FATE SPECIFICATION; PROTEIN; GENE; PHOSPHORYLATION	Neural stem and progenitor cells (NSCs/NPCs) give rise to neurons, astrocytes and oligodendrocytes. However, the mechanisms underlying the decision of a stem cell to either self-renew or differentiate are incompletely understood. We demonstrate here that Fbw7 (F-box and WD repeat domain containing-7), the substrate recognition component of an SCF (complex of SKP1, CUL1 and F-box protein)-type E3 ubiquitin ligase, is a key regulator of NSC/NPC viability and differentiation. The absence of Fbw7 in the mouse brain caused severely impaired stem cell differentiation and increased progenitor cell death. Fbw7 deficiency resulted in accumulation of two SCF(Fbw7) substrates, the transcription factors active Notch1 and N-terminally phosphorylated c-Jun. Genetic and pharmacological rescue experiments identified c-Jun as a key substrate of Fbw7 in controlling progenitor cell viability, whereas inhibition of Notch signaling alleviated the block in stem cell differentiation. Thus Fbw7 controls neurogenesis by antagonizing Notch and c-Jun N-terminal kinase (JNK)/c-Jun signaling.	[Hoeck, Joerg D.; Jandke, Anett; Blake, Sophia M.; Behrens, Axel] Canc Res UK London Res Inst, Mammalian Genet Lab, London, England; [Nye, Emma; Spencer-Dene, Bradley] Canc Res UK London Res Inst, Expt Pathol Lab, London, England; [Brandner, Sebastian] UCL, Inst Neurol, Dept Neurodegenerat Dis, Div Neuropathol, London, England	Cancer Research UK; Cancer Research UK; University of London; University College London	Behrens, A (corresponding author), Canc Res UK London Res Inst, Mammalian Genet Lab, London, England.	axel.behrens@cancer.org.uk	Jandke, Anett/AAK-4545-2021; Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-9821-0342; Behrens, Axel/0000-0002-1557-1143; Hoeck, Joerg/0000-0002-2142-1555; Jandke, Anett/0000-0002-7681-7952	Federation of the Societies of Biochemistry and Molecular Biology (FEBS); MRC [85704]; Cancer Research UK; Medical Research Council [G0800020] Funding Source: researchfish; MRC [G0800020] Funding Source: UKRI	Federation of the Societies of Biochemistry and Molecular Biology (FEBS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the Animal Unit, Equipment Park, FACS Lab and the Experimental Pathology Lab at the London Research Institute for technical help and advice on histology. We are grateful to F. Radtke (Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland) for floxed Notch1 mice. We thank R. Sancho for the data on Fbxw7 isoform expression in various tissues. We thank C. R. Da Costa, S. Marino and A. Martin-Villalba for critical reading of the manuscript. S. M. B. is supported by a Federation of the Societies of Biochemistry and Molecular Biology (FEBS) Long Term Fellowship. Part of this work is supported by an MRC project grant (85704) to A. B. The London Research Institute is funded by Cancer Research UK.	ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Behrens A, 2003, DEVELOPMENT, V130, P103, DOI 10.1242/dev.00186; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Besirli CG, 2005, J CELL BIOL, V170, P401, DOI 10.1083/jcb.200501138; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Fuchs SY, 2005, CANCER BIOL THER, V4, P506, DOI 10.4161/cbt.4.5.1703; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Hojo M, 2000, DEVELOPMENT, V127, P2515; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nelson BR, 2007, DEV BIOL, V304, P479, DOI 10.1016/j.ydbio.2007.01.001; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Sangfelt O, 2008, CELL CYCLE, V7, P1075, DOI 10.4161/cc.7.8.5648; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Tan YM, 2008, CANCER LETT, V271, P1, DOI 10.1016/j.canlet.2008.04.036; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Wang X, 2007, MOL CELL BIOL, V27, P7935, DOI 10.1128/MCB.00226-07; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018	45	132	133	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1365	U95		10.1038/nn.2644	http://dx.doi.org/10.1038/nn.2644			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935640				2022-12-17	WOS:000283658200017
J	Williams, MA; Baker, CI; Op de Beeck, HP; Shim, WM; Dang, S; Triantafyllou, C; Kanwisher, N				Williams, Mark A.; Baker, Chris I.; Op de Beeck, Hans P.; Shim, Won Mok; Dang, Sabin; Triantafyllou, Christina; Kanwisher, Nancy			Feedback of visual object information to foveal retinotopic cortex	NATURE NEUROSCIENCE			English	Article							FEATURE-BASED ATTENTION; CONTEXTUAL MODULATION; FMRI; REPRESENTATIONS; PATTERNS; AREAS; V1; DISCRIMINATION; STIMULATION; SELECTIVITY	The mammalian visual system contains an extensive web of feedback connections projecting from higher cortical areas to lower areas, including primary visual cortex. Although multiple theories have been proposed, the role of these connections in perceptual processing is not understood. We found that the pattern of functional magnetic resonance imaging response in human foveal retinotopic cortex contained information about objects presented in the periphery, far away from the fovea, which has not been predicted by prior theories of feedback. This information was position invariant, correlated with perceptual discrimination accuracy and was found only in foveal, but not peripheral, retinotopic cortex. Our data cannot be explained by differential eye movements, activation from the fixation cross, or spillover activation from peripheral retinotopic cortex or from lateral occipital complex. Instead, our findings indicate that position-invariant object information from higher cortical areas is fed back to foveal retinotopic cortex, enhancing task performance.	[Williams, Mark A.; Triantafyllou, Christina] MIT, McGovern Inst Brain Res, Athinoula A Martinos Imaging Ctr, Cambridge, MA 02139 USA; [Williams, Mark A.] Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia; [Baker, Chris I.] NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA; [Op de Beeck, Hans P.] Katholieke Univ Leuven, Expt Psychol Lab, B-3000 Louvain, Belgium; [Shim, Won Mok; Kanwisher, Nancy] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Macquarie University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); KU Leuven; Massachusetts Institute of Technology (MIT)	Williams, MA (corresponding author), MIT, McGovern Inst Brain Res, Athinoula A Martinos Imaging Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mark.williams@maccs.mq.edu.au	Baker, Chris/P-8442-2019; Triantafyllou, Christina/E-7724-2011	Baker, Chris/0000-0001-6861-8964; Shim, Won Mok/0000-0002-9107-0471; Op de Beeck, Hans/0000-0002-2250-212X; Williams, Mark/0000-0002-3897-5167	Australian National Health and Medical Research Council; US National Institutes of Health [EY013455, EY016159]; NATIONAL EYE INSTITUTE [R01EY013455, R01EY016159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002909] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank the members and friends of the Kanwisher laboratory for useful comments on the manuscript. M. A. W. was supported by a grant from the Australian National Health and Medical Research Council (C. J. Martin Fellowship) and H.P.O.d.B. was supported by the Research Foundation Flanders. This work was supported by grants from the US National Institutes of Health to N.K. (grants EY013455 and EY016159). We would also like to thank the Athinoula A. Martinos Imaging Center at the McGovern Institute for Brain Research for subsidizing the cost of scanning.	Angelucci A, 2002, J NEUROSCI, V22, P8633; Bressler D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000410; Carlson TA, 2003, J COGNITIVE NEUROSCI, V15, P704, DOI 10.1162/089892903322307429; Corthout E, 2004, EXP BRAIN RES, V156, P118, DOI 10.1007/s00221-004-1847-8; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Harrison LM, 2007, NEUROIMAGE, V34, P1199, DOI 10.1016/j.neuroimage.2006.10.017; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Heinen K, 2005, NEUROREPORT, V16, P1483, DOI 10.1097/01.wnr.0000175611.26485.c8; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Jehee JFM, 2007, BRAIN RES, V1157, P167, DOI 10.1016/j.brainres.2007.03.090; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Merriam EP, 2007, J NEUROPHYSIOL, V97, P1738, DOI 10.1152/jn.00189.2006; MUMFORD D, 1991, BIOL CYBERN, V65, P135, DOI 10.1007/BF00202389; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; Murray SO, 2002, P NATL ACAD SCI USA, V99, P15164, DOI 10.1073/pnas.192579399; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Olman CA, 2007, NEUROIMAGE, V34, P1126, DOI 10.1016/j.neuroimage.2006.08.045; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Schwarzlose RF, 2008, P NATL ACAD SCI USA, V105, P4447, DOI 10.1073/pnas.0800431105; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Slotnick SD, 2005, CEREB CORTEX, V15, P1570, DOI 10.1093/cercor/bhi035; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Viswanathan A, 2007, NAT NEUROSCI, V10, P1308, DOI 10.1038/nn1977; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; Williams MA, 2007, NAT NEUROSCI, V10, P685, DOI 10.1038/nn1900	35	132	134	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2008	11	12					1439	1445		10.1038/nn.2218	http://dx.doi.org/10.1038/nn.2218			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	375JF	18978780	Green Accepted			2022-12-17	WOS:000261109300017
J	Tankersley, D; Stowe, CJ; Huettel, SA				Tankersley, Dharol; Stowe, C. Jill; Huettel, Scott A.			Altruism is associated with an increased neural response to agency	NATURE NEUROSCIENCE			English	Article							EMPATHY; MIND; PSYCHOLOGY; OTHERS; PEOPLE	Although the neural mechanisms underlying altruism remain unknown, empathy and its component abilities, such as the perception of the actions and intentions of others, have been proposed as key contributors. Tasks requiring the perception of agency activate the posterior superior temporal cortex ( pSTC), particularly in the right hemisphere. Here, we demonstrate that differential activation of the human pSTC during action perception versus action performance predicts self-reported altruism.	Duke Univ, Fuqua Sch Business, Durham, NC 27708 USA; Duke Univ, Med Ctr, Ctr Neuroecon Studies, Durham, NC 27710 USA; Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Huettel, SA (corresponding author), Duke Univ, Fuqua Sch Business, 1 Towerview Dr, Durham, NC 27708 USA.	scott.huettel@duke.edu			PHS HHS [70685, 41328] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Post SG, 2005, INT J BEHAV MED, V12, P66, DOI 10.1207/s15327558ijbm1202_4; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022	14	132	139	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					150	151		10.1038/nn1833	http://dx.doi.org/10.1038/nn1833			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237779				2022-12-17	WOS:000244175200008
J	Chanda, B; Blunck, R; Faria, LC; Schweizer, FE; Mody, I; Bezanilla, F				Chanda, B; Blunck, R; Faria, LC; Schweizer, FE; Mody, I; Bezanilla, F			A hybrid approach to measuring electrical activity in genetically specified neurons	NATURE NEUROSCIENCE			English	Article							FLUORESCENT PROTEIN; CORTICAL ACTIVITY; TRANSGENIC MICE; NEURAL CIRCUITS; REAL-TIME; VOLTAGE; DYES; CELL; DISPLACEMENT; POTENTIALS	The development of genetically encoded fluorescent voltage probes is essential to image electrical activity from neuronal populations. Previous green fluorescent protein (GFP)-based probes have had limited success in recording electrical activity of neurons because of their low sensitivity and poor temporal resolution. Here we describe a hybrid approach that combines a genetically encoded fluorescent probe (membrane-anchored enhanced GFP) with dipicrylamine, a synthetic voltage-sensing molecule that partitions into the plasma membrane. The movement of the synthetic voltage sensor is translated via fluorescence resonance energy transfer (FRET) into a large fluorescence signal (up to 34% change per 100 mV) with a fast response and recovery time (0.5 ms). Using this two-component approach, we were able to optically record action potentials from neuronal cell lines and trains of action potentials from primary cultured neurons. This hybrid approach may form the basis for a new generation of protein-based voltage probes.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bezanilla, F (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	fbezanil@ucla.edu	Blunck, Rikard/AAM-3078-2020; Blunck, Rikard/L-4226-2013	Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907; Chanda, Baron/0000-0003-4954-7034	NIGMS NIH HHS [GM30376] Funding Source: Medline; NINDS NIH HHS [NS41317, NS30549] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030376, R01GM030376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041317, R37NS030549, R01NS030549] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; BEDLACK RS, 1994, NEURON, V13, P1187, DOI 10.1016/0896-6273(94)90056-6; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Blunck R, 2004, BIOPHYS J, V86, P3966, DOI 10.1529/biophysj.103.034512; Cacciatore TW, 1999, NEURON, V23, P449, DOI 10.1016/S0896-6273(00)80799-0; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Djurisic M, 2003, METHOD ENZYMOL, V361, P423; FERNANDEZ JM, 1983, J GEN PHYSIOL, V82, P331, DOI 10.1085/jgp.82.3.331; GONZALEZ JE, 1995, BIOPHYS J, V69, P1272, DOI 10.1016/S0006-3495(95)80029-9; Gordey M, 2001, NEUROSCIENCE, V105, P987, DOI 10.1016/S0306-4522(01)00234-2; GRINVALD A, 1987, BIOPHYS J, V51, P643, DOI 10.1016/S0006-3495(87)83389-1; HALES TG, 1994, NEUROENDOCRINOLOGY, V59, P297, DOI 10.1159/000126671; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Jiang W, 1998, BIOTECHNIQUES, V24, P349; KALYANARAMAN B, 1987, P NATL ACAD SCI USA, V84, P2999, DOI 10.1073/pnas.84.9.2999; Knopfel T, 2003, METHODS, V30, P42, DOI 10.1016/S1046-2023(03)00006-9; LIEKE EE, 1989, ANNU REV PHYSIOL, V51, P543, DOI 10.1146/annurev.physiol.51.1.543; LOEW LM, 1992, J MEMBRANE BIOL, V130, P1, DOI 10.1007/bf00233734; Metzger F, 2002, EUR J NEUROSCI, V15, P40, DOI 10.1046/j.0953-816x.2001.01837.x; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Miyawaki A, 2003, CURR OPIN NEUROBIOL, V13, P591, DOI 10.1016/j.conb.2003.09.005; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; ROHR S, 1994, BIOPHYS J, V67, P1301, DOI 10.1016/S0006-3495(94)80602-2; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; Salter-Cid L, 1999, P NATL ACAD SCI USA, V96, P5434, DOI 10.1073/pnas.96.10.5434; SALZBERG BM, 1977, J NEUROPHYSIOL, V40, P1281, DOI 10.1152/jn.1977.40.6.1281; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805	30	132	141	3	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1619	1626		10.1038/nn1558	http://dx.doi.org/10.1038/nn1558			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16205716				2022-12-17	WOS:000232966600038
J	Thomas, P; Mortensen, M; Hosie, AM; Smart, TG				Thomas, P; Mortensen, M; Hosie, AM; Smart, TG			Dynamic mobility of functional GABA(A) receptors at inhibitory synapses	NATURE NEUROSCIENCE			English	Article							ADULT-RAT BRAIN; GAMMA-2 SUBUNIT; BENZODIAZEPINE-RECEPTORS; SYNAPTIC-TRANSMISSION; GLYCINE RECEPTORS; BREFELDIN-A; TRAFFICKING; EXPRESSION; SUBTYPES; LOCALIZATION	Importing functional GABA(A) receptors into synapses is fundamental for establishing and maintaining inhibitory transmission and for controlling neuronal excitability. By introducing a binding site for an irreversible inhibitor into the GABA(A) receptor alpha 1 subunit channel lining region that can be accessed only when the receptor is activated, we have determined the dynamics of receptor mobility between synaptic and extrasynaptic locations in hippocampal pyramidal neurons. We demonstrate that the cell surface GABA(A) receptor population shows no fast recovery after irreversible inhibition. In contrast, after selective inhibition, the synaptic receptor population rapidly recovers by the import of new functional entities within minutes. The trafficking pathways that promote rapid importation of synaptic receptors do not involve insertion from intracellular pools, but reflect receptor diffusion within the plane of the membrane. This process offers the synapse a rapid mechanism to replenish functional GABA(A) receptors at inhibitory synapses and a means to control synaptic efficacy.	UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Smart, TG (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	t.smart@ucl.ac.uk		Mortensen, Martin/0000-0002-5873-7107	Medical Research Council [G0601529] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barnes EM, 1996, INT REV NEUROBIOL, V39, P53, DOI 10.1016/S0074-7742(08)60663-7; BENKE TA, 1993, P NATL ACAD SCI USA, V90, P7819, DOI 10.1073/pnas.90.16.7819; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; FRITSCHY JM, 1994, J NEUROSCI, V14, P5302; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Hutcheon B, 2004, EUR J NEUROSCI, V19, P2475, DOI 10.1111/j.0953-816X.2004.03349.x; KILLISCH I, 1991, NEURON, V7, P927, DOI 10.1016/0896-6273(91)90338-Z; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Mortensen M, 2004, J PHYSIOL-LONDON, V557, P389, DOI 10.1113/jphysiol.2003.054734; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Rasmussen H, 2002, MOL CELL NEUROSCI, V19, P201, DOI 10.1006/mcne.2001.1074; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Scotti AL, 2001, P NATL ACAD SCI USA, V98, P3489, DOI 10.1073/pnas.061028798; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; TEHRANI MHJ, 1991, J NEUROCHEM, V57, P1307, DOI 10.1111/j.1471-4159.1991.tb08295.x; Tovar KR, 2002, NEURON, V34, P253; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; VELAZQUEZ JL, 1989, J NEUROSCI, V9, P2163; Whiting PJ, 1995, INT REV NEUROBIOL, V38, P95, DOI 10.1016/S0074-7742(08)60525-5; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195	45	132	144	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					889	897		10.1038/nn1483	http://dx.doi.org/10.1038/nn1483			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15951809				2022-12-17	WOS:000230137100016
J	Liu, SQJ; Cull-Candy, SG				Liu, SQJ; Cull-Candy, SG			Subunit interaction with PICK and GRIP controls Ca2+ permeability of AMPARs at cerebellar synapses	NATURE NEUROSCIENCE			English	Article							GLUTAMATE-RECEPTOR CHANNELS; DOMAIN-CONTAINING PROTEINS; LONG-TERM DEPRESSION; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; FOREBRAIN ISCHEMIA; C-TERMINUS; GLUR-B; EXPRESSION; NSF	At many excitatory central synapses, activity produces a lasting change in the synaptic response by modifying postsynaptic AMPA receptors (AMPARs). Although much is known about proteins involved in the trafficking of Ca2+-impermeable (GluR2-containing) AMPARs, little is known about protein partners that regulate subunit trafficking and plasticity of Ca2+-permeable (GluR2-lacking) AMPARs. At cerebellar parallel fiber - stellate cell synapses, activity triggers a novel type of plasticity: Ca2+ influx through GluR2-lacking synaptic AMPARs drives incorporation of GluR2-containing AMPARs, generating rapid, lasting changes in excitatory postsynaptic current properties. Here we examine how glutamate receptor interacting protein ( GRIP, also known as AMPAR binding protein or ABP) and protein interacting with C-kinase-1 ( PICK) regulate subunit trafficking and plasticity. We find that repetitive synaptic activity triggers loss of synaptic GluR2-lacking AMPARs by selectively disrupting their interaction with GRIP and that PICK drives activity-dependent delivery of GluR2-containing receptors. This dynamic regulation of AMPARs provides a feedback mechanism for controlling Ca2+ permeability of synaptic receptors.	UCL, Dept Pharmacol, London WC1E 6BT, England; Penn State Univ, Dept Biol, State Coll, PA 16801 USA	University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Liu, SQJ (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	sjl16@psu.edu; s.cull-candy@ucl.ac.uk		Cull-Candy, Stuart G/0000-0002-0831-8326	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chung HJ, 2000, J NEUROSCI, V20, P7258; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Duprat F, 2003, PHILOS T ROY SOC B, V358, P715, DOI 10.1098/rstb.2002.1215; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Fuchs EC, 2001, P NATL ACAD SCI USA, V98, P3571, DOI 10.1073/pnas.051631898; Gardner SM, 1999, J NEUROSCI, V19, P8721, DOI 10.1523/JNEUROSCI.19-20-08721.1999; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lei SB, 2004, J NEUROSCI, V24, P2112, DOI 10.1523/JNEUROSCI.4645-03.2004; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Ogoshi F, 2003, J NEUROSCI, V23, P10521; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Washburn MS, 1997, J NEUROSCI, V17, P9393; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	50	132	140	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					768	775		10.1038/nn1468	http://dx.doi.org/10.1038/nn1468			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15895086				2022-12-17	WOS:000229345300017
J	Welchman, AE; Deubelius, A; Conrad, V; Bulthoff, HH; Kourtzi, Z				Welchman, AE; Deubelius, A; Conrad, V; Bulthoff, HH; Kourtzi, Z			3D shape perception from combined depth cues in human visual cortex	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; DISPARITY-SELECTIVE NEURONS; LATERAL OCCIPITAL COMPLEX; STRUCTURE-FROM-MOTION; SURFACE ORIENTATION; AREA MT; BINOCULAR DISPARITY; RELATIVE DISPARITY; CORTICAL-NEURONS; RESPONSES	Our perception of the world's three-dimensional (3D) structure is critical for object recognition, navigation and planning actions. To accomplish this, the brain combines different types of visual information about depth structure, but at present, the neural architecture mediating this combination remains largely unknown. Here, we report neuroimaging correlates of human 3D shape perception from the combination of two depth cues. We measured fMRI responses while observers judged the 3D structure of two sequentially presented images of slanted planes defined by binocular disparity and perspective. We compared the behavioral and fMRI responses evoked by changes in one or both of the depth cues. fMRI responses in extrastriate areas (hMT +/V5 and lateral occipital complex), rather than responses in early retinotopic areas, reflected differences in perceived 3D shape, suggesting 'combined-cue' representations in higher visual areas. These findings provide insight into the neural circuits engaged when the human brain combines different information sources for unified 3D visual perception.	Max Planck Inst Biol Cybernet, D-72012 Tubingen, Germany; Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	Max Planck Society; University of Birmingham	Kourtzi, Z (corresponding author), Max Planck Inst Biol Cybernet, Postfach 2169, D-72012 Tubingen, Germany.	zoe.kourtzi@tuebingen.mpg.de	Bülthoff, Heinrich/AAC-8818-2019; Bülthoff, Heinrich H/J-6579-2012; Welchman, Andrew/B-7542-2013	Bülthoff, Heinrich H/0000-0003-2568-0607; Welchman, Andrew/0000-0002-7559-3299; Kourtzi, Zoe/0000-0001-9441-7832				Albright T D, 1993, Rev Oculomot Res, V5, P177; Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; BACKUS BT, 2002, ADV NEURAL INFORMATI, V14; Bakin JS, 2000, J NEUROSCI, V20, P8188; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Clark J.J., 1990, DATA FUSION SENSORY; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; ENRIGHT JT, 1987, PERCEPTION, V16, P731, DOI 10.1068/p160731; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Gilaie-Dotan S, 2002, HUM BRAIN MAPP, V15, P67, DOI 10.1002/hbm.10008; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Hinkle DA, 2002, NAT NEUROSCI, V5, P665, DOI 10.1038/nn875; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Janssen P, 2001, J NEUROSCI, V21, P9419, DOI 10.1523/JNEUROSCI.21-23-09419.2001; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kourtzi Z, 2002, NAT NEUROSCI, V5, P17, DOI 10.1038/nn780; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Liu Y, 2004, J NEUROSCI, V24, P3795, DOI 10.1523/JNEUROSCI.0150-04.2004; Murray SO, 2003, CEREB CORTEX, V13, P508, DOI 10.1093/cercor/13.5.508; Neri P, 2004, J NEUROPHYSIOL, V92, P1880, DOI 10.1152/jn.01042.2003; Nguyenkim JD, 2003, J NEUROSCI, V23, P7117, DOI 10.1523/JNEUROSCI.23-18-07117.2003; Nienborg H, 2004, J NEUROSCI, V24, P2065, DOI 10.1523/JNEUROSCI.3887-03.2004; Orban GA, 2003, NEUROPSYCHOLOGIA, V41, P1757, DOI 10.1016/S0028-3932(03)00177-5; Palanca BJA, 2003, J NEUROSCI, V23, P7647; Paradis AL, 2000, CEREB CORTEX, V10, P772, DOI 10.1093/cercor/10.8.772; POGGIO GF, 1988, J NEUROSCI, V8, P4531; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Taira M, 2001, NEUROIMAGE, V14, P959, DOI 10.1006/nimg.2001.0895; Tanaka H, 2001, J NEUROPHYSIOL, V85, P735, DOI 10.1152/jn.2001.85.2.735; Thomas OM, 2002, NAT NEUROSCI, V5, P472, DOI 10.1038/nn837; Todd JT, 2004, TRENDS COGN SCI, V8, P115, DOI 10.1016/j.tics.2004.01.006; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Treue S, 1996, VISUAL NEUROSCI, V13, P797, DOI 10.1017/S095252380000866X; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Uka T, 2000, J NEUROPHYSIOL, V84, P120, DOI 10.1152/jn.2000.84.1.120; van Ee R, 2002, J VISION, V2, P597, DOI 10.1167/2.9.2; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; Watanabe M, 2002, J NEUROPHYSIOL, V87, P1960, DOI 10.1152/jn.00780.2000; ZEKI S, 1991, J NEUROSCI, V11, P641	50	132	133	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					820	827		10.1038/nn1461	http://dx.doi.org/10.1038/nn1461			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15864303				2022-12-17	WOS:000229345300024
J	Piper, M; Salih, S; Weinl, C; Holt, CE; Harris, WA				Piper, M; Salih, S; Weinl, C; Holt, CE; Harris, WA			Endocytosis-dependent desensitization and protein synthesis-dependent resensitization in retinal growth cone adaptation	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA; SIGNAL-TRANSDUCTION; RECEPTOR INTERNALIZATION; CHEMOTROPIC RESPONSES; MEDIATED ENDOCYTOSIS; HUMAN-NEUTROPHILS; SEMAPHORIN-III; EPHRIN-AS; F-ACTIN; CULTURE	It has been proposed that growth cones navigating through gradients adapt to baseline concentrations of guidance cues. This adaptation process is poorly understood. Using the collapse assay, we show that adaptation in Xenopus laevis retinal growth cones to the guidance cues Sema3A or netrin-1 involves two processes: a fast, ligand-specific desensitization that occurs within 2 min of exposure and is dependent on endocytosis, and a slower, ligand-specific resensitization, which occurs within 5 min and is dependent upon protein synthesis. These two phases of adaptation allow retinal axons to adjust their range of sensitivity to specific guidance cues.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Harris, WA (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	harris@mole.bio.cam.ac.uk	Piper, Michael J/B-2805-2010	Piper, Michael J/0000-0002-6759-2560; Holt, Christine Elizabeth/0000-0003-2829-121X; Salih, Saif/0000-0002-6877-6978	Wellcome Trust [070568] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bassell GJ, 1998, J NEUROSCI, V18, P251; Beaumont V, 1998, J BIOL CHEM, V273, P33174, DOI 10.1074/jbc.273.50.33174; Bibikov SI, 2004, J BACTERIOL, V186, P3730, DOI 10.1128/JB.186.12.3730-3737.2004; Bourke E, 2003, J IMMUNOL, V170, P5999, DOI 10.4049/jimmunol.170.12.5999; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Ferguson SSG, 1998, SEMIN CELL DEV BIOL, V9, P119, DOI 10.1006/scdb.1997.0216; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HERTEL C, 1985, J BIOL CHEM, V260, P2547; Jurney WM, 2002, J NEUROSCI, V22, P6019; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P1595; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; Li CX, 2004, J NEUROSCI, V24, P6161, DOI 10.1523/JNEUROSCI.1476-04.2004; LITMAN P, 1993, NEURON, V10, P627, DOI 10.1016/0896-6273(93)90165-N; Loschinger J, 2000, PHILOS T ROY SOC B, V355, P971, DOI 10.1098/rstb.2000.0633; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; OlinkCoux M, 1996, J NEUROSCI, V16, P1346; Pol A, 1998, FEBS LETT, V441, P34, DOI 10.1016/S0014-5793(98)01517-8; Ray E, 1996, FEBS LETT, V378, P235, DOI 10.1016/0014-5793(95)01462-4; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rosentreter SM, 1998, J NEUROBIOL, V37, P541, DOI 10.1002/(SICI)1097-4695(199812)37:4<541::AID-NEU4>3.3.CO;2-C; Sakurai T, 2002, P NATL ACAD SCI USA, V99, P10795, DOI 10.1073/pnas.162161499; SAMANTA AK, 1990, J BIOL CHEM, V265, P183; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Smythies J, 2000, P ROY SOC B-BIOL SCI, V267, P1363, DOI 10.1098/rspb.2000.1151; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sotelo-Silveira JR, 2000, J NEUROSCI RES, V62, P65, DOI 10.1002/1097-4547(20001001)62:1<65::AID-JNR7>3.0.CO;2-Z; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taylor BL, 2004, J BACTERIOL, V186, P3671, DOI 10.1128/JB.186.12.3671-3673.2004; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001	48	132	132	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					179	186		10.1038/nn1380	http://dx.doi.org/10.1038/nn1380			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15643427	Green Accepted			2022-12-17	WOS:000226638200017
J	Bensafi, M; Porter, J; Pouliot, S; Mainland, J; Johnson, B; Zelano, C; Young, N; Bremner, E; Aframian, D; Khan, R; Sobel, N				Bensafi, M; Porter, J; Pouliot, S; Mainland, J; Johnson, B; Zelano, C; Young, N; Bremner, E; Aframian, D; Khan, R; Sobel, N			Olfactomotor activity during imagery mimics that during perception	NATURE NEUROSCIENCE			English	Article							MITRAL CELL-ACTIVITY; CORTEX	Neural representations created in the absence of external sensory stimuli are referred to as imagery(1), and such representations may be augmented by reenactment of sensorimotor processes(2). We measured nasal airflow in human subjects while they imagined sights, sounds and smells, and only during olfactory imagery did subjects spontaneously enact the motor component of olfaction-that is, they sniffed. Moreover, as in perception(3,4), imagery of pleasant odors involved larger sniffs than imagery of unpleasant odors, suggesting that the act of sniffing has a functional role in creating of olfactory percepts.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; McGill Univ, Montreal Neurol Inst, Dept Psychol, Montreal, PQ, Canada	University of California System; University of California Berkeley; University of California System; University of California Berkeley; McGill University	Bensafi, M (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, 3210 Tolman Hall MC 1650, Berkeley, CA 94720 USA.		Bensafi, Moustafa/H-6618-2017; Mainland, Joel/C-5171-2009	Bensafi, Moustafa/0000-0002-2991-3036; Mainland, Joel/0000-0002-5056-4598; Sobel, Noam/0000-0002-3232-9391				Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Elmes DG, 1998, CHEM SENSES, V23, P443, DOI 10.1093/chemse/23.4.443; Fontanini A, 2003, J NEUROSCI, V23, P7993; FREEMAN WJ, 1983, BIOL PSYCHIAT, V18, P1107; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Herz RS, 2000, MEM COGNITION, V28, P957, DOI 10.3758/BF03209343; Johnson B. N., 2003, J NEUROPHYSIOL; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; KOSSLYN SM, 1995, NEUROPSYCHOLOGIA, V33, P1335, DOI 10.1016/0028-3932(95)00067-D; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; LAING DG, 1983, PERCEPTION, V12, P99, DOI 10.1068/p120099; Leopold D, 2002, CHEM SENSES, V27, P611, DOI 10.1093/chemse/27.7.611; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; TEGHTSOONIAN R, 1978, J EXP PSYCHOL HUMAN, V4, P144, DOI 10.1037/0096-1523.4.1.144	15	132	137	0	23	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1142	1144		10.1038/nn1145	http://dx.doi.org/10.1038/nn1145			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	737KH	14566343				2022-12-17	WOS:000186229200012
J	Turnley, AM; Faux, CH; Rietze, RL; Coonan, JR; Bartlett, PF				Turnley, AM; Faux, CH; Rietze, RL; Coonan, JR; Bartlett, PF			Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELL; VENTRICULAR ZONE; SOCS PROTEINS; MOUSE-BRAIN; RECEPTOR; GENES; PRECURSORS; MECHANISMS; PROLIFERATION	The intracellular mechanisms that determine the response of neural progenitor cells to growth factors and regulate their differentiation into either neurons or astrocytes remain unclear. We found that expression of SOCS2, an intracellular regulator of cytokine signaling, was restricted to mouse progenitor cells and neurons in response to leukemia inhibitory factor (LIF)-like cytokines. Progenitors lacking SOCS2 produced fewer neurons and more astrocytes in vitro, and Socs2(-/-) mice had fewer neurons and neurogenin-1 (Ngn1)-expressing cells in the developing cortex, whereas overexpression of SOCS2 increased neuronal differentiation. We also report that growth hormone inhibited Ngn1 expression and neuronal production, and this action was blocked by SOCS2 overexpression. These findings indicate that SOCS2 promotes neuronal differentiation by blocking growth hormone-mediated downregulation of Ngn1.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Queensland, Inst Brain Res, Brisbane, Qld 4072, Australia; Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Queensland; University of Melbourne	Bartlett, PF (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.	bartlett@wehi.edu.au	Bartlett, Perry/F-3813-2012; Turnley, Ann/A-8125-2010	Turnley, Ann/0000-0002-8442-127X				Bartlett PF, 1998, IMMUNOL CELL BIOL, V76, P414, DOI 10.1046/j.1440-1711.1998.00762.x; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Cai L, 2000, DEVELOPMENT, V127, P3021; DELFS J, 1980, NATURE, V283, P676, DOI 10.1038/283676a0; EDENS A, 1994, ENDOCRINOLOGY, V135, P2802, DOI 10.1210/en.135.6.2802; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Faux CH, 2001, J NEUROSCI, V21, P5587, DOI 10.1523/JNEUROSCI.21-15-05587.2001; Fode C, 2000, GENE DEV, V14, P67; Greenhalgh CJ, 2002, MOL ENDOCRINOL, V16, P1394, DOI 10.1210/me.16.6.1394; Hansen JA, 1999, MOL ENDOCRINOL, V13, P1832, DOI 10.1210/me.13.11.1832; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; HOJVAT S, 1982, BRAIN RES, V239, P543, DOI 10.1016/0006-8993(82)90529-7; HOJVAT S, 1982, DEV BRAIN RES, V4, P427, DOI 10.1016/0165-3806(82)90186-9; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; KRULICH L, 1968, ENDOCRINOLOGY, V83, P783, DOI 10.1210/endo-83-4-783; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Li WW, 1998, J NEUROSCI, V18, P8853; LOBIE PE, 1993, DEV BRAIN RES, V74, P225, DOI 10.1016/0165-3806(93)90008-X; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Polizzotto MN, 2000, J COMP NEUROL, V423, P348; Rajan P, 1998, J NEUROSCI, V18, P3620; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Ram PK, 2000, J BIOL CHEM, V275, P39487, DOI 10.1074/jbc.M004755200; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Richards LJ, 1996, EUR J NEUROSCI, V8, P291, DOI 10.1111/j.1460-9568.1996.tb01213.x; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Thomas HE, 1997, J NEUROIMMUNOL, V78, P132, DOI 10.1016/S0165-5728(97)00091-X; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4	41	132	137	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1155	1162		10.1038/nn954	http://dx.doi.org/10.1038/nn954			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368809				2022-12-17	WOS:000178884600018
J	Bockenhauer, D; Zilberberg, N; Goldstein, SAN				Bockenhauer, D; Zilberberg, N; Goldstein, SAN			KCNK2: reversible conversion of a hippocampal potassium leak into a voltage-dependent channel	NATURE NEUROSCIENCE			English	Article							DOMAIN K+ CHANNEL; 2 PORE DOMAINS; YEAST K+; FUNCTIONAL EXPRESSION; INWARD RECTIFICATION; TASK-1; PERMEABILITY; CURRENTS; SINGLE; FAMILY	Potassium leak channels are essential to neurophysiological function. Leaks suppress excitability through maintenance of resting membrane potential below the threshold for action potential firing. Conversely, voltage-dependent potassium channels permit excitation because they do not interfere with rise to threshold, and they actively promote recovery and rapid re-firing. Previously attributed to distinct transport pathways, we demonstrate here that phosphorylation of single, native hippocampal and cloned KCNK2 potassium channels produces reversible interconversion between leak and voltage-dependent phenotypes. The findings reveal a pathway for dynamic regulation of excitability.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA	Yale University; Yale University	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, 295 Congress Ave, New Haven, CT 06536 USA.	steve.goldstein@yale.edu	Bockenhauer, Detlef/C-5951-2008; Zilberberg, Noam/F-2005-2012; Bockenhauer, Detlef/AAF-6495-2020; Goldstein, Steven A./E-9817-2015	Bockenhauer, Detlef/0000-0001-5878-941X; Bockenhauer, Detlef/0000-0001-5878-941X; Zilberberg, Noam/0000-0002-7848-2391; Goldstein, Steven A./0000-0001-5207-5061				ADAMS DJ, 1980, ANNU REV NEUROSCI, V3, P141, DOI 10.1146/annurev.ne.03.030180.001041; Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; BACKX PH, 1993, CIRC RES, V72, P890, DOI 10.1161/01.RES.72.4.890; BAKER M, 1987, J PHYSIOL-LONDON, V383, P45; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Buckler KJ, 1997, J PHYSIOL-LONDON, V498, P649, DOI 10.1113/jphysiol.1997.sp021890; CHANG DC, 1986, BIOPHYS J, V50, P1095, DOI 10.1016/S0006-3495(86)83553-6; Colecraft HM, 2000, J GEN PHYSIOL, V115, P175, DOI 10.1085/jgp.115.2.175; Colquhoun David, 1995, P483; EVES EM, 1992, P NATL ACAD SCI USA, V89, P4373, DOI 10.1073/pnas.89.10.4373; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Goldstein SAN, 1998, J MOL MED-JMM, V76, P13, DOI 10.1007/s109-1998-8100-0; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Hille B, 1975, Membranes, V3, P255; HILLE B, 1973, J GEN PHYSIOL, V61, P669, DOI 10.1085/jgp.61.6.669; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Ilan N, 2001, BIOPHYS J, V80, P241, DOI 10.1016/S0006-3495(01)76010-9; JONES SW, 1989, NEURON, V3, P153, DOI 10.1016/0896-6273(89)90028-7; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Loukin SH, 1999, BIOPHYS J, V77, P3060, DOI 10.1016/S0006-3495(99)77137-7; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Meadows HJ, 2000, PFLUG ARCH EUR J PHY, V439, P714, DOI 10.1007/s004240050997; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; SCHMIDT H, 1966, PFLUG ARCH GES PHYS, V287, P311, DOI 10.1007/BF00363245; SHEN KZ, 1992, J PHYSIOL-LONDON, V445, P581, DOI 10.1113/jphysiol.1992.sp018941; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; Vergani P, 1997, FEBS LETT, V405, P337, DOI 10.1016/S0014-5793(97)00211-1; Vergani P, 1998, EMBO J, V17, P7190, DOI 10.1093/emboj/17.24.7190; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4; Zilberberg N, 2000, J GEN PHYSIOL, V116, P721, DOI 10.1085/jgp.116.5.721	46	132	139	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					486	491		10.1038/87434	http://dx.doi.org/10.1038/87434			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319556	Green Submitted			2022-12-17	WOS:000168412600011
J	Horenstein, J; Wagner, DA; Czajkowski, C; Akabas, MH				Horenstein, J; Wagner, DA; Czajkowski, C; Akabas, MH			Protein mobility and GABA-induced conformational changes in GABA(A) receptor pore-lining M2 segment	NATURE NEUROSCIENCE			English	Article							GATED ION-CHANNEL; ZN2+ BINDING-SITE; ACETYLCHOLINE-RECEPTOR; BETA-SUBUNIT; POINT MUTATIONS; ALPHA-SUBUNIT; A RECEPTORS; IDENTIFICATION; STOICHIOMETRY; AFFINITY	Protein movements underlying ligand-gated ion channel activation are poorly understood. Here we used disulfide bond trapping to examine the proximity and mobility of cysteines substituted for aligned GABA(A) receptor alpha (1) and beta (1) M2 segment channel-lining residues in resting and activated receptors. With or without GABA, disulfide bonds formed at alpha (1)N275C/beta (1)E270C (20') and alpha (1)S272C/beta (1)H267C (17'), near the extracellular end, suggesting that this end is more mobile and/or flexible than the rest of the segment. Near the middle of M2, at alpha (1)T261C/beta (1)T256C (6'), a disulfide bond formed only in the presence of GABA and locked the channels open. Channel activation must involve an asymmetric rotation of two adjacent subunits toward each other. This would move aligned engineered cysteines on different subunits into proximity and allow disulfide bond formation without blocking conduction. Asymmetric rotation of M2 segments is probably a common gating mechanism in other ligand-gated ion channels.	Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Columbia Univ, Dept Physiol, New York, NY 10032 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University; University of Wisconsin System; University of Wisconsin Madison	Akabas, MH (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, 1300 Morris Pk Ave, Bronx, NY 10461 USA.			Akabas, Myles/0000-0001-8781-7846	NIGMS NIH HHS [GM61925] Funding Source: Medline; NINDS NIH HHS [NS30808, NS34727] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030808, R01NS034727] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amato A, 1999, J PHYSIOL-LONDON, V517, P35, DOI 10.1111/j.1469-7793.1999.0035z.x; AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Boileau AJ, 1999, J NEUROSCI, V19, P4847; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Chang YC, 1996, J NEUROSCI, V16, P5415; CHARNET P, 1990, NEURON, V2, P87; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Gage PW, 1998, IMMUNOL CELL BIOL, V76, P436, DOI 10.1046/j.1440-1711.1998.00763.x; GURLEY D, 1995, RECEPTOR CHANNEL, V3, P13; HAMILTON SL, 1979, BIOCHEMISTRY-US, V18, P155, DOI 10.1021/bi00568a024; HIGAKI JN, 1992, TRENDS BIOCHEM SCI, V17, P100, DOI 10.1016/0968-0004(92)90245-5; Horenstein J, 1998, MOL PHARMACOL, V53, P870; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Krovetz HS, 1997, BIOPHYS J, V72, P117, DOI 10.1016/S0006-3495(97)78651-X; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033; Pan ZH, 2000, NEUROSCIENCE, V98, P333, DOI 10.1016/S0306-4522(00)00114-7; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Sieghart W, 1999, NEUROCHEM INT, V34, P379, DOI 10.1016/S0197-0186(99)00045-5; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; SMITH GB, 1994, J BIOL CHEM, V269, P20380; Tretter V, 1997, J NEUROSCI, V17, P2728; TWYMAN RE, 1992, J PHYSIOL-LONDON, V445, P97, DOI 10.1113/jphysiol.1992.sp018914; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Wooltorton JRA, 1997, J PHYSIOL-LONDON, V505, P633, DOI 10.1111/j.1469-7793.1997.633ba.x; Wu JH, 1996, P NATL ACAD SCI USA, V93, P14498, DOI 10.1073/pnas.93.25.14498; Xu M, 1995, BIOPHYS J, V69, P1858, DOI 10.1016/S0006-3495(95)80056-1; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; YU HB, 1995, BIOCHEMISTRY-US, V34, P14963, DOI 10.1021/bi00046a002; Zhang H, 1998, BIOCHEMISTRY-US, V37, P7952, DOI 10.1021/bi980143m	37	132	136	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					477	485		10.1038/87425	http://dx.doi.org/10.1038/87425			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319555				2022-12-17	WOS:000168412600010
J	Harmer, CJ; Thilo, KV; Rothwell, JC; Goodwin, GM				Harmer, CJ; Thilo, KV; Rothwell, JC; Goodwin, GM			Transcranial magnetic stimulation of medial-frontal cortex impairs the processing of angry facial expressions	NATURE NEUROSCIENCE			English	Article							DIFFERENTIAL NEURAL RESPONSE; ANTERIOR CINGULATE CORTEX; HUMAN AMYGDALA; RECOGNITION; EMOTION; DISGUST		Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; Inst Neurol, MRC, Human Movement & Balance Unit, London WC1N 3BG, England	University of Oxford; University of London; University College London	Harmer, CJ (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Roosevelt Dr, Oxford OX3 7JX, England.		Goodwin, Guy/ABE-6084-2020	Harmer, Catherine/0000-0002-1609-8335; Rothwell, John/0000-0003-1367-6467				ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Drevets WC, 1999, ANN NY ACAD SCI, V877, P614, DOI 10.1111/j.1749-6632.1999.tb09292.x; George MS, 1997, J NEUROPSYCH CLIN N, V9, P55; Gray JM, 1997, BRAIN, V120, P2029, DOI 10.1093/brain/120.11.2029; Jahanshahi M, 2000, EXP BRAIN RES, V131, P1, DOI 10.1007/s002219900224; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Phillips ML, 1999, PSYCHIAT RES-NEUROIM, V92, P11, DOI 10.1016/S0925-4927(99)00031-1; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P125; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6	14	132	132	1	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					17	18		10.1038/82854	http://dx.doi.org/10.1038/82854			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135640				2022-12-17	WOS:000167178000009
J	Peng, YW; Hao, Y; Petters, RM; Wong, F				Peng, YW; Hao, Y; Petters, RM; Wong, F			Ectopic synaptogenesis in the mammalian retina caused by rod photoreceptor-specific mutations	NATURE NEUROSCIENCE			English	Article							C-LIKE IMMUNOREACTIVITY; BIPOLAR CELLS; MORPHOMETRIC ANALYSIS; HORIZONTAL CELLS; TRANSGENIC MICE; AMACRINE CELLS; OUTER SEGMENTS; ANIMAL-MODEL; MUTANT MICE; RIM PROTEIN	In addition to rod photoreceptor loss, many mutations in rod photoreceptor-specific genes cause degeneration of other neuronal types. Identifying mechanisms of cell-cell interactions initiated by rod-specific mutations and affecting other retinal cells is important for understanding the pathogenesis and progression of retinal degeneration. Here we show in animals with rod and cone degeneration due to mutations in the genes encoding rhodopsin and cGMP phosphodiesterase beta -subunit (PDE-beta) respectively, that rod bipolar cells received ectopic synapses from cones in the absence of rods. Thus, synaptic plasticity links certain rod-specific mutations to retina-wide structural alterations that involve different types of neurons.	Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27710 USA; Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; N Carolina State Univ, Dept Anim Sci, Raleigh, NC 27695 USA; Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; University of North Carolina; North Carolina State University; Duke University	Wong, F (corresponding author), Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27710 USA.				NATIONAL EYE INSTITUTE [P30EY005722, R01EY011498] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY11498, P30EY05722] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Banin E, 1999, NEURON, V23, P549, DOI 10.1016/S0896-6273(00)80807-7; BERSON EL, 1979, ARCH OPHTHALMOL-CHIC, V97, P1286, DOI 10.1001/archopht.1979.01020020028006; BERSON EL, 1969, ARCH OPHTHALMOL-CHIC, V81, P226; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; BIRD AC, 1995, AM J OPHTHALMOL, V119, P543, DOI 10.1016/S0002-9394(14)70212-0; BLANKS JC, 1974, J COMP NEUROL, V156, P95, DOI 10.1002/cne.901560108; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; Brandstatter JH, 1996, J COMP NEUROL, V370, P1, DOI 10.1002/(SICI)1096-9861(19960617)370:1<1::AID-CNE1>3.0.CO;2-7; Brandstatter JH, 1998, VISION RES, V38, P1385, DOI 10.1016/S0042-6989(97)00176-4; CASINI G, 1995, J COMP NEUROL, V356, P132, DOI 10.1002/cne.903560109; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; CIDECIYAN AV, 1993, INVEST OPHTH VIS SCI, V34, P3253; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; Dowling J.E., 1987, RETINA APPROACHABLE; DRYJA TP, 1995, INVEST OPHTH VIS SCI, V36, P1197; FARBER DB, 1994, PROG RETIN EYE RES, V13, P31, DOI 10.1016/1350-9462(94)90004-3; Fariss RN, 2000, AM J OPHTHALMOL, V129, P215, DOI 10.1016/S0002-9394(99)00401-8; Gal A, 1997, PROG RETIN EYE RES, V16, P51, DOI 10.1016/S1350-9462(96)00021-3; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; GRUNERT U, 1994, J COMP NEUROL, V348, P607, DOI 10.1002/cne.903480410; HUANG PC, 1993, P NATL ACAD SCI USA, V90, P8484, DOI 10.1073/pnas.90.18.8484; Humayun MS, 1999, INVEST OPHTH VIS SCI, V40, P143; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Kedzierski W, 1998, J NEUROSCI, V18, P4076; Lam BL, 1999, OPHTHALMOLOGY, V106, P1109, DOI 10.1016/S0161-6420(99)90263-4; Lewis GP, 1998, INVEST OPHTH VIS SCI, V39, P424; LI ZY, 1995, J NEUROSCI, V15, P5429; LOLLEY RN, 1994, INVEST OPHTH VIS SCI, V35, P358; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; NEGISHI K, 1988, NEUROSCI LETT, V94, P247, DOI 10.1016/0304-3940(88)90025-0; ONG OC, 1995, J BIOL CHEM, V270, P8495, DOI 10.1074/jbc.270.15.8495; PEICHL L, 1984, SCIENCE, V223, P503, DOI 10.1126/science.6691162; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; Sieving P A, 1993, Trans Am Ophthalmol Soc, V91, P701; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; STERLING P, 1998, SYNAPTIC ORG BRAIN, P205; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; Vardi N, 1998, J COMP NEUROL, V395, P43; WASSLE H, 1991, VISUAL NEUROSCI, V7, P99, DOI 10.1017/S095252380001097X; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WASSLE H, 1993, J COMP NEUROL, V332, P407; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Ying SX, 2000, MOL VIS, V6, P101	49	132	135	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1121	1127		10.1038/80639	http://dx.doi.org/10.1038/80639			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036269				2022-12-17	WOS:000167177600017
J	Tresch, MC; Kiehn, O				Tresch, MC; Kiehn, O			Motor coordination without action potentials in the mammalian spinal cord	NATURE NEUROSCIENCE			English	Article							METHYL-D-ASPARTATE; VITRO NEONATAL RAT; IN-VITRO; VOLTAGE OSCILLATIONS; MEMBRANE-PROPERTIES; LOCOMOTOR-ACTIVITY; NEURAL MECHANISMS; NEURONS; MOTONEURONS; PACEMAKER	Coordination of neuronal activity to produce movement is generally thought to depend on spike activity in premotor interneuronal networks. Here we show that even without such activity, the neonatal rat spinal cord could produce a stable motor rhythm mediated by the synchronization of motor neuron oscillations across gap junctions. These rhythms, however, were not coordinated between motor pools in different parts of the spinal cord. We further showed that neural coordination through gap junctions contributed to the fundamental organization and function of spinal motor systems. These results suggest that neural coordination across gap junctions is important in motor-pattern generation in the mammalian spinal cord.	Univ Copenhagen, Panum Inst, Dept Physiol, Sect Neurophysiol, DK-2200 Copenhagen N, Denmark	University of Copenhagen	Kiehn, O (corresponding author), Univ Copenhagen, Panum Inst, Dept Physiol, Sect Neurophysiol, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	O.Kiehn@mfi.ku.dk	Kiehn, Ole/C-4679-2008; Tresch, Matthew C/B-7634-2009; kiehn, ole/AAT-7881-2021; kiehn, ole/AAB-1262-2019					Bennett MVL, 1997, J NEUROCYTOL, V26, P349, DOI 10.1023/A:1018560803261; Bernstein NA., 1967, COORDINATION REGULAT; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Chang Q, 1999, J NEUROSCI, V19, P10813, DOI 10.1523/JNEUROSCI.19-24-10813.1999; Chang QA, 2000, J NEUROSCI, V20, P674, DOI 10.1523/JNEUROSCI.20-02-00674.2000; COWLEY KC, 1994, NEUROSCI LETT, V171, P147, DOI 10.1016/0304-3940(94)90626-2; FULTON BP, 1980, PROC R SOC SER B-BIO, V208, P115, DOI 10.1098/rspb.1980.0045; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; HAYDON DA, 1986, J PHYSIOL-LONDON, V373, P311, DOI 10.1113/jphysiol.1986.sp016049; Hille B., 1992, IONIC CHANNELS EXCIT; HOCHMAN S, 1994, J NEUROPHYSIOL, V72, P565, DOI 10.1152/jn.1994.72.2.565; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; JOHNSON SM, 1994, J NEUROPHYSIOL, V72, P2598, DOI 10.1152/jn.1994.72.6.2598; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; KEPLER TB, 1990, SCIENCE, V248, P83, DOI 10.1126/science.2321028; Kiehn O, 1996, NEUROSCIENCE, V75, P263, DOI 10.1016/0306-4522(96)00250-3; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; KIEHN O, 1997, NEURONS NETWORKS MOT, P47; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; KUDO N, 1987, J PHYSIOL-LONDON, V389, P441, DOI 10.1113/jphysiol.1987.sp016665; MacLean JN, 1997, EUR J NEUROSCI, V9, P2702, DOI 10.1111/j.1460-9568.1997.tb01699.x; Manor Y, 1997, J NEUROPHYSIOL, V77, P2736, DOI 10.1152/jn.1997.77.5.2736; MATSUSHIMA T, 1992, J NEUROPHYSIOL, V67, P373, DOI 10.1152/jn.1992.67.2.373; Milner LD, 1999, J NEUROSCI, V19, P3007; Moore LE, 1999, J NEUROSCI, V19, P8271; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Prime L, 1999, J NEUROPHYSIOL, V82, P1069, DOI 10.1152/jn.1999.82.2.1069; Raastad M, 1998, P NATL ACAD SCI USA, V95, P10251, DOI 10.1073/pnas.95.17.10251; Rash JE, 1996, P NATL ACAD SCI USA, V93, P4235, DOI 10.1073/pnas.93.9.4235; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Rekling JC, 1997, J NEUROPHYSIOL, V78, P3508, DOI 10.1152/jn.1997.78.6.3508; SHERMAN A, 1992, P NATL ACAD SCI USA, V89, P2471, DOI 10.1073/pnas.89.6.2471; SILLAR KT, 1994, EUR J MORPHOL, V32, P185; SILLAR KT, 1994, EUR J MORPHOL, V32, P293; SMITH JC, 1988, FASEB J, V2, P2283, DOI 10.1096/fasebj.2.7.2450802; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; van der Want JJL, 1998, BRAIN RES, V779, P342, DOI 10.1016/S0006-8993(97)01238-9; WALLEN P, 1987, J NEUROSCI, V7, P2745; WALTON KD, 1991, J PHYSIOL-LONDON, V433, P283, DOI 10.1113/jphysiol.1991.sp018426	42	132	132	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					593	599		10.1038/75768	http://dx.doi.org/10.1038/75768			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816316				2022-12-17	WOS:000087249500016
J	Joiner, WJ; Tang, MD; Wang, LY; Dworetzky, SI; Boissard, CG; Gan, L; Gribkoff, VK; Kaczmarek, LK				Joiner, WJ; Tang, MD; Wang, LY; Dworetzky, SI; Boissard, CG; Gan, L; Gribkoff, VK; Kaczmarek, LK			Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits	NATURE NEUROSCIENCE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ADRENAL CHROMAFFIN CELLS; PROTEIN-KINASE-A; BETA-SUBUNIT; RAT-BRAIN; SMOOTH-MUSCLE; N-TERMINUS; VOLTAGE; EXPRESSION; MODULATION	Large-conductance calcium-activated potassium channels (maxi-K channels) have an essential role in the control of excitability and secretion. Only one gene Slo is known to encode maxi-K channels, which are sensitive to both membrane potential and intracellular calcium. We have isolated a potassium channel gene called Slack that is abundantly expressed in the nervous system. Slack channels rectify outwardly with a unitary conductance of about 25-65 pS and are inhibited by intracellular calcium. However, when Slack is co-expressed with Slo, channels with pharmacological properties and single-channel conductances that do not match either Slack or Slo are formed. The Slack/Slo channels have intermediate conductances of about 60-180 pS and are activated by cytoplasmic calcium. Our findings indicate that some intermediate-conductance channels in the nervous system may result from an interaction between Slack and Slo channel subunits.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Neurosci Drug Discovery, Wallingford, CT 06492 USA	Yale University; Yale University; Bristol-Myers Squibb	Kaczmarek, LK (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	kaczmarek@yale.edu						ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chang CP, 1997, MOL BRAIN RES, V45, P33, DOI 10.1016/S0169-328X(96)00230-6; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; DRYER SE, 1991, J PHYSIOL-LONDON, V443, P601, DOI 10.1113/jphysiol.1991.sp018854; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; DWORETZKY SI, 1994, MOL BRAIN RES, V27, P189, DOI 10.1016/0169-328X(94)90203-8; FARLEY J, 1988, BIOPHYS J, V53, P919, DOI 10.1016/S0006-3495(88)83173-4; Hanner M, 1997, P NATL ACAD SCI USA, V94, P2853, DOI 10.1073/pnas.94.7.2853; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hirsch JR, 1997, WIEN KLIN WOCHENSCHR, V109, P485; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Jones EMC, 1998, P ROY SOC B-BIOL SCI, V265, P685, DOI 10.1098/rspb.1998.0348; Kang J, 1996, J NEUROPHYSIOL, V76, P4194, DOI 10.1152/jn.1996.76.6.4194; Kanyicska B, 1997, ENDOCRINOLOGY, V138, P3141, DOI 10.1210/en.138.8.3141; Knaus HG, 1996, J NEUROSCI, V16, P955; LANCASTER B, 1991, J NEUROSCI, V11, P23; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; Lingle C J, 1996, Ion Channels, V4, P261; MCCOBB DP, 1995, AM J PHYSIOL, V267, pH767; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Mienville JM, 1996, PFLUG ARCH EUR J PHY, V431, P763, DOI 10.1007/s004240050063; Morita T, 1997, AM J PHYSIOL-RENAL, V273, pF615, DOI 10.1152/ajprenal.1997.273.4.F615; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; PACHA J, 1991, AM J PHYSIOL, V261, pF696, DOI 10.1152/ajprenal.1991.261.4.F696; Papazian DM, 1997, NEWS PHYSIOL SCI, V12, P203; PETERSEN OH, 1984, NATURE, V307, P693, DOI 10.1038/307693a0; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; REINHART PH, 1991, J NEUROSCI, V11, P1627; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Rosenblatt KP, 1997, NEURON, V19, P1061, DOI 10.1016/S0896-6273(00)80397-9; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Sakaba T, 1997, NEUROSCI RES, V27, P219, DOI 10.1016/S0168-0102(97)01155-3; Sansom SC, 1997, J BIOL CHEM, V272, P9902; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; STORM JF, 1990, PROG BRAIN RES, V83, P161; TORO L, 1991, AM J PHYSIOL, V260, pH1779, DOI 10.1152/ajpheart.1991.260.6.H1779; TRAUTMANN A, 1984, P NATL ACAD SCI-BIOL, V81, P611, DOI 10.1073/pnas.81.2.611; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; Wang WH, 1997, ANNU REV PHYSIOL, V59, P413, DOI 10.1146/annurev.physiol.59.1.413; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Xia XM, 1998, J NEUROSCI, V18, P2360	50	132	141	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					462	469		10.1038/2176	http://dx.doi.org/10.1038/2176			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196543				2022-12-17	WOS:000076406900010
J	Lloyd, AF; Davies, CL; Holloway, RK; Labrak, Y; Ireland, G; Carradori, D; Dillenburg, A; Borger, E; Soong, D; Richardson, JC; Kuhlmann, T; Williams, A; Pollard, JW; des Rieux, A; Priller, J; Miron, VE				Lloyd, Amy F.; Davies, Claire L.; Holloway, Rebecca K.; Labrak, Yasmine; Ireland, Graeme; Carradori, Dario; Dillenburg, Alessandra; Borger, Eva; Soong, Daniel; Richardson, Jill C.; Kuhlmann, Tanja; Williams, Anna; Pollard, Jeffrey W.; des Rieux, Anne; Priller, Josef; Miron, Veronique E.			Central nervous system regeneration is driven by microglia necroptosis and repopulation	NATURE NEUROSCIENCE			English	Article							MYELINOGENESIS; MACROPHAGES; ACTIVATION; PHENOTYPE; PATHWAY; CELL	Failed regeneration of CNS myelin contributes to clinical decline in neuroinflammatory and neurodegenerative diseases, for which there is an unmet therapeutic need. Here we reveal that efficient remyelination requires death of pro-inflammatory microglia followed by repopulation to a pro-regenerative state. We propose that impaired microglia death and/or repopulation may underpin dysregulated microglia activation in neurological diseases, and we reveal therapeutic targets to promote white matter regeneration.	[Lloyd, Amy F.; Davies, Claire L.; Holloway, Rebecca K.; Ireland, Graeme; Dillenburg, Alessandra; Soong, Daniel; Pollard, Jeffrey W.; Miron, Veronique E.] Univ Edinburgh, Med Res Council Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Labrak, Yasmine; Carradori, Dario; des Rieux, Anne] Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, Brussels, Belgium; [Borger, Eva; Williams, Anna] Univ Edinburgh, Med Res Council Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Richardson, Jill C.] GlaxoSmithKline Res & Dev Ltd, Neurosci Therapeut Area Unit, Stevenage, Herts, England; [Kuhlmann, Tanja] Univ Hosp Muenster, Inst Neuropathol, Munster, Germany; [Priller, Josef] Charite Univ Med Berlin, Dept Neuropsychiat, Berlin, Germany; [Priller, Josef] Charite Univ Med Berlin, Lab Mol Psychiat, Berlin, Germany; [Priller, Josef] Univ Edinburgh, United Kingdom Dementia Res Inst, Edinburgh, Midlothian, Scotland; [Richardson, Jill C.] London Biosci Innovat Ctr, Merck Sharp & Dohme, Discovery Res MRL UK, London, England	University of Edinburgh; Universite Catholique Louvain; University of Edinburgh; GlaxoSmithKline; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Edinburgh; University of London; University of London Royal Veterinary College	Miron, VE (corresponding author), Univ Edinburgh, Med Res Council Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	vmiron@ed.ac.uk	Miron, Veronique E./H-4280-2019; Priller, Josef/ABW-3835-2022	Miron, Veronique E./0000-0003-1738-0647; Priller, Josef/0000-0001-7596-0979; Lloyd, Amy/0000-0002-1168-5370; des Rieux, Anne/0000-0001-9953-3816; Richardson, Jill/0000-0001-6564-3187; Holloway, Rebecca/0000-0002-9396-7776	Biotechnology and Biological Sciences Research Council (BBSRC)-Collaborative Award in Science and Engineering studentship; GlaxoSmithKline [BB/M502777/1]; Medical Research Council; United Kingdom Multiple Sclerosis Society Career Development Award [MR/M020827/1]; Medical Research Council Centre for Reproductive Health [MR/N02256/1]; Wellcome Trust [101067/Z/13/Z]; Momentum Award from the United Kingdom Dementia Research Institute; German Research Foundation [SFB-TR167]; F.R.S.-FNRS; Fondation Charcot Stichting; International Foundation for Research in Paraplegia; MRC [MC_PC_16031, MR/P016022/1, MR/N022556/1, MR/S035915/1, MR/M020827/1] Funding Source: UKRI; Medical Research Council [MR/N022556/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)-Collaborative Award in Science and Engineering studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Kingdom Multiple Sclerosis Society Career Development Award; Medical Research Council Centre for Reproductive Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Momentum Award from the United Kingdom Dementia Research Institute; German Research Foundation(German Research Foundation (DFG)); F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS); Fondation Charcot Stichting; International Foundation for Research in Paraplegia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Biotechnology and Biological Sciences Research Council (BBSRC)-Collaborative Award in Science and Engineering studentship in collaboration with GlaxoSmithKline (V.E.M., J.C.R.; grant no. BB/M502777/1), a Medical Research Council and United Kingdom Multiple Sclerosis Society Career Development Award (V.E.M.; grant no. MR/M020827/1), funds from the Medical Research Council Centre for Reproductive Health (grant no. MR/N02256/1) and the Wellcome Trust (J.W.P.; grant no. 101067/Z/13/Z), and a Momentum Award from the United Kingdom Dementia Research Institute (J.P.). The cuprizone studies were supported by the German Research Foundation (T.K.; grant no. SFB-TR128-B7). The Cx3cr1-CreER experiments were supported by the German Research Foundation (J.P.; grant no. SFB-TR167). The LNC studies were supported by grants from F.R.S.-FNRS (A.d.R. and Y.L.), the Fondation Charcot Stichting and the International Foundation for Research in Paraplegia (A.d.R.). We thank the United Kingdom Multiple Sclerosis Society Tissue Bank for providing tissue, F. Roncaroli for neuropathological diagnosis of multiple sclerosis lesions and R. Nicholas for providing clinical history of patients with multiple sclerosis. We also thank I. Molina-Gonzalez, M. Tzioras, N. Fullerton, C. Watkins, C. Bottcher and J. Jamal El-Din for technical support, and O. Dando for helpful discussions.	Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Caccamo A, 2017, NAT NEUROSCI, V20, P1236, DOI 10.1038/nn.4608; Elmore MRP, 2018, AGING CELL, V17, DOI 10.1111/acel.12832; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Franklin RJM, 2017, NAT REV NEUROSCI, V18, P753, DOI 10.1038/nrn.2017.136; Hagemeyer N, 2017, ACTA NEUROPATHOL, V134, P441, DOI 10.1007/s00401-017-1747-1; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Huang YB, 2018, NAT NEUROSCI, V21, P530, DOI 10.1038/s41593-018-0090-8; J.C.O, 2007, VENNY INTERACTIVE TO; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Krukowski K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26039-7; Lewis ND, 2014, J NEUROIMMUNOL, V277, P26, DOI 10.1016/j.jneuroim.2014.09.014; Mei F, 2016, ELIFE, V5, DOI 10.7554/eLife.18246; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Rice RA, 2017, GLIA, V65, P931, DOI 10.1002/glia.23135; Rubino SJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05929-4; Wlodarczyk A, 2017, EMBO J, V36, P3292, DOI 10.15252/embj.201696056	21	131	132	3	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2019	22	7					1046	+		10.1038/s41593-019-0418-Z	http://dx.doi.org/10.1038/s41593-019-0418-Z			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IE8GO	31182869	Green Accepted			2022-12-17	WOS:000472612100004
J	Park, IM; Meister, MLR; Huk, AC; Pillow, JW				Park, Il Memming; Meister, Miriam L. R.; Huk, Alexander C.; Pillow, Jonathan W.			Encoding and decoding in parietal cortex during sensorimotor decision-making	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; PROBABILISTIC POPULATION CODES; SINGLE-TRIAL ANALYSIS; PERCEPTUAL DECISION; CUE SALIENCE; ACCUMULATOR MODEL; NEURAL MECHANISMS; NEURONS; LIP; MONKEY	It has been suggested that the lateral intraparietal area (LIP) of macaques plays a fundamental role in sensorimotor decision-making. We examined the neural code in LIP at the level of individual spike trains using a statistical approach based on generalized linear models. We found that LIP responses reflected a combination of temporally overlapping task- and decision-related signals. Our model accounts for the detailed statistics of LIP spike trains and accurately predicts spike trains from task events on single trials. Moreover, we derived an optimal decoder for heterogeneous, multiplexed LIP responses that could be implemented in biologically plausible circuits. In contrast with interpretations of LIP as providing an instantaneous code for decision variables, we found that optimal decoding requires integrating LIP spikes over two distinct timescales. These analyses provide a detailed understanding of neural representations in LIP and a framework for studying the coding of multiplexed signals in higher brain areas.	[Park, Il Memming; Huk, Alexander C.; Pillow, Jonathan W.] Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA; [Park, Il Memming; Huk, Alexander C.; Pillow, Jonathan W.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Park, Il Memming; Meister, Miriam L. R.; Huk, Alexander C.; Pillow, Jonathan W.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Meister, Miriam L. R.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Huk, Alexander C.] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA; [Pillow, Jonathan W.] Univ Texas Austin, Dept Stat & Data Sci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Pillow, JW (corresponding author), Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA.	pillow@mail.utexas.edu	Park, Memming/N-3092-2016; Huk, Alexander/A-8031-2016	Park, Memming/0000-0002-4255-7750; Huk, Alexander/0000-0003-1430-6935; Pillow, Jonathan/0000-0002-3638-8831	National Eye Institute [EY017366]; National Institute of Mental Health [MH099611]; Sloan Foundation; McKnight Foundation; National Science Foundation CAREER award [IIS-1150186]; Div Of Information & Intelligent Systems [1150186] Funding Source: National Science Foundation; NATIONAL EYE INSTITUTE [R01EY017366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099611] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sloan Foundation(Alfred P. Sloan Foundation); McKnight Foundation; National Science Foundation CAREER award(National Science Foundation (NSF)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Yates, K. Latimer and L. Cormack for discussions, K. Eastman for assistance with data collection, and C. Rorex and S. Winston for technical support. This project was supported by grants from the National Eye Institute (EY017366 to A.C.H.) and the National Institute of Mental Health (MH099611 to J.W.P. and A.C.H.), by the Sloan Foundation (J.W.P.), McKnight Foundation (J.W.P.), and a National Science Foundation CAREER award (IIS-1150186 to J.W.P.).	Barbieri R, 2005, IEEE T NEUR SYS REH, V13, P131, DOI 10.1109/TNSRE.2005.847368; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Bollimunta A, 2012, J NEUROSCI, V32, P12684, DOI 10.1523/JNEUROSCI.5752-11.2012; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Brown EN, 1998, J NEUROSCI, V18, P7411; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Fernandes HL, 2014, CEREB CORTEX, V24, P3232, DOI 10.1093/cercor/bht179; Foley NC, 2014, J NEUROSCI, V34, P7947, DOI 10.1523/JNEUROSCI.4171-13.2014; Fusi S, 2007, NEURON, V54, P319, DOI 10.1016/j.neuron.2007.03.017; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Gottlieb J, 2010, TRENDS COGN SCI, V14, P240, DOI 10.1016/j.tics.2010.03.001; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Huk AC, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00086; Jacobs AL, 2009, P NATL ACAD SCI USA, V106, P5936, DOI 10.1073/pnas.0900573106; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Jenison RL, 2011, J NEUROSCI, V31, P331, DOI 10.1523/JNEUROSCI.4461-10.2011; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Leathers ML, 2013, SCIENCE, V340, DOI 10.1126/science.1233367; Leathers ML, 2012, SCIENCE, V338, P132, DOI 10.1126/science.1226405; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Meister MLR, 2013, J NEUROSCI, V33, P2254, DOI 10.1523/JNEUROSCI.2984-12.2013; Newsome WT, 2013, SCIENCE, V340, DOI 10.1126/science.1233214; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Paninski L, 2004, J NEUROSCI, V24, P8551, DOI 10.1523/JNEUROSCI.0919-04.2004; Park J, 2010, J NEUROPHYSIOL, V103, P2664, DOI 10.1152/jn.00733.2009; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Premereur E, 2011, J NEUROSCI, V31, P12307, DOI 10.1523/JNEUROSCI.2241-11.2011; Purcell BA, 2012, J NEUROSCI, V32, P3433, DOI 10.1523/JNEUROSCI.4622-11.2012; Rishel CA, 2013, NEURON, V77, P969, DOI 10.1016/j.neuron.2013.01.007; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Schall JD, 2011, EUR J NEUROSCI, V33, P1991, DOI 10.1111/j.1460-9568.2011.07715.x; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Soltani A, 2010, NAT NEUROSCI, V13, P112, DOI 10.1038/nn.2450; Steenrod SC, 2013, J NEUROPHYSIOL, V109, P2596, DOI 10.1152/jn.00349.2012; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wong KF, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.006.2007; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008	50	131	132	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2014	17	10					1395	1403		10.1038/nn.3800	http://dx.doi.org/10.1038/nn.3800			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP8KD	25174005	Green Accepted			2022-12-17	WOS:000342327000020
J	Mendoza-Halliday, D; Torres, S; Martinez-Trujillo, JC				Mendoza-Halliday, Diego; Torres, Santiago; Martinez-Trujillo, Julio C.			Sharp emergence of feature-selective sustained activity along the dorsal visual pathway	NATURE NEUROSCIENCE			English	Article							CORTICAL AREA MT; WORKING-MEMORY; PREFRONTAL CORTEX; MOTION ADAPTATION; NEURAL MECHANISMS; NEURONS; DIRECTION; PARIETAL; SIGNALS; ATTENTION	Sustained activity encoding visual working memory representations has been observed in several cortical areas of primates. Where along the visual pathways this activity emerges remains unknown. Here we show in macaques that sustained spiking activity encoding memorized visual motion directions is absent in direction-selective neurons in early visual area middle temporal (MT). However, it is robustly present immediately downstream, in multimodal association area medial superior temporal (MST), as well as and in the lateral prefrontal cortex (LPFC). This sharp emergence of sustained activity along the dorsal visual pathway suggests a functional boundary between early visual areas, which encode sensory inputs, and downstream association areas, which additionally encode mnemonic representations. Moreover, local field potential oscillations in MT encoded the memorized directions and, in the low frequencies, were phase-coherent with LPFC spikes. This suggests that LPFC sustained activity modulates synaptic activity in MT, a putative top-down mechanism by which memory signals influence stimulus processing in early visual cortex.	[Mendoza-Halliday, Diego; Torres, Santiago; Martinez-Trujillo, Julio C.] McGill Univ, Dept Physiol, Cognit Neurophysiol Lab, Montreal, PQ, Canada	McGill University	Martinez-Trujillo, JC (corresponding author), McGill Univ, Dept Physiol, Cognit Neurophysiol Lab, Montreal, PQ, Canada.	julio.martinez@mcgill.ca	Martinez-Trujillo, Julio C/M-2146-2015; Mendoza-Halliday, Diego/C-5867-2008	Martinez-Trujillo, Julio C/0000-0003-3338-578X; Mendoza-Halliday, Diego/0000-0002-7185-472X	Canadian Institutes of Health Research (CIHR); Canada Research Chairs Program (CRC); EJLB Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program (CRC)(Canada Research ChairsAustralian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); EJLB Foundation	This study was supported by grants awarded to J.C.M.-T. from the Canadian Institutes of Health Research (CIHR), the Canada Research Chairs Program (CRC) and the EJLB Foundation. We thank M. Schneiderman for assistance with electrophysiological recordings, and W. Kucharski and S. Nuara for technical assistance.	ANDERSEN RA, 1987, EXP BRAIN RES, V67, P316; Angelaki DE, 2011, J PHYSIOL-LONDON, V589, P825, DOI 10.1113/jphysiol.2010.194720; Ardid S, 2007, J NEUROSCI, V27, P8486, DOI 10.1523/JNEUROSCI.1145-07.2007; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Bartolo MJ, 2011, EUR J NEUROSCI, V34, P1857, DOI 10.1111/j.1460-9568.2011.07877.x; Bisley JW, 2004, J NEUROPHYSIOL, V91, P286, DOI 10.1152/jn.00870.2003; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Cohen MR, 2009, J NEUROSCI, V29, P6635, DOI 10.1523/JNEUROSCI.5179-08.2009; Constantinidis Christos, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P444, DOI 10.3758/CABN.4.4.444; Denker M, 2011, CEREB CORTEX, V21, P2681, DOI 10.1093/cercor/bhr040; FERRERA VP, 1994, J NEUROSCI, V14, P6171; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Glasser DM, 2011, P NATL ACAD SCI USA, V108, pE1080, DOI 10.1073/pnas.1101141108; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; Hussar CR, 2013, J NEUROSCI, V33, P972, DOI 10.1523/JNEUROSCI.4075-12.2013; Khawaja FA, 2009, J NEUROSCI, V29, P13702, DOI 10.1523/JNEUROSCI.2844-09.2009; Lebedev MA, 2004, PLOS BIOL, V2, P1919, DOI 10.1371/journal.pbio.0020365; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Lennert T, 2011, NEURON, V70, P141, DOI 10.1016/j.neuron.2011.02.041; Liebe S, 2012, NAT NEUROSCI, V15, P456, DOI 10.1038/nn.3038; Lim S, 2013, NAT NEUROSCI, V16, P1306, DOI 10.1038/nn.3492; Lui LL, 2011, J NEUROPHYSIOL, V106, P1260, DOI 10.1152/jn.00016.2011; Magri C, 2012, J NEUROSCI, V32, P1395, DOI 10.1523/JNEUROSCI.3985-11.2012; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; Mendoza D, 2011, J VISION, V11, DOI 10.1167/11.1.11; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Miller EK, 1996, J NEUROSCI, V16, P5154; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Ninomiya T, 2012, J NEUROSCI, V32, P6851, DOI 10.1523/JNEUROSCI.6295-11.2012; Nobre AC, 2004, J COGNITIVE NEUROSCI, V16, P363, DOI 10.1162/089892904322926700; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Priebe NJ, 2002, J NEUROPHYSIOL, V88, P354, DOI 10.1152/jn.00852.2001; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; SAITO H, 1986, J NEUROSCI, V6, P145; Salazar RF, 2012, SCIENCE, V338, P1097, DOI 10.1126/science.1224000; Sneve MH, 2012, NEUROIMAGE, V63, P166, DOI 10.1016/j.neuroimage.2012.06.053; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Suzuki M, 2013, NAT NEUROSCI, V16, P98, DOI 10.1038/nn.3282; Swaminathan SK, 2012, NAT NEUROSCI, V15, P315, DOI 10.1038/nn.3016; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Van Wezel RJA, 2002, J NEUROPHYSIOL, V88, P3469, DOI 10.1152/jn.00276.2002; Zaksas D, 2006, J NEUROSCI, V26, P11726, DOI 10.1523/JNEUROSCI.3420-06.2006	50	131	131	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2014	17	9					1255	1262		10.1038/nn.3785	http://dx.doi.org/10.1038/nn.3785			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO2DJ	25108910	Green Accepted, Green Published			2022-12-17	WOS:000341125400020
J	Mazzoni, EO; Mahony, S; Closser, M; Morrison, CA; Nedelec, S; Williams, DJ; An, DS; Gifford, DK; Wichterle, H				Mazzoni, Esteban O.; Mahony, Shaun; Closser, Michael; Morrison, Carolyn A.; Nedelec, Stephane; Williams, Damian J.; An, Disi; Gifford, David K.; Wichterle, Hynek			Synergistic binding of transcription factors to cell-specific enhancers programs motor neuron identity	NATURE NEUROSCIENCE			English	Article							EMBRYONIC STEM-CELLS; DIRECT CONVERSION; SPINAL-CORD; HUMAN FIBROBLASTS; DEFINED FACTORS; PHOX2 GENES; EXPRESSION; MOUSE; MOTONEURONS; DIFFERENTIATION	Efficient transcriptional programming promises to open new frontiers in regenerative medicine. However, mechanisms by which programming factors transform cell fate are unknown, preventing more rational selection of factors to generate desirable cell types. Three transcription factors, Ngn2, Isl1 and Lhx3, were sufficient to program rapidly and efficiently spinal motor neuron identity when expressed in differentiating mouse embryonic stem cells. Replacement of Lhx3 by Phox2a led to specification of cranial, rather than spinal, motor neurons. Chromatin immunoprecipitation-sequencing analysis of Isl1, Lhx3 and Phox2a binding sites revealed that the two cell fates were programmed by the recruitment of Isl1-Lhx3 and Isl1-Phox2a complexes to distinct genomic locations characterized by a unique grammar of homeodomain binding motifs. Our findings suggest that synergistic interactions among transcription factors determine the specificity of their recruitment to cell type-specific binding sites and illustrate how a single transcription factor can be repurposed to program different cell types.	[Mazzoni, Esteban O.; Closser, Michael; Morrison, Carolyn A.; Nedelec, Stephane; Wichterle, Hynek] Columbia Univ, Ctr Motor Neuron Biol & Dis, Columbia Stem Cell Initiat, Dept Pathol & Cell Biol,Med Ctr, New York, NY 10027 USA; [Mazzoni, Esteban O.; Closser, Michael; Morrison, Carolyn A.; Nedelec, Stephane; Wichterle, Hynek] Columbia Univ, Ctr Motor Neuron Biol & Dis, Columbia Stem Cell Initiat, Dept Neurol,Med Ctr, New York, NY USA; [Mazzoni, Esteban O.; Closser, Michael; Morrison, Carolyn A.; Nedelec, Stephane; Wichterle, Hynek] Columbia Univ, Ctr Motor Neuron Biol & Dis, Columbia Stem Cell Initiat, Dept Neurosci,Med Ctr, New York, NY USA; [Mazzoni, Esteban O.; An, Disi] NYU, Dept Biol, New York, NY 10003 USA; [Mahony, Shaun; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Mahony, Shaun] Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Williams, Damian J.] Columbia Univ, Med Ctr, Dept Physiol & Cellular Biophys, New York, NY USA	Columbia University; Columbia University; Columbia University; New York University; Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Columbia University	Mazzoni, EO (corresponding author), Columbia Univ, Ctr Motor Neuron Biol & Dis, Columbia Stem Cell Initiat, Dept Pathol & Cell Biol,Med Ctr, New York, NY 10027 USA.	eom204@nyu.edu; gifford@mit.edu; hw350@columbia.edu	Young, Richard A/F-6495-2012; Williams, Damian/K-4023-2014; Mahony, Shaun/C-5699-2014; Nedelec, Stéphane/G-8469-2017; Martinat, Cecile/F-6777-2010	Young, Richard A/0000-0001-8855-8647; Mahony, Shaun/0000-0002-2641-1807; Nedelec, Stéphane/0000-0001-8044-2498; Williams, Damian/0000-0001-5891-6300; mazzoni, esteban/0000-0001-8994-681X; Wichterle, Hynek/0000-0002-7817-0080; Martinat, Cecile/0000-0002-5234-1064; An, Disi/0000-0002-3821-7497	Damon Runyon Cancer Research Foundation [DRG-1937-07]; Project ALS foundation; US National Institutes of Health [P01 NS055923, R01 NS078097]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923, R01NS078097] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Project ALS foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank I. Lieberam (King's College) for assistance introducing the Hb9-GFP transgene, members of the Wichterle laboratory for helpful comments, S. Brenner-Morton and T. Jessell (Columbia University) for sharing clones of Isl monoclonal antibodies, J.-F. Brunet for Phox2a and Phox2b antibodies, and I. Schieren for technical assistance with flow cytometry. E.O.M. receives funding from the Damon Runyon Cancer Research Foundation (DRG-1937-07). Personnel and work were supported by the Project ALS foundation and US National Institutes of Health grants P01 NS055923 (D.K.G. and H.W.) and R01 NS078097 (H.W.).	Albuquerque C., 2009, COLD SPRING HARBOR P, V8; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brunet JF, 2002, CURR OPIN GENET DEV, V12, P435, DOI 10.1016/S0959-437X(02)00322-2; Coppola E, 2005, EMBO J, V24, P4392, DOI 10.1038/sj.emboj.7600897; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dillon AK, 2005, J NEUROSCI, V25, P10119, DOI 10.1523/JNEUROSCI.3455-05.2005; Gao BX, 1998, J NEUROPHYSIOL, V80, P3047, DOI 10.1152/jn.1998.80.6.3047; Grillet N, 2003, J NEUROSCI, V23, P10613; Guo YC, 2010, BIOINFORMATICS, V26, P3028, DOI 10.1093/bioinformatics/btq590; Hasan KB, 2010, DEVELOPMENT, V137, P1205, DOI 10.1242/dev.041251; Hester ME, 2011, MOL THER, V19, P1905, DOI 10.1038/mt.2011.135; Hirsch MR, 2007, DEV BIOL, V303, P687, DOI 10.1016/j.ydbio.2006.12.006; Holmes G, 2001, DEV DYNAM, V222, P301, DOI 10.1002/dvdy.1182; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2012, P NATL ACAD SCI USA, V109, P3383, DOI 10.1073/pnas.1114515109; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; Mazzoni EO, 2011, NAT METHODS, V8, P1056, DOI [10.1038/NMETH.1775, 10.1038/nmeth.1775]; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MOORE RY, 1989, J COMP NEUROL, V282, P512, DOI 10.1002/cne.902820404; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Song MR, 2006, DEVELOPMENT, V133, P4945, DOI 10.1242/dev.02694; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wichterle Hynek, 2009, V482, P171, DOI 10.1007/978-1-59745-060-7_11; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	49	131	135	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1219	U86		10.1038/nn.3467	http://dx.doi.org/10.1038/nn.3467			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872598	Green Published, Green Accepted			2022-12-17	WOS:000323597500013
J	Kwon, HB; Kozorovitskiy, Y; Oh, WJ; Peixoto, RT; Akhtar, N; Saulnier, JL; Gu, CH; Sabatini, BL				Kwon, Hyung-Bae; Kozorovitskiy, Yevgenia; Oh, Won-Jong; Peixoto, Rui T.; Akhtar, Nazia; Saulnier, Jessica L.; Gu, Chenghua; Sabatini, Bernardo L.			Neuroligin-1-dependent competition regulates cortical synaptogenesis and synapse number	NATURE NEUROSCIENCE			English	Article							CELL-ADHESION MOLECULE; INHIBITORY SYNAPSES; DENDRITIC SPINES; NEUROLIGIN; NEUREXIN; PLASTICITY; PSD-95; MECHANISMS; MUTATIONS; AMYGDALA	Members of the neuroligin family of cell-adhesion proteins are found at excitatory and inhibitory synapses and are mutated in some familial forms of autism spectrum disorders. Although they display synaptogenic properties in heterologous systems, the function of neuroligins in vivo in the regulation of synapse formation and synapse number has been difficult to establish. We found that neuroligin-1 (NL1), which is located at excitatory postsynaptic densities, regulates activity-dependent synaptogenesis and mature synapse number on cortical layer 2/3 pyramidal neurons in vivo. However, synapse number was not sensitive to absolute NL1 levels but instead depended on transcellular differences in the relative amounts of NL1. These effects were independent of the cell-autonomous regulation of NMDA-type glutamate receptors by absolute levels of NL1. Our data indicate that transcellular competitive processes govern synapse formation and number in developing cortex and that NL1 has a central function in these processes.	[Kwon, Hyung-Bae; Kozorovitskiy, Yevgenia; Peixoto, Rui T.; Akhtar, Nazia; Saulnier, Jessica L.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Kozorovitskiy, Yevgenia/GOP-1185-2022	Kozorovitskiy, Yevgenia/0000-0002-3710-1484	US National Institutes of Health [R01NS064583]; Leonard and Isabelle Goldenson Research Fellowship; SFARI grant from the Simons Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064583, R01NS046579] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leonard and Isabelle Goldenson Research Fellowship; SFARI grant from the Simons Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Sabatini laboratory for their constructive comments on the manuscript. We also thank A. Giessel, J.F. Sturgill and B. Bloodgood for helping us with data analysis. We are grateful to F. Varoqueaux and N. Brose (Max Planck Institute for Experimental Medicine) for providing mouse NL1 expression vector and Nlgn1<SUP>+/-</SUP> mice. This work was supported by US National Institutes of Health grant R01NS064583 (to C. G.), a Leonard and Isabelle Goldenson Research Fellowship (to Y.K.) and a SFARI grant from the Simons Foundation (to B.L.S.).	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Barrow SL, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-17; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dresbach T, 2004, MOL CELL NEUROSCI, V27, P227, DOI 10.1016/j.mcn.2004.06.013; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Jung SY, 2010, P NATL ACAD SCI USA, V107, P4710, DOI 10.1073/pnas.1001084107; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kim J, 2008, P NATL ACAD SCI USA, V105, P9087, DOI 10.1073/pnas.0803448105; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; McClelland AC, 2010, P NATL ACAD SCI USA, V107, P8830, DOI 10.1073/pnas.0910644107; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Santamaria F, 2006, NEURON, V52, P635, DOI 10.1016/j.neuron.2006.10.025; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sturgill JF, 2009, J NEUROSCI, V29, P12845, DOI 10.1523/JNEUROSCI.1841-09.2009; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	54	131	134	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1667	+		10.1038/nn.3256	http://dx.doi.org/10.1038/nn.3256			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23143522	Green Accepted, Green Submitted			2022-12-17	WOS:000311706700012
J	Riccio, A				Riccio, Antonella			Dynamic epigenetic regulation in neurons: enzymes, stimuli and signaling pathways	NATURE NEUROSCIENCE			English	Review							HISTONE DEACETYLASE INHIBITORS; RUBINSTEIN-TAYBI SYNDROME; GENE-EXPRESSION; NITRIC-OXIDE; NERVOUS-SYSTEM; TRANSCRIPTION FACTORS; ARGININE METHYLATION; CHROMATIN REGULATION; SYNAPTIC PLASTICITY; BDNF TRANSCRIPTION	The development and function of neurons require the regulated expression of large numbers of very specific gene sets. Epigenetic modifications of both DNA and histone proteins are now emerging as fundamental mechanisms by which neurons adapt their transcriptional response to developmental and environmental cues. In the nervous system, the mechanisms by which extracellular signals regulate the activity of chromatin-modifying enzymes have just begun to be characterized. In this Review, I discuss how extracellular cues, including synaptic activity and neurotrophic factors, influence epigenetic modifications and regulate the neuronal transcriptional response. I also summarize additional mechanisms that induce chromatin remodeling events by combinatorial assembly of multiprotein complexes on neuronal gene promoters.	[Riccio, Antonella] UCL, MRC, Lab Mol & Cell Biol, London, England; [Riccio, Antonella] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London; University of London; University College London	Riccio, A (corresponding author), UCL, MRC, Lab Mol & Cell Biol, London, England.	a.riccio@ucl.ac.uk			MRC; MRC [G120/934, G0802010] Funding Source: UKRI; Medical Research Council [G0802010, G120/934] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The author is grateful to L. Crepaldi and A. Nott for reading the manuscript. A. R. is the recipient of an MRC Senior Non Clinical Fellowship.	Bai SM, 2005, MOL CELL BIOL, V25, P751, DOI 10.1128/MCB.25.2.751-766.2005; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Bowman GD, 2010, CURR OPIN STRUC BIOL, V20, P73, DOI 10.1016/j.sbi.2009.12.002; Brandl A, 2009, BIOL CELL, V101, P193, DOI 10.1042/BC20080158; BREDT DS, 1994, NEURON, V13, P301, DOI 10.1016/0896-6273(94)90348-4; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; Contestabile A, 2008, PROG NEUROBIOL, V84, P317, DOI 10.1016/j.pneurobio.2008.01.002; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Crosio C, 2003, J CELL SCI, V116, P4905, DOI 10.1242/jcs.00804; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dhakshinamoorthy S, 2007, NUCLEIC ACIDS RES, V35, P5439, DOI 10.1093/nar/gkm594; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Goodman RH, 2000, GENE DEV, V14, P1553; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Liu YZ, 1999, NEUROREPORT, V10, P1239, DOI 10.1097/00001756-199904260-00016; Liu YZ, 1998, J BIOL CHEM, V273, P32400, DOI 10.1074/jbc.273.49.32400; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; MacDonald JL, 2008, DEV DYNAM, V237, P2256, DOI 10.1002/dvdy.21626; MANUELIDIS L, 1984, P NATL ACAD SCI-BIOL, V81, P3123, DOI 10.1073/pnas.81.10.3123; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Merienne K, 2001, MOL CELL BIOL, V21, P7089, DOI 10.1128/MCB.21.20.7089-7096.2001; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; Nakahata Y, 2007, CURR OPIN CELL BIOL, V19, P230, DOI 10.1016/j.ceb.2007.02.016; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; Nishihara E, 2003, J NEUROSCI, V23, P213; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Partanen M, 1999, INT J DEV BIOL, V43, P487; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shahani N, 2011, ANTIOXID REDOX SIGN, V14, P1493, DOI 10.1089/ars.2010.3580; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; Turner BM, 2009, PHILOS T R SOC B, V364, P3403, DOI 10.1098/rstb.2009.0125; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wittmann M, 2009, J NEUROSCI, V29, P14687, DOI 10.1523/JNEUROSCI.1160-09.2009; Wong DS, 2004, J BIOL CHEM, V279, P55667, DOI 10.1074/jbc.M408174200; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	100	131	134	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1330	1337		10.1038/nn.2671	http://dx.doi.org/10.1038/nn.2671			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20975757				2022-12-17	WOS:000283658200010
J	Ambroggi, F; Turiault, M; Milet, A; Deroche-Gamonet, V; Parnaudeau, S; Balado, E; Barik, J; van der Veen, R; Maroteaux, G; Lemberger, T; Schutz, G; Lazar, M; Marinelli, M; Piazza, PV; Tronche, F				Ambroggi, Frederic; Turiault, Marc; Milet, Aude; Deroche-Gamonet, Veronique; Parnaudeau, Sebastien; Balado, Eric; Barik, Jacques; van der Veen, Rixt; Maroteaux, Gregoire; Lemberger, Thomas; Schuetz, Guenther; Lazar, Monique; Marinelli, Michela; Piazza, Pier Vincenzo; Tronche, Francois			Stress and addiction: glucocorticoid receptor in dopaminoceptive neurons facilitates cocaine seeking	NATURE NEUROSCIENCE			English	Article							SUBSTANCE USE DISORDERS; ANXIETY; EXPRESSION; GENE	The glucocorticoid receptor is a ubiquitous transcription factor mediating adaptation to environmental challenges and stress. Selective Nr3c1 (the glucocorticoid receptor gene) ablation in mouse dopaminoceptive neurons expressing dopamine receptor 1a, but not in dopamine-releasing neurons, markedly decreased the motivation of mice to self-administer cocaine, dopamine cell firing and the control exerted by dopaminoceptive neurons on dopamine cell firing activity. In contrast, anxiety was unaffected, indicating that glucocorticoid receptors modify a number of behavioral disorders through different neuronal populations.	[Ambroggi, Frederic; Deroche-Gamonet, Veronique; Balado, Eric; van der Veen, Rixt; Marinelli, Michela; Piazza, Pier Vincenzo] INSERM, NeuroCtr Magendie Pathophysiol Addict, U862, F-33077 Bordeaux, France; [Ambroggi, Frederic; Deroche-Gamonet, Veronique; Balado, Eric; van der Veen, Rixt; Marinelli, Michela; Piazza, Pier Vincenzo] Univ Bordeaux, F-33077 Bordeaux, France; [Turiault, Marc; Milet, Aude; Parnaudeau, Sebastien; Barik, Jacques; Maroteaux, Gregoire; Lazar, Monique; Tronche, Francois] CNRS, UMR7148, F-75231 Paris 5, France; [Turiault, Marc; Milet, Aude; Parnaudeau, Sebastien; Barik, Jacques; Maroteaux, Gregoire; Lazar, Monique; Tronche, Francois] Coll France, Inst Biol, F-75231 Paris 5, France; [Parnaudeau, Sebastien; Barik, Jacques; Tronche, Francois] CNRS, UMR7224, F-75252 Paris 05, France; [Lemberger, Thomas; Schuetz, Guenther] German Canc Res Ctr, D-69120 Heidelberg, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Helmholtz Association; German Cancer Research Center (DKFZ)	Piazza, PV (corresponding author), INSERM, NeuroCtr Magendie Pathophysiol Addict, U862, 147 Rue Leo Saignat, F-33077 Bordeaux, France.	pier-vincenzo.piazza@inserm.fr; francois.tronche@gmail.com	TRONCHE, François/F-3895-2011; Marinelli, Michela/P-7645-2018; van der Veen, Rixt/F-1673-2018; Deroche-Gamonet, Véronique/E-5728-2010	Marinelli, Michela/0000-0002-1903-1937; BARIK, Jacques/0000-0002-4276-0927; van der Veen, Rixt/0000-0002-0808-7396; Lemberger, Thomas/0000-0002-2499-4025; Deroche-Gamonet, Veronique/0000-0002-9704-6624	Action Concertee Incitative Neurosciences, Agence Nationale de la Recherche (Neuro-GRADA); European Union Sixth Framework Programme (STREP-PheCOMP); Centre National de la Recherche ATIPE; Fondation pour la Recherche Medicale; Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie; NRJ-Foundation; European Union Sixth Framework Programme (STREP-NovelTune); Deutsche Forschungsgemeinschaft [SFB636]	Action Concertee Incitative Neurosciences, Agence Nationale de la Recherche (Neuro-GRADA)(French National Research Agency (ANR)); European Union Sixth Framework Programme (STREP-PheCOMP)(European Commission); Centre National de la Recherche ATIPE; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie; NRJ-Foundation; European Union Sixth Framework Programme (STREP-NovelTune)(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from Action Concertee Incitative Neurosciences, Agence Nationale de la Recherche (Neuro-GRADA) and European Union Sixth Framework Programme (STREP-PheCOMP) to F. T. and P. V. P., Centre National de la Recherche ATIPE, Fondation pour la Recherche Medicale, Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie, NRJ-Foundation and European Union Sixth Framework Programme (STREP-NovelTune) to F. T., and Deutsche Forschungsgemeinschaft (SFB636) to G. S. Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie and Fondation pour la Recherche Medicale supported M. T.	Boyle MP, 2006, J NEUROSCI, V26, P1971, DOI 10.1523/JNEUROSCI.2173-05.2006; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Deroche-Gamonet V, 2003, J NEUROSCI, V23, P4785; Goodwin RD, 2002, COMPR PSYCHIAT, V43, P245, DOI 10.1053/comp.2002.33500; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Lemberger T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-4; Marinelli M, 2000, J NEUROSCI, V20, P8876; Merikangas KR, 1998, ADDICT BEHAV, V23, P893, DOI 10.1016/S0306-4603(98)00076-8; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Robinson TE, 2000, ADDICTION, V95, pS91; Shaham Y, 2005, NAT NEUROSCI, V8, P1437, DOI 10.1038/nn1105-1437; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Turiault M, 2007, FEBS J, V274, P3568, DOI 10.1111/j.1742-4658.2007.05886.x	15	131	135	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2009	12	3					247	249		10.1038/nn.2282	http://dx.doi.org/10.1038/nn.2282			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	410LF	19234455				2022-12-17	WOS:000263577900006
J	Bhattacharyya, S; Biou, V; Xu, WF; Schluter, O; Malenka, RC				Bhattacharyya, Samarjit; Biou, Virginie; Xu, Weifeng; Schlueter, Oliver; Malenka, Robert C.			A critical role for PSD-95/AKAP interactions in endocytosis of synaptic AMPA receptors	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; IONOTROPIC GLUTAMATE RECEPTORS; KINASE-ANCHORING PROTEINS; EXCITATORY SYNAPSES; SCAFFOLD PROTEIN; TRAFFICKING; ACTIVATION; PLASTICITY; AKAP79; LTD	The endocytosis of AMPA receptors (AMPARs) underlies several forms of synaptic plasticity, including NMDA receptor (NMDAR)-dependent long-term depression (LTD), but the molecular mechanisms responsible for this trafficking remain unknown. We found that PSD-95, a major postsynaptic density protein, is important for NMDAR-triggered endocytosis of synaptic AMPARs in rat neuron cultures because of its binding to A kinase-anchoring protein 150 (AKAP150), a scaffold for specific protein kinases and phosphatases. Knockdown of PSD-95 with shRNA blocked NMDAR-triggered, but not constitutive or mGluR-triggered, endocytosis of AMPARs. Deletion of PSD-95's Src homology 3 and guanylate kinase-like domains, as well as a point mutation (L460P), both of which inhibit binding of PSD-95 to AKAP150, also blocked NMDAR-triggered AMPAR endocytosis. Furthermore, expression of a mutant AKAP150 that does not bind calcineurin inhibited this NMDAR-triggered trafficking event. Our results suggest that PSD-95's interaction with AKAP150 is critical for NMDAR-triggered AMPAR endocytosis and LTD, possibly because these scaffolds position calcineurin in the appropriate subsynaptic domain.	[Bhattacharyya, Samarjit; Biou, Virginie; Xu, Weifeng; Schlueter, Oliver; Malenka, Robert C.] Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.	malenka@stanford.edu		Bhattacharyya, Samarjit/0000-0002-7055-7555	US National Institutes of Health [MH63394, MH080310]; DFG [SCHL592/4-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH080310, R01MH063394, R37MH063394, K99MH080310] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Ghosh and X. Cai for expert technical assistance and members of the Malenka laboratory for helpful discussions. This work was supported by US National Institutes of Health grant MH63394 (to R. C. M.) and MH080310 (to W. X.) and postdoctoral fellowship SCHL592/4-1 from the DFG (to O. S.).	Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Gomez LL, 2002, J NEUROSCI, V22, P7027; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Kashishian A, 1998, J BIOL CHEM, V273, P27412, DOI 10.1074/jbc.273.42.27412; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Regalado MP, 2006, J NEUROSCI, V26, P2343, DOI 10.1523/JNEUROSCI.5247-05.2006; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Schnabel R, 2001, BRIT J PHARMACOL, V132, P1095, DOI 10.1038/sj.bjp.0703905; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Stein V, 2003, J NEUROSCI, V23, P5503; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027	49	131	133	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2009	12	2					172	181		10.1038/nn.2249	http://dx.doi.org/10.1038/nn.2249			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	404VV	19169250	Green Accepted			2022-12-17	WOS:000263182000018
J	Sauvage, MM; Fortin, NJ; Owens, CB; Yonelinas, AP; Eichenbaum, H				Sauvage, Magdalena M.; Fortin, Norbert J.; Owens, Cullen B.; Yonelinas, Andrew P.; Eichenbaum, Howard			Recognition memory: opposite effects of hippocampal damage on recollection and familiarity	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; FACILITATION; COMPONENTS; AMNESIA; CORTEX	A major controversy in memory research concerns whether recognition is subdivided into distinct cognitive mechanisms of recollection and familiarity that are supported by different neural substrates. Here we developed a new associative recognition protocol for rats that enabled us to show that recollection is reduced, whereas familiarity is increased following hippocampal damage. These results provide strong evidence that these processes are qualitatively different and that the hippocampus supports recollection and not familiarity.	[Sauvage, Magdalena M.; Fortin, Norbert J.; Owens, Cullen B.; Yonelinas, Andrew P.; Eichenbaum, Howard] Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Eichenbaum, H (corresponding author), Boston Univ, Ctr Memory & Brain, 2 Cummington St, Boston, MA 02215 USA.	hbe@bu.edu		Sauvage, Magdalena/0000-0002-7586-6410; Fortin, Norbert/0000-0002-6793-6984; Yonelinas, Andrew/0000-0002-9580-4997	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071702, R01MH052090] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 71702, P50 MH071702-01A2, MH 52090, R01 MH052090, P50 MH071702, R01 MH052090-05] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aggleton JP, 2005, NEUROPSYCHOLOGIA, V43, P1810, DOI 10.1016/j.neuropsychologia.2005.01.019; Birrell JM, 2000, J NEUROSCI, V20, P4320; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum Howard, 1994, P147; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Giovanello KS, 2006, NEUROPSYCHOLOGIA, V44, P1859, DOI 10.1016/j.neuropsychologia.2006.03.004; Parks CM, 2007, PSYCHOL REV, V114, P188, DOI 10.1037/0033-295X.114.1.188; Quamme JR, 2007, HIPPOCAMPUS, V17, P192, DOI 10.1002/hipo.20257; Reinitz MT, 1996, MEM COGNITION, V24, P129, DOI 10.3758/BF03200875; Saksida LM, 2007, CEREB CORTEX, V17, P108, DOI 10.1093/cercor/bhj128; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Wais PE, 2006, NEURON, V49, P459, DOI 10.1016/j.neuron.2005.12.020; Wixted JT, 2007, PSYCHOL REV, V114, P152, DOI 10.1037/0033-295X.114.1.152; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Yonelinas AP, 2001, PHILOS T R SOC B, V356, P1363, DOI 10.1098/rstb.2001.0939	15	131	131	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					16	18		10.1038/nn2016	http://dx.doi.org/10.1038/nn2016			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18037884	Green Accepted			2022-12-17	WOS:000252117900007
J	Nicol, X; Voyatzis, S; Muzerelle, A; Narboux-Neme, N; Sudhof, TC; Miles, R; Gaspar, P				Nicol, Xavier; Voyatzis, Sylvie; Muzerelle, Aude; Narboux-Neme, Nicolas; Sudhof, Thomas C.; Miles, Richard; Gaspar, Patricia			cAMP oscillations and retinal activity are permissive for ephrin signaling during the establishment of the retinotopic map	NATURE NEUROSCIENCE			English	Article							GROWTH-CONE; ELECTRICAL-ACTIVITY; CALCIUM TRANSIENTS; CYCLIC-AMP; IN-VIVO; RETINOCOLLICULAR AXONS; NEURITE OUTGROWTH; ADENYLYL-CYCLASE; RHO-GTPASES; CELL	Spontaneous activity generated in the retina is necessary to establish a precise retinotopic map, but the underlying mechanisms are poorly understood. We demonstrate here that neural activity controls ephrin-A-mediated responses. In the mouse retinotectal system, we show that spontaneous activity of the retinal ganglion cells (RGCs) is needed, independently of synaptic transmission, for the ordering of the retinotopic map and the elimination of exuberant retinal axons. Activity blockade suppressed the repellent action of ephrin-A on RGC growth cones by cyclic AMP (cAMP)-dependent pathways. Unexpectedly, the ephrin-A5-induced retraction required cAMP oscillations rather than sustained increases in intracellular cAMP concentrations. Periodic photoinduced release of caged cAMP in growth cones rescued the response to ephrin-A5 when activity was blocked. These results provide a direct molecular link between spontaneous neural activity and axon guidance mechanisms during the refinement of neural maps.	Hop La Pitie Salpetriere, INSERM, U616, F-75013 Paris, France; Univ Paris 06, Paris, France; Inst Fer Moulin, F-75005 Paris, France; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Neurosci, Dallas, TX 75390 USA; Univ Paris 06, Hop Salpetriere, U739, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Gaspar, P (corresponding author), Hop La Pitie Salpetriere, INSERM, U616, 47 Blvd Hop, F-75013 Paris, France.	gaspar@chups.jussieu.fr	Gaspar, Patricia/G-8892-2011; Nicol, Xavier/D-6087-2012	Gaspar, Patricia/0000-0003-4217-5717; Nicol, Xavier/0000-0002-0310-8047; Narboux-Neme, Nicolas/0000-0002-3791-7459				Bansal A, 2000, J NEUROSCI, V20, P7672; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Cline H, 2003, TRENDS NEUROSCI, V26, P655, DOI 10.1016/j.tins.2003.10.005; Colonnese MT, 2001, J NEUROSCI, V21, P1557, DOI 10.1523/JNEUROSCI.21-05-01557.2001; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Fagan KA, 2000, J BIOL CHEM, V275, P40187, DOI 10.1074/jbc.M006606200; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; FIELDS RD, 1994, PROG BRAIN RES, V103, P127; FIELDS RD, 1990, J NEUROSCI, V10, P2950; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Kolls BJ, 2002, J NEUROSCI, V22, P2626, DOI 10.1523/JNEUROSCI.22-07-02626.2002; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Nicol X, 2006, J NEUROSCI, V26, P862, DOI 10.1523/JNEUROSCI.3385-05.2006; Nicol X, 2006, EUR J NEUROSCI, V24, P3401, DOI 10.1111/j.1460-9568.2006.05227.x; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Ravary A, 2003, J NEUROSCI, V23, P2228; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; SACHS GM, 1986, J COMP NEUROL, V246, P395, DOI 10.1002/cne.902460308; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spitzer NC, 2000, BIOESSAYS, V22, P811; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; Uesaka N, 2005, J NEUROSCI, V25, P1, DOI 10.1523/JNEUROSCI.3855-04.2005; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	50	131	133	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					340	347		10.1038/nn1842	http://dx.doi.org/10.1038/nn1842			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17259982				2022-12-17	WOS:000244480300016
J	Maimon, G; Assad, JA				Maimon, Gaby; Assad, John A.			A cognitive signal for the proactive timing of action in macaque LIP	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; SACCADE-RELATED ACTIVITY; NEURONAL-ACTIVITY; EYE-MOVEMENTS; TIME; MONKEY; CONNECTIONS; RESPONSES; VISION; CORTEX	Natural movements often occur without any immediate external event to cause them. In contrast to reactive movements, which are directly triggered by external cues, it is less clear how these proactive actions are initiated or when they will be made. We found that single neurons in the macaque's lateral intraparietal area ( LIP) exhibit gradual firing rate elevations that reach a consistent value - which may correspond to a threshold - at the time of proactive, but not reactive, arm movements. This activity differs from sensory- and motor-related activity recorded in nearby cortical areas and could provide an internal trigger for action when abrupt external triggers in the visual input are unavailable.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Assad, JA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jassad@hms.harvard.edu			NATIONAL EYE INSTITUTE [R01EY012106] Funding Source: NIH RePORTER; NEI NIH HHS [EY12106] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Deecke L, 1996, COGNITIVE BRAIN RES, V3, P59, DOI 10.1016/0926-6410(95)00046-1; DiCarlo JJ, 2005, J NEUROPHYSIOL, V93, P2974, DOI 10.1152/jn.00508.2004; Eskandar EN, 2002, J NEUROPHYSIOL, V88, P1777, DOI 10.1152/jn.2002.88.4.1777; Gallistel CR, 1990, ORG LEARNING; Gibson J.J., 1979, ECOLOGICAL APPROACH; Glimcher PW, 2003, BRADFORD BOOKS, P1; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Land M, 1999, PERCEPTION, V28, P1311, DOI 10.1068/p2935; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Lee DN, 2001, EXP BRAIN RES, V139, P151, DOI 10.1007/s002210100725; Lee IH, 2003, J NEUROPHYSIOL, V89, P2528, DOI 10.1152/jn.01055.2002; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Matelli M, 1998, J COMP NEUROL, V402, P327; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Meck WH, 2005, BRAIN COGNITION, V58, P1, DOI 10.1016/j.bandc.2004.09.004; Nakamura H, 2001, J NEUROSCI, V21, P8174, DOI 10.1523/JNEUROSCI.21-20-08174.2001; Onoe H, 2001, NEUROIMAGE, V13, P37, DOI 10.1006/nimg.2000.0670; Riehle A, 2005, FRON NEUROS, P213; Roitman JD, 2002, J NEUROSCI, V22, P9475; ROMO R, 1992, EXP BRAIN RES, V91, P396, DOI 10.1007/BF00227836; Scherberger H, 2003, J NEUROSCI METH, V130, P1, DOI 10.1016/S0165-0270(03)00190-0; SEAL J, 1985, EXP BRAIN RES, V58, P144; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0	36	131	131	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					948	955		10.1038/nn1716	http://dx.doi.org/10.1038/nn1716			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16751764				2022-12-17	WOS:000238590800022
J	Li, Y; Fitzpatrick, D; White, LE				Li, Y; Fitzpatrick, D; White, LE			The development of direction selectivity in ferret visual cortex requires early visual experience	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; OCULAR DOMINANCE COLUMNS; CATS STRIATE CORTEX; RECEPTIVE-FIELDS; ORIENTATION SELECTIVITY; SIMPLE CELLS; AREA 17; CRITICAL PERIOD; CORTICAL-CELLS; KITTENS	Development of the selective response properties that define columns in sensory cortex is thought to begin early in cortical maturation, without the need for experience. We investigated the development of direction selectivity in ferret visual cortex using optical imaging and electrophysiological techniques and found an exception to this view. Unlike orientation selectivity and ocular dominance, direction selectivity was not detected at eye opening. Direction selectivity emerged several days later and strengthened to adult levels over the following 2 weeks. Visual experience was essential for this process, as shown by the absence of direction selectivity in dark-reared ferrets. The impairment persisted in dark-reared ferrets that were given experience after this period, despite the recovery of response amplitude, preference and bandwidth for stimulus orientation, spatial and temporal frequency, and contrast. Visual experience in early postnatal life plays a necessary and unique role in the development of cortical direction selectivity.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Community & Family Med, Div Phys Therapy, Durham, NC 27710 USA	Duke University; Duke University	White, LE (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	len.white@duke.edu			NATIONAL EYE INSTITUTE [P30EY005722] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY005722, P30 EY005722-21] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; Bonhoeffer Tobias, 1996, P55; Braddick O, 2005, VISION RES, V45, P3169, DOI 10.1016/j.visres.2005.07.021; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 1996, J NEUROSCI, V16, P6443; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; CYNADER M, 1976, SCIENCE, V193, P504, DOI 10.1126/science.941025; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; DAW NW, 1978, SCIENCE, V199, P565, DOI 10.1126/science.622560; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Durack JC, 1996, CEREB CORTEX, V6, P178, DOI 10.1093/cercor/6.2.178; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; FREGNAC Y, 1978, J PHYSIOL-LONDON, V278, P27, DOI 10.1113/jphysiol.1978.sp012290; Hatta S, 1998, INVEST OPHTH VIS SCI, V39, P2259; Horton JC, 1996, J NEUROSCI, V16, P1791; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; Humphrey AL, 1998, J NEUROPHYSIOL, V80, P3005, DOI 10.1152/jn.1998.80.6.3005; Humphrey AL, 1998, J NEUROPHYSIOL, V80, P2991, DOI 10.1152/jn.1998.80.6.2991; IMBERT M, 1975, EXP BRAIN RES, V22, P25; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Kisvarday ZF, 2001, CEREB CORTEX, V11, P636, DOI 10.1093/cercor/11.7.636; Liao DS, 2004, J NEUROPHYSIOL, V92, P2113, DOI 10.1152/jn.00266.2004; Moore BD, 2005, J NEUROPHYSIOL, V94, P1336, DOI 10.1152/jn.01224.2004; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Movshon JA, 2005, J NEUROSCI, V25, P2712, DOI 10.1523/JNEUROSCI.2356-04.2005; MOWER GD, 1981, DEV BRAIN RES, V1, P418, DOI 10.1016/0165-3806(81)90079-1; MOWER GD, 1981, BRAIN RES, V220, P255, DOI 10.1016/0006-8993(81)91216-6; OLSON CR, 1974, BRAIN RES, V70, P189, DOI 10.1016/0006-8993(74)90312-6; PETERSON M, 2005, J NEUROPHYSIOL; Polimeni JR, 2005, P NATL ACAD SCI USA, V102, P4158, DOI 10.1073/pnas.0500291102; REID RC, 1991, J NEUROPHYSIOL, V66, P505, DOI 10.1152/jn.1991.66.2.505; Ruthazer ES, 1999, J COMP NEUROL, V407, P151; Ruthazer ES, 2005, NEURON, V45, P825, DOI 10.1016/j.neuron.2005.03.008; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Saul AB, 2002, J NEUROSCI, V22, P2945, DOI 10.1523/JNEUROSCI.22-07-02945.2002; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; Shmuel A, 1996, J NEUROSCI, V16, P6945; Swindale NV, 2003, CEREB CORTEX, V13, P225, DOI 10.1093/cercor/13.3.225; Tanaka S, 2004, NEURAL NETWORKS, V17, P1363, DOI 10.1016/j.neunet.2004.06.014; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; Wenisch OG, 2005, BIOL CYBERN, V93, P239, DOI 10.1007/s00422-005-0006-z; WIESEL TN, 1974, J COMP NEUROL, V158, P307, DOI 10.1002/cne.901580306; ZHOU YF, 1995, J NEUROSCI, V15, P689	50	131	132	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					676	681		10.1038/nn1684	http://dx.doi.org/10.1038/nn1684			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16604068				2022-12-17	WOS:000237417200019
J	Letinic, K; Rakic, P				Letinic, K; Rakic, P			Telencephalic origin of human thalamic GABAergic neurons	NATURE NEUROSCIENCE			English	Article							MEDIAL GANGLIONIC EMINENCE; DEVELOPING HUMAN BRAIN; INTERNEURON PRECURSORS; DLX GENES; MIGRATION; FOREBRAIN; NEOCORTEX; SYSTEM; ZONE; EXPRESSION	In non-primate mammalian species, telencephalic and diencephalic neurons originate from their respective local proliferative zones. Using vital dye labeling in organotypic slice cultures, we show that in human brain, a contingent of neurons from the ganglionic eminence of the telencephalon migrate to the dorsal thalamic association nuclei of the diencephalon. These neurons rely on homotypic-neurophilic guidance during their migration, are GABAergic, and express DIx1/2 homeodomain-containing proteins. Similar experiments in a non-human primate and in rodent embryos did not reveal a similar migratory pathway. Migration assays demonstrated that the human dorsal thalamus attracts telencephalic cells, an effect not observed in the mouse, in which such migration is inhibited by chemorepulsive cues. These data suggest that modifications in the pattern of migratory guidance cues in the forebrain may underlie the appearance of a new migratory pathway and thus contribute to the evolutionary expansion of the thalamic association nuclei in the human.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Yale University	Rakic, P (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.							Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; HARRIS RM, 1987, NEUROSCIENCE, V21, P229, DOI 10.1016/0306-4522(87)90335-6; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Haydar TF, 1999, BRAIN RES PROTOC, V4, P425, DOI 10.1016/S1385-299X(99)00033-1; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; Jones EG, 1997, SCHIZOPHRENIA BULL, V23, P483, DOI 10.1093/schbul/23.3.483; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Letinic K, 1997, J COMP NEUROL, V384, P373; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; MONTERO VM, 1986, EXP BRAIN RES, V62, P215; ORourke NA, 1997, DEVELOPMENT, V124, P997; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; PORTEUS MH, 1994, J NEUROSCI, V14, P6370; Rakic P, 2000, NEURON, V27, P409, DOI 10.1016/S0896-6273(00)00047-7; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1969, Z ANAT ENTWICKLUNGS, V129, P53, DOI 10.1007/BF00521955; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	29	131	132	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					931	936		10.1038/nn0901-931	http://dx.doi.org/10.1038/nn0901-931			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528425				2022-12-17	WOS:000170698600020
J	Heuss, C; Scanziani, M; Gahwiler, BH; Gerber, U				Heuss, C; Scanziani, M; Gahwiler, BH; Gerber, U			G-protein-independent signaling mediated by metabotropic glutamate receptors	NATURE NEUROSCIENCE			English	Article							SLOW SYNAPTIC RESPONSE; CA3 PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; POSTSYNAPTIC CURRENT; KAINATE RECEPTORS; TYROSINE KINASES; BINDING PROTEIN; NMDA RECEPTORS; ACTIVATION; STIMULATION	Synaptically released glutamate activates ionotropic and metabotropic receptors at central synapses. Metabotropic glutamate receptors (mGluRs) are thought to modulate membrane conductances through transduction cascades involving G proteins. Here we show, in CA3 pyramidal cells from rat hippocampus, that synaptic activation of type 1 mGluRs by mossy fiber stimulation evokes an excitatory postsynaptic response independent of G-protein function, while inhibiting an afterhyperpolarization current through a G-protein-coupled mechanism. Experiments using peptide activators and specific inhibitors identified a Src-family protein tyrosine kinase as a component of the G-protein-independent transduction pathway. These results represent the first functional evidence for a dual signaling mechanism associated with a heptahelical receptor such as mGluR1, in which intracellular transduction involves activation of either G proteins or tyrosine kinases.	Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland	University of Zurich	Heuss, C (corresponding author), Univ Zurich, Inst Brain Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	heuss@hifo.unizh.ch						Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Boxall AR, 1998, EUR J NEUROSCI, V10, P2; BRABET I, 1995, NEUROPHARMACOLOGY, V34, P895, DOI 10.1016/0028-3908(95)00079-L; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; CHARPAK S, 1991, P ROY SOC B-BIOL SCI, V243, P221, DOI 10.1098/rspb.1991.0035; Congar P, 1997, J NEUROSCI, V17, P5366; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dale TC, 1998, BIOCHEM J, V329, P209; Doherty AJ, 1997, NEUROPHARMACOLOGY, V36, P265, DOI 10.1016/S0028-3908(97)00001-4; DUNWIDDIE TV, 1985, J PHYSIOL-LONDON, V369, P365, DOI 10.1113/jphysiol.1985.sp015907; ECCLES JC, 1979, TRENDS NEUROSCI, V2, P39, DOI 10.1016/0166-2236(79)90017-1; ECKSTEIN F, 1979, J BIOL CHEM, V254, P9829; GAHWILER BH, 1998, CULTURING NERVE CELL, P379; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; GERBER U, 1993, P ROY SOC B-BIOL SCI, V254, P169, DOI 10.1098/rspb.1993.0142; GUERINEAU NC, 1995, J NEUROSCI, V15, P4395; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HAYASHI Y, 1993, NATURE, V366, P687, DOI 10.1038/366687a0; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; KEHOE J, 1994, NEURON, V13, P691, DOI 10.1016/0896-6273(94)90036-1; Lancaster B, 1998, EUR J NEUROSCI, V10, P2302, DOI 10.1046/j.1460-9568.1998.00241.x; LIU XQ, 1993, ONCOGENE, V8, P1119; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; Miller LDP, 1995, J NEUROSCI, V15, P8320; Milne JLS, 1997, ADV SEC MESS PHOSPH, V31, P83; Mitchell R, 1998, NATURE, V392, P411, DOI 10.1038/32937; Moroni F, 1997, J PHARMACOL EXP THER, V281, P721; Pankratov Y, 1998, EUR J NEUROSCI, V10, P3898, DOI 10.1046/j.1460-9568.1998.00419.x; Peavy RD, 1998, J NEUROCHEM, V71, P603; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; SHAPIRO MS, 1994, J NEUROSCI, V14, P7109; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Siciliano JC, 1996, J BIOL CHEM, V271, P28942, DOI 10.1074/jbc.271.46.28942; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; SWARUP G, 1982, J BIOL CHEM, V257, P7298; TRUDEL S, 1991, BIOCHEM J, V276, P611, DOI 10.1042/bj2760611; TRUSSELL LO, 1987, J NEUROSCI, V7, P3306; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; WINSLOW JW, 1987, J BIOL CHEM, V262, P4501; ZHENG F, 1995, NEUROPHARMACOLOGY, V34, P905, DOI 10.1016/0028-3908(95)00047-A	50	131	132	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1070	1077		10.1038/15996	http://dx.doi.org/10.1038/15996			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570483				2022-12-17	WOS:000085810100010
J	Nicolelis, MAL; Ghazanfar, AA; Stambaugh, CR; Oliveira, LMO; Laubach, M; Chapin, JK; Nelson, RJ; Kaas, JH				Nicolelis, MAL; Ghazanfar, AA; Stambaugh, CR; Oliveira, LMO; Laubach, M; Chapin, JK; Nelson, RJ; Kaas, JH			Simultaneous encoding of tactile information by three primate cortical areas	NATURE NEUROSCIENCE			English	Article							SOMATOSENSORY CORTEX; VISUAL-SYSTEM; NEURONS; DISCRIMINATION; REPRESENTATION; ORGANIZATION; COMPUTATION; ENSEMBLES; MONKEYS; PATTERN	We used simultaneous multi-site neural ensemble recordings to investigate the representation of tactile information in three areas of the primate somatosensory cortex (areas 3b, SII and 2). Small neural ensembles (30-40 neurons) of broadly tuned somatosensory neurons were able to identify correctly the location of a single tactile stimulus on a single trial, almost simultaneously. Furthermore, each of these cortical areas could use different combinations of encoding strategies, such as mean firing rate (areas 3b and 2) or temporal patterns of ensemble firing (area SII), to represent the location of a tactile stimulus. Based on these results, we propose that ensembles of broadly tuned neurons, located in three distinct areas of the primate somatosensory cortex, obtain information about the location of a tactile stimulus almost concurrently.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Allegheny Univ Hlth Sci, Dept Neurobiol & Anat, Philadelphia, PA 17129 USA; Univ Tennessee, Dept Anat & Neurobiol, Memphis, TN 38163 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA	Duke University; Drexel University; University of Tennessee System; University of Tennessee Health Science Center; Vanderbilt University	Nicolelis, MAL (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209,101 Res Dr,Bryan Res Bldg, Durham, NC 27710 USA.			Laubach, Mark/0000-0002-2403-4497				ABELES M, 1977, P IEEE, V65, P762, DOI 10.1109/PROC.1977.10559; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bishop Christopher M., 1995, NEURAL NETWORKS PATT; BULLIER J, 1995, CURR OPIN NEUROBIOL, V5, P497, DOI 10.1016/0959-4388(95)80011-5; CHAPMAN CE, 1991, EXP BRAIN RES, V87, P319; Churchland P. S., 1992, COMPUTATIONAL BRAIN, DOI 10.7551/mitpress/2010.001.0001; ERICKSON RP, 1968, PSYCHOL REV, V75, P447, DOI 10.1037/h0026752; FERRINGTON DG, 1980, J NEUROPHYSIOL, V43, P310, DOI 10.1152/jn.1980.43.2.310; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; HOPFIELD JJ, 1995, P NATL ACAD SCI USA, V92, P6655, DOI 10.1073/pnas.92.15.6655; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; IWAMURA Y, 1980, BRAIN RES, V197, P516, DOI 10.1016/0006-8993(80)91139-7; JOHNSON KO, 1997, COGNITIVE NEUROSCIEN, P253; Kaas J.H., 1988, P421; Kaas J H, 1991, Curr Opin Neurobiol, V1, P248, DOI 10.1016/0959-4388(91)90085-L; KAAS JH, 1994, AOTUS OWL MONKEY, P322; KOHONEN T, 1997, SELFORGANIZING MAPS; McClurkin JW, 1996, J NEUROPHYSIOL, V75, P481, DOI 10.1152/jn.1996.75.1.481; MERZENICH MM, 1980, PROGR PSYCHOBIOL PHY, V9, P1; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Nicolelis MAL, 1997, NEURON, V19, P219, DOI 10.1016/S0896-6273(00)80932-0; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; NICOLELIS MAL, 1994, J NEUROSCI, V14, P3511; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; Nicolelis MAL, 1997, J NEUROPHYSIOL, V78, P1691, DOI 10.1152/jn.1997.78.3.1691; NICOLELIS MAL, IN PRESS METHODS NEU; SARLE WS, 1995, P 27 S INT COMP SCI, V1, P352; Schiller PH, 1996, BEHAV BRAIN RES, V76, P21, DOI 10.1016/0166-4328(95)00186-7; Seidemann E, 1996, J NEUROSCI, V16, P752; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; WISE SP, 1988, SCIENCE, V242, P736, DOI 10.1126/science.3187520; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	38	131	142	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					621	630		10.1038/2855	http://dx.doi.org/10.1038/2855			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196571				2022-12-17	WOS:000077437100019
J	Challis, C; Hori, A; Sampson, TR; Yoo, BB; Challis, RC; Hamilton, AM; Mazmanian, SK; Volpicelli-Daley, LA; Gradinaru, V				Challis, Collin; Hori, Acacia; Sampson, Timothy R.; Yoo, Bryan B.; Challis, Rosemary C.; Hamilton, Adam M.; Mazmanian, Sarkis K.; Volpicelli-Daley, Laura A.; Gradinaru, Viviana			Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice	NATURE NEUROSCIENCE			English	Article							PARKINSONS-DISEASE; LEWY BODY; GASTROINTESTINAL-TRACT; PREFORMED FIBRILS; GENE-THERAPY; MOUSE MODEL; GLUCOCEREBROSIDASE; INFLAMMATION; EXPRESSION; SYSTEM	Parkinson's disease is a synucleinopathy that is characterized by motor dysfunction, death of midbrain dopaminergic neurons and accumulation of alpha-synuclein (alpha-Syn) aggregates. Evidence suggests that alpha-Syn aggregation can originate in peripheral tissues and progress to the brain via autonomic fibers. We tested this by inoculating the duodenal wall of mice with alpha-Syn preformed fibrils. Following inoculation, we observed gastrointestinal deficits and physiological changes to the enteric nervous system. Using the AAV-PHP.S capsid to target the lysosomal enzyme glucocerebrosidase for peripheral gene transfer, we found that alpha-Syn pathology is reduced due to the increased expression of this protein. Lastly, inoculation of alpha-Syn fibrils in aged mice, but not younger mice, resulted in progression of alpha-Syn histopathology to the midbrain and subsequent motor defects. Our results characterize peripheral synucleinopathy in prodromal Parkinson's disease and explore cellular mechanisms for the gut-to-brain progression of alpha-Syn pathology. Alpha-synuclein fibrils can disrupt the enteric nervous system, which is mitigated by peripheral GBA1 gene transfer via systemic AAVs. Aging increases susceptibility to alpha-synuclein pathology progression from the gut to the brain.	[Challis, Collin; Hori, Acacia; Sampson, Timothy R.; Yoo, Bryan B.; Challis, Rosemary C.; Mazmanian, Sarkis K.; Gradinaru, Viviana] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Sampson, Timothy R.; Hamilton, Adam M.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; [Volpicelli-Daley, Laura A.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL USA	California Institute of Technology; Emory University; University of Alabama System; University of Alabama Birmingham	Gradinaru, V (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	viviana@caltech.edu	Mazmanian, Sarkis/ABD-7729-2021	Mazmanian, Sarkis/0000-0003-2713-1513; Hori, Acacia/0000-0001-7308-6480; Hamilton, Adam/0000-0002-8857-3617	NIH [IDP20D017782-01]; PECASE; NIH/NIA [R01AG047664-01, F32AG054101]; NIH BRAIN [1U01NS090577]; Heritage Medical Research Institute; Pew Charitable Trust; Rogers Fellowship for Parkinson's Research; CZI Neurodegeneration Challenge Network; NIH/NINDS [R01NS085910]; Department of Defense grant [W81XWH-17-1-0588]; NINDS [R01NS102257]; Morris K. Udall Centers of Excellence for Parkinson's Disease Research [P50NS108675]; Larry L. Hillblom Foundation; NIH/NIGMS [5T32GM007616]; Caltech Center for Environmental Microbial Interactions (CEMI)	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PECASE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH BRAIN(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heritage Medical Research Institute; Pew Charitable Trust; Rogers Fellowship for Parkinson's Research; CZI Neurodegeneration Challenge Network; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Defense grant(United States Department of Defense); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Morris K. Udall Centers of Excellence for Parkinson's Disease Research; Larry L. Hillblom Foundation; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Caltech Center for Environmental Microbial Interactions (CEMI)	We thank C. Bedbrook for help with calcium imaging and K. Beadle and E. Mackey for additional technical support. This work was supported by the following grants to V.G.: NIH Director's New Innovator IDP20D017782-01 and PECASE; NIH/NIA R01AG047664-01; NIH BRAIN 1U01NS090577; the Heritage Medical Research Institute; the Pew Charitable Trust; the Rogers Fellowship for Parkinson's Research and the CZI Neurodegeneration Challenge Network. C.C. was supported by NIH/NIA F32AG054101. S.K.M. was supported by NIH/NINDS R01NS085910. V.G. and S.K.M. were supported by Department of Defense grant W81XWH-17-1-0588. L.A.V.-D. was supported by NINDS R01NS102257 and Morris K. Udall Centers of Excellence for Parkinson's Disease Research P50NS108675. T.R.S was supported by the Larry L. Hillblom Foundation. B.B.Y. was supported by NIH/NIGMS 5T32GM007616 and the Caltech Center for Environmental Microbial Interactions (CEMI).	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Bannon Anthony W, 2007, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0809s41; Barrenschee M, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0408-2; Boesmans W, 2015, J NEUROGASTROENTEROL, V21, P337, DOI 10.5056/jnm15096; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Challis RC, 2019, NAT PROTOC, V14, P379, DOI 10.1038/s41596-018-0097-3; Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593; Chandra R, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92295; Chesselet MF, 2012, NEUROTHERAPEUTICS, V9, P297, DOI 10.1007/s13311-012-0104-2; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; De Schepper S, 2018, CELL, V175, P400, DOI 10.1016/j.cell.2018.07.048; DEACON RMJ, 2013, JOVE J VIS EXP JUN, DOI DOI 10.3791/2610; Devos D, 2013, NEUROBIOL DIS, V50, P42, DOI 10.1016/j.nbd.2012.09.007; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Fishbein I, 2014, BRAIN, V137, P3235, DOI 10.1093/brain/awu291; Fleming SM, 2013, JOVE-J VIS EXP, DOI 10.3791/50303; Fox EA, 2000, J COMP NEUROL, V428, P558, DOI 10.1002/1096-9861(20001218)428:3<558::AID-CNE11>3.0.CO;2-M; Froula JM, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0537-x; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Grassi D, 2018, P NATL ACAD SCI USA, V115, pE2634, DOI 10.1073/pnas.1713849115; Hallett PJ, 2012, NEUROBIOL DIS, V47, P258, DOI 10.1016/j.nbd.2012.04.009; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Holmqvist S, 2014, ACTA NEUROPATHOL, V128, P805, DOI 10.1007/s00401-014-1343-6; Kim S, 2019, NEURON, V103, P627, DOI 10.1016/j.neuron.2019.05.035; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McCann H, 2014, PARKINSONISM RELAT D, V20, P62, DOI DOI 10.1016/S1353-8020(13)70017-8; Morabito G, 2017, MOL THER, V25, P2727, DOI 10.1016/j.ymthe.2017.08.004; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Neunlist M, 2014, GASTROENTEROLOGY, V147, P1230, DOI 10.1053/j.gastro.2014.09.040; O'Sullivan SS, 2008, MOVEMENT DISORD, V23, P101, DOI 10.1002/mds.21813; Park J, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0026-1; Reeve A, 2014, AGEING RES REV, V14, P19, DOI 10.1016/j.arr.2014.01.004; Rocha EM, 2015, NEUROBIOL DIS, V82, P495, DOI 10.1016/j.nbd.2015.09.009; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Rosenbloom B, 2011, BLOOD CELL MOL DIS, V46, P95, DOI 10.1016/j.bcmd.2010.10.006; Salvatore MF, 2012, JOVE-J VIS EXP, DOI 10.3791/4171; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sanchez-Ferro A, 2015, MOVEMENT DISORD, V30, P517, DOI 10.1002/mds.25988; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Schafer KH, 1999, J INTERF CYTOK RES, V19, P527, DOI 10.1089/107999099313974; Sehgal A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03638-6; Shannon KM, 2012, MOVEMENT DISORD, V27, P709, DOI 10.1002/mds.23838; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Treweek JB, 2015, NAT PROTOC, V10, P1860, DOI 10.1038/nprot.2015.122; Uemura N, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0257-5; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Yoo BB, 2017, IMMUNITY, V46, P910, DOI 10.1016/j.immuni.2017.05.011	56	130	132	14	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2020	23	3					327	+		10.1038/s41593-020-0589-7	http://dx.doi.org/10.1038/s41593-020-0589-7		FEB 2020	23	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KV1SH	32066981	Green Accepted			2022-12-17	WOS:000514067300008
J	DeNardo, LA; Liu, CD; Allen, WE; Adams, EL; Friedmann, D; Fu, LS; Guenthner, CJ; Tessier-Lavigne, M; Luo, LQ				DeNardo, Laura A.; Liu, Cindy D.; Allen, William E.; Adams, Eliza L.; Friedmann, Drew; Fu, Lisa; Guenthner, Casey J.; Tessier-Lavigne, Marc; Luo, Liqun			Temporal evolution of cortical ensembles promoting remote memory retrieval	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; PRELIMBIC CORTEX; BASOLATERAL AMYGDALA; CONTEXTUAL FEAR; NEURONS; EXPRESSION; CIRCUITS; HIPPOCAMPAL; PROJECTIONS; EXTINCTION	Memories of fearful events can last a lifetime. The prelimbic (PL) cortex, a subregion of prefrontal cortex, plays a critical role in fear memory retrieval over time. Most studies have focused on acquisition, consolidation, and retrieval of recent memories, but much less is known about the neural mechanisms of remote memory. Using a new knock-in mouse for activity-dependent genetic labeling (TRAP2), we demonstrate that neuronal ensembles in the PL cortex are dynamic. PL neurons TRAPed during later memory retrievals are more likely to be reactivated and make larger behavioral contributions to remote memory retrieval compared to those TRAPed during learning or early memory retrieval. PL activity during learning is required to initiate this time-dependent reorganization in PL ensembles underlying memory retrieval. Finally, while neurons TRAPed during earlier and later retrievals have similar broad projections throughout the brain, PL neurons TRAPed later have a stronger functional recruitment of cortical targets.	[DeNardo, Laura A.; Liu, Cindy D.; Allen, William E.; Adams, Eliza L.; Friedmann, Drew; Fu, Lisa; Guenthner, Casey J.; Tessier-Lavigne, Marc; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [DeNardo, Laura A.; Liu, Cindy D.; Allen, William E.; Friedmann, Drew; Fu, Lisa; Guenthner, Casey J.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Allen, William E.; Adams, Eliza L.; Guenthner, Casey J.; Tessier-Lavigne, Marc; Luo, Liqun] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [DeNardo, Laura A.] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; University of California System; University of California Los Angeles	DeNardo, LA; Luo, LQ (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; DeNardo, LA; Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.; Luo, LQ (corresponding author), Stanford Univ, Neurosci Program, Stanford, CA 94305 USA.; DeNardo, LA (corresponding author), Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA.	ldenardo@ucla.edu; lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264	NIH [F32NS087860]; Mentored Research Scientist Development Award [K01MH11626401]; Fannie & John Hertz Foundation Fellowship; National Science Foundation Graduate Research Fellowship [DGE-114747]; Standford Bio-X Ph.D Fellowship program; William K. Bowles Jr. Foundation; National Science Foundation; National Institutes of Health; Hughes Collaborative Innovation Award; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH116264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835, R01NS104698] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mentored Research Scientist Development Award; Fannie & John Hertz Foundation Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Standford Bio-X Ph.D Fellowship program; William K. Bowles Jr. Foundation; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hughes Collaborative Innovation Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Malanac for mouse genotyping, the Stanford Transgenic Facility for help in producing TRAP2 knock-in mice and Stanford Viral Core, K. Deisseroth and C. Ramakrishnan for AAV vectors, T. Bonhoeffer, P. Goltstein, and members of the Luo Lab for comments on the manuscript. L.A.D. was supported by an NIH postdoctoral fellowship (F32NS087860) and a Mentored Research Scientist Development Award (K01MH11626401). W.E.A. was supported by a Fannie & John Hertz Foundation Fellowship and a National Science Foundation Graduate Research Fellowship (grant DGE-114747). E.L.A. was supported by the Standford Bio-X Ph.D Fellowship program and the William K. Bowles Jr. Foundation. L.L. is an HHMI investigator. This work was supported by grants from National Science Foundation, National Institutes of Health, and a Hughes Collaborative Innovation Award.	Allen WE, 2017, SCIENCE, V357, P1149, DOI 10.1126/science.aan6747; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Bero AW, 2014, P NATL ACAD SCI USA, V111, P11852, DOI 10.1073/pnas.1408378111; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Coulon V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011235; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; DeNardo L, 2017, CURR OPIN NEUROBIOL, V45, P121, DOI 10.1016/j.conb.2017.05.014; DeNardo LA, 2015, NAT NEUROSCI, V18, P1687, DOI 10.1038/nn.4131; Do Monte FH, 2016, MOL PSYCHIATR, V21, P1027, DOI 10.1038/mp.2016.78; Do-Monte FH, 2015, NATURE, V519, P460, DOI 10.1038/nature14030; Driscoll LN, 2017, CELL, V170, P986, DOI 10.1016/j.cell.2017.07.021; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Grewe BF, 2017, NATURE, V543, P670, DOI 10.1038/nature21682; Guenthner CJ, 2013, NEURON, V78, P773, DOI 10.1016/j.neuron.2013.03.025; Hess US, 1995, J NEUROSCI, V15, P7796; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Karalis N, 2016, NAT NEUROSCI, V19, P605, DOI 10.1038/nn.4251; Kitamura T, 2017, SCIENCE, V356, P73, DOI 10.1126/science.aam6808; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Lesburgueres E, 2011, SCIENCE, V331, P924, DOI 10.1126/science.1196164; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Renier N, 2016, CELL, V165, P1789, DOI 10.1016/j.cell.2016.05.007; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Takehara-Nishiuchi K, 2014, NEUROSCI RES, V84, P27, DOI 10.1016/j.neures.2014.02.012; Todd TP, 2016, LEARN MEMORY, V23, P278, DOI 10.1101/lm.041822.116; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Vetere G, 2017, NEURON, V94, P363, DOI 10.1016/j.neuron.2017.03.037; Wayman WN, 2018, J NEUROSCI, V38, P1462, DOI 10.1523/JNEUROSCI.2503-17.2018; Wheeler AL, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002853; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; Zhou TT, 2017, SCIENCE, V357, P162, DOI 10.1126/science.aak9726; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	54	130	131	13	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2019	22	3					460	+		10.1038/s41593-018-0318-7	http://dx.doi.org/10.1038/s41593-018-0318-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HM4DL	30692687	Green Accepted, Green Submitted			2022-12-17	WOS:000459423800016
J	Menegas, W; Akiti, K; Amo, R; Uchida, N; Watabe-Uchida, M				Menegas, William; Akiti, Korleki; Amo, Ryunosuke; Uchida, Naoshige; Watabe-Uchida, Mitsuko			Dopamine neurons projecting to the posterior striatum reinforce avoidance of threatening stimuli	NATURE NEUROSCIENCE			English	Article							SUBSTANTIA-NIGRA; REWARD; PREDICTION; DYNAMICS; AMYGDALA; NUCLEUS; RELEASE; RATS; FEAR; INVOLVEMENT	Midbrain dopamine neurons are well known for their role in reward-based reinforcement learning. We found that the activity of dopamine axons in the posterior tail of the striatum (TS) scaled with the novelty and intensity of external stimuli, but did not encode reward value. We demonstrated that the ablation of TS-projecting dopamine neurons specifically inhibited avoidance of novel or high-intensity stimuli without affecting animals' initial avoidance responses, suggesting a role in reinforcement rather than simply in avoidance itself. Furthermore, we found that animals avoided optogenetic activation of dopamine axons in TS during a choice task and that this stimulation could partially reinstate avoidance of a familiar object. These results suggest that TS-projecting dopamine neurons reinforce avoidance of threatening stimuli. More generally, our results indicate that there are at least two axes of reinforcement learning using dopamine in the striatum: one based on value and one based on external threat.	[Menegas, William; Akiti, Korleki; Amo, Ryunosuke; Uchida, Naoshige; Watabe-Uchida, Mitsuko] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University	Watabe-Uchida, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA.	mitsuko@mcb.harvard.edu	Core, Vector/CAF-4832-2022	Uchida, Naoshige/0000-0002-5755-9409; Amo, Ryunosuke/0000-0001-8644-2296; Akiti, Korleki/0000-0001-6791-9482; Menegas, William/0000-0001-7483-994X	National Institutes of Health [R01MH095953, R01MH101207, R01MH110404]; Harvard Mind Brain and Behavior faculty grant; JSPS Overseas Research Fellowships; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095953, R01MH101207, R01MH110404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS108740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Mind Brain and Behavior faculty grant; JSPS Overseas Research Fellowships; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. Morgese, M. Tripodi, and E. Ciabatti at MRC Laboratory of Molecular Biology in Cambridge, UK, for the self-inactivating rabies virus amplification kit. We thank B. Lowell at Harvard University in Boston, MA, for the Vglut2<SUP>flox</SUP> mouse. We thank E. Boyden at MIT in Cambridge, MA, for pAAV-FLEX-GFP, K. Deisseroth at Stanford University in Stanford, CA, for pAAV-DIO-ChR2 and pAAV-fDIO-EYFP, and V. Jayaraman, R. Kerr, D. Kim, L. Looger, and K. Svoboda from the GENIE Project, Janelia Farm Research Campus, Howard Hughes Medical Institute for pGP-GCaMP6f and AAV-FLEX-GCaMP6m. We also appreciate C. Dulac and J. Assad for critically reading the manuscript. Finally, we thank H. Kim for help setting up the closed-loop optogenetic stimulation system. This work was supported by National Institutes of Health grants R01MH095953 (N.U.), R01MH101207 (N.U.), R01MH110404 (N.U.), Harvard Mind Brain and Behavior faculty grant (N.U.) and JSPS Overseas Research Fellowships (R.A.).	AINSWORT.MD, 1970, CHILD DEV, V41, P49, DOI 10.2307/1127388; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Albasser MM, 2011, EUR J NEUROSCI, V34, P331, DOI 10.1111/j.1460-9568.2011.07755.x; Athos J., 2001, CURR PROTOC NEUROS A; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; BARHILLEL M, 1991, ADV APPL MATH, V12, P428, DOI 10.1016/0196-8858(91)90029-I; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Belin D, 2011, NEUROPSYCHOPHARMACOL, V36, P569, DOI 10.1038/npp.2010.188; BERLYNE DE, 1966, SCIENCE, V153, P25, DOI 10.1126/science.153.3731.25; BONHOMME N, 1995, NEUROPHARMACOLOGY, V34, P269, DOI 10.1016/0028-3908(94)00145-I; Chang CY, 2016, NAT NEUROSCI, V19, P111, DOI 10.1038/nn.4191; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Choi JS, 2010, P NATL ACAD SCI USA, V107, P21773, DOI 10.1073/pnas.1010079108; Ciabatti E, 2017, CELL, V170, P382, DOI 10.1016/j.cell.2017.06.014; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; COREY DT, 1978, NEUROSCI BIOBEHAV R, V2, P235, DOI 10.1016/0149-7634(78)90033-7; Darvas M, 2009, P NATL ACAD SCI USA, V106, P14664, DOI 10.1073/pnas.0907299106; Eshel N, 2015, NATURE, V525, P243, DOI 10.1038/nature14855; Fiorillo CD, 2013, J NEUROSCI, V33, P4710, DOI 10.1523/JNEUROSCI.3883-12.2013; Ghazizadeh A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00378; Gittis AH, 2011, NEURON, V71, P858, DOI 10.1016/j.neuron.2011.06.035; Guarraci FA, 1999, BRAIN RES, V827, P28, DOI 10.1016/S0006-8993(99)01291-3; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Howe MW, 2016, NATURE, V535, P505, DOI 10.1038/nature18942; Ilango A, 2014, J NEUROSCI, V34, P817, DOI 10.1523/JNEUROSCI.1703-13.2014; James W., 1890, PRINCIPLES PSYCHOL, V2; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Kim CK, 2016, NAT METHODS, V13, P325, DOI [10.1038/NMETH.3770, 10.1038/nmeth.3770]; Kim HF, 2015, CELL, V163, P1165, DOI 10.1016/j.cell.2015.10.063; Kishioka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004157; KITA H, 1990, J COMP NEUROL, V298, P40, DOI 10.1002/cne.902980104; Krusemark EA, 2011, J NEUROSCI, V31, P3429, DOI 10.1523/JNEUROSCI.4394-10.2011; KUDO Y, 1992, NEUROSCIENCE, V50, P619, DOI 10.1016/0306-4522(92)90451-7; LeDoux J, 2018, NAT REV NEUROSCI, V19, P269, DOI 10.1038/nrn.2018.22; Lee DH, 2017, PSYCHOL SCI, V28, P494, DOI 10.1177/0956797616687364; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Lloyd K, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0099-7; LOUGHLIN SE, 1983, BRAIN RES, V262, P334, DOI 10.1016/0006-8993(83)91029-6; Matsumoto H, 2016, ELIFE, V5, DOI 10.7554/eLife.17328; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Menegas W, 2017, TRENDS NEUROSCI, V40, P589, DOI 10.1016/j.tins.2017.08.005; Menegas W, 2017, ELIFE, V6, DOI 10.7554/eLife.21886; Menegas W, 2015, ELIFE, V4, DOI 10.7554/eLife.10032; MOSER EI, 1994, LEARN MEMORY, V1, P55; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; Oleson EB, 2012, J NEUROSCI, V32, P14804, DOI 10.1523/JNEUROSCI.3087-12.2012; Pare D, 2017, NPJ SCI LEARN, V2, DOI 10.1038/s41539-017-0007-4; Parker NF, 2016, NAT NEUROSCI, V19, P845, DOI 10.1038/nn.4287; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Rogan MT, 2005, NEURON, V46, P309, DOI 10.1016/j.neuron.2005.02.017; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Sasson NJ, 2008, AUTISM RES, V1, P31, DOI 10.1002/aur.4; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schiemann J, 2012, NAT NEUROSCI, V15, P1272, DOI 10.1038/nn.3185; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Soltani A, 2006, NEURAL NETWORKS, V19, P1075, DOI 10.1016/j.neunet.2006.05.044; Stujenske JM, 2015, CELL REP, V12, P525, DOI 10.1016/j.celrep.2015.06.036; Thiele SL, 2012, JOVE-J VIS EXP, DOI 10.3791/3234; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Waddell S, 2013, CURR OPIN NEUROBIOL, V23, P324, DOI 10.1016/j.conb.2013.01.005; Wang AY, 2013, NAT NEUROSCI, V16, P639, DOI 10.1038/nn.3377; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Yamaguchi T, 2015, EUR J NEUROSCI, V41, P760, DOI 10.1111/ejn.12818; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	67	130	132	0	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2018	21	10					1421	+		10.1038/s41593-018-0222-1	http://dx.doi.org/10.1038/s41593-018-0222-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU9FY	30177795	Green Accepted			2022-12-17	WOS:000445651600017
J	Lim, RG; Salazar, LL; Wilton, DK; King, AR; Stocksdale, JT; Sharifabad, D; Lau, AL; Stevens, B; Reidling, JC; Winokur, ST; Casale, MS; Thompson, LM; Pardo, M; Diaz-Barriga, AGG; Straccia, M; Sanders, P; Alberch, J; Canals, JM; Kaye, JA; Dunlap, M; Jo, L; May, H; Mount, E; Anderson-Bergman, C; Haston, K; Finkbeiner, S; Kedaigle, AJ; Gipson, TA; Yildirim, F; Ng, CW; Milani, P; Housman, DE; Fraenkel, E; Allen, ND; Kemp, PJ; Atwal, RS; Biagioli, M; Gusella, JF; MacDonald, ME; Akimov, SS; Arbez, N; Stewart, J; Ross, CA; Mattis, VB; Tom, CM; Ornelas, L; Sahabian, A; Lenaeus, L; Mandefro, B; Sareen, D; Svendsen, CN				Lim, Ryan G.; Salazar, Lisa L.; Wilton, Daniel K.; King, Alvin R.; Stocksdale, Jennifer T.; Sharifabad, Delaram; Lau, Alice L.; Stevens, Beth; Reidling, Jack C.; Winokur, Sara T.; Casale, Malcolm S.; Thompson, Leslie M.; Pardo, Monica; Gerardo Garcia Diaz-Barriga, A.; Straccia, Marco; Sanders, Phil; Alberch, Jordi; Canals, Josep M.; Kaye, Julia A.; Dunlap, Mariah; Jo, Lisa; May, Hanna; Mount, Elliot; Anderson-Bergman, Cliff; Haston, Kelly; Finkbeiner, Steven; Kedaigle, Amanda J.; Gipson, Theresa A.; Yildirim, Ferah; Ng, Christopher W.; Milani, Pamela; Housman, David E.; Fraenkel, Ernest; Allen, Nicholas D.; Kemp, Paul J.; Atwal, Ranjit Singh; Biagioli, Marta; Gusella, James F.; MacDonald, Marcy E.; Akimov, Sergey S.; Arbez, Nicolas; Stewart, Jacqueline; Ross, Christopher A.; Mattis, Virginia B.; Tom, Colton M.; Ornelas, Loren; Sahabian, Anais; Lenaeus, Lindsay; Mandefro, Berhan; Sareen, Dhruv; Svendsen, Clive N.		HD iPSC Consortium	Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice	NATURE NEUROSCIENCE			English	Article							STEM-CELLS; MUTANT HUNTINGTIN; NEUROGENESIS; MATURATION; NEURONS; GENE; PROGENITORS; SURVIVAL; PROTEIN; MODEL	Neural cultures derived from Huntington's disease (HD) patient-derived induced pluripotent stem cells were used for 'omics' analyses to identify mechanisms underlying neurodegeneration. RNA-seq analysis identified genes in glutamate and GABA signaling, axonal guidance and calcium influx whose expression was decreased in HD cultures. One-third of gene changes were in pathways regulating neuronal development and maturation. When mapped to stages of mouse striatal development, the profiles aligned with earlier embryonic stages of neuronal differentiation. We observed a strong correlation between HD-related histone marks, gene expression and unique peak profiles associated with dysregulated genes, suggesting a coordinated epigenetic program. Treatment with isoxazole-9, which targets key dysregulated pathways, led to amelioration of expanded polyglutamine repeat-associated phenotypes in neural cells and of cognitive impairment and synaptic pathology in HD model R6/2 mice. These data suggest that mutant huntingtin impairs neurodevelopmental pathways that could disrupt synaptic homeostasis and increase vulnerability to the pathologic consequence of expanded polyglutamine repeats over time.	[Lim, Ryan G.; Thompson, Leslie M.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Salazar, Lisa L.; Thompson, Leslie M.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Wilton, Daniel K.; Stevens, Beth] Harvard Med Sch, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA USA; [King, Alvin R.; Sharifabad, Delaram; Winokur, Sara T.; Thompson, Leslie M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA; [Lau, Alice L.; Reidling, Jack C.; Thompson, Leslie M.] Univ Calif Irvine, UCI MIND, Irvine, CA 92717 USA; [Lau, Alice L.; Reidling, Jack C.; Casale, Malcolm S.; Thompson, Leslie M.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Irvine, CA 92717 USA; [Thompson, Leslie M.] Univ Barcelona, Fac Med & Hlth Sci, Dept Biomed Sci, Barcelona, Spain; [Thompson, Leslie M.; Pardo, Monica; Gerardo Garcia Diaz-Barriga, A.; Straccia, Marco; Sanders, Phil; Alberch, Jordi; Canals, Josep M.] August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain; [Thompson, Leslie M.; Pardo, Monica; Gerardo Garcia Diaz-Barriga, A.; Straccia, Marco; Sanders, Phil; Alberch, Jordi; Canals, Josep M.] Networked Biomed Res Ctr NeuroDegenerat Disorders, Barcelona, Spain; [Kaye, Julia A.; Dunlap, Mariah; Jo, Lisa; May, Hanna; Mount, Elliot; Haston, Kelly; Finkbeiner, Steven] Gladstone Inst & Taube, Koret Ctr Neurodegenerat Dis Res, Roddenberry Stem Cell Res Program, San Francisco, CA USA; [Anderson-Bergman, Cliff] Sandia Natl Labs, Livermore, CA USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Kedaigle, Amanda J.; Yildirim, Ferah; Milani, Pamela; Fraenkel, Ernest] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Gipson, Theresa A.; Ng, Christopher W.; Housman, David E.] MIT, Ctr Canc Res, Cambridge, MA 02139 USA; [Gipson, Theresa A.; Ng, Christopher W.; Housman, David E.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Allen, Nicholas D.; Kemp, Paul J.] Cardiff Univ, Sch Biomed Sci, Cardiff, S Glam, Wales; [Atwal, Ranjit Singh; Biagioli, Marta; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Akimov, Sergey S.; Arbez, Nicolas; Stewart, Jacqueline; Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurol, Baltimore, MD 21205 USA; [Akimov, Sergey S.; Arbez, Nicolas; Stewart, Jacqueline; Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Akimov, Sergey S.; Arbez, Nicolas; Stewart, Jacqueline; Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Mattis, Virginia B.; Tom, Colton M.; Ornelas, Loren; Sahabian, Anais; Lenaeus, Lindsay; Mandefro, Berhan; Sareen, Dhruv; Svendsen, Clive N.] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA; [Mattis, Virginia B.; Tom, Colton M.; Ornelas, Loren; Sahabian, Anais; Lenaeus, Lindsay; Mandefro, Berhan; Sareen, Dhruv; Svendsen, Clive N.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; United States Department of Energy (DOE); Sandia National Laboratories; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Cardiff University; Harvard University; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Thompson, LM (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA.; Thompson, LM (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA.; Thompson, LM (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA.; Thompson, LM (corresponding author), Univ Calif Irvine, UCI MIND, Irvine, CA 92717 USA.; Thompson, LM (corresponding author), Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Irvine, CA 92717 USA.	lmthomps@uci.edu	Straccia, Marco/L-8048-2014; Barriga, Alfonso Gerardo Garcia Diaz/K-6040-2017; Alberch, Jordi/K-5702-2014; Kedaigle, Amanda/AAA-8171-2022; Canals, Josep M/M-3846-2014; Sanders, Phil/I-1757-2015	Straccia, Marco/0000-0003-3903-4163; Barriga, Alfonso Gerardo Garcia Diaz/0000-0002-9713-3795; Alberch, Jordi/0000-0002-8684-2721; Kedaigle, Amanda/0000-0001-6156-5046; Canals, Josep M/0000-0001-6829-7670; Biagioli, Marta/0000-0001-8295-8025; Allen, Nicholas/0000-0003-4009-186X; Lim, Ryan/0000-0001-6388-5158; Sanders, Phil/0000-0002-5658-8400; Fraenkel, Ernest/0000-0001-9249-8181	NIH [NS078370, U54 NS091046, NS089076, P50NS16367, R01GM089903, NS101996-01, R01NS084298, T32GM008334]; CHDI Foundation; American Heart Association, CIRM fellowship; American Heart Association, NRSA fellowship; Hereditary Disease Foundation; Taube-Koret Center; Hellman Family Foundation; UCI Institute for Clinical and Translational Science; Huntington's Disease Society of America; HD CARE; Ministerio de Economia y Competitividad [SAF 2014-57160-R, SAF2015-66505-R]; ISCIII-Subdireccion General de Evaluacion; European Regional Development Fund (ERDF) (RETICS) [RD12/0019/0002]; ACCIO (Catalonia Trade Investment; Generalitat de Catalunya); European Community under the Catalonian ERDF operational program, Spain; European Union; Ser Cymru Life Sciences & Health Network in Drug Discovery Programme; Cancer Center Support Grant at the University of California, Irvine [CA-62203]; National Science Foundation [DB1-0821391]; National Institutes of Health [P30-ES002109]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089903, T32GM008334, T32GM087237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091161, U54NS091046, R01NS084298, R21NS090395, R37NS101996, R01NS089076, RC2NS069422, R01NS086452, U24NS078370, P50NS016367] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation; American Heart Association, CIRM fellowship; American Heart Association, NRSA fellowship(American Heart Association); Hereditary Disease Foundation; Taube-Koret Center; Hellman Family Foundation; UCI Institute for Clinical and Translational Science; Huntington's Disease Society of America; HD CARE; Ministerio de Economia y Competitividad(Spanish Government); ISCIII-Subdireccion General de Evaluacion; European Regional Development Fund (ERDF) (RETICS); ACCIO (Catalonia Trade Investment; Generalitat de Catalunya); European Community under the Catalonian ERDF operational program, Spain; European Union(European Commission); Ser Cymru Life Sciences & Health Network in Drug Discovery Programme; Cancer Center Support Grant at the University of California, Irvine; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the patients and their families for their essential contributions to this research. We also thank E. Cattaneo and J. Arjomond for discussions of the data, D. Merry for critique of the manuscript and data, S. Svendsen for editorial assistance, J. Dunn for technical culture assistance, G. Vatine (Cedars-Sinai Medical Center, Los Angeles) for the iPSC-derived oligodendrocyte precursors, M. Godoy and G. Gowing (Cedars-Sinai Medical Center, Los Angeles) for the rat muscle and R. Barrett (Cedars-Sinai Medical Center, Los Angeles) for the definitive endoderm positive control. We also thank F. Bennet and Ionis Pharmaceuticals for providing the HTT ASO. Primary support for this work was from NIH NS078370 (L.M.T., C.N.S., J.F.G., M.E.M., C.A.R. and S.F.) and from the CHDI Foundation (J.M.C, P.J.K. and N.D.A.). Additional support was provided by NIH: U54 NS091046 NeuroLINCS center (L.M.T., C.N.S., E.F.); NIH NS089076 (L.M.T., D.E.H., E.F.); P50NS16367 (HD Center Without Walls); NIH R01GM089903 (E.F.); NIH NS101996-01 (S.F.); NIH R01NS084298 (B.S.); American Heart Association, CIRM and NRSA fellowships (R.G.L.); the Hereditary Disease Foundation (V.B.M.); the Taube-Koret Center and the Hellman Family Foundation (S.F.); the UCI Institute for Clinical and Translational Science (L.M.T.); Huntington's Disease Society of America (L.L.S); HD CARE (L.M.T.) and the NIH Biotechnology Training Program Fellowship (T32GM008334, A.J.K.). Additional support was provided by grants from the Ministerio de Economia y Competitividad (SAF 2014-57160-R to JA; SAF2015-66505-R to J.M.C.), from the ISCIII-Subdireccion General de Evaluacion and European Regional Development Fund (ERDF) (RETICS to JMC (RD12/0019/0002; Red de Terapia Celular); ADVANCE(CAT) with the support of ACCIO (Catalonia Trade & Investment; Generalitat de Catalunya) and the European Community under the Catalonian ERDF operational program 2014-2020), Spain, from the European Union FP7 (P.J.K. and N.D.A.) and from the Ser Cymru Life Sciences & Health Network in Drug Discovery Programme (M.W.S.). This work was made possible, in part, through access to the Genomic High Throughput Facility Shared Resource of the Cancer Center Support Grant (CA-62203) at the University of California, Irvine. Support also included computing resources from National Science Foundation grant DB1-0821391 and sequencing support from National Institutes of Health grant P30-ES002109.	Achour M, 2015, HUM MOL GENET, V24, P3481, DOI 10.1093/hmg/ddv099; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Aylward EH, 2013, J HUNTINGTONS DIS, V2, P477, DOI 10.3233/JHD-130076; Bai G, 2015, HUM MOL GENET, V24, P1441, DOI 10.1093/hmg/ddu561; BANERJEE A, 1988, J BIOL CHEM, V263, P3029; Barmada SJ, 2014, NAT CHEM BIOL, V10, P677, DOI 10.1038/nchembio.1563; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; BINDER LI, 1986, ANN NY ACAD SCI, V466, P145, DOI 10.1111/j.1749-6632.1986.tb38392.x; Blockx I, 2012, NEUROIMAGE, V59, P957, DOI 10.1016/j.neuroimage.2011.08.062; Buckley NJ, 2010, NEUROBIOL DIS, V39, P28, DOI 10.1016/j.nbd.2010.02.003; Chang L, 2016, NEUROLOGY, V87, P585, DOI 10.1212/WNL.0000000000002939; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Covey MV, 2012, DEVELOPMENT, V139, P2878, DOI 10.1242/dev.074765; Curtis MA, 2005, J CHEM NEUROANAT, V30, P55, DOI 10.1016/j.jchemneu.2005.05.001; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Curtis MA, 2011, EUR J NEUROSCI, V33, P1170, DOI 10.1111/j.1460-9568.2011.07616.x; Dias JM, 2014, NEURON, V84, P927, DOI 10.1016/j.neuron.2014.10.033; Ebert AD, 2013, STEM CELL RES, V10, P417, DOI 10.1016/j.scr.2013.01.009; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Fedele V, 2011, NEUROSCIENCE, V173, P76, DOI 10.1016/j.neuroscience.2010.08.022; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Figueres-Onate M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00194; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Glajch KE, 2015, J HUNTINGTONS DIS, V4, P1, DOI [10.3233/JHD-140134, 10.3233/JHD-159001]; Gourfinkel-An I, 2003, J NEUROCHEM, V86, P1369, DOI 10.1046/j.1471-4159.2003.01916.x; Gowing G, 2014, NEUROREPORT, V25, P367, DOI 10.1097/WNR.0000000000000092; Hashimoto TB, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003494; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Hsieh J, 2013, SCIENCE, V339, P1534, DOI 10.1126/science.1237576; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Imaizumi Y, 2014, J NEUROCHEM, V129, P388, DOI 10.1111/jnc.12625; Jung ES, 2015, BBA-GENE REGUL MECH, V1849, P1081, DOI 10.1016/j.bbagrm.2015.07.001; Kintner C, 2002, J NEUROSCI, V22, P639, DOI 10.1523/JNEUROSCI.22-03-00639.2002; Labadorf A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143563; Langfelder P, 2016, NAT NEUROSCI, V19, P623, DOI 10.1038/nn.4256; Lee JK, 2012, NEUROLOGY, V79, P668, DOI 10.1212/WNL.0b013e3182648b65; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorincz MT, 2009, MOL CELL NEUROSCI, V40, P1, DOI 10.1016/j.mcn.2008.06.004; Luong MX, 2011, CELL STEM CELL, V8, P357, DOI 10.1016/j.stem.2011.03.002; Lynch G, 2007, NEUROPHARMACOLOGY, V52, P12, DOI 10.1016/j.neuropharm.2006.07.027; MacIsaac KD, 2006, BIOINFORMATICS, V22, P423, DOI 10.1093/bioinformatics/bti815; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marco S, 2013, NAT MED, V19, P1030, DOI 10.1038/nm.3246; Marcora E, 2003, P NATL ACAD SCI USA, V100, P9578, DOI 10.1073/pnas.1133382100; Marder K, 2012, NEUROLOGY, V79, P621, DOI 10.1212/WNL.0b013e3182648bfe; Mattis VB, 2015, HUM MOL GENET, V24, P3257, DOI 10.1093/hmg/ddv080; Miyawaki S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11471; Molero AE, 2016, P NATL ACAD SCI USA, V113, P5736, DOI 10.1073/pnas.1603871113; Molero AE, 2009, P NATL ACAD SCI USA, V106, P21900, DOI 10.1073/pnas.0912171106; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Niccolini F, 2014, WORLD J RADIOL, V6, P301, DOI 10.4329/wjr.v6.i6.301; Novak MJU, 2015, HUM BRAIN MAPP, V36, P1728, DOI 10.1002/hbm.22733; Ochaba J, 2016, NEURON, V90, P507, DOI 10.1016/j.neuron.2016.03.016; Oh D, 1999, ARCH PATHOL LAB MED, V123, P917; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Onorati M, 2014, NAT NEUROSCI, V17, P1804, DOI 10.1038/nn.3860; Pei Y, 2016, BRAIN RES, V1638, P57, DOI 10.1016/j.brainres.2015.07.048; RESKENIELSEN E, 1987, ACTA PATH MICRO IM A, V95, P339; Ring KL, 2015, STEM CELL REP, V5, P1023, DOI 10.1016/j.stemcr.2015.11.005; Rodenas-Ruano A, 2012, NAT NEUROSCI, V15, P1382, DOI 10.1038/nn.3214; Roider HG, 2009, NUCLEIC ACIDS RES, V37, P6305, DOI 10.1093/nar/gkp682; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Sareen D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039113; Scahill RI, 2013, HUM BRAIN MAPP, V34, P519, DOI 10.1002/hbm.21449; Schneider JW, 2008, NAT CHEM BIOL, V4, P408, DOI 10.1038/nchembio.95; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shah AR, 2007, BIOINFORMATICS, V23, P906, DOI 10.1093/bioinformatics/btm031; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Shi CH, 2014, HUM MOL GENET, V23, P1013, DOI 10.1093/hmg/ddt497; Skibinski G, 2014, J NEUROSCI, V34, P418, DOI 10.1523/JNEUROSCI.2712-13.2014; Smagin DA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00443; Sneddon JB, 2012, NATURE, V491, P765, DOI 10.1038/nature11463; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sun JD, 2015, J NEUROSCI, V35, P4706, DOI 10.1523/JNEUROSCI.4276-14.2015; Telezhkin V, 2016, AM J PHYSIOL-CELL PH, V310, pC520, DOI 10.1152/ajpcell.00166.2015; Thanasupawat T, 2015, NANOMED-NANOTECHNOL, V11, P913, DOI 10.1016/j.nano.2015.01.014; Vashishtha M, 2013, P NATL ACAD SCI USA, V110, pE3027, DOI 10.1073/pnas.1311323110; Waldvogel H J, 2015, Adv Pharmacol, V73, P223, DOI 10.1016/bs.apha.2014.11.010; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wu CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107943; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2016, EXP THER MED, V12, P777, DOI 10.3892/etm.2016.3428; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095	90	130	130	5	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2017	20	5					648	+		10.1038/nn.4532	http://dx.doi.org/10.1038/nn.4532			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET1CU	28319609	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000400004300006
J	Adams, HHH; Hibar, DP; Chouraki, V; Stein, JL; Nyquist, PA; Renteria, ME; Trompet, S; Arias-Vasquez, A; Seshadri, S; Desrivieres, S; Beecham, AH; Jahanshad, N; Wittfeld, K; Van der Lee, SJ; Abramovic, L; Alhusaini, S; Amin, N; Andersson, M; Arfanakis, K; Aribisala, BS; Armstrong, NJ; Athanasiu, L; Axelsson, T; Beiser, A; Bernard, M; Bis, JC; Blanken, LME; Blanton, SH; Bohlken, MM; Boks, MP; Bralten, J; Brickman, AM; Carmichael, O; Chakravarty, MM; Chauhan, G; Chen, Q; Ching, CRK; Cuellar-Partida, G; Den Braber, A; Doan, NT; Ehrlich, S; Filippi, I; Ge, T; Giddaluru, S; Goldman, AL; Gottesman, RF; Greven, CU; Grimm, O; Griswold, ME; Guadalupe, T; Hass, J; Haukvik, UK; Hilal, S; Hofer, E; Hoehn, D; Holmes, AJ; Hoogman, M; Janowitz, D; Jia, T; Kasperaviciute, D; Kim, S; Klein, M; Kraemer, B; Lee, PH; Liao, J; Liewald, DCM; Lopez, LM; Luciano, M; Macare, C; Marquand, A; Matarin, M; Mather, KA; Mattheisen, M; Mazoyer, B; Mckay, DR; McWhirter, R; Milaneschi, Y; Mirza-Schreiber, N; Muetzel, RL; Maniega, SM; Nho, K; Nugent, AC; Loohuis, LMO; Oosterlaan, J; Papmeyer, M; Pappa, I; Pirpamer, L; Pudas, S; Puetz, B; Rajan, KB; Ramasamy, A; Richards, JS; Risacher, SL; Roiz-Santianez, R; Rommelse, N; Rose, EJ; Royle, NA; Rundek, T; Samann, PG; Satizabal, CL; Schmaal, L; Schork, AJ; Shen, L; Shin, J; Shumskaya, E; Smith, AV; Sprooten, E; Strike, LT; Teumer, A; Thomson, R; Tordesillas-Gutierrez, D; Toro, R; Trabzuni, D; Vaidya, D; Van der Grond, J; Van der Meer, D; Van Donkelaar, MMJ; Van Eijk, KR; Van Erp, TGM; Van Rooij, D; Walton, E; Westlye, LT; Whelan, CD; Windham, BG; Winkler, AM; Woldehawariat, G; Wolf, C; Wolfers, T; Xu, B; Yanek, LR; Yang, JY; Zijdenbos, A; Zwiers, MP; Agartz, I; Aggarwal, NT; Almasy, L; Ames, D; Amouyel, P; Andreassen, OA; Arepalli, S; Assareh, AA; Barral, S; Bastin, ME; Becker, DM; Becker, JT; Bennett, DA; Blangero, J; van Bokhoven, H; Boomsma, DI; Brodaty, H; Brouwer, RM; Brunner, HG; Buckner, RL; Buitelaar, JK; Bulayeva, KB; Cahn, W; Calhoun, VD; Cannon, DM; Cavalleri, GL; Chen, C; Cheng, CY; Cichon, S; Cookson, MR; Corvin, A; Crespo-Facorro, B; Curran, JE; Czisch, M; Dale, AM; Davies, GE; De Geus, EJC; De Jager, PL; de Zubicaray, GI; Delanty, N; Depondt, C; DeStefano, AL; Dillman, A; Djurovic, S; Donohoe, G; Drevets, WC; Duggirala, R; Dyer, TD; Erk, S; Espeseth, T; Evans, DA; Fedko, I; Fernandez, G; Ferrucci, L; Fisher, SE; Fleischman, DA; Ford, I; Foroud, TM; Fox, PT; Francks, C; Fukunaga, M; Gibbs, JR; Glahn, DC; Gollub, RL; Goring, HHH; Grabe, HJ; Green, RC; Gruber, O; Gudnason, V; Guelfi, S; Hansell, NK; Hardy, J; Hartman, CA; Hashimoto, R; Hegenscheid, K; Heinz, A; Le Hellard, S; Hernandez, DG; Heslenfeld, DJ; Ho, BC; Hoekstra, PJ; Hoffmann, W; Hofman, A; Holsboer, F; Homuth, G; Hosten, N; Hottenga, JJ; Pol, HEH; Ikeda, M; Ikram, MK; Jack, CR; Jenldnson, M; Johnson, R; Jonsson, EG; Jukema, JW; Kahn, RS; Kanai, R; Kloszewska, I; Knopman, DS; Kochunov, P; Kwok, JB; Lawrie, SM; Lemaitre, H; Liu, XM; Longo, DL; Longstreth, WT; Lopez, OL; Lovestone, S; Martinez, O; Martinot, JL; Mattay, VS; McDonald, C; McIntosh, AM; McMahon, KL; McMahon, FJ; Mecocci, P; Melle, I; Meyer-Lindenberg, A; Mohnke, S; Montgomery, GW; Morris, DW; Mosley, TH; Muhleisen, TW; Muller-Myhsok, B; Nalls, MA; Nauck, M; Nichols, TE; Niessen, WJ; Nothen, MM; Nyberg, L; Ohi, K; Olvera, RL; Ophoff, RA; Pandolfo, M; Paus, T; Pausova, Z; Penninx, BWJH; Pike, GB; Potkin, SG; Psaty, BM; Reppermund, S; Rietschel, M; Roffman, JL; Romanczuk-Seiferth, N; Rotter, JI; Ryten, M; Sacco, RL; Sachdev, PS; Saykin, AJ; Schmidt, R; Schofield, PR; Sigurdsson, S; Simmons, A; Singleton, A; Sisodiya, SM; Smith, C; Smoller, JW; Soininen, H; Srikanth, V; Steen, VM; Stott, DJ; Sussmann, JE; Thalamuthu, A; Tiemeier, H; Toga, AW; Traynor, BJ; Troncoso, J; Turner, JA; Tzourio, C; Uitterlinden, AG; Hernandez, MCV; Van der Brug, M; Van der Lugt, A; Van der Wee, NJA; Van Duijn, CM; Van Haren, NEM; Van't Ent, D; Van Tol, MJ; Vardarajan, BN; Veltman, DJ; Vernooij, MW; Volzke, H; Walter, H; Wardlaw, JM; Wassink, TH; Weale, ME; Weinberger, DR; Weiner, MW; Wen, W; Westman, E; White, T; Wong, TY; Wright, CB; Zielke, HR; Zonderman, AB; Deary, IJ; DeCarli, C; Schmidt, H; Martin, NG; De Craen, AJM; Wright, MJ; Launer, LJ; Schumann, G; Fornage, M; Franke, B; Debette, S; Medland, SE; Ikram, MA; Thompson, PM				Adams, Hieab H. H.; Hibar, Derrek P.; Chouraki, Vincent; Stein, Jason L.; Nyquist, Paul A.; Renteria, Miguel E.; Trompet, Stella; Arias-Vasquez, Alejandro; Seshadri, Sudha; Desrivieres, Sylvane; Beecham, Ashley H.; Jahanshad, Neda; Wittfeld, Katharine; Van der Lee, Sven J.; Abramovic, Lucija; Alhusaini, Saud; Amin, Najaf; Andersson, Micael; Arfanakis, Konstantinos; Aribisala, Benjamin S.; Armstrong, Nicola J.; Athanasiu, Lavinia; Axelsson, Tomas; Beiser, Alexa; Bernard, Manon; Bis, Joshua C.; Blanken, Laura M. E.; Blanton, Susan H.; Bohlken, Marc M.; Boks, Marco P.; Bralten, Janita; Brickman, Adam M.; Carmichael, Owen; Chakravarty, M. Mallar; Chauhan, Ganesh; Chen, Qiang; Ching, Christopher R. K.; Cuellar-Partida, Gabriel; Den Braber, Anouk; Doan, Nhat Trung; Ehrlich, Stefan; Filippi, Irina; Ge, Tian; Giddaluru, Sudheer; Goldman, Aaron L.; Gottesman, Rebecca F.; Greven, Corina U.; Grimm, Oliver; Griswold, Michael E.; Guadalupe, Tulio; Hass, Johanna; Haukvik, Unn K.; Hilal, Saima; Hofer, Edith; Hoehn, David; Holmes, Avram J.; Hoogman, Martine; Janowitz, Deborah; Jia, Tianye; Kasperaviciute, Dalia; Kim, Sungeun; Klein, Marieke; Kraemer, Bernd; Lee, Phil H.; Liao, Jiemin; Liewald, David C. M.; Lopez, Lorna M.; Luciano, Michelle; Macare, Christine; Marquand, Andre; Matarin, Mar; Mather, Karen A.; Mattheisen, Manuel; Mazoyer, Bernard; Mckay, David R.; McWhirter, Rebekah; Milaneschi, Yuri; Mirza-Schreiber, Nazanin; Muetzel, Ryan L.; Maniega, Susana Munoz; Nho, Kwangsik; Nugent, Allison C.; Loohuis, Loes M. Olde; Oosterlaan, Jaap; Papmeyer, Martina; Pappa, Irene; Pirpamer, Lukas; Pudas, Sara; Puetz, Benno; Rajan, Kumar B.; Ramasamy, Adaikalavan; Richards, Jennifer S.; Risacher, Shannon L.; Roiz-Santianez, Roberto; Rommelse, Nanda; Rose, Emma J.; Royle, Natalie A.; Rundek, Tatjana; Saemann, Philipp G.; Satizabal, Claudia L.; Schmaal, Lianne; Schork, Andrew J.; Shen, Li; Shin, Jean; Shumskaya, Elena; Smith, Albert V.; Sprooten, Emma; Strike, Lachlan T.; Teumer, Alexander; Thomson, Russell; Tordesillas-Gutierrez, Diana; Toro, Roberto; Trabzuni, Daniah; Vaidya, Dhananjay; Van der Grond, Jeroen; Van der Meer, Dennis; Van Donkelaar, Marjolein M. J.; Van Eijk, Kristel R.; Van Erp, Theo G. M.; Van Rooij, Daan; Walton, Esther; Westlye, Lars T.; Whelan, Christopher D.; Windham, Beverly G.; Winkler, Anderson M.; Woldehawariat, Girma; Wolf, Christiane; Wolfers, Thomas; Xu, Bing; Yanek, Lisa R.; Yang, Jingyun; Zijdenbos, Alex; Zwiers, Marcel P.; Agartz, Ingrid; Aggarwal, Neelum T.; Almasy, Laura; Ames, David; Amouyel, Philippe; Andreassen, Ole A.; Arepalli, Sampath; Assareh, Amelia A.; Barral, Sandra; Bastin, Mark E.; Becker, Diane M.; Becker, James T.; Bennett, David A.; Blangero, John; van Bokhoven, Hans; Boomsma, Dorret I.; Brodaty, Henry; Brouwer, Rachel M.; Brunner, Han G.; Buckner, Randy L.; Buitelaar, Jan K.; Bulayeva, Kazima B.; Cahn, Wiepke; Calhoun, Vince D.; Cannon, Dara M.; Cavalleri, Gianpiero L.; Chen, Christopher; Cheng, Ching -Yu; Cichon, Sven; Cookson, Mark R.; Corvin, Aiden; Crespo-Facorro, Benedicto; Curran, Joanne E.; Czisch, Michael; Dale, Anders M.; Davies, Gareth E.; De Geus, Eco J. C.; De Jager, Philip L.; de Zubicaray, Greig I.; Delanty, Norman; Depondt, Chantal; DeStefano, Anita L.; Dillman, Allissa; Djurovic, Srdjan; Donohoe, Gary; Drevets, Wayne C.; Duggirala, Ravi; Dyer, Thomas D.; Erk, Susanne; Espeseth, Thomas; Evans, Denis A.; Fedko, Iryna; Fernandez, Guillen; Ferrucci, Luigi; Fisher, Simon E.; Fleischman, Debra A.; Ford, Ian; Foroud, Tatiana M.; Fox, Peter T.; Francks, Clyde; Fukunaga, Masaki; Gibbs, J. Raphael; Glahn, David C.; Gollub, Randy L.; Goring, Harald H. H.; Grabe, Hans J.; Green, Robert C.; Gruber, Oliver; Gudnason, Vilmundur; Guelfi, Sebastian; Hansell, Narelle K.; Hardy, John; Hartman, Catharina A.; Hashimoto, Ryota; Hegenscheid, Katrin; Heinz, Andreas; Le Hellard, Stephanie; Hernandez, Dena G.; Heslenfeld, Dirk J.; Ho, Beng-Choon; Hoekstra, Pieter J.; Hoffmann, Wolfgang; Hofman, Albert; Holsboer, Florian; Homuth, Georg; Hosten, Norbert; Hottenga, Jouke-Jan; Pol, Hilleke E. Hulshoff; Ikeda, Masashi; Ikram, M. Kamran; Jack, Clifford R., Jr.; Jenldnson, Mark; Johnson, Robert; Jonsson, Erik G.; Jukema, J. Wouter; Kahn, Rene S.; Kanai, Ryota; Kloszewska, Iwona; Knopman, David S.; Kochunov, Peter; Kwok, John B.; Lawrie, Stephen M.; Lemaitre, Herve; Liu, Xinmin; Longo, Dan L.; Longstreth, W. T., Jr.; Lopez, Oscar L.; Lovestone, Simon; Martinez, Oliver; Martinot, Jean-Luc; Mattay, Venkata S.; McDonald, Colm; McIntosh, Andrew M.; McMahon, Katie L.; McMahon, Francis J.; Mecocci, Patrizia; Melle, Ingrid; Meyer-Lindenberg, Andreas; Mohnke, Sebastian; Montgomery, Grant W.; Morris, Derek W.; Mosley, Thomas H.; Muhleisen, Thomas W.; Mueller-Myhsok, Bertram; Nalls, Michael A.; Nauck, Matthias; Nichols, Thomas E.; Niessen, Wiro J.; Noethen, Markus M.; Nyberg, Lars; Ohi, Kazutaka; Olvera, Rene L.; Ophoff, Roel A.; Pandolfo, Massimo; Paus, Tomas; Pausova, Zdenka; Penninx, Brenda W. J. H.; Pike, G. Bruce; Potkin, Steven G.; Psaty, Bruce M.; Reppermund, Simone; Rietschel, Marcella; Roffman, Joshua L.; Romanczuk-Seiferth, Nina; Rotter, Jerome I.; Ryten, Mina; Sacco, Ralph L.; Sachdev, Perminder S.; Saykin, Andrew J.; Schmidt, Reinhold; Schofield, Peter R.; Sigurdsson, Sigurdur; Simmons, Andy; Singleton, Andrew; Sisodiya, Sanjay M.; Smith, Colin; Smoller, Jordan W.; Soininen, Hindu.; Srikanth, Velandai; Steen, Vidar M.; Stott, David J.; Sussmann, Jessika E.; Thalamuthu, Anbupalam; Tiemeier, Henning; Toga, Arthur W.; Traynor, Bryan J.; Troncoso, Juan; Turner, Jessica A.; Tzourio, Christophe; Uitterlinden, Andre G.; Hernandez, Maria C. Valdes; Van der Brug, Marcel; Van der Lugt, Aad; Van der Wee, Nic J. A.; Van Duijn, Cornelia M.; Van Haren, Neeltje E. M.; Van't Ent, Dennis; Van Tol, Marie Jose; Vardarajan, Badri N.; Veltman, Dick J.; Vernooij, Meike W.; Voelzke, Henry; Walter, Henrik; Wardlaw, Joanna M.; Wassink, Thomas H.; Weale, Michael E.; Weinberger, Daniel R.; Weiner, Michael W.; Wen, Wei; Westman, Eric; White, Tonya; Wong, Tien Y.; Wright, Clinton B.; Zielke, H. Ronald; Zonderman, Alan B.; Deary, Ian J.; DeCarli, Charles; Schmidt, Helena; Martin, Nicholas G.; De Craen, Anton J. M.; Wright, Margaret J.; Launer, Lenore J.; Schumann, Gunter; Fornage, Myriam; Franke, Barbara; Debette, Stephanie; Medland, Sarah E.; Ikram, M. Arfan; Thompson, Paul M.		Alzheimer's Dis Neuroimaging Initi; EPIGEN; IMAGEN; SYS	Novel genetic loci underlying human intracranial volume identified through genome-wide association	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; COMMON VARIANTS; 17Q21.31 MICRODELETION; PARKINSONS-DISEASE; HEAD CIRCUMFERENCE; BRAIN SIZE; IGF-I; METAANALYSIS; CONSORTIUM; HEIGHT	Intracranial volume reflects the maximally attained brain size during development, and remains stable with loss of tissue in late life. It is highly heritable, but the underlying genes remain largely undetermined. In a genome-wide association study of 32,438 adults, we discovered five previously unknown loci for intracranial volume and confirmed two known signals. Four of the loci were also associated with adult human stature, but these remained associated with intracranial volume after adjusting for height. We found a high genetic correlation with child head circumference (rho(genetic) = 0.748), which indicates a similar genetic background and allowed us to identify four additional loci through meta-analysis (N-combined = 37,345). Variants for intracranial volume were also related to childhood and adult cognitive function, and Parkinson's disease, and were enriched near genes involved in growth pathways, including PI3K-AKT signaling. These findings identify the biological underpinnings of intracranial volume and their link to physiological and pathological traits.	[Adams, Hieab H. H.; Van der Lee, Sven J.; Amin, Najaf; Hofman, Albert; Ikram, M. Kamran; Tiemeier, Henning; Uitterlinden, Andre G.; Van Duijn, Cornelia M.; Vernooij, Meike W.; Ikram, M. Arfan] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Adams, Hieab H. H.; Niessen, Wiro J.; Van der Lugt, Aad; Vernooij, Meike W.; White, Tonya; Ikram, M. Arfan] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands; [Hibar, Derrek P.; Stein, Jason L.; Jahanshad, Neda; Ching, Christopher R. K.; Whelan, Christopher D.; Thompson, Paul M.] Univ Southern Calif, Keck Sch Med, USC Mark & Mary Stevens Neuroimaging & Informat I, Imaging Genet Ctr, Los Angeles, CA USA; [Chouraki, Vincent; Seshadri, Sudha; Beiser, Alexa; Satizabal, Claudia L.; Debette, Stephanie] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Chouraki, Vincent; Amouyel, Philippe] Univ Lille, RID AGE Risk Factors & Mol Determinants Aging Rel, CHU Lille, Inserm,Inst Pasteur Lille, Lille, France; [Chouraki, Vincent; Seshadri, Sudha; Beiser, Alexa; Satizabal, Claudia L.; DeStefano, Anita L.] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Stein, Jason L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Stein, Jason L.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC USA; [Nyquist, Paul A.] Johns Hopkins Univ, Dept Neurol, Dept Anesthesia Crit Care Med, Dept Neurosurg, Baltimore, MD 21218 USA; [Renteria, Miguel E.; Cuellar-Partida, Gabriel; Strike, Lachlan T.; Hansell, Narelle K.; Montgomery, Grant W.; Martin, Nicholas G.; Medland, Sarah E.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Arias-Vasquez, Alejandro; Bralten, Janita; Hoogman, Martine; Klein, Marieke; Shumskaya, Elena; Van Donkelaar, Marjolein M. J.; Wolfers, Thomas; van Bokhoven, Hans; Brunner, Han G.; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Arias-Vasquez, Alejandro; Rommelse, Nanda; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, Nijmegen, Netherlands; [Arias-Vasquez, Alejandro; Greven, Corina U.; Richards, Jennifer S.; Van Rooij, Daan; Buitelaar, Jan K.; Fernandez, Guillen] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, Nijmegen, Netherlands; [Arias-Vasquez, Alejandro; Bralten, Janita; Hoogman, Martine; Klein, Marieke; Marquand, Andre; Richards, Jennifer S.; Rommelse, Nanda; Shumskaya, Elena; Van Donkelaar, Marjolein M. J.; Van Rooij, Daan; Wolfers, Thomas; Zwiers, Marcel P.; van Bokhoven, Hans; Brunner, Han G.; Buitelaar, Jan K.; Fernandez, Guillen; Fisher, Simon E.; Francks, Clyde; Franke, Barbara] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Desrivieres, Sylvane; Jia, Tianye; Macare, Christine; Xu, Bing; Schumann, Gunter] Kings Coll London, Inst Psychiat Psychol & Neurosci, MRC SGDP Ctr, London, England; [Beecham, Ashley H.; Blanton, Susan H.] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL 33136 USA; [Beecham, Ashley H.; Blanton, Susan H.; Sacco, Ralph L.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Gen, Miami, FL 33136 USA; [Wittfeld, Katharine; Hoffmann, Wolfgang] German Ctr Neurodegenerat Dis DZNE Rostock Greifs, Greifswald, Germany; [Wittfeld, Katharine; Janowitz, Deborah; Grabe, Hans J.] Univ Med Greifswald, Dept Psychiat, Greifswald, Germany; [Abramovic, Lucija; Bohlken, Marc M.; Boks, Marco P.; Brouwer, Rachel M.; Cahn, Wiepke; Pol, Hilleke E. Hulshoff; Kahn, Rene S.; Ophoff, Roel A.; Van Haren, Neeltje E. M.] UMC Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Alhusaini, Saud] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Alhusaini, Saud; Whelan, Christopher D.; Cavalleri, Gianpiero L.; Delanty, Norman] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Andersson, Micael; Pudas, Sara; Nyberg, Lars] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Arfanakis, Konstantinos] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Arfanakis, Konstantinos; Yang, Jingyun; Aggarwal, Neelum T.; Bennett, David A.; Fleischman, Debra A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Arfanakis, Konstantinos] Rush Univ, Med Ctr, Dept Diagnost Radiol & Nucl Med, Chicago, IL 60612 USA; [Aribisala, Benjamin S.; Maniega, Susana Munoz; Royle, Natalie A.; Bastin, Mark E.; Hernandez, Maria C. Valdes; Wardlaw, Joanna M.] Univ Edinburgh, Brain Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Aribisala, Benjamin S.] Lagos State Univ, Dept Comp Sci, Lagos, Nigeria; [Aribisala, Benjamin S.; Maniega, Susana Munoz; Royle, Natalie A.; Bastin, Mark E.; Hernandez, Maria C. Valdes; Wardlaw, Joanna M.] Univ Edinburgh, Dept Neuroimaging Sci, Scottish Imaging Network, Edinburgh, Midlothian, Scotland; [Armstrong, Nicola J.; Mather, Karen A.; Assareh, Amelia A.; Brodaty, Henry; Reppermund, Simone; Sachdev, Perminder S.; Thalamuthu, Anbupalam; Wen, Wei] Univ New South Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Armstrong, Nicola J.] Murdoch Univ, Math & Stat, Perth, WA, Australia; [Athanasiu, Lavinia; Doan, Nhat Trung; Haukvik, Unn K.; Agartz, Ingrid; Andreassen, Ole A.; Jonsson, Erik G.; Melle, Ingrid] Univ Oslo, Inst Clin Med, NORMENT KG Jebsen Ctr, Oslo, Norway; [Athanasiu, Lavinia; Westlye, Lars T.; Andreassen, Ole A.; Espeseth, Thomas; Melle, Ingrid] Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT KG Jebsen Ctr, Oslo, Norway; [Axelsson, Tomas] Uppsala Univ, Dept Med Sci Mol Med, Uppsala, Sweden; [Axelsson, Tomas] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Beiser, Alexa] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Bernard, Manon; Shin, Jean; Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada; [Bis, Joshua C.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Blanken, Laura M. E.; Muetzel, Ryan L.; Pappa, Irene] Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands; [Blanken, Laura M. E.; Muetzel, Ryan L.; Tiemeier, Henning; White, Tonya] Erasmus MC Sophia Childrens Hosp, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands; [Brickman, Adam M.; Barral, Sandra; Vardarajan, Badri N.] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Brickman, Adam M.] Columbia Univ, GH Sergievsky Ctr, Med Ctr, New York, NY USA; [Brickman, Adam M.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Carmichael, Owen] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Chakravarty, M. Mallar] Douglas Mental Hlth Univ Inst, Cerebral Imaging Ctr, Montreal, PQ, Canada; [Chakravarty, M. Mallar] McGill Univ, Dept Psychiat & Biomed Engn, Montreal, PQ, Canada; [Chauhan, Ganesh] Univ Bordeaux, INSERM Unit U1219, Bordeaux, France; [Chen, Qiang; Goldman, Aaron L.; Mattay, Venkata S.; Weinberger, Daniel R.; Debette, Stephanie] Lieber Inst Brain Dev, Baltimore, MD USA; [Ching, Christopher R. K.] Univ Calif Los Angeles, Sch Med, Interdept Neurosci Grad Program, Los Angeles, CA USA; [Den Braber, Anouk; Boomsma, Dorret I.; De Geus, Eco J. C.; Fedko, Iryna; Hottenga, Jouke-Jan; Van't Ent, Dennis] Vrije Univ Amsterdam, Biol Psychol, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Den Braber, Anouk; Boomsma, Dorret I.; De Geus, Eco J. C.; Fedko, Iryna; Hottenga, Jouke-Jan; Van't Ent, Dennis] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Ehrlich, Stefan] Tech Univ Dresden, Fac Med, Div Psychol & Social Med & Dev Neurosci, Dresden, Germany; [Ehrlich, Stefan; Holmes, Avram J.; Lee, Phil H.; Buckner, Randy L.; Gollub, Randy L.; Roffman, Joshua L.; Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Ehrlich, Stefan; Ge, Tian; Gollub, Randy L.] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Filippi, Irina; Lemaitre, Herve; Martinot, Jean-Luc] Univ Paris Sud, Univ Paris Descartes, NSERM Unit Neuroimaging & Psychiat 1000, Paris, France; [Filippi, Irina; Lemaitre, Herve; Martinot, Jean-Luc] Hosp Cochin, AP HP, Maison Solenn Adolescent Psychopathol & Med Dept, Paris, France; [Ge, Tian; Lee, Phil H.; Smoller, Jordan W.] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Ge, Tian; Lee, Phil H.; De Jager, Philip L.; Gollub, Randy L.; Green, Robert C.; Smoller, Jordan W.] Harvard Med Sch, Boston, MA USA; [Ge, Tian; Lee, Phil H.; Smoller, Jordan W.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Boston, MA USA; [Giddaluru, Sudheer; Djurovic, Srdjan; Le Hellard, Stephanie; Steen, Vidar M.] Univ Bergen, Dept Clin Sci, NORMENT KG Jebsen Ctr Psychosis Res, N-5020 Bergen, Norway; [Giddaluru, Sudheer; DeStefano, Anita L.; Le Hellard, Stephanie; Steen, Vidar M.] Haukeland Hosp, Ctr Med Genet & Mol Med, Dr Einar Martens Res Grp Biol Psychiat, Bergen, Norway; [Gottesman, Rebecca F.; Mattay, Venkata S.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Greven, Corina U.; Richards, Jennifer S.; Rommelse, Nanda; Buitelaar, Jan K.] Karakter Child & Adolescent Psychiat Univ Ctr, Nijmegen, Netherlands; [Greven, Corina U.] Kings Coll London, Med Res Council Social, Genet & Dev Psychiat Ctr, Inst Psychol Psychiat & Neurosci, London, England; [Grimm, Oliver; Meyer-Lindenberg, Andreas; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Mannheim, Germany; [Griswold, Michael E.] Univ Mississippi, Med Ctr, Ctr Biostat & Bioinformat, Jackson, MS 39216 USA; [Guadalupe, Tulio; Fisher, Simon E.; Francks, Clyde] Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands; [Guadalupe, Tulio] Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands; [Hass, Johanna; Walton, Esther] Tech Univ Dresden, Fac Med, Dept Child & Adolescent Psychiat, Dresden, Germany; [Haukvik, Unn K.; Agartz, Ingrid] Diakonhjemmet Hosp, Dept Res & Dev, Oslo, Norway; [Hilal, Saima; Chen, Christopher; Ikram, M. Kamran] Natl Univ Singapore, Dept Pharmacol, Singapore, Singapore; [Hilal, Saima; Chen, Christopher; Ikram, M. Kamran] Natl Univ Hlth Syst, Mem Aging & Cognit Ctr, Singapore, Singapore; [Hofer, Edith; Pirpamer, Lukas; Schmidt, Reinhold] Med Univ Graz, Clin Div Neurogeriatr, Dept Neurol, Graz, Austria; [Hofer, Edith] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Hoehn, David; Mirza-Schreiber, Nazanin; Puetz, Benno; Saemann, Philipp G.; Czisch, Michael; Holsboer, Florian; Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, Dept Translat Res Psychiat, Munich, Germany; [Holmes, Avram J.] Yale Univ, Dept Psychol, New Haven, CT USA; [Kasperaviciute, Dalia; Matarin, Mar; Sisodiya, Sanjay M.] UCL, Inst Neurol, London, England; [Kasperaviciute, Dalia; Matarin, Mar; Sisodiya, Sanjay M.] Epilepsy Soc, Gerrards Cross, Bucks, England; [Kasperaviciute, Dalia] Imperial Coll London, Dept Med, London, England; [Nho, Kwangsik; Risacher, Shannon L.; Shen, Li; Saykin, Andrew J.] Indiana Univ, Sch Med, Ctr Neuroimaging Radiol & Imaging Sci, Indianapolis, IN USA; [Kim, Sungeun; Nho, Kwangsik; Shen, Li; Foroud, Tatiana M.] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Kim, Sungeun; Nho, Kwangsik; Risacher, Shannon L.; Shen, Li; Saykin, Andrew J.] Indiana Univ, Sch Med, Indiana Alzheimer Dis Ctr, Indianapolis, IN USA; [Kraemer, Bernd; Gruber, Oliver] Heidelberg Univ, Dept Gen Psychiat, Sect Expt Psychopathol & Neuroimaging, Heidelberg, Germany; [Lee, Phil H.] Harvard Med Sch, Massachusetts Gen Hosp, Lurie Ctr Autism, Lexington, MA USA; [Liao, Jiemin; Cheng, Ching -Yu; Ikram, M. Kamran; Wong, Tien Y.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Liewald, David C. M.; Lopez, Lorna M.; Luciano, Michelle; Maniega, Susana Munoz; Royle, Natalie A.; Bastin, Mark E.; McIntosh, Andrew M.; Hernandez, Maria C. Valdes; Wardlaw, Joanna M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol Psychol, Edinburgh, Midlothian, Scotland; [Marquand, Andre; Shumskaya, Elena; Zwiers, Marcel P.] Radboud Univ Nijmegen, Donders Ctr Cognit Neuroimaging, Nijmegen, Netherlands; [Matarin, Mar; Ramasamy, Adaikalavan; Trabzuni, Daniah; Gibbs, J. Raphael; Guelfi, Sebastian; Hardy, John; Hernandez, Dena G.; Ryten, Mina] UCL Inst Neurol, Reta Lila Weston Inst, London, England; [Matarin, Mar; Ramasamy, Adaikalavan; Trabzuni, Daniah; Gibbs, J. Raphael; Guelfi, Sebastian; Hardy, John; Hernandez, Dena G.; Ryten, Mina] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Mattheisen, Manuel] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Mattheisen, Manuel] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark; [Mattheisen, Manuel] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Copenhagen, Denmark; [Mattheisen, Manuel] Aarhus Univ, iSEQ, Ctr Integrated Sequencing, Aarhus, Denmark; [Mazoyer, Bernard] UMR5296 Univ Bordeaux, CNRS, CEA, Bordeaux, France; [Mckay, David R.; Sprooten, Emma; Winkler, Anderson M.; Glahn, David C.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Mckay, David R.; Sprooten, Emma; Glahn, David C.] Olin Neuropsychiat Res Ctr, Hartford, CT USA; [McWhirter, Rebekah] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Milaneschi, Yuri] VU Univ Med Ctr GGZ Geest, EMGO Inst Hlth & Care Res, Dept Psychiat, Amsterdam, Netherlands; [Milaneschi, Yuri] VU Univ Med Ctr GGZ Geest, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Nugent, Allison C.; Woldehawariat, Girma; Cannon, Dara M.; Drevets, Wayne C.; Liu, Xinmin; McMahon, Francis J.] NIMH, Exp Therapeut & Pathophysiol Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Loohuis, Loes M. Olde; Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Papmeyer, Martina; Sprooten, Emma; Lawrie, Stephen M.; McIntosh, Andrew M.; Sussmann, Jessika E.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh, Midlothian, Scotland; [Papmeyer, Martina] Univ Bern, Univ Hosp Psychiat, Translat Res Ctr, Div Syst Neurosci Psychopathol, CH-3012 Bern, Switzerland; [Pappa, Irene] Erasmus Univ, Sch Pedag & Educ Sci, Rotterdam, Netherlands; [Rajan, Kumar B.; Aggarwal, Neelum T.; Evans, Denis A.] Rush Univ, Med Ctr, Rush Inst Healthy Aging, Chicago, IL 60612 USA; [Ramasamy, Adaikalavan; Ryten, Mina; Weale, Michael E.] Kings Coll London, Dept Med & Mol Genet, London, England; [Ramasamy, Adaikalavan] Univ Oxford, Jenner Inst Labs, Oxford, England; [Roiz-Santianez, Roberto; Crespo-Facorro, Benedicto] Univ Cantabria IDIVAL, Sch Med, Dept Med & Psychiat, Univ Hosp Marques de Valdecilla, Santander, Spain; [Roiz-Santianez, Roberto; Tordesillas-Gutierrez, Diana; Crespo-Facorro, Benedicto] CIBERSAM Ctr Invest Biomed Red Salud Med, Santander, Spain; [Rose, Emma J.; Corvin, Aiden] Trinity Coll Dublin, Psychosis Res Grp, Dept Psychiat, Dublin, Ireland; [Rose, Emma J.; Corvin, Aiden] Trinity Coll Dublin, Trinity Translat Med Inst, Dublin, Ireland; [Royle, Natalie A.; Bastin, Mark E.; Hernandez, Maria C. Valdes; Wardlaw, Joanna M.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Rundek, Tatjana; Sacco, Ralph L.; Wright, Clinton B.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Rundek, Tatjana; Sacco, Ralph L.; Wright, Clinton B.] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth Sci, Miami, FL 33136 USA; [Schmaal, Lianne] Orygen, Melbourne, Vic, Australia; [Schmaal, Lianne] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic, Australia; [Schmaal, Lianne; Penninx, Brenda W. J. H.; Veltman, Dick J.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Schork, Andrew J.] Univ Calif San Diego, Dept Neurosci, Multimodal Imaging Lab, San Diego, CA 92103 USA; [Schork, Andrew J.] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA; [Smith, Albert V.; Gudnason, Vilmundur; Sigurdsson, Sigurdur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Sprooten, Emma] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Strike, Lachlan T.; Hansell, Narelle K.; Wright, Margaret J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Teumer, Alexander; Hoffmann, Wolfgang; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Thompson, Paul M.] Univ Western Sydney, Sch Comp Engn & Math, Parramatta, NSW, Australia; [Tordesillas-Gutierrez, Diana] Valdecilla Biomed Res Inst IDIVAL, Neuroimaging Unit, Technol Facil, Santander, Cantabria, Spain; [Toro, Roberto] Inst Pasteur, Paris, France; [Trabzuni, Daniah] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia; [Vaidya, Dhananjay; Yanek, Lisa R.; Becker, Diane M.] Johns Hopkins Univ, Sch Med, Dept Med, GeneSTAR Res Ctr, Baltimore, MD 21205 USA; [Van der Grond, Jeroen] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Van der Meer, Dennis; Van Rooij, Daan; Hartman, Catharina A.; Hoekstra, Pieter J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Van Eijk, Kristel R.] UMC Utrecht, Human Neurogenet Unit, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Van Erp, Theo G. M.; Potkin, Steven G.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Westlye, Lars T.; Espeseth, Thomas] Univ Oslo, Dept Psychol, NORMENT KG Jebsen Ctr, Oslo, Norway; [Windham, Beverly G.; Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Winkler, Anderson M.; Jenldnson, Mark; Jonsson, Erik G.; Nichols, Thomas E.] Univ Oxford, FMRIB Ctr, Oxford, England; [Wolf, Christiane] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Yang, Jingyun; Aggarwal, Neelum T.; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Zijdenbos, Alex] Biospect Inc, Montreal, PQ, Canada; [Agartz, Ingrid] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden; [Almasy, Laura; Blangero, John; Curran, Joanne E.; Duggirala, Ravi; Dyer, Thomas D.; Goring, Harald H. H.] Univ Texas Rio Grande Valley, Sch Med, South Texas Diabet & Obes Inst, Edinburg, TX USA; [Almasy, Laura; Blangero, John; Curran, Joanne E.; Duggirala, Ravi; Dyer, Thomas D.; Goring, Harald H. H.] Univ Texas Rio Grande Valley, Sch Med, South Texas Diabet & Obes Inst, Edinburg, TX USA; [Almasy, Laura; Blangero, John; Curran, Joanne E.; Duggirala, Ravi; Dyer, Thomas D.; Goring, Harald H. H.] Univ Texas Rio Grande Valley, Sch Med, South Texas Diabet & Obes Inst, San Antonio, TX USA; [Almasy, Laura] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Almasy, Laura] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Ames, David] Royal Melbourne Hosp, Natl Ageing Res Inst, Melbourne, Vic, Australia; [Ames, David] Univ Melbourne, Acad Unit Psychiat Old Age, Melbourne, Vic, Australia; [Arepalli, Sampath; Cookson, Mark R.; Dillman, Allissa; Gibbs, J. Raphael; Hernandez, Dena G.; Nalls, Michael A.; Singleton, Andrew; Traynor, Bryan J.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Becker, James T.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Becker, James T.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Becker, James T.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Brodaty, Henry] UNSW, Dementia Collaborat Res Ctr Assessment & Better, Sydney, NSW, Australia; [Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Buckner, Randy L.] Harvard Univ, Dept Psychol, Ctr Brain Sci, 33 Kirkland St, Cambridge, MA 02138 USA; [Bulayeva, Kazima B.; Wong, Tien Y.] Dagestan State Univ, Dept Evolut & Genet, Makhachkala, Dagestan, Russia; [Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [Calhoun, Vince D.] LBERI, Albuquerque, NM USA; [Calhoun, Vince D.] Univ New Mexico, Dept ECE, Albuquerque, NM 87131 USA; [Cannon, Dara M.; McDonald, Colm; Muhleisen, Thomas W.] Natl Univ Ireland Galway, Ctr Neuroimaging & Cognit Genom NICOG, NCBES Galway Neurosci Ctr, Coll Med Nursing & Hlth Sci,Clin Neuroimaging Lab, Galway, Ireland; [Cheng, Ching -Yu; Ikram, M. Kamran] Duke NUS Grad Med Sch, Acad Med Res Inst, Singapore, Singapore; [Cheng, Ching -Yu; Wong, Tien Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore; [Cichon, Sven] Univ Basel, Dept Biomed, Div Med Genet, Basel, Switzerland; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Cichon, Sven; Muhleisen, Thomas W.] Res Ctr Julich, Inst Neurosci & Med INM1, Julich, Germany; [Dale, Anders M.] Univ Calif San Diego, Ctr Multimodal Imaging & Genet, San Diego, CA 92103 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA; [Davies, Gareth E.] Avera Inst Human Genet, Sioux Falls, SD USA; [Davies, Gareth E.] Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Gen, 75 Francis St, Boston, MA 02115 USA; [Davies, Gareth E.] Brigham & Womens Hosp, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA; [Davies, Gareth E.] Harvard Med Sch, Boston, MA USA; [Davies, Gareth E.; De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [De Jager, Philip L.] Broad Inst, Cambridge, MA USA; [de Zubicaray, Greig I.] Queensland Univ Technol, Fac Hlth, Brisbane, Qld, Australia; [de Zubicaray, Greig I.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Delanty, Norman] Beaumont Hosp, Div Neurol, Dublin 9, Ireland; [Depondt, Chantal; Pandolfo, Massimo] Univ Libre Bruxelles, Hop Erasme, Dept Neurol, Brussels, Belgium; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Donohoe, Gary; Morris, Derek W.] Natl Univ Ireland Galway, Cognit Genet & Cognit Therapy Grp, Neuroimaging Cognit & Genom Ctr NICOG, Galway, Ireland; [Donohoe, Gary; Morris, Derek W.] Natl Univ Ireland Galway, NCBES Galway Neurosci Ctr, Sch Psychol, Galway, Ireland; [Donohoe, Gary; Morris, Derek W.] Natl Univ Ireland Galway, Discipline Biochem, Galway, Ireland; [Donohoe, Gary; Morris, Derek W.] Trinity Coll Dublin, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin 8, Ireland; [Donohoe, Gary; Morris, Derek W.] Trinity Coll Dublin, Inst Psychiat, Dublin 8, Ireland; [Drevets, Wayne C.] Janssen Res & Dev LLC, Titusville, NJ USA; [Erk, Susanne; Heinz, Andreas; Mohnke, Sebastian; Romanczuk-Seiferth, Nina; Walter, Henrik] Charite, CCM, Dept Psychiat & Psychotherapy, Berlin, Germany; [Ferrucci, Luigi] NIA, Intramural Res Program, Baltimore, MD 21224 USA; [Fleischman, Debra A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Fleischman, Debra A.] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Foroud, Tatiana M.; Saykin, Andrew J.] Indiana Univ, Sch Med, Med & Mol Genet, Indianapolis, IN USA; [Fox, Peter T.; Olvera, Rene L.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Fukunaga, Masaki] Natl Inst Physiol Sci, Div Cerebral Integrat, Aichi, Japan; [Green, Robert C.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Hashimoto, Ryota; Ohi, Kazutaka] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Hashimoto, Ryota] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Osaka, Japan; [Hegenscheid, Katrin; Hosten, Norbert] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Hernandez, Dena G.] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Heslenfeld, Dirk J.] Vrije Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Ho, Beng-Choon] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Holsboer, Florian] HMNC Brain Hlth, Munich, Germany; [Homuth, Georg] Univ Med Greifswald, Interfac Inst Genet & Funct Gen, Greifswald, Germany; [Ikeda, Masashi] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi, Japan; [Jack, Clifford R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Johnson, Robert; Zielke, H. Ronald] Univ Maryland, Sch Med, NICHD Brain & Tissue Bank Dev Disorders, Baltimore, MD 21201 USA; [Kanai, Ryota] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Kanai, Ryota] UCL, Inst Cognit Neurosci, London, England; [Kanai, Ryota] Araya Brain Imaging, Dept Neuroinformat, Tokyo, Japan; [Kloszewska, Iwona] Med Univ Lodz, Lodz, Poland; [Knopman, David S.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Kochunov, Peter] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Dept Psychiat, Baltimore, MD 21201 USA; [Kwok, John B.; Schofield, Peter R.] Neurosci Res Australia, Sydney, NSW, Australia; [Kwok, John B.; Schofield, Peter R.] UNSW, Sch Med Sci, Sydney, NSW, Australia; [Liu, Xinmin] Columbia Univ, Med Ctr, New York, NY USA; [Longo, Dan L.] NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Lopez, Oscar L.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Lopez, Oscar L.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Lovestone, Simon] Univ Oxford, Dept Psychiat, Oxford, England; [Lovestone, Simon] Kings Coll London, NIHR Dementia Biomed Res Unit, London, England; [Martinez, Oliver; DeCarli, Charles] Univ Calif Davis, Dept Neurol, Imaging Dementia & Aging IDeA Lab, Sacramento, CA 95817 USA; [Martinez, Oliver; DeCarli, Charles] Univ Calif Davis, Ctr Neurosci, Sacramento, CA 95817 USA; [Mattay, Venkata S.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [McMahon, Katie L.; Wright, Margaret J.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Mecocci, Patrizia] Univ Perugia, Dept Med, Sect Gerontol & Geriatr, Perugia, Italy; [Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Mueller-Myhsok, Bertram] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Nauck, Matthias] German Ctr Cardiovasc Res DZHK eV, Partner Site Greifswald, Berlin, Germany; [Nichols, Thomas E.] Univ Warwick, Dept Stat, Coventry, W Midlands, England; [Nichols, Thomas E.] Univ Warwick, Warwick Mfg Grp, Coventry, W Midlands, England; [Niessen, Wiro J.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Niessen, Wiro J.] Delft Univ Technol, Fac Sci Appl, Delft, Netherlands; [Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Paus, Tomas] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Paus, Tomas] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Paus, Tomas] Child Mind Inst, New York, NY USA; [Pausova, Zdenka] Univ Toronto, Dept Phys, Toronto, ON, Canada; [Pausova, Zdenka] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Pike, G. Bruce] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Pike, G. Bruce] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Grp Hlth, Seattle, WA USA; [Reppermund, Simone] UNSW Med, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Kensington, NSW, Australia; [Rotter, Jerome I.] Univ Calif Los Angeles, Med Ctr, Ilnst Translat Genom & Populat Sci, Los Angeles Biomed Res Inst & Pediat Harbor, Torrance, CA 90509 USA; [Sacco, Ralph L.; Wright, Clinton B.] Univ Miami, Miller Sch Med, Evelyn F McKnight Brain Inst, Miami, FL 33136 USA; [Sachdev, Perminder S.] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW, Australia; [Simmons, Andy] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London, England; [Simmons, Andy] Kings Coll London, Biomed Res Ctr Mental Hlth, London, England; [Simmons, Andy] Kings Coll London, Biomed Res Unit Dementia, London, England; [Smith, Colin] Univ Edinburgh, Acad Dept Neuropathol, Ctr Clin Brain Sci, MRC Edinburgh Brain Bank, Edinburgh, Midlothian, Scotland; [Soininen, Hindu.] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Soininen, Hindu.] Kuopio Univ Hosp, Neuroctr Neurol, Kuopio, Finland; [Srikanth, Velandai] Peninsula Hlth & Monash Univ, Dept Med, Melbourne, Vic, Australia; [Stott, David J.] Univ Glasgow, Fac Med, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Toga, Arthur W.] Univ Southern Calif, Keck Sch Med, Inst Neuroimaging & Informat, Lab Neuro Imaging, Los Angeles, CA USA; [Troncoso, Juan] Johns Hopkins Univ, Brain Resource Ctr, Baltimore, MD USA; [Turner, Jessica A.] Georgia State Univ, Atlanta, GA 30303 USA; [Tzourio, Christophe] Univ Bordeaux, Institute Neurodegenerat Disorders, CEA, CNRS,UMR 5293, Bordeaux, France; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Van der Brug, Marcel] Genentech Inc, San Francisco, CA 94080 USA; [Van der Wee, Nic J. A.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Van der Wee, Nic J. A.] Leiden Univ, Med Ctr, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Van Tol, Marie Jose] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Wassink, Thomas H.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; [Weiner, Michael W.] Univ Calif San Francisco, San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis, San Francisco, CA 94143 USA; [Westman, Eric] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Zonderman, Alan B.] NIA, Lab Epidemiol & Populat Sci, NIH, Bethesda, MD 20892 USA; [Schmidt, Helena] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [De Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Launer, Lenore J.] NIA, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med & Human Genet Ctr, Houston, TX 77030 USA; [Debette, Stephanie] Bordeaux Univ Hosp, Dept Neurol, Bordeaux, France; [Ikram, M. Arfan] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Andersson, Micael; Pudas, Sara; Nyberg, Lars] Umea Univ, Umea Ctr Funct Brain Imaging, Umea, Sweden	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Southern California; Boston University; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Framingham Heart Study; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; QIMR Berghofer Medical Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of London; King's College London; University of Miami; University of Miami; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Greifswald Medical School; Utrecht University; Utrecht University Medical Center; McGill University; Royal College of Surgeons - Ireland; Umea University; Illinois Institute of Technology; Rush University; Rush University; University of Edinburgh; Lagos State University; University of Edinburgh; University of New South Wales Sydney; Murdoch University; University of Oslo; University of Oslo; Uppsala University; Uppsala University; Boston University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Columbia University; Columbia University; Columbia University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; McGill University; UDICE-French Research Universities; Universite de Bordeaux; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Technische Universitat Dresden; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Bergen; University of Bergen; Haukeland University Hospital; Johns Hopkins University; Radboud University Nijmegen; University of London; King's College London; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Mississippi; University of Mississippi Medical Center; Max Planck Society; Max Planck Society; Technische Universitat Dresden; Diakonhjemmet Hospital; National University of Singapore; National University of Singapore; Medical University of Graz; Medical University of Graz; Max Planck Society; Yale University; University of London; University College London; Imperial College London; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Ruprecht Karls University Heidelberg; Harvard University; Massachusetts General Hospital; National University of Singapore; Singapore National Eye Center; University of Edinburgh; Radboud University Nijmegen; University of London; University College London; University of London; University College London; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; CEA; Centre National de la Recherche Scientifique (CNRS); Yale University; University of Tasmania; Menzies Institute for Medical Research; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of California System; University of California Los Angeles; Vrije Universiteit Amsterdam; Royal Infirmary of Edinburgh; University of Edinburgh; University of Bern; University Hospital of Bern; Erasmus University Rotterdam; Rush University; University of London; King's College London; University of Oxford; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Trinity College Dublin; Trinity College Dublin; University of Edinburgh; University of Miami; University of Miami; Orygen, The National Centre of Excellence in Youth Mental Health; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Vrije Universiteit Amsterdam; University of California System; University of California San Diego; University of California System; University of California San Diego; Icelandic Heart Association; University of Iceland; Icahn School of Medicine at Mount Sinai; University of Queensland; Greifswald Medical School; Western Sydney University; Hospital Universitario Marques de Valdecilla (HUMV); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; King Faisal Specialist Hospital & Research Center; Johns Hopkins University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Utrecht University; Utrecht University Medical Center; University of California System; University of California Irvine; University of Oslo; University of Mississippi; University of Mississippi Medical Center; University of Oxford; University of Wurzburg; Rush University; Karolinska Institutet; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Ageing Research Institute; Royal Melbourne Hospital; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of New South Wales Sydney; Maastricht University; Harvard University; Dagestan State University; Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute; University of New Mexico; Ollscoil na Gaillimhe-University of Galway; National University of Singapore; National University of Singapore; University of Basel; University of Bonn; Helmholtz Association; Research Center Julich; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Queensland University of Technology (QUT); Queensland University of Technology (QUT); Universite Libre de Bruxelles; University of Oslo; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Trinity College Dublin; Trinity College Dublin; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Rush University; Rush University; University of Glasgow; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Health San Antonio; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Harvard University; Brigham & Women's Hospital; Osaka University; Osaka University; Greifswald Medical School; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Vrije Universiteit Amsterdam; University of Iowa; Greifswald Medical School; Fujita Health University; Mayo Clinic; University System of Maryland; University of Maryland Baltimore; University of Sussex; University of London; University College London; Medical University Lodz; Mayo Clinic; University System of Maryland; University of Maryland Baltimore; Neuroscience Research Australia; University of New South Wales Sydney; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oxford; University of London; King's College London; University of California System; University of California Davis; University of California System; University of California Davis; Johns Hopkins University; University of Queensland; University of Perugia; University of Munich; University of Liverpool; Greifswald Medical School; German Centre for Cardiovascular Research; University of Warwick; University of Warwick; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology; University of Bonn; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Calgary; University of Calgary; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Miami; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of Edinburgh; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Glasgow; University of Southern California; Johns Hopkins University; University System of Georgia; Georgia State University; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Erasmus University Rotterdam; Erasmus MC; Roche Holding; Genentech; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Iowa; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Medical University of Graz; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Texas System; University of Texas Health Science Center Houston; CHU Bordeaux; Erasmus University Rotterdam; Erasmus MC; Umea University	Ikram, MA (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.; Ikram, MA (corresponding author), Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands.; Thompson, PM (corresponding author), Univ Southern Calif, Keck Sch Med, USC Mark & Mary Stevens Neuroimaging & Informat I, Imaging Genet Ctr, Los Angeles, CA USA.; Ikram, MA (corresponding author), Erasmus MC, Dept Neurol, Rotterdam, Netherlands.	m.a.ikram@erasmusmc.nl; pthomp@usc.edu	Debette, Stephanie/T-4946-2019; Vaidya, Dhananjay/AAL-5684-2020; Adams, Hieab/GLN-6421-2022; van Rooij, Daan/AAC-3526-2020; de Geus, Eco J.C./M-9318-2015; Partida, Gabriel Cuellar/C-6686-2017; Lemaitre, Herve/ABB-5427-2020; McWhirter, Rebekah E/J-7213-2014; Fisher, Simon E./E-9130-2012; Arfanakis, Konstantinos/AAN-3148-2021; Deary, Ian J/C-6297-2009; Westman, Eric/H-5771-2011; Cannon, Dara M/C-1323-2009; Cookson, Mark/AAW-2516-2021; Yang, Jingyun/D-5361-2009; Teumer, Alexander/S-7438-2019; Tordesillas-Gutierrez, Diana/H-6893-2015; Nyberg, Lars/M-5986-2019; Blangero, John/ABA-7175-2021; Lopez, Lorna/AAR-4912-2020; Mirza-Schreiber, Nazanin/AAD-1558-2022; Ohi, Kazutaka/J-7851-2019; Cheng, Ching-Yu/Y-2229-2019; Gibbs, J. Raphael/A-3984-2010; McMahon, Francis J/A-7290-2009; Sacco, Ralph/Y-9278-2019; Pappa, Irene/AAD-2738-2019; Hilal, Saima/D-6028-2016; McIntosh, Andrew M/B-9379-2008; Trabzuni, Daniah M/C-4034-2012; Simmons, Andrew/B-8848-2008; Jia, Tianye/AAC-3925-2019; Kochunov, Peter/GQH-9532-2022; Jukema, J. Wouter/ABD-6503-2021; Romanczuk-Seiferth, Nina/AFN-0829-2022; Jahanshad, Neda/ABD-5944-2021; Jack, Clifford R/F-2508-2010; Rentería, Miguel E./M-6671-2017; Bralten, Janita/AAB-9566-2019; Muetzel, Ryan/AFP-3412-2022; Tzourio, christophe/B-4015-2009; Mirza-Schreiber, Nazanin/AAD-1563-2022; Hoogman, Martine/G-8958-2015; Gruber, Oliver/AAY-5563-2020; Desrivières, Sylvane/ABC-4336-2021; Shen, Li/AAB-6870-2021; Wolfers, Thomas/ABF-1461-2020; Greven, Corina U/F-9729-2010; Gottesman, Rebecca/ABA-8468-2020; McMahon, Katie L/C-6440-2009; Crespo-Facorro, BENEDICTO/GXZ-9830-2022; Mattheisen, Manuel/S-3725-2019; Francks, Clyde/AGU-8875-2022; Sachdev, Perminder/ABC-1137-2020; Ehrlich, Stefan/ABB-4650-2020; Crespo-Facorro, BENEDICTO/AAY-2238-2021; Lawrie, Stephen MacGregor/AAD-1607-2021; Carmichael, Owen/N-1955-2017; McDonald, Colm/C-1430-2009; Chen, Christopher/E-7023-2013; Hernandez, María/GYU-3543-2022; Marquand, Andre F/B-6050-2012; Mecocci, Patrizia/W-2116-2019; Medland, Sarah E/C-7630-2013; Wong, Tien Yin/AAC-9724-2020; Turner, Jessica A/H-7282-2015; Nichols, Thomas E./N-9902-2017; Zwiers, Marcel P/D-2968-2009; Gudnason, Vilmundur/AAE-7126-2019; Ikram, M. Arfan/AAM-5225-2021; Medland, Sarah/AAT-7595-2020; White, Tonya/AAU-2226-2021; chen, qiang/HGU-5418-2022; Vernooij, Meike Willemijn/E-4061-2016; Longo, Dan L./F-6022-2011; Schmidt, Reinhold/E-1137-2014; Singleton, Andrew B/C-3010-2009; Penninx, Brenda WJH/S-7627-2017; chen, qiang/GWZ-7308-2022; Thompson, Paul M/C-4194-2018; Romanczuk-Seiferth, Nina/AFN-7029-2022; Walton, Esther/P-9832-2019; de Zubicaray, Greig/ABC-8955-2021; Hardy, John/C-2451-2009; Tiemeier, Henning/H-6534-2019; Thomson, Russell J/H-5653-2012; Pike, Bruce/K-5562-2014; Matarin, Mar/F-1771-2016; Heinz, Andreas/ABB-7736-2020; Fernandez, Guillen/B-3771-2009; Hansell, Narelle K/A-4553-2016; Franke, Barbara/D-4836-2009; Martinot, Jean-Luc/N-3704-2018; Fukunaga, Masaki/F-6441-2013; Donohoe, Gary/J-6481-2013; de Zubicaray, Greig I/B-1763-2008; Sprooten, Emma/N-3836-2017; Boomsma, Dorret I/AAX-4470-2020; Trabzuni, Daniah/AAI-2037-2021; Andreassen, Ole A./AAY-7531-2020; Almasy, Laura/V-3156-2019; Calhoun, Vince D./ACN-9399-2022; Wright, Margaret Jane/A-4560-2016; Morris, Derek/AAW-8343-2021; Greven, Corina/GRS-7921-2022; Montgomery, Grant W/B-7148-2008; Wardlaw, Joanna M/Y-3456-2019; van der Meer, Dennis/H-6663-2019; Walton, Esther/GSN-8429-2022; Ho, Beng-Choon/D-6959-2011; Bokhoven, J.H.L.M. van van/H-8015-2014; Francks, Clyde/E-1384-2012; Hulshoff Pol, Hilleke Evertje/B-4795-2014; Rommelse, Nanda NJ/D-4872-2009; Armstrong, Nicola J./AAF-3045-2021; Roffman, Joshua/G-8228-2012; Ryten, Mina/Q-8419-2016; Walter, Henrik/O-2612-2013; Tzourio, christophe/L-6344-2019; Thalamuthu, Anbupalam/Z-5545-2019; Mattheisen, Manuel/B-4949-2012; Muetzel, Ryan/AAA-8730-2022; Buitelaar, J.K./AAY-7522-2020; Blanton, Susan Halloran/ABF-1323-2021; mazoyer, bernard m/A-5369-2009; Richards, Jennifer/V-3715-2019; CHAUHAN, GANESH/AAI-5110-2021; Risacher, Shannon/AAI-2141-2019; /ABD-6198-2020; Ramasamy, Adaikalavan/G-2632-2010; Klein, Marieke/G-9870-2015; Weale, Michael E/F-2587-2010; Ford, Ian/ABE-6145-2020; Rotter, Jerome/AAY-6598-2021; DeCarli, Charles/B-5541-2009; Winkler, Anderson M/P-7773-2016; van Haren, Neeltje/AAC-7656-2020; Strike, Lachlan T/R-3902-2018; Saykin, Andrew/A-1318-2007; Schofield, Peter/C-9669-2011; Munoz Maniega, Susana/I-8730-2014; Smith, Albert Vernon/K-5150-2015; Cichon, Sven/B-9618-2014; Meyer-Lindenberg, Andreas/H-1076-2011	Debette, Stephanie/0000-0001-8675-7968; Vaidya, Dhananjay/0000-0002-7164-1601; de Geus, Eco J.C./0000-0001-6022-2666; Partida, Gabriel Cuellar/0000-0001-7648-4097; Lemaitre, Herve/0000-0002-5952-076X; McWhirter, Rebekah E/0000-0002-9409-8074; Fisher, Simon E./0000-0002-3132-1996; Arfanakis, Konstantinos/0000-0001-9705-597X; Deary, Ian J/0000-0002-1733-263X; Westman, Eric/0000-0002-3115-2977; Cannon, Dara M/0000-0001-7378-3411; Cookson, Mark/0000-0002-1058-3831; Yang, Jingyun/0000-0002-3495-3710; Teumer, Alexander/0000-0002-8309-094X; Tordesillas-Gutierrez, Diana/0000-0003-1458-3932; Nyberg, Lars/0000-0002-3367-1746; Lopez, Lorna/0000-0002-0241-9783; Ohi, Kazutaka/0000-0001-9577-9640; Cheng, Ching-Yu/0000-0003-0655-885X; Gibbs, J. Raphael/0000-0002-6985-0658; McMahon, Francis J/0000-0002-9469-305X; Hilal, Saima/0000-0001-5434-5635; McIntosh, Andrew M/0000-0002-0198-4588; Trabzuni, Daniah M/0000-0003-4826-9570; Simmons, Andrew/0000-0003-2306-5811; Jia, Tianye/0000-0001-5399-2953; Jukema, J. Wouter/0000-0002-3246-8359; Romanczuk-Seiferth, Nina/0000-0002-6931-269X; Jack, Clifford R/0000-0001-7916-622X; Rentería, Miguel E./0000-0003-4626-7248; Bralten, Janita/0000-0003-1440-8675; Muetzel, Ryan/0000-0003-3215-1287; Tzourio, christophe/0000-0002-6517-2984; Mirza-Schreiber, Nazanin/0000-0003-0836-8267; Hoogman, Martine/0000-0002-1261-7628; Desrivières, Sylvane/0000-0002-9120-7060; Wolfers, Thomas/0000-0002-7693-0621; Greven, Corina U/0000-0002-5433-7878; McMahon, Katie L/0000-0002-6357-615X; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Mattheisen, Manuel/0000-0002-8442-493X; Sachdev, Perminder/0000-0002-9595-3220; Ehrlich, Stefan/0000-0003-2132-4445; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Lawrie, Stephen MacGregor/0000-0002-2444-5675; McDonald, Colm/0000-0003-1661-5192; Chen, Christopher/0000-0002-1047-9225; Marquand, Andre F/0000-0001-5903-203X; Mecocci, Patrizia/0000-0003-0729-5246; Medland, Sarah E/0000-0003-1382-380X; Wong, Tien Yin/0000-0002-8448-1264; Turner, Jessica A/0000-0003-0076-8434; Nichols, Thomas E./0000-0002-4516-5103; Zwiers, Marcel P/0000-0001-5483-2935; Gudnason, Vilmundur/0000-0001-5696-0084; Medland, Sarah/0000-0003-1382-380X; White, Tonya/0000-0003-0271-1896; Penninx, Brenda WJH/0000-0001-7779-9672; Thompson, Paul M/0000-0002-4720-8867; Walton, Esther/0000-0002-0935-2200; de Zubicaray, Greig/0000-0003-4506-0579; Hardy, John/0000-0002-3122-0423; Tiemeier, Henning/0000-0002-4395-1397; Thomson, Russell J/0000-0003-4949-4120; Pike, Bruce/0000-0001-8924-683X; Matarin, Mar/0000-0002-4717-5735; Heinz, Andreas/0000-0001-5405-9065; Fernandez, Guillen/0000-0002-5522-0604; Hansell, Narelle K/0000-0002-8229-9741; Franke, Barbara/0000-0003-4375-6572; Fukunaga, Masaki/0000-0003-1010-2644; Donohoe, Gary/0000-0003-3037-7426; de Zubicaray, Greig I/0000-0003-4506-0579; Sprooten, Emma/0000-0002-1691-9105; Trabzuni, Daniah/0000-0003-4826-9570; Calhoun, Vince D./0000-0001-9058-0747; Wright, Margaret Jane/0000-0001-7133-4970; Morris, Derek/0000-0002-3413-570X; Montgomery, Grant W/0000-0002-4140-8139; Wardlaw, Joanna M/0000-0002-9812-6642; van der Meer, Dennis/0000-0002-0466-386X; Ho, Beng-Choon/0000-0003-3976-1555; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Francks, Clyde/0000-0002-9098-890X; Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; Rommelse, Nanda NJ/0000-0002-1711-0359; Armstrong, Nicola J./0000-0002-4477-293X; Roffman, Joshua/0000-0003-4073-532X; Tzourio, christophe/0000-0002-6517-2984; Thalamuthu, Anbupalam/0000-0002-7114-1260; Mattheisen, Manuel/0000-0002-8442-493X; Muetzel, Ryan/0000-0003-3215-1287; mazoyer, bernard m/0000-0003-0970-2837; Ramasamy, Adaikalavan/0000-0002-7598-2892; Klein, Marieke/0000-0001-8784-5679; Weale, Michael E/0000-0003-4593-1186; Winkler, Anderson M/0000-0002-4169-9781; van Haren, Neeltje/0000-0002-3090-7653; Strike, Lachlan T/0000-0003-2885-5898; van der Lee, Sven/0000-0003-1606-8643; Grimm, Oliver/0000-0002-0767-0301; Fedko, Iryna/0000-0003-1962-916X; Pappa, Irene/0000-0003-4936-5791; Saykin, Andrew/0000-0002-1376-8532; Risacher, Shannon/0000-0002-3304-7943; Amin, Najaf/0000-0002-8944-1771; Blangero, John/0000-0001-6250-5723; Walter, Henrik/0000-0002-9403-6121; Djurovic, Srdjan/0000-0002-8140-8061; Zonderman, Alan B/0000-0002-6523-4778; Jonsson, Erik/0000-0001-8368-6332; Schofield, Peter/0000-0003-2967-9662; Munoz Maniega, Susana/0000-0001-5185-6384; Pudas, Sara/0000-0001-9512-3289; Bastin, Mark/0000-0002-0490-0845; Westlye, Lars T./0000-0001-8644-956X; Ikram, Mohammad Kamran/0000-0003-0173-9571; Toro, Roberto/0000-0002-6671-858X; Adams, Hieab/0000-0003-3687-2508; Smith, Albert Vernon/0000-0003-1942-5845; Whelan, Christopher/0000-0003-0308-5583; Walters, James/0000-0002-6980-4053; Van Duijn, Cornelia/0000-0002-2374-9204; Cichon, Sven/0000-0002-9475-086X; Schmaal, Lianne/0000-0001-9822-048X; Kwok, John/0000-0001-9574-6195; Niessen, Wiro/0000-0002-5822-1995; Pirpamer, Lukas/0000-0002-4390-9703; Cavalleri, Gianpiero/0000-0002-9802-0506; Greven, Corina U./0000-0003-2402-3074; Haukvik, Unn Kristin/0000-0002-0363-4127; Mather, Karen Anne/0000-0003-4143-8941; Kanai, Ryota/0000-0002-0186-2687; Erk, Susanne/0000-0003-0961-3543; Carmichael, Owen/0000-0002-0576-0047; Stein, Jason/0000-0003-4829-0513; Curran, Joanne/0000-0002-6898-155X; den Braber, A./0000-0002-3377-2627; Wassink, Thomas/0000-0002-0952-8333; Vernooij, Meike/0000-0003-4658-2176; Chauhan, Ganesh/0000-0002-8564-5021; Wen, Wei/0000-0003-2753-3870; Lovestone, Simon/0000-0003-0473-4565; van 't Ent, Dennis/0000-0003-2001-1375; Seshadri, Sudha/0000-0001-6135-2622; Gollub, Randy L./0000-0002-9434-4044; Chouraki, Vincent/0000-0002-4698-1794; Satizabal, Claudia L/0000-0002-1115-4430; Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Beiser, Alexa/0000-0001-8551-7778; Amouyel, Philippe/0000-0001-9088-234X; Srikanth, Velandai/0000-0002-8442-8981; Le Hellard, Stephanie/0000-0002-8085-051X; Rose, Emma/0000-0001-5365-4794	National Heart, Lung and Blood Institute [HL105756]; National Institute on Aging [AG033193]; NIH Institute, NIBIB [U54 EB020403]; NIH Institute, NCI [U54 EB020403]; NIH [N01-AG-1-2100, 271201200022C, R01MH62873, K99MH102357, R01 HD050735, P30AG10161, RF1AG15819, R01AG17917, R01AG30146, R01AG40039, 5R01AG037212]; NIA Intramural Research Program; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); ADNI (National Institutes of Health Grant) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; lzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; Takeda Pharmaceutical Company; Canadian Institutes of Health Research; EU; Kuopio University Hospital; National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HSN268201100006C, HSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL70825, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health (NIH) [HHSN268200625226C, R01D0042157-01A, MH081802, 1RC2 MH089951, 1RC2 MH089995]; component of the NIH and NIH Roadmap for Medical Research [UL1RR025005]; NIH R01 grant [NS087541]; Austrian Science Fund (FWF) [1904]; Medical University of Graz; Steiermarkische Krankenanstalten Gesellschaft; Knut and Alice Wallenberg (KAW) foundation; Torsten and Ragnar Soderbergs Foundation; HelseVest RHF [911554]; Brain Research Imaging Centre Edinburgh, a center in the Scottish Funding Council Scottish Imaging Network-A Platform for Scientific Excellence (SINAPSE) Collaboration; National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Award; Health Foundation Clinician Scientist Fellowship; European Community [602450, 278948, 602805, 643051]; Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL); Hersenstichting Nederland; Netherlands Organization for Scientific Research (NWO); NWO Gravitation grant 'Language in Interaction'; ERC [268800-NEUROSCHEMA]; ENIGMA Consortium from the BD2K Initiative of a cross-NIH partnership [U54 EB020403]; Center for Brain Science Neuroinformatics Research Group; Athinoula A. Martinos Center for Biomedical Imaging; Center for Human Genetic Research; NIMH [K99 MH101367, R01-MH079799, K24MH094614, K01MH099232]; National Institute of Health [AG033193, AG011101, AG030146, AG008122, AG054076, AG049607, AG010129, NS017950, U01AG49505]; International Alzheimer's Association [NIRP-14-302587]; National Medical Research Council, Singapore [0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008, CG/SERI/2010]; Biomedical Research Council, Singapore [09/1/35/19/616]; National Medical Research Council, Singapore (NMRC/CG/NUHS) [R-184-006-184-511]; Singapore Ministry of Health's National Medical Research Council [NMRC/CSA/038/2013]; Wellcome Trust [084730, 082604/2/07/Z]; University College London (UCL)/University College London Hospitals (UCLH) NIHR Biomedical Research Centre/Specialist Biomedical Research Centres (CBRC/SBRC) [114]; European Union Marie Curie Reintegration; UK NIHR [08-08-SCC]; Comprehensive Local Research Network (CLRN) Flexibility and Sustainability Funding (FSF) [CEL1300]; Big Lottery Fund; Wolfson Trust; Epilepsy Society; UK Department of Health's NIHR Biomedical Research Centres funding scheme; Science Foundation Ireland [08/RFP/GEN1538]; Netherlands Organization for Scientific Research NWO [MW904-61-193, 400-07-080, MagW 480-04-004, 51.02.060, 668.772]; European Research Council [ERC-230374]; High Potential Grant Utrecht University; NWO Brain and Cognition [433-09-220]; Neuroscience Campus Amsterdam; NHLBI [HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, U01HL080295, R01HL087652, R01HL105756, R01HL103612, R01HL120393, R01HL130114, R01 HL105756]; National Institute on Aging (NIA) [R01AG023629, R01AG15928, R01AG20098, R01AG027002, R01AG05133, R01AG027058]; National Center for Advancing Translational Sciences, CTSI grant [UL1TR000124]; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) [DK063491]; Brainwave-the Irish Epilepsy Association; Epilepsy Research UK [F1206]; European Commission [018947 (LSHG-CT-2006-01947), 223004]; European Community's Seventh Framework Programme (FP7) by the European Commission under the programme "Quality of Life and Management of the Living Resources" of 5th Framework Programme [HEALTH-F4-2007-201413, QLG2-CT-2002-01254]; Netherlands Organization for Scientific Research; Russian Foundation for Basic Research [NWO-RFBR 047.017.043]; Netherlands Brain Foundation [F2013(1)-28, 15F07[2]27]; National Heart, Lung and Blood Institute's Framingham Heart Study [HHSN2682015000011]; ZonMw [TOP 40-00812-98-11021, 916.13.054]; National Institute of Neurological Disorders and Stroke [R01NS062059]; National Heart, Lung, and Blood Institute [U01 HL72518, HL097698]; National Institutes of Health/National Center for Research Resources [M01-RR000052]; National Institute of Mental Health [MH0708143, MH078111, MH083824]; Research Facilities Improvement Program from the National Center for Research Resources, NIH [C06 RR13556, C06 RR017515]; Swedish Research Council [K2007-62X-15077-04-1, K2008-62P-20597-01-3, K2010-62X-15078-07-2, K2012-61X-15078-09-3]; Stockholm County Council; Karolinska Institutet; Knut and Alice Wallenberg Foundation; HUBIN project; Swedish Research Council; European Union [602450, LSHM-CT-2007-037286, 603016]; Innovative Medicine Initiative Project EU-AIMS [115300-2]; Medical Research Council Programme Grant "Developmental pathways into adolescent substance abuse" [93558]; NIHR-biomedical Research Center "Mental Health": Swedish Research Council FORMAS; German Federal Ministry for Education and Research BMBF (Forschungsnetz AERIAL) [eMED SysAlc 01ZX1311A, 1EV0711]; US National Institutes of Health (Axon); US National Institutes of Health (Testosterone); US National Institutes of Health (Mental Health during Adolescence); US National Institutes of Health [MH085772-01A1]; French MILDECA; Fondation pour la Recherche Medicale; Brain & Cognition Excellence Program of the Netherlands Organization for Scientific Research (NWO) [433-09-229]; Netherlands Organization for Scientific Research (NWO) [016.130.669]; Research into Ageing programme grant; Age UK-Disconnected Mind project; UK Medical Research Council (MRC); Scottish Funding Council through the SINAPSE Collaboration; Row Fogo Charitable Trust; UK Biotechnology and Biological Sciences Research Council (BBSRC) [MRC MR/K026992/1]; UK MRC; BBSRC [BB/F019394/1]; Innovation-Oriented Research Program on Genomics (SenterNovem) [IGE05007]; Netherlands Consortium for Healthy Ageing [050-060-810]; Department of Energy [DE-FG02-08ER64581]; German Federal Ministry of Education and Research (BMBF) through the Integrated Genome Research Network (IG) MooDS (Systematic Investigation of the Molecular Causes of Major Mood Disorders and Schizophrenia) unde (NGFNplus) [01GS08144, 01GS08147, 01GS08148]; German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders) under e:Med Programme [01ZX1314A, 01ZX1314C, 01ZX1314G]; Exzellenz-Stiftung of the Max Planck Society; Federal Ministry of Education and Research (BMBF) [FKZ 01GS0481]; Bergen Research Foundation; University of Bergen; Dr. Einar Martens Fund; K.G. Jebsen Foundation; Research Council of Norway; Netherlands Organization for Scientific Research [10-000-1002]; Center for Medical Systems Biology (CSMB, NWO Genomics); Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL); VU University's Institutes for Health and Care Research (EMGO+); University Medical Center Groningen; Leiden University Medical Center; Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health; BiG Grid; Dutch e-Science Grid - NWO; NWO Large Investment Grant [1750102007010]; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; VU University Amsterdam; NIMH Intramural Research Program [ZIAMH002810, Z01MH002792, Z01MH002790]; Intramural Research Program of the NIH, National Institute on Aging; NHMRC/Australian Research Council Strategic Award [401162]; NHMRC [R01 HD050735, 1045325, 310667, 401184, 525453, 568940, 389875, 486682, 1009064, 1061457]; Commonwealth Scientific and Industrial Research Organisation Flagship Collaboration Fund Grant; Australian Government - Dementia Collaborative Research Centre (DCRC), UNSW; Alzheimer's Australia Dementia Research Foundation; Japanese Ministry of Health, Labor and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI; Scientific Research on Innovative Areas (Comprehensive Brain Science Network); Brain Sciences Project of the Center for Novel Science Initiatives (CNSI); National Institutes of Natural Sciences (NINS); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and development, AMED; Instituto de Salud Carlos III [FIS00/3095, 01/3129, PI020499, PI060507, PI10/00183, PI14/00639]; SENY Fundacio Research Grant [CI 2005-0308007]; Fundacion Marques de Valdecilla [API07/011]; Carlos III Health Institute [CA12/00312]; Bristol-Myers Squibb; Netherlands Heart Foundation [2001 D 032]; Netherlands Genomics Initiative (Netherlands Consortium for Healthy Aging) [050-060-810]; Autism Speaks; Australian Research Council [FT0991634]; National Health and Medical Research Council (NHMRC), Australia [1103623, 619667]; Translational Genomics Research Institute; Netherlands Organisation of Scientific Research NWO [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [050-060-810]; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Dutch Technology Foundation STW, NWO; Ministry of Economic Affairs; European Research Council (ERC) under the European Union's Horizon research and innovation programme [678543]; Joint Programme - Neurodegenerative Disease Research working group on High-Dimensional Research in Alzheimer's Disease (ZonMW) [733051031]; Van Leersum Grant of the Royal Netherlands Academy of Arts and Sciences; Heart and Stroke Foundation of Quebec; Canadian Foundation for Innovation; Tanenbaum Chair in Population Neuroscience at the Rotman Research Institute, University of Toronto; German Federal Ministry of Education and Research; German Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania [01ZZ9603, 01ZZ0103, 01ZZ0403]; network 'Greifswald Approach to Individualized Medicine (GANI_MED)' - Federal Ministry of Education and Research [03IS2061A]; Federal Ministry of Education and Research [03ZIK012]; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; Australian National Health and Medical Research Council (NHMRC) Program [350833, 568969]; National Health and Medical Research Council of Australia (NHMRC) [403000, 491109, 606543]; Wicking Dementia Education and Research Centre; Heart Foundation Future Leader Fellowship [100089]; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; Mutuelle Generale de l'Education Nationale (MGEN); Institut de la Longevite; Conseil Regionaux of Aquitaine; Conseil Regionaux of Bourgogne; Fondation de France; Ministry of Research INSEAM Programme "Cohortes et collections de donnees biologiques"; Fondation Leducq; Research Council of Norway [213837, 223273, 229129]; South-East Norway Health Authority [2013-123]; KG Jebsen Foundation; Netherlands Organization for Health Research and Development ZonMW [917.46.370, 908-02-123]; French National Foundation on Alzheimer's disease and related disorders; LABEX (laboratory of excellence program investment for the future) DISTALZ grant; Inserm; Institut Pasteur de Lille; University de Lille 2; Lille University Hospital; Medical Research Council [503480]; Alzheimer's Research UK [503176]; German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) [01G10102, 01G10711, 01G10420]; NIH/NIA grant [R01 AG033193, U01 AG032984, U24 AG021886, U01 AG016976]; NIA [AG081220]; AGES [N01-AG-12100]; Icelandic Heart Association; Erasmus University; Alzheimer's Association [ADGC-10-196728];  [NWO/SPI 56-464-14192];  [MH59490]; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [MR/K026992/1, MC_UU_12013/2, MR/N008324/1, MR/L016400/1, G0901858, MC_UU_12013/1, MR/K01417X/1, G0802462] Funding Source: researchfish; National Institute for Health Research [ACF-2012-17-017] Funding Source: researchfish; Parkinson&quot;s UK [J-0901, J-1403] Funding Source: researchfish; Wellcome Trust [100309/A/12/Z] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050735] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA081220] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863, UL1TR001108, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, C06RR013556, M01RR000052, C06RR017515] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL096812, R01HL087652, U01HL072518, R01HL105756, U01HL096902, U01HL096814, R01HL103612, U01HL080295, U01HL096899, R01HL086694, R01HL087641, R01HL070825, R01HL120393, R01HL085083, U01HL096917, R01HL059367] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020403, P41EB015922, R01EB015611, R01EB008432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083824, R01MH078111, R01MH097268, R01MH062873, R01MH094343, K24MH094614, R37MH059490, RC2MH089995, K99MH102357, T32MH073526, R01MH081802, K01MH099232, ZIAMH002810, R01MH090553, Z01MH002792, R01MH085667, R00MH101367, R00MH102357, Z01MH002790, R01MH079799, R01MH089722, R01MH059490, RC2MH089951, K99MH101367, R01MH085772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080655, R01NS087541, R01NS017950, R01NS062059, T32NS048004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008122, U01AG016976, P30AG010129, R01AG015928, R01AG033193, R01AG054076, R01AG017917, P30AG010161, ZIAAG007270, R01AG023629, RF1AG054023, RF1AG041915, R01AG011101, R01AG020098, RF1AG015819, P01AG052350, U01AG032984, R01AG037212, N01AG012100, R01AG027002, P50AG005146, U01AG024904, R01AG049607, P50AG005133, R01AG027058, R01AG040060, U01AG049505, U24AG021886, R01AG040039, R01AG030146] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R00LM011384] Funding Source: NIH RePORTER; MRC [MR/N008324/1, MR/K01417X/1, G0901858, G0901254, G0802462, MR/L016400/1, MC_UU_12013/1, MC_UU_12013/2, G0701075] Funding Source: UKRI	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH Institute, NIBIB; NIH Institute, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); ADNI (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); lzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare(General ElectricGE Healthcare); Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Medpace, Inc.; Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Synarc Inc.; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EU(European Commission); Kuopio University Hospital; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); component of the NIH and NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical University of Graz; Steiermarkische Krankenanstalten Gesellschaft; Knut and Alice Wallenberg (KAW) foundation(Knut & Alice Wallenberg Foundation); Torsten and Ragnar Soderbergs Foundation; HelseVest RHF; Brain Research Imaging Centre Edinburgh, a center in the Scottish Funding Council Scottish Imaging Network-A Platform for Scientific Excellence (SINAPSE) Collaboration; National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Award(NARSAD); Health Foundation Clinician Scientist Fellowship; European Community(European Commission); Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL); Hersenstichting Nederland; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO Gravitation grant 'Language in Interaction'; ERC(European Research Council (ERC)European Commission); ENIGMA Consortium from the BD2K Initiative of a cross-NIH partnership; Center for Brain Science Neuroinformatics Research Group; Athinoula A. Martinos Center for Biomedical Imaging; Center for Human Genetic Research; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Alzheimer's Association; National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council, Singapore (NMRC/CG/NUHS)(National Medical Research Council, Singapore); Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); Wellcome Trust(Wellcome Trust); University College London (UCL)/University College London Hospitals (UCLH) NIHR Biomedical Research Centre/Specialist Biomedical Research Centres (CBRC/SBRC); European Union Marie Curie Reintegration(European Commission); UK NIHR(National Institute for Health Research (NIHR)); Comprehensive Local Research Network (CLRN) Flexibility and Sustainability Funding (FSF); Big Lottery Fund; Wolfson Trust; Epilepsy Society; UK Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Netherlands Organization for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); High Potential Grant Utrecht University; NWO Brain and Cognition; Neuroscience Campus Amsterdam; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Advancing Translational Sciences, CTSI grant; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC); Brainwave-the Irish Epilepsy Association; Epilepsy Research UK; European Commission(European CommissionEuropean Commission Joint Research Centre); European Community's Seventh Framework Programme (FP7) by the European Commission under the programme "Quality of Life and Management of the Living Resources" of 5th Framework Programme; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Netherlands Brain Foundation; National Heart, Lung and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ZonMw(Netherlands Organization for Health Research and Development); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Research Facilities Improvement Program from the National Center for Research Resources, NIH; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); HUBIN project; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission); Innovative Medicine Initiative Project EU-AIMS; Medical Research Council Programme Grant "Developmental pathways into adolescent substance abuse"(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR-biomedical Research Center "Mental Health": Swedish Research Council FORMAS(Swedish Research Council Formas); German Federal Ministry for Education and Research BMBF (Forschungsnetz AERIAL); US National Institutes of Health (Axon)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (Testosterone)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (Mental Health during Adolescence); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French MILDECA; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Brain & Cognition Excellence Program of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Research into Ageing programme grant; Age UK-Disconnected Mind project(General Electric); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council through the SINAPSE Collaboration; Row Fogo Charitable Trust; UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Innovation-Oriented Research Program on Genomics (SenterNovem); Netherlands Consortium for Healthy Ageing; Department of Energy(United States Department of Energy (DOE)); German Federal Ministry of Education and Research (BMBF) through the Integrated Genome Research Network (IG) MooDS (Systematic Investigation of the Molecular Causes of Major Mood Disorders and Schizophrenia) unde (NGFNplus)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders) under e:Med Programme(Federal Ministry of Education & Research (BMBF)); Exzellenz-Stiftung of the Max Planck Society; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Bergen Research Foundation; University of Bergen; Dr. Einar Martens Fund; K.G. Jebsen Foundation; Research Council of Norway(Research Council of Norway); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Center for Medical Systems Biology (CSMB, NWO Genomics); Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL); VU University's Institutes for Health and Care Research (EMGO+); University Medical Center Groningen; Leiden University Medical Center; Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BiG Grid; Dutch e-Science Grid - NWO; NWO Large Investment Grant; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; VU University Amsterdam; NIMH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHMRC/Australian Research Council Strategic Award(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Commonwealth Scientific and Industrial Research Organisation Flagship Collaboration Fund Grant; Australian Government - Dementia Collaborative Research Centre (DCRC), UNSW(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Alzheimer's Australia Dementia Research Foundation; Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Scientific Research on Innovative Areas (Comprehensive Brain Science Network); Brain Sciences Project of the Center for Novel Science Initiatives (CNSI); National Institutes of Natural Sciences (NINS); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); SENY Fundacio Research Grant; Fundacion Marques de Valdecilla(Instituto de Salud Carlos III); Carlos III Health Institute(Instituto de Salud Carlos III); Bristol-Myers Squibb(Bristol-Myers Squibb); Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Genomics Initiative (Netherlands Consortium for Healthy Aging); Autism Speaks; Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Translational Genomics Research Institute; Netherlands Organisation of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Dutch Technology Foundation STW, NWO(Technologiestichting STWNetherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs; European Research Council (ERC) under the European Union's Horizon research and innovation programme(European Research Council (ERC)); Joint Programme - Neurodegenerative Disease Research working group on High-Dimensional Research in Alzheimer's Disease (ZonMW); Van Leersum Grant of the Royal Netherlands Academy of Arts and Sciences; Heart and Stroke Foundation of Quebec; Canadian Foundation for Innovation(Canada Foundation for Innovation); Tanenbaum Chair in Population Neuroscience at the Rotman Research Institute, University of Toronto; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; network 'Greifswald Approach to Individualized Medicine (GANI_MED)' - Federal Ministry of Education and Research; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Siemens Healthcare, Erlangen, Germany(Siemens AG); Federal State of Mecklenburg-West Pomerania; Australian National Health and Medical Research Council (NHMRC) Program(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Wicking Dementia Education and Research Centre; Heart Foundation Future Leader Fellowship; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); Mutuelle Generale de l'Education Nationale (MGEN)(General Electric); Institut de la Longevite; Conseil Regionaux of Aquitaine(Region Nouvelle-Aquitaine); Conseil Regionaux of Bourgogne(Region Bourgogne-Franche-Comte); Fondation de France(Fondation de France); Ministry of Research INSEAM Programme "Cohortes et collections de donnees biologiques"; Fondation Leducq(Leducq Foundation); Research Council of Norway(Research Council of Norway); South-East Norway Health Authority; KG Jebsen Foundation; Netherlands Organization for Health Research and Development ZonMW(Netherlands Organization for Health Research and Development); French National Foundation on Alzheimer's disease and related disorders; LABEX (laboratory of excellence program investment for the future) DISTALZ grant; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur de Lille; University de Lille 2; Lille University Hospital; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND)(Federal Ministry of Education & Research (BMBF)); NIH/NIA grant; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGES; Icelandic Heart Association; Erasmus University; Alzheimer's Association(Alzheimer's Association); ; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CHARGE: Infrastructure for the CHARGE Consortium is supported in part by the National Heart, Lung and Blood Institute grant HL105756 and for the neuroCHARGE phenotype working group through the National Institute on Aging grant AG033193.; ENIGMA: ENIGMA was supported in part by a Consortium grant (U54 EB020403 to PMT) from the NIH Institutes contributing to the Big Data to Knowledge (BD2K) Initiative, including the NIBIB and NCI.; Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-Reykjavik): This study has been funded by NIH contracts N01-AG-1-2100 and 271201200022C, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The study was approved by the Icelandic National Bioethics Committee, VSN: 00-063. The researchers are indebted to the participants for their willingness to participate in the study.; Alzheimer's Disease Neuroimaging Initiative (ADNI): Data collection and sharing for this project was funded by the ADNI (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research provides funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (http://www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory of Neuro Imaging at the University of Southern California.; ANM: AddNeuroMed was funded through the EU FP6 programme. HS: Academy of Finland, Research Council for Health, 258081, UEFBrain, University of Eastern Finland, VTR funding Kuopio University Hospital.; Atherosclerosis Risk In Communities Study (ARIC): The Atherosclerosis Risk in Communities study was performed as a collaborative study supported by National Heart, Lung, and Blood Institute (NHLBI) contracts (HHSN268201100005C, HSN268201100006C, HSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL70825, R01HL087641, R01HL59367, and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health (NIH) contract HHSN268200625226C. Infrastructure was partly supported by grant no. UL1RR025005, a component of the NIH and NIH Roadmap for Medical Research. This project was also supported by NIH R01 grant NS087541 to M.F.; Austrian Stroke Prevention Study Family (ASPS-Fam): The ASPS-Fam is funded by the Austrian Science Fund (FWF) project 1904, the Medical University of Graz and the Steiermarkische Krankenanstalten Gesellschaft.; BETULA: This sample collection was supported by a Wallenberg Scholar grant from the Knut and Alice Wallenberg (KAW) foundation and a grant from Torsten and Ragnar Soderbergs Foundation to Lars Nyberg. S.l.H. was supported by a grant from HelseVest RHF (grant 911554).; Bipolar Family Study (BFS): The Bipolar Family Study wishes to thank the Scottish Mental Health Research Network for research assistant support, the Brain Research Imaging Centre Edinburgh, a center in the Scottish Funding Council Scottish Imaging Network-A Platform for Scientific Excellence (SINAPSE) Collaboration, for image acquisition and the Wellcome Trust Clinical Research Facility for genotyping. Genotyping was supported by the National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Award (to A.M.M.), and data collection was supported by the Health Foundation Clinician Scientist Fellowship. The research leading to these results also receives funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements #602450 (IMAGEMEND) and ongoing support from the Wellcome Trust (Ref 104036/Z/14/Z).; Brain Imaging Genetics (BIG): This work makes use of the BIG database, first established in Nijmegen, The Netherlands, in 2007. This resource is now part of Cognomics (http://www.cognomics.nl), a joint initiative by researchers of the Donders Centre for Cognitive Neuroimaging, the Human Genetics and Cognitive Neuroscience Departments of the Radboud University Medical Center and the Max Planck Institute for Psycholinguistics in Nijmegen. The Board of the Cognomics Initiative consists of B. Franke, S. Fisher, G. Fernandez, P. Hagoort, H. Brunner, J. Buitelaar, H. van Bokhoven and D. Norris. The Cognomics Initiative has received supported from the participating departments and centers and from external grants, that is, the Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL), the Hersenstichting Nederland, and the Netherlands Organization for Scientific Research (NWO). The research leading to these results also receives funding from the NWO Gravitation grant 'Language in Interaction', the European Community's Seventh Framework Programme (FP7/2007-.2013) under grant agreements no 602450 (IMAGEMEND), no 278948 (TACTICS), and no 602805 (Aggressotype), as well as from the European Community's Horizon 2020 programme under grant agreement no 643051 (MiND) and from ERC-2010-AdG 268800-NEUROSCHEMA. In addition, the work was supported by a grant for the ENIGMA Consortium (grant number U54 EB020403) from the BD2K Initiative of a cross-NIH partnership. We wish to thank all persons who kindly participated in the BIG research.; Brain Genomics Superstruct Project (GSP): Data were provided in part by the Brain Genomics Superstruct Project of Harvard University and the Massachusetts General Hospital, with support from the Center for Brain Science Neuroinformatics Research Group, the Athinoula A. Martinos Center for Biomedical Imaging, and the Center for Human Genetic Research. 20 individual investigators at Harvard and MGH generously contributed data to GSP. This work is supported by NIMH grants K99 MH101367 (P.H.L.), R01-MH079799 (J.W.S.), K24MH094614 (J.W.S.) and K01MH099232 (A.J.H.).; Brainscale and NTR-Adults: We would like to thank all twin participants from the Netherlands Twin Register. The NTR-adult and Brainscale studies were supported by the Netherlands Organization for Scientific Research NWO [MW904-61-193 (E.d.G. and D.B.), MaGW-nr: 400-07-080 (D. V't E.), MagW 480-04-004 (D.B.), (51.02.060 (H.H.), 668.772 (D.B. and H.H.); NWO/SPI 56-464-14192 (D.B.), the European Research Council (ERC-230374) (D.B.), High Potential Grant Utrecht University (H.H.), NWO Brain and Cognition 433-09-220 (H.H.) and the Neuroscience Campus Amsterdam.; Cardiovascular Health Study (CHS): This research was supported by NHLBI contracts HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086; and NHLBI grants U01HL080295, R01HL087652, R01HL105756, R01HL103612, R01HL120393, and R01HL130114 with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided through R01AG023629, R01AG15928, R01AG20098, R01AG027002, R01AG05133, and R01AG027058 from the National Institute on Aging (NIA). A full list of principal CHS investigators and institutions can be found at http://CHS-NHLBI.org. The provision of genotyping data was supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR000124, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; CHAP: This research was funded by grants from the National Institute of Health (AG011101 and AG030146) and the International Alzheimer's Association (NIRP-14-302587). DNA samples were collected during clinical evaluations and population interviews, and analyzed at the Broad Institute.; Epidemiology of Dementia in Singapore (EDIS): The Singapore Malay Eye Study (SiMES) and the Singapore Chinese Eye. Study (SCES) are funded by National Medical Research Council (grants 0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008 and CG/SERI/2010) and Biomedical Research Council (grants 09/1/35/19/616), Singapore. The Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore provided services for genotyping. The Epidemiology of Dementia in Singapore study is supported by the National Medical Research Council, Singapore (NMRC/CG/NUHS/2010, grant no. R-184-006-184-511). M.K.I. received additional funding from the Singapore Ministry of Health's National Medical Research Council (NMRC/CSA/038/2013).; EPIGEN: Work from the London Cohort was supported by research grants from the Wellcome Trust (grant 084730 to S.M.S.), University College London (UCL)/University College London Hospitals (UCLH) NIHR Biomedical Research Centre/Specialist Biomedical Research Centres (CBRC/SBRC) (grant 114 to S.M.S.), the European Union Marie Curie Reintegration (to M. Matarin and S.M.S.), the UK NIHR (08-08-SCC), the Comprehensive Local Research Network (CLRN) Flexibility and Sustainability Funding (FSF) (grant CEL1300 to S.M.S.), The Big Lottery Fund, the Wolfson Trust and the Epilepsy Society. This work was undertaken at UCLH/UCL, which received a proportion of funding from the UK Department of Health's NIHR Biomedical Research Centres funding scheme. Work from the Royal College of Surgeons in Ireland was supported by research grants from the Science Foundation Ireland (Research Frontiers Programme award 08/RFP/GEN1538) and Brainwave-the Irish Epilepsy Association. M. Matarin is funded by Epilepsy Research UK (grant F1206).; Erasmus Rucphen Family study (ERF) The ERF study as a part of EUROSPAN (European Special Populations Research Network) was supported by European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947) and also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F4-2007-201413 by the European Commission under the programme "Quality of Life and Management of the Living Resources" of 5th Framework Programme (no. QLG2-CT-2002-01254). High-throughput analysis of the ERF data was supported by joint grant from Netherlands Organization for Scientific Research and the Russian Foundation for Basic Research (NWO-RFBR 047.017.043). We are grateful to all study participants and their relatives, general practitioners and neurologists for their contributions and to P. Veraart for her help in genealogy, J. Vergeer for the supervision of the laboratory work and P. Snijders for his help in data collection. N. Amin is supported by the Netherlands Brain Foundation (project number F2013(1)-28). The ERF study genome-wide array data and phenotype data (age and gender) is archived in European Genome-Phenome Database (EGA). The study is archived in the DAC named Erasmus Rucphen Family Study with the accession code: EGAS00001001134. Researchers who wish to use other phenotypic data of the Erasmus Rucphen Family Study must seek approval from the management team of the Erasmus Rucphen Family study. They are advised to contact Cornelia van Duijn (c.vanduijn@erasmusmc.nl).; Framingham Heart Study (FHS): This work was supported by the dedication of the Framingham Study participants, the National Heart, Lung and Blood Institute's Framingham Heart Study (Contract No. HHSN2682015000011), and by grants from the National Institute of Health (AG008122, AG054076, AG049607, AG033193, AG010129, NS017950, and U01AG49505).; Generation R: The Generation R Study is conducted by the Erasmus Medical Centre in close collaboration with the Municipal Health Service Rotterdam area, and the Stichting Trombosedienst & Artsenlaboratorium Rijnmond (STAR), Rotterdam. We gratefully acknowledge the contribution of general practitioners, hospitals, midwives and pharmacies in Rotterdam. Additional support for neuroimaging came from ZonMw TOP 40-00812-98-11021.; GeneSTAR: GeneSTAR was supported by grants from the National Institute of Neurological Disorders and Stroke (R01NS062059), the National Heart, Lung, and Blood Institute (U01 HL72518, HL097698) and the National Institutes of Health/National Center for Research Resources (M01-RR000052) to the Johns Hopkins General Clinical Research Center. We would like to thank the participants and families of GeneSTAR and our dedicated staff for all their sacrifices.; GOBS: We acknowledge the ultimate source of our data, the Mexican American community of San Antonio and surrounding areas. Financial support for this study was provided by grants from the National Institute of Mental Health MH0708143 (D.C. Glahn), MH078111 (J. Blangero) and MH083824 (D.C. Glahn and J. Blangero). Theoretical development of SOLAR is supported by MH59490 (J. Blangero). This investigation was conducted, in part, in facilities constructed with support from Research Facilities Improvement Program grant numbers C06 RR13556 and C06 RR017515 from the National Center for Research Resources, NIH. Some of this work was performed at Texas Biomedical Research Institute, where J. Blangero began this investigator-initiated competitively publicly funded work.; HUBIN: This study was financed by the Swedish Research Council (K2007-62X-15077-04-1, K2008-62P-20597-01-3. K2010-62X-15078-07-2, K2012-61X-15078-09-3), the regional agreement on medical training and clinical research between Stockholm County Council and the Karolinska Institutet, the Knut and Alice Wallenberg Foundation, and the HUBIN project. Genotyping was performed by the SNP&SEQ Technology Platform in Uppsala. The platform is part of Science for Life Laboratory at Uppsala University and supported as a national infrastructure by the Swedish Research Council.; IMAGEN: IMAGEN was supported by the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behavior in normal brain function and psychopathology) (LSHM-CT-2007-037286), the FP7 projects IMAGEMEND (602450) and MATRICS (603016), and the Innovative Medicine Initiative Project EU-AIMS (115300-2), the Medical Research Council Programme Grant "Developmental pathways into adolescent substance abuse" (93558), as well as the NIHR-biomedical Research Center "Mental Health": Further support was provided by the Swedish Research Council FORMAS, and the German Federal Ministry for Education and Research BMBF (eMED SysAlc 01ZX1311A; Forschungsnetz AERIAL; 1EV0711) and the US National Institutes of Health (Axon, Testosterone and Mental Health during Adolescence; MH085772-01A1), and grants from the French MILDECA and from the Fondation pour la Recherche Medicale.; IMpACT: This study was funded by a grant from the Brain & Cognition Excellence Program of the Netherlands Organization for Scientific Research (NWO, grant 433-09-229) and in part by the Netherlands Brain Foundation (grant number, 15F07[2]27). B. Franke is supported by a Vici grant from the Netherlands Organization for Scientific Research (NWO; grant no 016.130.669). The research leading to these results also receives funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements no 602450 (IMAGEMEND), no 278948 (TACTICS), and no 602805 (Aggressotype) as well as from the European Community's Horizon 2020 programme under grant agreement no 643051 (MiND). In addition, the work was supported by a grant for the ENIGMA Consortium (grant number U54 EB020403) from the BD2K Initiative of a cross-NIH partnership.; LBC1936: We thank the LBC1936 participants and the members of the LBC1936 research team who collected and collated the phenotypic and genotypic data. This work was undertaken as part of the Cross Council and University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE; http://www.ccace.ed.ac.uk). This work was supported by a Research into Ageing programme grant (to I.J.D.) and the Age UK-funded Disconnected Mind project (http://www.disconnectedmind.ed.ac.uk; to I.J.D. and J.M.W.), with additional funding from the UK Medical Research Council (MRC; to I.J.D., J.M.W. and M.E.B.). J.M.W. is supported by the Scottish Funding Council through the SINAPSE Collaboration (http://www.sinapse.ac.uk). M.V.M. is supported by the Row Fogo Charitable Trust. CCACE (MRC MR/K026992/1) is funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC) and the UK MRC. Genotyping was supported by a grant from the BBSRC (BB/F019394/1).The image acquisition and analysis was performed at the Brain Research Imaging Centre, University of Edinburgh (http://www.bric.ed.ac.uk).; Leiden Longevity Study (LLS): The Leiden Longevity Study was supported by a grant from the Innovation-Oriented Research Program on Genomics (SenterNovem IGE05007) and the Netherlands Consortium for Healthy Ageing (grant number 050-060-810).; Mind Clinical Imaging Consortium (MCIC): Data used in the preparation of this work were obtained from the Mind Clinical Imaging Consortium database through the Mind Research Network (http://www.mrn.org). The MCIC project was supported by the Department of Energy under Award Number DE-FG02-08ER64581. MCIC is the result of efforts of co-investigators from University of Iowa, University of Minnesota, University of New Mexico, and Massachusetts General Hospital.; MooDS: The establishment of the MooDS sample was funded by the German Federal Ministry of Education and Research (BMBF) through the Integrated Genome Research Network (IG) MooDS (Systematic Investigation of the Molecular Causes of Major Mood Disorders and Schizophrenia; grant 01GS08144 to M.M. Nothen and S. Cichon, grant 01GS08147 to J. Rietschel and A. Meyer-Lindenberg and grant 01GS08148 to A. Heinz), under the auspices of the National Genome Research Network plus (NGFNplus), and through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders), under the auspices of the e:Med Programme (grant 01ZX1314A to M.M. Nothen, grant 01ZX1314C to H. Walter, grant 01ZX1314G to M. Rietschel).; MPIP: The MPIP Munich Morphometry Sample comprises images acquired as part of the Munich Antidepressant Response Signature Study and the Recurrent Unipolar Depression (RUD) Case-Control study performed at the MPIP, and control subjects acquired at the Ludwig-Maximilians-University, Munich, Department of Psychiatry. We thank E. Meisenzahl and D. Rujescu for providing MRI and genetic data for inclusion into the MPIP Munich Morphometry sample. We wish to acknowledge A. Olynyik and radiographers R. Schirmer, E. Schreiter, R. Borschke and I. Eidner for image acquisition and data preparation. We thank D.P. Auer for local study management in the initial phase of the RUD study. We are grateful to GlaxoSmithKline for providing the genotypes of the Recurrent Unipolar Depression Case-Control Sample. We thank the staff of the Center of Applied Genotyping (CAGT) for generating the genotypes of the MARS cohort. The study is supported by a grant of the Exzellenz-Stiftung of the Max Planck Society. This work has also been funded by the Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN), FKZ 01GS0481.; NCNG: this sample collection was supported by grants from the Bergen Research Foundation and the University of Bergen, the Dr. Einar Martens Fund, the K.G. Jebsen Foundation, the Research Council of Norway, to S.L.H., V.M.S. and T.E.; NESDA: Funding was obtained from the Netherlands Organization for Scientific Research (Geestkracht program grant 10-000-1002); the Center for Medical Systems Biology (CSMB, NWO Genomics), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL), VU University's Institutes for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam, University Medical Center Groningen, Leiden University Medical Center, National Institutes of Health (NIH, R01D0042157-01A, MH081802, Grand Opportunity grants 1RC2 MH089951 and 1RC2 MH089995). Part of the genotyping and analyses were funded by the Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health. Computing was supported by BiG Grid, the Dutch e-Science Grid, which is financially supported by NWO.; NeuroIMAGE: The NeuroIMAGE project was supported by NIH Grant R01MH62873 (to S.V. Faraone), NWO Large Investment Grant 1750102007010 (to J. Buitelaar), and by grants from Radboud University Nijmegen Medical Center, University Medical Center Groningen and Accare, and VU University Amsterdam. The work contributing to this result also receives support from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements no 602450 (IMAGEMEND), no 278948 (TACTICS) and no 602805 (Aggressotype) as well as from the European Community's Horizon 2020 programme under grant agreement no 643051 (MiND). In addition, the work was supported by a grant for the ENIGMA Consortium (grant number U54 EB020403) from the BD2K Initiative of a cross-NIH partnership.; NIMH-IRP: Supported in part by the NIMH Intramural Research Program (ZIAMH002810; Z01MH002792; Z01MH002790).; North American Brain Expression Consortium (NABEC): This research was supported by the Intramural Research Program of the NIH, National Institute on Aging.; Older Australian Twins Study (OATS): We would like to acknowledge and thank the OATS participants, their supporters and respective Research Teams. This work was supported by a number of sources. OATS is supported by the NHMRC/Australian Research Council Strategic Award 401162 and NHMRC Project Grant 1045325 to P. Sachdev and colleagues. OATS was facilitated through access to the Australian Twin Registry, a national research resource supported by the NHMRC Enabling Grant 310667, administered by the University of Melbourne. DNA was extracted by Genetic Repositories Australia, an Enabling Facility supported by the NHMRC Grant 401184. OATS genotyping was partly funded by a Commonwealth Scientific and Industrial Research Organisation Flagship Collaboration Fund Grant. Henry Brodaty is supported by the Australian Government funded Dementia Collaborative Research Centre (DCRC), UNSW. Nicola Armstrong was supported by the NHMRC Project Grant 525453 and Karen Mather is supported by an Alzheimer's Australia Dementia Research Foundation Postdoctoral Fellowship and the NHMRC Capacity Building Grant 568940.; Osaka: This study was supported, in part, by research grants from the Japanese Ministry of Health, Labor and Welfare; the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI and Scientific Research on Innovative Areas (Comprehensive Brain Science Network); and the Brain Sciences Project of the Center for Novel Science Initiatives (CNSI), the National Institutes of Natural Sciences (NINS), and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and development, AMED.; PAFIP: The PAFIP study was supported by Instituto de Salud Carlos III, FIS00/3095, 01/3129, PI020499, PI060507, PI10/00183, PI14/00639, the SENY Fundacio Research Grant CI 2005-0308007, and the Fundacion Marques de Valdecilla API07/011. PAFIP wish to acknowledge WTCCC2 (Wellcome Trust Case Control Consortium 2) for DNA Genotyping, Valdecilla Biobank for providing the biological samples and associated data included in this study and Idival Neuroimaging Unit for its help in the technical execution of this work. D. Tordesillas-Gutierrez is funded by a contract from the Carlos III Health Institute (CA12/00312).; PROSPER: The PROSPER study was supported by an investigator-initiated grant obtained from Bristol-Myers Squibb. J.W. Jukema is an Established Clinical Investigator of the Netherlands Heart Foundation (grant 2001 D 032). Support for genotyping was provided by the seventh framework program of the European commission (grant 223004) and by the Netherlands Genomics Initiative (Netherlands Consortium for Healthy Aging grant 050-060-810).; QTIM: D.P.H., N.J., C.R.K.C. and P.M.T. are supported, in part, by NIH grants R01 NS080655, R01AG040060, R01 EB008432, R01 MH097268, U01 AG024904, R01 MH085667, R01 MH089722, P41 EB015922, and R01 MH094343. R.K.W. is supported by National Science Foundation (BCS-1229450). J.L.S. was supported by the NIMH (K99MH102357) and Autism Speaks. G.Z. is supported by a Future Fellowship (FT0991634) from the Australian Research Council. S.E.M. and G.W.M. are supported by a National Health and Medical Research Council (NHMRC), Australia, Fellowships (1103623, 619667). The QTIM study is supported by grants from NIH (R01 HD050735) and the NHMRC (389875, 486682, 1009064). We thank the twins and siblings for their participation, M. Grace and A. Eldridge for twin recruitment, A. Al Najjar and other radiographers for scanning, K. McAloney and D. Park for research support, and A. Henders and staff for DNA sample processing and preparation.; ROS and MAP: The clinical, genomic, and neuroimaging data for the Religious Orders Study and the Rush Memory and Aging Project was funded by NIH grants P30AG10161, RF1AG15819, R01AG17917, R01AG30146, R01AG40039, and the Translational Genomics Research Institute.; Rotterdam Study: The generation and management of GWAS genotype data for the Rotterdam Study are supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. This research is supported by the Dutch Technology Foundation STW, which is part of the NWO, and which is partly funded by the Ministry of Economic Affairs. This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No 678543). Further support was obtained through the Joint Programme - Neurodegenerative Disease Research working group on High-Dimensional Research in Alzheimer's Disease (ZonMW grant number 733051031). MAI is supported by ZonMW grant number 916.13.054. H.H.H.A. is supported by the Van Leersum Grant of the Royal Netherlands Academy of Arts and Sciences.; Saguenay Youth Study (SYS): The Saguenay Youth Study project is funded by the Canadian Institutes of Health Research (T.P., Z.P.), Heart and Stroke Foundation of Quebec (Z.P.), and the Canadian Foundation for Innovation (Z.P.). T.P. is supported by the Tanenbaum Chair in Population Neuroscience at the Rotman Research Institute, University of Toronto.; SHIP and TREND: The SHIP data sets are part of the Community Medicine Research net (CMR) of the University of Greifswald, which is funded by the German Federal Ministry of Education and Research and the German Ministry of Cultural Affairs, as well as by the Social Ministry of the Federal State of Mecklenburg-West Pomerania (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), and the network 'Greifswald Approach to Individualized Medicine (GANI_MED)' funded by the Federal Ministry of Education and Research (grant 03IS2061A). Genome-wide data and MRI scans were supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member oft the Cache Campus Program of the InterSystems GmbH.; Sydney Memory and Ageing Study (Sydney MAS): We would like to thank the Sydney MAS participants, their supporters and respective research teams. Sydney MAS was supported by the Australian National Health and Medical Research Council (NHMRC) Program Grants 350833 and 568969 to P. Sachdev, H. Brodaty and G. Andrews. DNA was extracted by Genetic Repositories Australia, an Enabling Facility supported by the NHMRC Grant 401184. H. Brodaty is supported by the Australian Government funded Dementia Collaborative Research Centre (DCRC), UNSW. N. Armstrong was supported by the NHMRC Project Grant 525453 and K. Mather is supported by an Alzheimer's Australia Dementia Research Foundation Postdoctoral Fellowship. Both S. Reppermund and K. Mather are supported by the NHMRC Capacity Building Grant 568940.; Tasmanian Study of Gait and Cognition (TASCOG): The Tasmanian Study of Gait and Cognition is supported by project grants from the National Health and Medical Research Council of Australia (NHMRC; 403000, 491109, and 606543) and a grant from the Wicking Dementia Education and Research Centre, Hobart. V.S. is supported by a cofunded NHMRC Career Development Fellowship (1061457) and a Heart Foundation Future Leader Fellowship (ID 100089).; Three-City Dijon Study: The Three-City Study is conducted under a partnership agreement among the Institut National de la Sante et de la Recherche Medicale (INSEAM), the Victor Segalen-Bordeaux II University, and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The Three-City Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale (MGEN), Institut de la Longevite, Conseils Regionaux of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research INSEAM Programme "Cohortes et collections de donnees biologiques." Christophe Tzourio and Stephanie Debette are supported by a grant from the Fondation Leducq.; TOP: The study was supported by the Research Council of Norway (#213837, #223273, #229129), South-East Norway Health Authority (#2013-123) and KG Jebsen Foundation. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 602450 (IMAGEMEND).; UMCU: UMCU acknowledgment data: This work was supported by 917.46.370 (H.H.) and 908-02-123 (H.H.) from the Netherlands Organization for Health Research and Development ZonMW.; WHICAP: This study was supported by a grant from the NIH (5R01AG037212). CHARGE consortium: See ref. 40 for the general cognitive function GWAS, and ref. 29 for the white matter lesion GWAS.; IGAP: We thank the International Genomics of Alzheimer's Project (IGAP) for providing summary results data for these analyses. The investigators within IGAP contributed to the design and implementation of IGAP and/or provided data but did not participate in analysis or writing of this report. IGAP was made possible by the generous participation of the control subjects, the patients, and their families. The i-Select chips was funded by the French National Foundation on Alzheimer's disease and related disorders. EADI was supported by the LABEX (laboratory of excellence program investment for the future) DISTALZ grant, Inserm, Institut Pasteur de Lille, University de Lille 2 and the Lille University Hospital. GERAD was supported by the Medical Research Council (Grant no 503480), Alzheimer's Research UK (Grant no 503176), the Wellcome Trust (Grant no 082604/2/07/Z) and German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) grant no 01G10102, 01G10711, 01G10420. CHARGE was partly supported by the NIH/NIA grant R01 AG033193 and the NIA AG081220 and AGES contract N01-AG-12100, the NHLBI grant R01 HL105756, the Icelandic Heart Association, and the Erasmus Medical Center and Erasmus University. ADGC was supported by the NIH/NIA grants: U01 AG032984, U24 AG021886, U01 AG016976, and the Alzheimer's Association grant ADGC-10-196728.	Balestrini A, 2010, NAT CELL BIOL, V12, P484, DOI 10.1038/ncb2050; Bartley AJ, 1997, BRAIN, V120, P257, DOI 10.1093/brain/120.2.257; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Boland E, 2007, AM J HUM GENET, V81, P292, DOI 10.1086/519999; Broer L, 2015, J GERONTOL A-BIOL, V70, P110, DOI 10.1093/gerona/glu166; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chan YL, 2015, AM J HUM GENET, V96, P695, DOI 10.1016/j.ajhg.2015.02.018; Chauhan G, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.12.028; Davies G, 2015, MOL PSYCHIATR, V20, P183, DOI 10.1038/mp.2014.188; DAVIS PJM, 1977, NEUROPATH APPL NEURO, V3, P341, DOI 10.1111/j.1365-2990.1977.tb00595.x; de Moor MHM, 2015, JAMA PSYCHIAT, V72, P642, DOI 10.1001/jamapsychiatry.2015.0554; Desikan RS, 2015, MOL PSYCHIATR, V20, P1588, DOI 10.1038/mp.2015.6; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Farias ST, 2012, NEUROBIOL AGING, V33, P1758, DOI 10.1016/j.neurobiolaging.2011.03.017; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fukumoto A, 2011, BRAIN DEV-JPN, V33, P569, DOI 10.1016/j.braindev.2010.09.004; Hevner RF, 2015, SEMIN PERINATOL, V39, P36, DOI 10.1053/j.semperi.2014.10.006; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; Horikoshi M, 2013, NAT GENET, V45, P76, DOI 10.1038/ng.2477; Ikram MA, 2012, NAT GENET, V44, P539, DOI 10.1038/ng.2245; Kaplan RC, 2011, HUM MOL GENET, V20, P1241, DOI 10.1093/hmg/ddq560; Kemp JP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004423; Kirchhoff M, 2007, EUR J MED GENET, V50, P256, DOI 10.1016/j.ejmg.2007.05.001; Koolen DA, 2012, NAT GENET, V44, P639, DOI 10.1038/ng.2262; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Li MX, 2012, AM J HUM GENET, V91, P478, DOI 10.1016/j.ajhg.2012.08.004; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Lynch SA, 2011, EUR J HUM GENET, V19, P534, DOI 10.1038/ejhg.2010.215; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Paus T, 2012, CEREB CORTEX, V22, P2634, DOI 10.1093/cercor/bhr350; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Quesada A, 2008, DEV NEUROBIOL, V68, P632, DOI 10.1002/dneu.20609; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Rzehak P, 2013, GROWTH HORM IGF RES, V23, P149, DOI 10.1016/j.ghir.2013.05.002; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Sgouros S, 1999, J NEUROSURG, V91, P610, DOI 10.3171/jns.1999.91.4.0610; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Sweet T, 2008, J CELL PHYSIOL, V214, P381, DOI 10.1002/jcp.21204; Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238; Thompson PM, 2014, BRAIN IMAGING BEHAV, V8, P153, DOI 10.1007/s11682-013-9269-5; van den Berg SM, 2016, BEHAV GENET, V46, P170, DOI 10.1007/s10519-015-9735-5; van der Valk RJP, 2015, HUM MOL GENET, V24, P1155, DOI 10.1093/hmg/ddu510; Verhaaren B.F., 2015, CIRCGENETICS, V114; Wang D, 2013, AM J MED GENET A, V161, P2016, DOI 10.1002/ajmg.a.35999; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097	55	130	130	4	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2016	19	12					1569	1582		10.1038/nn.4398	http://dx.doi.org/10.1038/nn.4398			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED7BY	27694991	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000389011900016
J	McDermott, JH; Schemitsch, M; Simoncelli, EP				McDermott, Josh H.; Schemitsch, Michael; Simoncelli, Eero P.			Summary statistics in auditory perception	NATURE NEUROSCIENCE			English	Article							TEMPORAL INTEGRATION; NOISE; LATERALIZATION; DISCRIMINATION; REPRESENTATION; INTERFERENCE; SIGNALS; SPEECH; SOUNDS; MEMORY	Sensory signals are transduced at high resolution, but their structure must be stored in a more compact format. Here we provide evidence that the auditory system summarizes the temporal details of sounds using time-averaged statistics. We measured discrimination of 'sound textures' that were characterized by particular statistical properties, as normally result from the superposition of many acoustic features in auditory scenes. When listeners discriminated examples of different textures, performance improved with excerpt duration. In contrast, when listeners discriminated different examples of the same texture, performance declined with duration, a paradoxical result given that the information available for discrimination grows with duration. These results indicate that once these sounds are of moderate length, the brain's representation is limited to time-averaged statistics, which, for different examples of the same texture, converge to the same values with increasing duration. Such statistical representations produce good categorical discrimination, but limit the ability to discern temporal detail.	[McDermott, Josh H.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Schemitsch, Michael; Simoncelli, Eero P.] NYU, Ctr Neural Sci, Howard Hughes Med Inst, New York, NY 10003 USA; [Schemitsch, Michael; Simoncelli, Eero P.] NYU, Courant Inst Math Sci, New York, NY USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; New York University; New York University	McDermott, JH (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	jhm@mit.edu		Simoncelli, Eero/0000-0002-1206-527X	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The authors thank B. Anderson, S. Keshvari and J. Traer for comments on earlier versions of the manuscript. Research was funded by the Howard Hughes Medical Institute.	Agus TR, 2010, NEURON, V66, P610, DOI 10.1016/j.neuron.2010.04.014; Alvarez GA, 2009, P NATL ACAD SCI USA, V106, P7345, DOI 10.1073/pnas.0808981106; Ariely D, 2001, PSYCHOL SCI, V12, P157, DOI 10.1111/1467-9280.00327; Athineos M, 2003, 2003 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL V, PROCEEDINGS, P648; Balas B, 2009, J VISION, V9, DOI [10.1167/9.2.16, 10.1167/9.12.13]; Carlyon RP, 2004, J ACOUST SOC AM, V116, P3629, DOI 10.1121/1.1811474; Chong SC, 2003, VISION RES, V43, P393, DOI 10.1016/S0042-6989(02)00596-5; COBLE SF, 1992, J ACOUST SOC AM, V92, P2630, DOI 10.1121/1.404402; CUTTING JE, 1974, PERCEPT PSYCHOPHYS, V16, P564, DOI 10.3758/BF03198588; Demany L, 2008, PSYCHOL SCI, V19, P85, DOI 10.1111/j.1467-9280.2008.02050.x; DEUTSCH D, 1970, SCIENCE, V168, P1604, DOI 10.1126/science.168.3939.1604; Dubnov S, 2002, IEEE COMPUT GRAPH, V22, P38, DOI 10.1109/MCG.2002.1016697; DYE RH, 1984, J ACOUST SOC AM, V75, P1593, DOI 10.1121/1.390868; Elhilali M, 2008, J ACOUST SOC AM, V124, P3751, DOI 10.1121/1.3001672; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; Geffen MN, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00015; GERKEN GM, 1990, J ACOUST SOC AM, V88, P767, DOI 10.1121/1.399726; Goossens T, 2008, J ACOUST SOC AM, V124, P2251, DOI 10.1121/1.2973184; Goossens T, 2009, J ACOUST SOC AM, V125, P3882, DOI 10.1121/1.3119626; Greenwood JA, 2009, P NATL ACAD SCI USA, V106, P13130, DOI 10.1073/pnas.0901352106; GUTTMAN N, 1963, J ACOUST SOC AM, V35, P610, DOI 10.1121/1.1918551; Haberman J, 2009, J EXP PSYCHOL HUMAN, V35, P718, DOI 10.1037/a0013899; HAFTER ER, 1979, J ACOUST SOC AM, V65, P471, DOI 10.1121/1.382346; HANNA TE, 1984, PERCEPT PSYCHOPHYS, V36, P409, DOI 10.3758/BF03207495; HELLER LM, 1995, J ACOUST SOC AM, V97, P3775, DOI 10.1121/1.412393; HOUTGAST T, 1968, J ACOUST SOC AM, V44, P807, DOI 10.1121/1.1911178; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Kaernbach C, 2004, EXP PSYCHOL, V51, P240, DOI 10.1027/1618-3169.51.4.240; Klein DJ, 2003, EURASIP J APPL SIG P, V2003, P659, DOI 10.1155/S1110865703303051; Latinus M, 2011, CURR BIOL, V21, pR143, DOI 10.1016/j.cub.2010.12.033; Lie L, 2004, IEEE T SPEECH AUDI P, V12, P156, DOI 10.1109/TSA.2003.819947; Lyzenga J, 2005, HEARING RES, V210, P30, DOI 10.1016/j.heares.2005.07.002; McDermott Josh H., 2009, 2009 IEEE Workshop on Applications of Signal Processing to Audio and Acoustics (WASPAA), P297, DOI 10.1109/ASPAA.2009.5346467; McDermott JH, 2011, NEURON, V71, P926, DOI 10.1016/j.neuron.2011.06.032; McDermott JH, 2011, P NATL ACAD SCI USA, V108, P1188, DOI 10.1073/pnas.1004765108; MOORE BCJ, 1973, J ACOUST SOC AM, V54, P610, DOI 10.1121/1.1913640; Nahum M, 2008, PLOS BIOL, V6, P978, DOI 10.1371/journal.pbio.0060126; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; PLOMP R, 1964, J ACOUST SOC AM, V36, P277, DOI 10.1121/1.1918946; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Popat K, 1995, P AJCAI WORKSH COMP, P293; Schwarz D., 2011, P 14 INT C DIG AUD E, P221; SHEFT S, 1990, J ACOUST SOC AM, V88, P796, DOI 10.1121/1.399729; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Starr GE, 1997, J ACOUST SOC AM, V102, P486, DOI 10.1121/1.419722; Tzanetakis G, 2002, IEEE T SPEECH AUDI P, V10, P293, DOI 10.1109/TSA.2002.800560; VIEMEISTER NF, 1979, J ACOUST SOC AM, V66, P1364, DOI 10.1121/1.383531; VIEMEISTER NF, 1991, J ACOUST SOC AM, V90, P858, DOI 10.1121/1.401953; Warren RM, 2001, PERCEPT PSYCHOPHYS, V63, P175, DOI 10.3758/BF03200511; Yabe H, 1998, PSYCHOPHYSIOLOGY, V35, P615, DOI 10.1017/S0048577298000183	50	130	130	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					493	U169		10.1038/nn.3347	http://dx.doi.org/10.1038/nn.3347			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23434915	Green Accepted, Green Published			2022-12-17	WOS:000316723700021
J	Froemke, RC; Carcea, I; Barker, AJ; Yuan, K; Seybold, BA; Martins, ARO; Zaika, N; Bernstein, H; Wachs, M; Levis, PA; Polley, DB; Merzenich, MM; Schreiner, CE				Froemke, Robert C.; Carcea, Ioana; Barker, Alison J.; Yuan, Kexin; Seybold, Bryan A.; Martins, Ana Raquel O.; Zaika, Natalya; Bernstein, Hannah; Wachs, Megan; Levis, Philip A.; Polley, Daniel B.; Merzenich, Michael M.; Schreiner, Christoph E.			Long-term modification of cortical synapses improves sensory perception	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; SPECTROTEMPORAL RECEPTIVE-FIELDS; VISUAL-CORTEX; SYNAPTIC PLASTICITY; NUCLEUS BASALIS; DEPENDENT PLASTICITY; MAP PLASTICITY; DISCRIMINATION; STIMULATION; RAT	Synapses and receptive fields of the cerebral cortex are plastic. However, changes to specific inputs must be coordinated within neural networks to ensure that excitability and feature selectivity are appropriately configured for perception of the sensory environment. We induced long-lasting enhancements and decrements to excitatory synaptic strength in rat primary auditory cortex by pairing acoustic stimuli with activation of the nucleus basalis neuromodulatory system. Here we report that these synaptic modifications were approximately balanced across individual receptive fields, conserving mean excitation while reducing overall response variability. Decreased response variability should increase detection and recognition of near-threshold or previously imperceptible stimuli. We confirmed both of these hypotheses in behaving animals. Thus, modification of cortical inputs leads to wide-scale synaptic changes, which are related to improved sensory perception and enhanced behavioral performance.	[Froemke, Robert C.; Carcea, Ioana; Martins, Ana Raquel O.; Zaika, Natalya; Bernstein, Hannah] NYU, Sch Med, Dept Physiol & Neurosci,Skirball Inst Biomol Med, Mol Neurobiol Program,Helen & Martin Kimmel Ctr B, New York, NY 10012 USA; [Froemke, Robert C.; Carcea, Ioana; Martins, Ana Raquel O.; Zaika, Natalya; Bernstein, Hannah] NYU, Sch Med, Dept Otolaryngol, New York, NY USA; [Froemke, Robert C.; Carcea, Ioana; Martins, Ana Raquel O.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Froemke, Robert C.; Barker, Alison J.; Yuan, Kexin; Seybold, Bryan A.; Merzenich, Michael M.; Schreiner, Christoph E.] Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA; [Froemke, Robert C.; Barker, Alison J.; Yuan, Kexin; Seybold, Bryan A.; Merzenich, Michael M.; Schreiner, Christoph E.] Univ Calif San Francisco, Dept Otolaryngol, Neurosci Grad Grp, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Martins, Ana Raquel O.] Univ Coimbra, Ctr Neurosci & Cell Biol, PhD Program Expt Biol & Biomed, P-3000 Coimbra, Portugal; [Wachs, Megan; Levis, Philip A.] Stanford Univ, Dept Elect Engn, Comp Syst Lab, Palo Alto, CA 94304 USA; [Wachs, Megan; Levis, Philip A.] Stanford Univ, Dept Comp Sci, Comp Syst Lab, Palo Alto, CA 94304 USA; [Polley, Daniel B.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Eaton Peabody Lab,Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA	New York University; New York University; New York University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade de Coimbra; Stanford University; Stanford University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Froemke, RC (corresponding author), NYU, Sch Med, Dept Physiol & Neurosci,Skirball Inst Biomol Med, Mol Neurobiol Program,Helen & Martin Kimmel Ctr B, New York, NY 10012 USA.	robert.froemke@med.nyu.edu	Barker, Alison/AAH-1905-2021	Barker, Alison/0000-0001-9103-9258; Seybold, Bryan/0000-0001-6081-8347; Froemke, Robert/0000-0002-1230-6811; Polley, Daniel/0000-0002-5120-2409; Schreiner, Christoph/0000-0002-4571-4328; Bernstein, Hannah/0000-0002-6512-1378	US National Institute on Deafness and Other Communication Disorders [DC009635, DC009836, DC02260]; US National Science Foundation [0615308, 0627126]; Intel Research; DoCoMo Capital; Conte Center for Neuroscience Research at the University of California, San Francisco [MH077970]; Hearing Research Inc.; John C. and Edward Coleman Fund; US National Academies Keck Future Initiatives; US National Science Foundation Predoctoral Fellowship; Sequoia Capital Stanford Graduate Fellowship; US National Institute of Mental Health training grant; Microsoft Research New Faculty Fellowship; Sloan Research Fellowship; Foundation Capital; Division Of Computer and Network Systems [0846014] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC009635, K99DC009635, R01DC002260, R01DC009836, R01DC012557] Funding Source: NIH RePORTER	US National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); US National Science Foundation(National Science Foundation (NSF)); Intel Research(Intel Corporation); DoCoMo Capital; Conte Center for Neuroscience Research at the University of California, San Francisco; Hearing Research Inc.; John C. and Edward Coleman Fund; US National Academies Keck Future Initiatives; US National Science Foundation Predoctoral Fellowship(National Science Foundation (NSF)); Sequoia Capital Stanford Graduate Fellowship; US National Institute of Mental Health training grant; Microsoft Research New Faculty Fellowship(Microsoft); Sloan Research Fellowship(Alfred P. Sloan Foundation); Foundation Capital; Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank L. F. Abbott, T. Babcock, M. Berry, E. Chang, Z. Chen, E. de Villers-Sidani, A. L. Dorrn, P. Dutta, A. Fairhall, S. P. Gandhi, G. Glassner, C. A. Hoeffer, K. Imaizumi, B.J. Jones, N. Kopell, R. Liu, G. Myers, P. O'Hara, J. Shih, A.Y. Tan, C.-L. Teng and L. Wilbrecht for comments, discussions and technical assistance. J. Pivkova created the artwork in Figure 1a. This work was supported by the US National Institute on Deafness and Other Communication Disorders (grant DC009635 to R. C. F., grant DC009836 to D. B. P. and grant DC02260 to C. E. S.), US National Science Foundation (grants 0615308 and 0627126 to P. A. L.), Intel Research (P. A. L.), DoCoMo Capital and Foundation Capital (P. A. L.), the Conte Center for Neuroscience Research at the University of California, San Francisco (grant MH077970 to M. M. M. and C. E. S.), Hearing Research Inc. (C. E. S.), the John C. and Edward Coleman Fund (M. M. M. and C. E. S.) and the US National Academies Keck Future Initiatives (R. C. F. and P. A. L.). A. J. B. is supported by a US National Science Foundation Predoctoral Fellowship. M. W. is supported by a Sequoia Capital Stanford Graduate Fellowship. I. C. is supported by an US National Institute of Mental Health training grant. P. A. L. is supported by a Microsoft Research New Faculty Fellowship. R. C. F. is supported by a Sloan Research Fellowship.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Brown M, 2004, CEREB CORTEX, V14, P952, DOI 10.1093/cercor/bhh056; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Dahmen Johannes C, 2008, J Neurosci, V28, P13629, DOI 10.1523/JNEUROSCI.4429-08.2008; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Deweese MR, 2004, J NEUROPHYSIOL, V92, P1840, DOI 10.1152/jn.00197.2004; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P82, DOI 10.1037/0735-7044.107.1.82; Elhilali M, 2007, J NEUROSCI, V27, P10372, DOI 10.1523/JNEUROSCI.1462-07.2007; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fritz J, 2005, HEARING RES, V206, P159, DOI 10.1016/j.heares.2005.01.015; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; GREUEL JM, 1988, SCIENCE, V242, P74, DOI 10.1126/science.2902687; Han YK, 2007, NAT NEUROSCI, V10, P1191, DOI 10.1038/nn1941; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Hirsch JA, 2006, TRENDS NEUROSCI, V29, P30, DOI 10.1016/j.tins.2005.11.001; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Jacob V, 2007, J NEUROSCI, V27, P1271, DOI 10.1523/JNEUROSCI.4264-06.2007; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; Lin SC, 2008, NEURON, V59, P138, DOI 10.1016/j.neuron.2008.04.031; Liu RC, 2007, PLOS BIOL, V5, P1426, DOI 10.1371/journal.pbio.0050173; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McLin DE, 2002, P NATL ACAD SCI USA, V99, P4002, DOI 10.1073/pnas.062057099; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; METHERATE R, 1993, SYNAPSE, V14, P132, DOI 10.1002/syn.890140206; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Reed A, 2011, NEURON, V70, P121, DOI 10.1016/j.neuron.2011.02.038; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Rumsey CC, 2004, J NEUROPHYSIOL, V91, P2273, DOI 10.1152/jn.00900.2003; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Talwar SK, 2001, J NEUROPHYSIOL, V86, P1555, DOI 10.1152/jn.2001.86.4.1555; TANNER WP, 1954, PSYCHOL REV, V61, P401, DOI 10.1037/h0058700; Toyoizumi T, 2009, J NEUROSCI, V29, P6514, DOI 10.1523/JNEUROSCI.0492-08.2009; Wright BA, 2010, J NEUROSCI, V30, P12868, DOI 10.1523/JNEUROSCI.0487-10.2010; Ye CQ, 2010, J NEUROSCI, V30, P1861, DOI 10.1523/JNEUROSCI.3088-09.2010; Zaborszky L, 1999, ANN NY ACAD SCI, V877, P339, DOI 10.1111/j.1749-6632.1999.tb09276.x	50	130	133	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					79	U120		10.1038/nn.3274	http://dx.doi.org/10.1038/nn.3274			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23178974	Green Accepted, Green Submitted			2022-12-17	WOS:000312633900016
J	Arzi, A; Shedlesky, L; Ben-Shaul, M; Nasser, K; Oksenberg, A; Hairston, IS; Sobel, N				Arzi, Anat; Shedlesky, Limor; Ben-Shaul, Mor; Nasser, Khitam; Oksenberg, Arie; Hairston, Ilana S.; Sobel, Noam			Humans can learn new information during sleep	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL CONNECTIVITY; MEMORY; RESPONSES; BRAIN; STATE; EEG; DISCRIMINATION; PATTERNS; IMPLICIT; CORTEX	During sleep, humans can strengthen previously acquired memories, but whether they can acquire entirely new information remains unknown. The nonverbal nature of the olfactory sniff response, in which pleasant odors drive stronger sniffs and unpleasant odors drive weaker sniffs, allowed us to test learning in humans during sleep. Using partial-reinforcement trace conditioning, we paired pleasant and unpleasant odors with different tones during sleep and then measured the sniff response to tones alone during the same nights' sleep and during ensuing wake. We found that sleeping subjects learned novel associations between tones and odors such that they then sniffed in response to tones alone. Moreover, these newly learned tone-induced sniffs differed according to the odor pleasantness that was previously associated with the tone during sleep. This acquired behavior persisted throughout the night and into ensuing wake, without later awareness of the learning process. Thus, humans learned new information during sleep.	[Arzi, Anat; Shedlesky, Limor; Ben-Shaul, Mor; Sobel, Noam] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Nasser, Khitam; Oksenberg, Arie] Loewenstein Hosp & Rehabil Ctr, Sleep Disorders Unit, Raanana, Israel; [Hairston, Ilana S.] Acad Coll Tel Aviv Jaffa, Sch Behav Sci, Jaffa, Israel	Weizmann Institute of Science	Arzi, A (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	anat.arzi@gmail.com	Hairston, Ilana/J-3367-2019; Hairston, Ilana/AAT-7442-2021	Hairston, Ilana/0000-0002-8461-4389; Arzi, Anat/0000-0003-1005-1752; Sobel, Noam/0000-0002-3232-9391	James S. McDonnell Foundation	James S. McDonnell Foundation	We would like to thank R. Paz for advice. This work was supported by the James S. McDonnell Foundation.	Antony JW, 2012, NAT NEUROSCI, V15, P1114, DOI 10.1038/nn.3152; Arzi A, 2010, CHEM SENSES, V35, P31, DOI 10.1093/chemse/bjp079; BADIA P, 1990, PHYSIOL BEHAV, V48, P87, DOI 10.1016/0031-9384(90)90266-7; Barnes DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018130; BEH HC, 1965, SCIENCE, V147, P1470, DOI 10.1126/science.147.3664.1470; Bekinschtein TA, 2009, NAT NEUROSCI, V12, P1343, DOI 10.1038/nn.2391; Bensafi M, 2003, NAT NEUROSCI, V6, P1142, DOI 10.1038/nn1145; BRAMHAM CR, 1989, BRAIN RES, V493, P74, DOI 10.1016/0006-8993(89)91001-9; Bruce D J, 1970, Nature, V225, P873, DOI 10.1038/225873a0; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Clark RE, 2002, TRENDS COGN SCI, V6, P524, DOI 10.1016/S1364-6613(02)02041-7; Deschenes M, 2012, CURR OPIN NEUROBIOL, V22, P243, DOI 10.1016/j.conb.2011.11.013; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; EMMONS WH, 1956, AM J PSYCHOL, V69, P76, DOI 10.2307/1418117; Fifer WP, 2010, P NATL ACAD SCI USA, V107, P10320, DOI 10.1073/pnas.1005061107; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Goel N, 2005, CHRONOBIOL INT, V22, P889, DOI 10.1080/07420520500263276; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; Hennevin E, 2007, NEUROBIOL LEARN MEM, V87, P416, DOI 10.1016/j.nlm.2006.10.006; Iber C., 2007, AASM MANUAL SCORING; Ikeda K, 1996, SLEEP, V19, P72, DOI 10.1093/sleep/19.1.72; LAING DG, 1983, PERCEPTION, V12, P99, DOI 10.1068/p120099; LEHMANN D, 1974, ELECTROEN CLIN NEURO, V37, P73, DOI 10.1016/0013-4694(74)90246-6; Livneh U, 2010, J NEUROSCI METH, V192, P90, DOI 10.1016/j.jneumeth.2010.07.027; MAHO C, 1992, BRAIN RES, V581, P115, DOI 10.1016/0006-8993(92)90350-I; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Nakano T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003912; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Nir Y, 2010, TRENDS COGN SCI, V14, P88, DOI 10.1016/j.tics.2009.12.001; Olbrich E, 2008, J BIOL PHYS, V34, P341, DOI 10.1007/s10867-008-9078-z; Peigneux P, 2001, NEUROREPORT, V12, pA111, DOI 10.1097/00001756-200112210-00001; Portas CM, 2000, NEURON, V28, P991, DOI 10.1016/S0896-6273(00)00169-0; Price JL, 1990, HUMAN NERVOUS SYSTEM, P979; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Resnik J, 2011, NAT NEUROSCI, V14, P791, DOI 10.1038/nn.2802; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; SIMON CW, 1956, J EXP PSYCHOL, V51, P89, DOI 10.1037/h0043637; Stuck BA, 2007, SLEEP, V30, P506, DOI 10.1093/sleep/30.4.506; TANI K, 1970, BRAIN RES, V17, P277, DOI 10.1016/0006-8993(70)90082-X; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Weinberger NM, 1998, NEUROBIOL LEARN MEM, V70, P226, DOI 10.1006/nlme.1998.3850; Wilson DA, 2011, NEUROSCI LETT, V497, P69, DOI 10.1016/j.neulet.2011.04.031; Wilson DA, 2010, J NEUROPHYSIOL, V104, P3231, DOI 10.1152/jn.00711.2010; Wilson DA, 2010, J NEUROSCI, V30, P1760, DOI 10.1523/JNEUROSCI.5636-09.2010; WOOD JM, 1992, PSYCHOL SCI, V3, P236, DOI 10.1111/j.1467-9280.1992.tb00035.x; Woodruff-Pak DS, 2008, TRENDS NEUROSCI, V31, P105, DOI 10.1016/j.tins.2007.11.006	50	130	137	6	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2012	15	10					1460	1465		10.1038/nn.3193	http://dx.doi.org/10.1038/nn.3193			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	013VZ	22922782				2022-12-17	WOS:000309335300028
J	Noh, J; Seal, RP; Garver, JA; Edwards, RH; Kandler, K				Noh, Jihyun; Seal, Rebecca P.; Garver, Jessica A.; Edwards, Robert H.; Kandler, Karl			Glutamate co-release at GABA/glycinergic synapses is crucial for the refinement of an inhibitory map	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; AUDITORY BRAIN-STEM; RAT MEDIAL NUCLEUS; VESICULAR GLUTAMATE; COCHLEAR NUCLEUS; TRANSPORTER TYPE-3; SUPERIOR OLIVE; DEAFNESS; VGLUT3; OTOFERLIN	Many nonglutamatergic synaptic terminals in the mammalian brain contain the vesicular glutamate transporter 3 (VGLUT3), indicating that they co-release the excitatory neurotransmitter glutamate. However, the functional role of glutamate co-transmission at these synapses is poorly understood. In the auditory system, VGLUT3 expression and glutamate co-transmission are prominent in a developing GABA/glycinergic sound-localization pathway. We found that mice with a genetic deletion of Vglut3 (also known as Slc17a8) had disrupted glutamate co-transmission and severe impairment in the refinement of this inhibitory pathway. Specifically, loss of glutamate co-transmission disrupted synaptic silencing and the strengthening of GABA/glycinergic connections that normally occur with maturation. Functional mapping studies further revealed that these deficits markedly degraded the precision of tonotopy in this inhibitory auditory pathway. These results indicate that glutamate co-transmission is crucial for the synaptic reorganization and topographic specification of a developing inhibitory circuit.	[Noh, Jihyun; Garver, Jessica A.; Kandler, Karl] Univ Pittsburgh, Sch Med, Inst Eye & Ear, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Noh, Jihyun; Garver, Jessica A.; Kandler, Karl] Univ Pittsburgh, Sch Med, Inst Eye & Ear, Dept Neurobiol, Pittsburgh, PA USA; [Seal, Rebecca P.; Edwards, Robert H.] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA; [Seal, Rebecca P.; Edwards, Robert H.] Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA; [Kandler, Karl] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kandler, K (corresponding author), Univ Pittsburgh, Sch Med, Inst Eye & Ear, Dept Otolaryngol, Pittsburgh, PA 15260 USA.	kkarl@pitt.edu		Kandler, Karl/0000-0002-6053-6400; Seal, Rebecca/0000-0003-4955-703X	National Institute on Deafness Other Communication Disorders [DC-04199]; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH068085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004199] Funding Source: NIH RePORTER	National Institute on Deafness Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Gillespie for initial recordings from Vglut3<SUP>-/-</SUP> mice and K. Cihil for help with genotyping. Otoferlin knockout mice (pachanga)<SUP>37</SUP> were generously supplied by U. Mueller (Scripps Institute). We are grateful to E. Aizenman, J. Castro, A. Clause and T. Tzounopoulos for comments on the manuscript. K. K. was supported by the National Institute on Deafness and Other Communication Disorders (DC-04199), R.P.S. by the National Alliance for Research on Schizophrenia and Depression and R. H. E. by the National Institute on Drug Abuse and the National Institute of Mental Health.	Aamodt SM, 2000, J NEUROPHYSIOL, V83, P1580, DOI 10.1152/jn.2000.83.3.1580; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; Allen TGJ, 2006, J NEUROSCI, V26, P1588, DOI 10.1523/JNEUROSCI.3979-05.2006; Behrends JC, 1998, J NEUROPHYSIOL, V79, P2999, DOI 10.1152/jn.1998.79.6.2999; Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; Blaesse P, 2005, CELL TISSUE RES, V320, P33, DOI 10.1007/s00441-004-1054-8; Boulland JL, 2004, J COMP NEUROL, V480, P264, DOI 10.1002/cne.20354; FORSYTHE ID, 1993, P ROY SOC B-BIOL SCI, V251, P143, DOI 10.1098/rspb.1993.0021; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Gabellec MM, 2007, EUR J NEUROSCI, V25, P1373, DOI 10.1111/j.1460-9568.2007.05400.x; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Gillespie DC, 2005, NAT NEUROSCI, V8, P332, DOI 10.1038/nn1397; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Gras C, 2005, NEUROPHARMACOLOGY, V49, P901, DOI 10.1016/j.neuropharm.2005.07.023; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; Herzog E, 2004, NEUROSCIENCE, V123, P983, DOI 10.1016/j.neuroscience.2003.10.039; Jones TA, 2007, J NEUROPHYSIOL, V98, P1898, DOI 10.1152/jn.00472.2007; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; KANDLER K, 1995, J NEUROSCI, V15, P6890; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; KIL J, 1995, J COMP NEUROL, V353, P317, DOI 10.1002/cne.903530302; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Kotak VC, 1998, J NEUROSCI, V18, P4646; Leake PA, 2006, J COMP NEUROL, V497, P13, DOI 10.1002/cne.20968; Leao RN, 2006, J PHYSIOL-LONDON, V571, P563, DOI 10.1113/jphysiol.2005.098780; Leao RN, 2004, J PHYSIOL-LONDON, V559, P25, DOI 10.1113/jphysiol.2004.067421; LIPPE WR, 1994, J NEUROSCI, V14, P1486, DOI 10.1523/JNEUROSCI.14-03-01486.1994; Longo-Guess C, 2007, HEARING RES, V234, P21, DOI 10.1016/j.heares.2007.09.005; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; Mentis GZ, 2005, P NATL ACAD SCI USA, V102, P7344, DOI 10.1073/pnas.0502788102; Morishita W, 1996, J NEUROPHYSIOL, V76, P59, DOI 10.1152/jn.1996.76.1.59; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P1364, DOI 10.1074/jbc.M803605200; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; SANES DH, 1988, J NEUROSCI, V8, P682; SANES DH, 1990, J NEUROSCI, V10, P3494; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Seal RP, 2006, CURR OPIN PHARMACOL, V6, P114, DOI 10.1016/j.coph.2005.12.001; SOMMER I, 1993, EXP BRAIN RES, V95, P223; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Tollin DJ, 2003, NEUROSCIENTIST, V9, P127, DOI 10.1177/1073858403252228; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Walmsley B, 2006, J PHYSIOL-LONDON, V572, P313, DOI 10.1113/jphysiol.2006.104851; WU SH, 1991, J NEUROPHYSIOL, V65, P230, DOI 10.1152/jn.1991.65.2.230	49	130	131	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2010	13	2					232	U120		10.1038/nn.2478	http://dx.doi.org/10.1038/nn.2478			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	548SE	20081852	Green Accepted			2022-12-17	WOS:000273985800019
J	Schmid, A; Hallermann, S; Kittel, RJ; Khorramshahi, O; Frolich, AMJ; Quentin, C; Rasse, TM; Mertel, S; Heckmann, M; Sigrist, SJ				Schmid, Andreas; Hallermann, Stefan; Kittel, Robert J.; Khorramshahi, Omid; Froelich, Andreas M. J.; Quentin, Christine; Rasse, Tobias M.; Mertel, Sara; Heckmann, Manfred; Sigrist, Stephan J.			Activity-dependent site-specific changes of glutamate receptor composition in vivo	NATURE NEUROSCIENCE			English	Article							PRESYNAPTIC RELEASE; RETROGRADE SIGNAL; QUANTAL SIZE; DROSOPHILA; MECHANISMS; SUBUNIT; PLASTICITY; SYNAPSE; TRAFFICKING; EXPRESSION	The subunit composition of postsynaptic non-NMDA-type glutamate receptors (GluRs) determines the function and trafficking of the receptor. Changes in GluR composition have been implicated in the homeostasis of neuronal excitability and synaptic plasticity underlying learning. Here, we imaged GluRs in vivo during the formation of new postsynaptic densities (PSDs) at Drosophila neuromuscular junctions coexpressing GluRIIA and GluRIIB subunits. GluR composition was independently regulated at directly neighboring PSDs on a submicron scale. Immature PSDs typically had large amounts of GluRIIA and small amounts of GluRIIB. During subsequent PSD maturation, however, the GluRIIA/GluRIIB composition changed and became more balanced. Reducing presynaptic glutamate release increased GluRIIA, but decreased GluRIIB incorporation. Moreover, the maturation of GluR composition correlated in a site-specific manner with the level of Bruchpilot, an active zone protein that is essential for mature glutamate release. Thus, we show that an activity-dependent, site-specific control of GluR composition can contribute to match pre-and postsynaptic assembly.	[Schmid, Andreas; Hallermann, Stefan; Kittel, Robert J.; Khorramshahi, Omid; Quentin, Christine; Mertel, Sara; Heckmann, Manfred; Sigrist, Stephan J.] Univ Wurzburg, Fac Med, Inst Clin Neurobiol, D-97080 Wurzburg, Germany; [Schmid, Andreas; Khorramshahi, Omid; Quentin, Christine; Mertel, Sara; Sigrist, Stephan J.] Univ Wurzburg, Deutsche Forschsgemeinshaft Res Ctr Expt Biomed, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany; [Schmid, Andreas; Kittel, Robert J.; Froelich, Andreas M. J.; Quentin, Christine; Rasse, Tobias M.; Mertel, Sara; Sigrist, Stephan J.] Univ Gottingen, European Neurosci Inst Gottingen, D-37077 Gottingen, Germany; [Hallermann, Stefan; Kittel, Robert J.; Heckmann, Manfred] Univ Leipzig, Carl Ludwig Inst Physiol, Fac Med, D-04103 Leipzig, Germany	University of Wurzburg; University of Wurzburg; University of Gottingen; Leipzig University	Sigrist, SJ (corresponding author), Univ Wurzburg, Fac Med, Inst Clin Neurobiol, Zinklesweg 10, D-97080 Wurzburg, Germany.	stephan.sigrist@virchow.uni-wuerzburg.de	Kittel, Robert J/G-6404-2015	Kittel, Robert J/0000-0002-9199-4826; Hallermann, Stefan/0000-0001-9376-7048; Heckmann, Manfred/0000-0002-4874-1735				Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bogdanik L, 2004, J NEUROSCI, V24, P9105, DOI 10.1523/JNEUROSCI.2724-04.2004; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BROADIE KS, 1993, J NEUROSCI, V13, P144; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen K, 2005, J NEUROSCI, V25, P6667, DOI 10.1523/JNEUROSCI.1527-05.2005; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; DiAntonio A, 1999, J NEUROSCI, V19, P3023; DiAntonio A, 2006, INT REV NEUROBIOL, V75, P165, DOI 10.1016/S0074-7742(06)75008-5; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Featherstone DE, 2005, J NEUROSCI, V25, P3199, DOI 10.1523/JNEUROSCI.4201-04.2005; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Holcman D, 2006, BIOPHYS J, V91, P2405, DOI 10.1529/biophysj.106.081935; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Nishikawa K, 1995, J NEUROSCI, V15, P7905; Pawlu C, 2004, NEURON, V42, P607, DOI 10.1016/S0896-6273(04)00269-7; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Reiff DF, 2002, J NEUROSCI, V22, P9399; Ruiz-Canada C, 2004, NEURON, V42, P567, DOI 10.1016/S0896-6273(04)00255-7; Schmid A, 2006, J NEUROSCI, V26, P11267, DOI 10.1523/JNEUROSCI.2722-06.2006; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Sigrist SJ, 2002, J NEUROSCI, V22, P7362; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Takahashi T, 2005, NEUROSCI RES, V53, P229, DOI 10.1016/j.neures.2005.07.005; Thiagarajan TC, 2007, NEUROPHARMACOLOGY, V52, P156, DOI 10.1016/j.neuropharm.2006.07.030; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Witzemann V, 1996, P NATL ACAD SCI USA, V93, P13286, DOI 10.1073/pnas.93.23.13286; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Zhong Y, 2004, J NEUROSCI, V24, P1439, DOI 10.1523/JNEUROSCI.0740-02.2004; ZHONG Y, 1992, J NEUROSCI, V12, P644	48	130	131	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					659	666		10.1038/nn.2122	http://dx.doi.org/10.1038/nn.2122			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18469810				2022-12-17	WOS:000256133700012
J	Fusi, S; Abbott, LF				Fusi, Stefano; Abbott, L. F.			Limits on the memory storage capacity of bounded synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; BIDIRECTIONAL SYNAPTIC PLASTICITY; TIMING-DEPENDENT PLASTICITY; FREQUENCY STIMULATION; INFORMATION-STORAGE; CORTICAL PLASTICITY; NEURAL NETWORKS; MODEL; HIPPOCAMPUS; LTP	Memories maintained in patterns of synaptic connectivity are rapidly overwritten and destroyed by ongoing plasticity related to the storage of new memories. Short memory lifetimes arise from the bounds that must be imposed on synaptic efficacy in any realistic model. We explored whether memory performance can be improved by allowing synapses to traverse a large number of states before reaching their bounds, or by changing the way these bounds are imposed. In the case of hard bounds, memory lifetimes grow proportional to the square of the number of synaptic states, but only if potentiation and depression are precisely balanced. Improved performance can be obtained without fine tuning by imposing soft bounds, but this improvement is only linear with respect to the number of synaptic states. We explored several other possibilities and conclude that improving memory performance requires a more radical modification of the standard model of memory storage.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Kolb Res Annex, New York, NY 10032 USA	Columbia University	Abbott, LF (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Kolb Res Annex, 1051 Riverside Dr, New York, NY 10032 USA.	lfa2103@columbia.edu	Fusi, Stefano/E-9109-2011	Fusi, Stefano/0000-0002-3035-6652	NIH HHS [5-DPI-OD114-02] Funding Source: Medline; PHS HHS [58754] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abraham WC, 2002, J NEUROSCI, V22, P9626; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; AMIT DJ, 1992, NETWORK-COMP NEURAL, V3, P443, DOI 10.1088/0954-898X/3/4/008; AMIT DJ, 1994, NEURAL COMPUT, V6, P957, DOI 10.1162/neco.1994.6.5.957; Amit DJ, 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BLOCK HD, 1962, REV MOD PHYS, V34, P123, DOI 10.1103/RevModPhys.34.123; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Brunel N, 1998, NETWORK-COMP NEURAL, V9, P123, DOI 10.1088/0954-898X/9/1/007; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; FESTA R, 1978, PHYSICA A, V90, P229, DOI 10.1016/0378-4371(78)90111-5; Fischer TM, 1997, NATURE, V389, P860, DOI 10.1038/39892; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Fusi S, 2002, BIOL CYBERN, V87, P459, DOI 10.1007/s00422-002-0356-8; Fusi S, 2006, CHAOS, V16, DOI 10.1063/1.2213587; GROSSBERG S, 1982, PSYCHOL REV, V89, P529, DOI 10.1037/0033-295X.89.5.529; Gutig R, 2003, J NEUROSCI, V23, P3697; Hertz J., 1991, INTRO THEORY NEURAL, DOI DOI 10.1201/9780429499661; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; KAHN PE, 1995, NETWORK-COMP NEURAL, V6, P415, DOI 10.1088/0954-898X/6/3/007; LARSON J, 1993, BRAIN RES, V600, P97, DOI 10.1016/0006-8993(93)90406-D; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Minsky M., 1988, PERCEPTRONS; Montgomery JM, 2004, TRENDS NEUROSCI, V27, P744, DOI 10.1016/j.tins.2004.10.006; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; O'Connor DH, 2005, J NEUROPHYSIOL, V94, P1565, DOI 10.1152/jn.00047.2005; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; O'Dell T J, 1994, Learn Mem, V1, P129; PARISI G, 1986, J PHYS A-MATH GEN, V19, pL617, DOI 10.1088/0305-4470/19/10/011; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Rubin JE, 2001, NETWORK-COMP NEURAL, V12, P131, DOI 10.1088/0954-898X/12/2/303; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; STAUBLI U, 1990, BRAIN RES, V513, P113, DOI 10.1016/0006-8993(90)91096-Y; Tsodyks M. V., 1990, Modern Physics Letters B, V4, P713, DOI 10.1142/S0217984990000891; TSODYKS MV, 1988, EUROPHYS LETT, V6, P101, DOI 10.1209/0295-5075/6/2/002; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Wixted JT, 1997, MEM COGNITION, V25, P731, DOI 10.3758/BF03211316; Xiao MY, 1996, EUR J NEUROSCI, V8, P1916, DOI 10.1111/j.1460-9568.1996.tb01335.x; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	48	130	133	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					485	493		10.1038/nn1859	http://dx.doi.org/10.1038/nn1859			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	150PL	17351638				2022-12-17	WOS:000245228600020
J	Larocque, D; Galarneau, A; Liu, HN; Scott, M; Almazan, G; Richard, S				Larocque, D; Galarneau, A; Liu, HN; Scott, M; Almazan, G; Richard, S			Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation	NATURE NEUROSCIENCE			English	Article							KINASE INHIBITOR P27(KIP1); MYELIN BASIC-PROTEIN; CELL-CYCLE; TRANSLATIONAL REGULATOR; SIGNAL-TRANSDUCTION; ECTOPIC EXPRESSION; STAR PROTEIN; MUTANT MICE; C-ELEGANS; GLD-1	The quaking (Qk) locus expresses a family of RNA binding proteins, and the expression of several alternatively spliced isoforms coincides with the development of oligodendrocytes and the onset of myelination. Quaking viable (Qk(v)) mice harboring an autosomal recessive mutation in this locus have uncompacted myelin in the central nervous system owing to the inability of oligodendrocytes to properly mature. Here we show that the expression of two QKI isoforms, absent from oligodendrocytes of Qk(v) mice, induces cell cycle arrest of primary rat oligodendrocyte progenitor cells and differentiation into oligodendrocytes. Injection of retroviruses expressing QKI into the telencephalon of mouse embryos induced differentiation and migration of multipotential neural progenitor cells into mature oligodendrocytes localized in the corpus callosum. The mRNA encoding the cyclin-dependent kinase (CDK)-inhibitor p27(Kip1) was bound and stabilized by QKI, leading to an increased accumulation of p27(Kip1) protein in oligodendrocytes. Our findings demonstrate that QKI is upstream of p27(Kip1) during oligodendrocyte differentiation.	Sir Mortimer B Davis Jewish Hosp, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada; Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Ctr Bioinformat, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University	Richard, S (corresponding author), Sir Mortimer B Davis Jewish Hosp, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada.	stephane.richard@mcgill.ca						ALMAZAN G, 1993, J NEUROSCI RES, V36, P163, DOI 10.1002/jnr.490360206; [Anonymous], MYELIN; Antic D, 1999, GENE DEV, V13, P449, DOI 10.1101/gad.13.4.449; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Casaccia-Bonnefil P, 2003, J NEUROSCI RES, V72, P1, DOI 10.1002/jnr.10565; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Cepko CL, 1998, METHODS, V14, P393, DOI 10.1006/meth.1998.0594; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Colognato H, 2004, CURR OPIN NEUROBIOL, V14, P37, DOI 10.1016/j.conb.2004.01.009; Darnell RB, 2004, ARCH NEUROL-CHICAGO, V61, P30, DOI 10.1001/archneur.61.1.30; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Fragoso G, 2003, EXP NEUROL, V183, P34, DOI 10.1016/S0014-4886(03)00101-8; Friessen AJ, 1997, J NEUROSCI RES, V50, P373; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Gopfert U, 2003, HUM MOL GENET, V12, P1767, DOI 10.1093/hmg/ddg177; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Hardy RJ, 1998, J NEUROSCI RES, V54, P46, DOI 10.1002/(SICI)1097-4547(19981001)54:1<46::AID-JNR6>3.0.CO;2-H; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Lee MH, 2004, GENE DEV, V18, P1047, DOI 10.1101/gad.1188404; Lee MH, 1996, P NATL ACAD SCI USA, V93, P3259, DOI 10.1073/pnas.93.8.3259; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Li ZH, 2003, DEV GROWTH DIFFER, V45, P449; Li ZZ, 2000, J NEUROSCI, V20, P4944; Lorenzetti D, 2004, MAMM GENOME, V15, P210, DOI 10.1007/s00335-003-2333-5; Lu QR, 2001, NAT NEUROSCI, V4, P973, DOI 10.1038/nn718; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nery S, 2001, DEVELOPMENT, V128, P527; Okano H, 2002, J CELL SCI, V115, P1355; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Pilotte J, 2001, GENE DEV, V15, P845, DOI 10.1101/gad.860301; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Saccomanno L, 1999, P NATL ACAD SCI USA, V96, P12605, DOI 10.1073/pnas.96.22.12605; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Song J, 2001, MOL CELL NEUROSCI, V17, P624, DOI 10.1006/mcne.2001.0974; Tikoo R, 1998, J NEUROBIOL, V36, P431, DOI 10.1002/(SICI)1097-4695(19980905)36:3<431::AID-NEU10>3.3.CO;2-N; Tokumoto YM, 2002, DEV BIOL, V245, P224, DOI 10.1006/dbio.2002.0626; TRAPP BD, 1984, J CELL BIOL, V99, P594, DOI 10.1083/jcb.99.2.594; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171; Zhang YY, 2001, J NEUROCHEM, V77, P165, DOI 10.1046/j.1471-4159.2001.00224.x	48	130	133	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					27	33		10.1038/nn1359	http://dx.doi.org/10.1038/nn1359			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15568022				2022-12-17	WOS:000225967600012
J	Krieglstein, K; Richter, S; Farkas, L; Schuster, N; Dunker, N; Oppenheim, RW; Unsicker, K				Krieglstein, K; Richter, S; Farkas, L; Schuster, N; Dunker, N; Oppenheim, RW; Unsicker, K			Reduction of endogenous transforming growth factors beta prevents ontogenetic neuron death	NATURE NEUROSCIENCE			English	Article							PROGRAMMED CELL-DEATH; NEUROTROPHIC FACTOR; SPINAL-CORD; NERVOUS-SYSTEM; CHICK-EMBRYO; IN-VIVO; ACTIVITY BLOCKADE; BCL-2 TRANSGENE; MOTOR-NEURONS; CNS NEURONS	We show that following immunoneutralization of endogenous transforming growth factors beta (TGF-beta) in the chick embryo, ontogenetic neuron death of ciliary, dorsal root and spinal motor neurons was largely prevented, and neuron losses following limb bud ablation were greatly reduced. Likewise, preventing TGF-beta signaling by treatment with a T betaR-II fusion protein during the period of ontogenetic cell death in the ciliary ganglion rescued all neurons that normally die. TUNEL staining revealed decreased numbers of apoptotic cells following antibody treatment. Exogenous TGF-beta rescued the TGF-beta -deprived phenotype. We conclude that TGF-beta is critical in regulating ontogenetic neuron death as well as cell death following neuronal target deprivation.	Univ Saarland, Fac Med, Dept Anat, D-66421 Homburg, Germany; Univ Heidelberg, Interdisciplinary Ctr Neurosci, Dept Neuroanat, D-69120 Heidelberg, Germany; Wake Forest Univ, Bowman Gray Sch Med, Neurosci Program, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27157 USA	Saarland University; Ruprecht Karls University Heidelberg; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Krieglstein, K (corresponding author), Univ Saarland, Fac Med, Dept Anat, Bldg 61, D-66421 Homburg, Germany.			Dunker, Nicole/0000-0003-1273-0644	NINDS NIH HHS [NS20402] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020402] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arsura M, 1996, IMMUNITY, V5, P31, DOI 10.1016/S1074-7613(00)80307-6; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barker PA, 1998, CELL DEATH DIFFER, V5, P346, DOI 10.1038/sj.cdd.4400375; Buske C, 1997, LEUKEMIA, V11, P386, DOI 10.1038/sj.leu.2400586; Caldero J, 1998, J NEUROSCI, V18, P356; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; DAHM LM, 1991, J NEUROSCI, V11, P238; DAHM LM, 1988, DEV BIOL, V130, P621, DOI 10.1016/0012-1606(88)90357-0; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; deLuca A, 1996, J NEUROSCI, V16, P4174; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4397, DOI 10.1073/pnas.92.10.4397; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1996, NATURE, V383, P166; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Graham A, 1996, MOL CELL NEUROSCI, V8, P76, DOI 10.1006/mcne.1996.0046; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; HAMBURGER V, 1958, AM J ANAT, V102, P365, DOI 10.1002/aja.1001020303; HAMBURGER V, 1975, J COMP NEUROL, V160, P535, DOI 10.1002/cne.901600408; HELLER S, 1995, DEVELOPMENT, V121, P2681; HOLLYDAY M, 1976, J COMP NEUROL, V170, P311, DOI 10.1002/cne.901700304; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; KORSCHING S, 1993, J NEUROSCI, V13, P2739; Krieglstein K, 1998, J NEUROBIOL, V37, P563, DOI 10.1002/(SICI)1097-4695(199812)37:4<563::AID-NEU5>3.3.CO;2-1; Krieglstein K, 1998, J NEUROSCI, V18, P9822; KRIEGLSTEIN K, 1995, INT J DEV NEUROSCI, V13, P301, DOI 10.1016/0736-5748(94)00062-8; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; LANDMESSER L, 1974, J PHYSIOL-LONDON, V241, P715, DOI 10.1113/jphysiol.1974.sp010680; Lewis G, 1996, INT REV PSYCHIATR, V8, P289, DOI 10.3109/09540269609051546; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; NISHI R, 1994, J NEUROBIOL, V25, P612, DOI 10.1002/neu.480250604; Oppenheim RW, 1999, MOL CELL NEUROSCI, V13, P348, DOI 10.1006/mcne.1999.0755; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; OPPENHEIM RW, 1993, J NEUROBIOL, V24, P1065, DOI 10.1002/neu.480240806; OPPENHEIM RW, 1978, J COMP NEUROL, V177, P87, DOI 10.1002/cne.901770107; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Roberts AB, 1990, HDB EXPT PHARM, V95, P419; Schober A, 1999, J NEUROSCI, V19, P2008; THOENEN H, 1990, HDB EXPT PHARM, V33, P813; UNSICKER K, 1991, NEUROSCIENCE, V44, P613, DOI 10.1016/0306-4522(91)90082-Y; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zanjani HS, 1996, J COMP NEUROL, V374, P332, DOI 10.1002/(SICI)1096-9861(19961021)374:3<332::AID-CNE2>3.0.CO;2-2	48	130	137	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1085	1090		10.1038/80598	http://dx.doi.org/10.1038/80598			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036264				2022-12-17	WOS:000167177600012
J	Orger, MB; Smear, MC; Anstis, SM; Baier, H				Orger, MB; Smear, MC; Anstis, SM; Baier, H			Perception of Fourier and non-Fourier motion by larval zebrafish	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; 2ND-ORDER MOTION; VISUAL-CORTEX; BEHAVIORAL SCREEN; DANIO-RERIO; CONTRAST; MECHANISMS; LUMINANCE; REVERSAL; MOVEMENT	A moving grating elicits innate optomotor behavior in zebrafish larvae; they swim in the direction of perceived motion. We took advantage of this behavior, using computer-animated displays, to del:ermine what attributes of motion are extracted by the fish visual system. As in humans, first-order (luminance-defined or Fourier) signals dominated motion perception in fish; edges or other features had little or no effect when presented with these signals. Humans can see complex movements that lack first-order cues, an ability that is usually ascribed to higher-level processing in the visual cortex. Here we show that second-order (non-Fourier) motion displays induced optomotor behavior in zebrafish larvae, which do not have a cortex. We suggest that second-order motion is extracted early in the lower vertebrate visual pathway.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Human Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Baier, H (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444,Room S762,513 Parnassus, San Francisco, CA 94143 USA.			Orger, Michael/0000-0002-9763-8902				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; ANSTIS SM, 1970, VISION RES, V10, P1411, DOI 10.1016/0042-6989(70)90092-1; ANSTIS SM, 1975, VISION RES, V15, P957, DOI 10.1016/0042-6989(75)90236-9; Baier H, 1996, DEVELOPMENT, V123, P415; Baker CL, 1999, CURR OPIN NEUROBIOL, V9, P461, DOI 10.1016/S0959-4388(99)80069-5; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P2985, DOI 10.1073/pnas.86.8.2985; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; Clark DT, 1981, VISUAL RESPONSES DEV; Demb JB, 1999, J NEUROSCI, V19, P9756; DERRINGTON AM, 1993, CURR BIOL, V3, P800, DOI 10.1016/0960-9822(93)90037-O; Driever W, 1996, DEVELOPMENT, V123, P37; Easter SS, 1996, DEV BIOL, V180, P646; Haffter P, 1996, DEVELOPMENT, V123, P1; HAMMETT ST, 1993, VISION RES, V33, P1119, DOI 10.1016/0042-6989(93)90245-R; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Nieder A, 1999, NAT NEUROSCI, V2, P660, DOI 10.1038/10217; Ohzawa I, 1999, NAT NEUROSCI, V2, P586, DOI 10.1038/10135; RAMACHAN.VS, 1973, VISION RES, V13, P1399, DOI 10.1016/0042-6989(73)90219-8; REICHARDT W, 1957, Z NATURFORSCH 2B, V12, P447, DOI DOI 10.1515/ZNB-1957-0707; Scott-Samuel NE, 1999, VISION RES, V39, P2853, DOI 10.1016/S0042-6989(98)00316-2; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Smith AT, 1997, VISION RES, V37, P45, DOI 10.1016/S0042-6989(96)00147-2; Smith AT, 1998, J NEUROSCI, V18, P3816; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; ZHOU YX, 1993, SCIENCE, V261, P98, DOI 10.1126/science.8316862	28	130	131	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1128	1133		10.1038/80649	http://dx.doi.org/10.1038/80649			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036270				2022-12-17	WOS:000167177600018
J	Ma, L; Zablow, L; Kandel, ER; Siegelbaum, SA				Ma, L; Zablow, L; Kandel, ER; Siegelbaum, SA			Cyclic AMP induces functional presynaptic boutons in hippocampal CA3-CA1 neuronal cultures	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; CA1 PYRAMIDAL CELLS; LATE-PHASE; NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; AXOSPINOUS SYNAPSES; BINDING PROTEIN; SILENT SYNAPSES; LTP	Long-term forms of synaptic plasticity that may underlie learning and memory have been suggested to depend on changes in the number of synapses between presynaptic and postsynaptic neurons. Here we have investigated a form of synaptic plasticity in cultures of hippocampal CA3 and CA1 neurons related to the late phase of long-term potentiation, which depends on cAMP and protein synthesis. Using the fluorescent dye FM 1-43 to label active presynaptic terminals, we find that a membrane permeable analog of cAMP enhances the number of active presynaptic terminals and that this effect requires protein synthesis.	Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Dept Physiol Psychiat & Biochem, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Dept Pharmacol, 722 W 168 St, New York, NY 10032 USA.	sas8@columbia.edu						Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; Chavis P, 1998, NEURON, V20, P773, DOI 10.1016/S0896-6273(00)81015-6; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Forti L, 1997, NATURE, V388, P874, DOI 10.1038/42251; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P435, DOI 10.1002/hipo.450030405; Geinisman Y, 1996, J COMP NEUROL, V368, P413; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; HUANG LLH, 1996, BIOMED ENG-APP BAS C, V8, P3; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MALGAROLI A, 1995, NATURE, V268, P1624; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; NAZIF FA, 1991, BRAIN RES, V539, P324, DOI 10.1016/0006-8993(91)91638-H; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; REDDY R, 1995, J BIOL CHEM, V270, P14340, DOI 10.1074/jbc.270.24.14340; Rusakov DA, 1997, NEUROSCIENCE, V80, P69, DOI 10.1016/S0306-4522(97)00125-5; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Sorra KE, 1998, J NEUROSCI, V18, P658; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; WOJTOWICZ JM, 1989, CAN J PHYSIOL PHARM, V67, P167, DOI 10.1139/y89-028; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972	46	130	131	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					24	30		10.1038/4525	http://dx.doi.org/10.1038/4525			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195176				2022-12-17	WOS:000078409300009
J	Kriegeskorte, N; Douglas, PK				Kriegeskorte, Nikolaus; Douglas, Pamela K.			Cognitive computational neuroscience	NATURE NEUROSCIENCE			English	Review							DEEP NEURAL-NETWORKS; DECISION-MAKING; PROBABILISTIC MODELS; OBJECT RECOGNITION; BRAIN; REPRESENTATIONS; INFORMATION; DYNAMICS; REVEALS; SYSTEMS	To learn how cognition is implemented in the brain, we must build computational models that can perform cognitive tasks, and test such models with brain and behavioral experiments. Cognitive science has developed computational models that decompose cognition into functional components. Computational neuroscience has modeled how interacting neurons can implement elementary components of cognition. It is time to assemble the pieces of the puzzle of brain computation and to better integrate these separate disciplines. Modern technologies enable us to measure and manipulate brain activity in unprecedentedly rich ways in animals and humans. However, experiments will yield theoretical insight only when employed to test brain-computational models. Here we review recent work in the intersection of cognitive science, computational neuroscience and artificial intelligence. Computational models that mimic brain information processing during perceptual, cognitive and control tasks are beginning to be developed and tested with brain and behavioral data.	[Kriegeskorte, Nikolaus] Columbia Univ, Zuckerman Mind Brain Behav Inst, Dept Elect Engn, Dept Psychol,Dept Neurosci, New York, NY 10027 USA; [Douglas, Pamela K.] Univ Calif Los Angeles, Ctr Cognit Neurosci, Los Angeles, CA USA	Columbia University; University of California System; University of California Los Angeles	Kriegeskorte, N (corresponding author), Columbia Univ, Zuckerman Mind Brain Behav Inst, Dept Elect Engn, Dept Psychol,Dept Neurosci, New York, NY 10027 USA.	n.kriegeskorte@columbia.edu		douglas, pamela/0000-0003-2277-7526; Douglas, PK/0000-0002-3506-6857	MRC [MC_U105597120] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH110645] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 2008, NEURON, V60, P489, DOI 10.1016/j.neuron.2008.10.019; Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Aitchison L, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005186; Anderson J.R., 1983, ARCHITECTURE COGNITI; [Anonymous], 2018, DEEP NEURAL NETWORKS; Anzellotti S, 2014, CEREB CORTEX, V24, P1988, DOI 10.1093/cercor/bht046; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Battaglia PW, 2013, P NATL ACAD SCI USA, V110, P18327, DOI 10.1073/pnas.1306572110; Beattie C, 2016, PREPRINT; Bengio Y, 2016, PREPRINT; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Borst J. P., 2014, INTRO MODEL BASED CO; Buesing L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002211; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Cadieu CF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003963; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Chang L, 2017, CELL, V169, P1013, DOI 10.1016/j.cell.2017.05.011; Chaudhuri R, 2016, NAT NEUROSCI, V19, P394, DOI 10.1038/nn.4237; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Cichy RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27755; Cohen JD, 2017, NAT NEUROSCI, V20, P304, DOI 10.1038/nn.4499; Dasgupta I, 2017, AMORTIZED HYPOTHESIS, DOI [10.1101/137190, DOI 10.1101/137190]; Daw ND, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0478; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P., 2001, THEORETICAL NEUROSCI; Deco G, 2015, NAT REV NEUROSCI, V16, P430, DOI 10.1038/nrn3963; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Dennett D., 1987, INTENTIONAL STANCE; Devereux BJ, 2013, J NEUROSCI, V33, P18906, DOI 10.1523/JNEUROSCI.3809-13.2013; DiCarlo JJ, 2007, TRENDS COGN SCI, V11, P333, DOI 10.1016/j.tics.2007.06.010; Diedrichsen J, 2011, NEUROIMAGE, V55, P1665, DOI 10.1016/j.neuroimage.2011.01.044; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Diedrichsen J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005508; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Eickenberg M, 2017, NEUROIMAGE, V152, P184, DOI 10.1016/j.neuroimage.2016.10.001; Eliasmith C, 2014, CURR OPIN NEUROBIOL, V25, P1, DOI 10.1016/j.conb.2013.09.009; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; FODOR JA, 1985, BEHAV BRAIN SCI, V8, P1, DOI 10.1017/S0140525X0001921X; Forstmann BU, 2011, TRENDS COGN SCI, V15, P272, DOI 10.1016/j.tics.2011.04.002; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 2011, NEUROIMAGE, V58, P303, DOI 10.1016/j.neuroimage.2009.09.031; Gal Y., 2016, PREPRINT; Gazzaniga M. S., 2004, COGNITIVE NEUROSCIEN; Gershman SJ, 2017, ANNU REV PSYCHOL, V68, P101, DOI 10.1146/annurev-psych-122414-033625; Gershman SJ, 2015, SCIENCE, V349, P273, DOI 10.1126/science.aac6076; Ghahramani Z, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0553; Gomez-Marin A, 2014, NAT NEUROSCI, V17, P1455, DOI 10.1038/nn.3812; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672, DOI 10.1145/3422622; Griffiths TL, 2015, TOP COGN SCI, V7, P217, DOI 10.1111/tops.12142; Griffiths TL, 2015, COGNITION, V135, P21, DOI 10.1016/j.cognition.2014.11.026; Griffiths TL, 2010, TRENDS COGN SCI, V14, P357, DOI 10.1016/j.tics.2010.05.004; Grill-Spector K, 2017, ANNU REV VIS SCI, V3, P167, DOI 10.1146/annurev-vision-102016-061214; Guclu U, 2015, J NEUROSCI, V35, P10005, DOI 10.1523/JNEUROSCI.5023-14.2015; Haefner RM, 2016, NEURON, V90, P649, DOI 10.1016/j.neuron.2016.03.020; Hassabis D, 2017, NEURON, V95, P245, DOI 10.1016/j.neuron.2017.06.011; Haxby JV, 2014, ANNU REV NEUROSCI, V37, P435, DOI 10.1146/annurev-neuro-062012-170325; Haynes JD, 2015, NEURON, V87, P257, DOI 10.1016/j.neuron.2015.05.025; Hazy T.E, 2014, PREPRINT; Helmholtz H., 1860, ENGLISH T, VVol. 3; Hong H, 2016, NAT NEUROSCI, V19, P613, DOI 10.1038/nn.4247; HORNIK K, 1991, NEURAL NETWORKS, V4, P251, DOI 10.1016/0893-6080(91)90009-T; Hunt LT, 2017, NAT REV NEUROSCI, V18, P172, DOI 10.1038/nrn.2017.7; Huth AG, 2016, NATURE, V532, P453, DOI 10.1038/nature17637; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Jin X, 2015, CURR OPIN NEUROBIOL, V33, P188, DOI 10.1016/j.conb.2015.06.011; Jozwik KM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01726; Kandel E.R., 2013, PRINCIPLES NEURAL SC, V15; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Khaligh-Razavi SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003915; Kingma D., 2013, ARXIV13126114STATML; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Krakauer JW, 2017, NEURON, V93, P480, DOI 10.1016/j.neuron.2016.12.041; Kriegeskorte N, 2007, P NATL ACAD SCI USA, V104, P20600, DOI 10.1073/pnas.0705654104; Kriegeskorte N, 2017, BEHAV BRAIN SCI, V40, DOI 10.1017/S0140525X17000188; Kriegeskorte N, 2015, ANNU REV VIS SCI, V1, P417, DOI 10.1146/annurev-vision-082114-035447; Kriegeskorte Nikolaus, 2008, Front Syst Neurosci, V2, P4, DOI 10.3389/neuro.06.004.2008; Kriegeskorte N, 2013, TRENDS COGN SCI, V17, P401, DOI 10.1016/j.tics.2013.06.007; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Krizhevsky A., 2012, COMMUN ACM, P1097, DOI DOI 10.1145/3065386; Kubilius J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004896; Kubricht JR, 2017, TRENDS COGN SCI, V21, P749, DOI 10.1016/j.tics.2017.06.002; Kumaran D, 2016, TRENDS COGN SCI, V20, P512, DOI 10.1016/j.tics.2016.05.004; Lake BM, 2017, BEHAV BRAIN SCI, V40, DOI 10.1017/S0140525X16001837; Lake BM, 2015, SCIENCE, V350, P1332, DOI 10.1126/science.aab3050; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lengyel M., 2008, ADV NEURAL INFORM PR, P889; Love BC, 2015, TOP COGN SCI, V7, P230, DOI 10.1111/tops.12131; Ma WJ, 2012, TRENDS COGN SCI, V16, P511, DOI 10.1016/j.tics.2012.08.010; MacKay David JC, 2003, INFORM THEORY INFERE; Marblestone AH, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00094; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Marr D., 1982, Vision. A computational investigation into the human representation and processing of visual information; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Moore C., 2011, NATURE COMPUTATION; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Naselaris T, 2018, TRENDS COGN SCI, V22, P365, DOI 10.1016/j.tics.2018.02.008; Naselaris T, 2015, TRENDS COGN SCI, V19, P551, DOI 10.1016/j.tics.2015.07.005; Newell A, 1973, TECHNICAL REPORT; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nili H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003553; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Doherty JP, 2017, ANNU REV PSYCHOL, V68, P73, DOI 10.1146/annurev-psych-010416-044216; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Orhan AE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00181-8; Pantelis PC, 2014, COGNITION, V130, P360, DOI 10.1016/j.cognition.2013.11.011; Parvizi J, 2012, J NEUROSCI, V32, P14915, DOI 10.1523/JNEUROSCI.2609-12.2012; Pouget A, 2013, NAT NEUROSCI, V16, P1170, DOI 10.1038/nn.3495; Rezende DJ, 2016, PR MACH LEARN RES, V48; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Rumelhart D. E., 1987, PARALLEL DISTRIBUTED, V1; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sanborn AN, 2016, TRENDS COGN SCI, V20, P883, DOI 10.1016/j.tics.2016.10.003; Schafer AM, 2007, INT J NEURAL SYST, V17, P253, DOI 10.1142/S0129065707001111; Schiess M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004638; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shadlen MN, 2016, NEURON, V90, P927, DOI 10.1016/j.neuron.2016.04.036; Shadlen MN, 2013, NEURON, V80, P791, DOI 10.1016/j.neuron.2013.10.047; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Simon H.A., 1990, UTILITY PROBABILITY, P15, DOI DOI 10.1007/978-1-349-20568-4_5; SIMON HA, 1971, AM PSYCHOL, V26, P145, DOI 10.1037/h0030806; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Spoerer CJ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01551; Srikumar V, 2012, P 2012 JOINT C EMP M, P1114; Sutton R. S., 1990, Machine Learning: Proceedings of the Seventh International Conference (1990), P216; Sutton RS, 1998, REINFORCEMENT LEARNI, V1; Szucs D, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000797; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Tervo DGR, 2016, CURR OPIN NEUROBIOL, V37, P99, DOI 10.1016/j.conb.2016.01.014; Tong F, 2012, ANNU REV PSYCHOL, V63, P483, DOI 10.1146/annurev-psych-120710-100412; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tversky Amos., 1975, UTILITY PROBABILITY, P141, DOI [10.1007/978-94-010-1834-0_8, DOI 10.1017/CBO9780511809477.002, DOI 10.1007/978-94-010-1834-0_8]; Ullman TD, 2017, TRENDS COGN SCI, V21, P649, DOI 10.1016/j.tics.2017.05.012; Van Essen DC, 2017, NEUROIMAGE, V144, P270, DOI 10.1016/j.neuroimage.2016.04.002; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Whittington JCR, 2017, NEURAL COMPUT, V29, P1229, DOI 10.1162/NECO_a_00949; Wyatte D, 2012, J COGNITIVE NEUROSCI, V24, P2248, DOI 10.1162/jocn_a_00282; Yamins DLK, 2016, NAT NEUROSCI, V19, P356, DOI 10.1038/nn.4244; Yamins DLK, 2014, P NATL ACAD SCI USA, V111, P8619, DOI 10.1073/pnas.1403112111; Yildirim I., 2015, ANN C COGN SCI SOC; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002	150	129	131	18	128	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2018	21	9					1148	1160		10.1038/s41593-018-0210-5	http://dx.doi.org/10.1038/s41593-018-0210-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GS0DU	30127428	Green Accepted, Green Submitted			2022-12-17	WOS:000443157700005
J	Heusser, AC; Poeppel, D; Ezzyat, Y; Davachi, L				Heusser, Andrew C.; Poeppel, David; Ezzyat, Youssef; Davachi, Lila			Episodic sequence memory is supported by a theta-gamma phase code	NATURE NEUROSCIENCE			English	Article							MULTIITEM WORKING-MEMORY; NEURONAL OSCILLATIONS; TEMPORAL CONTEXT; FRONTAL THETA; PLACE CELLS; HIPPOCAMPAL; ITEM; EEG; ORDER; TIME	The meaning we derive from our experiences is not a simple static extraction of the elements but is largely based on the order in which those elements occur. Models propose that sequence encoding is supported by interactions between high-and low-frequency oscillations, such that elements within an experience are represented by neural cell assemblies firing at higher frequencies (gamma) and sequential order is encoded by the specific timing of firing with respect to a lower frequency oscillation (theta). During episodic sequence memory formation in humans, we provide evidence that items in different sequence positions exhibit greater gamma power along distinct phases of a theta oscillation. Furthermore, this segregation is related to successful temporal order memory. Our results provide compelling evidence that memory for order, a core component of an episodic memory, capitalizes on the ubiquitous physiological mechanism of theta-gamma phase-amplitude coupling.	[Heusser, Andrew C.; Poeppel, David; Ezzyat, Youssef; Davachi, Lila] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Poeppel, David; Davachi, Lila] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Heusser, AC; Davachi, L (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.; Davachi, L (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	ach395@nyu.edu; lila.davachi@nyu.edu		Davachi, Lila/0000-0003-4317-0889	NIMH grant [RO1-MH074692]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005660] Funding Source: NIH RePORTER	NIMH grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank L. Lohnas and G. Cogan for critical discussions and readings of the manuscript; J. Walker for technical support during MEG recording; S. Haegens for advice and discussion regarding the source localization; and A. Flinker and K. Doelling for critical discussions around methodological considerations and statistical approaches. We'd also like to thank our financial supporters, NIMH grant RO1-MH074692 to L.D.	Aru J, 2015, CURR OPIN NEUROBIOL, V31, P51, DOI 10.1016/j.conb.2014.08.002; Attal Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059856; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Berens P., 2009, J STAT SOFTWARE, V31; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Blumenfeld RS, 2011, J COGNITIVE NEUROSCI, V23, P257, DOI 10.1162/jocn.2010.21459; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Dalal S., 2013, EPILEPSY BEHAV, DOI [10.1016/j.yebeh.2013.03.012, DOI 10.1016/J.YEBEH.2013.03.012)]; Dalal SS, 2007, P ANN INT IEEE EMBS, P4941, DOI 10.1109/IEMBS.2007.4353449; Davachi L, 2015, TRENDS COGN SCI, V19, P92, DOI 10.1016/j.tics.2014.12.004; de Cheveigne A, 2007, J NEUROSCI METH, V165, P297, DOI 10.1016/j.jneumeth.2007.06.003; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; DuBrow S, 2014, J NEUROSCI, V34, P13998, DOI 10.1523/JNEUROSCI.2535-14.2014; DuBrow S, 2013, J EXP PSYCHOL GEN, V142, P1277, DOI 10.1037/a0034024; Ezzyat Y, 2014, NEURON, V81, P1179, DOI 10.1016/j.neuron.2014.01.042; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Foster DJ, 2007, HIPPOCAMPUS, V17, P1093, DOI 10.1002/hipo.20345; Friese U, 2013, NEUROIMAGE, V66, P642, DOI 10.1016/j.neuroimage.2012.11.002; Fuentemilla L, 2010, CURR BIOL, V20, P606, DOI 10.1016/j.cub.2010.01.057; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Hsieh LT, 2014, NEURON, V81, P1165, DOI 10.1016/j.neuron.2014.01.015; Hsieh LT, 2011, J NEUROSCI, V31, P10803, DOI 10.1523/JNEUROSCI.0828-11.2011; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jenkins LJ, 2010, J NEUROSCI, V30, P15558, DOI 10.1523/JNEUROSCI.1337-10.2010; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jensen O, 1996, LEARN MEMORY, V3, P243, DOI 10.1101/lm.3.2-3.243; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; Koene RA, 2007, CEREB CORTEX, V17, P1766, DOI 10.1093/cercor/bhl088; Lega B, 2016, CEREB CORTEX, V26, P268, DOI 10.1093/cercor/bhu232; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Mills T, 2012, BRAIN TOPOGR, V25, P248, DOI 10.1007/s10548-012-0217-2; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Nolte G, 2003, PHYS MED BIOL, V48, P3637, DOI 10.1088/0031-9155/48/22/002; OKEEFE J, 1979, PROG NEUROBIOL, V13, P419, DOI 10.1016/0301-0082(79)90005-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Quraan MA, 2011, HUM BRAIN MAPP, V32, P812, DOI 10.1002/hbm.21068; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Ranganath C, 2016, ANN NY ACAD SCI, V1369, P93, DOI 10.1111/nyas.13043; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Scheeringa R, 2009, NEUROIMAGE, V44, P1224, DOI 10.1016/j.neuroimage.2008.08.041; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Staudigl T, 2013, CURR BIOL, V23, P1101, DOI 10.1016/j.cub.2013.04.074; Summerfield C, 2005, NEUROIMAGE, V24, P692, DOI 10.1016/j.neuroimage.2004.09.012; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Tubridy S, 2011, CEREB CORTEX, V21, P272, DOI 10.1093/cercor/bhq092; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Zheng CG, 2016, NEURON, V89, P398, DOI 10.1016/j.neuron.2015.12.005	56	129	132	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2016	19	10					1374	+		10.1038/nn.4374	http://dx.doi.org/10.1038/nn.4374			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DX7ER	27571010	Green Accepted			2022-12-17	WOS:000384549900018
J	Pleil, KE; Rinker, JA; Lowery-Gionta, EG; Mazzone, CM; McCall, NM; Kendra, AM; Olson, DP; Lowell, BB; Grant, KA; Thiele, TE; Kash, TL				Pleil, Kristen E.; Rinker, Jennifer A.; Lowery-Gionta, Emily G.; Mazzone, Christopher M.; McCall, Nora M.; Kendra, Alexis M.; Olson, David P.; Lowell, Bradford B.; Grant, Kathleen A.; Thiele, Todd E.; Kash, Thomas L.			NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking	NATURE NEUROSCIENCE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; AMINOBUTYRIC-ACID RELEASE; NEUROPEPTIDE-Y; C57BL/6J MICE; STRIA TERMINALIS; BED NUCLEUS; ETHANOL DRINKING; RHESUS MACAQUES; KEY ROLE; RECEPTOR	Binge alcohol drinking is a tremendous public health problem because it leads to the development of numerous pathologies, including alcohol abuse and anxiety. It is thought to do so by hijacking brain systems that regulate stress and reward, including neuropeptide Y (NPY) and corticotropin-releasing factor (CRF). The central actions of NPY and CRF have opposing functions in the regulation of emotional and reward-seeking behaviors; thus, dysfunctional interactions between these peptidergic systems could be involved in the development of these pathologies. We used converging physiological, pharmacological and chemogenetic approaches to identify a precise neural mechanism in the bed nucleus of the stria terminalis (BNST), a limbic brain region involved in pathological reward and anxiety behaviors, underlying the interactions between NPY and CRF in the regulation of binge alcohol drinking in both mice and monkeys. We found that NPY Y1 receptor (Y1R) activation in the BNST suppressed binge alcohol drinking by enhancing inhibitory synaptic transmission specifically in CRF neurons via a previously unknown Gi-mediated, PKA-dependent postsynaptic mechanism. Furthermore, chronic alcohol drinking led to persistent alterations in Y1R function in the BNST of both mice and monkeys, highlighting the enduring, conserved nature of this effect across mammalian species. Together, these data provide both a cellular locus and signaling framework for the development of new therapeutics for treatment of neuropsychiatric diseases, including alcohol use disorders.	[Pleil, Kristen E.; Lowery-Gionta, Emily G.; McCall, Nora M.; Kendra, Alexis M.; Kash, Thomas L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27514 USA; [Pleil, Kristen E.; Rinker, Jennifer A.; Lowery-Gionta, Emily G.; Mazzone, Christopher M.; McCall, Nora M.; Kendra, Alexis M.; Thiele, Todd E.; Kash, Thomas L.] Univ N Carolina, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC USA; [Rinker, Jennifer A.; Thiele, Todd E.; Kash, Thomas L.] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA; [Mazzone, Christopher M.] Univ N Carolina, Sch Med, Curriculum Neurobiol, Chapel Hill, NC USA; [Olson, David P.; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; [Olson, David P.; Lowell, Bradford B.] Harvard Univ, Sch Med, Boston, MA USA; [Grant, Kathleen A.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Oregon Health & Science University; Oregon National Primate Research Center	Kash, TL (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27514 USA.	thomas_kash@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; Core, Vector/CAF-4832-2022; Kash, Thomas/G-9625-2013	McCall, Nora/0000-0001-5793-1701; Rinker, Jennifer/0000-0003-3738-3693	US National Institutes of Health [AA021043, AA019454, AA020911, AA011605, AA013573, AA022048, AA013541, AA109431, DK071561, DK075632, DK096010, DK046200, DK057521]; Bowles Center for Alcohol Studies at the University of North Carolina School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, R01DK096010, P30DK020572, K08DK071561, P30DK057521, R01DK089044, R01DK075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022048, U01AA020911, R01AA019454, F32AA021043, R37AA013573, P60AA011605, R01AA013573, P50AA011605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007244] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bowles Center for Alcohol Studies at the University of North Carolina School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Chien for assistance with histological verification of DREADD virus and cannulae placements, R. Thomas and G. Sprow for help with drinking behavior experiments, and B. Roth (UNC School of Medicine) for viral constructs and CNO. This work was supported by US National Institutes of Health grants AA021043 to K.E.P.; AA019454, AA020911 and AA011605 to T.L.K.; AA013573 and AA022048 to T.E.T.; AA013541 and AA109431 to K.A.G.; DK071561 to D.P.O.; and DK075632, DK096010, DK046200 and DK057521 to B.B.L., and by the Bowles Center for Alcohol Studies at the University of North Carolina School of Medicine.	Barr CS, 2008, ARCH GEN PSYCHIAT, V65, P934, DOI 10.1001/archpsyc.65.8.934; Bonomo YA, 2004, ADDICTION, V99, P1520, DOI 10.1111/j.1360-0443.2004.00846.x; Borghese CM, 2012, ALCOHOL RES-CURR REV, V34, P345; Brumovsky P, 2005, J COMP NEUROL, V489, P328, DOI 10.1002/cne.20639; CALZA L, 1990, REGUL PEPTIDES, V27, P127, DOI 10.1016/0167-0115(90)90211-E; Chen ACH, 2010, ALCOHOL CLIN EXP RES, V34, P988, DOI 10.1111/j.1530-0277.2010.01173.x; Cippitelli A, 2012, PHARMACOL BIOCHEM BE, V100, P522, DOI 10.1016/j.pbb.2011.10.016; Cox BR, 2013, ALCOHOL CLIN EXP RES, V37, P1688, DOI 10.1111/acer.12145; Eiler WJA, 2003, SYNAPSE, V48, P45, DOI 10.1002/syn.10181; Gilpin NW, 2011, BIOL PSYCHIAT, V69, P1091, DOI 10.1016/j.biopsych.2011.02.004; Grant KA, 2008, ALCOHOL CLIN EXP RES, V32, P1824, DOI 10.1111/j.1530-0277.2008.00765.x; Hansson AC, 2008, EUR J NEUROSCI, V27, P1912, DOI 10.1111/j.1460-9568.2008.06159.x; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; HEILIG M, 1989, PSYCHOPHARMACOLOGY, V98, P524, DOI 10.1007/BF00441953; Heilig M, 2007, TRENDS NEUROSCI, V30, P399, DOI 10.1016/j.tins.2007.06.006; Helms CM, 2014, PSYCHOPHARMACOLOGY, V231, P1853, DOI 10.1007/s00213-013-3417-x; HYYTIA P, 1995, EUR J PHARMACOL, V283, P151, DOI 10.1016/0014-2999(95)00314-B; Ilveskoski E, 2001, ALCOHOL CLIN EXP RES, V25, P1420, DOI 10.1097/00000374-200110000-00003; Jennison KM, 2004, AM J DRUG ALCOHOL AB, V30, P659, DOI 10.1081/ADA-200032331; Kash TL, 2006, NEUROPHARMACOLOGY, V51, P1013, DOI 10.1016/j.neuropharm.2006.06.011; Kash TL, 2009, NEUROPSYCHOPHARMACOL, V34, P2420, DOI 10.1038/npp.2009.69; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Koob GF, 2009, BRAIN RES, V1293, P61, DOI 10.1016/j.brainres.2009.03.038; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; Kopp J, 2002, NEUROSCIENCE, V111, P443, DOI 10.1016/S0306-4522(01)00463-8; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Lindell SG, 2010, ARCH GEN PSYCHIAT, V67, P423, DOI 10.1001/archgenpsychiatry.2010.23; Lowery-Gionta EG, 2012, J NEUROSCI, V32, P3405, DOI 10.1523/JNEUROSCI.6256-11.2012; McElligott ZA, 2009, PROG NEURO-PSYCHOPH, V33, P1329, DOI 10.1016/j.pnpbp.2009.05.022; Melis M, 2002, J NEUROSCI, V22, P2074, DOI 10.1523/JNEUROSCI.22-06-02074.2002; Molosh AI, 2013, NEUROPSYCHOPHARMACOL, V38, P1352, DOI 10.1038/npp.2013.33; Moore EM, 2007, PHARMACOL BIOCHEM BE, V88, P105, DOI 10.1016/j.pbb.2007.07.011; Pandey SC, 2003, ALCOHOL CLIN EXP RES, V27, P149, DOI 10.1097/01.ALC.0000052706.21367.0E; Parker SL, 2001, EUR J BIOCHEM, V268, P877, DOI 10.1046/j.1432-1327.2001.01966.x; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Pleil KE, 2012, NEUROPHARMACOLOGY, V62, P1777, DOI 10.1016/j.neuropharm.2011.12.002; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Roberto M, 2010, BIOL PSYCHIAT, V67, P831, DOI 10.1016/j.biopsych.2009.11.007; Ron D, 2013, CURR TOP BEHAV NEURO, V13, P87, DOI 10.1007/7854_2011_161; Saha TD, 2007, DRUG ALCOHOL DEPEN, V89, P82, DOI 10.1016/j.drugalcdep.2006.12.003; Silberman Yuval, 2013, Front Psychiatry, V4, P42, DOI 10.3389/fpsyt.2013.00042; Sommer WH, 2008, BIOL PSYCHIAT, V63, P139, DOI 10.1016/j.biopsych.2007.01.010; Sparrow AM, 2012, NEUROPSYCHOPHARMACOL, V37, P1409, DOI 10.1038/npp.2011.327; Sparta DR, 2008, ALCOHOL CLIN EXP RES, V32, P259, DOI 10.1111/j.1530-0277.2007.00575.x; Sparta DR, 2013, ALCOHOL CLIN EXP RES, V37, P1680, DOI 10.1111/acer.12153; Thiele Todd E, 2014, Curr Protoc Neurosci, V68, DOI 10.1002/0471142301.ns0949s68; Valdez GR, 2004, PHARMACOL BIOCHEM BE, V79, P671, DOI 10.1016/j.pbb.2004.09.020; Valdez GR, 2004, ALCOHOL CLIN EXP RES, V28, P865, DOI 10.1097/01.ALC.0000128222.29875.40; Zhang HB, 2010, ALCOHOL CLIN EXP RES, V34, P451, DOI 10.1111/j.1530-0277.2009.01109.x	50	129	129	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2015	18	4					545	+		10.1038/nn.3972	http://dx.doi.org/10.1038/nn.3972			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE4DL	25751534	Green Submitted, Green Accepted			2022-12-17	WOS:000351780900016
J	Chang, J; Gilman, SR; Chiang, AH; Sanders, SJ; Vitkup, D				Chang, Jonathan; Gilman, Sarah R.; Chiang, Andrew H.; Sanders, Stephan J.; Vitkup, Dennis			Genotype to phenotype relationships in autism spectrum disorders	NATURE NEUROSCIENCE			English	Article							DE-NOVO MUTATIONS; PERVASIVE DEVELOPMENTAL DISORDERS; COPY-NUMBER VARIATION; POSTSYNAPTIC DENSITY; SYNAPTIC PLASTICITY; HUMAN-DISEASE; GENETICS; EPIDEMIOLOGY; NEUROBIOLOGY; TRANSLATION	Autism spectrum disorders (ASDs) are characterized by phenotypic and genetic heterogeneity. Our analysis of functional networks perturbed in ASD suggests that both truncating and nontruncating de novo mutations contribute to autism, with a bias against truncating mutations in early embryonic development. We find that functional mutations are preferentially observed in genes likely to be haploinsufficient. Multiple cell types and brain areas are affected, but the impact of ASD mutations appears to be strongest in cortical interneurons, pyramidal neurons and the medium spiny neurons of the striatum, implicating cortical and corticostriatal brain circuits. In females, truncating ASD mutations on average affect genes with 50-100% higher brain expression than in males. Our results also suggest that truncating de novo mutations play a smaller role in the etiology of high-functioning ASD cases. Overall, we find that stronger functional insults usually lead to more severe intellectual, social and behavioral ASD phenotypes.	[Chang, Jonathan; Gilman, Sarah R.; Chiang, Andrew H.; Vitkup, Dennis] Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA; [Chang, Jonathan; Gilman, Sarah R.; Chiang, Andrew H.; Vitkup, Dennis] Columbia Univ, Ctr Computat Biol & Bioinformat, Dept Syst Biol, New York, NY USA; [Sanders, Stephan J.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Sanders, Stephan J.] Yale Univ, Dept Psychiat, Dept Genet, New Haven, CT 06520 USA	Columbia University; Columbia University; University of California System; University of California San Francisco; Yale University	Vitkup, D (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA.	dv2121@columbia.edu	Sanders, Stephan/S-8645-2019	Sanders, Stephan/0000-0001-9112-5148	Simons Foundation SFARI [308962]; US National Centers for Biomedical Computing (MAGNet) [U54CA121852]; US NIGMS [T32 GM082797]; Howard Hughes Medical Institute International Student Research Fellowship; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM082797] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007079] Funding Source: NIH RePORTER	Simons Foundation SFARI; US National Centers for Biomedical Computing (MAGNet); US NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We would like to sincerely thank M. Wigler, M. State, D. Geschwind, A. Packer, G. Fischbach and all of the members of the Vitkup laboratory for helpful discussions. This work was supported by a grant from the Simons Foundation SFARI# 308962 to D.V. and US National Centers for Biomedical Computing (MAGNet) grant U54CA121852 to Columbia University S.R.G. was supported in part by US NIGMS training grant T32 GM082797. S.J.S. was supported by a Howard Hughes Medical Institute International Student Research Fellowship.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Berg JM, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-7-247, 10.1186/gb4034]; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Burguiere E, 2013, SCIENCE, V340, P1243, DOI 10.1126/science.1232380; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Gilman SR, 2012, NAT NEUROSCI, V15, P1723, DOI 10.1038/nn.3261; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Krey JF, 2007, CURR OPIN NEUROBIOL, V17, P112, DOI 10.1016/j.conb.2007.01.010; Langen M, 2011, NEUROSCI BIOBEHAV R, V35, P356, DOI 10.1016/j.neubiorev.2010.02.005; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Rothwell PE, 2014, CELL, V158, P198, DOI 10.1016/j.cell.2014.04.045; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Vogel-Ciernia A, 2013, NAT NEUROSCI, V16, P552, DOI 10.1038/nn.3359; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	48	129	133	4	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2015	18	2					191	198		10.1038/nn.3907	http://dx.doi.org/10.1038/nn.3907			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CA0UM	25531569	Green Submitted, Green Accepted			2022-12-17	WOS:000348631800009
J	Aghajan, ZM; Acharya, L; Moore, JJ; Cushman, JD; Vuong, C; Mehta, MR				Aghajan, Zahra M.; Acharya, Lavanya; Moore, Jason J.; Cushman, Jesse D.; Vuong, Cliff; Mehta, Mayank R.			Impaired spatial selectivity and intact phase precession in two-dimensional virtual reality	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PLACE CELLS; FREELY-MOVING RAT; ENTORHINAL CORTEX; GRID CELLS; VESTIBULAR SYSTEM; THETA-RHYTHM; NAVIGATION; CUES; CODE; REPRESENTATION	During real-world (RW) exploration, rodent hippocampal activity shows robust spatial selectivity, which is hypothesized to be governed largely by distal visual cues, although other sensory-motor cues also contribute. Indeed, hippocampal spatial selectivity is weak in primate and human studies that use only visual cues. To determine the contribution of distal visual cues only, we measured hippocampal activity from body-fixed rodents exploring a two-dimensional virtual reality (VR). Compared to that in RW, spatial selectivity was markedly reduced during random foraging and goal-directed tasks in VR. Instead we found small but significant selectivity to distance traveled. Despite impaired spatial selectivity in VR, most spikes occurred within similar to 2-s-long hippocampal motifs in both RW and VR that had similar structure, including phase precession within motif fields. Selectivity to space and distance traveled were greatly enhanced in VR tasks with stereotypical trajectories. Thus, distal visual cues alone are insufficient to generate a robust hippocampal rate code for space but are sufficient for a temporal code.	[Aghajan, Zahra M.; Acharya, Lavanya; Moore, Jason J.; Cushman, Jesse D.; Vuong, Cliff; Mehta, Mayank R.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, WM Keck Ctr Neurophys, Los Angeles, CA 90095 USA; [Aghajan, Zahra M.; Cushman, Jesse D.; Vuong, Cliff; Mehta, Mayank R.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA USA; [Acharya, Lavanya] Univ Calif Los Angeles, Biomed Engn Interdept Program, Los Angeles, CA USA; [Moore, Jason J.; Mehta, Mayank R.] Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mehta, MR (corresponding author), Univ Calif Los Angeles, Integrat Ctr Learning & Memory, WM Keck Ctr Neurophys, Los Angeles, CA 90095 USA.	mayankmehta@ucla.edu	Acharya, Lavanya/S-8153-2019	M. Aghajan, Zahra/0000-0003-4245-3975; Acharya, Lavanya/0000-0003-2419-5650; Mehta, Mayank/0000-0003-2005-2468	US National Institutes of Health [5R01MH092925-02]; W.M. Keck foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092925] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank F. Quezada and B. Popeney for help with behavioral training, F. Quezada for help with spike sorting, N. Agarwal for help with electrophysiology, B. Willers for help with the analyses, P. Ravassard and A. Kees for help with surgeries, technical support and manuscript comments, D. Aharoni for help with hardware and the participants of the Kavli Institute for Theoretical Physics workshop on 'Neurophysics of Space, Time and Learning' for discussions. This work was supported by grants to M.R.M. from the US National Institutes of Health (5R01MH092925-02) and the W.M. Keck foundation. Results presented in this manuscript were uploaded on a preprint server BioRxiv in December 2013 at http://dx.doi.org/10.1101/001636.	Aikath D, 2014, HIPPOCAMPUS, V24, P1039, DOI 10.1002/hipo.22289; Anderson MI, 2003, J NEUROSCI, V23, P8827; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Aronov D, 2014, NEURON, V84, P442, DOI 10.1016/j.neuron.2014.08.042; Battaglia FP, 2004, J NEUROSCI, V24, P4541, DOI 10.1523/JNEUROSCI.4896-03.2004; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Calton JL, 2003, J NEUROSCI, V23, P9719; Cei A, 2014, NAT NEUROSCI, V17, P719, DOI 10.1038/nn.3698; Chen GF, 2013, P NATL ACAD SCI USA, V110, P378, DOI 10.1073/pnas.1215834110; Cheng JH, 2013, ELIFE, V2, DOI 10.7554/eLife.00647; Cushman JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080465; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Gothard KM, 1996, J NEUROSCI, V16, P8027; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hahn TTG, 2012, NAT NEUROSCI, V15, P1531, DOI 10.1038/nn.3236; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Jacobs J, 2010, P NATL ACAD SCI USA, V107, P6487, DOI 10.1073/pnas.0911213107; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Knierim JJ, 2002, J NEUROSCI, V22, P6254; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; Mehta M. R., 1996, COMPUTATIONAL NEUROS, P741; Mehta MR, 2011, CELL, V147, P968, DOI 10.1016/j.cell.2011.11.005; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 2001, NEUROSCIENTIST, V7, P490, DOI 10.1177/107385840100700605; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Miller JF, 2013, SCIENCE, V342, P1111, DOI 10.1126/science.1244056; MULLER RU, 1987, J NEUROSCI, V7, P1951; Nitz DA, 2011, J NEUROPHYSIOL, V105, P1815, DOI 10.1152/jn.00573.2010; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Ravassard P, 2013, SCIENCE, V340, P1342, DOI 10.1126/science.1232655; Resnik E, 2012, J NEUROSCI, V32, P8952, DOI 10.1523/JNEUROSCI.6460-11.2012; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; Russell NA, 2006, J NEUROPHYSIOL, V96, P4, DOI 10.1152/jn.00953.2005; Save E, 2000, HIPPOCAMPUS, V10, P64, DOI 10.1002/(SICI)1098-1063(2000)10:1<64::AID-HIPO7>3.0.CO;2-Y; Schmidt-Hieber C, 2013, NAT NEUROSCI, V16, P325, DOI 10.1038/nn.3340; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; Stackman RW, 1997, J NEUROSCI, V17, P4349; Stackman RW, 2002, HIPPOCAMPUS, V12, P291, DOI 10.1002/hipo.1112; Terrazas A, 2005, J NEUROSCI, V25, P8085, DOI 10.1523/JNEUROSCI.0693-05.2005; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3	52	129	129	2	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2015	18	1					121	+		10.1038/nn.3884	http://dx.doi.org/10.1038/nn.3884			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX5WH	25420065	Green Submitted, Green Published			2022-12-17	WOS:000346995000019
J	Di Prisco, GV; Huang, W; Buffington, SA; Hsu, CC; Bonnen, PE; Placzek, A; Sidrauski, C; Krnjevic, K; Kaufman, RJ; Walter, P; Costa-Mattioli, M				Di Prisco, Gonzalo Viana; Huang, Wei; Buffington, Shelly A.; Hsu, Chih-Chun; Bonnen, Penelope E.; Placzek, AndonN; Sidrauski, Carmela; Krnjevic, Kresimir; Kaufman, Randal J.; Walter, Peter; Costa-Mattioli, Mauro			Translational control of mGluR-dependent long-term depression and object-place learning by eIF2 alpha	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; MENTAL-RETARDATION PROTEIN; SYNAPTIC PLASTICITY; IN-VIVO; GENERAL TRANSLATION; LTD; MEMORY; HIPPOCAMPUS; MECHANISMS; ACTIVATION	At hippocampal synapses, activation of group I metabotropic glutamate receptors (mGluRs) induces long-term depression (LTD), which requires new protein synthesis. However, the underlying mechanism remains elusive. Here we describe the translational program that underlies mGluR-LTD and identify the translation factor eIF2 alpha as its master effector. Genetically reducing eIF2 alpha phosphorylation, or specifically blocking the translation controlled by eIF2 alpha phosphorylation, prevented mGluR-LTD and the internalization of surface AMPA receptors (AMPARs). Conversely, direct phosphorylation of eIF2 alpha, bypassing mGluR activation, triggered a sustained LTD and removal of surface AMPARs. Combining polysome profiling and RNA sequencing, we identified the mRNAs translationally upregulated during mGluR-LTD. Translation of one of these mRNAs, oligophrenin-1, mediates the LTD induced by eIF2 alpha phosphorylation. Mice deficient in phospho-eIF2 alpha-mediated translation are impaired in object-place learning, a behavioral task that induces hippocampal mGluR-LTD in vivo. Our findings identify a new model of mGluR-LTD, which promises to be of value in the treatment of mGluR-LTD-linked cognitive disorders.	[Di Prisco, Gonzalo Viana; Huang, Wei; Buffington, Shelly A.; Hsu, Chih-Chun; Placzek, AndonN; Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Di Prisco, Gonzalo Viana; Huang, Wei; Buffington, Shelly A.; Hsu, Chih-Chun; Costa-Mattioli, Mauro] Baylor Coll Med, Memory & Brain Res Ctr, Houston, TX 77030 USA; [Bonnen, Penelope E.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Sidrauski, Carmela; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA USA; [Krnjevic, Kresimir] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Kaufman, Randal J.] Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of California System; University of California San Francisco; McGill University; Sanford Burnham Prebys Medical Discovery Institute	Costa-Mattioli, M (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	costamat@bcm.edu	Buffington, Shelly Alexandra/AAD-7637-2022	Buffington, Shelly Alexandra/0000-0001-7133-0064	US National Institutes of Health [NIMH 096816, NINDS 076708, DK042394, DK088227, HL052173]; Intellectual Disability Research Center [P30HD024064]; Dan L. Duncan Cancer Center [P30CA125123]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP100861]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, U54HD083092] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042394, R01DK088227, R01DK042394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076708] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intellectual Disability Research Center; Dan L. Duncan Cancer Center; Cancer Prevention and Research Institute of Texas (CPRIT); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Nakazawa and L. Van Aelst for the fPKR frozen embryos and Ophnl shRNA, respectively. This work was supported by grants from the US National Institutes of Health to M.C.-M. (NIMH 096816, NINDS 076708) and R.J.K. (DK042394, DK088227, HL052173), the Intellectual Disability Research Center (P30HD024064) and Dan L. Duncan Cancer Center (P30CA125123) Genomic and RNA Profiling Cores, and the Cancer Prevention and Research Institute of Texas (CPRIT) RP100861.	Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Gladding CM, 2009, PHARMACOL REV, V61, P395, DOI 10.1124/pr.109.001735; Goh JJ, 2013, CEREB CORTEX, V23, P1118, DOI 10.1093/cercor/bhs089; Goh JJ, 2013, HIPPOCAMPUS, V23, P129, DOI 10.1002/hipo.22072; Graber TE, 2013, P NATL ACAD SCI USA, V110, P16205, DOI 10.1073/pnas.1307747110; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010; Kasri NN, 2011, NEURON, V72, P300, DOI 10.1016/j.neuron.2011.09.001; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Ron D., 2007, TRANSLATIONAL CONTRO, V39, P345; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sung YJ, 2003, J BIOL CHEM, V278, P15669, DOI 10.1074/jbc.M211117200; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029	37	129	134	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2014	17	8					1073	1082		10.1038/nn.3754	http://dx.doi.org/10.1038/nn.3754			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AM1XA	24974795	Green Accepted			2022-12-17	WOS:000339641400013
J	Paz, JT; Bryant, AS; Peng, K; Fenno, L; Yizhar, O; Frankel, WN; Deisseroth, K; Huguenard, JR				Paz, Jeanne T.; Bryant, Astra S.; Peng, Kathy; Fenno, Lief; Yizhar, Ofer; Frankel, Wayne N.; Deisseroth, Karl; Huguenard, John R.			A new mode of corticothalamic transmission revealed in the Gria4(-/-) model of absence epilepsy	NATURE NEUROSCIENCE			English	Article							SELECTIVE GLUTAMATE RECEPTORS; THALAMIC RETICULAR NUCLEUS; SOMATOSENSORY THALAMUS; IN-VITRO; SYNAPTIC DISTRIBUTION; CORTICAL-NEURONS; WAVE DISCHARGES; BARREL CORTEX; RELAY CELLS; RAT	Cortico-thalamo-cortical circuits mediate sensation and generate neural network oscillations associated with slow-wave sleep and various epilepsies. Cortical input to sensory thalamus is thought to mainly evoke feed-forward synaptic inhibition of thalamocortical (TC) cells via reticular thalamic nucleus (nRT) neurons, especially during oscillations. This relies on a stronger synaptic strength in the cortico-nRT pathway than in the cortico-TC pathway, allowing the feed-forward inhibition of TC cells to overcome direct cortico-TC excitation. We found a systemic and specific reduction in strength in GluA4-deficient (Gria4(-/-)) mice of one excitatory synapse of the rhythmogenic cortico-thalamo-cortical system, the cortico-nRT projection, and observed that the oscillations could still be initiated by cortical inputs via the cortico-TC-nRT-TC pathway. These results reveal a previously unknown mode of cortico-thalamo-cortical transmission, bypassing direct cortico-nRT excitation, and describe a mechanism for pathological oscillation generation. This mode could be active under other circumstances, representing a previously unknown channel of cortico-thalamo-cortical information processing.	[Paz, Jeanne T.; Bryant, Astra S.; Peng, Kathy; Huguenard, John R.] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Fenno, Lief; Yizhar, Ofer; Deisseroth, Karl] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Frankel, Wayne N.] Jackson Lab, Bar Harbor, ME 04609 USA	Stanford University; Stanford University; Jackson Laboratory	Huguenard, JR (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA.	john.huguenard@stanford.edu	Huguenard, John/I-5016-2012; Huguenard, John/K-6429-2019; Fenno, Lief/AAK-2924-2020; Fenno, Lief/AAF-9638-2019; Ritter, Stefanie L/D-9312-2012; YIZHAR, OFER/AAV-8497-2021	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Bryant, Astra/0000-0002-0887-2044; Yizhar, Ofer/0000-0003-4228-1448	US National Institutes of Health; National Institute of Neurological Disorders and Stroke [NS34774, NS06477, NS031348]; DARPA; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034774, R01NS031348, R01NS034774, R01NS006477, R37NS031348] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Parada for her expert histology technical support and A. Herbert and S. Jin for their help with animal husbandry. We also thank T. Davidson for insightful discussions on the optogenetic approach and C. Lee for a generous help during virus injections. This work was supported by grants from the US National Institutes of Health and the National Institute of Neurological Disorders and Stroke (NS34774, NS06477 and NS031348), the DARPA REPAIR program and the Epilepsy Foundation.	AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; BAL T, 1995, J PHYSIOL-LONDON, V483, P665, DOI 10.1113/jphysiol.1995.sp020613; Bal T, 2000, J NEUROSCI, V20, P7478; Beenhakker MP, 2009, NEURON, V62, P612, DOI 10.1016/j.neuron.2009.05.015; BERNARDO KL, 1987, J COMP NEUROL, V258, P542, DOI 10.1002/cne.902580406; Beyer B, 2008, HUM MOL GENET, V17, P1738, DOI 10.1093/hmg/ddn064; Blumenfeld H, 2000, J NEUROSCI, V20, P5153; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bryant AS, 2009, J NEUROPHYSIOL, V102, P2880, DOI 10.1152/jn.00476.2009; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gentet LJ, 2003, J PHYSIOL-LONDON, V546, P801, DOI 10.1113/jphysiol.2002.032730; Golshani P, 2001, P NATL ACAD SCI USA, V98, P4172, DOI 10.1073/pnas.061013698; HOOGLAND PV, 1987, EXP BRAIN RES, V68, P73, DOI 10.1007/BF00255235; HUGUENARD JR, 1994, J NEUROSCI, V14, P5485; JONES EG, 1969, PROC R SOC SER B-BIO, V172, P173, DOI 10.1098/rspb.1969.0018; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; LIU XB, 1995, J COMP NEUROL, V352, P187, DOI 10.1002/cne.903520203; Liu XB, 1999, J COMP NEUROL, V414, P67; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Mineff EM, 2000, NEUROSCIENCE, V101, P969, DOI 10.1016/S0306-4522(00)00421-8; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; OHARA PT, 1985, J NEUROCYTOL, V14, P365, DOI 10.1007/BF01217752; Paz JT, 2010, J NEUROSCI, V30, P5465, DOI 10.1523/JNEUROSCI.5083-09.2010; Paz JT, 2007, J NEUROSCI, V27, P929, DOI 10.1523/JNEUROSCI.4677-06.2007; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pinault D, 1998, J PHYSIOL-LONDON, V509, P449, DOI 10.1111/j.1469-7793.1998.449bn.x; Pinault D, 2003, J PHYSIOL-LONDON, V552, P881, DOI 10.1113/jphysiol.2003.046573; PINAULT D, 1995, EUR J NEUROSCI, V7, P31, DOI 10.1111/j.1460-9568.1995.tb01017.x; Polack PO, 2007, J NEUROSCI, V27, P6590, DOI 10.1523/JNEUROSCI.0753-07.2007; Schofield CM, 2009, P NATL ACAD SCI USA, V106, P7630, DOI 10.1073/pnas.0811326106; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Sillito AM, 2002, PHILOS T R SOC B, V357, P1739, DOI 10.1098/rstb.2002.1170; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steriade M, 1998, Adv Neurol, V77, P105; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; STERIADE M, 1995, J NEUROSCI, V15, P623; Von Krosigk M, 1999, NEUROSCIENCE, V91, P7, DOI 10.1016/S0306-4522(98)00557-0; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; WARREN RA, 1994, J NEUROPHYSIOL, V72, P1993, DOI 10.1152/jn.1994.72.4.1993; WONGRILEY MTT, 1976, BRAIN RES, V108, P257, DOI 10.1016/0006-8993(76)90185-2	50	129	129	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1167	U225		10.1038/nn.2896	http://dx.doi.org/10.1038/nn.2896			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21857658	Green Accepted			2022-12-17	WOS:000294284900017
J	Jacob, C; Christen, CN; Pereira, JA; Somandin, C; Baggiolini, A; Lotscher, P; Ozcelik, M; Tricaud, N; Meijer, D; Yamaguchi, T; Matthias, P; Suter, U				Jacob, Claire; Christen, Carlos N.; Pereira, Jorge A.; Somandin, Christian; Baggiolini, Arianna; Loetscher, Pirmin; Oezcelik, Murat; Tricaud, Nicolas; Meijer, Dies; Yamaguchi, Teppei; Matthias, Patrick; Suter, Ueli			HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells	NATURE NEUROSCIENCE			English	Article							HISTONE DEACETYLASE INHIBITORS; PERIPHERAL NERVOUS-SYSTEM; BETA-CATENIN; GENE-EXPRESSION; DIFFERENTIATION; SOX10; REVEALS; MOUSE; REMYELINATION; PROGRESSION	Histone deacetylases (HDACs) are major epigenetic regulators. We show that HDAC1 and HDAC2 functions are critical for myelination of the peripheral nervous system. Using mouse genetics, we have ablated Hdac1 and Hdac2 specifically in Schwann cells, resulting in massive Schwann cell loss and virtual absence of myelin in mutant sciatic nerves. Expression of Sox10 and Krox20, the main transcriptional regulators of Schwann cell myelination, was greatly reduced. We demonstrate that in Schwann cells, HDAC1 and HDAC2 exert specific primary functions: HDAC2 activates the transcriptional program of myelination in synergy with Sox10, whereas HDAC1 controls Schwann cell survival by regulating the levels of active beta-catenin.	[Jacob, Claire; Christen, Carlos N.; Pereira, Jorge A.; Somandin, Christian; Baggiolini, Arianna; Loetscher, Pirmin; Oezcelik, Murat; Tricaud, Nicolas; Suter, Ueli] Swiss Fed Inst Technol, Dept Biol, Inst Cell Biol, Zurich, Switzerland; [Meijer, Dies] Erasmus Univ, Dept Cell Biol & Genet, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Yamaguchi, Teppei; Matthias, Patrick] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Erasmus University Rotterdam; Erasmus MC; Friedrich Miescher Institute for Biomedical Research; Novartis	Jacob, C (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Cell Biol, Zurich, Switzerland.	claire.jacob@cell.biol.ethz.ch; usuter@cell.biol.ethz.ch	Meijer, Dies/C-7786-2012; Suter, Ueli/A-1624-2010; Jacob, Claire/C-1485-2012	Meijer, Dies/0000-0002-8461-6341; Jacob, Claire/0000-0001-9567-3950; Tricaud, Nicolas/0000-0002-1620-4046; Baggiolini, Arianna/0000-0002-2476-561X	Swiss National Science Foundation (SNSF) [PMPDP3_122738/1]; Swiss National Center for Competence in Research (NCCR) Neural Plasticity and Repair; Novartis Research Foundation	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss National Center for Competence in Research (NCCR) Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Novartis Research Foundation	We thank M. Wegner (Universtat Erlangen-Nurnberg), E. Seto (Moffitt Cancer Center), S. Schreiber (Harvard University), Z. Werb and B. Welm (University of Utah), J. Crabtree (Stanford University), T. Reya (Duke University Medical Center), W. J. Pavan (US National Institutes of Health), A. McCallion and M. Prasad (Johns Hopkins University School of Medicine) and D. R. Colman (McGill University) for providing constructs and antibodies, T. Meier, W. Seufert and N. Mantei for critically reading the manuscript and the Functional Genomic Center Zurich for gene array analyses. These studies were supported by two Swiss National Science Foundation (SNSF) grants, a Marie-Heim Vogtlin subsidy (PMPDP3_122738/1) to C. Jacob, and another SNSF grant to U. Suter, and by a grant from the Swiss National Center for Competence in Research (NCCR) Neural Plasticity and Repair to U. Suter. The work in the laboratory of P. Matthias was supported by the Novartis Research Foundation.	Antonellis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000174; Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; Bordonaro M, 2007, EXP CELL RES, V313, P1652, DOI 10.1016/j.yexcr.2007.02.008; Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Dutton JR, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-105; Ferner RE, 2007, LANCET NEUROL, V6, P340, DOI 10.1016/S1474-4422(07)70075-3; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Ghazvini M, 2002, EMBO J, V21, P4612, DOI 10.1093/emboj/cdf475; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Jacob C, 2008, J CELL BIOL, V182, P519, DOI 10.1083/jcb.200710161; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Lindeboom F, 2003, NUCLEIC ACIDS RES, V31, P5405, DOI 10.1093/nar/gkg723; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; Pereira JA, 2009, J CELL BIOL, V185, P147, DOI 10.1083/jcb.200809008; Reiprich S, 2010, J NEUROCHEM, V112, P744, DOI 10.1111/j.1471-4159.2009.06498.x; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Ryu EJ, 2007, J NEUROSCI, V27, P11552, DOI 10.1523/JNEUROSCI.5497-06.2007; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Werner T, 2007, NUCLEIC ACIDS RES, V35, P6526, DOI 10.1093/nar/gkm727; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Zhang JM, 2002, NATURE, V420, P198, DOI 10.1038/nature01150; Zorick TS, 1999, DEVELOPMENT, V126, P1397; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	44	129	131	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					429	U53		10.1038/nn.2762	http://dx.doi.org/10.1038/nn.2762			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21423190				2022-12-17	WOS:000288849400013
J	Vaegter, CB; Jansen, P; Fjorback, AW; Glerup, S; Skeldal, S; Kjolby, M; Richner, M; Erdmann, B; Nyengaard, JR; Tessarollo, L; Lewin, GR; Willnow, TE; Chao, MV; Nykjaer, A				Vaegter, Christian B.; Jansen, Pernille; Fjorback, Anja W.; Glerup, Simon; Skeldal, Sune; Kjolby, Mads; Richner, Mette; Erdmann, Bettina; Nyengaard, Jens R.; Tessarollo, Lino; Lewin, Gary R.; Willnow, Thomas E.; Chao, Moses V.; Nykjaer, Anders			Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling	NATURE NEUROSCIENCE			English	Article							DORSAL-ROOT GANGLION; SENSORY NEURONS; NERVOUS-SYSTEM; BIOCHEMICAL-CHARACTERIZATION; TARGETED DISRUPTION; AXONAL-TRANSPORT; MICE LACKING; GENE; PROTEIN; BRAIN	Binding of target-derived neurotrophins to Trk receptors at nerve terminals is required to stimulate neuronal survival, differentiation, innervation and synaptic plasticity. The distance between the soma and nerve terminal is great, making efficient anterograde Trk transport critical for Trk synaptic translocation and signaling. The mechanism responsible for this trafficking remains poorly understood. Here we show that the sorting receptor sortilin interacts with TrkA, TrkB and TrkC and enables their anterograde axonal transport, thereby enhancing neurotrophin signaling. Cultured DRG neurons lacking sortilin showed blunted MAP kinase signaling and reduced neurite outgrowth upon stimulation with NGF. Moreover, deficiency for sortilin markedly aggravated TrkA, TrkB and TrkC phenotypes present in p75(NTR) knockouts, and resulted in increased embryonic lethality and sympathetic neuropathy in mice heterozygous for TrkA. Our findings demonstrate a role for sortilin as an anterograde trafficking receptor for Trk and a positive modulator of neurotrophin-induced neuronal survival.	[Vaegter, Christian B.; Jansen, Pernille; Glerup, Simon; Skeldal, Sune; Kjolby, Mads; Richner, Mette; Nykjaer, Anders] Aarhus Univ, Dept Med Biochem, Lundbeck Fdn, Res Ctr MIND, Aarhus, Denmark; [Fjorback, Anja W.; Nyengaard, Jens R.] Aarhus Univ, Stereol & Electron Microscopy Lab, Lundbeck Fdn, Res Ctr MIND, Aarhus, Denmark; [Erdmann, Bettina; Lewin, Gary R.; Willnow, Thomas E.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Tessarollo, Lino] NCI, Ctr Canc Res, Frederick, MD 21701 USA; [Chao, Moses V.] NYU, Sch Med, Skirball Inst Biomol Med, Kimmel Ctr, New York, NY USA	Aarhus University; Lundbeckfonden; Aarhus University; Lundbeckfonden; Helmholtz Association; Max Delbruck Center for Molecular Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University	Nykjaer, A (corresponding author), Aarhus Univ, Dept Med Biochem, Lundbeck Fdn, Res Ctr MIND, Aarhus, Denmark.	cv@biokemi.au.dk; an@biokemi.au.dk	Kjolby, Mads/ABB-4210-2020; Kjolby, Mads/F-3672-2011; Vægter, Christian Bjerggaard/A-7909-2008; Vægter, Christian Bjerggaard/AFW-0912-2022; Lewin, Gary R/B-8028-2011	Vægter, Christian Bjerggaard/0000-0001-6573-146X; Vægter, Christian Bjerggaard/0000-0001-6573-146X; Chao, Moses/0000-0002-6969-3744; Nykjaer, Anders/0000-0001-6422-6736; Kjolby, Mads/0000-0002-1043-6137; Willnow, Thomas/0000-0001-9515-7921; Lewin, Gary/0000-0002-2890-6352	Lundbeck Foundation; Danish Medical Research Council; Elvira and Rasmus Rissforts Foundation; MEMORIES (European Union); US National Institutes of Health [NS21072, AG025970, HD23315]; Deutsche Forschungsgemeinschaft; Danish Council for Strategic Research; Center for Stochastic Geometry and Advanced Bioimaging (Villum Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010390] Funding Source: NIH RePORTER; Villum Fonden [00008721] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Elvira and Rasmus Rissforts Foundation; MEMORIES (European Union)(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Center for Stochastic Geometry and Advanced Bioimaging (Villum Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Villum Fonden(Villum Fonden)	We thank L. Reichardt (University of California, San Francisco) for the TrkA antibody. The ImageJ KymoToolBox plug-in was kindly provided by F. Cordelieres (Universite Paris-Sud Orsay), and the NeuriteTracer plug-in by M. Pool (Rue University). This work was supported by the Lundbeck Foundation, The Danish Medical Research Council, Elvira and Rasmus Rissforts Foundation, MEMORIES (European Union, Framework Programme 6), US National Institutes of Health (NS21072, AG025970 and HD23315), the Deutsche Forschungsgemeinschaft, Danish Council for Strategic Research, and Center for Stochastic Geometry and Advanced Bioimaging (Villum Foundation).	Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Arnett MG, 2007, BRAIN RES, V1183, P32, DOI 10.1016/j.brainres.2007.09.051; Ascano M, 2009, J NEUROSCI, V29, P11674, DOI 10.1523/JNEUROSCI.1542-09.2009; Bergmann I, 1997, EUR J NEUROSCI, V9, P18, DOI 10.1111/j.1460-9568.1997.tb01349.x; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; CODERRE TJ, 1986, PAIN, V26, P61, DOI 10.1016/0304-3959(86)90174-0; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Gomes RA, 2006, J NEUROSCI, V26, P11487, DOI 10.1523/JNEUROSCI.2364-06.2006; Hermans-Borgmeyer I, 1999, MOL BRAIN RES, V65, P216, DOI 10.1016/S0169-328X(99)00022-4; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Holmes FE, 2000, P NATL ACAD SCI USA, V97, P11563, DOI 10.1073/pnas.210221897; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; HUBER LJ, 1995, DEV BIOL, V167, P227, DOI 10.1006/dbio.1995.1019; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Jenkins PM, 2009, J NEUROSCI, V29, P10541, DOI 10.1523/JNEUROSCI.1590-09.2009; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Minichiello L, 1995, DEVELOPMENT, V121, P4067; MU XJ, 1993, J NEUROSCI, V13, P4029; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Perez-Pinera P, 2008, NEUROSCI LETT, V433, P43, DOI 10.1016/j.neulet.2007.12.035; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Runeberg-Roos P, 2007, ANN MED, V39, P572, DOI 10.1080/07853890701646256; Russell FD, 2000, NEUROSCIENCE, V97, P575, DOI 10.1016/S0306-4522(00)00079-8; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Sokoloff AJ, 2007, MUSCLE NERVE, V36, P183, DOI 10.1002/mus.20797; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thang SH, 2000, J NEUROSCI, V20, P2917; Wallrabe H, 2003, BIOPHYS J, V85, P559, DOI 10.1016/S0006-3495(03)74500-7; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	50	129	136	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					54	U78		10.1038/nn.2689	http://dx.doi.org/10.1038/nn.2689			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21102451	Green Accepted			2022-12-17	WOS:000285684900014
J	Liu, C; Maejima, T; Wyler, SC; Casadesus, G; Herlitze, S; Deneris, ES				Liu, Chen; Maejima, Takashi; Wyler, Steven C.; Casadesus, Gemma; Herlitze, Stefan; Deneris, Evan S.			Pet-1 is required across different stages of life to regulate serotonergic function	NATURE NEUROSCIENCE			English	Article							TRANSPORTER MESSENGER-RNA; NORMAL ANXIETY-LIKE; NEURON DEVELOPMENT; RAPHE NEURONS; BEHAVIOR; STRESS; RAT; VULNERABILITY; PROJECTIONS; ACTIVATION	Transcriptional cascades are required for the specification of serotonin (5-HT) neurons and behaviors modulated by 5-HT. Several cascade factors are expressed throughout the lifespan, which suggests that their control of behavior might not be temporally restricted to programming normal numbers of 5-HT neurons. We used new mouse conditional targeting approaches to investigate the ongoing requirements for Pet-1 (also called Fev), a cascade factor that is required for the initiation of 5-HT synthesis, but whose expression persists into adulthood. We found that Pet-1 was required after the generation of 5-HT neurons for multiple steps in 5-HT neuron maturation, including axonal innervation of the somatosensory cortex, expression of appropriate firing properties, and the expression of the Htr1a and Htr1b autoreceptors. Pet-1 was still required in adult 5-HT neurons to preserve normal anxiety-related behaviors through direct autoregulated control of serotonergic gene expression. These findings indicate that Pet-1 is required across the lifespan of the mouse and that behavioral pathogenesis can result from both developmental and adult-onset alterations in serotonergic transcription.	[Liu, Chen; Maejima, Takashi; Wyler, Steven C.; Casadesus, Gemma; Herlitze, Stefan; Deneris, Evan S.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Deneris, ES (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	esd@case.edu		Casadesus, Gemma/0000-0002-5206-5637; Liu, Chen/0000-0002-5922-0951	US National Institutes of Health [MH062723, MH078028]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH078028, R01MH062723] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank L. Landmesser for suggestions on retrograde tracing; S. Dymecki and P. Chambon for CreER<SUP>T2</SUP> plasmids; Q. Ma for the mycPet-1 vector; J. Zhu for the Gata3<SUP>loxP/loxP</SUP> mice; K. Lobur for assistance with genotyping of mice; J. Reeves for behavioral testing in the Case Rodent Behavior Core; and L. Landmesser, S. Maricich and J. Silver for comments on the manuscript. This work was supported by grants MH062723 and MH078028 to E.S.D. (US National Institutes of Health).	Ansorge MS, 2007, CURR OPIN PHARMACOL, V7, P8, DOI 10.1016/j.coph.2006.11.006; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Bayliss DA, 1997, J NEUROPHYSIOL, V77, P1349, DOI 10.1152/jn.1997.77.3.1349; Bonnin A, 2006, NEUROSCIENCE, V141, P781, DOI 10.1016/j.neuroscience.2006.04.036; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; Cordes SP, 2005, CLIN GENET, V68, P487, DOI 10.1111/j.1399-0004.2005.00534.x; Craven SE, 2004, DEVELOPMENT, V131, P1165, DOI 10.1242/dev.01024; Dai JX, 2008, P NATL ACAD SCI USA, V105, P11981, DOI 10.1073/pnas.0801329105; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; FORNAL CA, 1994, J PHARMACOL EXP THER, V270, P1345; Gardner KL, 2009, BRAIN RES, V1305, P47, DOI 10.1016/j.brainres.2009.09.065; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Hendricks T, 1999, J NEUROSCI, V19, P10348; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Holmes A, 2008, NEUROSCI BIOBEHAV R, V32, P1293, DOI 10.1016/j.neubiorev.2008.03.006; Jacob J, 2007, NAT NEUROSCI, V10, P1433, DOI 10.1038/nn1985; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Janusonis S, 2004, J NEUROSCI, V24, P1652, DOI 10.1523/JNEUROSCI.4651-03.2004; Krueger KC, 2008, J NEUROSCI, V28, P12748, DOI 10.1523/JNEUROSCI.4349-08.2008; Le Francois B, 2008, NEUROPHARMACOLOGY, V55, P977, DOI 10.1016/j.neuropharm.2008.06.046; Lerch-Haner JK, 2008, NAT NEUROSCI, V11, P1001, DOI 10.1038/nn.2176; LIDOV HGW, 1982, BRAIN RES BULL, V8, P389, DOI 10.1016/0361-9230(82)90077-6; Ludwig V, 2007, J NEUROSCI METH, V162, P108, DOI 10.1016/j.jneumeth.2006.12.011; Maciag D, 2006, NEUROPSYCHOPHARMACOL, V31, P47, DOI 10.1038/sj.npp.1300823; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pum ME, 2009, BEHAV NEUROSCI, V123, P449, DOI 10.1037/a0014478; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Rivera HM, 2009, BRAIN RES, V1259, P51, DOI 10.1016/j.brainres.2008.12.067; Salichon N, 2001, J NEUROSCI, V21, P884, DOI 10.1523/JNEUROSCI.21-03-00884.2001; Sari Y, 2004, NEUROSCI BIOBEHAV R, V28, P565, DOI 10.1016/j.neubiorev.2004.08.008; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Scott MM, 2005, INT J DEV NEUROSCI, V23, P277, DOI 10.1016/j.ijdevneu.2004.05.012; Scott MM, 2005, J NEUROSCI, V25, P2628, DOI 10.1523/JNEUROSCI.4979-04.2005; Shishkina GT, 2007, NEUROSCIENCE, V150, P404, DOI 10.1016/j.neuroscience.2007.09.017; Sommer W, 2001, NEUROPSYCHOPHARMACOL, V24, P430, DOI 10.1016/S0893-133X(00)00210-4; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; Vertes RP, 1999, J COMP NEUROL, V407, P555; Vitalis T, 2007, EUR J NEUROSCI, V26, P331, DOI 10.1111/j.1460-9568.2007.05661.x; Vogt MA, 2008, EXP NEUROL, V211, P25, DOI 10.1016/j.expneurol.2007.12.012; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	47	129	130	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1190	1198		10.1038/nn.2623	http://dx.doi.org/10.1038/nn.2623			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20818386	Green Submitted, Green Accepted			2022-12-17	WOS:000282171300010
J	Vrontou, E; Nilsen, SP; Demir, E; Kravitz, EA; Dickson, BJ				Vrontou, Eleftheria; Nilsen, Steven P.; Demir, Ebru; Kravitz, Edward A.; Dickson, Barry J.			fruitless regulates aggression and dominance in Drosophila	NATURE NEUROSCIENCE			English	Article							MALE SEXUAL-BEHAVIOR; MELANOGASTER; GENE; ORIENTATION; PATHWAY	When competing for resources, two Drosophila melanogaster flies of the same sex fight each other. Males and females fight with distinctly different styles, and males but not females establish dominance relationships. Here we show that sex-specific splicing of the fruitless gene plays a critical role in determining who and how a fly fights, and whether a dominance relationship forms.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Harvard University; Harvard Medical School	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X	NIGMS NIH HHS [GM067645, GM072411] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067645, F32GM072411] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; HOFFMANN AA, 1987, ANIM BEHAV, V35, P807, DOI 10.1016/S0003-3472(87)80117-3; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; JACOBS ME, 1960, ECOLOGY, V41, P182, DOI 10.2307/1931952; Lee G, 2000, BEHAV GENET, V30, P263, DOI 10.1023/A:1026541215546; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259	13	129	130	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1469	1471		10.1038/nn1809	http://dx.doi.org/10.1038/nn1809			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115036				2022-12-17	WOS:000242404000007
J	Fisher, PM; Meltzer, CC; Ziolko, SK; Price, JC; Hariri, AR				Fisher, P. M.; Meltzer, C. C.; Ziolko, S. K.; Price, J. C.; Hariri, A. R.			Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity	NATURE NEUROSCIENCE			English	Article							GENETIC-VARIATION; MAJOR DEPRESSION; MICE LACKING; POLYMORPHISM; BINDING	We examined the contribution of 5-HT1A autoreceptors ( with [ C-11] WAY100635 positron emission tomography) to amygdala reactivity ( with blood oxygenation level - dependent functional magnetic resonance imaging) in 20 healthy adult volunteers. We found a significant inverse relationship wherein 5-HT1A autoreceptor density predicted a notable 30 - 44% of the variability in amygdala reactivity. Our data suggest a potential molecular mechanism by which a reduced capacity for negative feedback regulation of 5-HT release is associated with increased amygdala reactivity.	Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hariri, AR (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA.	haririar@upmc.edu	Hariri, Ahmad/D-5761-2011; Fisher, Patrick MacDonald/V-8158-2017	Fisher, Patrick MacDonald/0000-0002-8115-0611	NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH072837, R01MH079164, K24MH064625, R01MH067602] Funding Source: NIH RePORTER; NIMH NIH HHS [MH64625, R01 MH067602, MH072837, MH067602, K24 MH064625, R01 MH079164] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arborelius L, 1999, IDrugs, V2, P121; Blier P, 1999, NEUROPSYCHOPHARMACOL, V21, pS91, DOI 10.1016/S0893-133X(99)00036-6; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; David SP, 2005, J NEUROSCI, V25, P2586, DOI 10.1523/JNEUROSCI.3769-04.2005; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lemonde S, 2004, INT J NEUROPSYCHOPH, V7, P501, DOI 10.1017/S1461145704004699; Lemonde S, 2003, J NEUROSCI, V23, P8788; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Parsey RV, 2006, BIOL PSYCHIAT, V59, P106, DOI 10.1016/j.biopsych.2005.06.016	12	129	130	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1362	1363		10.1038/nn1780	http://dx.doi.org/10.1038/nn1780			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17013380				2022-12-17	WOS:000242403800010
J	Paz, R; Pelletier, JG; Bauer, EP; Pare, D				Paz, Rony; Pelletier, Joe Guillaume; Bauer, Elizabeth P.; Pare, Denis			Emotional enhancement of memory via amygdala-driven facilitation of rhinal interactions	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; PERIRHINAL CORTEX; BASOLATERAL AMYGDALA; ENTORHINAL CORTEX; GLUCOCORTICOID ENHANCEMENT; NORADRENERGIC ACTIVATION; NEOCORTICAL INPUTS; DECLARATIVE MEMORY; LONG-TERM; HIPPOCAMPAL	Emotions generally facilitate memory, an effect mediated by the basolateral amygdala (BLA). To study the underlying mechanisms, we recorded BLA, perirhinal and entorhinal neurons during an appetitive trace-conditioning task. We focused on the rhinal cortices because they constitute the interface between the hippocampus, a mediator of memory consolidation, and the neocortex, the storage site of declarative memories. We found that, after unexpected rewards, BLA activity increased impulse transmission from perirhinal to entorhinal neurons and that this effect decayed as the association between conditioned stimuli and rewards was learned. At this late phase of learning, the BLA effect occurred when the animals were anticipating the reward. By enhancing the processing of sensory cues, the BLA-mediated facilitation of rhinal interactions may explain how the amygdala promotes memory formation in emotional conditions.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Pare, D (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	rony.paz@gmail.com; pare@axon.rutgers.edu			NIMH NIH HHS [R01 MH-073610, MH-066856] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073610, R01MH066856] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adolphs R, 2005, NAT NEUROSCI, V8, P512, DOI 10.1038/nn1413; Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Biella G, 2002, J NEUROSCI, V22, P9972; Brown MW, 2002, PHILOS T R SOC B, V357, P1083, DOI 10.1098/rstb.2002.1097; Buckley MJ, 1998, NEUROPSYCHOLOGIA, V36, P535, DOI 10.1016/S0028-3932(97)00120-6; BURWELL RD, 2002, PARAHIPPOCAMPAL REGI, P53; Bussey TJ, 2002, EUR J NEUROSCI, V15, P365, DOI 10.1046/j.0953-816x.2001.01851.x; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Christianson S. A., 1992, HDB EMOTION MEMORY C; de Curtis M, 2004, PROG NEUROBIOL, V74, P101, DOI 10.1016/j.pneurobio.2004.08.005; DEDOUX JE, 2000, ANNU REV NEUROSCI, V23, P155; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; Ferry B, 1999, BIOL PSYCHIAT, V46, P1140, DOI 10.1016/S0006-3223(99)00157-2; Ferry B, 1999, BEHAV NEUROSCI, V113, P118, DOI 10.1037/0735-7044.113.1.118; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Kajiwara R, 2003, J NEUROPHYSIOL, V89, P2176, DOI 10.1152/jn.01033.2002; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Luft T, 2004, NEUROBIOL LEARN MEM, V82, P52, DOI 10.1016/j.nlm.2004.03.002; MCGAUGH JL, 1990, NEUROSCI BIOBEHAV R, V14, P425, DOI 10.1016/S0149-7634(05)80065-X; Muir GM, 2003, HIPPOCAMPUS, V13, P93, DOI 10.1002/hipo.10052; Munera A, 2000, NEUROSCI LETT, V292, P33, DOI 10.1016/S0304-3940(00)01430-0; MURRAY EA, 1986, J NEUROSCI, V6, P1991; Murray EA, 2005, Q J EXP PSYCHOL-B, V58, P378, DOI 10.1080/02724990544000077; PACKARD MG, 1994, P NATL ACAD SCI USA, V91, P8477, DOI 10.1073/pnas.91.18.8477; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; Pelletier JG, 2005, J NEUROPHYSIOL, V94, P1837, DOI 10.1152/jn.00260.2005; Pelletier JG, 2005, LEARN MEMORY, V12, P96, DOI 10.1101/lm.88605; Pelletier JG, 2004, J NEUROPHYSIOL, V91, P2079, DOI 10.1152/jn.01197.2003; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pinto A, 2006, J COMP NEUROL, V495, P722, DOI 10.1002/cne.20905; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Quirarte GL, 1997, P NATL ACAD SCI USA, V94, P14048, DOI 10.1073/pnas.94.25.14048; Roesler R, 2002, EUR J NEUROSCI, V15, P905, DOI 10.1046/j.1460-9568.2002.01924.x; Roozendaal B, 1996, NEUROBIOL LEARN MEM, V65, P1, DOI 10.1006/nlme.1996.0001; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Ryou JW, 2001, NEUROBIOL LEARN MEM, V75, P121, DOI 10.1006/nlme.2000.3966; Seager MA, 1999, BEHAV BRAIN RES, V100, P143, DOI 10.1016/S0166-4328(98)00123-5; SMITH Y, 1994, J COMP NEUROL, V342, P232, DOI 10.1002/cne.903420207; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Suzuki WA, 2000, ANN NY ACAD SCI, V911, P175; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; WITTER MP, 1986, J COMP NEUROL, V252, P1, DOI 10.1002/cne.902520102	50	129	130	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1321	1329		10.1038/nn1771	http://dx.doi.org/10.1038/nn1771			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	098BB	16964249				2022-12-17	WOS:000241493900026
J	Lamsa, K; Heeroma, JH; Kullmann, DM				Lamsa, K; Heeroma, JH; Kullmann, DM			Hebbian LTP in feed-forward inhibitory interneurons and the temporal fidelity of input discrimination	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT HIPPOCAMPAL SLICES; EXCITATORY SYNAPSES; SYNAPTIC PLASTICITY; DENDRITIC SPINES; CA1 NEURONS; CELL; FORM; EXCITABILITY; MECHANISMS	Cortical information processing requires a delicate balance of excitatory and inhibitory signaling. How is this balance preserved during hippocampal memory encoding, which involves NMDA receptor-dependent long term potentiation (LTP)? This form of LTP occurs at synapses between pyramidal neurons but has not been detected in feed-forward inhibitory interneurons. We show that paired pre- and postsynaptic activity evokes pathway-specific LTP in half of rat stratum radiatum interneurons if cytoplasmic integrity is preserved. LTP occurs in aspiny feed-forward interneurons and propagates to pyramidal neurons as an enhancement of disynaptic inhibition. We also show that when LTP is restricted to synapses on pyramidal neurons, the temporal fidelity of synaptic integration and action potential generation in pyramidal cells is compromised. However, when LTP also occurs at synapses on feed-forward interneurons, temporal fidelity is preserved. We propose that Hebbian LTP at synapses driving disynaptic inhibition is necessary to maintain information processing without degradation during memory encoding.	UCL, Inst Neurol, London WC1N 3BG, England	University of London; University College London	Kullmann, DM (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009; Lamsa, Karri/T-2025-2019; Heeroma, Joost/AAF-4310-2022; Heeroma, Joost/AFI-8727-2022; Heeroma, Joost/C-1749-2008	Kullmann, Dimitri M/0000-0001-6696-3545; Lamsa, Karri/0000-0002-4609-1337				ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; ASZTELY F, 1994, HIPPOCAMPUS, V4, P148, DOI 10.1002/hipo.450040205; Bauer EP, 2004, J NEUROSCI, V24, P9507, DOI 10.1523/JNEUROSCI.3567-04.2004; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Christie BR, 2000, HIPPOCAMPUS, V10, P673, DOI 10.1002/1098-1063(2000)10:6<673::AID-HIPO1005>3.0.CO;2-O; Cowan AI, 1998, J NEUROPHYSIOL, V79, P13, DOI 10.1152/jn.1998.79.1.13; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P67, DOI 10.1113/jphysiol.2003.042598; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Gulyas AI, 1998, EUR J NEUROSCI, V10, P3813, DOI 10.1046/j.1460-9568.1998.00402.x; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; Kaiser KMM, 2004, J NEUROSCI, V24, P1319, DOI 10.1523/JNEUROSCI.2852-03.2004; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Laezza F, 2004, J NEUROPHYSIOL, V92, P3575, DOI 10.1152/jn.00425.2004; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Maccaferri G, 1996, J NEUROSCI, V16, P5334; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Marder CP, 2004, J NEUROSCI, V24, P8873, DOI 10.1523/JNEUROSCI.2661-04.2004; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; McBain CJ, 1999, TRENDS NEUROSCI, V22, P228, DOI 10.1016/S0166-2236(98)01347-2; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; Nyiri G, 2003, NEUROSCIENCE, V119, P347, DOI 10.1016/S0306-4522(03)00157-X; OUARDOUZ M, 1995, J NEUROPHYSIOL, V73, P810, DOI 10.1152/jn.1995.73.2.810; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Sourdet V, 2003, J NEUROSCI, V23, P10238; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; WIGSTROM H, 1986, J PHYSIOL-PARIS, V81, P228; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609	42	129	131	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					916	924		10.1038/nn1486	http://dx.doi.org/10.1038/nn1486			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15937481				2022-12-17	WOS:000230137100019
J	Gerachshenko, T; Blackmer, T; Yoon, EJ; Bartleson, C; Hamm, HE; Alford, S				Gerachshenko, T; Blackmer, T; Yoon, EJ; Bartleson, C; Hamm, HE; Alford, S			G beta gamma acts at the C terminus of SNAP-25 to mediate presynaptic inhibition	NATURE NEUROSCIENCE			English	Article							G-PROTEIN MODULATION; BLOCK NEUROTRANSMITTER RELEASE; DEPENDENT CALCIUM CHANNELS; BOTULINUM NEUROTOXIN-A; TRANSMITTER RELEASE; CLOSTRIDIAL NEUROTOXINS; FUSION COMPLEX; GLUTAMATERGIC TRANSMISSION; ANGSTROM RESOLUTION; MEMBRANE-FUSION	Presynaptic inhibition mediated by G protein-coupled receptors may involve a direct interaction between G proteins and the vesicle fusion machinery. The molecular target of this pathway is unknown. We demonstrate that G beta gamma-mediated presynaptic inhibition in lamprey central synapses occurs downstream from voltage-gated Ca2+ channels. Using presynaptic microinjections of botulinum toxins (BoNTs) during paired recordings, we find that cleavage of synaptobrevin in unprimed vesicles leads to an eventual exhaustion of synaptic transmission but does not prevent G beta gamma-mediated inhibition. In contrast, cleavage of the C-terminal nine amino acids of the 25 kDa synaptosome-associated protein (SNAP-25) by BoNT A prevents G beta gamma-mediated inhibition. Moreover, a peptide containing the region of SNAP-25 cleaved by BoNT A blocks the G beta gamma inhibitory effect. Finally, removal of the last nine amino acids of the C-terminus of SNAP-25 weakens G beta gamma interactions with soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complexes. Thus, the C terminus of SNAP-25, which links synaptotagmin I to the SNARE complex, may represent a target of G beta gamma for presynaptic inhibition.	Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University	Alford, S (corresponding author), Univ Illinois, Dept Biol Sci, 840 W Taylor, Chicago, IL 60607 USA.	heidi.hamm@mcmail.vanderbilt.edu; sta@uic.edu	Hamm, Heidi E/G-2374-2014	Alford, Simon/0000-0002-0454-4246				AHNERTHILGER G, 1995, PROG NEUROBIOL, V46, P83, DOI 10.1016/0301-0082(95)00003-E; Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; BINZ T, 1994, J BIOL CHEM, V269, P1617; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Blanes-Mira C, 2003, BIOCHEM J, V375, P159, DOI 10.1042/BJ20030509; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BRODIN L, 1994, ADV SEC MESS PHOSPH, V29, P205; BRODIN L, 1988, ARCH ITAL BIOL, V126, P317; BRODIN L, 1986, NEUROSCI LETT, V67, P53, DOI 10.1016/0304-3940(86)90207-7; Bruns D, 1997, J NEUROSCI, V17, P1898; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DOLPHIN AC, 1993, BIOCHEM SOC T, V21, P391, DOI 10.1042/bst0210391; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Gustafsson JS, 2002, J COMP NEUROL, V450, P167, DOI 10.1002/cne.10310; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hanson MA, 2000, NAT STRUCT BIOL, V7, P687, DOI 10.1038/77997; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HOLZ GG, 1989, J NEUROSCI, V9, P657; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; Kajikawa Y, 2001, P NATL ACAD SCI USA, V98, P8054, DOI 10.1073/pnas.141031298; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; MULKEY RM, 1993, J PHYSIOL-LONDON, V462, P243, DOI 10.1113/jphysiol.1993.sp019553; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; OTTO H, 1995, BIOCHEM BIOPH RES CO, V212, P945, DOI 10.1006/bbrc.1995.2061; PELLEGRINI LL, 1994, FEBS LETT, V353, P319, DOI 10.1016/0014-5793(94)01070-6; PHILLIPS WJ, 1991, J BIOL CHEM, V266, P11017; Pinxteren JA, 1998, EMBO J, V17, P6210, DOI 10.1093/emboj/17.21.6210; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schibeci R, 1999, J MED ETHICS, V25, P335, DOI 10.1136/jme.25.4.335; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; Schwartz EJ, 2005, J NEUROPHYSIOL, V93, P980, DOI 10.1152/jn.00669.2004; SHUPLIAKOV O, 1995, EUR J NEUROSCI, V7, P1111, DOI 10.1111/j.1460-9568.1995.tb01099.x; SILINSKY EM, 1992, J PHYSIOL-LONDON, V457, P315, DOI 10.1113/jphysiol.1992.sp019380; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takahashi M, 2001, J PHYSIOL-LONDON, V532, P323, DOI 10.1111/j.1469-7793.2001.0323f.x; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Wei SH, 2000, EMBO J, V19, P1279, DOI 10.1093/emboj/19.6.1279; Williamson LC, 1996, J BIOL CHEM, V271, P7694, DOI 10.1074/jbc.271.13.7694; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	50	129	133	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					597	605		10.1038/nn1439	http://dx.doi.org/10.1038/nn1439			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15834421				2022-12-17	WOS:000228895100020
J	Muzio, L; DiBenedetto, B; Stoykova, A; Boncinelli, E; Gruss, P; Mallamaci, A				Muzio, L; DiBenedetto, B; Stoykova, A; Boncinelli, E; Gruss, P; Mallamaci, A			Conversion of cerebral cortex into basal ganglia in Emx2(-/-) Pax6(Sey/Sey) double-mutant mice	NATURE NEUROSCIENCE			English	Article							DORSAL TELENCEPHALON; TRANSCRIPTION FACTOR; AREA IDENTITY; GENE; MOUSE; NEURONS; EMX2; EXPRESSION; PAX6; HOMEODOMAIN	The molecular mechanisms that activate morphogenesis of cerebral cortex are currently the subject of intensive experimental analysis. Transcription factor genes of the homeobox, basic helix-loop-helix (bHLH) and zinc-finger families have recently been shown to have essential roles in this process. However, the actual selector genes activating corticogenesis have not yet been identified. Here we show that high-level expression of at least one functional allele of either of the homeobox genes Emx2 or Pax6 in the dorsal telencephalon is necessary and sufficient to stably activate morphogenesis of cerebral cortex and to repress that of adjacent structures, such as striatum.	Ist Sci H San Raffaele, Dept Biol & Technol Res DIBIT, I-20132 Milan, Italy; Max Planck Inst Biophys Chem, D-37018 Gottingen, Germany; Scuola Int Super Studi Avanzati, I-34014 Trieste, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Max Planck Society; International School for Advanced Studies (SISSA)	Mallamaci, A (corresponding author), Ist Sci H San Raffaele, Dept Biol & Technol Res DIBIT, Via Olgettina 58, I-20132 Milan, Italy.	mallamaci.antonio@hsr.it	Di Benedetto, Barbara/B-7190-2016; Muzio, Luca/AAB-2308-2022; Mallamaci, Antonello/A-2975-2015; Di Benedetto, Barbara/E-2315-2013	Di Benedetto, Barbara/0000-0001-6537-9072; Muzio, Luca/0000-0002-1068-865X; Mallamaci, Antonello/0000-0002-3621-1307; 				Ajiro K, 1996, J BIOL CHEM, V271, P13197, DOI 10.1074/jbc.271.22.13197; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Briata P, 1996, MECH DEVELOP, V57, P169, DOI 10.1016/0925-4773(96)00544-8; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Caric D, 1997, DEVELOPMENT, V124, P5087; Chapouton P, 1999, DEVELOPMENT, V126, P5569; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Dou CL, 1999, CEREB CORTEX, V9, P543, DOI 10.1093/cercor/9.6.543; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Fode C, 2000, GENE DEV, V14, P67; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Grove EA, 1998, DEVELOPMENT, V125, P2315; HALL PA, 1990, CELL TISSUE KINET, V23, P505, DOI 10.1111/j.1365-2184.1990.tb01343.x; Hallonet M, 1998, DEVELOPMENT, V125, P2599; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Inoue T, 2001, DEVELOPMENT, V128, P561; Kohtz JD, 1998, DEVELOPMENT, V125, P5079; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee SMK, 2000, DEVELOPMENT, V127, P457; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Shimamura K, 1997, DEVELOPMENT, V124, P2709; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; Stoykova A, 2000, J NEUROSCI, V20, P8042; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Sussel L, 1999, DEVELOPMENT, V126, P3359; Takahashi T, 1996, J NEUROSCI, V16, P5762; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Theil T, 1999, DEVELOPMENT, V126, P3561; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tole S, 2000, J NEUROSCI, V20, P2618; Tole S, 2000, DEV BIOL, V217, P254, DOI 10.1006/dbio.1999.9509; Toresson H, 2000, DEVELOPMENT, V127, P4361; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Warren N, 1999, CEREB CORTEX, V9, P627, DOI 10.1093/cercor/9.6.627; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Yoshida M, 1997, DEVELOPMENT, V124, P101; Yun K, 2001, DEVELOPMENT, V128, P193	50	129	130	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					737	745		10.1038/nn892	http://dx.doi.org/10.1038/nn892			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12118260	Green Published			2022-12-17	WOS:000177088900016
J	Geisler, WS; Kersten, D				Geisler, WS; Kersten, D			Illusions, perception and Bayes	NATURE NEUROSCIENCE			English	Editorial Material								A new model shows that a range of visual illusions in humans can be explained as rational inferences about the odds that a motion stimulus on the retina results from a particular real-world source.	Univ Texas, Ctr Perceptual Syst, Austin, TX 78712 USA; Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Texas System; University of Texas Austin; University of Minnesota System; University of Minnesota Twin Cities	Geisler, WS (corresponding author), Univ Texas, Ctr Perceptual Syst, Seay Psychol Bldg, Austin, TX 78712 USA.			Geisler, Wilson/0000-0003-4630-6614				Bloj MG, 1999, NATURE, V402, P877, DOI 10.1038/47245; Brainard DH, 1997, J OPT SOC AM A, V14, P1393, DOI 10.1364/JOSAA.14.001393; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; GEISLER WS, 1989, PSYCHOL REV, V96, P267, DOI 10.1037/0033-295X.96.2.267; Geisler WS, 2002, PHILOS T R SOC B, V357, P419, DOI 10.1098/rstb.2001.1055; Kersten D, 1999, NEW COGNITIVE NEUROS, P353; Knill D. C., 1996, PERCEPTION BAYESIAN, P1, DOI [10.1017/cbo9780511984037, DOI 10.1017/CBO9780511984037, 10.1017/CBO9780511984037]; Liu ZL, 1998, VISION RES, V38, P2507, DOI 10.1016/S0042-6989(98)00063-7; MAMASSIAN P, 2002, STAT THEORIES BRAIN, P13; Saunders JA, 2001, VISION RES, V41, P3163, DOI 10.1016/S0042-6989(01)00187-0; Schrater PR, 2000, INT J COMPUT VISION, V40, P73, DOI 10.1023/A:1026557704054; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Yuille A. L., 1996, PERCEPTION BAYESIAN, P123, DOI DOI 10.1017/CBO9780511984037.006	15	129	131	0	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					508	510		10.1038/nn0602-508	http://dx.doi.org/10.1038/nn0602-508			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12037517				2022-12-17	WOS:000175874600005
J	Lumeng, C; Phelps, S; Crawford, GE; Walden, PD; Barald, K; Chamberlain, JS				Lumeng, C; Phelps, S; Crawford, GE; Walden, PD; Barald, K; Chamberlain, JS			Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases	NATURE NEUROSCIENCE			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; DUCHENNE MUSCULAR-DYSTROPHY; CENTRAL-NERVOUS-SYSTEM; SKELETAL-MUSCLE SARCOLEMMA; NITRIC-OXIDE SYNTHASE; POSTSYNAPTIC DENSITY; PDZ DOMAINS; RAT-BRAIN; DEFICIENT MICE; PROTEIN	A screen for proteins that interact with beta 2-syntrophin led to the isolation of MAST205 (microtubule-associated serine/threonine kinase-205 kD) and a newly identified homologue, SAST (syntrophin-associated serine/threonine kinase). Binding studies showed that beta 2-syntrophin and MAST205/SAST associated via a PDZ-PDZ domain interaction. MAST205 colocalized with beta 2-syntrophin and utrophin at neuromuscular junctions. SAST colocalized with syntrophin in cerebral vasculature, spermatic acrosomes and neuronal processes. SAST and syntrophin were highly associated with purified microtubules and microtubule-associated proteins, whereas utrophin and dystrophin were only partially associated with microtubules. Our data suggest that MAST205 and SAST link the dystrophin/utrophin network with microtubule filaments via the syntrophins.	Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Mol & Cellular Biol Program, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Gene Therapy, Ann Arbor, MI 48109 USA; NYU, Sch Med, Dept Urol, New York, NY 10016 USA; Univ Michigan, Sch Med, Dept Anat & Cell Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; New York University; University of Michigan System; University of Michigan	Chamberlain, JS (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.	chamberl@umich.edu		Lumeng, Carey/0000-0003-0303-6204; Chamberlain, Jeffrey/0000-0001-5299-0059	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044533, P60AR020557] Funding Source: NIH RePORTER; NIAMS NIH HHS [P60AR20557, AR44533] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADAMS ME, 1995, J BIOL CHEM, V270, P25859, DOI 10.1074/jbc.270.43.25859; ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; AHN AH, 1995, J CELL BIOL, V128, P363, DOI 10.1083/jcb.128.3.363; Amalfitano Andrea, 1997, P1; BARALD KF, 1989, DEV BIOL, V135, P349, DOI 10.1016/0012-1606(89)90185-1; Brenman JE, 1997, CURR OPIN NEUROBIOL, V7, P374, DOI 10.1016/S0959-4388(97)80065-7; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1998, J NEUROSCI, V18, P8805; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COX GA, 1994, NAT GENET, V8, P333, DOI 10.1038/ng1294-333; Crosbie RH, 1997, J BIOL CHEM, V272, P31221, DOI 10.1074/jbc.272.50.31221; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Gee SH, 1998, J NEUROSCI, V18, P128; Grady RM, 1997, J CELL BIOL, V136, P871, DOI 10.1083/jcb.136.4.871; JASMIN BJ, 1990, NATURE, V344, P673, DOI 10.1038/344673a0; KAMAKURA K, 1994, J NEUROSCI RES, V37, P728, DOI 10.1002/jnr.490370607; KIM TW, 1992, P NATL ACAD SCI USA, V89, P11642, DOI 10.1073/pnas.89.23.11642; KIRSCH J, 1995, J NEUROSCI, V15, P4148; LIDOV HGW, 1990, NATURE, V348, P725, DOI 10.1038/348725a0; LIDOV HGW, 1993, NEUROSCIENCE, V54, P167, DOI 10.1016/0306-4522(93)90392-S; Lin JW, 1998, J NEUROSCI, V18, P2017; Lumeng CN, 1999, HUM MOL GENET, V8, P593, DOI 10.1093/hmg/8.4.593; MAN NT, 1991, J CELL BIOL, V115, P1695; Mummery R, 1996, J NEUROCHEM, V66, P2455; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Rafael JA, 1996, J CELL BIOL, V134, P93, DOI 10.1083/jcb.134.1.93; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; SUNADA Y, 1995, CURR OPIN NEUROL, V8, P379, DOI 10.1097/00019052-199510000-00010; TALIAN JC, 1983, J CELL BIOL, V97, P1277, DOI 10.1083/jcb.97.4.1277; UCHINO M, 1994, MUSCLE NERVE, V17, P533, DOI 10.1002/mus.880170511; VALLEE RB, 1986, METHOD ENZYMOL, V134, P89; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; WAGNER KR, 1994, J NEUROCHEM, V62, P1947; WAGNER KR, 1993, NEURON, V10, P511, DOI 10.1016/0896-6273(93)90338-R; WALDEN PD, 1993, MOL CELL BIOL, V13, P7625, DOI 10.1128/MCB.13.12.7625; Walden PD, 1996, BIOL REPROD, V55, P1039, DOI 10.1095/biolreprod55.5.1039; Willis SA, 1996, MOL ENDOCRINOL, V10, P367, DOI 10.1210/me.10.4.367; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2; Zimmerman CM, 1996, BIOCHEM SOC SYMP, P25	48	129	137	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					611	617		10.1038/10165	http://dx.doi.org/10.1038/10165			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404183				2022-12-17	WOS:000083882600011
J	Valero, M; Cid, E; Averkin, RG; Aguilar, J; Sanchez-Aguilera, A; Viney, TJ; Gomez-Dominguez, D; Bellistri, E; de la Prida, LM				Valero, Manuel; Cid, Elena; Averkin, Robert G.; Aguilar, Juan; Sanchez-Aguilera, Alberto; Viney, Tim J.; Gomez-Dominguez, Daniel; Bellistri, Elisa; Menendez de la Prida, Liset			Determinants of different deep and superficial CA1 pyramidal cell dynamics during sharp-wave ripples	NATURE NEUROSCIENCE			English	Article							RAT HIPPOCAMPUS; IN-VIVO; BASKET CELLS; MONOCLONAL-ANTIBODIES; INTACT HIPPOCAMPUS; GLYCINE RECEPTOR; AXON TERMINALS; GABA RELEASE; OSCILLATIONS; NEURONS	Sharp-wave ripples represent a prominent synchronous activity pattern in the mammalian hippocampus during sleep and immobility. GABAergic interneuronal types are silenced or fire during these events, but the mechanism of pyramidal cell (PC) participation remains elusive. We found opposite membrane polarization of deep (closer to stratum oriens) and superficial (closer to stratum radiatum) rat CA1 PCs during sharp-wave ripples. Using sharp and multi-site recordings in combination with neurochemical profiling, we observed a predominant inhibitory drive of deep calbindin (CB)-immunonegative PCs that contrasts with a prominent depolarization of superficial CB-immunopositive PCs. Biased contribution of perisomatic GABAergic inputs, together with suppression of CA2 PCs, may explain the selection of CA1 PCs during sharp-wave ripples. A deep-superficial gradient interacted with behavioral and spatial effects to determine cell participation during sleep and awake sharp-wave ripples in freely moving rats. Thus, the firing dynamics of hippocampal PCs are exquisitely controlled at subcellular and microcircuit levels in a cell type-selective manner.	[Valero, Manuel; Cid, Elena; Sanchez-Aguilera, Alberto; Gomez-Dominguez, Daniel; Bellistri, Elisa; Menendez de la Prida, Liset] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Averkin, Robert G.] Univ Szeged, Hungarian Acad Sci, Res Grp Cort Microcircuits, Dept Physiol Anat & Neurosci, Szeged, Hungary; [Aguilar, Juan] Hosp Nacl Paraplej, Serv Salud Castilla La Mancha, Toledo, Spain; [Sanchez-Aguilera, Alberto] Univ Complutense Madrid, Fac Med, Dept Fisiol, E-28040 Madrid, Spain; [Viney, Tim J.] Univ Oxford, Dept Pharmacol, Med Res Council Brain Network Dynam Unit, Oxford OX1 3QT, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Hungarian Academy of Sciences; Szeged University; Hospital Nacional de Paraplejicos; Complutense University of Madrid; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford	de la Prida, LM (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	lmprida@cajal.csic.es	Aguilar, Juan/N-3850-2019; Aguilar, Juan/Q-2206-2015; de la Prida, Liset M/O-1342-2013; Sanchez-Aguilera Lopez, Alberto/H-5793-2017; Cid, Elena/N-5072-2014	Aguilar, Juan/0000-0002-8070-3923; Aguilar, Juan/0000-0002-8070-3923; de la Prida, Liset M/0000-0002-0160-6472; Sanchez-Aguilera Lopez, Alberto/0000-0001-9679-1158; Viney, Tim/0000-0001-6444-1188; Averkin, Robert G./0000-0003-2622-6975; Cid, Elena/0000-0003-4852-595X	Spanish Ministerio de Economia y Competitividad [BFU2012-37156-C03-01]; CSIC JAE Program; European Social Fund; Spanish Ministry of Education, Culture and Sports [FPU12/03776, BES-2013-064171]; MRC Anatomical Neuropharmacological Unit in Oxford [FPU-EST13/01046]; Universidad Complutense de Madrid; UK Medical Research Council; ERC Advanced grant (INTERIMPACT); MRC [MC_UU_12020/3, MC_UU_12024/4] Funding Source: UKRI; Medical Research Council [MC_UU_12020/3, MC_UU_12024/4] Funding Source: researchfish	Spanish Ministerio de Economia y Competitividad(Spanish Government); CSIC JAE Program; European Social Fund(European Social Fund (ESF)); Spanish Ministry of Education, Culture and Sports(Spanish Government); MRC Anatomical Neuropharmacological Unit in Oxford(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Universidad Complutense de Madrid; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC Advanced grant (INTERIMPACT); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank P. Somogyi for his valuable guidance and suggestions on histological procedures and analyses. For gephyrin counting, B. Micklem advised on stereological approaches and K. Wagner helped with tissue processing. We thank B. Gal for histological processing for immunofluorescence studies and F. Laurent for suggestions for analysis. R. Miles, A. Gulyas and A. Colino provided useful comments and discussion. We also thank G. Tamas and V. Szemenyei for their generous support. This work was supported by a grant from the Spanish Ministerio de Economia y Competitividad (BFU2012-37156-C03-01). E.C. receives funding from the CSIC JAE Program, co-funded by the European Social Fund. M.V. was supported by the Spanish Ministry of Education, Culture and Sports (FPU12/03776) and by a short-term grant to visit the MRC Anatomical Neuropharmacological Unit in Oxford (FPU-EST13/01046). A.S.-A. is funded by the Universidad Complutense de Madrid. T.J.V. was supported by the UK Medical Research Council. R.G.A. was supported by an ERC Advanced grant (INTERIMPACT) to G. Tamas. D.G.-D. is funded by the Spanish Ministerio de Economia y Competitividad (BES-2013-064171).	Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; Aivar P, 2014, J NEUROSCI, V34, P2989, DOI 10.1523/JNEUROSCI.2826-13.2014; Alvarado-Rojas C, 2015, ANN NEUROL, V77, P281, DOI 10.1002/ana.24324; Antonio AS, 2014, J COMP NEUROL, V522, P1333, DOI DOI 10.1002/CNE.23486; Bahner F, 2011, P NATL ACAD SCI USA, V108, pE607, DOI 10.1073/pnas.1103546108; BAIMBRIDGE KG, 1991, SYNAPSE, V7, P269, DOI 10.1002/syn.890070404; BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; Bartos M, 2012, J PHYSIOL-LONDON, V590, P669, DOI 10.1113/jphysiol.2011.226175; Bland BH, 2005, EXP NEUROL, V195, P458, DOI 10.1016/j.expneurol.2005.06.007; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Cea-del Rio CA, 2010, J NEUROSCI, V30, P6011, DOI 10.1523/JNEUROSCI.5040-09.2010; CELIO MR, 1990, CELL CALCIUM, V11, P599, DOI 10.1016/0143-4160(90)90014-L; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Ellender TJ, 2010, J NEUROSCI, V30, P5979, DOI 10.1523/JNEUROSCI.3962-09.2010; English DF, 2014, J NEUROSCI, V34, P16509, DOI 10.1523/JNEUROSCI.2600-14.2014; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fukudome Y, 2004, EUR J NEUROSCI, V19, P2682, DOI 10.1111/j.0953-816X.2004.03384.x; Glickfeld LL, 2008, J NEUROSCI, V28, P1824, DOI 10.1523/JNEUROSCI.4700-07.2008; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Jefferys JGR, 2012, PROG NEUROBIOL, V98, P250, DOI 10.1016/j.pneurobio.2012.02.005; Kamondi A, 1998, J NEUROSCI, V18, P3919; Katona I, 1999, J NEUROSCI, V19, P4544; Katona L, 2014, NEURON, V82, P872, DOI 10.1016/j.neuron.2014.04.007; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kohara K, 2014, NAT NEUROSCI, V17, P269, DOI 10.1038/nn.3614; KORSHUNOV VA, 1995, J NEUROSCI METH, V57, P77, DOI 10.1016/0165-0270(94)00130-9; Lapray D, 2012, NAT NEUROSCI, V15, P1265, DOI 10.1038/nn.3176; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; Lee SH, 2014, NEURON, V82, P1129, DOI 10.1016/j.neuron.2014.03.034; Lenkey N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7557; Maier N, 2011, NEURON, V72, P137, DOI 10.1016/j.neuron.2011.08.016; Mercer A, 2007, J NEUROSCI, V27, P7329, DOI 10.1523/JNEUROSCI.1829-07.2007; Mizuseki K, 2011, NAT NEUROSCI, V14, P1174, DOI 10.1038/nn.2894; MORRIS ME, 1995, HIPPOCAMPUS, V5, P25, DOI 10.1002/hipo.450050105; Nielsen JV, 2010, CEREB CORTEX, V20, P1904, DOI 10.1093/cercor/bhp261; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Paxinos G, 2005, RAT BRAIN STEREOTAXI, DOI 10.1016/c2009-0-63235-9; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Roumis DK, 2015, CURR OPIN NEUROBIOL, V35, P6, DOI 10.1016/j.conb.2015.05.001; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwaller B, 1999, AM J PHYSIOL-CELL PH, V276, pC395, DOI 10.1152/ajpcell.1999.276.2.C395; Senior TJ, 2008, J NEUROSCI, V28, P2274, DOI 10.1523/JNEUROSCI.4669-07.2008; Skaggs WE, 2007, J NEUROPHYSIOL, V98, P898, DOI 10.1152/jn.00401.2007; Slomianka L, 2011, BRAIN STRUCT FUNCT, V216, P301, DOI 10.1007/s00429-011-0322-0; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; Stark E, 2014, NEURON, V83, P467, DOI 10.1016/j.neuron.2014.06.023; Takacs VT, 2015, BRAIN STRUCT FUNCT, V220, P919, DOI 10.1007/s00429-013-0692-6; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; VANBETTERAY JNF, 1991, PHYSIOL BEHAV, V50, P79, DOI 10.1016/0031-9384(91)90501-E; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109; Viney TJ, 2013, NAT NEUROSCI, V16, P1802, DOI 10.1038/nn.3550; Worrell GA, 2008, BRAIN, V131, P928, DOI 10.1093/brain/awn006; YLINEN A, 1995, J NEUROSCI, V15, P30	64	128	128	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2015	18	9					1281	+		10.1038/nn.4074	http://dx.doi.org/10.1038/nn.4074			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CQ0NI	26214372	Green Accepted			2022-12-17	WOS:000360292600018
J	Levine, AJ; Hinckley, CA; Hilde, KL; Driscoll, SP; Poon, TH; Montgomery, JM; Pfaff, SL				Levine, Ariel J.; Hinckley, Christopher A.; Hilde, Kathryn L.; Driscoll, Shawn P.; Poon, Tiffany H.; Montgomery, Jessica M.; Pfaff, Samuel L.			Identification of a cellular node for motor control pathways	NATURE NEUROSCIENCE			English	Article							ORDER PREMOTOR INTERNEURONS; LUMBAR SPINAL-CORD; RABIES VIRUS; GENE-EXPRESSION; REFLEX PATHWAYS; WITHDRAWAL REFLEXES; HINDLIMB MUSCLES; GRAY-MATTER; RAT; MOUSE	The rich behavioral repertoire of animals is encoded in the CNS as a set of motorneuron activation patterns, also called 'motor synergies'. However, the neurons that orchestrate these motor programs as well as their cellular properties and connectivity are poorly understood. Here we identify a population of molecularly defined motor synergy encoder (MSE) neurons in the mouse spinal cord that may represent a central node in neural pathways for voluntary and reflexive movement. This population receives direct inputs from the motor cortex and sensory pathways and, in turn, has monosynaptic outputs to spinal motorneurons. Optical stimulation of MSE neurons drove reliable patterns of activity in multiple motor groups, and we found that the evoked motor patterns varied on the basis of the rostrocaudal location of the stimulated MSE. We speculate that these neurons comprise a cellular network for encoding coordinated motor output programs.	[Levine, Ariel J.; Hinckley, Christopher A.; Hilde, Kathryn L.; Driscoll, Shawn P.; Poon, Tiffany H.; Montgomery, Jessica M.; Pfaff, Samuel L.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Levine, Ariel J.; Hinckley, Christopher A.; Hilde, Kathryn L.; Driscoll, Shawn P.; Poon, Tiffany H.; Montgomery, Jessica M.; Pfaff, Samuel L.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pfaff@salk.edu		Levine, Ariel/0000-0002-0335-0730	George E. Hewitt Foundation for Medical Research; US National Research Service Award fellowship from US National Institutes of Health NINDS; Howard Hughes Medical Institute investigator; National Institute of Neurological Disorders and Stroke [R37NS037116]; Marshall Foundation; Christopher and Dana Reeve Foundation; National Science Foundation; Benjamin H. Lewis chair in neuroscience; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054172, R37NS037116, R01NS037116] Funding Source: NIH RePORTER	George E. Hewitt Foundation for Medical Research; US National Research Service Award fellowship from US National Institutes of Health NINDS; Howard Hughes Medical Institute investigator(Howard Hughes Medical Institute); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Marshall Foundation; Christopher and Dana Reeve Foundation; National Science Foundation(National Science Foundation (NSF)); Benjamin H. Lewis chair in neuroscience; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge the generosity and advice of M. Goulding, R. Edgerton, A. Engmann, E. Callaway, J. Young, F. Osakada and F. Stam, P. Joshi and S. McConnell for instruction in cortical injections, and Q. Ma (Harvard Medical School, in situ probes) and C. Birchmeier (Max Delbruck Center for Molecular Medicine, Tlx3 antibody) for providing reagents. M. Sternfeld, M. Hayashi, K. Lettieri and Y. Bogoch provided support and advice. We thank R. Levine for his helpful reading of the manuscript. A.J.L. was supported by George E. Hewitt Foundation for Medical Research and Christopher and Dana Reeve Foundation. C.A.H. was supported by a US National Research Service Award fellowship from US National Institutes of Health NINDS. K.L.H. is supported as a National Science Foundation Graduate Research Fellow. S.L.P. is supported as a Howard Hughes Medical Institute investigator and as a Benjamin H. Lewis chair in neuroscience. This research was supported by the National Institute of Neurological Disorders and Stroke (grant R37NS037116), the Marshall Foundation and the Christopher and Dana Reeve Foundation.	Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; ANTAL M, 1992, J COMP NEUROL, V325, P22, DOI 10.1002/cne.903250103; Asante CO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074454; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Barthelemy D, 2006, J NEUROPHYSIOL, V96, P3273, DOI 10.1152/jn.00203.2006; Bizzi E, 2008, BRAIN RES REV, V57, P125, DOI 10.1016/j.brainresrev.2007.08.004; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; BROWN LT, 1974, J COMP NEUROL, V154, P169, DOI 10.1002/cne.901540205; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Clarke RW, 2004, BRAIN RES REV, V46, P163, DOI 10.1016/j.brainresrev.2004.07.005; Coulon P, 2011, J COMP NEUROL, V519, P3470, DOI 10.1002/cne.22717; CURFS MHJM, 1994, DEV BRAIN RES, V78, P182, DOI 10.1016/0165-3806(94)90025-6; DELEON R, 1994, BRAIN RES, V654, P241, DOI 10.1016/0006-8993(94)90485-5; Duysens J, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00014; Gianino S, 1999, DEV BRAIN RES, V112, P189, DOI 10.1016/S0165-3806(98)00168-0; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; HARRISON PJ, 1986, J PHYSIOL-LONDON, V371, P147, DOI 10.1113/jphysiol.1986.sp015965; Harrison TC, 2012, NEURON, V74, P397, DOI 10.1016/j.neuron.2012.02.028; Henry AM, 2012, MAMM GENOME, V23, P539, DOI 10.1007/s00335-012-9406-2; HONGO T, 1989, BRAIN RES, V505, P163, DOI 10.1016/0006-8993(89)90131-5; HONGO T, 1989, BRAIN RES, V505, P167, DOI 10.1016/0006-8993(89)90132-7; ISHIZUKA N, 1979, J COMP NEUROL, V186, P189, DOI 10.1002/cne.901860206; Joshi PS, 2008, NEURON, V60, P258, DOI 10.1016/j.neuron.2008.08.006; Leyton ASF, 1917, Q J EXP PHYSIOL, V11, P135, DOI 10.1113/expphysiol.1917.sp000240; Liang HZ, 2012, BRAIN STRUCT FUNCT, V217, P221, DOI 10.1007/s00429-011-0348-3; Lundberg A, 1979, Prog Brain Res, V50, P11; LUNDBERG A., 1964, PROGR BRAIN RES, V12, P197, DOI 10.1016/S0079-6123(08)60624-X; Martin JH, 1996, EXP BRAIN RES, V108, P191; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Mushahwar VK, 2004, CAN J PHYSIOL PHARM, V82, P702, DOI 10.1139/Y04-079; NICOLOPOULOSSTOURNARAS S, 1983, J COMP NEUROL, V217, P75, DOI 10.1002/cne.902170107; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; PierrotDeseilligny E, 2012, CIRCUITRY OF THE HUMAN SPINAL CORD: SPINAL AND CORTICOSPINAL MECHANISMS OF MOVEMENT, P1, DOI 10.1017/CBO9781139026727; Puskar Z, 1997, J COMP NEUROL, V389, P377, DOI 10.1002/(SICI)1096-9861(19971222)389:3<377::AID-CNE2>3.0.CO;2-Y; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; Ruigrok TJH, 2008, EUR J NEUROSCI, V28, P181, DOI 10.1111/j.1460-9568.2008.06294.x; Saltiel P, 1998, J NEUROPHYSIOL, V80, P2323, DOI 10.1152/jn.1998.80.5.2323; SCHEIBEL MADGE E., 1968, BRAIN RES, V9, P32, DOI 10.1016/0006-8993(68)90256-4; SCHEIBEL ME, 1969, BRAIN RES, V13, P417, DOI 10.1016/0006-8993(69)90258-3; SCHOMBURG ED, 1990, NEUROSCI RES, V7, P265, DOI 10.1016/0168-0102(90)90008-3; SCHOUENBORG J, 1990, EXP BRAIN RES, V83, P67; SCHOUENBORG J, 1995, EXP BRAIN RES, V106, P19; Sengul G, 2012, ANAT REC, V295, P837, DOI 10.1002/ar.22450; Sherrington CS, 1903, J PHYSIOL-LONDON, V29, P58; Sherrington CS., 1906, INTEGRATIVE ACTION N; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Tresch MC, 2002, BRAIN RES REV, V40, P66, DOI 10.1016/S0165-0173(02)00189-3; Tresch MC, 1999, EXP BRAIN RES, V129, P401, DOI 10.1007/s002210050908; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Wildner H, 2013, J NEUROSCI, V33, P7299, DOI 10.1523/JNEUROSCI.0491-13.2013	53	128	140	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2014	17	4					586	U206		10.1038/nn.3675	http://dx.doi.org/10.1038/nn.3675			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AD6XR	24609464	Green Accepted			2022-12-17	WOS:000333405300019
J	Higginbotham, H; Guo, JM; Yokota, Y; Umberger, NL; Su, CY; Li, JJ; Verma, N; Hirt, J; Ghukasyan, V; Caspary, T; Anton, ES				Higginbotham, Holden; Guo, Jiami; Yokota, Yukako; Umberger, Nicole L.; Su, Chen-Ying; Li, Jingjun; Verma, Nisha; Hirt, Joshua; Ghukasyan, Vladimir; Caspary, Tamara; Anton, E. S.			Arl13b-regulated cilia activities are essential for polarized radial glial scaffold formation	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; JOUBERT-SYNDROME; CEREBROSPINAL-FLUID; BASAL PROGENITORS; CORTICAL-NEURONS; ARL13B; DIFFERENTIATION; PROTEIN; NEUROGENESIS; CILIOGENESIS	The construction of cerebral cortex begins with the formation of radial glia. Once formed, polarized radial glial cells divide either symmetrically or asymmetrically to balance appropriate production of progenitor cells and neurons. Following birth, neurons use the processes of radial glia as scaffolding for oriented migration. Radial glia therefore provide an instructive structural matrix to coordinate the generation and placement of distinct groups of cortical neurons in the developing cerebral cortex. We found that Arl13b, a cilia-enriched small GTPase that is mutated in Joubert syndrome, was critical for the initial formation of the polarized radial progenitor scaffold. Using developmental stage-specific deletion of Arl13b in mouse cortical progenitors, we found that early neuroepithelial deletion of ciliary Arl13b led to a reversal of the apical-basal polarity of radial progenitors and aberrant neuronal placement. Arl13b modulated ciliary signaling necessary for radial glial polarity. Our findings indicate that Arl13b signaling in primary cilia is crucial for the initial formation of a polarized radial glial scaffold and suggest that disruption of this process may contribute to aberrant neurodevelopment and brain abnormalities in Joubert syndrome-related ciliopathies.	[Higginbotham, Holden; Guo, Jiami; Yokota, Yukako; Li, Jingjun; Verma, Nisha; Hirt, Joshua; Ghukasyan, Vladimir; Anton, E. S.] Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC USA; [Higginbotham, Holden; Guo, Jiami; Yokota, Yukako; Li, Jingjun; Verma, Nisha; Hirt, Joshua; Ghukasyan, Vladimir; Anton, E. S.] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Umberger, Nicole L.; Su, Chen-Ying; Caspary, Tamara] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Emory University	Caspary, T (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	tcaspar@emory.edu; anton@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; Caspary, Tamara/AAH-5625-2020	Caspary, Tamara/0000-0002-6579-7589	US National Institutes of Health [MH060929, NS056380]; NARSAD Young Investigator Award; US National Institutes of Health predoctoral training grant [T32GM008490]; National Institute of Neurological Disorders and Stroke [P30 NS045892]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH087977, R01MH060929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, R01NS056380] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Young Investigator Award(NARSAD); US National Institutes of Health predoctoral training grant; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A.-S. Lamantia, L. Pevny, M. Deshmukh and W. Snider for helpful comments and C. T. Strauss for editing. This research was supported by US National Institutes of Health grants MH060929 to E. S. A. and NS056380 to T. C., a NARSAD Young Investigator Award to H. H., a US National Institutes of Health predoctoral training grant to N.L.U. (T32GM008490) and the confocal imaging core of a National Institute of Neurological Disorders and Stroke institutional center core grant (P30 NS045892).	Amador-Arjona A, 2011, J NEUROSCI, V31, P9933, DOI 10.1523/JNEUROSCI.1062-11.2011; Aruga J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-79; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Brancati F, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-20; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Higginbotham H, 2012, DEV CELL, V23, P925, DOI 10.1016/j.devcel.2012.09.019; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Horner VL, 2011, DEV BIOL, V355, P43, DOI 10.1016/j.ydbio.2011.04.019; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mukhopadhyay S, 2008, DEV CELL, V14, P762, DOI 10.1016/j.devcel.2008.03.002; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Reiter JF, 2008, DEV CELL, V14, P635, DOI 10.1016/j.devcel.2008.04.011; Sahara S, 2009, NEURON, V63, P48, DOI 10.1016/j.neuron.2009.06.006; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Siegenthaler JA, 2011, CURR OPIN GENET DEV, V21, P249, DOI 10.1016/j.gde.2010.12.005; Su CY, 2012, DEVELOPMENT, V139, P4062, DOI 10.1242/dev.082321; Tabata H, 2009, CEREB CORTEX, V19, P2092, DOI 10.1093/cercor/bhn227; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Wilsch-Brauninger M, 2012, DEVELOPMENT, V139, P95, DOI 10.1242/dev.069294; Wilson SL, 2012, DEV NEUROBIOL, V72, P1196, DOI 10.1002/dneu.20985; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yokota Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000794; Yokota Y, 2007, NEURON, V54, P429, DOI 10.1016/j.neuron.2007.04.016; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	47	128	131	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1000	U44		10.1038/nn.3451	http://dx.doi.org/10.1038/nn.3451			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817546	Green Accepted, Green Submitted			2022-12-17	WOS:000322323000009
J	Baseler, HA; Gouws, A; Haak, KV; Racey, C; Crossland, MD; Tufail, A; Rubin, GS; Cornelissen, FW; Morland, AB				Baseler, Heidi A.; Gouws, Andre; Haak, Koen V.; Racey, Christopher; Crossland, Michael D.; Tufail, Adnan; Rubin, Gary S.; Cornelissen, Frans W.; Morland, Antony B.			Large-scale remapping of visual cortex is absent in adult humans with macular degeneration	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE COLUMNS; RECEPTIVE-FIELD; STRIATE CORTEX; CORTICAL MAPS; FUNCTIONAL MRI; RETINAL LESIONS; V1 NEURONS; MACAQUE V1; REORGANIZATION; MONKEY	The occipital lobe contains retinotopic representations of the visual field. The representation of the central retina in early visual areas (V1-3) is found at the occipital pole. When the central retina is lesioned in both eyes by macular degeneration, this region of visual cortex at the occipital pole is accordingly deprived of input. However, even when such lesions occur in adulthood, some visually driven activity in and around the occipital pole can be observed. It has been suggested that this activity is a result of remapping of this area so that it now responds to inputs from intact, peripheral retina. We evaluated whether or not remapping of visual cortex underlies this activity. Our functional magnetic resonance imaging results provide no evidence of remapping, questioning the contemporary view that early visual areas of the adult human brain have the capacity to reorganize extensively.	[Baseler, Heidi A.; Gouws, Andre; Racey, Christopher; Morland, Antony B.] Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England; [Haak, Koen V.; Cornelissen, Frans W.] Univ Groningen, Lab Expt Ophthalmol, Univ Med Ctr Groningen, Groningen, Netherlands; [Haak, Koen V.; Cornelissen, Frans W.] Univ Groningen, BCN Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands; [Crossland, Michael D.; Tufail, Adnan; Rubin, Gary S.] UCL, Inst Ophthalmol, London, England; [Crossland, Michael D.; Tufail, Adnan] Moorfields Eye Hosp NHS Fdn Trust, London, England; [Morland, Antony B.] Hull York Med Sch, York, N Yorkshire, England	University of York - UK; University of Groningen; University of Groningen; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Hull; University of York - UK	Morland, AB (corresponding author), Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England.	a.morland@psychology.york.ac.uk	Haak, Koen/AAM-5500-2020; Crossland, Michael D/B-5600-2008; Baseler, Heidi/AAI-7387-2020; Haak, Koen V/G-6417-2018	Haak, Koen/0000-0001-9309-1906; Crossland, Michael D/0000-0001-6833-6043; Baseler, Heidi/0000-0003-0995-8453; Haak, Koen V/0000-0001-9309-1906; Morland, Antony/0000-0002-6754-5545; Gouws, Andre/0000-0003-0674-7829; Tufail, Adnan/0000-0001-6131-7640	Medical Research Council [G0401339]; Stichting Nederlands Oogheelkundig Onderzoek; European Union [043157, 043261]; Department of Health; MRC [G0401339] Funding Source: UKRI; Medical Research Council [G0700729B] Funding Source: researchfish; Fight for Sight [1777/78] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stichting Nederlands Oogheelkundig Onderzoek; European Union(European Commission); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight	We would like to thank all of our participants. We thank Edward Silson for constructive discussion of the manuscript. We are also grateful to the Medical Research Council for funding this study (G0401339). K. V. H. and F. W. C. were supported by a grant from Stichting Nederlands Oogheelkundig Onderzoek and by European Union grants #043157 (Syntex) and #043261 (Percept). A. T., G. S. R. and M. D. C. also received financial support from the Department of Health through an award made by the National Institute for Health Research to Moorfields Eye Hospital National Health Service (NHS) Foundation Trust and University College London Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, the Department of Health or the EU commission.	Andrews TJ, 1997, J NEUROSCI, V17, P2859; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Angelucci A, 2006, J COMP NEUROL, V498, P330, DOI 10.1002/cne.21060; Baker CI, 2008, VISION RES, V48, P1910, DOI 10.1016/j.visres.2008.05.020; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Baseler HA, 2002, NAT NEUROSCI, V5, P364, DOI 10.1038/nn817; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; Cowey A, 2000, NEUROREPORT, V11, P3269, DOI 10.1097/00001756-200009280-00044; Crossland MD, 2008, INVEST OPHTH VIS SCI, V49, P3734, DOI 10.1167/iovs.07-1621; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Giannikopoulos DV, 2006, P NATL ACAD SCI USA, V103, P10805, DOI 10.1073/pnas.0604539103; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; Hoffmann MB, 2003, J NEUROSCI, V23, P8921; Horton JC, 1997, J NEUROSCI, V17, P3684; Horton JC, 1998, J NEUROSCI, V18, P5433, DOI 10.1523/JNEUROSCI.18-14-05433.1998; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaas JH, 2002, PROG BRAIN RES, V138, P167, DOI 10.1016/S0079-6123(02)38077-4; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Levin N, 2010, NEURON, V65, P21, DOI 10.1016/j.neuron.2009.12.006; Lewis SM, 2005, EXP BRAIN RES, V165, P447, DOI 10.1007/s00221-005-2336-4; Liu TT, 2010, INVEST OPHTH VIS SCI, V51, P6826, DOI 10.1167/iovs.09-4926; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.neuro.11.1.253; Masuda Y, 2008, CEREB CORTEX, V18, P2483, DOI 10.1093/cercor/bhm256; Masuda Y, 2010, INVEST OPHTH VIS SCI, V51, P5356, DOI 10.1167/iovs.09-4775; Morland AB, 2001, ACTA PSYCHOL, V107, P229, DOI 10.1016/S0001-6918(01)00025-7; Muckli L, 2009, P NATL ACAD SCI USA, V106, P13034, DOI 10.1073/pnas.0809688106; Parrish TB, 2000, MAGNET RESON MED, V44, P925, DOI 10.1002/1522-2594(200012)44:6<925::AID-MRM14>3.0.CO;2-M; Schumacher EH, 2008, RESTOR NEUROL NEUROS, V26, P391; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Smirnakis SM, 2005, NATURE, V435, P300, DOI 10.1038/nature03495; Sunness JS, 2004, OPHTHALMOLOGY, V111, P1595, DOI 10.1016/j.ophtha.2003.12.050; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Wandell BA, 2005, PHILOS T R SOC B, V360, P693, DOI 10.1098/rstb.2005.1628; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wandell BA, 2009, NAT REV NEUROSCI, V10, P873, DOI 10.1038/nrn2741; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218; Winawer J, 2010, J VISION, V10, DOI 10.1167/10.5.1	50	128	131	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					649	U148		10.1038/nn.2793	http://dx.doi.org/10.1038/nn.2793			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441924				2022-12-17	WOS:000289886600022
J	Kantak, SS; Sullivan, KJ; Fisher, BE; Knowlton, BJ; Winstein, CJ				Kantak, Shailesh S.; Sullivan, Katherine J.; Fisher, Beth E.; Knowlton, Barbara J.; Winstein, Carolee J.			Neural substrates of motor memory consolidation depend on practice structure	NATURE NEUROSCIENCE			English	Article							CORTEX	Motor-skill practice drives subsequent offline activity in functionally related resting human brain networks. We investigated the manner in which offline neural networks are modulated by practice structures that affect motor-skill retention. Interference to dorsolateral-prefrontal cortex (DLPFC), but not to primary motor cortex (M1), after variable practice attenuated motor-skill retention, whereas interference to M1, but not to DLPFC, after constant practice attenuated motor-skill retention. We conclude that neural substrates of motor-memory consolidation are modulated by practice structure.	[Kantak, Shailesh S.; Sullivan, Katherine J.; Fisher, Beth E.; Winstein, Carolee J.] Univ So Calif, Herman Ostrow Sch Dent, Div Biokinesiol & Phys Therapy, Motor Behav & Neurorehabil Lab, Los Angeles, CA 90089 USA; [Kantak, Shailesh S.; Fisher, Beth E.] Univ So Calif, Herman Ostrow Sch Dent, Div Biokinesiol & Phys Therapy, Neuroplast & Imaging Lab, Los Angeles, CA USA; [Knowlton, Barbara J.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Winstein, Carolee J.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of Southern California	Winstein, CJ (corresponding author), Univ So Calif, Herman Ostrow Sch Dent, Div Biokinesiol & Phys Therapy, Motor Behav & Neurorehabil Lab, Los Angeles, CA 90089 USA.	winstein@usc.edu	Fisher, Beth E/G-5430-2012	Winstein, Carolee/0000-0001-9789-4626	North American Society for the Psychology of Sport and Physical Activity; Graduate School of the University of Southern California	North American Society for the Psychology of Sport and Physical Activity; Graduate School of the University of Southern California	We thank E. M. Robertson for his thoughtful and constructive comments on an earlier version of the manuscript. The research was supported by a grant from the North American Society for the Psychology of Sport and Physical Activity and an Oakley Fellowship from the Graduate School of the University of Southern California.	Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; Braun DA, 2009, CURR BIOL, V19, P352, DOI 10.1016/j.cub.2009.01.036; Cahill L, 2001, TRENDS NEUROSCI, V24, P578, DOI 10.1016/S0166-2236(00)01885-3; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Lee T.D., 2004, SKILL ACQUISITION SP, P29; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Robertson EM, 2006, NEUROSCIENTIST, V12, P261, DOI 10.1177/1073858406287935; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Robertson EM, 2005, J NEUROSCI, V25, P6372, DOI 10.1523/JNEUROSCI.1851-05.2005; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; SCHMIDT RA, 1992, PSYCHOL SCI, V3, P207, DOI 10.1111/j.1467-9280.1992.tb00029.x; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; SHEA CH, 1991, RES Q EXERCISE SPORT, V62, P187, DOI 10.1080/02701367.1991.10608709; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0	15	128	131	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					923	925		10.1038/nn.2596	http://dx.doi.org/10.1038/nn.2596			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	632DK	20622872				2022-12-17	WOS:000280400600009
J	Popescu, AT; Popa, D; Pare, D				Popescu, Andrei T.; Popa, Daniela; Pare, Denis			Coherent gamma oscillations couple the amygdala and striatum during learning	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; MULTIPLE MEMORY-SYSTEMS; WATER MAZE TASKS; BASOLATERAL AMYGDALA; CAUDATE-NUCLEUS; ORBITOFRONTAL CORTEX; RHINAL INTERACTIONS; DOUBLE DISSOCIATION; EMOTIONAL AROUSAL; PRIMATE AMYGDALA	The basolateral amygdala (BLA) mediates the facilitating effects of emotions on memory. The BLA's enhancing influence extends to various types of memories, including striatal-dependent habit formation. To shed light on the underlying mechanisms, we carried out unit and local field potential (LFP) recordings in BLA, striatum, auditory cortex and intralaminar thalamus in cats trained on a stimulus-response task in which the presentation of one of two tones predicted reward delivery. The coherence of BLA, but not of cortical or thalamic, LFPs was highest with striatal gamma activity, and intra-BLA muscimol infusions selectively reduced striatal gamma power. Moreover, coupling of BLA-striatal unit activity increased when LFP gamma power was augmented. Early in training, the rewarded and unrewarded tones elicited a modest increase in coherent BLA-striatal gamma. As learning progressed, this gamma coupling selectively increased in relation to the rewarded tone. Thus, coherent gamma oscillations coordinate amygdalostriatal interactions during learning and might facilitate synaptic plasticity.	[Popescu, Andrei T.; Popa, Daniela; Pare, Denis] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Pare, D (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	pare@andromeda.rutgers.edu		Popa, Daniela/0000-0002-8389-1122	National Institute of Mental Health [RO1 MH073610]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073610] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a National Institute of Mental Health grant (RO1 MH073610) to D. Pare	Akirav I, 1999, J NEUROSCI, V19, P10530; Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Balleine BW, 2003, J NEUROSCI, V23, P666, DOI 10.1523/JNEUROSCI.23-02-00666.2003; Bauer EP, 2007, J NEUROSCI, V27, P9369, DOI 10.1523/JNEUROSCI.2153-07.2007; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; CARR GD, 1984, PSYCHOPHARMACOLOGY, V82, P203, DOI 10.1007/BF00427774; CASTELLANO C, 1989, BEHAV NEURAL BIOL, V52, P170, DOI 10.1016/S0163-1047(89)90285-9; Christianson S. A., 1992, HDB EMOTION MEMORY C; DICKINSONANSON H, 1993, BEHAV NEURAL BIOL, V60, P1, DOI 10.1016/0163-1047(93)90638-X; Dringenberg HC, 2004, EUR J NEUROSCI, V20, P557, DOI 10.1111/j.1460-9568.2004.03515.x; Frey S, 2001, J NEUROSCI, V21, P3697, DOI 10.1523/JNEUROSCI.21-10-03697.2001; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Hatfield T, 1999, NEUROBIOL LEARN MEM, V71, P232, DOI 10.1006/nlme.1998.3875; IKEGAYA Y, 1995, NEUROSCI RES, V22, P203, DOI 10.1016/0168-0102(95)00894-7; IZQUIERDO I, 1993, BEHAV NEURAL BIOL, V59, P1, DOI 10.1016/0163-1047(93)91061-Q; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; MESULAM MM, 1992, J COMP NEUROL, V323, P252, DOI 10.1002/cne.903230209; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; PACKARD MG, 1994, P NATL ACAD SCI USA, V91, P8477, DOI 10.1073/pnas.91.18.8477; Packard MG, 1997, NEUROBIOL LEARN MEM, V68, P172, DOI 10.1006/nlme.1997.3785; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; PACKARD MG, 1991, BEHAV NEUROSCI, V105, P295, DOI 10.1037/0735-7044.105.2.295; Packard MG, 1997, NEUROBIOL LEARN MEM, V68, P42, DOI 10.1006/nlme.1996.3762; Packard MG, 1997, BEHAV NEUROSCI, V111, P543, DOI 10.1037/0735-7044.111.3.543; Packard MG, 1998, NEUROBIOL LEARN MEM, V69, P163, DOI 10.1006/nlme.1997.3815; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; PARE D, 1995, NEUROSCIENCE, V69, P567, DOI 10.1016/0306-4522(95)00272-K; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paz R, 2007, J NEUROSCI, V27, P6542, DOI 10.1523/JNEUROSCI.1077-07.2007; Paz R, 2006, NAT NEUROSCI, V9, P1321, DOI 10.1038/nn1771; Pelletier JG, 2005, LEARN MEMORY, V12, P96, DOI 10.1101/lm.88605; Popescu AT, 2007, P NATL ACAD SCI USA, V104, P341, DOI 10.1073/pnas.0609831104; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Salinas JA, 1997, NEUROBIOL LEARN MEM, V68, P51, DOI 10.1006/nlme.1997.3776; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; VIAUD MD, 1989, BEHAV BRAIN RES, V32, P31, DOI 10.1016/S0166-4328(89)80069-5; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	41	128	131	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2009	12	6					801	U161		10.1038/nn.2305	http://dx.doi.org/10.1038/nn.2305			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	450DJ	19430471	Green Accepted			2022-12-17	WOS:000266380900025
J	Morishima, Y; Akaishi, R; Yamada, Y; Okuda, J; Toma, K; Sakai, K				Morishima, Yosuke; Akaishi, Rei; Yamada, Yohei; Okuda, Jiro; Toma, Keiichiro; Sakai, Katsuyuki			Task-specific signal transmission from prefrontal cortex in visual selective attention	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; FRONTAL EYE FIELDS; EFFECTIVE CONNECTIVITY; NEURONAL OSCILLATIONS; NEURAL MECHANISMS; CORTICAL AREAS; MODULATION; TMS; PERCEPTION	Our voluntary behaviors are thought to be controlled by top-down signals from the prefrontal cortex that modulate neural processing in the posterior cortices according to the behavioral goal. However, we have insufficient evidence for the causal effect of the top-down signals. We applied a single-pulse transcranial magnetic stimulation over the human prefrontal cortex and measured the strength of the top-down signals as an increase in the efficiency of neural impulse transmission. The impulse induced by the stimulation transmitted to different posterior visual areas depending on the domain of visual features to which subjects attended. We also found that the amount of impulse transmission was associated with the level of attentional preparation and the performance of visual selective-attention tasks, consistent with the causal role of prefrontal top-down signals.	[Morishima, Yosuke; Akaishi, Rei; Yamada, Yohei; Toma, Keiichiro; Sakai, Katsuyuki] Univ Tokyo, Grad Sch Med, Dept Cognit Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; [Okuda, Jiro] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo 1948610, Japan	University of Tokyo	Sakai, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cognit Neurosci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	ksakai@m.u-tokyo.ac.jp	Akaishi, Rei/AAM-3072-2020; Morishima, Yosuke/K-8258-2013	Morishima, Yosuke/0000-0001-9363-697X	Japan Society for the Promotion of Science; Center of Excellence Program; Ministry of Education, Culture, Sports, Science and Technology, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center of Excellence Program; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank M. Okamoto and N. Yamamoto for assistance with EEG recording. This work was supported by a Grant-in-Aid for Scientific Research (A) and a Grant-in-Aid for Young Scientists (S) from the Japan Society for the Promotion of Science, and a Grant-in-Aid from the Center of Excellence Program, Center for Brain Medical Science, from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Armstrong KM, 2007, P NATL ACAD SCI USA, V104, P9499, DOI 10.1073/pnas.0701104104; Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Brass M, 2005, J COGNITIVE NEUROSCI, V17, P1367, DOI 10.1162/0898929054985400; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Egner T, 2008, J NEUROSCI, V28, P6141, DOI 10.1523/JNEUROSCI.1262-08.2008; Fuggetta G, 2006, J NEUROPHYSIOL, V95, P3277, DOI 10.1152/jn.01273.2005; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Grent-'T-Jong T, 2007, PLOS BIOL, V5, P114, DOI 10.1371/journal.pbio.0050012; Grosbras MH, 2003, EUR J NEUROSCI, V18, P3121, DOI 10.1111/j.1460-9568.2003.03055.x; Grosbras MH, 2002, J COGNITIVE NEUROSCI, V14, P1109, DOI 10.1162/089892902320474553; Grosbras MN, 2005, HUM BRAIN MAPP, V25, P140, DOI 10.1002/hbm.20145; Horwitz B, 2005, PHILOS T R SOC B, V360, P1093, DOI 10.1098/rstb.2005.1647; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Kahkonen S, 2001, NEUROIMAGE, V14, P322, DOI 10.1006/nimg.2001.0849; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Khayat PS, 2006, J NEUROSCI, V26, P138, DOI 10.1523/JNEUROSCI.2784-05.2006; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Matsumoto R, 2007, BRAIN, V130, P181, DOI 10.1093/brain/awl257; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Nikouline V, 1999, CLIN NEUROPHYSIOL, V110, P1325, DOI 10.1016/S1388-2457(99)00070-X; O'Shea J, 2004, J COGNITIVE NEUROSCI, V16, P1060, DOI 10.1162/0898929041502634; O'Shea J, 2007, J COGNITIVE NEUROSCI, V19, P1140, DOI 10.1162/jocn.2007.19.7.1140; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Peng XM, 2008, J NEUROPHYSIOL, V100, P796, DOI 10.1152/jn.01188.2007; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Roelfsema PR, 2007, NEURON, V56, P785, DOI 10.1016/j.neuron.2007.10.006; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Silvanto J, 2006, J NEUROPHYSIOL, V96, P941, DOI 10.1152/jn.00015.2006; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Taylor PCJ, 2007, J NEUROSCI, V27, P11343, DOI 10.1523/JNEUROSCI.2877-07.2007; Taylor PCJ, 2007, CEREB CORTEX, V17, P391, DOI 10.1093/cercor/bhj156; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; TOWLE VL, 1993, ELECTROEN CLIN NEURO, V86, P1, DOI 10.1016/0013-4694(93)90061-Y	49	128	129	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2009	12	1					85	91		10.1038/nn.2237	http://dx.doi.org/10.1038/nn.2237			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	388HL	19098905				2022-12-17	WOS:000262010800019
J	Arevian, AC; Kapoor, V; Urban, NN				Arevian, Armen C.; Kapoor, Vikrant; Urban, Nathaniel N.			Activity-dependent gating of lateral inhibition in the mouse olfactory bulb	NATURE NEUROSCIENCE			English	Article							ODORANT MOLECULAR-FEATURES; GRANULE CELLS; DENDRODENDRITIC INHIBITION; HORIZONTAL CONNECTIONS; RESPONSE PROPERTIES; REPRESENTATIONS; ORGANIZATION; MAPS; DISCRIMINATION; COMBINATORIAL	Lateral inhibition is a circuit motif found throughout the nervous system that often generates contrast enhancement and center-surround receptive fields. We investigated the functional properties of the circuits mediating lateral inhibition between olfactory bulb principal neurons (mitral cells) in vitro. We found that the lateral inhibition received by mitral cells is gated by postsynaptic firing, such that a minimum threshold of postsynaptic activity is required before effective lateral inhibition is recruited. This dynamic regulation allows the strength of lateral inhibition to be enhanced between cells with correlated activity. Simulations show that this regulation of lateral inhibition causes decorrelation of mitral cell activity that is evoked by similar stimuli, even when stimuli have no clear spatial structure. These results show that this previously unknown mechanism for specifying lateral inhibitory connections allows functional inhibitory connectivity to be dynamically remapped to relevant populations of neurons.	[Arevian, Armen C.; Urban, Nathaniel N.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Arevian, Armen C.; Kapoor, Vikrant; Urban, Nathaniel N.] Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Kapoor, Vikrant; Urban, Nathaniel N.] Carnegie Mellon Univ, Dept Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Urban, NN (corresponding author), Univ Pittsburgh, Ctr Neurosci, A210 Langley Hall, Pittsburgh, PA 15260 USA.	nurban@cmu.edu	Urban, Nathaniel/A-4974-2008	Urban, Nathaniel/0000-0002-0365-9068	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F30DC008274, R01DC005798] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC 005798, F30 DC008274-01A2, F30 DC008274-02, F30 DC008274-03, F30 DC008274, R01 DC005798, F30 DC 008274] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/S0896-6273(04)00753-6; Bosking WH, 1997, J NEUROSCI, V17, P2112; Carlson GC, 2000, J NEUROSCI, V20, P2011; Dietz SB, 2005, J PHYSIOL-LONDON, V569, P475, DOI 10.1113/jphysiol.2005.095844; Egana JI, 2005, NEUROSCIENCE, V134, P1069, DOI 10.1016/j.neuroscience.2005.04.027; Egger V, 2005, J NEUROSCI, V25, P3521, DOI 10.1523/JNEUROSCI.4746-04.2005; Egger V, 2006, SEMIN CELL DEV BIOL, V17, P424, DOI 10.1016/j.semcdb.2006.04.006; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, CURR OPIN NEUROBIOL, V11, P468, DOI 10.1016/S0959-4388(00)00236-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Johnson BA, 2004, J COMP NEUROL, V480, P234, DOI 10.1002/cne.20335; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kapoor V, 2006, J NEUROSCI, V26, P11709, DOI 10.1523/JNEUROSCI.3371-06.2006; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Linster C, 2005, J NEUROPHYSIOL, V93, P3410, DOI 10.1152/jn.01285.2004; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Meister M, 2001, J NEUROSCI, V21, P1351; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; PRICE JL, 1970, J CELL SCI, V7, P125; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Shepherd G.M., 2004, NEUROBIOLOGY; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Takahashi YK, 2004, J NEUROPHYSIOL, V92, P2413, DOI 10.1152/jn.00236.2004; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	42	128	130	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					80	87		10.1038/nn2030	http://dx.doi.org/10.1038/nn2030			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18084286	Green Accepted			2022-12-17	WOS:000252117900015
J	Friedman, MJ; Shah, AG; Fang, ZH; Ward, EG; Warren, ST; Li, SH; Li, XJ				Friedman, Meyer J.; Shah, Anjali G.; Fang, Zhi-Hui; Ward, Elizabeth G.; Warren, Stephen T.; Li, Shihua; Li, Xiao-Jiang			Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration	NATURE NEUROSCIENCE			English	Article							TATA-BINDING PROTEIN; DOMINANT CEREBELLAR-ATAXIA; NEURONS IN-VITRO; REPEAT EXPANSION; CELL-DEATH; HEAT-SHOCK-PROTEIN-27; TRANSCRIPTION; DISEASE; HUNTINGTIN; EXPRESSION	Expansion of the polyglutamine (polyQ) tract in human TATA-box binding protein (TBP) causes the neurodegenerative disease spinocerebellar ataxia 17 (SCA17). It remains unclear how the polyQ tract regulates normal protein function and induces selective neuropathology in SCA17. We generated transgenic mice expressing polyQ-expanded TBP. These mice showed weight loss, progressive neurological symptoms and neurodegeneration before early death. Expanded polyQ tracts reduced TBP dimerization but enhanced the interaction of TBP with the general transcription factor IIB (TFIIB). In SCA17 transgenic mice, the small heat shock protein HSPB1, a potent neuroprotective factor, was downregulated, and TFIIB occupancy of the Hspb1 promoter was decreased. Overexpression of HSPB1 or TFIIB alleviated mutant TBP-induced neuritic defects. These findings implicate the polyQ domain of TBP in transcriptional regulation and provide insight into the molecular pathogenesis of SCA17.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Emory University	Li, XJ (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	xiaoli@genetics.emory.edu	Warren, Stephen T/A-2498-2012		NIA NIH HHS [R01 AG031153, AG19206] Funding Source: Medline; NIGMS NIH HHS [T32 GM008490] Funding Source: Medline; NINDS NIH HHS [R01 NS045016, NS36232, R01 NS041669, NS045016, NS41669] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041669, R01NS045016, R01NS036232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031153, R01AG019206] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; Armstrong CL, 2001, J COMP NEUROL, V434, P262, DOI 10.1002/cne.1176; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Bondareva AA, 2003, MOL BIOL EVOL, V20, P1932, DOI 10.1093/molbev/msg205; Bruni AC, 2004, ARCH NEUROL-CHICAGO, V61, P1314, DOI 10.1001/archneur.61.8.1314; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Chang WH, 2005, BIOCHEM BIOPH RES CO, V336, P258, DOI 10.1016/j.bbrc.2005.08.065; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fujigasaki H, 2001, BRAIN, V124, P1939, DOI 10.1093/brain/124.10.1939; GAESTEL M, 1993, GENE, V128, P279, DOI 10.1016/0378-1119(93)90575-N; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Jackson-Fisher AJ, 1999, MOL CELL, V3, P717, DOI 10.1016/S1097-2765(01)80004-6; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lasek K, 2006, BRAIN, V129, P2341, DOI 10.1093/brain/awl148; Lee M, 1997, MOL CELL BIOL, V17, P1336, DOI 10.1128/MCB.17.3.1336; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Maltecca F, 2003, NEUROLOGY, V61, P1441, DOI 10.1212/01.WNL.0000094123.09098.A0; Michalik A, 2001, BIOTECHNIQUES, V31, P250, DOI 10.2144/01312bm02; Mittal V, 1997, SCIENCE, V275, P1136, DOI 10.1126/science.275.5303.1136; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Parker JA, 2001, P NATL ACAD SCI USA, V98, P13318, DOI 10.1073/pnas.231476398; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rolfs A, 2003, ANN NEUROL, V54, P367, DOI 10.1002/ana.10676; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schmidt EE, 2003, J BIOL CHEM, V278, P6168, DOI 10.1074/jbc.M211205200; SEIPEL K, 1994, MOL REPROD DEV, V39, P215, DOI 10.1002/mrd.1080390215; Sharp P, 2006, EXP NEUROL, V198, P511, DOI 10.1016/j.expneurol.2005.12.031; Taggart AKP, 1996, SCIENCE, V272, P1331, DOI 10.1126/science.272.5266.1331; Tansey WP, 1997, SCIENCE, V275, P829, DOI 10.1126/science.275.5301.829; Toyoshima Y, 2004, ANN NEUROL, V55, P281, DOI 10.1002/ana.10824; Tsai HF, 2005, BIOCHEM BIOPH RES CO, V334, P1279, DOI 10.1016/j.bbrc.2005.06.207; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; Williams KL, 2006, J NEUROSCI RES, V84, P716, DOI 10.1002/jnr.20983; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	45	128	131	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1519	1528		10.1038/nn2011	http://dx.doi.org/10.1038/nn2011			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17994014				2022-12-17	WOS:000251172900008
J	Wu, CL; Xia, S; Fu, TF; Wang, H; Chen, YH; Leong, D; Chiang, AS; Tully, T				Wu, Chia-Lin; Xia, Shouzhen; Fu, Tsai-Feng; Wang, Huaien; Chen, Ying-Hsiu; Leong, Daniel; Chiang, Ann-Shyn; Tully, Tim			Specific requirement of NMDA receptors for long-term memory consolidation in Drosophila ellipsoid body	NATURE NEUROSCIENCE			English	Article							DOUBLE-STRANDED-RNA; MUSHROOM BODIES; CENTRAL COMPLEX; NEURONS; GENE; MELANOGASTER; BRAIN; ORGANIZATION; INTERFERENCE; EXPRESSION	In humans and many other animals, memory consolidation occurs through multiple temporal phases and usually involves more than one neuroanatomical brain system. Genetic dissection of Pavlovian olfactory learning in Drosophila melanogaster has revealed multiple memory phases, but the predominant view holds that all memory phases occur in mushroom body neurons. Here, we demonstrate an acute requirement for NMDA receptors (NMDARs) outside of the mushroom body during long-term memory (LTM) consolidation. Targeted dsRNA-mediated silencing of Nmdar1 and Nmdar2 (also known as dNR1 or dNR2, respectively) in cholinergic R4m-subtype large-field neurons of the ellipsoid body specifically disrupted LTM consolidation, but not retrieval. Similar silencing of functional NMDARs in the mushroom body disrupted an earlier memory phase, leaving LTM intact. Our results clearly establish an anatomical site outside of the mushroom body involved with LTM consolidation, thus revealing both a distributed brain system subserving olfactory memory formation and the existence of a system-level memory consolidation in Drosophila.	Natl Tsing Hua Univ, Inst Biotechnol, Dept Life Sci, Hsinchu 30013, Taiwan; Natl Tsing Hua Univ, Univ Syst Taiwan, Brain Res Ctr, Hsinchu 30013, Taiwan; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Natl Chi Nan Univ, Dept Appl Chem, Nantou 545, Taiwan	National Tsing Hua University; National Tsing Hua University; Cold Spring Harbor Laboratory; National Chi Nan University	Chiang, AS (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Dept Life Sci, Sect 2,Kuang-Fu Rd, Hsinchu 30013, Taiwan.	aschiang@life.nthu.edu.tw; tully@cshl.edu		Fu, Tsai-Feng/0000-0002-0343-3018; Chiang, Ann-Shyn/0000-0001-9668-7115; Wu, Chia-Lin/0000-0002-7906-2364	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066910] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH066910-03] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akalal DBG, 2006, LEARN MEMORY, V13, P659, DOI 10.1101/lm.221206; ALLWEIS C, 1991, NEURAL BEHAV PLASTIC, P370; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Dash PK, 2004, BRAIN RES REV, V45, P30, DOI 10.1016/j.brainresrev.2004.02.001; Davis J, 2002, OXFORD REV EDUC, V28, P275, DOI 10.1080/03054980220143423; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; EICHENBAUM H, 2001, CONDITIONING CONSCIO, P583; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Flockhart I, 2006, NUCLEIC ACIDS RES, V34, pD489, DOI 10.1093/nar/gkj114; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lee T, 1999, DEVELOPMENT, V126, P4065; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Pascual A, 2004, NATURE, V427, P605, DOI 10.1038/427605a; Renn SCP, 1999, J NEUROBIOL, V41, P189; Roberts AC, 2003, TRENDS NEUROSCI, V26, P662, DOI 10.1016/j.tins.2003.09.014; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Xia S, 2007, PLOS BIOL, V5, P2398, DOI 10.1371/journal.pbio.0050264; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037	48	128	136	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1578	1586		10.1038/nn2005	http://dx.doi.org/10.1038/nn2005			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17982450	Green Accepted			2022-12-17	WOS:000251172900015
J	Knoll, B; Kretz, O; Fiedler, C; Alberti, S; Schutz, G; Frotscher, M; Nordheim, A				Knoll, B; Kretz, O; Fiedler, C; Alberti, S; Schutz, G; Frotscher, M; Nordheim, A			Serum response factor controls neuronal circuit assembly in the hippocampus	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; CALCIUM INFLUX; MICE LACKING; RHO-GTPASES; EPHRIN-AS; SRF; ACTIVATION; DYNAMICS; FAMILY	Higher organisms rely on multiple modes of memory storage using the hippocampal network, which is built by precisely orchestrated mechanisms of axonal outgrowth, guidance and synaptic targeting. We demonstrate essential roles of the transcription factor serum response factor ( SRF), a sensor of cytoskeletal actin dynamics, in all these processes. Conditional deletion of the mouse Srf gene reduced neurite outgrowth and abolished mossy fiber segregation, resulting in ectopic fiber growth inside the pyramidal layer. SRF-deficient mossy fibers aberrantly targeted CA3 somata for synapse formation. Axon guidance assays showed that SRF was a key mediator of ephrin-A and semaphorin guidance cues; in SRF-deficient neurons, these resulted in the formation of F-actin-microtubule rings rather than complete growth cone collapse. Dominant-negative variants of the SRF cofactor megakaryocytic acute leukemia ( MAL) severely impeded neurite outgrowth and guidance. These data highlight essential links between SRF-mediated transcription and axon guidance and circuit formation in the hippocampus.	Univ Tubingen, Interfak Inst Zellbiol, Abt Mol Biol, D-72076 Tubingen, Germany; Univ Freiburg, Inst Anat & Zellbiol, D-79104 Freiburg, Germany; Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany	Eberhard Karls University of Tubingen; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ)	Nordheim, A (corresponding author), Univ Tubingen, Interfak Inst Zellbiol, Abt Mol Biol, Morgenstelle 15, D-72076 Tubingen, Germany.	alfred.nordheim@uni-tuebingen.de		Kretz, Oliver/0000-0003-1152-5956				Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; BLACKSTAD T, 1961, J COMP NEUROL, V117, P133, DOI 10.1002/cne.901170202; BRAENDGAARD H, 1986, J NEUROSCI METH, V18, P39, DOI 10.1016/0165-0270(86)90112-3; Brownlee H, 2000, J COMP NEUROL, V425, P315, DOI 10.1002/1096-9861(20000918)425:2<315::AID-CNE12>3.0.CO;2-#; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen B, 2001, SPECTROSC SPECT ANAL, V21, P263; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Goetze B, 2004, J NEUROBIOL, V60, P517, DOI 10.1002/neu.20073; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; LIPP HP, 1988, J NEUROSCI, V8, P1905; LIPP HP, 1989, EXPERIENTIA, V45, P845, DOI 10.1007/BF01954059; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Singec I, 2002, J COMP NEUROL, V452, P139, DOI 10.1002/cne.10371; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tabuchi A, 2005, J NEUROCHEM, V94, P169, DOI 10.1111/j.1471-4159.2005.03179.x; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wiebel FF, 2002, GENESIS, V32, P124, DOI 10.1002/gene.10049; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yue Y, 2002, P NATL ACAD SCI USA, V99, P10777, DOI 10.1073/pnas.162354599	50	128	131	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					195	204		10.1038/nn1627	http://dx.doi.org/10.1038/nn1627			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415869				2022-12-17	WOS:000234990100014
J	Williams, ZM; Elfar, JC; Eskandar, EN; Toth, LJ; Assad, JA				Williams, ZM; Elfar, JC; Eskandar, EN; Toth, LJ; Assad, JA			Parietal activity and the perceived direction of ambiguous apparent motion	NATURE NEUROSCIENCE			English	Article							PERCEPTUAL DECISION; VISUAL GUIDANCE; MACAQUE MONKEY; CORTICAL AREAS; MT; CORTEX; ATTENTION; SIGNALS; PERFORMANCE; MODULATION	We recorded from parietal neurons in monkeys (Macacca mulatta) trained to report the direction of an apparent motion stimulus consisting of regularly spaced columns of dots surrounded by an aperture. Displacing the dots by half their inter-column spacing produced vivid apparent motion that could be perceived in either the preferred or anti-preferred direction for each neuron. Many neurons in the lateral intraparietal area (LIP) responded more strongly on trials in which the animals reported perceiving the neurons' preferred direction, independent of the hand movement used to report their percept. This selectivity was less common in the medial superior temporal area (MST) and virtually absent in the middle temporal area (MT). Variations in activity of LIP and MST neurons just before motion onset were also predictive of the animals' subsequent perceived direction. These data suggest a hierarchy of representation in parietal cortex, whereby neuronal responses become more aligned with subjective perception in higher parietal areas.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Assad, JA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jassad@hms.harvard.edu	Elfar, J./Q-7371-2017	Elfar, J./0000-0002-4438-7118; Toth, Louis/0000-0003-4986-7046	NATIONAL EYE INSTITUTE [R01EY012106] Funding Source: NIH RePORTER; NEI NIH HHS [EY12106] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRIGHT TD, 1993, REV OCULOMOT RES, V51, P77; Andersen RA, 1997, NEURON, V18, P865, DOI 10.1016/S0896-6273(00)80326-8; Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; Basso MA, 1998, J NEUROSCI, V18, P7519; Battelli L, 2001, NEURON, V32, P985, DOI 10.1016/S0896-6273(01)00536-0; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Dorris MC, 2000, J NEUROSCI, V20; Eskandar EN, 1999, NAT NEUROSCI, V2, P88, DOI 10.1038/4594; Eskandar EN, 2002, J NEUROPHYSIOL, V88, P1777, DOI 10.1152/jn.2002.88.4.1777; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Livingstone MS, 2001, NEURON, V30, P781, DOI 10.1016/S0896-6273(01)00313-0; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1328, DOI 10.1152/jn.1986.55.6.1328; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Verstraten FAJ, 2000, VISION RES, V40, P3651, DOI 10.1016/S0042-6989(00)00213-3; WATANABE T, 1995, VISION RES, V35, P2853, DOI 10.1016/0042-6989(95)00064-7	30	128	128	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					616	623		10.1038/nn1055	http://dx.doi.org/10.1038/nn1055			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12730699				2022-12-17	WOS:000183140400019
J	Riddoch, MJ; Humphreys, GW; Edwards, S; Baker, T; Willson, K				Riddoch, MJ; Humphreys, GW; Edwards, S; Baker, T; Willson, K			Seeing the action: neuropsychological evidence for action-based effects on object selection	NATURE NEUROSCIENCE			English	Article							VISUAL SELECTION; EXTINCTION; NEGLECT	Previous studies have shown that selection for perceptual report is often limited to one object at a time, with elements being selected together if they belong to part of the same perceptual group. Here we used the neuropsychological phenomenon of extinction in human patients with parietal lesions to show that selection is influenced also by action relations between objects. Performance was better for objects that were positioned spatially so that they could be used together, relative to objects that were positioned inappropriately for their combined use. The action relation was critical, as performance for pictures did not improve if the items were only verbally associated. We found the opposite result with words. Effects of action relations emerged even on trials where only one object could be reported, showing implicit coding of 'action' units for selection. The effects of verbal associations may instead reflect priming between lexical entries.	Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Riddoch, MJ (corresponding author), Univ Birmingham, Sch Psychol, Behav Brain Sci Ctr, Birmingham B15 2TT, W Midlands, England.		Riddoch, Jane/F-7968-2010					Allport D.A., 1985, CURRENT PERSPECTIVES, P32; COSLETT HB, 1991, BRAIN, V114, P1523, DOI 10.1093/brain/114.4.1523; Critchley M., 1953, PARIETAL LOBES; Driver J., 1996, CONVERGENT OPERATION, P193; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; Duncan J., 1996, ATTENTION PERFORM, P549; GADO M, 1979, J COMPUT ASSIST TOMO, V3, P1, DOI 10.1097/00004728-197902000-00001; Gilchrist ID, 1996, COGNITIVE NEUROPSYCH, V13, P1223, DOI 10.1080/026432996381737; Humphreys GW, 1998, PHILOS T R SOC B, V353, P1341, DOI 10.1098/rstb.1998.0288; Humphreys GW, 2001, BEHAV BRAIN SCI, V24, P453, DOI 10.1017/S0140525X01004150; HUMPHREYS GW, 1993, ATTENTION PERFORM, V14, P143; Kumada T, 2001, COGNITIVE NEUROPSYCH, V18, P465, DOI 10.1080/02643290042000224; Mattingley JB, 1997, SCIENCE, V275, P671, DOI 10.1126/science.275.5300.671; Moss Helen, 1996, BIRKBECK WORD ASS NO; Oppenheim H., 1885, NEUROLOGISCHES CENTR, V4, P529; SERON X, 1989, COGNITIVE NEUROPSYCH, V6, P475, DOI 10.1080/02643298908253427; Shalev L, 2000, COGNITIVE NEUROPSYCH, V17, P339, DOI 10.1080/026432900380436; Ward R., 1994, VIS COGN, V1, P101, DOI DOI 10.1080/13506289408402295; Wilson B., 1987, BEHAV INATTENTION TE	19	128	129	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					82	89		10.1038/nn984	http://dx.doi.org/10.1038/nn984			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469129				2022-12-17	WOS:000180089300019
J	Arikawa-Hirasawa, E; Rossi, SG; Rotundo, RL; Yamada, Y				Arikawa-Hirasawa, E; Rossi, SG; Rotundo, RL; Yamada, Y			Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice	NATURE NEUROSCIENCE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; COLLAGEN-TAILED ACETYLCHOLINESTERASE; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANES; SKELETAL-MUSCLE; ALPHA-DYSTROGLYCAN; BASAL LAMINA; CHOLINESTERASE; CARTILAGE; DIAPHRAGM	The collagen-tailed form of acetylcholinesterase (AChE) is concentrated at the vertebrate neuromuscular junction (NMJ), where it is responsible for rapidly terminating neurotransmission. This unique oligomeric form of AChE, consisting of three tetramers covalently attached to a collagen-like tail, is more highly expressed in innervated regions of skeletal muscle fibers, where it is externalized and attached to the synaptic basal lamina interposed between the nerve terminal and the receptor-rich postsynaptic membrane. Although it is clear that the enzyme is preferentially synthesized in regions of muscle contacted by the motoneuron, the molecular events underlying its localization to the NMJ are not known. Here we show that perlecan, a multifunctional heparan sulfate proteoglycan concentrated at the NMJ, is the unique acceptor molecule for collagen-tailed AChE at sites of nerve-muscle contact and is the principal mechanism for localizing AChE to the synaptic basal lamina.	Univ Miami, Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; Univ Miami, Sch Med, Neurosci Program, Miami, FL 33136 USA; Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA	University of Miami; University of Miami; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Rotundo, RL (corresponding author), Univ Miami, Sch Med, Dept Cell Biol & Anat, 1600 NW 10th Ave, Miami, FL 33136 USA.				NIA NIH HHS [R01 AG005917] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG005917] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON MJ, 1983, J CELL BIOL, V97, P1396, DOI 10.1083/jcb.97.5.1396; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; BAYNE EK, 1984, J CELL BIOL, V99, P1486, DOI 10.1083/jcb.99.4.1486; BON S, 1978, EUR J BIOCHEM, V85, P1, DOI 10.1111/j.1432-1033.1978.tb12207.x; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801; BRANDAN E, 1987, FEBS LETT, V213, P159, DOI 10.1016/0014-5793(87)81483-7; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Donger C, 1998, AM J HUM GENET, V63, P967, DOI 10.1086/302059; Feng GP, 1999, J CELL BIOL, V144, P1349, DOI 10.1083/jcb.144.6.1349; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; HALL ZW, 1973, J NEUROBIOL, V4, P343, DOI 10.1002/neu.480040404; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; JASMIN BJ, 1993, NEURON, V11, P467, DOI 10.1016/0896-6273(93)90151-G; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; LEGAY C, 1995, EUR J NEUROSCI, V7, P1803, DOI 10.1111/j.1460-9568.1995.tb00699.x; LEIVO I, 1988, P NATL ACAD SCI USA, V85, P1544, DOI 10.1073/pnas.85.5.1544; LWEBUGAMUKASA JS, 1976, BIOCHEMISTRY-US, V15, P1425, DOI 10.1021/bi00652a012; MARNA A, 1938, J PHYSIOL-LONDON, V92, P34; MASSOULIE J, 1969, EUR J BIOCHEM, V11, P441, DOI 10.1111/j.1432-1033.1969.tb00794.x; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MCMAHAN UJ, 1978, NATURE, V271, P172, DOI 10.1038/271172a0; MICHEL RN, 1994, J CELL BIOL, V127, P1061, DOI 10.1083/jcb.127.4.1061; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; PEREZTUR J, 1991, FEBS LETT, V286, P25, DOI 10.1016/0014-5793(91)80932-S; ROSSI SG, 1992, J CELL BIOL, V119, P1657, DOI 10.1083/jcb.119.6.1657; Rossi SG, 1996, J BIOL CHEM, V271, P1979, DOI 10.1074/jbc.271.4.1979; ROSSI SG, 1993, J BIOL CHEM, V268, P19152; Rotundo RL, 1997, J CELL BIOL, V136, P367, DOI 10.1083/jcb.136.2.367; Rotundo RL, 1994, MYOLOGY, P607; SANES JR, 1986, J CELL BIOL, V102, P420, DOI 10.1083/jcb.102.2.420; SANES JR, 1994, MYOLOGY, P242; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; TORRES JC, 1985, CELL MOL NEUROBIOL, V5, P303, DOI 10.1007/BF00711015; VIGNY M, 1983, J BIOL CHEM, V258, P8794	39	128	135	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					119	123		10.1038/nn801	http://dx.doi.org/10.1038/nn801			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802174				2022-12-17	WOS:000173558400013
J	Xiao, ZJ; Suga, N				Xiao, ZJ; Suga, N			Modulation of cochlear hair cells by the auditory cortex in the mustached bat	NATURE NEUROSCIENCE			English	Article							CROSSED OLIVOCOCHLEAR BUNDLE; MIDBRAIN FREQUENCY MAP; PTERONOTUS-P-PARNELLII; MOUSTACHED BAT; INFERIOR COLLICULUS; CORTICOFUGAL MODULATION; ELECTRICAL-STIMULATION; NERVE RESPONSE; SYSTEM; MECHANICS	The corticofugal (descending) auditory system forms multiple feedback loops, and adjusts and improves auditory signal processing in the subcortical auditory nuclei. However, the mechanism by which the corticofugal system modulates cochlear hair cells has been unexplored. We found that electric stimulation of cortical neurons via the corticofugal system modulates cochlear hair cells in a highly specific way according to the relationship in terms of best frequency between cortical neurons and hair cells. Such frequency-specific effects can be explained by selective corticofugal modulation of individual olivocochlear efferent fibers.	Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Suga, N (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000175] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-00175] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BISHOP AL, 1987, HEARING RES, V31, P175, DOI 10.1016/0378-5955(87)90124-9; DESMEDT JE, 1961, NATURE, V193, P1263; DEWSON JH, 1968, J NEUROPHYSIOL, V31, P122, DOI 10.1152/jn.1968.31.1.122; DOLAN DF, 1988, J ACOUST SOC AM, V83, P1081, DOI 10.1121/1.396052; GAIONI SJ, 1990, J NEUROPHYSIOL, V64, P1801, DOI 10.1152/jn.1990.64.6.1801; Gao E, 1998, P NATL ACAD SCI USA, V95, P12663, DOI 10.1073/pnas.95.21.12663; Gao EQ, 2000, P NATL ACAD SCI USA, V97, P8081, DOI 10.1073/pnas.97.14.8081; GEISLER CD, 1974, J ACOUST SOC AM, V56, P1908, DOI 10.1121/1.1903532; Goldberg RL, 1998, HEARING RES, V122, P71, DOI 10.1016/S0378-5955(98)00078-1; GOLDMAN LJ, 1977, BEHAV ECOL SOCIOBIOL, V2, P411, DOI 10.1007/BF00299509; HENSON OW, 1972, PHYSIOL BEHAV, V8, P1185, DOI 10.1016/0031-9384(72)90220-X; HENSON OW, 1982, HEARING RES, V7, P127, DOI 10.1016/0378-5955(82)90010-7; Henson OW., 1980, ANIMAL SONAR SYSTEMS, P913, DOI [10.1007/978-1-4684-7254-7_56, DOI 10.1007/978-1-4684-7254-7_56]; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; HUFFMAN RF, 1991, HEARING RES, V56, P79, DOI 10.1016/0378-5955(91)90156-4; HUFFMAN RF, 1993, J COMP PHYSIOL A, V171, P725, DOI 10.1007/BF00213069; KAWASE T, 1993, J NEUROPHYSIOL, V70, P2533, DOI 10.1152/jn.1993.70.6.2533; Khalfa S, 2001, NEUROSCIENCE, V104, P347, DOI 10.1016/S0306-4522(01)00072-0; Liu W, 1997, J COMP PHYSIOL A, V181, P599, DOI 10.1007/s003590050143; Ma XF, 2001, J NEUROPHYSIOL, V85, P1078, DOI 10.1152/jn.2001.85.3.1078; Maison S, 2001, PSYCHOPHYSIOLOGY, V38, P35, DOI 10.1017/S0048577201990109; MANABE T, 1978, SCIENCE, V200, P339, DOI 10.1126/science.635594; MOUNTAIN DC, 1980, SCIENCE, V210, P71, DOI 10.1126/science.7414321; Mulders WHA, 2000, HEARING RES, V149, P11, DOI 10.1016/S0378-5955(00)00157-X; NIEDER P, 1970, NATURE, V227, P184, DOI 10.1038/227184a0; OATMAN LC, 1977, EXP NEUROL, V57, P200, DOI 10.1016/0014-4886(77)90057-7; OLSEN JF, 1991, J NEUROPHYSIOL, V65, P1275, DOI 10.1152/jn.1991.65.6.1275; POLLAK G, 1972, SCIENCE, V176, P66, DOI 10.1126/science.176.4030.66; PUEL JL, 1988, BRAIN RES, V447, P380, DOI 10.1016/0006-8993(88)91144-4; RAJAN R, 1990, BRAIN RES, V506, P192, DOI 10.1016/0006-8993(90)91251-B; RIQUIMAROUX H, 1991, SCIENCE, V251, P565, DOI 10.1126/science.1990432; SCHNITZLER HU, 1970, Z VERGL PHYSIOL, V68, P25, DOI 10.1007/BF00297809; SIEGEL JH, 1982, HEARING RES, V6, P171, DOI 10.1016/0378-5955(82)90052-1; SUGA N, 1987, J NEUROPHYSIOL, V58, P643, DOI 10.1152/jn.1987.58.4.643; SUGA N, 1975, J EXP BIOL, V62, P277; SUGA N, 1982, J NEUROPHYSIOL, V47, P225, DOI 10.1152/jn.1982.47.2.225; SUGA N, 1985, J NEUROPHYSIOL, V53, P1109, DOI 10.1152/jn.1985.53.4.1109; Suga N, 2000, P NATL ACAD SCI USA, V97, P11807, DOI 10.1073/pnas.97.22.11807; SUGA N, 1977, J EXP BIOL, V69, P207; Warr WB, 1992, MAMMALIAN AUDITORY P, P410; WIEDERHOLD ML, 1970, J ACOUST SOC AM, V48, P966, DOI 10.1121/1.1912235; Xie DH, 1998, HEARING RES, V124, P60, DOI 10.1016/S0378-5955(98)00122-1; Yan J, 1996, SCIENCE, V273, P1100, DOI 10.1126/science.273.5278.1100; Yan W, 1998, NAT NEUROSCI, V1, P54, DOI 10.1038/255; Zhang YF, 1997, NATURE, V387, P900, DOI 10.1038/43180; Zhang YF, 2000, J NEUROPHYSIOL, V84, P325, DOI 10.1152/jn.2000.84.1.325; Zhang YF, 1997, J NEUROPHYSIOL, V78, P3489, DOI 10.1152/jn.1997.78.6.3489	47	128	130	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					57	63		10.1038/nn786	http://dx.doi.org/10.1038/nn786			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753417				2022-12-17	WOS:000173031800016
J	Karst, H; Karten, YJG; Reichardt, HM; de Kloet, ER; Schutz, G; Joels, M				Karst, H; Karten, YJG; Reichardt, HM; de Kloet, ER; Schutz, G; Joels, M			Corticosteroid actions in hippocampus require DNA binding of glucocorticoid receptor homodimers	NATURE NEUROSCIENCE			English	Article							PYRAMIDAL NEURONS; BRAIN; ACTIVATION; STRESS; MODULATION; HORMONES		Univ Amsterdam, Inst Neurobiol, NL-1098 SM Amsterdam, Netherlands; German Canc Res Ctr, D-69120 Heidelberg, Germany; Leiden Univ, Sylvius Lab, NL-2300 RA Leiden, Netherlands	University of Amsterdam; Helmholtz Association; German Cancer Research Center (DKFZ); Leiden University; Leiden University - Excl LUMC	Joels, M (corresponding author), Univ Amsterdam, Inst Neurobiol, Kruislaan 320, NL-1098 SM Amsterdam, Netherlands.		Joëls, Marian/P-6415-2016; Reichardt, Holger/AAF-3048-2020	Reichardt, Holger/0000-0003-4647-057X; de Kloet, Ron/0000-0001-9176-1830; Joels, Marian/0000-0002-4826-6209				ANDRADE R, 1987, J PHYSIOL-LONDON, V394, P99, DOI 10.1113/jphysiol.1987.sp016862; Beck SG, 1996, NEUROPSYCHOPHARMACOL, V14, P27, DOI 10.1016/S0893-133X(96)80056-X; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; Hesen W, 1996, J NEUROSCI, V16, P6766; Hesen W, 1996, J NEUROENDOCRINOL, V8, P433, DOI 10.1046/j.1365-2826.1996.04724.x; Holsboer F, 1996, ENDOCR REV, V17, P187, DOI 10.1210/er.17.2.187; Joels M, 1997, FRONT NEUROENDOCRIN, V18, P2, DOI 10.1006/frne.1996.0144; KARST H, 1994, BRAIN RES, V649, P234, DOI 10.1016/0006-8993(94)91069-3; KERR DS, 1992, P NATL ACAD SCI USA, V89, P8527, DOI 10.1073/pnas.89.18.8527; Kim JJ, 1998, TRENDS NEUROSCI, V21, P505, DOI 10.1016/S0166-2236(98)01322-8; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Porter NM, 1998, NAT NEUROSCI, V1, P3, DOI 10.1038/196; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 1998, MOL CELL ENDOCRINOL, V146, P1, DOI 10.1016/S0303-7207(98)00208-1; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148	15	128	131	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					977	978		10.1038/79910	http://dx.doi.org/10.1038/79910			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017168				2022-12-17	WOS:000167177500013
J	Zhou, HB; Liu, JL; Zhou, CY; Gao, N; Rao, ZP; Li, H; Hu, XD; Li, CL; Yao, X; Shen, XW; Sun, YD; Wei, Y; Liu, F; Ying, WQ; Zhang, JM; Tang, C; Zhang, X; Xu, HT; Shi, LY; Cheng, LP; Huang, PY; Yang, H				Zhou, Haibo; Liu, Junlai; Zhou, Changyang; Gao, Ni; Rao, Zhiping; Li, He; Hu, Xinde; Li, Changlin; Yao, Xuan; Shen, Xiaowen; Sun, Yidi; Wei, Yu; Liu, Fei; Ying, Wenqin; Zhang, Junming; Tang, Cheng; Zhang, Xu; Xu, Huatai; Shi, Linyu; Cheng, Leping; Huang, Pengyu; Yang, Hui			In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR-dCas9-activator transgenic mice	NATURE NEUROSCIENCE			English	Article							CONVERTS FIBROBLASTS; NEURONAL CELLS; CRISPR; GENOME; EXPRESSION; SYSTEM; COMPLEX; DIFFERENTIATION; OVEREXPRESSION; MODULATION	Despite rapid progresses in the genome-editing field, in vivo simultaneous overexpression of multiple genes remains challenging. We generated a transgenic mouse using an improved dCas9 system that enables simultaneous and precise in vivo transcriptional activation of multiple genes and long noncoding RNAs in the nervous system. As proof of concept, we were able to use targeted activation of endogenous neurogenic genes in these transgenic mice to directly and efficiently convert astrocytes into functional neurons in vivo. This system provides a flexible and rapid screening platform for studying complex gene networks and gain-of-function phenotypes in the mammalian brain.	[Zhou, Haibo; Zhou, Changyang; Gao, Ni; Rao, Zhiping; Li, He; Hu, Xinde; Li, Changlin; Yao, Xuan; Shen, Xiaowen; Wei, Yu; Liu, Fei; Ying, Wenqin; Zhang, Junming; Tang, Cheng; Zhang, Xu; Xu, Huatai; Shi, Linyu; Cheng, Leping; Yang, Hui] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Shanghai Inst Biol Sci, Inst Neurosci,State Key Lab Neurosci, Shanghai, Peoples R China; [Liu, Junlai; Huang, Pengyu] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Liu, Junlai; Zhou, Changyang; Gao, Ni; Rao, Zhiping; Li, He; Hu, Xinde; Liu, Fei; Tang, Cheng] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Liu, Junlai] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Sun, Yidi] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Yang, H (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Shanghai Inst Biol Sci, Inst Neurosci,State Key Lab Neurosci, Shanghai, Peoples R China.; Huang, PY (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.	huangpy@shanghaitech.edu.cn; huiyang@ion.ac.cn	Liu, Junlai/ABE-4481-2021; Huang, Pengyu/ABH-1721-2021; Liu, Junlai/GNP-3178-2022; ZHOU, Haibo/M-7373-2017; Huang, Pengyu/ABF-5330-2021	Huang, Pengyu/0000-0001-8394-7280; 	National Science and Technology Major Project [2017YFC1001302]; CAS Strategic Priority Research Program [XDB02050007, XDA01010409]; MoST863 Program [2015AA020307]; NSFC [31522037, 31500825, 31571509, 31522038]; China Youth Thousand Talents Program; Break through project of Chinese Academy of Sciences, Shanghai Sailing Plan for the Young Scientific Talents [15YF1414700]; Ministry of Science and Technology of China (MOST) [2016YFA0100500]	National Science and Technology Major Project; CAS Strategic Priority Research Program; MoST863 Program(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); China Youth Thousand Talents Program; Break through project of Chinese Academy of Sciences, Shanghai Sailing Plan for the Young Scientific Talents; Ministry of Science and Technology of China (MOST)(Ministry of Science and Technology, China)	We thank D. Li, F. Zuo, Y. Shi, Y. Liu, J. He, J. Pan, Y. Zhong, Y. Lu, Y. Zhang, J. Yang and X. Tang for technical assistance and valuable discussion. This work was supported by National Science and Technology Major Project (2017YFC1001302), CAS Strategic Priority Research Program (XDB02050007, XDA01010409), the MoST863 Program (2015AA020307), NSFC grants (31522037, 31500825, 31571509, 31522038), China Youth Thousand Talents Program (to H.Y.), Break through project of Chinese Academy of Sciences, Shanghai Sailing Plan for the Young Scientific Talents (15YF1414700), and The Ministry of Science and Technology of China (MOST; 2016YFA0100500).	Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Black JB, 2016, CELL STEM CELL, V19, P406, DOI 10.1016/j.stem.2016.07.001; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/NMETH.3312, 10.1038/nmeth.3312]; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cheng L, 2015, CELL RES, V25, P1269, DOI 10.1038/cr.2015.120; Chow RD, 2017, NAT NEUROSCI, V20, P1329, DOI 10.1038/nn.4620; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Dahlman JE, 2016, NAT BIOTECHNOL, V34, P441, DOI 10.1038/nbt0416-441a; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Gao YC, 2016, NAT METHODS, V13, P1043, DOI [10.1038/nmeth.4042, 10.1038/NMETH.4042]; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Greferath U, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00293; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Huang MG, 2008, DEV BIOL, V322, P394, DOI 10.1016/j.ydbio.2008.06.031; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ivaniutsin U, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-3; Joung J, 2017, NATURE, V548, P343, DOI 10.1038/nature23451; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li CL, 2016, CELL RES, V26, P83, DOI 10.1038/cr.2015.149; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Liu YG, 2015, J NEUROSCI, V35, P9336, DOI 10.1523/JNEUROSCI.3975-14.2015; Lombardi LM, 2015, J CLIN INVEST, V125, P2914, DOI 10.1172/JCI78167; Lundgaard I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7807; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McCracken Jennifer M., 2017, Gene Expression, V17, P187, DOI 10.3727/105221617X695050; Mertens J, 2016, NAT REV NEUROSCI, V17, P424, DOI 10.1038/nrn.2016.46; Nihongaki Y, 2017, NAT METHODS, V14, P963, DOI [10.1038/NMETH.4430, 10.1038/nmeth.4430]; Ou ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32463; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramer MS, 2008, J COMP NEUROL, V510, P283, DOI 10.1002/cne.21785; Schinko J., 2009, COLD SPRING HARB PRO, pt5258; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/nmeth.3433, 10.1038/NMETH.3433]; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; Wang P, 2009, CARCINOGENESIS, V30, P1497, DOI 10.1093/carcin/bgp154; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Yang S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00750-x; Yao X, 2017, CELL RES, V27, P801, DOI 10.1038/cr.2017.76; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhou HB, 2014, ELIFE, V3, DOI 10.7554/eLife.02536	56	127	133	9	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2018	21	3					440	+		10.1038/s41593-017-0060-6	http://dx.doi.org/10.1038/s41593-017-0060-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FZ7JH	29335603				2022-12-17	WOS:000427776400019
J	Sztainberg, Y; Zoghbi, HY				Sztainberg, Yehezkel; Zoghbi, Huda Y.			Lessons learned from studying syndromic autism spectrum disorders	NATURE NEUROSCIENCE			English	Review							FRAGILE-X-SYNDROME; MECP2 DUPLICATION SYNDROME; SEVERE MENTAL-RETARDATION; 22Q13 DELETION SYNDROME; CPG-BINDING PROTEIN-2; RETT-SYNDROME; TUBEROUS SCLEROSIS; MOUSE MODEL; BEHAVIORAL-PHENOTYPE; ANIMAL-MODEL	Syndromic autism spectrum disorders represent a group of childhood neurological conditions, typically associated with chromosomal abnormalities or mutations in a single gene. The discovery of their genetic causes has increased our understanding of the molecular pathways critical for normal cognitive and social development. Human studies have revealed that the brain is particularly sensitive to changes in dosage of various proteins from transcriptional and translational regulators to synaptic proteins. Investigations of these disorders in animals have shed light on previously unknown pathogenic mechanisms leading to the identification of potential targets for therapeutic intervention. The demonstration of reversibility of several phenotypes in adult mice is encouraging, and brings hope that with novel therapies, skills and functionality might improve in affected children and young adults. As new research reveals points of convergence between syndromic and nonsyndromic autism spectrum disorders, we believe there will be opportunities for shared therapeutics for this class of conditions.	[Sztainberg, Yehezkel; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Sztainberg, Yehezkel] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Zoghbi, HY (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Zoghbi, Huda/0000-0002-0700-3349	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057819] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anney R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/hmg/dds301; Baker SA, 2013, CELL, V152, P984, DOI 10.1016/j.cell.2013.01.038; Bambini V, 2011, BRAIN RES, V1408, P8, DOI 10.1016/j.brainres.2011.06.015; Battaglia A, 2005, BRAIN DEV-JPN, V27, P365, DOI 10.1016/j.braindev.2004.08.006; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Bauman MD, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.47; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beaudet AL, 2016, HUM MOL GENET, V25, pR18, DOI 10.1093/hmg/ddv476; Beltrao-Braga P.C., 2016, BRAIN RES; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Carney RM, 2003, PEDIATR NEUROL, V28, P205, DOI 10.1016/S0887-8994(02)00624-0; Castren E, 2012, J NEUROSCI, V32, P14074, DOI 10.1523/JNEUROSCI.3287-12.2012; Castro J, 2014, P NATL ACAD SCI USA, V111, P9941, DOI 10.1073/pnas.1311685111; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chomiak Taylor, 2013, Patholog Res Int, V2013, P712758, DOI 10.1155/2013/712758; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; D'Hulst C, 2006, BRAIN RES, V1121, P238, DOI 10.1016/j.brainres.2006.08.115; Dahlhaus R, 2010, BEHAV BRAIN RES, V208, P96, DOI 10.1016/j.bbr.2009.11.019; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Dissanayake C, 2009, J CHILD PSYCHOL PSYC, V50, P290, DOI 10.1111/j.1469-7610.2008.01988.x; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Engineer CT, 2015, NEUROBIOL DIS, V83, P26, DOI 10.1016/j.nbd.2015.08.019; Esclassan F, 2015, BEHAV NEUROSCI, V129, P74, DOI 10.1037/bne0000024; Friez MJ, 2006, PEDIATRICS, V118, pE1687, DOI 10.1542/peds.2006-0395; FRYER AE, 1987, LANCET, V1, P659; Gadalla KKE, 2013, MOL THER, V21, P18, DOI 10.1038/mt.2012.200; Garg SK, 2013, J NEUROSCI, V33, P13612, DOI 10.1523/JNEUROSCI.1854-13.2013; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Gennarino VA, 2015, ELIFE, V4, DOI 10.7554/eLife.10782; Griesi-Oliveira K, 2015, MOL PSYCHIATR, V20, P1350, DOI 10.1038/mp.2014.141; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hagerman R, 2011, J NEURODEV DISORD, V3, P211, DOI 10.1007/s11689-011-9084-5; Hall SS, 2010, J AM ACAD CHILD PSY, V49, P921, DOI 10.1016/j.jaac.2010.07.001; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Hao S, 2015, NATURE, V526, P430, DOI 10.1038/nature15694; Hatton DD, 2006, AM J MED GENET A, V140A, P1804, DOI 10.1002/ajmg.a.31286; Heckman LD, 2014, ELIFE, V3, DOI 10.7554/eLife.02676; Hulbert SW, 2016, NEUROSCIENCE, V321, P3, DOI 10.1016/j.neuroscience.2015.12.040; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Ito-Ishida A, 2015, NEURON, V88, P651, DOI 10.1016/j.neuron.2015.10.029; Jeste SS, 2008, J CHILD NEUROL, V23, P520, DOI 10.1177/0883073807309788; Jeste SS, 2016, NEUROLOGY, V87, P766, DOI 10.1212/WNL.0000000000003002; Jeste SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9874; KANDT RS, 1992, NAT GENET, V2, P37, DOI 10.1038/ng0992-37; Kanner L, 1943, NERV CHILD, V2, P217; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kim KC, 2011, TOXICOL LETT, V201, P137, DOI 10.1016/j.toxlet.2010.12.018; Kline DD, 2010, J NEUROSCI, V30, P5303, DOI 10.1523/JNEUROSCI.5503-09.2010; Kuwano Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024723; Levenga J, 2010, TRENDS MOL MED, V16, P516, DOI 10.1016/j.molmed.2010.08.005; Liu Z, 2016, NATURE, V530, P98, DOI 10.1038/nature16533; Loat CS, 2008, GENES BRAIN BEHAV, V7, P754, DOI 10.1111/j.1601-183X.2008.00414.x; Lombardi LM, 2015, J CLIN INVEST, V125, P2914, DOI 10.1172/JCI78167; Lubs H, 1999, AM J MED GENET, V85, P243, DOI 10.1002/(SICI)1096-8628(19990730)85:3<243::AID-AJMG11>3.0.CO;2-E; Lubs HA, 2012, AM J HUM GENET, V90, P579, DOI 10.1016/j.ajhg.2012.02.018; Lugtenberg D, 2009, EUR J HUM GENET, V17, P444, DOI 10.1038/ejhg.2008.208; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; Mabunga DFN, 2015, EXP NEUROBIOL, V24, P285, DOI 10.5607/en.2015.24.4.285; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Martin JP, 1943, J NEUROL PSYCHIATRY, V6, P154, DOI 10.1136/jnnp.6.3-4.154; Martin LA, 2008, BRAIN BEHAV IMMUN, V22, P806, DOI 10.1016/j.bbi.2007.12.007; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Mei Y, 2016, NATURE, V530, P481, DOI 10.1038/nature16971; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Meng LY, 2015, NATURE, V518, P409, DOI 10.1038/nature13975; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; Na ES, 2012, J NEUROSCI, V32, P3109, DOI 10.1523/JNEUROSCI.6000-11.2012; Nagarajan RP, 2006, EPIGENETICS-US, V1, P172, DOI 10.4161/epi.1.4.3514; Nageshappa S, 2016, MOL PSYCHIATR, V21, P178, DOI 10.1038/mp.2015.128; NELLIST M, 1993, CELL, V75, P1305; Nelson SB, 2015, NEURON, V87, P684, DOI 10.1016/j.neuron.2015.07.033; Neul Jeffrey Lorenz, 2012, Dialogues Clin Neurosci, V14, P253; O'Callaghan FJK, 1998, LANCET, V351, P1490, DOI 10.1016/S0140-6736(05)78872-3; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Oguro-Ando A, 2015, MOL PSYCHIATR, V20, P1069, DOI 10.1038/mp.2014.124; Palferman S, 2001, AM J HUM GENET, V69, P570; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Paul R, 2008, CHILD ADOL PSYCH CL, V17, P835, DOI 10.1016/j.chc.2008.06.011; Percy AK, 2011, ARCH NEUROL-CHICAGO, V68, P985, DOI 10.1001/archneurol.2011.149; Peters SU, 2013, AUTISM RES, V6, P42, DOI 10.1002/aur.1262; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Ramocki MB, 2009, ANN NEUROL, V66, P771, DOI 10.1002/ana.21715; Reith RM, 2013, NEUROBIOL DIS, V51, P93, DOI 10.1016/j.nbd.2012.10.014; Reith RM, 2011, NEUROBIOL DIS, V43, P113, DOI 10.1016/j.nbd.2011.02.014; Rett A, 1966, Wien Med Wochenschr, V116, P723; Richards C, 2015, LANCET PSYCHIAT, V2, P909, DOI 10.1016/S2215-0366(15)00376-4; Rogers SJ, 2008, J CLIN CHILD ADOLESC, V37, P8, DOI 10.1080/15374410701817808; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Samaco RC, 2004, HUM MOL GENET, V13, P629, DOI 10.1093/hmg/ddh063; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Samaco RC, 2013, HUM MOL GENET, V22, P96, DOI 10.1093/hmg/dds406; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144; Santini E, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005832; Sato A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2295; Schaefer GB, 2008, GENET MED, V10, P4, DOI 10.1097/GIM.0b013e31815efdd7; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schneider T, 2008, PSYCHONEUROENDOCRINO, V33, P728, DOI 10.1016/j.psyneuen.2008.02.011; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Siviy SM, 2011, NEUROSCI BIOBEHAV R, V35, P1821, DOI 10.1016/j.neubiorev.2011.03.006; Smith LE, 2012, AJIDD-AM J INTELLECT, V117, P1, DOI 10.1352/1944-7558-117.1.1; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Soorya L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-18; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Spooren W, 2012, TRENDS PHARMACOL SCI, V33, P669, DOI 10.1016/j.tips.2012.09.004; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Sztainberg Y, 2015, NATURE, V528, P123, DOI 10.1038/nature16159; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Thanseem I, 2012, BIOL PSYCHIAT, V71, P410, DOI 10.1016/j.biopsych.2011.09.020; Till SM, 2015, HUM MOL GENET, V24, P5977, DOI 10.1093/hmg/ddv299; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang F, 2014, TRENDS NEUROSCI, V37, P674, DOI 10.1016/j.tins.2014.07.005; Weisenfeld NI, 2013, PEDIATR NEUROL, V48, P105, DOI 10.1016/j.pediatrneurol.2012.10.011; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Wolff JJ, 2012, J AM ACAD CHILD PSY, V51, P1324, DOI 10.1016/j.jaac.2012.09.001; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	150	127	132	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2016	19	11					1408	1417		10.1038/nn.4420	http://dx.doi.org/10.1038/nn.4420			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EA3WL	27786181				2022-12-17	WOS:000386539900008
J	Parisiadou, L; Yu, J; Sgobio, C; Xie, CS; Liu, GX; Sun, LX; Gu, XL; Lin, X; Crowley, NA; Lovinger, DM; Cai, HB				Parisiadou, Loukia; Yu, Jia; Sgobio, Carmelo; Xie, Chengsong; Liu, Guoxiang; Sun, Lixin; Gu, Xing-Long; Lin, Xian; Crowley, Nicole A.; Lovinger, David M.; Cai, Huaibin			LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-A; POSTSYNAPTIC DENSITY; SYNAPTIC PLASTICITY; ROC DOMAIN; CYCLIC-AMP; PHOSPHORYLATION; BRAIN; MICE; EXPRESSION; LTP	Leucine-rich repeat kinase 2 (LRRK2) is enriched in the striatal projection neurons (SPNs). We found that LRRK2 negatively regulates protein kinase A (PKA) activity in the SPNs during synaptogenesis and in response to dopamine receptor Drd1 activation. LRRK2 interacted with PKA regulatory subunit II beta (PKARII beta). A lack of LRRK2 promoted the synaptic translocation of PKA and increased PKA-mediated phosphorylation of actin-disassembling enzyme cofilin and glutamate receptor GluR1, resulting in abnormal synaptogenesis and transmission in the developing SPNs. Furthermore, PKA-dependent phosphorylation of GluR1 was also aberrantly enhanced in the striatum of young and aged Lrrk2(-/-) mice after treatment with a Drd1 agonist. Notably, a Parkinson's disease-related Lrrk2 R1441C missense mutation that impaired the interaction of LRRK2 with PKARIIb also induced excessive PKA activity in the SPNs. Our findings reveal a previously unknown regulatory role for LRRK2 in PKA signaling and suggest a pathogenic mechanism of SPN dysfunction in Parkinson's disease.	[Parisiadou, Loukia; Yu, Jia; Sgobio, Carmelo; Xie, Chengsong; Liu, Guoxiang; Sun, Lixin; Gu, Xing-Long; Lin, Xian; Cai, Huaibin] NIA, Transgen Sect, Neurogenet Lab, US NIH, Bethesda, MD 20892 USA; [Parisiadou, Loukia; Liu, Guoxiang] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Yu, Jia] Beijing Geriatr Hosp, Dept Geriatr, Beijing, Peoples R China; [Crowley, Nicole A.; Lovinger, David M.] NIAAA, Lab Integrat Neurosci, US NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Cai, HB (corresponding author), NIA, Transgen Sect, Neurogenet Lab, US NIH, Bethesda, MD 20892 USA.	loukia.parisiadou@northwestern.edu; caih@mail.nih.gov	Sgobio, Carmelo/AAD-7207-2021; Cai, Huaibin/H-3359-2013; Sgobio, Carmelo/AAU-4652-2021; gu, xinglong/A-3054-2011; Sgobio, Carmelo/AAH-3257-2020; Yu, Jia/J-2792-2014	Sgobio, Carmelo/0000-0002-6282-369X; Cai, Huaibin/0000-0002-8596-6108; gu, xinglong/0000-0002-0437-5606; Parisiadou, Loukia/0000-0002-2569-4200	National Institute on Aging [AG000944, AG000928]; National Institute of Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON AGING [ZIAAG000959, ZIAAG000928, ZIAAG000944, ZIAAG000945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416, ZIAAA000407] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank H. Zhong (Vollum Institute) for providing PKA expression vectors, M. Cookson (National Institute on Aging) for providing human Lrrk2 expression vector, J. Shen and Y. Tong (Harvard University) for providing Lrrk2 R1441C knock-in mice, P. Lewis (University College London) for providing LRRK2 wild-type and R1441C recombinant proteins, and V. Alvarez (National Institute of Alcohol Abuse and Alcoholism), B. Ma (National Institute on Aging) and Z. Li, J.-M. Jia and S. Jiao (National Institute of Mental Health) for their advice and technical support. We also thank L. Donahue and N. Sastry for their assistance in editing the manuscript. This work was supported by the intramural research programs of National Institute on Aging (AG000944 and AG000928 to H. C.) and National Institute of Alcohol Abuse and Alcoholism (D.L.).	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 2008, CURR BIOL, V18, pR273, DOI 10.1016/j.cub.2008.02.002; Bauman AL, 2004, NEUROPHARMACOLOGY, V46, P299, DOI 10.1016/j.neuropharm.2003.09.016; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; BLACKSTONE C, 1994, J NEUROSCI, V14, P7585; Brandon EP, 1998, J NEUROSCI, V18, P3639; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; Cai HB, 2005, J NEUROSCI, V25, P7567, DOI 10.1523/JNEUROSCI.1645-05.2005; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Chandran JS, 2008, NEUROBIOL DIS, V29, P505, DOI 10.1016/j.nbd.2007.11.011; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI [10.1038/nchembio.538, 10.1038/NCHEMBIO.538]; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; GRAYBIEL AM, 1979, EXP BRAIN RES, V34, P189; Gungabissoon RA, 2003, J HISTOCHEM CYTOCHEM, V51, P411, DOI 10.1177/002215540305100402; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kim DS, 2000, J NEUROSCI, V20, P4405, DOI 10.1523/JNEUROSCI.20-12-04405.2000; Li XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017153; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Mandemakers W, 2012, NEUROBIOL DIS, V48, P582, DOI 10.1016/j.nbd.2012.07.017; Mathur BN, 2011, J NEUROSCI, V31, P7402, DOI 10.1523/JNEUROSCI.6250-10.2011; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Nadella KS, 2009, EMBO REP, V10, P599, DOI 10.1038/embor.2009.58; Nagaoka R, 1996, CELL MOTIL CYTOSKEL, V35, P200, DOI 10.1002/(SICI)1097-0169(1996)35:3<200::AID-CM3>3.0.CO;2-C; Napolitano F, 2010, J NEUROSCI, V30, P11043, DOI 10.1523/JNEUROSCI.1682-10.2010; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Oliveira RF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002383; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Shen J, 2010, NEURODEGENER DIS, V7, P80, DOI 10.1159/000285511; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Smith Y, 2009, PARKINSONISM RELAT D, V15, pS156, DOI 10.1016/S1353-8020(09)70805-3; Snyder GL, 1998, J NEUROSCI, V18, P10297; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Stephens B, 2005, NEUROSCIENCE, V132, P741, DOI 10.1016/j.neuroscience.2005.01.007; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tang KC, 2001, P NATL ACAD SCI USA, V98, P1255, DOI 10.1073/pnas.031374698; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Ventra C, 1996, J NEUROCHEM, V66, P1752; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Westerlund M, 2008, NEUROSCIENCE, V152, P429, DOI 10.1016/j.neuroscience.2007.10.062; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Zaja-Milatovic S, 2005, NEUROLOGY, V64, P545, DOI 10.1212/01.WNL.0000150591.33787.A4; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	59	127	128	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2014	17	3					367	376		10.1038/nn.3636	http://dx.doi.org/10.1038/nn.3636			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8CA	24464040	Green Accepted			2022-12-17	WOS:000332016500009
J	Carandini, M				Carandini, Matteo			From circuits to behavior: a bridge too far?	NATURE NEUROSCIENCE			English	Article							NEUROSCIENCE; SELECTIVITY; INHIBITION; BRAIN; MODEL	Neuroscience seeks to understand how neural circuits lead to behavior. However, the gap between circuits and behavior is too wide. An intermediate level is one of neural computations, which occur in individual neurons and populations of neurons. Some computations seem to be canonical: repeated and combined in different ways across the brain. To understand neural computations, we must record from a myriad of neurons in multiple brain regions. Understanding computation guides research in the underlying circuits and provides a language for theories of behavior.	UCL, London, England	University of London; University College London	Carandini, M (corresponding author), UCL, London, England.	matteo@carandinilab.net	Carandini, Matteo/ABD-8296-2021	Carandini, Matteo/0000-0003-4880-7682	MRC [G0800791] Funding Source: UKRI; Medical Research Council [G0800791] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; BIZZI E, 1995, TRENDS NEUROSCI, V18, P442, DOI 10.1016/0166-2236(95)94494-P; Blakemore C. B., 1988, MIND MACHINE; Bower J. M, 1998, BOOK GENESIS EXPLORI; Bower J. M., 1993, BOOK GENESIS; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; DiCarlo JJ, 2002, BEHAV BRAIN RES, V135, P167, DOI 10.1016/S0166-4328(02)00162-6; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Graham N., 1989, VISUAL PATTERN ANAL; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; Harris KD, 2011, HEARING RES, V271, P37, DOI 10.1016/j.heares.2010.06.006; KOCH C, 1999, BIOPHYS COMPUTATION; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P32, DOI 10.1073/pnas.97.1.32; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P28, DOI 10.1073/pnas.97.1.28; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Marr D., 1982, VISION; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; SEJNOWSKI TJ, 1988, SCIENCE, V241, P1299, DOI 10.1126/science.3045969; Seung HS, 2011, NATURE, V471, P170, DOI 10.1038/471170a; Waldrop MM, 2012, NATURE, V482, P456, DOI 10.1038/482456a; Watson AB, 2005, J VISION, V5, P717, DOI 10.1167/5.9.6; Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20040; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	32	127	128	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					507	509		10.1038/nn.3043	http://dx.doi.org/10.1038/nn.3043			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22449960				2022-12-17	WOS:000302114500007
J	Mameli, M; Bellone, C; Brown, MTC; Luscher, C				Mameli, Manuel; Bellone, Camilla; Brown, Matthew T. C.; Luescher, Christian			Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DOPAMINE NEURONS; AMPA RECEPTORS; IN-VIVO; PERSISTENCE	The manner in which drug-evoked synaptic plasticity affects reward circuits remains largely elusive. We found that cocaine reduced NMDA receptor excitatory postsynaptic currents and inserted GluA2-lacking AMPA receptors in dopamine neurons of mice. Consequently, a stimulation protocol pairing glutamate release with hyperpolarizing current injections further strengthened synapses after cocaine treatment. Our data suggest that early cocaine-evoked plasticity in the ventral tegmental area inverts the rules for activity-dependent plasticity, eventually leading to addictive behavior.	[Mameli, Manuel; Bellone, Camilla; Brown, Matthew T. C.; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland; [Mameli, Manuel] UPMC, INSERM, Inst Fer Moulin, UMR S 839, Paris, France; [Luescher, Christian] Univ Hosp Geneva, Neurol Clin, Dept Clin Neurosci, Geneva, Switzerland	University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Mameli, Manuel/0000-0002-0570-6964; Brown, Matthew/0000-0001-6983-962X; bellone, camilla/0000-0002-6774-6275	Swiss National Science Foundation; Systems X initiative of the Swiss Confederation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Systems X initiative of the Swiss Confederation	We thank the members of the Luscher laboratory as well as M. Frerking and A. Holtmaat for comments on the manuscript and B. Cerutti for help with the statistical analysis. This work is supported by the Swiss National Science Foundation (C.L.), the Systems X initiative of the Swiss Confederation (NeuroChoice, C.L.).	Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bowers MS, 2010, NEURON, V67, P11, DOI 10.1016/j.neuron.2010.06.004; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Good CH, 2010, J NEUROSCI, V30, P7900, DOI 10.1523/JNEUROSCI.1507-10.2010; Kullmann DM, 1999, PHILOS T ROY SOC B, V354, P395, DOI 10.1098/rstb.1999.0392; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Lane DA, 2010, NEUROSCIENCE, V169, P559, DOI 10.1016/j.neuroscience.2010.05.056; Luu P, 2008, J NEUROPHYSIOL, V100, P533, DOI 10.1152/jn.01384.2007; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wang HX, 2010, J PHYSIOL-LONDON, V588, P2823, DOI 10.1113/jphysiol.2010.187591	15	127	130	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					414	416		10.1038/nn.2763	http://dx.doi.org/10.1038/nn.2763			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21336270				2022-12-17	WOS:000288849400008
J	Fu, AKY; Hung, KW; Fu, WY; Shen, C; Chen, Y; Xia, J; Lai, KO; Ip, NY				Fu, Amy K. Y.; Hung, Kwok-Wang; Fu, Wing-Yu; Shen, Chong; Chen, Yu; Xia, Jun; Lai, Kwok-On; Ip, Nancy Y.			APC(Cdh1) mediates EphA4-dependent downregulation of AMPA receptors in homeostatic plasticity	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINE MORPHOGENESIS; UBIQUITIN-PROTEASOME SYSTEM; ANAPHASE-PROMOTING COMPLEX; POSTSYNAPTIC DENSITY; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; PROTEIN-DEGRADATION; EXPRESSION; MODULATION; TRAFFICKING	Homeostatic plasticity is crucial for maintaining neuronal output by counteracting unrestrained changes in synaptic strength. Chronic elevation of synaptic activity by bicuculline reduces the amplitude of miniature excitatory postsynaptic currents (mEPSCs), but the underlying mechanisms of this effect remain unclear. We found that activation of EphA4 resulted in a decrease in synaptic and surface GluR1 and attenuated mEPSC amplitude through a degradation pathway that requires the ubiquitin proteasome system (UPS). Elevated synaptic activity resulted in increased tyrosine phosphorylation of EphA4, which associated with the ubiquitin ligase anaphase-promoting complex (APC) and its activator Cdh1 in neurons in a ligand-dependent manner. APC(Cdh1) interacted with and targeted GluR1 for proteasomal degradation in vitro, whereas depletion of Cdh1 in neurons abolished the EphA4-dependent downregulation of GluR1. Knockdown of EphA4 or Cdh1 prevented the reduction in mEPSC amplitude in neurons that was a result of chronic elevated activity. Our results define a mechanism by which EphA4 regulates homeostatic plasticity through an APC(Cdh1)-dependent degradation pathway.	[Fu, Amy K. Y.; Hung, Kwok-Wang; Fu, Wing-Yu; Shen, Chong; Chen, Yu; Xia, Jun; Lai, Kwok-On; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Ctr Neurosci, State Key Lab Mol Neurosci & Mol, Dept Biochem, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Ctr Neurosci, State Key Lab Mol Neurosci & Mol, Dept Biochem, Hong Kong, Peoples R China.	boip@ust.hk	Lai, Kwok-On/L-7468-2019; Lai, Kwok-On/E-5182-2011; shen, chong/J-7256-2015; Lai, Kwok On/ABC-8046-2021; Xia, Jun/C-7234-2009	Lai, Kwok-On/0000-0002-4069-054X; shen, chong/0000-0002-6222-4304; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Xia, Jun/0000-0001-9308-2188; Fu, Kit Yu/0000-0003-4085-6201	Research Grants Council of Hong Kong SAR (HKUST) [6444/06M, 661007, 661109, 1/06C, 6/CRF/08]; Area of Excellence Scheme of the University Grants Committee [AoE/B-15/01]; Hong Kong Jockey Club; Croucher Foundation	Research Grants Council of Hong Kong SAR (HKUST)(Hong Kong Research Grants Council); Area of Excellence Scheme of the University Grants Committee; Hong Kong Jockey Club; Croucher Foundation	We thank P. Bartlett for EphA4<SUP>-/-</SUP> mice, R. Huganir for GluR1 antibodies and the GluR1 4KR mutant expression construct, R. Malinow for the GluR1-GFP construct, J. Chamberlain for the mouse muscle cDNA library, L. Shi, W. Chau, K. Kong, X.-N. Li, W. Fang, E. Cheung, B. Butt and C. Kwong for technical assistance, and members of the Ip laboratory for discussions. This study was supported in part by the Research Grants Council of Hong Kong SAR (HKUST, 6444/06M, 661007, 661109, 1/06C and 6/CRF/08), the Area of Excellence Scheme of the University Grants Committee (AoE/B-15/01) and the Hong Kong Jockey Club. N.Y. Ip and K.-O. Lai were recipients of the Croucher Foundation Senior Research Fellowship and Croucher Foundation Fellowship, respectively.	Ang XL, 2008, J BIOL CHEM, V283, P29424, DOI 10.1074/jbc.M802475200; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Cheng K, 2002, J BIOL CHEM, V277, P31988, DOI 10.1074/jbc.M201161200; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Deininger K, 2008, P NATL ACAD SCI USA, V105, P12539, DOI 10.1073/pnas.0801174105; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Helton TD, 2008, P NATL ACAD SCI USA, V105, P19492, DOI 10.1073/pnas.0802280105; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Matyskiela Mary E., 2009, Journal of Biology (London), V8, P92, DOI 10.1186/jbiol184; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zhang DW, 2009, J NEUROSCI, V29, P4498, DOI 10.1523/JNEUROSCI.6094-08.2009; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4	50	127	128	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					181	U263		10.1038/nn.2715	http://dx.doi.org/10.1038/nn.2715			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21186356				2022-12-17	WOS:000286595400015
J	Fleidervish, IA; Lasser-Ross, N; Gutnick, MJ; Ross, WN				Fleidervish, Ilya A.; Lasser-Ross, Nechama; Gutnick, Michael J.; Ross, William N.			Na+ imaging reveals little difference in action potential-evoked Na+ influx between axon and soma	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; CEREBELLAR PURKINJE NEURONS; PERSISTENT SODIUM CURRENT; INITIAL SEGMENT; SYNAPTIC EFFICACY; BASAL DENDRITES; OPTIC NERVES; CHANNELS; RAT; CALCIUM	In cortical pyramidal neurons, the axon initial segment (AIS) is pivotal in synaptic integration. It has been asserted that this is because there is a high density of Na+ channels in the AIS. However, we found that action potential-associated Na+ flux, as measured by high-speed fluorescence Na+ imaging, was about threefold larger in the rat AIS than in the soma. Spike-evoked Na+ flux in the AIS and the first node of Ranvier was similar and was eightfold lower in basal dendrites. At near-threshold voltages, persistent Na+ conductance was almost entirely axonal. On a time scale of seconds, passive diffusion, and not pumping, was responsible for maintaining transmembrane Na+ gradients in thin axons during high-frequency action potential firing. In computer simulations, these data were consistent with the known features of action potential generation in these neurons.	[Fleidervish, Ilya A.] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel; [Fleidervish, Ilya A.; Lasser-Ross, Nechama; Gutnick, Michael J.; Ross, William N.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Fleidervish, Ilya A.; Gutnick, Michael J.] Hebrew Univ Jerusalem, Koret Sch Vet Med, IL-76100 Rehovot, Israel; [Lasser-Ross, Nechama; Ross, William N.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA	Ben Gurion University; Marine Biological Laboratory - Woods Hole; Hebrew University of Jerusalem; New York Medical College	Fleidervish, IA (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel.	ilya@bgu.ac.il	FLEIDERVISH, Ilya/F-2324-2012; Gutnick, Michael/P-7910-2019	Fleidervish, Ilya/0000-0002-5501-726X; Gutnick, Michael/0000-0003-2564-5094	US-Israel Binational Science Foundation [2003082]; Israel Science Foundation [1376-06]; Marine Biological Laboratory; US National Institutes of Health [NS16295]; Multiple Sclerosis Society [PP1367]; Gruss Lipper Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016295, R56NS016295] Funding Source: NIH RePORTER	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Marine Biological Laboratory; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Sclerosis Society(National Multiple Sclerosis Society); Gruss Lipper Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Manita for excellent help with the preparation of slices. This work was supported by a US-Israel Binational Science Foundation grant (2003082), a grant from the Israel Science Foundation (1376-06), a Grass Faculty grant from the Marine Biological Laboratory, a US National Institutes of Health grant (NS16295), a Multiple Sclerosis Society grant (PP1367) and a fellowship from the Gruss Lipper Foundation.	Acker CD, 2009, J NEUROPHYSIOL, V101, P1524, DOI 10.1152/jn.00651.2007; Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; ALZHEIMER C, 1993, J NEUROSCI, V13, P660; Astman N, 2006, J NEUROSCI, V26, P3465, DOI 10.1523/JNEUROSCI.4907-05.2006; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Callaway JC, 1997, J NEUROPHYSIOL, V77, P145, DOI 10.1152/jn.1997.77.1.145; Carter BC, 2009, NEURON, V64, P898, DOI 10.1016/j.neuron.2009.12.011; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Fleidervish IA, 1996, J NEUROPHYSIOL, V76, P2125, DOI 10.1152/jn.1996.76.3.2125; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1956, J PHYSIOL-LONDON, V131, P592, DOI 10.1113/jphysiol.1956.sp005485; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Kole MHP, 2008, NAT NEUROSCI, V11, P1253, DOI 10.1038/nn.2203; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; KUSHMERICK MJ, 1969, SCIENCE, V166, P1297, DOI 10.1126/science.166.3910.1297; Larkum ME, 2003, J PHYSIOL-LONDON, V549, P471, DOI 10.1113/jphysiol.2002.037614; LASSERROSS N, 1992, P ROY SOC B-BIOL SCI, V247, P35, DOI 10.1098/rspb.1992.0006; LELIEVRE L, 1979, BIOCHIM BIOPHYS ACTA, V557, P399, DOI 10.1016/0005-2736(79)90338-9; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MATA M, 1991, J NEUROCHEM, V57, P184, DOI 10.1111/j.1471-4159.1991.tb02114.x; MINTA A, 1989, J BIOL CHEM, V264, P19449; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; PETERS A, 1966, Q J EXP PHYSIOL CMS, V51, P229, DOI 10.1113/expphysiol.1966.sp001852; Rose CR, 1999, PFLUG ARCH EUR J PHY, V439, P201, DOI 10.1007/s004240051145; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; SHRAGER P, 1987, J PHYSIOL-LONDON, V392, P587, DOI 10.1113/jphysiol.1987.sp016798; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; SUGIHARA I, 1993, J PHYSIOL-LONDON, V470, P243, DOI 10.1113/jphysiol.1993.sp019857; Zhang CL, 2006, J NEUROPHYSIOL, V96, P695, DOI 10.1152/jn.00083.2006	41	127	129	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					852	U96		10.1038/nn.2574	http://dx.doi.org/10.1038/nn.2574			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20543843	Green Submitted, Green Accepted			2022-12-17	WOS:000279173900018
J	Liu, J; Ward, A; Gao, JW; Dong, YM; Nishio, N; Inada, H; Kang, LJ; Yu, Y; Ma, D; Xu, T; Mori, I; Xie, ZX; Xu, XZS				Liu, Jie; Ward, Alex; Gao, Jingwei; Dong, Yongming; Nishio, Nana; Inada, Hitoshi; Kang, Lijun; Yu, Yong; Ma, Di; Xu, Tao; Mori, Ikue; Xie, Zhixiong; Xu, X. Z. Shawn			C-elegans phototransduction requires a G protein-dependent cGMP pathway and a taste receptor homolog	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE-GATED CHANNEL; OLFACTORY RECEPTORS; SUGAR PERCEPTION; PHOTORECEPTORS; EXPRESSION; SUBUNIT; FAMILY; ALPHA; SENSITIVITY; NEURONS	The eyeless animal C. elegans is able to sense light and engages in phototaxis behavior that is mediated by photoreceptor cells. However, the molecular and cellular mechanisms underlying phototransduction in C. elegans remain largely unclear. By recording the photoreceptor neuron ASJ in wild-type and various mutant worms, we found that phototransduction in ASJ is a G protein-mediated process and requires membrane-associated guanylate cyclases, but not typical phosphodiesterases. In addition, we found that C. elegans phototransduction requires LITE-1, a candidate photoreceptor protein known to be a member of the invertebrate taste receptor family. Our genetic, pharmacological and electrophysiological data suggest a model in which LITE-1 transduces light signals in ASJ via G protein signaling, which leads to upregulation of the second messenger cGMP, followed by opening of cGMP-sensitive CNG channels and stimulation of photoreceptor cells. Our results identify a phototransduction cascade in C. elegans and implicate the function of a 'taste receptor' in phototransduction.	[Liu, Jie; Ward, Alex; Gao, Jingwei; Dong, Yongming; Kang, Lijun; Yu, Yong; Ma, Di; Xu, X. Z. Shawn] Univ Michigan, Inst Life Sci, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Liu, Jie; Ward, Alex; Gao, Jingwei; Dong, Yongming; Kang, Lijun; Yu, Yong; Ma, Di; Xu, X. Z. Shawn] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA; [Gao, Jingwei; Xie, Zhixiong] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Nishio, Nana; Inada, Hitoshi; Mori, Ikue] Nagoya Univ, Grp Mol Neurobiol, Nagoya, Aichi 4648601, Japan; [Nishio, Nana; Inada, Hitoshi; Mori, Ikue] Nagoya Univ, Grad Sch Sci, CREST JST, Nagoya, Aichi 4648601, Japan; [Inada, Hitoshi] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Yu, Yong; Xu, Tao] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wuhan University; Nagoya University; Japan Science & Technology Agency (JST); Nagoya University; Harvard University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu	Dong, Yongming/H-9502-2013; liu, jie/B-4901-2011; Inada, Hitoshi/T-2773-2019; Inada, Hitoshi/GQH-1084-2022	Dong, Yongming/0000-0002-6510-0913; Inada, Hitoshi/0000-0002-6121-3830; Inada, Hitoshi/0000-0002-6121-3830; KANG, Lijun/0000-0001-9939-5134; liu, jie/0000-0002-1215-5814	National Eye Institute [T32EY13934]; Chinese 111 project [CB06081]; National Institute of General Medical Sciences; Pew scholar award; NATIONAL EYE INSTITUTE [T32EY013934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083241, R01GM078276] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Chinese 111 project(Ministry of Education, China - 111 Project); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pew scholar award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Hu, A. Kumar and B. Ye for comments, M. Koelle for PTX plasmid and B. Decaluwe and S. Gu for technical assistance. Some strains were obtained from the Caenorhabditis Genetics Center, the Oklahoma Knockout Consortium and S. Mitani. A.W. was supported by a predoctoral training grant from the National Eye Institute (T32EY13934 to The University of Michigan). J.G. and Z.X. received support from the Chinese 111 project (CB06081). This work was supported by grants from the National Institute of General Medical Sciences and a Pew scholar award to X.Z.S.X.	Bargmann C.I., 2006, CHEMOSENSATION C ELE, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Birnby DA, 2000, GENETICS, V155, P85; Bounoutas A, 2007, PFLUG ARCH EUR J PHY, V454, P691, DOI 10.1007/s00424-006-0187-x; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Darby C, 2001, INFECT IMMUN, V69, P6271, DOI 10.1128/IAI.69.10.6271-6275.2001; Ebbs ML, 2007, PFLUG ARCH EUR J PHY, V454, P735, DOI 10.1007/s00424-007-0246-y; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Gardiner A, 2009, BIOL LETTERS, V5, P244, DOI 10.1098/rsbl.2008.0723; Gomez MD, 2000, J NEUROSCI, V20, P5254, DOI 10.1523/JNEUROSCI.20-14-05254.2000; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gotow T, 2008, BRAIN RES, V1225, P3, DOI 10.1016/j.brainres.2008.04.059; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Ishimoto H, 2005, EMBO J, V24, P3259, DOI 10.1038/sj.emboj.7600796; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; LEYTE A, 1992, EMBO J, V11, P4795, DOI 10.1002/j.1460-2075.1992.tb05585.x; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Miranda-Vizuete A, 2006, FEBS LETT, V580, P484, DOI 10.1016/j.febslet.2005.12.046; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; O'Halloran DM, 2006, J MOL EVOL, V63, P87, DOI 10.1007/s00239-005-0215-z; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; STERN JH, 1986, P NATL ACAD SCI USA, V83, P1163, DOI 10.1073/pnas.83.4.1163; Tanis JE, 2008, GENETICS, V178, P157, DOI 10.1534/genetics.107.079780; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Tremblay J, 2002, MOL CELL BIOCHEM, V230, P31, DOI 10.1023/A:1014260204524; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Ueno K, 2006, J NEUROSCI, V26, P6143, DOI 10.1523/JNEUROSCI.0857-06.2006; Ueno K, 2008, EUR J NEUROSCI, V28, P1956, DOI 10.1111/j.1460-9568.2008.06507.x; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Xiong WH, 1998, NAT NEUROSCI, V1, P359, DOI 10.1038/nn0998_359	50	127	147	2	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					715	U88		10.1038/nn.2540	http://dx.doi.org/10.1038/nn.2540			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20436480	Green Accepted			2022-12-17	WOS:000278003300016
J	Anderson, D; Mehaffey, WH; Iftinca, M; Rehak, R; Engbers, JDT; Hameed, S; Zamponi, GW; Turner, RW				Anderson, Dustin; Mehaffey, W. Hamish; Iftinca, Mircea; Rehak, Renata; Engbers, Jordan D. T.; Hameed, Shahid; Zamponi, Gerald W.; Turner, Ray W.			Regulation of neuronal activity by Cav3-Kv4 channel signaling complexes	NATURE NEUROSCIENCE			English	Article							CEREBELLAR STELLATE CELLS; A-TYPE; POTASSIUM CHANNELS; K+ CHANNEL; HIPPOCAMPAL-NEURONS; PYRAMIDAL NEURONS; CALCIUM-CHANNELS; CA2+ CHANNELS; CURRENTS; PROTEIN	Kv4 low voltage-activated A-type potassium channels are widely expressed in excitable cells, where they control action potential firing, dendritic activity and synaptic integration. Kv4 channels exist as a complex that includes K+ channel-interacting proteins (KChIPs), which contain calcium-binding domains and therefore have the potential to confer calcium dependence on the Kv4 channel. We found that T-type calcium channels and Kv4 channels form a signaling complex in rat that efficiently couples calcium influx to KChIP3 to modulate Kv4 function. This interaction was critical for allowing Kv4 channels to function in the subthreshold membrane potential range to regulate neuronal firing properties. The widespread expression of these channels and accessory proteins indicates that the Cav3-Kv4 signaling complex is important for the function of a wide range of electrically excitable cells.	[Turner, Ray W.] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada; Univ Calgary, Dept Cell Biol & Anat, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Turner, RW (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada.	rwturner@ucalgary.ca	Patten, Scott/B-4434-2011	Patten, Scott/0000-0001-9871-4041; Zamponi, Gerald W./0000-0002-0644-9066	Canadian Institutes of Health Research; Achievers in Medical Sciences and T. Chen Fong Award; Alberta Heritage Foundation for Medical Research (AHFMR); National Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Achievers in Medical Sciences and T. Chen Fong Award; Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	We gratefully acknowledge J. McRory and M. L. Molineux for early contributions to protein analysis, H. Jerng and P. Pfaffinger for access to DPLP cDNA clones, and M. Kruskic and L. Chen for expert technical assistance. This work was supported by a grant from Canadian Institutes of Health Research (R. W. T. and G.W.Z.) and studentship support through an Achievers in Medical Sciences and T. Chen Fong Award (D. A.), Alberta Heritage Foundation for Medical Research (AHFMR) (W. H. M., R. R. and J. D. T. E.), Canadian Institutes of Health Research (W. H. M.), National Sciences and Engineering Research Council (R. R.), and an AHFMR Postdoctoral Fellowship (M. I.). R. W. T. is an AHFMR Scientist and G.W.Z. is an AHFMR Scientist and Canada Research Chair.	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Bourdeau ML, 2007, J NEUROSCI, V27, P1942, DOI 10.1523/JNEUROSCI.3208-06.2007; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; CHEN QX, 1991, J NEUROSCI, V11, P337; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Covarrubias M, 2008, NEUROCHEM RES, V33, P1558, DOI 10.1007/s11064-008-9650-8; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; Cueni L, 2009, PFLUG ARCH EUR J PHY, V457, P1161, DOI 10.1007/s00424-008-0582-6; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Hamid J, 2006, NEUROSCIENCE, V143, P717, DOI 10.1016/j.neuroscience.2006.08.023; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Jung SC, 2008, NEURON, V60, P657, DOI 10.1016/j.neuron.2008.08.029; Khaliq ZM, 2008, J NEUROSCI, V28, P10905, DOI 10.1523/JNEUROSCI.2237-08.2008; Kollo M, 2006, J NEUROSCI, V26, P2684, DOI 10.1523/JNEUROSCI.5257-05.2006; Leclerc GM, 2007, MOL CELL ENDOCRINOL, V267, P70, DOI 10.1016/j.mce.2006.12.040; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Lusin JD, 2008, BIOCHEMISTRY-US, V47, P2252, DOI 10.1021/bi7017267; Maffie J, 2008, J PHYSIOL-LONDON, V586, P5609, DOI 10.1113/jphysiol.2008.161620; Marionneau C, 2009, CHANNELS, V3, P284; McDonough SI, 1998, MOL PHARMACOL, V54, P1080, DOI 10.1124/mol.54.6.1080; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; Molineux ML, 2005, J NEUROSCI, V25, P10863, DOI 10.1523/JNEUROSCI.3436-05.2005; Murakoshi H, 1999, J NEUROSCI, V19, P1728; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; Patel SP, 2002, J PHYSIOL-LONDON, V545, P5, DOI 10.1113/jphysiol.2002.031856; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Suter KJ, 2004, NEUROSCIENCE, V124, P305, DOI 10.1016/j.neuroscience.2003.11.015; Tadayonnejad R, 2009, CHANNELS, V3, P149, DOI 10.4161/chan.3.3.8872; Talley EM, 1999, J NEUROSCI, V19, P1895; Venn N, 2008, BIOCHEM J, V413, P71, DOI 10.1042/BJ20080441; Wang LT, 2007, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2007/04/032; Wang X, 2005, J NEUROSCI RES, V81, P530, DOI 10.1002/jnr.20576	41	127	128	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					333	U14		10.1038/nn.2493	http://dx.doi.org/10.1038/nn.2493			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20154682				2022-12-17	WOS:000274860100015
J	Brigande, JV; Heller, S				Brigande, John V.; Heller, Stefan			Quo vadis, hair cell regeneration?	NATURE NEUROSCIENCE			English	Article							MOUSE INNER-EAR; GUINEA-PIG COCHLEA; NEURAL STEM-CELLS; HEARING-LOSS; MAMMALIAN COCHLEA; GENE-TRANSFER; RETINOBLASTOMA PROTEIN; TECTORIAL MEMBRANE; ACOUSTIC TRAUMA; IN-VIVO	Hearing loss is a global health problem with profound socioeconomic impact. We contend that acquired hearing loss is mainly a modern disorder caused by man-made noise and modern drugs, among other causes. These factors, combined with increasing lifespan, have exposed a deficit in cochlear self-regeneration that was irrelevant for most of mammalian evolution. Nevertheless, the mammalian cochlea has evolved from phylogenetically older structures, which do have the capacity for self-repair. Moreover, nonmammalian vertebrates can regenerate auditory hair cells that restore sensory function. We will offer a critical perspective on recent advances in stem cell biology, gene therapy, cell cycle regulation and pharmacotherapeutics to define and validate regenerative medical interventions for mammalian hair cell loss. Although these advances are promising, we are only beginning to fully appreciate the complexity of the many challenges that lie ahead.	[Heller, Stefan] Stanford Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Stanford, CA 94305 USA; [Brigande, John V.] Oregon Hlth & Sci Univ, Dept Otolaryngol, Oregon Hearing Res Ctr, Portland, OR 97201 USA	Stanford University; Oregon Health & Science University	Heller, S (corresponding author), Stanford Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Stanford, CA 94305 USA.	hellers@stanford.edu			US National Institutes of Health [DC008595, DC06167]; McKnight Endowment Fund for Neuroscience; California Institute for Regenerative Medicine [RC1-00119]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC007132, R01DC006167, R01DC008595] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Endowment Fund for Neuroscience; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We gratefully acknowledge support by the US National Institutes of Health (DC008595 to J.V.B. and DC06167 to S. H.), the McKnight Endowment Fund for Neuroscience (J.V.B. and S. H.) and the California Institute for Regenerative Medicine (RC1-00119 to S. H.).	Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bhatt KA, 2001, ANN OTO RHINOL LARYN, V110, P1147, DOI 10.1177/000348940111001212; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Chen P, 2003, NAT CELL BIOL, V5, P422, DOI 10.1038/ncb976; Chen P, 1999, DEVELOPMENT, V126, P1581; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; DALLOS P, 1972, SCIENCE, V177, P356, DOI 10.1126/science.177.4046.356; Daudet N, 2009, DEV BIOL, V326, P86, DOI 10.1016/j.ydbio.2008.10.033; FLOCK A, 1984, NATURE, V310, P597, DOI 10.1038/310597a0; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; HAWKINS JE, 1976, ACTA OTO-LARYNGOL, V81, P337, DOI 10.3109/00016487609119971; Hayashi T, 2007, DEV DYNAM, V236, P525, DOI 10.1002/dvdy.21026; Heller Stefan, 2008, V31, P321; Hori R, 2007, NEUROREPORT, V18, P1911, DOI 10.1097/WNR.0b013e3282f213e0; Hu ZQ, 2007, P NATL ACAD SCI USA, V104, P16675, DOI 10.1073/pnas.0704576104; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Kawamoto K, 2003, J NEUROSCI, V23, P4395; Konishi M, 2008, J GENE MED, V10, P610, DOI 10.1002/jgm.1189; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; Mansour SL, 2009, HUM MOL GENET, V18, P43, DOI 10.1093/hmg/ddn311; Mantela J, 2005, DEVELOPMENT, V132, P2377, DOI 10.1242/dev.01834; Merchant SN, 2005, OTOL NEUROTOL, V26, P151, DOI 10.1097/00129492-200503000-00004; Nadol JB, 2001, INT J PEDIATR OTORHI, V61, P1, DOI 10.1016/S0165-5876(01)00546-8; Nin F, 2008, P NATL ACAD SCI USA, V105, P1751, DOI 10.1073/pnas.0711463105; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; RAPHAEL Y, 1991, CELL MOTIL CYTOSKEL, V18, P215, DOI 10.1002/cm.970180307; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Richter CP, 2007, BIOPHYS J, V93, P2265, DOI 10.1529/biophysj.106.094474; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Sage C, 2006, P NATL ACAD SCI USA, V103, P7345, DOI 10.1073/pnas.0510631103; Savary E, 2007, STEM CELLS, V25, P332, DOI 10.1634/stemcells.2006-0303; Takebayashi S, 2007, DEV BIOL, V307, P165, DOI 10.1016/j.ydbio.2007.04.035; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; Weber T, 2008, P NATL ACAD SCI USA, V105, P781, DOI 10.1073/pnas.0708061105; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Yamamoto N, 2006, J MOL MED, V84, P37, DOI 10.1007/s00109-005-0706-9; Zhai SQ, 2005, J NEUROBIOL, V65, P282, DOI 10.1002/neu.20190; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zine A, 2000, DEVELOPMENT, V127, P3373	50	127	141	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2009	12	6					679	685		10.1038/nn.2311	http://dx.doi.org/10.1038/nn.2311			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	450DJ	19471265	Green Accepted			2022-12-17	WOS:000266380900007
J	Petit, C; Richardson, GP				Petit, Christine; Richardson, Guy P.			Linking genes underlying deafness to hair-bundle development and function	NATURE NEUROSCIENCE			English	Review							PLANAR CELL POLARITY; MECHANOELECTRICAL TRANSDUCTION; TIP-LINK; TECTORIAL MEMBRANE; STEREOCILIA SIDE; ACTIN-FILAMENTS; MOUSE MODELS; MYOSIN VIIA; CROSS-LINKS; ADAPTATION	The identification of mutations underlying monogenic, early-onset forms of deafness in humans has provided unprecedented insight into the molecular mechanisms of hearing in the peripheral auditory system. The molecules involved in the development and function of the cochlea eluded characterization until recently owing to the scarcity of the principal cell types present. The genetic approach has circumvented this problem and succeeded in identifying proteins and deciphering some of the molecular complexes that operate in these cells. In combination with mouse models, the genetic approach is now revealing some of the principles underlying the development and physiology of the cochlea. Focusing on the hair bundle, the mechanosensory device of the sensory hair cell, we highlight recent advances in understanding the way in which the hair bundle is formed, how it operates as a mechanotransducer and how it processes sound. In particular, we discuss how these findings confer a central role on the various hair-bundle links in these processes.	[Richardson, Guy P.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Petit, Christine] Univ Paris 06, Coll France, Inst Pasteur,Unite Genet & Physiol Audit, INSERM,Unite Mixte Rech Sante 587, Paris, France	University of Sussex; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite	Richardson, GP (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.	christine.petit@pasteur.fr; g.p.richardson@sussex.ac.uk		Petit, Christine/0000-0002-9069-002X	Wellcome Trust [071394] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adato A, 2005, HUM MOL GENET, V14, P3921, DOI 10.1093/hmg/ddi416; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Beurg M, 2008, BIOPHYS J, V94, P2639, DOI 10.1529/biophysj.107.123257; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bregman A. S., 1990, AUDITORY SCENE ANAL; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Cheung ELM, 2006, BIOPHYS J, V90, P124, DOI 10.1529/biophysj.105.061226; COREY DP, 1983, J NEUROSCI, V3, P962; COTANCHE DA, 1991, HEARING RES, V52, P379, DOI 10.1016/0378-5955(91)90027-7; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Donaudy F, 2006, J MED GENET, V43, P157, DOI 10.1136/jmg.2005.032086; EATOCK RA, 1987, J NEUROSCI, V7, P2821; El-Amraoui A., 2008, MYOS SUP MOL MOT, V7, P353; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Friedman LM, 2007, INT J DEV BIOL, V51, P609, DOI 10.1387/ijdb.072365lf; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; FURNESS DN, 1989, HEARING RES, V38, P95, DOI 10.1016/0378-5955(89)90131-7; GOLD T, 1948, PROC R SOC SER B-BIO, V135, P492, DOI 10.1098/rspb.1948.0025; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Goodyear RJ, 2003, J NEUROSCI, V23, P4878; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; He DZZ, 2004, NATURE, V429, P766, DOI 10.1038/nature02591; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; KALTENBACH JA, 1994, J COMP NEUROL, V350, P187, DOI 10.1002/cne.903500204; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Leibovici M, 2008, CURR TOP DEV BIOL, V84, P385, DOI 10.1016/S0070-2153(08)00608-X; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; LUMPKIN EA, 1995, P NATL ACAD SCI USA, V92, P10297, DOI 10.1073/pnas.92.22.10297; Manor U, 2008, SEMIN CELL DEV BIOL, V19, P502, DOI 10.1016/j.semcdb.2008.07.006; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Martin P, 2003, J NEUROSCI, V23, P4533; Martin P, 2001, P NATL ACAD SCI USA, V98, P14386, DOI 10.1073/pnas.251530498; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; MOORE BC, 2008, PERCEPTION SPEECH SO, V363; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Nayak GD, 2007, INT J DEV BIOL, V51, P597, DOI 10.1387/ijdb.072392gn; Naz S, 2004, J MED GENET, V41, P591, DOI 10.1136/jmg.2004.018523; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Ohm GS, 1843, ANN PHYS CHEM, V135, P513, DOI [10.1002/andp.18431350802, DOI 10.1002/ANDP.18431350802]; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; PICKLES JO, 1991, HEARING RES, V54, P153, DOI 10.1016/0378-5955(91)90116-Q; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Richardson GP, 2008, CURR OPIN OTOLARYNGO, V16, P458, DOI 10.1097/MOO.0b013e32830e20c4; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; TILNEY LG, 1988, J CELL BIOL, V106, P355, DOI 10.1083/jcb.106.2.355; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cellbio.8.1.257; Tsuprun V, 2003, J NEUROCYTOL, V32, P1117, DOI 10.1023/B:NEUR.0000021906.08847.d2; Tsuprun V, 2002, J HISTOCHEM CYTOCHEM, V50, P493, DOI 10.1177/002215540205000406; Tsuprun V, 1998, J NEUROCYTOL, V27, P517, DOI 10.1023/A:1006903926571; van Aken AFJ, 2008, J PHYSIOL-LONDON, V586, P5403, DOI 10.1113/jphysiol.2008.156992; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Verpy E, 2001, NAT GENET, V29, P345, DOI 10.1038/ng726; Verpy E, 2008, NATURE, V456, P255, DOI 10.1038/nature07380; von Helmholtz H, 1862, LEHRE TONEMPFINDUNGE; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007	100	127	129	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2009	12	6					703	710		10.1038/nn.2330	http://dx.doi.org/10.1038/nn.2330			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	450DJ	19471269	Green Accepted			2022-12-17	WOS:000266380900011
J	Gaillard, A; Prestoz, L; Dumartin, B; Cantereau, A; Morel, F; Roger, M; Jaber, M				Gaillard, Afsaneh; Prestoz, Laetitia; Dumartin, Brigitte; Cantereau, Anne; Morel, Franck; Roger, Michel; Jaber, Mohamed			Reestablishment of damaged adult motor pathways by grafted embryonic cortical neurons	NATURE NEUROSCIENCE			English	Article							FRONTAL-CORTEX; PURKINJE NEURONS; BRAIN INFARCTS; RATS; TRANSPLANTS; MICE; NEOCORTEX; TISSUE; CELLS; CONNECTIONS	Damage to the adult motor cortex leads to severe and frequently irreversible deficits in motor function. Transplantation of embryonic cortical neurons into the damaged adult motor cortex was previously shown to induce partial recovery, but reports on graft efferents have varied from no efferent projections to sparse innervation. Here, we grafted embryonic cortical tissue from transgenic mice overexpressing a green fluorescent protein into the damaged motor cortex of adult mice. Grafted neurons developed efferent projections to appropriate cortical and subcortical host targets, including the thalamus and spinal cord. These projections were not a result of cell fusion between the transplant and the host neurons. Host and transplanted neurons formed synaptic contacts and numerous graft efferents were myelinated. These findings demonstrate that there is substantial anatomical reestablishment of cortical circuitry following embryonic cortex grafting into the adult brain. They suggest that there is an unsuspected potential for neural cell transplantation to promote reconstruction after brain injury.	Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, F-86022 Poitiers, France; Univ Bordeaux 2, Lab Mouvement Adaptat Cognit, CNRS, F-33077 Bordeaux, France; Univ Poitiers, Lab Cytokines & Inflammat, EA 3806, F-86022 Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Universite de Poitiers	Gaillard, A (corresponding author), Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, 40 Ave Recteur Pineau, F-86022 Poitiers, France.	Afsaneh.Gaillard@univ-poitiers.fr	Morel, Franck/AAI-4274-2021	Morel, Franck/0000-0003-3812-9304; Jaber, Mohamed/0000-0003-2536-1913; prestoz, Laetitia/0000-0002-2407-195X				Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; BRAGIN AG, 1988, NEUROSCIENCE, V25, P751, DOI 10.1016/0306-4522(88)90034-6; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Chen KA, 2006, EXP NEUROL, V198, P129, DOI 10.1016/j.expneurol.2005.11.016; DAS GD, 1972, BRAIN RES, V38, P233, DOI 10.1016/0006-8993(72)90710-X; Dumartin B, 2000, P NATL ACAD SCI USA, V97, P1879, DOI 10.1073/pnas.97.4.1879; DUNNETT SB, 1987, BEHAV NEUROSCI, V101, P489, DOI 10.1037/0735-7044.101.4.489; EBRAHIMIGAILLAR.A, 1994, BRAIN RES DEV BRAIN, V18, P271; EBRAHIMIGAILLARD A, 1995, NEUROSCIENCE, V64, P49, DOI 10.1016/0306-4522(94)00396-M; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Fricker-Gates RA, 2002, J NEUROSCI, V22, P4045, DOI 10.1523/JNEUROSCI.22-10-04045.2002; Gaillard A, 2000, CEREB CORTEX, V10, P443, DOI 10.1093/cercor/10.5.443; Gaillard A, 1998, ADV ANAT EMBRYOL CEL, V148, P1; Gaillard F, 2004, NEUROSCIENCE, V126, P631, DOI 10.1016/j.neuroscience.2004.04.011; Gates M A, 2000, Prog Brain Res, V127, P115; GONZALEZ MF, 1988, EXP NEUROL, V99, P154, DOI 10.1016/0014-4886(88)90135-5; GRABOWSKI M, 1993, ANN NEUROL, V34, P362, DOI 10.1002/ana.410340310; GUITET J, 1994, NEUROSCI LETT, V180, P265, DOI 10.1016/0304-3940(94)90535-5; HernitGrant CS, 1996, EXP NEUROL, V139, P131, DOI 10.1006/exnr.1996.0088; ISACSON O, 1988, PROG BRAIN RES, V78, P13; Kingsbury MA, 2005, P NATL ACAD SCI USA, V102, P6143, DOI 10.1073/pnas.0408171102; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pinaudeau C, 2000, EUR J NEUROSCI, V12, P2486, DOI 10.1046/j.1460-9568.2000.00148.x; PLUMET J, 1993, RESTOR NEUROL NEUROS, V6, P9, DOI 10.3233/RNN-1993-6102; Riolobos AS, 2001, NEUROBIOL LEARN MEM, V75, P274, DOI 10.1006/nlme.2000.3979; Roger M, 1994, Rev Neurosci, V5, P11; Sorensen JC, 1996, EXP NEUROL, V138, P227, DOI 10.1006/exnr.1996.0061; STEIN DG, 1987, ANN NY ACAD SCI, V495, P444, DOI 10.1111/j.1749-6632.1987.tb23693.x; Uematsu J, 1996, BRAIN DEV-JPN, V18, P29, DOI 10.1016/0387-7604(95)00102-6; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; Zhou WB, 1998, BRAIN RES, V792, P97, DOI 10.1016/S0006-8993(98)00125-5	36	127	130	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1294	1299		10.1038/nn1970	http://dx.doi.org/10.1038/nn1970			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828256				2022-12-17	WOS:000249720800016
J	Priebe, NJ; Ferster, D				Priebe, NJ; Ferster, D			Mechanisms underlying cross-orientation suppression in cat visual cortex	NATURE NEUROSCIENCE			English	Article							CORTICAL SIMPLE CELLS; STRIATE CORTEX; RECEPTIVE-FIELDS; DIRECTION SELECTIVITY; CONTRAST ADAPTATION; COMPLEX CELLS; INHIBITION; NEURONS; EXCITATION; INPUT	In simple cells of the cat primary visual cortex, null-oriented stimuli, which by themselves evoke no response, can completely suppress the spiking response to optimally oriented stimuli. This cross-orientation suppression has been interpreted as evidence for cross-orientation inhibition: synaptic inhibition among cortical cells with different preferred orientations. In intracellular recordings from simple cells, however, we found that cross-oriented stimuli suppressed, rather than enhanced, synaptic inhibition and, at the same time, suppressed synaptic excitation. Much of the suppression of excitation could be accounted for by the behavior of geniculate relay cells: contrast saturation and rectification in relay cell responses, when applied to a linear feed-forward model, predicted cross-orientation suppression of the modulation (F1) component of excitation evoked in simple cells. In addition, we found that the suppression of the spike output of simple cells was almost twice the suppression of their synaptic inputs. Thus, cross-orientation suppression, like orientation selectivity, is strongly amplified by threshold.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Ferster, D (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2145 N Sheridan Rd, Evanston, IL 60208 USA.	ferster@northwestern.edu			NEI NIH HHS [EY-014499, EY-04726] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY014499, R01EY004726] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Allison JD, 2001, VISUAL NEUROSCI, V18, P941, DOI 10.1017/S0952523801186116; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BISHOP PO, 1973, J PHYSIOL-LONDON, V231, P31, DOI 10.1113/jphysiol.1973.sp010218; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2002, J NEUROSCI, V22, P10053; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Heeger DJ, 1996, P NATL ACAD SCI USA, V93, P623, DOI 10.1073/pnas.93.2.623; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Lauritzen TZ, 2001, J NEUROPHYSIOL, V86, P1803, DOI 10.1152/jn.2001.86.4.1803; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; McLaughlin D, 2003, J PHYSIOL-PARIS, V97, P237, DOI 10.1016/j.jphysparis.2003.09.019; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; MORRONE MC, 1987, EXP BRAIN RES, V67, P635; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; REIG R, 2005, CEREB CORTEX    0817; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SMITH MA, 2006, IN PRESS J NEUROSCI; Sokal R. R., 1995, BIOMETRY PRINCIPLES; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Troyer TW, 1998, J NEUROSCI, V18, P5908; TSUMOTO T, 1979, EXP BRAIN RES, V34, P351	50	127	129	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					552	561		10.1038/nn1660	http://dx.doi.org/10.1038/nn1660			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16520737				2022-12-17	WOS:000236310700023
J	Altier, C; Khosravani, H; Evans, RM; Hameed, S; Peloquin, JB; Vartian, BA; Chen, L; Beedle, AM; Ferguson, SSG; Mezghrani, A; Dubel, SJ; Bourinet, E; McRory, JE; Zamponi, GW				Altier, C; Khosravani, H; Evans, RM; Hameed, S; Peloquin, JB; Vartian, BA; Chen, L; Beedle, AM; Ferguson, SSG; Mezghrani, A; Dubel, SJ; Bourinet, E; McRory, JE; Zamponi, GW			ORL1 receptor-mediated internalization of N-type calcium channels	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; INTRATHECALLY ADMINISTERED NOCICEPTIN; ROOT GANGLION NEURONS; MU-OPIOID RECEPTORS; RAT SPINAL-CORD; ORPHANIN-FQ; MORPHINE-TOLERANCE; CA2+ CHANNELS; PERIPHERAL INFLAMMATION; NEUROPATHIC PAIN	The inhibition of N-type calcium channels by opioid receptor like receptor 1 (ORL1) is a key mechanism for controlling the transmission of nociceptive signals. We recently reported that signaling complexes consisting of ORL1 receptors and N-type channels mediate a tonic inhibition of calcium entry. Here we show that prolonged (similar to 30 min) exposure of ORL1 receptors to their agonist nociceptin triggers an internalization of these signaling complexes into vesicular compartments. This effect is dependent on protein kinase C activation, occurs selectively for N-type channels and cannot be observed with mu-opioid or angiotensin receptors. In expression systems and in rat dorsal root ganglion neurons, the nociceptin-mediated internalization of the channels is accompanied by a significant downregulation of calcium entry, which parallels the selective removal of N-type calcium channels from the plasma membrane. This may provide a new means for long-term regulation of calcium entry in the pain pathway.	Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; John P Robarts Res Inst, Cell Biol Res Grp, London, ON N6A 5K8, Canada; Univ UMI, Dept Physiol, Inst Genom Fonct, CNRS,UMR5203,INSERM,U661, F-34094 Montpellier, France; Univ UMII, Dept Physiol, Inst Genom Fonct, CNRS,UMR5203,INSERM,U661, F-34094 Montpellier, France	University of Calgary; Western University (University of Western Ontario); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Zamponi, GW (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada.	zamponi@ucalgary.ca	Khosravani, Houman/X-2391-2019; Beedle, Aaron M/K-1902-2015; Beedle, Aaron/AAI-7014-2020	Beedle, Aaron M/0000-0002-1019-3235; Dubel, Stefan/0000-0001-8811-7390; Zamponi, Gerald W./0000-0002-0644-9066				Abdulla FA, 1997, J NEUROSCI, V17, P8721; Abdulla FA, 1998, J NEUROSCI, V18, P9685; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Andoh T, 1997, NEUROREPORT, V8, P2793, DOI 10.1097/00001756-199708180-00028; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Becker JAJ, 1999, J BIOL CHEM, V274, P27513, DOI 10.1074/jbc.274.39.27513; Beedle AM, 2004, NAT NEUROSCI, V7, P118, DOI 10.1038/nn1180; Borgland SL, 2001, J PHYSIOL-LONDON, V536, P35, DOI 10.1111/j.1469-7793.2001.t01-1-00035.x; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; Briscini L, 2002, EUR J PHARMACOL, V447, P59, DOI 10.1016/S0014-2999(02)01833-2; BUNZOW JR, 1994, FEBS LETT, V347, P284, DOI 10.1016/0014-5793(94)00561-3; Connor M, 1998, J PHYSIOL-LONDON, V509, P47, DOI 10.1111/j.1469-7793.1998.047bo.x; Cooper CB, 2000, J BIOL CHEM, V275, P40777, DOI 10.1074/jbc.C000673200; Corbani M, 2004, ENDOCRINOLOGY, V145, P2876, DOI 10.1210/en.2004-0062; Dale LB, 2004, J BIOL CHEM, V279, P13110, DOI 10.1074/jbc.M313333200; DE WM, 1997, NATURE, V385, P446; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Gouarderes C, 1999, BRAIN RES, V838, P85, DOI 10.1016/S0006-8993(99)01713-8; Hao JX, 1997, NEUROSCI LETT, V223, P49, DOI 10.1016/S0304-3940(97)13401-2; Hatakeyama S, 2001, NEUROREPORT, V12, P2423, DOI 10.1097/00001756-200108080-00027; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; IKEDA SR, 1996, NATURE, V380, P258; Jhamandas KH, 1998, CAN J PHYSIOL PHARM, V76, P314, DOI 10.1139/cjpp-76-3-314; Jia YP, 1998, NEUROSCI LETT, V250, P21, DOI 10.1016/S0304-3940(98)00430-3; Knoflach F, 1996, J NEUROSCI, V16, P6657; Larsson KP, 2000, NEUROSCI LETT, V296, P121, DOI 10.1016/S0304-3940(00)01640-2; Lutfy K, 2003, J NEUROSCI, V23, P10331; Mandyam CD, 2002, J PHARMACOL EXP THER, V302, P502, DOI 10.1124/jpet.102.033159; Mills RH, 2004, J NEUROSCI, V24, P947, DOI 10.1523/JNEUROSCI.1366-03.2004; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Neal CR, 1999, J COMP NEUROL, V406, P503; Patil PG, 1996, BIOPHYS J, V71, P2509, DOI 10.1016/S0006-3495(96)79444-4; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Scott DA, 2002, EUR J PHARMACOL, V451, P279, DOI 10.1016/S0014-2999(02)02247-1; Scott RH, 1997, NEUROPHARMACOLOGY, V36, P195, DOI 10.1016/S0028-3908(97)83783-5; Spampinato S, 2002, CELL MOL LIFE SCI, V59, P2172, DOI 10.1007/s000180200016; Spampinato S, 2001, NEUROREPORT, V12, P3159, DOI 10.1097/00001756-200110080-00035; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Sutton KG, 2002, BRIT J PHARMACOL, V135, P257, DOI 10.1038/sj.bjp.0704439; Toth PT, 1996, J NEUROSCI, V16, P4617; Ueda H, 2000, J NEUROSCI, V20, P7640; von Zastrow M, 2003, CURR OPIN NEUROBIOL, V13, P348, DOI 10.1016/S0959-4388(03)00069-2; Wick M J, 1994, Brain Res Mol Brain Res, V27, P37; Yamamoto T, 1997, NEUROSCI LETT, V224, P107, DOI 10.1016/S0304-3940(97)13475-9; Yamamoto T, 1997, NEUROSCIENCE, V81, P249, DOI 10.1016/S0306-4522(97)00166-8; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zamponi GW, 2001, CELL BIOCHEM BIOPHYS, V34, P79, DOI 10.1385/CBB:34:1:79; Zaratin PF, 2004, J PHARMACOL EXP THER, V308, P454, DOI 10.1124/jpet.103.055848	49	127	135	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					31	40		10.1038/nn1605	http://dx.doi.org/10.1038/nn1605			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16311589				2022-12-17	WOS:000234288000015
J	van Swinderen, B; Greenspan, RJ				van Swinderen, B; Greenspan, RJ			Salience modulates 20-30 Hz brain activity in Drosophila	NATURE NEUROSCIENCE			English	Article							TARGETED EXPRESSION; NEURAL ACTIVITY; MINI-BRAIN; SHIBIRE; MELANOGASTER; INFORMATION; MECHANISM; ATTENTION; BEHAVIOR; CIRCUIT	Fruit flies selectively orient toward the visual stimuli that are most salient in their environment. We recorded local field potentials (LFPs) from the brains of Drosophila melanogaster as they responded to the presentation of visual stimuli. Coupling of salience effects (odor, heat or novelty) to these stimuli modulated LFPs in the 20-30 Hz range by evoking a transient, selective increase. We demonstrated the association of these responses with behavioral tracking and initiated a genetic approach to investigating neural correlates of perception.	Inst Neurosci, San Diego, CA 92121 USA		Greenspan, RJ (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.	greenspan@nsi.edu		van Swinderen, Bruno/0000-0001-6552-7418	NCRR NIH HHS [P41-RR09754] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		[Anonymous], 1989, REMEMBERED PRESENT; Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; Bushnell PJ, 1998, PSYCHOPHARMACOLOGY, V138, P231, DOI 10.1007/s002130050668; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; COLLETT TS, 1980, J COMP PHYSIOL, V138, P271, DOI 10.1007/BF00657045; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crick F., 1990, Seminars in the Neurosciences, V2, P263; DILL M, 1995, PHILOS T ROY SOC B, V349, P143, DOI 10.1098/rstb.1995.0100; Egelhaaf M, 2002, TRENDS NEUROSCI, V25, P96, DOI 10.1016/S0166-2236(02)02063-5; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Gatti S, 2000, CURR BIOL, V10, P667, DOI 10.1016/S0960-9822(00)00517-0; GOETZ KG, 1994, NEURAL BASIS BEHAV A, P47; Guo A, 1997, LEARN MEMORY, V4, P192, DOI 10.1101/lm.4.2.192; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; James W., 1890, PRINCIPLES PSYCHOL, V2; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Joiner MLA, 1999, LEARN MEMORY, V6, P177; KAISER W, 1983, NATURE, V301, P707, DOI 10.1038/301707a0; Keller A, 2002, J NEUROBIOL, V50, P221, DOI 10.1002/neu.10029; KIM YT, 1990, J NEUROGENET, V7, P1, DOI 10.3109/01677069009084149; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; Lehmann FO, 1997, J EXP BIOL, V200, P1133; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; MIMURA K, 1982, J COMP PHYSIOL, V146, P229, DOI 10.1007/BF00610242; Niebur E, 2002, CURR OPIN NEUROBIOL, V12, P190, DOI 10.1016/S0959-4388(02)00310-0; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wang YL, 2001, NEURON, V29, P267, DOI 10.1016/S0896-6273(01)00196-9; Wolf R, 1998, LEARN MEMORY, V5, P166; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; WOLF R, 1991, J COMP PHYSIOL A, V169, P699; Wu ZH, 2000, BIOL CYBERN, V82, P61, DOI 10.1007/s004220050006	42	127	129	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					579	586		10.1038/nn1054	http://dx.doi.org/10.1038/nn1054			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12717438				2022-12-17	WOS:000183140400014
J	Haruta, M; Kosaka, M; Kanegae, Y; Saito, I; Inoue, T; Kageyama, R; Nishida, A; Honda, Y; Takahashi, M				Haruta, M; Kosaka, M; Kanegae, Y; Saito, I; Inoue, T; Kageyama, R; Nishida, A; Honda, Y; Takahashi, M			Induction of photoreceptor-specific phenotypes in adult mammalian iris tissue	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; RAT RETINA; PROGENITOR CELLS; DIFFERENTIATION; INTEGRATION; EXPRESSION; ADENOVIRUS; PROTEIN; GENE; EYE		Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan; Japan Sci & Technol Corp, TOREST, Okayama Technol Ctr, Okayama 7011221, Japan; Univ Tokyo, Inst Med Sci, Mol Genet Lab, Minato Ku, Tokyo 1088639, Japan; Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Japan Science & Technology Agency (JST); University of Tokyo; Kyoto University	Takahashi, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan.		KOSAKA, Mitsuko/B-1603-2011	KOSAKA, Mitsuko/0000-0001-6146-5184				Ahmad I, 2000, BIOCHEM BIOPH RES CO, V270, P517, DOI 10.1006/bbrc.2000.2473; BARNSTABLE CJ, 1980, NATURE, V286, P231, DOI 10.1038/286231a0; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Hojo M, 2000, DEVELOPMENT, V127, P2515; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; McGinnis JF, 1999, J NEUROSCI RES, V55, P252, DOI 10.1002/(SICI)1097-4547(19990115)55:2<252::AID-JNR13>3.0.CO;2-N; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Nishida A, 2000, INVEST OPHTH VIS SCI, V41, P4268; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; Young MJ, 2000, MOL CELL NEUROSCI, V16, P197, DOI 10.1006/mcne.2000.0869	15	127	137	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1163	1164		10.1038/nn762	http://dx.doi.org/10.1038/nn762			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11704762	Green Submitted			2022-12-17	WOS:000172525000006
J	Klier, EM; Wang, HY; Crawford, JD				Klier, EM; Wang, HY; Crawford, JD			The superior colliculus encodes gaze commands in retinal coordinates	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; ALERT RHESUS-MONKEY; HEAD-FREE CAT; VISUAL SPACE; PARIETAL CORTEX; MOTOR MAP; STIMULATION; SHIFTS; NEURONS; PRIMATE	The superior colliculus (SC) has a topographic map of visual space, but the spatial nature of its output command for orienting gaze shifts remains unclear. Here we show that the SC codes neither desired gaze displacement nor gaze direction in space (as debated previously), but rather, desired gaze direction in retinal coordinates. Electrical micro-stimulation of the SC in two head-free (nonimmobilized) monkeys evoked natural-looking, eye-head gaze shifts, with anterior sites producing small, fixed-vector movements and posterior sites producing larger, strongly converging movements. However, when correctly calculated in retinal coordinates, all of these trajectories became 'fixed-vector.' Moreover, our data show that this eye-centered SC command is then further transformed, as a function of eye and head position, by downstream mechanisms into the head- and body-centered commands for coordinated eye-head gaze shifts.	York Univ, CIHR Grp Act & Percept, Toronto, ON M3J 1P3, Canada; York Univ, York Ctr Vis Res, Toronto, ON M3J 1P3, Canada; York Univ, Dept Psychol, Toronto, ON M3J 1P3, Canada; York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; York Univ, Dept Kinesiol & Hlth Sci, Toronto, ON M3J 1P3, Canada	York University - Canada; York University - Canada; York University - Canada; York University - Canada; York University - Canada	Crawford, JD (corresponding author), York Univ, CIHR Grp Act & Percept, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	jdc@yorku.ca		Crawford, Doug/0000-0003-2288-1286				ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; APTER JT, 1945, J NEUROPHYSIOL, V8, P123, DOI 10.1152/jn.1945.8.2.123; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Crawford JD, 1999, J NEUROPHYSIOL, V81, P1760, DOI 10.1152/jn.1999.81.4.1760; Crawford JD, 2000, J NEUROSCI, V20, P2360; Crawford JD, 1997, J NEUROPHYSIOL, V78, P1447, DOI 10.1152/jn.1997.78.3.1447; CYNADER M, 1972, J NEUROPHYSIOL, V35, P187, DOI 10.1152/jn.1972.35.2.187; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Freedman EG, 1996, J NEUROPHYSIOL, V76, P927, DOI 10.1152/jn.1996.76.2.927; Freedman EG, 1997, J NEUROPHYSIOL, V77, P2328, DOI 10.1152/jn.1997.77.5.2328; Freedman EG, 1997, J NEUROPHYSIOL, V78, P1669, DOI 10.1152/jn.1997.78.3.1669; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; GUITTON D, 1980, EXP BRAIN RES, V39, P63; HARRIS LR, 1980, J PHYSIOL-LONDON, V300, P367, DOI 10.1113/jphysiol.1980.sp013167; Henriques DYP, 1998, J NEUROSCI, V18, P1583; HENRIQUES DYP, IN PRESS NEUROCOMPUT; HEPP K, 1993, J NEUROPHYSIOL, V69, P965, DOI 10.1152/jn.1993.69.3.965; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Klier EM, 1998, J NEUROPHYSIOL, V80, P2274, DOI 10.1152/jn.1998.80.5.2274; MCILWAIN JT, 1986, J NEUROPHYSIOL, V55, P97, DOI 10.1152/jn.1986.55.1.97; Moschovakis AK, 1998, J NEUROPHYSIOL, V80, P3373, DOI 10.1152/jn.1998.80.6.3373; MUNOZ DP, 1991, J NEUROPHYSIOL, V66, P1624, DOI 10.1152/jn.1991.66.5.1624; PARE M, 1994, EXP BRAIN RES, V101, P123; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROUCOUX A, 1980, EXP BRAIN RES, V39, P75; Russo GS, 1996, J NEUROPHYSIOL, V76, P825, DOI 10.1152/jn.1996.76.2.825; SCHILLER PH, 1971, J NEUROPHYSIOL, V34, P920, DOI 10.1152/jn.1971.34.5.920; SCHILLER PH, 1972, J NEUROPHYSIOL, V35, P915, DOI 10.1152/jn.1972.35.6.915; SEGRAVES MA, 1992, HEAD NECK SENSORY MO, P292; Smith MA, 2001, J COMPUT NEUROSCI, V10, P127, DOI 10.1023/A:1011264913465; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; STEIN BE, 1976, BRAIN RES, V118, P469, DOI 10.1016/0006-8993(76)90314-0; STRASCHILL M, 1973, BRAIN RES, V59, P211, DOI 10.1016/0006-8993(73)90262-X; UEMURA T, 1980, ACTA OTO-LARYNGOL, V90, P191, DOI 10.3109/00016488009131715; VANOPSTAL AJ, 1991, SCIENCE, V252, P1313, DOI 10.1126/science.1925545; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; WHITE JM, 1994, VISION RES, V34, P79, DOI 10.1016/0042-6989(94)90259-3; WURTZ RH, 1971, SCIENCE, V171, P82, DOI 10.1126/science.171.3966.82	40	127	129	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					627	632		10.1038/88450	http://dx.doi.org/10.1038/88450			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369944				2022-12-17	WOS:000169061800016
J	Small, SA; Nava, AS; Perera, GM; DeLaPaz, R; Mayeux, R; Stern, Y				Small, SA; Nava, AS; Perera, GM; DeLaPaz, R; Mayeux, R; Stern, Y			Circuit mechanisms underlying memory encoding and retrieval in the long axis of the hippocampal formation	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; FUNCTIONAL-DIFFERENTIATION; CORTICAL AFFERENTS; TERM POTENTIATION; ENTORHINAL CORTEX; ORGANIZATION; MONKEY; REPRESENTATION; ACTIVATIONS; FMRI	Circuits within the hippocampal formation are active during memory processing. Here we used functional magnetic resonance imaging (fMRI) to examine multiple sites across the long axis of the hippocampal formation while subjects performed different phases of an associative memory task, learning to associate faces with names. Viewing faces and hearing names in isolation resulted in separate hippocampal activation patterns. Pairing faces with names resulted a spatially redistributed activation pattern, rather than a simple summation of the activation patterns resulting from viewing faces and hearing names in isolation. Recalling names when cued with faces reactivated a pattern similar to that found during paired training. Finally, the activation patterns representing faces and names were found to be experience dependent, emerging with repeated exposure. Interpreted in the context of hippocampal anatomy and physiology, these findings reveal hippocampal circuit mechanisms that underlie memory encoding and retrieval.	Columbia Univ Coll Phys & Surg, Taub Inst Alzheimers Dis & Aging Brain, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Small, SA (corresponding author), Columbia Univ Coll Phys & Surg, Taub Inst Alzheimers Dis & Aging Brain, 630 W 168th St, New York, NY 10032 USA.		Mayeux, Richard/E-9788-2013	Mayeux, Richard/0000-0001-6519-9696; Stern, Yaakov/0000-0001-7542-3241	NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER; NIA NIH HHS [AG08702, AG00946] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amaral D G, 1993, Curr Opin Neurobiol, V3, P225, DOI 10.1016/0959-4388(93)90214-J; Amaral DG, 1990, HUMAN NERVOUS SYSTEM, P711; ANDERSEN P, 1971, EXP BRAIN RES, V13, P222; Colombo M, 1998, J NEUROPHYSIOL, V80, P1002, DOI 10.1152/jn.1998.80.2.1002; DEBSKI EA, 1990, J NEUROBIOL, V21, P18, DOI 10.1002/neu.480210103; Duvernoy H, 1998, HUMAN HIPPOCAMPUS; EICHENBAUM H, 1989, BEHAV NEUROSCI, V103, P1207, DOI 10.1037/0735-7044.103.6.1207; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Kohonen T, 1977, ASS MEMORY SYSTEM TH; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; Moser MB, 1998, J NEUROSCI, V18, P7535; PARE D, 1994, HIPPOCAMPUS, V4, P403, DOI 10.1002/hipo.450040403; Pavlidis P, 2000, J NEUROSCI, V20, P4497, DOI 10.1523/JNEUROSCI.20-12-04497.2000; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Saykin AJ, 1999, BRAIN, V122, P1963, DOI 10.1093/brain/122.10.1963; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SQUIRE LR, 1992, PSYCHOL REV, V99, P582; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; VarghaKhadem F, 1997, SCIENCE, V277, P1117; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; WITTER MP, 1991, J COMP NEUROL, V307, P437, DOI 10.1002/cne.903070308; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028	33	127	133	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					442	449		10.1038/86115	http://dx.doi.org/10.1038/86115			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276237	Green Published			2022-12-17	WOS:000168762200027
J	Holcombe, AO; Cavanagh, P				Holcombe, AO; Cavanagh, P			Early binding of feature pairs for visual perception	NATURE NEUROSCIENCE			English	Article							ATTENTION		Harvard Univ, Dept Psychol, Vis Sci Lab, Cambridge, MA 02138 USA	Harvard University	Holcombe, AO (corresponding author), Harvard Univ, Dept Psychol, Vis Sci Lab, 33 Kirkland St, Cambridge, MA 02138 USA.		Holcombe, Alex/A-2344-2012	Holcombe, Alex/0000-0003-2869-0085	NATIONAL EYE INSTITUTE [R01EY009258] Funding Source: NIH RePORTER; NEI NIH HHS [EY09258] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CAVANAGH P, 1987, J OPT SOC AM A, V4, P1428, DOI 10.1364/JOSAA.4.001428; Gur M, 1997, VISION RES, V37, P377, DOI 10.1016/S0042-6989(96)00183-6; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; LEE BB, 1989, J PHYSIOL-LONDON, V414, P245, DOI 10.1113/jphysiol.1989.sp017686; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; SCHOLL BJ, IN PRESS COGNITION; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Verstraten FAJ, 2000, VISION RES, V40, P3651, DOI 10.1016/S0042-6989(00)00213-3; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	9	127	131	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					127	128		10.1038/83945	http://dx.doi.org/10.1038/83945			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175871				2022-12-17	WOS:000167178100009
J	Deken, SL; Beckman, ML; Boos, L; Quick, MW				Deken, SL; Beckman, ML; Boos, L; Quick, MW			Transport rates of GABA transporters: regulation by the N-terminal domain and syntaxin 1A	NATURE NEUROSCIENCE			English	Article							PROTEIN-PROTEIN INTERACTIONS; CELL-SURFACE EXPRESSION; CFTR CHLORIDE CHANNELS; FUNCTIONAL REGULATION; RECEPTORS; RELEASE	Plasma membrane GABA transporters participate in neural signaling through re-uptake of neurotransmitter. The domains of the transporter that mediate GABA translocation and regulate transport are not well understood. In the present experiments, the N-terminal cytoplasmic domain of the GABA transporter GAT1 regulated substrate transport rates. This domain directly interacted with syntaxin 1A, a SNARE protein involved in both neurotransmitter release and modulation of calcium channels and cystic fibrosis transmembrane regulator (CFTR) chloride channels. The interaction resulted in a decrease in transporter transport rates. These data demonstrate that intracellular domains of the GABA and protein-protein interactions regulate substrate translocation, and identify a direct link between the machinery involved in transmitter release and re-uptake.	Univ Alabama, Dept Neurobiol, CIRC 446, Birmingham, AL 35294 USA; Univ Alabama, Med Sci Training Program, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Quick, MW (corresponding author), Univ Alabama, Dept Neurobiol, CIRC 446, 1719 6th Ave S, Birmingham, AL 35294 USA.				NIDA NIH HHS [DA10509] Funding Source: Medline; NIMH NIH HHS [MH61468] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R29DA010509, R01DA010509] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Beckman ML, 1998, J NEUROSCI, V18, P6103; Beckman ML, 1998, J MEMBRANE BIOL, V164, P1; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; Bernstein EM, 1999, J BIOL CHEM, V274, P889, DOI 10.1074/jbc.274.2.889; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; COREY JL, 1994, MOL MEMBR BIOL, V11, P23, DOI 10.3109/09687689409161026; Davis KE, 1998, J NEUROSCI, V18, P2475; Fenster CP, 1997, J NEUROSCI, V17, P5747; Gegelashvili G, 1997, MOL PHARMACOL, V52, P6, DOI 10.1124/mol.52.1.6; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; Hoffman BJ, 1998, FRONT NEUROENDOCRIN, V19, P187, DOI 10.1006/frne.1998.0168; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; IVERSEN LL, 1975, HDB PSYCHOPHARMACOLO, P381; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; Quick Michael W., 1994, V19, P261; Quick MW, 1997, J NEUROSCI, V17, P2967; Rothman JE, 1996, PROTEIN SCI, V5, P185; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; SHENG ZH, 1996, NATURE, V378, P623; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0	28	127	131	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					998	1003		10.1038/79939	http://dx.doi.org/10.1038/79939			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017172				2022-12-17	WOS:000167177500017
J	Kim, SH; Wang, R; Gordon, DJ; Bass, J; Steiner, DF; Lynn, DG; Thinakaran, G; Meredith, SC; Sisodia, SS				Kim, SH; Wang, R; Gordon, DJ; Bass, J; Steiner, DF; Lynn, DG; Thinakaran, G; Meredith, SC; Sisodia, SS			Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia	NATURE NEUROSCIENCE			English	Article							CONSTITUTIVE SECRETORY PATHWAY; PSEUDOMONAS EXOTOXIN-A; PRECURSOR PROTEINS; SEQUENCE REQUIREMENTS; ENDOPROTEASE; GENE; ANGIOPATHY; EXPRESSION; RESISTANT; VIRUSES	The genetic lesion underlying familial British dementia (FBD), an autosomal dominant neurodegenerative disorder, is a T-A transversion at the termination codon of the BRI gene. The mutant gene encodes BRI-L, the precursor of ABri peptides that accumulate in amyloid deposits in FBD brain. We now report that both BRI-L and its wild-type counterpart, BRI, were constitutively processed by the proprotein convertase, furin, resulting in the secretion of carboxyl-terminal peptides that encompass all or part of ABri. Elevated levels of peptides were generated from the mutant BRI precursor. Electron microscopic studies revealed that synthetic ABri peptides assembled into irregular, short fibrils. Collectively, our results support the view that enhanced furin-mediated processing of mutant BRI generates fibrillogenic peptides that initiate the pathogenesis of FBD.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Med Scientists Training Program, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Dept Chem, Chicago, IL 60637 USA; Rockefeller Univ, Lab Mass Spectrometry, New York, NY 10021 USA	University of Chicago; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; Rockefeller University	Sisodia, SS (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Abbott 316,947 E 58th St, Chicago, IL 60637 USA.		Wang, Rong/A-8721-2009	Gordon, David/0000-0003-1830-4371	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014248] Funding Source: NIH RePORTER; NIA NIH HHS [AG14248] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07281] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Duguay SJ, 1997, J BIOL CHEM, V272, P6663, DOI 10.1074/jbc.272.10.6663; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GRIFFITHS RA, 1982, J NEUROL NEUROSUR PS, V45, P396, DOI 10.1136/jnnp.45.5.396; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MOEHRING JM, 1983, INFECT IMMUN, V41, P998, DOI 10.1128/IAI.41.3.998-1009.1983; MOEHRING JM, 1993, J BIOL CHEM, V268, P2590; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Pittois K, 1998, GENE, V217, P141, DOI 10.1016/S0378-1119(98)00354-0; PLANT GT, 1990, BRAIN, V113, P721, DOI 10.1093/brain/113.3.721; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SPENCE MJ, 1995, SOMAT CELL MOLEC GEN, V21, P1, DOI 10.1007/BF02255818; TAKAHASHI S, 1994, J BIOCHEM-TOKYO, V116, P47, DOI 10.1093/oxfordjournals.jbchem.a124501; Vidal R, 1999, NATURE, V399, P776; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; WATANABE T, 1993, FEBS LETT, V320, P215, DOI 10.1016/0014-5793(93)80589-M; WATANABE T, 1992, J BIOL CHEM, V267, P8270; Worster-Drought C, 1940, BRAIN, V63, P237, DOI 10.1093/brain/63.3.237; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970	25	127	131	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					984	988		10.1038/14783	http://dx.doi.org/10.1038/14783			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526337				2022-12-17	WOS:000083883300015
J	Kar, K; Kubilius, J; Schmidt, K; Issa, EB; DiCarlo, JJ				Kar, Kohitij; Kubilius, Jonas; Schmidt, Kailyn; Issa, Elias B.; DiCarlo, James J.			Evidence that recurrent circuits are critical to the ventral stream's execution of core object recognition behavior	NATURE NEUROSCIENCE			English	Article							CATEGORY REPRESENTATIONS; FEEDBACK CONNECTIONS; CORTEX; MONKEY; FEEDFORWARD; ATTENTION; RESPONSES; MODELS; SPEED; V1	Non-recurrent deep convolutional neural networks (CNNs) are currently the best at modeling core object recognition, a behavior that is supported by the densely recurrent primate ventral stream, culminating in the inferior temporal (IT) cortex. If recurrence is critical to this behavior, then primates should outperform feedforward-only deep CNNs for images that require additional recurrent processing beyond the feedforward IT response. Here we first used behavioral methods to discover hundreds of these 'challenge' images. Second, using large-scale electrophysiology, we observed that behaviorally sufficient object identity solutions emerged similar to 30 ms later in the IT cortex for challenge images compared with primate performance-matched 'control' images. Third, these behaviorally critical late-phase IT response patterns were poorly predicted by feedforward deep CNN activations. Notably, very-deep CNNs and shallower recurrent CNNs better predicted these late IT responses, suggesting that there is a functional equivalence between additional nonlinear transformations and recurrence. Beyond arguing that recurrent circuits are critical for rapid object identification, our results provide strong constraints for future recurrent model development.	[Kar, Kohitij; Kubilius, Jonas; Schmidt, Kailyn; Issa, Elias B.; DiCarlo, James J.] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kar, Kohitij; Kubilius, Jonas; Schmidt, Kailyn; Issa, Elias B.; DiCarlo, James J.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Kar, Kohitij; DiCarlo, James J.] MIT, Ctr Brains Minds & Machines, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kubilius, Jonas] Katholieke Univ Leuven, Brain & Cognit, Leuven, Belgium; [Issa, Elias B.] Columbia Univ, Dept Neurosci, Zuckerman Mind Brain Behav Inst, New York, NY USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); KU Leuven; Columbia University	Kar, K (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Kar, K (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Kar, K (corresponding author), MIT, Ctr Brains Minds & Machines, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	kohitij@mit.edu	; Kar, Kohitij/J-8264-2015	DiCarlo, James/0000-0002-1592-5896; Kar, Kohitij/0000-0002-4283-9256	Office of Naval Research [MURI-114407]; US National Eye Institute [R01-EY014970, K99-EY022671]; European Union [705498]; Center for Brains, Minds and Machines (CBMM) - NSF STC award [CCF-1231216]; NATIONAL EYE INSTITUTE [R00EY022671] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); European Union(European Commission); Center for Brains, Minds and Machines (CBMM) - NSF STC award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was primarily supported by the Office of Naval Research MURI-114407 (to J.J.D) and in part by US National Eye Institute grants R01-EY014970 (to J.J.D.) and K99-EY022671 (to E.B.I.), and the European Union's Horizon 2020 research and innovation programme under grant agreement no 705498 (to J.K.). This work was also supported by the Center for Brains, Minds and Machines (CBMM), funded by NSF STC award CCF-1231216. The authors thank A. Afraz for his surgical assistance.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bichot NP, 2015, NEURON, V88, P832, DOI 10.1016/j.neuron.2015.10.001; Bugatus L, 2017, NEUROIMAGE, V155, P437, DOI 10.1016/j.neuroimage.2017.03.062; Cadieu CF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003963; Chatfield K, 2014, P BMVC BRIT MACH VIS, DOI [10.5244/C.28.6, DOI 10.5244/C.28.6]; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Elsayed G.F., 2018, ADVERSARIAL EXAMPLES; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fyall AM, 2017, ELIFE, V6, DOI 10.7554/eLife.25784; Geirhos R., 2017, COMP DEEP NEURAL NET; Guclu U, 2015, J NEUROSCI, V35, P10005, DOI 10.1523/JNEUROSCI.5023-14.2015; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; HINTON GE, 1995, SCIENCE, V268, P1158, DOI 10.1126/science.7761831; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Jeurissen D, 2016, ELIFE, V5, DOI 10.7554/eLife.14320; Krizhevsky A., 2012, COMMUN ACM, P1097, DOI DOI 10.1145/3065386; Kubilius J., 2018, BIORXIV, DOI [10.1101/408385v1, DOI 10.1101/408385V1]; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Liao Q., 2016, BRIDGING GAPS RESIDU; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; Majaj NJ, 2015, J NEUROSCI, V35, P13402, DOI 10.1523/JNEUROSCI.5181-14.2015; McKee JL, 2014, J NEUROSCI, V34, P16065, DOI 10.1523/JNEUROSCI.1660-14.2014; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; Oram MW, 2010, J PHYSIOL-PARIS, V104, P167, DOI 10.1016/j.jphysparis.2009.11.021; Rajalingham R, 2018, J NEUROSCI, V38, P7255, DOI 10.1523/JNEUROSCI.0388-18.2018; Rajalingham R, 2015, J NEUROSCI, V35, P12127, DOI 10.1523/JNEUROSCI.0573-15.2015; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; ROCKLAND KS, 1989, J COMP NEUROL, V285, P54, DOI 10.1002/cne.902850106; ROCKLAND KS, 1994, CEREB CORTEX, V4, P300, DOI 10.1093/cercor/4.3.300; ROCKLAND KS, 1994, VISUAL NEUROSCI, V11, P579, DOI 10.1017/S0952523800002480; ROLLS ET, 1985, VISION RES, V25, P1021, DOI 10.1016/0042-6989(85)90091-4; Rosenholtz R, 2007, J VISION, V7, DOI 10.1167/7.2.17; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Santos A, 1997, J MICROSC-OXFORD, V188, P264, DOI 10.1046/j.1365-2818.1997.2630819.x; Schrimpf M., 2018, BIORXIV; Seger CA, 2008, NEUROSCI BIOBEHAV R, V32, P265, DOI 10.1016/j.neubiorev.2007.07.010; Spoerer CJ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01551; Stojanoski B, 2014, J VISION, V14, DOI 10.1167/14.12.6; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Tang HL, 2018, P NATL ACAD SCI USA, V115, P8835, DOI 10.1073/pnas.1719397115; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; TOVEE MJ, 1994, CURR BIOL, V4, P1125, DOI 10.1016/S0960-9822(00)00253-0; van Kerkoerle T, 2014, P NATL ACAD SCI USA, V111, P14332, DOI 10.1073/pnas.1402773111; Walther D, 2005, COMPUT VIS IMAGE UND, V100, P41, DOI 10.1016/j.cviu.2004.09.004; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671; Yamins DLK, 2016, CURR OPIN NEUROBIOL, V37, P114, DOI 10.1016/j.conb.2016.02.001; Yamins DLK, 2014, P NATL ACAD SCI USA, V111, P8619, DOI 10.1073/pnas.1403112111	53	126	127	5	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2019	22	6					974	+		10.1038/s41593-019-0392-5	http://dx.doi.org/10.1038/s41593-019-0392-5			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HZ5HT	31036945	Green Submitted, Green Accepted			2022-12-17	WOS:000468883100016
J	Su, YJ; Shin, J; Zhong, C; Wang, S; Roychowdhury, P; Lim, J; Kim, D; Ming, GL; Song, H				Su, Yijing; Shin, Jaehoon; Zhong, Chun; Wang, Sabrina; Roychowdhury, Prith; Lim, Jongseuk; Kim, David; Ming, Guo-li; Song, Hongjun			Neuronal activity modifies the chromatin accessibility landscape in the adult brain	NATURE NEUROSCIENCE			English	Article							HUMAN GENOME; EPIGENETIC MECHANISMS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MEME-CHIP; ENHANCERS; PLASTICITY; ARC/ARG3.1; PROTEINS; SIGNALS	Neuronal activity-induced gene expression modulates the function and plasticity of the nervous system. It is unknown whether and to what extent neuronal activity may trigger changes in chromatin accessibility, a major mode of epigenetic regulation of gene expression. Here we compared chromatin accessibility landscapes of adult mouse dentate granule neurons in vivo before and after synchronous neuronal activation using an assay for transposase-accessible chromatin using sequencing (ATAC-seq). We found genome-wide changes 1 h after activation, with enrichment of gained-open sites at active enhancer regions and at binding sites for API-complex components, including c-Fos. Some changes remained stable for at least 24 h. Functional analysis further implicates a critical role of c-Fos in initiating, but not maintaining, neuronal activity-induced chromatin opening. Our results reveal dynamic changes of chromatin accessibility in adult mammalian brains and suggest an epigenetic mechanism by which transient neuronal activation leads to dynamic changes in gene expression via modifying chromatin accessibility.	[Su, Yijing; Shin, Jaehoon; Zhong, Chun; Wang, Sabrina; Roychowdhury, Prith; Lim, Jongseuk; Kim, David; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Su, Yijing; Shin, Jaehoon; Zhong, Chun; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Song, H (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.; Song, H (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Song, H (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	shongju1@jhmi.edu		Wang, Sabrina/0000-0002-5541-7327; Lim, Jongseuk/0000-0002-2854-5737; Ming, Guo-li/0000-0002-2517-6075	NIH [R37NS047344, P01NS097206, R35NS097370, R01MH105128]; SFARI [240011]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Brain and Behavior Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047344, R01NS048271, R35NS097370, P01NS097206, R01NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SFARI; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Brain and Behavior Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the members of the Song and Ming laboratories for discussions, K. Christian for comments and Y. Cai and L. Liu for technical support. This work was supported by NIH (R37NS047344 and P01NS097206 to H.S., R35NS097370 and R01MH105128 to G.-l.M.), SFARI (Award 240011 to H.S.), The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (to G.-l.M.) and The Brain and Behavior Research Foundation (to Y.S.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cholewa-Waclaw J, 2016, J NEUROSCI, V36, P11427, DOI 10.1523/JNEUROSCI.2492-16.2016; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; CURRAN T, 1995, J NEUROBIOL, V26, P403, DOI 10.1002/neu.480260312; Davie K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004994; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Descalzi G, 2015, TRENDS NEUROSCI, V38, P237, DOI 10.1016/j.tins.2015.02.001; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Felling RJ, 2015, EXP NEUROL, V268, P37, DOI 10.1016/j.expneurol.2014.09.017; Frank CL, 2015, NAT NEUROSCI, V18, P647, DOI 10.1038/nn.3995; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jang MH, 2013, CELL STEM CELL, V12, P215, DOI 10.1016/j.stem.2012.11.021; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lattal KM, 2013, NAT NEUROSCI, V16, P124, DOI 10.1038/nn.3302; Lisanby SH, 2007, NEW ENGL J MED, V357, P1939, DOI 10.1056/NEJMct075234; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Ma WX, 2014, NAT PROTOC, V9, P1428, DOI 10.1038/nprot.2014.083; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Malik AN, 2014, NAT NEUROSCI, V17, P1330, DOI 10.1038/nn.3808; Meaney MJ, 2010, NAT NEUROSCI, V13, P1313, DOI 10.1038/nn1110-1313; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Neunuebel JP, 2012, J NEUROSCI, V32, P3848, DOI 10.1523/JNEUROSCI.6038-11.2012; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Schmid RS, 2016, NEURO-ONCOLOGY, V18, P962, DOI 10.1093/neuonc/nov321; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shin J, 2014, NAT NEUROSCI, V17, P1463, DOI 10.1038/nn.3814; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Sweatt JD, 2013, NEURON, V80, P624, DOI 10.1016/j.neuron.2013.10.023; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Weng YL, 2013, NEUROTHERAPEUTICS, V10, P556, DOI 10.1007/s13311-013-0223-4; West A., 2011, COLD SPRING HARB PER; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416	43	126	128	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2017	20	3					476	483		10.1038/nn.4494	http://dx.doi.org/10.1038/nn.4494			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9DU	28166220	Green Accepted			2022-12-17	WOS:000394920400025
J	Robel, S; Sontheimer, H				Robel, Stefanie; Sontheimer, Harald			Glia as drivers of abnormal neuronal activity	NATURE NEUROSCIENCE			English	Review							IMPERMEANT ANIONS ESTABLISH; EXTRACELLULAR-MATRIX PROTEIN; SYNAPTIC-TRANSMISSION; GLUTAMINE-SYNTHETASE; IN-VIVO; GLIOMA; VITRONECTIN; EXPRESSION; ASTROCYTES; RELEASE	Reactive astrocytes have been proposed to become incompetent bystanders in epilepsy as a result of cellular changes rendering them unable to perform important housekeeping functions. Indeed, successful surgical treatment of mesiotemporal lobe epilepsy hinges on the removal of the glial scar. New research now extends the role of astrocytes, suggesting that they may drive the disease process by impairing the inhibitory action of neuronal GABA receptors. Here we discuss studies that include hyperexcitability resulting from impaired supply of astrocytic glutamine for neuronal GABA synthesis, and epilepsy resulting from genetically induced astrogliosis or malignant transformation, both of which render the inhibitory neurotransmitter GABA excitatory. In these examples, glial cells alter the expression or function of neuronal proteins involved in excitability. Although epilepsy has traditionally been thought of as a disease caused by changes in neuronal properties exclusively, these new findings challenge us to consider the contribution of glial cells as drivers of epileptogenesis in acquired epilepsies.	[Robel, Stefanie; Sontheimer, Harald] Virginia Tech, Caril Res Inst, Glial Biol Hlth Dis & Canc Ctr, Roanoke, VA 24016 USA	Virginia Polytechnic Institute & State University	Sontheimer, H (corresponding author), Virginia Tech, Caril Res Inst, Glial Biol Hlth Dis & Canc Ctr, Roanoke, VA 24016 USA.	sontheimer@vt.edu	Robel, Stefanie/AAA-7166-2019	Robel, Stefanie/0000-0001-6716-3670; Sontheimer, Harald/0000-0002-5843-9871	US National Institutes of Health [RO1NS052634, RO1NS082851, RO1NS036692]; American Brain Tumor Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036692, R01NS052634, R01NS082851] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Brain Tumor Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the US National Institutes of Health (RO1NS052634, RO1NS082851, RO1NS036692) and the American Brain Tumor Association.	Agulhon C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00139; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Binder DK, 2012, GLIA, V60, P1203, DOI 10.1002/glia.22317; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; BRISMAR T, 1995, GLIA, V15, P231, DOI 10.1002/glia.440150305; Buckingham SC, 2013, NEUROCHEM INT, V63, P696, DOI 10.1016/j.neuint.2013.01.027; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Butt A, 2013, NEUROGLIA, P601; Campbell SL, 2015, GLIA, V63, P23, DOI 10.1002/glia.22730; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Clasadonte J, 2013, P NATL ACAD SCI USA, V110, P17540, DOI 10.1073/pnas.1311967110; Coulter DA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022434; De Pitta M, 2016, NEUROSCIENCE, V323, P43, DOI 10.1016/j.neuroscience.2015.04.001; Di Angelantonio S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.437; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Dityatev A, 2008, NEURON GLIA BIOL, V4, P235, DOI 10.1017/S1740925X09000118; DURING MJ, 1993, LANCET, V341, P1607; Eid T, 2004, LANCET, V363, P28, DOI 10.1016/S0140-6736(03)15166-5; Eid T, 2013, NEUROCHEM INT, V63, P670, DOI 10.1016/j.neuint.2013.06.008; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Fujita T, 2014, J NEUROSCI, V34, P16594, DOI 10.1523/JNEUROSCI.2585-14.2014; Gagnon M, 2013, NAT MED, V19, P1524, DOI 10.1038/nm.3356; Gaudet AD, 2014, EXP NEUROL, V258, P24, DOI 10.1016/j.expneurol.2013.11.020; Gibbons MB, 2013, NEUROCHEM INT, V63, P660, DOI 10.1016/j.neuint.2012.12.008; GLADSON CL, 1995, J CELL SCI, V108, P947; GLADSON CL, 1991, J CLIN INVEST, V88, P1924, DOI 10.1172/JCI115516; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; Holmseth S, 2009, NEUROSCIENCE, V162, P1055, DOI 10.1016/j.neuroscience.2009.03.048; Huberfeld G, 2015, REV NEUROL-FRANCE, V171, P236, DOI 10.1016/j.neurol.2015.01.563; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; Kam K, 2007, J NEUROSCI, V27, P9192, DOI 10.1523/JNEUROSCI.1198-07.2007; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; KUFFLER SW, 1964, J NEUROPHYSIOL, V27, P290, DOI 10.1152/jn.1964.27.2.290; Lee HHC, 2011, NAT NEUROSCI, V14, P736, DOI 10.1038/nn.2806; Liang SL, 2006, J NEUROSCI, V26, P8537, DOI 10.1523/JNEUROSCI.0329-06.2006; Loscher W, 2013, NEUROPHARMACOLOGY, V69, P62, DOI 10.1016/j.neuropharm.2012.05.045; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Luhmann HJ, 2014, SCIENCE, V345, DOI [10.1126/science.1255337, 10.1126/science.1252978]; MacKenzie G, 2015, EPILEPSY RES, V109, P13, DOI 10.1016/j.eplepsyres.2014.10.003; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Marcaggi P, 2004, GLIA, V47, P217, DOI 10.1002/glia.20027; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; Muthukumar AK, 2014, NAT NEUROSCI, V17, P1340, DOI 10.1038/nn.3791; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Pallud J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008065; Perea G, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/1ncel.2014.00378, 10.3389/fncel.2014.00378]; PEREZ VJ, 1973, BRAIN RES, V59, P181, DOI 10.1016/0006-8993(73)90259-X; Rivera-Zengotita M, 2012, ADV ANAT PATHOL, V19, P239, DOI 10.1097/PAP.0b013e31825c6a04; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Robel S, 2009, GLIA, V57, P1630, DOI 10.1002/glia.20876; Robert SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8103; Roycik MD, 2013, CURR MOL MED, V13, P1299, DOI 10.2174/15665240113139990067; Schousboe A, 2014, NEUROCHEM RES, V39, P1980, DOI 10.1007/s11064-014-1263-9; Seifert G, 2010, BRAIN RES REV, V63, P212, DOI 10.1016/j.brainresrev.2009.10.004; Silver DJ, 2009, TRENDS NEUROSCI, V32, P303, DOI 10.1016/j.tins.2009.01.008; Sloan SA, 2014, NEURON, V84, P1112, DOI 10.1016/j.neuron.2014.12.003; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Soleman S, 2013, NEUROSCIENCE, V253, P194, DOI 10.1016/j.neuroscience.2013.08.050; Steinhauser C, 2016, NEUROSCIENCE, V323, P157, DOI 10.1016/j.neuroscience.2014.12.047; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Uhm JH, 1999, CLIN CANCER RES, V5, P1587; Vasilyev DV, 2004, J PHYSIOL-LONDON, V560, P659, DOI 10.1113/jphysiol.2004.069104; Vasilyev DV, 2003, J PHYSIOL-LONDON, V547, P859, DOI 10.1113/jphysiol.2002.036889; Yang CZ, 2013, CELL MOL LIFE SCI, V70, P4201, DOI 10.1007/s00018-013-1274-8; YANG HY, 1994, MOL CHEM NEUROPATHOL, V21, P155, DOI 10.1007/BF02815349; Ye ZC, 1999, CANCER RES, V59, P4383; Zong H, 2012, EXPERT REV MOL DIAGN, V12, P383, DOI [10.1586/erm.12.30, 10.1586/ERM.12.30]	73	126	131	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2016	19	1					28	33		10.1038/nn.4184	http://dx.doi.org/10.1038/nn.4184			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ7BH	26713746	Green Accepted			2022-12-17	WOS:000367254400008
J	Collin, SHP; Milivojevic, B; Doeller, CF				Collin, Silvy H. P.; Milivojevic, Branka; Doeller, Christian F.			Memory hierarchies map onto the hippocampal long axis in humans	NATURE NEUROSCIENCE			English	Article							REPRESENTATION; DISTINCT; NEURONS	Memories, similar to the internal representation of space, can be recalled at different resolutions ranging from detailed events to more comprehensive, multi-event narratives. Single-cell recordings in rodents have suggested that different spatial scales are represented as a gradient along the hippocampal axis. We found that a similar organization holds for human episodic memory: memory representations systematically vary in scale along the hippocampal long axis, which may enable the formation of mnemonic hierarchies.	[Collin, Silvy H. P.; Milivojevic, Branka; Doeller, Christian F.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Collin, SHP (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	s.collin@donders.ru.nl; christian.doeller@donders.ru.nl	Milivojevic, Branka/G-9344-2012; Collin, Silvy/N-8215-2015; Collin, Silvy/Q-4727-2019	Milivojevic, Branka/0000-0002-1850-4114; Collin, Silvy/0000-0002-9257-8664; Collin, Silvy/0000-0002-9257-8664	European Research Council [ERC-StG RECONTEXT 261177]; Netherlands Organization for Scientific Research [NWO-Vidi 452-12-009]	European Research Council(European Research Council (ERC)European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The authors would like to thank A. Backus, S. Bosch and L. Deuker for useful discussions, N. Muller for help during stimulus development, and K. Georgelou for help during behavioral pilot work. This work was supported by the European Research Council (ERC-StG RECONTEXT 261177) and the Netherlands Organization for Scientific Research (NWO-Vidi 452-12-009).	Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Horner AJ, 2014, CURR BIOL, V24, P988, DOI 10.1016/j.cub.2014.03.012; Komorowski RW, 2013, J NEUROSCI, V33, P8079, DOI 10.1523/JNEUROSCI.5458-12.2013; Komorowski RW, 2009, J NEUROSCI, V29, P9918, DOI 10.1523/JNEUROSCI.1378-09.2009; Kumaran D, 2009, NEURON, V63, P889, DOI 10.1016/j.neuron.2009.07.030; Liang JC, 2013, CEREB CORTEX, V23, P80, DOI 10.1093/cercor/bhr379; McKenzie S, 2014, NEURON, V83, P202, DOI 10.1016/j.neuron.2014.05.019; Milivojevic B, 2015, CURR BIOL, V25, P821, DOI 10.1016/j.cub.2015.01.033; Milivojevic B, 2013, J EXP PSYCHOL GEN, V142, P1231, DOI 10.1037/a0033746; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Poppenk J, 2013, TRENDS COGN SCI, V17, P230, DOI 10.1016/j.tics.2013.03.005; Ritchey M, 2015, ELIFE, V4, DOI 10.7554/eLife.05025; Schapiro AC, 2013, NAT NEUROSCI, V16, P486, DOI 10.1038/nn.3331; Shohamy D, 2008, NEURON, V60, P378, DOI 10.1016/j.neuron.2008.09.023; Staresina BP, 2012, NAT NEUROSCI, V15, P1167, DOI 10.1038/nn.3154; Staresina BP, 2009, NEURON, V63, P267, DOI 10.1016/j.neuron.2009.06.024; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107; Zeithamova D, 2012, NEURON, V75, P168, DOI 10.1016/j.neuron.2012.05.010	20	126	126	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2015	18	11					1562	1564		10.1038/nn.4138	http://dx.doi.org/10.1038/nn.4138			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8YT	26479587	Green Accepted, Green Published			2022-12-17	WOS:000363830700010
J	von Reyn, CR; Breads, P; Peek, MY; Zheng, GZ; Williamson, WR; Yee, AL; Leonardo, A; Card, GM				von Reyn, Catherine R.; Breads, Patrick; Peek, Martin Y.; Zheng, Grace Zhiyu; Williamson, W. Ryan; Yee, Alyson L.; Leonardo, Anthony; Card, Gwyneth M.			A spike-timing mechanism for action selection	NATURE NEUROSCIENCE			English	Article							DECISION-MAKING; ESCAPE RESPONSE; OBJECT APPROACH; MOTOR-NEURON; WIDE-FIELD; DROSOPHILA; COMPUTATION; FIBER; BEHAVIOR; ACETYLCHOLINE	We discovered a bimodal behavior in the genetically tractable organism Drosophila melanogaster that allowed us to directly probe the neural mechanisms of an action selection process. When confronted by a predator-mimicking looming stimulus, a fly responds with either a long-duration escape behavior sequence that initiates stable flight or a distinct, short-duration sequence that sacrifices flight stability for speed. Intracellular recording of the descending giant fiber (GF) interneuron during head-fixed escape revealed that GF spike timing relative to parallel circuits for escape actions determined which of the two behavioral responses was elicited. The process was well described by a simple model in which the GF circuit has a higher activation threshold than the parallel circuits, but can override ongoing behavior to force a short takeoff. Our findings suggest a neural mechanism for action selection in which relative activation timing of parallel circuits creates the appropriate motor output.	[von Reyn, Catherine R.; Breads, Patrick; Peek, Martin Y.; Zheng, Grace Zhiyu; Williamson, W. Ryan; Yee, Alyson L.; Leonardo, Anthony; Card, Gwyneth M.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	von Reyn, CR (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	cardg@janelia.hhmi.org		Williamson, Wallace/0000-0003-0010-8516; von Reyn, Catherine/0000-0002-5753-2134; Yee, Alyson/0000-0001-7613-2438	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Allen MJ, 2007, EUR J NEUROSCI, V26, P439, DOI 10.1111/j.1460-9568.2007.05686.x; Allen MJ, 2006, SEMIN CELL DEV BIOL, V17, P31, DOI 10.1016/j.semcdb.2005.11.011; BACON JP, 1986, J COMP PHYSIOL A, V158, P529, DOI 10.1007/BF00603798; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Bullock T.H., 1984, P1; BURROWS M, 1973, J COMP PHYSIOL, V85, P221, DOI 10.1007/BF00694231; Card G, 2008, CURR BIOL, V18, P1300, DOI 10.1016/j.cub.2008.07.094; Card G, 2008, J EXP BIOL, V211, P341, DOI 10.1242/jeb.012682; Card GM, 2012, CURR OPIN NEUROBIOL, V22, P180, DOI 10.1016/j.conb.2011.12.009; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; de Vries SEJ, 2012, CURR BIOL, V22, P353, DOI 10.1016/j.cub.2012.01.007; Eaton RC, 2001, PROG NEUROBIOL, V63, P467, DOI 10.1016/S0301-0082(00)00047-2; Edwards DH, 1999, TRENDS NEUROSCI, V22, P153, DOI 10.1016/S0166-2236(98)01340-X; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Fayyazuddin A, 1996, J NEUROSCI, V16, P5225; Fotowat H, 2009, J NEUROPHYSIOL, V102, P875, DOI 10.1152/jn.00073.2009; Gabbiani F, 1999, J NEUROSCI, V19, P1122; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; Gray JR, 2010, J COMP PHYSIOL A, V196, P927, DOI 10.1007/s00359-010-0576-7; Harley CM, 2009, J EXP BIOL, V212, P1463, DOI 10.1242/jeb.028381; HATSOPOULOS N, 1995, SCIENCE, V270, P1000, DOI 10.1126/science.270.5238.1000; Hemmi JM, 2012, CURR OPIN NEUROBIOL, V22, P194, DOI 10.1016/j.conb.2011.11.012; Herberholz J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00125; HOLMQVIST MH, 1994, VISUAL NEUROSCI, V11, P1149, DOI 10.1017/S0952523800006957; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Kristan WB, 2008, CURR BIOL, V18, pR928, DOI 10.1016/j.cub.2008.07.081; LEVINE J, 1973, J COMP PHYSIOL, V87, P213, DOI 10.1007/BF00696043; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; McPeek RM, 2002, J NEUROPHYSIOL, V87, P1805, DOI 10.1152/jn.00501.2001; Mu LY, 2012, J NEUROSCI, V32, P6061, DOI 10.1523/JNEUROSCI.0221-12.2012; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; RIND FC, 1984, J EXP BIOL, V110, P143; Seelig JD, 2013, NATURE, V503, P262, DOI 10.1038/nature12601; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Svoboda KR, 1996, J NEUROSCI, V16, P843; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; THOMAS JB, 1984, J NEUROSCI, V4, P530; Tootoonian S, 2012, J NEUROSCI, V32, P787, DOI 10.1523/JNEUROSCI.5104-11.2012; TRIMARCHI JR, 1995, J EXP BIOL, V198, P1099; WIERSMA CAG, 1964, COMP BIOCHEM PHYSIOL, V12, P509, DOI 10.1016/0010-406X(64)90153-7; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357	50	126	126	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2014	17	7					962	970		10.1038/nn.3741	http://dx.doi.org/10.1038/nn.3741			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AK0IX	24908103				2022-12-17	WOS:000338097200013
J	Silva, BA; Mattucci, C; Krzywkowski, P; Murana, E; Illarionova, A; Grinevich, V; Canteras, NS; Ragozzino, D; Gross, CT				Silva, Bianca A.; Mattucci, Camilla; Krzywkowski, Piotr; Murana, Emanuele; Illarionova, Anna; Grinevich, Valery; Canteras, Newton S.; Ragozzino, Davide; Gross, Cornelius T.			Independent hypothalamic circuits for social and predator fear	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; VENTROMEDIAL HYPOTHALAMUS; ORGANIZATION; REVEALS; SYSTEM; RATS	The neural circuits mediating fear to naturalistic threats are poorly understood. We found that functionally independent populations of neurons in the ventromedial hypothalamus (VMH), a region that has been implicated in feeding, sex and aggression, are essential for predator and social fear in mice. Our results establish a critical role for VMH in fear and have implications for selective intervention in pathological fear in humans.	[Silva, Bianca A.; Mattucci, Camilla; Krzywkowski, Piotr; Gross, Cornelius T.] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [Murana, Emanuele; Ragozzino, Davide] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Murana, Emanuele; Ragozzino, Davide] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, I-00185 Rome, Italy; [Illarionova, Anna; Grinevich, Valery] Heidelberg Univ, Schaller Res Grp Neuropeptides, German Canc Res Ctr DKFZ, CellNetwork Cluster Excellence, Heidelberg, Germany; [Canteras, Newton S.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Ragozzino, Davide] IRCCS Neuromed, Pozzilli, Italy	European Molecular Biology Laboratory (EMBL); Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Universidade de Sao Paulo; IRCCS Neuromed	Gross, CT (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy.	gross@embl.it	ragozzino, davide/K-6521-2016; Silva, Bianca Ambrogina/AAE-3354-2020; Canteras, Newton/F-2402-2013	ragozzino, davide/0000-0002-3290-7665; Silva, Bianca Ambrogina/0000-0003-3877-1356; Grinevich, Valery/0000-0002-6337-8866; Canteras, Newton/0000-0002-7205-5372	US National Institutes of Health [MH093887-01]; EMBL; German Research Foundation (DFG) [GR 3619/2-1, 3619/3-1, GR 3619/4-11]; Chica and Heinz Schaller Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH093887] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBL; German Research Foundation (DFG)(German Research Foundation (DFG)); Chica and Heinz Schaller Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank F. Zonfrillo, R. Migliozzi, E. Audero, P. Hublitz, L. Carbonari, E. Amendola, B. Klaus and the EMBL Transgenic Facility and Mechanical Workshop for experimental support, M. Yang and S. Motta for critical advice, and R. Sotillo and M. Jechlinger (Mouse Biology Unit, EMBL) for antibodies. This work was supported by funds from the US National Institutes of Health (MH093887-01) to C.T.G., from the EMBL to C.T.G., B.A.S., C.M. and P.K., and from the German Research Foundation (DFG, GR 3619/2-1, 3619/3-1, GR 3619/4-1) and Chica and Heinz Schaller Research Foundation to V.G.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Brandao ML, 2008, BEHAV BRAIN RES, V188, P1, DOI 10.1016/j.bbr.2007.10.018; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Canteras NS, 2002, PHARMACOL BIOCHEM BE, V71, P481, DOI 10.1016/S0091-3057(01)00685-2; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; KRUK MR, 1983, BRAIN RES, V260, P61, DOI 10.1016/0006-8993(83)90764-3; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Motta SC, 2009, P NATL ACAD SCI USA, V106, P4870, DOI 10.1073/pnas.0900939106; Wilent WB, 2010, J NEUROSURG, V112, P1295, DOI 10.3171/2009.9.JNS09577	12	126	126	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1731	1733		10.1038/nn.3573	http://dx.doi.org/10.1038/nn.3573			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24212674	Green Accepted, Green Submitted			2022-12-17	WOS:000327416800009
J	Hayama, T; Noguchi, J; Watanabe, S; Takahashi, N; Hayashi-Takagi, A; Ellis-Davies, GCR; Matsuzaki, M; Kasai, H				Hayama, Tatsuya; Noguchi, Jun; Watanabe, Satoshi; Takahashi, Noriko; Hayashi-Takagi, Akiko; Ellis-Davies, Graham C. R.; Matsuzaki, Masanori; Kasai, Haruo			GABA promotes the competitive selection of dendritic spines by controlling local Ca2+ signaling	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; TIMING-DEPENDENT PLASTICITY; CRITICAL PERIOD PLASTICITY; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; CALCIUM-BINDING; 2-PHOTON; GLUTAMATE; MEMORY; LTD	Activity-dependent competition of synapses plays a key role in neural organization and is often promoted by GABA; however, its cellular bases are poorly understood. Excitatory synapses of cortical pyramidal neurons are formed on small protrusions known as dendritic spines, which exhibit structural plasticity. We used two-color uncaging of glutamate and GABA in rat hippocampal CA1 pyramidal neurons and found that spine shrinkage and elimination were markedly promoted by the activation of GABA(A) receptors shortly before action potentials. GABA(ergic) inhibition suppressed bulk increases in cytosolic Ca2+ concentrations, whereas it preserved the Ca2+ nanodomains generated by NMDA-type receptors, both of which were necessary for spine shrinkage. Unlike spine enlargement, spine shrinkage spread to neighboring spines (< 15 mu m) and competed with their enlargement, and this process involved the actin-depolymerizing factor ADF/cofilin. Thus, GABA(ergic) inhibition directly suppresses local dendritic Ca2+ transients and strongly promotes the competitive selection of dendritic spines.	[Hayama, Tatsuya; Noguchi, Jun; Watanabe, Satoshi; Takahashi, Noriko; Hayashi-Takagi, Akiko; Kasai, Haruo] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Struct Physiol,Bunkyo Ku, Tokyo 113, Japan; [Hayama, Tatsuya; Noguchi, Jun; Watanabe, Satoshi; Takahashi, Noriko; Hayashi-Takagi, Akiko; Matsuzaki, Masanori; Kasai, Haruo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Hayashi-Takagi, Akiko; Matsuzaki, Masanori] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Ellis-Davies, Graham C. R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Matsuzaki, Masanori] Grad Univ Adv Studies Sokendai, Natl Inst Basic Biol, Div Brain Circuits, Okazaki, Aichi, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Icahn School of Medicine at Mount Sinai; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Kasai, H (corresponding author), Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Struct Physiol,Bunkyo Ku, Tokyo 113, Japan.	hkasai@m.u-tokyo.ac.jp	Takahashi, Noriko/AAL-1011-2020	Noguchi, Jun/0000-0002-8350-791X; Kasai, Haruo/0000-0003-2327-9027; Matsuzaki, Masanori/0000-0003-3872-4322	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21000009, 21500367, 20021008, 19680020, 22115005]; US National Institutes of Health [GM53395, NS69720]; Mitsubishi Foundation; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069720] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24116003, 21000009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitsubishi Foundation; Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Mizuno, K. Ohashi, G.J. Augustine, C.O'Donnell, S. Okabe and J. Eilers for discussions and C. Maeda, M. Ogasawara, H. Ohno, M. Ishikawa and K. Tamura for technical assistance. This work was supported by Grants-in-Aid for Specially Promoted Area (no. 21000009 to H.K.), Scientific Research (C) (no. 21500367 to J.N.), Scientific Research on Priority Areas ('Elucidation of neural network function in the brain', no. 20021008 to M.M.), Young Scientist (A) (no. 19680020 to M.M.), Scientific Research on Innovative Areas 'Mesoscopic Neurocircuitry' (no. 22115005 to M.M.), the Global COE Program ('Integrative Life Science based on the study of Biosignaling Mechanisms' to H.K.) and the Strategic Research Program for Brain Sciences ('Neuroinformatics of Emotion' to H.K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the US National Institutes of Health (grants GM53395 and NS69720 to G.C.R.E.-D.). In addition, this work was supported by a Mitsubishi Foundation grant to M.M. and a Research Grant from the Human Frontier Science Program to H.K.	ABRAHAM WC, 1991, BRAIN RES, V546, P336, DOI 10.1016/0006-8993(91)91498-P; ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; ADLER EM, 1991, J NEUROSCI, V11, P1496; Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Ellis-Davies GCR, 2007, J NEUROSCI, V27, P6601, DOI 10.1523/JNEUROSCI.1519-07.2007; Ellis-Davies GCR, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.193; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Fino E, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.002.2009; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Kanemoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022652; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1998, J COMPUT NEUROSCI, V5, P331, DOI 10.1023/A:1008891229546; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matsuzaki M., 2011, COLD SPRING HARBOR P; Matsuzaki M, 2010, NAT CHEM BIOL, V6, P255, DOI [10.1038/NCHEMBIO.321, 10.1038/nchembio.321]; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; Nakayama H, 2012, NEURON, V74, P384, DOI 10.1016/j.neuron.2012.02.032; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; Naraghi M, 1997, J NEUROSCI, V17, P6961; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Nishiyama Makoto, 2010, Front Synaptic Neurosci, V2, P22, DOI 10.3389/fnsyn.2010.00022; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oh WC, 2013, P NATL ACAD SCI USA, V110, pE305, DOI 10.1073/pnas.1214705110; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Steele PM, 1999, J NEUROPHYSIOL, V81, P1559, DOI 10.1152/jn.1999.81.4.1559; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Verde EMR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.002.2008; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Yang EJ, 2012, P NATL ACAD SCI USA, V109, P17213, DOI 10.1073/pnas.1200705109; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	55	126	126	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1409	+		10.1038/nn.3496	http://dx.doi.org/10.1038/nn.3496			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23974706	Green Accepted			2022-12-17	WOS:000324795300013
J	Dietz, DM; Sun, HS; Lobo, MK; Cahill, ME; Chadwick, B; Gao, V; Koo, JW; Mazei-Robison, MS; Dias, C; Maze, I; Damez-Werno, D; Dietz, KC; Scobie, KN; Ferguson, D; Christoffel, D; Ohnishi, Y; Hodes, GE; Zheng, Y; Neve, RL; Hahn, KM; Russo, SJ; Nestler, EJ				Dietz, David M.; Sun, Haosheng; Lobo, Mary Kay; Cahill, Michael E.; Chadwick, Benjamin; Gao, Virginia; Koo, Ja Wook; Mazei-Robison, Michelle S.; Dias, Caroline; Maze, Ian; Damez-Werno, Diane; Dietz, Karen C.; Scobie, Kimberly N.; Ferguson, Deveroux; Christoffel, Daniel; Ohnishi, Yoko; Hodes, Georgia E.; Zheng, Yi; Neve, Rachael L.; Hahn, Klaus M.; Russo, Scott J.; Nestler, Eric J.			Rac1 is essential in cocaine-induced structural plasticity of nucleus accumbens neurons	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINES; GLUTAMATE TRANSMISSION; BEHAVIORAL-RESPONSES; SYNAPTIC PLASTICITY; DRUG-SEEKING; LIM-KINASE; ADDICTION; ACTIN; GTPASE; REWARD	Repeated cocaine administration increases the dendritic arborization of nucleus accumbens neurons, but the underlying signaling events remain unknown. Here we show that repeated exposure to cocaine negatively regulates the active form of Rac1, a small GTPase that controls actin remodeling in other systems. Further, we show, using viral-mediated gene transfer, that overexpression of a dominant negative mutant of Rac1 or local knockout of Rac1 is sufficient to increase the density of immature dendritic spines on nucleus accumbens neurons, whereas overexpression of a constitutively active Rac1 or light activation of a photoactivatable form of Rac1 blocks the ability of repeated cocaine exposure to produce this effect. Downregulation of Rac1 activity likewise promotes behavioral responses to cocaine exposure, with activation of Rac1 producing the opposite effect. These findings establish that Rac1 signaling mediates structural and behavioral plasticity in response to cocaine exposure.	[Dietz, David M.; Sun, Haosheng; Lobo, Mary Kay; Cahill, Michael E.; Chadwick, Benjamin; Gao, Virginia; Koo, Ja Wook; Mazei-Robison, Michelle S.; Dias, Caroline; Maze, Ian; Damez-Werno, Diane; Dietz, Karen C.; Scobie, Kimberly N.; Ferguson, Deveroux; Christoffel, Daniel; Ohnishi, Yoko; Hodes, Georgia E.; Russo, Scott J.; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Dietz, David M.; Sun, Haosheng; Lobo, Mary Kay; Cahill, Michael E.; Chadwick, Benjamin; Gao, Virginia; Koo, Ja Wook; Mazei-Robison, Michelle S.; Dias, Caroline; Maze, Ian; Dietz, Karen C.; Scobie, Kimberly N.; Ferguson, Deveroux; Christoffel, Daniel; Ohnishi, Yoko; Hodes, Georgia E.; Russo, Scott J.; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Zheng, Yi] Univ Cincinnati, Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Massachusetts Institute of Technology (MIT); University of North Carolina; University of North Carolina Chapel Hill	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	Russo, Scott/R-7107-2019; Zheng, Yi/J-7235-2015; Dietz, David/AAW-4574-2021; Maze, Ian/P-8077-2018; Lobo, Mary Kay/K-7734-2015; Hodes, Georgia/L-8022-2016; Mazei-Robison, Michelle/I-4304-2017; Dietz, David/J-9458-2015	Russo, Scott/0000-0002-6470-1805; Zheng, Yi/0000-0001-7089-6074; Dietz, David/0000-0002-6927-9236; Lobo, Mary Kay/0000-0002-9419-2079; Hodes, Georgia/0000-0002-1551-2178; Mazei-Robison, Michelle/0000-0002-2372-1420; Dietz, David/0000-0002-6927-9236; Hahn, Klaus/0000-0002-1970-7562; Ferguson, Deveroux/0000-0001-9302-5992; Sun, Haosheng/0000-0003-3919-559X; Christoffel, Dan/0000-0002-6303-5134; Maze, Ian/0000-0003-1490-7781; Gao, Virginia/0000-0002-5595-1175; Cahill, Michael/0000-0003-0574-2655	US National Institute on Drug Abuse [R01 DA14133, P01 DA08227]; US National Institute of Mental Health [R01 MH51399]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH094405, R01MH051399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014133, P01DA008227] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Golden, A. Robison and V. Vialou for helpful discussions and comments on the manuscript. This work was supported by grants from the US National Institute on Drug Abuse (R01 DA14133, P01 DA08227) and US National Institute of Mental Health (R01 MH51399).	Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Chen L, 2009, DEV BIOL, V325, P162, DOI 10.1016/j.ydbio.2008.10.023; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Fard SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009647; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kim WY, 2009, NEUROSCIENCE, V163, P501, DOI 10.1016/j.neuroscience.2009.06.067; Kiraly DD, 2010, BIOL PSYCHIAT, V68, P249, DOI 10.1016/j.biopsych.2010.03.024; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; McFarland K, 2003, J NEUROSCI, V23, P3531; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Schmidt HD, 2010, ANN NY ACAD SCI, V1187, P35, DOI 10.1111/j.1749-6632.2009.05144.x; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Soetanto A, 2010, ARCH GEN PSYCHIAT, V67, P448, DOI 10.1001/archgenpsychiatry.2010.48; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Toda S, 2010, NEUROTOX RES, V18, P410, DOI 10.1007/s12640-010-9193-z; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wolf ME, 2010, TRENDS NEUROSCI, V33, P391, DOI 10.1016/j.tins.2010.06.003; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	50	126	130	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					891	U117		10.1038/nn.3094	http://dx.doi.org/10.1038/nn.3094			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22522400	Green Accepted, Green Submitted			2022-12-17	WOS:000304546700017
J	Fu, J; Bottegoni, G; Sasso, O; Bertorelli, R; Rocchia, W; Masetti, M; Guijarro, A; Lodola, A; Armirotti, A; Garau, G; Bandiera, T; Reggiani, A; Mor, M; Cavalli, A; Piomelli, D				Fu, Jin; Bottegoni, Giovanni; Sasso, Oscar; Bertorelli, Rosalia; Rocchia, Walter; Masetti, Matteo; Guijarro, Ana; Lodola, Alessio; Armirotti, Andrea; Garau, Gianpiero; Bandiera, Tiziano; Reggiani, Angelo; Mor, Marco; Cavalli, Andrea; Piomelli, Daniele			A catalytically silent FAAH-1 variant drives anandamide transport in neurons	NATURE NEUROSCIENCE			English	Article							ACID AMIDE HYDROLASE; CANNABINOID RECEPTOR; FORCE-FIELDS; INHIBITORS; INACTIVATION; ACCUMULATION; CELLS; 2-ARACHIDONOYLGLYCEROL; IDENTIFICATION; MODULATION	The endocannabinoid anandamide is removed from the synaptic space by a selective transport system, expressed in neurons and astrocytes, that remains molecularly uncharacterized. Here we describe a partly cytosolic variant of the intracellular anandamide-degrading enzyme fatty acid amide hydrolase-1 (FAAH-1), termed FAAH-like anandamide transporter (FLAT), that lacked amidase activity but bound anandamide with low micromolar affinity and facilitated its translocation into cells. Known anandamide transport inhibitors, such as AM404 and OMDM-1, blocked these effects. We also identified a competitive antagonist of the interaction of anandamide with FLAT, the phthalazine derivative ARN272, that prevented anandamide internalization in vitro, interrupted anandamide deactivation in vivo and exerted profound analgesic effects in rodent models of nociceptive and inflammatory pain, which were mediated by CB1 cannabinoid receptors. The results identify FLAT as a critical molecular component of anandamide transport in neural cells and a potential target for therapeutic drugs.	[Fu, Jin; Guijarro, Ana; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Bottegoni, Giovanni; Sasso, Oscar; Bertorelli, Rosalia; Rocchia, Walter; Masetti, Matteo; Armirotti, Andrea; Garau, Gianpiero; Bandiera, Tiziano; Reggiani, Angelo; Cavalli, Andrea; Piomelli, Daniele] Italian Inst Technol, Genoa, Italy; [Lodola, Alessio; Mor, Marco] Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy; [Cavalli, Andrea] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy	University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT; University of Parma; University of Bologna	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	piomelli@uci.edu	Mor, Marco/D-2394-2009; Rocchia, Walter/H-3784-2012; Lodola, Alessio/H-9078-2013; Armirotti, Andrea/AAB-3284-2019; Fu, Jin/A-3510-2012; bertorelli, rosalia/A-2989-2012; Garau, Gianpiero/A-2800-2012; Garau, Gianpiero/AAM-4234-2021	Mor, Marco/0000-0003-0199-1849; Rocchia, Walter/0000-0003-2480-7151; Lodola, Alessio/0000-0002-8675-1002; Garau, Gianpiero/0000-0001-9473-5814; Garau, Gianpiero/0000-0001-9473-5814; Bottegoni, Giovanni/0000-0003-1251-583X; Armirotti, Andrea/0000-0002-3766-8755; GUIJARRO ANTON, Ana Isabel/0000-0002-1595-2173; Masetti, Matteo/0000-0002-3757-7802; BERTORELLI, Rosalia/0000-0002-7913-3564; CAVALLI, ANDREA/0000-0002-6370-1176	US National Institute on Drug Abuse; US National Institute on Alcohol Abuse and Alcoholism [DA-012413]; US National Institute on General Medicine [1R01GM093937-01]; Agilent/University of California Irvine Analytical Discovery Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012413] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); US National Institute on General Medicine; Agilent/University of California Irvine Analytical Discovery Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Colombano, J. Kim, S. Mandrup-Bertozzi, D. Thongkham, G. Moreno-Sanz and R. Scarpelli for help with experiments and discussions about the project. This research was supported by grants from the US National Institute on Drug Abuse and the US National Institute on Alcohol Abuse and Alcoholism (DA-012413 to D. P.) and the US National Institute on General Medicine (1R01GM093937-01 to W. R.). The support provided by the Agilent/University of California Irvine Analytical Discovery Facility is gratefully acknowledged.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Beltramo M, 2000, NEUROREPORT, V11, P1231, DOI 10.1097/00001756-200004270-00018; Bisogno T, 2001, EUR J BIOCHEM, V268, P1982, DOI 10.1046/j.1432-1327.2001.02072.x; Bojesen IN, 2003, J LIPID RES, V44, P1790, DOI 10.1194/jlr.M300170-JLR200; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Evans MS, 1998, J NEUROSCI METH, V79, P37, DOI 10.1016/S0165-0270(97)00159-3; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Glaser ST, 2003, P NATL ACAD SCI USA, V100, P4269, DOI 10.1073/pnas.0730816100; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hillard CJ, 2007, J MOL NEUROSCI, V33, P18, DOI 10.1007/s12031-007-0045-0; Hillard CJ, 2003, BRIT J PHARMACOL, V140, P802, DOI 10.1038/sj.bjp.0705468; Hillard CJ, 1997, J NEUROCHEM, V69, P631, DOI 10.1046/j.1471-4159.1997.69020631.x; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jacobsson SOP, 2001, BRIT J PHARMACOL, V132, P1743, DOI 10.1038/sj.bjp.0704029; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; La Rana G, 2006, J PHARMACOL EXP THER, V317, P1365, DOI 10.1124/jpet.105.100792; Li XQ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-11; Lichtman AH, 2004, J PHARMACOL EXP THER, V311, P441, DOI 10.1124/jpet.104.069401; Ligresti A, 2004, BIOCHEM J, V380, P265, DOI 10.1042/BJ20031812; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; Maione S, 2008, BRIT J PHARMACOL, V155, P775, DOI 10.1038/bjp.2008.308; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Niot I, 2009, PROG LIPID RES, V48, P101, DOI 10.1016/j.plipres.2009.01.001; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Ortar G, 2003, BIOCHEM PHARMACOL, V65, P1473, DOI 10.1016/S0006-2952(03)00109-6; Ortega-Gutierrez S, 2004, BIOCHEMISTRY-US, V43, P8184, DOI 10.1021/bi049395f; Patricelli MP, 1999, BIOCHEMISTRY-US, V38, P14125, DOI 10.1021/bi991876p; PEARSON GDN, 1982, P NATL ACAD SCI-BIOL, V79, P2976, DOI 10.1073/pnas.79.9.2976; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piomelli D, 1999, P NATL ACAD SCI USA, V96, P5802, DOI 10.1073/pnas.96.10.5802; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Reese-Wagoner A, 1999, BBA-MOL CELL BIOL L, V1441, P106, DOI 10.1016/S1388-1981(99)00154-7; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rosso L, 2008, J COMPUT CHEM, V29, P24, DOI 10.1002/jcc.20675; Russo R, 2007, J PHARMACOL EXP THER, V322, P236, DOI 10.1124/jpet.107.119941; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Seierstad M, 2008, J MED CHEM, V51, P7327, DOI 10.1021/jm800311k; Speers AE, 2007, CHEM REV, V107, P3687, DOI 10.1021/cr068286z; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; Yates ML, 2009, MOL PHARMACOL, V76, P11, DOI 10.1124/mol.109.055251	49	126	131	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2012	15	1					64	U82		10.1038/nn.2986	http://dx.doi.org/10.1038/nn.2986			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866VO	22101642	Green Submitted, Green Accepted			2022-12-17	WOS:000298414400015
J	Chua, HF; Ho, SS; Jasinska, AJ; Polk, TA; Welsh, RC; Liberzon, I; Strecher, VJ				Chua, Hannah Faye; Ho, S. Shaun; Jasinska, Agnes J.; Polk, Thad A.; Welsh, Robert C.; Liberzon, Israel; Strecher, Victor J.			Self-related neural response to tailored smoking-cessation messages predicts quitting	NATURE NEUROSCIENCE			English	Article							METAANALYSIS; EDUCATION; BRAIN	Tailored health interventions can be more effective in eliciting positive behavior change than generic interventions, but the underlying neural mechanisms are not yet understood. Here, 91 smokers participated in a functional magnetic resonance imaging session and a tailored smoking-cessation program. We found that increases in activation in self-related processing regions, particularly dorsomedial prefrontal cortex, to tailored messages predicted quitting during a 4-month follow-up.	[Chua, Hannah Faye; Jasinska, Agnes J.] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chua, HF (corresponding author), Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA.	hchua@umich.edu	Welsh, Robert/ABH-3526-2021	Ho, Shao-Hsuan/0000-0003-2617-1628; Liberzon, Israel/0000-0002-4990-556X	National Institute of Drug Abuse [R21-DA024429-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024429] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Drug Abuse grant R21DA024429-01 to H.F.C. and V.J.S.	Brug J, 1999, PATIENT EDUC COUNS, V36, P145, DOI 10.1016/S0738-3991(98)00131-1; Chua HF, 2009, BIOL PSYCHIAT, V65, P165, DOI 10.1016/j.biopsych.2008.08.030; Dijkstra A, 2005, HEALTH EDUC RES, V20, P527, DOI 10.1093/her/cyh014; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub3, 10.1002/14651858.CD001292.pub2]; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Schmitz TW, 2006, NEUROIMAGE, V30, P1050, DOI 10.1016/j.neuroimage.2005.10.030; Strecher V, 2007, ANNU REV CLIN PSYCHO, V3, P53, DOI 10.1146/annurev.clinpsy.3.022806.091428; Strecher VJ, 2008, AM J PREV MED, V34, P373, DOI 10.1016/j.amepre.2007.12.024; Symons CS, 1997, PSYCHOL BULL, V121, P371, DOI 10.1037/0033-2909.121.3.371; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; Velicer WF, 2004, ADDICT BEHAV, V29, P51, DOI 10.1016/S0306-4603(03)00084-4	12	126	126	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					426	427		10.1038/nn.2761	http://dx.doi.org/10.1038/nn.2761			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	741FQ	21358641	Green Accepted			2022-12-17	WOS:000288849400012
J	Chan, CS; Glajch, KE; Gertler, TS; Guzman, JN; Mercer, JN; Lewis, AS; Goldberg, AB; Tkatch, T; Shigemoto, R; Fleming, SM; Chetkovich, DM; Osten, P; Kita, H; Surmeier, DJ				Chan, C. Savio; Glajch, Kelly E.; Gertler, Tracy S.; Guzman, Jaime N.; Mercer, Jeff N.; Lewis, Alan S.; Goldberg, Alan B.; Tkatch, Tatiana; Shigemoto, Ryuichi; Fleming, Sheila M.; Chetkovich, Dane M.; Osten, Pavel; Kita, Hitoshi; Surmeier, D. James			HCN channelopathy in external globus pallidus neurons in models of Parkinson's disease	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; IN-VITRO; ABSENCE EPILEPSY; DOPAMINE; PLASTICITY; OSCILLATIONS; DISORDERS; RECEPTORS; MICE; PATHOPHYSIOLOGY	Parkinson's disease is a common neurodegenerative disorder characterized by a profound motor disability that is traceable to the emergence of synchronous, rhythmic spiking in neurons of the external segment of the globus pallidus (GPe). The origins of this pathophysiology are poorly defined for the generation of pacemaking. After the induction of a parkinsonian state in mice, there was a progressive decline in autonomous GPe pacemaking, which normally serves to desynchronize activity. The loss was attributable to the downregulation of an ion channel that is essential in pacemaking, the hyperpolarization and cyclic nucleotide-gated (HCN) channel. Viral delivery of HCN2 subunits restored pacemaking and reduced burst spiking in GPe neurons. However, the motor disability induced by dopamine (DA) depletion was not reversed, suggesting that the loss of pacemaking was a consequence, rather than a cause, of key network pathophysiology, a conclusion that is consistent with the ability of L-type channel antagonists to attenuate silencing after DA depletion.	[Chan, C. Savio; Glajch, Kelly E.; Gertler, Tracy S.; Guzman, Jaime N.; Mercer, Jeff N.; Goldberg, Alan B.; Tkatch, Tatiana; Chetkovich, Dane M.; Osten, Pavel; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Lewis, Alan S.; Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Shigemoto, Ryuichi] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 444, Japan; [Fleming, Sheila M.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Osten, Pavel] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kita, Hitoshi] Univ Tennessee, Coll Med, Dept Anat & Neurobiol, Memphis, TN USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University System of Ohio; University of Cincinnati; Cold Spring Harbor Laboratory; University of Tennessee System; University of Tennessee Health Science Center	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Chetkovich, Dane/AAV-5457-2021; Lewis, Alan/AAV-9582-2021; Shigemoto, Ryuichi/E-3628-2013	Lewis, Alan/0000-0002-7165-5376; Shigemoto, Ryuichi/0000-0001-8761-9444; Tkatch, Tatiana/0000-0001-6626-7435; Chan, C. Savio/0000-0002-3474-1718	Parkinson's Disease Foundation; American Parkinson Disease Association Research; Michael J. Fox Foundation; Hartmann Foundation; US National Institutes of Health [NS069777, MH082522, NS064757, NS05595, NS059934, NS042762, NS047085]; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH082522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059934, R21NS065391, P50NS047085, F30NS064757, R01NS069777, R01NS042762, K02NS055995] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; American Parkinson Disease Association Research; Michael J. Fox Foundation; Hartmann Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Chen, K. Saporito and S. Ulrich for technical assistance. This work was supported by grants from the Parkinson's Disease Foundation and American Parkinson Disease Association Research to C.S.C.; a grant from the Michael J. Fox Foundation to P.O.; a grant from the Hartmann Foundation to D.J.S. and US National Institutes of Health grants NS069777 to C.S.C., MH082522 to T.S.G., NS064757 to A.S.L., NS05595 and NS059934 to D.M.C., NS042762 to H.K. and NS047085 to D.J.S.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Blume SR, 2009, EXP NEUROL, V219, P208, DOI 10.1016/j.expneurol.2009.05.017; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; Chung WK, 2009, NEUROBIOL DIS, V33, P499, DOI 10.1016/j.nbd.2008.12.004; Cooper AJ, 2001, NEUROPHARMACOLOGY, V41, P62, DOI 10.1016/S0028-3908(01)00038-7; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Destexhe A, 2004, NATURE, V431, P789, DOI 10.1038/nature03011; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Galati S, 2009, J PHYSIOL-LONDON, V587, P4405, DOI 10.1113/jphysiol.2009.172759; Gillies A, 2002, P ROY SOC B-BIOL SCI, V269, P545, DOI 10.1098/rspb.2001.1817; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Heimer G, 2002, J NEUROSCI, V22, P7850; Hernandez A, 2006, J NEUROPHYSIOL, V96, P2877, DOI 10.1152/jn.00664.2006; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; KITA H, 1991, BRAIN RES, V564, P296, DOI 10.1016/0006-8993(91)91466-E; Kole MHP, 2007, J PHYSIOL-LONDON, V578, P507, DOI 10.1113/jphysiol.2006.122028; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Mallet N, 2008, J NEUROSCI, V28, P14245, DOI 10.1523/JNEUROSCI.4199-08.2008; Mercer JN, 2007, J NEUROSCI, V27, P13552, DOI 10.1523/JNEUROSCI.3430-07.2007; NAMBU A, 1994, J NEUROPHYSIOL, V72, P1127, DOI 10.1152/jn.1994.72.3.1127; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS8, DOI 10.1016/S1471-1931(00)00028-8; Rivlin-Etzion M, 2006, CURR OPIN NEUROBIOL, V16, P629, DOI 10.1016/j.conb.2006.10.002; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shin RM, 2003, J NEUROSCI, V23, P11662; Stanford IM, 2003, J NEUROPHYSIOL, V89, P1713, DOI 10.1152/jn.00864.2002; Strauss U, 2004, EUR J NEUROSCI, V19, P3048, DOI 10.1111/j.0953-816X.2004.03392.x; Surmeier DJ, 2005, CURR OPIN NEUROBIOL, V15, P312, DOI 10.1016/j.conb.2005.05.007; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Walters JR, 2007, NEUROSCIENCE, V144, P762, DOI 10.1016/j.neuroscience.2006.10.006; Walters JR, 2000, TRENDS NEUROSCI, V23, pS41, DOI 10.1016/S1471-1931(00)00024-0; Watanabe K, 2009, J NEUROPHYSIOL, V101, P665, DOI 10.1152/jn.90806.2008; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	47	126	127	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					85	U117		10.1038/nn.2692	http://dx.doi.org/10.1038/nn.2692			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21076425	Green Accepted			2022-12-17	WOS:000285684900018
J	d'Avossa, G; Tosetti, M; Crespi, S; Biagi, L; Burr, DC; Morrone, MC				d'Avossa, Giovanni; Tosetti, Michela; Crespi, Sofia; Biagi, Laura; Burr, David C.; Morrone, Maria Concetta			Spatiotopic selectivity of BOLD responses to visual motion in human area MT	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL; CORTICAL AREA; OPTIC FLOW; CORTEX; REPRESENTATION; INTEGRATION; LOCATIONS; SHAPE; FORM	Many neurons in the monkey visual extrastriate cortex have receptive fields that are affected by gaze direction. In humans, psychophysical studies suggest that motion signals may be encoded in a spatiotopic fashion. Here we use functional magnetic resonance imaging to study spatial selectivity in the human middle temporal cortex ( area MT or V5), an area that is clearly implicated in motion perception. The results show that the response of MT is modulated by gaze direction, generating a spatial selectivity based on screen rather than retinal coordinates. This area could be the neurophysiological substrate of the spatiotopic representation of motion signals.	Univ Vita Salute San Raffaele, Fac Psicol, I-20132 Milan, Italy; Washington Univ, Sch Med, St Louis, MO 63110 USA; Fdn Stella Maris, I-56018 Pisa, Italy; Univ Milan, Dept Psychol, I-20126 Milan, Italy; Univ Florence, Dept Psychol, Florence, Italy; Univ Western Australia, Dept Psychol, Nedlands, WA 6009, Australia	Vita-Salute San Raffaele University; Washington University (WUSTL); IRCCS Fondazione Stella Maris; University of Milan; University of Milano-Bicocca; University of Florence; University of Western Australia	Morrone, MC (corresponding author), Univ Vita Salute San Raffaele, Fac Psicol, Via Olgettina 58, I-20132 Milan, Italy.	concetta.morrone@hsr.it	Tosetti, Michela/K-5749-2016; Morrone, Maria Concetta/C-6756-2014; Biagi, Laura/K-5692-2016	Tosetti, Michela/0000-0002-2515-7560; Morrone, Maria Concetta/0000-0002-1025-0316; Biagi, Laura/0000-0003-2159-439X; CRESPI, Sofia Allegra/0000-0001-7429-0440; Burr, David/0000-0003-1541-8832				ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; d'Avossa G, 2003, J NEUROPHYSIOL, V90, P360, DOI 10.1152/jn.01040.2002; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; DeSouza JFX, 2002, CEREB CORTEX, V12, P991, DOI 10.1093/cercor/12.9.991; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Fox MD, 2005, NEUROIMAGE, V28, P956, DOI 10.1016/j.neuroimage.2005.06.025; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; Goossens J, 2006, J NEUROSCI, V26, P5616, DOI 10.1523/JNEUROSCI.0730-06.2006; Hasnain MK, 1998, HUM BRAIN MAPP, V6, P301, DOI 10.1002/(SICI)1097-0193(1998)6:4<301::AID-HBM8>3.0.CO;2-7; HAYHOE M, 1991, PERCEPTION, V20, P393, DOI 10.1068/p200393; Huk AC, 2002, J NEUROSCI, V22, P7195; MCKYTON A, 2006, CEREB CORTEX, DOI DOI 10.1093/CERCORBH1027; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Melcher D, 2003, NAT NEUROSCI, V6, P877, DOI 10.1038/nn1098; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Nieman DR, 2005, VISION RES, V45, P2885, DOI 10.1016/j.visres.2005.06.029; Nishida S, 2003, VISION RES, V43, P639, DOI 10.1016/S0042-6989(03)00007-5; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Sereno MI, 2006, NAT NEUROSCI, V9, P1337, DOI 10.1038/nn1777; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Talairach J., 1988, STEREOTACTIC COPLANA; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Zaksas D, 2005, J NEUROPHYSIOL, V94, P4156, DOI 10.1152/jn.00505.2005; ZEKI S, 1991, J NEUROSCI, V11, P641; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	40	126	125	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					249	255		10.1038/nn1824	http://dx.doi.org/10.1038/nn1824			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17195842				2022-12-17	WOS:000244175200020
J	Amitay, S; Irwin, A; Moore, DR				Amitay, Sygal; Irwin, Amy; Moore, David R.			Discrimination learning induced by training with identical stimuli	NATURE NEUROSCIENCE			English	Article							AUDITORY FREQUENCY DISCRIMINATION; ADAPTIVE PROCEDURES; TASK-DIFFICULTY; SPECIFICITY; CORTEX; PLASTICITY; PERCEPTION; MODULATION; CHILDREN	Sensory stimuli become easier to detect or distinguish with practice. It is generally assumed that the task-relevant stimulus dimension becomes increasingly more salient as a result of attentively performing the task at a level that is neither too easy nor too difficult. However, here we show improved auditory frequency discrimination following training with physically identical tones that were impossible to discriminate. We also show that learning transfers across tone frequencies and across modalities: training on a silent visuospatial computer game improved thresholds on the auditory discrimination task. We suggest that three processes are necessary for optimal perceptual learning: sensitization through exposure to the stimulus, modality- and dimension-specific attention, and general arousal.	UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, London WC1N 1EH, England; MTC Inst Hearing Res, Nottingham NG7 2RD, England	University of London; University College London	Amitay, S (corresponding author), UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, 30 Guilford St, London WC1N 1EH, England.	s.amitay@ich.ucl.ac.uk	Amitay, Sygal/D-7323-2012	Amitay, Sygal/0000-0001-9482-3435	MRC [MC_U135079241] Funding Source: UKRI; Medical Research Council [MC_U135079241] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahissar M, 1996, VISION RES, V36, P3487, DOI 10.1016/0042-6989(96)00036-3; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Amitay S, 2005, PERCEPT PSYCHOPHYS, V67, P691, DOI 10.3758/BF03193525; Amitay S, 2006, J ACOUST SOC AM, V119, P1616, DOI 10.1121/1.2164988; [Anonymous], 1981, Br J Audiol, V15, P213; Delhommeau K, 2002, PERCEPT PSYCHOPHYS, V64, P426, DOI 10.3758/BF03194715; DEMANY L, 1985, J ACOUST SOC AM, V78, P1118, DOI 10.1121/1.393034; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P82, DOI 10.1037/0735-7044.107.1.82; Fahle M, 1997, VISION RES, V37, P1885, DOI 10.1016/S0042-6989(96)00308-2; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; GREEN DM, 1993, J ACOUST SOC AM, V93, P2096, DOI 10.1121/1.406696; Hawkey DJC, 2004, NAT NEUROSCI, V7, P1055, DOI 10.1038/nn1315; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; Karmarkar UR, 2003, LEARN MEMORY, V10, P141, DOI 10.1101/lm.55503; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Linkenhoker BA, 2002, NATURE, V419, P293, DOI 10.1038/nature01002; Moore DR, 2005, BRAIN LANG, V94, P72, DOI 10.1016/j.bandl.2004.11.009; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Rubin N, 1997, CURR BIOL, V7, P461, DOI 10.1016/S0960-9822(06)00217-X; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; TRAHIOTIS C, 1990, J ACOUST SOC AM, V87, P1359, DOI 10.1121/1.399513; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Woldorff MG, 1998, PSYCHOPHYSIOLOGY, V35, P283, DOI 10.1017/S0048577298961601; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Wright BA, 1997, J NEUROSCI, V17, P3956; Wright BA, 2001, P NATL ACAD SCI USA, V98, P12307, DOI 10.1073/pnas.211220498	27	126	133	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1446	1448		10.1038/nn1787	http://dx.doi.org/10.1038/nn1787			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17028582				2022-12-17	WOS:000242403800024
J	Spudich, A; Kilic, E; Xing, HY; Kilic, U; Rentsch, KM; Wunderli-Allenspach, H; Bassetti, CL; Hermann, DM				Spudich, A; Kilic, E; Xing, HY; Kilic, U; Rentsch, KM; Wunderli-Allenspach, H; Bassetti, CL; Hermann, DM			Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia	NATURE NEUROSCIENCE			English	Article							EFFLUX	The blood-brain barrier possesses active transporters carrying brain-permeable xenobiotics back into the blood against concentration gradients. We demonstrate that multidrug resistance transporter (Mdr)-1 is upregulated on capillary endothelium after focal cerebral ischemia; moreover, Mdr-1 deactivation by pharmacological inhibition or genetic knockout preferably enhances the accumulation and efficacy of two neuroprotectants known as Mdr-1 substrates in the ischemic brain. We predict that Mdr-1 inhibition may greatly facilitate neuroprotective therapies.	Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Clin Chem, CH-8091 Zurich, Switzerland; Swiss Fed Inst Technol, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hermann, DM (corresponding author), Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.	dirk.hermann@usz.ch	Hermann, Dirk/GZB-9350-2022; Hermann, Dirk M/AAP-5538-2020; Kilic, Ertugrul/W-4563-2018; Hermann, Dirk M./AAT-3652-2021	Kilic, Ertugrul/0000-0001-6494-8923; Hermann, Dirk M./0000-0003-0198-3152; Bassetti, Claudio/0000-0002-4535-0245				Comerford KM, 2002, CANCER RES, V62, P3387; Fisher M, 2005, STROKE, V36, P1808, DOI 10.1161/01.STR.0000173403.60553.27; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Loscher W, 2002, J PHARMACOL EXP THER, V301, P7, DOI 10.1124/jpet.301.1.7; Loscher W, 2005, NAT REV NEUROSCI, V6, P591, DOI 10.1038/nrn1728; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Sisodiya SM, 2001, LANCET, V357, P42, DOI 10.1016/S0140-6736(00)03573-X; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; Wartenberg M, 2003, FASEB J, V17, P503, DOI 10.1096/fj.02-0358fje; Yulug B, 2004, BRAIN RES, V996, P76, DOI 10.1016/j.brainres.2003.10.012	11	126	133	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					487	488		10.1038/nn1676	http://dx.doi.org/10.1038/nn1676			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16565717				2022-12-17	WOS:000236310700014
J	Wolfart, J; Debay, D; Le Masson, G; Destexhe, A; Bal, T				Wolfart, J; Debay, D; Le Masson, G; Destexhe, A; Bal, T			Synaptic background activity controls spike transfer from thalamus to cortex	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; RELAY NEURONS; ELECTROPHYSIOLOGICAL PROPERTIES; NEOCORTICAL NEURONS; VISUAL INFORMATION; PYRAMIDAL NEURONS; SENSORY INPUT; IN-VIVO; CAT; CELLS	Characterizing the responsiveness of thalamic neurons is crucial to understanding the flow of sensory information. Typically, thalamocortical neurons possess two distinct firing modes. At depolarized membrane potentials, thalamic cells fire single action potentials and faithfully relay synaptic inputs to the cortex. At hyperpolarized potentials, the activation of T-type calcium channels promotes burst firing, and the transfer is less accurate. Our results suggest that this duality no longer holds if synaptic background activity is taken into account. By injecting stochastic conductances into guinea-pig thalamocortical neurons in slices, we show that the transfer function of these neurons is strongly influenced by conductance noise. The combination of synaptic noise with intrinsic properties gives a global responsiveness that is more linear, mixing single-spike and burst responses at all membrane potentials. Because in thalamic neurons, background synaptic input originates mainly from cortex, these results support a determinant role of corticothalamic feedback during sensory information processing.	CNRS, Unite Neurosci Integrat & Computat, F-91198 Gif Sur Yvette, France; Univ Bordeaux 2, INSERM 358, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Bal, T (corresponding author), CNRS, Unite Neurosci Integrat & Computat, F-91198 Gif Sur Yvette, France.	jakob.wolfart@unklinik-freiburg.de; thierry.bal@iaf.cnrs-gif.fr	Wolfart, Jakob/F-1698-2011	Wolfart, Jakob/0000-0003-0594-2112; Destexhe, Alain/0000-0001-7405-0455				Ahissar E, 1997, P NATL ACAD SCI USA, V94, P11633, DOI 10.1073/pnas.94.21.11633; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Barber MJ, 2003, NEURAL COMPUT, V15, P1843, DOI 10.1162/08997660360675062; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Destexhe A, 2002, PHILOS T ROY SOC B, V357, P1649, DOI 10.1098/rstb.2002.1154; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; Erisir A, 1997, P NATL ACAD SCI USA, V94, P1517, DOI 10.1073/pnas.94.4.1517; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HIRSCH JC, 1983, BRAIN RES, V259, P308, DOI 10.1016/0006-8993(83)91264-7; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; KOCH C, 1987, NEUROSCIENCE, V23, P399, DOI 10.1016/0306-4522(87)90064-9; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Le Masson G, 2002, NATURE, V417, P854, DOI 10.1038/nature00825; Leresche N, 2004, J NEUROSCI, V24, P5592, DOI 10.1523/JNEUROSCI.1038-04.2004; Lewis JE, 1999, J COMP PHYSIOL A, V185, P373, DOI 10.1007/s003590050397; LIU XB, 1995, J COMP NEUROL, V352, P69, DOI 10.1002/cne.903520106; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; Mainen T.J., 1998, METHODS NEURONAL MOD, V2, P1; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; Montero VM, 1999, NEUROSCIENCE, V91, P805, DOI 10.1016/S0306-4522(98)00632-0; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Rudolph M, 2004, J NEUROPHYSIOL, V91, P2884, DOI 10.1152/jn.01223.2003; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; Shu YS, 2003, J NEUROSCI, V23, P10388; Sillito AM, 2002, PHILOS T R SOC B, V357, P1739, DOI 10.1098/rstb.2002.1170; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Steriade M, 2001, NAT NEUROSCI, V4, P671, DOI 10.1038/89434; Steriade M, 1997, THALAMUS, VI; TANAKA K, 1985, VISION RES, V25, P357, DOI 10.1016/0042-6989(85)90060-4; TROY JB, 1992, VISUAL NEUROSCI, V9, P535, DOI 10.1017/S0952523800001784; TURNER JP, 1994, J PHYSIOL-LONDON, V480, P281, DOI 10.1113/jphysiol.1994.sp020359; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; Van Horn SC, 2000, J COMP NEUROL, V416, P509; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042	49	126	129	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1760	1767		10.1038/nn1591	http://dx.doi.org/10.1038/nn1591			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16261132				2022-12-17	WOS:000233576200026
J	Ergenzinger, ER; Glasier, MM; Hahm, JO; Pons, TP				Ergenzinger, ER; Glasier, MM; Hahm, JO; Pons, TP			Cortically induced thalamic plasticity in the primate somatosensory system	NATURE NEUROSCIENCE			English	Article							MACAQUE MONKEYS; RELAY NEURONS; ADULT MONKEYS; CORTEX; DEAFFERENTATION; REORGANIZATION; ORGANIZATION; NUCLEUS; CAT; RAT	The influence of cortical feedback on receptive field organization in the thalamus was assessed in the primate somatosensory system. Chronic and acute suppression of neuronal activity in primary somatosensory cortex resulted in a striking enlargement of receptive fields in the ventroposterior thalamus. This finding demonstrates a dramatic 'top-down' influence of cortex on receptive field size in the somatosensory thalamus. In addition, this result has important implications for studies of adult neuronal plasticity because it indicates that changes in 'higher-order' areas of the brain can trigger extensive changes in the receptive field characteristics of neurons located earlier in the processing pathway.	Wake Forest Univ, Sch Med, Dept Neurosurg, Winston Salem, NC 27127 USA; Wake Forest Univ, Sch Med, Program Neurosci, Winston Salem, NC 27127 USA; Georgetown Univ, Dept Neurosurg, Washington, DC 20057 USA	Wake Forest University; Wake Forest University; Georgetown University	Pons, TP (corresponding author), Wake Forest Univ, Sch Med, Dept Neurosurg, Winston Salem, NC 27127 USA.	tpons@wfubmc.edu			NIMH NIH HHS [MH53369-02, MH11950-01] Funding Source: Medline; NINDS NIH HHS [NS35246-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011950, R01MH053369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035246] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAVA A, 1968, ARCH ITAL BIOL, V106, P204; BURCHFIEL JL, 1974, BRAIN RES, V70, P395, DOI 10.1016/0006-8993(74)90251-0; CONTI F, 1996, EXCITATORY AMINO ACI, P81; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; DOSTROVSKY JO, 1976, EXP NEUROL, V52, P480, DOI 10.1016/0014-4886(76)90219-3; GARRAGHTY PE, 1991, NEUROREPORT, V2, P747, DOI 10.1097/00001756-199112000-00004; Garraghty PE, 1996, J COMP NEUROL, V367, P319, DOI 10.1002/(SICI)1096-9861(19960401)367:2<319::AID-CNE12>3.0.CO;2-L; GHOSH S, 1994, EXP BRAIN RES, V100, P276; Jones EG, 1985, THALAMUS; Kaas J.H., 1988, P421; LIU XB, 1995, J COMP NEUROL, V352, P69, DOI 10.1002/cne.903520106; LOE PR, 1977, J NEUROPHYSIOL, V40, P1339, DOI 10.1152/jn.1977.40.6.1339; MCMAHON SB, 1983, EXP NEUROL, V80, P195, DOI 10.1016/0014-4886(83)90016-X; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; POGGIO GF, 1963, J NEUROPHYSIOL, V26, P775, DOI 10.1152/jn.1963.26.5.775; POLLIN B, 1979, BRAIN RES, V173, P431, DOI 10.1016/0006-8993(79)90240-3; PONS TP, 1987, SCIENCE, V237, P417, DOI 10.1126/science.3603028; PONS TP, 1985, J COMP NEUROL, V241, P445, DOI 10.1002/cne.902410405; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; PONS TP, 1987, SOMATOSENS MOT RES, V4, P309, DOI 10.3109/07367228709144612; PONS TP, 1996, SOMESTHESIS NEUROBIO, P187; SHIN HC, 1990, SOMATOSENS MOT RES, V7, P421, DOI 10.3109/08990229009144717; TSUMOTO T, 1974, EXP BRAIN RES, V21, P195; YUAN B, 1985, J NEUROSCI, V5, P2971	25	126	126	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					226	229		10.1038/673	http://dx.doi.org/10.1038/673			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195147				2022-12-17	WOS:000076361200013
J	Durak, O; Gao, F; Kaeser-Woo, YJ; Rueda, R; Martorell, AJ; Nott, A; Liu, CY; Watson, LA; Tsai, LH				Durak, Omer; Gao, Fan; Kaeser-Woo, Yea Jin; Rueda, Richard; Martorell, Anthony J.; Nott, Alexi; Liu, Carol Y.; Watson, L. Ashley; Tsai, Li-Huei			Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling	NATURE NEUROSCIENCE			English	Article							CATENIN-BINDING PROTEIN; CHROMATIN REMODELING FACTOR; DE-NOVO MUTATIONS; BETA-CATENIN; NEURONAL DIFFERENTIATION; NEURAL STEM; EXPRESSION; GENES; ACTIVATION; PATTERNS	De novo mutations in CHD8 are strongly associated with autism spectrum disorder, but the basic biology of CHD8 remains poorly understood. Here we report that Chd8 knockdown during cortical development results in defective neural progenitor proliferation and differentiation that ultimately manifests in abnormal neuronal morphology and behaviors in adult mice. Transcriptome analysis revealed that while Chd8 stimulates the transcription of cell cycle genes, it also precludes the induction of neural specific genes by regulating the expression of PRC2 complex components. Furthermore, knockdown of Chd8 disrupts the expression of key transducers of Writ signaling, and enhancing Wnt signaling rescues the transcriptional and behavioral deficits caused by Chd8 knockdown. We propose that these roles of Chd8 and the dynamics of Chd8 expression during development help negotiate the fine balance between neural progenitor proliferation and differentiation. Together, these observations provide new insights into the neurodevelopmental role of Chd8.	[Durak, Omer; Gao, Fan; Kaeser-Woo, Yea Jin; Rueda, Richard; Martorell, Anthony J.; Nott, Alexi; Liu, Carol Y.; Watson, L. Ashley; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Durak, Omer; Martorell, Anthony J.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Tsai, Li-Huei] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Tsai, LH (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	lhtsai@mit.edu	Nott, Alexi/K-6103-2019	Nott, Alexi/0000-0002-2029-7193; Liu, Carol/0000-0002-3670-9623; Durak, Omer/0000-0001-8426-6188; Rueda, Richard/0000-0002-0191-6921	Simons Foundation (Simons Center for the Social Brain, Massachusetts Institute of Technology); Natural Science and Engineering Council of Canada; JPB Foundation; NIH U01 grant [MH106018-03]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH106018] Funding Source: NIH RePORTER	Simons Foundation (Simons Center for the Social Brain, Massachusetts Institute of Technology); Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); JPB Foundation; NIH U01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R. Madabhushi, J. Penney and A. Mungenast for critical reading of the manuscript. We are thankful to R. Madabhushi, J.D. Cheng, J. Penney and Y.T. Lin for technical help and suggestions with the project. The Super8xTOPFLASH luciferase reporter construct was a kind gift from Dr. R. Moon (University of Washington, WA). O.D. is a Henry Singleton (1940) Fellow (Brain and Cognitive Sciences, Massachusetts Institute of Technology). Y.J.K.-W. and L.A.W. were supported by a postdoctoral fellowship from the Simons Foundation (Simons Center for the Social Brain, Massachusetts Institute of Technology). L.A.W. is supported by postdoctoral fellowship from Natural Science and Engineering Council of Canada. We would like to thank the JPB Foundation for supporting our study. This work was partially supported by a NIH U01 grant (MH106018-03) to L.-H.T.	Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Balow SA, 2013, DEV BIOL, V382, P57, DOI 10.1016/j.ydbio.2013.07.026; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn Anjen, 2008, Organogenesis, V4, P76; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fang MG, 2014, MOL CELL, V55, P904, DOI 10.1016/j.molcel.2014.08.010; Hardwick LJA, 2014, TRENDS GENET, V30, P254, DOI 10.1016/j.tig.2014.04.001; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Hurd EA, 2010, DEVELOPMENT, V137, P3139, DOI 10.1242/dev.047894; Kalkman HO, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-10; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kobayashi M, 2002, J BIOL CHEM, V277, P5816, DOI 10.1074/jbc.M108433200; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Layman WS, 2009, HUM MOL GENET, V18, P1909, DOI 10.1093/hmg/ddp112; Menon T, 2010, MOL ENDOCRINOL, V24, P1165, DOI 10.1210/me.2009-0421; Miles JH, 2011, GENET MED, V13, P278, DOI 10.1097/GIM.0b013e3181ff67ba; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Nishiyama M, 2004, MOL CELL BIOL, V24, P8386, DOI 10.1128/MCB.24.19.8386-8394.2004; Nishiyama M, 2012, MOL CELL BIOL, V32, P501, DOI 10.1128/MCB.06409-11; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Platt JL, 2013, DEVELOPMENT, V140, P4926, DOI 10.1242/dev.099879; Rodriguez-Paredes M, 2009, NUCLEIC ACIDS RES, V37, P2449, DOI 10.1093/nar/gkp101; Rosso SB, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00103; Sakamoto I, 2000, J BIOL CHEM, V275, P32871, DOI 10.1074/jbc.M004089200; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sher F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040399; Subtil-Rodriguez A, 2014, NUCLEIC ACIDS RES, V42, P2185, DOI 10.1093/nar/gkt1161; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Terriente-Felix A, 2011, DEV BIOL, V350, P382, DOI 10.1016/j.ydbio.2010.12.003; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang P, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0048-6; Watts TJ, 2008, CLIN MED INSIGHTS-PA, V1; Wilkinson B, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.62; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132	50	125	128	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2016	19	11					1477	1488		10.1038/nn.4400	http://dx.doi.org/10.1038/nn.4400			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA3WL	27694995	Green Accepted, Green Submitted			2022-12-17	WOS:000386539900017
J	Calzolari, F; Michel, J; Baumgart, EV; Theis, F; Gotz, M; Ninkovic, J				Calzolari, Filippo; Michel, Julia; Baumgart, Emily Violette; Theis, Fabian; Goetz, Magdalena; Ninkovic, Jovica			Fast clonal expansion and limited neural stem cell self-renewal in the adult subependymal zone	NATURE NEUROSCIENCE			English	Article							LINEAGE PROGRESSION; DIVISION	We analyzed the progeny of individual neural stem cells (NSCs) of the mouse adult subependymal zone (SEZ) in vivo and found a markedly fast lineage amplification, as well as limited NSC self-renewal and exhaustion in a few weeks. We further unraveled the mechanisms of neuronal subtype generation, finding that a higher proportion of NSCs were dedicated to generate deep granule cells in the olfactory bulb and that larger clones were produced by these NSCs.	[Calzolari, Filippo; Michel, Julia; Baumgart, Emily Violette; Goetz, Magdalena; Ninkovic, Jovica] Helmholtz Ctr, Inst Stem Cell Res, Munich, Germany; [Calzolari, Filippo; Goetz, Magdalena; Ninkovic, Jovica] Univ Munich, Biomed Ctr, Munich, Germany; [Theis, Fabian] Helmholtz Ctr, Inst Computat Biol, Munich, Germany; [Theis, Fabian] Tech Univ Munich, Inst Math Sci, Garching, Germany; [Goetz, Magdalena; Ninkovic, Jovica] Univ Munich, Munich Cluster Syst Neurol SYNERGY, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich	Ninkovic, J (corresponding author), Helmholtz Ctr, Inst Stem Cell Res, Munich, Germany.	magdalena.goetz@helmholtz.muenchen.de; ninkovic@helmholtz-muenchen.de	Ninkovic, Jovica/AAH-5220-2019; Theis, Fabian J/ABD-5212-2021	Ninkovic, Jovica/0000-0002-4381-0041; Theis, Fabian J/0000-0002-2419-1943; Gotz, Magdalena/0000-0003-1551-9203	German Research foundation (DFG) [SFB 870, SPP 1392, Go 640/11-1]; Munich Cluster for Systems Neurology [EXC 1010 SyNergy]; Helmholtz Foundation by the ICEMED Alliance; European Research Council by an ERC Advanced Grant	German Research foundation (DFG)(German Research Foundation (DFG)); Munich Cluster for Systems Neurology; Helmholtz Foundation by the ICEMED Alliance; European Research Council by an ERC Advanced Grant	We foremost would like to thank H. Clevers and H. Snippert for the Confetti mouse line. In addition, we are thankful to T. Ozturk for excellent technical help and L. Dimou, A. Saghatelyan, S. Stricker and P. Malatesta for critical reading of the manuscript. We also gratefully acknowledge funding to J.N. from the German Research foundation (DFG) by the SFB 870 and SPP 1392 and to M.G. from the German Research foundation (DFG) by the SFB 870, Go 640/11-1, the Munich Cluster for Systems Neurology (EXC 1010 SyNergy), the Helmholtz Foundation by the ICEMED Alliance and the European Research Council by an ERC Advanced Grant.	Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Costa MR, 2011, DEVELOPMENT, V138, P1057, DOI 10.1242/dev.061663; DeCarolis NA, 2013, HIPPOCAMPUS, V23, P708, DOI 10.1002/hipo.22130; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Lugert E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1670; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Merkle FT, 2014, NAT NEUROSCI, V17, P207, DOI 10.1038/nn.3610; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Ponti G, 2013, P NATL ACAD SCI USA, V110, pE1045, DOI 10.1073/pnas.1219563110; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Shook BA, 2012, J NEUROSCI, V32, P6947, DOI 10.1523/JNEUROSCI.5987-11.2012; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016	19	125	128	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2015	18	4					490	+		10.1038/nn.3963	http://dx.doi.org/10.1038/nn.3963			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE4DL	25730673				2022-12-17	WOS:000351780900006
J	Wainger, BJ; Buttermore, ED; Oliveira, JT; Mellin, C; Lee, S; Saber, WA; Wang, AJ; Ichida, JK; Chiu, IM; Barrett, L; Huebner, EA; Bilgin, C; Tsujimoto, N; Brenneis, C; Kapur, K; Rubin, LL; Eggan, K; Woolf, CJ				Wainger, Brian J.; Buttermore, Elizabeth D.; Oliveira, Julia T.; Mellin, Cassidy; Lee, Seungkyu; Saber, Wardiya Afshar; Wang, Amy J.; Ichida, Justin K.; Chiu, Isaac M.; Barrett, Lee; Huebner, Eric A.; Bilgin, Canan; Tsujimoto, Naomi; Brenneis, Christian; Kapur, Kush; Rubin, Lee L.; Eggan, Kevin; Woolf, Clifford J.			Modeling pain in vitro using nociceptor neurons reprogrammed from fibroblasts	NATURE NEUROSCIENCE			English	Article							ROOT GANGLION NEURONS; SENSORY NEURONS; FAMILIAL DYSAUTONOMIA; NEUROPATHIC PAIN; TRANSCRIPTION FACTORS; MEMBRANE-PROPERTIES; SODIUM-CHANNELS; NERVOUS-SYSTEM; DRG NEURONS; CELL FATES	Reprogramming somatic cells from one cell fate to another can generate specific neurons suitable for disease modeling. To maximize the utility of patient-derived neurons, they must model not only disease-relevant cell classes, but also the diversity of neuronal subtypes found in vivo and the pathophysiological changes that underlie specific clinical diseases. We identified five transcription factors that reprogram mouse and human fibroblasts into noxious stimulus-detecting (nociceptor) neurons. These recapitulated the expression of quintessential nociceptor-specific functional receptors and channels found in adult mouse nociceptor neurons, as well as native subtype diversity. Moreover, the derived nociceptor neurons exhibited TrpV1 sensitization to the inflammatory mediator prostaglandin E2 and the chemotherapeutic drug oxaliplatin, modeling the inherent mechanisms underlying inflammatory pain hypersensitivity and painful chemotherapy-induced neuropathy. Using fibroblasts from patients with familial dysautonomia (hereditary sensory and autonomic neuropathy type III), we found that the technique was able to reveal previously unknown aspects of human disease phenotypes in vitro.	[Wainger, Brian J.; Buttermore, Elizabeth D.; Oliveira, Julia T.; Mellin, Cassidy; Lee, Seungkyu; Saber, Wardiya Afshar; Wang, Amy J.; Chiu, Isaac M.; Barrett, Lee; Huebner, Eric A.; Bilgin, Canan; Brenneis, Christian; Kapur, Kush; Woolf, Clifford J.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Cambridge, MA 02142 USA; [Wainger, Brian J.; Buttermore, Elizabeth D.; Oliveira, Julia T.; Mellin, Cassidy; Lee, Seungkyu; Saber, Wardiya Afshar; Wang, Amy J.; Chiu, Isaac M.; Barrett, Lee; Huebner, Eric A.; Bilgin, Canan; Brenneis, Christian; Kapur, Kush; Woolf, Clifford J.] Harvard Stem Cell Inst, Cambridge, MA USA; [Wainger, Brian J.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Wainger, Brian J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Wainger, Brian J.; Buttermore, Elizabeth D.; Lee, Seungkyu; Chiu, Isaac M.; Huebner, Eric A.; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Oliveira, Julia T.] Univ Fed Rio de Janeiro, Fac Med, Dept Patol, Lab Neurodegeneracao & Reparo, Rio De Janeiro, Brazil; [Ichida, Justin K.; Tsujimoto, Naomi; Rubin, Lee L.; Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ichida, Justin K.] Univ So Calif, Dept Stem Cell Biol & Regenerat Med, Eli & Edythe Broad, Los Angeles, CA USA; [Ichida, Justin K.] Univ So Calif, CIRM Ctr Regenerat Med, Stem Cell Res, Los Angeles, CA USA; [Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Universidade Federal do Rio de Janeiro; Harvard University; University of Southern California; University of Southern California; Harvard University; Howard Hughes Medical Institute	Woolf, CJ (corresponding author), Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Cambridge, MA 02142 USA.	clifford.woolf@childrens.harvard.edu	Eggan, Kevin/P-7119-2018; Kapur, Kush/AAQ-3437-2020; Wainger, Brian/L-7553-2017; Woolf, Clifford/A-9784-2010; Chiu, Isaac/R-3803-2016	Kapur, Kush/0000-0001-9022-913X; Lee, Seungkyu/0000-0002-1929-3320; Mellin, Cassidy/0000-0002-1057-0985; Rubin, Lee/0000-0002-8658-841X; Chiu, Isaac/0000-0002-0723-4841; Afshar-Saber, Wardiya/0000-0001-9488-7893	National Institute of General Medical Sciences [T32 GM07592]; National Institute of Neurological Disorders and Stroke [1K08-NS082364, NS038253]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; GlaxoSmithKline Regenerative Medicine DPU; Dr. Miriam and Sheldon G. Adelson Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS082364, R00NS077435, R01NS038253] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); GlaxoSmithKline Regenerative Medicine DPU; Dr. Miriam and Sheldon G. Adelson Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Costigan for assistance with RT-PCR, A. Yekkirala and J. Sprague for help with calcium imaging, Q. Ma (Dana-Farber Cancer Institute) and E. Turner (Seattle Children's Research Institute) for constructs, J. Gardner and J. McNeish for helpful advice and support, and K. Wainger for assistance with figure preparation. We also thank the Boston Children's Hospital IDDRC Molecular Genetics Core Facility for RNA Bioanalyzer analyses and the Harvard Medical School ICCB Screening Facility for assistance with ImageXpress and MetaXpress analyses. This research was supported by the National Institute of General Medical Sciences (T32 GM07592) and National Institute of Neurological Disorders and Stroke (1K08-NS082364) to B.J.W. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (J.T.O.), GlaxoSmithKline Regenerative Medicine DPU (C.J.W.), the National Institute of Neurological Disorders and Stroke (NS038253 to C.J.W.), and the Dr. Miriam and Sheldon G. Adelson Medical Foundation (C.J.W.).	Allen Institute for Brain Science, 2012, ALL SPIN CORD ATL; Anand U, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-82; Anderson DJ, 1999, CURR OPIN NEUROBIOL, V9, P517, DOI 10.1016/S0959-4388(99)00015-X; BANERJEE A, 1990, J BIOL CHEM, V265, P1794; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Belghiti M, 2013, J BIOL CHEM, V288, P9675, DOI 10.1074/jbc.M113.455162; Blair NT, 2002, J NEUROSCI, V22, P10277; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Cuajungco MP, 2003, AM J HUM GENET, V72, P749, DOI 10.1086/368263; Davidson S, 2014, PAIN, V155, P1861, DOI 10.1016/j.pain.2014.06.017; Dib-Hajj SD, 1999, FEBS LETT, V462, P117, DOI 10.1016/S0014-5793(99)01519-7; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dietrich P, 2012, HUM MOL GENET, V21, P5078, DOI 10.1093/hmg/dds354; Dykes IM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-3; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Fornaro M, 2008, NEUROSCIENCE, V153, P1153, DOI 10.1016/j.neuroscience.2008.02.080; George L, 2013, P NATL ACAD SCI USA, V110, P18698, DOI 10.1073/pnas.1308596110; Ghilardi JR, 2011, BONE, V48, P389, DOI 10.1016/j.bone.2010.09.019; Han C, 2012, NEUROLOGY, V78, P1635, DOI 10.1212/WNL.0b013e3182574f12; Hoffmann S, 2007, MOL CELL ENDOCRINOL, V264, P74, DOI 10.1016/j.mce.2006.10.009; Huang JY, 2013, J NEUROSCI, V33, P14087, DOI 10.1523/JNEUROSCI.2710-13.2013; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Knecht AK, 2002, NAT REV GENET, V3, P453, DOI 10.1038/nrg819; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lei L, 2005, GENE DEV, V19, P1354, DOI 10.1101/gad.1227705; Li YQ, 2007, MOL BIOL REP, V34, P19, DOI 10.1007/s11033-006-9003-0; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Lopshire JC, 1997, J NEUROPHYSIOL, V78, P3154, DOI 10.1152/jn.1997.78.6.3154; Lysakowski A, 1999, HEARING RES, V133, P149, DOI 10.1016/S0378-5955(99)00065-9; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Maatkamp A, 2004, EUR J NEUROSCI, V20, P14, DOI 10.1111/j.1460-9568.2004.03430.x; NAGY I, 1993, BRAIN RES, V609, P193, DOI 10.1016/0006-8993(93)90873-L; Panayi H, 2010, J NEUROSCI, V30, P12274, DOI 10.1523/JNEUROSCI.2402-10.2010; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; PITCHFORD S, 1991, NEUROSCI LETT, V132, P105, DOI 10.1016/0304-3940(91)90444-X; Qiang L, 2013, NEURON, V78, P957, DOI 10.1016/j.neuron.2013.06.002; Rebelo S, 2006, MOL CELL NEUROSCI, V33, P236, DOI 10.1016/j.mcn.2006.07.013; Regad T, 2007, NAT CELL BIOL, V9, P531, DOI 10.1038/ncb1573; Reimann F, 2010, P NATL ACAD SCI USA, V107, P5148, DOI 10.1073/pnas.0913181107; Renganathan M, 2002, MOL BRAIN RES, V106, P70, DOI 10.1016/S0169-328X(02)00411-4; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Sorge RE, 2012, NAT MED, V18, P595, DOI 10.1038/nm.2710; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Waxman SG, 2010, NEURON, V66, P622, DOI 10.1016/j.neuron.2010.05.029; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Woolf CJ, 2010, NAT MED, V16, P1241, DOI 10.1038/nm.2230; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114	59	125	129	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2015	18	1					17	+		10.1038/nn.3886	http://dx.doi.org/10.1038/nn.3886			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX5WH	25420066	Green Accepted, Green Published			2022-12-17	WOS:000346995000007
J	Zhang, Y; Bonnan, A; Bony, G; Ferezou, I; Pietropaolo, S; Ginger, M; Sans, N; Rossier, J; Oostra, B; Le Masson, G; Frick, A				Zhang, Yu; Bonnan, Audrey; Bony, Guillaume; Ferezou, Isabelle; Pietropaolo, Susanna; Ginger, Melanie; Sans, Nathalie; Rossier, Jean; Oostra, Ben; Le Masson, Gwen; Frick, Andreas			Dendritic channelopathies contribute to neocortical and sensory hyperexcitability in Fmr1-(/y) mice	NATURE NEUROSCIENCE			English	Article							FRAGILE-X-SYNDROME; FMR1 KO MICE; MOUSE MODEL; POTASSIUM CHANNELS; PYRAMIDAL NEURONS; H-CHANNELS; PLASTICITY; INHIBITION; SPINES; CORTEX	Hypersensitivity in response to sensory stimuli and neocortical hyperexcitability are prominent features of Fragile X Syndrome (FXS) and autism spectrum disorders, but little is known about the dendritic mechanisms underlying these phenomena. We found that the primary somatosensory neocortex (Si) was hyperexcited in response to tactile sensory stimulation in Fmr1(-/y) mice. This correlated with neuronal and dendritic hyperexcitability of Si pyramidal neurons, which affect all major aspects of neuronal computation, from the integration of synaptic input to the generation of action potential output. Using dendritic electrophysiological recordings, calcium imaging, pharmacology, biochemistry and a computer model, we found that this defect was, at least in part, attributable to the reduction and dysfunction of dendritic h- and BKCa channels. We pharmacologically rescued several core hyperexcitability phenomena by targeting Bk-Ca channels. Our results provide strong evidence pointing to the utility of BKCa channel openers for the treatment of the sensory hypersensitivity aspects of FXS.	[Zhang, Yu; Bonnan, Audrey; Bony, Guillaume; Ginger, Melanie; Sans, Nathalie; Le Masson, Gwen; Frick, Andreas] INSERM, Neuroctr Magendie, U862, Bordeaux, France; [Zhang, Yu; Bonnan, Audrey; Bony, Guillaume; Ginger, Melanie; Sans, Nathalie; Le Masson, Gwen; Frick, Andreas] Univ Bordeaux, Neuroctr Magendie, U862, Bordeaux, France; [Ferezou, Isabelle; Rossier, Jean] ESPCI ParisTech, CNRS UMR 7637, Neurobiol Lab, Paris, France; [Pietropaolo, Susanna] Univ Bordeaux, INCIA, Talence, France; [Pietropaolo, Susanna] CNRS, INCIA, Talence, France; [Oostra, Ben] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Erasmus University Rotterdam; Erasmus MC	Frick, A (corresponding author), INSERM, Neuroctr Magendie, U862, Bordeaux, France.	andreas.frick@inserm.fr	Sans, Nathalie/N-7008-2017	Sans, Nathalie/0000-0001-7658-2471; pietropaolo, susanna/0000-0002-8993-1922; Ferezou, Isabelle/0000-0001-7602-1295	FRAXA Research Foundation; INSERM; CNRS; Conseil de la Region d'Aquitaine; Fondation Jerome Lejeune; Federation pour la Recherche sur le Cerveau; Fondation pour la Recherche Medicale [SPF20130526794]; Labex-BRAIN [ANR-10-LABEX-43]; Max Planck Society; Deutsche Forschungsgemeinschaft	FRAXA Research Foundation; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Conseil de la Region d'Aquitaine; Fondation Jerome Lejeune; Federation pour la Recherche sur le Cerveau; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Labex-BRAIN; Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank B. Sakmann, P. Seeburg, the Max Planck Society and the Deutsche Forschungsgemeinschaft for initial support of this study. We thank J.-C. Delpech, S. Dos Santos Carvalho and W. Crusio for technical and scientific advice. Some data was acquired using equipment of the Bordeaux Imaging Center, the ESPCI ParisTech and Biochemistry Facility of the Bordeaux Neurocampus. This research was funded by FRAXA Research Foundation, INSERM, CNRS, Conseil de la Region d'Aquitaine, Fondation Jerome Lejeune, Federation pour la Recherche sur le Cerveau, Fondation pour la Recherche Medicale (SPF20130526794) and Labex-BRAIN (ANR-10-LABEX-43).	Baranek Grace T, 2008, Phys Occup Ther Pediatr, V28, P79; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Benhassine N, 2009, PFLUG ARCH EUR J PHY, V457, P1133, DOI 10.1007/s00424-008-0569-3; Brager DH, 2012, CELL REP, V1, P225, DOI 10.1016/j.celrep.2012.02.002; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Cruz-Martin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032446; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Deng PY, 2013, NEURON, V77, P696, DOI 10.1016/j.neuron.2012.12.018; Faber ESL, 2003, J PHYSIOL-LONDON, V552, P483, DOI 10.1113/jphysiol.2003.050120; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Frick A, 2005, J NEUROBIOL, V64, P100, DOI 10.1002/neu.20148; Gallagher A, 2012, J NEUROL, V259, P401, DOI 10.1007/s00415-011-6161-3; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Goncalves JT, 2013, NAT NEUROSCI, V16, P903, DOI 10.1038/nn.3415; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Hay E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002107; Hays SA, 2011, J NEUROSCI, V31, P14223, DOI 10.1523/JNEUROSCI.3157-11.2011; He CX, 2013, NEUROSCIENCE, V251, P120, DOI 10.1016/j.neuroscience.2012.03.049; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; Lee HY, 2012, CURR OPIN NEUROBIOL, V22, P887, DOI 10.1016/j.conb.2012.03.010; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Merenstein SA, 1996, AM J MED GENET, V64, P388, DOI 10.1002/(SICI)1096-8628(19960809)64:2<388::AID-AJMG31>3.3.CO;2-S; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Miller LJ, 1999, AM J MED GENET, V83, P268, DOI 10.1002/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.3.CO;2-B; Nardi A, 2008, CURR MED CHEM, V15, P1126, DOI 10.2174/092986708784221412; Nielsen DM, 2002, BRAIN RES, V927, P8, DOI 10.1016/S0006-8993(01)03309-1; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Paluszkiewicz SM, 2011, J NEUROPHYSIOL, V106, P2264, DOI 10.1152/jn.00421.2011; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Potez S, 2008, J NEUROPHYSIOL, V99, P1394, DOI 10.1152/jn.01126.2007; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rotschafer S, 2013, BRAIN RES, V1506, P12, DOI 10.1016/j.brainres.2013.02.038; Rotschafer SE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00019; Routh BN, 2013, J NEUROSCI, V33, P19442, DOI 10.1523/JNEUROSCI.3256-13.2013; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Shruti S, 2008, NEUROBIOL DIS, V30, P323, DOI 10.1016/j.nbd.2008.02.002; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Szlapczynska M., 2014, HORIZONS NEUROSCIENC, V14, P41; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Ulrich D, 2002, J NEUROPHYSIOL, V87, P2753, DOI 10.1152/jn.2002.87.6.2753	50	125	125	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2014	17	12					1701	1709		10.1038/nn.3864	http://dx.doi.org/10.1038/nn.3864			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU2ZY	25383903				2022-12-17	WOS:000345484000017
J	Vigano, F; Mobius, W; Gotz, M; Dimou, L				Vigano, Francesca; Moebius, Wiebke; Goetz, Magdalena; Dimou, Leda			Transplantation reveals regional differences in oligodendrocyte differentiation in the adult brain	NATURE NEUROSCIENCE			English	Article							CEREBRAL-CORTEX; NERVOUS-SYSTEM; WHITE-MATTER; RAT CNS; CELLS; PROGENITORS; LINEAGE; MOUSE; MICE; EXPRESSION	To examine the role of gray and white matter niches for oligodendrocyte differentiation, we used homo- and heterotopic transplantations into the adult mouse cerebral cortex. White matter-derived cells differentiated into mature oligodendrocytes in both niches with equal efficiency, whereas gray matter-derived cells did not. Thus, white matter promotes oligodendrocyte differentiation, and cells from this niche differentiate more easily, even in the less supportive gray matter environment.	[Vigano, Francesca; Goetz, Magdalena; Dimou, Leda] Univ Munich, Inst Physiol, D-80539 Munich, Germany; [Vigano, Francesca; Goetz, Magdalena; Dimou, Leda] HelmholtzZentrum, Inst Stem Cell Res, Neuherberg, Germany; [Vigano, Francesca] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Moebius, Wiebke] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Moebius, Wiebke] Ctr Nanoscale Microscopy & Mol Physiol Brain, Gottingen, Germany; [Goetz, Magdalena] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Munich; University of Milan; Max Planck Society; University of Munich	Dimou, L (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-80539 Munich, Germany.	leda.dimou@lrz.uni-muenchen.de	Dimou, Leda/E-7968-2012	Gotz, Magdalena/0000-0003-1551-9203; /0000-0002-2902-7165	European Research Council Advanced Investigator Grant AXOGLIA; Cluster of Excellence; DFG research Center Nanoscale Microscopy and Molecular Physiology of the Brain; University of Milan; International Brain Research Organization InEurope grant; Deutsche Forschungsgemeinschaft [SFB 596, SFB 870]; Helmholtz Association of Mental Aging; Friedrich Bauer Stiftung	European Research Council Advanced Investigator Grant AXOGLIA; Cluster of Excellence; DFG research Center Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG)); University of Milan; International Brain Research Organization InEurope grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Association of Mental Aging; Friedrich Bauer Stiftung	We thank J. Trotter (Johannes Gutenberg-University) for the NG2-EYFP and F. Kirchhoff (University of Saarland) for the PLP-DsRed mouse lines, K. Karram for advice regarding cell isolation procedures, J. Ninkovic for help with the statistics, and E. Violette and S. Sirko for carefully reading the manuscript. We are also grateful to B. Sadowski for technical help with the electron microscope, as well as the technical assistants in the Physiological Genomics. W.M. is funded by the European Research Council Advanced Investigator Grant AXOGLIA to K.-A. Nave and is supported by the Cluster of Excellence and DFG research Center Nanoscale Microscopy and Molecular Physiology of the Brain. F.V. was, in part, supported by a doctorate fellowship from the University of Milan and an International Brain Research Organization InEurope grant. This work was mainly supported by the SFB 596 and the SFB 870 of the Deutsche Forschungsgemeinschaft, the Helmholtz Association of Mental Aging and the Friedrich Bauer Stiftung.	Albert M, 2007, BRAIN PATHOL, V17, P129, DOI 10.1111/j.1750-3639.2006.00043.x; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Fischer J, 2011, NAT PROTOC, V6, P1981, DOI 10.1038/nprot.2011.412; Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Peters PJ, 2008, METHOD CELL BIOL, V88, P131, DOI [10.1016/S0091-679X(08)00409-1, 10.1016/S0091-679X(08)00408-1]; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	18	125	126	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1370	+		10.1038/nn.3503	http://dx.doi.org/10.1038/nn.3503			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995069				2022-12-17	WOS:000324795300008
J	Abe, K; Watanabe, D				Abe, Kentaro; Watanabe, Dai			Songbirds possess the spontaneous ability to discriminate syntactic rules	NATURE NEUROSCIENCE			English	Article							MALE ZEBRA FINCHES; LANGUAGE-ACQUISITION; SONG-DISCRIMINATION; NEURAL MECHANISMS; CONSPECIFIC SONG; BIRDSONG; SPEECH; LESIONS; NEUROBIOLOGY; ORGANIZATION	Whether the computational systems in language perception involve specific abilities in humans is debated. The vocalizations of songbirds share many features with human speech, but whether songbirds possess a similar computational ability to process auditory information as humans is unknown. We analyzed their spontaneous discrimination of auditory stimuli and found that the Bengalese finch (Lonchura striata var. domestica) can use the syntactical information processing of syllables to discriminate songs). These finches were also able to acquire artificial grammatical rules from synthesized syllable strings and to discriminate novel auditory information according to them. We found that a specific brain region was involved in such discrimination and that this ability was acquired postnatally through the encounter with various conspecific songs. Our results indicate that passerine songbirds spontaneously acquire the ability to process hierarchical structures, an ability that was previously supposed to be specific to humans.	[Abe, Kentaro; Watanabe, Dai] Kyoto Univ, Grad Sch Biostudies, Dept Mol & Syst Biol, Kyoto, Japan; [Abe, Kentaro] Japan Sci & Technol Agcy, Saitama, Japan; [Watanabe, Dai] Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University	Abe, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Mol & Syst Biol, Kyoto, Japan.	k.abe.789@gmail.com	Abe, Kentaro/T-2247-2019	Abe, Kentaro/0000-0002-3923-6323	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Science and Technology Agency; Sumitomo Foundation; Inamori Foundation; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Sumitomo Foundation; Inamori Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank N. Yokoi, M. Wajima and F. Ageta for maintenance of animals, as well as members of Watanabe laboratory for various suggestions and K. Fujita for critical reading of the initial manuscript. This work was supported by Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science (K.A.) and of the Ministry of Education, Culture, Sports, Science and Technology in Japan (D.W.), the Precursory Research for Embryonic Science and Technology program of Japan Science and Technology Agency (K.A.) and scientific research grants from the Sumitomo Foundation (K.A.), the Inamori Foundation (K.A.) and Takeda Science Foundation (D.W.).	Bahlmann J, 2008, NEUROIMAGE, V42, P525, DOI 10.1016/j.neuroimage.2008.04.249; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; Burt JM, 2000, J NEUROBIOL, V42, P1, DOI 10.1002/(SICI)1097-4695(200001)42:1<1::AID-NEU1>3.0.CO;2-6; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chomsky Noam, 1957, SYNTACTIC STRUCTURES; Chomsky Noam, 1965, ASPECTS THEORY SYNTA; de Vries MH, 2008, COGNITION, V107, P763, DOI 10.1016/j.cognition.2007.09.002; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Feher O, 2009, NATURE, V459, P564, DOI 10.1038/nature07994; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2004, TRENDS COGN SCI, V8, P245, DOI 10.1016/j.tics.2004.04.013; Friederici AD, 2006, NEURON, V52, P941, DOI 10.1016/j.neuron.2006.12.002; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Gentner TQ, 2000, J NEUROBIOL, V42, P117, DOI 10.1002/(SICI)1097-4695(200001)42:1<117::AID-NEU11>3.0.CO;2-M; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Grodzinsky Y, 2008, TRENDS COGN SCI, V12, P474, DOI 10.1016/j.tics.2008.09.001; Hauser MD, 2007, LANG LEARN DEV, V3, P101, DOI 10.1080/15475440701225394; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Hopcroft J.E., 2008, INTRO AUTOMATA THEOR; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; JOHNSON F, 1995, J COMP NEUROL, V358, P260, DOI 10.1002/cne.903580208; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; MARLER P, 1970, AM SCI, V58, P669; MARLER P, 1985, ANIM BEHAV, V33, P57, DOI 10.1016/S0003-3472(85)80120-2; Mello CV, 2004, ANN NY ACAD SCI, V1016, P263, DOI 10.1196/annals.1298.021; Mooney R, 2009, CURR OPIN NEUROBIOL, V19, P654, DOI 10.1016/j.conb.2009.10.004; Okanoya K, 2004, ANN NY ACAD SCI, V1016, P724, DOI 10.1196/annals.1298.026; Pena M, 2002, SCIENCE, V298, P604, DOI 10.1126/science.1072901; Perruchet P, 2005, PSYCHON B REV, V12, P307, DOI 10.3758/BF03196377; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; Pinker S., 1994, LANGUAGE INSTINCT; Prather JF, 2009, NAT NEUROSCI, V12, P221, DOI 10.1038/nn.2246; Saffran J, 2008, COGNITION, V107, P479, DOI 10.1016/j.cognition.2007.10.010; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Sakai KL, 2005, SCIENCE, V310, P815, DOI 10.1126/science.1113530; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; Stripling R, 2003, NEUROBIOL LEARN MEM, V79, P41, DOI 10.1016/S1074-7427(02)00005-9; Stripling R, 1997, J NEUROSCI, V17, P3883; van Heijningen CAA, 2009, P NATL ACAD SCI USA, V106, P20538, DOI 10.1073/pnas.0908113106; Vicario DS, 2004, ANN NY ACAD SCI, V1016, P246, DOI 10.1196/annals.1298.040; Wahl M, 2008, NEURON, V59, P695, DOI 10.1016/j.neuron.2008.07.011	50	125	129	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2011	14	8					1067	U173		10.1038/nn.2869	http://dx.doi.org/10.1038/nn.2869			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	797KC	21706017				2022-12-17	WOS:000293123700022
J	Faas, GC; Raghavachari, S; Lisman, JE; Mody, I				Faas, Guido C.; Raghavachari, Sridhar; Lisman, John E.; Mody, Istvan			Calmodulin as a direct detector of Ca2+ signals	NATURE NEUROSCIENCE			English	Article							IQ-MOTIF PROTEINS; CALCIUM-BINDING; HIPPOCAMPAL-NEURONS; CALBINDIN-D-28K; DENDRITES; SPINES; BRAIN	Many forms of signal transduction occur when Ca2+ enters the cytoplasm of a cell. It has been generally thought that there is a fast buffer that rapidly reduces the free Ca2+ level and that it is this buffered level of Ca2+ that triggers downstream biochemical processes, notably the activation of calmodulin (CaM) and the resulting activation of CaM-dependent enzymes. Given the importance of these transduction processes, it is crucial to understand exactly how Ca2+ activates CaM. We have determined the rate at which Ca2+ binds to CaM and found that Ca2+ binds more rapidly to CaM than to other Ca2+-binding proteins. This property of CaM and its high concentration support a new view of signal transduction: CaM directly intercepts incoming Ca2+ and sets the free Ca2+ level (that is, it strongly contributes to fast Ca2+ buffering) rather than responding to the lower Ca2+ level set by other buffers. This property is crucial for making CaM an efficient transducer. Our results also suggest that other Ca2+ binding proteins have a previously undescribed role in regulating the lifetime of Ca2+ bound to CaM and thereby setting the gain of signal transduction.	[Faas, Guido C.; Mody, Istvan] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Raghavachari, Sridhar] Duke Univ, Dept Neurobiol, Durham, NC USA; [Lisman, John E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Mody, Istvan] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Duke University; Brandeis University; University of California System; University of California Los Angeles	Faas, GC (corresponding author), Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA.	gfaas@ucla.edu		Faas, Guido/0000-0002-1339-7698	US National Institutes of Health (NIH) [NS027528, NS030549]; Coelho Endowment; NIH [DA027807]; National Science Foundation [NSF0642000]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030549, R01NS027528, R01NS030549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027807] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coelho Endowment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Adelman (The Vollum Institute) for purified CaM and mutants of CaM (CaM<INF>EF12</INF> and CaM<INF>EF34</INF>), K. Baimbridge (University of Britsh Columbia) for purified calbindin and E. B. S. Faas (Syrinx Design) for help in designing the photodiode pre-amplifier. J. E. L. would like to thank W. Ross and I. Llano for conversations at the Marine Biological Laboratory Woods Hole that led to important insights into this problem. Supported by the US National Institutes of Health (NIH) grants NS027528, NS030549 and the Coelho Endowment to I. M., NIH grant DA027807 to J. E. L. and S. R., and the National Science Foundation grant NSF0642000 to S.R.	Arnold DB, 1997, P NATL ACAD SCI USA, V94, P8842, DOI 10.1073/pnas.94.16.8842; BANAYSCHWARTZ M, 1992, AGE, V15, P51, DOI 10.1007/BF02435024; Berggard T, 2002, J BIOL CHEM, V277, P16662, DOI 10.1074/jbc.M200415200; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; BIBER A, 1984, EXP BRAIN RES, V56, P323; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; BROWN BL, 1985, CLIN ENDOCRINOL, V23, P201, DOI 10.1111/j.1365-2265.1985.tb00216.x; Cornelisse LN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001073; Faas GC, 2005, BIOPHYS J, V88, P4421, DOI 10.1529/biophysj.104.057745; Faas GC, 2007, PLOS BIOL, V5, P2646, DOI 10.1371/journal.pbio.0050311; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Kubota Y, 2008, J NEUROPHYSIOL, V99, P264, DOI 10.1152/jn.00876.2007; Kubota Y, 2007, BIOPHYS J, V93, P3848, DOI 10.1529/biophysj.107.106849; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lee SH, 2000, J PHYSIOL-LONDON, V525, P405, DOI 10.1111/j.1469-7793.2000.t01-3-00405.x; LINSE S, 1991, J BIOL CHEM, V266, P8050; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Muller A, 2005, J NEUROSCI, V25, P558, DOI 10.1523/JNEUROSCI.3799-04.2005; Nagerl UV, 2000, BIOPHYS J, V79, P3009, DOI 10.1016/S0006-3495(00)76537-4; Nagerl UV, 2000, J NEUROSCI, V20, P1831; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Otmakhov N, 1997, J NEUROSCI, V17, P5357; PORUMB T, 1994, ANAL BIOCHEM, V220, P227, DOI 10.1006/abio.1994.1332; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Scheuss V, 2006, J NEUROSCI, V26, P8183, DOI 10.1523/JNEUROSCI.1962-06.2006; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647	28	125	126	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					301	304		10.1038/nn.2746	http://dx.doi.org/10.1038/nn.2746			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21258328	Green Accepted			2022-12-17	WOS:000287650100009
J	Di Marzo, V				Di Marzo, Vincenzo			Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight	NATURE NEUROSCIENCE			English	Article							DIACYLGLYCEROL LIPASE-ALPHA; VANILLOID TYPE-1 RECEPTORS; MOUSE-BRAIN; IMMUNOHISTOCHEMICAL LOCALIZATION; INHIBITORY SYNAPSES; MULTIPLE MECHANISMS; CEREBELLAR CORTEX; DOPAMINE NEURONS; 2-ARACHIDONOYLGLYCEROL; SYSTEM	Studies of the endocannabinoid system in the CNS have been mostly focused on endocannabinoid receptors and inactivating mechanisms. Until recently, very little was known about the role of biosynthetic enzymes in endocannabinoid signaling. New data from the recent development of pharmacological and genetic tools for the study of these enzymes point to their fundamental role in determining where and when endocannabinoids function, and raise the possibility of new intriguing and previously unsuspected concepts in the general strategy of endocannabinoid signaling. However, even with these new tools, the cross-talk between anandamide and 2-arachidonoylglycerol biosynthesis makes it difficult to dissect one from the other, and data will need to be interpreted with this in mind.	CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuoli, Italy	Consiglio Nazionale delle Ricerche (CNR)	Di Marzo, V (corresponding author), CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuoli, Italy.	vdimarzo@icmib.na.cnr.it	Di Marzo, Vincenzo/AAD-7742-2019	Di Marzo, Vincenzo/0000-0002-1490-3070	US National Institutes of Health [DA-009789]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The author thanks T. Bisogno and S. Petrosino for their help. Support from the US National Institutes of Health (grant DA-009789) is also acknowledged.	Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 2006, BBA-MOL CELL BIOL L, V1761, P205, DOI 10.1016/j.bbalip.2005.12.009; Bisogno T, 2009, CHEMMEDCHEM, V4, P946, DOI 10.1002/cmdc.200800442; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; D'Asti E, 2010, ENDOCRINOLOGY, V151, P1685, DOI 10.1210/en.2009-1092; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Edwards DA, 2006, J NEUROPHYSIOL, V95, P67, DOI 10.1152/jn.00813.2005; Edwards DA, 2008, P NATL ACAD SCI USA, V105, P8142, DOI 10.1073/pnas.0803558105; Egertova M, 2008, J COMP NEUROL, V506, P604, DOI 10.1002/cne.21568; Fukaya M, 2008, EUR J NEUROSCI, V28, P1744, DOI 10.1111/j.1460-9568.2008.06495.x; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gomez O, 2010, GLIA, V58, P1913, DOI 10.1002/glia.21061; Goncalves MB, 2008, MOL CELL NEUROSCI, V38, P526, DOI 10.1016/j.mcn.2008.05.001; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Hashimotodani Y, 2008, NEUROPHARMACOLOGY, V54, P58, DOI 10.1016/j.neuropharm.2007.06.002; Hashimotodani Y, 2007, J NEUROSCI, V27, P1211, DOI 10.1523/JNEUROSCI.4159-06.2007; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Maione S, 2006, J PHARMACOL EXP THER, V316, P969, DOI 10.1124/jpet.105.093286; Marinelli S, 2009, NAT NEUROSCI, V12, P1488, DOI 10.1038/nn.2430; Marinelli S, 2008, J NEUROSCI, V28, P13532, DOI 10.1523/JNEUROSCI.0847-08.2008; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Melis M, 2004, J NEUROSCI, V24, P10707, DOI 10.1523/JNEUROSCI.3502-04.2004; Melis M, 2006, NEUROBIOL DIS, V24, P15, DOI 10.1016/j.nbd.2006.04.010; Min R, 2010, J NEUROSCI, V30, P2710, DOI 10.1523/JNEUROSCI.BC-3622-09.2010; Nomura DK, 2008, BIOORG MED CHEM LETT, V18, P5875, DOI 10.1016/j.bmcl.2008.08.007; Nomura S, 2007, EUR J NEUROSCI, V25, P659, DOI 10.1111/j.1460-9568.2007.05334.x; Nyilas R, 2008, J NEUROSCI, V28, P1058, DOI 10.1523/JNEUROSCI.5102-07.2008; Oddi S, 2008, CELL MOL LIFE SCI, V65, P840, DOI 10.1007/s00018-008-7494-7; Ortar G, 2008, J MED CHEM, V51, P6970, DOI 10.1021/jm800978m; Roloff AM, 2010, J NEUROSCI, V30, P3072, DOI 10.1523/JNEUROSCI.4603-09.2010; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Simon GM, 2010, MOL BIOSYST, V6, P1411, DOI 10.1039/c000237b; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Straiker A, 2009, MOL PHARMACOL, V76, P1220, DOI 10.1124/mol.109.059030; Suarez J, 2008, J COMP NEUROL, V509, P400, DOI 10.1002/cne.21774; Szabo B, 2006, J PHYSIOL-LONDON, V577, P263, DOI 10.1113/jphysiol.2006.119362; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; van der Stelt M, 2005, EMBO J, V24, P3026, DOI 10.1038/sj.emboj.7600784; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006	50	125	126	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					9	15		10.1038/nn.2720	http://dx.doi.org/10.1038/nn.2720			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21187849				2022-12-17	WOS:000285684900005
J	Wu, HH; Bellmunt, E; Scheib, JL; Venegas, V; Burkert, C; Reichardt, LF; Zhou, Z; Farinas, I; Carter, BD				Wu, Hsiao-Huei; Bellmunt, Elena; Scheib, Jami L.; Venegas, Victor; Burkert, Cornelia; Reichardt, Louis F.; Zhou, Zheng; Farinas, Isabel; Carter, Bruce D.			Glial precursors clear sensory neuron corpses during development via Jedi-1, an engulfment receptor	NATURE NEUROSCIENCE			English	Article							APOPTOTIC CELL ENGULFMENT; IMMUNOHISTOCHEMICAL LOCALIZATION; NERVOUS-SYSTEM; PHAGOCYTOSIS; DRAPER; DEATH; DEGENERATION; DIFFERENTIATION; NEUROGENESIS; MACROPHAGES	During the development of peripheral ganglia, 50% of the neurons that are generated undergo apoptosis. How the massive numbers of corpses are removed is unknown. We found that satellite glial cell precursors are the primary phagocytic cells for apoptotic corpse removal in developing mouse dorsal root ganglia (DRG). Confocal and electron microscopic analysis revealed that glial precursors, rather than macrophages, were responsible for clearing most of the dead DRG neurons. Moreover, we identified Jedi-1, an engulfment receptor, and MEGF10, a purported engulfment receptor, as homologs of the invertebrate engulfment receptors Draper and CED-1 expressed in the glial precursor cells. Expression of Jedi-1 or MEGF10 in fibroblasts facilitated binding to dead neurons, and knocking down either protein in glial cells or overexpressing truncated forms lacking the intracellular domain inhibited engulfment of apoptotic neurons. Together, these results suggest a cellular and molecular mechanism by which neuronal corpses are culled during DRG development.	[Wu, Hsiao-Huei; Scheib, Jami L.; Burkert, Cornelia; Carter, Bruce D.] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Kennedy Ctr Human Dev, Nashville, TN 37212 USA; [Wu, Hsiao-Huei; Scheib, Jami L.; Burkert, Cornelia; Carter, Bruce D.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Bellmunt, Elena; Farinas, Isabel] Univ Valencia, Dept Biol Celular, E-46100 Burjassot, Spain; [Bellmunt, Elena; Farinas, Isabel] Univ Valencia, CIBERNED, E-46100 Burjassot, Spain; [Venegas, Victor; Zhou, Zheng] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Reichardt, Louis F.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	Vanderbilt University; Vanderbilt University; University of Valencia; CIBERNED; University of Valencia; Baylor College of Medicine; University of California System; University of California San Francisco	Carter, BD (corresponding author), Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Kennedy Ctr Human Dev, Nashville, TN 37212 USA.	bruce.carter@vanderbilt.edu	Fariñas, Isabel/L-7118-2014		US National Institutes of Health [NS048249, NS064278, GM067848]; Muscular Dystrophy Association Development grant [MDA4023]; US National Institutes of Health Minority Access to Research Careers Predoctoral Fellowship [GM079911]; Ministerio de Ciencia e Innovacion; Ministerio de Sanidad; Fundacion la Caixa; Generalitat Valenciana; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067848, F31GM079911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048249, R01NS064278] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association Development grant(Muscular Dystrophy Association); US National Institutes of Health Minority Access to Research Careers Predoctoral Fellowship; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government); Fundacion la Caixa(La Caixa Foundation); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the Statistics and Methodology Services at the Vanderbilt Kennedy Center for assistance on statistical analysis and C. Yoon, C. Jones and other members of the Carter laboratory for technical assistance and helpful suggestions. This work was supported by grants from the US National Institutes of Health (NS048249 and NS064278 to B. D. C., GM067848 to Z. Z.), a Muscular Dystrophy Association Development grant (MDA4023) to H.-H. W., a US National Institutes of Health Minority Access to Research Careers Predoctoral Fellowship (GM079911) to V. V., and the Ministerio de Ciencia e Innovacion (SAF), Ministerio de Sanidad (TerCel and Ciberned), Fundacion la Caixa, and Generalitat Valenciana (Prometeo) to I. F.	ALDSKOGIUS H, 1978, J NEUROCYTOL, V7, P229, DOI 10.1007/BF01217921; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Bennett MR, 2002, AUTON NEUROSCI-BASIC, V95, P1, DOI 10.1016/S1566-0702(01)00358-7; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Bratton DL, 2008, CURR BIOL, V18, pR76, DOI 10.1016/j.cub.2007.11.024; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Farinas I, 2002, BRAIN RES BULL, V57, P809, DOI 10.1016/S0361-9230(01)00767-5; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; Fenzi F, 2001, ARCH ITAL BIOL, V139, P357; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Gregory CD, 2005, NAT CELL BIOL, V7, P1161, DOI 10.1038/ncb1205-1161; GRIFFIN JW, 1993, J NEUROPATH EXP NEUR, V52, P553, DOI 10.1097/00005072-199311000-00001; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Hirata K, 2002, MICROSC RES TECHNIQ, V57, P541, DOI 10.1002/jemt.10108; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; HUME DA, 1983, J CELL BIOL, V97, P253, DOI 10.1083/jcb.97.1.253; Jin YS, 1999, J NEUROSCI, V19, P539; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; KURTZ A, 1994, DEVELOPMENT, V120, P2637; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Murphy P, 1996, DEVELOPMENT, V122, P2847; Nagata S, 2007, IMMUNOL REV, V220, P237, DOI 10.1111/j.1600-065X.2007.00571.x; OCONNOR TM, 1974, J CELL BIOL, V60, P448, DOI 10.1083/jcb.60.2.448; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; PANNESE E, 1978, CELL TISSUE RES, V190, P1; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schreiner S, 2007, DEVELOPMENT, V134, P3271, DOI 10.1242/dev.003350; Silva MT, 2008, APOPTOSIS, V13, P463, DOI 10.1007/s10495-008-0187-8; Suzuki E, 2007, EXP CELL RES, V313, P3729, DOI 10.1016/j.yexcr.2007.06.015; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; White FA, 1996, J NEUROSCI, V16, P4662; Woodhoo A, 2004, MOL CELL NEUROSCI, V25, P30, DOI 10.1016/j.mcn.2003.09.006; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	49	125	125	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1534	U79		10.1038/nn.2446	http://dx.doi.org/10.1038/nn.2446			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19915564	Green Accepted			2022-12-17	WOS:000272065600013
J	Blackmer, T; Larsen, EC; Bartleson, C; Kowalchyk, JA; Yoon, EJ; Preininger, AM; Alford, S; Hamm, HE; Martin, TFJ				Blackmer, T; Larsen, EC; Bartleson, C; Kowalchyk, JA; Yoon, EJ; Preininger, AM; Alford, S; Hamm, HE; Martin, TFJ			G protein beta gamma directly regulates SNARE protein fusion machinery for secretory granule exocytosis	NATURE NEUROSCIENCE			English	Article							GTP-BINDING PROTEIN; PHOSPHOLIPASE-C; MEMBRANE-FUSION; SUBUNITS; CELLS; SYNAPTOTAGMIN; ACTS; MODULATION; ACTIVATION; RESOLUTION	The activation of G protein - coupled receptors (GPCRs) can result in an inhibition of Ca2+-dependent hormone and neurotransmitter secretion. This has been attributed in part to G protein inhibition of Ca2+ influx. However, a frequently dominant inhibitory effect, of unknown mechanism, also occurs distal to Ca2+ entry. Here we characterize direct inhibitory actions of G protein beta gamma (G beta gamma) on Ca2+-triggered vesicle exocytosis in permeable PC12 cells. G beta gamma inhibition was rapid (<1 s) and was attenuated by cleavage of synaptosome-associated protein of 25 kD (SNAP25). G beta gamma bound soluble N-ethylmaleimide-sensitive factor attachment protein receptor ( SNARE) complexes, and binding was reduced to SNARE complexes containing cleaved SNAP25 or by Ca2+-dependent synaptotagmin binding. Here we show inhibitory coupling between GPCRs and vesicle exocytosis mediated directly by G beta gamma interactions with the Ca2+-dependent fusion machinery.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	heidi.hamm@mcmail.vanderbilt.edu; tfmartin@facstaff.wisc.edu	Hamm, Heidi E/G-2374-2014	Alford, Simon/0000-0002-0454-4246; Preininger, Anita/0000-0001-8011-9391				AHNERTHILGER G, 1987, BIOCHEMISTRY-US, V26, P7842, DOI 10.1021/bi00398a046; Banerjee A, 1996, J BIOL CHEM, V271, P20223, DOI 10.1074/jbc.271.34.20223; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; BLANK JL, 1992, J BIOL CHEM, V267, P23069; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; KNIGHT DE, 1985, FEBS LETT, V189, P345, DOI 10.1016/0014-5793(85)81053-X; LANG J, 1995, EMBO J, V14, P3635, DOI 10.1002/j.1460-2075.1995.tb00033.x; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; LUINI A, 1990, J NEUROCHEM, V54, P30, DOI 10.1111/j.1471-4159.1990.tb13279.x; MANSONHING H, 1989, NATURE, V341, P237, DOI 10.1038/341237a0; Martin TFJ, 1997, TRENDS CELL BIOL, V7, P271, DOI 10.1016/S0962-8924(97)01060-X; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Muller S, 1996, J BIOL CHEM, V271, P11781, DOI 10.1074/jbc.271.20.11781; OHARAIMAIZUMI M, 1992, J NEUROCHEM, V58, P2275, DOI 10.1111/j.1471-4159.1992.tb10974.x; Sharp GWG, 1996, AM J PHYSIOL-CELL PH, V271, pC1781, DOI 10.1152/ajpcell.1996.271.6.C1781; SILINSKY EM, 1992, J PHYSIOL-LONDON, V457, P315, DOI 10.1113/jphysiol.1992.sp019380; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; UEDA N, 1994, J BIOL CHEM, V269, P4388; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	31	125	128	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					421	425		10.1038/nn1423	http://dx.doi.org/10.1038/nn1423			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15778713				2022-12-17	WOS:000228040400011
J	Pasquale, EB				Pasquale, EB			Eph-ephrin promiscuity is now crystal clear	NATURE NEUROSCIENCE			English	Editorial Material							RECEPTOR		Burnham Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Pasquale, EB (corresponding author), Burnham Inst, La Jolla, CA 92037 USA.	elenap@burnham.org						Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Yin Y, 2004, NEUROSCI RES, V48, P285, DOI 10.1016/j.neures.2003.11.009	15	125	133	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					417	418		10.1038/nn0504-417	http://dx.doi.org/10.1038/nn0504-417			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114347				2022-12-17	WOS:000221101300002
J	Mizrahi, A; Katz, LC				Mizrahi, A; Katz, LC			Dendritic stability in the adult olfactory bulb	NATURE NEUROSCIENCE			English	Article							TERM SYNAPTIC PLASTICITY; IN-VIVO; ODORANT REPRESENTATIONS; POSTNATAL NEUROGENESIS; RECEPTOR NEURONS; LIVING MICE; CORTEX; MEMORY; SPINES; SYNAPSES	In many regions of the adult mammalian brain, pronounced changes in synaptic input caused by lesions or severe sensory deprivation induce marked sprouting or retraction of neuronal dendrites. In the adult olfactory bulb, adult neurogenesis produces less pronounced, but continuously ongoing synapse turnover. To test the structural stability of adult dendrites in this context, we used two-photon microscopy to image dendrites of mitral and tufted (M/T) cells over prolonged periods in adult mice. Although pharmacologically increased activity could elicit morphological changes, under natural conditions such as ongoing neurogenesis, an odor-enriched environment or olfactory-based learning, M/T cell dendrites remained highly stable. Thus, in a context of ongoing adult synaptogenesis, dendritic stability could serve as a structural scaffold to maintain the organization of local circuits.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Mizrahi, A (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	mizrahi@neuro.duke.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005671] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC005671] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Acebes A, 2000, TRENDS NEUROSCI, V23, P557, DOI 10.1016/S0166-2236(00)01646-5; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Brennan PA, 1998, NEUROSCIENCE, V87, P583, DOI 10.1016/S0306-4522(98)00182-1; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen BE, 2000, LEARN MEMORY, V7, P433, DOI 10.1101/lm.32700; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Dudai Y., 2002, MEMORY A Z; Dunaevsky A, 2003, TRENDS NEUROSCI, V26, P155, DOI 10.1016/S0166-2236(03)00028-6; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Geinisman Y, 2000, CEREB CORTEX, V10, P952, DOI 10.1093/cercor/10.10.952; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kosaka K, 2001, J COMP NEUROL, V440, P219, DOI 10.1002/cne.1381; MACKAYSIM A, 1991, EUR J NEUROSCI, V3, P209, DOI 10.1111/j.1460-9568.1991.tb00081.x; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; PURVES D, 1987, SCIENCE, V238, P1122, DOI 10.1126/science.3685967; PURVES D, 1986, J NEUROSCI, V6, P1051; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SAMANEN DW, 1984, J COMP NEUROL, V225, P201, DOI 10.1002/cne.902250206; Schellinck HM, 2001, CHEM SENSES, V26, P663, DOI 10.1093/chemse/26.6.663; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Swann JW, 2000, HIPPOCAMPUS, V10, P617, DOI 10.1002/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Wu GY, 1999, J NEUROSCI, V19, P4472; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	49	125	128	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1201	1207		10.1038/nn1133	http://dx.doi.org/10.1038/nn1133			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14528309				2022-12-17	WOS:000186229200020
J	Li, B; Chen, NS; Luo, T; Otsu, Y; Murphy, TH; Raymond, LA				Li, B; Chen, NS; Luo, T; Otsu, Y; Murphy, TH; Raymond, LA			Differential regulation of synaptic and extrasynaptic NMDA receptors	NATURE NEUROSCIENCE			English	Article							CHANNEL ACTIVITY; INTERNALIZATION; PHOSPHATASE; NEURONS; SUBUNIT		Univ British Columbia, Dept Psychiat, Kinsmen Lab, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Raymond, LA (corresponding author), Univ British Columbia, Dept Psychiat, Kinsmen Lab, Vancouver, BC V6T 1Z3, Canada.		Raymond, Lynn A/A-6664-2010; Raymond, Lynn A./R-6707-2016; Chen, Nansheng/E-6450-2012; Murphy, Timothy/AAW-1975-2021; Murphy, Timothy H/I-4982-2014; Otsu, Yo/P-6353-2017	Raymond, Lynn A/0000-0002-8610-1042; Raymond, Lynn A./0000-0002-8610-1042; Murphy, Timothy/0000-0002-0093-4490; Murphy, Timothy H/0000-0002-0093-4490; Otsu, Yo/0000-0003-2828-5063; Li, Bo/0000-0002-0154-3088				Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Dingledine R, 1999, PHARMACOL REV, V51, P7; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tovar KR, 1999, J NEUROSCI, V19, P4180; Umemiya M, 2001, J NEUROSCI, V21, P1, DOI 10.1523/JNEUROSCI.21-01-00001.2001; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721	14	125	132	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					833	834		10.1038/nn912	http://dx.doi.org/10.1038/nn912			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195433				2022-12-17	WOS:000177656300008
J	Hilfiker, S; Schweizer, FE; Kao, HT; Czernik, AJ; Greengard, P; Augustine, GJ				Hilfiker, S; Schweizer, FE; Kao, HT; Czernik, AJ; Greengard, P; Augustine, GJ			Two sites of action for synapsin domain E in regulating neurotransmitter release	NATURE NEUROSCIENCE			English	Article							SQUID GIANT SYNAPSE; PROTEIN-KINASE-II; FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; VESICLE PHOSPHOPROTEINS; EXOCYTOSIS; CALCIUM; FUSION; TRANSMISSION; DEPRESSION	Synapsins, a family of synaptic vesicle proteins, have been shown to regulate neurotransmitter release; the mechanism(s) by which they act are not fully understood. Here we have studied the role of domain E of synapsins in neurotransmitter release at the squid giant synapse. Two squid synapsin isoforms were cloned and found to contain a carboxy (C)-terminal domain homologous to domain E of the vertebrate a-type synapsin isoforms. Presynaptic injection of a peptide fragment of domain E greatly reduced the number of synaptic vesicles in the periphery of the active zone, and increased the rate and extent of synaptic depression, suggesting that domain E is essential for synapsins to regulate a reserve pool of synaptic vesicles. Domain E peptide had no effect on the number of docked synaptic vesicles, yet reversibly inhibited and slowed the kinetics of neurotransmitter release, indicating a second role for synapsins that is more intimately associated with the release process itself. Thus, synapsin domain E is involved in at least two distinct reactions that are crucial for exocytosis in presynaptic terminals.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Marine Biol Lab, Woods Hole, MA 02543 USA	Rockefeller University; Duke University; Marine Biological Laboratory - Woods Hole	Greengard, P (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.		Hilfiker, Sabine N/L-6369-2014; Augustine, George James/J-9228-2013	Hilfiker, Sabine N/0000-0002-5167-7682; 				Augustine GJ, 1996, ANNU REV PHARMACOL, V36, P659, DOI 10.1146/annurev.pa.36.040196.003303; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; Burns ME, 1998, J GEN PHYSIOL, V111, P243, DOI 10.1085/jgp.111.2.243; CHARLTON MP, 1978, J GEN PHYSIOL, V72, P471, DOI 10.1085/jgp.72.4.471; DEBELLO WM, 1995, NATURE, V373, P626, DOI 10.1038/373626a0; Esser L, 1998, EMBO J, V17, P977, DOI 10.1093/emboj/17.4.977; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HACKETT JT, 1990, J NEUROPHYSIOL, V63, P701, DOI 10.1152/jn.1990.63.4.701; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; HESS SD, 1993, SCIENCE, V259, P1169, DOI 10.1126/science.8438167; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; HONG RM, 1994, FEBS LETT, V350, P253, DOI 10.1016/0014-5793(94)00778-0; Hosaka M, 1998, J BIOL CHEM, V273, P1425, DOI 10.1074/jbc.273.3.1425; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; Klagges BRE, 1996, J NEUROSCI, V16, P3154; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; LIN JW, 1990, P NATL ACAD SCI USA, V87, P8257, DOI 10.1073/pnas.87.21.8257; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Rahamimoff R, 1997, NEURON, V18, P17, DOI 10.1016/S0896-6273(01)80043-X; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; SANCHEZ ME, 1990, J EXP BIOL, V152, P369; SCHELLER RH, 1995, NEURON, V14, P894; Schikorski T, 1997, J NEUROSCI, V17, P5858; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; Schweizer FE, 1998, SCIENCE, V279, P1203, DOI 10.1126/science.279.5354.1203; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Takei Y, 1995, J CELL BIOL, V131, P1789, DOI 10.1083/jcb.131.6.1789; TORRITARELLI F, 1990, J CELL BIOL, V110, P449, DOI 10.1083/jcb.110.2.449; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALTORTA F, 1988, NEUROSCIENCE, V24, P593, DOI 10.1016/0306-4522(88)90353-3; Vogel SS, 1996, J CELL BIOL, V134, P329, DOI 10.1083/jcb.134.2.329; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	47	125	125	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					29	35		10.1038/229	http://dx.doi.org/10.1038/229			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195105				2022-12-17	WOS:000076361000014
J	Gompers, AL; Su-Feher, L; Ellegood, J; Copping, NA; Riyadh, MA; Stradleigh, TW; Pride, MC; Schaffler, MD; Wade, AA; Catta-Preta, R; Zdilar, I; Louis, S; Kaushik, G; Mannion, BJ; Plajzer-Frick, I; Afzal, V; Visel, A; Pennacchio, LA; Dickel, DE; Lerch, JP; Crawley, JN; Zarbalis, KS; Silverman, JL; Nord, AS				Gompers, Andrea L.; Su-Feher, Linda; Ellegood, Jacob; Copping, Nycole A.; Riyadh, M. Asrafuzzaman; Stradleigh, Tyler W.; Pride, Michael C.; Schaffler, Melanie D.; Wade, A. Ayanna; Catta-Preta, Rinaldo; Zdilar, Iva; Louis, Shreya; Kaushik, Gaurav; Mannion, Brandon J.; Plajzer-Frick, Ingrid; Afzal, Veena; Visel, Axel; Pennacchio, Len A.; Dickel, Diane E.; Lerch, Jason P.; Crawley, Jacqueline N.; Zarbalis, Konstantinos S.; Silverman, Jill L.; Nord, Alex S.			Germline Chd8 haploinsufficiency alters brain development in mouse	NATURE NEUROSCIENCE			English	Article							AUTISM SPECTRUM DISORDER; CORTICAL NEUROGENESIS; MICE; MODELS; IMAGE; EXPRESSION; PROJECTION; MUTATIONS; PHENOTYPE; REGISTRATION	The chromatin remodeling gene CHD8 represents a central node in neurodevelopmental gene networks implicated in autism. We examined the impact of germline heterozygous frameshift Chd8 mutation on neurodevelopment in mice. Chd8(+/del5) mice displayed normal social interactions with no repetitive behaviors but exhibited cognitive impairment correlated with increased regional brain volume, validating that phenotypes of Chd8(+/del5) mice overlap pathology reported in humans with CHD8 mutations. We applied network analysis to characterize neurodevelopmental gene expression, revealing widespread transcriptional changes in Chd8(+/del5) mice across pathways disrupted in neurodevelopmental disorders, including neurogenesis, synaptic processes and neuroimmune signaling. We identified a co-expression module with peak expression in early brain development featuring dysregulation of RNA processing, chromatin remodeling and cell-cycle genes enriched for promoter binding by Chd8, and we validated increased neuronal proliferation and developmental splicing perturbation in Chd8(+/del5) mice. This integrative analysis offers an initial picture of the consequences of Chd8 haploinsufficiency for brain development.	[Gompers, Andrea L.; Su-Feher, Linda; Copping, Nycole A.; Stradleigh, Tyler W.; Pride, Michael C.; Schaffler, Melanie D.; Wade, A. Ayanna; Catta-Preta, Rinaldo; Zdilar, Iva; Louis, Shreya; Crawley, Jacqueline N.; Silverman, Jill L.; Nord, Alex S.] Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; [Gompers, Andrea L.; Su-Feher, Linda; Stradleigh, Tyler W.; Wade, A. Ayanna; Catta-Preta, Rinaldo; Zdilar, Iva; Louis, Shreya; Nord, Alex S.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Ellegood, Jacob; Lerch, Jason P.] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON, Canada; [Copping, Nycole A.; Pride, Michael C.; Schaffler, Melanie D.; Crawley, Jacqueline N.; Silverman, Jill L.] Univ Calif Davis, MIND Inst, Sch Med, Davis, CA 95616 USA; [Riyadh, M. Asrafuzzaman; Kaushik, Gaurav; Zarbalis, Konstantinos S.] Univ Calif Davis, Dept Pathol & Lab Med, Shriners Hosp Children, Inst Pediat Regenerat Med, Sacramento, CA 95817 USA; [Mannion, Brandon J.; Plajzer-Frick, Ingrid; Afzal, Veena; Visel, Axel; Pennacchio, Len A.; Dickel, Diane E.] Lawrence Berkeley Natl Lab, Funct Genom Dept, Berkeley, CA USA; [Visel, Axel; Pennacchio, Len A.] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Visel, Axel] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Lerch, Jason P.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of California System; University of California Davis; University of California System; University of California Davis; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Merced; University of Toronto	Nord, AS (corresponding author), Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA.; Nord, AS (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	asnord@ucdavis.edu	Visel, Axel/A-9398-2009; Kaushik, Gaurav/L-1499-2019; Catta-Preta, Rinaldo/AAX-8199-2020; Louis, Shreya/ABH-9259-2020	Visel, Axel/0000-0002-4130-7784; Kaushik, Gaurav/0000-0001-6743-7811; Catta-Preta, Rinaldo/0000-0001-9833-1278; Louis, Shreya/0000-0001-5752-6271; Wade, Alexandria/0000-0002-3318-2117; Mannion, Brandon/0000-0002-1149-3790; Stradleigh, Tyler/0000-0003-3000-4240; Su, Linda/0000-0002-0660-7925; Dickel, Diane/0000-0001-5497-6824; Schaffler, Melanie/0000-0001-9368-5608; Pennacchio, Len/0000-0002-8748-3732	UC Davis Center for Neuroscience; UC Davis MIND Institute Intellectual and Developmental Disabilities Research Center [U54 HD079125]; NIGMS [R35 GM119831]; UC Davis Floyd; Mary Schwall Fellowship in Medical Research; NIGMS-NIH [T32-GM008799]; NIH-NIGMS [T32-GM007377]; CNPq (Brazil); National Institutes of Health [R24HL123879, U01DE024427, R01HG003988, U54HG006997, UM1HL098166]; Department of Energy, University of California [DE-AC02-05CH11231]; Canadian Institute for Health Research; Brain Canada; Ontario Brain Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079125] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL123879, UM1HL098166] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006997, R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE024427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008799, T32GM007377, R35GM119831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085709] Funding Source: NIH RePORTER	UC Davis Center for Neuroscience; UC Davis MIND Institute Intellectual and Developmental Disabilities Research Center; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UC Davis Floyd; Mary Schwall Fellowship in Medical Research; NIGMS-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, University of California(United States Department of Energy (DOE)University of California System); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Brain Canada; Ontario Brain Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Sequencing was performed at the UC Berkeley and UC Davis DNA cores. This work was supported by institutional funds from the UC Davis Center for Neuroscience, by the UC Davis MIND Institute Intellectual and Developmental Disabilities Research Center (U54 HD079125) and by NIGMS R35 GM119831. L.S.-F. was supported by the UC Davis Floyd and Mary Schwall Fellowship in Medical Research and by grant number T32-GM008799 from NIGMS-NIH. A.A.W. was supported by Training Grant number T32-GM007377 from NIH-NIGMS. R.C.-P. was supported by a Science Without Borders Fellowship from CNPq (Brazil). A.V., L.A.P. and D.E.D. were supported by National Institutes of Health grants R24HL123879, U01DE024427, R01HG003988, U54HG006997 and UM1HL098166. Research conducted at the E.O. Lawrence Berkeley National Laboratory was performed under Department of Energy Contract DE-AC02-05CH11231, University of California. J.E. and J.P.L. were supported by the Canadian Institute for Health Research, Brain Canada and the Ontario Brain Institute.	Alrahbeni T, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0122-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bales KL, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.117; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Bock NA, 2006, J NEUROSCI, V26, P4455, DOI 10.1523/JNEUROSCI.5438-05.2006; Brunner D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134572; Cahill LS, 2012, NEUROIMAGE, V60, P933, DOI 10.1016/j.neuroimage.2012.01.100; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Du C, 2014, J LIPID RES, V55, P1886, DOI 10.1194/jlr.M047555; Durak O, 2016, NAT NEUROSCI, V19, P1477, DOI 10.1038/nn.4400; Ellegood J, 2015, MOL PSYCHIATR, V20, P118, DOI [10.1038/mp.2014.98, 10.1038/mp.2014.168]; Espuny-Camacho I, 2017, NEURON, V93, P1066, DOI 10.1016/j.neuron.2017.02.001; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; Flannery BM, 2015, NEUROTOXICOL TERATOL, V47, P36, DOI 10.1016/j.ntt.2014.10.008; Galazo MJ, 2016, NEURON, V91, P90, DOI 10.1016/j.neuron.2016.05.024; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Hagerman R, 2011, J NEURODEV DISORD, V3, P211, DOI 10.1007/s11689-011-9084-5; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Nguyen KH, 2015, ENDOCRINOLOGY, V156, P462, DOI 10.1210/en.2014-1271; Hormozdiari F, 2015, GENOME RES, V25, P142, DOI 10.1101/gr.178855.114; Huang ZH, 2012, J COMP NEUROL, V520, P1227, DOI 10.1002/cne.22772; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Katayama Y, 2016, NATURE, V537, P675, DOI 10.1038/nature19357; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laumonnier F, 2010, MOL PSYCHIATR, V15, P767, DOI 10.1038/mp.2009.14; Lee JA, 2016, NEURON, V89, P113, DOI 10.1016/j.neuron.2015.11.025; Lerch JP, 2008, NEUROIMAGE, V41, P243, DOI 10.1016/j.neuroimage.2008.02.019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lloyd-Burton S, 2012, J COMP NEUROL, V520, P2575, DOI 10.1002/cne.23029; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; Medina-Rivera A, 2015, NUCLEIC ACIDS RES, V43, pW50, DOI 10.1093/nar/gkv362; Nieman BJ, 2006, PHYSIOL GENOMICS, V24, P154, DOI 10.1152/physiolgenomics.00217.2005; Nieman BJ, 2005, MAGN RESON MED, V54, P532, DOI 10.1002/mrm.20590; Nishiyama M, 2004, MOL CELL BIOL, V24, P8386, DOI 10.1128/MCB.24.19.8386-8394.2004; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Orosco LA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5692; Parikshak NN, 2016, NATURE, V540, P423, DOI 10.1038/nature20612; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Platt RJ, 2017, CELL REP, V19, P335, DOI 10.1016/j.celrep.2017.03.052; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanders SJ, 2015, CURR OPIN GENET DEV, V33, P80, DOI 10.1016/j.gde.2015.10.002; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Silverman JL, 2015, NEUROPSYCHOPHARMACOL, V40, P2228, DOI 10.1038/npp.2015.66; Silverman JL, 2010, NEUROSCIENCE, V171, P1197, DOI 10.1016/j.neuroscience.2010.09.059; Silverman JL, 2013, NEUROPHARMACOLOGY, V68, P210, DOI 10.1016/j.neuropharm.2012.07.042; Silverman JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003501; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; Steadman PE, 2014, AUTISM RES, V7, P124, DOI 10.1002/aur.1344; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Thomas AM, 2012, PSYCHOPHARMACOLOGY, V219, P47, DOI 10.1007/s00213-011-2375-4; Tipps ME, 2014, LEARN MEMORY, V21, P380, DOI 10.1101/lm.035261.114; Ullmann JFP, 2015, J COMP NEUROL, V523, P391, DOI 10.1002/cne.23678; Van Laere S, 2007, BRIT J CANCER, V97, P1165, DOI 10.1038/sj.bjc.6603967; Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Wohr M, 2013, BEHAV BRAIN RES, V251, P5, DOI 10.1016/j.bbr.2013.05.047; Yang M, 2015, LEARN MEMORY, V22, P622, DOI 10.1101/lm.039602.115; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yeung J, 2016, J NEUROSCI, V36, P9057, DOI 10.1523/JNEUROSCI.4385-15.2016; Yoo SW, 2017, J COMP NEUROL, V525, P291, DOI 10.1002/cne.24064; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang XC, 2016, CELL, V166, P1147, DOI 10.1016/j.cell.2016.07.025	90	124	124	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2017	20	8					1062	+		10.1038/nn.4592	http://dx.doi.org/10.1038/nn.4592			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FB7CO	28671691	Green Published, Green Accepted, Green Submitted			2022-12-17	WOS:000406298900007
J	Peixoto, RT; Wang, WG; Croney, DM; Kozorovitskiy, Y; Sabatini, BL				Peixoto, Rui T.; Wang, Wengang; Croney, Donyell M.; Kozorovitskiy, Yevgenia; Sabatini, Bernardo L.			Early hyperactivity and precocious maturation of corticostriatal circuits in Shank3B(-/-) mice	NATURE NEUROSCIENCE			English	Article							AUTISM SPECTRUM DISORDERS; MEDIUM SPINY NEURONS; POSTNATAL-DEVELOPMENT; DEVELOPING NEOCORTEX; REPETITIVE BEHAVIOR; MOTOR STEREOTYPIES; SILENT SYNAPSES; MUTANT MICE; CORTEX; MUTATIONS	Some autistic individuals exhibit abnormal development of the caudate nucleus and associative cortical areas, suggesting potential dysfunction of cortico-basal ganglia (BG) circuits. Using optogenetic and electrophysiological approaches in mice, we identified a narrow postnatal period that is characterized by extensive glutamatergic synaptogenesis in striatal spiny projection neurons (SPNs) and a concomitant increase in corticostriatal circuit activity. SPNs during early development have high intrinsic excitability and respond strongly to cortical afferents despite sparse excitatory inputs. As a result, striatum and corticostriatal connectivity are highly sensitive to acute and chronic changes in cortical activity, suggesting that early imbalances in cortical function alter BG development. Indeed, a mouse model of autism with deletions in Shank3 (Shank3B-/-) shows early cortical hyperactivity, which triggers increased SPN excitatory synapse and corticostriatal hyperconnectivity. These results indicate that there is a tight functional coupling between cortex and striatum during early postnatal development and suggest a potential common circuit dysfunction that is caused by cortical hyperactivity.	[Peixoto, Rui T.; Wang, Wengang; Croney, Donyell M.; Kozorovitskiy, Yevgenia; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Kozorovitskiy, Yevgenia/GOP-1185-2022	Kozorovitskiy, Yevgenia/0000-0002-3710-1484	Alice and Joseph Brooks fellowship; Nancy Lurie Marks clinical and research fellowship in autism; Leonard and Isabelle Goldenson Research Fellowship; Nancy Lurie Marks Family Foundation; National Institute of Neurological Disorders and Stroke [NS046579]; Nancy Lurie Marks Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579] Funding Source: NIH RePORTER	Alice and Joseph Brooks fellowship; Nancy Lurie Marks clinical and research fellowship in autism; Leonard and Isabelle Goldenson Research Fellowship; Nancy Lurie Marks Family Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Nancy Lurie Marks Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Oldenburg for help with in vivo recordings and analysis and J. Levasseur and R. Pemberton for mouse genotyping and colony management. We thank S. da Silva, C. Deister and the members of the Sabatini laboratory for helpful discussions and critical reading of the manuscript. R.T.P. was supported by the Alice and Joseph Brooks fellowship and the Nancy Lurie Marks clinical and research fellowship in autism. Y.K. was supported by the Leonard and Isabelle Goldenson Research Fellowship and the Nancy Lurie Marks Family Foundation. This work was supported by the National Institute of Neurological Disorders and Stroke (NS046579, to B.L.S.) and the Nancy Lurie Marks Foundation.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Arons MH, 2012, J NEUROSCI, V32, P14966, DOI 10.1523/JNEUROSCI.2215-12.2012; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Busetto G, 2008, J PHYSIOL-LONDON, V586, P1519, DOI 10.1113/jphysiol.2007.149336; Carter AG, 2007, J NEUROSCI, V27, P8967, DOI 10.1523/JNEUROSCI.2798-07.2007; Choi S, 1997, P NATL ACAD SCI USA, V94, P2665, DOI 10.1073/pnas.94.6.2665; Colonnese MT, 2010, NEURON, V67, P480, DOI 10.1016/j.neuron.2010.07.015; DeLong M, 2010, CLIN EEG NEUROSCI, V41, P61, DOI 10.1177/155005941004100204; DIFIGLIA M, 1980, J COMP NEUROL, V190, P303, DOI 10.1002/cne.901900207; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Etherington SJ, 2011, J NEUROSCI, V31, P9526, DOI 10.1523/JNEUROSCI.0458-11.2011; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Gogolla N, 2014, NEURON, V83, P894, DOI 10.1016/j.neuron.2014.06.033; Goldman S, 2013, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00121; Goldman S, 2009, DEV MED CHILD NEUROL, V51, P30, DOI 10.1111/j.1469-8749.2008.03178.x; Goncalves JT, 2013, NAT NEUROSCI, V16, P903, DOI 10.1038/nn.3415; Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; Harris KM, 2008, PEDIATR NEUROL, V38, P267, DOI 10.1016/j.pediatrneurol.2007.12.008; Jiang YH, 2013, NEURON, V78, P8, DOI 10.1016/j.neuron.2013.03.016; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Kilb W, 2011, EUR J NEUROSCI, V34, P1677, DOI 10.1111/j.1460-9568.2011.07878.x; Kirkby LA, 2013, NEURON, V80, P1129, DOI 10.1016/j.neuron.2013.10.030; Kozorovitskiy Y, 2015, ELIFE, V4, DOI 10.7554/eLife.10111.001; Kozorovitskiy Y, 2012, NATURE, V489, P326, DOI 10.1038/nature11372; Langen M, 2007, BIOL PSYCHIAT, V62, P262, DOI 10.1016/j.biopsych.2006.09.040; Langen M, 2014, BIOL PSYCHIAT, V76, P405, DOI 10.1016/j.biopsych.2013.08.013; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; LEVINE MS, 1986, DEV BRAIN RES, V24, P47, DOI 10.1016/0165-3806(86)90172-0; Lewine JD, 1999, PEDIATRICS, V104, P405, DOI 10.1542/peds.104.3.405; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Martin LJ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00294; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; Oldenburg IA, 2015, NEURON, V86, P1174, DOI 10.1016/j.neuron.2015.05.008; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Sohur US, 2014, CEREB CORTEX, V24, P293, DOI 10.1093/cercor/bhs342; Tepper JM, 1998, DEV NEUROSCI-BASEL, V20, P125, DOI 10.1159/000017308; Verpelli C, 2011, J BIOL CHEM, V286, P34839, DOI 10.1074/jbc.M111.258384; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Wolff JJ, 2014, J CHILD PSYCHOL PSYC, V55, P945, DOI 10.1111/jcpp.12207; Wolff JJ, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-12; Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012	51	124	124	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2016	19	5					716	+		10.1038/nn.4260	http://dx.doi.org/10.1038/nn.4260			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK2RM	26928064	Green Submitted, Green Accepted			2022-12-17	WOS:000374762100011
J	Eshel, N; Tian, J; Bukwich, M; Uchida, N				Eshel, Neir; Tian, Ju; Bukwich, Michael; Uchida, Naoshige			Dopamine neurons share common response function for reward prediction error	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; MIDBRAIN DOPAMINE; MOTIVATIONAL SIGNALS; NUCLEUS-ACCUMBENS; DORSAL STRIATUM; NEURAL ACTIVITY; REVEAL; BRAIN; REPRESENTATIONS; IDENTIFICATION	Dopamine neurons are thought to signal reward prediction error, or the difference between actual and predicted reward. How dopamine neurons jointly encode this information, however, remains unclear. One possibility is that different neurons specialize in different aspects of prediction error; another is that each neuron calculates prediction error in the same way. We recorded from optogenetically identified dopamine neurons in the lateral ventral tegmental area (VTA) while mice performed classical conditioning tasks. Our tasks allowed us to determine the full prediction error functions of dopamine neurons and compare them to each other. We found marked homogeneity among individual dopamine neurons: their responses to both unexpected and expected rewards followed the same function, just scaled up or down. As a result, we were able to describe both individual and population responses using just two parameters. Such uniformity ensures robust information coding, allowing each dopamine neuron to contribute fully to the prediction error signal.	[Eshel, Neir; Tian, Ju; Bukwich, Michael; Uchida, Naoshige] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Eshel, Neir] Harvard Univ, Sch Med, MD PhD Program, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	Uchida, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA.	uchida@mcb.harvard.edu	Eshel, Neir/AAV-5548-2021	Eshel, Neir/0000-0002-5976-2013; Uchida, Naoshige/0000-0002-5755-9409	Sackler Fellowship in Psychobiology; US National Institutes of Health [T32GM007753, F30MH100729, 2T32MH020017-16, 5T32MH020017-17, R01MH095953, R01MH101207]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017, R01MH095953, R01MH101207, F30MH100729] Funding Source: NIH RePORTER	Sackler Fellowship in Psychobiology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Fitzgerald for assistance with analysis, J. Assad, R. Born, J. Maunsell, R. Wilson and members of the Uchida laboratory for discussions, C. Dulac for sharing resources, and K. Deisseroth (Stanford University) for the AAV-FLEX-ChR2 construct. This work was supported by a Sackler Fellowship in Psychobiology (N. E.) and US National Institutes of Health grants T32GM007753 (N. E.), F30MH100729 (N. E.), 2T32MH020017-16 (M. B.), 5T32MH020017-17 (M. B.), R01MH095953 (N. U.) and R01MH101207 (N.U.).	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Blaess S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-29; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Dayan P, 2012, NEURON, V76, P240, DOI 10.1016/j.neuron.2012.09.027; Eshel N, 2015, NATURE, V525, P243, DOI 10.1038/nature14855; Fiorillo CD, 2013, J NEUROSCI, V33, P4710, DOI 10.1523/JNEUROSCI.3883-12.2013; Fiorillo CD, 2013, J NEUROSCI, V33, P4693, DOI 10.1523/JNEUROSCI.3886-12.2013; Fiorillo CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003298; Fitzgerald JK, 2013, NEURON, V77, P180, DOI 10.1016/j.neuron.2012.11.014; FREUND TF, 1984, NEUROSCIENCE, V13, P1189, DOI 10.1016/0306-4522(84)90294-X; Fuxe K, 2010, PROG NEUROBIOL, V90, P82, DOI 10.1016/j.pneurobio.2009.10.012; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Joshua M, 2009, NEURON, V62, P695, DOI 10.1016/j.neuron.2009.04.026; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029766; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Matsumoto M, 2013, NEURON, V79, P1011, DOI 10.1016/j.neuron.2013.07.002; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Menegas W, 2015, ELIFE, V4, DOI 10.7554/eLife.10032; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Roeper J, 2013, TRENDS NEUROSCI, V36, P336, DOI 10.1016/j.tins.2013.03.003; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Schmitzer-Torbert N, 2004, J NEUROPHYSIOL, V91, P2259, DOI 10.1152/jn.00687.2003; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Tian J, 2015, NEURON, V87, P1304, DOI 10.1016/j.neuron.2015.08.028; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Vandecasteele M, 2005, J NEUROSCI, V25, P291, DOI 10.1523/JNEUROSCI.4167-04.2005; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; ZAHM DS, 1992, BRAIN RES, V575, P341, DOI 10.1016/0006-8993(92)90102-F; Zhang LF, 2009, MOL PHARMACOL, V76, P396, DOI 10.1124/mol.109.056317; Zweifel LS, 2011, NAT NEUROSCI, V14, P620, DOI 10.1038/nn.2808	59	124	123	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2016	19	3					479	+		10.1038/nn.4239	http://dx.doi.org/10.1038/nn.4239			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE7MU	26854803	Green Submitted, Green Accepted			2022-12-17	WOS:000370822200020
J	Maglione, M; Sigrist, SJ				Maglione, Marta; Sigrist, Stephan J.			Seeing the forest tree by tree: super-resolution light microscopy meets the neurosciences	NATURE NEUROSCIENCE			English	Review							STED MICROSCOPY; LIVE CELLS; ACTIVE ZONE; FLUORESCENCE MICROSCOPY; STIMULATED-EMISSION; DENDRITIC SPINES; RESOLUTION LIMIT; PROTEIN; NANOSCOPY; DYNAMICS	Light microscopy can be applied in vivo and can sample large tissue volumes, features crucial for the study of single neurons and neural circuits. However, light microscopy per se is diffraction-limited in resolution, and the substructure of core signaling compartments of neuronal circuits-axons, presynaptic active zones, postsynaptic densities and dendritic spines-can be only insufficiently characterized by standard light microscopy. Recently, several forms of super-resolution light microscopy breaking the diffraction-imposed resolution limit have started to allow highly resolved, dynamic imaging in the cell-biologically highly relevant 10-100 nanometer range ('mesoscale'). New, sometimes surprising answers concerning how protein mobility and protein architectures shape neuronal communication have already emerged. Here we start by briefly introducing super-resolution microscopy techniques, before we describe their use in the analysis of neuronal compartments. We conclude with long-term prospects for super-resolution light microscopy in the molecular and cellular neurosciences.	[Maglione, Marta; Sigrist, Stephan J.] Free Univ Berlin, Inst Biol, Dept Genet, Berlin, Germany; [Sigrist, Stephan J.] Charite, NeuroCure Cluster Excellence, Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sigrist, SJ (corresponding author), Free Univ Berlin, Inst Biol, Dept Genet, Berlin, Germany.	stephan.sigrist@fu-berlin.de			Deutsche Forschungsgemeinschaft [TP A3/SFB 958, SI849 7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We would like to thank D. Choquet, T. Kuner and S. Smith for sharing unpublished data and for scientific discussions. We thank T.A. Blanpied, H. Ewers, S. Hell, V. Nagerl, O. Shupliakov and X. Zhuang for permission to use their work. The authors are supported by grants from the Deutsche Forschungsgemeinschaft (TP A3/SFB 958; SI849 7-1).	Anderson JR, 2011, MOL VIS, V17; Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Arenkiel BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029423; Arenkiel BR, 2009, NATURE, V461, P900, DOI 10.1038/nature08536; Bar-On D, 2012, J BIOL CHEM, V287, P27158, DOI 10.1074/jbc.M112.353250; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bates M, 2012, CHEMPHYSCHEM, V13, P99, DOI 10.1002/cphc.201100735; Berning S, 2012, SCIENCE, V335, P551, DOI 10.1126/science.1215369; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Buckers J, 2011, OPT EXPRESS, V19, P3130, DOI 10.1364/OE.19.003130; Choquet D, 2010, EUR J NEUROSCI, V32, P250, DOI 10.1111/j.1460-9568.2010.07350.x; Cognet Laurent, 2006, Sci STKE, V2006, ppe13, DOI 10.1126/stke.3272006pe13; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Fiolka R, 2012, P NATL ACAD SCI USA, V109, P5311, DOI 10.1073/pnas.1119262109; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Gold MG, 2012, BIOESSAYS, V34, P599, DOI 10.1002/bies.201200009; Gould TJ, 2012, OPT EXPRESS, V20, P20998, DOI 10.1364/OE.20.020998; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hallermann S, 2010, J NEUROSCI, V30, P14340, DOI 10.1523/JNEUROSCI.2495-10.2010; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hein B, 2008, P NATL ACAD SCI USA, V105, P14271, DOI 10.1073/pnas.0807705105; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hoze N, 2012, P NATL ACAD SCI USA, V109, P17052, DOI 10.1073/pnas.1204589109; Hua YF, 2011, NAT NEUROSCI, V14, P833, DOI 10.1038/nn.2838; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; Jia N, 2012, P NATL ACAD SCI USA, V109, P22, DOI 10.1073/pnas.1109202108; Jiao W, 2010, J STRUCT BIOL, V172, P389, DOI 10.1016/j.jsb.2010.07.007; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Kerr JM, 2012, J NEUROSCI, V32, P658, DOI 10.1523/JNEUROSCI.2927-11.2012; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Lakadamyali M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030826; Lau L, 2012, BIOPHYS J, V102, P2926, DOI 10.1016/j.bpj.2012.05.015; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; MacGillavry HD, 2011, MOL CELL NEUROSCI, V48, P321, DOI 10.1016/j.mcn.2011.09.001; Manley S, 2008, NAT METHODS, V5, P155, DOI [10.1038/nmeth.1176, 10.1038/NMETH.1176]; Meyer L, 2008, SMALL, V4, P1095, DOI 10.1002/smll.200800055; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Nanguneri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038098; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Opazo F, 2012, NAT METHODS, V9, P938, DOI 10.1038/nmeth.2179; Owald D, 2010, J CELL BIOL, V188, P565, DOI 10.1083/jcb.200908055; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Rostaing P, 2006, EUR J NEUROSCI, V24, P3463, DOI 10.1111/j.1460-9568.2006.05234.x; Rueckel M, 2006, P NATL ACAD SCI USA, V103, P17137, DOI 10.1073/pnas.0604791103; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saka S, 2012, BIOESSAYS, V34, P386, DOI 10.1002/bies.201100080; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schmidt R, 2008, NAT METHODS, V5, P539, DOI 10.1038/nmeth.1214; Schmidt R, 2009, NANO LETT, V9, P2508, DOI 10.1021/nl901398t; Shao L, 2011, NAT METHODS, V8, P1044, DOI [10.1038/NMETH.1734, 10.1038/nmeth.1734]; Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Sigrist SJ, 2012, CURR OPIN NEUROBIOL, V22, P86, DOI 10.1016/j.conb.2011.10.014; Sigrist SJ, 2011, CURR OPIN NEUROBIOL, V21, P144, DOI 10.1016/j.conb.2010.08.012; Sochacki KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2158; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Tatavarty V, 2012, MOL BIOL CELL, V23, P3167, DOI 10.1091/mbc.E12-02-0165; Tatavarty V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007724; Tonnesen J, 2013, EXP NEUROL, V242, P33, DOI 10.1016/j.expneurol.2012.10.004; Toomre D, 2010, ANNU REV CELL DEV BI, V26, P285, DOI 10.1146/annurev-cellbio-100109-104048; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Urban NT, 2011, BIOPHYS J, V101, P1277, DOI 10.1016/j.bpj.2011.07.027; van de Linde S, 2010, J BIOTECHNOL, V149, P260, DOI 10.1016/j.jbiotec.2010.02.010; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Wildanger D, 2009, J MICROSC-OXFORD, V236, P35, DOI [10.1111/j.1365-2818.2009.03.188.x, 10.1111/j.1365-2818.2009.03188.x]; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wilmes S, 2012, ANGEW CHEM INT EDIT, V51, P4868, DOI 10.1002/anie.201200853; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/nmeth.1841, 10.1038/NMETH.1841]; York AG, 2012, NAT METHODS, V9, P749, DOI [10.1038/nmeth.2025, 10.1038/NMETH.2025]; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]	100	124	128	4	171	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					790	797		10.1038/nn.3403	http://dx.doi.org/10.1038/nn.3403			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799471				2022-12-17	WOS:000321180900008
J	Swaminathan, SK; Freedman, DJ				Swaminathan, Sruthi K.; Freedman, David J.			Preferential encoding of visual categories in parietal cortex compared with prefrontal cortex	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; SINGLE NEURONS; RHESUS-MONKEYS; MACAQUE MONKEY; DECISION; REPRESENTATIONS; INFORMATION; INTENTION; IMAGES; LOBE	The ability to recognize the behavioral relevance, or category membership, of sensory stimuli is critical for interpreting the meaning of events in our environment. Neurophysiological studies of visual categorization have found categorical representations of stimuli in prefrontal cortex (PFC), an area that is closely associated with cognitive and executive functions. Recent studies have also identified neuronal category signals in parietal areas that are typically associated with visual-spatial processing. It has been proposed that category-related signals in parietal cortex and other visual areas may result from 'top-down' feedback from PFC. We directly compared neuronal activity in the lateral intraparietal (LIP) area and PFC in monkeys performing a visual motion categorization task. We found that LIP showed stronger, more reliable and shorter latency category signals than PFC. These findings suggest that LIP is strongly involved in visual categorization and argue against the idea that parietal category signals arise as a result of feedback from PFC during this task.	[Swaminathan, Sruthi K.; Freedman, David J.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	University of Chicago	Freedman, DJ (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	dfreedman@uchicago.edu			US National Institutes of Health [R01 EY019041, 5T32GM007839]; NATIONAL EYE INSTITUTE [R01EY019041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007839] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. McClellan for animal training and technical assistance, G. Huang, C. Rishel and S. Thomas for technical assistance, and the staff of The University of Chicago Animal Resources Center for expert veterinary assistance. We also thank J. Assad, J. Fitzgerald, T. Herrington, G. Ibos, J. McKee, E. Miller, C. Pack, M. Riesenhuber and A. Sarma for helpful discussions and/or comments on an earlier version of this manuscript. This work was supported by US National Institutes of Health grant R01 EY019041. Additional support was provided by a National Science Foundation Faculty Early Career Development Award, the Alfred P. Sloan Foundation, the Brain Research Foundation and US National Institutes of Health Training Grant 5T32GM007839.	Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; Ferrera VP, 2006, NAT NEUROSCI, V9, P1207, DOI 10.1038/nn1006-1207; Ferrera VP, 2009, NAT NEUROSCI, V12, P1458, DOI 10.1038/nn.2434; Fitzgerald JK, 2011, NAT NEUROSCI, V14, P1075, DOI 10.1038/nn.2878; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2011, NAT NEUROSCI, V14, P143, DOI 10.1038/nn.2740; Freedman DJ, 2009, J NEUROSCI, V29, P5671, DOI 10.1523/JNEUROSCI.2878-08.2009; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gottlieb J, 2010, CURR OPIN NEUROBIOL, V20, P731, DOI 10.1016/j.conb.2010.09.015; Jiang X, 2007, NEURON, V53, P891, DOI 10.1016/j.neuron.2007.02.015; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Merchant H, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00069; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Oristaglio J, 2006, J NEUROSCI, V26, P8310, DOI 10.1523/JNEUROSCI.1779-06.2006; ROBERTS WA, 1988, J EXP PSYCHOL ANIM B, V14, P247, DOI 10.1037/0097-7403.14.3.247; Roy JE, 2010, J NEUROSCI, V30, P8519, DOI 10.1523/JNEUROSCI.4837-09.2010; Shadlen MN, 2008, BETTER CONSCIOUS DEC, P71, DOI 10.7551/mitpress/9780262195805.003.0004; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Stoet G, 2004, NEURON, V42, P1003, DOI 10.1016/j.neuron.2004.06.003; Vogels R, 1999, EUR J NEUROSCI, V11, P1223, DOI 10.1046/j.1460-9568.1999.00530.x; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542	31	124	124	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					315	320		10.1038/nn.3016	http://dx.doi.org/10.1038/nn.3016			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22246435	Green Accepted			2022-12-17	WOS:000299603500024
J	Graybeal, C; Feyder, M; Schulman, E; Saksida, LM; Bussey, TJ; Brigman, JL; Holmes, A				Graybeal, Carolyn; Feyder, Michael; Schulman, Emily; Saksida, Lisa M.; Bussey, Timothy J.; Brigman, Jonathan L.; Holmes, Andrew			Paradoxical reversal learning enhancement by stress or prefrontal cortical damage: rescue with BDNF	NATURE NEUROSCIENCE			English	Article							FEAR EXTINCTION; MICE; REORGANIZATION; EXPOSURE; CORTEX	Stress affects various forms of cognition. We found that moderate stress enhanced late reversal learning in a mouse touchscreen-based choice task. Ventromedial prefrontal cortex (vmPFC) lesions mimicked the effect of stress, whereas orbitofrontal and dorsolateral striatal lesions impaired reversal. Stress facilitation of reversal was prevented by BDNF infusion into the vmPFC. These findings suggest a mechanism by which stress-induced vmPFC dysfunction disinhibits learning by alternate (for example, striatal) systems.	[Graybeal, Carolyn; Feyder, Michael; Schulman, Emily; Brigman, Jonathan L.; Holmes, Andrew] NIAAA, Lab Behav & Genom Neurosci, US Natl Inst Hlth, Bethesda, MD USA; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Dept Expt Psychol, Med Res Council, Cambridge CB2 3EB, England; [Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge	Holmes, A (corresponding author), NIAAA, Lab Behav & Genom Neurosci, US Natl Inst Hlth, Bethesda, MD USA.	andrew.holmes@mail.nih.gov	Saksida, Lisa M/M-2753-2016; Bussey, Timothy J/M-2758-2016	Saksida, Lisa M/0000-0002-8416-8171; Bussey, Timothy J/0000-0001-7518-4041	National Institute on Alcohol Abuse; Alcoholism Intramural Research Program [Z01-AA000411]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000411, ZIAAA000411, K22AA020303] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Alcoholism Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Y. Shaham, G. Quirk and G. Schoenbaum for valuable discussions. This work was supported by the National Institute on Alcohol Abuse and Alcoholism Intramural Research Program (Z01-AA000411).	Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; BALLEINE B, 1992, Q J EXP PSYCHOL-B, V45, P285; Brigman JL, 2010, CEREB CORTEX, V20, P1955, DOI 10.1093/cercor/bhp266; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Duman Ronald S, 2009, Dialogues Clin Neurosci, V11, P239; Gourley SL, 2009, NEUROPSYCHOPHARMACOL, V34, P707, DOI 10.1038/npp.2008.123; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Izquierdo A, 2006, J NEUROSCI, V26, P5733, DOI 10.1523/JNEUROSCI.0474-06.2006; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; Shors TJ, 2006, ANNU REV PSYCHOL, V57, P55, DOI 10.1146/annurev.psych.57.102904.190205; Stalnaker TA, 2009, NEUROPHARMACOLOGY, V56, P63, DOI 10.1016/j.neuropharm.2008.07.019	15	124	125	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1507	1509		10.1038/nn.2954	http://dx.doi.org/10.1038/nn.2954			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	855EJ	22057192	Green Accepted, Green Submitted			2022-12-17	WOS:000297546300007
J	Puente, N; Cui, YH; Lassalle, O; Lafourcade, M; Georges, F; Venance, L; Grandes, P; Manzoni, OJ				Puente, Nagore; Cui, Yihui; Lassalle, Olivier; Lafourcade, Mathieu; Georges, Francois; Venance, Laurent; Grandes, Pedro; Manzoni, Olivier J.			Polymodal activation of the endocannabinoid system in the extended amygdala	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; BED NUCLEUS; ENDOGENOUS CANNABINOIDS; TRPV1; LOCALIZATION; ANANDAMIDE; RECEPTORS; SYNAPSES; CHANNELS; 2-ARACHIDONOYL-GLYCEROL	The reason why neurons synthesize more than one endocannabinoid (eCB) and how this is involved in the regulation of synaptic plasticity in a single neuron is not known. We found that 2-arachidonoylglycerol (2-AG) and anandamide mediate different forms of plasticity in the extended amygdala of rats. Dendritic L-type Ca2+ channels and the subsequent release of 2-AG acting on presynaptic CB1 receptors triggered retrograde short-term depression. Long-term depression was mediated by postsynaptic mGluR5-dependent release of anandamide acting on postsynaptic TRPV1 receptors. In contrast, 2-AG/CB1R-mediated retrograde signaling mediated both forms of plasticity in the striatum. These data illustrate how the eCB system can function as a polymodal signal integrator to allow the diversification of synaptic plasticity in a single neuron.	[Cui, Yihui; Venance, Laurent] Coll France, Ctr Interdisciplinary Res Biol, CNRS, INSERM,U1050,UMR 7241, F-75231 Paris, France; [Puente, Nagore; Lassalle, Olivier; Lafourcade, Mathieu; Georges, Francois; Manzoni, Olivier J.] INSERM, U862, Bordeaux, France; [Puente, Nagore; Lassalle, Olivier; Lafourcade, Mathieu; Georges, Francois; Manzoni, Olivier J.] Univ Bordeaux, Bordeaux, France; [Puente, Nagore; Grandes, Pedro] Univ Basque Country, Fac Med & Dent, Dept Neurosci, Leioa, Spain; [Puente, Nagore; Lassalle, Olivier; Manzoni, Olivier J.] INSERM, U901, F-13258 Marseille, France; [Puente, Nagore; Lassalle, Olivier] Univ Mediterranee UMR S901, Marseille, France; [Puente, Nagore; Lassalle, Olivier; Manzoni, Olivier J.] INMED, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Basque Country; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Venance, L (corresponding author), Coll France, Ctr Interdisciplinary Res Biol, CNRS, INSERM,U1050,UMR 7241, F-75231 Paris, France.	laurent.venance@college-de-france.fr; pedro.grandes@ehu.es; olivier.manzoni@inserm.fr	Grandes, Pedro/H-7494-2015; Manzoni, Olivier/M-7899-2016; Grandes, Pedro/AAA-1627-2019; Puente, Nagore/H-7054-2015; Cui, Yihui/AAB-9328-2022; Lafourcade, Mathieu/GQZ-7267-2022; Venance, Laurent/E-5840-2016	Grandes, Pedro/0000-0003-3947-4230; Manzoni, Olivier/0000-0002-5579-6208; Puente, Nagore/0000-0003-0866-5747; Venance, Laurent/0000-0003-0738-1662; Lafourcade, Mathieu/0000-0001-6117-1194; GEORGES, Francois/0000-0002-2628-2638; Cui, Yihui/0000-0002-7362-6237	INSERM; Agence National pour la Recherche Neurosciences (Neurologie et Psychiatrie) [ANR-06-NEURO-043-01]; Region Aquitaine; Basque Country University; Basque Country Government [ANR-06-NEURO-043-01, GIC07/70-IT-432-07]; Ministerio de Ciencia e Innovacion [SAF2009-07065]; Neuroscience School of Paris; Agence National pour la Recherche Neurosciences "Mobil,"; "Red de Trastornos Adictivos," RETICS, Instituto de Salud Carlos III, MICINN [RD07/0001/2001]; College de France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence National pour la Recherche Neurosciences (Neurologie et Psychiatrie)(French National Research Agency (ANR)); Region Aquitaine(Region Nouvelle-Aquitaine); Basque Country University; Basque Country Government(Basque Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Neuroscience School of Paris; Agence National pour la Recherche Neurosciences "Mobil,"(French National Research Agency (ANR)); "Red de Trastornos Adictivos," RETICS, Instituto de Salud Carlos III, MICINN(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); College de France	The authors thank N. Stella, M. Sepers and P. Chavis for critical reading of the manuscript, and R. Martinez for invaluable help in setting up the Manzoni laboratory. Work in the Manzoni laboratory was supported by INSERM, Agence National pour la Recherche Neurosciences (Neurologie et Psychiatrie ANR-06-NEURO-043-01) and Region Aquitaine. N. P. was supported by Basque Country Government Postdoctoral grant BFI05.185 and by a Basque Country University grant for PhD Researcher's Specialization. P.G. was supported by Basque Country Government grant GIC07/70-IT-432-07, by Ministerio de Ciencia e Innovacion (SAF2009-07065) and by "Red de Trastornos Adictivos," RETICS, Instituto de Salud Carlos III, MICINN, grant RD07/0001/2001. Y.C. was supported by the Neuroscience School of Paris, Agence National pour la Recherche Neurosciences "Mobil," INSERM and College de France.	Almasi R, 2008, LIFE SCI, V82, P644, DOI 10.1016/j.lfs.2007.12.022; Bisogno T, 1999, BIOCHEM BIOPH RES CO, V256, P377, DOI 10.1006/bbrc.1999.0254; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Chavez AE, 2010, NAT NEUROSCI, V13, P1511, DOI 10.1038/nn.2684; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; Di Marzo V, 2002, PROSTAG LEUKOTR ESS, V66, P377, DOI 10.1054/plef.2001.0349; Di Marzo V, 2001, TRENDS PHARMACOL SCI, V22, P346, DOI 10.1016/S0165-6147(00)01712-0; Di Marzo V, 2008, TRENDS PHARMACOL SCI, V29, P594, DOI 10.1016/j.tips.2008.09.004; Dumont EC, 2004, J NEUROSCI, V24, P8198, DOI 10.1523/JNEUROSCI.0425-04.2004; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Gaetani S, 2009, INT REV NEUROBIOL, V85, P57, DOI 10.1016/S0074-7742(09)85005-8; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Jalabert M, 2009, PROG NEURO-PSYCHOPH, V33, P1336, DOI 10.1016/j.pnpbp.2009.07.010; Jung KM, 2005, MOL PHARMACOL, V68, P1196, DOI 10.1124/mol.105.013961; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Karbarz MJ, 2009, ANESTH ANALG, V108, P316, DOI 10.1213/ane.0b013e31818c7cbd; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Maione S, 2009, J PHYSIOL-LONDON, V587, P2521, DOI 10.1113/jphysiol.2009.171900; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Massi L, 2008, J NEUROSCI, V28, P10496, DOI 10.1523/JNEUROSCI.2291-08.2008; Mato S, 2008, NEUROPHARMACOLOGY, V54, P87, DOI 10.1016/j.neuropharm.2007.04.014; McElligott ZA, 2009, PROG NEURO-PSYCHOPH, V33, P1329, DOI 10.1016/j.pnpbp.2009.05.022; Nyilas R, 2009, EUR J NEUROSCI, V29, P1964, DOI 10.1111/j.1460-9568.2009.06751.x; Petrosino S, 2010, CURR OPIN INVEST DR, V11, P51; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Puente N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008869; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Robbe D, 2001, J NEUROSCI, V21, P109, DOI 10.1523/JNEUROSCI.21-01-00109.2001; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Rubino T, 2008, CEREB CORTEX, V18, P1292, DOI 10.1093/cercor/bhm161; Starowicz K, 2008, CURR PHARM DESIGN, V14, P42; Starowicz K, 2007, J NEUROSCI, V27, P13739, DOI 10.1523/JNEUROSCI.3258-07.2007; Tippens AL, 2008, J COMP NEUROL, V506, P569, DOI 10.1002/cne.21567; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Valenti M, 2004, CELL MOL LIFE SCI, V61, P945, DOI 10.1007/s00018-003-3453-5; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006	50	124	124	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1542	U67		10.1038/nn.2974	http://dx.doi.org/10.1038/nn.2974			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22057189				2022-12-17	WOS:000297546300013
J	Silver, DL; Watkins-Chow, DE; Schreck, KC; Pierfelice, TJ; Larson, DM; Burnetti, AJ; Liaw, HJ; Myung, K; Walsh, CA; Gaiano, N; Pavan, WJ				Silver, Debra L.; Watkins-Chow, Dawn E.; Schreck, Karisa C.; Pierfelice, Tarran J.; Larson, Denise M.; Burnetti, Anthony J.; Liaw, Hung-Jiun; Myung, Kyungjae; Walsh, Christopher A.; Gaiano, Nicholas; Pavan, William J.			The exon junction complex component Magoh controls brain size by regulating neural stem cell division	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA LOCALIZATION; CEREBRAL CORTICAL SIZE; SPINDLE ORIENTATION; LISSENCEPHALY GENE; HUMAN-CHROMOSOMES; LIS1 EXPRESSION; SECKEL-SYNDROME; PROTEIN; NEUROGENESIS; NASHI	Brain structure and size require precise division of neural stem cells (NSCs), which self-renew and generate intermediate neural progenitors (INPs) and neurons. The factors that regulate NSCs remain poorly understood, and mechanistic explanations of how aberrant NSC division causes the reduced brain size seen in microcephaly are lacking. Here we show that Magoh, a component of the exon junction complex (EJC) that binds RNA, controls mouse cerebral cortical size by regulating NSC division. Magoh haploinsufficiency causes microcephaly because of INP depletion and neuronal apoptosis. Defective mitosis underlies these phenotypes, as depletion of EJC components disrupts mitotic spindle orientation and integrity, chromosome number and genomic stability. In utero rescue experiments showed that a key function of Magoh is to control levels of the microcephaly-associated protein Lis1 during neurogenesis. Our results uncover requirements for the EJC in brain development, NSC maintenance and mitosis, thereby implicating this complex in the pathogenesis of microcephaly.	[Silver, Debra L.; Watkins-Chow, Dawn E.; Larson, Denise M.; Burnetti, Anthony J.; Pavan, William J.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Schreck, Karisa C.; Pierfelice, Tarran J.; Gaiano, Nicholas] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA; [Liaw, Hung-Jiun; Myung, Kyungjae] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Walsh, Christopher A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Genet, Boston, MA USA; [Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Pavan, WJ (corresponding author), NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA.	bpavan@mail.nih.gov	Liaw, Hungjiun/G-7034-2014; Schreck, Karisa/Y-4399-2019	Liaw, Hungjiun/0000-0002-3481-709X; Schreck, Karisa/0000-0001-7181-3269; Watkins-Chow, Dawn/0000-0002-4355-0868; Pavan, William/0000-0001-8281-5120; Silver, Debra/0000-0001-9189-844X	National Institute of General Medical Sciences PRAT; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG012003, ZIAHG000070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032457, R00NS064197] Funding Source: NIH RePORTER	National Institute of General Medical Sciences PRAT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	For advice, we thank Pavan laboratory members, including L. Baxter for reading the manuscript. For technical assistance, we thank A. Incao (mouse husbandry); G. Elliot and A. Chen (mouse transgenics); A. Dutra, E. Pak and S. Witchovitch (metaphase, SKY, microscopy assistance); S. Anderson and M. Kirby (FACS analysis); B. Bhorate (microarray statistics); M. Bryant (pathology analysis); Harvard Partners Center for Genetics and Genomics (candidate gene sequencing); and J. Fekecs and D. Leja (assistance with figures). This research was funded in part by an National Institute of General Medical Sciences PRAT fellowship and K99/R00 Pathway to Independence Award (to D. L. S.), by the Intramural Research program of NIH/NHGRI (to W. J. P., K. M.) and by the NIH/NHGRI (to N.G.). C.A.W. is an Investigator of the Howard Hughes Medical Institute.	Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733; Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Buac K, 2009, PIGM CELL MELANOMA R, V22, P773, DOI 10.1111/j.1755-148X.2009.00616.x; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; LUNDSTEEN C, 1985, CLIN GENET, V28, P260; Matera I, 2008, HUM MOL GENET, V17, P2118, DOI 10.1093/hmg/ddn110; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mulatinho M, 2008, AM J MED GENET A, V146A, P2284, DOI 10.1002/ajmg.a.32454; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Pawlisz AS, 2008, HUM MOL GENET, V17, P2441, DOI 10.1093/hmg/ddn144; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; van der Weele CM, 2007, MOL BIOL CELL, V18, P3711, DOI 10.1091/mbc.E06-11-0979; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Yamada M, 2009, NAT MED, V15, P1202, DOI 10.1038/nm.2023; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	43	124	126	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					551	U53		10.1038/nn.2527	http://dx.doi.org/10.1038/nn.2527			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20364144	Green Accepted			2022-12-17	WOS:000277065700012
J	Davidson, S; Zhang, XJ; Khasabov, SG; Simone, DA; Giesler, GJ				Davidson, Steve; Zhang, Xijing; Khasabov, Sergey G.; Simone, Donald A.; Giesler, Glenn J., Jr.			Relief of itch by scratching: state-dependent inhibition of primate spinothalamic tract neurons	NATURE NEUROSCIENCE			English	Article							HISTAMINE; RESPONSES; STIMULI	Itch is relieved by scratching, but the neural mechanisms that are responsible for this are unknown. Spinothalamic tract (STT) neurons respond to itch-producing agents and transmit pruritic information to the brain. We observed that scratching the cutaneous receptive field of primate STT neurons produced inhibition during histamine-evoked activity but not during spontaneous activity or activity evoked by a painful stimulus, suggesting that scratching inhibits the transmission of itch in the spinal cord in a state-dependent manner.	[Davidson, Steve; Simone, Donald A.; Giesler, Glenn J., Jr.] Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA; [Davidson, Steve; Zhang, Xijing; Giesler, Glenn J., Jr.] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Khasabov, Sergey G.; Simone, Donald A.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Giesler, GJ (corresponding author), Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA.	giesler@umn.edu		Davidson, Steve/0000-0003-2944-1144	US National Institutes of Health/National Institute of Neurological Disorders and Stroke [NS-047399, NS-059199]; Graduate School of the University of Minnesota; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS059199, P01NS047399] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Graduate School of the University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Truong for his valuable technical assistance. This work was supported by US National Institutes of Health/National Institute of Neurological Disorders and Stroke grants NS-047399 and NS-059199 and by the Graduate School of the University of Minnesota.	Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; Brull SJ, 1999, SOMATOSENS MOT RES, V16, P299; Carstens E, 1997, J NEUROPHYSIOL, V77, P2499, DOI 10.1152/jn.1997.77.5.2499; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; GRAHAM DT, 1951, J CLIN INVEST, V30, P37, DOI 10.1172/JCI102414; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Mochizuki H, 2003, PAIN, V105, P339, DOI 10.1016/S0304-3959(03)00249-5; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Simone DA, 2004, J NEUROPHYSIOL, V91, P213, DOI 10.1152/jn.00527.2003; SIMONE DA, 1987, SOMATOSENS MOT RES, V5, P81, DOI 10.3109/07367228709144620; Ward L, 1996, PAIN, V64, P129, DOI 10.1016/0304-3959(95)00080-1; Yosipovitch G, 2007, BRIT J DERMATOL, V156, P629, DOI 10.1111/j.1365-2133.2006.07711.x	14	124	128	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2009	12	5					544	546		10.1038/nn.2292	http://dx.doi.org/10.1038/nn.2292			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438SJ	19349977	Green Accepted			2022-12-17	WOS:000265575400008
J	Raingo, J; Castiglioni, AJ; Lipscombe, D				Raingo, Jesica; Castiglioni, Andrew J.; Lipscombe, Diane			Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors	NATURE NEUROSCIENCE			English	Article							GAMMA-BINDING DOMAIN; G-BETA-GAMMA; CA2+ CHANNELS; SENSORY NEURONS; CA(V)2.2 CHANNELS; KINASE-C; MODULATION; CURRENTS; PATHWAYS; SUBUNITS	Neurotransmitter release from mammalian sensory neurons is controlled by Ca(V)2.2 N-type calcium channels. N-type channels are a major target of neurotransmitters and drugs that inhibit calcium entry, transmitter release and nociception through their specific G protein-coupled receptors. G protein-coupled receptor inhibition of these channels is typically voltage-dependent and mediated by G beta gamma, whereas N-type channels in sensory neurons are sensitive to a second G protein - coupled receptor pathway that inhibits the channel independent of voltage. Here we show that preferential inclusion in nociceptors of exon 37a in rat Cacna1b ( encoding CaV2.2) creates, de novo, a C-terminal module that mediates voltage-independent inhibition. This inhibitory pathway requires tyrosine kinase activation but not G beta gamma. A tyrosine encoded within exon 37a constitutes a critical part of a molecular switch controlling N-type current density and G protein-mediated voltage-independent inhibition. Our data define the molecular origins of voltage-independent inhibition of N-type channels in the pain pathway.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Lipscombe, D (corresponding author), Brown Univ, Dept Neurosci, Sidney E Frank Hall Life Sci,185 Meeting St, Providence, RI 02912 USA.	Diane_Lipscombe@brown.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055251, R29NS029967, R01NS029967] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007601] Funding Source: Medline; NINDS NIH HHS [NS55251, R01 NS055251, NS29967, R01 NS055251-04, R01 NS029967] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bourinet E, 2005, CURR TOP MED CHEM, V5, P539, DOI 10.2174/1568026054367610; Brody DL, 2000, J NEUROSCI, V20, P889, DOI 10.1523/JNEUROSCI.20-03-00889.2000; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; Castiglioni AJ, 2006, J PHYSIOL-LONDON, V576, P119, DOI 10.1113/jphysiol.2006.115030; Delmas P, 2005, NEURON, V47, P179, DOI 10.1016/j.neuron.2005.07.001; DiversePierluissi M, 1996, NEURON, V16, P579, DOI 10.1016/S0896-6273(00)80077-X; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; DiversePierluissi M, 1997, P NATL ACAD SCI USA, V94, P5417, DOI 10.1073/pnas.94.10.5417; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Elmslie KS, 2003, J BIOENERG BIOMEMBR, V35, P477, DOI 10.1023/B:JOBB.0000008021.55853.18; Fujikawa S, 1997, PFLUG ARCH EUR J PHY, V434, P84, DOI 10.1007/s004240050366; Hamid J, 1999, J BIOL CHEM, V274, P6195, DOI 10.1074/jbc.274.10.6195; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HILLE B, 1995, LIFE SCI, V56, P989, DOI 10.1016/0024-3205(95)00038-8; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; IKEDA SR, 1996, NATURE, V380, P258; Kammermeier PJ, 1999, NEURON, V22, P819, DOI 10.1016/S0896-6273(00)80740-0; Li B, 2004, MOL PHARMACOL, V66, P761; Lin YX, 2004, J NEUROPHYSIOL, V92, P2820, DOI 10.1152/jn.00048.2004; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; Lipscombe D, 2006, NAT NEUROSCI, V9, P8, DOI 10.1038/nn0106-8; LUEBKE JI, 1994, PFLUG ARCH EUR J PHY, V428, P499, DOI 10.1007/BF00374571; Onofri F, 1997, P NATL ACAD SCI USA, V94, P12168, DOI 10.1073/pnas.94.22.12168; Ossipov MH, 2000, ANN NY ACAD SCI, V909, P12; Park D, 1998, J NEUROSCI, V18, P6757; Polo-Parada L, 1999, J NEUROSCI, V19, P5213; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; RANE SG, 1986, P NATL ACAD SCI USA, V83, P184, DOI 10.1073/pnas.83.1.184; Richman RW, 2004, J BIOL CHEM, V279, P24649, DOI 10.1074/jbc.M312182200; Richman RW, 2004, METHOD ENZYMOL, V390, P224; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; ROUSSEL RR, 1991, P NATL ACAD SCI USA, V88, P10696, DOI 10.1073/pnas.88.23.10696; Strock J, 2004, MOL PHARMACOL, V66, P1071, DOI 10.1124/mol.104.002261; TADDESE A, 1995, SCIENCE, V270, P1366, DOI 10.1126/science.270.5240.1366; Thaler C, 2004, P NATL ACAD SCI USA, V101, P5675, DOI 10.1073/pnas.0303402101; Tombler E, 2006, J BIOL CHEM, V281, P1827, DOI 10.1074/jbc.M508829200	43	124	132	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					285	292		10.1038/nn1848	http://dx.doi.org/10.1038/nn1848			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17293861	Green Accepted			2022-12-17	WOS:000244480300010
J	Tojima, T; Akiyama, H; Itofusa, R; Li, Y; Katayama, H; Miyawaki, A; Kamiguchi, H				Tojima, Takuro; Akiyama, Hiroki; Itofusa, Rurika; Li, Yan; Katayama, Hiroyuki; Miyawaki, Atsushi; Kamiguchi, Hiroyuki			Attractive axon guidance involves asymmetric membrane transport and exocytosis in the growth cone	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH; FLUORESCENT PROTEIN; SIGNAL-TRANSDUCTION; TRPC CHANNELS; RHO-GTPASES; DYNAMICS; FILOPODIA; ADHESION; NEURONS; SNARE	Asymmetric elevation of the Ca2+ concentration in the growth cone can mediate both attractive and repulsive axon guidance. Ca2+ signals that are accompanied by Ca2+-induced Ca2+ release (CICR) trigger attraction, whereas Ca2+ signals that are not accompanied by CICR trigger repulsion. The molecular machinery downstream of Ca2+ signals, however, remains largely unknown. Here we report that asymmetric membrane trafficking mediates growth cone attraction. Local photolysis of caged Ca2+, together with CICR, on one side of the growth cone of a chick dorsal root ganglion neuron facilitated the microtubule-dependent centrifugal transport of vesicles towards the leading edge and their subsequent vesicle-associated membrane-protein 2 (VAMP2)-mediated exocytosis on the side with an elevated Ca2+ concentration. In contrast, Ca2+ signals without CICR had no effect on the vesicle transport. Furthermore, pharmacological inhibition of VAMP2-mediated exocytosis prevented growth cone attraction, but not repulsion. These results strongly suggest that growth cone attraction and repulsion are driven by distinct mechanisms, rather than using the same molecular machinery with opposing polarities.	RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Neuronal Growth Mech, Wako, Saitama 3510198, Japan; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama 3510198, Japan	RIKEN; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; RIKEN	Kamiguchi, H (corresponding author), RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Neuronal Growth Mech, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kamiguchi@brain.riken.jp	Miyawaki, Atsushi/K-3569-2014; Kamiguchi, Hiroyuki/N-5409-2015; Tojima, Takuro/C-3667-2017	Miyawaki, Atsushi/0000-0002-2329-3235; Kamiguchi, Hiroyuki/0000-0003-1802-6324; Tojima, Takuro/0000-0002-9140-3205				Bonanomi D, 2005, J NEUROSCI, V25, P7299, DOI 10.1523/JNEUROSCI.1573-05.2005; Bridgman PC, 2004, J NEUROBIOL, V58, P164, DOI 10.1002/neu.10320; Buck KB, 2002, J NEUROSCI, V22, P9358; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Challacombe JF, 1997, J NEUROSCI, V17, P3085; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Diefenbach TJ, 1999, J NEUROSCI, V19, P9436; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Igarashi M, 1996, J CELL BIOL, V134, P205, DOI 10.1083/jcb.134.1.205; Igarashi M, 1997, J NEUROSCI, V17, P1460; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P429, DOI 10.1177/002215540305100404; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; LOCKERBIE RO, 1991, J CELL BIOL, V112, P1215, DOI 10.1083/jcb.112.6.1215; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; OsenSand A, 1996, J COMP NEUROL, V367, P222, DOI 10.1002/(SICI)1096-9861(19960401)367:2<222::AID-CNE5>3.0.CO;2-7; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Sabo SL, 2003, NAT NEUROSCI, V6, P1264, DOI 10.1038/nn1149; Saxena S, 2005, MOL CELL NEUROSCI, V28, P571, DOI 10.1016/j.mcn.2004.11.011; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zakharenko S, 1998, J CELL BIOL, V143, P1077, DOI 10.1083/jcb.143.4.1077; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zheng JQ, 1996, J NEUROSCI, V16, P1140	49	124	124	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					58	66		10.1038/nn1814	http://dx.doi.org/10.1038/nn1814			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17159991				2022-12-17	WOS:000243096100016
J	Nozaki, D; Kurtzer, I; Scott, SH				Nozaki, Daichi; Kurtzer, Isaac; Scott, Stephen H.			Limited transfer of learning between unimanual and bimanual skills within the same limb	NATURE NEUROSCIENCE			English	Article							MOTOR; REPRESENTATION; DYNAMICS	Although a limb's motion appears to be similar across unimanual and bimanual movements, here we demonstrate partial, but not complete, transfer of learning across these behavioral contexts, hidden learning that remains intact ( but invisible) until the original context is again encountered, and the ability to associate two conflicting force fields simultaneously, one with each context. These results suggest partial, but not complete, overlap in the learning processes involved in the acquisition of unimanual and bimanual skills.	Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo 1130033, Japan; Res Inst Natl Rehabil Ctr Persons Disabilities, Dept Rehabil Movement Funct, Tokorozawa, Saitama 3598555, Japan; Queens Univ, Ctr Neurosci Studies, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada	University of Tokyo; Queens University - Canada	Scott, SH (corresponding author), Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo 1130033, Japan.	steve@biomed.queensu.ca	Nozaki, Daichi/B-7909-2010	Nozaki, Daichi/0000-0002-1338-8337				Bagesteiro LB, 2002, J NEUROPHYSIOL, V88, P2408, DOI 10.1152/jn.00901.2001; Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005; Cunningham CL, 2002, ACTA PSYCHOL, V110, P321, DOI 10.1016/S0001-6918(02)00040-9; Donchin O, 2002, J NEUROPHYSIOL, V88, P3498, DOI 10.1152/jn.00335.2001; FINCH M, 2004, TRIATHLON TRAINING; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Kurtzer I, 2005, NAT NEUROSCI, V8, P498, DOI 10.1038/nn1420; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Osu R, 2004, NAT NEUROSCI, V7, P111, DOI 10.1038/nn1184; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807	12	124	124	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1364	1366		10.1038/nn1785	http://dx.doi.org/10.1038/nn1785			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17028583				2022-12-17	WOS:000242403800011
J	Majdan, M; Shatz, CJ				Majdan, M; Shatz, CJ			Effects of visual experience on activity-dependent gene regulation in cortex	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; FACTOR MESSENGER-RNA; MONOCULAR DEPRIVATION; CRITICAL PERIOD; POSTNATAL-DEVELOPMENT; SYNAPTIC PLASTICITY; IMPULSE ACTIVITY; COLUMN FORMATION; NERVOUS-SYSTEM; EXPRESSION	There are critical periods in development when sensory experience directs the maturation of synapses and circuits within neocortex. We report that the critical period in mouse visual cortex has a specific molecular logic of gene regulation. Four days of visual deprivation regulated one set of genes during the critical period, and different sets before or after. Dark rearing perturbed the regulation of these age-specific gene sets. In addition, a 'common gene set', comprised of target genes belonging to a mitogen-activated protein (MAP) kinase signaling pathway, was regulated by vision at all ages but was impervious to prior history of sensory experience. Together, our results demonstrate that vision has dual effects on gene regulation in visual cortex and that sensory experience is needed for the sequential acquisition of age-specific, but not common, gene sets. Thus, a dynamic interplay between experience and gene expression drives activity-dependent circuit maturation.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shatz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	carla_shatz@hms.harvard.edu			NEI NIH HHS [EY02858] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY002858, R01EY002858] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Bear MF, 1999, J NEUROBIOL, V41, P83, DOI 10.1002/(SICI)1097-4695(199910)41:1<83::AID-NEU11>3.0.CO;2-Z; Berti C, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-9; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Cancedda L, 2003, J NEUROSCI, V23, P7012, DOI 10.1523/JNEUROSCI.23-18-07012.2003; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; CHAPMAN B, 1986, NATURE, V324, P154, DOI 10.1038/324154a0; CYNADER M, 1983, DEV BRAIN RES, V8, P155, DOI 10.1016/0165-3806(83)90002-0; Danik M, 1999, CRIT REV NEUROBIOL, V13, P357, DOI 10.1615/CritRevNeurobiol.v13.i4.20; Deak F, 1997, J BIOL CHEM, V272, P9268; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Finkenstadt PM, 2002, J NEUROCHEM, V83, P202, DOI 10.1046/j.1471-4159.2002.01158.x; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gordon JA, 1996, J NEUROSCI, V16, P3274; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Kaczmarek L, 1997, BRAIN RES REV, V23, P237, DOI 10.1016/S0165-0173(97)00005-2; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lachance PED, 2004, J NEUROCHEM, V88, P1455, DOI 10.1046/j.1471-4159.2003.02274.x; Lein ES, 2000, J NEUROSCI, V20, P1470; MartinezRodriguez R, 1997, J BRAIN RES, V38, P61; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Mize RR, 2000, BRAIN RES, V886, P15, DOI 10.1016/S0006-8993(00)02750-5; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Mower GD, 2002, MOL BRAIN RES, V105, P157, DOI 10.1016/S0169-328X(02)00405-9; Nagano T, 2000, J NEUROCHEM, V75, P1, DOI 10.1046/j.1471-4159.2000.0750001.x; Ossipow V, 2004, MOL CELL NEUROSCI, V27, P70, DOI 10.1016/j.mcn.2004.05.003; Ozawa H, 1995, CELL STRUCT FUNCT, V20, P415, DOI 10.1247/csf.20.415; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Prasad SS, 2002, NEUROSCIENCE, V111, P35, DOI 10.1016/S0306-4522(01)00570-X; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Sgambato V, 1998, J NEUROSCI, V18, P8814; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000	50	124	124	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					650	659		10.1038/nn1674	http://dx.doi.org/10.1038/nn1674			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16582906				2022-12-17	WOS:000237417200016
J	Zhu, HT; Hummel, T; Clemens, JC; Berdnik, D; Zipursky, SL; Luo, LQ				Zhu, HT; Hummel, T; Clemens, JC; Berdnik, D; Zipursky, SL; Luo, LQ			Dendritic patterning by Dscam and synaptic partner matching in the Drosophila antennal lobe	NATURE NEUROSCIENCE			English	Article							OLFACTORY PROJECTION NEURONS; ODORANT RECEPTORS; AXON GUIDANCE; WIRING SPECIFICITY; SENSORY MAP; FLY BRAIN; REPRESENTATION; CONNECTIONS; EXPRESSION; GLOMERULI	In the olfactory system of Drosophila melanogaster, axons of olfactory receptor neurons (ORNs) and dendrites of second-order projection neurons typically target 1 of similar to 50 glomeruli. Dscam, an immunoglobulin superfamily protein, acts in ORNs to regulate axon targeting. Here we show that Dscam acts in projection neurons and local interneurons to control the elaboration of dendritic fields. The removal of Dscam selectively from projection neurons or local interneurons led to clumped dendrites and marked reduction in their dendritic field size. Overexpression of Dscam in projection neurons caused dendrites to be more diffuse during development and shifted their relative position in adulthood. Notably, the positional shift of projection neuron dendrites caused a corresponding shift of its partner ORN axons, thus maintaining the connection specificity. This observation provides evidence for a pre- and postsynaptic matching mechanism independent of precise glomerular positioning.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lzipursky@mednet.ucla.edu; lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264; Zipursky, Stephen/0000-0001-5630-7181	NIDCD NIH HHS [R01-DC005982, R01-DC006485] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006485, R01DC005982] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; COUTO A, 2005, CURR BIOL; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	34	124	127	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					349	355		10.1038/nn1652	http://dx.doi.org/10.1038/nn1652			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474389				2022-12-17	WOS:000235645600014
J	Hawkey, DJC; Amitay, S; Moore, DR				Hawkey, DJC; Amitay, S; Moore, DR			Early and rapid perceptual learning	NATURE NEUROSCIENCE			English	Article							FREQUENCY DISCRIMINATION; IMPAIRED CHILDREN; PLASTICITY; PATTERNS	Major, rapid performance improvements in perceptual training are often dismissed as `task' or `procedural' learning because they are fast and generalize within a task. We assessed the contributions of perceptual and procedural learning to improvement in an auditory tone frequency learning task in humans and found that perceptual learning accounted for between 76% and 98% of the rapid early performance improvement.	MRC, Inst Hearing Res, Nottingham NG7 2RD, England		Amitay, S (corresponding author), MRC, Inst Hearing Res, Univ Pk, Nottingham NG7 2RD, England.	sygal@ihr.mrc.ac.uk	Amitay, Sygal/D-7323-2012	Amitay, Sygal/0000-0001-9482-3435				Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Delhommeau K, 2002, PERCEPT PSYCHOPHYS, V64, P426, DOI 10.3758/BF03194715; Demany L, 2002, J ACOUST SOC AM, V111, P1377, DOI 10.1121/1.1445791; DEMANY L, 1985, J ACOUST SOC AM, V78, P1118, DOI 10.1121/1.393034; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Gottselig JM, 2004, LEARN MEMORY, V11, P162, DOI 10.1101/lm.63304; Irvine DRF, 2000, J ACOUST SOC AM, V108, P2964, DOI 10.1121/1.1323465; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kujala T, 2001, P NATL ACAD SCI USA, V98, P10509, DOI 10.1073/pnas.181589198; LEEK MR, 1988, PERCEPT PSYCHOPHYS, V43, P389, DOI 10.3758/BF03208810; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; RECANZONE GH, 1993, J NEUROSCI, V13, P87; ROBINSON K, 1996, EAR HEARING, V17, P51; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Wright BA, 2001, P NATL ACAD SCI USA, V98, P12307, DOI 10.1073/pnas.211220498	15	124	132	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1055	1056		10.1038/nn1315	http://dx.doi.org/10.1038/nn1315			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15361880				2022-12-17	WOS:000224156900013
J	Bazhenov, M; Timofeev, I; Steriade, M; Sejnowski, TJ				Bazhenov, M; Timofeev, I; Steriade, M; Sejnowski, TJ			Self-sustained rhythmic activity in the thalamic reticular nucleus mediated by depolarizing GABA(A) receptor potentials	NATURE NEUROSCIENCE			English	Article							PIG HIPPOCAMPAL SLICE; IN-VITRO; THALAMOCORTICAL OSCILLATIONS; SPINDLE RHYTHMICITY; IONIC MECHANISMS; AFTER-DISCHARGES; RELAY NEURONS; CURRENTS; MODEL; CAT	Intracellular recordings from reticular thalamic (RE) neurons in vivo revealed inhibitory postsynaptic potentials (IPSPs) between RE cells that reversed and became depolarizing at the hyperpolarized membrane potentials that occur during sleep. These excitatory IPSPs can directly trigger low-threshold spikes (LTSs). The oscillatory mechanisms underlying IPSP-triggered LTSs crowned by spike bursts were investigated in models of isolated RE networks. In a one-dimensional network model, external stimulation evoked waves of excitation propagating at a constant velocity of 25-150 cells per second. In a large-scale, two-dimensional model of the reticular nucleus, the network showed transient or self-sustained oscillations controlled by the maximum conductance of the low-threshold calcium current and the membrane potential. This model predicts that the isolated reticular nucleus could initiate sequences of spindle oscillations in thalamocortical networks in vivo.	Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA; Univ Laval, Sch Med, Neurophysiol Lab, Quebec City, PQ G1K 7P4, Canada; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; Laval University; University of California System; University of California San Diego	Bazhenov, M (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bazhenov@salk.edu	Timofeev, Igor/AAP-7529-2021; Sejnowski, Terrence/AAV-5558-2021; Timofeev, Igor/E-8828-2012	Timofeev, Igor/0000-0002-1389-5857				Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0; Bazhenov M, 1998, J NEUROPHYSIOL, V79, P2730, DOI 10.1152/jn.1998.79.5.2730; BAZHENOV M, 1994, PHYSICA D, V73, P318, DOI 10.1016/0167-2789(94)90103-1; Budde T, 1997, J PHYSIOL-LONDON, V503, P79, DOI 10.1111/j.1469-7793.1997.079bi.x; CONTRERAS D, 1993, J PHYSIOL-LONDON, V470, P273, DOI 10.1113/jphysiol.1993.sp019858; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; CONTRERAS D, 1995, J NEUROSCI, V15, P604; COULLET P, 1989, PHYS REV LETT, V62, P1619, DOI 10.1103/PhysRevLett.62.1619; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Destexhe A, 1996, J NEUROSCI, V16, P169; DESTEXHE A, 1994, J NEUROPHYSIOL, V72, P803, DOI 10.1152/jn.1994.72.2.803; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; DOMICH L, 1986, J PHYSIOL-LONDON, V379, P429, DOI 10.1113/jphysiol.1986.sp016262; Golomb D, 1998, J NEUROPHYSIOL, V79, P1; GOLOMB D, 1994, J NEUROPHYSIOL, V72, P1109, DOI 10.1152/jn.1994.72.3.1109; Golomb D, 1997, J NEUROPHYSIOL, V78, P1199, DOI 10.1152/jn.1997.78.3.1199; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Luthi A, 1998, J NEUROPHYSIOL, V79, P3284, DOI 10.1152/jn.1998.79.6.3284; MICHELSON HB, 1991, SCIENCE, V253, P1420, DOI 10.1126/science.1654594; MICHELSON HB, 1994, J PHYSIOL-LONDON, V477, P35, DOI 10.1113/jphysiol.1994.sp020169; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; QIAN N, 1990, P NATL ACAD SCI USA, V87, P8145, DOI 10.1073/pnas.87.20.8145; Rinzel J, 1998, SCIENCE, V279, P1351, DOI 10.1126/science.279.5355.1351; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; STERIADE M, 1985, J NEUROPHYSIOL, V54, P1473, DOI 10.1152/jn.1985.54.6.1473; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 1997, THALAMUS ORG FUNCTIO; Steriade M, 1990, THALAMIC OSCILLATION; Timofeev I, 1998, J NEUROPHYSIOL, V79, P2716, DOI 10.1152/jn.1998.79.5.2716; Timofeev I, 1996, J NEUROPHYSIOL, V76, P4152, DOI 10.1152/jn.1996.76.6.4152; Traub R.D., 1991, NEURONAL NETWORKS HI; TRAUB RD, 1993, J PHYSIOL-LONDON, V472, P267, DOI 10.1113/jphysiol.1993.sp019946; TRAUB RD, 1993, J PHYSIOL-LONDON, V461, P525, DOI 10.1113/jphysiol.1993.sp019527; Ulrich D, 1996, P NATL ACAD SCI USA, V93, P13245, DOI 10.1073/pnas.93.23.13245; Ulrich D, 1997, J NEUROSCI, V17, P2348; Ulrich D, 1997, J NEUROPHYSIOL, V78, P1748, DOI 10.1152/jn.1997.78.3.1748; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; WINFREE AT, 1987, WHEN TIME BREAKS DOW; Zhang SLJ, 1997, J NEUROPHYSIOL, V78, P2280, DOI 10.1152/jn.1997.78.5.2280	43	124	125	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					168	174		10.1038/5729	http://dx.doi.org/10.1038/5729			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195202				2022-12-17	WOS:000078231600017
J	Huang, J; Polgar, E; Solinski, HJ; Mishra, SK; Tseng, PY; Iwagaki, N; Boyle, KA; Dickie, AC; Kriegbaum, MC; Wildner, H; Zeilhofer, HU; Watanabe, M; Riddell, JS; Todd, AJ; Hoon, MA				Huang, Jing; Polgar, Erika; Solinski, Hans Jurgen; Mishra, Santosh K.; Tseng, Pang-Yen; Iwagaki, Noboru; Boyle, Kieran A.; Dickie, Allen C.; Kriegbaum, Mette C.; Wildner, Hendrik; Zeilhofer, Hanns Ulrich; Watanabe, Masahiko; Riddell, John S.; Todd, Andrew J.; Hoon, Mark A.			Circuit dissection of the role of somatostatin in itch and pain	NATURE NEUROSCIENCE			English	Article							GASTRIN-RELEASING-PEPTIDE; DORSAL-HORN; SPINAL-CORD; EXCITATORY INTERNEURONS; INHIBITORY INTERNEURONS; GABAERGIC NEURONS; PRIMARY AFFERENT; SUBSTANCE-P; POPULATIONS; PROTEIN	Stimuli that elicit itch are detected by sensory neurons that innervate the skin. This information is processed by the spinal cord; however, the way in which this occurs is still poorly understood. Here we investigated the neuronal pathways for itch neurotransmission, particularly the contribution of the neuropeptide somatostatin. We find that in the periphery, somatostatin is exclusively expressed in Nppb(+) neurons, and we demonstrate that Nppb(+) somatostatin(+) cells function as pruriceptors. Employing chemogenetics, pharmacology and cell-specific ablation methods, we demonstrate that somatostatin potentiates itch by inhibiting inhibitory dynorphin neurons, which results in disinhibition of GRPR(+) neurons. Furthermore, elimination of somatostatin from primary afferents and/or from spinal interneurons demonstrates differential involvement of the peptide released from these sources in itch and pain. Our results define the neural circuit underlying somatostatin-induced itch and characterize a contrasting antinociceptive role for the peptide.	[Huang, Jing; Solinski, Hans Jurgen; Mishra, Santosh K.; Tseng, Pang-Yen; Kriegbaum, Mette C.; Hoon, Mark A.] Natl Inst Dent & Craniofacial Res, Mol Genet Unit, Lab Sensory Biol, NIH, Bethesda, MD 20892 USA; [Polgar, Erika; Iwagaki, Noboru; Boyle, Kieran A.; Dickie, Allen C.; Riddell, John S.; Todd, Andrew J.] Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Wildner, Hendrik; Zeilhofer, Hanns Ulrich] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Wildner, Hendrik; Zeilhofer, Hanns Ulrich] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Watanabe, Masahiko] Hokkaido Univ, Dept Anat, Sch Med, Sapporo, Hokkaido, Japan; [Huang, Jing] Fourth Mil Med Univ, Dept Anat Histol & Embryol, KK Leung Brain Res Ctr, Xian, Shaanxi, Peoples R China; [Mishra, Santosh K.] North Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA; [Mishra, Santosh K.] North Carolina State Univ, Comparat Med Inst, Raleigh, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Glasgow; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Hokkaido University; Air Force Military Medical University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Hoon, MA (corresponding author), Natl Inst Dent & Craniofacial Res, Mol Genet Unit, Lab Sensory Biol, NIH, Bethesda, MD 20892 USA.; Todd, AJ (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	andrew.todd@glasgow.ac.uk; mark.hoon@nih.gov	WATANABE, Masahiko/A-4055-2012; Todd, Andrew J/A-6855-2011; Watanabe, Masahiko/S-3614-2019; Zeilhofer, Hanns Ulrich/A-4600-2008; Core, Vector/CAF-4832-2022; TSENG, PANG-YEN/B-3218-2013; Mishra, Santosh/S-7516-2017; Mishra, Santosh/AAP-4977-2020	WATANABE, Masahiko/0000-0001-5037-7138; Todd, Andrew J/0000-0002-3007-6749; Watanabe, Masahiko/0000-0001-5037-7138; Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Mishra, Santosh/0000-0001-8616-2606; Dickie, Allen/0000-0002-6339-2801; Riddell, John/0000-0001-6366-6545	National Institute of Dental and Craniofacial Research (NIDCR)-National Institutes of Health (MAH); Medical Research Council [MR/L003430/1]; Biotechnology and Biological Sciences Research Council [N006119]; Wellcome Trust [102645]; Swiss National Science Foundation [156393]; Natural Science Foundation of China [31671247]; National Center for Research Resources (NCRR)-NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000721] Funding Source: NIH RePORTER; BBSRC [BB/N006119/1] Funding Source: UKRI; MRC [MR/L003430/1, MR/N003403/1] Funding Source: UKRI	National Institute of Dental and Craniofacial Research (NIDCR)-National Institutes of Health (MAH); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for Research Resources (NCRR)-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the NIDCR Gene targeting facility for help generating chimeric Sst<SUP>f/f</SUP> mice. We also thank C. Birchmeier, Max Delbruck Center, Berlin; M. Krashes, NIH, Bethesda; and Q. Ma, Dana-Faber Cancer Institute, Boston, for generously providing mice. We are very grateful to T. Furuta, Kyoto University, Kyoto, for the gift of PPD antibody, to A. Bell and D. Hughes for comments on the manuscript, to X. Gu for help in some of the experiments and to R. Kerr and C. Watt for expert technical help. This work was supported by the intramural research program of the National Institute of Dental and Craniofacial Research (NIDCR)-National Institutes of Health (MAH) and grants from the Medical Research Council (MR/L003430/1), the Biotechnology and Biological Sciences Research Council (grant N006119), the Wellcome Trust (102645)(A.J.T.), the Swiss National Science Foundation (156393) (H.U.Z.) and the Natural Science Foundation of China (31671247) (J.H.). The Sst<SUP>f/f</SUP> mice used in this study were generated from ES cells obtained from the National Center for Research Resources (NCRR)-NIH-supported KOMP repository and engineered by the Welcome Trust Sanger Institute and the Mouse Biology Program.	Abraira VE, 2017, CELL, V168, P295, DOI 10.1016/j.cell.2016.12.010; Akiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022665; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bautista DM, 2014, NAT NEUROSCI, V17, P175, DOI 10.1038/nn.3619; Bell AM, 2016, MOL PAIN, V12, DOI 10.1177/1744806916649602; Bencivinni I, 2011, EUR J PAIN, V15, P591, DOI 10.1016/j.ejpain.2010.11.001; Boyle KA, 2017, NEUROSCIENCE, V363, P120, DOI 10.1016/j.neuroscience.2017.08.044; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; Brohl D, 2008, DEV BIOL, V322, P381, DOI 10.1016/j.ydbio.2008.08.002; Carlton SA, 2004, PAIN, V110, P616, DOI 10.1016/j.pain.2004.04.042; Carlton SM, 2001, J NEUROSCI, V21, P4042, DOI 10.1523/JNEUROSCI.21-11-04042.2001; Cevikbas F, 2017, J ALLERGY CLIN IMMUN, V140, P454, DOI 10.1016/j.jaci.2017.02.001; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHAPMAN V, 1992, NEUROPEPTIDES, V23, P147, DOI 10.1016/0143-4179(92)90115-D; Chiu IM, 2014, ELIFE, V3, DOI 10.7554/eLife.04660; Christensen AJ, 2016, CELL REP, V17, P1699, DOI 10.1016/j.celrep.2016.10.010; CHRUBASIK J, 1984, LANCET, V2, P1208; Cui L, 2016, NEURON, V91, P1413, DOI 10.1016/j.neuron.2016.09.010; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; Duan B, 2014, CELL, V159, P1417, DOI 10.1016/j.cell.2014.11.003; Foster E, 2015, NEURON, V85, P1289, DOI 10.1016/j.neuron.2015.02.028; Gutierrez-Mecinas M, 2016, MOL PAIN, V12, DOI 10.1177/1744806916629065; Gutierrez-Mecinas M, 2017, PAIN, V158, P440, DOI 10.1097/j.pain.0000000000000778; Gutierrez-Mecinas M, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-79; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; HOKFELT T, 1976, NEUROSCIENCE, V1, P131, DOI 10.1016/0306-4522(76)90008-7; HOKFELT T, 1991, NEURON, V7, P867, DOI 10.1016/0896-6273(91)90333-U; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Kardon AP, 2014, NEURON, V82, P573, DOI 10.1016/j.neuron.2014.02.046; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Le Pichon CE, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00021; Lee T, 1997, J COMP NEUROL, V386, P229, DOI 10.1002/(SICI)1096-9861(19970922)386:2<229::AID-CNE5>3.0.CO;2-3; Li CL, 2016, CELL RES, V26, P83, DOI 10.1038/cr.2015.149; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Lu Y, 2013, J CLIN INVEST, V123, P4050, DOI 10.1172/JCI70026; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Mishra SK, 2012, J NEUROSCI, V32, P8686, DOI 10.1523/JNEUROSCI.1533-12.2012; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nguyen MQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185543; Peirs C, 2015, NEURON, V87, P797, DOI 10.1016/j.neuron.2015.07.029; Petitjean H, 2015, CELL REP, V13, P1246, DOI 10.1016/j.celrep.2015.09.080; Polgar E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078309; PROUDLOCK F, 1993, J COMP NEUROL, V327, P289, DOI 10.1002/cne.903270210; Roberson DP, 2013, NAT NEUROSCI, V16, P910, DOI 10.1038/nn.3404; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; SEYBOLD VS, 1982, PEPTIDES, V3, P49, DOI 10.1016/0196-9781(82)90141-3; SIMMONS DR, 1995, NEUROSCI LETT, V187, P119, DOI 10.1016/0304-3940(95)11358-4; Solorzano C, 2015, J NEUROSCI, V35, P648, DOI 10.1523/JNEUROSCI.2955-14.2015; Stantcheva KK, 2016, EMBO REP, V17, P585, DOI 10.15252/embr.201540983; Sun SH, 2017, NEURON, V93, P840, DOI 10.1016/j.neuron.2017.01.012; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; TAURA P, 1994, PAIN, V59, P135, DOI 10.1016/0304-3959(94)90057-4; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; WIESENFELDHALLIN Z, 1985, NEUROSCI LETT, V62, P69, DOI 10.1016/0304-3940(85)90286-1; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008; Zeyda T, 2001, BRAIN RES, V906, P107, DOI 10.1016/S0006-8993(01)02563-X	65	123	124	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2018	21	5					707	+		10.1038/s41593-018-0119-z	http://dx.doi.org/10.1038/s41593-018-0119-z			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GE4EB	29556030	Green Accepted			2022-12-17	WOS:000431166100010
J	Mor, DE; Tsika, E; Mazzulli, JR; Gould, NS; Kim, H; Daniels, MJ; Doshi, S; Gupta, P; Grossman, JL; Tan, VX; Kalb, RG; Caldwell, KA; Caldwell, GA; Wolfe, JH; Ischiropoulos, H				Mor, Danielle E.; Tsika, Elpida; Mazzulli, Joseph R.; Gould, Neal S.; Kim, Hanna; Daniels, Malcolm J.; Doshi, Shachee; Gupta, Preetika; Grossman, Jennifer L.; Tan, Victor X.; Kalb, Robert G.; Caldwell, Kim A.; Caldwell, Guy A.; Wolfe, John H.; Ischiropoulos, Harry			Dopamine induces soluble alpha-synuclein oligomers and nigrostriatal degeneration	NATURE NEUROSCIENCE			English	Article							SUBSTANTIA-NIGRA NEURONS; PARKINSONS-DISEASE; CAENORHABDITIS-ELEGANS; OXIDATIVE DAMAGE; LEWY BODIES; IN-VIVO; NEURODEGENERATION; MICE; MUTATION; PROTEIN	Parkinson's disease (PD) is defined by the loss of dopaminergic neurons in the substantia nigra and the formation of Lewy body inclusions containing aggregated alpha-synuclein. Efforts to explain dopamine neuron vulnerability are hindered by the lack of dopaminergic cell death in a-synuclein transgenic mice. To address this, we manipulated both dopamine levels and alpha-synuclein expression. Nigrally targeted expression of mutant tyrosine hydroxylase with enhanced catalytic activity increased dopamine levels without damaging neurons in non-transgenic mice. In contrast, raising dopamine levels in mice expressing human A53T mutant alpha-synuclein induced progressive nigrostriatal degeneration and reduced locomotion. Dopamine elevation in A53T mice increased levels of potentially toxic alpha-synuclein oligomers, resulting in conformationally and functionally modified species. Moreover, in genetically tractable Caenorhabditis elegans models, expression of alpha-synuclein mutated at the site of interaction with dopamine prevented dopamine-induced toxicity. These data suggest that a unique mechanism links two cardinal features of PD: dopaminergic cell death and alpha-synuclein aggregation.	[Mor, Danielle E.; Doshi, Shachee; Gupta, Preetika; Kalb, Robert G.; Wolfe, John H.; Ischiropoulos, Harry] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Tsika, Elpida] Ecole Polytech Fed Lausanne, AC Immune SA, Innovat Pk, Lausanne, Switzerland; [Mazzulli, Joseph R.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Gould, Neal S.; Kalb, Robert G.; Wolfe, John H.; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Kim, Hanna; Caldwell, Kim A.; Caldwell, Guy A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Daniels, Malcolm J.; Ischiropoulos, Harry] Univ Penn, Pharmacol Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA; [Grossman, Jennifer L.] State Univ New York Downstate Coll Med, Brooklyn, NY USA; [Tan, Victor X.] Univ Penn, Coll Arts & Sci, Philadelphia, PA 19104 USA; [Wolfe, John H.] Univ Penn, Sch Vet Med, WF Goodman Ctr Comparat Med Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Northwestern University; Feinberg School of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Alabama System; University of Alabama Tuscaloosa; University of Pennsylvania; Pennsylvania Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Pennsylvania; University of Pennsylvania	Ischiropoulos, H (corresponding author), Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA.; Ischiropoulos, H (corresponding author), Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA.; Ischiropoulos, H (corresponding author), Univ Penn, Pharmacol Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA.	ischirop@mail.med.upenn.edu	Mazzulli, joseph/AAS-4480-2020	Mor, Danielle/0000-0003-3851-5010; Caldwell, Guy/0000-0002-8283-9090; Wolfe, John H./0000-0002-7497-3943; Caldwell, Kim/0000-0003-1580-6122; Tsika, Elpida/0000-0003-4189-4234; Kim, Hanna/0000-0003-1362-371X	US National Institutes of Health [AG013966, NS038690, NS087077, NS052325]; US National Institutes of Health Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship [NS087779]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092823, F31NS087779, R21NS087077, R01NS038690, R01NS052325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013966] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. Clarke and T. Pierson from the Wolfe lab for technical assistance with animals and for helpful advice on vector production. We thank H. Bennett from the Kalb lab for initial work on the dopamine neuron degeneration assay in C. elegans and input on worm breeding. We thank L. Spruce, H. Fazelinia and S. Seeholzer from the Children's Hospital of Philadelphia Proteomic Core facility for mass spectrometry. We thank V. Lee (University of Pennsylvania) and G. Miller (Emory University) for generously providing a-synuclein and VMAT2 antibodies, respectively, and S. Przedborski (Columbia University) for the use of stereology equipment and helpful feedback on the manuscript. Finally, we thank R. Lightfoot and members of the Ischiropoulos lab for productive discussions and technical support. This work was supported by grants from the US National Institutes of Health: AG013966 (H. I.), NS038690 (J.H.W.) and NS087077 and NS052325 (R. G. K.). D.E.M. was supported by the US National Institutes of Health Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship NS087779. The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Baba M, 1998, AM J PATHOL, V152, P879; Berkowitz Laura A, 2008, J Vis Exp, DOI 10.3791/833; BRENNER S, 1974, GENETICS, V77, P71; Brichta L, 2015, NAT NEUROSCI, V18, P1325, DOI 10.1038/nn.4070; Cao PX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009312; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Choi BK, 2013, P NATL ACAD SCI USA, V110, P4087, DOI 10.1073/pnas.1218424110; Colebrooke RE, 2006, EUR J NEUROSCI, V24, P2622, DOI 10.1111/j.1460-9568.2006.05143.x; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Eales KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5701; EHRINGER H, 1960, KLIN WOCHENSCHR, V38, P1236, DOI 10.1007/BF01485901; Fahn S, 2004, NEW ENGL J MED, V351, P2498; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; Herrera FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003394; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Khasnavis S, 2013, J BIOL CHEM, V288, P20843, DOI 10.1074/jbc.M112.443556; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Lohr KM, 2014, P NATL ACAD SCI USA, V111, P9977, DOI 10.1073/pnas.1402134111; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; Mazzulli JR, 2016, ANAL CHEM, V88, P2399, DOI 10.1021/acs.analchem.5b04420; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nakashima A, 2002, J NEUROCHEM, V82, P202, DOI 10.1046/j.1471-4159.2002.00921.x; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Olanow CW, 2015, MOVEMENT DISORD, V30, P37, DOI 10.1002/mds.26119; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Qian Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140974; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093999; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Waxman EA, 2008, ACTA NEUROPATHOL, V116, P37, DOI 10.1007/s00401-008-0375-1; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5	63	123	127	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2017	20	11					1560	+		10.1038/nn.4641	http://dx.doi.org/10.1038/nn.4641			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL0QV	28920936	Green Accepted			2022-12-17	WOS:000413916800017
J	Holtmaat, A; Caroni, P				Holtmaat, Anthony; Caroni, Pico			Functional and structural underpinnings of neuronal assembly formation in learning	NATURE NEUROSCIENCE			English	Review							LONG-TERM-MEMORY; PRIMARY SOMATOSENSORY CORTEX; DENDRITIC SPINES; SYNAPTIC PLASTICITY; HIPPOCAMPAL REPLAY; MOTOR CORTEX; DISINHIBITORY MICROCIRCUIT; DEPENDENT PLASTICITY; INHIBITORY SYNAPSES; GENE-EXPRESSION	Learning and memory are associated with the formation and modification of neuronal assemblies: populations of neurons that encode what has been learned and mediate memory retrieval upon recall. Functional studies of neuronal assemblies have progressed dramatically thanks to recent technological advances. Here we discuss how a focus on assembly formation and consolidation has provided a powerful conceptual framework to relate mechanistic studies of synaptic and circuit plasticity to behaviorally relevant aspects of learning and memory. Neurons are likely recruited to particular learning-related assemblies as a function of their relative excitabilities and synaptic activation, followed by selective strengthening of pre-existing synapses, formation of new connections and elimination of outcompeted synapses to ensure memory formation. Mechanistically, these processes involve linking transcription to circuit modification. They include the expression of immediate early genes and specific molecular and cellular events, supported by network-wide activities that are shaped and modulated by local inhibitory microcircuits.	[Holtmaat, Anthony] Univ Geneva, Dept Basic Neurosci, Geneva Neurosci Ctr, Fac Med, Geneva, Switzerland; [Caroni, Pico] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	University of Geneva; Friedrich Miescher Institute for Biomedical Research	Holtmaat, A (corresponding author), Univ Geneva, Dept Basic Neurosci, Geneva Neurosci Ctr, Fac Med, Geneva, Switzerland.; Caroni, P (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	anthony.holtmaat@unige.ch; pico.caroni@fmi.ch		Holtmaat, Anthony/0000-0002-7577-0769	National Centre of Competence in Research (NCCR) SYNAPSY; Swiss National Science Foundation [51AU40_125759, 31003A_153448]; International Foundation for Research on Paraplegia; Hans Wilsdorf Foundation	National Centre of Competence in Research (NCCR) SYNAPSY(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); International Foundation for Research on Paraplegia; Hans Wilsdorf Foundation	We thank S. Arber, H. Kessels and K. Zito for their input and comments on the manuscript. Our work is financially supported by the National Centre of Competence in Research (NCCR) SYNAPSY and financed by the Swiss National Science Foundation (51AU40_125759, A.H., P.C.), a Swiss National Science Foundation project grant (31003A_153448, A.H.), the International Foundation for Research on Paraplegia (A.H.) and the Hans Wilsdorf Foundation (A.H.).	Attardo A, 2015, NATURE, V523, P592, DOI 10.1038/nature14467; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Bendor D, 2012, NAT NEUROSCI, V15, P1439, DOI 10.1038/nn.3203; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; Braitenberg VB, 1998, CORTEX STAT GEOMETRY; Brandalise F, 2014, P NATL ACAD SCI USA, V111, P4303, DOI 10.1073/pnas.1317667111; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Cane M, 2014, J NEUROSCI, V34, P2075, DOI 10.1523/JNEUROSCI.3353-13.2014; Caroni P, 2014, TRENDS NEUROSCI, V37, P604, DOI 10.1016/j.tins.2014.08.011; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Chen JL, 2015, NAT NEUROSCI, V18, P1101, DOI 10.1038/nn.4046; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Chen SX, 2015, NAT NEUROSCI, V18, P1109, DOI 10.1038/nn.4049; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Cichon J, 2015, NATURE, V520, P180, DOI 10.1038/nature14251; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; David C, 2007, EUR J NEUROSCI, V25, P2329, DOI 10.1111/j.1460-9568.2007.05496.x; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; de Lavilleon G, 2015, NAT NEUROSCI, V18, P493, DOI 10.1038/nn.3970; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DeFelipe J, 2012, FRONT NEUROANAT, V6, DOI [10.3389/fnana.2012.00022, 10.3389/fnana.2012.00005, 10.3389/fnsyn.2012.00002]; Donato F, 2015, NEURON, V85, P770, DOI 10.1016/j.neuron.2015.01.011; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dragoi G, 2013, P NATL ACAD SCI USA, V110, P9100, DOI 10.1073/pnas.1306031110; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Dudai Y, 2013, NEURON, V80, P742, DOI 10.1016/j.neuron.2013.09.039; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Fu Y, 2015, ELIFE, V4, DOI 10.7554/eLife.05558; Gambino F, 2014, NATURE, V515, P116, DOI 10.1038/nature13664; Gambino F, 2012, NEURON, V75, P490, DOI 10.1016/j.neuron.2012.05.020; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Gdalyahu A, 2012, NEURON, V75, P121, DOI 10.1016/j.neuron.2012.04.035; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Gore F, 2015, CELL, V162, P134, DOI 10.1016/j.cell.2015.06.027; Grillo FW, 2013, P NATL ACAD SCI USA, V110, pE1514, DOI 10.1073/pnas.1218731110; Grosmark AD, 2016, SCIENCE, V351, P1440, DOI 10.1126/science.aad1935; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hangya B, 2015, CELL, V162, P1155, DOI 10.1016/j.cell.2015.07.057; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hayashi-Takagi A, 2015, NATURE, V525, P333, DOI 10.1038/nature15257; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hill TC, 2013, J NEUROSCI, V33, P678, DOI 10.1523/JNEUROSCI.1404-12.2013; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hsiang HL, 2014, J NEUROSCI, V34, P14115, DOI 10.1523/JNEUROSCI.3327-14.2014; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Hubener M, 2010, NEURON, V67, P363, DOI 10.1016/j.neuron.2010.06.033; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Joachimsthaler B, 2015, J NEUROSCI, V35, P3772, DOI 10.1523/JNEUROSCI.2043-14.2015; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Karunakaran S, 2016, NAT NEUROSCI, V19, P454, DOI 10.1038/nn.4231; Kastellakis G, 2015, PROG NEUROBIOL, V126, P19, DOI 10.1016/j.pneurobio.2014.12.002; Katche C, 2013, NEUROBIOL LEARN MEM, V106, P40, DOI 10.1016/j.nlm.2013.06.018; Katche C, 2010, P NATL ACAD SCI USA, V107, P349, DOI 10.1073/pnas.0912931107; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kim J, 2014, NAT NEUROSCI, V17, P65, DOI 10.1038/nn.3592; Klinshov VV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094292; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Kuhlman SJ, 2014, J NEUROSCI, V34, P6078, DOI 10.1523/JNEUROSCI.4919-12.2014; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lisman J, 2001, NATURE, V411, P248, DOI 10.1038/35077185; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Ma L, 2016, DEV NEUROBIOL, V76, P277, DOI 10.1002/dneu.22313; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Makino H, 2015, NAT NEUROSCI, V18, P1116, DOI 10.1038/nn.4061; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Mayrhofer JM, 2015, NEUROIMAGE, V115, P52, DOI 10.1016/j.neuroimage.2015.04.045; Middei S, 2012, LEARN MEMORY, V19, P330, DOI 10.1101/lm.025817.112; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; Moczulska KE, 2013, P NATL ACAD SCI USA, V110, P18315, DOI 10.1073/pnas.1312508110; Mostany R, 2013, J NEUROSCI, V33, P4094, DOI 10.1523/JNEUROSCI.4825-12.2013; Munoz-Cuevas FJ, 2013, NAT NEUROSCI, V16, P1367, DOI 10.1038/nn.3498; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Nakayama D, 2015, J NEUROSCI, V35, P819, DOI 10.1523/JNEUROSCI.2525-14.2015; Nomura H, 2012, NEUROIMAGE, V60, P153, DOI 10.1016/j.neuroimage.2011.12.022; Nonaka A, 2014, J NEUROSCI, V34, P9305, DOI 10.1523/JNEUROSCI.4233-13.2014; Oh WC, 2015, CELL REP, V10, P162, DOI 10.1016/j.celrep.2014.12.016; Oh WC, 2013, P NATL ACAD SCI USA, V110, pE305, DOI 10.1073/pnas.1214705110; Ohkawa N, 2015, CELL REP, V11, P261, DOI 10.1016/j.celrep.2015.03.017; Onoue K, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-30; Palm G, 2014, BIOL CYBERN, V108, P559, DOI 10.1007/s00422-014-0596-4; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Pfeiffer BE, 2015, SCIENCE, V349, P180, DOI 10.1126/science.aaa9633; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Poort J, 2015, NEURON, V86, P1478, DOI 10.1016/j.neuron.2015.05.037; Quiroga RQ, 2012, NAT REV NEUROSCI, V13, P587, DOI 10.1038/nrn3251; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Rich PD, 2014, SCIENCE, V345, P814, DOI 10.1126/science.1255635; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Rogerson T, 2014, NAT REV NEUROSCI, V15, P157, DOI 10.1038/nrn3667; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Ryan TJ, 2015, SCIENCE, V348, P1007, DOI 10.1126/science.aaa5542; Sanders J, 2012, J NEUROSCI, V32, P12570, DOI 10.1523/JNEUROSCI.1131-12.2012; Sargin D, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00209; SCHACTER DL, 1978, J VERB LEARN VERB BE, V17, P721, DOI 10.1016/S0022-5371(78)90443-7; Schubert V, 2013, J NEUROSCI, V33, P9474, DOI 10.1523/JNEUROSCI.1032-13.2013; Shao YR, 2013, NEURON, V80, P210, DOI 10.1016/j.neuron.2013.07.026; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Silva D, 2015, NAT NEUROSCI, V18, P1772, DOI 10.1038/nn.4151; Singer AC, 2013, NEURON, V77, P1163, DOI 10.1016/j.neuron.2013.01.027; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stark E, 2015, P NATL ACAD SCI USA, V112, P10521, DOI 10.1073/pnas.1508785112; Stefanelli T, 2016, NEURON, V89, P1074, DOI 10.1016/j.neuron.2016.01.024; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; Tanaka KZ, 2014, NEURON, V84, P347, DOI 10.1016/j.neuron.2014.09.037; Thompson LT, 1996, J NEUROPHYSIOL, V76, P1836, DOI 10.1152/jn.1996.76.3.1836; Tonegawa S, 2015, NEURON, V87, P918, DOI 10.1016/j.neuron.2015.08.002; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tschida KA, 2012, NEURON, V73, P1028, DOI 10.1016/j.neuron.2011.12.038; van Rheede JJ, 2015, NEURON, V87, P1050, DOI 10.1016/j.neuron.2015.08.021; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Viosca J, 2009, LEARN MEMORY, V16, P193, DOI 10.1101/lm.1254209; Wiegert JS, 2013, P NATL ACAD SCI USA, V110, pE4510, DOI 10.1073/pnas.1315926110; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Winnubst J, 2015, NEURON, V87, P399, DOI 10.1016/j.neuron.2015.06.029; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2014, SCIENCE, V344, P1173, DOI 10.1126/science.1249098; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yassin L, 2010, NEURON, V68, P1043, DOI 10.1016/j.neuron.2010.11.029; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Zhang Y, 2015, NAT NEUROSCI, V18, P402, DOI 10.1038/nn.3936; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	149	123	124	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2016	19	12					1553	1562		10.1038/nn.4418	http://dx.doi.org/10.1038/nn.4418			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	ED7BY	27749830				2022-12-17	WOS:000389011900013
J	Gandal, MJ; Leppa, V; Won, HJ; Parikshak, NN; Geschwind, DH				Gandal, Michael J.; Leppa, Virpi; Won, Hyejung; Parikshak, Neelroop N.; Geschwind, Daniel H.			The road to precision psychiatry: translating genetics into disease mechanisms	NATURE NEUROSCIENCE			English	Review							GENOME-WIDE ASSOCIATION; AUTISM SPECTRUM DISORDERS; DE-NOVO MUTATIONS; HUMAN BRAIN TRANSCRIPTOME; COPY NUMBER VARIATION; POLYGENIC RISK SCORE; IPSC-DERIVED NEURONS; OF-FUNCTION VARIANTS; SCHIZOPHRENIA RISK; INTELLECTUAL DISABILITY	Hundreds of genetic loci increasing risk for neuropsychiatric disorders have recently been identified. This success, perhaps paradoxically, has posed challenges for therapeutic development, which are amplified by the highly polygenic and pleiotropic nature of these genetic contributions. Success requires understanding the biological impact of single genetic variants and predicting their effects within an individual. Comprehensive functional genomic annotation of risk loci provides a framework for interpretation of neurobiological impact, requiring experimental validation with in vivo or in vitro model systems. Systems-level, integrative pathway analyses are beginning to elucidate the additive, polygenic contributions of risk variants on specific cellular, molecular, developmental, or circuit-level processes. Although most neuropsychiatric disease modeling has focused on genes disrupted by rare, large-effect-size mutations, common smaller-effect-size variants may also provide solid therapeutic targets to inform precision medicine approaches. Here we enumerate the promise and challenges of a genomics-driven approach to uncovering neuropsychiatric disease mechanisms and facilitating therapeutic development.	[Gandal, Michael J.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Dept Psychiat, Los Angeles, CA 90095 USA; [Gandal, Michael J.; Leppa, Virpi; Won, Hyejung; Parikshak, Neelroop N.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Program Neurobehav Genet, Los Angeles, CA 90095 USA; [Gandal, Michael J.; Leppa, Virpi; Won, Hyejung; Parikshak, Neelroop N.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Ctr Autism Res & Treatment,Dept Neurol, Los Angeles, CA 90095 USA; [Gandal, Michael J.; Leppa, Virpi; Won, Hyejung; Parikshak, Neelroop N.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Program Neurobehav Genet, Los Angeles, CA 90095 USA.; Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Ctr Autism Res & Treatment,Dept Neurol, Los Angeles, CA 90095 USA.; Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	dhg@mednet.ucla.edu	Gandal, Michael/AAE-4282-2020	Gandal, Michael/0000-0001-5800-5128; Leppa, Virpi/0000-0003-2942-2656; Parikshak, Neel/0000-0003-2027-1871	US National Institute of Health (NIH) [5R01MH094714, 5P50MH106438, 1R01MH109912, F30MH099886]; Glenn/AFAR Postdoctoral Fellowship [20145357]; Basic Science Research Program through the National Research Foundation of Korea [2013024227]; UCLA Medical Scientist Training Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094714, P50MH106438, R01MH109912, F30MH099886] Funding Source: NIH RePORTER	US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn/AFAR Postdoctoral Fellowship; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); UCLA Medical Scientist Training Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank A. Gordon, L. Perez-Cano, G. Ramaswami, E. Ruzzo, J. Rexach, G. Morris, and members of the Geschwind laboratory for discussions. This work was supported by US National Institute of Health (NIH) grants 5R01MH094714 (D.H.G.), 5P50MH106438 (D.H.G.), 1R01MH109912 (D.H.G.), and F30MH099886 (N.N.P.). This work was also supported by the Glenn/AFAR Postdoctoral Fellowship (20145357, H.W.), Basic Science Research Program through the National Research Foundation of Korea (2013024227, H.W.), and the UCLA Medical Scientist Training Program (N.N.P.). D.H.G. is a scientific advisor to Ovid Pharmaceuticals.	Akbarian S, 2015, NAT NEUROSCI, V18, P1707, DOI 10.1038/nn.4156; Akey JM, 2007, NAT GENET, V39, P807, DOI 10.1038/ng0707-807; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arnedo J, 2015, AM J PSYCHIAT, V172, P139, DOI 10.1176/appi.ajp.2014.14040435; Bakken TE, 2016, NATURE, V535, P367, DOI 10.1038/nature18637; Belgard TG, 2014, MOL PSYCHIATR, V19, P405, DOI 10.1038/mp.2013.34; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Browne HA, 2014, PSYCHIAT CLIN N AM, V37, P319, DOI 10.1016/j.psc.2014.06.002; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bush WS, 2016, NAT REV GENET, V17, P129, DOI 10.1038/nrg.2015.36; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Cook EH, 1997, AM J HUM GENET, V60, P928; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cotsapas C., 2016, NR1H3 P ARG415GIN IS; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; de la Torre-Ubieta L, 2016, NAT MED, V22, P345, DOI 10.1038/nm.4071; de Leeuw CA, 2016, NAT REV GENET, V17, P353, DOI 10.1038/nrg.2016.29; del Rosario RCH, 2015, NAT METHODS, V12, P458, DOI [10.1038/NMETH.3326, 10.1038/nmeth.3326]; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Felix MA, 2015, NAT REV GENET, V16, P483, DOI 10.1038/nrg3949; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Flint J, 2014, TRENDS NEUROSCI, V37, P733, DOI 10.1016/j.tins.2014.08.007; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.01.027, 10.1016/j.neuron.2014.02.033]; Franke B, 2016, NAT NEUROSCI, V19, P420, DOI 10.1038/nn.4228; French L, 2015, JAMA PSYCHIAT, V72, P1002, DOI 10.1001/jamapsychiatry.2015.1131; Fromer M., 2016, GENE EXPRESSION ELUC; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Geschwind DH, 2015, SCIENCE, V349, P1489, DOI 10.1126/science.aaa8954; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Gilman SR, 2012, NAT NEUROSCI, V15, P1723, DOI 10.1038/nn.3261; Goldstein JI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5757; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Hamilton SM, 2014, BEHAV NEUROSCI, V128, P103, DOI 10.1037/a0035988; Hannon E, 2016, NAT NEUROSCI, V19, P48, DOI 10.1038/nn.4182; Hawi Z, 2015, MOL PSYCHIATR, V20, P289, DOI 10.1038/mp.2014.183; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hiroi N, 2013, MOL PSYCHIATR, V18, P1153, DOI 10.1038/mp.2013.92; Hoffman EJ, 2016, NEURON, V89, P725, DOI 10.1016/j.neuron.2015.12.039; Hou LP, 2016, LANCET, V387, P1085, DOI 10.1016/S0140-6736(16)00143-4; Hyman SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003142; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jaffe AE, 2016, NAT NEUROSCI, V19, P40, DOI 10.1038/nn.4181; Jeste SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9874; Kaiser T, 2015, NAT MED, V21, P979, DOI 10.1038/nm.3935; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kendler KS, 2015, AM J PSYCHIAT, V172, P1092, DOI 10.1176/appi.ajp.2015.15010126; Kendler KS, 2013, MOL PSYCHIATR, V18, P1058, DOI 10.1038/mp.2013.50; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kwan KY, 2012, CELL, V149, P899, DOI 10.1016/j.cell.2012.02.060; Lajonchere CM, 2010, NEURON, V68, P187, DOI 10.1016/j.neuron.2010.10.009; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li J, 2016, BRIEF BIOINFORM, V17, P2, DOI 10.1093/bib/bbv020; Li JJ, 2015, CELL SYST, V1, P361, DOI 10.1016/j.cels.2015.11.002; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu Z, 2016, NATURE, V530, P98, DOI 10.1038/nature16533; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Maillard AM, 2015, MOL PSYCHIATR, V20, P140, DOI 10.1038/mp.2014.145; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCarro SA, 2014, NAT NEUROSCI, V17, P756, DOI 10.1038/nn.3716; Mei Y, 2016, NATURE, V530, P481, DOI 10.1038/nature16971; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mutsuddi M, 2006, AM J HUM GENET, V79, P903, DOI 10.1086/508942; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nelson MR, 2016, NAT REV GENET, V17, P197, DOI 10.1038/nrg.2016.12; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Nord AS, 2015, NEURON, V85, P27, DOI 10.1016/j.neuron.2014.11.011; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Pasaniuc B., 2016, DISSECTING GENETICS; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Petersen Ashley, 2011, BMC Proc, V5 Suppl 9, pS48, DOI 10.1186/1753-6561-5-S9-S48; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Plomin R, 2013, PSYCHOL SCI, V24, P562, DOI 10.1177/0956797612457952; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Portmann T, 2014, CELL REP, V7, P1077, DOI 10.1016/j.celrep.2014.03.036; Price AL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1684; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Rastegar-Mojarad M, 2015, NAT BIOTECHNOL, V33, DOI 10.1038/nbt.3183; Reichenberg A, 2016, P NATL ACAD SCI USA, V113, P1098, DOI 10.1073/pnas.1508093112; Ridge PG, 2016, NEUROBIOL AGING, V41, DOI 10.1016/j.neurobiolaging.2016.02.024; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Roussos P, 2014, CELL REP, V9, P1417, DOI 10.1016/j.celrep.2014.10.015; Ruderfer DM, 2014, MOL PSYCHIATR, V19, P1017, DOI 10.1038/mp.2013.138; Ruderfer DM, 2016, LANCET PSYCHIAT, V3, P350, DOI 10.1016/S2215-0366(15)00553-2; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Sebastiani P., 2010, SCIENCE, V2010; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sham PC, 2014, NAT REV GENET, V15, P335, DOI 10.1038/nrg3706; Singh T, 2016, NAT NEUROSCI, V19, P571, DOI 10.1038/nn.4267; Skafidas E, 2014, MOL PSYCHIATR, V19, P504, DOI 10.1038/mp.2012.126; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Stein JL, 2014, NEURON, V83, P69, DOI 10.1016/j.neuron.2014.05.035; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Szatkiewicz JP, 2014, MOL PSYCHIATR, V19, P762, DOI 10.1038/mp.2014.40; Tammimies K, 2015, JAMA-J AM MED ASSOC, V314, P895, DOI 10.1001/jama.2015.10078; Tansey KE, 2016, MOL PSYCHIATR, V21, P1085, DOI 10.1038/mp.2015.143; Tenesa A, 2013, NAT REV GENET, V14, P139, DOI 10.1038/nrg3377; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vassos E, 2016, BIOL PSYCHIAT; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wang Z, 2016, NEURON, V90, P948, DOI 10.1016/j.neuron.2016.04.039; Whalen S, 2016, NAT GENET, V48, P488, DOI 10.1038/ng.3539; Wray NR, 2008, CURR OPIN GENET DEV, V18, P257, DOI 10.1016/j.gde.2008.07.006; Xu XX, 2014, J NEUROSCI, V34, P1420, DOI 10.1523/JNEUROSCI.4488-13.2014; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zhou Y, 2016, NEURON, V89, P147, DOI 10.1016/j.neuron.2015.11.023	149	123	124	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2016	19	11					1397	1407		10.1038/nn.4409	http://dx.doi.org/10.1038/nn.4409			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EA3WL	27786179	Green Published, Green Accepted			2022-12-17	WOS:000386539900007
J	Harris, KD; Quiroga, RQ; Freeman, J; Smith, SL				Harris, Kenneth D.; Quiroga, Rodrigo Quian; Freeman, Jeremy; Smith, Spencer L.			Improving data quality in neuronal population recordings	NATURE NEUROSCIENCE			English	Review							SPIKE-SORTING ALGORITHMS; MOUSE VISUAL-CORTEX; LARGE-SCALE; CELLULAR RESOLUTION; LONG-TERM; NEURAL ACTIVITY; MULTIUNIT RECORDINGS; RECEPTIVE-FIELDS; HIGH-DENSITY; WAVE-FORM	Understanding how the brain operates requires understanding how large sets of neurons function together. Modern recording technology makes it possible to simultaneously record the activity of hundreds of neurons, and technological developments will soon allow recording of thousands or tens of thousands. As with all experimental techniques, these methods are subject to confounds that complicate the interpretation of such recordings, and could lead to erroneous scientific conclusions. Here we discuss methods for assessing and improving the quality of data from these techniques and outline likely future directions in this field.	[Harris, Kenneth D.] UCL, UCL Inst Neurol, London, England; [Harris, Kenneth D.] UCL, UCL Dept Neurosci Physiol & Pharmacol, London, England; [Quiroga, Rodrigo Quian] Univ Leicester, Ctr Syst Neurosci, Leicester, Leics, England; [Freeman, Jeremy] Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA; [Smith, Spencer L.] UNC Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of London; University College London; University of London; University College London; University of Leicester; Howard Hughes Medical Institute; University of North Carolina School of Medicine	Harris, KD (corresponding author), UCL, UCL Inst Neurol, London, England.; Harris, KD (corresponding author), UCL, UCL Dept Neurosci Physiol & Pharmacol, London, England.; Smith, SL (corresponding author), UNC Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.	kenneth.harris@ucl.ac.uk; slab@email.unc.edu		Harris, Kenneth/0000-0002-5930-6456	Wellcome Trust [95668, 95669, 100154]; EPSRC [K015141, 1005102]; MRC; Simons foundation [SCGB 325512, SCGB 325407SS]; Human Frontier Science Program [CDA00063/2012, RGP0027/2016]; National Science Foundation [1450824]; Whitehall Foundation; Klingenstein Foundation; McKnight Foundation; National Institutes of Health [R01NS091335, R0IEY024294]; Human Frontiers Science Program [RGP0015/2013]; Engineering and Physical Sciences Research Council [EP/I005102/1] Funding Source: researchfish; EPSRC [EP/I005102/1] Funding Source: UKRI; NATIONAL EYE INSTITUTE [R01EY024294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091335] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Simons foundation; Human Frontier Science Program(Human Frontier Science Program); National Science Foundation(National Science Foundation (NSF)); Whitehall Foundation; Klingenstein Foundation(Klingenstein Philanthropies); McKnight Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Steinmetz and M. Pachitariu for comments on the manuscript. K.D.H. is supported by the Wellcome Trust (95668, 95669, 100154), EPSRC (K015141, 1005102), MRC and Simons foundation (SCGB 325512). S.L.S. is supported by the Human Frontier Science Program (CDA00063/2012, RGP0027/2016), National Science Foundation (1450824), Whitehall Foundation, Klingenstein Foundation, McKnight Foundation, Simons Foundation (SCGB 325407SS) and the National Institutes of Health (R01NS091335, R0IEY024294). R.Q.Q. is supported by the Human Frontiers Science Program (RGP0015/2013).	Anastassiou CA, 2015, J NEUROPHYSIOL, V114, P608, DOI 10.1152/jn.00628.2014; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Bai Q, 2001, IEEE T BIO-MED ENG, V48, P911, DOI 10.1109/10.936367; Bar-Hillel A, 2006, J NEUROSCI METH, V157, P303, DOI 10.1016/j.jneumeth.2006.04.023; Barnett AH, 2016, J NEUROSCI METH, V264, P65, DOI 10.1016/j.jneumeth.2016.02.022; Barretto RPJ, 2009, NAT METHODS, V6, P511, DOI 10.1038/nmeth.1339; Berenyi A, 2014, J NEUROPHYSIOL, V111, P1132, DOI 10.1152/jn.00785.2013; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Camunas-Mesa LA, 2013, NEURAL COMPUT, V25, P1191, DOI 10.1162/NECO_a_00433; Chen JL, 2013, J PHYSIOL-LONDON, V591, P4689, DOI 10.1113/jphysiol.2013.259804; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Claverol-Tinture E, 2004, IEEE T BIO-MED ENG, V51, P2211, DOI 10.1109/TBME.2004.834274; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cotton RJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00151; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Dana H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108697; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Delescluse M, 2006, J NEUROSCI METH, V150, P16, DOI 10.1016/j.jneumeth.2005.05.023; Dhawale A.K., 2015, BIORXIV; Diego F., 2014, ADV NEURAL INFORM PR, P64; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; DRAKE KL, 1988, IEEE T BIO-MED ENG, V35, P719, DOI 10.1109/10.7273; Dubbs A, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00006; Dufour P, 2006, APPL OPTICS, V45, P9246, DOI 10.1364/AO.45.009246; Dunn AK, 2000, APPL OPTICS, V39, P1194, DOI 10.1364/AO.39.001194; Einevoll GT, 2012, CURR OPIN NEUROBIOL, V22, P11, DOI 10.1016/j.conb.2011.10.001; Ekanadham C, 2014, J NEUROSCI METH, V222, P47, DOI 10.1016/j.jneumeth.2013.10.001; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Fee MS, 1996, J NEUROPHYSIOL, V76, P3823, DOI 10.1152/jn.1996.76.6.3823; Franke F, 2010, J COMPUT NEUROSCI, V29, P127, DOI 10.1007/s10827-009-0163-5; Fraser GW, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055004; Frey U, 2009, BIOSENS BIOELECTRON, V24, P2191, DOI 10.1016/j.bios.2008.11.028; Ganguly K, 2011, NAT NEUROSCI, V14, P662, DOI 10.1038/nn.2797; GERSTEIN GL, 1964, SCIENCE, V143, P1325, DOI 10.1126/science.143.3612.1325; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Glickfeld LL, 2013, NAT NEUROSCI, V16, P219, DOI 10.1038/nn.3300; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Greenberg DS, 2009, J NEUROSCI METH, V176, P1, DOI 10.1016/j.jneumeth.2008.08.020; Greenberg PA, 2004, J NEUROPHYSIOL, V92, P1042, DOI 10.1152/jn.00062.2004; Hamel EJO, 2015, NEURON, V86, P140, DOI 10.1016/j.neuron.2015.03.055; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; Jackson A, 2007, J NEUROPHYSIOL, V98, P3109, DOI 10.1152/jn.00569.2007; Jia N, 2012, P NATL ACAD SCI USA, V109, P22, DOI 10.1073/pnas.1109202108; Keller PJ, 2015, NAT METHODS, V12, P27, DOI 10.1038/nmeth.3214; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Laffray S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019928; Lambacher A, 2011, APPL PHYS A-MATER, V102, P1, DOI 10.1007/s00339-010-6046-9; Lecoq J, 2014, NAT NEUROSCI, V17, P1825, DOI 10.1038/nn.3867; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Linden H., 2014, FRONT NEUROINFORM, V7, P41, DOI DOI 10.3389/fninf.2013.00041; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Lopez CM, 2016, ISSCC DIG TECH PAP I, V59, P392, DOI 10.1109/ISSCC.2016.7418072; Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007; Martinez J, 2009, J NEUROSCI METH, V184, P285, DOI 10.1016/j.jneumeth.2009.08.017; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; Menne KML, 2002, NEUROCOMPUTING, V44, P1119, DOI 10.1016/S0925-2312(02)00432-0; Moffitt MA, 2005, CLIN NEUROPHYSIOL, V116, P2240, DOI 10.1016/j.clinph.2005.05.018; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Navajas J, 2014, J NEUROSCI METH, V230, P51, DOI 10.1016/j.jneumeth.2014.04.018; Neto J.P., 2016, BIORXIV; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Okun M., 2015, PLOS ONE; Pachitariu M., 2013, ADV NEURAL INFORM PR; Pachitariu M, 2016, BIORXIV; Pazienti A, 2006, J COMPUT NEUROSCI, V21, P329, DOI 10.1007/s10827-006-8899-7; Pedreira C, 2012, J NEUROSCI METH, V211, P58, DOI 10.1016/j.jneumeth.2012.07.010; Peron SP, 2015, NEURON, V86, P783, DOI 10.1016/j.neuron.2015.03.027; Pettersen KH, 2008, BIOPHYS J, V94, P784, DOI 10.1529/biophysj.107.111179; Pillow JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062123; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Podgorski K., 2016, J NEUROPHYSIOL; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; Quiroga RQ, 2007, J NEUROPHYSIOL, V98, P1997, DOI 10.1152/jn.00125.2007; Quiroga RQ, 2012, NAT REV NEUROSCI, V13, P587, DOI 10.1038/nrn3251; Quiroga RQ, 2012, CURR BIOL, V22, pR45, DOI 10.1016/j.cub.2011.11.005; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Quiroga RQ, 2013, PRINCIPLES OF NEURAL CODING, P1, DOI 10.1201/b14756; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Rey HG, 2015, J ANAT, V227, P394, DOI 10.1111/joa.12228; Rey HG, 2015, BRAIN RES BULL, V119, P106, DOI 10.1016/j.brainresbull.2015.04.007; ROBINSON DA, 1968, PR INST ELECTR ELECT, V56, P1065, DOI 10.1109/PROC.1968.6458; Rose T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00088; Rossant C, 2016, NAT NEUROSCI, V19, P634, DOI 10.1038/nn.4268; Sadovsky AJ, 2011, J NEUROPHYSIOL, V106, P1591, DOI 10.1152/jn.00334.2011; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Schultz SR, 2009, J NEUROSCI, V29, P8005, DOI 10.1523/JNEUROSCI.4919-08.2009; Shoham S, 2006, J COMP PHYSIOL A, V192, P777, DOI 10.1007/s00359-006-0117-6; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; Spira ME, 2013, NAT NANOTECHNOL, V8, P83, DOI [10.1038/nnano.2012.265, 10.1038/NNANO.2012.265]; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stirman J.N., 2016, NAT BIOTECHNOL; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Swindale NV, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00006; Theis L, 2016, NEURON, V90, P471, DOI 10.1016/j.neuron.2016.04.014; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007; Tung CK, 2004, MICROSC RES TECHNIQ, V65, P308, DOI 10.1002/jemt.20116; Valmianski I, 2010, J NEUROPHYSIOL, V104, P1803, DOI 10.1152/jn.00484.2010; Ventura V, 2012, P NATL ACAD SCI USA, V109, P7230, DOI 10.1073/pnas.1115236109; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; von Diezmann A, 2015, OPTICA, V2, P985, DOI 10.1364/OPTICA.2.000985; Wang C, 2013, OPT EXPRESS, V21, P27142, DOI 10.1364/OE.21.027142; Wehr M, 1999, NEUROCOMPUTING, V26-7, P1061, DOI 10.1016/S0925-2312(99)00105-8; Williams JC, 1999, NEUROCOMPUTING, V26-7, P1069, DOI 10.1016/S0925-2312(99)00106-X; Wilms CD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7464; Wilt BA, 2013, BIOPHYS J, V104, P51, DOI 10.1016/j.bpj.2012.07.058; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yang WJ, 2016, NEURON, V89, P269, DOI 10.1016/j.neuron.2015.12.012; Yasuda Ryohei, 2004, Sci STKE, V2004, ppl5, DOI 10.1126/stke.2192004pl5; Young MD, 2015, ADV OPT PHOTONICS, V7, P276, DOI 10.1364/AOP.7.000276; Zheng GA, 2013, OPT EXPRESS, V21, P15131, DOI 10.1364/OE.21.015131	140	123	123	3	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2016	19	9					1165	1174		10.1038/nn.4365	http://dx.doi.org/10.1038/nn.4365			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU5SA	27571195	Green Accepted, Green Submitted			2022-12-17	WOS:000382270400012
J	Gourley, SL; Taylor, JR				Gourley, Shannon L.; Taylor, Jane R.			Going and stopping: dichotomies in behavioral control by the prefrontal cortex	NATURE NEUROSCIENCE			English	Review							COCAINE-SEEKING BEHAVIOR; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; NUCLEUS-ACCUMBENS SHELL; INDUCED STRUCTURAL PLASTICITY; ACCELERATED HABIT FORMATION; GOAL-DIRECTED ACTIONS; CUE-INDUCED RELAPSE; FEAR EXTINCTION; INFRALIMBIC CORTEX; PRELIMBIC CORTEX	The rodent dorsal medial prefrontal cortex (PFC), specifically the prelimbic cortex (PL), regulates the expression of conditioned fear and behaviors interpreted as reward seeking. Meanwhile, the ventral medial PFC, namely the infralimbic cortex (IL), is essential to extinction conditioning in both appetitive and aversive domains. Here we review evidence that supports, or refutes, this "PL-go/IL-stop" dichotomy. We focus on the extinction of conditioned fear and the extinction and reinstatement of cocaine-or heroin-reinforced responding following abstinence. We then synthesize evidence that the PL is essential for developing goal-directed response strategies, while the IL supports habit behavior. Finally, we propose that some functions of the orbital PFC parallel those of the medial PFC in the regulation of response selection. Integration of these discoveries may provide points of intervention for inhibiting untethered drug seeking in drug use disorders, extinction failures in post-traumatic stress disorder, or co-morbidities between the two.	[Gourley, Shannon L.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Gourley, Shannon L.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Gourley, Shannon L.] Emory Univ, Grad Program Neurosci, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Taylor, Jane R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Taylor, Jane R.] Yale Univ, Dept Psychol, Interdept Neurosci Program, New Haven, CT USA	Emory University; Emory University; Emory University; Yale University; Yale University	Gourley, SL (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA.; Gourley, SL (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA.; Gourley, SL (corresponding author), Emory Univ, Grad Program Neurosci, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	shannon.l.gourley@emory.edu	Gourley, Shannon/AAW-6790-2020		PHS [DA011717, DA027844, MH101477, DA034808, DA036737]; Connecticut Department of Mental Health and Addiction Services; Office of Research Infrastructure Programs/OD [P51OD011132]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA027844, R03DA036737, R01DA011717, R21DA034808] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Connecticut Department of Mental Health and Addiction Services; Office of Research Infrastructure Programs/OD; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank L. Shapiro, A. Allen, L. DePoy, and E. Pitts for valuable feedback and contributions to Figures 1 and 3. This work was supported by PHS DA011717, DA027844 (JRT), MH101477, DA034808 and DA036737 (S.L.G.), and the Connecticut Department of Mental Health and Addiction Services (J.R.T.). The Yerkes National Primate Research Center is supported by the Office of Research Infrastructure Programs/OD P51OD011132.	Alvarez-Jaimes L, 2008, NEUROPSYCHOPHARMACOL, V33, P2483, DOI 10.1038/sj.npp.1301630; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Barker JM, 2014, LEARN MEMORY, V21, P441, DOI 10.1101/lm.035501.114; Barker JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00126; Blum S, 2006, NEUROREPORT, V17, P341, DOI 10.1097/01.wnr.0000201509.53750.bc; Bossert JM, 2012, J NEUROSCI, V32, P4982, DOI 10.1523/JNEUROSCI.0005-12.2012; Bossert JM, 2011, NAT NEUROSCI, V14, P420, DOI 10.1038/nn.2758; Bravo-Rivera C, 2014, J NEUROSCI, V34, P9736, DOI 10.1523/JNEUROSCI.0191-14.2014; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Burke AR, 2014, PSYCHOPHARMACOLOGY, V231, P1557, DOI 10.1007/s00213-013-3369-1; Butkovich LM, 2015, EUR J NEUROSCI, V42, P2114, DOI 10.1111/ejn.12995; Capriles N, 2003, PSYCHOPHARMACOLOGY, V168, P66, DOI 10.1007/s00213-002-1283-z; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Chen BT, 2013, NATURE, V496, P359, DOI 10.1038/nature12024; Choi DC, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.128; Corbit LH, 2014, NEUROPSYCHOPHARMACOL, V39, P1893, DOI 10.1038/npp.2014.37; Corbit LH, 2003, BEHAV BRAIN RES, V146, P145, DOI 10.1016/j.bbr.2003.09.023; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Coutureau E, 2003, BEHAV BRAIN RES, V146, P167, DOI 10.1016/j.bbr.2003.09.025; DePoy LM, 2015, TRAFFIC, V16, P919, DOI 10.1111/tra.12295; Di Pietro NC, 2006, EUR J NEUROSCI, V24, P3285, DOI 10.1111/j.1460-9568.2006.05193.x; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Dickinson A., 1980, CONT ANIMAL LEARNING; Do-Monte FH, 2015, NATURE, V519, P460, DOI 10.1038/nature14030; Do-Monte FH, 2015, J NEUROSCI, V35, P3607, DOI 10.1523/JNEUROSCI.3137-14.2015; Dutech A, 2011, J PHYSIOL-PARIS, V105, P36, DOI 10.1016/j.jphysparis.2011.07.017; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fitzgerald PJ, 2014, BRAIN RES BULL, V105, P46, DOI 10.1016/j.brainresbull.2013.12.007; Fuchs RA, 2004, J NEUROSCI, V24, P6600, DOI 10.1523/JNEUROSCI.1924-04.2004; Fuchs RA, 2005, NEUROPSYCHOPHARMACOL, V30, P296, DOI 10.1038/sj.npp.1300579; Gabbott PLA, 2006, NEUROSCIENCE, V139, P1039, DOI 10.1016/j.neuroscience.2006.01.026; Gipson CD, 2013, NEURON, V77, P867, DOI 10.1016/j.neuron.2013.01.005; Gourley SL, 2013, EUR J NEUROSCI, V38, P2382, DOI 10.1111/ejn.12239; Gourley SL, 2013, J NEUROSCI, V33, P11811, DOI 10.1523/JNEUROSCI.1034-13.2013; Gourley SL, 2013, J NEUROSCI, V33, P3107, DOI 10.1523/JNEUROSCI.2138-12.2013; Gourley SL, 2012, P NATL ACAD SCI USA, V109, P20714, DOI 10.1073/pnas.1208342109; Gourley SL, 2010, EUR J NEUROSCI, V32, P1726, DOI 10.1111/j.1460-9568.2010.07438.x; Gourley SL, 2009, LEARN MEMORY, V16, P756, DOI 10.1101/lm.1547909; Gourley SL, 2009, NEUROPSYCHOPHARMACOL, V34, P707, DOI 10.1038/npp.2008.123; Gremel CM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3264; Gross C, 2015, CELL REP, V11, P681, DOI 10.1016/j.celrep.2015.03.065; Hart G, 2014, NEUROBIOL LEARN MEM, V108, P104, DOI 10.1016/j.nlm.2013.11.003; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Herry C, 2014, NAT NEUROSCI, V17, P1644, DOI 10.1038/nn.3869; Hinton EA, 2014, LEARN MEMORY, V21, P253, DOI 10.1101/lm.033290.113; Hitchcott PK, 2007, CEREB CORTEX, V17, P2820, DOI 10.1093/cercor/bhm010; Iafrati J, 2014, MOL PSYCHIATR, V19, P417, DOI 10.1038/mp.2013.66; Izquierdo A, 2006, J NEUROSCI, V26, P5733, DOI 10.1523/JNEUROSCI.0474-06.2006; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Jedynak JP, 2007, EUR J NEUROSCI, V25, P847, DOI 10.1111/j.1460-9568.2007.05316.x; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Joel D, 1997, BRAIN RES, V765, P37, DOI 10.1016/S0006-8993(97)00334-X; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Kolb B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00377; Koya E, 2009, NEUROPHARMACOLOGY, V56, P177, DOI 10.1016/j.neuropharm.2008.04.022; LaLumiere RT, 2012, EUR J NEUROSCI, V35, P614, DOI 10.1111/j.1460-9568.2012.07991.x; LaLumiere RT, 2010, LEARN MEMORY, V17, P168, DOI 10.1101/lm.1576810; Laurent V, 2009, LEARN MEMORY, V16, P520, DOI 10.1101/lm.1474609; LeBlanc KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061355; LeDoux JE, 2014, P NATL ACAD SCI USA, V111, P2871, DOI 10.1073/pnas.1400335111; Li X, 2015, NEUROPSYCHOPHARMACOL, V40, P1297, DOI 10.1038/npp.2014.320; Limpens JHW, 2015, BRAIN RES, V1628, P210, DOI 10.1016/j.brainres.2014.10.045; Lubbers BR, 2014, BIOL PSYCHIAT, V76, P750, DOI 10.1016/j.biopsych.2014.02.001; Lucantonio F, 2014, NEUROPHARMACOLOGY, V76, P407, DOI 10.1016/j.neuropharm.2013.05.033; Luk CH, 2013, J NEUROSCI, V33, P1864, DOI 10.1523/JNEUROSCI.4920-12.2013; Ma YY, 2014, NEURON, V83, P1453, DOI 10.1016/j.neuron.2014.08.023; Mailly P, 2013, J NEUROSCI, V33, P5718, DOI 10.1523/JNEUROSCI.5248-12.2013; Maren S, 2016, NEUROPSYCHOPHARMACOL, V41, P58, DOI 10.1038/npp.2015.180; Martin-Garcia E, 2014, NEUROPSYCHOPHARMACOL, V39, P2317, DOI 10.1038/npp.2014.66; Mashhoon Y, 2010, PHARMACOL BIOCHEM BE, V96, P347, DOI 10.1016/j.pbb.2010.06.005; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P1, DOI 10.1016/0306-4522(91)90247-L; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; McFarland K, 2003, J NEUROSCI, V23, P3531; McFarland K, 2001, J NEUROSCI, V21, P8655; McLaughlin J, 2003, PSYCHOPHARMACOLOGY, V168, P57, DOI 10.1007/s00213-002-1196-x; Mihindou C, 2013, BIOL PSYCHIAT, V73, P271, DOI 10.1016/j.biopsych.2012.08.011; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Milstein JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057308; Moorman DE, 2015, BRAIN RES, V1628, P130, DOI 10.1016/j.brainres.2014.12.024; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Moscarello JM, 2013, J NEUROSCI, V33, P3815, DOI 10.1523/JNEUROSCI.2596-12.2013; Mueller D, 2008, J NEUROSCI, V28, P369, DOI 10.1523/JNEUROSCI.3248-07.2008; Mueller D, 2010, BIOL PSYCHIAT, V68, P1055, DOI 10.1016/j.biopsych.2010.08.014; Munoz-Cuevas FJ, 2013, NAT NEUROSCI, V16, P1367, DOI 10.1038/nn.3498; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Nelson AJD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00076; Nordquist RE, 2007, EUR NEUROPSYCHOPHARM, V17, P532, DOI 10.1016/j.euroneuro.2006.12.005; Olmstead MC, 2001, BEHAV NEUROSCI, V115, P394, DOI 10.1037/0735-7044.115.2.394; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Ostlund SB, 2005, J NEUROSCI, V25, P7763, DOI 10.1523/JNEUROSCI.1921-05.2005; Ovari J, 2008, NEUROSCI LETT, V444, P52, DOI 10.1016/j.neulet.2008.08.015; Park WK, 2002, J NEUROSCI, V22, P2916, DOI 10.1523/JNEUROSCI.22-07-02916.2002; Pelloux Y, 2013, EUR J NEUROSCI, V38, P3018, DOI 10.1111/ejn.12289; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Peters J, 2008, PSYCHOPHARMACOLOGY, V197, P319, DOI 10.1007/s00213-007-1034-2; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Pfarr S, 2015, J NEUROSCI, V35, P10750, DOI 10.1523/JNEUROSCI.0684-15.2015; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Ramirez DR, 2009, EUR J NEUROSCI, V30, P901, DOI 10.1111/j.1460-9568.2009.06889.x; RESCORLA RA, 1975, J EXP PSYCHOL-ANIM B, V104, P88, DOI 10.1037/0097-7403.1.1.88; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Rocha A, 2010, EUR J NEUROSCI, V31, P903, DOI 10.1111/j.1460-9568.2010.07134.x; Rogers JL, 2008, NEUROSCIENCE, V151, P579, DOI 10.1016/j.neuroscience.2007.10.012; Rosen GD, 2000, INT MOUSE GENOME C, V14, P166; Rudebeck PH, 2014, NEURON, V84, P1143, DOI 10.1016/j.neuron.2014.10.049; Sangha S, 2014, NEUROPSYCHOPHARMACOL, V39, P2405, DOI 10.1038/npp.2014.89; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Schilman EA, 2008, NEUROSCI LETT, V432, P40, DOI 10.1016/j.neulet.2007.12.024; Schmitzer-Torbert N, 2015, NEUROBIOL LEARN MEM, V118, P105, DOI 10.1016/j.nlm.2014.11.007; Schoenbaum G, 2005, CEREB CORTEX, V15, P1162, DOI 10.1093/cercor/bhh216; See RE, 2009, INT J NEUROPSYCHOPH, V12, P431, DOI 10.1017/S1461145709000054; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Sgobio C, 2008, GENES BRAIN BEHAV, V7, P427, DOI 10.1111/j.1601-183X.2007.00367.x; Shen HW, 2014, NEUROPSYCHOPHARMACOL, V39, P1169, DOI 10.1038/npp.2013.318; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Sierra-Mercado D, 2006, EUR J NEUROSCI, V24, P1751, DOI 10.1111/j.1460-9568.2006.05014.x; Smith KS, 2013, NEURON, V79, P361, DOI 10.1016/j.neuron.2013.05.038; Smith KS, 2012, P NATL ACAD SCI USA, V109, P18932, DOI 10.1073/pnas.1216264109; Sorg BA, 2015, NEUROPHARMACOLOGY, V92, P25, DOI 10.1016/j.neuropharm.2014.12.029; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Stefanik MT, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00213; Stefanik MT, 2013, ADDICT BIOL, V18, P50, DOI 10.1111/j.1369-1600.2012.00479.x; Stefanik MT, 2015, BRAIN STRUCT FUNCT; Swanson AM, 2015, NEUROPSYCHOPHARMACOL, V40, P1027, DOI 10.1038/npp.2014.292; Szalay JJ, 2013, EUR J NEUROSCI, V37, P269, DOI 10.1111/ejn.12035; Thomases DR, 2014, J NEUROSCI, V34, P9059, DOI 10.1523/JNEUROSCI.1395-14.2014; Todd TP, 2014, NEUROBIOL LEARN MEM, V108, P52, DOI 10.1016/j.nlm.2013.08.012; Torregrossa MM, 2011, NEUROBIOL LEARN MEM, V96, P609, DOI 10.1016/j.nlm.2011.02.014; Torregrossa MM, 2010, J NEUROSCI, V30, P10526, DOI 10.1523/JNEUROSCI.2523-10.2010; Tran-Tu-Yen DAS, 2009, EUR J NEUROSCI, V30, P464, DOI 10.1111/j.1460-9568.2009.06834.x; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; Van den Oever MC, 2013, J NEUROSCI, V33, P18225, DOI 10.1523/JNEUROSCI.2412-13.2013; Vassoler FM, 2013, J NEUROSCI, V33, P14446, DOI 10.1523/JNEUROSCI.4804-12.2013; Vetere G, 2011, LEARN MEMORY, V18, P554, DOI 10.1101/lm.2246711; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Wallis JD, 2012, NAT NEUROSCI, V15, P13, DOI 10.1038/nn.2956; Weissenborn R, 1997, PSYCHOPHARMACOLOGY, V134, P242, DOI 10.1007/s002130050447; West EA, 2014, EUR J NEUROSCI, V39, P1891, DOI 10.1111/ejn.12578; Willcocks AL, 2013, EUR J NEUROSCI, V37, P259, DOI 10.1111/ejn.12031; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Zapata A, 2010, J NEUROSCI, V30, P15457, DOI 10.1523/JNEUROSCI.4072-10.2010; Zimmermann K.S., 2016, BIOL PSYCHIAT	150	123	123	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2016	19	5					656	664		10.1038/nn.4275	http://dx.doi.org/10.1038/nn.4275			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK2RM	29162973	Green Accepted			2022-12-17	WOS:000374762100004
J	Wimber, M; Alink, A; Charest, I; Kriegeskorte, N; Anderson, MC				Wimber, Maria; Alink, Arjen; Charest, Ian; Kriegeskorte, Nikolaus; Anderson, Michael C.			Retrieval induces adaptive forgetting of competing memories via cortical pattern suppression	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; MEDIAL TEMPORAL-LOBE; TOP-DOWN MODULATION; SELECTIVE ATTENTION; PREFRONTAL CORTEX; NEURAL MECHANISMS; COGNITIVE CONTROL; WORKING-MEMORY; FMRI; RECONSOLIDATION	Remembering a past experience can, surprisingly, cause forgetting. Forgetting arises when other competing traces interfere with retrieval and inhibitory control mechanisms are engaged to suppress the distraction they cause. This form of forgetting is considered to be adaptive because it reduces future interference. The effect of this proposed inhibition process on competing memories has, however, never been observed, as behavioral methods are 'blind' to retrieval dynamics and neuroimaging methods have not isolated retrieval of individual memories. We developed a canonical template tracking method to quantify the activation state of individual target memories and competitors during retrieval. This method revealed that repeatedly retrieving target memories suppressed cortical patterns unique to competitors. Pattern suppression was related to engagement of prefrontal regions that have been implicated in resolving retrieval competition and, critically, predicted later forgetting. Thus, our findings demonstrate a cortical pattern suppression mechanism through which remembering adaptively shapes which aspects of our past remain accessible.	[Wimber, Maria] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Wimber, Maria; Alink, Arjen; Charest, Ian; Kriegeskorte, Nikolaus; Anderson, Michael C.] MRC Cognit & Brain Sci Unit, Cambridge, England; [Anderson, Michael C.] Behav & Clin Neurosci Inst, Cambridge, England	University of Birmingham; University of Cambridge	Wimber, M (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	m.wimber@bham.ac.uk	Charest, Ian/P-1736-2016	Charest, Ian/0000-0002-3939-3003; Wimber, Maria/0000-0002-1917-353X; Alink, Arjen/0000-0001-6468-5449; Anderson, Michael/0000-0001-9505-9299	German Research Foundation [WI-3784/1-1]; UK Medical Research Council grant [MC-A060-5PR00]; Medical Research Council [MC_U105597121, MC_U105597120] Funding Source: researchfish; MRC [MC_U105597121, MC_U105597120] Funding Source: UKRI	German Research Foundation(German Research Foundation (DFG)); UK Medical Research Council grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank B. Staresina and S. Hanslmayr for commenting on previous versions of the manuscript. This work was supported by a fellowship from the German Research Foundation (WI-3784/1-1) awarded to M.W. and by UK Medical Research Council grant MC-A060-5PR00 awarded to M.C.A.	ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Anderson MC, 2000, J EXP PSYCHOL LEARN, V26, P1141, DOI 10.1037/0278-7393.26.5.1141; Anderson MC, 2003, J MEM LANG, V49, P415, DOI 10.1016/j.jml.2003.08.006; ANDERSON MC, 1995, PSYCHOL REV, V102, P68, DOI 10.1037/0033-295X.102.1.68; ANDERSON MC, 1994, J EXP PSYCHOL LEARN, V20, P1063, DOI 10.1037/0278-7393.20.5.1063; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; Cerf M, 2010, NATURE, V467, P1104, DOI 10.1038/nature09510; Chadwick MJ, 2010, CURR BIOL, V20, P544, DOI 10.1016/j.cub.2010.01.053; Chun MM, 2011, NEURON, V72, P520, DOI 10.1016/j.neuron.2011.10.026; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Detre GJ, 2013, NEUROPSYCHOLOGIA, V51, P2371, DOI 10.1016/j.neuropsychologia.2013.02.017; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Hardt O, 2013, TRENDS COGN SCI, V17, P111, DOI 10.1016/j.tics.2013.01.001; Hardt O, 2010, ANNU REV PSYCHOL, V61, P141, DOI 10.1146/annurev.psych.093008.100455; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Kim G, 2014, P NATL ACAD SCI USA, V111, P8997, DOI 10.1073/pnas.1319438111; Kriegeskorte N, 2013, TRENDS COGN SCI, V17, P401, DOI 10.1016/j.tics.2013.06.007; Kriegeskorte N, 2011, NEUROIMAGE, V56, P411, DOI 10.1016/j.neuroimage.2011.01.061; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Kuhl BA, 2007, NAT NEUROSCI, V10, P908, DOI 10.1038/nn1918; Kuhl BA, 2012, J NEUROSCI, V32, P3453, DOI 10.1523/JNEUROSCI.5846-11.2012; Kuhl BA, 2011, P NATL ACAD SCI USA, V108, P5903, DOI 10.1073/pnas.1016939108; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; Norman KA, 2006, NEURAL COMPUT, V18, P1577, DOI 10.1162/neco.2006.18.7.1577; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Poppenk J, 2014, J NEUROSCI, V34, P8010, DOI 10.1523/JNEUROSCI.4584-13.2014; Ritchey M, 2013, CEREB CORTEX, V23, P2818, DOI 10.1093/cercor/bhs258; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Seidl KN, 2012, J NEUROSCI, V32, P11812, DOI 10.1523/JNEUROSCI.1693-12.2012; Spitzer B, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01102; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Staresina BP, 2012, J NEUROSCI, V32, P18150, DOI 10.1523/JNEUROSCI.4156-12.2012; Storm BC, 2012, MEM COGNITION, V40, P827, DOI 10.3758/s13421-012-0211-7; Suzuki M, 2013, NAT NEUROSCI, V16, P98, DOI 10.1038/nn.3282; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Wimber M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.15; Wimber M, 2009, J COGNITIVE NEUROSCI, V21, P538, DOI 10.1162/jocn.2009.21043; Wimber M, 2008, J NEUROSCI, V28, P13419, DOI 10.1523/JNEUROSCI.1916-08.2008; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773	45	123	125	4	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2015	18	4					582	+		10.1038/nn.3973	http://dx.doi.org/10.1038/nn.3973			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE4DL	25774450	Green Submitted, Green Accepted			2022-12-17	WOS:000351780900022
J	Ghosh, S; Chattarji, S				Ghosh, Supriya; Chattarji, Sumantra			Neuronal encoding of the switch from specific to generalized fear	NATURE NEUROSCIENCE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; AUDITORY-CORTEX; STIMULUS-GENERALIZATION; LATERAL AMYGDALA; CONDITIONED FEAR; MEMORY; EXTINCTION; CIRCUITS; RAT; DISCRIMINATION	Fear memories are crucial for survival. However, excessive generalization of such memories, characterized by a failure to discriminate dangerous from safe stimuli, is common in anxiety disorders. Neuronal encoding of the transition from cue-specific to generalized fear is poorly understood. We identified distinct neuronal populations in the lateral amygdala (LA) of rats that signaled generalized versus cue-specific associations and determined how their distributions switched during fear generalization. Notably, the same LA neurons that were cue specific before the behavioral shift to generalized fear lost their specificity afterwards, thereby tilting the balance of activity toward a greater proportion of generalizing neurons. Neuronal activity in the LA, but not the auditory cortex, was necessary for fear generalization. Furthermore, targeted activation of cAMP-PKA signaling in the LA increased neuronal excitability of LA neurons and led to generalized fear. These results provide a cellular basis in the amygdala for the alteration of emotional states from normal to pathological fear.	[Ghosh, Supriya; Chattarji, Sumantra] Natl Ctr Biol Sci, Tata Inst Fundamental Res, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Chattarji, S (corresponding author), Natl Ctr Biol Sci, Tata Inst Fundamental Res, Bangalore, Karnataka, India.	shona@ncbs.res.in	Ghosh, Supriya/ABG-2932-2021	Ghosh, Supriya/0000-0002-1956-1807	National Centre for Biological Sciences and Department of Biotechnology, India; Wellcome Trust, UK [GR 0701339 MA]	National Centre for Biological Sciences and Department of Biotechnology, India; Wellcome Trust, UK(Wellcome Trust)	We are grateful to A. Luthi and M. Thattai for discussions and advice. This work was supported by the National Centre for Biological Sciences and Department of Biotechnology, India, and an International Senior Research Fellowship to S.C. (GR 0701339 MA) from The Wellcome Trust, UK.	Antunes R, 2010, J NEUROSCI, V30, P9782, DOI 10.1523/JNEUROSCI.1037-10.2010; Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Baldi E, 2004, NEUROBIOL LEARN MEM, V81, P162, DOI 10.1016/j.nlm.2004.02.004; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Bremner JD, 2005, PSYCHOL MED, V35, P791, DOI 10.1017/S0033291704003290; Bryant RA, 2008, HUM BRAIN MAPP, V29, P517, DOI 10.1002/hbm.20415; Faber ESL, 2008, J NEUROSCI, V28, P10803, DOI 10.1523/JNEUROSCI.1796-08.2008; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Ghirlanda S, 2003, ANIM BEHAV, V66, P15, DOI 10.1006/anbe.2003.2174; GUTTMAN N, 1956, J EXP PSYCHOL, V51, P79, DOI 10.1037/h0046219; Han JH, 2008, LEARN MEMORY, V15, P443, DOI 10.1101/lm.993608; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hawkins R. D., 1989, COMPUTATIONAL MODELS; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; HONIG WK, 1981, J EXP ANAL BEHAV, V36, P405, DOI 10.1901/jeab.1981.36-405; JARRELL TW, 1987, BRAIN RES, V412, P285, DOI 10.1016/0006-8993(87)91135-8; Jovanovic T, 2012, NEUROPHARMACOLOGY, V62, P695, DOI 10.1016/j.neuropharm.2011.02.023; Laxmi TR, 2003, BEHAV BRAIN RES, V145, P89, DOI 10.1016/S0166-4328(03)00101-3; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1043; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lissek S, 2008, BEHAV RES THER, V46, P678, DOI 10.1016/j.brat.2008.02.005; Lonsdorf TB, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.36; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Pape HC, 2005, HIPPOCAMPUS, V15, P874, DOI 10.1002/hipo.20120; Pavlov I., 1927, CONDITIONED REFLEX I; Paxinos G., 2006, RAT BRAIN STEREOTAXI; Protopopescu X, 2005, BIOL PSYCHIAT, V57, P464, DOI 10.1016/j.biopsych.2004.12.026; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rescorla R., 1972, CLASSICAL CONDITION; RESCORLA RA, 1982, ANNU REV PSYCHOL, V33, P265, DOI 10.1146/annurev.ps.33.020182.001405; Resnik J, 2011, NAT NEUROSCI, V14, P791, DOI 10.1038/nn.2802; ROMANSKI LM, 1993, CEREB CORTEX, V3, P515, DOI 10.1093/cercor/3.6.515; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; THOMPSON RF, 1962, J COMP PHYSIOL PSYCH, V55, P279, DOI 10.1037/h0047856; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; WHEELER BC, 1999, CRC METH NEUROSCI S, P61; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	47	123	125	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2015	18	1					112	+		10.1038/nn.3888	http://dx.doi.org/10.1038/nn.3888			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX5WH	25436666				2022-12-17	WOS:000346995000018
J	Lichtman, JW; Pfister, H; Shavit, N				Lichtman, Jeff W.; Pfister, Hanspeter; Shavit, Nir			The big data challenges of connectomics	NATURE NEUROSCIENCE			English	Article							VOLUME ELECTRON-MICROSCOPY; CIRCUIT RECONSTRUCTION; NEURONS; SYNAPSES; CORTEX	The structure of the nervous system is extraordinarily complicated because individual neurons are interconnected to hundreds or even thousands of other cells in networks that can extend over large volumes. Mapping such networks at the level of synaptic connections, a field called connectomics, began in the 1970s with a the study of the small nervous system of a worm and has recently garnered general interest thanks to technical and computational advances that automate the collection of electron-microscopy data and offer the possibility of mapping even large mammalian brains. However, modern connectomics produces 'big data', unprecedented quantities of digital information at unprecedented rates, and will require, as with genomics at the time, breakthrough algorithmic and computational solutions. Here we describe some of the key difficulties that may arise and provide suggestions for managing them.	[Lichtman, Jeff W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Lichtman, Jeff W.; Pfister, Hanspeter] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Pfister, Hanspeter] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Shavit, Nir] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Shavit, Nir] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lichtman, JW (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	jeff@mcb.harvard.edu		Pfister, Hanspeter/0000-0002-3620-2582	US National Institute of Mental Health Silvio Conte Center [1P50MH094271]; US National Institutes of Health [NS076467, 2R44MH088088-03]; National Science Foundation [OIA-1125087, CCF-1217921, CCF-1301926, IIS-1447786, IIS-1447344]; Department of Energy Advanced Scientific Computing Research grant [ER26116/DE-SC0008923]; Nvidia; Oracle; Intel; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094271, R44MH088088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076467] Funding Source: NIH RePORTER	US National Institute of Mental Health Silvio Conte Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Energy Advanced Scientific Computing Research grant; Nvidia; Oracle; Intel(Intel Corporation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support is gratefully acknowledged from the US National Institute of Mental Health Silvio Conte Center (1P50MH094271 to J.W.L.), the US National Institutes of Health (NS076467 to J.W.L. and 2R44MH088088-03 to H.P.), the National Science Foundation (OIA-1125087 to H.P., CCF-1217921 to N.S., CCF-1301926 to N.S., IIS-1447786 to N.S., and IIS-1447344 to H.P. and J.W.L.), a Department of Energy Advanced Scientific Computing Research grant (ER26116/DE-SC0008923 to N.S.), Nvidia (H.P.), Oracle (N.S.) and Intel (N.S.).	Amdahl G. M., 1967, P AFIPS C P, V30, P483; Becker C, 2013, IEEE T MED IMAGING, V32, P1864, DOI 10.1109/TMI.2013.2267747; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Briggman KL, 2012, CURR OPIN NEUROBIOL, V22, P154, DOI 10.1016/j.conb.2011.10.022; Bunke H, 2007, ADV PATTERN RECOGNIT, P165, DOI 10.1007/978-1-84628-726-8_8; Burns R., 2012, P 25 INT C SCI STAT, V27, P1; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Eppstein D., 2005, P 21 ANN S COMP GEOM, P296, DOI DOI 10.1145/1064092.1064138; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Helmstaedter M, 2013, NAT METHODS, V10, P501, DOI [10.1038/nmeth.2476, 10.1038/NMETH.2476]; Herlihy M., 2012, ART MULTIPROCESSOR P, V1st; Kaynig V, 2013, LARGE SCALE AUTOMATI; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; KORBO L, 1990, J NEUROSCI METH, V31, P93, DOI 10.1016/0165-0270(90)90153-7; Lakadamyali M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030826; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; O'Rourke NA, 2012, NAT REV NEUROSCI, V13, P365, DOI 10.1038/nrn3170; Peddie CJ, 2014, MICRON, V61, P9, DOI 10.1016/j.micron.2014.01.009; Plaza SM, 2014, CURR OPIN NEUROBIOL, V25, P201, DOI 10.1016/j.conb.2014.01.019; SCHUZ A, 1989, J COMP NEUROL, V286, P442, DOI 10.1002/cne.902860404; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066	25	123	126	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2014	17	11					1448	1454		10.1038/nn.3837	http://dx.doi.org/10.1038/nn.3837			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS0LT	25349911	Green Accepted, Green Submitted, Green Published			2022-12-17	WOS:000343969300009
J	Lin, SW; Owald, D; Chandra, V; Talbot, C; Huetteroth, W; Waddell, S				Lin, Suewei; Owald, David; Chandra, Vikram; Talbot, Clifford; Huetteroth, Wolf; Waddell, Scott			Neural correlates of water reward in thirsty Drosophila	NATURE NEUROSCIENCE			English	Article							MUSHROOM BODY; DOPAMINE; NEURONS; OCTOPAMINE; MEMORY; EXPRESSION; HONEYBEES; BEHAVIOR; SIGNALS; TASTE	Drinking water is innately rewarding to thirsty animals. In addition, the consumed value can be assigned to behavioral actions and predictive sensory cues by associative learning. Here we show that thirst converts water avoidance into water-seeking in naive Drosophila melanogaster. Thirst also permitted flies to learn olfactory cues paired with water reward. Water learning required water taste and <40 water-responsive dopaminergic neurons that innervate a restricted zone of the mushroom body gamma lobe. These water learning neurons are different from those that are critical for conveying the reinforcing effects of sugar. Naive water-seeking behavior in thirsty flies did not require water taste but relied on another subset of water-responsive dopaminergic neurons that target the mushroom body beta' lobe. Furthermore, these naive water-approach neurons were not required for learned water-seeking. Our results therefore demonstrate that naive water-seeking, learned water-seeking and water learning use separable neural circuitry in the brain of thirsty flies.	[Lin, Suewei; Owald, David; Chandra, Vikram; Talbot, Clifford; Huetteroth, Wolf; Waddell, Scott] Univ Oxford, Ctr Neural Circuits & Behav, Oxford, England; [Chandra, Vikram] Univ Oxford Balliol Coll, Oxford OX1 3BJ, England	University of Oxford; University of Oxford	Waddell, S (corresponding author), Univ Oxford, Ctr Neural Circuits & Behav, Oxford, England.	scott.waddell@cncb.ox.ac.uk	Huetteroth, Wolf/I-6661-2015; Huetteroth, Wolf/L-5252-2019; Owald, David/ABB-5432-2020; Lin, Suewei/AAA-3962-2021	Huetteroth, Wolf/0000-0003-3421-9935; Lin, Suewei/0000-0001-7079-7818; Chandra, Vikram/0000-0002-8020-0664; Owald, David/0000-0001-7747-7884; Waddell, Scott/0000-0003-4503-6229	EMBO Long-Term Fellowship; Sir Henry Wellcome Postdoctoral Fellowship; Andrew Mason Memorial Scholarship; Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences; Gatsby Charitable Foundation; Oxford Martin School	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Sir Henry Wellcome Postdoctoral Fellowship; Andrew Mason Memorial Scholarship; Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences(Wellcome Trust); Gatsby Charitable Foundation; Oxford Martin School	We thank C.J. Burke for his extensive failings and teachings in the art of water learning. We also thank Y. Huang and R. Brain for technical support and the Bloomington stock center, T. Clandinin (Stanford University), D. Gohl (Stanford University), M. Silies (Stanford University), G. Rubin and the Janelia Farm Project, Y. Ben-Shahar (Washington University), K. Scott (University of California, Berkeley), T. Lee (Janelia Farm Research Campus) and J. Dubnau (Cold Spring Harbor) for fly lines. S.L. was supported by an EMBO Long-Term Fellowship. D.O. was supported by an EMBO Long-Term Fellowship and a Sir Henry Wellcome Postdoctoral Fellowship. V.C. was supported by a Andrew Mason Memorial Scholarship. S.W. is funded by a Wellcome Trust Senior Research Fellowship in the Basic Biomedical Sciences and by funds from the Gatsby Charitable Foundation and Oxford Martin School.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Azanchi R, 2013, P NATL ACAD SCI USA, V110, P21153, DOI 10.1073/pnas.1320208110; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Changizi MA, 2002, PHYSIOL BEHAV, V75, P295, DOI 10.1016/S0031-9384(01)00660-6; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Marella S, 2012, NEURON, V73, P941, DOI 10.1016/j.neuron.2011.12.032; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Matsumoto Y, 2004, LEARN MEMORY, V11, P288, DOI 10.1101/lm.72504; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Perisse E, 2013, NEURON, V79, P945, DOI 10.1016/j.neuron.2013.07.045; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Qin HT, 2012, CURR BIOL, V22, P608, DOI 10.1016/j.cub.2012.02.014; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Rolls B.J., 1982, THIRST; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482	34	123	123	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2014	17	11					1536	1542		10.1038/nn.3827	http://dx.doi.org/10.1038/nn.3827			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS0LT	25262493	Green Submitted, Green Accepted			2022-12-17	WOS:000343969300018
J	Elman, JA; Oh, H; Madison, CM; Baker, SL; Vogel, JW; Marks, SM; Crowley, S; O'Neil, JP; Jagust, WJ				Elman, Jeremy A.; Oh, Hwamee; Madison, Cindee M.; Baker, Suzanne L.; Vogel, Jacob W.; Marks, Shawn M.; Crowley, Sam; O'Neil, James P.; Jagust, William J.			Neural compensation in older people with brain amyloid-beta deposition	NATURE NEUROSCIENCE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; IN-VIVO; MEMORY; ACTIVATION	Recruitment of extra neural resources may allow people to maintain normal cognition despite amyloid-beta (A beta) plaques. Previous fMRI studies have reported such hyperactivation, but it is unclear whether increases represent compensation or aberrant overexcitation. We found that older adults with A beta deposition had reduced deactivations in task-negative regions, but increased activation in task-positive regions related to more detailed memory encoding. The association between higher activity and more detailed memories suggests that A beta-related hyperactivation is compensatory.	[Elman, Jeremy A.; Baker, Suzanne L.; O'Neil, James P.; Jagust, William J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Oh, Hwamee; Madison, Cindee M.; Vogel, Jacob W.; Marks, Shawn M.; Crowley, Sam; Jagust, William J.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Elman, JA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	jelman@berkeley.edu; jagust@berkeley.edu	Jagust, William/ABE-6426-2020	Elman, Jeremy/0000-0002-5840-1769; Marks, Shawn/0000-0001-9884-8461	US National Institutes of Health [AG034570]; NATIONAL INSTITUTE ON AGING [R01AG034570] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Qin for task stimuli and W Huijbers for discussion. Supported by US National Institutes of Health grant AG034570.	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jagust WJ, 2011, TRENDS COGN SCI, V15, P520, DOI 10.1016/j.tics.2011.09.004; Morcom AM, 2007, CEREB CORTEX, V17, P2491, DOI 10.1093/cercor/bhl155; Mormino EC, 2012, CEREB CORTEX, V22, P1813, DOI 10.1093/cercor/bhr255; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Naghavi HR, 2005, CONSCIOUS COGN, V14, P390, DOI 10.1016/j.concog.2004.10.003; O'Brien JL, 2010, NEUROLOGY, V74, P1969, DOI 10.1212/WNL.0b013e3181e3966e; Oh H, 2013, J NEUROSCI, V33, P18425, DOI 10.1523/JNEUROSCI.2775-13.2013; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Qin SZ, 2011, J NEUROSCI, V31, P8920, DOI 10.1523/JNEUROSCI.2587-10.2011; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Spreng RN, 2010, NEUROSCI BIOBEHAV R, V34, P1178, DOI 10.1016/j.neubiorev.2010.01.009; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	20	123	123	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2014	17	10					1316	1318		10.1038/nn.3806	http://dx.doi.org/10.1038/nn.3806			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP8KD	25217827	Green Submitted, Green Accepted			2022-12-17	WOS:000342327000010
J	Zheng, JJ; Li, SJ; Zhang, XD; Miao, WY; Zhang, DH; Yao, HS; Yu, X				Zheng, Jing-Jing; Li, Shu-Jing; Zhang, Xiao-Di; Miao, Wan-Ying; Zhang, Dinghong; Yao, Haishan; Yu, Xiang			Oxytocin mediates early experience-dependent cross-modal plasticity in the sensory cortices	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; RELEASE; AUTISM; NEUROSCIENCE; VASOPRESSIN; MECHANISMS; DISORDERS; RESPONSES	Sensory experience is critical to development and plasticity of neural circuits. Here we report a new form of plasticity in neonatal mice, where early sensory experience cross-modally regulates development of all sensory cortices via oxytocin signaling. Unimodal sensory deprivation from birth through whisker deprivation or dark rearing reduced excitatory synaptic transmission in the correspondent sensory cortex and cross-modally in other sensory cortices. Sensory experience regulated synthesis and secretion of the neuropeptide oxytocin as well as its level in the cortex. Both in vivo oxytocin injection and increased sensory experience elevated excitatory synaptic transmission in multiple sensory cortices and significantly rescued the effects of sensory deprivation. Together, these results identify a new function for oxytocin in promoting cross-modal, experience-dependent cortical development. This link between sensory experience and oxytocin is particularly relevant to autism, where hypersensitivity or hyposensitivity to sensory inputs is prevalent and oxytocin is a hotly debated potential therapy.	[Zheng, Jing-Jing; Li, Shu-Jing; Zhang, Xiao-Di; Miao, Wan-Ying; Zhang, Dinghong; Yao, Haishan; Yu, Xiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; [Zheng, Jing-Jing; Li, Shu-Jing; Zhang, Xiao-Di; Miao, Wan-Ying; Zhang, Dinghong; Yao, Haishan; Yu, Xiang] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China; [Zhang, Xiao-Di; Zhang, Dinghong] Univ Chinese Acad Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, X (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China.	yuxiang@ion.ac.cn	Zhang, Dinghong/J-5100-2019	Miao, Wanying/0000-0003-3972-2572; Li, Shujing/0000-0003-2793-3065; Yu, Xiang/0000-0003-1225-7666; zhang, dinghong/0000-0002-6291-0750	Ministry of Science and Technology [2011CBA00400]; National Natural Science Foundation of China [31125015, 31321091]; China Postdoctoral Science Foundation [2013M540393]; Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2013KIP306]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences	We thank S. Young (US National Institute of Mental Health) for the oxytocin knockout mice, V. Grinevich (Max Planck Institute, Heidelberg, Germany) for the AAV-OXT-Venus construct, Y. Lu, X. Zeng and S. He for technical assistance, and colleagues at ION and members of the Yu laboratory for suggestions and comments. This work was supported by grants from the Ministry of Science and Technology (2011CBA00400) to X. Y. and H. Y., the National Natural Science Foundation of China (31125015 and 31321091) to X. Y., the China Postdoctoral Science Foundation (2013M540393) and Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2013KIP306) to S.-J.L.	Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Caldwell HK, 2009, MOL PSYCHIATR, V14, P190, DOI 10.1038/sj.mp.4002150; Chevaleyre V, 2000, J NEUROSCI, V20, P5813, DOI 10.1523/JNEUROSCI.20-15-05813.2000; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Durand S, 2012, NEURON, V76, P1078, DOI 10.1016/j.neuron.2012.12.004; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Fox K, 2005, NEURON, V48, P465, DOI 10.1016/j.neuron.2005.10.013; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Frasnelli J, 2011, PROG BRAIN RES, V191, P233, DOI 10.1016/B978-0-444-53752-2.00002-3; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Green JJ, 2010, NEUROTHERAPEUTICS, V7, P250, DOI 10.1016/j.nurt.2010.05.006; Hammock EAD, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00195; He KW, 2012, J NEUROSCI, V32, P8469, DOI 10.1523/JNEUROSCI.1424-12.2012; He S, 2010, J NEUROSCI, V30, P7910, DOI 10.1523/JNEUROSCI.6375-09.2010; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hrabetova S., 2007, BIOPHYSICAL PROPERTI; Huttenlocher P., 2002, NEURAL PLASTICITY EF; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Jitsuki S, 2011, NEURON, V69, P780, DOI 10.1016/j.neuron.2011.01.016; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Leng G, 2008, J PHYSIOL-LONDON, V586, P5625, DOI 10.1113/jphysiol.2008.159103; Liu Li, 2008, J Vis Exp, DOI 10.3791/960; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Ludwig M, 2002, NATURE, V418, P85, DOI 10.1038/nature00822; Malone BJ, 2007, J NEUROPHYSIOL, V97, P407, DOI 10.1152/jn.00830.2006; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI 10.1109/SPL.2011.5782616; McEwen B. B., 2004, ADV PHARMACOL, V50, P655, DOI DOI 10.1016/S1054-3589(04)50001-7; McEwen Barbara B, 2004, Adv Pharmacol, V50, P531; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Miller G, 2013, SCIENCE, V339, P267, DOI 10.1126/science.339.6117.267; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; Suarez MA, 2012, PEDIATR CLIN N AM, V59, P203, DOI 10.1016/j.pcl.2011.10.012; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; TRIBOLLET E, 1992, ANN NY ACAD SCI, V652, P29, DOI 10.1111/j.1749-6632.1992.tb34343.x; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Veening JG, 2010, PHYSIOL BEHAV, V101, P193, DOI 10.1016/j.physbeh.2010.05.004; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Yamasue H, 2012, J NEUROSCI, V32, P14109, DOI 10.1523/JNEUROSCI.3327-12.2012; Yeh CI, 2009, J NEUROSCI, V29, P11753, DOI 10.1523/JNEUROSCI.1991-09.2009; Zhu YJ, 2013, CEREB CORTEX, V23, P1923, DOI 10.1093/cercor/bhs178	54	123	125	5	56	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2014	17	3					391	399		10.1038/nn.3634	http://dx.doi.org/10.1038/nn.3634			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8CA	24464043				2022-12-17	WOS:000332016500012
J	Borota, D; Murray, E; Keceli, G; Chang, A; Watabe, JM; Ly, M; Toscano, JP; Yassa, MA				Borota, Daniel; Murray, Elizabeth; Keceli, Gizem; Chang, Allen; Watabe, Joseph M.; Ly, Maria; Toscano, John P.; Yassa, Michael A.			Post-study caffeine administration enhances memory consolidation in humans	NATURE NEUROSCIENCE			English	Article							INHIBITORY AVOIDANCE MEMORY; PATTERN SEPARATION; HIPPOCAMPUS; DECLINE; RATS; MICE	It is currently not known whether caffeine has an enhancing effect on long-term memory in humans. We used post-study caffeine administration to test its effect on memory consolidation using a behavioral discrimination task. Caffeine enhanced performance 24 h after administration according to an inverted U-shaped dose-response curve; this effect was specific to consolidation and not retrieval. We conclude that caffeine enhanced consolidation of long-term memories in humans.	[Borota, Daniel; Murray, Elizabeth; Chang, Allen; Watabe, Joseph M.; Ly, Maria; Yassa, Michael A.] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; [Keceli, Gizem; Toscano, John P.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA; [Yassa, Michael A.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA	Johns Hopkins University; Johns Hopkins University; University of California System; University of California Irvine	Yassa, MA (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	myassa@uci.edu	Keceli, Gizem/A-1263-2015; Yassa, Michael/A-8474-2013	Keceli, Gizem/0000-0002-9562-7994; Yassa, Michael/0000-0002-8635-1498; Toscano, John/0000-0002-4277-3533; Ly, Maria/0000-0003-3546-0149	US National Institute on Aging [P50 AG05146, R01 AG034613]; US National Science Foundation [CHE-1213438]; Johns Hopkins University Provost Undergraduate Research Award; NATIONAL INSTITUTE ON AGING [R01AG034613, P50AG005146] Funding Source: NIH RePORTER	US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US National Science Foundation(National Science Foundation (NSF)); Johns Hopkins University Provost Undergraduate Research Award; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	MAY. is supported by US National Institute on Aging P50 AG05146 and R01 AG034613. J.P.T. is supported by US National Science Foundation CHE-1213438. D.B. is supported by a Johns Hopkins University Provost Undergraduate Research Award. We thank A. Newman and C. Townsend for the use of their high-performance liquid chromatography instrument, D. Spira, A. Ward and J. Kim for help with participant testing, Z. Reagh for help with data analysis, and J. Knierim for helpful discussions regarding this manuscript.	Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021; Caruana DA, 2012, LEARN MEMORY, V19, P391, DOI 10.1101/lm.025304.111; Costa MS, 2008, NEUROSCIENCE, V153, P1071, DOI 10.1016/j.neuroscience.2008.03.038; Cunha RA, 2010, J ALZHEIMERS DIS, V20, pS95, DOI 10.3233/JAD-2010-1408; Huff ML, 2013, P NATL ACAD SCI USA, V110, P3597, DOI 10.1073/pnas.1219593110; Kopf SR, 1999, PSYCHOPHARMACOLOGY, V146, P214, DOI 10.1007/s002130051109; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Nehlig A, 2010, J ALZHEIMERS DIS, V20, pS85, DOI 10.3233/JAD-2010-091315; Ochiishi T, 1999, NEUROSCIENCE, V93, P955, DOI 10.1016/S0306-4522(99)00179-7; Restivo L, 2009, J NEUROSCI, V29, P8206, DOI 10.1523/JNEUROSCI.0966-09.2009; Sallaberry C, 2013, NEUROPHARMACOLOGY, V64, P153, DOI 10.1016/j.neuropharm.2012.07.010; Segal SK, 2012, NEUROBIOL LEARN MEM, V97, P465, DOI 10.1016/j.nlm.2012.03.010; Shohamy D, 2010, TRENDS COGN SCI, V14, P464, DOI 10.1016/j.tics.2010.08.002; Simons SB, 2012, NAT NEUROSCI, V15, P23, DOI 10.1038/nn.2962; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; Wright GA, 2013, SCIENCE, V339, P1202, DOI 10.1126/science.1228806; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Yassa MA, 2011, HIPPOCAMPUS, V21, P968, DOI 10.1002/hipo.20808	19	123	129	6	288	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2014	17	2					201	203		10.1038/nn.3623	http://dx.doi.org/10.1038/nn.3623			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA2FH	24413697	Green Accepted			2022-12-17	WOS:000330910000012
J	Sprague, TC; Serences, JT				Sprague, Thomas C.; Serences, John T.			Attention modulates spatial priority maps in the human occipital, parietal and frontal cortices	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL-CORTEX; MACAQUE AREA V4; RECEPTIVE-FIELDS; WORKING-MEMORY; SELECTIVE ATTENTION; NEURAL MECHANISMS; TOPOGRAPHIC MAPS; MT NEURONS; EYE-FIELD; RESPONSES	Computational theories propose that attention modulates the topographical landscape of spatial 'priority' maps in regions of the visual cortex so that the location of an important object is associated with higher activation levels. Although studies of single-unit recordings have demonstrated attention-related increases in the gain of neural responses and changes in the size of spatial receptive fields, the net effect of these modulations on the topography of region-level priority maps has not been investigated. Here we used functional magnetic resonance imaging and a multivariate encoding model to reconstruct spatial representations of attended and ignored stimuli using activation patterns across entire visual areas. These reconstructed spatial representations reveal the influence of attention on the amplitude and size of stimulus representations within putative priority maps across the visual hierarchy. Our results suggest that attention increases the amplitude of stimulus representations in these spatial maps, particularly in higher visual areas, but does not substantively change their size.	[Sprague, Thomas C.; Serences, John T.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Serences, John T.] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Sprague, TC (corresponding author), Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA.	tsprague@ucsd.edu; jserences@ucsd.edu		Sprague, Thomas/0000-0001-9530-2463	National Science Foundation Graduate Research Fellowship; National Institutes of Health [ROT MH-092345]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092345] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E Vul and S. Itthipuripat for assistance with statistical methods and M. Scolari and M. Smith for assistance with parietal cortex mapping protocols. This work was supported by a National Science Foundation Graduate Research Fellowship to T.C.S. and by US National Institutes of Health grant ROT MH-092345 and a fames S. McDonnell Scholar Award to J.T.S.	Anton-Erxleben K, 2013, NAT REV NEUROSCI, V14, P188, DOI 10.1038/nrn3443; Anton-Erxleben K, 2009, CEREB CORTEX, V19, P2466, DOI 10.1093/cercor/bhp002; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Brouwer GJ, 2009, J NEUROSCI, V29, P13992, DOI 10.1523/JNEUROSCI.3577-09.2009; Conner CE, 1997, J NEUROSCI, V17, P3201; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Fischer J, 2009, CURR BIOL, V19, P1356, DOI 10.1016/j.cub.2009.06.059; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Gattass R, 2005, PHILOS T R SOC B, V360, P709, DOI 10.1098/rstb.2005.1629; Hamed SB, 2002, CEREB CORTEX, V12, P234, DOI 10.1093/cercor/12.3.234; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jehee JFM, 2011, J NEUROSCI, V31, P8210, DOI 10.1523/JNEUROSCI.6153-09.2011; Jerde TA, 2012, J NEUROSCI, V32, P17382, DOI 10.1523/JNEUROSCI.3810-12.2012; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kastner S, 2007, J NEUROPHYSIOL, V97, P3494, DOI 10.1152/jn.00010.2007; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MOHLER CW, 1973, BRAIN RES, V61, P385, DOI 10.1016/0006-8993(73)90543-X; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MURRAY SO, 2008, J VIS, V8; Naselaris T, 2011, NEUROIMAGE, V56, P400, DOI 10.1016/j.neuroimage.2010.07.073; Niebergall R, 2011, J NEUROSCI, V31, P15499, DOI 10.1523/JNEUROSCI.2822-11.2011; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Saproo S, 2010, J NEUROPHYSIOL, V104, P885, DOI 10.1152/jn.00369.2010; Saygin AP, 2008, CEREB CORTEX, V18, P2158, DOI 10.1093/cercor/bhm242; Scolari M, 2012, J NEUROSCI, V32, P7723, DOI 10.1523/JNEUROSCI.5558-11.2012; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Serences JT, 2012, NEUROPSYCHOLOGIA, V50, P435, DOI 10.1016/j.neuropsychologia.2011.07.013; Serences JT, 2006, TRENDS COGN SCI, V10, P38, DOI 10.1016/j.tics.2005.11.008; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Srimal R, 2008, NEUROIMAGE, V39, P455, DOI 10.1016/j.neuroimage.2007.08.040; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Womelsdorf T, 2008, J NEUROSCI, V28, P8934, DOI 10.1523/JNEUROSCI.4030-07.2008; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748	50	123	126	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1879	1887		10.1038/nn.3574	http://dx.doi.org/10.1038/nn.3574			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24212672	Green Accepted, Green Submitted			2022-12-17	WOS:000327416800027
J	Ghosh, A; Haiss, F; Sydekum, E; Schneider, R; Gullo, M; Wyss, MT; Mueggler, T; Baltes, C; Rudin, M; Weber, B; Schwab, ME				Ghosh, Arko; Haiss, Florent; Sydekum, Esther; Schneider, Regula; Gullo, Miriam; Wyss, Matthias T.; Mueggler, Thomas; Baltes, Christof; Rudin, Markus; Weber, Bruno; Schwab, Martin E.			Rewiring of hindlimb corticospinal neurons after spinal cord injury	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; PYRAMIDAL TRACT CELLS; MOTOR CORTEX; ADULT-RATS; PLASTICITY; REGENERATION; CONNECTIONS; STIMULATION; ACTIVATION; RESPONSES	Little is known about the functional role of axotomized cortical neurons that survive spinal cord injury. Large thoracic spinal cord injuries in adult rats result in impairments of hindlimb function. Using retrograde tracers, we found that axotomized corticospinal axons from the hindlimb sensorimotor cortex sprouted in the cervical spinal cord. Mapping of these neurons revealed the emergence of a new forelimb corticospinal projection from the rostral part of the former hindlimb cortex. Voltage-sensitive dye (VSD) imaging and blood-oxygen-level-dependent functional magnetic resonance imaging (BOLD fMRI) revealed a stable expansion of the forelimb sensory map, covering in particular the former hindlimb cortex containing the rewired neurons. Therefore, axotomised hindlimb corticospinal neurons can be incorporated into the sensorimotor circuits of the unaffected forelimb.	[Ghosh, Arko; Sydekum, Esther; Schneider, Regula; Gullo, Miriam; Mueggler, Thomas; Baltes, Christof; Rudin, Markus; Schwab, Martin E.] Swiss Fed Inst Technol, Zurich, Switzerland; [Haiss, Florent; Wyss, Matthias T.; Rudin, Markus; Weber, Bruno] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Sydekum, Esther; Mueggler, Thomas; Baltes, Christof; Rudin, Markus] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Ghosh, Arko; Schneider, Regula; Gullo, Miriam; Schwab, Martin E.] Univ Zurich, Brain Res Inst, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; University of Zurich	Ghosh, A (corresponding author), Univ Zurich, Inst Neuroinformat, Zurich, Switzerland.	arko@ini.phys.ethz.ch	Weber, Bruno/E-4400-2013; Wyss, Matthias T/A-9659-2012; Schwab, Martin E/B-6818-2016; Wyss, Matthias/F-4095-2011; Mueggler, Thomas/AAC-7998-2020; Rudin, Markus/F-2417-2010; Ghosh, Arko/I-4235-2016; Haiss, Florent/L-1685-2015	Wyss, Matthias T/0000-0002-2037-3424; Ghosh, Arko/0000-0002-2924-5146; Haiss, Florent/0000-0001-8351-3685	Swiss National Science Foundation [31-63633.00]; National Center of Competence in Research; Christopher Reeve Paralysis Foundation; European Consortium for Research in Neurodegenerative Diseases	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research(Swiss National Science Foundation (SNSF)); Christopher Reeve Paralysis Foundation; European Consortium for Research in Neurodegenerative Diseases	We thank J. Scholl, E. Hochreutener, R. Schob and L. Schnell for technical assistance. We thank A. Buchli, I. Maier, M. Starkey, V. Pernet, D. Margolis and B. Kampa for helpful discussions. This work was supported by the Swiss National Science Foundation, Grant 31-63633.00, the National Center of Competence in Research "Neural Plasticity and Repair" of the Swiss National Science Foundation, the Spinal Cord Consortium of the Christopher Reeve Paralysis Foundation, and NeuroNe, Network of Excellence of the European Consortium for Research in Neurodegenerative Diseases ( Sixth Framework EU Program).	Adrian ED, 1939, J PHYSIOL-LONDON, V97, P153, DOI 10.1113/jphysiol.1939.sp003798; AKINTUNDE A, 1992, BRAIN RES, V575, P86, DOI 10.1016/0006-8993(92)90427-B; AOKI M, 1986, Neuroscience Research, V3, P617, DOI 10.1016/0168-0102(86)90058-1; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Brown CE, 2009, J NEUROSCI, V29, P1719, DOI 10.1523/JNEUROSCI.4249-08.2009; Choi D, 2002, J NEUROSCI METH, V117, P167, DOI 10.1016/S0165-0270(02)00098-5; Curt A, 2002, J NEUROTRAUM, V19, P43, DOI 10.1089/089771502753460222; Doetsch GS, 1996, EXP BRAIN RES, V112, P505; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; Fawcett JW, 1998, TRENDS NEUROSCI, V21, P179, DOI 10.1016/S0166-2236(98)01241-7; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; FOERSTER AP, 1982, J COMP NEUROL, V210, P335, DOI 10.1002/cne.902100403; Fouad K, 2001, CURR BIOL, V11, P1766, DOI 10.1016/S0960-9822(01)00535-8; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; GUILBAUD G, 1992, EXP BRAIN RES, V92, P227; Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; HESS G, 1994, J NEUROPHYSIOL, V71, P2543, DOI 10.1152/jn.1994.71.6.2543; Huntley GW, 1997, CEREB CORTEX, V7, P143, DOI 10.1093/cercor/7.2.143; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; JAIN N, 1995, J NEUROPHYSIOL, V73, P1537, DOI 10.1152/jn.1995.73.4.1537; Jain N, 2000, P NATL ACAD SCI USA, V97, P5546, DOI 10.1073/pnas.090572597; Kaas JH, 2008, EXP NEUROL, V209, P407, DOI 10.1016/j.expneurol.2007.06.014; KALIL K, 1975, BRAIN RES, V89, P15, DOI 10.1016/0006-8993(75)90130-4; Kim BG, 2006, EXP NEUROL, V198, P401, DOI 10.1016/j.expneurol.2005.12.010; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Liu ZHM, 2004, MAGN RESON MED, V52, P277, DOI 10.1002/mrm.20148; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; MCCOMAS AJ, 1968, J PHYSIOL-LONDON, V194, P271, DOI 10.1113/jphysiol.1968.sp008407; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; NEAFSEY EJ, 1982, BRAIN RES, V232, P151, DOI 10.1016/0006-8993(82)90617-5; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Rosenkranz K, 2007, J NEUROSCI, V27, P5200, DOI 10.1523/JNEUROSCI.0836-07.2007; Salimi I, 2008, J NEUROSCI, V28, P7426, DOI 10.1523/JNEUROSCI.1078-08.2008; SCHREYER DJ, 1988, DEV BRAIN RES, V38, P103, DOI 10.1016/0165-3806(88)90089-2; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; SIEVERT CF, 1986, BRAIN RES, V381, P15, DOI 10.1016/0006-8993(86)90684-0; SWETT JE, 1967, J PHYSIOL-LONDON, V189, P101, DOI 10.1113/jphysiol.1967.sp008157; Sydekum E, 2009, NEUROIMAGE, V44, P1345, DOI 10.1016/j.neuroimage.2008.10.015; Tseng GF, 1996, J NEUROPHYSIOL, V75, P248, DOI 10.1152/jn.1996.75.1.248; Turner JA, 2003, NEUROREHAB NEURAL RE, V17, P37, DOI 10.1177/0888439002250443; WALL PD, 1971, NATURE, V232, P542, DOI 10.1038/232542a0; Wannier T, 2005, J NEUROTRAUM, V22, P703, DOI 10.1089/neu.2005.22.703; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798	47	123	125	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					97	U266		10.1038/nn.2448	http://dx.doi.org/10.1038/nn.2448			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	20010824				2022-12-17	WOS:000273056300019
J	Woolfrey, KM; Srivastava, DP; Photowala, H; Yamashita, M; Barbolina, MV; Cahill, ME; Xie, Z; Jones, KA; Quilliam, LA; Prakriya, M; Penzes, P				Woolfrey, Kevin M.; Srivastava, Deepak P.; Photowala, Huzefa; Yamashita, Megumi; Barbolina, Maria V.; Cahill, Michael E.; Xie, Zhong; Jones, Kelly A.; Quilliam, Lawrence A.; Prakriya, Murali; Penzes, Peter			Epac2 induces synapse remodeling and depression and its disease-associated forms alter spines	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; DENDRITIC SPINES; HIPPOCAMPAL-NEURONS; PREFRONTAL CORTEX; EXCHANGE PROTEIN; D1 RECEPTORS; MAP KINASE; CYCLIC-AMP; CAMP; PLASTICITY	Dynamic remodeling of spiny synapses is crucial for cortical circuit development, refinement and plasticity, whereas abnormal morphogenesis is associated with neuropsychiatric disorders. We found that activation of Epac2, a PKA-independent cAMP target and Rap guanine-nucleotide exchange factor (GEF), in cultured rat cortical neurons induced spine shrinkage, increased spine motility, removed synaptic GluR2/3-containing AMPA receptors and depressed excitatory transmission, whereas its inhibition promoted spine enlargement and stabilization. Epac2 was required for dopamine D1-like receptor-dependent spine shrinkage and GluR2 removal from spines. Epac2 interaction with neuroligin promoted its membrane recruitment and enhanced its GEF activity. Rare missense mutations in the EPAC2 (also known as RAPGEF4) gene, previously found in individuals with autism, affected basal and neuroligin-stimulated GEF activity, dendritic Rap signaling, synaptic protein distribution and spine morphology. Thus, we identify a previously unknown mechanism that promotes dynamic remodeling and depression of spiny synapses, disruption of which may contribute to some aspects of disease.	[Woolfrey, Kevin M.; Srivastava, Deepak P.; Photowala, Huzefa; Cahill, Michael E.; Xie, Zhong; Jones, Kelly A.; Penzes, Peter] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Yamashita, Megumi; Prakriya, Murali] Northwestern Univ, Dept Biol Chem & Mol Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA; [Barbolina, Maria V.] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL USA; [Quilliam, Lawrence A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Quilliam, Lawrence A.] Walther Canc Inst, Indianapolis, IN USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute	Penzes, P (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	p-penzes@northwestern.edu	Quilliam, Lawrence/B-6447-2015; Quilliam, Lawrence/Q-4987-2019; Penzes, Peter/L-3987-2016; Xie, Zhong/B-6829-2011	Penzes, Peter/0000-0001-5449-1640; Xie, Zhong/0000-0002-8348-4455; Prakriya, Murali/0000-0003-0781-4480; Cahill, Michael/0000-0003-0574-2655; Yamashita, Megumi/0000-0003-0196-0428; Srivastava, Deepak Prakash/0000-0001-6512-9065	National Alliance for Autism Research; National Alliance for Research on Schizophrenia and Depression; Alzheimer's Association; US National Institutes of Health [MH 071316, NS057499, CA108647]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA108647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS057499, R01NS057499] Funding Source: NIH RePORTER	National Alliance for Autism Research; National Alliance for Research on Schizophrenia and Depression(NARSAD); Alzheimer's Association(Alzheimer's Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. L. Huganir ( Johns Hopkins University) for antibodies to AMPAR and NMDAR subunits, J. Bos ( Utrecht University) and P. Stork ( Vollum Institute) for plasmids, A. El- Husseini ( University of British Columbia) and P. Scheiffele ( University of Basel) for antibodies to neuroligin and plasmid constructs, and G. Borisy and S.- I. Kojima ( Northwestern University) for the pGSuper plasmid. We thank A. K. Srivastava ( J. C. Self Research Institute of Human Genetics) and G. Swanson ( Northwestern University) for thoughtful discussion. This work was supported by the National Alliance for Autism Research, the National Alliance for Research on Schizophrenia and Depression, the Alzheimer's Association, grants from the US National Institutes of Health ( MH 071316 to P. P., NS057499 to M. P. and CA108647 to L. A. Q.), a pre- doctoral American Heart Association fellowship to K. M. W. and a post- doctoral American Heart Association fellowship to D. P. S.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Bacchelli E, 2003, MOL PSYCHIATR, V8, P916, DOI 10.1038/sj.mp.4001340; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Chen ZX, 1996, RECEPTOR CHANNEL, V4, P1; Cheung U, 2006, J NEUROBIOL, V66, P273, DOI 10.1002/neu.20218; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gekel I, 2008, J NEUROSCI, V28, P7991, DOI 10.1523/JNEUROSCI.0268-08.2008; Gelinas JN, 2008, LEARN MEMORY, V15, P403, DOI 10.1101/lm.830008; GEREAU RW, 1994, NEURON, V12, P1121, DOI 10.1016/0896-6273(94)90319-0; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kelly MP, 2009, MOL PSYCHIATR, V14, P398, DOI 10.1038/mp.2008.124; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Li Y, 2006, J BIOL CHEM, V281, P2506, DOI 10.1074/jbc.M508165200; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; Otmakhov N, 2002, J NEUROPHYSIOL, V87, P3018, DOI 10.1152/jn.2002.87.6.3018; Ouyang M, 2008, P NATL ACAD SCI USA, V105, P11993, DOI 10.1073/pnas.0804172105; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Pickett J, 2005, J NEUROPATH EXP NEUR, V64, P925, DOI 10.1097/01.jnen.0000186921.42592.6c; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Srivastava DP, 2008, P NATL ACAD SCI USA, V105, P14650, DOI 10.1073/pnas.0801581105; Ster J, 2009, J PHYSIOL-LONDON, V587, P101, DOI 10.1113/jphysiol.2008.157461; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Ulucan C, 2007, AM J PHYSIOL-HEART C, V293, pH1662, DOI 10.1152/ajpheart.00159.2007; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037	48	123	123	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1275	U96		10.1038/nn.2386	http://dx.doi.org/10.1038/nn.2386			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19734897	Green Accepted			2022-12-17	WOS:000270170200016
J	Kwon, Y; Shim, HS; Wang, XY; Montell, C				Kwon, Young; Shim, Hye-Seok; Wang, Xiaoyue; Montell, Craig			Control of thermotactic behavior via coupling of a TRP channel to a phospholipase C signaling cascade	NATURE NEUROSCIENCE			English	Article							RETINAL-DEGENERATION; DROSOPHILA; PHOTOTRANSDUCTION; PHOSPHATASE; GENE	In animals such as the fruitfly, even minor deviations in environmental temperature can have major impacts on development and lifespan. Here we demonstrated that the ability of Drosophila melanogaster larvae to discriminate between the optimal temperature of 18 degrees C and slightly higher temperatures (19-24 degrees C) depended on the TRPA1 channel, which functioned downstream of a phospholipase C-dependent signaling cascade similar to that used in fly phototransduction. We propose that activation of TRPA1 through a signaling cascade promotes amplification of small differences in temperature and facilitates adaptation to temperatures within the comfortable range.	[Kwon, Young; Shim, Hye-Seok; Wang, Xiaoyue; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA; [Kwon, Young; Shim, Hye-Seok; Wang, Xiaoyue; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Montell, Craig/AAH-3357-2021; Wang, Xiaoyue/D-1046-2010	Montell, Craig/0000-0001-5637-1482; Kwon, Young/0000-0002-8937-3182	NEI NIH HHS [EY010852] Funding Source: Medline; NIGMS NIH HHS [GM085335] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085335] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; Kwon Y, 2006, CURR BIOL, V16, P723, DOI 10.1016/j.cub.2006.02.057; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1	13	123	125	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					871	873		10.1038/nn.2170	http://dx.doi.org/10.1038/nn.2170			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18660806				2022-12-17	WOS:000257969100008
J	Louis, M; Huber, T; Benton, R; Sakmar, TP; Vosshall, LB				Louis, Matthieu; Huber, Thomas; Benton, Richard; Sakmar, Thomas P.; Vosshall, Leslie B.			Bilateral olfactory sensory input enhances chemotaxis behavior	NATURE NEUROSCIENCE			English	Article							C-ELEGANS; WORKING-MEMORY; DROSOPHILA; SMELL; LATERALIZATION; MECHANISMS; RECEPTORS; TRACKING; SYSTEM; CORTEX	Neural comparisons of bilateral sensory inputs are essential for visual depth perception and accurate localization of sounds in space. All animals, from single-cell prokaryotes to humans, orient themselves in response to environmental chemical stimuli, but the contribution of spatial integration of neural activity in olfaction remains unclear. We investigated this problem in Drosophila melanogaster larvae. Using high-resolution behavioral analysis, we studied the chemotaxis behavior of larvae with a single functional olfactory neuron on either the left or right side of the head, allowing us to examine unilateral or bilateral olfactory input. We developed new spectroscopic methods to create stable odorant gradients in which odor concentrations were experimentally measured. In these controlled environments, we observed that a single functional neuron provided sufficient information to permit larval chemotaxis. We found additional evidence that the overall accuracy of navigation is enhanced by the increase in the signal-to-noise ratio conferred by bilateral sensory input.	[Louis, Matthieu; Benton, Richard; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Huber, Thomas; Sakmar, Thomas P.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave, New York, NY 10065 USA.	leslie@rockefeller.edu	Huber, Thomas/A-8016-2008; Sakmar, Thomas P/D-1833-2015; Louis, Matthieu/J-5566-2015	Huber, Thomas/0000-0002-1844-262X; Sakmar, Thomas P/0000-0002-2836-8953; Louis, Matthieu/0000-0002-2267-0262; Vosshall, Leslie/0000-0002-6060-8099				Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BENHAMOU S, 1992, ANIM BEHAV, V43, P371, DOI 10.1016/S0003-3472(05)80097-1; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BERG HC, 2004, E COIL MOTION; Bray D, 2007, CURR BIOL, V17, P12, DOI 10.1016/j.cub.2006.11.027; Cobb M, 1999, BIOL REV, V74, P425, DOI 10.1017/S0006323199005393; COBB M, 1992, P ROY SOC B-BIOL SCI, V248, P103, DOI 10.1098/rspb.1992.0048; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fraenkel GS, 1961, ORIENTATION ANIMALS; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Letzkus P, 2006, CURR BIOL, V16, P1471, DOI 10.1016/j.cub.2006.05.060; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Ning QA, 1997, NEURON, V18, P359, DOI 10.1016/S0896-6273(00)81238-6; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Quaranta A, 2007, CURR BIOL, V17, pR199, DOI 10.1016/j.cub.2007.02.008; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Samadani A, 2006, P NATL ACAD SCI USA, V103, P11549, DOI 10.1073/pnas.0601909103; Schrick K, 1997, GENETICS, V147, P19; THESEN A, 1993, J EXP BIOL, V180, P247; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VALLORTIGARA G, 1994, NEUROPSYCHOLOGIA, V32, P417, DOI 10.1016/0028-3932(94)90087-6; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Vetter RS, 2006, CHEM SENSES, V31, P359, DOI 10.1093/chemse/bjj040; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wallace DG, 2002, BEHAV BRAIN RES, V131, P185, DOI 10.1016/S0166-4328(01)00384-9; Zar J.R., 1999, BIOSTAT ANAL; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	47	123	124	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					187	199		10.1038/nn2031	http://dx.doi.org/10.1038/nn2031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18157126				2022-12-17	WOS:000252712100013
J	Ledda, F; Paratcha, G; Sandoval-Guzman, T; Ibanez, CF				Ledda, Fernanda; Paratcha, Gustavo; Sandoval-Guzman, Tatiana; Ibanez, Carlos F.			GDNF and GFR alpha 1 promote formation of neuronal synapses by ligand-induced cell adhesion	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; RECEPTOR TYROSINE KINASE; NEUROTROPHIC FACTOR; C-RET; MOLECULE NCAM; IN-VIVO; BINDING; ACTIVATION; FAMILY; BRAIN	The establishment of synaptic connections requires precise alignment of pre- and postsynaptic terminals. The glial cell line derived neurotrophic factor (GDNF) receptor GFR alpha 1 is enriched at pre- and postsynaptic compartments in hippocampal neurons, suggesting that it has a function in synapse formation. GDNF triggered trans-homophilic binding between GFR alpha 1 molecules and cell adhesion between GFR alpha 1-expressing cells. This represents the first example of a cell-cell interaction being mediated by a ligand-induced cell adhesion molecule (LICAM). In the presence of GDNF, ectopic GFR alpha 1 induced localized presynaptic differentiation in hippocampal neurons, as visualized by clustering of vesicular proteins and neurotransmitter transporters, and by activity-dependent vesicle recycling. Presynaptic differentiation induced by GDNF was markedly reduced in neurons lacking GFR alpha 1. Gdnf mutant mice showed reduced synaptic localization of presynaptic proteins and a marked decrease in the density of presynaptic puncta, indicating a role for GDNF signaling in hippocampal synaptogenesis in vivo. We propose that GFR alpha 1 functions as a LICAM to establish precise synaptic contacts and induce presynaptic differentiation.	Karolinska Inst, Div Mol Neurobiol, S-17177 Stockholm, Sweden; Karolinska Inst, Mol & Cellular Neurosci Lab, Dept Neurosci, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Ledda, F (corresponding author), Karolinska Inst, Div Mol Neurobiol, S-17177 Stockholm, Sweden.	fernanda.ledda@ki.se; carlos.ibanez@ki.se	Sandoval-Guzmán, Tatiana/B-8172-2017; Sandoval-Guzmán, Tatiana/P-2473-2019; Sandoval-Guzman, Tatiana/P-3795-2018	Sandoval-Guzmán, Tatiana/0000-0003-1802-5145; Sandoval-Guzmán, Tatiana/0000-0003-1802-5145; 				Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bourque MJ, 2000, EUR J NEUROSCI, V12, P3172, DOI 10.1046/j.1460-9568.2000.00219.x; Cammarota M, 1999, J NEUROCHEM, V72, P2272, DOI 10.1046/j.1471-4159.1999.0722272.x; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; Leppanen VM, 2004, EMBO J, V23, P1452, DOI 10.1038/sj.emboj.7600174; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Maximov A, 2002, J NEUROSCI, V22, P6939; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Miyazaki H, 2001, BRAIN RES, V922, P165, DOI 10.1016/S0006-8993(01)03013-X; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Scott RP, 2001, J BIOL CHEM, V276, P1450, DOI 10.1074/jbc.M006157200; Serra MP, 2002, BRAIN RES, V928, P138, DOI 10.1016/S0006-8993(01)03377-7; Sytnyk V, 2006, J CELL BIOL, V174, P1071, DOI 10.1083/jcb.200604145; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Trupp M, 1997, J NEUROSCI, V17, P3554; TRUPP M, 1996, NATURE, V381, P789; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Voikar V, 2004, EUR J NEUROSCI, V20, P308, DOI 10.1111/j.1460-9568.2004.03475.x; Wang CY, 2002, J BIOL CHEM, V277, P10614, DOI 10.1074/jbc.M106116200; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Yamada MK, 2002, J NEUROSCI, V22, P7580; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	45	123	130	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					293	300		10.1038/nn1855	http://dx.doi.org/10.1038/nn1855			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17310246				2022-12-17	WOS:000244480300011
J	Soler-Llavina, GJ; Sabatini, BL				Soler-Llavina, Gilberto J.; Sabatini, Bernardo L.			Synapse-specific plasticity and compartmentalized signaling in cerebellar stellate cells	NATURE NEUROSCIENCE			English	Article							BOVINE CHROMAFFIN CELLS; CALCIUM-PERMEABLE AMPA; DENDRITIC SPINES; HIPPOCAMPAL INTERNEURONS; PURKINJE-CELLS; RETROGRADE INHIBITION; ENDOGENOUS CANNABINOIDS; EXCITATORY SYNAPSES; CA2+; RECEPTORS	Here we demonstrate that cerebellar stellate cells diffusionally isolate synaptically evoked signals in dendrites and are capable of input-specific synaptic plasticity. Sustained activity of parallel fibers induces a form of long-term depression that requires opening of calcium (Ca21)-permeable AMPA-type glutamate receptors (CP-AMPARs) and signaling through class 1 metabotropic glutamate receptors (mGluR1) and CB1 receptors. This depression is induced by postsynaptic increases in Ca2+ concentration ([Ca2+]) and is limited to activated synapses. To understand how synapse-specific plasticity is induced by diffusible second messengers in aspiny dendrites, we examined diffusion of Ca2+ and small molecules within stellate cell dendrites. Activation of a single parallel fiber opened CP-AMPARs, generating long-lived Ca2+ transients that were confined to submicron dendritic stretches. The diffusion of Ca2+ was severely retarded due to interactions with parvalbumin and a general restriction of small molecule mobility. Thus stellate cell dendrites spatially restrict signaling cascades that lead from CP-AMPAR activation to endocannabinoid production and trigger the selective regulation of active synapses.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS049655, R01NS046579] Funding Source: NIH RePORTER; NINDS NIH HHS [1 F31 NS049655-01, R01 NS046579] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Brenowitz SD, 2003, J NEUROSCI, V23, P6373; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Cowan AI, 1998, J NEUROPHYSIOL, V79, P13, DOI 10.1152/jn.1998.79.1.13; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gabso M, 1997, NEURON, V18, P473, DOI 10.1016/S0896-6273(00)81247-7; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HERKENHAM M, 1992, ANN NY ACAD SCI, V654, P19, DOI 10.1111/j.1749-6632.1992.tb25953.x; HOU TT, 1991, J PHYSIOL-LONDON, V441, P285, DOI 10.1113/jphysiol.1991.sp018752; Jasuja R, 1999, BIOPHYS J, V76, P1706, DOI 10.1016/S0006-3495(99)77329-7; Kaiser KMM, 2004, J NEUROSCI, V24, P1319, DOI 10.1523/JNEUROSCI.2852-03.2004; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; KOSAKA T, 1993, EXP BRAIN RES, V93, P483; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; KUSHMERICK MJ, 1969, SCIENCE, V166, P1297, DOI 10.1126/science.166.3910.1297; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; Li-Smerin YY, 2001, J PHYSIOL-LONDON, V533, P729, DOI 10.1111/j.1469-7793.2001.t01-1-00729.x; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Maejima T, 2001, NEUROSCI RES, V40, P205, DOI 10.1016/S0168-0102(01)00241-3; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; Michailova A, 2002, BIOPHYS J, V83, P3134, DOI 10.1016/S0006-3495(02)75317-4; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; PALAY SL, 1974, STELLATE CELL, P216; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; POPOV S, 1992, J NEUROSCI, V12, P77; Rancillac A, 2005, J NEUROSCI RES, V80, P414, DOI 10.1002/jnr.20473; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Rozsa B, 2004, J NEUROSCI, V24, P661, DOI 10.1523/JNEUROSCI.3906-03.2004; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; STRAUTMAN AF, 1990, J NEUROSCI, V10, P3564; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Topolnik L, 2005, J NEUROSCI, V25, P990, DOI 10.1523/JNEUROSCI.4388-04.2005; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Xia P, 1998, BIOPHYS J, V74, P3302, DOI 10.1016/S0006-3495(98)78037-3; YASUDA R, 2004, SCI STKE, pP15; ZADOR A, 1994, J NEUROSCI, V14, P4705; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	50	123	127	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					798	806		10.1038/nn1698	http://dx.doi.org/10.1038/nn1698			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16680164				2022-12-17	WOS:000237895200020
J	Bao, JX; Lin, H; Ouyang, Y; Lei, DB; Osman, A; Kim, TW; Mei, L; Dai, PG; Ohlemiller, KK; Ambron, RT				Bao, JX; Lin, H; Ouyang, Y; Lei, DB; Osman, A; Kim, TW; Mei, L; Dai, PG; Ohlemiller, KK; Ambron, RT			Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos	NATURE NEUROSCIENCE			English	Article							SYNAPTIC-TRANSMISSION; PLASTICITY; GENE; EXPRESSION; MECHANISMS; PROTEINS; CLEAVAGE; REQUIRES; RELEASE; FAMILY	Neuregulin-1 (Nrg-1) contains an intracellular domain (Nrg-ICD) that translocates into the nucleus, where it may regulate gene expression upon neuronal depolarization. However, the identity of its target promoters and the mechanisms by which it regulates transcription have been elusive. Here we report that, in the mouse cochlea, synaptic activity increases the level of nuclear Nrg-ICD and upregulates postsynaptic density protein-95 (PSD-95), a scaffolding protein that is enriched in post-synaptic structures. Nrg-ICD enhances the transcriptional activity of the PSD-95 promoter by binding to a zinc-finger transcription factor, Eos. The Nrg-ICD-Eos complex induces endogenous PSD-95 expression in vivo through a signaling pathway that is mostly independent of gamma-secretase regulation. This upregulation of PSD-95 expression by the Nrg-ICD- Eos complex provides a molecular basis for activity-dependent synaptic plasticity.	Washington Univ, Dept Otolaryngol, St Louis, MO 63110 USA; Washington Univ, Ctr Aging, St Louis, MO 63110 USA; Washington Univ, Dept Neurol, St Louis, MO 63110 USA; Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Med Coll Georgia, Dept Neurol, Inst Mol Med & Genet, Augusta, GA 30912 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Columbia University; Columbia University; University System of Georgia; Augusta University	Bao, JX (corresponding author), Washington Univ, Dept Otolaryngol, St Louis, MO 63110 USA.	jbao@wustl.edu	Mei, Lin/G-8755-2012		NATIONAL INSTITUTE ON AGING [K01AG001016, P50AG005681] Funding Source: NIH RePORTER; NIA NIH HHS [AG01016, AG05681] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; Chaudhury AR, 2003, J NEUROPATH EXP NEUR, V62, P42, DOI 10.1093/jnen/62.1.42; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 2002, NEURON, V34, P179, DOI 10.1016/S0896-6273(02)00664-5; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Grimm S, 1998, J EXP MED, V188, P1535, DOI 10.1084/jem.188.8.1535; Honma Y, 1999, FEBS LETT, V447, P76, DOI 10.1016/S0014-5793(99)00265-3; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Liu XF, 1998, J BIOL CHEM, V273, P34335, DOI 10.1074/jbc.273.51.34335; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Morley BJ, 1998, MOL BRAIN RES, V54, P170, DOI 10.1016/S0169-328X(97)00355-0; Muller T J, 2001, World J Biol Psychiatry, V2, P9; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Ohlemiller KK, 2000, HEARING RES, V149, P239, DOI 10.1016/S0378-5955(00)00191-X; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Perdomo J, 2000, J BIOL CHEM, V275, P38347, DOI 10.1074/jbc.M005457200; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Puel JL, 1995, PROG NEUROBIOL, V47, P449, DOI 10.1016/0301-0082(95)00028-3; Quaranta A, 1998, SCAND AUDIOL, V27, P75; Rowan MJ, 2003, PHILOS T R SOC B, V358, P821, DOI 10.1098/rstb.2002.1240; Roysommuti S, 2003, NEUROSCIENCE, V121, P779, DOI 10.1016/S0306-4522(03)00503-7; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Stathakis DG, 1999, J NEUROCHEM, V73, P2250, DOI 10.1046/j.1471-4159.1999.0732250.x; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Steward O, 2002, NEUROBIOL LEARN MEM, V78, P508, DOI 10.1006/nlme.2002.4102; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Wang CH, 1998, NEUROGENETICS, V1, P273; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wolpaw JR, 2001, ANNU REV NEUROSCI, V24, P807, DOI 10.1146/annurev.neuro.24.1.807; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; Zhang M, 2002, HEARING RES, V169, P56, DOI 10.1016/S0378-5955(02)00339-8; Zito K, 2003, NEURON, V37, P1, DOI 10.1016/S0896-6273(02)01182-0	50	123	133	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1250	1258		10.1038/nn1342	http://dx.doi.org/10.1038/nn1342			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494726				2022-12-17	WOS:000224749400018
J	Bradley, SR; Pieribone, VA; Wang, WG; Severson, CA; Jacobs, RA; Richerson, GB				Bradley, SR; Pieribone, VA; Wang, WG; Severson, CA; Jacobs, RA; Richerson, GB			Chemosensitive serotonergic neurons are closely associated with large medullary arteries	NATURE NEUROSCIENCE			English	Article							INFANT-DEATH-SYNDROME; RAPHE NEURONS; IMMUNOREACTIVITY; NUCLEI; SYSTEM; CATS; RAT		Yale Univ, Dept Neurol, New Haven, CT 06510 USA; Yale Univ, Dept Cell & Mol Physiol, New Haven, CT 06510 USA; J Pierce Lab, New Haven, CT 06510 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Vet Affairs Med Ctr, West Haven, CT 06516 USA	Yale University; Yale University; Yale University; The John B Pierce Laboratory, Inc; Salk Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Richerson, GB (corresponding author), Yale Univ, Dept Neurol, 333 Cedar St, New Haven, CT 06510 USA.			Richerson, George/0000-0001-5696-1554; Pieribone, Vincent/0000-0002-5836-5454	NHLBI NIH HHS [HL-52539] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bernard DG, 1996, J APPL PHYSIOL, V80, P108, DOI 10.1152/jappl.1996.80.1.108; FELTEN DL, 1979, AM J ANAT, V155, P467, DOI 10.1002/aja.1001550405; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; LALLEY PM, 1986, J PHYSIOL-LONDON, V380, P373, DOI 10.1113/jphysiol.1986.sp016291; LARNICOL N, 1994, J PHYSIOLOGY-PARIS, V88, P81, DOI 10.1016/0928-4257(94)90094-9; MITCHELL RA, 1963, J APPL PHYSIOL, V18, P523, DOI 10.1152/jappl.1963.18.3.523; Panigrahy A, 2000, J NEUROPATH EXP NEUR, V59, P377, DOI 10.1093/jnen/59.5.377; Richerson GB, 2001, RESP PHYSIOL, V129, P175, DOI 10.1016/S0034-5687(01)00289-4; SCHEIBEL ME, 1975, EXP NEUROL, V47, P316, DOI 10.1016/0014-4886(75)90260-5; SCHLAEFKE ME, 1970, RESP PHYSIOL, V10, P198, DOI 10.1016/0034-5687(70)90083-6; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; VEASEY SC, 1995, J NEUROSCI, V15, P5346; Wang WG, 1998, J PHYSIOL-LONDON, V511, P433, DOI 10.1111/j.1469-7793.1998.433bh.x; Wang WG, 2001, J NEUROPHYSIOL, V85, P2224, DOI 10.1152/jn.2001.85.5.2224	15	123	125	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					401	402		10.1038/nn848	http://dx.doi.org/10.1038/nn848			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11967547				2022-12-17	WOS:000175272000008
J	Swindale, NV; Shoham, D; Grinvald, A; Bonhoeffer, T; Hubener, M				Swindale, NV; Shoham, D; Grinvald, A; Bonhoeffer, T; Hubener, M			Visual cortex maps are optimized for uniform coverage	NATURE NEUROSCIENCE			English	Article							OCULAR-DOMINANCE COLUMNS; MONKEY STRIATE CORTEX; RECEPTIVE-FIELD; CAT AREA-17; ORIENTATION; ORGANIZATION; DIRECTION; PREFERENCE; GEOMETRY	Cat visual cortex contains a topographic map of visual space, plus superimposed, spatially periodic maps of ocular dominance, spatial frequency and orientation. It is hypothesized that the layout of these maps is determined by two constraints: continuity or smooth mapping of stimulus properties across the cortical surface, and coverage uniformity or uniform representation of combinations of map features over visual space. Here we use a quantitative measure of coverage uniformity (c') to test the hypothesis that cortical maps are optimized for coverage. When we perturbed the spatial relationships between ocular dominance, spatial frequency and orientation maps obtained in single regions of cortex, we found that cortical maps are at a local minimum for c'. This suggests that coverage optimization is an important organizing principle governing cortical map development.	Univ British Columbia, Dept Ophthalmol, Vancouver, BC V5Z 3N9, Canada; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	University of British Columbia; Weizmann Institute of Science; Max Planck Society	Swindale, NV (corresponding author), Univ British Columbia, Dept Ophthalmol, 2550 Willow St, Vancouver, BC V5Z 3N9, Canada.		Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634				ALBUS K, 1975, EXP BRAIN RES, V24, P159, DOI 10.1007/BF00234061; BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; DURBIN R, 1987, NATURE, V326, P698; Hetherington PA, 1999, VISUAL NEUROSCI, V16, P637, DOI 10.1017/S0952523899164046; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubener M, 1997, J NEUROSCI, V17, P9270; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; OBERMAYER K, 1992, PHYS REV A, V45, P7568, DOI 10.1103/PhysRevA.45.7568; OBERMAYER K, 1990, P NATL ACAD SCI USA, V87, P8345, DOI 10.1073/pnas.87.21.8345; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; Shmuel A, 1996, J NEUROSCI, V16, P6945; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; SWINDALE N V, 1992, Current Biology, V2, P429, DOI 10.1016/0960-9822(92)90326-6; SWINDALE NV, 1991, BIOL CYBERN, V65, P415, DOI 10.1007/BF00204654; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; SWINDALE NV, 1987, J NEUROSCI, V7, P1414; SWINDALE NV, IN PRESS CEREB CORTE; THOMPSON ID, 1981, J PHYSL, V300, P58; TOOTELL RB, 1981, SCIENCE, V214, P813, DOI 10.1126/science.7292014; TOOTELL RBH, 1988, J NEUROSCI, V8, P1569; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0	27	123	123	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					822	826		10.1038/77731	http://dx.doi.org/10.1038/77731			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903576				2022-12-17	WOS:000167177300018
J	Joo, JY; Schaukowitch, K; Farbiak, L; Kilaru, G; Kim, TK				Joo, Jae-Yeol; Schaukowitch, Katie; Farbiak, Lukas; Kilaru, Gokhul; Kim, Tae-Kyung			Stimulus-specific combinatorial functionality of neuronal c-fos enhancers	NATURE NEUROSCIENCE			English	Article							ACTIVITY-DEPENDENT REGULATION; GENE-EXPRESSION; TRANSCRIPTIONAL PROGRAM; IN-VIVO; ACTIVATION; MECHANISMS; MEMORY; ARCHITECTURE; PLASTICITY; LANDSCAPE	The c-fos gene (also known as Fos) is induced by a broad range of stimuli and is a reliable marker for neural activity. Its induction mechanism and available reporter mouse lines are based exclusively on c-fos promoter activity. Here we demonstrate that multiple enhancers surrounding the c-fos gene are crucial for ensuring robust c-fos response to various stimuli. Membrane depolarization, brain-derived neurotrophic factor (BDNF) and forskolin activate distinct subsets of the enhancers to induce c-fos transcription in neurons, suggesting that stimulus-specific combinatorial activation of multiple enhancers underlies the broad inducibility of the c-fos gene. Accordingly, the functional requirement of key transcription factors varies depending on the type of stimulation. Combinatorial enhancer activation also occurs in the brain. Providing a comprehensive picture of the c-fos induction mechanism beyond the minimal promoter, our study should help in understanding the physiological nature of c-fos induction in relation to neural activity and plasticity.	[Joo, Jae-Yeol; Schaukowitch, Katie; Farbiak, Lukas; Kilaru, Gokhul; Kim, Tae-Kyung] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Kim, TK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	taekyung.kim@utsouthwestern.edu	Kim, Tae-Kyung/AAX-4230-2020	Kim, Tae-Kyung/0000-0001-5161-9864; Joo, Jae-Yeol/0000-0003-2571-3173; Farbiak, Lukas/0000-0003-4107-1676	US National Science Foundation (NSF) BRAIN EAGER Award [IOS1451034]; US National Institute of Neurological Disorders and Stroke (NINDS) [R01NS085418]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085418] Funding Source: NIH RePORTER	US National Science Foundation (NSF) BRAIN EAGER Award(National Science Foundation (NSF)); US National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Monteggia and members of her laboratory for providing conditional Bdnf KO mice. We thank M. Greenberg for providing MEF2A and MEF2D antibodies used for ChIP experiments. We also thank W. Xu for advice on stereotaxic injection, and C. Green and J. Stubblefield for providing the dark controlled-environment chamber. This work was supported by the US National Science Foundation (NSF) BRAIN EAGER Award (IOS1451034) and the US National Institute of Neurological Disorders and Stroke (NINDS) under award number R01NS085418 (T.-K.K.).	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Guenthner CJ, 2013, NEURON, V78, P773, DOI 10.1016/j.neuron.2013.03.025; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kawashima T, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00037; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Lamprecht R, 1996, LEARN MEMORY, V3, P31, DOI 10.1101/lm.3.1.31; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Lyons MR, 2011, PROG NEUROBIOL, V94, P259, DOI 10.1016/j.pneurobio.2011.05.003; Malik AN, 2014, NAT NEUROSCI, V17, P1330, DOI 10.1038/nn.3808; Mileusnic R, 1996, NEUROREPORT, V7, P1269, DOI 10.1097/00001756-199605170-00010; MISRA RP, 1994, J BIOL CHEM, V269, P25483; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pereira AHM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008472; Pinheiro EM, 2011, NAT CELL BIOL, V13, P989, DOI 10.1038/ncb2292; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaukowitch K, 2014, MOL CELL, V56, P29, DOI 10.1016/j.molcel.2014.08.023; Schwarzer W, 2014, CURR OPIN GENET DEV, V27, P74, DOI 10.1016/j.gde.2014.03.014; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004610	53	122	128	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2016	19	1					75	+		10.1038/nn.4170	http://dx.doi.org/10.1038/nn.4170			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ7BH	26595656	Green Accepted			2022-12-17	WOS:000367254400015
J	Busche, MA; Kekus, M; Adelsberger, H; Noda, T; Forstl, H; Nelken, I; Konnerth, A				Busche, Marc Aurel; Kekus, Maja; Adelsberger, Helmuth; Noda, Takahiro; Foerstl, Hans; Nelken, Israel; Konnerth, Arthur			Rescue of long-range circuit dysfunction in Alzheimer's disease models	NATURE NEUROSCIENCE			English	Article							SLOW-WAVE SLEEP; IN-VIVO; AMYLOID-BETA; NEOCORTICAL NETWORKS; MEMORY CONSOLIDATION; VISUAL-CORTEX; BRAIN RHYTHMS; MOUSE MODEL; OSCILLATION; MICE	Alzheimer's disease (AD) is associated with defects of synaptic connectivity. Such defects may not be restricted to local neuronal interactions but may extend to long-range brain activities, such as slow-wave oscillations that are particularly prominent during non rapid eye movement (non-REM) sleep and are important for integration of information across distant brain regions involved in memory consolidation. There is increasing evidence that sleep is often impaired in AD, but it is unclear whether this impairment is directly related to amyloid-beta (A beta) pathology. Here we demonstrate that slow-wave activity is severely altered in the neocortex, thalamus and hippocampus in mouse models of AD amyloidosis. Most notably, our results reveal an A beta-dependent impairment of slow-wave propagation, which causes a breakdown of the characteristic long-range coherence of slow-wave activity. The finding that the impairment can be rescued by enhancing GABA(A)ergic inhibition identifies a synaptic mechanism underlying A beta-dependent large-scale circuit dysfunction.	[Busche, Marc Aurel; Kekus, Maja; Adelsberger, Helmuth; Noda, Takahiro; Konnerth, Arthur] Tech Univ Munich, Inst Neurosci, D-80290 Munich, Germany; [Foerstl, Hans] Tech Univ Munich, Dept Psychiat & Psychotherapy, D-80290 Munich, Germany; [Busche, Marc Aurel; Konnerth, Arthur] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Busche, Marc Aurel; Konnerth, Arthur] Ctr Integrated Prot Sci Munich CIPSM, Munich, Germany; [Nelken, Israel] Hebrew Univ Jerusalem, Dept Neurobiol, Alexander Silberman Inst Life Sci, Jerusalem, Israel; [Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel	Technical University of Munich; Technical University of Munich; University of Munich; University of Munich; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Konnerth, A (corresponding author), Tech Univ Munich, Inst Neurosci, D-80290 Munich, Germany.	aurel.busche@tum.de; arthurkonnerth@tum.de	Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X; Busche, Marc Aurel/0000-0002-4416-7553; Forstl, Hans/0000-0002-6188-6883	Advanced European Research Council; European Union; Deutsche Forschungsgemeinschaft [RTG 1373, SFB870]; Langmatz Stiftung; Israel Science Foundation	Advanced European Research Council(European Research Council (ERC)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Langmatz Stiftung; Israel Science Foundation(Israel Science Foundation)	We thank C. Tischbirek for assistance with graphics, A. Beazley for help with data analysis and M. Staufenbiel for discussions and comments. This work was funded by an Advanced European Research Council grant to A.K., the European Union FP7 program (Project Corticonic) and the Deutsche Forschungsgemeinschaft (RTG 1373 and SFB870). M.A.B. was supported by the Langmatz Stiftung. I.N. was supported by a grant from the Israel Science Foundation and by the Deutsche Forschungsgemeinschaft (SFB870).	Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Bero AW, 2012, J NEUROSCI, V32, P4334, DOI 10.1523/JNEUROSCI.5845-11.2012; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Busche MA, 2015, BIOESSAYS, V37, P624, DOI 10.1002/bies.201500004; Busche MA, 2012, P NATL ACAD SCI USA, V109, P8740, DOI 10.1073/pnas.1206171109; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Chauvette S, 2011, J NEUROSCI, V31, P14998, DOI 10.1523/JNEUROSCI.2339-11.2011; Chauvette S, 2010, CEREB CORTEX, V20, P2660, DOI 10.1093/cercor/bhq009; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; de Gage SB, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5205; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Eichhoff G, 2008, EUR J NUCL MED MOL I, V35, pS99, DOI 10.1007/s00259-007-0709-6; Fastbom J, 1998, ALZ DIS ASSOC DIS, V12, P14, DOI 10.1097/00002093-199803000-00002; Genzel L, 2014, TRENDS NEUROSCI, V37, P10, DOI 10.1016/j.tins.2013.10.002; Grienberger C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1783; Grienberger C, 2012, J PHYSIOL-LONDON, V590, P899, DOI 10.1113/jphysiol.2011.222513; Hahn TTG, 2007, P NATL ACAD SCI USA, V104, P5169, DOI 10.1073/pnas.0700222104; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hoffman KL, 2007, J NEUROSCI, V27, P11838, DOI 10.1523/JNEUROSCI.3501-07.2007; Huang YF, 2012, ARCH NEUROL-CHICAGO, V69, P51, DOI 10.1001/archneurol.2011.235; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269; Ju YES, 2013, JAMA NEUROL, V70, P587, DOI 10.1001/jamaneurol.2013.2334; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; Lim ASP, 2013, SLEEP, V36, P1027, DOI 10.5665/sleep.2802; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Mohajerani MH, 2010, J NEUROSCI, V30, P3745, DOI 10.1523/JNEUROSCI.6437-09.2010; Phillips KG, 2012, NEURON, V76, P526, DOI 10.1016/j.neuron.2012.09.016; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Sheroziya M, 2014, J NEUROSCI, V34, P8875, DOI 10.1523/JNEUROSCI.4460-13.2014; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1993, J NEUROSCI, V13, P3284; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Stroh A, 2013, NEURON, V77, P1136, DOI 10.1016/j.neuron.2013.01.031; Tampellini D, 2010, J NEUROSCI, V30, P14299, DOI 10.1523/JNEUROSCI.3383-10.2010; Tannenbaum C, 2012, DRUG AGING, V29, P639, DOI 10.2165/11633250-000000000-00000; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vyazovskiy VV, 2013, NAT REV NEUROSCI, V14, P445, DOI 10.1038/nrn3494	50	122	123	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2015	18	11					1623	1630		10.1038/nn.4137	http://dx.doi.org/10.1038/nn.4137			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8YT	26457554				2022-12-17	WOS:000363830700020
J	Kennedy, PJ; Feng, J; Robison, AJ; Maze, I; Badimon, A; Mouzon, E; Chaudhury, D; Damez-Werno, DM; Haggarty, SJ; Han, MH; Bassel-Duby, R; Olson, EN; Nestler, EJ				Kennedy, Pamela J.; Feng, Jian; Robison, A. J.; Maze, Ian; Badimon, Ana; Mouzon, Ezekiell; Chaudhury, Dipesh; Damez-Werno, Diane M.; Haggarty, Stephen J.; Han, Ming-Hu; Bassel-Duby, Rhonda; Olson, Eric N.; Nestler, Eric J.			Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylation	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; DEACETYLASE INHIBITORS; DELTA-FOSB; AMPHETAMINE; EXPRESSION; ACETYLATION; ACTIVATION; GLUTAMATE; MECHANISM	Induction of histone acetylation in the nucleus accumbens (NAc), a key brain reward region, promotes cocaine-induced alterations in gene expression. Histone deacetylases (HDACs) tightly regulate the acetylation of histone tails, but little is known about the functional specificity of different HDAC isoforms in the development and maintenance of cocaine-induced plasticity, and previous studies of HDAC inhibitors report conflicting effects on cocaine-elicited behavioral adaptations. Here we demonstrate that specific and prolonged blockade of HDAC1 in NAc of mice increased global levels of histone acetylation, but also induced repressive histone methylation and antagonized cocaine-induced changes in behavior, an effect mediated in part through a chromatin-mediated suppression of GABA(A) receptor subunit expression and inhibitory tone on NAc neurons. Our findings suggest a new mechanism by which prolonged and selective HDAC inhibition can alter behavioral and molecular adaptations to cocaine and inform the development of therapeutics for cocaine addiction.	[Kennedy, Pamela J.; Feng, Jian; Robison, A. J.; Badimon, Ana; Mouzon, Ezekiell; Damez-Werno, Diane M.; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY USA; [Kennedy, Pamela J.; Feng, Jian; Robison, A. J.; Badimon, Ana; Mouzon, Ezekiell; Damez-Werno, Diane M.; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA; [Maze, Ian] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10021 USA; [Chaudhury, Dipesh; Han, Ming-Hu] Mt Sinai Sch Med, Friedman Brain Inst, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Haggarty, Stephen J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res,Dept Neurol, Boston, MA USA; [Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rockefeller University; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas	Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY USA.	eric.nestler@mssm.edu	Robison, Alfred J/P-8521-2018; Haggarty, Stephen J/M-9495-2016; Han, Ming-Hu/G-8836-2012; Maze, Ian/P-8077-2018	Robison, Alfred J/0000-0002-4150-9570; Haggarty, Stephen J/0000-0002-7872-168X; Maze, Ian/0000-0003-1490-7781	US National Institute on Drug Abuse; US National Institute of Mental Health; Canadian Institutes for Health Research [MFE 90086]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028301, P01DA008227, R01DA007359] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank R. Neve (Massachusetts Institute of Technology) for viral vectors and M. Baxter for statistical expertise. This work was supported by grants from the US National Institute on Drug Abuse and National Institute of Mental Health (E.J.N.) and the Canadian Institutes for Health Research (P.J.K.; MFE 90086).	Badiani A, 2004, BEHAV PHARMACOL, V15, P327, DOI 10.1097/00008877-200409000-00004; Bahari-Javan S, 2012, J NEUROSCI, V32, P5062, DOI 10.1523/JNEUROSCI.0079-12.2012; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Brown TE, 2011, J NEUROSCI, V31, P8163, DOI 10.1523/JNEUROSCI.0016-11.2011; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dixon CI, 2010, P NATL ACAD SCI USA, V107, P2289, DOI 10.1073/pnas.0910117107; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Kalda A, 2007, BEHAV BRAIN RES, V181, P76, DOI 10.1016/j.bbr.2007.03.027; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kim WY, 2008, NEUROSCI LETT, V432, P54, DOI 10.1016/j.neulet.2007.12.005; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Kurita M, 2012, NAT NEUROSCI, V15, P1245, DOI 10.1038/nn.3181; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Levine AA, 2005, P NATL ACAD SCI USA, V102, P19186, DOI 10.1073/pnas.0509735102; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Malvaez M, 2011, J NEUROSCI, V31, P16941, DOI 10.1523/JNEUROSCI.2747-11.2011; Malvaez M, 2010, BIOL PSYCHIAT, V67, P36, DOI 10.1016/j.biopsych.2009.07.032; Maze I, 2011, P NATL ACAD SCI USA, V108, P3035, DOI 10.1073/pnas.1015483108; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Pierce RC, 1996, J NEUROSCI, V16, P1550; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Romieu P, 2008, J NEUROSCI, V28, P9342, DOI 10.1523/JNEUROSCI.0379-08.2008; Schroeder FA, 2008, NEUROPSYCHOPHARMACOL, V33, P2981, DOI 10.1038/npp.2008.15; Shen HY, 2008, NEUROSCIENCE, V157, P644, DOI 10.1016/j.neuroscience.2008.09.019; Sun J, 2008, NEUROSCI LETT, V441, P72, DOI 10.1016/j.neulet.2008.05.010; Wang L, 2010, NEUROPSYCHOPHARMACOL, V35, P913, DOI 10.1038/npp.2009.193; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445	45	122	127	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2013	16	4					434	U95		10.1038/nn.3354	http://dx.doi.org/10.1038/nn.3354			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114EM	23475113	Green Submitted, Green Accepted			2022-12-17	WOS:000316723700013
J	Shin, JB; Krey, JF; Hassan, A; Metlagel, Z; Tauscher, AN; Pagana, JM; Sherman, NE; Jeffery, ED; Spinelli, KJ; Zhao, HY; Wilmarth, PA; Choi, D; David, LL; Auer, M; Barr-Gillespie, PG				Shin, Jung-Bum; Krey, Jocelyn F.; Hassan, Ahmed; Metlagel, Zoltan; Tauscher, Andrew N.; Pagana, James M.; Sherman, Nicholas E.; Jeffery, Erin D.; Spinelli, Kateri J.; Zhao, Hongyu; Wilmarth, Phillip A.; Choi, Dongseok; David, Larry L.; Auer, Manfred; Barr-Gillespie, Peter G.			Molecular architecture of the chick vestibular hair bundle	NATURE NEUROSCIENCE			English	Article							SCAFFOLDING PROTEIN EBP50; CELL STEREOCILIA; INNER-EAR; SENSORY EPITHELIA; ACTIN; LOCALIZATION; PHOSPHORYLATION; ROOTLETS; TURNOVER; DYNAMICS	Hair bundles of the inner ear have a specialized structure and protein composition that underlies their sensitivity to mechanical stimulation. Using mass spectrometry, we identified and quantified >1,100 proteins, present from a few to 400,000 copies per stereocilium, from purified chick bundles; 336 of these were significantly enriched in bundles. Bundle proteins that we detected have been shown to regulate cytoskeleton structure and dynamics, energy metabolism, phospholipid synthesis and cell signaling. Three-dimensional imaging using electron tomography allowed us to count the number of actin-actin cross-linkers and actin-membrane connectors; these values compared well to those obtained from mass spectrometry. Network analysis revealed several hub proteins, including RDX (radixin) and SLC9A3R2 (NHERF2), which interact with many bundle proteins and may perform functions essential for bundle structure and function. The quantitative mass spectrometry of bundle proteins reported here establishes a framework for future characterization of dynamic processes that shape bundle structure and function.	[Shin, Jung-Bum; Pagana, James M.] Univ Virginia, Dept Neurosci, Charlottesville, VA USA; [Shin, Jung-Bum; Krey, Jocelyn F.; Pagana, James M.; Spinelli, Kateri J.; Zhao, Hongyu; Barr-Gillespie, Peter G.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Hassan, Ahmed; Metlagel, Zoltan; Tauscher, Andrew N.; Auer, Manfred] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Sherman, Nicholas E.; Jeffery, Erin D.] Univ Virginia, WM Keck Biomed Mass Spectrometry Lab, Charlottesville, VA USA; [Wilmarth, Phillip A.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Choi, Dongseok] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Barr-Gillespie, Peter G.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	University of Virginia; Oregon Health & Science University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Virginia; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Barr-Gillespie, PG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	gillespp@ohsu.edu		Sherman, Nicholas/0000-0003-3206-3113; Jeffery, Erin/0000-0001-9511-7719; Choi, Dongseok/0000-0002-1552-4072; Barr-Gillespie, Peter/0000-0002-9787-5860; Spinelli, Kateri/0000-0002-6290-0886	US National Institutes of Health (NIH) National Center for Research Resources [RR017573]; National Center for Research Resources (NIH) [S10 RR023432, S10 RR025440]; NIH [K99/R00 DC009412, F32 DC012455, R01 DC002368, R01 DC011034, P30 DC005983, R01 EY007755, P30 EY10572, P01 GM051487]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573, S10RR025440, S10RR023432] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007755, P30EY010572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, P01GM051487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC006097, F32DC012455, K99DC009412, R01DC011034, R21DC008801, R01DC002368, P30DC005983, R00DC009412] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Mass spectrometry was carried out by the W.M. Keck Biomedical Mass Spectrometry Laboratory and The University of Virginia Biomedical Research Facility. We thank K. McDonald, R. Zalpuri and G. Min of the University of California Berkeley Electron Microscopy Laboratory for assistance with high-pressure freezing and imaging; D. Jorgens provided mentoring in high-pressure freezing. We would like to thank A. Cheng, B. Carragher and C. Potter for help with electron microscopy data collection at the National Resource for Automated Molecular Microscopy, supported by US National Institutes of Health (NIH) National Center for Research Resources grant RR017573. For technical assistance, we acknowledge A. Snyder of the Advanced Light Microscopy Core at The Jungers Center (Oregon Health & Science University), supported by shared instrumentation grants S10 RR023432 and S10 RR025440 from the National Center for Research Resources (NIH). Work described here was supported by NIH grants K99/R00 DC009412 (J.B.S.), F32 DC012455 (J.F.K.), R01 DC002368 (P.G.B.-G.), R01 DC011034 (P.G.B.-G.), P30 DC005983 (P.G.B.-G.), R01 EY007755 (L.L.D.), P30 EY10572 (L L D) and P01 GM051487 (M.A.).	Auer M, 2008, JARO-J ASSOC RES OTO, V9, P215, DOI 10.1007/s10162-008-0114-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BURNHAM JA, 1984, J NEUROCYTOL, V13, P617, DOI 10.1007/BF01148082; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fischer RS, 2003, TRENDS CELL BIOL, V13, P593, DOI 10.1016/j.tcb.2003.09.007; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625; Grati M, 2012, J NEUROSCI, V32, P14288, DOI 10.1523/JNEUROSCI.3071-12.2012; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Jones SM, 2000, JARO-J ASSOC RES OTO, V1, P232, DOI 10.1007/s101620010026; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Kruger RP, 1999, J NEUROSCI, V19, P4815; Ma'ayan A, 2009, J BIOL CHEM, V284, P5451, DOI 10.1074/jbc.R800056200; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Peng AW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1533; Ponsioen B, 2009, MOL BIOL CELL, V20, P4664, DOI 10.1091/mbc.E09-06-0529; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Sakaguchi H, 2008, CELL MOTIL CYTOSKEL, V65, P528, DOI 10.1002/cm.20275; SCHULTE BA, 1989, J HISTOCHEM CYTOCHEM, V37, P1787, DOI 10.1177/37.12.2685109; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shaw RJ, 1998, MOL BIOL CELL, V9, P403, DOI 10.1091/mbc.9.2.403; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Shin JB, 2010, J NEUROSCI, V30, P9683, DOI 10.1523/JNEUROSCI.1541-10.2010; Spinelli KJ, 2012, P NATL ACAD SCI USA, V109, pE268, DOI 10.1073/pnas.1115866109; Steel KP, 2007, GENES AND COMMON DISEASES: GENETICS IN MODERN MEDICINE, P505; TANAKA K, 1978, AM J ANAT, V153, P251, DOI 10.1002/aja.1001530206; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cellbio.8.1.257; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; WALKER RG, 1993, P NATL ACAD SCI USA, V90, P2807, DOI 10.1073/pnas.90.7.2807; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745; Zhao HY, 2012, J NEUROSCI, V32, P4600, DOI 10.1523/JNEUROSCI.6184-11.2012	50	122	124	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					365	374		10.1038/nn.3312	http://dx.doi.org/10.1038/nn.3312			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23334578	Green Accepted			2022-12-17	WOS:000315474800020
J	Li, KX; Lu, YM; Xu, ZH; Zhang, J; Zhu, JM; Zhang, JM; Cao, SX; Chen, XJ; Chen, Z; Luo, JH; Duan, SM; Li, XM				Li, Ke-Xin; Lu, Ying-Mei; Xu, Zheng-Hao; Zhang, Jing; Zhu, Jun-Ming; Zhang, Jian-Ming; Cao, Shu-Xia; Chen, Xiao-Juan; Chen, Zhong; Luo, Jian-Hong; Duan, Shumin; Li, Xiao-Ming			Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy	NATURE NEUROSCIENCE			English	Article							PARVALBUMIN-POSITIVE INTERNEURONS; LONG-TERM POTENTIATION; PRIMARY VISUAL-CORTEX; GABAERGIC INTERNEURONS; POTASSIUM CHANNELS; NEURAL DEVELOPMENT; TYROSINE KINASE; NMDA RECEPTORS; K+ CHANNELS; ERBB4	Dysfunction of fast-spiking, parvalbumin-positive (FS-PV) interneurons is implicated in the pathogenesis of epilepsy. ErbB4, a key Neuregulin 1 (NRG1) receptor, is mainly expressed in this type of interneurons, and recent studies suggest that parvalbumin interneurons are a major target of NRG1-ErbB4 signaling in adult brain. Thus, we hypothesized that downregulation of NRG1-ErbB4 signaling in FS-PV interneurons is involved in epilepsy. We found that NRG1, through its receptor ErbB4, increased the intrinsic excitability of FS-PV interneurons. This effect was mediated by increasing the near-threshold responsiveness and decreasing the voltage threshold for action potentials through Kv1.1, a voltage-gated potassium channel. Furthermore, mice with specific deletion of ErbB4 in parvalbumin interneurons were more susceptible to pentylenetetrazole- and pilocarpine-induced models of epilepsy. Exogenous NRG1 delayed the onset of seizures and decreased their incidence and stage. Moreover, expression of ErbB4, but not ErbB2, was downregulated in human epileptogenic tissue. Together, our findings suggest that NRG1-ErbB4 signaling contributes to human epilepsy through regulating the excitability of FS-PV interneurons. ErbB4 may be a new target for anticonvulsant drugs in epilepsy.	[Li, Ke-Xin; Lu, Ying-Mei; Xu, Zheng-Hao; Zhang, Jing; Cao, Shu-Xia; Chen, Xiao-Juan; Chen, Zhong; Luo, Jian-Hong; Duan, Shumin; Li, Xiao-Ming] Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth China,Dept Neur, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Jun-Ming; Zhang, Jian-Ming] Zhejiang Univ, Sch Med, Dept Neurosurg, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Luo, Jian-Hong; Duan, Shumin; Li, Xiao-Ming] Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Li, XM (corresponding author), Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth China,Dept Neur, Hangzhou 310003, Zhejiang, Peoples R China.	lixm@zju.edu.cn	Luo, jian/HGE-7331-2022	Li, Ke-Xin/0000-0003-3879-294X; Xu, Zhenghao/0000-0003-0033-525X	National Natural Science Foundation of China [30970916, 31070926, 30725047]; state Ministry of Science and Technology of China [2010CB912004, 2010CB912002]; Zhejiang Provincial Natural Science Foundation of China [Z2090127]; Foundation for the Author of National Excellent Doctoral Dissertation of China [200937]; Science Foundation of Chinese Universities [JD09023]; Zhejiang Provincial Qianjiang Talent Plan [2010R10057]; Fundamental Research Funds for the Central Universities [2011XZZX002]; Zhejiang Province Key Technology Innovation Team [2010R50049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); state Ministry of Science and Technology of China(Ministry of Science and Technology, China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Science Foundation of Chinese Universities; Zhejiang Provincial Qianjiang Talent Plan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang Province Key Technology Innovation Team	We thank L. Mei (Georgia Health Sciences University) for advice. We are grateful to T.M. Gao (Southern Medical University), Z.J. Huang (Cold Spring Harbor), X.H. Zhang (Institute of Neuroscience, Chinese Academy of Sciences) and L. Bao (Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences) for providing reagents and/or mice. We express our gratitude to the subjects and their families for their participation. We also thank T.M. Gao and I.C. Bruce for critical reading of this manuscript, and Q.L. Miao for technical assistance. This work was supported by grants from the National Natural Science Foundation of China (30970916, 31070926 and 30725047), the Major Research Program from the state Ministry of Science and Technology of China (2010CB912004, 2010CB912002), the Zhejiang Provincial Natural Science Foundation of China (Z2090127), the Foundation for the Author of National Excellent Doctoral Dissertation of China (200937), the Science Foundation of Chinese Universities (JD09023), the Zhejiang Provincial Qianjiang Talent Plan (2010R10057), the Fundamental Research Funds for the Central Universities (2011XZZX002) and Zhejiang Province Key Technology Innovation Team (2010R50049).	Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012; Cascella NG, 2009, NEUROSCI RES, V63, P227, DOI 10.1016/j.neures.2009.01.002; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chen YJ, 2010, P NATL ACAD SCI USA, V107, P21818, DOI 10.1073/pnas.1010669107; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cook KK, 2002, J BIOL CHEM, V277, P13268, DOI 10.1074/jbc.M108898200; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Dreyfus J, 1998, REMARKABLE MED HAS B; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fisahn A, 2009, CEREB CORTEX, V19, P612, DOI 10.1093/cercor/bhn107; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Guan D, 2006, J PHYSIOL-LONDON, V571, P371, DOI 10.1113/jphysiol.2005.097006; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lau D, 2000, J NEUROSCI, V20, P9071; Law AJ, 2004, NEUROSCIENCE, V127, P125, DOI 10.1016/j.neuroscience.2004.04.026; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Liguori R, 2001, MUSCLE NERVE, V24, P630, DOI 10.1002/mus.1048; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Neddens J, 2010, HIPPOCAMPUS, V20, P724, DOI 10.1002/hipo.20675; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Perucca E, 2007, LANCET, V370, P313, DOI 10.1016/S0140-6736(07)61149-0; Pitcher GM, 2011, NAT MED, V17, P470, DOI 10.1038/nm.2315; Robertson B, 1996, FEBS LETT, V383, P26, DOI 10.1016/0014-5793(96)00211-6; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; Ting AK, 2011, J NEUROSCI, V31, P15, DOI 10.1523/JNEUROSCI.2538-10.2011; Tucker K, 2002, J PHYSIOL-LONDON, V542, P413, DOI 10.1113/jphysiol.2002.017376; Vullhorst D, 2009, J NEUROSCI, V29, P12255, DOI 10.1523/JNEUROSCI.2454-09.2009; WANG H, 1994, J NEUROSCI, V14, P4588; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Ziyatdinova S, 2011, EPILEPSY RES, V94, P75, DOI 10.1016/j.eplepsyres.2011.01.003; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	49	122	125	3	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2012	15	2					267	273		10.1038/nn.3006	http://dx.doi.org/10.1038/nn.3006			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882ZX	22158511				2022-12-17	WOS:000299603500018
J	Lee, CC; Middlebrooks, JC				Lee, Chen-Chung; Middlebrooks, John C.			Auditory cortex spatial sensitivity sharpens during task performance	NATURE NEUROSCIENCE			English	Article							CORTICAL MAP REORGANIZATION; LEARNING-INDUCED PLASTICITY; THALAMIC RETICULAR NUCLEUS; SOUND-LOCALIZATION; RECEPTIVE-FIELDS; DORSAL ZONE; NEURONS; REPRESENTATION; CAT; ATTENTION	Activity in the primary auditory cortex (A1) is essential for normal sound localization behavior, but previous studies of the spatial sensitivity of neurons in A1 have found broad spatial tuning. We tested the hypothesis that spatial tuning sharpens when an animal engages in an auditory task. Cats performed a task that required evaluation of the locations of sounds and one that required active listening, but in which sound location was irrelevant. Some 26-44% of the units recorded in A1 showed substantially sharpened spatial tuning during the behavioral tasks as compared with idle conditions, with the greatest sharpening occurring during the location-relevant task. Spatial sharpening occurred on a scale of tens of seconds and could be replicated multiple times in similar to 1.5-h test sessions. Sharpening resulted primarily from increased suppression of responses to sounds at least-preferred locations. That and an observed increase in latencies suggest an important role of inhibitory mechanisms.	[Lee, Chen-Chung; Middlebrooks, John C.] Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Irvine, CA 92717 USA; [Lee, Chen-Chung; Middlebrooks, John C.] Univ Calif Irvine, Ctr Hearing Res, Irvine, CA USA; [Lee, Chen-Chung] Univ Michigan, Dept Otolaryngol Head & Neck Surg, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Michigan System; University of Michigan	Middlebrooks, JC (corresponding author), Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Irvine, CA 92717 USA.	j.midd@uci.edu			National Institute on Deafness and Other Communication Disorders [R01 DC-000420, P30 DC-05188]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005188, R01DC000420] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank I. Harrington, E. Macpherson, J. Wiler, E. Hand, G. Rising, D. Vailliencourt, C. Ellinger and Z. Onsan for technical support. We thank A. Kirby and R. Adrian for helpful comments on the manuscript. This work was supported by National Institute on Deafness and Other Communication Disorders grants R01 DC-000420, and P30 DC-05188 (to J. Schacht).	Allen K, 2009, ATTEN PERCEPT PSYCHO, V71, P164, DOI 10.3758/APP.71.1.164; Atiani S, 2009, NEURON, V61, P467, DOI 10.1016/j.neuron.2008.12.027; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BENSON DA, 1981, BRAIN RES, V219, P249, DOI 10.1016/0006-8993(81)90290-0; Best V, 2008, P NATL ACAD SCI USA, V105, P13174, DOI 10.1073/pnas.0803718105; Brechmann A, 2005, CEREB CORTEX, V15, P578, DOI 10.1093/cercor/bhh159; Cansino S, 1997, BRAIN RES, V764, P53, DOI 10.1016/S0006-8993(97)00321-1; Cotillon-Williams N, 2008, J NEUROPHYSIOL, V99, P1137, DOI 10.1152/jn.01159.2007; DIAMOND DM, 1989, BEHAV NEUROSCI, V103, P471, DOI 10.1037/0735-7044.103.3.471; Efron B., 1993, INTRO BOOTSTRAP; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Furukawa S, 2002, J NEUROPHYSIOL, V87, P1749, DOI 10.1152/jn.00491.2001; Ghose GM, 2004, CURR OPIN NEUROBIOL, V14, P513, DOI 10.1016/j.conb.2004.07.003; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; Green DM., 1966, SIGNAL DETECTION THE; IMIG TJ, 1990, J NEUROPHYSIOL, V63, P1448, DOI 10.1152/jn.1990.63.6.1448; JENKINS WM, 1984, J NEUROPHYSIOL, V52, P819, DOI 10.1152/jn.1984.52.5.819; Kidd G, 2005, J ACOUST SOC AM, V118, P3804, DOI 10.1121/1.2109187; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimura A, 2007, EUR J NEUROSCI, V26, P3524, DOI 10.1111/j.1460-9568.2007.05925.x; Kopco N, 2007, J ACOUST SOC AM, V121, P420, DOI 10.1121/1.2390677; Lee CC, 2008, J COMP NEUROL, V507, P1920, DOI 10.1002/cne.21613; Ma XF, 2009, J NEUROSCI, V29, P4888, DOI 10.1523/JNEUROSCI.0167-09.2009; Malhotra S, 2004, J NEUROPHYSIOL, V92, P1625, DOI 10.1152/jn.01205.2003; Malhotra S, 2008, J NEUROPHYSIOL, V99, P1628, DOI 10.1152/jn.01228.2007; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; McDonald JJ, 1999, J EXP PSYCHOL HUMAN, V25, P1234, DOI 10.1037/0096-1523.25.5.1234; Mickey BJ, 2003, J NEUROSCI, V23, P8649; MIDDLEBROOKS JC, 1981, J NEUROSCI, V1, P107, DOI 10.1523/JNEUROSCI.01-01-00107.1981; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; MONDOR TA, 1995, J EXP PSYCHOL HUMAN, V21, P387, DOI 10.1037/0096-1523.21.2.387; MOORE BCJ, 1983, J ACOUST SOC AM, V74, P750, DOI 10.1121/1.389861; Nunamaker EA, 2007, J BIOMED MATER RES A, V83A, P1128, DOI 10.1002/jbm.a.31275; Ohl FW, 2005, CURR OPIN NEUROBIOL, V15, P470, DOI 10.1016/j.conb.2005.07.002; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Rasmusson DD, 2007, NEUROSCIENCE, V149, P232, DOI 10.1016/j.neuroscience.2007.06.057; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RHODES G, 1987, PERCEPT PSYCHOPHYS, V42, P1, DOI 10.3758/BF03211508; Roberts KL, 2009, J EXP PSYCHOL HUMAN, V35, P1178, DOI 10.1037/a0014249; Scott BH, 2007, J NEUROSCI, V27, P6489, DOI 10.1523/JNEUROSCI.0016-07.2007; SPENCE CJ, 1994, J EXP PSYCHOL HUMAN, V20, P555, DOI 10.1037/0096-1523.20.3.555; Stecker GC, 2005, J NEUROPHYSIOL, V94, P1267, DOI 10.1152/jn.00104.2005; Ter-Mikaelian M, 2007, J NEUROSCI, V27, P6091, DOI 10.1523/JNEUROSCI.4848-06.2007; Verbny YI, 2006, J NEUROPHYSIOL, V96, P3194, DOI 10.1152/jn.00484.2006; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Witte RS, 2005, COGNITIVE BRAIN RES, V23, P171, DOI 10.1016/j.cogbrainres.2004.10.018; Zhang YF, 2008, CEREB CORTEX, V18, P1521, DOI 10.1093/cercor/bhm188; ZHOU B, 1992, J ACOUST SOC AM, V92, P1169, DOI 10.1121/1.404045; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	50	122	122	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					108	U144		10.1038/nn.2713	http://dx.doi.org/10.1038/nn.2713			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21151120	Green Submitted, Green Accepted			2022-12-17	WOS:000285684900021
J	Grandl, J; Hu, HZ; Bandell, M; Bursulaya, B; Schmidt, M; Petrus, M; Patapoutian, A				Grandl, Joerg; Hu, Hongzhen; Bandell, Michael; Bursulaya, Badry; Schmidt, Manuela; Petrus, Matt; Patapoutian, Ardem			Pore region of TRPV3 ion channel is specifically required for heat activation	NATURE NEUROSCIENCE			English	Article							COLD RECEPTOR; 2-AMINOETHOXYDIPHENYL BORATE; CAPSAICIN RECEPTOR; SCREEN REVEALS; THERMOSENSATION; VOLTAGE; TRPM8; MECHANISM; SENSATION; STIMULI	Ion channels can be activated (gated) by a variety of stimuli, including chemicals, voltage, mechanical force or temperature. Although molecular mechanisms of ion channel gating by chemical and voltage stimuli are understood in principal, the mechanisms of temperature activation remain unknown. The transient receptor potential channel TRPV3 is a nonselective cation channel that is activated by warm temperatures and sensory chemicals such as camphor. Here we screened similar to 14,000 random mutant clones of mouse TRPV3 and identified five single point mutations that specifically abolish heat activation but do not perturb chemical activation or voltage modulation. Notably, all five mutations are located in the putative sixth transmembrane helix and the adjacent extracellular loop in the pore region of mouse TRPV3. Although distinct in sequence, we found that the corresponding loop of frog TRPV3 is also specifically required for heat activation. These findings demonstrate that the temperature sensitivity of TRPV3 is separable from all other known activation mechanisms and implicate a specific region in temperature sensing.	[Grandl, Joerg; Schmidt, Manuela; Patapoutian, Ardem] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Hu, Hongzhen; Petrus, Matt; Patapoutian, Ardem] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	apatapou@gnf.org		Hu, Hongzhen/0000-0002-8967-7522; Schmidt, Manuela/0000-0003-1972-3519; Grandl, Jorg/0000-0001-7179-7609	US National Institutes of Health; Novartis Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046303] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. J. Wilson and J. Mainquist for manufacturing the temperature device, A. Marelli and T. Orth for preparing miniprep DNA and M. Caterina for providing rat TRPV1 plasmid DNA. We thank T. Bartfai, E. Lattman, I. MacRae and A. Dubin for helpful discussion. This research was supported by grants from the US National Institutes of Health and by the Novartis Research Foundation.	Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Filevich O, 2006, ANAL CHEM, V78, P7499, DOI 10.1021/ac061382f; Guler AD, 2002, J NEUROSCI, V22, P6408; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Owsianik G, 2006, REV PHYSIOL BIOCH P, V156, P61, DOI 10.1007/s10254-005-0006-3; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882	37	122	122	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2008	11	9					1007	1013		10.1038/nn.2169	http://dx.doi.org/10.1038/nn.2169			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	341NA	19160498	Green Accepted			2022-12-17	WOS:000258720000010
J	Wang, WY; Takimoto, JK; Louie, GV; Baiga, TJ; Noel, JP; Lee, KF; Slesinger, PA; Wang, L				Wang, Wenyuan; Takimoto, Jeffrey K.; Louie, Gordon V.; Baiga, Thomas J.; Noel, Joseph P.; Lee, Kuo-Fen; Slesinger, Paul A.; Wang, Lei			Genetically encoding unnatural amino acids for cellular and neuronal studies	NATURE NEUROSCIENCE			English	Article							TRANSFER-RNA-SYNTHETASE; GREEN FLUORESCENT PROTEINS; POLYMERASE-III; K+ CHANNEL; POTASSIUM CHANNELS; INACTIVATION GATE; ESCHERICHIA-COLI; MAMMALIAN-CELLS; BINDING-SITE; CODE	Proteins participate in various biological processes and can be harnessed to probe and control biological events selectively and reproducibly, but the genetic code limits the building block to 20 common amino acids for protein manipulation in living cells. The genetic encoding of unnatural amino acids will remove this restriction and enable new chemical and physical properties to be precisely introduced into proteins. Here we present new strategies for generating orthogonal tRNA-synthetase pairs, which made possible the genetic encoding of diverse unnatural amino acids in different mammalian cells and primary neurons. Using this new methodology, we incorporated unnatural amino acids with extended side chains into the K(+) channel Kv1.4, and found that the bulkiness of residues in the inactivation peptide is essential for fast channel inactivation, a finding that had not been possible using conventional mutagenesis. This technique will stimulate and facilitate new molecular studies using tailored unnatural amino acids for cell biology and neurobiology.	Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Proteom, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Wang, L (corresponding author), Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Proteom, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slesinger@salk.edu; lwang@salk.edu	Wang, Lei/E-7912-2011; Noel, Joseph P/A-9459-2009; wang, wenyuan/F-7218-2011	Wang, Lei/0000-0002-5859-2526; 	Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [R01 HD034534-10A2, R01 HD034534-11, R01 HD034534] Funding Source: Medline; NINDS NIH HHS [R01 NS060833-01A1, R01 NS060833] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060833] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antz C, 1997, NATURE, V385, P272, DOI 10.1038/385272a0; Beene DL, 2004, J NEUROSCI, V24, P9097, DOI 10.1523/JNEUROSCI.2429-04.2004; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; CORNISH VW, 1995, ANGEW CHEM INT EDIT, V34, P621, DOI 10.1002/anie.199506211; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; DOCTOR BP, 1963, J BIOL CHEM, V238, P3677; Drabkin HJ, 1996, MOL CELL BIOL, V16, P907; EDWARDS H, 1990, MOL CELL BIOL, V10, P1633, DOI 10.1128/MCB.10.4.1633; GALLI G, 1981, NATURE, V294, P626, DOI 10.1038/294626a0; Gandhi CS, 2005, TRENDS NEUROSCI, V28, P472, DOI 10.1016/j.tins.2005.07.005; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Kondoh S, 1997, J BIOL CHEM, V272, P19333, DOI 10.1074/jbc.272.31.19333; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lummis SCR, 2005, CHEM BIOL, V12, P993, DOI 10.1016/j.chembiol.2005.06.012; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; MURPHY S, 1987, CELL, V51, P81, DOI 10.1016/0092-8674(87)90012-2; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Myslinski E, 2001, NUCLEIC ACIDS RES, V29, P2502, DOI 10.1093/nar/29.12.2502; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Summerer D, 2006, P NATL ACAD SCI USA, V103, P9785, DOI 10.1073/pnas.0603965103; Wang L, 2005, ANGEW CHEM INT EDIT, V44, P34, DOI 10.1002/anie.200460627; Wang L, 2001, CHEM BIOL, V8, P883, DOI 10.1016/S1074-5521(01)00063-1; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2000, J AM CHEM SOC, V122, P5010, DOI 10.1021/ja000595y; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Wissmann R, 2003, J BIOL CHEM, V278, P16142, DOI 10.1074/jbc.M210191200; YUAN Y, 1991, BIOCHIM BIOPHYS ACTA, V1089, P33, DOI 10.1016/0167-4781(91)90081-V; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	38	122	129	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1063	1072		10.1038/nn1932	http://dx.doi.org/10.1038/nn1932			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17603477	Green Accepted			2022-12-17	WOS:000248357500021
J	Otten, LJ; Quayle, AH; Akram, S; Ditewig, TA; Rugg, MD				Otten, LJ; Quayle, AH; Akram, S; Ditewig, TA; Rugg, MD			Brain activity before an event predicts later recollection	NATURE NEUROSCIENCE			English	Article							MEMORY; ATTENTION; STATE	Neural activity elicited by an event can predict whether the event is successfully encoded into memory. Here we assessed whether memory encoding relies not only on neural activity that follows an event, but also on activity that precedes it. In two experiments we found that human brain activity elicited by a cue presented just before a word could predict whether the word would be recollected in a later memory test.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1N 3AR, England; Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of London; University College London; University of London; University College London; University of California System; University of California Irvine; University of California System; University of California Irvine	Otten, LJ (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	l.otten@ucl.ac.uk	Otten, Leun/C-6036-2008		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074528] Funding Source: NIH RePORTER; NIMH NIH HHS [1R01MH074528] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission)		Driver J, 2000, NAT REV NEUROSCI, V1, P147, DOI 10.1038/35039083; Duzel E, 2005, NEUROIMAGE, V25, P690, DOI 10.1016/j.neuroimage.2004.11.038; MANGUN GR, 1995, OX PSYCH S, P40; Meeter M, 2004, HIPPOCAMPUS, V14, P722, DOI 10.1002/hipo.10214; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Pashler H, 2001, ANNU REV PSYCHOL, V52, P629, DOI 10.1146/annurev.psych.52.1.629; Ruchkin DS, 2003, BEHAV BRAIN SCI, V26, P709, DOI 10.1017/S0140525X03000165; Rugg M.D., 1995, OX PSYCH S, P133; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; SANQUIST TF, 1980, PSYCHOPHYSIOLOGY, V17, P568, DOI 10.1111/j.1469-8986.1980.tb02299.x; Uhl F, 1990, J Cogn Neurosci, V2, P373, DOI 10.1162/jocn.1990.2.4.373; van Boxtel GJM, 2004, J PSYCHOPHYSIOL, V18, P61, DOI 10.1027/0269-8803.18.23.61; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188	15	122	123	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					489	491		10.1038/nn1663	http://dx.doi.org/10.1038/nn1663			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16501566				2022-12-17	WOS:000236310700015
J	Yu, TW; Hao, JC; Lim, W; Tessier-Lavigne, M; Bargmann, CI				Yu, TW; Hao, JC; Lim, W; Tessier-Lavigne, M; Bargmann, CI			Shared receptors in axon guidance: SAX-3/Robo signals via UNC-34/enabled and a Netrin-independent UNC-40/DCC function	NATURE NEUROSCIENCE			English	Article							GROWTH CONE MIGRATIONS; C-ELEGANS; CAENORHABDITIS-ELEGANS; LISTERIA-MONOCYTOGENES; COLORECTAL-CANCER; TYROSINE KINASE; SLIT PROTEINS; CNS MIDLINE; DROSOPHILA; GENES	The C. elegans SAX-3/Robo receptor acts in anterior-posterior, dorsal-ventral and midline guidance decisions. Here we show that SAX-3 signaling involves the C. elegans Enabled protein UNC-34 and an unexpected Netrin-independent function of the Netrin receptor UNC-40/DCC. Genetic interactions with gain- and loss-of-function mutations suggest that unc-34 and unc-40 act together with sax-3 in several guidance decisions, but the C. elegans Netrin gene unc-6 does not act in the same genetic pathways. Within the migrating axon, sax-3, unc-34 and unc-40 all act cell-autonomously. Our results support a role for UNC-34/Enabled proteins in SAX-3-mediated repulsion, and show that UNC-40/DCC can potentiate SAX-3/Robo signaling via a mechanism that may involve direct binding of the two guidance receptors. A combinatorial logic dictates alternative functions for UNC-40/DCC, which can act in attraction to UNC-6/Netrin, repulsion from Netrin (with UNC-5), or repulsion from Slit (with SAX-3).	Univ Calif San Francisco, Dept Anat, Program Neurosci, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Dept Anat, Program Neurosci, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	cori@itsa.ucsf.edu	Yu, Timothy W./AAF-5738-2019	Yu, Timothy W./0000-0003-2988-7701; Bargmann, Cornelia/0000-0002-8484-0618				Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Flanagan JG, 1998, CELL, V92, P429, DOI 10.1016/S0092-8674(00)80935-6; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Forrester WC, 1997, DEVELOPMENT, V124, P1831; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Fritz JL, 2000, DEVELOPMENT, V127, P1991; Gallo G, 1999, CURR BIOL, V9, pR490, DOI 10.1016/S0960-9822(99)80304-2; GERTLER FB, 1990, SCIENCE, V248, P857, DOI 10.1126/science.2188361; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Guthrie S, 2001, CURR BIOL, V11, pR300, DOI 10.1016/S0960-9822(01)00169-5; HAMELIN M, 1992, EMBO J, V11, P2885, DOI 10.1002/j.1460-2075.1992.tb05357.x; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Honigberg L, 2000, DEVELOPMENT, V127, P4655; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kim S, 1999, DEVELOPMENT, V126, P3881; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Lin MZ, 2000, CELL, V101, P239, DOI 10.1016/S0092-8674(00)80833-8; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; Merz DC, 2000, J NEUROBIOL, V44, P281, DOI 10.1002/1097-4695(200008)44:2&lt;281::AID-NEU16&gt;3.0.CO;2-4; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sun Q, 2000, DEVELOPMENT, V127, P801; Tear G, 1993, Perspect Dev Neurobiol, V1, P183; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	50	122	132	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1147	1154		10.1038/nn956	http://dx.doi.org/10.1038/nn956			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379860				2022-12-17	WOS:000178884600017
J	Hirono, M; Yoshioka, T; Konishi, S				Hirono, M; Yoshioka, T; Konishi, S			GABA(B) receptor activation enhances mGIuR-mediated responses at cerebellar excitatory synapses	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; TERM SYNAPTIC DEPRESSION; PURKINJE-CELLS; PRESYNAPTIC INHIBITION; INWARD CURRENT; NEUROTRANSMITTER RELEASE; B RECEPTORS; A RECEPTORS; CROSS-TALK; NEURONS	Metabotropic gamma -aminobutyric acid type B (GABA(B)) and glutamate receptors (mGluRs) are postsynaptically co-expressed at cerebellar parallel fiber (PF)-Purkinje cell (PC) excitatory synapses, but their functional interactions are unclear. We found that mGluR1 agonist-induced currents and [Ca2+](i) increases in PCs were enhanced following co-activation of GABA(B) receptors. A GABA(B) antagonist and a G-protein uncoupler suppressed these effects. Low-concentration baclofen, a GABA(B) agonist, augmented mGluR1-mediated excitatory synaptic current produced by stimulating PFs. These results indicate that postsynaptic GABA(B) receptors functionally interact with mGluR1 and enhance mGluR1-mediated excitatory transmission at PF-PC synapses. The interaction between the two types of metabotropic receptors provides a likely mechanism for regulating cerebellar synaptic plasticity.	Mitsubishi Kagaku Inst Life Sci, Mol Neurobiol Lab, Machida, Tokyo 1948511, Japan; Waseda Univ, Adv Res Inst Sci & Engn, Dept Mol Neurobiol, Tokyo 1698555, Japan; Waseda Univ, Sch Human Sci, Dept Mol Neurobiol, Tokorozawa, Saitama 3591192, Japan; JST, CREST, Machida, Tokyo 1948511, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); Waseda University; Waseda University; Japan Science & Technology Agency (JST)	Konishi, S (corresponding author), Mitsubishi Kagaku Inst Life Sci, Mol Neurobiol Lab, 11 Minamiooya, Machida, Tokyo 1948511, Japan.		Konishi, Shiro/ABA-5905-2020	Hirono, Moritoshi/0000-0001-6068-1045				Barnard EA, 1998, PHARMACOL REV, V50, P291; BATCHELOR AM, 1993, NEUROPHARMACOLOGY, V32, P11, DOI 10.1016/0028-3908(93)90124-L; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; BOWERY NG, 1993, ANNU REV PHARMACOL, V33, P109, DOI 10.1146/annurev.pa.33.040193.000545; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Dittman JS, 1996, J NEUROSCI, V16, P1623; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; GOODMAN RR, 1983, SCIENCE, V220, P967, DOI 10.1126/science.6302841; HAHNER L, 1991, FASEB J, V5, P2466, DOI 10.1096/fasebj.5.10.1648524; Hirono M, 1998, BIOCHEM BIOPH RES CO, V251, P753, DOI 10.1006/bbrc.1998.9465; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.neuro.12.1.85; Jaarsma D, 1995, J CHEM NEUROANAT, V9, P241, DOI 10.1016/0891-0618(95)00089-5; JIN WZ, 1994, J NEUROSCI, V14, P1920; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kawaguchi S, 2000, NEURON, V27, P339, DOI 10.1016/S0896-6273(00)00041-6; KERR DIB, 1995, PHARMACOL THERAPEUT, V67, P187, DOI 10.1016/0163-7258(95)00016-A; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Komatsu Y, 1996, J NEUROSCI, V16, P6342; Konishi S, 1997, ROLE ADENOSINE NERVO, P89; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LINDEN DJ, 1994, J NEUROPHYSIOL, V71, P1992, DOI 10.1152/jn.1994.71.5.1992; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; MALEOS JM, 2000, J NEUROCHEM, V74, P1301; MARTINELLI GP, 1992, NEUROSCIENCE, V46, P23, DOI 10.1016/0306-4522(92)90005-M; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; MIQUEL MC, 1994, DEV BRAIN RES, V80, P149, DOI 10.1016/0165-3806(94)90099-X; Mitoma H, 1999, NEUROSCIENCE, V88, P871, DOI 10.1016/S0306-4522(98)00260-7; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; MOTT DD, 1991, SCIENCE, V252, P1718, DOI 10.1126/science.1675489; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Sodickson DL, 1996, J NEUROSCI, V16, P6374; STAUB C, 1992, EUR J NEUROSCI, V4, P832, DOI 10.1111/j.1460-9568.1992.tb00193.x; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; TURGEON SM, 1993, NEUROSCIENCE, V55, P311, DOI 10.1016/0306-4522(93)90501-6; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4	50	122	124	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1207	1216		10.1038/nn764	http://dx.doi.org/10.1038/nn764			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11704764				2022-12-17	WOS:000172525000017
J	Yang, F; Feng, LY; Zheng, F; Johnson, SW; Du, J; Shen, LY; Wu, CP; Lu, B				Yang, F; Feng, LY; Zheng, F; Johnson, SW; Du, J; Shen, LY; Wu, CP; Lu, B			GDNF acutely modulates excitability and A-type K+ channels in midbrain dopaminergic neurons	NATURE NEUROSCIENCE			English	Article							VENTRAL MESENCEPHALIC NEURONS; MICE LACKING GDNF; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM; ELECTROPHYSIOLOGICAL PROPERTIES; SYNAPTIC TRANSMISSION; TYROSINE KINASE; CATION CURRENT; IN-VIVO; RECEPTOR	Glial cell line-derived neurotrophic factor (GDNF) prevents lesion-induced death of midbrain dopaminergic neurons, but its function in normal brain remains uncertain. Here we show that GDNF acutely and reversibly potentiated the excitability of cultured midbrain neurons by inhibiting transient A-type K+ channels. The effects of GDNF were limited to large, tyrosine hydroxylase (TH)positive dopaminergic neurons, and were mediated by mitogen associated protein (MAP) kinase. Application of GDNF also elicited a MAP kinase-dependent enhancement of the excitability in dopaminergic neurons in midbrain slice. These results demonstrate an acute regulation of GDNF on ion channels and its underlying signaling mechanism, and reveal an unexpected role of GDNF in normal midbrain dopaminergic neurons.	NICHHD, Unit Synapse Dev & Plast, LCSN, NIH, Bethesda, MD 20892 USA; Oregon Hlth Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; NCI, Lab Carcinogenesis & Tumor Promot, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Oregon Health & Science University; Chinese Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lu, B (corresponding author), NICHHD, Unit Synapse Dev & Plast, LCSN, NIH, Bethesda, MD 20892 USA.		Lu, Bai/A-4018-2012; Du, Jing/A-9023-2012; Yang, Feng/C-9530-2011; Du, Jing/GWC-9642-2022	Du, Jing/0000-0003-3128-9997; Yang, Feng/0000-0003-1275-6641; Lu, Bai/0000-0001-5418-9759				Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; ANDERSEN P, 1987, J PHYSIOL-LONDON, V383, P509; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Beck KD, 1996, NEURON, V16, P665, DOI 10.1016/S0896-6273(00)80085-9; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BOWENKAMP KE, 1995, J COMP NEUROL, V355, P479, DOI 10.1002/cne.903550402; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Cass WA, 1996, J NEUROSCI, V16, P8132; Chung YH, 2000, BRAIN RES, V875, P164, DOI 10.1016/S0006-8993(00)02586-5; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Feng L, 1999, NEUROSCIENCE, V93, P265, DOI 10.1016/S0306-4522(99)00129-3; Feng LY, 1999, MOL BRAIN RES, V66, P62, DOI 10.1016/S0169-328X(99)00015-7; Gao WQ, 1997, EXPERT OPIN THER PAT, V7, P325, DOI 10.1517/13543776.7.4.325; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Granholm AC, 2000, J NEUROSCI, V20, P3182, DOI 10.1523/JNEUROSCI.20-09-03182.2000; HERBERT MA, 1996, J PHARMACOL EXP THER, V279, P1181; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; HUDSON J, 1995, BRAIN RES BULL, V36, P425, DOI 10.1016/0361-9230(94)00224-O; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; LACEY MG, 1989, J NEUROSCI, V9, P1233; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LINDSAY RM, 1993, EXP NEUROL, V124, P103, DOI 10.1006/exnr.1993.1181; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Lu B, 1999, J NEUROSCI RES, V58, P76, DOI 10.1002/(SICI)1097-4547(19991001)58:1<76::AID-JNR8>3.0.CO;2-0; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MERCURI NB, 1995, EUR J NEUROSCI, V7, P462, DOI 10.1111/j.1460-9568.1995.tb00342.x; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; MOUNT HTJ, 1995, P NATL ACAD SCI USA, V92, P9092, DOI 10.1073/pnas.92.20.9092; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Oppenheim RW, 2000, J NEUROSCI, V20, P5001; Plant TD, 1998, J NEUROSCI, V18, P9573; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Soler RM, 1999, J NEUROSCI, V19, P9160; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; WANG C, IN PRESS NEURON; Washio H, 1999, NEUROSCI RES, V34, P91, DOI 10.1016/S0168-0102(99)00039-5; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P661, DOI 10.1113/jphysiol.1995.sp020998	50	122	125	1	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1071	1078		10.1038/nn734	http://dx.doi.org/10.1038/nn734			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11593232				2022-12-17	WOS:000171970900009
J	Chang, S; De Camilli, P				Chang, S; De Camilli, P			Glutamate regulates actin-based motility in axonal filopodia	NATURE NEUROSCIENCE			English	Article							PRESYNAPTIC KAINATE RECEPTORS; HIPPOCAMPAL PYRAMIDAL NEURONS; DENDRITIC SPINES; SYNAPTIC VESICLES; CALCIUM DYNAMICS; SYNAPTOGENESIS; SYNAPSES; CHANNELS; RECRUITMENT; PLASTICITY	The dynamics of axonal arbors during synaptogenesis and their plasticity in the adult nervous system remain poorly understood. Axonal filopodia, which emerge from the shaft of axonal branches and contain small synaptic vesicle clusters, initiate synaptic formation. We found that the movement of axonal filopodia is strongly inhibited by the neurotransmitter glutamate. This inhibitory effect is local, requires extracellular Ca2+, and can be blocked by CNQX treatment but not by NMDA, implicating axonal AMPA/kainate glutamate receptors. Transport and exo-endocytic recycling of synaptic vesicle packages in filopodia are not affected. These results reveal that the effect of glutamate on axonal filopodia is similar to its previously described effect on dendritic spines. Our results raise the possibility that axonal ionotropic glutamate receptors are also involved in synaptic plasticity in the adult nervous system.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06515 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cell Biol, New Haven, CT 06515 USA	Howard Hughes Medical Institute; Yale University; Yale University	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 295 Congress Ave,POB 9812, New Haven, CT 06515 USA.	pietro.decamilli@yale.edu	Chang, Sunghoe/J-2784-2012	chang, sunghoe/0000-0002-3446-7288	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251, R01NS036251] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36251] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; BRORSON JR, 1992, MOL PHARMACOL, V41, P603; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chang SH, 1999, NAT CELL BIOL, V1, P399, DOI 10.1038/15629; Chang SH, 1999, P NATL ACAD SCI USA, V96, P4095, DOI 10.1073/pnas.96.7.4095; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; CHOI DW, 1994, PROG BRAIN RES, V100, P47; CRAIG A, 2000, SYNAPSES, V1, P571; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; DECAMILLI P, 2000, SYNAPSES, V1, P89; Denk W, 1996, CURR OPIN NEUROBIOL, V6, P372, DOI 10.1016/S0959-4388(96)80122-X; Dingledine R, 1999, PHARMACOL REV, V51, P7; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Halpain S, 1998, J NEUROSCI, V18, P9835; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kraszewski K, 1996, J NEUROSCI, V16, P5905; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MATTSON MP, 1988, J NEUROSCI, V8, P2087; McKinney RA, 1999, P NATL ACAD SCI USA, V96, P11631, DOI 10.1073/pnas.96.20.11631; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; POPOV S, 1992, J NEUROSCI, V12, P77; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; SHEETZ MP, 1992, CELL MOTIL CYTOSKEL, V22, P160, DOI 10.1002/cm.970220303; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; SUDHOF T, 2000, SYNAPSES, V1, P275; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Turetsky D M, 1994, Neurobiol Dis, V1, P101, DOI 10.1006/nbdi.1994.0013; VERDERIO C, 1994, J CELL BIOL, V126, P1527, DOI 10.1083/jcb.126.6.1527; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yin HZ, 1999, J COMP NEUROL, V409, P250; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	49	122	123	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					787	793		10.1038/90489	http://dx.doi.org/10.1038/90489			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477424				2022-12-17	WOS:000170137300011
J	Cho, K; Kemp, N; Noel, J; Aggleton, JP; Brown, MW; Bashir, ZI				Cho, K; Kemp, N; Noel, J; Aggleton, JP; Brown, MW; Bashir, ZI			A new form of long-term depression in the perirhinal cortex	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; 2 DISTINCT FORMS; 1-AMINOINDAN-1,5-DICARBOXYLIC ACID; SYNAPTIC ACTIVATION; RECOGNITION MEMORY; VISUAL RECOGNITION; RAT HIPPOCAMPUS; IN-VITRO; AREA CA1; INDUCTION	We demonstrate a form of long-term depression (LTD) in the perirhinal cortex that relies on interaction between different glutamate receptors. Group II metabotropic glutamate (mGlu) receptors facilitated group 1 mGlu receptor-mediated increases in intracellular calcium. This facilitation plus NMDA receptor activation may be necessary for induction of LTD at resting membrane potentials. However, depolarization enhanced NMDA receptor function and removed the requirement of synergy between group I and group II mGlu receptors: under these conditions, activation of only NMDA and group I mGlu receptors was required for LTD. Such glutamate receptor interactions potentially provide new rules for synaptic plasticity. These forms of LTD occur in the perirhinal cortex, where long-term decreases in neuronal responsiveness may mediate recognition memory.	Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; Univ Nice Sophia Antipolis, Fac Sci, F-06108 Nice, France; Cardiff Univ, Sch Psychol, Cardiff CF10 3YJ, S Glam, Wales	University of Bristol; UDICE-French Research Universities; Universite Cote d'Azur; Cardiff University	Bashir, ZI (corresponding author), Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.			Cho, Kwangwook/0000-0001-6724-7073; Bashir, Zafar/0000-0003-3650-2136; Aggleton, John/0000-0002-5573-1308				Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BASHIR ZI, 1994, EXP BRAIN RES, V100, P437, DOI 10.1007/BF02738403; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bilkey DK, 1996, BRAIN RES, V733, P297, DOI 10.1016/0006-8993(96)00789-5; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Burwell RD, 1995, HIPPOCAMPUS, V5, P390, DOI 10.1002/hipo.450050503; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; CORODIMAS KP, 1995, BEHAV NEUROSCI, V109, P613, DOI 10.1037/0735-7044.109.4.613; Doherty AJ, 1999, BRIT J PHARMACOL, V126, P205, DOI 10.1038/sj.bjp.0702297; Domenici MR, 1998, P NATL ACAD SCI USA, V95, P8310, DOI 10.1073/pnas.95.14.8310; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; EATON SA, 1993, EUR J PHARM-MOLEC PH, V244, P195, DOI 10.1016/0922-4106(93)90028-8; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Huang LQ, 1997, NEUROREPORT, V8, P687, DOI 10.1097/00001756-199702100-00022; ITO I, 1992, NEUROREPORT, V3, P1013, DOI 10.1097/00001756-199211000-00017; Kerr DS, 1996, HIPPOCAMPUS, V6, P30, DOI 10.1002/(SICI)1098-1063(1996)6:1<30::AID-HIPO6>3.3.CO;2-6; ManahanVaughan D, 1997, J NEUROSCI, V17, P3303; MANAHANVAUGHAN D, 1998, J NEUROSCI, V37, P1459; McCaffery B, 1999, NEUROSCIENCE, V93, P977, DOI 10.1016/S0306-4522(99)00205-5; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; Mistry R, 1998, BRIT J PHARMACOL, V123, P581, DOI 10.1038/sj.bjp.0701626; Moroni F, 1997, J PHARMACOL EXP THER, V281, P721; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Otani S, 1998, J PHYSIOL-LONDON, V511, P761, DOI 10.1111/j.1469-7793.1998.761bg.x; PELLICCIARI R, 1995, J MED CHEM, V38, P3717, DOI 10.1021/jm00019a002; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Reyes M, 1996, J NEUROSCI, V16, P5951; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; SALT TE, 1995, NEUROSCIENCE, V65, P5, DOI 10.1016/0306-4522(94)00464-G; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schoepp DD, 1996, NEUROPHARMACOLOGY, V35, P1661, DOI 10.1016/S0028-3908(96)00121-9; Tzounopoulos T, 1998, NEURON, V21, P837, DOI 10.1016/S0896-6273(00)80599-1; WILSCH VW, 1994, EUR J PHARMACOL, V262, P287, DOI 10.1016/0014-2999(94)90743-9; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; ZHU XO, 1995, BRAIN RES, V689, P101, DOI 10.1016/0006-8993(95)00550-A; Zhu XO, 1996, NEUROREPORT, V7, P1871, DOI 10.1097/00001756-199607290-00037; Ziakopoulos Z, 1999, NEUROSCIENCE, V92, P459, DOI 10.1016/S0306-4522(98)00764-7	44	122	124	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					150	156		10.1038/72093	http://dx.doi.org/10.1038/72093			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649570				2022-12-17	WOS:000085810300012
J	Zhong, HJ; Yokoyama, CT; Scheuer, T; Catterall, WA				Zhong, HJ; Yokoyama, CT; Scheuer, T; Catterall, WA			Reciprocal regulation of P/Q-type Ca2+ channels by SNAP-25, syntaxin and synaptotagmin	NATURE NEUROSCIENCE			English	Article							CALCIUM-CHANNEL; ALPHA(1A) SUBUNITS; N-TYPE; BRAIN; ISOFORMS; PROTEINS		Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Mailstop 357280, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER; NINDS NIH HHS [NS22625] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Kim K, 1997, P NATL ACAD SCI USA, V94, P14782, DOI 10.1073/pnas.94.26.14782; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; MARTINMOUTOT N, 1995, FEBS LETT, V366, P21, DOI 10.1016/0014-5793(95)00467-N; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; Sakurai T, 1996, J CELL BIOL, V134, P511, DOI 10.1083/jcb.134.2.511; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x	14	122	126	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					939	941		10.1038/14721	http://dx.doi.org/10.1038/14721			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526329				2022-12-17	WOS:000083883300007
J	Shou, J; Rim, PC; Calof, AL				Shou, J; Rim, PC; Calof, AL			BMPs inhibit neurogenesis by a mechanism involving degradation of a transcription factor	NATURE NEUROSCIENCE			English	Article							BONE MORPHOGENETIC PROTEINS; UBIQUITIN-PROTEASOME PATHWAY; MOUSE OLFACTORY EPITHELIUM; ACHAETE-SCUTE HOMOLOG-1; TGF-BETA SUPERFAMILY; NEURAL CREST CELLS; NEURONAL DIFFERENTIATION; IN-VITRO; OSTEOGENIC PROTEIN-1; PROGENITOR CELLS	Bone morphogenetic proteins (BMPs), negative regulators of neural determination in the early embryo, were found to be potent inhibitors of neurogenesis in olfactory epithelium (OE) cultures. BMPs 2, 4 or 7 decreased the number of proliferating progenitor cells and blocked production of olfactory receptor neurons (ORNs). Experiments suggested that this effect was due to an action of BMPs on an early-stage progenitor in the ORN lineage. Further analysis revealed that progenitors exposed to BMPs rapidly (< 2 h) lost MASH1, a transcription factor known to be required for the production of ORNs. This disappearance was due to proteolysis of existing MASH1 protein, but new gene expression was required to trigger it. The data suggest a novel mechanism of BMP action, whereby the induced degradation of an essential transcription factor results in premature termination of a neuronal lineage.	Univ Calif Irvine, Coll Med, Dept Anat & Neurobiol, Irvine, CA 92697 USA; Univ Calif Irvine, Coll Med, Ctr Dev Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Calof, AL (corresponding author), Univ Calif Irvine, Coll Med, Dept Anat & Neurobiol, 364 Med Surge 2, Irvine, CA 92697 USA.	alcalof@uci.edu	Calof, Anne/A-8644-2013	Calof, Anne/0000-0003-3676-2499; Shou, Jianyong/0000-0002-3752-7215	NIDCD NIH HHS [DC03583] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003583] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Arkell R, 1997, DEVELOPMENT, V124, P1; Bushdid PB, 1998, NATURE, V392, P615, DOI 10.1038/33435; Calof AL, 1998, J NEUROBIOL, V36, P190, DOI 10.1002/(SICI)1097-4695(199808)36:2<190::AID-NEU7>3.0.CO;2-X; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; Calof AL, 1998, ANN NY ACAD SCI, V855, P226, DOI 10.1111/j.1749-6632.1998.tb10571.x; CALOF AL, 1999, IBRO HB S M, V18, P23; Cau E, 1997, DEVELOPMENT, V124, P1611; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; CLARK MS, 1995, J NEUROSCI, V15, P6167; DEHAMER MK, 1994, NEURON, V13, P1083, DOI 10.1016/0896-6273(94)90047-7; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Engel ME, 1998, J BIOL CHEM, V273, P9921, DOI 10.1074/jbc.273.16.9921; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Furuta Y, 1997, DEVELOPMENT, V124, P2203; GORDON MK, 1995, MOL CELL NEUROSCI, V6, P363, DOI 10.1006/mcne.1995.1028; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; HELDER MN, 1995, J HISTOCHEM CYTOCHEM, V43, P1035, DOI 10.1177/43.10.7560881; HOLCOMB JD, 1995, DEV BIOL, V172, P307, DOI 10.1006/dbio.1995.0025; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; KIM S, 1987, J CELL BIOL, V104, P51, DOI 10.1083/jcb.104.1.51; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; LEVEY MS, 1991, J NEUROSCI, V11, P3556; Li WW, 1998, J NEUROSCI, V18, P8853; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; MAGAE J, ONCOGENE; Marazzi G, 1997, DEV BIOL, V186, P127, DOI 10.1006/dbio.1997.8576; Mumm JS, 1996, P NATL ACAD SCI USA, V93, P11167, DOI 10.1073/pnas.93.20.11167; PIXLEY SK, 1992, NEURON, V8, P1191, DOI 10.1016/0896-6273(92)90139-5; REH TA, 1986, DEV BIOL, V114, P463, DOI 10.1016/0012-1606(86)90210-1; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SCHWOB JE, 1992, J NEUROSCI, V12, P3896; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Strom A, 1997, GENE DEV, V11, P3168, DOI 10.1101/gad.11.23.3168; TEMPLE S, 1995, NEURON, V15, P249, DOI 10.1016/0896-6273(95)90030-6; VARLEY JE, 1995, DEV DYNAM, V203, P434, DOI 10.1002/aja.1002030406; Weissman AM, 1997, IMMUNOL TODAY, V18, P189, DOI 10.1016/S0167-5699(97)84666-X; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wu DK, 1996, J NEUROSCI, V16, P6454; Zhang DM, 1998, J NEUROSCI, V18, P3314; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	49	122	130	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					339	345		10.1038/7251	http://dx.doi.org/10.1038/7251			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204540	Green Published			2022-12-17	WOS:000080532000012
J	Taubenfeld, SM; Wiig, KA; Bear, MF; Alberini, CM				Taubenfeld, SM; Wiig, KA; Bear, MF; Alberini, CM			A molecular correlate of memory and amnesia in the hippocampus	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; PASSIVE-AVOIDANCE RESPONSE; RATS; CREB; CONSOLIDATION; DROSOPHILA; PROTEIN; CORTEX; FORNIX		Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Brown Univ, Howard Hughes Med Inst, Providence, RI 02912 USA	Brown University; Brown University; Howard Hughes Medical Institute	Alberini, CM (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.			Bear, Mark/0000-0002-9903-2541				Baldi E, 1998, BRAIN RES, V799, P270, DOI 10.1016/S0006-8993(98)00466-1; Bear MF, 1997, NATURE, V385, P481, DOI 10.1038/385481a0; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; DECASTRO J, 1975, PHYSL PSYCHOL, V3, P201; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Lorenzini CA, 1996, BRAIN RES, V730, P32, DOI 10.1016/0006-8993(96)00427-1; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Squire L.R., 1987, MEMORY BRAIN; Wiig KA, 1996, LEARN MEMORY, V3, P313, DOI 10.1101/lm.3.4.313; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	15	122	129	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					309	310		10.1038/7217	http://dx.doi.org/10.1038/7217			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204535				2022-12-17	WOS:000080532000007
J	Stowell, RD; Sipe, GO; Dawes, RP; Batchelor, HN; Lordy, KA; Whitelaw, BS; Stoessel, MB; Bidlack, JM; Brown, E; Sur, M; Majewska, AK				Stowell, Rianne D.; Sipe, Grayson O.; Dawes, Ryan P.; Batchelor, Hanna N.; Lordy, Katheryn A.; Whitelaw, Brendan S.; Stoessel, Mark B.; Bidlack, Jean M.; Brown, Edward; Sur, Mriganka; Majewska, Ania K.			Noradrenergic signaling in the wakeful state inhibits microglial surveillance and synaptic plasticity in the mouse visual cortex	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; FRACTALKINE RECEPTOR; OCULAR DOMINANCE; SLEEP; BRAIN; MECHANISMS; NEURONS; PHARMACOLOGY; RAMIFICATION; SYNAPSES	Microglia are the brain's resident innate immune cells and also have a role in synaptic plasticity. Microglial processes continuously survey the brain parenchyma, interact with synaptic elements and maintain tissue homeostasis. However, the mechanisms that control surveillance and its role in synaptic plasticity are poorly understood. Microglial dynamics invivo have been primarily studied in anesthetized animals. Here we report that microglial surveillance and injury response are reduced in awake mice as compared to anesthetized mice, suggesting that arousal state modulates microglial function. Pharmacologic stimulation of beta(2)-adrenergic receptors recapitulated these observations and disrupted experience-dependent plasticity, and these effects required the presence of beta(2)-adrenergic receptors in microglia. These results indicate that microglial roles in surveillance and synaptic plasticity in the mouse brain are modulated by noradrenergic tone fluctuations between arousal states and emphasize the need to understand the effect of disruptions of adrenergic signaling in neurodevelopment and neuropathology.	[Stowell, Rianne D.; Dawes, Ryan P.; Batchelor, Hanna N.; Lordy, Katheryn A.; Whitelaw, Brendan S.; Stoessel, Mark B.; Majewska, Ania K.] Univ Rochester, Med Ctr, Dept Neurosci, Rochester, NY 14642 USA; [Stowell, Rianne D.; Dawes, Ryan P.; Whitelaw, Brendan S.; Stoessel, Mark B.] Univ Rochester, Med Ctr, Neurosci Grad Program, Rochester, NY 14642 USA; [Stowell, Rianne D.; Sipe, Grayson O.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA; [Sipe, Grayson O.; Sur, Mriganka] Univ Rochester, Med Ctr, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; [Bidlack, Jean M.] Univ Rochester, Dept Biomed Engn, Rochester, NY USA; [Brown, Edward] Univ Rochester, Med Ctr, Ctr Visual Sci, Rochester, NY 14642 USA	University of Rochester; University of Rochester; Massachusetts Institute of Technology (MIT); Northwell Health; University of Rochester; University of Rochester; University of Rochester	Majewska, AK (corresponding author), Univ Rochester, Med Ctr, Dept Neurosci, Rochester, NY 14642 USA.	ania_majewska@urmc.rochester.edu	Stowell, Rianne/AAV-6895-2021	Stoessel, Mark/0000-0002-7785-2645; /0000-0003-2442-5671; Majewska, Ania/0000-0002-2167-6849; Whitelaw, Brendan/0000-0001-5552-1506	National Institutes of Health [R01 EY019277, R21 NS099973, R01 AA027111, R01 EY028219, F31 NS105249, T32 NS007489, F31 NS086241, F32 EY028028]; National Science Foundation [NSF 1557971]; Schmitt Program on Integrative Brain Research grant; University of Rochester Bilski-Mayer Fellowship; University of Rochester Medical Center Summer Scholars Fellowship; NATIONAL EYE INSTITUTE [R01EY028219, R01EY019277, F32EY028028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH120974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS099973, F31NS086241, F31NS105249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA027111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Schmitt Program on Integrative Brain Research grant; University of Rochester Bilski-Mayer Fellowship; University of Rochester Medical Center Summer Scholars Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank the University of Rochester Medical Center Flow Core for their expert training and services. We thank C. Lamantia for assistance with animal management; J. Olschowka and K. O'Banion for shared PCR resources; F. Rivera-Escalera for providing training on tissue preparation for microglial FACS; A. Ghosh for the Sholl analysis ImageJ plugin; and J. Cang for sharing MATLAB code for OD analysis. This work was supported by National Institutes of Health grants R01 EY019277 (A.K.M.), R21 NS099973 (A.K.M.), R01 AA027111 (A.K.M.), R01 EY028219 (M.S.), F31 NS105249 (R.D.S.), T32 NS007489 (R.D.S., G.O.S.), F31 NS086241 (G.O.S.) and F32 EY028028 (G.O.S.); National Science Foundation grant NSF 1557971 (A.K.M.); a Schmitt Program on Integrative Brain Research grant (G.O.S. and R.P.D.); the University of Rochester Bilski-Mayer Fellowship (H.N.B.); and the University of Rochester Medical Center Summer Scholars Fellowship (K.A.L.).	Aton SJ, 2009, NEURON, V61, P454, DOI 10.1016/j.neuron.2009.01.007; Bellesi M, 2016, SLEEP, V39, P143, DOI 10.5665/sleep.5336; Bernier LP, 2019, CELL REP, V27, P2895, DOI 10.1016/j.celrep.2019.05.010; BILSKI AJ, 1983, J CARDIOVASC PHARM, V5, P430, DOI 10.1097/00005344-198305000-00013; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Ding FF, 2013, CELL CALCIUM, V54, P387, DOI 10.1016/j.ceca.2013.09.001; Dissing-Olesen L, 2014, J NEUROSCI, V34, P10511, DOI 10.1523/JNEUROSCI.0405-14.2014; Farneback G, 2003, LECT NOTES COMPUT SC, V2749, P363, DOI 10.1007/3-540-45103-x_50; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; FRISHMAN W, 1980, AM HEART J, V99, P124, DOI 10.1016/0002-8703(80)90322-1; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guneykaya D, 2018, CELL REP, V24, P2773, DOI 10.1016/j.celrep.2018.08.001; Gyoneva S, 2013, J BIOL CHEM, V288, P15291, DOI 10.1074/jbc.M113.458901; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; Hoshiko M, 2012, J NEUROSCI, V32, P15106, DOI 10.1523/JNEUROSCI.1167-12.2012; JONSSON G, 1981, EUR J PHARMACOL, V72, P173, DOI 10.1016/0014-2999(81)90272-7; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; KASAMATSU T, 1976, SCIENCE, V194, P206, DOI 10.1126/science.959850; Kolmus K, 2015, BRAIN BEHAV IMMUN, V45, P297, DOI 10.1016/j.bbi.2014.10.007; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Labrousse VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006006; Li YY, 2016, EUR J NEUROSCI, V43, P131, DOI 10.1111/ejn.13065; Lowery RL, 2017, GLIA, V65, P1744, DOI 10.1002/glia.23192; Luo F, 2018, J NEUROCHEM, V144, P152, DOI 10.1111/jnc.14248; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Madrigal JLM, 2017, NEUROPHARMACOLOGY, V114, P146, DOI 10.1016/j.neuropharm.2016.12.001; Madry C, 2018, P NATL ACAD SCI USA, V115, pE1608, DOI 10.1073/pnas.1715354115; Madry C, 2018, NEURON, V97, P299, DOI 10.1016/j.neuron.2017.12.002; Miyamoto A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12540; Musiek ES, 2016, SCIENCE, V354, P1004, DOI 10.1126/science.aah4968; Nelson LE, 2003, ANESTHESIOLOGY, V98, P428, DOI 10.1097/00000542-200302000-00024; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; O'Donnell J, 2012, NEUROCHEM RES, V37, P2496, DOI 10.1007/s11064-012-0818-x; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; PETTIGREW JD, 1978, NATURE, V271, P761, DOI 10.1038/271761a0; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Qian L, 2011, J IMMUNOL, V186, P4443, DOI 10.4049/jimmunol.1002449; Root DH, 2015, J NEUROSCI, V35, P3460, DOI 10.1523/JNEUROSCI.4525-13.2015; Ryan KM, 2016, BRAIN BEHAV IMMUN, V56, P114, DOI 10.1016/j.bbi.2016.02.023; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schneble N, 2017, MOL CELL NEUROSCI, V78, P1, DOI 10.1016/j.mcn.2016.11.002; Sipe GO, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10905; Smith AJ, 2017, ELIFE, V6, DOI [10.7554/elife.27679, 10.7554/eLife.27679]; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Stowell RD, 2018, DEV NEUROBIOL, V78, P627, DOI 10.1002/dneu.22572; Toth LA, 2013, COMPARATIVE MED, V63, P91; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wong EL, 2018, BRAIN BEHAV IMMUN, V67, P257, DOI 10.1016/j.bbi.2017.09.003; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yang G, 2014, SCIENCE, V344, P1173, DOI 10.1126/science.1249098; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	59	121	122	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2019	22	11					1782	+		10.1038/s41593-019-0514-0	http://dx.doi.org/10.1038/s41593-019-0514-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JI3VI	31636451	Green Accepted, Green Submitted			2022-12-17	WOS:000493396600007
J	Girardeau, G; Inema, I; Buzsaki, G				Girardeau, Gabrielle; Inema, Ingrid; Buzsaki, Gyorgy			Reactivations of emotional memory in the hippocampus-amygdala system during sleep	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; BASOLATERAL AMYGDALA; VENTRAL HIPPOCAMPUS; CONTEXTUAL FEAR; NEURONAL ENSEMBLES; PREFRONTAL CORTEX; CELL ASSEMBLIES; DENTATE GYRUS; REM-SLEEP; IN-VIVO	The consolidation of context-dependent emotional memory requires communication between the hippocampus and the basolateral amygdala (BLA), but the mechanisms of this process are unknown. We recorded neuronal ensembles in the hippocampus and BLA while rats learned the location of an aversive air puff on a linear track, as well as during sleep before and after training. We found coordinated reactivations between the hippocampus and the BLA during non-REM sleep following training. These reactivations peaked during hippocampal sharp wave-ripples (SPW-Rs) and involved a subgroup of BLA cells positively modulated during hippocampal SPW-Rs. Notably, reactivation was stronger for the hippocampus-BLA correlation patterns representing the run direction that involved the air puff than for the 'safe' direction. These findings suggest that consolidation of contextual emotional memory occurs during ripple-reactivation of hippocampus-amygdala circuits.	[Girardeau, Gabrielle; Inema, Ingrid; Buzsaki, Gyorgy] NYU, Neurosci Inst, New York, NY 10003 USA; [Buzsaki, Gyorgy] NYU, Dept Neurol, Med Ctr, New York, NY 10016 USA; [Buzsaki, Gyorgy] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Inema, Ingrid] McGill Univ, Douglas Inst, Montreal, PQ, Canada	New York University; New York University; New York University; McGill University	Buzsaki, G (corresponding author), NYU, Neurosci Inst, New York, NY 10003 USA.; Buzsaki, G (corresponding author), NYU, Dept Neurol, Med Ctr, New York, NY 10016 USA.; Buzsaki, G (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	gyorgy.buzsaki@nyumc.org		Buzsaki, Gyorgy/0000-0002-3100-4800	Fondation pour la Recherche Medicale (FRM); Fyssen Foundation; Charles H. Revson Senior Fellowship in Biomedical Science; Simons Foundations; NIH [MH54671, MH107396, NS 090583]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fyssen Foundation; Charles H. Revson Senior Fellowship in Biomedical Science; Simons Foundations; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. LeDoux, C. Lena, E. Stark, A. Peyrache and L. Roux for comments and discussions on the analyses and manuscript and all the members of the Buzsaki laboratory for their support. This work was supported by the Fondation pour la Recherche Medicale (FRM), the Fyssen Foundation, a Charles H. Revson Senior Fellowship in Biomedical Science (G.G.), NIH MH54671 and MH107396, NS 090583 and the Simons Foundations (G.B.).	Atherton LA, 2015, TRENDS NEUROSCI, V38, P560, DOI 10.1016/j.tins.2015.07.004; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Boyce R, 2016, SCIENCE, V352, P812, DOI 10.1126/science.aad5252; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Ciocchi S, 2015, SCIENCE, V348, P560, DOI 10.1126/science.aaa3245; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; Genzel L, 2015, NEUROBIOL LEARN MEM, V122, P110, DOI 10.1016/j.nlm.2015.01.008; Girardeau G, 2011, CURR OPIN NEUROBIOL, V21, P452, DOI 10.1016/j.conb.2011.02.005; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Hsiang HL, 2014, J NEUROSCI, V34, P14115, DOI 10.1523/JNEUROSCI.3327-14.2014; Huff ML, 2013, P NATL ACAD SCI USA, V110, P3597, DOI 10.1073/pnas.1219593110; Hutchison IC, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01439; IKEGAYA Y, 1994, BRAIN RES, V656, P157, DOI 10.1016/0006-8993(94)91377-3; IKEGAYA Y, 1995, NEUROSCI RES, V22, P203, DOI 10.1016/0168-0102(95)00894-7; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; LeDoux JE, 2014, P NATL ACAD SCI USA, V111, P2871, DOI 10.1073/pnas.1400335111; Logothetis NK, 2012, NATURE, V491, P547, DOI 10.1038/nature11618; Lopes-dos-Santos V, 2013, J NEUROSCI METH, V220, P149, DOI 10.1016/j.jneumeth.2013.04.010; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MAREN S, 1995, J NEUROSCI, V15, P7548; Mizuseki K, 2012, HIPPOCAMPUS, V22, P1659, DOI 10.1002/hipo.22002; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; Patel J, 2013, J NEUROSCI, V 33, P17029, DOI 10.1523/JNEUROSCI.2036-13.2013; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Shen JM, 1998, J SLEEP RES, V7, P6, DOI 10.1046/j.1365-2869.7.s1.2.x; Small SA, 2002, REV NEUROSCIENCE, V13, P183; Sparta DR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00129; van de Ven GM, 2016, NEURON, V92, P968, DOI 10.1016/j.neuron.2016.10.020; Vandecasteele M, 2012, JOVE-J VIS EXP, DOI 10.3791/3568; Vazdarjanova A, 1999, J NEUROSCI, V19, P6615; Wang DV, 2015, NAT NEUROSCI, V18, P728, DOI 10.1038/nn.3998; Wang ME, 2013, HIPPOCAMPUS, V23, P451, DOI 10.1002/hipo.22105; Wilson M., 1994, SCIENCE, V5, P14, DOI DOI 10.1126/SCIENCE.8036517; Xu C, 2016, CELL, V167, P961, DOI 10.1016/j.cell.2016.09.051; Zelikowsky M, 2014, J NEUROSCI, V34, P8462, DOI 10.1523/JNEUROSCI.3624-13.2014	54	121	122	5	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2017	20	11					1634	+		10.1038/nn.4637	http://dx.doi.org/10.1038/nn.4637			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL0QV	28892057				2022-12-17	WOS:000413916800024
J	Rahnev, D; Maniscalco, B; Graves, T; Huang, E; de Lange, FP; Lau, H				Rahnev, Dobromir; Maniscalco, Brian; Graves, Tashina; Huang, Elliott; de lange, Floris P.; Lau, Hakwan			Attention induces conservative subjective biases in visual perception	NATURE NEUROSCIENCE			English	Article							SPATIAL ATTENTION; REPRESENTATION; MECHANISMS	Although attention usually enhances perceptual sensitivity, we found that it can also lead to relatively conservative detection biases and lower visibility ratings in discrimination tasks. These results are explained by a model in which attention reduces the trial-by-trial variability of the perceptual signal, and we determined how this model led to the observed behavior. These findings may partially reflect our impression of 'seeing' the whole visual scene despite our limited processing capacity outside of the focus of attention.	[Rahnev, Dobromir; Maniscalco, Brian; Graves, Tashina; Huang, Elliott; Lau, Hakwan] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Rahnev, Dobromir; de lange, Floris P.; Lau, Hakwan] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Graves, Tashina] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD USA	Columbia University; Radboud University Nijmegen; Johns Hopkins University	Lau, H (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	drahnev@gmail.com; hakwan@gmail.com	de Lange, Floris/D-2860-2009; Rahnev, Dobromir/AAC-4506-2019	de Lange, Floris/0000-0002-6730-1452; Rahnev, Dobromir/0000-0002-5265-2559; Maniscalco, Brian/0000-0003-3116-6188	Human Frontiers Science Project; Templeton Foundation [21569]	Human Frontiers Science Project; Templeton Foundation	H.L. received funding from the Human Frontiers Science Project (Short-Term Fellowship) and the Templeton Foundation (grant number 21569).	AZZOPARDI P, 1993, NATURE, V361, P719, DOI 10.1038/361719a0; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Dosher BA, 2000, PSYCHOL SCI, V11, P139, DOI 10.1111/1467-9280.00229; GORDON J, 1977, J OPT SOC AM, V67, P202, DOI 10.1364/JOSA.67.000202; Gorea A, 2000, P NATL ACAD SCI USA, V97, P12380, DOI 10.1073/pnas.97.22.12380; Green DM., 1966, SIGNAL DETECTION THE; Kim CY, 2005, TRENDS COGN SCI, V9, P381, DOI 10.1016/j.tics.2005.06.012; Lau H, 2011, TRENDS COGN SCI, V15, P365, DOI 10.1016/j.tics.2011.05.009; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002	15	121	122	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1513	1515		10.1038/nn.2948	http://dx.doi.org/10.1038/nn.2948			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22019729	Green Published			2022-12-17	WOS:000297546300009
J	Tsujimoto, S; Genovesio, A; Wise, SP				Tsujimoto, Satoshi; Genovesio, Aldo; Wise, Steven P.			Evaluating self-generated decisions in frontal pole cortex of monkeys	NATURE NEUROSCIENCE			English	Article							ROSTRAL PREFRONTAL CORTEX; MACAQUE MONKEYS; HUMAN COGNITION; BRAIN-FUNCTION; DEFAULT MODE; AREA-10; TASK; FMRI; REPRESENTATION; HUMANS	The frontal pole cortex (FPC) expanded markedly during human evolution, but its function remains uncertain in both monkeys and humans. Accordingly, we examined single-cell activity in this area. On every trial, monkeys decided between two response targets on the basis of a 'stay' or 'shift' cue. Feedback followed at a fixed delay. FPC cells did not encode the monkeys' decisions when they were made, but did so later on, as feedback approached. This finding indicates that the FPC is involved in monitoring or evaluating decisions. Using a control task and delayed feedback, we found that decision coding lasted until feedback only when the monkeys combined working memory with sensory cues to 'self-generate' decisions, as opposed to when they simply followed trial-by-trial instructions. A role in monitoring or evaluating self-generated decisions could account for FPC's expansion during human evolution.	[Tsujimoto, Satoshi; Genovesio, Aldo; Wise, Steven P.] NIMH, Lab Syst Neurosci, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Tsujimoto, Satoshi] Kobe Univ, Grad Sch Human Dev & Environm, Dev Cognit Neurosci Lab, Nada Ku, Kobe, Hyogo 657, Japan; [Genovesio, Aldo] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Kobe University; Sapienza University Rome	Tsujimoto, S (corresponding author), NIMH, Lab Syst Neurosci, US Natl Inst Hlth, Bethesda, MD 20892 USA.	tsujimoto@ruby.kobe-u.ac.jp	Tsujimoto, Satoshi/B-8223-2011	Genovesio, Aldo/0000-0003-2521-143X	National Institute of Mental Health [Z01MH-01092]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21119513]; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH001092, ZIAMH001092] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Bunge, G. di Pellegrino, E. Murray, R. Passingham, N. Ramnani and P. Rudebeck for comments on drafts of this manuscript. A. Mitz, J. Fellows and P.-Y. Chen provided technical support. This work was supported by the Division of Intramural Research of the National Institute of Mental Health (Z01MH-01092) and by a Grant-in-Aid for Scientific Research on Innovative Areas (21119513) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. S. T. was supported by a research fellowship from the Japan Society for the Promotion of Science.	Bengtsson SL, 2009, CEREB CORTEX, V19, P1929, DOI 10.1093/cercor/bhn222; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Bunge SA, 2009, NEUROIMAGE, V46, P338, DOI 10.1016/j.neuroimage.2009.01.064; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; BURGESS PW, 2009, MEASURING MIND SPEED, P215; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Christoff K, 2004, CORTEX, V40, P623, DOI 10.1016/S0010-9452(08)70158-8; Christoff K, 2003, BEHAV NEUROSCI, V117, P1161, DOI 10.1037/0735-7044.117.6.1161; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Forstmann BU, 2005, NEUROPSYCHOLOGIA, V43, P943, DOI 10.1016/j.neuropsychologia.2004.08.008; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; Genovesio A, 2008, EUR J NEUROSCI, V27, P984, DOI 10.1111/j.1460-9568.2008.06048.x; Genovesio A, 2006, J NEUROSCI, V26, P7305, DOI 10.1523/JNEUROSCI.0699-06.2006; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Jacobs B, 2001, CEREB CORTEX, V11, P558, DOI 10.1093/cercor/11.6.558; JONES EG, 1970, BRAIN, V93, P37, DOI 10.1093/brain/93.1.37; Karim AA, 2010, CEREB CORTEX, V20, P205, DOI 10.1093/cercor/bhp090; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Lawrence NS, 2009, CEREB CORTEX, V19, P1134, DOI 10.1093/cercor/bhn154; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; Mithen SJ., 1996, PREHISTORY MIND; Mitz AR, 2009, J NEUROSCI METH, V177, P60, DOI 10.1016/j.jneumeth.2008.09.032; Mitz AR, 2005, J NEUROSCI METH, V148, P19, DOI 10.1016/j.jneumeth.2005.07.012; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Ramnani N, 2004, NEUROIMAGE, V23, P777, DOI 10.1016/j.neuroimage.2004.07.028; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.0.CO;2-I; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Tsujimoto S, 2008, CEREB CORTEX, V18, P2748, DOI 10.1093/cercor/bhn033; van Duijvenvoorde ACK, 2008, J NEUROSCI, V28, P9495, DOI 10.1523/JNEUROSCI.1485-08.2008; Walker AE, 1940, J COMP NEUROL, V73, P59, DOI 10.1002/cne.900730106; Walsh ND, 2010, CEREB CORTEX, V20, P271, DOI 10.1093/cercor/bhp098; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	50	121	122	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					120	U293		10.1038/nn.2453	http://dx.doi.org/10.1038/nn.2453			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19966838	Green Accepted			2022-12-17	WOS:000273056300022
J	Jin, JZ; Weng, C; Yeh, CI; Gordon, JA; Ruthazer, ES; Stryker, MP; Swadlow, HA; Alonso, JM				Jin, Jianzhong Z.; Weng, Chong; Yeh, Chun-I; Gordon, Joshua A.; Ruthazer, Edward S.; Stryker, Michael P.; Swadlow, Harvey A.; Alonso, Jose-Manuel			On and off domains of geniculate afferents in cat primary visual cortex	NATURE NEUROSCIENCE			English	Article							REVERSED-CONTRAST CHARTS; OFF-CENTER INPUTS; GANGLION-CELLS; RECEPTIVE-FIELDS; ON-CENTER; LAMINAR ORGANIZATION; ORIENTATION COLUMNS; STRIATE CORTEX; GENICULOCORTICAL AFFERENTS; ALPHA-GANGLION	On- and off-center geniculate afferents form two major channels of visual processing that are thought to converge in the primary visual cortex. However, humans with severely reduced on responses can have normal visual acuity when tested in a white background, which indicates that off channels can function relatively independently from on channels under certain conditions. Consistent with this functional independence of channels, we demonstrate here that on- and off-center geniculate afferents segregate in different domains of the cat primary visual cortex and that off responses dominate the cortical representation of the area centralis. On average, 70% of the geniculate afferents converging at the same cortical domain had receptive fields of the same contrast polarity. Moreover, off-center afferents dominated the representation of the area centralis in the cortex, but not in the thalamus, indicating that on- and off-center afferents are balanced in number, but not in the amount of cortical territory that they cover.	[Jin, Jianzhong Z.; Weng, Chong; Yeh, Chun-I; Swadlow, Harvey A.; Alonso, Jose-Manuel] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA; [Yeh, Chun-I; Swadlow, Harvey A.; Alonso, Jose-Manuel] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Gordon, Joshua A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Gordon, Joshua A.; Ruthazer, Edward S.; Stryker, Michael P.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Ruthazer, Edward S.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	State University of New York (SUNY) System; SUNY Optometry; University of Connecticut; Columbia University; University of California System; University of California San Francisco; McGill University	Alonso, JM (corresponding author), SUNY Coll Optometry, Dept Biol Sci, 33 W 42 St, New York, NY 10036 USA.	jalonso@sunyopt.edu	Gordon, Joshua A/E-6778-2012; Ruthazer, Edward S/P-5935-2014; Ruthazer, Edward/H-4782-2019	Gordon, Joshua A/0000-0002-5488-8266; Ruthazer, Edward S/0000-0003-0452-3151; Ruthazer, Edward/0000-0003-0452-3151; Stryker, Michael/0000-0003-1546-5831; YEH, CHUN-I/0000-0002-2375-0723	NEI NIH HHS [EY 05253, R37 EY002874, R01 EY005253-22, R37 EY002874-24S2, R01 EY005253, EY 02874, R01 EY002874] Funding Source: Medline; NIMH NIH HHS [MH 64024, R01 MH064024] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005253, R37EY002874, R37EY005253, R01EY002874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064024] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Aronov D, 2003, J NEUROPHYSIOL, V89, P3304, DOI 10.1152/jn.00826.2002; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; BERMAN NEJ, 1989, NEUROSCIENCE, V32, P721, DOI 10.1016/0306-4522(89)90293-5; BOWLING DB, 1986, J PHYSIOL-LONDON, V375, P561, DOI 10.1113/jphysiol.1986.sp016133; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chatterjee S, 2003, NATURE, V426, P668, DOI [10.1038/nature02167, 10.1038/nature02163]; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; CONLEY M, 1984, J NEUROSCI, V4, P171; CONWAY JL, 1983, J NEUROPHYSIOL, V50, P1330, DOI 10.1152/jn.1983.50.6.1330; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; FAMIGLIETTI EV, 1977, SCIENCE, V198, P1267, DOI 10.1126/science.73223; FREUND TF, 1985, J COMP NEUROL, V242, P263, DOI 10.1002/cne.902420208; Gheorghita F, 2006, J NEUROSCI, V26, P10057, DOI 10.1523/JNEUROSCI.1263-06.2006; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1985, J COMP NEUROL, V233, P159, DOI 10.1002/cne.902330203; KRETZ R, 1986, J COMP NEUROL, V251, P135, DOI 10.1002/cne.902510110; LEVAY S, 1982, NATURE, V300, P350, DOI 10.1038/300350a0; MCCONNELL SK, 1984, P NATL ACAD SCI-BIOL, V81, P1590, DOI 10.1073/pnas.81.5.1590; MILLER KD, 1992, NEUROREPORT, V3, P73, DOI 10.1097/00001756-199201000-00019; MILLER KD, 1994, J NEUROSCI, V14, P409; Nakagama H, 2000, BIOL CYBERN, V83, P85, DOI 10.1007/s004220000148; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; PEICHL L, 1989, J COMP NEUROL, V286, P120, DOI 10.1002/cne.902860108; PEICHL L, 1987, PROC R SOC SER B-BIO, V231, P169, DOI 10.1098/rspb.1987.0040; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; RACZKOWSKI D, 1990, J COMP NEUROL, V302, P500, DOI 10.1002/cne.903020307; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; SCHILLER PH, 1986, NATURE, V322, P824, DOI 10.1038/322824a0; SCHILLER PH, 1978, J NEUROPHYSIOL, V41, P788, DOI 10.1152/jn.1978.41.3.788; STRYKER MP, 1983, J NEUROSCI, V3, P1943; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; WEHRHAHN C, 1992, J NEUROSCI, V12, P2247; Westheimer G, 2003, OPTOMETRY VISION SCI, V80, P749, DOI 10.1097/00006324-200311000-00011; Westheimer G, 2003, OPTOMETRY VISION SCI, V80, P745, DOI 10.1097/00006324-200311000-00010; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; ZAHS KR, 1988, J NEUROPHYSIOL, V59, P1410, DOI 10.1152/jn.1988.59.5.1410; ZEMON V, 1988, VISUAL NEUROSCI, V1, P145, DOI 10.1017/S0952523800001085	50	121	121	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					88	94		10.1038/nn2029	http://dx.doi.org/10.1038/nn2029			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18084287	Green Accepted			2022-12-17	WOS:000252117900016
J	Lunn, ML; Nassirpour, R; Arrabit, C; Tan, J; Mcleod, I; Arias, CM; Sawchenko, PE; Yates, JR; Slesinger, PA				Lunn, Marie-Louise; Nassirpour, Rounak; Arrabit, Christine; Tan, Joshua; Mcleod, Ian; Arias, Carlos M.; Sawchenko, Paul E.; Yates, John R., III; Slesinger, Paul A.			A unique sorting nexin regulates trafficking of potassium channels via a PDZ domain interaction	NATURE NEUROSCIENCE			English	Article							RECTIFYING K+ CHANNELS; MESSENGER-RNAS; PROTEINS; BINDING; RECEPTORS; MODULATION; ACTIVATE; SUBUNITS; HOMOLOG; NEURONS	G protein-gated potassium (Kir3) channels are important for controlling neuronal excitability in the brain. Using a proteomics approach, we have identified a unique rodent intracellular protein, sorting nexin 27 (SNX27), which regulates the trafficking of Kir3 channels. Like most sorting nexins, SNX27 possesses a functional PX domain that selectively binds the membrane phospholipid phosphatidylinositol-3-phosphate (P13P) and is important for trafficking to the early endosome. SNX27, however, is the only sorting nexin to contain a PDZ domain. This PDZ domain discriminates between channels with similar class I PDZ-binding motifs, associating with the C-terminal end of Kir3.3 and Kir3.2c (-ESKV), but not with that of Kir2.1 (-ESEI) or Kv1.4 (-ETDV). SNX27 promotes the endosomal movement of Kir3 channels, leading to reduced surface expression, increased degradation and smaller Kir3 potassium currents. The regulation of endosomal trafficking via sorting nexins reveals a previously unknown mechanism for controlling potassium channel surface expression.	Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Neuronal Struct & Funct Lab, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Salk Institute	Slesinger, PA (corresponding author), Salk Inst Biol Studies, Peptide Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slesinger@salk.edu			NINDS NIH HHS [R01 NS37682] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037682] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; DiMagno L, 1996, PFLUG ARCH EUR J PHY, V431, P335, DOI 10.1007/BF02207270; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hibino H, 2000, EMBO J, V19, P78, DOI 10.1093/emboj/19.1.78; Horazdovsky BF, 1997, MOL BIOL CELL, V8, P1529, DOI 10.1091/mbc.8.8.1529; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Inanobe A, 1999, J NEUROSCI, V19, P1006; Jelacic TM, 1999, J MEMBRANE BIOL, V169, P123, DOI 10.1007/s002329900524; Joubert L, 2004, J CELL SCI, V117, P5367, DOI 10.1242/jcs.01379; Kajii Y, 2003, MOL PSYCHIATR, V8, P434, DOI 10.1038/sj.mp.4001258; Karschin C, 1996, J NEUROSCI, V16, P3559; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; Leyland ML, 2004, J BIOL CHEM, V279, P43427, DOI 10.1074/jbc.M407575200; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Marker CL, 2005, J NEUROSCI, V25, P3551, DOI 10.1523/JNEUROSCI.4899-04.2005; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Slesinger PA, 1997, P NATL ACAD SCI USA, V94, P12210, DOI 10.1073/pnas.94.22.12210; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; Sun QQ, 2001, J PHYSIOL-LONDON, V531, P67, DOI 10.1111/j.1469-7793.2001.0067j.x; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	46	121	128	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1249	1259		10.1038/nn1953	http://dx.doi.org/10.1038/nn1953			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828261				2022-12-17	WOS:000249720800011
J	Torborg, CL; Hansen, KA; Feller, MB				Torborg, CL; Hansen, KA; Feller, MB			High frequency, synchronized bursting drives eye-specific segregation of retinogeniculate projections	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LATERAL GENICULATE-NUCLEUS; RETINAL WAVES; MAMMALIAN RETINA; BETA-2 SUBUNIT; MICE LACKING; FUNCTIONAL-DEVELOPMENT; CORRELATED ACTIVITY; GANGLION-CELLS; MOUSE RETINA	Blockade of retinal waves prevents the segregation of retinogeniculate afferents into eye-specific layers in the visual thalamus. However, the key features of retinal waves that drive this refinement are controversial. Some manipulations of retinal waves lead to normal eye-specific segregation but others do not. By comparing retinal spiking patterns in several mutant mice with differing levels of eye-specific segregation, we show that the presence of high-frequency bursts synchronized across neighboring retinal ganglion cells correlates with robust eye-specific segregation and that the presence of high levels of asynchronous spikes does not inhibit this segregation. These findings provide a possible resolution to previously described discrepancies regarding the role of retinal waves in retinogeniculate segregation.	Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Feller, MB (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mfeller@ucsd.edu			NEI NIH HHS [R01 EY013528] Funding Source: Medline; NINDS NIH HHS [NS13528-01A1] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013528] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bansal A, 2000, J NEUROSCI, V20, P7672; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Birtoli B, 2004, J NEUROSCI, V24, P4935, DOI 10.1523/JNEUROSCI.0795-04.2004; Buhl DL, 2003, J NEUROSCI, V23, P1013; Butts DA, 2002, NEUROSCIENTIST, V8, P243; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Demas J, 2003, J NEUROSCI, V23, P2851; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Grubb MS, 2004, J NEUROSCI, V24, P8459, DOI 10.1523/JNEUROSCI.1527-04.2004; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Guldenagel M, 2000, J COMP NEUROL, V425, P193; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2002, J NEUROSCI, V22, P9419; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Long MA, 2002, J NEUROSCI, V22, P10898; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Sohl G, 2000, BRAIN RES REV, V32, P138, DOI 10.1016/S0165-0173(99)00074-0; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Wang GY, 1997, J NEUROPHYSIOL, V78, P2895, DOI 10.1152/jn.1997.78.6.2895; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Zoli M, 1998, J NEUROSCI, V18, P4461	36	121	124	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					72	78		10.1038/nn1376	http://dx.doi.org/10.1038/nn1376			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608630	Green Accepted			2022-12-17	WOS:000225967600018
J	Ren, TY				Ren, TY			Reverse propagation of sound in the gerbil cochlea	NATURE NEUROSCIENCE			English	Article							BASILAR-MEMBRANE; OTOACOUSTIC EMISSIONS; 2-TONE DISTORTION; MECHANISMS; VIBRATION; WAVES	It is commonly believed that the cochlea emits sounds through backward-traveling waves. In the present experiment using a scanning-laser interferometer, I detected forward-traveling but not backward-traveling waves and found that the stapes vibrates earlier than the basilar membrane. These results contradict the current theory and show that the ear emits sounds through the cochlear fluids as compression waves rather than along the basilar membrane as backward-traveling waves.	Oregon Hlth & Sci Univ, Dept Otolaryngol & Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97239 USA	Oregon Health & Science University	Ren, TY (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol & Head & Neck Surg, Oregon Hearing Res Ctr, 3181 SW Sam Jackson Pk Rd,NRC 04, Portland, OR 97239 USA.	rent@ohsu.edu			NIDCD NIH HHS [R21 DC006695-01, R21 DC006695, R01 DC004554, R01 DC004554-02] Funding Source: Medline; NIDDK NIH HHS [DK55819, DK62179] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062179, P01DK055819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC006695, R01DC004554] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Cooper NP, 1997, J NEUROPHYSIOL, V78, P261, DOI 10.1152/jn.1997.78.1.261; KEMP DT, 1986, HEARING RES, V22, P95, DOI 10.1016/0378-5955(86)90087-0; KHANNA SM, 1982, SCIENCE, V215, P305, DOI 10.1126/science.7053580; Knight RD, 2001, J ACOUST SOC AM, V109, P1513, DOI 10.1121/1.1354197; Narayan SS, 1998, SCIENCE, V282, P1882, DOI 10.1126/science.282.5395.1882; Olson ES, 1999, NATURE, V402, P526, DOI 10.1038/990092; PROBST R, 1991, J ACOUST SOC AM, V89, P2027, DOI 10.1121/1.400897; Ren TY, 2002, P NATL ACAD SCI USA, V99, P17101, DOI 10.1073/pnas.262663699; RHODE WS, 1971, J ACOUST SOC AM, V49, P1218, DOI 10.1121/1.1912485; Robles L, 1997, J NEUROPHYSIOL, V77, P2385, DOI 10.1152/jn.1997.77.5.2385; Russell IJ, 1997, P NATL ACAD SCI USA, V94, P2660, DOI 10.1073/pnas.94.6.2660; Shera CA, 1999, J ACOUST SOC AM, V105, P782, DOI 10.1121/1.426948; von Bekesy G., 1960, EXPT HEARING; ZWISLOCKI J, 1953, J ACOUST SOC AM, V25, P986, DOI 10.1121/1.1907231	14	121	130	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					333	334		10.1038/nn1216	http://dx.doi.org/10.1038/nn1216			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034589				2022-12-17	WOS:000220482500008
J	Schoppa, NE; Westbrook, GL				Schoppa, NE; Westbrook, GL			AMPA autoreceptors drive correlated spiking in olfactory bulb glomeruli	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; MITRAL CELLS; GAP-JUNCTIONS; TEMPORAL INFORMATION; RAT-BRAIN; NEURONS; EXPRESSION; SYNCHRONY; SYNAPSES; EXCITATION	Information processing in the brain may rely on temporal correlations in spike activity between neurons. Within the olfactory bulb, correlated spiking in output mitral cells could affect the odor code by either binding or amplifying signals from individual odorant receptors. We examined the timing of spike trains in mitral cells of rat olfactory bulb slices. Depolarization of mitral cell pairs elicited spikes that were correlated on a rapid timescale (less than or equal to10 ms) for cells whose primary dendrites projected to the same glomerulus. Correlated spiking was driven by a novel mechanism that depended on electrical coupling at mitral cell primary dendrites; the specific synchronizing signal was a coupled depolarization (similar to20 ms) that was mediated by dendritic AMPA autoreceptors. We suggest that glomerulus-specific correlated spiking in mitral cells helps to preserve the fidelity of odor signals that are delivered to the olfactory cortex.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Schoppa, NE (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	schoppan@hotmail.com			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS026494, R01NS026494] Funding Source: NIH RePORTER; NINDS NIH HHS [NS26494] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Aroniadou-Anderjaska V, 1999, J NEUROPHYSIOL, V82, P489, DOI 10.1152/jn.1999.82.1.489; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Bozza TC, 2001, CURR BIOL, V11, pR687, DOI 10.1016/S0960-9822(01)00409-2; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Carlson GC, 2000, J NEUROSCI, V20, P2011; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; Didier A, 2001, P NATL ACAD SCI USA, V98, P6441, DOI 10.1073/pnas.101126398; DildyMayfield JE, 1996, J PHARMACOL EXP THER, V276, P1058; FREEMAN WJ, 1972, J NEUROPHYSIOL, V35, P762, DOI 10.1152/jn.1972.35.6.762; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; Friedrich RW, 2001, CURR OPIN NEUROBIOL, V11, P468, DOI 10.1016/S0959-4388(00)00236-1; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kirson ED, 1998, BRIT J PHARMACOL, V124, P1607, DOI 10.1038/sj.bjp.0701996; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Miragall F, 1996, NEUROSCI LETT, V216, P199, DOI 10.1016/0304-3940(96)13042-1; Montague AA, 1999, J COMP NEUROL, V405, P233, DOI 10.1002/(SICI)1096-9861(19990308)405:2<233::AID-CNE7>3.0.CO;2-A; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NICOLL RA, 1982, NATURE, V296, P441, DOI 10.1038/296441a0; PATERNOSTRO MA, 1995, DEV BRAIN RES, V84, P1; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; Salin PA, 2001, J NEUROPHYSIOL, V85, P1275, DOI 10.1152/jn.2001.85.3.1275; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Shadlen M.N., 1999, NEURON, V24.1, P111, DOI DOI 10.1016/S0896-627380822-3; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shen GYY, 1999, J NEUROPHYSIOL, V82, P3006, DOI 10.1152/jn.1999.82.6.3006; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Srinivas M, 1999, J NEUROSCI, V19, P9848; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Teubner B, 2000, J MEMBRANE BIOL, V176, P249, DOI 10.1007/s002320001094; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Veenstra RD, 1996, J BIOENERG BIOMEMBR, V28, P327, DOI 10.1007/BF02110109; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Zhang CB, 2002, BRAIN RES, V929, P37, DOI 10.1016/S0006-8993(01)03372-8; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	51	121	123	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1194	1202		10.1038/nn953	http://dx.doi.org/10.1038/nn953			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379859				2022-12-17	WOS:000178884600023
J	Smolders, I; Bortolotto, ZA; Clarke, VRJ; Warre, R; Khan, GM; O'Neill, MJ; Ornstein, PL; Bleakman, D; Ogden, A; Weiss, B; Stables, JP; Ho, KH; Ebinger, G; Collingridge, GL; Lodge, D; Michotte, Y				Smolders, I; Bortolotto, ZA; Clarke, VRJ; Warre, R; Khan, GM; O'Neill, MJ; Ornstein, PL; Bleakman, D; Ogden, A; Weiss, B; Stables, JP; Ho, KH; Ebinger, G; Collingridge, GL; Lodge, D; Michotte, Y			Antagonists of GLU(K5)-containing kainate receptors prevent pilocarpine-induced limbic seizures	NATURE NEUROSCIENCE			English	Article							MOSSY FIBER SYNAPSES; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; RAT HIPPOCAMPUS; KAINIC ACID; EPILEPTIFORM ACTIVITY; ANTIEPILEPTIC DRUGS; CEREBRAL-ISCHEMIA; PYRAMIDAL CELLS; GLUR5 SUBTYPE	Developments in the molecular biology and pharmacology of GLU(K5), a subtype of the kainate class of ionotropic glutamate receptors, have enabled insights into the roles of this subunit in synaptic transmission and plasticity. However, little is known about the possible functions of GLU(K5)-containing kainate receptors in pathological conditions. We report here that, in hippocampal slices, selective antagonists of GLU(K5)-containing kainate receptors prevented development of epileptiform activity-evoked by the muscarinic agonist, pilocarpine-and inhibited the activity when it was preestablished. In conscious rats, these GLU(K5) antagonists prevented and interrupted limbic seizures induced by intra-hippocampal pilocarpine perfusion, and attenuated accompanying rises in extracellular L-glutamate and GABA. This anticonvulsant activity occurred without overt side effects. GLU(K5) antagonism also prevented epileptiform activity induced by electrical stimulation, both in vitro and in vivo. Therefore, we propose that subtype-selective GLU(K5) kainate receptor antagonists offer a potential new therapy for epilepsy.	Free Univ Brussels, Inst Pharmaceut, Dept Pharmaceut Chem & Drug Anal, B-1090 Brussels, Belgium; Univ Bristol, Sch Med, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; Eli Lilly & Co, Lilly Res Ctr, Windlesham GU20 6PH, Surrey, England; Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; NINDS, Epilepsy Branch, NIH, Bethesda, MD 20892 USA; Allelix Pharmaceut, Mississauga, ON L4V 1V7, Canada; Univ Hosp AZ VUB, Dept Neurol, B-1090 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Bristol; Eli Lilly; Eli Lilly; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Vrije Universiteit Brussel	Lodge, D (corresponding author), Free Univ Brussels, Inst Pharmaceut, Dept Pharmaceut Chem & Drug Anal, Laarbeeklaan 103, B-1090 Brussels, Belgium.		Smolders, Ilse J/J-9399-2013; Collingridge, Graham L/C-4605-2015; Ornstein, Paul/E-4212-2016; Michotte, Yvette/G-9818-2013; collingridge, graham/AAI-8362-2020	Smolders, Ilse J/0000-0003-2140-0751; Collingridge, Graham L/0000-0002-9572-5359; Ornstein, Paul/0000-0002-4335-1877; Clarke, Vernon/0000-0002-6154-6555				ASHWOOD TJ, 1986, EXP BRAIN RES, V62, P189; BENARI Y, 1980, BRAIN RES, V191, P79, DOI 10.1016/0006-8993(80)90316-9; BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; Bleakman D, 1996, MOL PHARMACOL, V49, P581; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Curry WJ, 1998, AM FAM PHYSICIAN, V57, P513; De Sarro G, 1999, PHARMACOL BIOCHEM BE, V63, P621, DOI 10.1016/S0091-3057(99)00027-1; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Huettner JE, 2001, TRENDS NEUROSCI, V24, P365, DOI 10.1016/S0166-2236(00)01830-0; KEHL SJ, 1984, NEUROSCIENCE, V11, P111, DOI 10.1016/0306-4522(84)90217-3; KRNJEVIC K, 1991, GABA MECH EPILEPSY, P47; Lauri SE, 2001, NEUROPHARMACOLOGY, V41, P907, DOI 10.1016/S0028-3908(01)00152-6; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Li H, 1998, NEUROPHARMACOLOGY, V37, P1279, DOI 10.1016/S0028-3908(98)00109-9; Li H, 2001, NAT NEUROSCI, V4, P612, DOI 10.1038/88432; LODGE D, 2000, IUPHAR COMPENDIUM RE, P189; Matagne A, 1998, EPILEPSY RES, V31, P59, DOI 10.1016/S0920-1211(98)00016-3; MATTSON RH, 1995, EPILEPSIA S2, V36, P13; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; O'Neill MJ, 1998, NEUROPHARMACOLOGY, V37, P1211, DOI 10.1016/S0028-3908(98)00134-8; O'Neill MJ, 2000, NEUROPHARMACOLOGY, V39, P1575, DOI 10.1016/S0028-3908(99)00250-6; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Rodriguez-Moreno A, 2000, P NATL ACAD SCI USA, V97, P1293, DOI 10.1073/pnas.97.3.1293; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Rogawski MA, 2001, NEUROPHARMACOLOGY, V40, P28, DOI 10.1016/S0028-3908(00)00112-X; RogviHansen BA, 1995, PHARMACOL THERAPEUT, V68, P425, DOI 10.1016/0163-7258(95)02014-4; Rutecki PA, 1998, J NEUROPHYSIOL, V79, P3019, DOI 10.1152/jn.1998.79.6.3019; Sander T, 1997, AM J MED GENET, V74, P416; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Smolders I, 1997, BRIT J PHARMACOL, V121, P1171, DOI 10.1038/sj.bjp.0701231; SMOLDERS I, 1995, J NEUROSCI METH, V57, P47, DOI 10.1016/0165-0270(94)00124-Y; STASHEFF SF, 1985, BRAIN RES, V344, P296, DOI 10.1016/0006-8993(85)90807-8; TURSKI L, 1989, SYNAPSE, V3, P154, DOI 10.1002/syn.890030207; Vignes M, 1997, NEUROPHARMACOLOGY, V36, P1477, DOI 10.1016/S0028-3908(97)00158-5; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wilding TJ, 2001, J PHYSIOL-LONDON, V532, P411, DOI 10.1111/j.1469-7793.2001.0411f.x; WILDING TJ, 1995, MOL PHARMACOL, V47, P582	50	121	126	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					796	804		10.1038/nn880	http://dx.doi.org/10.1038/nn880			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12080343				2022-12-17	WOS:000177088900024
J	Sherman, SM				Sherman, SM			A wake-up call from the thalamus	NATURE NEUROSCIENCE			English	News Item							SYNAPSES	The role of thalamic burst firing in normal behavior has been controversial, but a paper in this issue offers powerful evidence that bursting may serve as a 'wake-up call' to cortex.	SUNY Stony Brook, Dept Neurobiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sherman, SM (corresponding author), SUNY Stony Brook, Dept Neurobiol, Stony Brook, NY 11794 USA.							CastroAlamancos MA, 1997, PROG NEUROBIOL, V51, P581, DOI 10.1016/S0301-0082(97)00002-6; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054	7	121	126	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					344	346		10.1038/85973	http://dx.doi.org/10.1038/85973			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276218				2022-12-17	WOS:000168762200009
J	Hynes, M; Ye, WL; Wang, K; Stone, D; Murone, M; de Sauvage, F; Rosenthal, A				Hynes, M; Ye, WL; Wang, K; Stone, D; Murone, M; de Sauvage, F; Rosenthal, A			The seven-transmembrane receptor Smoothened cell-autonomously induces multiple ventral cell types	NATURE NEUROSCIENCE			English	Article							MOTOR-NEURON INDUCTION; SONIC-HEDGEHOG; FLOOR PLATE; POLARIZING ACTIVITY; CANDIDATE GENE; PATCHED GENE; SPINAL-CORD; HOMEO BOX; EXPRESSION; PATTERN	Sonic Hedgehog (Shh) is a secreted protein that controls cell fate and mitogenesis in the developing nervous system. Here we show that a constitutively active form of Smoothened (Smo-M2) mimics concentration-dependent actions of Shh in the;developing neural tube, including activation of ventral marker genes (HNF3 beta, patched, Nkx2.2, netrin-1), suppression of dorsal markers (Pax-3, Gli-3, Ephrin A5) and induction of ventral neurons (dopaminergic, serotonergic) and ventrolateral motor neurons (Islet-1+, Islet-2+, HB9+) and interneurons (Engrailed-1+, CHX10+). Furthermore, Smo-M2's patterning activities were cell autonomous, occurring exclusively in cells expressing Smo-M2 These findings suggest that Smo is a key signaling component in the Hh receptor and that Shh patterns the vertebrate nervous system as a morphogen, rather than through secondary relay signals.	Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Hynes, M (corresponding author), Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA.	mah@gene.com; ar@gene.com		Ye, Weilan/0000-0002-6219-3982; Hynes, Mary/0000-0001-6623-6727; Wang, Kevin/0000-0002-9343-6473				Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1998, DEVELOPMENT, V125, P4943; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DAVIS CA, 1988, GENE DEV, V2, P361, DOI 10.1101/gad.2.3.361; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; HEEMSKERK J, 1994, CELL, V76, P449, DOI 10.1016/0092-8674(94)90110-4; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Johnson RL, 1995, DEVELOPMENT, V121, P4161; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; Marigo V, 1996, DEVELOPMENT, V122, P1225; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; PERRIMON N, 1995, CELL, V80, P517, DOI 10.1016/0092-8674(95)90503-0; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Sasaki H, 1997, DEVELOPMENT, V124, P1313; SASAKI H, 1994, CELL, V76, P103, DOI 10.1016/0092-8674(94)90176-7; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SPECHT LA, 1981, J COMP NEUROL, V199, P255, DOI 10.1002/cne.901990208; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Struhl G, 1997, DEVELOPMENT, V124, P2155; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Tremblay P, 1996, DEVELOPMENT, V122, P2555; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; WANG MZ, 1995, NAT MED, V1, P1184, DOI 10.1038/nm1195-1184; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; Yang Y, 1997, DEVELOPMENT, V124, P4393; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; [No title captured]	49	121	126	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					41	46		10.1038/71114	http://dx.doi.org/10.1038/71114			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TB	10607393				2022-12-17	WOS:000085810200010
J	Rushton, SK; Wann, JP				Rushton, SK; Wann, JP			Weighted combination of size and disparity: a computational model for timing a ball catch	NATURE NEUROSCIENCE			English	Article							CHANGING-SIZE; TIME; CONTACT; PERCEPTION; MOTION; DEPTH; TASKS	How do we time hand closure to catch a ball? Binocular disparity and optical looming provide two sources of information about an object's motion in depth, but the relative effectiveness of the two cues depends on ball size. Based on results from a virtual reality ball-catching task, we derive a simple model that uses both cues. The model is sensitive to the relative effectiveness of size and disparity and implicitly switches its response to the cue that specifies the earliest arrival and away from a cue that is lost or below threshold. We demonstrate the model's robustness by predicting the response of participants to some very unusual ball trajectories in a virtual reality task.	Univ Reading, Dept Psychol, Reading RG6 6AL, Berks, England; Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland	University of Reading; University of Edinburgh	Wann, JP (corresponding author), Univ Reading, Dept Psychol, 3 Earley Gate, Reading RG6 6AL, Berks, England.	J.P.Wann@reading.ac.uk	Rushton, Simon/A-1659-2010					ALDERSON GJ, 1974, J MOTOR BEHAV, V6, P217, DOI 10.1080/00222895.1974.10734998; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; Gray R, 1998, VISION RES, V38, P499, DOI 10.1016/S0042-6989(97)00230-7; HEUER H, 1993, PERCEPTION, V22, P549, DOI 10.1068/p220549; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Laurent M, 1996, PERCEPTION, V25, P1437, DOI 10.1068/p251437; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; MILNER AD, 1996, VISUAL BRAIN ACTION; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; REGAN D, 1979, VISION RES, V19, P1331, DOI 10.1016/0042-6989(79)90205-0; REGAN D, 1986, INVEST OPHTH VIS SCI, V27, P584; REGAN D, 1993, VISION RES, V33, P447, DOI 10.1016/0042-6989(93)90252-R; REGAN D, 1992, PERCEPTION, V21, P91, DOI 10.1068/p210091; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; TRESILIAN JR, 1995, PERCEPT PSYCHOPHYS, V57, P231, DOI 10.3758/BF03206510; TRESILIAN JR, 1994, HUM MOVEMENT SCI, V13, P335, DOI 10.1016/0167-9457(94)90045-0; Wann JP, 1996, J EXP PSYCHOL HUMAN, V22, P1031, DOI 10.1037/0096-1523.22.4.1031	18	121	121	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					186	190		10.1038/5750	http://dx.doi.org/10.1038/5750			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	160LF	10195204				2022-12-17	WOS:000078231600019
J	Munji, RN; Soung, AL; Weiner, GA; Sohet, F; Semple, BD; Trivedi, A; Gimlin, K; Kotoda, M; Korai, M; Aydin, S; Batugal, A; Cabangcala, AC; Schupp, PG; Oldham, MC; Hashimoto, T; Noble-Haeusslein, LJ; Daneman, R				Munji, Roeben Nocon; Soung, Allison Luen; Weiner, Geoffrey Aaron; Sohet, Fabien; Semple, Bridgette Deanne; Trivedi, Alpa; Gimlin, Kayleen; Kotoda, Masakazu; Korai, Masaaki; Aydin, Sidar; Batugal, Austin; Cabangcala, Anne Christelle; Schupp, Patrick Georg; Oldham, Michael Clark; Hashimoto, Tomoki; Noble-Haeusslein, Linda J.; Daneman, Richard			Profiling the mouse brain endothelial transcriptome in health and disease models reveals a core blood-brain barrier dysfunction module	NATURE NEUROSCIENCE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; P-SELECTIN; VASCULAR DEVELOPMENT; IN-VITRO; EXPRESSION; ICAM-1; CELLS; CNS; LIPOCALIN-2; INTEGRITY	Blood vessels in the CNS form a specialized and critical structure, the blood-brain barrier (BBB). We present a resource to understand the molecular mechanisms that regulate BBB function in health and dysfunction during disease. Using endothelial cell enrichment and RNA sequencing, we analyzed the gene expression of endothelial cells in mice, comparing brain endothelial cells with peripheral endothelial cells. We also assessed the regulation of CNS endothelial gene expression in models of stroke, multiple sclerosis, traumatic brain injury and seizure, each having profound BBB disruption. We found that although each is caused by a distinct trigger, they exhibit strikingly similar endothelial gene expression changes during BBB disruption, comprising a core BBB dysfunction module that shifts the CNS endothelial cells into a peripheral endothelial cell-like state. The identification of a common pathway for BBB dysfunction suggests that targeting therapeutic agents to limit it may be effective across multiple neurological disorders.	[Munji, Roeben Nocon; Soung, Allison Luen; Weiner, Geoffrey Aaron; Sohet, Fabien; Aydin, Sidar; Batugal, Austin; Cabangcala, Anne Christelle; Daneman, Richard] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Munji, Roeben Nocon; Soung, Allison Luen; Weiner, Geoffrey Aaron; Sohet, Fabien; Aydin, Sidar; Batugal, Austin; Cabangcala, Anne Christelle; Daneman, Richard] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Semple, Bridgette Deanne; Trivedi, Alpa; Gimlin, Kayleen; Schupp, Patrick Georg; Oldham, Michael Clark; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Kotoda, Masakazu; Korai, Masaaki; Hashimoto, Tomoki] Barrow Neurol Inst, Barrow Aneurysm & AVM Res Ctr, Dept Neurosurg & Neurobiol, Phoenix, AZ 85013 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; Barrow Neurological Institute	Daneman, R (corresponding author), Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA.; Daneman, R (corresponding author), Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA.	Rdaneman@ucsd.edu		Soung, Allison/0000-0002-1590-6038; Aydin, Sidar/0000-0001-7791-7931; Korai, Masaaki/0000-0002-5326-3467	National Institutes of Health (NIH)/National Institue of Neurological Disorders and Stroke (NINDS) [R01 NS091281-01A1]; National Multiple Sclerosis Society Pilot Grant; Takeda Pharmaceuticals New Frontier Science Program; UCSF Department of Clinical Pharmacology and Therapeutics NIH T32 grant [GM007546]; UCSF Department of Anesthesia and Perioperative Care NIH T32 grant [GM008440]; NIH/National Institue of Mental Health [R01 MH113896]; NIH/NINDS [R01 NS050159, NS077767, R01NS055876, R01NS082280]; Barrow Neurological Foundation grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198, T32GM008440, T32GM007546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH113896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082280, R01NS077767, R01NS091281] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institue of Neurological Disorders and Stroke (NINDS); National Multiple Sclerosis Society Pilot Grant; Takeda Pharmaceuticals New Frontier Science Program; UCSF Department of Clinical Pharmacology and Therapeutics NIH T32 grant; UCSF Department of Anesthesia and Perioperative Care NIH T32 grant; NIH/National Institue of Mental Health; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Barrow Neurological Foundation grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank N. Lescano and A. Schroeder and the Parnassus Flow Cytometry Core, T. Rambaldo and the UCSD Veterans Hospital Flow Cytometry Core, R. Chadwick and the Gladstone Genomics Core, A. Williams and The Gladstone Bioinformatics Core and K. Jepsen and the UCSD Institute for Genomics Medicine Genomics Center. R.D. is funded by the National Institutes of Health (NIH)/National Institue of Neurological Disorders and Stroke (NINDS) (grant no. R01 NS091281-01A1), a National Multiple Sclerosis Society Pilot Grant and Takeda Pharmaceuticals New Frontier Science Program. R.N.M. was funded by the UCSF Department of Clinical Pharmacology and Therapeutics (grant no. GM007546) and the Department of Anesthesia and Perioperative Care (grant no. GM008440) NIH T32 grants. M.C.O. is funded by the NIH/National Institue of Mental Health (grant no. R01 MH113896). L.J.N.-H. is funded by the NIH/NINDS (grant nos. R01 NS050159 and NS077767). T.H. is funded by the NIH/NINDS (grant nos. R01NS055876 and R01NS082280) and the Barrow Neurological Foundation grant.	Aggarwal Bharat B., 2002, Current Drug Targets - Inflammation and Allergy, V1, P327, DOI 10.2174/1568010023344571; Akamatsu Y, 2015, J NEUROSCI, V35, P3851, DOI 10.1523/JNEUROSCI.3838-14.2015; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; BOWES MP, 1993, EXP NEUROL, V119, P215, DOI 10.1006/exnr.1993.1023; Cheng BH, 2012, PEPTIDES, V37, P171, DOI 10.1016/j.peptides.2012.07.012; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; Daneman R, 2012, ANN NEUROL, V72, P648, DOI 10.1002/ana.23648; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Doring A, 2007, J IMMUNOL, V179, P8470, DOI 10.4049/jimmunol.179.12.8470; Ferreira AC, 2015, PROG NEUROBIOL, V131, P120, DOI 10.1016/j.pneurobio.2015.06.005; Henninger DD, 1997, J IMMUNOL, V158, P1825; Huang J, 2000, STROKE, V31, P3047, DOI 10.1161/01.STR.31.12.3047; Ioannidou S, 2006, P NATL ACAD SCI USA, V103, P16770, DOI 10.1073/pnas.0603501103; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jin AY, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-12; Keuschnigg J, 2009, BLOOD, V114, P478, DOI 10.1182/blood-2008-11-188763; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Love S, 2001, NEUROPATH APPL NEURO, V27, P465, DOI 10.1046/j.1365-2990.2001.00356.x; Lui JH, 2014, NATURE, V515, P264, DOI 10.1038/nature13973; Lyck R, 2003, BLOOD, V102, P3675, DOI 10.1182/blood-2003-02-0358; Ma S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001469; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; OKADA Y, 1994, STROKE, V25, P202, DOI 10.1161/01.STR.25.1.202; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pinzon-Daza ML, 2014, J CEREBR BLOOD F MET, V34, P1258, DOI 10.1038/jcbfm.2014.100; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Semple BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143386; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; SHARIEF MK, 1993, J NEUROIMMUNOL, V43, P15, DOI 10.1016/0165-5728(93)90070-F; Shue EH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-29; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; Sun CR, 2013, J NEUROSCI, V33, P17314, DOI 10.1523/JNEUROSCI.2129-13.2013; Troletti CD, 2016, BBA-MOL BASIS DIS, V1862, P452, DOI 10.1016/j.bbadis.2015.10.010; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Weidenfeller C, 2007, J NEUROCHEM, V101, P555, DOI 10.1111/j.1471-4159.2006.04394.x; Xing CH, 2014, STROKE, V45, P2085, DOI 10.1161/STROKEAHA.114.005733; Zhou T, 2019, NAT NEUROSCI, V22, P421, DOI 10.1038/s41593-018-0324-9; Zhou YL, 2014, DEV CELL, V31, P248, DOI 10.1016/j.devcel.2014.08.018; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	47	120	121	4	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2019	22	11					1892	+		10.1038/s41593-019-0497-x	http://dx.doi.org/10.1038/s41593-019-0497-x			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JI3VI	31611708	Green Accepted, Green Submitted			2022-12-17	WOS:000493396600016
J	Hruska, M; Henderson, N; Le Marchand, SJ; Jafri, H; Dalva, MB				Hruska, Martin; Henderson, Nathan; Le Marchand, Sylvain J.; Jafri, Haani; Dalva, Matthew B.			Synaptic nanomodules underlie the organization and plasticity of spine synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SINGLE-CELL RESOLUTION; DENDRITIC SPINES; AMPA RECEPTORS; IN-VIVO; POSTSYNAPTIC DENSITY; EXCITATORY SYNAPSES; RAT HIPPOCAMPUS; PSD-95; STARGAZIN	Experience results in long-lasting changes in dendritic spine size, yet how the molecular architecture of the synapse responds to plasticity remains poorly understood. Here a combined approach of multicolor stimulated emission depletion microscopy ( STED) and confocal imaging in rat and mouse demonstrates that structural plasticity is linked to the addition of unitary synaptic nanomodules to spines. Spine synapses in vivo and in vitro contain discrete and aligned subdiffraction modules of pre- and postsynaptic proteins whose number scales linearly with spine size. Live-cell time-lapse super-resolution imaging reveals that NMDA receptor-dependent increases in spine size are accompanied both by enhanced mobility of pre- and postsynaptic modules that remain aligned with each other and by a coordinated increase in the number of nanomodules. These findings suggest a simplified model for experience-dependent structural plasticity relying on an unexpectedly modular nanomolecular architecture of synaptic proteins.	[Hruska, Martin; Henderson, Nathan; Jafri, Haani; Dalva, Matthew B.] Thomas Jefferson Univ, Dept Neurosci, Vickie & Jack Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Le Marchand, Sylvain J.] Univ Delaware, Bioimaging Ctr, Newark, DE USA	Jefferson University; University of Delaware	Dalva, MB (corresponding author), Thomas Jefferson Univ, Dept Neurosci, Vickie & Jack Farber Inst Neurosci, Philadelphia, PA 19107 USA.	matthew.dalva@jefferson.edu		Dalva, Matthew/0000-0002-7737-8787; Hruska, Martin/0000-0003-3186-770X	NIDA [DA022727]; NIMH [MH100093]; Vickie and Jack Farber Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022727] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Vickie and Jack Farber Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Hodge and the other members of the Dalva laboratory and S. Datta and J. Kauer for suggestions and comments. Grants from NIDA (DA022727), NIMH (MH100093) and the Vickie and Jack Farber Foundation to M.B.D. supported this work.	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; Broadhead MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24626; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Gehne N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182106; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Gross GG, 2013, NEURON, V78, P971, DOI 10.1016/j.neuron.2013.04.017; Hafner AS, 2015, NEURON, V86, P475, DOI 10.1016/j.neuron.2015.03.013; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hruska M, 2015, NAT NEUROSCI, V18, P1594, DOI 10.1038/nn.4140; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kim IH, 2015, NAT NEUROSCI, V18, P883, DOI 10.1038/nn.4015; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Liu KKL, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0328; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McClelland AC, 2010, P NATL ACAD SCI USA, V107, P8830, DOI 10.1073/pnas.0910644107; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Nair D, 2013, J NEUROSCI, V33, P13204, DOI 10.1523/JNEUROSCI.2381-12.2013; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Nicoll RA, 2017, NEURON, V93, P281, DOI 10.1016/j.neuron.2016.12.015; Nolt MJ, 2011, J NEUROSCI, V31, P5353, DOI 10.1523/JNEUROSCI.0282-11.2011; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Rankin BR, 2011, BIOPHYS J, V100, pL63, DOI 10.1016/j.bpj.2011.05.020; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Schoonderwoert V, 2013, MICROSC TODAY, V21, P38; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Sinnen BL, 2017, NEURON, V93, P646, DOI 10.1016/j.neuron.2016.12.037; Sorra KE, 1998, J COMP NEUROL, V398, P225; Spence EF, 2016, J NEUROSCI, V36, P9696, DOI 10.1523/JNEUROSCI.0876-16.2016; Stein V, 2003, J NEUROSCI, V23, P5503; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Sun Q, 2011, J NEUROSCI, V31, P6800, DOI 10.1523/JNEUROSCI.5616-10.2011; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Tang AH, 2016, NATURE, V536, P210, DOI 10.1038/nature19058; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Yang Y, 2016, NAT NEUROSCI, V19, P1348, DOI 10.1038/nn.4370; Zeng ML, 2016, CELL, V166, P1163, DOI 10.1016/j.cell.2016.07.008; Zhang Y, 2015, NAT NEUROSCI, V18, P402, DOI 10.1038/nn.3936	58	120	122	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2018	21	5					671	+		10.1038/s41593-018-0138-9	http://dx.doi.org/10.1038/s41593-018-0138-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GE4EB	29686261	Green Accepted, Green Submitted			2022-12-17	WOS:000431166100007
J	Kragel, PA; Kano, M; Van Oudenhove, L; Ly, HG; Dupont, P; Rubio, A; Delon-Martin, C; Bonaz, BL; Manuck, SB; Gianaros, PJ; Ceko, M; Losin, EAR; Woo, CW; Nichols, TE; Wager, TD				Kragel, Philip A.; Kano, Michiko; Van Oudenhove, Lukas; Ly, Huynh Giao; Dupont, Patrick; Rubio, Amandine; Delon-Martin, Chantal; Bonaz, Bruno L.; Manuck, Stephen B.; Gianaros, Peter J.; Ceko, Marta; Losin, Elizabeth A. Reynolds; Woo, Choong-Wan; Nichols, Thomas E.; Wager, Tor D.			Generalizable representations of pain, cognitive control, and negative emotion in medial frontal cortex	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; RECTAL DISTENSION; BRAIN RESPONSES; FMRI; DISTINCT; SYSTEM; ORGANIZATION; ANTICIPATION; METAANALYSIS; INFORMATION	The medial frontal cortex, including anterior midcingulate cortex, has been linked to multiple psychological domains, including cognitive control, pain, and emotion. However, it is unclear whether this region encodes representations of these domains that are generalizable across studies and subdomains. Additionally, if there are generalizable representations, do they reflect a single underlying process shared across domains or multiple domain-specific processes? We decomposed multivariate patterns of functional MRI activity from 270 participants across 18 studies into study-specific, subdomain-specific, and domain-specific components and identified latent multivariate representations that generalized across subdomains but were specific to each domain. Pain representations were localized to anterior midcingulate cortex, negative emotion representations to ventromedial prefrontal cortex, and cognitive control representations to portions of the dorsal midcingulate. These findings provide evidence for medial frontal cortex representations that generalize across studies and subdomains but are specific to distinct psychological domains rather than reducible to a single underlying process.	[Kragel, Philip A.; Wager, Tor D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Kano, Michiko] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi, Japan; [Kano, Michiko] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi, Japan; [Van Oudenhove, Lukas; Ly, Huynh Giao] Univ Leuven, Dept Clin & Expt Med, Leuven, Belgium; [Dupont, Patrick] Univ Leuven, Dept Neurosci, Leuven, Belgium; [Rubio, Amandine; Delon-Martin, Chantal; Bonaz, Bruno L.] Univ Grenoble Alpes, GIN, Grenoble, France; [Rubio, Amandine; Delon-Martin, Chantal; Bonaz, Bruno L.] INSERM, Grenoble, France; [Rubio, Amandine; Bonaz, Bruno L.] CHU Grenoble Alpes, Grenoble, France; [Manuck, Stephen B.; Gianaros, Peter J.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Losin, Elizabeth A. Reynolds] Univ Miami, Dept Psychol, Miami, FL USA; [Woo, Choong-Wan] Inst Basic Sci, Ctr Neurosci Imaging Res, Suwon, South Korea; [Woo, Choong-Wan] Sungkyunkwan Univ, Dept Biomed Engn, Suwon, South Korea; [Nichols, Thomas E.] Univ Oxford, Oxford Big Data Inst, Nuffield Dept Populat Hlth, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England	University of Colorado System; University of Colorado Boulder; Tohoku University; Tohoku University; KU Leuven; KU Leuven; CEA; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Miami; Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU); University of Oxford	Kragel, PA; Wager, TD (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	philip.kragel@colorado.edu; tor.wager@colorado.edu	Delon-Martin, Chantal/C-6076-2009; Nichols, Thomas E./N-9902-2017; Dupont, Patrick/B-8044-2009; Woo, Choong-Wan/J-2030-2019; Ceko, Marta/AAD-2011-2022	Delon-Martin, Chantal/0000-0003-0766-0346; Nichols, Thomas E./0000-0002-4516-5103; Dupont, Patrick/0000-0003-1980-2540; Woo, Choong-Wan/0000-0002-7423-5422; Van Oudenhove, Lukas/0000-0002-6540-3113; Kragel, Philip/0000-0001-9463-6381; CEKO, MARTA/0000-0001-8679-8145	JSPS-FWO grant [VS.014.13 N]; JSPS-KAKENHI grant [26460898]; Direction de la Recherche Clinique of the University Hospital of Grenoble Alpes; pharmaceutical lab Ferring; pharmaceutical lab Cephalon; KU Leuven Special Research Fund; Wellcome Trust;  [R01 HL089850];  [P01 HL040962];  [OCI-1131801];  [R01 DA035484];  [R01 MH076136];  [R01 MH076137];  [R01 AG043463]; NATIONAL CANCER INSTITUTE [U01CA193632] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089850, P01HL040962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076136, R01MH076137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035484] Funding Source: NIH RePORTER	JSPS-FWO grant; JSPS-KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Direction de la Recherche Clinique of the University Hospital of Grenoble Alpes; pharmaceutical lab Ferring(Ferring Pharmaceuticals); pharmaceutical lab Cephalon; KU Leuven Special Research Fund; Wellcome Trust(Wellcome TrustEuropean Commission); ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Fukudo, T. Muratsubaki and J. Morishita for assistance with data collection; K. Ochsner for sharing data from studies of negative emotion; T. Braver and J. Gray for sharing working memory data; and R. Poldrack for sharing response selection data (available at https://openfmri.org/). This research was supported by grants R01 HL089850 to P.J.G.; P01 HL040962 to S.B.M.; grants OCI-1131801, R01 DA035484, and R01 MH076136 to T.D.W.; JSPS-FWO grant VS.014.13 N to L.V.O. and S. Fukudo; JSPS-KAKENHI grant 26460898 to M.K.; R01 MH076137 and R01 AG043463 to K.O.; by the Direction de la Recherche Clinique of the University Hospital of Grenoble Alpes; and by the pharmaceutical labs Ferring and Cephalon. L.V.O. is funded by the KU Leuven Special Research Fund. T.E.N. is supported by the Wellcome Trust.	Amiez C, 2014, CEREB CORTEX, V24, P563, DOI 10.1093/cercor/bhs329; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Atlas LY, 2010, J NEUROSCI, V30, P12964, DOI 10.1523/JNEUROSCI.0057-10.2010; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Bougakov D., 2009, LURIAS LEGACY 21 CEN, P30, DOI DOI 10.1093/ACPROF:OSO/9780195176704.003.0004; Bradley M. M., 2007, TECHNICAL REPORT B 3; Buchel C, 2002, J NEUROSCI, V22, P970, DOI 10.1523/JNEUROSCI.22-03-00970.2002; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Cosmides L., 1994, MAPPING MIND DOMAIN, P85, DOI [https://doi.org/10.1017/cbo9780511752902.005, DOI 10.1017/CBO9780511752902.005]; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; de la Vega A, 2016, J NEUROSCI, V36, P6553, DOI 10.1523/JNEUROSCI.4402-15.2016; DeYoung CG, 2009, J PERS SOC PSYCHOL, V97, P883, DOI 10.1037/a0016615; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Ebitz RB, 2016, NAT NEUROSCI, V19, P1278, DOI 10.1038/nn.4387; Eisenberger NI, 2004, TRENDS COGN SCI, V8, P294, DOI 10.1016/j.tics.2004.05.010; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Gallistel CR, 2009, PSYCHOL REV, V116, P439, DOI 10.1037/a0015251; Gianaros PJ, 2014, BIOL PSYCHIAT, V75, P738, DOI 10.1016/j.biopsych.2013.10.012; Haynes JD, 2015, NEURON, V87, P257, DOI 10.1016/j.neuron.2015.05.025; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Jahn A, 2016, J NEUROSCI, V36, P12385, DOI 10.1523/JNEUROSCI.2180-16.2016; Kano M, 2017, PSYCHOSOM MED, V79, P988, DOI 10.1097/PSY.0000000000000484; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2013, TRENDS COGN SCI, V17, P401, DOI 10.1016/j.tics.2013.06.007; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Krishnan A, 2016, ELIFE, V5, DOI 10.7554/eLife.15166; Kross E, 2011, P NATL ACAD SCI USA, V108, P6270, DOI 10.1073/pnas.1102693108; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; Lieberman MD, 2015, P NATL ACAD SCI USA, V112, P15250, DOI 10.1073/pnas.1515083112; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; McNamee D, 2013, NAT NEUROSCI, V16, P479, DOI 10.1038/nn.3337; Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Paus T, 1996, CEREB CORTEX, V6, P207, DOI 10.1093/cercor/6.2.207; Peelen MV, 2010, J NEUROSCI, V30, P10127, DOI 10.1523/JNEUROSCI.2161-10.2010; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Poldrack Russell A, 2011, Front Neuroinform, V5, P17, DOI 10.3389/fninf.2011.00017; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Rubio A, 2015, NEUROIMAGE, V107, P10, DOI 10.1016/j.neuroimage.2014.11.043; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; van Ast VA, 2016, CEREB CORTEX, V26, P544, DOI 10.1093/cercor/bhu206; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; Vogt BA, 2016, J CHEM NEUROANAT, V74, P28, DOI 10.1016/j.jchemneu.2016.01.010; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Woo CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6380; Xue G, 2008, CEREB CORTEX, V18, P1923, DOI 10.1093/cercor/bhm220; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	75	120	122	1	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2018	21	2					283	+		10.1038/s41593-017-0051-7	http://dx.doi.org/10.1038/s41593-017-0051-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FV0TB	29292378	Green Accepted			2022-12-17	WOS:000424269900019
J	Messina, A; Langlet, F; Chachlaki, K; Roa, J; Rasika, S; Jouy, N; Gallet, S; Gaytan, F; Parkash, J; Tena-Sempere, M; Giacobini, P; Prevot, V				Messina, Andrea; Langlet, Fanny; Chachlaki, Konstantina; Roa, Juan; Rasika, Sowmyalakshmi; Jouy, Nathalie; Gallet, Sarah; Gaytan, Francisco; Parkash, Jyoti; Tena-Sempere, Manuel; Giacobini, Paolo; Prevot, Vincent			A microRNA switch regulates the rise in hypothalamic GnRH production before puberty	NATURE NEUROSCIENCE			English	Article							HORMONE GENE-EXPRESSION; BINDING PROTEIN-BETA; HYPOGONADOTROPIC HYPOGONADISM; TRANSCRIPTION FACTORS; TRANSGENIC MICE; NITRIC-OXIDE; FEMALE PUBERTY; FERTILITY; RECEPTOR; NEURONS	A sparse population of a few hundred primarily hypothalamic neurons forms the hub of a complex neuroglial network that controls reproduction in mammals by secreting the 'master molecule' gonadotropin-releasing hormone ( GnRH). Timely postnatal changes in GnRH expression are essential for puberty and adult fertility. Here we report that a multilayered microRNA-operated switch with built-in feedback governs increased GnRH expression during the infantile-to-juvenile transition and that impairing microRNA synthesis in GnRH neurons leads to hypogonadotropic hypogonadism and infertility in mice. Two essential components of this switch, miR-200 and miR-155, respectively regulate Zeb1, a repressor of Gnrh transcriptional activators and Gnrh itself, and Cebpb, a nitric oxide-mediated repressor of Gnrh that acts both directly and through Zeb1, in GnRH neurons. This alteration in the delicate balance between inductive and repressive signals induces the normal GnRH-fuelled run-up to correct puberty initiation, and interfering with this process disrupts the neuroendocrine control of reproduction.	[Messina, Andrea; Langlet, Fanny; Chachlaki, Konstantina; Jouy, Nathalie; Gallet, Sarah; Parkash, Jyoti; Giacobini, Paolo; Prevot, Vincent] Jean Pierre Aubert Res Ctr, Lab Dev & Plast Neuroendocrine Brain, INSERM, U1172, Lille, France; [Messina, Andrea; Langlet, Fanny; Chachlaki, Konstantina; Jouy, Nathalie; Gallet, Sarah; Parkash, Jyoti; Giacobini, Paolo; Prevot, Vincent] Univ Lille, FHU Days Hlth 1000, Sch Med, Lille, France; [Langlet, Fanny] Columbia Univ, Med Ctr, New York, NY USA; [Langlet, Fanny] Columbia Univ, Berrie Diabet Ctr, New York, NY USA; [Roa, Juan; Gaytan, Francisco; Tena-Sempere, Manuel] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba, Spain; [Roa, Juan; Gaytan, Francisco; Tena-Sempere, Manuel] Inst Maimonides Invest Biomed Cordoba IMIBIC HURS, Cordoba, Spain; [Roa, Juan; Gaytan, Francisco; Tena-Sempere, Manuel] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Cordoba, Spain; [Rasika, Sowmyalakshmi] INSERM, UMR1141, PROTECT Promoting Res Oriented Early CNS Therapie, Paris, France; [Messina, Andrea] CHU Vaudois, Endocrinol Diabet & Metab Serv, Lausanne, Switzerland; [Parkash, Jyoti] Cent Univ Punjab, Ctr Anim Sci, Bathinda, India	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Columbia University; Columbia University; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Central University of Punjab	Prevot, V (corresponding author), Jean Pierre Aubert Res Ctr, Lab Dev & Plast Neuroendocrine Brain, INSERM, U1172, Lille, France.; Prevot, V (corresponding author), Univ Lille, FHU Days Hlth 1000, Sch Med, Lille, France.	vincent.prevot@inserm.fr	Prevot, Vincent/E-5720-2016; Rivas, Juan Roa/L-3689-2014; giacobini, paolo/P-5451-2015; Tena-Sempere, Manuel/AAX-3602-2021; Giacobini, Paolo/P-9878-2019	Prevot, Vincent/0000-0001-7185-3615; Rivas, Juan Roa/0000-0002-8970-421X; giacobini, paolo/0000-0002-3075-1441; Tena-Sempere, Manuel/0000-0002-4741-5567; Giacobini, Paolo/0000-0002-3075-1441; Chachlaki, Konstantina/0000-0002-7496-3526; Gallet, Sarah/0000-0002-9285-4083; Messina, Andrea/0000-0002-2393-1874	Fondation pour la Recherche Medicale (FRM); FRM (France) [DEQ20130326524]; Spanish Ministry of Economy and Science [BFI2011-025021]; ERC COST action [BM1015]; Fondation Bettencourt Schueller	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); FRM (France); Spanish Ministry of Economy and Science(Spanish Government); ERC COST action; Fondation Bettencourt Schueller	A.M. was a postdoctoral fellow supported by the Fondation pour la Recherche Medicale (FRM). We are indebted to D. Accili for his help in conducting the ChIP assays. We thank M. Tardivel (microscopy core facility), M.-H. Gevaert (histology core facility), D. Taillieu and J. Devassine (animal core facility) and the BICeL core facility of the Lille University School of Medicine for expert technical assistance. This research was supported by the FRM (Equipe FRM 2005 and DEQ20130326524, France to V.P.), grant BFI2011-025021 from the Spanish Ministry of Economy and Science (M.T.-S.), the ERC COST action BM1015 (V.P., P.G. and M.T.-S.) and the Fondation Bettencourt Schueller (F.L.).	Alisi A, 2011, LAB INVEST, V91, P283, DOI 10.1038/labinvest.2010.166; BEAUVILLAIN JC, 1980, J HISTOCHEM CYTOCHEM, V28, P1014, DOI 10.1177/28.9.6157712; Bellefontaine N, 2014, J CLIN INVEST, V124, P2550, DOI 10.1172/JCI65928; Belsham DD, 2000, MOL ENDOCRINOL, V14, P212, DOI 10.1210/me.14.2.212; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boehm U, 2015, NAT REV ENDOCRINOL, V11, P547, DOI 10.1038/nrendo.2015.112; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Caron E, 2012, J NEUROSCI, V32, P11486, DOI 10.1523/JNEUROSCI.6074-11.2012; Chachlaki K, 2016, P NATL ACAD SCI USA, V113, P2563, DOI 10.1073/pnas.1600717113; Choe HK, 2015, NEUROENDOCRINOLOGY, V102, P194, DOI 10.1159/000371805; Cossenza M, 2014, VITAM HORM, V96, P79, DOI 10.1016/B978-0-12-800254-4.00005-2; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Cottrell EC, 2006, ENDOCRINOLOGY, V147, P3652, DOI 10.1210/en.2006-0296; d'Anglemont de Tassigny X, 2010, J NEUROSCI, V30, P8581, DOI DOI 10.1523/JNEUR; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Forni PE, 2015, FRONT NEUROENDOCRIN, V36, P165, DOI 10.1016/j.yfrne.2014.09.004; Franzoni E, 2015, ELIFE, V4, DOI 10.7554/eLife.04263; Garcia-Galiano D, 2012, ENDOCRINOLOGY, V153, P316, DOI 10.1210/en.2011-1260; Garthwaite J, 2016, J PHYSIOL-LONDON, V594, P9, DOI 10.1113/JP270297; Giacobini P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001808; Givens ML, 2005, J BIOL CHEM, V280, P19156, DOI 10.1074/jbc.M502004200; Grueter CE, 2012, CELL, V149, P671, DOI 10.1016/j.cell.2012.03.029; Hanchate NK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002896; Hanchate NK, 2012, J NEUROSCI, V32, P932, DOI 10.1523/JNEUROSCI.4765-11.2012; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Issler O, 2014, NEURON, V83, P344, DOI 10.1016/j.neuron.2014.05.042; Klein D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055064; Koch M, 2012, P NATL ACAD SCI USA, V109, pE1153, DOI 10.1073/pnas.1116125109; Kuiri-Hanninen T, 2014, HORM RES PAEDIAT, V82, P73, DOI 10.1159/000362414; Le Bechec A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-67; Lee VHY, 2008, FEBS J, V275, P5458, DOI 10.1111/j.1742-4658.2008.06676.x; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Lomniczi A., 2015, NAT COMMUN, V6; Lomniczi A, 2013, NAT NEUROSCI, V16, P281, DOI 10.1038/nn.3319; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; Messina A, 2011, HUM MOL GENET, V20, P4759, DOI 10.1093/hmg/ddr403; Novaira HJ, 2012, J NEUROSCI, V32, P17391, DOI 10.1523/JNEUROSCI.2438-12.2012; Ojeda SR, 2014, NAT REV ENDOCRINOL, V10, P67, DOI 10.1038/nrendo.2013.233; Papaioannou MD, 2010, J ANDROL, V31, P26, DOI 10.2164/jandrol.109.008128; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Prevot V, 2003, J NEUROSCI, V23, P230; Prevot V., 2015, KNOBIL NEILLS PHYSL, V4th ed., P1395, DOI DOI 10.1016/B978-0-12-397175-3.00030-2; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; Spergel DJ, 1999, J NEUROSCI, V19, P2037; URBANSKI HF, 1990, ENDOCRINOLOGY, V126, P1774, DOI 10.1210/endo-126-3-1774; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Wierman ME, 2011, FRONT NEUROENDOCRIN, V32, P43, DOI 10.1016/j.yfrne.2010.07.005; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039	56	120	127	4	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2016	19	6					835	+		10.1038/nn.4298	http://dx.doi.org/10.1038/nn.4298			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DN0HI	27135215	Green Submitted			2022-12-17	WOS:000376744600014
J	Borst, A; Helmstaedter, M				Borst, Alexander; Helmstaedter, Moritz			Common circuit design in fly and mammalian motion vision	NATURE NEUROSCIENCE			English	Review							STARBURST AMACRINE CELLS; RETINAL GANGLION-CELLS; UNDERLYING DIRECTIONAL SELECTIVITY; VISUAL RESPONSE PROPERTIES; GIANT VERTICAL CELLS; RABBIT RETINA; LOBULA PLATE; DROSOPHILA-MELANOGASTER; BLOWFLY CALLIPHORA; MOVEMENT DETECTORS	Motion-sensitive neurons have long been studied in both the mammalian retina and the insect optic lobe, yet striking similarities have become obvious only recently. Detailed studies at the circuit level revealed that, in both systems, (i) motion information is extracted from primary visual information in parallel ON and OFF pathways; (ii) in each pathway, the process of elementary motion detection involves the correlation of signals with different temporal dynamics; and (iii) primary motion information from both pathways converges at the next synapse, resulting in four groups of ON-OFF neurons, selective for the four cardinal directions. Given that the last common ancestor of insects and mammals lived about 550 million years ago, this general strategy seems to be a robust solution for how to compute the direction of visual motion with neural hardware.	[Borst, Alexander] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Helmstaedter, Moritz] Max Planck Inst Brain Res, Frankfurt, Germany	Max Planck Society; Max Planck Society	Borst, A (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	aborst@neuro.mpg.de						AMTHOR FR, 1989, J COMP NEUROL, V280, P72, DOI 10.1002/cne.902800107; AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; Baden T, 2013, CURR BIOL, V23, P48, DOI 10.1016/j.cub.2012.11.006; Bahl A, 2013, NAT NEUROSCI, V16, P730, DOI 10.1038/nn.3386; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Behnia R, 2014, NATURE, V512, P427, DOI 10.1038/nature13427; Beier KT, 2013, J NEUROSCI, V33, P35, DOI 10.1523/JNEUROSCI.0245-12.2013; BORST A, 1990, P NATL ACAD SCI USA, V87, P9363, DOI 10.1073/pnas.87.23.9363; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; Borst A, 2007, PHILOS T R SOC B, V362, P369, DOI 10.1098/rstb.2006.1964; Borst A, 2014, EUR J NEUROSCI, V40, P3285, DOI 10.1111/ejn.12731; Borst A, 2014, NAT REV NEUROSCI, V15, P590, DOI 10.1038/nrn3799; Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; BRAITENBERG V, 1967, EXP BRAIN RES, V3, P271; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; BUCHNER E, 1976, BIOL CYBERN, V24, P85, DOI 10.1007/BF00360648; BUCHNER E, 1984, J COMP PHYSIOL, V155, P471, DOI 10.1007/BF00611912; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chadderton P, 2014, NAT REV NEUROSCI, V15, P71, DOI 10.1038/nrn3648; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; EGELHAAF M, 1989, J OPT SOC AM A, V6, P116, DOI 10.1364/JOSAA.6.000116; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; FAMIGLIETTI EV, 1983, BRAIN RES, V261, P138, DOI 10.1016/0006-8993(83)91293-3; FENNEMA CL, 1979, COMPUT VISION GRAPH, V9, P301, DOI 10.1016/0146-664X(79)90097-2; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; Haag J, 2004, P NATL ACAD SCI USA, V101, P16333, DOI 10.1073/pnas.0407368101; Haag J, 1999, J COMPUT NEUROSCI, V7, P213, DOI 10.1023/A:1008950515719; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; HATSOPOULOS N, 1995, SCIENCE, V270, P1000, DOI 10.1126/science.270.5238.1000; HAUSEN K, 1982, BIOL CYBERN, V46, P67, DOI 10.1007/BF00335352; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; HENGSTENBERG R, 1982, J COMP PHYSIOL, V149, P179, DOI 10.1007/BF00619212; HENGSTENBERG R, 1982, J COMP PHYSIOL, V149, P163, DOI 10.1007/BF00619211; HILDRETH EC, 1987, ANNU REV NEUROSCI, V10, P477, DOI 10.1146/annurev.ne.10.030187.002401; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2013, J NEUROSCI, V33, P902, DOI 10.1523/JNEUROSCI.3374-12.2013; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Koch C., 1992, SINGLE NEURON COMPUT, P315; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; Limb J. O., 1975, Computer Graphics and Image Processing, V4, P311, DOI 10.1016/0146-664X(75)90001-5; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Mauss AS, 2014, J NEUROSCI, V34, P2254, DOI 10.1523/JNEUROSCI.3938-13.2014; Meier M, 2014, CURR BIOL, V24, P385, DOI 10.1016/j.cub.2014.01.006; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; PIERANTONI R, 1976, CELL TISSUE RES, V171, P101; REICHARDT W, 1987, J COMP PHYSIOL A, V161, P533, DOI 10.1007/BF00603660; Reichardt W, 1961, SENS COMMUN, P303; RIEHLE A, 1984, EXP BRAIN RES, V54, P390; Rister J, 2011, DEV NEUROBIOL, V71, P1212, DOI 10.1002/dneu.20905; Rivlin-Etzion M, 2012, NEURON, V76, P518, DOI 10.1016/j.neuron.2012.08.041; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sanchez D, 1915, CONTRIBUCION CONOCIM; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Schnell B, 2012, J COMP PHYSIOL A, V198, P389, DOI 10.1007/s00359-012-0716-3; Scott EK, 2002, J COMP NEUROL, V454, P470, DOI 10.1002/cne.10467; Shinomiya K, 2014, CURR BIOL, V24, P1062, DOI 10.1016/j.cub.2014.03.051; Silies M, 2013, NEURON, V79, P111, DOI 10.1016/j.neuron.2013.04.029; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; SRINIVASAN MV, 1990, BIOL CYBERN, V63, P421, DOI 10.1007/BF00199574; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Strother JA, 2014, CURR BIOL, V24, P976, DOI 10.1016/j.cub.2014.03.017; Sun WZ, 2006, J PHYSIOL-LONDON, V576, P197, DOI 10.1113/jphysiol.2006.115857; Szikra T, 2014, NAT NEUROSCI, V17, P1728, DOI 10.1038/nn.3852; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Takemura SY, 2011, CURR BIOL, V21, P2077, DOI 10.1016/j.cub.2011.10.053; Taylor WR, 2002, J NEUROSCI, V22, P7712; TORRE V, 1978, PROC R SOC SER B-BIO, V202, P409, DOI 10.1098/rspb.1978.0075; Trenholm S, 2011, NEURON, V71, P683, DOI 10.1016/j.neuron.2011.06.020; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Vlasits AL, 2014, NEURON, V83, P1172, DOI 10.1016/j.neuron.2014.07.037; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; WYATT HJ, 1975, J NEUROPHYSIOL, V38, P613, DOI 10.1152/jn.1975.38.3.613; WYATT HJ, 1976, SCIENCE, V191, P204, DOI 10.1126/science.1857; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Yonehara K, 2013, NEURON, V79, P1078, DOI 10.1016/j.neuron.2013.08.005; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	98	120	122	3	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2015	18	8					1067	1076		10.1038/nn.4050	http://dx.doi.org/10.1038/nn.4050			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN7HO	26120965				2022-12-17	WOS:000358605400005
J	Beirowski, B; Babetto, E; Golden, JP; Chen, Y; Yang, K; Gross, RW; Patti, GJ; Milbrandt, J				Beirowski, Bogdan; Babetto, Elisabetta; Golden, Judith P.; Chen, Ying-Jr; Yang, Kui; Gross, Richard W.; Patti, Gary J.; Milbrandt, Jeffrey			Metabolic regulator LKB1 is crucial for Schwann cell-mediated axon maintenance	NATURE NEUROSCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; HEMATOPOIETIC STEM-CELLS; DIABETIC-NEUROPATHY; ENERGY HOMEOSTASIS; AMPK; PATHWAY; MTOR; MYELINATION; SUPPORT; NEURONS	Schwann cells (SCs) promote axonal integrity independently of myelination by poorly understood mechanisms. Current models suggest that SC metabolism is critical for this support function and that SC metabolic deficits may lead to axonal demise. The LKB1-AMP-activated protein kinase (AMPK) kinase pathway targets several downstream effectors, including mammalian target of rapamycin (mTOR), and is a key metabolic regulator implicated in metabolic diseases. We found through molecular, structural and behavioral characterization of SC-specific mutant mice that LKB1 activity is central to axon stability, whereas AMPK and mTOR in SCs are largely dispensable. The degeneration of axons in LKB1 mutants was most dramatic in unmyelinated small sensory fibers, whereas motor axons were comparatively spared. LKB1 deletion in SCs led to abnormalities in nerve energy and lipid homeostasis and to increased lactate release. The latter acts in a compensatory manner to support distressed axons. LKB1 signaling is essential for SC-mediated axon support, a function that may be dysregulated in diabetic neuropathy.	[Beirowski, Bogdan; Patti, Gary J.; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Babetto, Elisabetta] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Golden, Judith P.] Washington Univ, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; [Chen, Ying-Jr; Patti, Gary J.] Washington Univ, Dept Chem, St Louis, MO 63110 USA; [Yang, Kui; Gross, Richard W.; Patti, Gary J.] Washington Univ, Sch Med, Dept Internal Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Milbrandt, Jeffrey] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	bbeirowski@wustl.edu; jmilbrandt@wustl.edu		Milbrandt, Jeffrey/0000-0002-5477-7689; Golden, Judith/0000-0002-5168-8525; Babetto, Elisabetta/0000-0002-6385-8288	European Molecular Biology Organization (EMBO) long-term fellowship; Muscular Dystrophy Association (MDA) Development Award; American-Italian Cancer Foundation (AICF) postdoctoral research fellowship; US National Institutes of Health (NIH) [NS040745, NS087306, AG13730, PPG 2P01 HL057278, R21NS059566, AG0 038036]; MDA grant [237041]; NIH Neuroscience Blueprint Center [P30 NS057105]; HOPE Center for Neurological Disorders, Washington University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040745, R21NS087306, R21NS059566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG013730, R01AG013730] Funding Source: NIH RePORTER	European Molecular Biology Organization (EMBO) long-term fellowship(European Molecular Biology Organization (EMBO)); Muscular Dystrophy Association (MDA) Development Award; American-Italian Cancer Foundation (AICF) postdoctoral research fellowship; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MDA grant; NIH Neuroscience Blueprint Center; HOPE Center for Neurological Disorders, Washington University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to R. DePinho (University of Texas MD Anderson Cancer Center) for the conditional Lkb1 mice, L. Wrabetz (Hunter James Kelly Research Institute) and A. Messing (University of Wisconsin-Madison) for the P0-cre transgenic mice, and the Genome Technology Access Center (GTAC) in the Department of Genetics for help with genomic analysis. We thank members of the Holtzman laboratory for help with glucose and lactate measurements, members of the Solnica-Krezel laboratory for assistance with live imaging, and Y. Sasaki and J. Gerdts for comments on the manuscript. This work was supported by an European Molecular Biology Organization (EMBO) long-term fellowship (B.B.), Muscular Dystrophy Association (MDA) Development Award (B.B.), American-Italian Cancer Foundation (AICF) postdoctoral research fellowship (E.B.); US National Institutes of Health (NIH) grants NS040745, NS087306 (J.M.) and AG13730 (J.M.), PPG 2P01 HL057278 (R.W.G), R21NS059566 (J.P.G), AG0 038036 (G.J.P.); and MDA grant 237041 (J.M.). This study was also supported by NIH Neuroscience Blueprint Center core grant P30 NS057105 and the HOPE Center for Neurological Disorders, Washington University.	Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Beirowski B, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00256; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Bright NJ, 2009, ACTA PHYSIOL, V196, P15, DOI 10.1111/j.1748-1716.2009.01971.x; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Chowdhury SKR, 2013, NEUROBIOL DIS, V51, P56, DOI 10.1016/j.nbd.2012.03.016; Chowdhury SKR, 2011, MITOCHONDRION, V11, P845, DOI 10.1016/j.mito.2011.06.007; Chrast R, 2011, J LIPID RES, V52, P419, DOI 10.1194/jlr.R009761; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Eckersley L, 2002, INT REV NEUROBIOL, V50, P293; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Goebbels S, 2012, EMBO MOL MED, V4, P486, DOI 10.1002/emmm.201200227; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Hofmeijer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067113; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jaleel M, 2005, FEBS LETT, V579, P1417, DOI 10.1016/j.febslet.2005.01.042; Jessen N, 2010, BBA-MOL BASIS DIS, V1802, P593, DOI 10.1016/j.bbadis.2010.04.008; Laden BP, 2001, J LIPID RES, V42, P235; Lai LP, 2013, P NATL ACAD SCI USA, V110, P19450, DOI 10.1073/pnas.1309001110; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Obrosova IG, 1999, DIABETOLOGIA, V42, P1187, DOI 10.1007/s001250051290; Patti GJ, 2012, NAT PROTOC, V7, P508, DOI 10.1038/nprot.2011.454; Ramj N, 2007, NEUROBIOL DIS, V26, P301, DOI 10.1016/j.nbd.2006.11.016; Said G, 2007, NAT CLIN PRACT NEURO, V3, P331, DOI 10.1038/ncpneuro0504; Schmidt RE, 2002, INT REV NEUROBIOL, V50, P257; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Sherman DL, 2012, J NEUROSCI, V32, P1817, DOI 10.1523/JNEUROSCI.4814-11.2012; Shorning BY, 2011, FEBS LETT, V585, P958, DOI 10.1016/j.febslet.2011.01.019; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stevens MJ, 2000, DIABETES, V49, P1006, DOI 10.2337/diabetes.49.6.1006; Sun XL, 2013, J MOL ENDOCRINOL, V51, pR15, DOI 10.1530/JME-13-0063; van der Velden YU, 2011, P NATL ACAD SCI USA, V108, P4358, DOI 10.1073/pnas.1010210108; Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012; Viader A, 2011, J NEUROSCI, V31, P10128, DOI 10.1523/JNEUROSCI.0884-11.2011; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zochodne DW, 2001, BRAIN, V124, P2319, DOI 10.1093/brain/124.11.2319	50	120	121	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2014	17	10					1351	1361		10.1038/nn.3809	http://dx.doi.org/10.1038/nn.3809			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP8KD	25195104	Green Accepted			2022-12-17	WOS:000342327000015
J	Huang, TN; Chuang, HC; Chou, WH; Chen, CY; Wang, HF; Chou, SJ; Hsueh, YP				Huang, Tzyy-Nan; Chuang, Hsiu-Chun; Chou, Wen-Hsi; Chen, Chiung-Ya; Wang, Hsiao-Fang; Chou, Shen-Ju; Hsueh, Yi-Ping			Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality	NATURE NEUROSCIENCE			English	Article							DE-NOVO MUTATIONS; EXPRESSION; BRACHYURY; AXONIN-1; COMPLEX; GENES	The neuron-specific transcription factor T-box brain 1 (TBR1) regulates brain development. Disruptive mutations in the TBR1 gene have been repeatedly identified in patients with autism spectrum disorders (ASDs). Here, we show that Tbr1 haploinsufficiency results in defective axonal projections of amygdalar neurons and the impairment of social interaction, ultrasonic vocalization, associative memory and cognitive flexibility in mice. Loss of a copy of the Tbr1 gene altered the expression of Ntng1, Cntn2 and Cdh8 and reduced both inter- and intra-amygdalar connections. These developmental defects likely impair neuronal activation upon behavioral stimulation, which is indicated by fewer c-FOS-positive neurons and lack of GRIN2B induction in Tbr1(+/-) amygdalae. We also show that upregulation of amygdalar neuronal activity by local infusion of a partial NMDA receptor agonist, D-cycloserine, ameliorates the behavioral defects of Tbr1(+/-) mice. Our study suggests that TBR1 is important in the regulation of amygdalar axonal connections and cognition.	[Huang, Tzyy-Nan; Chuang, Hsiu-Chun; Chou, Wen-Hsi; Chen, Chiung-Ya; Wang, Hsiao-Fang; Hsueh, Yi-Ping] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Chuang, Hsiu-Chun; Hsueh, Yi-Ping] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chou, Shen-Ju] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; Academia Sinica - Taiwan	Hsueh, YP (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	yph@gate.sinica.edu.tw	Huang, Tzyy-Nan/AAV-5588-2021; Hsueh, Yi-Ping/ABH-5052-2020	Huang, Tzyy-Nan/0000-0002-7509-6305; Hsueh, Yi-Ping/0000-0002-0866-6275	National Research Program for Genomic Medicine, National Science Council, Taiwan [NSC99-3112-B-001-020]; Academia Sinica; National Science Council of Taiwan (NSC) [102-2321-B-001-054, 102-2321-B-001-029]; National Science Council (NSC) [102-2811-B-001-060, 102-2811-B-001-037]	National Research Program for Genomic Medicine, National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan); National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	We thank R. Hevner (University of Washington, Seattle) for the Tbr1<SUP>+/-</SUP> mice; the Functional and Micro-Magnetic Resonance Imaging Center (supported by the National Research Program for Genomic Medicine, National Science Council, Taiwan, NSC99-3112-B-001-020); S.-Y. Tung, the MicroArray Facility and the Bioinformatics Core of the Institute of Molecular Biology and DNA MicroArray Core Facility of the Institute of Plant and Microbial Biology, Academia Sinica; J. Kung and Animal Facility of Institute of Molecular Biology, Academia Sinica; C.-Y. Chang, W-R. Wong and C.-W. Tsai for technical assistance; C. Cepko for pCAG-GFP; and M. Loney for English editing. This work was supported by Academia Sinica and the National Science Council of Taiwan (NSC 102-2321-B-001-054 and 102-2321-B-001-029 to Y.-P.H.). T.-N.H. was supported by National Science Council (NSC 102-2811-B-001-060). C.-Y.C. was also supported by National Science Council (NSC 102-2811-B-001-037).	Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bekirov IH, 2008, HIPPOCAMPUS, V18, P349, DOI 10.1002/hipo.20395; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Holmes NM, 2013, J NEUROSCI, V33, P13112, DOI 10.1523/JNEUROSCI.1998-13.2013; Horio M, 2013, BIOL PSYCHIAT, V73, pE33, DOI 10.1016/j.biopsych.2012.07.013; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Huang TN, 2009, BIOCHEM BIOPH RES CO, V382, P219, DOI 10.1016/j.bbrc.2009.03.015; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kunz S, 1998, J CELL BIOL, V143, P1673, DOI 10.1083/jcb.143.6.1673; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Remedios R, 2007, NAT NEUROSCI, V10, P1141, DOI 10.1038/nn1955; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Wang GS, 2004, NEURON, V42, P113, DOI 10.1016/S0896-6273(04)00139-4; Wang TF, 2004, J NEUROCHEM, V91, P1483, DOI 10.1111/j.1471-4159.2004.02845.x; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002	25	120	122	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2014	17	2					240	247		10.1038/nn.3626	http://dx.doi.org/10.1038/nn.3626			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA2FH	24441682				2022-12-17	WOS:000330910000018
J	Lee, SH; Kravitz, DJ; Baker, CI				Lee, Sue-Hyun; Kravitz, Dwight J.; Baker, Chris I.			Goal-dependent dissociation of visual and prefrontal cortices during working memory	NATURE NEUROSCIENCE			English	Article							SHORT-TERM-MEMORY; NEURAL FRAMEWORK; CORTEX; OBJECTS; REPRESENTATIONS; VISUALIZATION; INFORMATION; AREAS	To determine the specific contribution of brain regions to working memory, human participants performed two distinct tasks on the same visually presented objects. During the maintenance of visual properties, object identity could be decoded from extrastriate, but not prefrontal, cortex, whereas the opposite held for nonvisual properties. Thus, the ability to maintain information during working memory is a general and flexible cortical property, with the role of individual regions being goal-dependent.	[Lee, Sue-Hyun; Kravitz, Dwight J.; Baker, Chris I.] NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Lee, SH (corresponding author), NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA.	sue-hyun.lee@nih.gov	Baker, Chris/P-8442-2019; Lee, Sue-Hyun/F-5490-2015; Kravitz, Dwight/AAO-5860-2020	Baker, Chris/0000-0001-6861-8964; Lee, Sue-Hyun/0000-0002-5318-5657; Kravitz, Dwight/0000-0002-8108-1329	US National Institute of Mental Health Intramural Research Program; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002909] Funding Source: NIH RePORTER	US National Institute of Mental Health Intramural Research Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the US National Institute of Mental Health Intramural Research Program. Thanks to S. Marrett and S. Inati for help with data acquisition, E. Bilger and E. Aguila for data collection, A. Harel and A. Martin for comments and members of the Laboratory of Brain and Cognition for discussion.	Brady MJ, 2003, J VISION, V3, P413, DOI 10.1167/3.6.2; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Christophel TB, 2012, J NEUROSCI, V32, P12983, DOI 10.1523/JNEUROSCI.0184-12.2012; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Kravitz DJ, 2010, CEREB CORTEX, V20, P2916, DOI 10.1093/cercor/bhq042; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Lee SH, 2012, NEUROIMAGE, V59, P4064, DOI 10.1016/j.neuroimage.2011.10.055; Lee TG, 2012, J NEUROSCI, V32, P15458, DOI 10.1523/JNEUROSCI.0627-12.2012; Lewis-Peacock JA, 2012, NEUROPSYCHOLOGIA, V50, P470, DOI 10.1016/j.neuropsychologia.2011.11.006; Linden DEJ, 2012, J NEUROPHYSIOL, V107, P628, DOI 10.1152/jn.00105.2011; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Romero L, 2006, J COGNITIVE NEUROSCI, V18, P1147, DOI 10.1162/jocn.2006.18.7.1147; Saad ZS, 2012, NEUROIMAGE, V62, P768, DOI 10.1016/j.neuroimage.2011.09.016; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Simmons WK, 2007, NEUROPSYCHOLOGIA, V45, P2802, DOI 10.1016/j.neuropsychologia.2007.05.002; Sligte IG, 2013, J NEUROSCI, V33, P1293, DOI 10.1523/JNEUROSCI.4860-12.2013; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009	25	120	120	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					997	U35		10.1038/nn.3452	http://dx.doi.org/10.1038/nn.3452			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817547	Green Accepted			2022-12-17	WOS:000322323000008
J	Kakegawa, W; Miyoshi, Y; Hamase, K; Matsuda, S; Matsuda, K; Kohda, K; Emi, K; Motohashi, J; Konno, R; Zaitsu, K; Yuzaki, M				Kakegawa, Wataru; Miyoshi, Yurika; Hamase, Kenji; Matsuda, Shinji; Matsuda, Keiko; Kohda, Kazuhisa; Emi, Kyoichi; Motohashi, Junko; Konno, Ryuichi; Zaitsu, Kiyoshi; Yuzaki, Michisuke			D-Serine regulates cerebellar LTD and motor coordination through the delta 2 glutamate receptor	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; D-ASPARTATE RECEPTORS; AMINO-ACID OXIDASE; SYNAPTIC PLASTICITY; IN-VIVO; MAMMALIAN BRAIN; GRANULE CELLS; RAT-BRAIN; RACEMASE; GLIA	D-Serine (D-Ser) is an endogenous co-agonist for NMDA receptors and regulates neurotransmission and synaptic plasticity in the forebrain. D-Ser is also found in the cerebellum during the early postnatal period. Although D-Ser binds to the delta 2 glutamate receptor (GluD2, Grid2) in vitro, its physiological significance has remained unclear. Here we show that D-Ser serves as an endogenous ligand for GluD2 to regulate long-term depression (LTD) at synapses between parallel fibers and Purkinje cells in the immature cerebellum. D-Ser was released mainly from Bergmann glia after the burst stimulation of parallel fibers in immature, but not mature, cerebellum. D-Ser rapidly induced endocytosis of AMPA receptors and mutually occluded LTD in wild-type, but not Grid2-null, Purkinje cells. Moreover, mice expressing mutant GluD2 in which the binding site for D-Ser was disrupted showed impaired LTD and motor dyscoordination during development. These results indicate that glial D-Ser regulates synaptic plasticity and cerebellar functions by interacting with GluD2.	[Kakegawa, Wataru; Matsuda, Shinji; Matsuda, Keiko; Kohda, Kazuhisa; Emi, Kyoichi; Motohashi, Junko; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Kakegawa, Wataru; Matsuda, Shinji; Matsuda, Keiko; Kohda, Kazuhisa; Emi, Kyoichi; Motohashi, Junko; Yuzaki, Michisuke] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Miyoshi, Yurika; Hamase, Kenji] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 812, Japan; [Konno, Ryuichi] Int Univ Hlth & Welf Grad Sch, Ctr Med Sci, Ohtawara, Tochigi, Japan	Keio University; Japan Science & Technology Agency (JST); Kyushu University; International University of Health & Welfare	Yuzaki, M (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan.	myuzaki@a5.keio.jp	Kakegawa, Wataru/L-4900-2013; Matsuda, Keiko/L-5778-2013; Kakegawa, Wataru/G-5569-2016; Kohda, Kazuhisa/L-4731-2013; Matsuda, Shinji/GRR-5226-2022; Yuzaki, Michisuke/K-5328-2013; Matsuda, Shinji/L-4727-2013	Yuzaki, Michisuke/0000-0002-5750-3544; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Science and Technology Agency; Keio Gijuku Academic Development Funds; Research Grants for Life Science and Medicine; Naito Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); Keio Gijuku Academic Development Funds; Research Grants for Life Science and Medicine; Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	We appreciate Shiseido Co., Ltd. for their technical support concerning the 2D-HPLC analysis of D-Ser. We thank M. Watanabe for the antibodies to GluD2 and 3-PGDH, S. Nakanishi for the GFP-TeNT cDNA, M. Mishina for the Grid2-null mouse, and T. Takahashi, S. Jitsuki and T. Nishikawa for comments. This work was supported by a Grant-in-Aid for the Ministry of Education, Culture, Sports, Science and Technology of Japan (M.Y. and W. K.), Core Research for Evolutional Science and Technology from the Japanese Science and Technology Agency (M.Y.), Keio Gijuku Academic Development Funds (W. K.), the Keio University Medical Science Fund, Research Grants for Life Science and Medicine (W. K.), the Naito Foundation Subsidy for Promotion of Specific Research Projects (W. K.) and the Takeda Science Foundation (M.Y.).	Billard JM, 2008, J CELL MOL MED, V12, P1872, DOI 10.1111/j.1582-4934.2008.00315.x; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Hansen KB, 2009, J NEUROSCI, V29, P907, DOI 10.1523/JNEUROSCI.4081-08.2009; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; HASHIMOTO A, 1995, NEUROSCIENCE, V66, P635, DOI 10.1016/0306-4522(94)00597-X; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Hirai H, 2005, EMBO REP, V6, P90, DOI 10.1038/sj.embor.7400312; Hirai H, 2003, NAT NEUROSCI, V6, P869, DOI 10.1038/nn1086; Jurado S, 2003, J CELL SCI, V116, P3165, DOI 10.1242/jcs.00620; Kakegawa W, 2008, J NEUROSCI, V28, P1460, DOI 10.1523/JNEUROSCI.2553-07.2008; Kakegawa W, 2007, J PHYSIOL-LONDON, V584, P89, DOI 10.1113/jphysiol.2007.141291; Kakegawa W, 2009, J NEUROSCI, V29, P5738, DOI 10.1523/JNEUROSCI.6013-08.2009; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lehre KP, 2002, BIOPHYS J, V83, P125, DOI 10.1016/S0006-3495(02)75154-0; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Miyoshi Y, 2009, J CHROMATOGR B, V877, P2506, DOI 10.1016/j.jchromb.2009.06.028; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Naur P, 2007, P NATL ACAD SCI USA, V104, P14116, DOI 10.1073/pnas.0703718104; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; Oliet SHR, 2009, NEUROSCIENCE, V158, P275, DOI 10.1016/j.neuroscience.2008.01.071; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schell MJ, 1997, J NEUROSCI, V17, P1604; Shin JH, 2005, J NEUROPHYSIOL, V94, P4281, DOI 10.1152/jn.00661.2005; Tanaka K, 2008, NEURON, V59, P608, DOI 10.1016/j.neuron.2008.06.026; Tregnago M, 1998, BRAIN RES, V793, P54, DOI 10.1016/S0006-8993(98)00161-9; Wang LZ, 2003, ACTA PHARMACOL SIN, V24, P965; Wang W, 1998, DEV BRAIN RES, V111, P65, DOI 10.1016/S0165-3806(98)00123-0; Williams SM, 2006, GLIA, V53, P401, DOI 10.1002/glia.20300; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yao Y, 2008, EMBO J, V27, P2158, DOI 10.1038/emboj.2008.140; Yuzaki M, 2009, NEUROSCIENCE, V162, P633, DOI 10.1016/j.neuroscience.2008.12.002; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	45	120	121	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					603	U93		10.1038/nn.2791	http://dx.doi.org/10.1038/nn.2791			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21460832				2022-12-17	WOS:000289886600016
J	Jin, JZ; Wang, YS; Swadlow, HA; Alonso, JM				Jin, Jianzhong; Wang, Yushi; Swadlow, Harvey A.; Alonso, Jose M.			Population receptive fields of ON and OFF thalamic inputs to an orientation column in visual cortex	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; CORTICAL SIMPLE CELLS; CAT STRIATE CORTEX; OFF-CENTER INPUTS; ON-CENTER; SELECTIVITY; NEURONS; AFFERENTS; MODEL; ARCHITECTURE	The primary visual cortex of primates and carnivores is organized into columns of neurons with similar preferences for stimulus orientation, but the developmental origin and function of this organization are still matters of debate. We found that the orientation preference of a cortical column is closely related to the population receptive field of its ON and OFF thalamic inputs. The receptive field scatter from the thalamic inputs was more limited than previously thought and matched the average receptive field size of neurons at the input layers of cortex. Moreover, the thalamic population receptive field (calculated as ON - OFF average) had separate ON and OFF subregions, similar to cortical neurons in layer 4, and provided an accurate prediction of the preferred orientation of the column. These results support developmental models of orientation maps that are based on the receptive field arrangement of ON and OFF visual inputs to cortex.	[Jin, Jianzhong; Wang, Yushi; Swadlow, Harvey A.; Alonso, Jose M.] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10010 USA; [Swadlow, Harvey A.; Alonso, Jose M.] Univ Connecticut, Dept Psychol, Storrs, CT USA	State University of New York (SUNY) System; SUNY Optometry; University of Connecticut	Alonso, JM (corresponding author), SUNY Coll Optometry, Dept Biol Sci, New York, NY 10010 USA.	jalonso@sunyopt.edu			US National Institutes of Health [EY05253, MH085357]; NATIONAL EYE INSTITUTE [R37EY005253, R01EY005253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085357] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Weng for helping with some experiments. This work was supported by the US National Institutes of Health (grants EY05253 to J.M.A. and MH085357 to H. A. S.).	Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BULLIER J, 1982, J NEUROPHYSIOL, V47, P417, DOI 10.1152/jn.1982.47.3.417; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chapman B, 2000, J NEUROSCI, V20, P1922; Chatterjee S, 2003, NATURE, V426, P668, DOI [10.1038/nature02167, 10.1038/nature02163]; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; Debanne D, 1998, J PHYSIOL-LONDON, V508, P523, DOI 10.1111/j.1469-7793.1998.00523.x; FERSTER D, 1990, VISUAL NEUROSCI, V4, P135, DOI 10.1017/S0952523800002297; FREEMAN JA, 1975, J NEUROPHYSIOL, V38, P369, DOI 10.1152/jn.1975.38.2.369; Gardner JL, 1999, VISUAL NEUROSCI, V16, P1115, DOI 10.1017/S0952523899166112; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1985, J COMP NEUROL, V233, P159, DOI 10.1002/cne.902330203; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; MCCONNELL SK, 1984, P NATL ACAD SCI-BIOL, V81, P1590, DOI 10.1073/pnas.81.5.1590; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; MILLER KD, 1992, NEUROREPORT, V3, P73, DOI 10.1097/00001756-199201000-00019; Miller KD, 2003, CEREB CORTEX, V13, P73, DOI 10.1093/cercor/13.1.73; MILLER KD, 1994, J NEUROSCI, V14, P409; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Nakagama H, 2000, BIOL CYBERN, V83, P85, DOI 10.1007/s004220000148; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; POLLEN DA, 1981, SCIENCE, V212, P1409, DOI 10.1126/science.7233231; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Stoelzel CR, 2008, J NEUROSCI, V28, P5018, DOI 10.1523/JNEUROSCI.4726-07.2008; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; Usrey WM, 2003, J NEUROPHYSIOL, V89, P1003, DOI 10.1152/jn.00749.2002; Yeh CI, 2009, J NEUROPHYSIOL, V101, P2166, DOI 10.1152/jn.91088.2008; ZAHS KR, 1988, J NEUROPHYSIOL, V59, P1410, DOI 10.1152/jn.1988.59.5.1410	44	120	121	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					232	U323		10.1038/nn.2729	http://dx.doi.org/10.1038/nn.2729			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21217765				2022-12-17	WOS:000286595400021
J	Uemura, M; Nakao, S; Suzuki, ST; Takeichi, M; Hirano, S				Uemura, Masato; Nakao, Shinsuke; Suzuki, Shintaro T.; Takeichi, Masatoshi; Hirano, Shinji			OL-protocadherin is essential for growth of striatal axons and thalamocortical projections	NATURE NEUROSCIENCE			English	Article							GANGLIONIC EMINENCE; GAMMA-PROTOCADHERINS; INTERMEDIATE TARGET; MOUSE-BRAIN; CORTEX; MICE; CONNECTIVITY; EXPRESSION; NEURONS; SYSTEM	The ventral telencephalon in the embryonic brain is thought to provide guidance cues for navigation of thalamocortical axons, but the mechanisms involved remain largely elusive. OL-protocadherin ( OL-pc), a member of the cadherin superfamily, is highly expressed by striatal neurons in the developing ventral telencephalon. Here we show that OL-pc-deficient ( Pcdh10(-/-)) mice have defects in axon pathways through the ventral telencephalon; for example, thalamocortical and corticothalamic projections cannot cross the ventral telencephalon. In the ventral telencephalon, striatal axons fail to grow out, and, concomitantly, the caudal portion of the globus pallidus and the associated 'corridor' thought to be important for thalamocortical fiber navigation do not form. The inability of the striatum to extend axons is also observed in vitro. These results show that OL-pc is essential for both elongation of striatal axons and patterning of the putative guidance cues for thalamocortical projections.	Ctr Dev Biol, RIKEN, Chuo Ku, Kobe, Hyogo 6500047, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda, Hyogo 6691337, Japan; Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan	RIKEN; Kyoto University; Kwansei Gakuin University; Japan Science & Technology Agency (JST)	Takeichi, M (corresponding author), Ctr Dev Biol, RIKEN, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp; s-hirano@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378				Aoki E, 2003, NEUROSCIENCE, V117, P593, DOI 10.1016/S0306-4522(02)00944-2; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Garel S, 1999, DEVELOPMENT, V126, P5285; Garel S, 2004, TRENDS NEUROSCI, V27, P533, DOI 10.1016/j.tins.2004.06.014; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Hanashima C, 2006, CELL, V125, P24, DOI 10.1016/j.cell.2006.03.021; Hirano S, 2003, FRONT BIOSCI-LANDMRK, V8, pD306, DOI 10.2741/972; Hirano S, 1999, J NEUROSCI, V19, P995; HOGAN B, 1994, MANIPULATING MOUSE E; Inoue T, 2000, DEV BIOL, V219, P373, DOI 10.1006/dbio.2000.9616; Jones L, 2002, DEVELOPMENT, V129, P5041; Kimura J, 2005, J NEUROSCI, V25, P5097, DOI 10.1523/JNEUROSCI.0239-05.2005; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lopez-Bendito G, 2002, J COMP NEUROL, V451, P153, DOI 10.1002/cne.10345; Luckner R, 2001, CELL TISSUE RES, V303, P159, DOI 10.1007/s004410000292; Metin C, 1996, J NEUROSCI, V16, P3219; Metin C, 1997, DEVELOPMENT, V124, P5063; MITROFANIS J, 1993, TRENDS NEUROSCI, V16, P240, DOI 10.1016/0166-2236(93)90163-G; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Muller K, 2004, J COMP NEUROL, V470, P240, DOI 10.1002/cne.11044; Nakao S, 2005, MOL BRAIN RES, V134, P294, DOI 10.1016/j.molbrainres.2004.11.017; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Phillips GR, 2003, J NEUROSCI, V23, P5096; Polleux F, 2005, NEURON, V46, P395, DOI 10.1016/j.neuron.2005.04.017; Redies C, 2005, CELL MOL LIFE SCI, V62, P2840, DOI 10.1007/s00018-005-5320-z; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Toresson H, 2000, DEVELOPMENT, V127, P4361; Tuttle R, 1999, DEVELOPMENT, V126, P1903; Ulupinar E, 1999, MOL CELL NEUROSCI, V13, P281, DOI 10.1006/mcne.1999.0747; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Yamagata K, 1999, J BIOL CHEM, V274, P19473, DOI 10.1074/jbc.274.27.19473; Yun KS, 2003, J COMP NEUROL, V461, P151, DOI 10.1002/cne.10685	42	120	120	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1151	1159		10.1038/nn1960	http://dx.doi.org/10.1038/nn1960			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17721516				2022-12-17	WOS:000249144000017
J	Schenk, T				Schenk, Thomas			An allocentric rather than perceptual deficit in patient DF	NATURE NEUROSCIENCE			English	Article							VISUAL FORM AGNOSIA; OPTIC ATAXIA; ILLUSIONS	The perception/action model states that vision for perception and vision for action are processed in separate pathways. This model was inspired by observations in patient D. F. who seemed unable to use vision for perceptual tasks while retaining 'normal' visuomotor capacity. I found that D.F.'s performance is preserved in perceptual and visuomotor tasks when the required spatial information is hand-centered and impaired when the information is object-centered.	Univ Durham, Wolfson Res Inst, Cognit Neurosci Res Unit, Stockton On Tees TS17 6BH, England	Durham University	Schenk, T (corresponding author), Univ Durham, Wolfson Res Inst, Cognit Neurosci Res Unit, Queens Campus, Stockton On Tees TS17 6BH, England.	thomas.schenk@dur.ac.uk	S, T/GXF-0648-2022; S, T/GRY-0013-2022		MRC [G0401090] Funding Source: UKRI; Medical Research Council [G0401090] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bruno N, 2001, TRENDS COGN SCI, V5, P379, DOI 10.1016/S1364-6613(00)01725-3; Carey DP, 1996, NEUROPSYCHOLOGIA, V34, P329, DOI 10.1016/0028-3932(95)00169-7; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Franz VH, 2001, J EXP PSYCHOL HUMAN, V27, P1124, DOI 10.1037//0096-1523.27.5.1124; Glover S, 2002, TRENDS COGN SCI, V6, P288, DOI 10.1016/S1364-6613(02)01920-4; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Goodale Melvyn A., 2004, SIGHT UNSEEN EXPLORA; JACOB P, 2003, WAYS SEEING SCOPE LI; Khan AZ, 2005, NAT NEUROSCI, V8, P418, DOI 10.1038/nn1425; Milner A. D., 1995, VISUAL BRAIN ACTION; MILNER AD, 1991, BRAIN, V114, P405, DOI 10.1093/brain/114.1.405; Norman J, 2002, BEHAV BRAIN SCI, V25, P73, DOI 10.1017/S0140525X0200002X; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Rossetti Y, 2003, EXP BRAIN RES, V153, P171, DOI 10.1007/s00221-003-1590-6; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549	15	120	120	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1369	1370		10.1038/nn1784	http://dx.doi.org/10.1038/nn1784			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17028584	Green Accepted			2022-12-17	WOS:000242403800013
J	Morgan, JL; Dhingra, A; Vardi, N; Wong, ROL				Morgan, JL; Dhingra, A; Vardi, N; Wong, ROL			Axons and dendrites originate from neuroepithelial-like processes of retinal bipolar cells	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; NEURONAL POLARITY; GANGLION-CELLS; MOUSE RETINA; HIPPOCAMPAL-NEURONS; MIGRATORY BEHAVIOR; CHICK RETINA; LOCALIZATION; MGLUR6; DIFFERENTIATION	The cellular mechanisms underlying axogenesis and dendritogenesis are not completely understood. The axons and dendrites of retinal bipolar cells, which contact their synaptic partners within specific laminae in the inner and outer retina, provide a good system for exploring these issues. Using transgenic mice expressing enhanced green fluorescent protein (GFP) in a subset of bipolar cells, we determined that axonal and dendritic arbors of these interneurons develop directly from apical and basal processes attached to the outer and inner limiting membranes, respectively. Selective stabilization of processes contributed to stratification of axonal and dendritic arbors within the appropriate synaptic layer. This unusual mode of axogenesis and dendritogenesis from neuroepithelial-like processes may act to preserve neighbor-neighbor relationships in synaptic wiring between the outer and inner retina.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	Washington University (WUSTL); University of Pennsylvania	Wong, ROL (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	wongr@pcg.wustl.edu			NEI NIH HHS [EY11105, EY10699] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010699, R01EY011105] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; CAJAL RY, 1960, STUDIES VERTEBRATE N; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Claes E, 2004, INVEST OPHTH VIS SCI, V45, P2039, DOI 10.1167/iovs.03-0741; COHEN E, 1990, PHILOS T R SOC B, V330, P305, DOI 10.1098/rstb.1990.0201; COHEN E, 1991, J NEUROPHYSIOL, V65, P352, DOI 10.1152/jn.1991.65.2.352; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Demas J, 2003, J NEUROSCI, V23, P2851; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DOTTI CG, 1988, J NEUROSCI, V8, P1454; FREED MA, 1992, P NATL ACAD SCI USA, V89, P236, DOI 10.1073/pnas.89.1.236; GOSLIN K, 1990, J CELL BIOL, V110, P1319, DOI 10.1083/jcb.110.4.1319; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; Gunhan-Agar E, 2000, J NEUROSCI, V20, P306, DOI 10.1523/JNEUROSCI.20-01-00306.2000; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Higgins D, 1997, CURR OPIN NEUROBIOL, V7, P599, DOI 10.1016/S0959-4388(97)80078-5; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Kirby MA, 1996, PERSPECT DEV NEUROBI, V3, P177; Lin B, 2005, EUR J NEUROSCI, V21, P1257, DOI 10.1111/j.1460-9568.2005.03967.x; LOHMANN C, 2005, IMAGING NEUROSCIENCE, P159; Morest AK, 2003, GLIA, V43, P6, DOI [10.1002/glia.10288, 10.1002/glia.10238]; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; QUESADA A, 1985, J MORPHOL, V184, P205, DOI 10.1002/jmor.1051840210; QUESADA A, 1981, ZBL VET MED C, V10, P328, DOI 10.1111/j.1439-0264.1981.tb00697.x; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; SNOW RL, 1995, EXP NEUROL, V134, P13, DOI 10.1006/exnr.1995.1032; SNOW RL, 1994, NEUROSCIENCE, V58, P399, DOI 10.1016/0306-4522(94)90046-9; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Tehrani A, 2000, INVEST OPHTH VIS SCI, V41, P314; Vardi N, 1997, VISUAL NEUROSCI, V14, P789, DOI 10.1017/S0952523800012736; Vardi N, 2000, J COMP NEUROL, V423, P402, DOI 10.1002/1096-9861(20000731)423:3<402::AID-CNE4>3.0.CO;2-E; Wong GT, 1999, J NEUROSCI, V19, P5802, DOI 10.1523/JNEUROSCI.19-14-05802.1999	39	120	122	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					85	92		10.1038/nn1615	http://dx.doi.org/10.1038/nn1615			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16341211				2022-12-17	WOS:000234288000021
J	Craig, AM; Boudin, H				Craig, AM; Boudin, H			Molecular heterogeneity of central synapses: afferent and target regulation	NATURE NEUROSCIENCE			English	Review							METABOTROPIC GLUTAMATE-RECEPTOR; LONG-TERM DEPRESSION; CULTURED HIPPOCAMPAL-NEURONS; DEPENDENT PROTEIN-KINASE; AMPA RECEPTORS; NMDA RECEPTOR; TRANSMITTER RELEASE; GABAERGIC SYNAPSES; GABA(A) RECEPTORS; SYNAPTIC-TRANSMISSION	Electrophysiological recordings show a functional spectrum even within a single class of synapse, with individual synapses ranging widely in fundamental properties, including release probability, unitary response and effects of previous stimulation on subsequent response. Molecular and cellular biological approaches have shown a corresponding diversity in the complement of ion channels, receptors, scaffolds and signal transducing proteins that make up individual synapses. Indeed, we believe that each individual synapse is unique, a function of presynaptic cell type, postsynaptic cell type, environment, developmental stage and history of activity. We review here the molecular diversity of glutamatergic and GABAergic synapses in the mammalian brain in the context of potential cell biological mechanisms that may explain how individual cells develop and maintain such a mosaic of synaptic connections.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Craig, AM (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid,Campus Box 8108,958 McDonnell Sci Bl, St Louis, MO 63110 USA.	acraig@thalamus.wustl.edu	Craig, Ann Marie/M-2054-2014; Boudin, Helene/K-2400-2015	Boudin, Helene/0000-0002-9714-2384	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034448, R01NS039286, R01NS033184] Funding Source: NIH RePORTER; NINDS NIH HHS [NS33184, NS34448, NS39286] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allison DW, 1998, J NEUROSCI, V18, P2423; Alvarez FJ, 1997, J COMP NEUROL, V379, P150; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Benson DL, 1998, J NEUROSCI, V18, P6892; Benson DL, 1996, J NEUROSCI, V16, P6424; Benson DL, 1997, NEUROREPORT, V8, P823, DOI 10.1097/00001756-199703030-00004; Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Colman DR, 1997, MOL CELL NEUROSCI, V10, P1, DOI 10.1006/mcne.1997.0648; Cottrell JR, 2000, J NEUROPHYSIOL, V84, P1573, DOI 10.1152/jn.2000.84.3.1573; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Crump FT, 1999, MOL CELL NEUROSCI, V13, P25, DOI 10.1006/mcne.1998.0727; CRUMP FT, IN PRESS J NEUROSCI; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Dumoulin A, 1999, J CELL SCI, V112, P811; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Elgersma Y, 1999, CURR OPIN NEUROBIOL, V9, P209, DOI 10.1016/S0959-4388(99)80029-4; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; Francis NJ, 1999, ANNU REV NEUROSCI, V22, P541, DOI 10.1146/annurev.neuro.22.1.541; Fritschy JM, 1998, J COMP NEUROL, V390, P194; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; GRAY EG, 1959, J ANAT, V93, P420; Hanson JE, 1999, J NEUROSCI, V19, P6488; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kennedy MB, 1998, BRAIN RES REV, V26, P243, DOI 10.1016/S0165-0173(97)00043-X; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Levi S, 1998, J CELL SCI, V111, P335; Levi S, 1999, J NEUROSCI, V19, P7434, DOI 10.1523/JNEUROSCI.19-17-07434.1999; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lissin DV, 1999, J NEUROSCI, V19, P3275; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Lissin DV, 1999, J NEUROSCI, V19, P1263; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Mammen AL, 1997, J NEUROSCI, V17, P7351; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; MATSUDA S, 2000, XIAO J, V19, P2765; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; MINELLI A, 1995, J NEUROSCI, V15, P7734, DOI 10.1523/jneurosci.15-11-07734.1995; Missler M, 1998, J NEUROCHEM, V71, P1339; Mohrmann R, 1999, J NEUROSCI, V19, P10004; Morgans CW, 1996, J NEUROSCI, V16, P6713; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1996, J NEUROSCI, V16, P103; NUSSER Z, 1995, J NEUROSCI, V15, P2948; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; PUIA G, 1994, NEURON, V12, P117, DOI 10.1016/0896-6273(94)90157-0; Racca C, 1997, J NEUROSCI, V17, P1691; Racca C, 2000, J NEUROSCI, V20, P2512; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rao A, 2000, J NEUROSCI, V20, P8344, DOI 10.1523/JNEUROSCI.20-22-08344.2000; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; RIBAK CE, 1990, J ELECTRON MICR TECH, V15, P34, DOI 10.1002/jemt.1060150105; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rubio ME, 1999, J NEUROSCI, V19, P5549; Sagne C, 1997, FEBS LETT, V417, P177, DOI 10.1016/S0014-5793(97)01279-9; Sassoe-Pognetto M, 2000, EUR J NEUROSCI, V12, P2205, DOI 10.1046/j.1460-9568.2000.00106.x; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schinder AF, 2000, NEURON, V25, P151, DOI 10.1016/S0896-6273(00)80879-X; SEGAL MM, 1991, J NEUROPHYSIOL, V65, P761, DOI 10.1152/jn.1991.65.4.761; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Sik A, 1998, P NATL ACAD SCI USA, V95, P3245, DOI 10.1073/pnas.95.6.3245; Staple JK, 1997, EUR J NEUROSCI, V9, P721, DOI 10.1111/j.1460-9568.1997.tb01420.x; Steward Oswald, 1995, Current Opinion in Neurobiology, V5, P55, DOI 10.1016/0959-4388(95)80087-5; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; TRILLER A, 1990, New Biologist, V2, P637; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; TRIMBLE WS, 1990, J NEUROSCI, V10, P1380; Tsen G, 2000, NAT NEUROSCI, V3, P126, DOI 10.1038/72066; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; VERDERIO C, 1994, J CELL BIOL, V126, P1527, DOI 10.1083/jcb.126.6.1527; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Yoshimura Y, 1997, J BIOL CHEM, V272, P26354, DOI 10.1074/jbc.272.42.26354; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999; Zhao HM, 1998, J NEUROSCI, V18, P5517, DOI 10.1523/JNEUROSCI.18-14-05517.1998	131	120	124	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					569	578		10.1038/88388	http://dx.doi.org/10.1038/88388			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369937				2022-12-17	WOS:000169061800009
J	Cantallops, I; Haas, K; Cline, HT				Cantallops, I; Haas, K; Cline, HT			Postsynaptic CPG15 promotes synaptic maturation and presynaptic axon arbor elaboration in vivo	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; IN-VIVO; DENDRITIC GROWTH; AMPA RECEPTORS; MAP FORMATION; SYNAPSES; PLASTICITY; XENOPUS; NEURONS; EXPRESSION	The formation of CNS circuits is characterized by the coordinated development of neuronal structure and synaptic function. The activity-regulated candidate plasticity gene 15 (cpg15) encodes a glycosylphosphatidylinositol (GPI)-linked protein whose in vivo expression increases the dendritic arbor growth rate of Xenopus optic tectal cells. We now demonstrate that tectal cell expression of CPG15 significantly increases the elaboration of presynaptic retinal axons by decreasing rates of branch retractions. Whole-cell recordings from optic tectal neurons indicate that CPG15 expression promotes retinotectal synapse maturation by recruiting functional AMPA receptors to synapses. Expression of truncated CPG15, lacking its GPI anchor, does not promote axon arbor growth and blocks synaptic maturation. These results suggest that CPG15 coordinately increases the growth of pre- and postsynaptic structures and the number and strength of their synaptic contacts.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Cline, HT (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Haas, Kurt/B-3812-2009	Haas, Kurt/0000-0003-4754-1560				ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; CLINE HT, 1999, IMAGING LAB MANUAL; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Corriveau RA, 1999, J NEUROSCI, V19, P7999, DOI 10.1523/jneurosci.19-18-07999.1999; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FaivreSarrailh C, 1997, MOL CELL NEUROSCI, V9, P109, DOI 10.1006/mcne.1997.0609; Feldman DE, 1996, SCIENCE, V271, P525, DOI 10.1126/science.271.5248.525; Fiala J.C., 1999, DENDRITES, P1, DOI DOI 10.1093/ACPROF:OSO/9780198566564.003.0001; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; FUJISAWA H, 1987, J COMP NEUROL, V260, P127, DOI 10.1002/cne.902600110; Gao WQ, 1998, MOL CELL NEUROSCI, V11, P247, DOI 10.1006/mcne.1998.0696; GAZE RM, 1979, J EMBRYOL EXP MORPH, V53, P103; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HICKMOTT PW, 1993, J NEUROSCI, V13, P4339; Horejsi V, 1999, IMMUNOL TODAY, V20, P356, DOI 10.1016/S0167-5699(99)01489-9; ISAAC JTR, 1997, NEURON, V18, P1; Jankowsky JL, 1999, MOL CELL NEUROSCI, V14, P273, DOI 10.1006/mcne.1999.0792; Li P, 1998, NATURE, V393, P695, DOI 10.1038/31496; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; Nedivi E, 1999, J NEUROBIOL, V41, P135, DOI 10.1002/(SICI)1097-4695(199910)41:1<135::AID-NEU17>3.0.CO;2-F; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nedivi E, 1996, P NATL ACAD SCI USA, V93, P2048, DOI 10.1073/pnas.93.5.2048; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Rajan I, 1998, J NEUROSCI, V18, P7836; REH TA, 1984, J NEUROSCI, V4, P442; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Spruston N., 1999, DENDRITES, P231; WALSH FS, 1991, CELL BIOL INT REP, V15, P1151, DOI 10.1016/0309-1651(91)90061-M; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1999, J NEUROSCI, V19, P4472; WU GY, 1995, NEURON, V14, P681, DOI 10.1016/0896-6273(95)90211-2; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999; Zou DJ, 1996, NEURON, V16, P529, DOI 10.1016/S0896-6273(00)80072-0	48	120	126	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					1004	1011		10.1038/79823	http://dx.doi.org/10.1038/79823			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017173				2022-12-17	WOS:000167177500018
J	Ritzenthaler, S; Suzuki, E; Chiba, A				Ritzenthaler, S; Suzuki, E; Chiba, A			Postsynaptic filopodia in muscle cells interact with innervating motoneuron axons	NATURE NEUROSCIENCE			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; GROWTH CONE GUIDANCE; DENDRITIC SPINES; IN-VIVO; DYNAMICS; PLASTICITY; PROTEIN; OUTGROWTH; PROSPERO; NEURONS	Precise synaptogenesis is crucial to brain development, and depends on the ability of specific partner cells to locate and communicate with one another. Dynamic properties of axonal filopodia during synaptic targeting are well documented, but the cytomorphological dynamics of postsynaptic cells have received less attention. In Drosophila embryos, muscle cells bear numerous postsynaptic filopodia ('myopodia') during motoneuron targeting. Here we show that myopodia are actin-filled microprocesses, which progressively clustered at the site of motoneuron innervation while intermingling with presynaptic filopodia. In prospero mutants, which have severe delays in axon outgrowth from the CNS, myopodia were present initially but clustering behavior was not observed, demonstrating that clustering depends on innervating axons. Thus, postsynaptic filopodia are capable of intimate interaction with innervating presynaptic axons. We propose that, by contributing to direct long-distance cellular communication, they are dynamically involved in synaptic matchmaking.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Program Neurosci, Urbana, IL 61801 USA; Univ Tokyo, Inst Med Sci, Dept Fine Morphol, Tokyo 1088639, Japan	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Tokyo	Chiba, A (corresponding author), Univ Illinois, Dept Cell & Struct Biol, B605 CLS Lab,601 S Goodwin Ave, Urbana, IL 61801 USA.	a-chiba@uiuc.edu		Suzuki, Emiko/0000-0002-4005-0542				BATE M, 1990, DEVELOPMENT, V110, P791; Bate Michael, 1993, P1013; BROADIE KS, 1993, J NEUROSCI, V13, P144; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Chiba A, 1999, INT REV NEUROBIOL, V43, P1, DOI 10.1016/S0074-7742(08)60538-3; CHIBA A, 1999, CELL TECHNOL, V18, P852; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Grabham PW, 1997, J NEUROSCI, V17, P5455; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; Kater S. B., 1995, Current Opinion in Neurobiology, V5, P68, DOI 10.1016/0959-4388(95)80089-1; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Landgraf M, 1997, J NEUROSCI, V17, P9642; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Murray MJ, 1999, J NEUROSCI, V19, P7901; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Saito Y, 1997, J NEUROSCI, V17, P8792; Smith SJ, 1999, SCIENCE, V283, P1860, DOI 10.1126/science.283.5409.1860; Suzuki E, 2000, J NEUROBIOL, V42, P448, DOI 10.1002/(SICI)1097-4695(200003)42:4<448::AID-NEU6>3.0.CO;2-H; SUZUKI E, 1994, J ELECTRON MICROSC, V43, P183; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Verkhusha VV, 1999, FEBS LETT, V445, P395, DOI 10.1016/S0014-5793(99)00124-6; Wolf BD, 2000, DEVELOPMENT, V127, P2001; Wu GY, 1999, J NEUROSCI, V19, P4472; Yoshihara M, 1997, J NEUROSCI, V17, P8408; Zheng JQ, 1996, J NEUROSCI, V16, P1140; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	36	120	120	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					1012	1017		10.1038/79833	http://dx.doi.org/10.1038/79833			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017174				2022-12-17	WOS:000167177500019
J	Porciatti, V; Bonanni, P; Fiorentini, A; Guerrini, R				Porciatti, V; Bonanni, P; Fiorentini, A; Guerrini, R			Lack of cortical contrast gain control in human photosensitive epilepsy	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; RESPONSES; CAT; LUMINANCE; FREQUENCY; CELLS; COLOR	Television and video games may be powerful triggers for visually induced epileptic seizures. To better understand the triggering elements of visual stimuli and cortical mechanisms of hyperexcitability, we examined eleven patients with idiopathic photosensitive epilepsy by recording visually evoked potentials (VEPs) in response to temporally modulated patterns of different contrast. For stimuli of low-medium, but not high, temporal frequency, the contrast dependence of VEP amplitude and latency is remarkably abnormal for luminance contrast (black-white), but not so for chromatic contrast (equiluminant red-green) stimuli. We conclude that cortical mechanisms of contrast gain control for pattern stimuli of relatively low temporal frequency and high luminance contrast are lacking or severely impaired in photosensitive subjects.	CNR, Inst Neurophysiol, Area Ric, I-56100 Pisa, Italy; Univ Pisa, Inst Dev Neurol & Psychiat, I-56018 Pisa, Italy; IRCCS Stella Maris, Med Res Inst, I-56018 Pisa, Italy; Kings Coll Hosp London, Div Neurosci, London SE5 9RS, England	Consiglio Nazionale delle Ricerche (CNR); University of Pisa; IRCCS Fondazione Stella Maris; King's College Hospital NHS Foundation Trust; King's College Hospital	Porciatti, V (corresponding author), CNR, Inst Neurophysiol, Area Ric, 1 Via Alfieri, I-56100 Pisa, Italy.	porciatt@in.pi.cnr.it	bonanni, paolo/T-7360-2017	bonanni, paolo/0000-0002-9448-9059; Guerrini, Renzo/0000-0002-7272-7079; Porciatti, Vittorio/0000-0002-1592-3532				ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BERNARDETE EA, 1999, VISUAL NEUROSCI, V16, P355; BINNIE CD, 1985, ELECTROEN CLIN NEURO, V61, P1, DOI 10.1016/0013-4694(85)91065-X; BINNIE CD, 1998, REFLEX EPILEPSIES RE, P123; BINNIE CD, 1994, EPILEPTIC SEIZURES S, P49; CAMPBELL FW, 1970, J PHYSIOL-LONDON, V207, P635, DOI 10.1113/jphysiol.1970.sp009085; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, J NEUROSCI, V17, P8621; CHRISTIE T, 1993, SUN             0121, P5; Fiorentini A, 1996, VISION RES, V36, P3557, DOI 10.1016/0042-6989(96)00032-6; GEISLER WS, 1992, VISION RES, V8, P149; Guerrini R, 1997, EPILEPSIA, V38, P777, DOI 10.1111/j.1528-1157.1997.tb01464.x; GUERRINI R, 1995, EPILEPSIA, V36, P883, DOI 10.1111/j.1528-1157.1995.tb01631.x; Guerrini Renzo, 1998, V75, P159; Harding G., 1994, PHOTOSENSITIVE EPILE; Ishida S, 1998, EPILEPSIA, V39, P1340, DOI 10.1111/j.1528-1157.1998.tb01334.x; MORRONE C, 1994, VISUAL NEUROSCI, V11, P861, DOI 10.1017/S0952523800003825; MORRONE MC, 1987, EXP BRAIN RES, V67, P635; MULLEN KT, 1985, J PHYSIOL-LONDON, V359, P381, DOI 10.1113/jphysiol.1985.sp015591; NEWMARK ME, 1979, PHOTOSNESITIVITY EPI; Porciatti V, 1997, VISION RES, V37, P1975, DOI 10.1016/S0042-6989(97)00018-7; PORCIATTI V, 1992, VISION RES, V32, P1199, DOI 10.1016/0042-6989(92)90214-4; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; SIMON F, 1992, VISION RES, V32, P591, DOI 10.1016/0042-6989(92)90175-I; SPEKREIJSE H, 1973, VISION RES, V13, P1577, DOI 10.1016/0042-6989(73)90016-3; SULLIVAN K, 1997, HERALD INT TRIB 1219, P5; TRENITE DGA, 1998, REFLEX EPILEPSIES RE, P99; WILKINS A, 1989, REFLEX SEIZURES REFL, P153; WILKINS AJ, 1979, BRAIN, V102, P1, DOI 10.1093/brain/102.1.1	30	120	123	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					259	263		10.1038/72972	http://dx.doi.org/10.1038/72972			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700258				2022-12-17	WOS:000085810500015
J	Kamiya, A; Hayama, Y; Kato, S; Shimomura, A; Shimomura, T; Irie, K; Kaneko, R; Yanagawa, Y; Kobayashi, K; Ochiya, T				Kamiya, Atsunori; Hayama, Yohsuke; Kato, Shigeki; Shimomura, Akihiko; Shimomura, Takushi; Irie, Katsumasa; Kaneko, Ryosuke; Yanagawa, Yuchio; Kobayashi, Kazuto; Ochiya, Takahiro			Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression	NATURE NEUROSCIENCE			English	Article							BETA-BLOCKER USAGE; INTERFERON-GAMMA; T-CELLS; MOUSE MODEL; EXPRESSION; SYSTEM; TRANSDUCTION; NEUROGENESIS; MORTALITY; SURVIVAL	The effects of autonomic innervation of tumors on tumor growth remain unclear. Here we developed a series of genetic techniques to manipulate autonomic innervation in a tumor-and fiber-type-specific manner in mice with human breast cancer xenografts and in rats with chemically induced breast tumors. Breast cancer growth and progression were accelerated following stimulation of sympathetic nerves in tumors, but were reduced following stimulation of parasympathetic nerves. Tumor-specific sympathetic denervation suppressed tumor growth and downregulated the expression of immune checkpoint molecules (programed death-1 (PD-1), programed death ligand-1 (PD-L1), and FOXP3) to a greater extent than with pharmacological a-or beta-adrenergic receptor blockers. Genetically induced simulation of parasympathetic innervation of tumors decreased PD-1 and PD-L1 expression. In humans, a retrospective analysis of breast cancer specimens from 29 patients revealed that increased sympathetic and decreased parasympathetic nerve density in tumors were associated with poor clinical outcomes and correlated with higher expression of immune checkpoint molecules. These findings suggest that autonomic innervation of tumors regulates breast cancer progression.	[Kamiya, Atsunori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cellular Physiol, Okayama, Japan; [Kamiya, Atsunori; Hayama, Yohsuke] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Dynam, Res Inst, Suita, Osaka, Japan; [Kamiya, Atsunori] Japan Agcy Med Res & Dev, PRIME, Tokyo, Japan; [Kato, Shigeki; Kobayashi, Kazuto] Fukushima Med Univ, Inst Biomed Sci, Dept Mol Genet, Sch Med, Fukushima, Japan; [Shimomura, Akihiko] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan; [Shimomura, Takushi; Irie, Katsumasa] Nagoya Univ, Cellular & Struct Physiol Inst CeSPI, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan; [Kaneko, Ryosuke; Yanagawa, Yuchio] Gunma Univ, Dept Genet & Behav Neurosci, Grad Sch Med, Maebashi, Gunma, Japan; [Ochiya, Takahiro] Natl Canc Ctr, Div Mol & Cellular Med, Res Inst, Tokyo, Japan; [Ochiya, Takahiro] Tokyo Med Univ, Inst Med Sci, Tokyo, Japan; [Shimomura, Takushi] Natl Inst Physiol Sci, Div Biophys & Neurobiol, Dept Mol Physiol, Okazaki, Aichi, Japan	Okayama University; National Cerebral & Cardiovascular Center - Japan; Fukushima Medical University; National Cancer Center - Japan; Nagoya University; Gunma University; National Cancer Center - Japan; Tokyo Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Kamiya, A (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cellular Physiol, Okayama, Japan.; Kamiya, A (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Dynam, Res Inst, Suita, Osaka, Japan.; Kamiya, A (corresponding author), Japan Agcy Med Res & Dev, PRIME, Tokyo, Japan.	kamiyaa@okayama-u.ac.jp	Ochiya, Takahiro/AAH-7585-2019; Irie, Katsumasa/D-7332-2013	Irie, Katsumasa/0000-0002-8178-1552; Shimomura, Akihiko/0000-0002-2557-8170	Ministry of Education, Culture, Sports, Science, and Technology in Japan [17H04365, 18K19950, 18H04707]; Japan Agency for Medical Research and Development (AMED-PRIME)	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED-PRIME)(Japan Agency for Medical Research and Development (AMED))	This study was supported by a research project promoted by the Grants-in-Aid for Scientific Research promoted by the Ministry of Education, Culture, Sports, Science, and Technology in Japan (17H04365, 18K19950, and 18H04707, received by A.K.) and the Japan Agency for Medical Research and Development (AMED-PRIME, received by A.K.).	Asamoto M, 2000, CARCINOGENESIS, V21, P243, DOI 10.1093/carcin/21.2.243; Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; Bellinger DL, 2014, AUTON NEUROSCI-BASIC, V182, P15, DOI 10.1016/j.autneu.2014.01.006; Bhat P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.67; Borg ML, 2014, DIABETES, V63, P3647, DOI 10.2337/db13-1762; Bucsek MJ, 2017, CANCER RES, V77, P5639, DOI 10.1158/0008-5472.CAN-17-0546; Cardwell CR, 2013, INT J EPIDEMIOL, V42, P1852, DOI 10.1093/ije/dyt196; Chen LP, 2015, J CLIN INVEST, V125, P3384, DOI 10.1172/JCI80011; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Cole SW, 2015, NAT REV CANCER, V15, P563, DOI 10.1038/nrc3978; Eto K, 2012, J NEUROSCI, V32, P16552, DOI 10.1523/JNEUROSCI.2104-12.2012; FELTEN DL, 1976, J NEURAL TRANSM, V39, P209, DOI 10.1007/BF01256510; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grytli HH, 2014, EUR UROL, V65, P635, DOI 10.1016/j.eururo.2013.01.007; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hanoun M, 2015, NEURON, V86, P360, DOI 10.1016/j.neuron.2015.01.026; Hayakawa Y, 2017, CANCER CELL, V31, P21, DOI 10.1016/j.ccell.2016.11.005; Hicks BM, 2013, ANN ONCOL, V24, P3100, DOI 10.1093/annonc/mdt381; Hollis ER, 2008, MOL THER, V16, P296, DOI 10.1038/sj.mt.6300367; Irie K, 2010, J BIOL CHEM, V285, P3685, DOI 10.1074/jbc.M109.057455; Kamiya A, 2011, J PHYSIOL-LONDON, V589, P1769, DOI 10.1113/jphysiol.2011.203455; KENNEDY JD, 1992, J IMMUNOL, V148, P1620; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Lamkin DM, 2015, PSYCHONEUROENDOCRINO, V51, P262, DOI 10.1016/j.psyneuen.2014.10.004; Ligocki AJ, 2016, J LEUKOCYTE BIOL, V99, P735, DOI 10.1189/jlb.3A0315-093RRR; Lin CW, 2010, NEURON, V65, P32, DOI 10.1016/j.neuron.2009.12.001; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; McCourt C, 2014, BRIT J DERMATOL, V170, P930, DOI 10.1111/bjd.12894; Melhem-Bertrandt A, 2011, J CLIN ONCOL, V29, P2645, DOI 10.1200/JCO.2010.33.4441; Nakajima C, 2001, CANCER RES, V61, P3399; Oh MS, 2009, GENE THER, V16, P437, DOI 10.1038/gt.2008.148; Perron L, 2004, CANCER CAUSE CONTROL, V15, P535, DOI 10.1023/B:CACO.0000036152.58271.5e; Pirozzi M, 2006, J CLIN INVEST, V116, P202, DOI 10.1172/JCI26210; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Sakamoto M, 2011, P NATL ACAD SCI USA, V108, P8479, DOI 10.1073/pnas.1018782108; Schuller HM, 2012, CARCINOGENESIS, V33, P191, DOI 10.1093/carcin/bgr251; Shaashua L, 2017, CLIN CANCER RES, V23, P4651, DOI 10.1158/1078-0432.CCR-17-0152; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Sorensen GV, 2013, J CLIN ONCOL, V31, P2265, DOI 10.1200/JCO.2012.43.9190; STRUYKER-BOUDIER H A J, 1986, American Journal of Nephrology, V6, P25, DOI 10.1159/000167329; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Ubil E, 2014, NATURE, V514, P585, DOI 10.1038/nature13839; Zahalka AH, 2017, SCIENCE, V358, P321, DOI 10.1126/science.aah5072; Zanetti M, 2015, J IMMUNOL, V194, P2049, DOI 10.4049/jimmunol.1402669; Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569; Zhou J, 2016, MOL MED REP, V13, P3197, DOI 10.3892/mmr.2016.4884; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780	50	119	126	17	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2019	22	8					1289	+		10.1038/s41593-019-0430-3	http://dx.doi.org/10.1038/s41593-019-0430-3			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IL1MZ	31285612				2022-12-17	WOS:000477065500012
J	Apicco, DJ; Ash, PEA; Maziuk, B; LeBlang, C; Medalla, M; Al Abdullatif, A; Ferragud, A; Botelho, E; Ballance, HI; Dhawan, U; Boudeau, S; Cruz, AL; Kashy, D; Wong, A; Goldberg, LR; Yazdani, N; Zhang, C; Ung, CY; Tripodis, Y; Kanaan, NM; Ikezu, T; Cottone, P; Leszyk, J; Li, H; Luebke, J; Bryant, CD; Wolozin, B				Apicco, Daniel J.; Ash, Peter E. A.; Maziuk, Brandon; LeBlang, Chelsey; Medalla, Maria; Al Abdullatif, Ali; Ferragud, Antonio; Botelho, Emily; Ballance, Heather I.; Dhawan, Uma; Boudeau, Samantha; Cruz, Anna Lourdes; Kashy, Daniel; Wong, Aria; Goldberg, Lisa R.; Yazdani, Neema; Zhang, Cheng; Ung, Choong Y.; Tripodis, Yorghos; Kanaan, Nicholas M.; Ikezu, Tsuneya; Cottone, Pietro; Leszyk, John; Li, Hu; Luebke, Jennifer; Bryant, Camron D.; Wolozin, Benjamin			Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo	NATURE NEUROSCIENCE			English	Article							STRESS GRANULES; PHASE-TRANSITIONS; ALS; AGGREGATION; DOMAINS; DISEASE; GENES; CELLS; MODEL	Emerging studies suggest a role for tau in regulating the biology of RNA binding proteins (RBPs). We now show that reducing the RBP T-cell intracellular antigen 1 (TIA1) in vivo protects against neurodegeneration and prolongs survival in transgenic P301S Tau mice. Biochemical fractionation shows co-enrichment and co-localization of tau oligomers and RBPs in transgenic P301S Tau mice. Reducing TIA1 decreased the number and size of granules co-localizing with stress granule markers. Decreasing TIA1 also inhibited the accumulation of tau oligomers at the expense of increasing neurofibrillary tangles. Despite the increase in neurofibrillary tangles, TIA1 reduction increased neuronal survival and rescued behavioral deficits and lifespan. These data provide in vivo evidence that TIA1 plays a key role in mediating toxicity and further suggest that RBPs direct the pathway of tau aggregation and the resulting neurodegeneration. We propose a model in which dysfunction of the translational stress response leads to tau-mediated pathology.	[Apicco, Daniel J.; Ash, Peter E. A.; Maziuk, Brandon; Al Abdullatif, Ali; Ferragud, Antonio; Botelho, Emily; Ballance, Heather I.; Dhawan, Uma; Boudeau, Samantha; Cruz, Anna Lourdes; Kashy, Daniel; Wong, Aria; Goldberg, Lisa R.; Yazdani, Neema; Ikezu, Tsuneya; Cottone, Pietro; Bryant, Camron D.; Wolozin, Benjamin] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [LeBlang, Chelsey; Medalla, Maria; Luebke, Jennifer] Boston Univ, Sch Med, Dept Anat, Boston, MA 02118 USA; [Zhang, Cheng; Ung, Choong Y.; Li, Hu] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Kanaan, Nicholas M.] Michigan State Univ, Coll Human Med, Dept Translat Sci & Mol Med, E Lansing, MI 48824 USA; [Ikezu, Tsuneya; Wolozin, Benjamin] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Leszyk, John] Univ Massachusetts, Med Ctr, Dept Biochem & Mol Pathol, Worcester, MA USA	Boston University; Boston University; Mayo Clinic; Boston University; Michigan State University; Michigan State University College of Human Medicine; Boston University; University of Massachusetts System; University of Massachusetts Worcester	Wolozin, B (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.; Wolozin, B (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.	bwolozin@bu.edu	Ferragud, Antonio/AAB-1592-2019; Tripodis, Yorghos/GRY-0583-2022; Kanaan, Nicholas M./J-3428-2016; Ferragud, Antonio/AAD-8772-2019; Bryant, Camron D/J-2408-2015; Dhawan, Uma/AAM-5377-2020	Kanaan, Nicholas M./0000-0002-4362-2593; Ferragud, Antonio/0000-0002-6739-007X; Bryant, Camron D/0000-0003-4505-5809; Dhawan, Uma/0000-0001-7124-393X; Cruz, Anna Lourdes/0000-0002-9889-3868; Apicco, Daniel/0000-0002-4136-4367; Tripodis, Yorghos/0000-0003-2190-7608; Kashy, Daniel/0000-0003-3276-8666; Medalla, Maria/0000-0003-4890-2532; Ikezu, Tsuneya/0000-0002-3979-8596; Luebke, Jennifer/0000-0003-1399-6073; LeBlang, Chelsey/0000-0003-0780-3810; Zhang, Cheng/0000-0003-3843-1562	NIH [AG050471, NS089544, ES020395, R01 AG054199]; BrightFocus Foundation; Alzheimer Association; Cure Alzheimer's Fund; Thome Medical Foundation; UGC-Raman Fellowship; Government of India; Paul F. Glenn Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG054199, P30AG013846, R01AG050471] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus Foundation(BrightFocus Foundation); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Cure Alzheimer's Fund; Thome Medical Foundation; UGC-Raman Fellowship; Government of India; Paul F. Glenn Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Davies (Feinstein Institute) for provision of CP13 and PHF1 antibodies. We thank the following funding agencies for their support: B.W. received support from the NIH (AG050471, NS089544 and ES020395), BrightFocus Foundation, Alzheimer Association, Cure Alzheimer's Fund and the Thome Medical Foundation; U.D. received support from a UGC-Raman Fellowship and the Government of India; T.I. received support from the NIH (R01 AG054199); H.L. received support from the Paul F. Glenn Foundation.	Abraha A, 2000, J CELL SCI, V113, P3737; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Ash PEA, 2014, BRAIN RES, V1584, P52, DOI 10.1016/j.brainres.2014.05.052; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Brunello CA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30498; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; Combs B, 2016, NEUROBIOL DIS, V94, P18, DOI 10.1016/j.nbd.2016.05.016; Darnell RB, 2013, ANNU REV NEUROSCI, V36, P243, DOI 10.1146/annurev-neuro-062912-114322; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irwin DJ, 2015, ACTA NEUROPATHOL, V129, P469, DOI 10.1007/s00401-014-1380-1; Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386; Kuchibhotla KV, 2014, P NATL ACAD SCI USA, V111, P510, DOI 10.1073/pnas.1318807111; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Maziuk B, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00089; Meier S, 2016, J NEUROSCI, V36, P1001, DOI 10.1523/JNEUROSCI.3029-15.2016; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Panas MD, 2016, J CELL BIOL, V215, P313, DOI 10.1083/jcb.201609081; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Phillips K, 2004, P NATL ACAD SCI USA, V101, P2011, DOI 10.1073/pnas.0400148101; Rocher AB, 2010, EXP NEUROL, V223, P385, DOI 10.1016/j.expneurol.2009.07.029; Sahara N, 2013, J ALZHEIMERS DIS, V33, P249, DOI 10.3233/JAD-2012-121093; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Vanderweyde T, 2016, CELL REP, V15, P1455, DOI 10.1016/j.celrep.2016.04.045; Vanderweyde T, 2012, J NEUROSCI, V32, P8270, DOI 10.1523/JNEUROSCI.1592-12.2012; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zempell H, 2014, TRENDS NEUROSCI, V37, P721, DOI 10.1016/j.tins.2014.08.004; Zhang XM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002183	45	119	123	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2018	21	1					72	+		10.1038/s41593-017-0022-z	http://dx.doi.org/10.1038/s41593-017-0022-z			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT4WL	29273772	Green Accepted			2022-12-17	WOS:000423155800015
J	Sharpe, MJ; Chang, CY; Liu, MA; Batchelor, HM; Mueller, LE; Jones, JL; Niv, Y; Schoenbaum, G				Sharpe, Melissa J.; Chang, Chun Yun; Liu, Melissa A.; Batchelor, Hannah M.; Mueller, Lauren E.; Jones, Joshua L.; Niv, Yael; Schoenbaum, Geoffrey			Dopamine transients are sufficient and necessary for acquisition of model-based associations	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; REWARD PREDICTION-ERROR; ORBITOFRONTAL CORTEX; UNCONDITIONED STIMULUS; NUCLEUS-ACCUMBENS; DECISION-MAKING; NEURONS; SIGNALS; REINFORCEMENT; ATTENTION	Associative learning is driven by prediction errors. Dopamine transients correlate with these errors, which current interpretations limit to endowing cues with a scalar quantity reflecting the value of future rewards. We tested whether dopamine might act more broadly to support learning of an associative model of the environment. Using sensory preconditioning, we show that prediction errors underlying stimulus-stimulus learning can be blocked behaviorally and reinstated by optogenetically activating dopamine neurons. We further show that suppressing the firing of these neurons across the transition prevents normal stimulus-stimulus learning. These results establish that the acquisition of model-based information about transitions between nonrewarding events is also driven by prediction errors and that, contrary to existing canon, dopamine transients are both sufficient and necessary to support this type of learning. Our findings open new possibilities for how these biological signals might support associative learning in the mammalian brain in these and other contexts.	[Sharpe, Melissa J.; Chang, Chun Yun; Liu, Melissa A.; Batchelor, Hannah M.; Mueller, Lauren E.; Jones, Joshua L.; Schoenbaum, Geoffrey] NIDA, Intramural Res Program, Baltimore, MD 21224 USA; [Sharpe, Melissa J.; Niv, Yael] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Sharpe, Melissa J.; Niv, Yael] Princeton Univ, Neurosci Inst, Princeton, NJ 08544 USA; [Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Neurobiol & Psychiat, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Princeton University; Princeton University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University	Sharpe, MJ; Schoenbaum, G (corresponding author), NIDA, Intramural Res Program, Baltimore, MD 21224 USA.; Sharpe, MJ (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.; Sharpe, MJ (corresponding author), Princeton Univ, Neurosci Inst, Princeton, NJ 08544 USA.; Schoenbaum, G (corresponding author), Univ Maryland, Sch Med, Dept Anat, Baltimore, MD 21201 USA.; Schoenbaum, G (corresponding author), Univ Maryland, Sch Med, Dept Neurobiol & Psychiat, Baltimore, MD 21201 USA.; Schoenbaum, G (corresponding author), Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	melissa.sharpe@nih.gov; geoffrey.schoenbaum@nih.gov	Core, Vector/CAF-4832-2022	Liu, Melissa/0000-0001-5625-1149; Schoenbaum, Geoffrey/0000-0001-8180-0701; Batchelor, Hannah/0000-0002-2053-5227; Niv, Yael/0000-0002-0259-8371; Sharpe, Melissa/0000-0002-5375-2076	Intramural Research Program at NIDA [ZIA-DA000587];  [R01-MH098861]; Intramural NIH HHS [ZIA DA000587-02, ZIA DA000587] Funding Source: Medline; NIMH NIH HHS [R01 MH098861] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000587] Funding Source: NIH RePORTER	Intramural Research Program at NIDA; ; Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank K. Deisseroth and the Gene Therapy Center at the University of North Carolina at Chapel Hill for providing viral reagents and G. Stuber for technical advice on their use. We also thank B. Harvey and the NIDA Optogenetic and Transgenic Core, M. Morales and the NIDA Histology Core for their assistance, and P. Dayan and N. Daw for their comments. This work was supported by R01-MH098861 (to Y.N.) and by the Intramural Research Program at NIDA ZIA-DA000587 (to G.S.). The opinions expressed in this article are the authors' own and do not reflect the view of the NIH/DHHS.	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Aitken TJ, 2016, J NEUROCHEM, V136, P1026, DOI 10.1111/jnc.13494; Blundell P, 2003, J NEUROSCI, V23, P7702; Brogden WJ, 1939, J EXP PSYCHOL, V25, P323, DOI 10.1037/h0058944; Bromberg-Martin ES, 2010, J NEUROPHYSIOL, V104, P1068, DOI 10.1152/jn.00158.2010; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Chang CY, 2016, NAT NEUROSCI, V19, P111, DOI 10.1038/nn.4191; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Colwill R. M., 1993, CURRENT DIRECTIONS P, V2, P111, DOI [10.1111/1467-8721.ep10772598, DOI 10.1111/1467-8721.EP10772598]; Cone JJ, 2016, P NATL ACAD SCI USA, V113, P1943, DOI 10.1073/pnas.1519643113; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Deserno L, 2015, P NATL ACAD SCI USA, V112, P1595, DOI 10.1073/pnas.1417219112; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Esber GR, 2011, P ROY SOC B-BIOL SCI, V278, P2553, DOI 10.1098/rspb.2011.0836; Eshel N, 2016, NAT NEUROSCI, V19, P479, DOI 10.1038/nn.4239; Eshel N, 2015, NATURE, V525, P243, DOI 10.1038/nature14855; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; HOLLAND PC, 1993, BEHAV NEUROSCI, V107, P235, DOI 10.1037/0735-7044.107.2.235; Holland PC, 2005, J EXP PSYCHOL ANIM B, V31, P155, DOI 10.1037/0097-7403.31.2.155; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; HOLLAND PC, 1977, J EXP PSYCHOL ANIM B, V3, P77, DOI 10.1037/0097-7403.3.1.77; HOLLAND PC, 1975, J EXP PSYCHOL ANIM B, V1, P355, DOI 10.1037/0097-7403.1.4.355; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Horvitz JC, 1997, BRAIN RES, V759, P251, DOI 10.1016/S0006-8993(97)00265-5; Ilango A, 2014, J NEUROSCI, V34, P817, DOI 10.1523/JNEUROSCI.1703-13.2014; Johnson A, 2009, TRENDS COGN SCI, V13, P55, DOI 10.1016/j.tics.2008.11.005; Jones JL, 2012, SCIENCE, V338, P953, DOI 10.1126/science.1227489; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Kamin L. J., 1968, MIAMI S PREDICTION B, P9; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; Nakahara H, 2014, CURR OPIN NEUROBIOL, V25, P123, DOI 10.1016/j.conb.2014.01.001; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Parker NF, 2016, NAT NEUROSCI, V19, P845, DOI 10.1038/nn.4287; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Popescu AT, 2016, P NATL ACAD SCI USA, V113, pE3169, DOI 10.1073/pnas.1606098113; RIZLEY RC, 1972, J COMP PHYSIOL PSYCH, V81, P1, DOI 10.1037/h0033333; Robinson S, 2014, J NEUROSCI, V34, P10982, DOI 10.1523/JNEUROSCI.1349-14.2014; Sadacca BF, 2016, ELIFE, V5, DOI 10.7554/eLife.13665; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; Schultz W, 2016, NAT REV NEUROSCI, V17, P183, DOI 10.1038/nrn.2015.26; Sharpe MJ, 2014, CEREB CORTEX, V24, P1066, DOI 10.1093/cercor/bhs393; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Stopper CM, 2014, NEURON, V84, P177, DOI 10.1016/j.neuron.2014.08.033; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Tobler PN, 2003, J NEUROSCI, V23, P10402; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Wimmer GE, 2012, SCIENCE, V338, P270, DOI 10.1126/science.1223252; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028	56	119	119	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2017	20	5					735	+		10.1038/nn.4538	http://dx.doi.org/10.1038/nn.4538			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET1CU	28368385	Green Accepted			2022-12-17	WOS:000400004300015
J	Doiron, B; Litwin-Kumar, A; Rosenbaum, R; Ocker, GK; Josic, K				Doiron, Brent; Litwin-Kumar, Ashok; Rosenbaum, Robert; Ocker, Gabriel K.; Josic, Kresimir			The mechanics of state-dependent neural correlations	NATURE NEUROSCIENCE			English	Review							PRIMARY VISUAL-CORTEX; TERM SYNAPTIC DEPRESSION; MEMBRANE-POTENTIAL SYNCHRONY; NOISE CORRELATIONS; CORTICAL CIRCUITS; AREA MT; INTERNEURONAL CORRELATIONS; ORIENTATION SELECTIVITY; NEURONAL CORRELATIONS; SOMATOSENSORY CORTEX	Simultaneous recordings from large neural populations are becoming increasingly common. An important feature of population activity is the trial-to-trial correlated fluctuation of spike train outputs from recorded neuron pairs. Similar to the firing rate of single neurons, correlated activity can be modulated by a number of factors, from changes in arousal and attentional state to learning and task engagement. However, the physiological mechanisms that underlie these changes are not fully understood. We review recent theoretical results that identify three separate mechanisms that modulate spike train correlations: changes in input correlations, internal fluctuations and the transfer function of single neurons. We first examine these mechanisms in feedforward pathways and then show how the same approach can explain the modulation of correlations in recurrent networks. Such mechanistic constraints on the modulation of population activity will be important in statistical analyses of high-dimensional neural data.	[Doiron, Brent; Litwin-Kumar, Ashok; Rosenbaum, Robert; Ocker, Gabriel K.] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Doiron, Brent; Litwin-Kumar, Ashok; Rosenbaum, Robert; Ocker, Gabriel K.] Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Litwin-Kumar, Ashok] Columbia Univ, Ctr Theoret Neurosci, New York, NY USA; [Rosenbaum, Robert] Univ Notre Dame, Dept Appl & Computat Math & Stat, Notre Dame, IN 46556 USA; [Rosenbaum, Robert] Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat, Notre Dame, IN 46556 USA; [Ocker, Gabriel K.] Allen Inst Brain Sci, Seattle, WA USA; [Josic, Kresimir] Univ Houston, Dept Math, Houston, TX 77204 USA; [Josic, Kresimir] Univ Houston, Dept Biol & Biochem, Houston, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; University of Notre Dame; University of Notre Dame; Allen Institute for Brain Science; University of Houston System; University of Houston; University of Houston System; University of Houston	Doiron, B (corresponding author), Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA.; Doiron, B (corresponding author), Ctr Neural Basis Cognit, Pittsburgh, PA USA.	bdoiron@pitt.edu		Rosenbaum, Robert/0000-0003-2105-9282; Ocker, Gabriel/0000-0001-9627-9576; Litwin-Kumar, Ashok/0000-0003-2422-6576	National Science Foundation [NSF-DMS-1313225, NSF-DMS-1517082, NIH-CRCNS R01DC015139-01ZRG1, NSF-DMS-1122094, NSF-DMS-1517629]; National Institute of Health [NIH: 1F32DC014387]; Simons Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015139, F32DC014387] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1517828, 1517082] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was funded by National Science Foundation grants NSF-DMS-1313225 (B. D.), NSF-DMS-1517082 (B. D.), NIH-CRCNS R01DC015139-01ZRG1 (B. D.), NSF-DMS-1122094 (K. J.), NSF-DMS-1517629 (K. J.) and NSF-DMS-1517828 (R. R.), National Institute of Health grant NIH: 1F32DC014387 (A.L.-K.), a grant from the Simons Foundation collaboration on the global brain (B. D.), and a Simons Foundation fellowship (K.J.).	Abouzeid A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061914; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Barak O, 2014, CURR OPIN NEUROBIOL, V25, P20, DOI 10.1016/j.conb.2013.10.008; Barreiro AK, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011916; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Berman NJ, 1998, J NEUROPHYSIOL, V80, P3173, DOI 10.1152/jn.1998.80.6.3173; Biederlack J, 2006, NEURON, V52, P1073, DOI 10.1016/j.neuron.2006.11.012; Bird AD, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00002; Branco T, 2009, NAT REV NEUROSCI, V10, P373, DOI 10.1038/nrn2634; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Bruno RM, 2002, J NEUROSCI, V22, P10966; Bujan AF, 2015, J NEUROSCI, V35, P8611, DOI 10.1523/JNEUROSCI.4536-14.2015; Burak Y, 2009, NEURAL COMPUT, V21, P2269, DOI 10.1162/neco.2009.07-08-830; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Cardin JA, 2008, NEURON, V59, P150, DOI 10.1016/j.neuron.2008.05.002; Cecchi GA, 2000, P NATL ACAD SCI USA, V97, P5557, DOI 10.1073/pnas.100113597; Chacron MJ, 2008, J NEUROPHYSIOL, V99, P1825, DOI 10.1152/jn.01266.2007; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cunningham JP, 2014, NAT NEUROSCI, V17, P1500, DOI 10.1038/nn.3776; de la Rocha J, 2005, J NEUROSCI, V25, P8416, DOI 10.1523/JNEUROSCI.0631-05.2005; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Doiron B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.048101; Doiron B, 2001, NEURAL COMPUT, V13, P227, DOI 10.1162/089976601300014691; Doiron B, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00056; Downer JD, 2015, J NEUROSCI, V35, P7565, DOI 10.1523/JNEUROSCI.4094-14.2015; Ecker AS, 2014, NEURON, V82, P235, DOI 10.1016/j.neuron.2014.02.006; Ecker AS, 2011, J NEUROSCI, V31, P14272, DOI 10.1523/JNEUROSCI.2539-11.2011; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Eggermann E, 2014, CELL REP, V9, P1654, DOI 10.1016/j.celrep.2014.11.005; Erisken S, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.045; Ermentrout B, 1998, REP PROG PHYS, V61, P353, DOI 10.1088/0034-4885/61/4/002; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Gal A, 2010, J NEUROSCI, V30, P16332, DOI 10.1523/JNEUROSCI.4859-10.2010; Galan RF, 2006, J NEUROSCI, V26, P3646, DOI 10.1523/JNEUROSCI.4605-05.2006; Ganmor E, 2015, ELIFE, V4, DOI 10.7554/eLife.06134; Gerstner W, 2014, NEURONAL DYNAMICS: FROM SINGLE NEURONS TO NETWORKS AND MODELS OF COGNITION, P1, DOI 10.1017/CBO9781107447615; GINZBURG I, 1994, PHYS REV E, V50, P3171, DOI 10.1103/PhysRevE.50.3171; Giocomo LM, 2011, NEURON, V71, P589, DOI 10.1016/j.neuron.2011.07.023; Goldman MS, 2004, NEURAL COMPUT, V16, P1137, DOI 10.1162/089976604773717568; Goris RLT, 2014, NAT NEUROSCI, V17, P858, DOI 10.1038/nn.3711; Graupner M, 2013, J NEUROSCI, V33, P15075, DOI 10.1523/JNEUROSCI.0347-13.2013; Gregoriou GG, 2014, NAT NEUROSCI, V17, P1003, DOI 10.1038/nn.3742; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Gururangan SS, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003710; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Hansen BJ, 2012, NEURON, V76, P590, DOI 10.1016/j.neuron.2012.08.029; Harish O, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004266; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Helias M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003428; Herrero JL, 2013, NEURON, V78, P729, DOI 10.1016/j.neuron.2013.03.029; Hertz J, 2010, NEURAL COMPUT, V22, P427, DOI 10.1162/neco.2009.06-08-806; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; Hong SH, 2012, J NEUROSCI, V32, P1413, DOI 10.1523/JNEUROSCI.3735-11.2012; Hu Y, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003469; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jeanne JM, 2013, NEURON, V78, P352, DOI 10.1016/j.neuron.2013.02.023; Kass RE, 2006, NEURAL COMPUT, V18, P2583, DOI 10.1162/neco.2006.18.11.2583; Keane A, 2015, J NEUROSCI, V35, P1591, DOI 10.1523/JNEUROSCI.1669-14.2015; Kelly RC, 2010, J COMPUT NEUROSCI, V29, P567, DOI 10.1007/s10827-009-0208-9; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kriener B, 2009, J COMPUT NEUROSCI, V27, P177, DOI 10.1007/s10827-008-0135-1; Kruscha A, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.052817; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Lee SH, 2012, NEURON, V76, P209, DOI 10.1016/j.neuron.2012.09.012; Lin IC, 2015, NEURON, V87, P644, DOI 10.1016/j.neuron.2015.06.035; Lindner B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061919; Lindner B, 2001, PHYS REV LETT, V86, P2934, DOI 10.1103/PhysRevLett.86.2934; Litwin-Kumar A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002667; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Litwin-Kumar A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002305; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Ly C, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00007; Lyamzin DR, 2015, J NEUROSCI, V35, P8065, DOI 10.1523/JNEUROSCI.4738-14.2015; Markowitz DA, 2008, P NATL ACAD SCI USA, V105, P8422, DOI 10.1073/pnas.0803183105; McGinley MJ, 2015, NEURON, V87, P1143, DOI 10.1016/j.neuron.2015.09.012; Middleton JW, 2012, J NEUROSCI, V32, P506, DOI 10.1523/JNEUROSCI.3474-11.2012; Miller KD, 2001, CURR OPIN NEUROBIOL, V11, P488, DOI 10.1016/S0959-4388(00)00239-7; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Miura K, 2012, NEURON, V74, P1087, DOI 10.1016/j.neuron.2012.04.021; Mochol G, 2015, P NATL ACAD SCI USA, V112, P3529, DOI 10.1073/pnas.1410509112; Moreno-Bote R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028101; Moreno-Bote R, 2014, NAT NEUROSCI, V17, P1410, DOI 10.1038/nn.3807; Ocker GK, 2014, J NEUROPHYSIOL, V112, P340, DOI 10.1152/jn.00084.2014; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Ostojic S, 2014, NAT NEUROSCI, V17, P594, DOI 10.1038/nn.3658; Ostojic S, 2009, J NEUROSCI, V29, P10234, DOI 10.1523/JNEUROSCI.1275-09.2009; Parga N, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/03/P03010; Pernice V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002059; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Polk A, 2012, P NATL ACAD SCI USA, V109, P6295, DOI 10.1073/pnas.1121274109; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Prescott SA, 2003, P NATL ACAD SCI USA, V100, P2076, DOI 10.1073/pnas.0337591100; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Qi XL, 2012, EUR J NEUROSCI, V36, P3538, DOI 10.1111/j.1460-9568.2012.08267.x; Reimer J, 2014, NEURON, V84, P355, DOI 10.1016/j.neuron.2014.09.033; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Rosenbaum R, 2013, J NEUROPHYSIOL, V109, P475, DOI 10.1152/jn.00733.2012; Rosenbaum R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002557; Rosenbaum R, 2011, NEURAL COMPUT, V23, P1261, DOI 10.1162/NECO_a_00116; Rosenbaum R, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00058; RUBINSTEIN JT, 1995, BIOPHYS J, V68, P779, DOI 10.1016/S0006-3495(95)80252-3; Ruff DA, 2014, NAT NEUROSCI, V17, P1591, DOI 10.1038/nn.3835; Schaub MT, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004196; Schulz DPA, 2015, J NEUROPHYSIOL, V114, P1022, DOI 10.1152/jn.00094.2015; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shea-Brown E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108102; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Silver RA, 2010, NAT REV NEUROSCI, V11, P474, DOI 10.1038/nrn2864; Simmonds B, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004034; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Snyder AC, 2014, J NEUROSCI, V34, P11222, DOI 10.1523/JNEUROSCI.0762-14.2014; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Tan AYY, 2014, NATURE, V509, P226, DOI 10.1038/nature13159; Tchumatchenko T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058102; Tetzlaff T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002596; Trousdale J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002408; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; VEREJONE.D, 1966, AUST J STAT, V8, P53, DOI 10.1111/j.1467-842X.1966.tb00164.x; Vinck M, 2015, NEURON, V86, P740, DOI 10.1016/j.neuron.2015.03.028; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0; Wimmer K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7177; Yatsenko D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004083; Yu JN, 2010, NEURON, V68, P1187, DOI 10.1016/j.neuron.2010.11.027; Yuste R, 2015, NAT REV NEUROSCI, V16, P487, DOI 10.1038/nrn3962; Zhou PC, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00113; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	150	119	119	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2016	19	3					383	393		10.1038/nn.4242	http://dx.doi.org/10.1038/nn.4242			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE7MU	26906505	Green Accepted			2022-12-17	WOS:000370822200007
J	Das, U; Wang, LN; Ganguly, A; Saikia, JM; Wagner, SL; Koo, EH; Roy, S				Das, Utpal; Wang, Lina; Ganguly, Archan; Saikia, Junmi M.; Wagner, Steven L.; Koo, Edward H.; Roy, Subhojit			Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway	NATURE NEUROSCIENCE			English	Article							AXONAL-TRANSPORT KINETICS; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; BETA-SECRETASE; PRESYNAPTIC TERMINALS; RECYCLING ENDOSOMES; GOLGI NETWORK; CELL BIOLOGY; LIVING CELLS; TRAFFICKING	Cleavage of amyloid precursor protein (APP) by BACE-1 (beta-site APP cleaving enzyme-1) is the rate-limiting step in amyloid-beta (A beta) production and a neuropathologic hallmark of Alzheimer's disease; thus, physical approximation of this substrate-enzyme pair is a crucial event with broad biological and therapeutic implications. Despite much research, neuronal locales of APP and BACE-1 convergence and APP cleavage remain unclear. Here we report an optical assay, based on fluorescence complementation, for visualizing in cellulo APP-BACE-1 interactions as a simple on/ off signal. Combining this with other assays tracking the fate of internalized APP in hippocampal neurons, we found that APP and BACE-1 interacted in both biosynthetic and endocytic compartments, particularly along recycling microdomains such as dendritic spines and presynaptic boutons. In axons, APP and BACE-1 were cotransported, and they also interacted during transit. Finally, our assay revealed that the Alzheimer's disease-protective 'Icelandic' mutation greatly attenuates APP-BACE-1 interactions, suggesting a mechanistic basis for protection. Collectively, the data challenge canonical models and provide concrete insights into long-standing controversies in the field.	[Das, Utpal; Wang, Lina; Ganguly, Archan; Roy, Subhojit] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Das, Utpal; Wang, Lina; Ganguly, Archan; Saikia, Junmi M.; Wagner, Steven L.; Koo, Edward H.; Roy, Subhojit] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Koo, Edward H.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med & Physiol, Singapore 117595, Singapore	University of California System; University of California San Diego; University of California System; University of California San Diego; National University of Singapore	Das, U (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	udas@ucsd.edu; s1roy@ucsd.edu	Ganguly, Archan/K-7125-2019; Das, Utpal/E-4692-2013; Wang, Lina/M-4491-2015	Ganguly, Archan/0000-0002-0351-9284	pilot award from the UCSD Alzheimer's Center [P50 AG005131]; NIH/NIA [R01AG048218]; NIH/NINDS [R01NS075233]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048218, P50AG005131] Funding Source: NIH RePORTER	pilot award from the UCSD Alzheimer's Center; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank G. Banker (Oregon Health and Science University) for the NPYss:mCherry and TfR:mCherry/GFP constructs, G. Patterson and J. Lipincott-Schwartz (NIH) for the GalT:mCherry/GFP constructs, Z.-H. Sheng (NIH) for the synaptophysin-mRFP construct, W. Almers (Oregon Health and Science University) for the broken CMV promoter and D. Boehning (The University of Texas Health Science Center) for the APP(Lon):GFP construct. Constructs from Addgene and investigators are acknowledged in the Online Methods. U.D. was partly supported by a pilot award from the UCSD Alzheimer's Center (P50 AG005131). This work was supported by grants from the NIH/NIA (R01AG048218 and NIH/NINDS (R01NS075233) to S.R.	Benilova I, 2014, J BIOL CHEM, V289, P30977, DOI 10.1074/jbc.M114.599027; Buggia-Prevot V, 2013, CELL REP, V5, P1552, DOI 10.1016/j.celrep.2013.12.006; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; DeBoer SR, 2014, J NEUROSCI, V34, P12313, DOI 10.1523/JNEUROSCI.2255-14.2014; El Meskini R, 2005, DEV NEUROSCI-BASEL, V27, P333, DOI 10.1159/000086713; Ganguly A, 2014, METHODS MOL BIOL, V1148, P203, DOI 10.1007/978-1-4939-0470-9_13; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; Goldsbury C, 2006, TRAFFIC, V7, P873, DOI 10.1111/j.1600-0854.2006.00434.x; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kaech Stefanie, 2012, Cold Spring Harb Protoc, V2012, P340, DOI 10.1101/pdb.prot068247; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kandalepas PC, 2013, ACTA NEUROPATHOL, V126, P329, DOI 10.1007/s00401-013-1152-3; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Knowles MK, 2010, P NATL ACAD SCI USA, V107, P20810, DOI 10.1073/pnas.1014840107; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Maloney JA, 2014, J BIOL CHEM, V289, P30990, DOI 10.1074/jbc.M114.589069; Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Prasad H, 2015, J BIOL CHEM, V290, P5311, DOI 10.1074/jbc.M114.602219; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Sahlin C, 2007, J NEUROCHEM, V101, P854, DOI 10.1111/j.1471-4159.2006.04443.x; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Sisodia SS, 2002, SCIENCE, V295, P805, DOI 10.1126/science.1069661; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Szodorai A, 2009, J NEUROSCI, V29, P14534, DOI 10.1523/JNEUROSCI.1546-09.2009; Tang Y, 2012, TRAFFIC, V13, P681, DOI 10.1111/j.1600-0854.2012.01340.x; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Wang LN, 2014, CURR BIOL, V24, P2319, DOI 10.1016/j.cub.2014.08.027; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Yap CC, 2012, NEURON, V74, P440, DOI 10.1016/j.neuron.2012.04.015	46	119	122	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2016	19	1					55	+		10.1038/nn.4188	http://dx.doi.org/10.1038/nn.4188			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ7BH	26642089	Green Accepted			2022-12-17	WOS:000367254400013
J	Feng, J; Shao, NY; Szulwach, KE; Vialou, V; Huynh, J; Zhong, C; Le, T; Ferguson, D; Cahill, ME; Li, YJ; Koo, JW; Ribeiro, E; Labonte, B; Laitman, BM; Estey, D; Stockman, V; Kennedy, P; Courouss, T; Mensah, I; Turecki, G; Faull, KF; Ming, GL; Song, HJ; Fan, GP; Casaccia, P; Shen, L; Jin, P; Nestler, EJ				Feng, Jian; Shao, Ningyi; Szulwach, Keith E.; Vialou, Vincent; Huynh, Jimmy; Zhong, Chun; Le, Thuc; Ferguson, Deveroux; Cahill, Michael E.; Li, Yujing; Koo, Ja Wook; Ribeiro, Efrain; Labonte, Benoit; Laitman, Benjamin M.; Estey, David; Stockman, Victoria; Kennedy, Pamela; Courouss, Thomas; Mensah, Isaac; Turecki, Gustavo; Faull, Kym F.; Ming, Guo-li; Song, Hongjun; Fan, Guoping; Casaccia, Patrizia; Shen, Li; Jin, Peng; Nestler, Eric J.			Role of Tet1 and 5-hydroxymethylcytosine in cocaine action	NATURE NEUROSCIENCE			English	Article							DNA DEMETHYLATION; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; DELTA-FOSB; MEMORY FORMATION; DRUG-ADDICTION; MAMMALIAN DNA; 5-METHYLCYTOSINE; TRANSCRIPTION; ENHANCERS	Ten-eleven translocation (TET) enzymes mediate the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), which is enriched in brain, and its ultimate DNA demethylation. However, the influence of TET and 5hmC on gene transcription in brain remains elusive. We found that ten-eleven translocation protein 1 (TET1) was downregulated in mouse nucleus accumbens (NAc), a key brain reward structure, by repeated cocaine administration, which enhanced behavioral responses to cocaine. We then identified 5hmC induction in putative enhancers and coding regions of genes that have pivotal roles in drug addiction. Such induction of 5hmC, which occurred similarly following TET1 knockdown alone, correlated with increased expression of these genes as well as with their alternative splicing in response to cocaine administration. In addition, 5hmC alterations at certain loci persisted for at least 1 month after cocaine exposure. Together, these reveal a previously unknown epigenetic mechanism of cocaine action and provide new insight into how 5hmC regulates transcription in brain in vivo.	[Feng, Jian; Shao, Ningyi; Vialou, Vincent; Huynh, Jimmy; Ferguson, Deveroux; Cahill, Michael E.; Koo, Ja Wook; Ribeiro, Efrain; Labonte, Benoit; Laitman, Benjamin M.; Estey, David; Stockman, Victoria; Kennedy, Pamela; Mensah, Isaac; Casaccia, Patrizia; Shen, Li; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Szulwach, Keith E.; Li, Yujing; Jin, Peng] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Vialou, Vincent; Courouss, Thomas] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Zhong, Chun; Ming, Guo-li; Song, Hongjun] UPMC UM18, Neurosci Paris Seine, CNRS UMR8246, Inst Natl Sante & Rech Med INSERM U1130, Paris, France; [Le, Thuc; Fan, Guoping] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA; [Turecki, Gustavo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Faull, Kym F.] McGill Univ, Douglas Hosp Res Ctr, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Shao, Ningyi; Szulwach, Keith E.; Vialou, Vincent] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Emory University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; McGill University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	Labonte, Benoit/GPF-5629-2022; Turecki, Gustavo/K-5100-2015; vialou, vincent/F-2968-2013; Li, Yujing/AAJ-1411-2020; SHAO, Ning-Yi/N-4947-2015; Li, yujing/GQA-4109-2022	Labonte, Benoit/0000-0002-1251-5605; vialou, vincent/0000-0002-8212-751X; Li, Yujing/0000-0002-4363-2484; SHAO, Ning-Yi/0000-0003-4231-828X; Laitman, Benjamin/0000-0002-9582-6088; Turecki, Gustavo/0000-0003-4075-2736; Ferguson, Deveroux/0000-0001-9302-5992; Ming, Guo-li/0000-0002-2517-6075; Cahill, Michael/0000-0003-0574-2655	National Institute on Drug Abuse; National Institutes of Health; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS042925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007359, P01DA008227] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Chess for critical comments and O. Jabado and M. Mahajan from the Mount Sinai Genomics Core for technical support. This work was supported by grants from the National Institute on Drug Abuse (E.J.N.), the National Institutes of Health (P.J., P.C., G.F., K.F.F. and H.S.) and the Simons Foundation (H.S.).	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booth MJ, 2013, NAT PROTOC, V8, P1841, DOI 10.1038/nprot.2013.115; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cruz FC, 2013, NAT REV NEUROSCI, V14, P743, DOI 10.1038/nrn3597; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feng J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r65; Feng J, 2013, CURR OPIN NEUROBIOL, V23, P521, DOI 10.1016/j.conb.2013.01.001; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Graham DL, 2009, BIOL PSYCHIAT, V65, P696, DOI 10.1016/j.biopsych.2008.09.032; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kaas GA, 2013, NEURON, V79, P1086, DOI 10.1016/j.neuron.2013.08.032; Khare T, 2012, NAT STRUCT MOL BIOL, V19, P1037, DOI 10.1038/nsmb.2372; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Li X, 2014, P NATL ACAD SCI USA, V111, P7120, DOI 10.1073/pnas.1318906111; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Malik AN, 2014, NAT NEUROSCI, V17, P1330, DOI 10.1038/nn.3808; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Mitchell AC, 2014, BIOL PSYCHIAT, V75, P961, DOI 10.1016/j.biopsych.2013.07.015; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Robison AJ, 2013, J NEUROSCI, V33, P4295, DOI 10.1523/JNEUROSCI.5192-12.2013; Rudenko A, 2013, NEURON, V79, P1109, DOI 10.1016/j.neuron.2013.08.003; Sasai N, 2010, NUCLEIC ACIDS RES, V38, P5015, DOI 10.1093/nar/gkq280; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thuc L, 2011, ANAL BIOCHEM, V412, P203, DOI 10.1016/j.ab.2011.01.026; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vialou V, 2012, J NEUROSCI, V32, P7577, DOI 10.1523/JNEUROSCI.1381-12.2012; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Vogel-Ciernia A, 2013, NAT NEUROSCI, V16, P552, DOI 10.1038/nn.3359; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Zachariou V, 2008, BIOL PSYCHIAT, V63, P1013, DOI 10.1016/j.biopsych.2007.11.021; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006	66	119	125	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2015	18	4					536	+		10.1038/nn.3976	http://dx.doi.org/10.1038/nn.3976			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE4DL	25774451	Green Accepted, Green Published			2022-12-17	WOS:000351780900015
J	Chung, W; Choi, SY; Lee, E; Park, H; Kang, J; Park, H; Choi, Y; Lee, D; Park, SG; Kim, R; Cho, YS; Choi, J; Kim, MH; Lee, JW; Lee, S; Rhim, I; Jung, MW; Kim, D; Bae, YC; Kim, E				Chung, Woosuk; Choi, Su Yeon; Lee, Eunee; Park, Haram; Kang, Jaeseung; Park, Hanwool; Choi, Yeonsoo; Lee, Dongsoo; Park, Sae-Geun; Kim, Ryunhee; Cho, Yi Sul; Choi, Jeonghoon; Kim, Myoung-Hwan; Lee, Jong Won; Lee, Seungjoon; Rhim, Issac; Jung, Min Whan; Kim, Daesoo; Bae, Yong Chul; Kim, Eunjoon			Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression	NATURE NEUROSCIENCE			English	Article							INSULIN-RECEPTOR SUBSTRATE; LONG-TERM POTENTIATION; RARE DE-NOVO; AUTISM; ACTIN; HIPPOCAMPAL; ASSOCIATION; MUTATIONS; BAIAP2; DYSFUNCTION	Social deficits are observed in diverse psychiatric disorders, including autism spectrum disorders and schizophrenia. We found that mice lacking the excitatory synaptic signaling scaffold IRSp53 (also known as BAIAP2) showed impaired social interaction and communication. Treatment of IRSp53(-1-) mice, which display enhanced NMDA receptor (NMDAR) function in the hippocampus, with memantine, an NMDAR antagonist, or MPEP, a metabotropic glutamate receptor 5 antagonist that indirectly inhibits NMDAR function, normalized social interaction. This social rescue was accompanied by normalization of NMDAR function and plasticity in the hippocampus and neuronal firing in the medial prefrontal cortex. These results, together with the reduced NMDAR function implicated in social impairments, suggest that deviation of NMDAR function in either direction leads to social deficits and that correcting the deviation has beneficial effects.	[Chung, Woosuk; Park, Hanwool] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Choi, Su Yeon; Park, Haram; Kang, Jaeseung; Choi, Yeonsoo; Park, Sae-Geun; Kim, Ryunhee; Choi, Jeonghoon; Lee, Seungjoon; Jung, Min Whan; Kim, Daesoo; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Lee, Eunee; Lee, Dongsoo; Lee, Jong Won; Rhim, Issac; Jung, Min Whan; Kim, Eunjoon] Inst for Basic Sci Korea, Ctr Synapt Brain Dysfunct, Taejon, South Korea; [Cho, Yi Sul; Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Anat & Neurobiol, Taegu, South Korea; [Kim, Myoung-Hwan] Seoul Natl Univ, Dept Physiol, Coll Med, Seoul, South Korea; [Kim, Myoung-Hwan] Seoul Natl Univ, Bundang Hosp, Gyeonggi, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Institute for Basic Science - Korea (IBS); Kyungpook National University; Seoul National University (SNU); Seoul National University (SNU)	Kim, E (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	kime@kaist.ac.kr	Kim, Eunjoon/C-1566-2011; Kim, Daesoo/C-1625-2011; Chung, Woosuk/AAF-5110-2021; Jung, Min Whan/GXF-5216-2022; Lee, Eunee/O-8451-2014	Kim, Daesoo/0000-0001-9915-1463; Chung, Woosuk/0000-0002-6409-2325; Lee, Seungjoon/0000-0002-8583-528X; Park, Haram/0000-0002-6312-2668; Lee, Eunee/0000-0001-9726-4819; Kang, Jaeseung/0000-0002-0288-6410; Lee, Dongsoo/0000-0002-6730-7125; Rhim, Issac/0000-0003-4275-1999	National Research Foundation of Korea [2012-0008795, 2012-0009328]; Institute for Basic Science [IBS-R002-Dl, IBS-R002-G1]	National Research Foundation of Korea(National Research Foundation of Korea); Institute for Basic Science	This study was supported by the National Research Foundation of Korea (to D.K., 2012-0008795; to Y.C.B., 2012-0009328) and the Institute for Basic Science (IBS-R002-Dl to E.K. and IBS-R002-G1 to M.W.J.).	Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; Alagarsamy S, 1999, NAT NEUROSCI, V2, P234, DOI 10.1038/6338; Allison DW, 1998, J NEUROSCI, V18, P2423; Bagni C, 2013, AM J MED GENET A, V161, P2809, DOI 10.1002/ajmg.a.36241; Bockmann J, 2002, J NEUROCHEM, V83, P1013, DOI 10.1046/j.1471-4159.2002.01204.x; Burette AC, 2014, J COMP NEUROL, V522, P2164, DOI 10.1002/cne.23526; Chang JPC, 2014, CURR PHARM DESIGN, V20, P5180, DOI 10.2174/1381612819666140110115227; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379; Delorme R, 2013, NAT MED, V19, P685, DOI 10.1038/nm.3193; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Ehninger D, 2011, TRENDS MOL MED, V17, P78, DOI 10.1016/j.molmed.2010.10.002; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Halpain S, 1998, J NEUROSCI, V18, P9835; Harris KM, 2012, COLD SPRING HARB PER, V4, P5, DOI DOI 10.1101/CSHPERSPECT.A005587; Hosenbocus S, 2013, J CAN ACAD CHILD ADO, V22, P166; Huang TN, 2014, NAT NEUROSCI, V17, P240, DOI 10.1038/nn.3626; Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431; Jia ZP, 1998, LEARN MEMORY, V5, P331; Jiang YH, 2013, NEURON, V78, P8, DOI 10.1016/j.neuron.2013.03.016; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; Kleijer KTE, 2014, PSYCHOPHARMACOLOGY, V231, P1037, DOI 10.1007/s00213-013-3403-3; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Liu L, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-48; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Ribases M, 2009, BIOL PSYCHIAT, V66, P926, DOI 10.1016/j.biopsych.2009.06.024; Sawallisch C, 2009, J BIOL CHEM, V284, P9225, DOI 10.1074/jbc.M808425200; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Shalom DB, 2009, NEUROSCIENTIST, V15, P589, DOI 10.1177/1073858409336371; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shim SS, 2014, J PSYCHIATR RES, V51, P19, DOI 10.1016/j.jpsychires.2013.12.007; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Soltau M, 2004, J NEUROCHEM, V90, P659, DOI 10.1111/j.1471-4159.2004.02523.x; Spooren W, 2012, TRENDS PHARMACOL SCI, V33, P669, DOI 10.1016/j.tips.2012.09.004; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Ting JT, 2012, ANNU REV NEUROSCI, V35, P49, DOI 10.1146/annurev-neuro-062111-150442; Toma C, 2011, J PSYCHIATR RES, V45, P280, DOI 10.1016/j.jpsychires.2010.09.001; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Yadav R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032969; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	49	119	121	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2015	18	3					435	443		10.1038/nn.3927	http://dx.doi.org/10.1038/nn.3927			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC2SO	25622145				2022-12-17	WOS:000350195100024
J	Insolera, R; Bazzi, H; Shao, W; Anderson, KV; Shi, SH				Insolera, Ryan; Bazzi, Hisham; Shao, Wei; Anderson, Kathryn V.; Shi, Song-Hai			Cortical neurogenesis in the absence of centrioles	NATURE NEUROSCIENCE			English	Article							OUTER SUBVENTRICULAR ZONE; SPINDLE ORIENTATION; RADIAL GLIA; NEURAL PRECURSORS; CELL; PROGENITORS; DIVISIONS; CDK5RAP2; NEURONS; DUPLICATION	Neuronal production in the mammalian cortex depends on extensive mitoses of radial glial progenitors (RGPs) residing in the ventricular zone (VZ). We examined the function of centrioles in RGPs during cortical neurogenesis in mice by conditional removal of SAS-4, a protein that is required for centriole biogenesis. SAS-4 deletion led to a progressive loss of centrioles, accompanied by RGP detachment from the VZ. De localized RGPs did not become outer subventricular zone RGPs (oRGs). Although they remained proliferative, ectopic RGPs, as well as those in the VZ, with a centrosomal deficit exhibited prolonged mitosis, p53 upregulation and apoptosis, resulting in neuronal loss and microcephaly. Simultaneous removal of p53 fully rescued RGP death and microcephaly, but not RGP delocalization and randomized mitotic spindle orientation. Our findings define the functions of centrioles in anchoring RGPs in the VZ and ensuring their efficient mitoses, and reveal the robust adaptability of RGPs in the developing cortex.	[Insolera, Ryan; Bazzi, Hisham; Shao, Wei; Anderson, Kathryn V.; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA; [Insolera, Ryan; Shi, Song-Hai] Weill Cornell Med Coll, Grad Program Neurosci, New York, NY USA; [Shao, Wei; Shi, Song-Hai] Weill Cornell Med Coll, Cell & Mol Biol Allied Program, Grad Program Biochem, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Anderson, KV (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA.	k-anderson@ski.mskcc.org; shis@mskcc.org	Bazzi, Hisham/AAA-6584-2021	Bazzi, Hisham/0000-0001-8388-4005; Insolera, Ryan/0000-0001-8282-9370; Anderson, Kathryn/0000-0003-1657-2161	US National Institutes of Health [R01DA024681, R01NS085004, R01NS044385]; National Kidney Foundation; Ruth L. Kirschstein National Research Service Award from the US National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085004, R01NS044385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; Ruth L. Kirschstein National Research Service Award from the US National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B.M.-F. Tsou (Memorial Sloan Kettering Cancer Center) for reagents and advice, P. Gonczy (Institut Suisse de Recherches Experimentales sur le Cancer) for reagents, D. Solit (Memorial Sloan Kettering Cancer Center) for p53<SUP>loxP/loxP</SUP> mice, and V. Boyko and Y. Romin at the Molecular Cytology Core Facility for their technical support. We thank the Anderson and Shi laboratory members for their input and comments on the manuscript. This work was supported by grants from the US National Institutes of Health (R01DA024681 and R01NS085004 to S.-H.S., and R01NS044385 to K.V.A.). H.B. was supported by the National Kidney Foundation and a Ruth L. Kirschstein National Research Service Award from the US National Institutes of Health.	Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bayer S.A., 1991, NEOCORTICAL DEV; Bazzi H, 2014, P NATL ACAD SCI USA, V111, pE1491, DOI 10.1073/pnas.1400568111; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Hutton SR, 2011, DEV BIOL, V352, P40, DOI 10.1016/j.ydbio.2011.01.015; Kamei Y, 1998, GLIA, V23, P191, DOI 10.1002/(SICI)1098-1136(199807)23:3<191::AID-GLIA2>3.0.CO;2-8; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lancaster MA, 2012, CURR OPIN NEUROBIOL, V22, P737, DOI 10.1016/j.conb.2012.04.003; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746; Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041386, 10.1371/journal.pone.0030178]; McIntyre RE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003022; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026	50	119	123	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2014	17	11					1528	1535		10.1038/nn.3831	http://dx.doi.org/10.1038/nn.3831			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS0LT	25282615	Green Accepted			2022-12-17	WOS:000343969300017
J	Glynn, MW; Elmer, BM; Garay, PA; Liu, XB; Needleman, LA; El-Sabeawy, F; McAllister, AK				Glynn, Marian W.; Elmer, Bradford M.; Garay, Paula A.; Liu, Xiao-Bo; Needleman, Leigh A.; El-Sabeawy, Faten; McAllister, A. Kimberley			MHCI negatively regulates synapse density during the establishment of cortical connections	NATURE NEUROSCIENCE			English	Article							CLASS-I MOLECULES; ACTIVITY-DEPENDENT REGULATION; RECEPTOR INTERNALIZATION; ACTIVITY BLOCKADE; GENE-EXPRESSION; HEAVY-CHAINS; CNS; PLASTICITY; ABSENCE; SURFACE	Major histocompatibility complex class I (MHCI) molecules modulate activity-dependent refinement and plasticity. We found that MHCI also negatively regulates the density and function of cortical synapses during their initial establishment both in vitro and in vivo. MHCI molecules are expressed on cortical neurons before and during synaptogenesis. In vitro, decreasing surface MHCI (sMHCI) on neurons increased glutamatergic and GABAergic synapse density, whereas overexpression decreased it. In vivo, synapse density was higher throughout development in beta 2m(-/-) mice. MHCI also negatively regulated the strength of excitatory, but not inhibitory, synapses and controlled the balance of excitation and inhibition onto cortical neurons. sMHCI levels were modulated by activity and were necessary for activity to negatively regulate glutamatergic synapse density. Finally, acute changes in sMHCI and activity altered synapse density exclusively during early postnatal development. These results identify a previously unknown function for immune proteins in the negative regulation of the initial establishment and function of cortical connections.	[Glynn, Marian W.; Elmer, Bradford M.; Garay, Paula A.; Liu, Xiao-Bo; Needleman, Leigh A.; El-Sabeawy, Faten; McAllister, A. Kimberley] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis	McAllister, AK (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	kmcallister@ucdavis.edu		McAllister, A. Kimberley/0000-0001-9177-9889	National Institute for Environmental Health Sciences; John Merck Fund; March of Dimes; Cure Autism Now; Autism Speaks; National Institute of Neurological Disorders and Stroke [R01NS060125]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060125] Funding Source: NIH RePORTER	National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); John Merck Fund; March of Dimes(March of Dimes); Cure Autism Now; Autism Speaks; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to M. Edidin (Johns Hopkins University) for the H2-K<SUP>b</SUP>-CFP construct, J. Fritschy (University of Zurich) for antibodies to GABA receptor and J. Trimmer (University of California Davis) for the antibody to PSD-95. We also thank J. Trimmer and E. Diaz (University of California Davis) for advice and for supporting the project. This project was funded by a National Institute for Environmental Health Sciences Training grant (M. W. G.), the John Merck Fund (A. K. M.), the March of Dimes (A. K. M.), Cure Autism Now (A. K. M.), Autism Speaks (A. K. M.) and National Institute of Neurological Disorders and Stroke grant R01NS060125 (A. K. M.). We are especially grateful to the Higgins and Gassin Family Foundations for their invaluable support of basic science research and our work.	Abbas A., 2017, CELLULAR MOL IMMUNOL, P281; Bodnar A, 2003, INT IMMUNOL, V15, P331, DOI 10.1093/intimm/dxg042; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Bouwman J, 2004, NEUROSCIENCE, V126, P115, DOI 10.1016/j.neuroscience.2004.03.027; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; CHAKRABARTI A, 1992, BIOCHEMISTRY-US, V31, P7182, DOI 10.1021/bi00146a022; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; DeFelipe J, 1999, CEREB CORTEX, V9, P722, DOI 10.1093/cercor/9.7.722; DEMARIA S, 1992, CELL IMMUNOL, V142, P103, DOI 10.1016/0008-8749(92)90272-Q; Fishman D, 2004, FOLIA BIOL-PRAGUE, V50, P35; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Harms KJ, 2005, J COMP NEUROL, V490, P72, DOI 10.1002/cne.20635; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; HOCHMAN JH, 1988, J IMMUNOL, V140, P2322; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Huupponen J, 2007, J PHYSIOL-LONDON, V581, P505, DOI 10.1113/jphysiol.2007.130062; Kirov SA, 2004, NEUROPHARMACOLOGY, V47, P640, DOI 10.1016/j.neuropharm.2004.07.039; Lauri SE, 2003, MOL CELL NEUROSCI, V22, P107, DOI 10.1016/S1044-7431(02)00012-X; MADRIGAL JA, 1991, J EXP MED, V174, P1085, DOI 10.1084/jem.174.5.1085; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; MCALLISTER AK, 2007, ANN REV NEU IN PRESS; Naranda T, 1997, P NATL ACAD SCI USA, V94, P11692, DOI 10.1073/pnas.94.21.11692; Nawa H, 2000, MOL PSYCHIATR, V5, P594, DOI 10.1038/sj.mp.4000730; Needleman LA, 2010, P NATL ACAD SCI USA, V107, P16999, DOI 10.1073/pnas.1006087107; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; O'Connor TP, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-18; OLSSON L, 1994, P NATL ACAD SCI USA, V91, P9086, DOI 10.1073/pnas.91.19.9086; Patel MR, 2009, SCIENCE, V323, P1500, DOI 10.1126/science.1169025; Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Sabo SL, 2003, NAT NEUROSCI, V6, P1264, DOI 10.1038/nn1149; Santos SG, 2004, J BIOL CHEM, V279, P53062, DOI 10.1074/jbc.M408794200; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; SCHNABL E, 1990, J EXP MED, V171, P1431, DOI 10.1084/jem.171.5.1431; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Spiliotis ET, 2002, MOL BIOL CELL, V13, P1566, DOI 10.1091/mbc.01-07-0322; Stagsted J, 1998, APMIS Suppl, V85, P1; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006; WILLIAMS DB, 1989, J IMMUNOL, V142, P2796	49	119	126	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					442	U71		10.1038/nn.2764	http://dx.doi.org/10.1038/nn.2764			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21358642	Green Accepted			2022-12-17	WOS:000288849400015
J	Tanigawa, H; Lu, HDD; Roe, AW				Tanigawa, Hisashi; Lu, Haidong D.; Roe, Anna W.			Functional organization for color and orientation in macaque V4	NATURE NEUROSCIENCE			English	Article							MONKEY VISUAL-CORTEX; INFERIOR TEMPORAL CORTEX; FEATURE-BASED ATTENTION; AREA V4; STRIATE CORTEX; RHESUS-MONKEY; VISUOTOPIC ORGANIZATION; PRESTRIATE CORTEX; SELECTIVE NEURONS; PRELUNATE GYRUS	Visual area V4 in the macaque monkey is a cortical area that is strongly involved in color and shape perception. However, fundamental questions about V4 are still debated. V4 was initially characterized as a color-processing area, but subsequent studies revealed that it contains a diverse complement of cells, including those with preference for color, orientation, disparity and higher-order feature preferences. This has led to disputes and uncertainty about the role of V4 in vision. Using intrinsic signal optical imaging methods in awake, behaving monkeys, we found that different feature preferences are functionally organized in V4. Optical images revealed that regions with preferential response to color were largely separate from orientation-selective regions. Our results help to resolve long-standing controversies regarding functional diversity and retinotopy in V4 and indicate the presence of spatially biased distribution of featural representation in V4 in the ventral visual pathway.	[Tanigawa, Hisashi; Lu, Haidong D.; Roe, Anna W.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA	Vanderbilt University	Roe, AW (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	anna.w.roe@vanderbilt.edu	Tanigawa, Hisashi/H-4792-2014	Tanigawa, Hisashi/0000-0002-7736-0683; Roe, Anna Wang/0000-0003-4146-9705	US National Institutes of Health; Vanderbilt Vision Research Center; Vanderbilt University Center for Integrative & Cognitive Neuroscience; NATIONAL EYE INSTITUTE [R01EY011744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023002] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Vision Research Center; Vanderbilt University Center for Integrative & Cognitive Neuroscience; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J.H. Kaas and G. Chen for comments on the manuscript and Y. Chu for technical assistance. This work was supported by grants from the US National Institutes of Health, Vanderbilt Vision Research Center and Vanderbilt University Center for Integrative & Cognitive Neuroscience to A.W.R.	BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bonhoeffer Tobias, 1996, P55; Chen LM, 2002, J NEUROSCI METH, V113, P41, DOI 10.1016/S0165-0270(01)00475-7; Conway BR, 2007, NEURON, V56, P560, DOI 10.1016/j.neuron.2007.10.008; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; Dobkins KR, 2000, J OPT SOC AM A, V17, P545, DOI 10.1364/JOSAA.17.000545; Fize D, 2003, J NEUROSCI, V23, P7395; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; GATTASS R, 1988, J NEUROSCI, V8, P1831; Ghose GM, 1997, J NEUROPHYSIOL, V77, P2191, DOI 10.1152/jn.1997.77.4.2191; Harada T, 2009, EUR J NEUROSCI, V30, P1960, DOI 10.1111/j.1460-9568.2009.06995.x; Hayden BY, 2005, NEURON, V47, P637, DOI 10.1016/j.neuron.2005.07.020; HUBEL DH, 1987, J NEUROSCI, V7, P3378; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; Huettel S., 2004, FUNCTIONAL MAGNETIC; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Koida K, 2007, NAT NEUROSCI, V10, P108, DOI 10.1038/nn1823; Kotake Y, 2009, J NEUROPHYSIOL, V102, P15, DOI 10.1152/jn.90624.2008; KRUGER J, 1980, J NEUROPHYSIOL, V43, P1055, DOI 10.1152/jn.1980.43.4.1055; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Lu HD, 2008, CEREB CORTEX, V18, P516, DOI 10.1093/cercor/bhm081; MAGUIRE WM, 1984, J NEUROSCI, V4, P1690; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; ROE AW, 1995, J NEUROSCI, V15, P3689; SCHEIN SJ, 1982, J NEUROPHYSIOL, V47, P193, DOI 10.1152/jn.1982.47.2.193; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Stepniewska I, 2005, CEREB CORTEX, V15, P809, DOI 10.1093/cercor/bhh182; TANAKA M, 1986, EXP BRAIN RES, V65, P11; Tootell RBH, 2004, CEREB CORTEX, V14, P353, DOI 10.1093/cercor/bhh001; Vanduffel W, 2002, CEREB CORTEX, V12, P647, DOI 10.1093/cercor/12.6.647; VANESSEN DC, 1978, J PHYSIOL-LONDON, V277, P193; Vanzetta I, 2004, NEURON, V42, P843, DOI 10.1016/j.neuron.2004.04.004; Wang Y, 2007, CEREB CORTEX, V17, P116, DOI 10.1093/cercor/bhj131; Xiao YP, 2007, NEUROIMAGE, V35, P771, DOI 10.1016/j.neuroimage.2006.11.059; Xiao YP, 1999, CEREB CORTEX, V9, P792, DOI 10.1093/cercor/9.8.792; Xiao YP, 2003, NATURE, V421, P535, DOI 10.1038/nature01372; Xu XM, 2004, J NEUROSCI, V24, P6237, DOI 10.1523/JNEUROSCI.1144-04.2004; ZEKI S, 1983, PROC R SOC SER B-BIO, V217, P449, DOI 10.1098/rspb.1983.0020; ZEKI SM, 1973, BRAIN RES, V53, P422, DOI 10.1016/0006-8993(73)90227-8; ZEKI SM, 1971, BRAIN RES, V34, P19, DOI 10.1016/0006-8993(71)90348-9; Zhan CA, 2006, CEREB CORTEX, V16, P896, DOI 10.1093/cercor/bhj033	47	119	119	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1542	U135		10.1038/nn.2676	http://dx.doi.org/10.1038/nn.2676			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21076422	Green Accepted			2022-12-17	WOS:000284525800020
J	Clayton, EL; Sue, N; Smillie, KJ; O'Leary, T; Bache, N; Cheung, G; Cole, AR; Wyllie, DJ; Sutherland, C; Robinson, PJ; Cousin, MA				Clayton, Emma L.; Sue, Nancy; Smillie, Karen J.; O'Leary, Timothy; Bache, Nicolai; Cheung, Giselle; Cole, Adam R.; Wyllie, David J.; Sutherland, Calum; Robinson, Phillip J.; Cousin, Michael A.			Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles	NATURE NEUROSCIENCE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; MEMBRANE RETRIEVAL; STIMULATION; INHIBITORS; DISCOVERY; CDK5; VIVO; WNT	Glycogen synthase kinase 3 (GSK3) is a critical enzyme in neuronal physiology; however, it is not yet known whether it has any specific role in presynaptic function. We found that GSK3 phosphorylates a residue on the large GTPase dynamin I (Ser-774) both in vitro and in primary rat neuronal cultures. This was dependent on prior phosphorylation of Ser-778 by cyclin-dependent kinase 5. Using both acute inhibition with pharmacological antagonists and silencing of expression with short hairpin RNA, we found that GSK3 was specifically required for activity-dependent bulk endocytosis (ADBE) but not clathrin-mediated endocytosis. Moreover we found that the specific phosphorylation of Ser-774 on dynamin I by GSK3 was both necessary and sufficient for ADBE. These results demonstrate a presynaptic role for GSK3 and they indicate that a protein kinase signaling cascade prepares synaptic vesicles for retrieval during elevated neuronal activity.	[Clayton, Emma L.; Smillie, Karen J.; O'Leary, Timothy; Cheung, Giselle; Wyllie, David J.; Cousin, Michael A.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Sue, Nancy; Bache, Nicolai; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Sydney, NSW 2006, Australia; [Cole, Adam R.; Sutherland, Calum] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland	University of Edinburgh; Children's Medical Research Institute - Australia; University of Sydney; University of Dundee	Cousin, MA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	m.cousin@ed.ac.uk	Robinson, Phillip J/G-4008-2011; Wyllie, David J A/AAK-4678-2021; Cole, Adam/B-9785-2011	Robinson, Phillip J/0000-0002-7878-0313; Wyllie, David J A/0000-0002-4957-6049; Smillie, Karen/0000-0003-4369-0470; O'Leary, Timothy/0000-0002-1029-0158; Clayton, Emma/0000-0003-0937-2874; Cousin, Michael/0000-0002-1762-160X; Cheung, Giselle/0000-0001-8457-2572; Sutherland, Calum/0000-0003-4398-7434	Wellcome Trust [070569, 084277]; Epilepsy Research UK [0503]; Cancer Institute NSW; Ramaciotti Foundation; Australian National Health and Medical Research Council; Alzheimer's Research Trust [ART/PG2007/4]; MRC [88158]; Danish Agency for Science, Technology and Innovation [274-08-0066]; Australian NHMRC [454886]; Alzheimers Research UK [ART-PG2005-1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [C18727] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Epilepsy Research UK; Cancer Institute NSW; Ramaciotti Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Alzheimer's Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Agency for Science, Technology and Innovation; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We wish to thank A. Prescott and J. James (both University of Dundee) for excellent technical assistance. This work was supported by grants from the Wellcome Trust (Ref: 070569 & 084277), Epilepsy Research UK (0503), Cancer Institute NSW, The Ramaciotti Foundation, and the Australian National Health and Medical Research Council. C.S. is supported by the Alzheimer's Research Trust (ART/PG2007/4) and the MRC (88158). N.B. is supported by the Danish Agency for Science, Technology and Innovation (grant 274-08-0066). A.R.C. is supported by an Australian NH&MRC Peter Doherty Fellowship (454886).	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Andersson F, 2008, J NEUROSCI, V28, P3925, DOI 10.1523/JNEUROSCI.1754-07.2008; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Evans GJO, 2007, J NEUROSCI, V27, P401, DOI 10.1523/JNEUROSCI.3809-06.2007; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Graham ME, 2007, J BIOL CHEM, V282, P14695, DOI 10.1074/jbc.M609713200; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Hongisto V, 2008, MOL CELL BIOL, V28, P1515, DOI 10.1128/MCB.02227-06; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Teng HB, 2007, J PHYSIOL-LONDON, V582, P243, DOI 10.1113/jphysiol.2007.130989; Wagman AS, 2004, CURR PHARM DESIGN, V10, P1105, DOI 10.2174/1381612043452668; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Zhu YL, 2009, NEURON, V61, P397, DOI 10.1016/j.neuron.2008.12.024	31	119	123	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					845	U85		10.1038/nn.2571	http://dx.doi.org/10.1038/nn.2571			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20526333	Green Accepted, Green Submitted			2022-12-17	WOS:000279173900017
J	Mathews, PJ; Jercog, PE; Rinzel, J; Scott, LL; Golding, NL				Mathews, Paul J.; Jercog, Pablo E.; Rinzel, John; Scott, Luisa L.; Golding, Nace L.			Control of submillisecond synaptic timing in binaural coincidence detectors by K(v)1 channels	NATURE NEUROSCIENCE			English	Article							MEDIAL SUPERIOR OLIVE; VENTRAL COCHLEAR NUCLEUS; THRESHOLD POTASSIUM CURRENTS; INACTIVATING K+ CURRENT; SOUND LOCALIZATION; PRINCIPAL NEURONS; TEMPORAL INTEGRATION; PYRAMIDAL NEURONS; AUDITORY NEURONS; OCTOPUS CELLS	Neurons in the medial superior olive process sound-localization cues via binaural coincidence detection, in which excitatory synaptic inputs from each ear are segregated onto different branches of a bipolar dendritic structure and summed at the soma and axon with submillisecond time resolution. Although synaptic timing and dynamics critically shape this computation, synaptic interactions with intrinsic ion channels have received less attention. Using paired somatic and dendritic patch-clamp recordings in gerbil brainstem slices together with compartmental modeling, we found that activation of K(v)1 channels by dendritic excitatory postsynaptic potentials (EPSPs) accelerated membrane repolarization in a voltage-dependent manner and actively improved the time resolution of synaptic integration. We found that a somatically biased gradient of K(v)1 channels underlies the degree of compensation for passive cable filtering during propagation of EPSPs in dendrites. Thus, both the spatial distribution and properties of K(v)1 channels are important for preserving binaural synaptic timing.	[Mathews, Paul J.; Scott, Luisa L.; Golding, Nace L.] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; [Mathews, Paul J.; Scott, Luisa L.; Golding, Nace L.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Jercog, Pablo E.; Rinzel, John] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Rinzel, John] NYU, Courant Inst Math Sci, New York, NY USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; New York University; New York University	Golding, NL (corresponding author), Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA.	golding@mail.utexas.edu	Mathews, Paul J./J-5516-2019; MATHEWS, PAUL/ABD-5504-2021; Jercog, Pablo E/A-8973-2018	MATHEWS, PAUL/0000-0002-1991-0798; Jercog, Pablo E/0000-0001-7852-5884	US National Institutes of Health [DC006877, DC008543]; Ruth Kirschstein National Research Service; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006877, R01DC008543] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Johnston and A. Reyes for their comments on a previous version of the manuscript. This work was supported by grants from the US National Institutes of Health (DC006877 to N.L.G. and DC008543 to J.R.) and Ruth Kirschstein National Research Service Awards to P.J.M and L. L. S.	Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; Allen PD, 2008, HEARING RES, V246, P52, DOI 10.1016/j.heares.2008.09.009; Ashida G, 2007, J NEUROPHYSIOL, V97, P2267, DOI 10.1152/jn.00399.2006; Barnes-Davies M, 2004, EUR J NEUROSCI, V19, P325, DOI 10.1111/j.0953-816X.2003.03133.x; Bekkers JM, 2001, J NEUROSCI, V21, P6553, DOI 10.1523/JNEUROSCI.21-17-06553.2001; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brew HM, 2003, J PHYSIOL-LONDON, V548, P1, DOI 10.1113/jphysiol.2002.035568; Brew HM, 1995, J NEUROSCI, V15, P8011; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; Dasika VK, 2007, J NEUROPHYSIOL, V97, P3449, DOI 10.1152/jn.00669.2005; Ferragamo MJ, 2002, J NEUROPHYSIOL, V87, P2262, DOI 10.1152/jn.00587.2001; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Grau-Serrat V, 2003, BIOL CYBERN, V89, P388, DOI 10.1007/s00422-003-0444-4; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; HOPKINS WF, 1994, PFLUG ARCH EUR J PHY, V428, P382, DOI 10.1007/BF00724522; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Joris P, 2007, TRENDS NEUROSCI, V30, P70, DOI 10.1016/j.tins.2006.12.004; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; McGinley MJ, 2006, HEARING RES, V216, P52, DOI 10.1016/j.heares.2006.02.006; McKay BE, 2005, J NEUROSCI, V25, P1481, DOI 10.1523/JNEUROSCI.3523-04.2005; Metz AE, 2007, J PHYSIOL-LONDON, V581, P175, DOI 10.1113/jphysiol.2006.127068; Oertel D, 2000, P NATL ACAD SCI USA, V97, P11773, DOI 10.1073/pnas.97.22.11773; Rathouz M, 1998, J NEUROPHYSIOL, V80, P2824, DOI 10.1152/jn.1998.80.6.2824; REYES AD, 1994, J NEUROSCI, V14, P5352; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3083, DOI 10.1152/jn.00126.2002; Scott LL, 2005, J NEUROSCI, V25, P7887, DOI 10.1523/JNEUROSCI.1016-05.2005; Scott LL, 2007, J PHYSIOL-LONDON, V583, P647, DOI 10.1113/jphysiol.2007.136366; Scott LL, 2010, J NEUROSCI, V30, P2039, DOI 10.1523/JNEUROSCI.2385-09.2010; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Segev I., 1998, COMPUT MATH APPL, DOI [10.1016/s0898-1221(98)91179-8, DOI 10.1016/S0898-1221(98)91179-8]; SHENG M, 1994, J NEUROSCI, V14, P2408; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Sokolov MV, 2007, NEUROPHARMACOLOGY, V53, P272, DOI 10.1016/j.neuropharm.2007.05.008; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; STOTLER WA, 1953, J COMP NEUROL, V98, P401, DOI 10.1002/cne.900980303; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Svirskis G, 2004, J NEUROPHYSIOL, V91, P2465, DOI 10.1152/jn.00717.2003; Svirskis G, 2002, J NEUROSCI, V22, P11019; WANG H, 1994, J NEUROSCI, V14, P4588; Willms AR, 2002, J NEUROSCI METH, V121, P139, DOI 10.1016/S0165-0270(02)00227-3; Yamada R, 2005, J NEUROSCI, V25, P8867, DOI 10.1523/JNEUROSCI.2541-05.2005; Zhou Y, 2005, J NEUROSCI, V25, P3046, DOI 10.1523/JNEUROSCI.3064-04.2005	48	119	119	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					601	U115		10.1038/nn.2530	http://dx.doi.org/10.1038/nn.2530			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20364143	Green Accepted			2022-12-17	WOS:000277065700018
J	Muraguchi, T; Takegami, Y; Ohtsuka, T; Kitajima, S; Chandana, EPS; Omura, A; Miki, T; Takahashi, R; Matsumoto, N; Ludwig, A; Noda, M; Takahashi, C				Muraguchi, Teruyuki; Takegami, Yujiro; Ohtsuka, Toshiyuki; Kitajima, Shunsuke; Chandana, Ediriweera P. S.; Omura, Akira; Miki, Takao; Takahashi, Rei; Matsumoto, Naoya; Ludwig, Andreas; Noda, Makoto; Takahashi, Chiaki			RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity	NATURE NEUROSCIENCE			English	Article							CELL-CELL ADHESION; METALLOPROTEINASE INHIBITORS; MATRIX-METALLOPROTEINASE; ALPHA-SECRETASE; DOWN-REGULATION; NERVOUS-SYSTEM; KEY REGULATOR; STEM-CELLS; CLEAVAGE; GENES	We report that during cortical development in the mouse embryo, reversion-inducing cysteine-rich protein with Kazal motifs (RECK) critically regulates Notch signaling by antagonizing the ectodomain shedding of Notch ligands, which is mediated by a disintegrin and metalloproteinase domain 10 (ADAM10). In the embryonic brain, RECK is specifically expressed in Nest-inpositive neural precursor cells (NPCs). Reck-deficient NPCs undergo precocious differentiation that is associated with downregulated Nestin expression, impaired Notch signaling and defective self-renewal. These phenotypes were substantially rescued either by enhancing Notch signaling or by suppressing endogenous ADAM10 activity. Consequently, we found that RECK regulates the ectodomain shedding of Notch ligands by directly inhibiting the proteolytic activity of ADAM10. This mechanism appeared to be essential for Notch ligands to properly induce Notch signaling in neighboring cells. These findings indicate that RECK is a physiological inhibitor of ADAM10, an upstream regulator of Notch signaling and a critical modulator of brain development.	Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto 606, Japan; Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 606, Japan; Kyoto Univ, Grad Sch Med, Dept Anat & Neurobiol, Kyoto 606, Japan; Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Cardiovasc Res IMCAR, D-52074 Aachen, Germany; Kanazawa Univ, Canc Res Inst, Ctr Canc & Stem Cell Res, Div Mol Genet, Kanazawa, Ishikawa 920, Japan	Kyoto University; Kyoto University; Kyoto University; RWTH Aachen University; RWTH Aachen University Hospital; Kanazawa University	Takahashi, C (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 606, Japan.	chtakaha@virus.kyoto-u.ac.jp	Ludwig, Andreas/I-5685-2012	Ludwig, Andreas/0000-0001-8536-4986				Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Bland CE, 2003, J BIOL CHEM, V278, P13607, DOI 10.1074/jbc.C300016200; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CACCAMO DV, 1989, AM J PATHOL, V135, P801; Chang HC, 2007, CANCER SCI, V98, P169, DOI 10.1111/j.1349-7006.2006.00367.x; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Echizenya M, 2005, ONCOGENE, V24, P5850, DOI 10.1038/sj.onc.1208733; EHEBAUER M, 2006, SCI STKE; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Han W, 2000, BLOOD, V95, P1616, DOI 10.1182/blood.V95.5.1616.005k31_1616_1625; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Karkkainen I, 2000, MOL CELL NEUROSCI, V15, P547, DOI 10.1006/mcne.2000.0848; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Miki T, 2007, J BIOL CHEM, V282, P12341, DOI 10.1074/jbc.M610948200; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; NYE JS, 1994, DEVELOPMENT, V120, P2421; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Oh J, 2004, ONCOGENE, V23, P5041, DOI 10.1038/sj.onc.1207688; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Small D, 2001, J BIOL CHEM, V276, P32022, DOI 10.1074/jbc.M100933200; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004	50	119	121	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					838	845		10.1038/nn1922	http://dx.doi.org/10.1038/nn1922			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558399	Green Submitted			2022-12-17	WOS:000247560200013
J	Rodriguez, J; Esteve, P; Weinl, C; Ruiz, JM; Fermin, Y; Trousse, F; Dwivedy, A; Holt, C; Bovolenta, P				Rodriguez, J; Esteve, P; Weinl, C; Ruiz, JM; Fermin, Y; Trousse, F; Dwivedy, A; Holt, C; Bovolenta, P			SFRP1 regulates the growth of retinal ganglion cell axons through the Fz2 receptor	NATURE NEUROSCIENCE			English	Article							NEGATIVE FEEDBACK REGULATOR; WNT; PROTEIN; GUIDANCE; PATHWAY; MODULATION; EXPRESSION; GENES; DIFFERENTIATION; IDENTIFICATION	Axon growth is governed by the ability of growth cones to interpret attractive and repulsive guidance cues. Recent studies have shown that secreted signaling molecules known as morphogens can also act as axon guidance cues. Of the large family of Wnt signaling components, only Wnt4 and Wnt5 seem to participate directly in axon guidance. Here we show that secreted Frizzled-related protein 1 (SFRP1), a proposed Wnt signaling inhibitor, can directly modify and reorient the growth of chick and Xenopus laevis retinal ganglion cell axons. This activity does not require Wnt inhibition and is modulated by extracellular matrix molecules. Intracellularly, SFRP1 function requires G(alpha) protein activation, protein synthesis and degradation, and it is modulated by cyclic nucleotide levels. Because SFRP1 interacts with Frizzled-2 (Fz2) and interference with Fz2 expression abolishes growth cone responses to SFRP1, we propose a previously unknown function for this molecule: the ability to guide growth cone movement via the Fz2 receptor.	CSIC, Inst Cajal, Dept Neurobiol Desarrollo, E-28002 Madrid, Spain; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); University of Cambridge	Bovolenta, P (corresponding author), CSIC, Inst Cajal, Dept Neurobiol Desarrollo, Dr Arce 37, E-28002 Madrid, Spain.	bovolenta@cajal.csic.es		Holt, Christine Elizabeth/0000-0003-2829-121X; , francoise/0000-0002-6354-3331	Wellcome Trust [070568] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chapman SC, 2004, DEV DYNAM, V229, P668, DOI 10.1002/dvdy.10491; Chong JM, 2002, J BIOL CHEM, V277, P5134, DOI 10.1074/jbc.M108533200; Chuman Y, 2004, PEPTIDES, V25, P1831, DOI 10.1016/j.peptides.2004.07.010; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Collavin L, 2003, DEVELOPMENT, V130, P805, DOI 10.1242/dev.00306; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Deiner MS, 1999, J NEUROSCI, V19, P9900; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Esteve P, 2000, MECH DEVELOP, V97, P217, DOI 10.1016/S0925-4773(00)00421-4; Esteve P, 2004, MECH DEVELOP, V121, P687, DOI 10.1016/j.mod.2004.03.003; Esteve P, 2003, J CELL SCI, V116, P2471, DOI 10.1242/jcs.00452; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Irie A, 2002, DEVELOPMENT, V129, P61; Jin EJ, 2002, MECH DEVELOP, V116, P173, DOI 10.1016/S0925-4773(02)00128-4; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kubo F, 2003, DEVELOPMENT, V130, P587, DOI 10.1242/dev.00244; Kuhl M, 2004, FRONT BIOSCI-LANDMRK, V9, P967; Lee JL, 2004, J BIOL CHEM, V279, P14602, DOI 10.1074/jbc.M309008200; Lim YS, 2002, J NEUROSCI, V22, P7080; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Morissette N, 1995, J NEUROSCI, V15, P8067; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Sanchez-Camacho C, 2005, BRAIN RES REV, V49, P242, DOI 10.1016/j.brainresrev.2004.10.004; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Trousse F, 2001, DEVELOPMENT, V128, P3927; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; van Horck FPG, 2004, CURR OPIN NEUROBIOL, V14, P61, DOI 10.1016/j.conb.2004.01.002; Wang HY, 2004, CELL MOL LIFE SCI, V61, P69, DOI 10.1007/s00018-003-3165-x; Wang YS, 2002, J NEUROSCI, V22, P8563; Weinl C, 2003, DEVELOPMENT, V130, P1635, DOI 10.1242/dev.00386; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Xu QH, 1998, DEVELOPMENT, V125, P4767; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	50	119	121	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1301	1309		10.1038/nn1547	http://dx.doi.org/10.1038/nn1547			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16172602				2022-12-17	WOS:000232145900013
J	Di Cristo, G; Wu, CZ; Chattopadhyaya, B; Ango, F; Enott, G; Welker, E; Svoboda, K; Huang, ZJ				Di Cristo, G; Wu, CZ; Chattopadhyaya, B; Ango, F; Enott, G; Welker, E; Svoboda, K; Huang, ZJ			Subcellular domain-restricted GABAergic innervation in primary visual cortex in the absence of sensory and thalamic inputs	NATURE NEUROSCIENCE			English	Article							INTERNEURONS; HIPPOCAMPUS; INHIBITION; EXPERIENCE; SUBTYPES; NEURONS	Distinct classes of GABAergic synapses target restricted subcellular domains, thereby differentially regulating the input, integration and output of principal neurons, but the underlying mechanism for such synapse segregation is unclear. Here we show that the distributions of two major classes of GABAergic synapses along the perisomatic and dendritic domains of pyramidal neurons were indistinguishable between primary visual cortex in vivo and cortical organotypic cultures. Therefore, subcellular synapse targeting is independent of thalamic input and probably involves molecular labels and experience-independent forms of activity.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Stony Brook, NY 11790 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Lausanne	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu		Huang, Z. Josh/0000-0003-0592-028X; Knott, Graham W/0000-0002-2956-9052; Ango, Fabrice/0000-0002-5548-209X	NEI NIH HHS [R01 EY 13564-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013564] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CHATTOPADHYAYA B, IN PRESS J NEUROSCI; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123	15	119	119	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1184	1186		10.1038/nn1334	http://dx.doi.org/10.1038/nn1334			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15475951				2022-12-17	WOS:000224749400008
J	Watt, AJ; Sjostrom, PJ; Hausser, M; Nelson, SB; Turrigiano, GG				Watt, AJ; Sjostrom, PJ; Hausser, M; Nelson, SB; Turrigiano, GG			A proportional but slower NMDA potentiation follows AMPA potentiation in LTP	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; PYRAMIDAL NEURONS; SYNAPTIC ACTIVITY; SILENT SYNAPSES; NEOCORTICAL SYNAPSES; SURFACE EXPRESSION; VISUAL-CORTEX; ACTIVATION	Most excitatory glutamatergic synapses contain both AMPA and NMDA receptors, but whether these receptors are regulated together or independently during synaptic plasticity has been controversial. Although long-term potentiation (LTP) is thought to selectively enhance AMPA currents and alter the NMDA-to-AMPA ratio, this ratio is well conserved across synapses onto the same neuron. This suggests that the NMDA-to-AMPA ratio is only transiently perturbed by LTP. To test this, we induced LTP at rat neocortical synapses and recorded mixed AMPA-NMDA currents. We observed rapid LTP of AMPA currents, as well as delayed potentiation of NMDA currents that required previous AMPA potentiation. The delayed potentiation of NMDA currents restored the original NMDA-to-AMPA ratio within 2 h of LTP induction. These data suggest that recruitment of AMPA receptors to synapses eventually induces a proportional increase in NMDA current. This may ensure that LTP does not alter the relative contributions of these two receptors to synaptic transmission and information processing.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England	Brandeis University; Brandeis University; University of London; University College London; University of London; University College London	Turrigiano, GG (corresponding author), Brandeis Univ, Dept Biol, MS 08,415 South St, Waltham, MA 02454 USA.	turrigiano@brandeis.edu	Sjöström, Per Jesper/B-9696-2019; Hausser, Michael/AAW-6827-2020	Sjöström, Per Jesper/0000-0001-7085-2223; Hausser, Michael/0000-0002-2673-8957; Nelson, Sacha/0000-0002-0108-8599; Watt, Alanna/0000-0002-6371-6220	NEI NIH HHS [EY11116] Funding Source: Medline; NINDS NIH HHS [NS36853] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036853, R56NS036853] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alagarsamy S, 2001, CURR OPIN NEUROBIOL, V11, P357, DOI 10.1016/S0959-4388(00)00219-1; Aniksztejn L, 1995, J NEUROPHYSIOL, V74, P2349, DOI 10.1152/jn.1995.74.6.2349; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BERRETTA N, 1991, EUR J NEUROSCI, V3, P850, DOI 10.1111/j.1460-9568.1991.tb00096.x; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fitzjohn SM, 2001, NEUROPHARMACOLOGY, V41, P693, DOI 10.1016/S0028-3908(01)00128-9; Groc L, 2002, J NEUROSCI, V22, P5552; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Lambolez B, 1996, P NATL ACAD SCI USA, V93, P1797, DOI 10.1073/pnas.93.5.1797; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; Myme CIO, 2003, J NEUROPHYSIOL, V90, P771, DOI 10.1152/jn.00070.2003; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Pratt KG, 2003, NEURON, V39, P269, DOI 10.1016/S0896-6273(03)00422-7; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rivadulla C, 2001, J NEUROSCI, V21, P1710, DOI 10.1523/JNEUROSCI.21-05-01710.2001; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Umemiya M, 1999, J PHYSIOL-LONDON, V521, P113, DOI 10.1111/j.1469-7793.1999.00113.x; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; XIAO MY, 1995, NEUROSCIENCE, V68, P625, DOI 10.1016/0306-4522(95)00173-G	50	119	124	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					518	524		10.1038/nn1220	http://dx.doi.org/10.1038/nn1220			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15048122				2022-12-17	WOS:000221101300029
J	Li, RW; Levi, DM; Klein, SA				Li, RW; Levi, DM; Klein, SA			Perceptual learning improves efficiency by re-tuning the decision 'template' for position discrimination	NATURE NEUROSCIENCE			English	Article							ORIENTATION	Visual position discrimination improves with practice; however, the mechanism(s) underlying this improvement are not yet known. We used positional noise to explore the underlying neural mechanisms and found that position discrimination improved with practice over a range of noise levels. This improvement can be largely explained by an increasing efficiency with which observers used positional information in the stimulus. In a second experiment, we tested the hypothesis that the improved efficiency reflects a re-tuning of the observers' perceptual 'template'-the weightings of inputs from basic visual mechanisms to more closely match the ideal template required to perform the perceptual task. Using a new technique to measure which parts of the stimulus influenced the observer's performance, we were able to record the re-tuning of the decision template across training sessions; we found a robust and steady increase in template efficiency during learning.	Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Levi, DM (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	dlevi@uclink.berkeley.edu	Levi, Dennis/J-7836-2019	Levi, Dennis/0000-0002-5350-8639; Li, Roger/0000-0002-1666-0543	NEI NIH HHS [R01EY01728] Funding Source: Medline; PHS HHS [R0104776] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY001728] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; VOGELS R, 1985, VISION RES, V25, P1679, DOI 10.1016/0042-6989(85)90140-3	2	119	123	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					178	183		10.1038/nn1183	http://dx.doi.org/10.1038/nn1183			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14730311				2022-12-17	WOS:000188468500016
J	Beg, AA; Jorgensen, EM				Beg, AA; Jorgensen, EM			EXP-1 is an excitatory GABA-gated cation channel	NATURE NEUROSCIENCE			English	Article							GAMMA-AMINOBUTYRIC-ACID; ACETYLCHOLINE-RECEPTOR CHANNEL; CAENORHABDITIS-ELEGANS; GLYCINE RECEPTOR; ION CHANNELS; AMINO-ACID; NICOTINIC RECEPTOR; ALPHA(1) SUBUNIT; POINT MUTATIONS; LINING RESIDUES	gamma-aminobutyric acid (GABA) mediates fast inhibitory neurotransmission by activating anion-selective ligand-gated ion channels. Although electrophysiological studies indicate that GABA may activate cation-selective ligand-gated ion channels in some cell types, such a channel has never been characterized at the molecular level. Here we show that GABA mediates enteric muscle contraction in the nematode Caenorhabditis elegans via the EXP-1 receptor, a cation-selective ligand-gated ion channel. The EXP-1 protein resembles ionotropic GABA receptor subunits in almost all domains. In the pore-forming domain of EXP-1, however, the residues that confer anion selectivity are exchanged for those that specify cation selectivity. When expressed in Xenopus laevis oocytes, EXP-1 forms a GABA receptor that is permeable to cations and not anions. We conclude that some of the excitatory functions assigned to GABA are mediated by cation channels rather than by anion channels.	Univ Utah, Neurosci Program, Salt Lake City, UT 84112 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Neurosci Program, 257 South 1400 East, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu						AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Bamber BA, 1999, J NEUROSCI, V19, P5348; BARNARD EA, 1995, ADV BIOCHEM PSYCHOPH, V48, P1; BENARI Y, 1990, PROG BRAIN RES, V83, P313; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; Boileau AJ, 1999, J NEUROSCI, V19, P4847; Boileau AJ, 2002, J BIOL CHEM, V277, P2931, DOI 10.1074/jbc.M109334200; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; CLARK SG, 1994, GENETICS, V137, P987; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Goldmakher GV, 2000, BRAIN RES, V871, P7, DOI 10.1016/S0006-8993(00)02282-4; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; GURLEY D, 1995, RECEPTOR CHANNEL, V3, P13; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jin YS, 1999, J NEUROSCI, V19, P539; Kaila K, 1997, J NEUROSCI, V17, P7662; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; Keramidas A, 2002, J GEN PHYSIOL, V119, P393, DOI 10.1085/jgp.20028552; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; LESTER HA, 1992, ANNU REV BIOPH BIOM, V21, P267, DOI 10.1146/annurev.bb.21.060192.001411; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moorhouse AJ, 2002, J GEN PHYSIOL, V119, P411, DOI 10.1085/jgp.20028553; Norekian TP, 1999, J NEUROSCI, V19, P1863; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Perkins KL, 1999, J NEUROPHYSIOL, V82, P768, DOI 10.1152/jn.1999.82.2.768; REINER DJ, 1995, J NEUROSCI, V15, P6094; SIEGHART W, 1995, PHARMACOL REV, V47, P181; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Swensen AM, 2000, J EXP BIOL, V203, P2075; THOMAS JH, 1990, GENETICS, V124, P855; VARANDA WA, 1985, MOL PHARMACOL, V28, P128; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001; WANG TL, 1995, P NATL ACAD SCI USA, V92, P11751, DOI 10.1073/pnas.92.25.11751; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2; Westh-Hansen SE, 1999, NEUROREPORT, V10, P2417, DOI 10.1097/00001756-199908020-00036; WesthHansen SE, 1997, EUR J PHARMACOL, V329, P253, DOI 10.1016/S0014-2999(97)89186-8; WHITE JG, 1983, COLD SPRING HARB SYM, V48, P633, DOI 10.1101/SQB.1983.048.01.067; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; YAROWSKY PJ, 1978, BRAIN RES, V144, P75, DOI 10.1016/0006-8993(78)90436-5; ZHANG DX, 1995, P NATL ACAD SCI USA, V92, P11756, DOI 10.1073/pnas.92.25.11756; Zhang W, 1997, GEN PHARMACOL-VASC S, V28, P45, DOI 10.1016/S0306-3623(96)00152-8	50	119	130	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1145	1152		10.1038/nn1136	http://dx.doi.org/10.1038/nn1136			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14555952				2022-12-17	WOS:000186229200013
J	Lee, HS; Nelms, JL; Nguyen, M; Silver, R; Lehman, MN				Lee, HS; Nelms, JL; Nguyen, M; Silver, R; Lehman, MN			The eye is necessary for a circadian rhythm in the suprachiasmatic nucleus	NATURE NEUROSCIENCE			English	Article							CALBINDIN-D-28K CELLS; PROTEIN-KINASE; MAP KINASE; HAMSTER; ACTIVATION; LIGHT		Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Program Neurosci, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Phys Sci Training Program, Cincinnati, OH 45267 USA; Columbia Univ, New York, NY 10027 USA; Barnard Coll, Dept Psychol, New York, NY 10027 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Columbia University	Lehman, MN (corresponding author), Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA.	michael.lehman@uc.edu	Jansen, Heiko T./A-5770-2008; Lehman, Michael/ABC-9076-2020	Jansen, Heiko T./0000-0003-0178-396X; Silver, Rae/0000-0001-8633-739X; Lehman, Michael/0000-0002-9076-5108				Bryant DN, 2000, J BIOL RHYTHM, V15, P103, DOI 10.1177/074873040001500204; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; CARD JP, 1984, NEUROSCIENCE, V13, P415, DOI 10.1016/0306-4522(84)90240-9; Hastings MH, 1997, TRENDS NEUROSCI, V20, P459, DOI 10.1016/S0166-2236(97)01087-4; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Lupi D, 1999, NEUROSCIENCE, V89, P363, DOI 10.1016/S0306-4522(98)00353-4; Matsumoto S, 1996, J BIOL RHYTHM, V11, P145, DOI 10.1177/074873049601100207; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Sanada K, 2000, J NEUROSCI, V20, P986, DOI 10.1523/JNEUROSCI.20-03-00986.2000; Silver R, 1996, NEUROREPORT, V7, P1224, DOI 10.1097/00001756-199604260-00026; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405	14	119	120	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					111	112		10.1038/nn1006	http://dx.doi.org/10.1038/nn1006			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536213				2022-12-17	WOS:000180669100007
J	Kao, HT; Song, HJ; Porton, B; Ming, GL; Hoh, J; Abraham, M; Czernik, AJ; Pieribone, VA; Poo, MM; Greengard, P				Kao, HT; Song, HJ; Porton, B; Ming, GL; Hoh, J; Abraham, M; Czernik, AJ; Pieribone, VA; Poo, MM; Greengard, P			A protein kinase A-dependent molecular switch in synapsins regulates neurite outgrowth	NATURE NEUROSCIENCE			English	Article							SYNAPTIC VESICLE PHOSPHOPROTEINS; GROWTH CONE GUIDANCE; NEUROTRANSMITTER RELEASE; NEURONAL DIFFERENTIATION; NEUROMUSCULAR SYNAPSES; ACTIN POLYMERIZATION; AXONAL GROWTH; PHOSPHORYLATION; CELLS; RAT	Cyclic AMP (cAMP) promotes neurite outgrowth in a variety of neuronal cell lines through the activation of protein kinase A (PKA). We show here, using both Xenopus laevis embryonic neuronal culture and intact X. laevis embryos, that the nerve growth-promoting action of cAMP/PKA is mediated in part by the phosphorylation of synapsins at a single amino acid residue. Expression of a mutated form of synapsin that prevents phosphorylation at this site, or introduction of phospho-specific antibodies directed against this site, decreased basal and dibutyryl cAMP-stimulated neurite outgrowth. Expression of a mutation mimicking constitutive phosphorylation at this site increased neurite outgrowth, both under basal conditions and in the presence of a PKA inhibitor. These results provide a potential molecular approach for stimulating neuron regeneration, after injury and in neuro-degenerative diseases.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; NYU, Med Ctr, Dept Psychiat, New York, NY 10016 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Yale Univ, Sch Med, John B Pierce Lab, New Haven, CT 06510 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Rockefeller University; Rockefeller University; New York University; Salk Institute; University of California System; University of California San Diego; Yale University; The John B Pierce Laboratory, Inc; University of California System; University of California Berkeley	Kao, HT (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.	kaoh@rockvax.rockefeller.edu	Ming, Guo-li/J-7880-2013	Pieribone, Vincent/0000-0002-5836-5454; Ming, Guo-li/0000-0002-2517-6075	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039327, R01MH039327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037831, R29NS035941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015072] Funding Source: NIH RePORTER; NIA NIH HHS [AG15072] Funding Source: Medline; NIMH NIH HHS [MH39327] Funding Source: Medline; NINDS NIH HHS [NS37831, R29 NS35941] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CACERES A, 1991, J NEUROSCI, V11, P1515; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; CZERNIK AJ, 1991, METHOD ENZYMOL, P264; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Esser L, 1998, EMBO J, V17, P977, DOI 10.1093/emboj/17.4.977; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Ferreira A, 2000, J NEUROSCI, V20, P3736, DOI 10.1523/JNEUROSCI.20-10-03736.2000; FERREIRA A, 1995, P NATL ACAD SCI USA, V92, P9225, DOI 10.1073/pnas.92.20.9225; FESCE R, 1992, J BIOL CHEM, V267, P11289; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GRANT P, 1986, DEV BIOL, V114, P475, DOI 10.1016/0012-1606(86)90212-5; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HAN HQ, 1991, NATURE, V349, P697, DOI 10.1038/349697a0; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Hosaka M, 1998, J BIOL CHEM, V273, P13371, DOI 10.1074/jbc.273.22.13371; Hosaka M, 1998, J BIOL CHEM, V273, P1425, DOI 10.1074/jbc.273.3.1425; JOHNSON EM, 1972, J BIOL CHEM, V247, P5650; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kao HT, 1999, J EXP ZOOL, V285, P360, DOI 10.1002/(SICI)1097-010X(19991215)285:4<360::AID-JEZ4>3.3.CO;2-V; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; LEVITAN IB, 1997, NEURON; LIESI P, 1983, NATURE, V306, P265, DOI 10.1038/306265a0; Lin WC, 1995, J NEUROSCI, V15, P8331; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; Lu B, 1996, NEUROSCIENCE, V74, P1087, DOI 10.1016/0306-4522(96)00187-X; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Nielander HB, 1997, EUR J NEUROSCI, V9, P2712, DOI 10.1111/j.1460-9568.1997.tb01700.x; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; PICCIOTTO MR, 1993, J BIOL CHEM, V268, P26512; Porton B, 1999, J NEUROCHEM, V73, P2266, DOI 10.1046/j.1471-4159.1999.0732266.x; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; SCHAEFFER E, 1994, P NATL ACAD SCI USA, V91, P3882, DOI 10.1073/pnas.91.9.3882; Sive HL, 2000, EARLY DEV XENOPUS LA; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Tabti N, 1998, CULTURING NERVE CELL, P237; Zhong ZG, 1999, NEUROSCI LETT, V260, P93, DOI 10.1016/S0304-3940(98)00969-0	45	119	124	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					431	437		10.1038/nn840	http://dx.doi.org/10.1038/nn840			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11976703				2022-12-17	WOS:000175272000013
J	Swadlow, HA; Gusev, AG				Swadlow, HA; Gusev, AG			Receptive-field construction in cortical inhibitory interneurons	NATURE NEUROSCIENCE			English	Article							AWAKE RABBIT; CORTEX; NEURONS		Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; Russian Acad Med Sci, Moscow Brain Res Inst, Moscow 103064, Russia	University of Connecticut; Russian Academy of Medical Sciences	Swadlow, HA (corresponding author), Univ Connecticut, Dept Psychol, 406 Babbidge Rd, Storrs, CT 06269 USA.	swadlow@psych.psy.uconn.edu			NIMH NIH HHS [MH64024] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064024] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; HARRIS RM, 1983, J COMP NEUROL, V220, P63, DOI 10.1002/cne.902200107; Krukowski AE, 2001, NAT NEUROSCI, V4, P424, DOI 10.1038/86084; Miller KD, 2001, CURR OPIN NEUROBIOL, V11, P488, DOI 10.1016/S0959-4388(00)00239-7; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; SWADLOW HA, 1989, J NEUROPHYSIOL, V62, P288, DOI 10.1152/jn.1989.62.1.288; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; Troyer TW, 1998, J NEUROSCI, V18, P5908; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	15	119	122	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					403	404		10.1038/nn847	http://dx.doi.org/10.1038/nn847			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11967546				2022-12-17	WOS:000175272000009
J	De Weerd, P; Peralta, MR; Desimone, R; Ungerleider, LG				De Weerd, P; Peralta, MR; Desimone, R; Ungerleider, LG			Loss of attentional stimulus selection after extrastriate cortical lesions in macaques	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; AREA V4; INFEROTEMPORAL CORTEX; VISUAL-SEARCH; SHAPE-DISCRIMINATION; NEURAL MECHANISMS; CEREBRAL-CORTEX; NEURONS; MONKEY; COLOR	Many objects in natural visual scenes compete for attention. To identify the neural mechanisms necessary for visual attention, we made restricted lesions, affecting different quadrants of the visual field but leaving one quadrant intact, in extrastriate cortical areas V4 and TEO of two monkeys. Monkeys were trained to discriminate the orientation of a target grating surrounded by distracters. As distracter contrast increased, performance deteriorated in quadrants affected by V4 and TEO lesions, but not in the normal quadrant. Performance in affected quadrants was restored by increasing the contrast of the target relative to distracters. Thus, without V4 and TEO, visual attention is 'captured' by strong stimuli, regardless of their behavioral relevance.	NIMH, Lab Brain Cognit, Bethesda, MD 20892 USA; NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	De Weerd, P (corresponding author), Univ Arizona, Coll Social & Behav Sci, Dept Psychol, POB 210068, Tucson, AZ 85721 USA.		Desimone, Robert/G-1121-2018					BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; BRITTEN KH, 1992, EXP BRAIN RES, V88, P292, DOI 10.1007/BF02259104; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; COWEY A, 1970, EXP BRAIN RES, V11, P128; DEAN P, 1976, PSYCHOL BULL, V83, P41, DOI 10.1037/0033-2909.83.1.41; DEAN P, 1978, EXP BRAIN RES, V32, P445; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DESIMONE R, 1980, BRAIN RES, V184, P41, DOI 10.1016/0006-8993(80)90586-7; Desimone R., 1989, HDB NEUROPSYCHOLOGY, P267; DeWeerd P, 1996, VISUAL NEUROSCI, V13, P529, DOI 10.1017/S0952523800008208; DISTLER C, 1993, J COMP NEUROL, V334, P125, DOI 10.1002/cne.903340111; DRIVER J, 1989, J EXP PSYCHOL HUMAN, V15, P448, DOI 10.1037/0096-1523.15.3.448; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GAFFAN D, 1986, Q J EXP PSYCHOL-B, V38, P5; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; GATTASS R, 1988, J NEUROSCI, V8, P1831; Groh JM, 1996, CURR BIOL, V6, P1406, DOI 10.1016/S0960-9822(96)00743-9; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HEYWOOD CA, 1992, J NEUROSCI, V12, P4056; IWAI E, 1969, EXP NEUROL, V25, P585, DOI 10.1016/0014-4886(69)90101-0; JULESZ B, 1986, BIOL CYBERN, V54, P245, DOI 10.1007/BF00318420; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; KOMATSU H, 1993, J NEUROPHYSIOL, V70, P677, DOI 10.1152/jn.1993.70.2.677; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Merigan WH, 1996, VISUAL NEUROSCI, V13, P51, DOI 10.1017/S0952523800007124; MIYASHITA Y, 1993, NEUROPSYCHOLOGIA, V31, P1119, DOI 10.1016/0028-3932(93)90036-Y; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; NAKAMURA H, 1993, J NEUROSCI, V13, P3681; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Reynolds JH, 1999, J NEUROSCI, V19, P1736; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; SCHEIN SJ, 1990, J NEUROSCI, V10, P3369; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; SCHILLER PH, 1993, VISUAL NEUROSCI, V10, P717, DOI 10.1017/S0952523800005423; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; WALSH V, 1992, BEHAV BRAIN RES, V50, P115, DOI 10.1016/S0166-4328(05)80293-1; WETHERILL GB, 1965, BRIT J MATH STAT PSY, V18, P1, DOI 10.1111/j.2044-8317.1965.tb00689.x; WILD HM, 1985, NATURE, V313, P133, DOI 10.1038/313133a0; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0	50	119	122	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					753	758		10.1038/11234	http://dx.doi.org/10.1038/11234			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FA	10412066				2022-12-17	WOS:000083882800016
J	Schreiber, M; Yuan, A; Salkoff, L				Schreiber, M; Yuan, A; Salkoff, L			Transplantable sites confer calcium sensitivity to BK channels	NATURE NEUROSCIENCE			English	Article							ACTIVATED POTASSIUM CHANNELS; CA-2+-ACTIVATED K+ CHANNELS; RAT SKELETAL-MUSCLE; N-BROMOACETAMIDE; HAIR-CELLS; VOLTAGE; DROSOPHILA; VARIANTS; DOMAIN; MSLO	Both intracellular calcium and voltage activate Slo1, a high-conductance potassium channel, linking calcium with electrical excitability. Using molecular techniques, we created a calcium-insensitive variant of this channel gated by voltage alone. Calcium sensitivity was restored by adding back small portions of the carboxyl (C)-terminal 'tail' domain. Two separate regions of the tail independently conferred different degrees of calcium sensitivity; together, they restored essentially wild-type calcium dependence. These results suggest that, in the absence of calcium, the Slo1 tail inhibits voltage-dependent gating, and that calcium removes this inhibition. Slo1 may have evolved from an ancestral voltage-sensitive potassium channel represented by the core; the tail may represent the more recent addition of a calcium-dependent modulatory domain.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Salkoff, L (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.			Yuan, Alex/0000-0003-0191-8035				ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CORNEJO M, 1987, J MEMBRANE BIOL, V99, P147, DOI 10.1007/BF01871234; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Cox DH, 1997, J GEN PHYSIOL, V109, P633, DOI 10.1085/jgp.109.5.633; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Dichiara TJ, 1995, J PHYSIOL-LONDON, V489, P403, DOI 10.1113/jphysiol.1995.sp021061; Fuchs P A, 1992, Curr Opin Neurobiol, V2, P457, DOI 10.1016/0959-4388(92)90180-S; GOLOWASCH J, 1986, J EXP BIOL, V124, P5; HILLE B, 1983, IONIC CHANNELS EXCIT; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KUME H, 1990, J PHYSIOL-LONDON, V424, P445, DOI 10.1113/jphysiol.1990.sp018076; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MCMANUS OB, 1991, J PHYSIOL-LONDON, V443, P739, DOI 10.1113/jphysiol.1991.sp018861; MCMANUS OB, 1988, J PHYSIOL-LONDON, V402, P79, DOI 10.1113/jphysiol.1988.sp017195; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; METHFESSEL C, 1982, BIOPHYS STRUCT MECH, V9, P35, DOI 10.1007/BF00536014; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; Moss GWJ, 1996, J GEN PHYSIOL, V108, P473, DOI 10.1085/jgp.108.6.473; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; PALLOTTA BS, 1985, J GEN PHYSIOL, V86, P601, DOI 10.1085/jgp.86.5.601; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Rosenblatt KP, 1997, NEURON, V19, P1061, DOI 10.1016/S0896-6273(00)80397-9; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TABCHARANI JA, 1989, BIOCHIM BIOPHYS ACTA, V982, P62, DOI 10.1016/0005-2736(89)90174-0; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; WU YC, 1995, PROG BIOPHYS MOL BIO, V63, P131, DOI 10.1016/0079-6107(95)00002-5	43	119	122	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					416	421		10.1038/8077	http://dx.doi.org/10.1038/8077			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321244				2022-12-17	WOS:000084609400010
J	Schafer, ST; Paquola, ACM; Stern, S; Gosselin, D; Ku, M; Pena, M; Kuret, TJM; Liyanage, M; Mansour, AA; Jaeger, BN; Marchetto, MC; Glass, CK; Mertens, J; Gage, FH				Schafer, Simon T.; Paquola, Apua C. M.; Stern, Shani; Gosselin, David; Ku, Manching; Pena, Monique; Kuret, Thomas J. M.; Liyanage, Marvin; Mansour, Abed AlFatah; Jaeger, Baptiste N.; Marchetto, Maria C.; Glass, Christopher K.; Mertens, Jerome; Gage, Fred H.			Pathological priming causes developmental gene network heterochronicity in autistic subject-derived neurons	NATURE NEUROSCIENCE			English	Article							EARLY BRAIN-DEVELOPMENT; CORTICAL DEVELOPMENT; INTEGRATIVE ANALYSIS; FUNCTIONAL-NEURONS; DIRECT CONVERSION; F-BOX; FIBROBLASTS; FRAMEWORK; TIME; DYSREGULATION	Autism spectrum disorder (ASD) is thought to emerge during early cortical development. However, the exact developmental stages and associated molecular networks that prime disease propensity are elusive. To profile early neurodevelopmental alterations in ASD with macrocephaly, we monitored subject-derived induced pluripotent stem cells (iPSCs) throughout the recapitulation of cortical development. Our analysis revealed ASD-associated changes in the maturational sequence of early neuron development, involving temporal dysregulation of specific gene networks and morphological growth acceleration. The observed changes tracked back to a pathologically primed stage in neural stem cells (NSCs), reflected by altered chromatin accessibility. Concerted over-representation of network factors in control NSCs was sufficient to trigger ASD-like features, and circumventing the NSC stage by direct conversion of ASD iPSCs into induced neurons abolished ASD-associated phenotypes. Our findings identify heterochronic dynamics of a gene network that, while established earlier in development, contributes to subsequent neurodevelopmental aberrations in ASD.	[Schafer, Simon T.; Paquola, Apua C. M.; Stern, Shani; Pena, Monique; Kuret, Thomas J. M.; Liyanage, Marvin; Mansour, Abed AlFatah; Jaeger, Baptiste N.; Marchetto, Maria C.; Mertens, Jerome; Gage, Fred H.] Salk Inst Biol Studies, Lab Genet, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Paquola, Apua C. M.] Lieber Inst Brain Dev, Baltimore, MD USA; [Paquola, Apua C. M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gosselin, David] Univ Laval, Fac Med, Dept Med Mol, Ctr Rech,Ctr Hosp Univ,Quebec, Quebec City, PQ, Canada; [Ku, Manching] Salk Inst Biol Studies, Next Generat Sequencing Core, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Ku, Manching] Univ Freiburg, Fac Med, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, Freiburg, Germany; [Jaeger, Baptiste N.] Univ Zurich, Fac Med, Brain Res Inst, Lab Neural Plastic, Zurich, Switzerland; [Jaeger, Baptiste N.] Univ Zurich, Fac Sci, Brain Res Inst, Lab Neural Plastic, Zurich, Switzerland; [Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Mertens, Jerome] Univ Innsbruck, Dept Genom Stem Cell Biol & Regenerat Med, Inst Mol Biol, Innsbruck, Austria; [Mertens, Jerome] Univ Innsbruck, CMBI, Innsbruck, Austria	Salk Institute; Johns Hopkins University; Laval University; Salk Institute; University of Freiburg; University of Geneva; University of Zurich; University of Zurich; University of California System; University of California San Diego; University of Innsbruck; University of Innsbruck	Gage, FH (corresponding author), Salk Inst Biol Studies, Lab Genet, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Mertens, Jerome/P-1931-2015; Glass, Christopher/AAI-3933-2021; mansour, abed/GWC-2134-2022	Mertens, Jerome/0000-0002-4291-4121; Glass, Christopher/0000-0003-4344-3592; Mansour, Abed AlFatah/0000-0001-9025-6998; Schafer, Simon/0000-0002-2370-3652; Stern, Shani/0000-0002-2644-7068; Jaeger, Baptiste N./0000-0001-8728-797X; Kuret, Thomas/0000-0003-3931-4923	Flow Cytometry Core Facility of the Salk Institute; NGS core facility of the Salk Institute; NIH-NCI [CCSG: P30 014195]; Chapman Foundation; Helmsley Charitable Trust; James S. McDonnell Foundation; G. Harold & Leila Y. Mathers Charitable Foundation; JPB Foundation; March of Dimes Foundation; NIH [MH095741, MH090258, RO3 MH115426-01A1]; Engman Foundation; Paul G. Allen Family Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2017-PGMED001]; German Research Foundation; Brain & Behavior Research Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH115426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS096170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG056306] Funding Source: NIH RePORTER	Flow Cytometry Core Facility of the Salk Institute; NGS core facility of the Salk Institute; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chapman Foundation; Helmsley Charitable Trust; James S. McDonnell Foundation; G. Harold & Leila Y. Mathers Charitable Foundation; JPB Foundation; March of Dimes Foundation(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Engman Foundation; Paul G. Allen Family Foundation; Leona M. and Harry B. Helmsley Charitable Trust; German Research Foundation(German Research Foundation (DFG)); Brain & Behavior Research Foundation(NARSAD); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the subjects who participated in this study. We also thank M.L. Gage and M. Pena for editorial comments; E. Courchesne for his contribution to fibroblast collection; L. Moore, A. Mendes, B. Miller, K. Rehder, A. Mar and K. Niedrig for technical assistance; K. Diffenderfer and the Salk STEM core facility for technical support; C. Fitzpatrick and C. O'Connor for help with flow cytometry; and T. Toda for helpful discussions. This work was supported by the Flow Cytometry Core Facility and the NGS core facility of the Salk Institute with funding from NIH-NCI CCSG: P30 014195, the Chapman Foundation and the Helmsley Charitable Trust. We also acknowledge support from The James S. McDonnell Foundation, G. Harold & Leila Y. Mathers Charitable Foundation, JPB Foundation, the March of Dimes Foundation, NIH (grant nos MH095741 and MH090258 to F.H.G. and RO3 MH115426-01A1 to M.C.M.), The Engman Foundation, Annette C. Merle-Smith, The Paul G. Allen Family Foundation and The Leona M. and Harry B. Helmsley Charitable Trust (grant no. 2017-PGMED001). S.T.S. was funded by a fellowship from the German Research Foundation and was recently awarded the NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation.	Aach J, 2001, BIOINFORMATICS, V17, P495, DOI 10.1093/bioinformatics/17.6.495; Abudureyimu S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24064-0; Allan Institute for Brain Science, 2016, ATL DEV HUM BRAIN BR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atkin G, 2015, J NEUROSCI, V35, P6165, DOI 10.1523/JNEUROSCI.3013-14.2015; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Briggs JA, 2017, ELIFE, V6, DOI 10.7554/eLife.26945; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Casanova MF, 2006, CLIN NEUROSCI RES, V6, P127, DOI 10.1016/j.cnr.2006.06.003; Casanova MF, 2002, NEUROLOGY, V58, P428, DOI 10.1212/WNL.58.3.428; Chomiak T, 2014, NEUROSCIENCE, V268, P212, DOI 10.1016/j.neuroscience.2014.02.049; Chomiak T, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-102; Chow ML, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002592; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; de la Torre-Ubieta L, 2016, NAT MED, V22, P345, DOI 10.1038/nm.4071; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Emerson RW, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2882; Erhardt JA, 1998, J BIOL CHEM, V273, P35222, DOI 10.1074/jbc.273.52.35222; Fishman VS, 2015, CELL CYCLE, V14, P1188, DOI 10.1080/15384101.2015.1012875; Giorgino T, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i07; Gupta S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6748; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; Hazlett HC, 2017, NATURE, V542, P348, DOI 10.1038/nature21369; Hazlett HC, 2011, ARCH GEN PSYCHIAT, V68, P467, DOI 10.1001/archgenpsychiatry.2011.39; Heger A, 2013, BIOINFORMATICS, V29, P2046, DOI 10.1093/bioinformatics/btt343; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HOSACK DA, 2003, GENOME BIOL, V4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lim ET, 2017, NAT NEUROSCI, V20, P1217, DOI 10.1038/nn.4598; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mandai K, 2014, NEURON, V83, P93, DOI 10.1016/j.neuron.2014.05.020; Marchetto MC, 2017, MOL PSYCHIATR, V22, P820, DOI 10.1038/mp.2016.95; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Parikshak NN, 2016, NATURE, V540, P423, DOI 10.1038/nature20612; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Stein JL, 2014, NEURON, V83, P69, DOI 10.1016/j.neuron.2014.05.035; Sun WJ, 2016, CELL, V167, P1385, DOI 10.1016/j.cell.2016.10.031; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Toma K, 2016, DEV GROWTH DIFFER, V58, P59, DOI 10.1111/dgd.12257; VELICHKO VM, 1970, INT J MAN MACH STUD, V2, P223, DOI 10.1016/S0020-7373(70)80008-6; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vitucci D, 2016, NEUROPSYCHOPHARMACOL, V41, P916, DOI 10.1038/npp.2015.228; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Weir RK, 2018, J COMP NEUROL, V526, P262, DOI 10.1002/cne.24332; Wilczynski B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002798; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	71	118	119	8	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2019	22	2					243	+		10.1038/s41593-018-0295-x	http://dx.doi.org/10.1038/s41593-018-0295-x			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI9BQ	30617258	Green Accepted			2022-12-17	WOS:000456750100010
J	White, MA; Kim, E; Duffy, A; Adalbert, R; Phillips, BU; Peters, OM; Stephenson, J; Yang, S; Massenzio, F; Lin, ZQ; Andrews, S; Segonds-Pichon, A; Metterville, J; Saksida, LM; Mead, R; Ribchester, RR; Barhomi, Y; Serre, T; Coleman, MP; Fallon, J; Bussey, TJ; Brown, RH; Sreedharan, J				White, Matthew A.; Kim, Eosu; Duffy, Amanda; Adalbert, Robert; Phillips, Benjamin U.; Peters, Owen M.; Stephenson, Jodie; Yang, Sujeong; Massenzio, Francesca; Lin, Ziqiang; Andrews, Simon; Segonds-Pichon, Anne; Metterville, Jake; Saksida, Lisa M.; Mead, Richard; Ribchester, Richard R.; Barhomi, Youssef; Serre, Thomas; Coleman, Michael P.; Fallon, Justin; Bussey, Timothy J.; Brown, Robert H.; Sreedharan, Jemeen			TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; ALDEHYDE OXIDASE; MESSENGER-RNA; MUTATIONS; DEMENTIA; TAU; EXPRESSION; MICE	Amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) constitutes a devastating disease spectrum characterized by 43-kDa TAR DNA-binding protein (TDP-43) pathology. Understanding how TDP-43 contributes to neurodegeneration will help direct therapeutic efforts. Here we have created a TDP-43 knock-in mouse with a human-equivalent mutation in the endogenous mouse Tardbp gene. TDP-43(Q331K) mice demonstrate cognitive dysfunction and a paucity of parvalbumin interneurons. Critically, TDP-43 autoregulation is perturbed, leading to a gain of TDP-43 function and altered splicing of Mapt, another pivotal dementia-associated gene. Furthermore, a new approach to stratify transcriptomic data by phenotype in differentially affected mutant mice revealed 471 changes linked with improved behavior. These changes included downregulation of two known modifiers of neurodegeneration, Atxn2 and Arid4a, and upregulation of myelination and translation genes. With one base change in murine Tardbp, this study identifies TDP-43 misregulation as a pathogenic mechanism that may underpin ALS-FTD and exploits phenotypic heterogeneity to yield candidate suppressors of neurodegenerative disease.	[White, Matthew A.; Massenzio, Francesca; Lin, Ziqiang; Andrews, Simon; Segonds-Pichon, Anne; Coleman, Michael P.; Sreedharan, Jemeen] Babraham Inst, Cambridge, England; [White, Matthew A.; Massenzio, Francesca; Lin, Ziqiang; Sreedharan, Jemeen] Kings Coll London, Maurice Wohl Clin Neurosci Inst, Inst Psychiat Psychol & Neurosci, London, England; [Kim, Eosu; Phillips, Benjamin U.; Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, Dept Psychol, Cambridge, England; [Kim, Eosu; Phillips, Benjamin U.; Saksida, Lisa M.; Bussey, Timothy J.] Univ Cambridge, MRC Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England; [Kim, Eosu] Yonsei Univ, Coll Med, Dept Psychiat, Inst Behav Sci Med,Brain Korea Plus Project Med S, Seoul, South Korea; [Duffy, Amanda; Fallon, Justin] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Adalbert, Robert; Yang, Sujeong; Coleman, Michael P.] Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge, England; [Peters, Owen M.] Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA; [Stephenson, Jodie; Mead, Richard] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [Metterville, Jake; Brown, Robert H.] UMass Med Sch, Dept Neurol, Worcester, MA USA; [Saksida, Lisa M.; Bussey, Timothy J.] Western Univ, Mol Med Res Grp, Robarts Res Inst, London, ON, Canada; [Saksida, Lisa M.; Bussey, Timothy J.] Western Univ, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada; [Saksida, Lisa M.; Bussey, Timothy J.] Western Univ, Brain & Mind Inst, London, ON, Canada; [Ribchester, Richard R.] Univ Edinburgh, SBMS, Edinburgh, Midlothian, Scotland; [Barhomi, Youssef; Serre, Thomas] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Peters, Owen M.] Cardiff Univ, Dementia Res Inst, Sch Biosci, Cardiff, S Glam, Wales; [Stephenson, Jodie] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Neurosci & Trauma, Blizard Inst, London, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of London; King's College London; University of Cambridge; University of Cambridge; Yonsei University; Yonsei University Health System; Brown University; University of Cambridge; Oregon Health & Science University; University of Sheffield; University of Massachusetts System; University of Massachusetts Worcester; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Edinburgh; Brown University; Cardiff University; University of London; Queen Mary University London	Sreedharan, J (corresponding author), Babraham Inst, Cambridge, England.; Sreedharan, J (corresponding author), Kings Coll London, Maurice Wohl Clin Neurosci Inst, Inst Psychiat Psychol & Neurosci, London, England.	jemeen.sreedharan@kcl.ac.uk	Massenzio, Francesca/AAZ-6842-2020; Massenzio, Francesca/AEL-3075-2022; Bussey, Timothy J/M-2758-2016; Saksida, Lisa M/M-2753-2016; Mead, Richard/B-4779-2009; sreedharan, jemeen/E-7327-2016	Massenzio, Francesca/0000-0002-5189-7546; Bussey, Timothy J/0000-0001-7518-4041; Saksida, Lisa M/0000-0002-8416-8171; Mead, Richard/0000-0002-3207-0068; Peters, Owen/0000-0002-6824-0663; White, Matthew Anthony/0000-0002-4147-4267; sreedharan, jemeen/0000-0002-8682-6844; Adalbert, Robert/0000-0003-0782-1402; Ribchester, Richard/0000-0003-2670-6995; Kim, Eosu/0000-0001-9472-9465; Watkins, Jodie/0000-0002-0692-0938	Korean Health Technology RD Project; Korea-UK AD Collaborative Project [HI14C2173]; Ministry of Health and Welfare, Republic of Korea; MRC [MR/L003813/1]; ARUK [RF-2016A-1]; van Geest Foundation; ALS Association; Project ALS; Target ALS; ALS-One; ALS Finding A Cure; Max Rosenfeld fund for ALS Research; NIH [RO1NS088689, RO1FD004127, RO1NS065847, RO1 NS073873]; Motor Neuron Disease Association; Medical Research Council UK; Lady Edith Wolfson Fellowship Fund; FOOD AND DRUG ADMINISTRATION [R01FD004127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088689, R01NS073873, R01NS065847] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016366] Funding Source: NIH RePORTER; Alzheimers Research UK [ARUK-RF2016A-1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0433] Funding Source: researchfish; Medical Research Council [MR/L003813/1] Funding Source: researchfish; Motor Neurone Disease Association [SITraN/Apr13/983-797, SITraN/Jul16/987-797, Ribchester/Apr15/838-791] Funding Source: researchfish; National Centre for the Replacement [NC/N001451/1] Funding Source: researchfish; BBSRC [BBS/E/B/000C0433] Funding Source: UKRI; MRC [MR/K010611/1] Funding Source: UKRI	Korean Health Technology RD Project; Korea-UK AD Collaborative Project; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ARUK(Alzheimer's Research UK (ARUK)); van Geest Foundation; ALS Association; Project ALS; Target ALS; ALS-One; ALS Finding A Cure; Max Rosenfeld fund for ALS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Motor Neuron Disease Association; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lady Edith Wolfson Fellowship Fund; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Motor Neurone Disease Association; National Centre for the Replacement; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Babraham Institute Experimental Unit staff for technical assistance, A. Weiss for technical assistance at UMMS, M. Brodsky for assistance with CRISPR mutagenesis, the DERC morphology core at UMMS for assistance with histological preparations, and S. Hilton for assistance with OR testing. We thank members of M.P.C.s laboratory and J.-M. Gallo for discussions. E.K. is supported by a grant from the Korean Health Technology R&D Project, Korea-UK AD Collaborative Project (HI14C2173), Ministry of Health and Welfare, Republic of Korea. R.A is supported by MRC grant MR/L003813/1. S.Y. is supported by an ARUK grant (RF-2016A-1). M.P.C is supported by the van Geest Foundation. R.H.B. gratefully acknowledges support from the ALS Association, Project ALS, Target ALS, ALS-One, ALS Finding A Cure, the Max Rosenfeld fund for ALS Research, and NIH grants RO1NS088689, RO1FD004127, RO1NS065847 and RO1 NS073873. J. Sreedharan is funded by the Motor Neuron Disease Association, the Medical Research Council UK, the Lady Edith Wolfson Fellowship Fund, and the van Geest Foundation.	Ahmed RM, 2016, JAMA NEUROL, V73, P282, DOI 10.1001/jamaneurol.2015.4478; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Baghirova S, 2015, METHODSX, V2, P440, DOI 10.1016/j.mex.2015.11.001; Becker LA, 2017, NATURE, V544, P367, DOI 10.1038/nature22038; Behrouzi R, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0301-z; Benajiba L, 2009, ANN NEUROL, V65, P470, DOI 10.1002/ana.21612; BERGER R, 1995, SOMAT CELL MOLEC GEN, V21, P121, DOI 10.1007/BF02255787; Borghero G, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.07.012; Borroni B, 2005, ARCH NEUROL-CHICAGO, V62, P1419, DOI 10.1001/archneur.62.9.1419; Brenner D, 2016, BRAIN, V139, pCP14, DOI 10.1093/brain/aww033; Buratti E, 2015, ADV GENET, V91, P1, DOI 10.1016/bs.adgen.2015.07.001; Burden SJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009167; Burrell JR, 2016, LANCET, V388, P919, DOI 10.1016/S0140-6736(16)00737-6; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Garattini Enrico, 2009, Human Genomics, V4, P119; Harauz G, 2013, J NEUROCHEM, V125, P334, DOI 10.1111/jnc.12195; Heath CJ, 2015, PSYCHOPHARMACOLOGY, V232, P4043, DOI 10.1007/s00213-015-4009-8; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jhuang H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1064; Jiang YM, 2005, ANN NEUROL, V57, P236, DOI 10.1002/ana.20379; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Kalmar Bernadett, 2012, Curr Protoc Mouse Biol, V2, P231, DOI 10.1002/9780470942390.mo110229; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kenna KP, 2016, NAT GENET, V48, P1037, DOI 10.1038/ng.3626; Kim H, 2016, CELL, V164, P208, DOI 10.1016/j.cell.2015.11.038; Kolarcik Christi L, 2012, Am J Neurodegener Dis, V1, P130; Koyama A, 2016, NUCLEIC ACIDS RES, V44, P5820, DOI 10.1093/nar/gkw499; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; Liu C, 2016, J BIOL CHEM, V291, P8173, DOI 10.1074/jbc.M115.641902; Mar AC, 2013, NAT PROTOC, V8, P1985, DOI 10.1038/nprot.2013.123; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; NIHEI K, 1993, ACTA NEUROPATHOL, V86, P55, DOI 10.1007/BF00454899; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Philips Thomas, 2015, Curr Protoc Pharmacol, V69, DOI 10.1002/0471141755.ph0567s69; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Romberg C, 2013, J NEUROSCI, V33, P7057, DOI 10.1523/JNEUROSCI.6267-11.2013; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sreedharan J, 2015, CURR BIOL, V25, P2130, DOI 10.1016/j.cub.2015.06.045; Swanson E, 2017, J ALZHEIMERS DIS, V58, P803, DOI 10.3233/JAD-170168; Takahashi Y, 2013, AM J HUM GENET, V93, P900, DOI 10.1016/j.ajhg.2013.09.008; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Trabzuni D, 2012, HUM MOL GENET, V21, P4094, DOI 10.1093/hmg/dds238; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Wu LS, 2012, J BIOL CHEM, V287, P27335, DOI 10.1074/jbc.M112.359000; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424	56	118	118	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2018	21	4					552	+		10.1038/s41593-018-0113-5	http://dx.doi.org/10.1038/s41593-018-0113-5			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB1FG	29556029	Green Submitted, Green Accepted			2022-12-17	WOS:000428796000014
J	Palmigiano, A; Geisel, T; Wolf, F; Battaglia, D				Palmigiano, Agostina; Geisel, Theo; Wolf, Fred; Battaglia, Demian			Flexible information routing by transient synchrony	NATURE NEUROSCIENCE			English	Article							VISUAL WORKING-MEMORY; GAMMA-BAND ACTIVITY; CELL ASSEMBLIES; FUNCTIONAL CONNECTIVITY; CORTICAL NETWORKS; CEREBRAL-CORTEX; FIRING RATES; OSCILLATIONS; FREQUENCY; COHERENCE	Perception, cognition and behavior rely on flexible communication between microcircuits in distinct cortical regions. The mechanisms underlying rapid information rerouting between such microcircuits are still unknown. It has been proposed that changing patterns of coherence between local gamma rhythms support flexible information rerouting. The stochastic and transient nature of gamma oscillations in vivo, however, is hard to reconcile with such a function. Here we show that models of cortical circuits near the onset of oscillatory synchrony selectively route input signals despite the short duration of gamma bursts and the irregularity of neuronal firing. In canonical multiarea circuits, we find that gamma bursts spontaneously arise with matched timing and frequency and that they organize information flow by large-scale routing states. Specific self-organized routing states can be induced by minor modulations of background activity.	[Palmigiano, Agostina; Geisel, Theo; Wolf, Fred] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Palmigiano, Agostina; Geisel, Theo; Wolf, Fred; Battaglia, Demian] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Palmigiano, Agostina; Geisel, Theo; Wolf, Fred] Georg August Univ, Inst Nonlinear Dynam, Sch Sci, Gottingen, Germany; [Palmigiano, Agostina; Wolf, Fred] SFB 889 Cellular Mech Sensory Proc, Gottingen, Germany; [Battaglia, Demian] Aix Marseille Univ, INSERM, Inst Neurosci & Syst, Marseille, France	Max Planck Society; University of Gottingen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Palmigiano, A (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.; Palmigiano, A; Battaglia, D (corresponding author), Bernstein Ctr Computat Neurosci, Gottingen, Germany.; Palmigiano, A (corresponding author), Georg August Univ, Inst Nonlinear Dynam, Sch Sci, Gottingen, Germany.; Palmigiano, A (corresponding author), SFB 889 Cellular Mech Sensory Proc, Gottingen, Germany.; Battaglia, D (corresponding author), Aix Marseille Univ, INSERM, Inst Neurosci & Syst, Marseille, France.	agos@nld.ds.mpg.de; demian.battaglia@univ-amu.fr	Battaglia, Demian/C-1281-2017	Battaglia, Demian/0000-0003-2021-7920; Wolf, Fred/0000-0002-7068-3762	Federal Ministry for Education and Research (BMBF) [01GQ1005B]; GGNB Excellence Stipend of the University of Gottingen; Deutsche Forschungsgemeinschaft [CRC 889]; VolkswagenStiftung [ZN2632]; FP7 Marie Curie career development fellowship [IEF 330792]	Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); GGNB Excellence Stipend of the University of Gottingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); VolkswagenStiftung(Volkswagen); FP7 Marie Curie career development fellowship	We thank U. Ernst, C.M. Gray, A. Kreiter, K. Pawelzik and R. Shapley for discussions. This work was partially supported by the Federal Ministry for Education and Research (BMBF) under grant no. 01GQ1005B (to A.P., T.G., F.W. and D.B.), by a GGNB Excellence Stipend of the University of Gottingen (to A.P.), through CRC 889 by the Deutsche Forschungsgemeinschaft and by the VolkswagenStiftung under grant no. ZN2632 (to F.W.), and by the FP7 Marie Curie career development fellowship IEF 330792 (DynViB) (to D.B.).	Abeles M, 2004, J COMPUT NEUROSCI, V17, P179, DOI 10.1023/B:JCNS.0000037682.18051.5f; Akam T, 2010, NEURON, V67, P308, DOI 10.1016/j.neuron.2010.06.019; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bastos AM, 2015, CURR OPIN NEUROBIOL, V31, P173, DOI 10.1016/j.conb.2014.11.001; Bastos AM, 2015, NEURON, V85, P390, DOI 10.1016/j.neuron.2014.12.018; Battaglia D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002438; Battaglia D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.238106; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Burkhalter A, 2008, FRONT NEUROSCI-SWITZ, V2, P155, DOI 10.3389/neuro.01.026.2008; Burns SP, 2011, J NEUROSCI, V31, P9658, DOI 10.1523/JNEUROSCI.0660-11.2011; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cannon J, 2014, EUR J NEUROSCI, V39, P705, DOI 10.1111/ejn.12453; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Chakrabarti S, 2014, J NEUROPHYSIOL, V112, P3138, DOI 10.1152/jn.00621.2013; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Cover T.M., 2005, ELEMENTS INFORM THEO, P13; Dotson NM, 2014, J NEUROSCI, V34, P13600, DOI 10.1523/JNEUROSCI.1961-14.2014; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Frenzel S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.204101; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Golomb D, 2000, NEURAL COMPUT, V12, P1095, DOI 10.1162/089976600300015529; GOLOMB D, 1994, PHYSICA D, V72, P259, DOI 10.1016/0167-2789(94)90214-3; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Grothe I., 2015, ATTENTION SELECTIVEL; Grothe I, 2012, J NEUROSCI, V32, P16172, DOI 10.1523/JNEUROSCI.0890-12.2012; Hahn G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003811; Harnack D, 2015, J NEUROPHYSIOL, V114, P1593, DOI 10.1152/jn.01038.2014; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Jia XX, 2013, NEURON, V77, P762, DOI 10.1016/j.neuron.2012.12.036; Jia XX, 2013, J NEUROSCI, V33, P17, DOI 10.1523/JNEUROSCI.1687-12.2013; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Kumar A, 2008, J NEUROSCI, V28, P5268, DOI 10.1523/JNEUROSCI.2542-07.2008; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; Lungarella M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056117; Mazzoni A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000239; Okun M, 2015, NATURE, V521, P511, DOI 10.1038/nature14273; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Orlandi JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098842; Osborne LC, 2008, J NEUROSCI, V28, P13522, DOI 10.1523/JNEUROSCI.4390-08.2008; Ray S, 2015, TRENDS COGN SCI, V19, P78, DOI 10.1016/j.tics.2014.12.002; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Roberts MJ, 2013, NEURON, V78, P523, DOI 10.1016/j.neuron.2013.03.003; Salazar RF, 2012, SCIENCE, V338, P1097, DOI 10.1126/science.1224000; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; SOMERS D, 1993, BIOL CYBERN, V68, P393, DOI 10.1007/BF00198772; Stetter O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002653; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Tiesinga PH, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00196; Vakorin VA, 2009, J NEUROSCI METH, V184, P152, DOI 10.1016/j.jneumeth.2009.07.014; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Wang XJ, 1996, J NEUROSCI, V16, P6402; Wibral M, 2014, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-3-642-54474-3; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Witt A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00049; Xing DJ, 2012, J NEUROSCI, V32, P13873, DOI 10.1523/JNEUROSCI.5644-11.2012; Zylberberg A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000765	66	118	119	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2017	20	7					1014	+		10.1038/nn.4569	http://dx.doi.org/10.1038/nn.4569			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY6TB	28530664				2022-12-17	WOS:000404115100019
J	Traka, M; Podojil, JR; McCarthy, DP; Miller, SD; Popko, B				Traka, Maria; Podojil, Joseph R.; McCarthy, Derrick P.; Miller, Stephen D.; Popko, Brian			Oligodendrocyte death results in immune-mediated CNS demyelination	NATURE NEUROSCIENCE			English	Article							SITE-SPECIFIC RECOMBINATION; T-CELL FUNCTION; MULTIPLE-SCLEROSIS; AXONAL LOSS; MOUSE; MICE; REMYELINATION; ABLATION; DISEASE; PATHOLOGY	Although multiple sclerosis is a common neurological disorder, the origin of the autoimmune response against myelin, which is the characteristic feature of the disease, remains unclear. To investigate whether oligodendrocyte death could cause this autoimmune response, we examined the oligodendrocyte ablation Plp1-CreER(T); ROSA26-eGFP-DTA (DTA) mouse model. Approximately 30 weeks after recovering from oligodendrocyte loss and demyelination, DTA mice develop a fatal secondary disease characterized by extensive myelin and axonal loss. Strikingly, late-onset disease was associated with increased numbers of T lymphocytes in the CNS and myelin oligodendrocyte glycoprotein (MOG)-specific T cells in lymphoid organs. Transfer of T cells derived from DTA mice to naive recipients resulted in neurological defects that correlated with CNS white matter inflammation. Furthermore, immune tolerization against MOG ameliorated symptoms. Overall, these data indicate that oligodendrocyte death is sufficient to trigger an adaptive autoimmune response against myelin, suggesting that a similar process can occur in the pathogenesis of multiple sclerosis.	[Traka, Maria; Popko, Brian] Univ Chicago, Dept Neurol, Ctr Peripheral Neuropathy, Chicago, IL 60637 USA; [Podojil, Joseph R.; McCarthy, Derrick P.; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Dept Immunol Microbiol, Chicago, IL 60611 USA; [Podojil, Joseph R.; McCarthy, Derrick P.; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Interdept Immunobiol Ctr, Chicago, IL 60611 USA	University of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Miller, SD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Immunol Microbiol, Chicago, IL 60611 USA.	s-d-miller@northwestern.edu; bpopko@uchicago.edu	Traka, Maria/U-2176-2019	Popko, Brian/0000-0001-9948-2553	Myelin Repair Foundation; National Multiple Sclerosis Society [RG 4952-A-5]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026543] Funding Source: NIH RePORTER	Myelin Repair Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Liu, A. Solanki, A.X. Tang and S. Labak for technical assistance, G. Wright for assistance with the morphometric analysis of the EM images using the ImageJ software and V. Bindokas from the University of Chicago Integrated Light Microscopy Core Facility for help with image acquisition and image processing. The work was supported by awards from the Myelin Repair Foundation and the National Multiple Sclerosis Society (RG 4952-A-5) to B.P. and S.D.M.	Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; BLAKEMORE WF, 1973, J NEUROL SCI, V20, P63, DOI 10.1016/0022-510X(73)90118-4; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Caprariello AV, 2012, ANN NEUROL, V72, P395, DOI 10.1002/ana.23606; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Emerson MR, 2001, J NEUROIMMUNOL, V119, P205, DOI 10.1016/S0165-5728(01)00394-0; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Ghosh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022735; Gritsch S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6472; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Henderson APD, 2009, ANN NEUROL, V66, P739, DOI 10.1002/ana.21800; Hunter Z, 2014, ACS NANO, V8, P2148, DOI 10.1021/nn405033r; Ip CW, 2006, J NEUROSCI, V26, P8206, DOI 10.1523/JNEUROSCI.1921-06.2006; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Linden JR, 2015, MBIO, V6, DOI 10.1128/mBio.02513-14; Locatelli G, 2012, NAT NEUROSCI, V15, P543, DOI 10.1038/nn.3062; Mana P, 2009, J NEUROIMMUNOL, V210, P13, DOI 10.1016/j.jneuroim.2009.02.013; Manrique-Hoyos N, 2012, ANN NEUROL, V71, P227, DOI 10.1002/ana.22681; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nakahara J, 2010, ARCH IMMUNOL THER EX, V58, P325, DOI 10.1007/s00005-010-0094-x; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; OHNO M, 1993, BRAIN RES, V625, P186, DOI 10.1016/0006-8993(93)91058-Z; Oluich LJ, 2012, J NEUROSCI, V32, P8317, DOI 10.1523/JNEUROSCI.1053-12.2012; Podojil JR, 2013, J AUTOIMMUN, V44, P71, DOI 10.1016/j.jaut.2013.04.001; Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Pusic AD, 2014, J NEUROIMMUNOL, V266, P12, DOI 10.1016/j.jneuroim.2013.10.014; RODRIGUEZ M, 1994, ULTRASTRUCT PATHOL, V18, P3, DOI 10.3109/01913129409016267; Rumah KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076359; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schwartz M, 2014, NEUROSCIENTIST, V20, P343, DOI 10.1177/1073858413516799; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stys PK, 2012, NAT REV NEUROSCI, V13, P507, DOI 10.1038/nrn3275; Suzuki K, 2003, J CHILD NEUROL, V18, P595, DOI 10.1177/08830738030180090201; Suzuki K, 1998, NEUROCHEM RES, V23, P251, DOI 10.1023/A:1022436928925; Traka M, 2008, J NEUROSCI, V28, P11537, DOI 10.1523/JNEUROSCI.1490-08.2008; Traka M, 2010, BRAIN, V133, P3017, DOI 10.1093/brain/awq247; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	46	118	120	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2016	19	1					65	+		10.1038/nn.4193	http://dx.doi.org/10.1038/nn.4193			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ7BH	26656646	Green Accepted			2022-12-17	WOS:000367254400014
J	Hoischen, A; Krumm, N; Eichler, EE				Hoischen, Alexander; Krumm, Niklas; Eichler, Evan E.			Prioritization of neurodevelopmental disease genes by discovery of new mutations	NATURE NEUROSCIENCE			English	Review							DE-NOVO MUTATIONS; COPY-NUMBER VARIATION; CHROMATIN-REMODELING COMPLEX; INTELLECTUAL-DISABILITY; CLINICAL-SIGNIFICANCE; MENTAL-RETARDATION; NOTCH2 CAUSE; VARIANTS; HAPLOINSUFFICIENCY; MICRODELETION	Advances in genome sequencing technologies have begun to revolutionize neurogenetics, allowing the full spectrum of genetic variation to be better understood in relation to disease. Exome sequencing of hundreds to thousands of samples from patients with autism spectrum disorder, intellectual disability, epilepsy and schizophrenia provides strong evidence of the importance of de novo and gene-disruptive events. There are now several hundred new candidate genes and targeted resequencing technologies that allow screening of dozens of genes in tens of thousands of individuals with high specificity and sensitivity. The decision of which genes to pursue depends on many factors, including recurrence, previous evidence of overlap with pathogenic copy number variants, the position of the mutation in the protein, the mutational burden among healthy individuals and membership of the candidate gene in disease-implicated protein networks. We discuss these emerging criteria for gene prioritization and the potential impact on the field of neuroscience.	[Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Med Life Sci, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Krumm, Niklas; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Radboud University Nijmegen; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	alexanderhoischen@radboudumc.nl; eee@gs.washington.edu	Hoischen, Alexander/D-1282-2013; Hoischen, Alexander/AGF-7293-2022	Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476	ZonMW grant [916-12-095]; US National Institute of Mental Health grant [1R01MH101221-01]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221] Funding Source: NIH RePORTER	ZonMW grant; US National Institute of Mental Health grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to T. Brown and C. Gilissen for assistance during manuscript preparation, F. Kooy for early preprint access and H.G. Brunner for sharing patient photographs used in Figure 3. A.H. is supported by a ZonMW grant (916-12-095); E.E.E. is supported by a US National Institute of Mental Health grant (1R01MH101221-01) and is an investigator of the Howard Hughes Medical Institute.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Banka S, 2013, CLIN GENET, V83, P467, DOI 10.1111/j.1399-0004.2012.01955.x; Beyer K, 2012, NEUROGENETICS, V13, P61, DOI 10.1007/s10048-011-0311-8; Bowen ME, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002050; Carter H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S3; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Classen CF, 2013, HUM GENET, V132, P825, DOI 10.1007/s00439-013-1296-1; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Filges I, 2011, J MED GENET, V48, P117, DOI 10.1136/jmg.2010.084582; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Genovese G, 2013, NAT GENET, V45, P406, DOI 10.1038/ng.2565; Gibson WT, 2012, AM J HUM GENET, V90, P110, DOI 10.1016/j.ajhg.2011.11.018; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; Helsmoortel C, 2014, NAT GENET, V46, P380, DOI 10.1038/ng.2899; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Hoischen A, 2011, NAT GENET, V43, P729, DOI 10.1038/ng.868; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Huisman SA, 2013, J MED GENET, V50, P339, DOI 10.1136/jmedgenet-2012-101477; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kamath BM, 2012, J MED GENET, V49, P138, DOI 10.1136/jmedgenet-2011-100544; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Karakoc E, 2012, NAT METHODS, V9, P176, DOI [10.1038/NMETH.1810, 10.1038/nmeth.1810]; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Krumm N, 2013, AM J HUM GENET, V93, P595, DOI 10.1016/j.ajhg.2013.07.024; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; Makishima H, 2013, NAT GENET, V45, P942, DOI 10.1038/ng.2696; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Marseglia G, 2012, EUR J MED GENET, V55, P216, DOI 10.1016/j.ejmg.2012.01.005; McGrath JJ, 2014, JAMA PSYCHIAT, V71, P301, DOI 10.1001/jamapsychiatry.2013.4081; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Parikshak N.N., CELL IN PRESS; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Santen GWE, 2013, HUM MUTAT, V34, P1519, DOI 10.1002/humu.22394; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1122, DOI 10.1016/j.ajhg.2012.10.013; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; van Bokhoven H, 2002, AM J HUM GENET, V71, P1, DOI 10.1086/341450; van Bon BWM, 2011, CLIN GENET, V79, P296, DOI 10.1111/j.1399-0004.2010.01544.x; van Bon BWM, 2010, EUR J HUM GENET, V18, P163, DOI 10.1038/ejhg.2009.152; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Vulih-Shultzman I, 2007, J PHARMACOL EXP THER, V323, P438, DOI 10.1124/jpet.107.129551; Vulto-van Silfhout AT, 2013, HUM MUTAT, V34, P1679, DOI 10.1002/humu.22442; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	93	118	120	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2014	17	6					764	772		10.1038/nn.3703	http://dx.doi.org/10.1038/nn.3703			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI1TO	24866042	Green Accepted			2022-12-17	WOS:000336638000009
J	Wang, CR; Liang, CC; Bian, ZC; Zhu, Y; Guan, JL				Wang, Chenran; Liang, Chun-Chi; Bian, Z. Christine; Zhu, Yuan; Guan, Jun-Lin			FIP200 is required for maintenance and differentiation of postnatal neural stem cells	NATURE NEUROSCIENCE			English	Article							SELF-RENEWAL; P53; AUTOPHAGY; NEUROGENESIS; SUPPRESSION; MECHANISMS; DELETION; NEURONS; ASTROCYTES; INDUCTION	Despite recent studies showing that inhibition of autophagy depletes the hematopoietic stem cell pool and increases intracellular reactive oxygen species (ROS), it remains unknown whether autophagy is essential in the maintenance of other stem cells. Moreover, it is unclear whether and how the aberrant ROS increase causes depletion of stem cells. Here we report that ablation of FIP200 (also known as Rb1cc1), a gene essential for autophagy induction in mammalian cells, results in a progressive loss of neural stem cells (NSCs) and impairment in neuronal differentiation specifically in the postnatal brain, but not the embryonic brain, in mice. The defect in maintaining the postnatal NSC pool was caused by p53-dependent apoptotic responses and cell cycle arrest. However, the impaired neuronal differentiation was rescued by treatment with the antioxidant N-acetylcysteine but not by p53 inactivation. These data reveal that FIP200-mediated autophagy contributes to the maintenance and functions of NSCs through regulation of oxidative state.	[Wang, Chenran; Liang, Chun-Chi; Bian, Z. Christine; Zhu, Yuan; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Zhu, Yuan; Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	Zhu, Yuan/ABF-8405-2020; wang, chenran/N-6629-2013; Liang, Chun-Chi/D-7986-2016	Liang, Chun-Chi/0000-0002-8345-8564	US National Institutes of Health [GM052890]; NATIONAL CANCER INSTITUTE [R01CA150926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052890] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Yuan of Harvard Medical School for Spautin-1. We thank our laboratory colleagues for their discussions, help throughout the project and comments of the manuscript. This research was supported by US National Institutes of Health grant GM052890 to J.-L.G.	Assaily W, 2011, MOL CELL, V44, P491, DOI 10.1016/j.molcel.2011.08.038; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Liang CC, 2010, J BIOL CHEM, V285, P3499, DOI 10.1074/jbc.M109.072389; Liu DP, 2010, NAT CELL BIOL, V12, P993, DOI 10.1038/ncb2100; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Madhavan L, 2006, STEM CELLS, V24, P2110, DOI 10.1634/stemcells.2006-0018; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Noble M, 2005, ANTIOXID REDOX SIGN, V7, P1456, DOI 10.1089/ars.2005.7.1456; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Quick KL, 2001, ANN NEUROL, V49, P627, DOI 10.1002/ana.1005; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Wei HJ, 2009, J BIOL CHEM, V284, P6004, DOI 10.1074/jbc.M806375200; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	52	118	121	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					532	+		10.1038/nn.3365	http://dx.doi.org/10.1038/nn.3365			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23542691	Green Accepted			2022-12-17	WOS:000318029300009
